Citrus Sinensis ID: 002857
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 873 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGP4 | 1010 | Probable LRR receptor-lik | yes | no | 0.504 | 0.435 | 0.472 | 1e-114 | |
| C0LGT6 | 1031 | LRR receptor-like serine/ | no | no | 0.538 | 0.455 | 0.440 | 1e-110 | |
| Q9SD62 | 1025 | Putative receptor-like pr | no | no | 0.500 | 0.426 | 0.463 | 1e-99 | |
| Q9ZUI0 | 980 | Putative leucine-rich rep | no | no | 0.513 | 0.457 | 0.341 | 2e-61 | |
| O22476 | 1196 | Protein BRASSINOSTEROID I | no | no | 0.446 | 0.326 | 0.329 | 7e-52 | |
| Q9FL28 | 1173 | LRR receptor-like serine/ | no | no | 0.504 | 0.375 | 0.314 | 7e-52 | |
| C0LGF4 | 591 | LRR receptor-like serine/ | no | no | 0.439 | 0.649 | 0.345 | 7e-50 | |
| C0LGD9 | 871 | Probable LRR receptor-lik | no | no | 0.406 | 0.407 | 0.356 | 2e-49 | |
| Q9FIZ3 | 1252 | LRR receptor-like serine/ | no | no | 0.478 | 0.333 | 0.315 | 6e-49 | |
| O64556 | 877 | Putative leucine-rich rep | no | no | 0.379 | 0.377 | 0.347 | 3e-48 |
| >sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 412 bits (1058), Expect = e-114, Method: Compositional matrix adjust.
Identities = 225/476 (47%), Positives = 311/476 (65%), Gaps = 36/476 (7%)
Query: 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPT 60
+ GNLF G I L L G+K +DLS N+LSG IPE+ A F L+ LNLS NN E +P
Sbjct: 536 LEGNLFYGDIP-DLKGLVGVKEVDLSNNDLSGSIPEYFASFSKLEYLNLSFNNLEGKVPV 594
Query: 61 EGIFKNASATSVFGNNKLCGGIPEFQLPTCVSKK---TKQNRSTLPLKLVIAIDCGL-LV 116
+GIF+NA+ S+ GNN LCGGI FQL C+S+ K++ S L K+VI + G+ L+
Sbjct: 595 KGIFENATTVSIVGNNDLCGGIMGFQLKPCLSQAPSVVKKHSSRLK-KVVIGVSVGITLL 653
Query: 117 LTLALSSLFCRLMCMKKR------GNPTPSISIDLDFPYVSYEALYSATKGFSSENLIGA 170
L L ++S L+ ++KR NPTPS ++++ +SY L +AT GFSS N++G+
Sbjct: 654 LLLFMAS--VTLIWLRKRKKNKETNNPTPS-TLEVLHEKISYGDLRNATNGFSSSNMVGS 710
Query: 171 GNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVD 230
G+F +VYK +L VA+KV N A KSF ECE +++I HR ++K++TACS +D
Sbjct: 711 GSFGTVYKALLLTEKKVVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACSSID 770
Query: 231 YQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHL 290
+QGN+F+AL+YEFMPNGSL+ W+HP E ++ H+ L LERLNIAIDVAS L+YLH+
Sbjct: 771 FQGNEFRALIYEFMPNGSLDMWLHP-EEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHV 829
Query: 291 GCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNE-----QTSSIGVKGTTGYIA 345
C PIAHCD+KPSN+LL+D++TA V+DFG+AR L +E Q SS GV+GT GY A
Sbjct: 830 HCHEPIAHCDLKPSNVLLDDDLTAHVSDFGLARLLLKFDEESFFNQLSSAGVRGTIGYAA 889
Query: 346 PEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPERVEEIVDT 405
PEYG+G + S GDVYSFGILLLEMFTG RP++++F N L ++ +SALPER+ +IVD
Sbjct: 890 PEYGVGGQPSINGDVYSFGILLLEMFTGKRPTNELFGGNFTLNSYTKSALPERILDIVD- 948
Query: 406 LFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDV 461
E ++ + ++ECL + E+G+ C E P R+ + V
Sbjct: 949 --------ESILHIGLRVGFP------VVECLTMVFEVGLRCCEESPMNRLATSIV 990
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1 | Back alignment and function description |
|---|
Score = 399 bits (1025), Expect = e-110, Method: Compositional matrix adjust.
Identities = 226/513 (44%), Positives = 312/513 (60%), Gaps = 43/513 (8%)
Query: 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPT 60
M GN F+G I +S L LK +D S NNLSG IP +LA L+NLNLS N FE +PT
Sbjct: 544 MQGNSFDGAIP-DISRLVSLKNVDFSNNNLSGRIPRYLASLPSLRNLNLSMNKFEGRVPT 602
Query: 61 EGIFKNASATSVFGNNKLCGGIPEFQLPTCVSKKTKQNRSTLPL--KLVIAIDCGL--LV 116
G+F+NA+A SVFGN +CGG+ E QL C+ + + + R L + K+V I G+ L+
Sbjct: 603 TGVFRNATAVSVFGNTNICGGVREMQLKPCIVQASPRKRKPLSVRKKVVSGICIGIASLL 662
Query: 117 LTLALSSLFCRLMCMKKR-----GNPTPSISIDLDFPYVSYEALYSATKGFSSENLIGAG 171
L + ++SL C M KK+ GNP+ S ++ + VSYE L+SAT FSS NLIG+G
Sbjct: 663 LIIIVASL-CWFMKRKKKNNASDGNPSDSTTLGMFHEKVSYEELHSATSRFSSTNLIGSG 721
Query: 172 NFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDY 231
NF +V+KG+L VA+KV N L H A+KSF ECE + I HR ++K++T CS +D
Sbjct: 722 NFGNVFKGLLGPENKLVAVKVLNLLKHGATKSFMAECETFKGIRHRNLVKLITVCSSLDS 781
Query: 232 QGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLG 291
+GNDF+ALVYEFMP GSL+ W+ + + ++ + +L E+LNIAIDVASALEYLH+
Sbjct: 782 EGNDFRALVYEFMPKGSLDMWLQ-LEDLERVNDHSRSLTPAEKLNIAIDVASALEYLHVH 840
Query: 292 CKPPIAHCDIKPSNILLNDEMTACVADFGIARFL-----EATNEQTSSIGVKGTTGYIAP 346
C P+AHCDIKPSNILL+D++TA V+DFG+A+ L E+ Q SS GV+GT GY AP
Sbjct: 841 CHDPVAHCDIKPSNILLDDDLTAHVSDFGLAQLLYKYDRESFLNQFSSAGVRGTIGYAAP 900
Query: 347 EYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPERVEEIVDTL 406
EYGMG + S GDVYSFGILLLEMF+G +P+D+ F + NL ++ +S L
Sbjct: 901 EYGMGGQPSIQGDVYSFGILLLEMFSGKKPTDESFAGDYNLHSYTKSIL----------- 949
Query: 407 FFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLR 466
+SS + I E L + ++G+ CS E P +RM+ ++ L
Sbjct: 950 ---------------SGCTSSGGSNAIDEGLRLVLQVGIKCSEEYPRDRMRTDEAVRELI 994
Query: 467 LIKKKLLETPVYEEKQTINMPLSRGKEGYCNDE 499
I+ K + + + P S +E N +
Sbjct: 995 SIRSKFFSSKTTITESPRDAPQSSPQEWMLNTD 1027
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 364 bits (935), Expect = 1e-99, Method: Compositional matrix adjust.
Identities = 220/475 (46%), Positives = 290/475 (61%), Gaps = 38/475 (8%)
Query: 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPT 60
+ GN F GPI + L GL+ LDLS+NNLSG IPE++A F LQNLNLS NNF+ +PT
Sbjct: 552 LQGNSFVGPIP-DIRGLTGLRFLDLSKNNLSGTIPEYMANFSKLQNLNLSLNNFDGAVPT 610
Query: 61 EGIFKNASATSVFGNNKLCGGIPEFQLPTC---VSKKTKQNRSTLPLKLVIAIDCGLLVL 117
EG+F+N SA SVFGN LCGGIP QL C + ++ R + + + + LL+
Sbjct: 611 EGVFRNTSAMSVFGNINLCGGIPSLQLQPCSVELPRRHSSVRKIITICVSAVMAALLLLC 670
Query: 118 TLALSSLFCRLMCMKKRGN---------PTPSISIDLDFPYVSYEALYSATKGFSSENLI 168
+ + +L R N P S + +SY+ LY T GFSS NLI
Sbjct: 671 LCVVYLCWYKLRVKSVRANNNENDRSFSPVKSF-----YEKISYDELYKTTGGFSSSNLI 725
Query: 169 GAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSR 228
G+GNF +V+KG L AVAIKV N A+KSF ECE + I HR ++K+VT CS
Sbjct: 726 GSGNFGAVFKGFLGSKNKAVAIKVLNLCKRGAAKSFIAECEALGGIRHRNLVKLVTICSS 785
Query: 229 VDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYL 288
D++GNDF+ALVYEFMPNG+L+ W+HP E ++ L RLNIAIDVASAL YL
Sbjct: 786 SDFEGNDFRALVYEFMPNGNLDMWLHP-DEIEETGNPSRTLGLFARLNIAIDVASALVYL 844
Query: 289 HLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFL-----EATNEQTSSIGVKGTTGY 343
H C PIAHCDIKPSNILL+ ++TA V+DFG+A+ L + + Q SS GV+GT GY
Sbjct: 845 HTYCHNPIAHCDIKPSNILLDKDLTAHVSDFGLAQLLLKFDRDTFHIQFSSAGVRGTIGY 904
Query: 344 IAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPERVEEIV 403
APEYGMG S GDVYSFGI+LLE+FTG RP++ +F D L L ++ +SAL +R + +
Sbjct: 905 AAPEYGMGGHPSIMGDVYSFGIVLLEIFTGKRPTNKLFVDGLTLHSFTKSALQKR--QAL 962
Query: 404 DTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKI 458
D +ET+ + A Q ++ECL + +GV+CS E P R+ +
Sbjct: 963 DI-------TDETILRGAYA-----QHFNMVECLTLVFRVGVSCSEESPVNRISM 1005
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZUI0|Y2241_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130 OS=Arabidopsis thaliana GN=At2g24130 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 238 bits (607), Expect = 2e-61, Method: Compositional matrix adjust.
Identities = 167/489 (34%), Positives = 248/489 (50%), Gaps = 41/489 (8%)
Query: 4 NLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGI 63
N F + SL L LK LD+S N L+G IP L++LN S N + +G
Sbjct: 501 NGFSSTLPSSLGQLPYLKELDVSFNRLTGAIPPSFQQSSTLKHLNFSFNLLSGNVSDKGS 560
Query: 64 FKNASATSVFGNNKLCGGIPEFQLPTCVSKKTKQNRSTLPLKLVIAIDCGLLVLTLALSS 123
F + S G++ LCG I Q K L + + C + L S
Sbjct: 561 FSKLTIESFLGDSLLCGSIKGMQACKKKHKYPSVLLPVLLSLIATPVLC-VFGYPLVQRS 619
Query: 124 LFCRLMCMKKRG---NPTPSISIDLDFPYVSYEALYSATKGFSSENLIGAGNFASVYKGI 180
F + + + + + D +P +SY+ L +AT GF++ +LIG+G F VYKG+
Sbjct: 620 RFGKNLTVYAKEEVEDEEKQNQNDPKYPRISYQQLIAATGGFNASSLIGSGRFGHVYKGV 679
Query: 181 LFEGAPAVAIKVFN-FLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKAL 239
L VA+KV + + S SF EC++++ HR +I+++T CS+ F AL
Sbjct: 680 LRNNT-KVAVKVLDPKTALEFSGSFKRECQILKRTRHRNLIRIITTCSK-----PGFNAL 733
Query: 240 VYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHC 299
V MPNGSLE ++P K NL+ ++ +NI DVA + YLH + HC
Sbjct: 734 VLPLMPNGSLERHLYPGEYSSK------NLDLIQLVNICSDVAEGIAYLHHYSPVKVVHC 787
Query: 300 DIKPSNILLNDEMTACVADFGIARFLEATNEQTS-----SIGVK-----GTTGYIAPEYG 349
D+KPSNILL+DEMTA V DFGI+R ++ E S S G G+ GYIAPEYG
Sbjct: 788 DLKPSNILLDDEMTALVTDFGISRLVQGVEETVSTDDSVSFGSTDGLLCGSVGYIAPEYG 847
Query: 350 MGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPERVEEIVDTLFFK 409
MG S++GDVYSFG+LLLE+ +G RP+D + + +L +++S P+ +E I
Sbjct: 848 MGKRASTHGDVYSFGVLLLEIVSGRRPTDVLVNEGSSLHEFMKSHYPDSLEGI------- 900
Query: 410 EIEEEETVYKYKKAPSSSTQ--RSIILECLNSICEIGVACSAELPGERMKINDVELGLRL 467
IE+ + +K + P + R +ILE + E+G+ C+ P R + DV +
Sbjct: 901 -IEQALSRWKPQGKPEKCEKLWREVILE----MIELGLVCTQYNPSTRPDMLDVAHEMGR 955
Query: 468 IKKKLLETP 476
+K+ L P
Sbjct: 956 LKEYLFACP 964
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O22476|BRI1_ARATH Protein BRASSINOSTEROID INSENSITIVE 1 OS=Arabidopsis thaliana GN=BRI1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 206 bits (524), Expect = 7e-52, Method: Compositional matrix adjust.
Identities = 148/449 (32%), Positives = 211/449 (46%), Gaps = 59/449 (13%)
Query: 4 NLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGI 63
N G I + LRGL +LDLS N L G IP+ ++ L ++LS+NN IP G
Sbjct: 688 NDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQ 747
Query: 64 FKNASATSVFGNNKLCGGIPEFQLPTCVSKKT------KQNRSTLPLKLVIAIDCGLLVL 117
F+ N LCG + LP C +++ P L ++ GLL
Sbjct: 748 FETFPPAKFLNNPGLCG----YPLPRCDPSNADGYAHHQRSHGRRPASLAGSVAMGLLFS 803
Query: 118 TLALSSLFC---------------RLMCMKKRGNP---------------TPSISIDLD- 146
+ + L M + GN ++SI+L
Sbjct: 804 FVCIFGLILVGREMRKRRRKKEAELEMYAEGHGNSGDRTANNTNWKLTGVKEALSINLAA 863
Query: 147 ----FPYVSYEALYSATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASK 202
+++ L AT GF +++LIG+G F VYK IL +G+ AVAIK + +
Sbjct: 864 FEKPLRKLTFADLLQATNGFHNDSLIGSGGFGDVYKAILKDGS-AVAIKKLIHVSGQGDR 922
Query: 203 SFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKR 262
F E E + I HR ++ ++ C + D + LVYEFM GSLE+ +H
Sbjct: 923 EFMAEMETIGKIKHRNLVPLLGYC-----KVGDERLLVYEFMKYGSLEDVLH------DP 971
Query: 263 HKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIA 322
KA LN R IAI A L +LH C P I H D+K SN+LL++ + A V+DFG+A
Sbjct: 972 KKAGVKLNWSTRRKIAIGSARGLAFLHHNCSPHIIHRDMKSSNVLLDENLEARVSDFGMA 1031
Query: 323 RFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDM-F 381
R + A + S + GT GY+ PEY S+ GDVYS+G++LLE+ TG RP+D F
Sbjct: 1032 RLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSPDF 1091
Query: 382 KDNLNLQNWVQSALPERVEEIVDTLFFKE 410
DN NL WV+ R+ ++ D KE
Sbjct: 1092 GDN-NLVGWVKQHAKLRISDVFDPELMKE 1119
|
Receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development, including expression of light- and stress-regulated genes, promotion of cell elongation, normal leaf and chloroplast senescence, and flowering. Binds brassinolide, and less effectively castasterone, but not 2,3,22,23-O-tetramethylbrassinolide or ecdysone. May be involved in a feedback regulation of brassinosteroid biosynthesis. Phosphorylates BRI1-associated receptor kinase 1 (BAK1), Transthyretin-Like protein (TTL) and SERK1 on 'Ser-299' and 'Thr-462' in vitro. May have a guanylyl cyclase activity. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FL28|FLS2_ARATH LRR receptor-like serine/threonine-protein kinase FLS2 OS=Arabidopsis thaliana GN=FLS2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 206 bits (524), Expect = 7e-52, Method: Compositional matrix adjust.
Identities = 151/480 (31%), Positives = 252/480 (52%), Gaps = 40/480 (8%)
Query: 4 NLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGI 63
N F G I S + L LDLS NNL+GEIPE LA L++L L+ NN + +P G+
Sbjct: 708 NSFSGEIPQSFGNMTHLVSLDLSSNNLTGEIPESLANLSTLKHLKLASNNLKGHVPESGV 767
Query: 64 FKNASATSVFGNNKLCGGIPEFQLPTCVSKKTKQNRSTLPLKLVIAIDCGLLVLTLALSS 123
FKN +A+ + GN LCG + T K + ++ T + +++ LL++ L +
Sbjct: 768 FKNINASDLMGNTDLCGSKKPLKPCTIKQKSSHFSKRTRVILIILGSAAALLLVLLLVLI 827
Query: 124 LFCRLMCMKKRGNPTPSISIDLD----FPYVSYEALYSATKGFSSENLIGAGNFASVYKG 179
L C KK N + S DLD + L AT F+S N+IG+ + ++VYKG
Sbjct: 828 LTCCKKKEKKIENSSESSLPDLDSALKLKRFEPKELEQATDSFNSANIIGSSSLSTVYKG 887
Query: 180 ILFEGAPAVAIKVFNF--LHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFK 237
L +G +A+KV N ++ K F E + + + HR ++K++ ++ K
Sbjct: 888 QLEDGT-VIAVKVLNLKEFSAESDKWFYTEAKTLSQLKHRNLVKILGFA----WESGKTK 942
Query: 238 ALVYEFMPNGSLEEWIHPITEEDKRHKAP-GNLNSLERLNIAIDVASALEYLHLGCKPPI 296
ALV FM NG+LE+ IH AP G+L LE++++ + +AS ++YLH G PI
Sbjct: 943 ALVLPFMENGNLEDTIH-------GSAAPIGSL--LEKIDLCVHIASGIDYLHSGYGFPI 993
Query: 297 AHCDIKPSNILLNDEMTACVADFGIARFL---EATNEQTSSIGVKGTTGYIAPEYGMGHE 353
HCD+KP+NILL+ + A V+DFG AR L E + S+ +GT GY+APE+ +
Sbjct: 994 VHCDLKPANILLDSDRVAHVSDFGTARILGFREDGSTTASTSAFEGTIGYLAPEFAYMRK 1053
Query: 354 TSSYGDVYSFGILLLEMFTGLRPS--DDMFKDNLNLQNWVQSALPERVEEIVDTLFFKEI 411
++ DV+SFGI+++E+ T RP+ +D ++ L+ V+ ++ + +V L ++
Sbjct: 1054 VTTKADVFSFGIIMMELMTKQRPTSLNDEDSQDMTLRQLVEKSIGNGRKGMVRVL---DM 1110
Query: 412 EEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLIKKK 471
E +++ K+ E + ++ + C++ P +R +N++ L ++ K
Sbjct: 1111 ELGDSIVSLKQE-----------EAIEDFLKLCLFCTSSRPEDRPDMNEILTHLMKLRGK 1159
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of flagellin (flg22), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Flagellin-binding to the receptor is the first step to initiate the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6), resulting in enhanced resistance against pathogens. Binding to the effector AvrPto1 from Pseudomonas syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGF4|FEI1_ARATH LRR receptor-like serine/threonine-protein kinase FEI 1 OS=Arabidopsis thaliana GN=FEI1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 199 bits (507), Expect = 7e-50, Method: Compositional matrix adjust.
Identities = 147/426 (34%), Positives = 215/426 (50%), Gaps = 42/426 (9%)
Query: 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPT 60
+ N F GPI + L GL+ LD+S N LSG IP L K L N N+S+N IP+
Sbjct: 129 LQSNYFTGPIPAEMGDLPGLQKLDMSSNTLSGPIPASLGQLKKLSNFNVSNNFLVGQIPS 188
Query: 61 EGIFKNASATSVFGNNKLCGGIPEFQL------PTCVSKKTKQNRSTLPLKLVIAIDCGL 114
+G+ S S GN LCG + P+ S ++ QN+ KL+I+
Sbjct: 189 DGVLSGFSKNSFIGNLNLCGKHVDVVCQDDSGNPSSHS-QSGQNQKKNSGKLLISASA-- 245
Query: 115 LVLTLALSSLFCRLMCM--KKRGN-PTPSISIDL-----------DFPYVSYEALYSATK 160
V L L +L C C KK G S++ D+ D PY S + + +
Sbjct: 246 TVGALLLVALMCFWGCFLYKKLGKVEIKSLAKDVGGGASIVMFHGDLPYSSKD-IIKKLE 304
Query: 161 GFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKII 220
+ E++IG G F +VYK + +G A+K L+ + F E E++ +I HR ++
Sbjct: 305 MLNEEHIIGCGGFGTVYKLAMDDGK-VFALKRILKLNEGFDRFFERELEILGSIKHRYLV 363
Query: 221 KVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAID 280
+ C+ K L+Y+++P GSL+E +H E+ L+ R+NI I
Sbjct: 364 NLRGYCNSPTS-----KLLLYDYLPGGSLDEALHERGEQ---------LDWDSRVNIIIG 409
Query: 281 VASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGT 340
A L YLH C P I H DIK SNILL+ + A V+DFG+A+ LE ++I V GT
Sbjct: 410 AAKGLSYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTI-VAGT 468
Query: 341 TGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMF-KDNLNLQNWVQSALPE-R 398
GY+APEY + DVYSFG+L+LE+ +G RP+D F + LN+ W++ + E R
Sbjct: 469 FGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNVVGWLKFLISEKR 528
Query: 399 VEEIVD 404
+IVD
Sbjct: 529 PRDIVD 534
|
Involved in the signaling pathway that regulates cell wall function, including cellulose biosynthesis, likely via an 1-aminocyclopropane-1-carboxylic acid (ACC)-mediated signal (a precursor of ethylene). Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGD9|Y1756_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g07560 OS=Arabidopsis thaliana GN=At1g07560 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 197 bits (502), Expect = 2e-49, Method: Compositional matrix adjust.
Identities = 142/398 (35%), Positives = 206/398 (51%), Gaps = 43/398 (10%)
Query: 6 FEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGI-- 63
G I + L LK LD S NNL+G +PEFLA K L +NLS NN +P +
Sbjct: 424 LTGIIVPEIQNLTELKKLDFSNNNLTGGVPEFLAKMKSLLVINLSGNNLSGSVPQALLNK 483
Query: 64 FKNASATSVFGNNKLCGGIPEFQLPTCVSKKTKQNRSTLPLKLVIAIDCGLLVLTLALSS 123
KN ++ GN LC +C KK N LP V+A L + ++
Sbjct: 484 VKNGLKLNIQGNPNLCFS------SSCNKKK---NSIMLP---VVASLASLAAIIAMIAL 531
Query: 124 LFCRLMCMKKRGN----PTPSI-SIDLDFPYVSYEALYSATKGFSSENLIGAGNFASVYK 178
LF +C+K+R + P+PS SI+ +Y + + TK F E ++G G F VY
Sbjct: 532 LF---VCIKRRSSSRKGPSPSQQSIETIKKRYTYAEVLAMTKKF--ERVLGKGGFGMVYH 586
Query: 179 GILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKA 238
G + G VA+K+ + K F E E++ + H ++ +V C D+ A
Sbjct: 587 GYI-NGTEEVAVKLLSPSSAQGYKEFKTEVELLLRVYHTNLVSLVGYCDEKDHL-----A 640
Query: 239 LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNS-LERLNIAIDVASALEYLHLGCKPPIA 297
L+Y++M NG L K+H + ++ S ++RLNIA+D AS LEYLH+GCKP I
Sbjct: 641 LIYQYMVNGDL-----------KKHFSGSSIISWVDRLNIAVDAASGLEYLHIGCKPLIV 689
Query: 298 HCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSY 357
H D+K SNILL+D++ A +ADFG++R +E S V GT GY+ EY + S
Sbjct: 690 HRDVKSSNILLDDQLQAKLADFGLSRSFPIGDESHVSTLVAGTFGYLDHEYYQTNRLSEK 749
Query: 358 GDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSAL 395
DVYSFG++LLE+ T +P D +D ++ WV+ L
Sbjct: 750 SDVYSFGVVLLEIITN-KPVIDHNRDMPHIAEWVKLML 786
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 196 bits (499), Expect = 6e-49, Method: Compositional matrix adjust.
Identities = 151/478 (31%), Positives = 226/478 (47%), Gaps = 60/478 (12%)
Query: 4 NLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGI 63
N F G I ++S L L+ LDLS N L GE+P + K L LNLS+NN E + +
Sbjct: 779 NNFTGRIPSTISTLPKLESLDLSHNQLVGEVPGQIGDMKSLGYLNLSYNNLEGKLKKQ-- 836
Query: 64 FKNASATSVFGNNKLCGGIPEFQLPTCVSKKTKQNRSTLPLKLVI--AID----CGLLVL 117
F A + GN LCG L C +K RS P +VI AI L+VL
Sbjct: 837 FSRWQADAFVGNAGLCGS----PLSHCNRAGSKNQRSLSPKTVVIISAISSLAAIALMVL 892
Query: 118 TLALSSLFCRLMCMKKRGN-----------PTPSISIDLDFPYVSYEALYSATKGFSSEN 166
+ L + K RG P S + ++ + AT + E
Sbjct: 893 VIILFFKQNHDLFKKVRGGNSAFSSNSSSSQAPLFSNGGAKSDIKWDDIMEATHYLNEEF 952
Query: 167 LIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTAC 226
+IG+G VYK L G K+ ++KSF E + + I HR ++K++ C
Sbjct: 953 MIGSGGSGKVYKAELKNGETIAVKKILWKDDLMSNKSFNREVKTLGTIRHRHLVKLMGYC 1012
Query: 227 SRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALE 286
S + + L+YE+M NGS+ +W+H E K+ + G RL IA+ +A +E
Sbjct: 1013 SS---KADGLNLLIYEYMANGSVWDWLHA-NENTKKKEVLG---WETRLKIALGLAQGVE 1065
Query: 287 YLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEA---TNEQTSSIGVKGTTGY 343
YLH C PPI H DIK SN+LL+ + A + DFG+A+ L TN +++++ G+ GY
Sbjct: 1066 YLHYDCVPPIVHRDIKSSNVLLDSNIEAHLGDFGLAKILTGNYDTNTESNTM-FAGSYGY 1124
Query: 344 IAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSAL-----PER 398
IAPEY + + DVYS GI+L+E+ TG P++ MF + ++ WV++ L E
Sbjct: 1125 IAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTEAMFDEETDMVRWVETVLDTPPGSEA 1184
Query: 399 VEEIVDTLFFKEIE-EEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGER 455
E+++D+ + EEE Y+ + EI + C+ P ER
Sbjct: 1185 REKLIDSELKSLLPCEEEAAYQ--------------------VLEIALQCTKSYPQER 1222
|
Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64556|Y2923_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g19230 OS=Arabidopsis thaliana GN=At2g19230 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 194 bits (492), Expect = 3e-48, Method: Compositional matrix adjust.
Identities = 128/368 (34%), Positives = 193/368 (52%), Gaps = 37/368 (10%)
Query: 9 PIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNAS 68
P+ ++L+PL+ L DLS N L+G +P+FLA L LNL N ++P + + ++
Sbjct: 432 PVFITLTPLQKL---DLSNNRLTGTVPDFLANLPDLTELNLEENKLTGILPEKLLERSKD 488
Query: 69 AT---SVFGNNKLCGGIPEFQLPTCVSKKTKQNRSTLPLKLVIAIDCGLLVLTLALSSLF 125
+ V GN LC +C +KKT++ +P +A GL L LAL S +
Sbjct: 489 GSLSLRVGGNPDLCVS------DSCRNKKTERKEYIIP---SVASVTGLFFLLLALISFW 539
Query: 126 CRLMCMKKRGNPTPSISIDLDFPYVSYEALYSATKGFSSENLIGAGNFASVYKGILFEGA 185
KKR + +D Y Y + T F E ++G G F VY G+L
Sbjct: 540 Q----FKKRQQSVKTGPLDTK-RYYKYSEIVEITNNF--ERVLGQGGFGKVYYGVL--RG 590
Query: 186 PAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKALVYEFMP 245
VAIK+ + K F E E++ + H+ +I ++ C ++G D AL+YE++
Sbjct: 591 EQVAIKMLSKSSAQGYKEFRAEVELLLRVHHKNLIALIGYC----HEG-DQMALIYEYIG 645
Query: 246 NGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSN 305
NG+L +++ K L+ ERL I++D A LEYLH GCKPPI H D+KP+N
Sbjct: 646 NGTLGDYLS--------GKNSSILSWEERLQISLDAAQGLEYLHNGCKPPIVHRDVKPTN 697
Query: 306 ILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGI 365
IL+N+++ A +ADFG++R + S V GT GY+ PE+ + S DVYSFG+
Sbjct: 698 ILINEKLQAKIADFGLSRSFTLEGDSQVSTEVAGTIGYLDPEHYSMQQFSEKSDVYSFGV 757
Query: 366 LLLEMFTG 373
+LLE+ TG
Sbjct: 758 VLLEVITG 765
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 873 | ||||||
| 359486510 | 965 | PREDICTED: probable LRR receptor-like se | 0.538 | 0.487 | 0.564 | 1e-143 | |
| 255581223 | 1015 | receptor-kinase, putative [Ricinus commu | 0.529 | 0.455 | 0.549 | 1e-139 | |
| 359482058 | 1040 | PREDICTED: probable LRR receptor-like se | 0.544 | 0.456 | 0.548 | 1e-136 | |
| 255586722 | 936 | serine-threonine protein kinase, plant-t | 0.531 | 0.495 | 0.545 | 1e-135 | |
| 147853780 | 1904 | hypothetical protein VITISV_030954 [Viti | 0.539 | 0.247 | 0.549 | 1e-135 | |
| 255570308 | 1033 | receptor-kinase, putative [Ricinus commu | 0.526 | 0.445 | 0.535 | 1e-134 | |
| 224097752 | 1025 | predicted protein [Populus trichocarpa] | 0.530 | 0.451 | 0.536 | 1e-133 | |
| 224081190 | 1011 | predicted protein [Populus trichocarpa] | 0.523 | 0.452 | 0.524 | 1e-132 | |
| 224127492 | 1022 | predicted protein [Populus trichocarpa] | 0.530 | 0.453 | 0.524 | 1e-132 | |
| 224121306 | 966 | predicted protein [Populus trichocarpa] | 0.505 | 0.456 | 0.523 | 1e-132 |
| >gi|359486510|ref|XP_002271317.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like, partial [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 516 bits (1328), Expect = e-143, Method: Compositional matrix adjust.
Identities = 273/484 (56%), Positives = 337/484 (69%), Gaps = 14/484 (2%)
Query: 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPT 60
M GN F+G I S S LRG+++LDLS NNLSG+IPEFL F Q +NLS+N+FE ++PT
Sbjct: 480 MKGNFFQGSIPSSFSSLRGIRILDLSHNNLSGKIPEFLQDIHF-QLVNLSYNDFEGILPT 538
Query: 61 EGIFKNASATSVFGNNKLCGGIPEFQLPTCVSKKTKQNRSTLPLKLVIAIDCGLLVLTLA 120
EG+FKN SATS+ GN+KLCGGIPEFQLP C ++ K+ +L LK++IA GLL +T
Sbjct: 539 EGVFKNVSATSIMGNSKLCGGIPEFQLPKCNLQEPKKRGLSLALKIIIATVSGLLAITCV 598
Query: 121 LSSLFCRLMCMKKRGNPTPSISIDLDFPYVSYEALYSATKGFSSENLIGAGNFASVYKGI 180
LS L L KK+G P S S VSY++L AT GFSS NLIG G+F SVYKGI
Sbjct: 599 LSFLIF-LWLRKKKGEPASSSSEKSLL-KVSYQSLLRATDGFSSSNLIGVGSFGSVYKGI 656
Query: 181 LFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKALV 240
L A+A+KV N L ASKSF ECE +RNI HR ++KV+TACS VDYQGNDFKA+V
Sbjct: 657 LDHDGTAIAVKVLNLLRKGASKSFIAECEALRNIRHRNLVKVLTACSGVDYQGNDFKAVV 716
Query: 241 YEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCD 300
YEFM NGSLE+W+HP + P LN L+RLNIAIDVA AL+YLH C+ PI HCD
Sbjct: 717 YEFMVNGSLEQWLHPTPTTAEASAPPRKLNFLQRLNIAIDVACALDYLHHQCQTPIVHCD 776
Query: 301 IKPSNILLNDEMTACVADFGIARFL-EATNE----QTSSIGVKGTTGYIAPEYGMGHETS 355
+KPSN+LL+ EMT V DFGIA+FL EA Q+SSIG++GT GY APEYGMG E S
Sbjct: 777 LKPSNVLLDTEMTGHVGDFGIAKFLPEAATRVPEIQSSSIGIRGTIGYAAPEYGMGSEVS 836
Query: 356 SYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPERVEEIVDTLFFKE-IEEE 414
+ GDVYSFGILLLEMFTG RP++DMFKD+LN+ N+V++A+PERV EI D + +E +E +
Sbjct: 837 TSGDVYSFGILLLEMFTGKRPTEDMFKDSLNIHNFVKTAVPERVAEIADPVLLQEGVEMD 896
Query: 415 ETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLIKKKLLE 474
T + + A S Q ECL SI IG+ACSAELP ER I D L ++ L
Sbjct: 897 NTTSQRRMASSHDAQ-----ECLISIFGIGLACSAELPRERKNITDAAAELNSVRDIFLG 951
Query: 475 TPVY 478
T ++
Sbjct: 952 TGLH 955
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255581223|ref|XP_002531424.1| receptor-kinase, putative [Ricinus communis] gi|223528974|gb|EEF30966.1| receptor-kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 503 bits (1296), Expect = e-139, Method: Compositional matrix adjust.
Identities = 263/479 (54%), Positives = 332/479 (69%), Gaps = 17/479 (3%)
Query: 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPT 60
+ GN F+G + SLS LRGL+VLD S NNLSGEIPEFL F L++LNLS+NNFE +P
Sbjct: 545 LQGNFFDGLVPSSLSSLRGLRVLDFSSNNLSGEIPEFLQSFDLLESLNLSYNNFEGRVPV 604
Query: 61 EGIFKNASATSVFGNNKLCGGIPEFQLPTCVSKKTKQNRSTLPLKLVIAIDCGLLVLTLA 120
EGIF+NAS T V GN+KLCGGIPEF L C +K K + TL LK+VI+ C LL L+
Sbjct: 605 EGIFRNASTTLVMGNDKLCGGIPEFHLAKCNAKSPK--KLTLLLKIVISTICSLLGLSFI 662
Query: 121 LSSLFCRLMCMKKRGNPTPSISIDLDFPYVSYEALYSATKGFSSENLIGAGNFASVYKGI 180
L +F ++K+ S VS+++L AT GFSS NLIG G+F VYKG
Sbjct: 663 L--IFALTFWLRKKKEEPTSDPYGHLLLNVSFQSLLRATDGFSSANLIGRGSFGHVYKGF 720
Query: 181 LFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKALV 240
L EG +A+KV N LHH AS SF ECE +RNI HR ++KV+TACS +DYQGNDFKALV
Sbjct: 721 LDEGNVTIAVKVLNLLHHGASTSFIAECEALRNIRHRNLVKVLTACSGIDYQGNDFKALV 780
Query: 241 YEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCD 300
YE+M NGSLEEW+HPI ++ + P +LN L+RLNIAIDVASAL+YLH C PI HCD
Sbjct: 781 YEYMVNGSLEEWLHPIPRTEEV-EPPRSLNLLQRLNIAIDVASALDYLHNQCTTPIVHCD 839
Query: 301 IKPSNILLNDEMTACVADFGIARFL-EATN----EQTSSIGVKGTTGYIAPEYGMGHETS 355
+KPSN+LL+ EM V+DFG+A+ L E+TN Q+SSIGV+GT G+ PEYG+G S
Sbjct: 840 LKPSNVLLDSEMNGHVSDFGLAKILSESTNSFPVSQSSSIGVRGTVGFAPPEYGVGSNVS 899
Query: 356 SYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPERVEEIVDTLFFKEIEEEE 415
+YGDVYS+GILLLE+FTG RP+DDMFK++LNL N+ + A +++ E+ D + +E E
Sbjct: 900 TYGDVYSYGILLLELFTGKRPTDDMFKEDLNLHNFAEIAFRDQLAEVADPILLQETAVRE 959
Query: 416 TVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLIKKKLLE 474
T +K QR + ECL S+ IGVACS E+P ERMKINDV GL I+ KL+
Sbjct: 960 TRLNSRKC-----QR--LEECLFSMLRIGVACSTEMPQERMKINDVVTGLHAIRDKLVR 1011
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359482058|ref|XP_002274540.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 491 bits (1265), Expect = e-136, Method: Compositional matrix adjust.
Identities = 265/483 (54%), Positives = 322/483 (66%), Gaps = 8/483 (1%)
Query: 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPT 60
M GN F+G I S LRGL LDLS+NNLSG+IPEFL L NLNLS NNFE +PT
Sbjct: 553 MEGNFFKGSIPPSFISLRGLLDLDLSRNNLSGQIPEFLQQLS-LSNLNLSFNNFEGQLPT 611
Query: 61 EGIFKNASATSVFGNNKLCGGIPEFQLPTCVSKKTKQNRSTLPLKLVIAIDCGLLVLTLA 120
+G+F NA++TSV GNNKLCGGIPE LP C K K S LKL+I + G L L L
Sbjct: 612 KGVFNNATSTSVAGNNKLCGGIPELHLPACPVTKPKTGESKRGLKLMIGLLTGFLGLVLI 671
Query: 121 LSSLFC-RLMCMKKRGNPTPSISIDLDFPYVSYEALYSATKGFSSENLIGAGNFASVYKG 179
+S L RL +K+ + T + S DL VSY+ L+ AT GFSS NLIG G F SVYKG
Sbjct: 672 MSLLVINRLRRVKREPSQTSASSKDLIL-NVSYDGLFKATGGFSSANLIGTGGFGSVYKG 730
Query: 180 ILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKAL 239
IL + VA+KV A KSF ECE +RNI HR ++KV+T CS VDYQGNDFKAL
Sbjct: 731 ILGQDETVVAVKVIQLHQRGAVKSFKAECEALRNIRHRNLVKVLTTCSSVDYQGNDFKAL 790
Query: 240 VYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHC 299
VYEFMPNGSLE W+HP+ D+ + L+ +RLNIAIDVASAL+YLH C PI HC
Sbjct: 791 VYEFMPNGSLENWLHPVPTPDEINDVLRILSLPQRLNIAIDVASALDYLHHHCHKPIVHC 850
Query: 300 DIKPSNILLNDEMTACVADFGIARFL-EATNE----QTSSIGVKGTTGYIAPEYGMGHET 354
D+KPSNILL+++MTA V DFG+ARF+ EA Q+SSIG+KGT GY APEYGMG +
Sbjct: 851 DLKPSNILLDNDMTAHVGDFGLARFIPEAAGRSHPSQSSSIGLKGTIGYAAPEYGMGTKV 910
Query: 355 SSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPERVEEIVDTLFFKEIEEE 414
S+ GD YS+GILLLEMFTG RP++ MF D LNL N+V+ ALPER+ +I+D F +E
Sbjct: 911 SALGDTYSYGILLLEMFTGKRPTESMFSDQLNLHNFVKMALPERIADIIDPFFLSSEAKE 970
Query: 415 ETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLIKKKLLE 474
E + + +R + ECL SI IGV+CS E P ERM I + L+LI+K LL
Sbjct: 971 EETTAADSSNLAHMKREKMHECLISILRIGVSCSLESPRERMAITEAIKELQLIRKILLG 1030
Query: 475 TPV 477
V
Sbjct: 1031 NGV 1033
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255586722|ref|XP_002533985.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223526036|gb|EEF28405.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 490 bits (1261), Expect = e-135, Method: Compositional matrix adjust.
Identities = 259/475 (54%), Positives = 332/475 (69%), Gaps = 11/475 (2%)
Query: 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPT 60
M GN F+G I SL L+ L+VLDLS NNLSG+IPEFL+ LQ LNLSHNNFE +P
Sbjct: 471 MKGNNFQGLIPSSLGSLKALQVLDLSHNNLSGQIPEFLSQIVLLQ-LNLSHNNFEGPVPA 529
Query: 61 EGIFKNASATSVFGNNKLCGGIPEFQLPTCVSKKTKQNRSTLPLKLVIAIDCGLLVLTLA 120
+G+F+N SATS+ GNNKLCGGIPEF L C+S + K++ T L++V+A C L+ +TL
Sbjct: 530 KGVFRNVSATSLEGNNKLCGGIPEFHLAPCISTRHKKSGLTHNLRIVVATVCVLVGVTLL 589
Query: 121 LSSLFCRLMCMKKRGNPTPSISIDLDFPYVSYEALYSATKGFSSENLIGAGNFASVYKGI 180
L + + K+R + S S +SY LY AT GFSS N +GAG+F +V+KG
Sbjct: 590 LWVIVVFFLKKKRRKESSSSFSEKKALE-LSYHTLYKATDGFSSANTLGAGSFGTVFKGE 648
Query: 181 LFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKALV 240
L G ++A+KVFN + H A KSF ECE +RNI HR ++KV+TACS VDYQGN+FKALV
Sbjct: 649 LGGGETSIAVKVFNLMRHGAFKSFIAECEALRNIRHRNLVKVLTACSSVDYQGNEFKALV 708
Query: 241 YEFMPNGSLEEWIHPITEEDKRHKAP-GNLNSLERLNIAIDVASALEYLHLGCKPPIAHC 299
YEFM NGSLEEW+HP D+ P NLN L+RLNIA+DVA AL+YLH C+ PI HC
Sbjct: 709 YEFMVNGSLEEWLHP---PDEAKAIPRNNLNILQRLNIAVDVACALDYLHNHCETPIIHC 765
Query: 300 DIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGD 359
D+KPSNILL++EMT V DFG+A+F + Q+SSIG++G+ GY EYG G+E S+ GD
Sbjct: 766 DLKPSNILLDNEMTGHVGDFGLAKFYRERSHQSSSIGIRGSLGYAPAEYGTGNEVSTSGD 825
Query: 360 VYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYK 419
VYS+GILLLE+FTG RP DD F ++++L N+V++ALPE+V EI+D F+E E ++ +
Sbjct: 826 VYSYGILLLEIFTGKRPMDDWFNEDVSLHNYVKNALPEQVVEILDPTLFQEGEGGISLIR 885
Query: 420 YKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLIKKKLLE 474
A + T +ECL SICEIGVACSAE PGERM I DV L I+ KLL
Sbjct: 886 RSNASINRT-----MECLISICEIGVACSAETPGERMNICDVAGQLVSIRNKLLR 935
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147853780|emb|CAN83822.1| hypothetical protein VITISV_030954 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 488 bits (1256), Expect = e-135, Method: Compositional matrix adjust.
Identities = 263/479 (54%), Positives = 320/479 (66%), Gaps = 8/479 (1%)
Query: 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPT 60
M GN F+G I S LRGL LDLS+NNLSG+IPEFL L NLNLS NNFE +PT
Sbjct: 584 MEGNFFKGSIPPSFISLRGLLDLDLSRNNLSGQIPEFLQQLS-LSNLNLSFNNFEGQLPT 642
Query: 61 EGIFKNASATSVFGNNKLCGGIPEFQLPTCVSKKTKQNRSTLPLKLVIAIDCGLLVLTLA 120
+G+F NA++TSV GNNKLCGGIPE LP C K K S LKL+I + G L L L
Sbjct: 643 KGVFNNATSTSVAGNNKLCGGIPELHLPACPVTKPKTGESKRGLKLMIGLLTGFLGLVLI 702
Query: 121 LSSLFC-RLMCMKKRGNPTPSISIDLDFPYVSYEALYSATKGFSSENLIGAGNFASVYKG 179
+S L RL +K+ + T + S DL VSY+ L+ AT GFSS NLIG G F SVYKG
Sbjct: 703 MSLLVINRLRRVKREPSQTSASSKDLIL-NVSYDGLFKATGGFSSANLIGTGGFGSVYKG 761
Query: 180 ILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKAL 239
L + VA+KV A KSF ECE +RNI HR ++KV+T CS VDYQGNDFKAL
Sbjct: 762 XLGQDETVVAVKVIQLHQRGAVKSFKAECEALRNIRHRNLVKVLTTCSSVDYQGNDFKAL 821
Query: 240 VYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHC 299
VYEFMPNGSLE W+HP+ D+ + L+ +RLNIAIDVASAL+YLH C PI HC
Sbjct: 822 VYEFMPNGSLENWLHPVPTPDEINDVLRILSLPQRLNIAIDVASALDYLHHHCHKPIVHC 881
Query: 300 DIKPSNILLNDEMTACVADFGIARFL-EATNE----QTSSIGVKGTTGYIAPEYGMGHET 354
D+KPSNILL+++MTA V DFG+ARF+ EA Q+SSIG+KGT GY APEYGMG +
Sbjct: 882 DLKPSNILLDNDMTAHVGDFGLARFIPEAAGRSHPSQSSSIGLKGTIGYAAPEYGMGTKV 941
Query: 355 SSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPERVEEIVDTLFFKEIEEE 414
S+ GD YS+GILLLEMFTG RP++ MF D LNL N+V+ ALPER+ +I+D F +E
Sbjct: 942 SALGDTYSYGILLLEMFTGKRPTESMFSDQLNLHNFVKMALPERIADIIDPFFLSSEAKE 1001
Query: 415 ETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLIKKKLL 473
E + + +R + ECL SI IGV+CS E P ERM I + L+LI+K LL
Sbjct: 1002 EETTAADSSNLAHMKREKMHECLISILRIGVSCSLESPRERMAITEAIKELQLIRKILL 1060
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255570308|ref|XP_002526114.1| receptor-kinase, putative [Ricinus communis] gi|223534611|gb|EEF36308.1| receptor-kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 486 bits (1251), Expect = e-134, Method: Compositional matrix adjust.
Identities = 257/480 (53%), Positives = 334/480 (69%), Gaps = 20/480 (4%)
Query: 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPT 60
M N F+G I SLS LRGL+V+DLS NNLSG+IPEFL F FLQ+LNLS N+FE ++PT
Sbjct: 548 MRDNSFKGSIPSSLSALRGLQVVDLSHNNLSGQIPEFLGSFPFLQSLNLSFNDFEGLVPT 607
Query: 61 EGIFKNASATSVFGNNKLCGGIPEFQLPTCVSKKTKQNRSTLPLKLVIAIDCGLLVLTLA 120
EG+FKNAS+TSV GNNKLCGG+ +F L C + + R L LK +IA + VL A
Sbjct: 608 EGVFKNASSTSVMGNNKLCGGVSDFHLLACNIRSSTNRR--LKLKAIIA---SVAVLLGA 662
Query: 121 LSSLFCRLMCMKKRGNPTPSISIDLDFPYVSYEALYSATKGFSSENLIGAGNFASVYKGI 180
L L L+ ++ + P++S ++ VSY+ L+ ATKGFSS NLI G F SVY+G+
Sbjct: 663 LLMLSFLLILRSRKKSQAPALSSEIPLLRVSYQNLHDATKGFSSSNLINVGGFGSVYQGV 722
Query: 181 LFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKALV 240
L E VA+KV N H A+KSF VECEV+++I HR ++KV+TACS +DYQGNDFKALV
Sbjct: 723 LGESGQLVAVKVLNVQHQTAAKSFMVECEVLKSIRHRNLVKVLTACSSIDYQGNDFKALV 782
Query: 241 YEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCD 300
YEFM NGSLEEW+HP+ D + P L+ L+RLNIAID+ASALEYL C+ I HCD
Sbjct: 783 YEFMVNGSLEEWLHPVV-VDGSDEPPKKLDLLQRLNIAIDIASALEYLQNHCETTIVHCD 841
Query: 301 IKPSNILLNDEMTACVADFGIARFLEATNEQ-----TSSIGVKGTTGYIAPEYGMGHETS 355
+KPSN+LL+ E+T V+DFGIA+FL N +SS+ ++GT GY PEYGMG + S
Sbjct: 842 LKPSNVLLDAELTGHVSDFGIAKFLLKDNNNRSTNLSSSVQLRGTIGYAPPEYGMGGQVS 901
Query: 356 SYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPERVEEIVDTLFFKEIEEEE 415
+GD+YS+GILLLEMFTG RP++DMFK+ LNL + +SALP+ V EI+D + +E E +
Sbjct: 902 IFGDIYSYGILLLEMFTGKRPTNDMFKEGLNLHKFAKSALPDGVAEILDPVLLQESGEID 961
Query: 416 TVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLIKKKLLET 475
S S + I++CL SI +IGV+CSAELPG+R+ +DV L L I+ KLL T
Sbjct: 962 ---------SRSIRTKKIMDCLISIVDIGVSCSAELPGDRVCTSDVALKLSSIRSKLLWT 1012
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224097752|ref|XP_002311067.1| predicted protein [Populus trichocarpa] gi|222850887|gb|EEE88434.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 482 bits (1241), Expect = e-133, Method: Compositional matrix adjust.
Identities = 258/481 (53%), Positives = 331/481 (68%), Gaps = 18/481 (3%)
Query: 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPT 60
M GNLF+GPI SLS LR L++L+LS NNLSGEIP+FLA K L +L+LS NN E +P
Sbjct: 547 MEGNLFQGPIPESLSSLRALQILNLSHNNLSGEIPKFLAELKLLTSLDLSFNNLEGEVPV 606
Query: 61 EGIFKNASATSVFGNNKLCGGIPEFQLPTCVSKKTKQNRSTLPLKLVIAIDCGLLVLTLA 120
+GIF AS S+ GN KLCGG+P+ L C SKK+++ +S+ LKL+IAI CG + + L
Sbjct: 607 QGIFARASGFSMLGNKKLCGGMPQLNLSRCTSKKSRKLKSSTKLKLIIAIPCGFVGIILV 666
Query: 121 LSSLFCRLMCMKKRGNPTPSISIDLDFPYVSYEALYSATKGFSSENLIGAGNFASVYKGI 180
+S + +K+ P + F V+YE L AT GFS NLIGAG+F SVYKGI
Sbjct: 667 VSYMLF-FFLKEKKSRPASGSPWESTFQRVAYEDLLQATNGFSPANLIGAGSFGSVYKGI 725
Query: 181 LFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKALV 240
L AVA+KVFN L ASKSF EC + NI HR ++KV+TACS +D+QGNDFKALV
Sbjct: 726 LRSDGAAVAVKVFNLLREGASKSFMAECAALINIRHRNLVKVLTACSGIDFQGNDFKALV 785
Query: 241 YEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCD 300
YEFM NGSLEEW+HP D+ H+ +L+ L+RLNIAIDVASAL+YLH C+ I HCD
Sbjct: 786 YEFMVNGSLEEWLHPAQISDEAHRRR-DLSLLQRLNIAIDVASALDYLHNHCQIAIVHCD 844
Query: 301 IKPSNILLNDEMTACVADFGIARFLEATN-----EQTSSIGVKGTTGYIAPEYGMGHETS 355
+KPSN+LL+ ++TA V DFG+AR L + +QTSSIG+KGT GY APEYG+G E S
Sbjct: 845 LKPSNVLLDGDLTAHVGDFGLARLLPQASHQLCLDQTSSIGLKGTIGYAAPEYGLGSEVS 904
Query: 356 SYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPERVEEIVDTLFFKEIEEEE 415
YGDVYS+GILLLE+FTG RP+D +FKD LNL N+ ++ALP V E++D + E EE
Sbjct: 905 PYGDVYSYGILLLEVFTGRRPTDGLFKDGLNLHNFAKTALPISVAEVLDPVLVTEAEE-- 962
Query: 416 TVYKYKKAPSSSTQRSII---LECLNSICEIGVACSAELPGERMKINDVELGLRLIKKKL 472
+ +S + S I +ECL +I ++GVACSAE P ERM+I+ V + LR I+ L
Sbjct: 963 ------TSGDASRRMSHIGNHMECLAAIVKVGVACSAEFPRERMEISSVAVELRRIRHIL 1016
Query: 473 L 473
L
Sbjct: 1017 L 1017
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224081190|ref|XP_002306327.1| predicted protein [Populus trichocarpa] gi|222855776|gb|EEE93323.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 480 bits (1235), Expect = e-132, Method: Compositional matrix adjust.
Identities = 250/477 (52%), Positives = 320/477 (67%), Gaps = 20/477 (4%)
Query: 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPT 60
+ GN FEGP+ LS LR L++L LS NNLSG+IP+FL FK L+ L+LS+N+FE +P
Sbjct: 545 LGGNFFEGPVP-DLSSLRALQMLLLSYNNLSGQIPQFLKDFKLLETLDLSYNDFEGEVPE 603
Query: 61 EGIFKNASATSVFGNNKLCGGIPEFQLPTCVSKKTKQNRSTLPLKLVIAIDCGLLVLTLA 120
+G+F+N S SV GN KLCGGIP+ LP C S + + +S L L+IAI CG L + L
Sbjct: 604 QGVFENTSRISVQGNKKLCGGIPQLDLPKCTSNEPARPKSHTKLILIIAIPCGFLGIVLM 663
Query: 121 LSSLFCRLMCMKKRGNPTPSISIDLDFPYVSYEALYSATKGFSSENLIGAGNFASVYKGI 180
S F K + P S + F ++Y+ L AT GFSS NL+GAG F SVY+G
Sbjct: 664 TS--FLLFYSRKTKDEPASGPSWESSFQRLTYQDLLQATDGFSSSNLVGAGAFGSVYRGT 721
Query: 181 LFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKALV 240
L VA+KV N L ASKSF EC + NI HR ++KV+TACS D+QGNDFKALV
Sbjct: 722 LTSDGAVVAVKVLNLLRKGASKSFMAECAALINIRHRNLVKVITACSSNDFQGNDFKALV 781
Query: 241 YEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCD 300
YEFM NGSLEEW+HP+ D + NL+ ++RLNIAIDVASAL+YLH C+ P+ HCD
Sbjct: 782 YEFMVNGSLEEWLHPVHISDVTPETR-NLDLVQRLNIAIDVASALDYLHNHCQVPVVHCD 840
Query: 301 IKPSNILLNDEMTACVADFGIARFL-EATNE----QTSSIGVKGTTGYIAPEYGMGHETS 355
+KPSN+LL D+MTACV DFG+ARFL EA+N+ ++SS+G+KGT GY APEYGMG E S
Sbjct: 841 LKPSNVLLGDDMTACVGDFGLARFLPEASNQLPADESSSVGLKGTIGYAAPEYGMGSEVS 900
Query: 356 SYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPERVEEIVDTLFFKEIEEEE 415
+YGDVYS+GILLLEMFTG RP+D MFKD NL N+ + LP+ V E VD + E
Sbjct: 901 TYGDVYSYGILLLEMFTGRRPTDGMFKDGHNLHNYAKMVLPDNVLEFVDPTLREHEEMNH 960
Query: 416 TVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLIKKKL 472
+K ++EC+ SI ++G+ACSAELPGERM I +V + L I++ L
Sbjct: 961 NDDSHK-----------VMECMVSIIKVGLACSAELPGERMGIANVVVELHRIREML 1006
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224127492|ref|XP_002329291.1| predicted protein [Populus trichocarpa] gi|222870745|gb|EEF07876.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 480 bits (1235), Expect = e-132, Method: Compositional matrix adjust.
Identities = 250/477 (52%), Positives = 319/477 (66%), Gaps = 14/477 (2%)
Query: 4 NLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGI 63
N +GPI ++LS LR ++ L+LS NNL+G+IPEFL FK L++LNLS N+FE +P +G
Sbjct: 551 NFLQGPIPITLSSLRAIQELNLSYNNLTGQIPEFLEDFKLLESLNLSFNDFEGEVPVQGA 610
Query: 64 FKNASATSVFGNNKLCGGIPEFQLPTCVSKKTKQNRSTLPLKLVIAIDCGLLVLTLALSS 123
F+N SA S+FGN KLCGGIP+ L C S + ++S L +I CG L + L +S
Sbjct: 611 FQNTSAISIFGNKKLCGGIPQLNLTRCPSSEPTNSKSPTKLIWIIGSVCGFLGVILIIS- 669
Query: 124 LFCRLMCM-KKRGNPTPSI-SIDLDFPYVSYEALYSATKGFSSENLIGAGNFASVYKGIL 181
F C KK+ P S S++ FP V+YE L AT GFSS NLIG G+F SV+KGIL
Sbjct: 670 -FLLFYCFRKKKDKPAASQPSLETSFPRVAYEDLLGATDGFSSANLIGEGSFGSVFKGIL 728
Query: 182 FEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKALVY 241
VA+KV N L ASKSF ECE +++I HR ++K++T CS +D+QGNDFKALVY
Sbjct: 729 GPDKIVVAVKVLNLLRKGASKSFMAECEALKSIRHRNLVKLLTTCSSIDFQGNDFKALVY 788
Query: 242 EFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDI 301
EFM NG+LEEW+HP+ D+ + P L+ + RLNIAI +ASAL YLH C+ PI HCD+
Sbjct: 789 EFMVNGNLEEWLHPVQTSDEAN-GPKALDLMHRLNIAIHMASALNYLHHDCQMPIIHCDL 847
Query: 302 KPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVY 361
KPSNILL+ MTA V DFG+ARF + QTSS+G+KGT GY APEYG+G + S+YGDVY
Sbjct: 848 KPSNILLDTNMTAHVGDFGLARFHSEASNQTSSVGLKGTIGYAAPEYGIGGKVSTYGDVY 907
Query: 362 SFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPERVEEIVDTLFFKEIE---EEETVY 418
S+GILLLEMFTG RP D MFKD LNL ++ + ALP+R+ E+VD L +EI + +
Sbjct: 908 SYGILLLEMFTGKRPVDGMFKDGLNLHSYAKMALPDRIVEVVDPLLVREIRSVNSSDEMG 967
Query: 419 KYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLIKKKLLET 475
Y P I CL +I ++GVACS ELP ERM I DV L IK LL T
Sbjct: 968 MYHIGPHE------ISACLMTIIKMGVACSVELPRERMDIGDVVTELNRIKDTLLGT 1018
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224121306|ref|XP_002330794.1| predicted protein [Populus trichocarpa] gi|222872596|gb|EEF09727.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 479 bits (1233), Expect = e-132, Method: Compositional matrix adjust.
Identities = 252/481 (52%), Positives = 330/481 (68%), Gaps = 40/481 (8%)
Query: 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPT 60
M N F+G I S LRGL+VL+LS NNL+G IP+F F+ L LNLS NNFE ++PT
Sbjct: 506 MQNNFFQGTIPSSFISLRGLQVLNLSHNNLTGSIPDFFLDFRALATLNLSFNNFEGLVPT 565
Query: 61 EGIFKNASATSVFGNNKLCGGIPEFQLPTCVSKKTKQNRSTLPLKLVIAIDCGLLVLTLA 120
+G+F+N+SA SV GN+KLCGGI EFQL C K TK+ R TL +KL
Sbjct: 566 DGVFRNSSAVSVVGNSKLCGGIAEFQLLECNFKGTKKGRLTLAMKL-------------- 611
Query: 121 LSSLFCRLMCMKKRGNPTPSISIDLDFPYVSYEALYSATKGFSSENLIGAGNFASVYKGI 180
+K+ PTP+ + F +SY +L AT GFS NL+G G F SVYKGI
Sbjct: 612 -----------RKKVEPTPTSPENSVFQ-MSYRSLLKATDGFSLTNLLGVGGFGSVYKGI 659
Query: 181 LFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKALV 240
L VA+KV N L+ ASKSF ECEV+RN+ HR ++K++TACS DYQGNDFKALV
Sbjct: 660 LDNDEKLVAVKVLNLLNPRASKSFKAECEVLRNVRHRNLVKLLTACSGSDYQGNDFKALV 719
Query: 241 YEFMPNGSLEEWIHPITEE-DKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHC 299
YEFM NGSLEEW+HPIT D+ ++ +LN ++RLNIAID++ ALEYLH GC+ PI HC
Sbjct: 720 YEFMVNGSLEEWLHPITPGIDEARESSRSLNFVQRLNIAIDISCALEYLHRGCRTPIVHC 779
Query: 300 DIKPSNILLNDEMTACVADFGIARFL-EATN----EQTSSIGVKGTTGYIAPEYGMGHET 354
D+KPSN+LL+DEM V DFG+ARF EATN ++S+ GV+GT GY APEYGMG+E
Sbjct: 780 DLKPSNVLLDDEMIGHVGDFGLARFFPEATNNLSFNRSSTNGVRGTIGYTAPEYGMGNEV 839
Query: 355 SSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPERVEEIVDTLFFKEIEEE 414
S+ GDV+S+GILLLEMF+G RP+D +F+D+LNL ++++ALP +VEEI+D + +EI+ E
Sbjct: 840 STSGDVFSYGILLLEMFSGKRPTDVIFEDSLNLHTYMKAALPGKVEEILDPILVQEIKGE 899
Query: 415 ETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLIKKKLLE 474
+ SS S + +C+ S+ E+G+ACSAELP ERM I++V L+ IK+KLL
Sbjct: 900 RS--------SSYMWNSKVQDCVVSVFEVGIACSAELPSERMDISEVTAELQAIKEKLLR 951
Query: 475 T 475
+
Sbjct: 952 S 952
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 873 | ||||||
| TAIR|locus:2079142 | 1010 | AT3G47570 [Arabidopsis thalian | 0.521 | 0.450 | 0.453 | 2.5e-104 | |
| TAIR|locus:2149922 | 1031 | EFR "EF-TU receptor" [Arabidop | 0.450 | 0.381 | 0.497 | 6.5e-104 | |
| TAIR|locus:2075631 | 1009 | AT3G47090 [Arabidopsis thalian | 0.520 | 0.449 | 0.441 | 1e-100 | |
| TAIR|locus:2075661 | 1025 | AT3G47110 [Arabidopsis thalian | 0.501 | 0.427 | 0.468 | 9.1e-100 | |
| TAIR|locus:2079157 | 1011 | AT3G47580 [Arabidopsis thalian | 0.523 | 0.452 | 0.422 | 2.8e-98 | |
| UNIPROTKB|Q40640 | 1025 | Xa21 "Receptor kinase-like pro | 0.520 | 0.442 | 0.443 | 1.6e-95 | |
| TAIR|locus:2175703 | 502 | AT5G39390 [Arabidopsis thalian | 0.407 | 0.709 | 0.474 | 2.1e-90 | |
| TAIR|locus:2047525 | 980 | AT2G24130 [Arabidopsis thalian | 0.510 | 0.455 | 0.352 | 1.3e-60 | |
| UNIPROTKB|O24435 | 813 | O24435 "Receptor kinase-like p | 0.297 | 0.319 | 0.442 | 4.1e-54 | |
| TAIR|locus:2170483 | 1173 | FLS2 "FLAGELLIN-SENSITIVE 2" [ | 0.499 | 0.371 | 0.316 | 4.8e-51 |
| TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1033 (368.7 bits), Expect = 2.5e-104, P = 2.5e-104
Identities = 221/487 (45%), Positives = 306/487 (62%)
Query: 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPT 60
+ GNLF G I L L G+K +DLS N+LSG IPE+ A F L+ LNLS NN E +P
Sbjct: 536 LEGNLFYGDIP-DLKGLVGVKEVDLSNNDLSGSIPEYFASFSKLEYLNLSFNNLEGKVPV 594
Query: 61 EGIFKNASATSVFGNNKLCGGIPEFQLPTCVSKK---TKQNRSTLPLKLVIAIDCGXXXX 117
+GIF+NA+ S+ GNN LCGGI FQL C+S+ K++ S L K+VI + G
Sbjct: 595 KGIFENATTVSIVGNNDLCGGIMGFQLKPCLSQAPSVVKKHSSRLK-KVVIGVSVGITLL 653
Query: 118 XXXXXXXFCRLMCMKKR-----GNPTPSISIDLDFPYVSYEALYSATKGFSSENLIGAGN 172
+ K++ NPTPS ++++ +SY L +AT GFSS N++G+G+
Sbjct: 654 LLLFMASVTLIWLRKRKKNKETNNPTPS-TLEVLHEKISYGDLRNATNGFSSSNMVGSGS 712
Query: 173 FASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQ 232
F +VYK +L VA+KV N A KSF ECE +++I HR ++K++TACS +D+Q
Sbjct: 713 FGTVYKALLLTEKKVVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQ 772
Query: 233 GNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGC 292
GN+F+AL+YEFMPNGSL+ W+HP E ++ H+ L LERLNIAIDVAS L+YLH+ C
Sbjct: 773 GNEFRALIYEFMPNGSLDMWLHP-EEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHC 831
Query: 293 KPPIAHCDIKPSNILLNDEMTACVADFGIARFL-----EATNEQTSSIGVKGTTGYIAPE 347
PIAHCD+KPSN+LL+D++TA V+DFG+AR L E+ Q SS GV+GT GY APE
Sbjct: 832 HEPIAHCDLKPSNVLLDDDLTAHVSDFGLARLLLKFDEESFFNQLSSAGVRGTIGYAAPE 891
Query: 348 YGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPERVEEIVDTLF 407
YG+G + S GDVYSFGILLLEMFTG RP++++F N L ++ +SALPER+ +IVD
Sbjct: 892 YGVGGQPSINGDVYSFGILLLEMFTGKRPTNELFGGNFTLNSYTKSALPERILDIVD--- 948
Query: 408 FKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRL 467
E++ ++ECL + E+G+ C E P R+ + V L
Sbjct: 949 -------ESILHIGLRVGFP-----VVECLTMVFEVGLRCCEESPMNRLATSIVVKELIS 996
Query: 468 IKKKLLE 474
I+++ +
Sbjct: 997 IRERFFK 1003
|
|
| TAIR|locus:2149922 EFR "EF-TU receptor" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 979 (349.7 bits), Expect = 6.5e-104, Sum P(2) = 6.5e-104
Identities = 203/408 (49%), Positives = 268/408 (65%)
Query: 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPT 60
M GN F+G I +S L LK +D S NNLSG IP +LA L+NLNLS N FE +PT
Sbjct: 544 MQGNSFDGAIP-DISRLVSLKNVDFSNNNLSGRIPRYLASLPSLRNLNLSMNKFEGRVPT 602
Query: 61 EGIFKNASATSVFGNNKLCGGIPEFQLPTCVSKKTKQNRSTLPL--KLVIAIDCGXXXXX 118
G+F+NA+A SVFGN +CGG+ E QL C+ + + + R L + K+V I G
Sbjct: 603 TGVFRNATAVSVFGNTNICGGVREMQLKPCIVQASPRKRKPLSVRKKVVSGICIGIASLL 662
Query: 119 XXXX-XXFCRLMCMKKR-----GNPTPSISIDLDFPYVSYEALYSATKGFSSENLIGAGN 172
C M KK+ GNP+ S ++ + VSYE L+SAT FSS NLIG+GN
Sbjct: 663 LIIIVASLCWFMKRKKKNNASDGNPSDSTTLGMFHEKVSYEELHSATSRFSSTNLIGSGN 722
Query: 173 FASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQ 232
F +V+KG+L VA+KV N L H A+KSF ECE + I HR ++K++T CS +D +
Sbjct: 723 FGNVFKGLLGPENKLVAVKVLNLLKHGATKSFMAECETFKGIRHRNLVKLITVCSSLDSE 782
Query: 233 GNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGC 292
GNDF+ALVYEFMP GSL+ W+ + + ++ + +L E+LNIAIDVASALEYLH+ C
Sbjct: 783 GNDFRALVYEFMPKGSLDMWLQ-LEDLERVNDHSRSLTPAEKLNIAIDVASALEYLHVHC 841
Query: 293 KPPIAHCDIKPSNILLNDEMTACVADFGIARFL-----EATNEQTSSIGVKGTTGYIAPE 347
P+AHCDIKPSNILL+D++TA V+DFG+A+ L E+ Q SS GV+GT GY APE
Sbjct: 842 HDPVAHCDIKPSNILLDDDLTAHVSDFGLAQLLYKYDRESFLNQFSSAGVRGTIGYAAPE 901
Query: 348 YGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSAL 395
YGMG + S GDVYSFGILLLEMF+G +P+D+ F + NL ++ +S L
Sbjct: 902 YGMGGQPSIQGDVYSFGILLLEMFSGKKPTDESFAGDYNLHSYTKSIL 949
|
|
| TAIR|locus:2075631 AT3G47090 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 999 (356.7 bits), Expect = 1.0e-100, P = 1.0e-100
Identities = 213/482 (44%), Positives = 300/482 (62%)
Query: 4 NLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGI 63
N F+G I + L G+K +DLS NNLSG I E+ F L+ LNLS NNFE +PTEGI
Sbjct: 540 NHFDGTIP-DIKGLMGVKNVDLSNNNLSGSISEYFENFSKLEYLNLSDNNFEGRVPTEGI 598
Query: 64 FKNASATSVFGNNKLCGGIPEFQLPTCVSKK--TKQNRSTLPLKLVIAIDCGXXXXXXXX 121
F+NA+ SVFGN LCG I E +L C+++ + +L K+ I + G
Sbjct: 599 FQNATLVSVFGNKNLCGSIKELKLKPCIAQAPPVETRHPSLLKKVAIGVSVGIALLLLLF 658
Query: 122 XXX---FCRLMCMKKRGNPTPSISIDLDFPYVSYEALYSATKGFSSENLIGAGNFASVYK 178
F + +K N P ++++ +SY L +AT GFSS N++G+G+F +V+K
Sbjct: 659 IVSLSWFKKRKNNQKINNSAP-FTLEIFHEKLSYGDLRNATDGFSSSNIVGSGSFGTVFK 717
Query: 179 GILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKA 238
+L VA+KV N A KSF ECE +++I HR ++K++TAC+ +D+QGN+F+A
Sbjct: 718 ALLQTENKIVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACASIDFQGNEFRA 777
Query: 239 LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAH 298
L+YEFMPNGSL++W+HP E ++ H+ L LERLNIAIDVAS L+YLH+ C PIAH
Sbjct: 778 LIYEFMPNGSLDKWLHP-EEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAH 836
Query: 299 CDIKPSNILLNDEMTACVADFGIARFL-----EATNEQTSSIGVKGTTGYIAPEYGMGHE 353
CD+KPSNILL+D++TA V+DFG+AR L E+ Q SS GV+GT GY APEYGMG +
Sbjct: 837 CDLKPSNILLDDDLTAHVSDFGLARLLLKFDQESFFNQLSSAGVRGTIGYAAPEYGMGGQ 896
Query: 354 TSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPERVEEIVDTLFFKEIEE 413
S +GDVYSFG+L+LEMFTG RP++++F N L ++ ++ALPERV +I D K I
Sbjct: 897 PSIHGDVYSFGVLVLEMFTGKRPTNELFGGNFTLNSYTKAALPERVLDIAD----KSILH 952
Query: 414 EETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLIKKKLL 473
+ P +LECL I ++G+ C E P R+ ++ L I+++
Sbjct: 953 SGLRVGF---P--------VLECLKGILDVGLRCCEESPLNRLATSEAAKELISIRERFF 1001
Query: 474 ET 475
+T
Sbjct: 1002 KT 1003
|
|
| TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 990 (353.6 bits), Expect = 9.1e-100, P = 9.1e-100
Identities = 222/474 (46%), Positives = 292/474 (61%)
Query: 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPT 60
+ GN F GPI + L GL+ LDLS+NNLSG IPE++A F LQNLNLS NNF+ +PT
Sbjct: 552 LQGNSFVGPIP-DIRGLTGLRFLDLSKNNLSGTIPEYMANFSKLQNLNLSLNNFDGAVPT 610
Query: 61 EGIFKNASATSVFGNNKLCGGIPEFQLPTCVSKKTKQNRSTLPLKLVIAIDCGXXXXXXX 120
EG+F+N SA SVFGN LCGGIP QL C + +++ S ++ +I I C
Sbjct: 611 EGVFRNTSAMSVFGNINLCGGIPSLQLQPCSVELPRRHSS---VRKIITI-CVSAVMAAL 666
Query: 121 XXXXFCRL-MCMKK------RGNPTP---SIS-IDLDFPYVSYEALYSATKGFSSENLIG 169
C + +C K R N S S + + +SY+ LY T GFSS NLIG
Sbjct: 667 LLLCLCVVYLCWYKLRVKSVRANNNENDRSFSPVKSFYEKISYDELYKTTGGFSSSNLIG 726
Query: 170 AGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRV 229
+GNF +V+KG L AVAIKV N A+KSF ECE + I HR ++K+VT CS
Sbjct: 727 SGNFGAVFKGFLGSKNKAVAIKVLNLCKRGAAKSFIAECEALGGIRHRNLVKLVTICSSS 786
Query: 230 DYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLH 289
D++GNDF+ALVYEFMPNG+L+ W+HP E ++ L RLNIAIDVASAL YLH
Sbjct: 787 DFEGNDFRALVYEFMPNGNLDMWLHP-DEIEETGNPSRTLGLFARLNIAIDVASALVYLH 845
Query: 290 LGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFL-----EATNEQTSSIGVKGTTGYI 344
C PIAHCDIKPSNILL+ ++TA V+DFG+A+ L + + Q SS GV+GT GY
Sbjct: 846 TYCHNPIAHCDIKPSNILLDKDLTAHVSDFGLAQLLLKFDRDTFHIQFSSAGVRGTIGYA 905
Query: 345 APEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPERVEEIVD 404
APEYGMG S GDVYSFGI+LLE+FTG RP++ +F D L L ++ +SAL +R + +D
Sbjct: 906 APEYGMGGHPSIMGDVYSFGIVLLEIFTGKRPTNKLFVDGLTLHSFTKSALQKR--QALD 963
Query: 405 TLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKI 458
+ET+ + + Q ++ECL + +GV+CS E P R+ +
Sbjct: 964 IT-------DETILR-----GAYAQHFNMVECLTLVFRVGVSCSEESPVNRISM 1005
|
|
| TAIR|locus:2079157 AT3G47580 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 976 (348.6 bits), Expect = 2.8e-98, P = 2.8e-98
Identities = 206/487 (42%), Positives = 300/487 (61%)
Query: 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPT 60
+ GN F+G I ++ L G++ +DLS N+LSG IPE+ A F L+ LNLS NNF +P+
Sbjct: 537 LQGNSFDGAIP-NIRGLMGVRRVDLSNNDLSGSIPEYFANFSKLEYLNLSINNFTGKVPS 595
Query: 61 EGIFKNASATSVFGNNKLCGGIPEFQLPTCVSKK----TKQNRSTLPLKLVIAIDCGXXX 116
+G F+N++ VFGN LCGGI + +L C++++ TK + + ++++I
Sbjct: 596 KGNFQNSTIVFVFGNKNLCGGIKDLKLKPCLAQEPPVETKHSSHLKKVAILVSIGIALLL 655
Query: 117 XXXXXXXXFCRLMCMKKR---GNPTPSISIDLDFPYVSYEALYSATKGFSSENLIGAGNF 173
C +K N PS +++ +SY L +AT GFSS N++G+G+F
Sbjct: 656 LLVIASMVLCWFRKRRKNQQTNNLVPS-KLEIFHEKISYGDLRNATNGFSSSNMVGSGSF 714
Query: 174 ASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQG 233
+V+K +L + VA+KV N A KSF ECE +++ HR ++K++TAC+ D+QG
Sbjct: 715 GTVFKALLPTESKIVAVKVLNMQRRGAMKSFMAECESLKDTRHRNLVKLLTACASTDFQG 774
Query: 234 NDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCK 293
N+F+AL+YE++PNGS++ W+HP E+ R + P L LERLNI IDVAS L+YLH+ C
Sbjct: 775 NEFRALIYEYLPNGSVDMWLHPEEVEEIR-RPPRTLTLLERLNIVIDVASVLDYLHVHCH 833
Query: 294 PPIAHCDIKPSNILLNDEMTACVADFGIARFL-----EATNEQTSSIGVKGTTGYIAPEY 348
PIAHCD+KPSN+LL D++TA V+DFG+AR L E+ Q SS GV+GT GY APEY
Sbjct: 834 EPIAHCDLKPSNVLLEDDLTAHVSDFGLARLLLKFDKESFLNQLSSAGVRGTIGYAAPEY 893
Query: 349 GMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPERVEEIVDTLFF 408
GMG + S +GDVYSFG+LLLEMFTG RP+D++F NL L ++ + ALPE+V EI D
Sbjct: 894 GMGGQPSIHGDVYSFGVLLLEMFTGKRPTDELFGGNLTLHSYTKLALPEKVFEIAD---- 949
Query: 409 KEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLI 468
K I ++ A ECL + E+G+ C E P R+ ++V L I
Sbjct: 950 KAILHIGLRVGFRTA-----------ECLTLVLEVGLRCCEEYPTNRLATSEVAKELISI 998
Query: 469 KKKLLET 475
+++ +T
Sbjct: 999 RERFFKT 1005
|
|
| UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)] | Back alignment and assigned GO terms |
|---|
Score = 950 (339.5 bits), Expect = 1.6e-95, P = 1.6e-95
Identities = 212/478 (44%), Positives = 285/478 (59%)
Query: 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPT 60
+ NL G I +L L+GL+ LDLS NNLSG+IP LA L +LNLS N+F +PT
Sbjct: 552 LQNNLLSGSIPSALGQLKGLETLDLSSNNLSGQIPTSLADITMLHSLNLSFNSFVGEVPT 611
Query: 61 EGIFKNASATSVFGNNKLCGGIPEFQLPTCVSKKTKQNRSTLPLKLVIAIDCGXXXXXXX 120
G F AS S+ GN KLCGGIP+ LP C +NR P V+ I
Sbjct: 612 IGAFAAASGISIQGNAKLCGGIPDLHLPRCCP--LLENRKHFP---VLPISVSLAAALAI 666
Query: 121 XXXXFCRLMCMKKRGNPTPSISIDLDFPYVSYEALYSATKGFSSENLIGAGNFASVYKGI 180
+ + K+ PS + P VSY L AT GF+ NL+G+G+F SVYKG
Sbjct: 667 LSSLYLLITWHKRTKKGAPSRTSMKGHPLVSYSQLVKATDGFAPTNLLGSGSFGSVYKGK 726
Query: 181 LFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKALV 240
L VA+KV + A KSFT ECE +RN+ HR ++K+VT CS +D +GNDFKA+V
Sbjct: 727 L-NIQDHVAVKVLKLENPKALKSFTAECEALRNMRHRNLVKIVTICSSIDNRGNDFKAIV 785
Query: 241 YEFMPNGSLEEWIHPITEE--DKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAH 298
Y+FMPNGSLE+WIHP T + D+RH LN R+ I +DVA AL+YLH P+ H
Sbjct: 786 YDFMPNGSLEDWIHPETNDQADQRH-----LNLHRRVTILLDVACALDYLHRHGPEPVVH 840
Query: 299 CDIKPSNILLNDEMTACVADFGIARFL-EATN---EQTSSIGVKGTTGYIAPEYGMGHET 354
CDIK SN+LL+ +M A V DFG+AR L + T+ + TSS+G GT GY APEYG+G
Sbjct: 841 CDIKSSNVLLDSDMVAHVGDFGLARILVDGTSLIQQSTSSMGFIGTIGYAAPEYGVGLIA 900
Query: 355 SSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPERVEEIVDTLFFKEIEEE 414
S++GD+YS+GIL+LE+ TG RP+D F+ +L L+ +V+ L RV ++VDT K I +
Sbjct: 901 STHGDIYSYGILVLEIVTGKRPTDSTFRPDLGLRQYVELGLHGRVTDVVDT---KLILDS 957
Query: 415 ETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLIKKKL 472
E + + ++S R I EC+ + +G++CS ELP R D+ L IK+ L
Sbjct: 958 EN---WLNSTNNSPCRRIT-ECIVWLLRLGLSCSQELPSSRTPTGDIIDELNAIKQNL 1011
|
|
| TAIR|locus:2175703 AT5G39390 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 852 (305.0 bits), Expect = 2.1e-90, Sum P(2) = 2.1e-90
Identities = 183/386 (47%), Positives = 239/386 (61%)
Query: 23 LDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIP--------TEGIFKNASATSVFG 74
LDL LSG I + FL++LNL N+F+S IP T+G+F+N + SVFG
Sbjct: 78 LDLGGFKLSGSISPSIGNLSFLRSLNLGDNSFQSNIPQEFEGSVPTKGVFQNGTTVSVFG 137
Query: 75 NNKLCGGIPEFQLPTCVSKKTKQNRSTLPLKLVIAIDCGXXXXXXXXXXXFCRLMCMKKR 134
N LCGG+ E QL C+ + +Q + P L + G L KK+
Sbjct: 138 NENLCGGVIEMQLKPCI-ESPRQKK---PFSLGEKVAVGVGVALLFLFIIVASLSWFKKK 193
Query: 135 GNPTPSISIDLDFPYVSYEALYSATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFN 194
+ +SYE LY+AT GFSS NLIG+GNF+ V+KG+L VA+KV N
Sbjct: 194 NDK------------ISYEELYNATSGFSSSNLIGSGNFSDVFKGLLGLEEKLVAVKVLN 241
Query: 195 FLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIH 254
L H A+KSF ECE + I HR + K++T CS +D QGNDF+ALVYEFMP GSL+ W+
Sbjct: 242 LLKHGATKSFIAECESFKGIRHRNLAKLITVCSSLDSQGNDFRALVYEFMPKGSLDMWLQ 301
Query: 255 PITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTA 314
P E + + +L E++NIAIDVASALEYLH+ C P+AHCDIKPSN+LL+D++TA
Sbjct: 302 PEDLESANNHSR-SLTFAEKVNIAIDVASALEYLHVYCHDPVAHCDIKPSNVLLDDDLTA 360
Query: 315 CVADFGIARFLEATNEQT-----SSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLE 369
V+DFG+AR L +E+T SS GV+GT GY APEYGMG + S GDVYSFG+LLLE
Sbjct: 361 HVSDFGLARLLYNFDEKTFLNQFSSAGVRGTIGYAAPEYGMGSKPSIQGDVYSFGVLLLE 420
Query: 370 MFTGLRPSDDMFKDNLNLQNWVQSAL 395
MFTG +P+D+ F NL + +S L
Sbjct: 421 MFTGKKPTDNSFGGGYNLHGYTKSVL 446
|
|
| TAIR|locus:2047525 AT2G24130 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 626 (225.4 bits), Expect = 1.3e-60, P = 1.3e-60
Identities = 173/491 (35%), Positives = 254/491 (51%)
Query: 4 NLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGI 63
N F + SL L LK LD+S N L+G IP L++LN S N + +G
Sbjct: 501 NGFSSTLPSSLGQLPYLKELDVSFNRLTGAIPPSFQQSSTLKHLNFSFNLLSGNVSDKGS 560
Query: 64 FKNASATSVFGNNKLCGGIPEFQLPTCVSKKTKQNRSTLPLKL-VIA--IDC--GXXXXX 118
F + S G++ LCG I Q C KK K LP+ L +IA + C G
Sbjct: 561 FSKLTIESFLGDSLLCGSIKGMQ--AC-KKKHKYPSVLLPVLLSLIATPVLCVFGYPLVQ 617
Query: 119 XXXXXXFCRLMCMKKRGNPTPSISIDLDFPYVSYEALYSATKGFSSENLIGAGNFASVYK 178
+ ++ + D +P +SY+ L +AT GF++ +LIG+G F VYK
Sbjct: 618 RSRFGKNLTVYAKEEVEDEEKQNQNDPKYPRISYQQLIAATGGFNASSLIGSGRFGHVYK 677
Query: 179 GILFEGAPAVAIKVFN-FLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFK 237
G+L VA+KV + + S SF EC++++ HR +I+++T CS+ G F
Sbjct: 678 GVLRNNTK-VAVKVLDPKTALEFSGSFKRECQILKRTRHRNLIRIITTCSK---PG--FN 731
Query: 238 ALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIA 297
ALV MPNGSLE ++P K NL+ ++ +NI DVA + YLH +
Sbjct: 732 ALVLPLMPNGSLERHLYPGEYSSK------NLDLIQLVNICSDVAEGIAYLHHYSPVKVV 785
Query: 298 HCDIKPSNILLNDEMTACVADFGIARFLEATNEQTS-----SIG-----VKGTTGYIAPE 347
HCD+KPSNILL+DEMTA V DFGI+R ++ E S S G + G+ GYIAPE
Sbjct: 786 HCDLKPSNILLDDEMTALVTDFGISRLVQGVEETVSTDDSVSFGSTDGLLCGSVGYIAPE 845
Query: 348 YGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPERVEEIVDTLF 407
YGMG S++GDVYSFG+LLLE+ +G RP+D + + +L +++S P+ +E I
Sbjct: 846 YGMGKRASTHGDVYSFGVLLLEIVSGRRPTDVLVNEGSSLHEFMKSHYPDSLEGI----- 900
Query: 408 FKEIEEEETVYKYKKAPSSSTQ--RSIILECLNSICEIGVACSAELPGERMKINDVELGL 465
IE+ + +K + P + R +ILE + E+G+ C+ P R + DV +
Sbjct: 901 ---IEQALSRWKPQGKPEKCEKLWREVILEMI----ELGLVCTQYNPSTRPDMLDVAHEM 953
Query: 466 RLIKKKLLETP 476
+K+ L P
Sbjct: 954 GRLKEYLFACP 964
|
|
| UNIPROTKB|O24435 O24435 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)] | Back alignment and assigned GO terms |
|---|
Score = 575 (207.5 bits), Expect = 4.1e-54, P = 4.1e-54
Identities = 119/269 (44%), Positives = 162/269 (60%)
Query: 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPT 60
+ N G I ++L+ L+GL LDLS NNLSG+IP L L +LNLS N+F +PT
Sbjct: 526 LQNNFLNGSIPIALTQLKGLDTLDLSGNNLSGQIPMSLGDMPLLHSLNLSFNSFHGEVPT 585
Query: 61 EGIFKNASATSVFGNNKLCGGIPEFQLPTCVSKKTKQNRSTLPLKLVIAIDCGXXXXXXX 120
G+F NAS + GN +CGGIPE LPTC K K+ + + L LV+ I C
Sbjct: 586 NGVFANASEIYIQGNAHICGGIPELHLPTCSLKSRKKKKHQI-LLLVVVI-C-LVSTLAV 642
Query: 121 XXXXFCRLMCMKKRGNPTPSISIDLDFPYVSYEALYSATKGFSSENLIGAGNFASVYKGI 180
+ L C K+R P+ + P ++Y+ L AT GFSS +L+G+G+F SVYKG
Sbjct: 643 FSLLYMLLTCHKRRKKEVPATTSMQGHPMITYKQLVKATDGFSSSHLLGSGSFGSVYKGE 702
Query: 181 LF--EG--APAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDF 236
+G VA++V A KSFT ECE +RN HR ++K+VT CS +D +GNDF
Sbjct: 703 FDSQDGEITSLVAVRVLKLETPKALKSFTAECETLRNTRHRNLVKIVTICSSIDNRGNDF 762
Query: 237 KALVYEFMPNGSLEEWIHPITEE--DKRH 263
KA+VY+FMPNGSLE+W+HP T + ++RH
Sbjct: 763 KAIVYDFMPNGSLEDWLHPETNDQAEQRH 791
|
|
| TAIR|locus:2170483 FLS2 "FLAGELLIN-SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 558 (201.5 bits), Expect = 4.8e-51, P = 4.8e-51
Identities = 153/484 (31%), Positives = 250/484 (51%)
Query: 4 NLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGI 63
N F G I S + L LDLS NNL+GEIPE LA L++L L+ NN + +P G+
Sbjct: 708 NSFSGEIPQSFGNMTHLVSLDLSSNNLTGEIPESLANLSTLKHLKLASNNLKGHVPESGV 767
Query: 64 FKNASATSVFGNNKLCGGIPEFQLPTCVSKKTKQNRSTLPLKLVIAIDCGXXXXXXXXXX 123
FKN +A+ + GN LCG + L C K+ K + + ++++ I G
Sbjct: 768 FKNINASDLMGNTDLCGS--KKPLKPCTIKQ-KSSHFSKRTRVILII-LGSAAALLLVLL 823
Query: 124 XFCRLMCMKKRG----NPTPSISIDLD--FPYVSYEA--LYSATKGFSSENLIGAGNFAS 175
L C KK+ N + S DLD +E L AT F+S N+IG+ + ++
Sbjct: 824 LVLILTCCKKKEKKIENSSESSLPDLDSALKLKRFEPKELEQATDSFNSANIIGSSSLST 883
Query: 176 VYKGILFEGAPAVAIKVFNFLHHDAS--KSFTVECEVMRNIIHRKIIKVVTACSRVDYQG 233
VYKG L +G +A+KV N A K F E + + + HR ++K++ ++
Sbjct: 884 VYKGQLEDGT-VIAVKVLNLKEFSAESDKWFYTEAKTLSQLKHRNLVKILGFA----WES 938
Query: 234 NDFKALVYEFMPNGSLEEWIHPITEEDKRHKAP-GNLNSLERLNIAIDVASALEYLHLGC 292
KALV FM NG+LE+ IH AP G+L LE++++ + +AS ++YLH G
Sbjct: 939 GKTKALVLPFMENGNLEDTIHGSA-------APIGSL--LEKIDLCVHIASGIDYLHSGY 989
Query: 293 KPPIAHCDIKPSNILLNDEMTACVADFGIARFL---EATNEQTSSIGVKGTTGYIAPEYG 349
PI HCD+KP+NILL+ + A V+DFG AR L E + S+ +GT GY+APE+
Sbjct: 990 GFPIVHCDLKPANILLDSDRVAHVSDFGTARILGFREDGSTTASTSAFEGTIGYLAPEFA 1049
Query: 350 MGHETSSYGDVYSFGILLLEMFTGLRPS--DDMFKDNLNLQNWVQSALPERVEEIVDTLF 407
+ ++ DV+SFGI+++E+ T RP+ +D ++ L+ V+ ++ + +V L
Sbjct: 1050 YMRKVTTKADVFSFGIIMMELMTKQRPTSLNDEDSQDMTLRQLVEKSIGNGRKGMVRVL- 1108
Query: 408 FKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRL 467
++E +++ K+ E + ++ + C++ P +R +N++ L
Sbjct: 1109 --DMELGDSIVSLKQE-----------EAIEDFLKLCLFCTSSRPEDRPDMNEILTHLMK 1155
Query: 468 IKKK 471
++ K
Sbjct: 1156 LRGK 1159
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00029263001 | SubName- Full=Chromosome chr13 scaffold_48, whole genome shotgun sequence; (886 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 873 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-39 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 5e-39 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-35 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-31 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-31 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-30 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-29 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-29 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 5e-28 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-27 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 6e-25 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-23 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 8e-23 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-22 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 8e-22 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-21 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-21 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-20 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-20 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-19 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 8e-19 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-18 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-18 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 5e-18 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 6e-18 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 8e-18 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-17 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-17 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-17 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-17 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-17 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 5e-17 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 8e-17 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 9e-17 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-16 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-16 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-16 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 5e-16 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 6e-16 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 8e-16 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 8e-16 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-15 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-15 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-15 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-15 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 5e-15 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 7e-15 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 7e-15 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 8e-15 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 9e-15 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-14 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-14 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-14 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-14 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-14 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 5e-14 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-13 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-13 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-13 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-13 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-13 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 5e-13 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 6e-13 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 7e-13 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 7e-13 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 8e-13 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 9e-13 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 9e-13 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-12 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-12 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-12 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-12 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-12 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-12 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 5e-12 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 6e-12 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-11 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-11 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-11 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-11 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-11 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-11 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-11 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-11 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-11 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-11 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-11 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-11 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-11 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-11 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-11 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-11 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-11 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-11 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 5e-11 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 5e-11 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 5e-11 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 5e-11 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 5e-11 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 6e-11 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 6e-11 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 8e-11 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 8e-11 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-10 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-10 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-10 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-10 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-10 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-10 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 4e-10 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 4e-10 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-10 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 6e-10 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 7e-10 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 8e-10 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 8e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 9e-10 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 9e-10 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 9e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 9e-10 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-09 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-09 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-09 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-09 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-09 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-09 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-09 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-09 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-09 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-09 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-09 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-09 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-09 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-09 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-09 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-09 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 5e-09 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 5e-09 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 6e-09 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 7e-09 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 7e-09 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 7e-09 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 7e-09 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 8e-09 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 9e-09 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-08 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-08 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-08 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-08 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-08 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-08 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-08 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-08 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-08 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-08 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-08 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-08 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-08 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-08 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-08 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-08 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 4e-08 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 4e-08 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-08 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 5e-08 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-08 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 5e-08 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 6e-08 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 6e-08 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 7e-08 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 8e-08 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 8e-08 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 8e-08 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 8e-08 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 9e-08 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-07 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-07 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-07 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-07 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-07 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-07 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-07 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-07 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-07 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-07 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-07 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-07 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-07 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-07 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-07 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-07 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-07 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-07 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-07 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 4e-07 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 5e-07 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 6e-07 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 6e-07 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 6e-07 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 7e-07 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 8e-07 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 8e-07 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 8e-07 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 9e-07 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 9e-07 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 9e-07 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-06 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-06 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-06 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-06 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-06 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-06 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-06 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-06 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-06 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-06 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-06 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-06 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-06 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-06 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-06 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-06 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 4e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 4e-06 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-06 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 4e-06 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 6e-06 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 7e-06 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 7e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 7e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 7e-06 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 7e-06 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-05 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-05 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-05 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-05 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-05 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-05 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-05 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-05 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-05 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-05 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-05 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-05 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-05 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-05 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-05 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 4e-05 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 4e-05 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-05 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 4e-05 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 4e-05 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-05 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 4e-05 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 5e-05 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 5e-05 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 5e-05 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-05 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 6e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 6e-05 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 6e-05 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 7e-05 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 7e-05 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 7e-05 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 7e-05 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 9e-05 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 9e-05 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 9e-05 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-04 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-04 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-04 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-04 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-04 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-04 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-04 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-04 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-04 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-04 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-04 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-04 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-04 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-04 | |
| pfam12799 | 43 | pfam12799, LRR_4, Leucine Rich repeats (2 copies) | 3e-04 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 4e-04 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 4e-04 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 5e-04 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 5e-04 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 5e-04 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-04 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-04 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 6e-04 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 6e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 6e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 7e-04 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 7e-04 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 8e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 0.001 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 0.001 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 0.002 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 0.002 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 0.002 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 0.002 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 0.003 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 0.003 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 0.003 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 0.003 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 0.003 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 3e-39
Identities = 59/206 (28%), Positives = 95/206 (46%), Gaps = 22/206 (10%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIKVFNF-LHHDASKSFTVECEVMRNIIHRKIIKVVTAC 226
+G G F +VY + VAIK+ + E E+++ + H I+K+
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 227 SRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALE 286
+ + LV E+ GSL++ + + G L+ E L I + + LE
Sbjct: 61 -----EDENHLYLVMEYCEGGSLKDLLK---------ENEGKLSEDEILRILLQILEGLE 106
Query: 287 YLHLGCKPPIAHCDIKPSNILL-NDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIA 345
YLH I H D+KP NILL +D +ADFG+++ L + +I GT Y+A
Sbjct: 107 YLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV--GTPAYMA 161
Query: 346 PEYGMGHETSSY-GDVYSFGILLLEM 370
PE +G S D++S G++L E+
Sbjct: 162 PEVLLGKGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 5e-39
Identities = 64/234 (27%), Positives = 106/234 (45%), Gaps = 38/234 (16%)
Query: 162 FSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDAS-KSFTVECEVMRNIIHRKII 220
+ +G G+F VY + VAIKV + E ++++ + H I+
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 221 KVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIH---PITEEDKRHKAPGNLNSLERLNI 277
++ ++ D LV E+ G L + + ++E++ R
Sbjct: 61 RLYDV-----FEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARF-------------Y 102
Query: 278 AIDVASALEYLH-LGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIG 336
+ SALEYLH G I H D+KP NILL+++ +ADFG+AR L+ + T+ +
Sbjct: 103 LRQILSALEYLHSKG----IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFV- 157
Query: 337 VKGTTGYIAPE--YGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQ 388
GT Y+APE G G+ + D++S G++L E+ TG P F + L
Sbjct: 158 --GTPEYMAPEVLLGKGYGKAV--DIWSLGVILYELLTGKPP----FPGDDQLL 203
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 4e-35
Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 27/211 (12%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIKVFN--FLHHDASKSFTVECEVMRNIIHRKIIKVVTA 225
+G+G+F +VYK VA+K+ ++ E ++R + H I++++ A
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 226 CSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASAL 285
D LV E+ G L +++ R G L+ E IA+ + L
Sbjct: 67 FED-----KDHLYLVMEYCEGGDLFDYLS-------RG---GPLSEDEAKKIALQILRGL 111
Query: 286 EYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIA 345
EYLH I H D+KP NILL++ +ADFG+A+ L ++ ++ GT Y+A
Sbjct: 112 EYLH---SNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV--GTPWYMA 166
Query: 346 PE---YGMGHETSSYGDVYSFGILLLEMFTG 373
PE G G+ DV+S G++L E+ TG
Sbjct: 167 PEVLLGGNGYGPKV--DVWSLGVILYELLTG 195
|
Length = 260 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 60/219 (27%), Positives = 100/219 (45%), Gaps = 23/219 (10%)
Query: 168 IGAGNFASVYKGILFEGAPA----VAIKVFN-FLHHDASKSFTVECEVMRNIIHRKIIKV 222
+G G F VYKG L VA+K + + F E +M+ + H I+++
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 223 VTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVA 282
+ C+ QG +V E+MP G L +++ K L + L +A+ +A
Sbjct: 67 LGVCT----QGEPLY-IVTEYMPGGDLLDFLR---------KHGEKLTLKDLLQMALQIA 112
Query: 283 SALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTG 342
+EYL H D+ N L+ + + ++DFG++R + + G K
Sbjct: 113 KGMEYLE---SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIK 169
Query: 343 YIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDM 380
++APE + +S DV+SFG+LL E+FT G +P M
Sbjct: 170 WMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGM 208
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 61/221 (27%), Positives = 99/221 (44%), Gaps = 33/221 (14%)
Query: 166 NLIGAGNFASVYKGILFEGAP---AVAIKVFNFLHHDASKS----FTVECEVMRNIIHRK 218
+G G F VYKG L VA+K L DAS+ F E VM+ + H
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKT---LKEDASEEERKDFLKEARVMKKLGHPN 57
Query: 219 IIKVVTACSRVD--YQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLN 276
+++++ C+ + Y LV E+M G L +++ + L+ + L+
Sbjct: 58 VVRLLGVCTEEEPLY-------LVLEYMEGGDLLDYLRKSRPVFPSPE-KSTLSLKDLLS 109
Query: 277 IAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIG 336
AI +A +EYL H D+ N L+ +++ ++DFG++R + +
Sbjct: 110 FAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDY-----Y 161
Query: 337 VKGTTGYI-----APEYGMGHETSSYGDVYSFGILLLEMFT 372
K T G + APE +S DV+SFG+LL E+FT
Sbjct: 162 RKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFT 202
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 64/235 (27%), Positives = 107/235 (45%), Gaps = 32/235 (13%)
Query: 168 IGAGNFASVYKGILFEGAPA----VAIKVFNFLHHDAS----KSFTVECEVMRNIIHRKI 219
+G G F VYKG L VA+K L DAS + F E +MR + H +
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKT---LKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 220 IKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAI 279
+K++ C+ + +V E+M G L ++ K L+ + L+ A+
Sbjct: 64 VKLLGVCT----EEEPLY-IVMEYMEGGDLLSYLR---------KNRPKLSLSDLLSFAL 109
Query: 280 DVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKG 339
+A +EYL H D+ N L+ + + ++DFG++R L + G K
Sbjct: 110 QIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD-DYYRKRGGKL 165
Query: 340 TTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQS 393
++APE + +S DV+SFG+LL E+FT G +P M N + ++++
Sbjct: 166 PIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGM--SNEEVLEYLKN 218
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 65/222 (29%), Positives = 106/222 (47%), Gaps = 29/222 (13%)
Query: 168 IGAGNFASVYKGILFEGAP----AVAIKVFNFLHHDAS----KSFTVECEVMRNIIHRKI 219
+G G F VYKG L VA+K L DAS + F E +MR + H I
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKT---LKEDASEQQIEEFLREARIMRKLDHPNI 63
Query: 220 IKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAI 279
+K++ C+ + +V E+MP G L +++ ++++ P L+ + L+ A+
Sbjct: 64 VKLLGVCT----EEEPLM-IVMEYMPGGDLLDYL-------RKNR-PKELSLSDLLSFAL 110
Query: 280 DVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKG 339
+A +EYL H D+ N L+ + + ++DFG++R L + G K
Sbjct: 111 QIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGG-KL 166
Query: 340 TTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDM 380
++APE + +S DV+SFG+LL E+FT G P M
Sbjct: 167 PIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGM 208
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 2e-29
Identities = 102/400 (25%), Positives = 168/400 (42%), Gaps = 54/400 (13%)
Query: 4 NLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGI 63
N G I S S + L LDLSQN LSGEIP+ L + L +N+SHN+ +P+ G
Sbjct: 533 NQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGA 592
Query: 64 FKNASATSVFGNNKLCGGIPEFQLPTCVSKKTKQNRSTLPLKLVIAIDCGLLVLTLALSS 123
F +A++V GN LCGG LP C K+ R T I C L +
Sbjct: 593 FLAINASAVAGNIDLCGGDTTSGLPPC-----KRVRKTPSWWFYIT--CTLGAFLVLALV 645
Query: 124 LFCRLMCMKKRGNPTPSI-----SIDLDF------PYVSYEALYSATKGFSSENLIGAGN 172
F + + + + +L F ++ + S+ K EN+I G
Sbjct: 646 AFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDILSSLK---EENVISRGK 702
Query: 173 FASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQ 232
+ YKG + +K N + S + M + H I+K++ C +
Sbjct: 703 KGASYKGKSIKNGMQFVVKEIN-DVNSIPSSEIAD---MGKLQHPNIVKLIGLC-----R 753
Query: 233 GNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGC 292
L++E++ +L E + ++ E +R IAI +A AL +LH C
Sbjct: 754 SEKGAYLIHEYIEGKNLSEVLRNLSWERRR-------------KIAIGIAKALRFLHCRC 800
Query: 293 KPPIAHCDIKPSNILLN--DEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGM 350
P + ++ P I+++ DE + + L + S + Y+APE
Sbjct: 801 SPAVVVGNLSPEKIIIDGKDEPHLRL---SLPGLLCTDTKCFIS------SAYVAPETRE 851
Query: 351 GHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNW 390
+ + D+Y FG++L+E+ TG P+D F + ++ W
Sbjct: 852 TKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEW 891
|
Length = 968 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 5e-28
Identities = 75/294 (25%), Positives = 118/294 (40%), Gaps = 42/294 (14%)
Query: 161 GFSSENLIGAGNFASVYKGILFEGAPAVAIKVFN---FLHHDASKSFTVECEVMRNIIHR 217
+ +G G+F VY + VA+KV + F E +++ ++ H
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRK---LVALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 218 K-IIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLN 276
I+K+ +Q LV E++ GSLE+ + K+ G L+ E L
Sbjct: 58 PNIVKLYDF-----FQDEGSLYLVMEYVDGGSLEDLL-------KKIGRKGPLSESEALF 105
Query: 277 IAIDVASALEYLHLGCKPPIAHCDIKPSNILLN-DEMTACVADFGIARFLEATNEQTSSI 335
I + SALEYLH I H DIKP NILL+ D + DFG+A+ L +S
Sbjct: 106 ILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIP 162
Query: 336 GVK----GTTGYIAPEYGMGHETSSYG---DVYSFGILLLEMFTGLRPSDDMFKDNLNLQ 388
+ GT GY+APE +G + D++S GI L E+ TGL P + + Q
Sbjct: 163 ALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQ 222
Query: 389 NWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICE 442
+I+ L + + S ++ + L +
Sbjct: 223 TL----------KIILELPTPSLASP--LSPSNPELISKAASDLLKKLLAKDPK 264
|
Length = 384 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 4e-27
Identities = 56/218 (25%), Positives = 91/218 (41%), Gaps = 28/218 (12%)
Query: 166 NLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECE--VMRNIIHRKIIKVV 223
L+G G+F SVY + + +A+K + +E E ++ ++ H I++
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVR-- 63
Query: 224 TAC--SRVDYQGNDFKALVYEFMPNGSLEEWIH---PITEEDKRHKAPGNLNSLERLNIA 278
S D + N + E++ GSL + + E R
Sbjct: 64 --YYGSERDEEKNTLN-IFLEYVSGGSLSSLLKKFGKLPEPVIRK-------------YT 107
Query: 279 IDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVK 338
+ L YLH I H DIK +NIL++ + +ADFG A+ L + V+
Sbjct: 108 RQILEGLAYLH-SNG--IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVR 164
Query: 339 GTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRP 376
GT ++APE G E D++S G ++EM TG P
Sbjct: 165 GTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 6e-25
Identities = 61/222 (27%), Positives = 92/222 (41%), Gaps = 40/222 (18%)
Query: 162 FSSENLIGAGNFASVYKGI-LFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKII 220
F IG G F VYK G VAIKV + + E ++++ H I+
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKE-VAIKVIKLESKEKKEKIINEIQILKKCKHPNIV 60
Query: 221 KVVTACSRVDYQGNDFKALVYEFMPNGSLEE----WIHPITEEDKRHKAPGNLNSLERLN 276
K + Y D +V EF GSL++ +TE
Sbjct: 61 KYYGS-----YLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQ---------------- 99
Query: 277 IA---IDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTS 333
IA ++ LEYLH I H DIK +NILL + + DFG++ L T + +
Sbjct: 100 IAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNT 156
Query: 334 SIGVKGTTGYIAPEY--GMGHETSSYGDVYSFGILLLEMFTG 373
+ GT ++APE G ++ + D++S GI +E+ G
Sbjct: 157 MV---GTPYWMAPEVINGKPYDYKA--DIWSLGITAIELAEG 193
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 66/219 (30%), Positives = 105/219 (47%), Gaps = 35/219 (15%)
Query: 162 FSSENLIGAGNFASVYKGILFEGAPAVAIKVF---NFLHHDASKSFTVECEVMRNIIHRK 218
F+ E +G+G F V++G L++ VAIK+ + L F E + ++ + H+
Sbjct: 8 FTLERKLGSGYFGEVWEG-LWKNRVRVAIKILKSDDLLKQQ---DFQKEVQALKRLRHKH 63
Query: 219 IIKVVTACSRVD--YQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLN 276
+I + CS + Y ++ E M GSL ++ + E + L ++
Sbjct: 64 LISLFAVCSVGEPVY-------IITELMEKGSLLAFLR--SPEGQ------VLPVASLID 108
Query: 277 IAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSS-- 334
+A VA + YL + H D+ NIL+ +++ VADFG+AR ++ +S
Sbjct: 109 MACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKK 165
Query: 335 IGVKGTTGYIAPEYGMGHET-SSYGDVYSFGILLLEMFT 372
I K T APE H T S+ DV+SFGILL EMFT
Sbjct: 166 IPYKWT----APE-AASHGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.1 bits (245), Expect = 8e-23
Identities = 71/230 (30%), Positives = 111/230 (48%), Gaps = 38/230 (16%)
Query: 166 NLIGAGNFASVYKGILFEGAPAVAIK--VFNFLHHDASKSFTVECEVMRNIIHRKIIKVV 223
+LIG G F VYKG+ E VAIK + +A KS E ++++N+ H I+K +
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 224 TACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVA- 282
+ + +D ++ E+ NGSL + I K+ G E L +A+ V
Sbjct: 66 GS-----IETSDSLYIILEYAENGSLRQII-------KKF---GPFP--ESL-VAVYVYQ 107
Query: 283 --SALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGT 340
L YLH + + H DIK +NIL + +ADFG+A L ++ +S V GT
Sbjct: 108 VLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS--VVGT 162
Query: 341 TGYIAPEY--GMGHETSSYGDVYSFGILLLEMFTG------LRPSDDMFK 382
++APE G T+S D++S G ++E+ TG L P +F+
Sbjct: 163 PYWMAPEVIEMSGASTAS--DIWSLGCTVIELLTGNPPYYDLNPMAALFR 210
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 1e-22
Identities = 62/207 (29%), Positives = 98/207 (47%), Gaps = 23/207 (11%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACS 227
+GAG F V++G L+ VA+K D K F E ++M+ + H K+I++ C+
Sbjct: 14 LGAGQFGEVWEG-LWNNTTPVAVKTLKPGTMDP-KDFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 228 RVD--YQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASAL 285
+ Y +V E M GSL E++ A L + +++A VAS +
Sbjct: 72 LEEPIY-------IVTELMKYGSLLEYLQ--------GGAGRALKLPQLIDMAAQVASGM 116
Query: 286 EYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIA 345
YL H D+ N+L+ + VADFG+AR ++ + + G K + A
Sbjct: 117 AYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIK-EDIYEAREGAKFPIKWTA 172
Query: 346 PEYGMGHETSSYGDVYSFGILLLEMFT 372
PE + + S DV+SFGILL E+ T
Sbjct: 173 PEAALYNRFSIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 95.7 bits (239), Expect = 8e-22
Identities = 61/212 (28%), Positives = 95/212 (44%), Gaps = 24/212 (11%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIKVFNFLHHDAS-KSFTVECEVMRNIIHRKIIKVVTAC 226
+G G+ VYK A+K + + K E + +R+ ++K C
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVK----C 64
Query: 227 SRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKA--PGNLNSLERLNIAIDVASA 284
Y+ + ++V E+M GSL + + K+ L IA +
Sbjct: 65 YGAFYKEGEI-SIVLEYMDGGSLADLL-------KKVGKIPEPVLAY-----IARQILKG 111
Query: 285 LEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYI 344
L+YLH I H DIKPSN+L+N + +ADFGI++ LE T +Q ++ GT Y+
Sbjct: 112 LDYLHTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTF--VGTVTYM 167
Query: 345 APEYGMGHETSSYGDVYSFGILLLEMFTGLRP 376
+PE G S D++S G+ LLE G P
Sbjct: 168 SPERIQGESYSYAADIWSLGLTLLECALGKFP 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 95.7 bits (239), Expect = 1e-21
Identities = 65/243 (26%), Positives = 102/243 (41%), Gaps = 44/243 (18%)
Query: 162 FSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH---HDASKSFTVECEVM-RNIIHR 217
F +IG G+F++V E AIK+ + K +E EV+ R H
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62
Query: 218 KIIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNI 277
IIK+ +Q + V E+ PNG L ++I G+L+
Sbjct: 63 GIIKLYYT-----FQDEENLYFVLEYAPNGELLQYIRKY----------GSLDEKCTRFY 107
Query: 278 AIDVASALEYLH-LGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIG 336
A ++ ALEYLH G I H D+KP NILL+ +M + DFG A+ L+ + S+ G
Sbjct: 108 AAEILLALEYLHSKG----IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKG 163
Query: 337 VK------------------GTTGYIAPEYGMGHETSSYG-DVYSFGILLLEMFTGLRPS 377
GT Y++PE + + + D+++ G ++ +M TG P
Sbjct: 164 DATNIDSQIEKNRRRFASFVGTAEYVSPEL-LNEKPAGKSSDLWALGCIIYQMLTGKPPF 222
Query: 378 DDM 380
Sbjct: 223 RGS 225
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 1e-21
Identities = 63/207 (30%), Positives = 104/207 (50%), Gaps = 26/207 (12%)
Query: 167 LIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTAC 226
IG G F V G + G VA+K A+++F E VM + H +++++
Sbjct: 13 TIGKGEFGDVMLGD-YRGQ-KVAVKCLK-DDSTAAQAFLAEASVMTTLRHPNLVQLLGVV 69
Query: 227 SRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALE 286
QGN +V E+M GSL +++ R + + ++L A+DV +E
Sbjct: 70 ----LQGNPL-YIVTEYMAKGSLVDYL--------RSRGRAVITLAQQLGFALDVCEGME 116
Query: 287 YLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSS-IGVKGTTGYIA 345
YL + H D+ N+L+++++ A V+DFG+A+ EA+ Q S + VK T A
Sbjct: 117 YLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAK--EASQGQDSGKLPVKWT----A 167
Query: 346 PEYGMGHETSSYGDVYSFGILLLEMFT 372
PE + S+ DV+SFGILL E+++
Sbjct: 168 PEALREKKFSTKSDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 3e-20
Identities = 62/209 (29%), Positives = 102/209 (48%), Gaps = 26/209 (12%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKS---FTVECEVMRNIIHRKIIKVVT 224
+G+G F V+ G + G VAIK+ + + S F E +VM + H ++++
Sbjct: 12 LGSGQFGVVHLG-KWRGKIDVAIKMI----REGAMSEDDFIEEAKVMMKLSHPNLVQLYG 66
Query: 225 ACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASA 284
C++ Q F +V E+M NG L ++ + K G L + L++ DV A
Sbjct: 67 VCTK---QRPIF--IVTEYMANGCLLNYL-------RERK--GKLGTEWLLDMCSDVCEA 112
Query: 285 LEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYI 344
+EYL H D+ N L+ ++ V+DFG+AR++ ++ TSS G K +
Sbjct: 113 MEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYV-LDDQYTSSQGTKFPVKWA 168
Query: 345 APEYGMGHETSSYGDVYSFGILLLEMFTG 373
PE SS DV+SFG+L+ E+F+
Sbjct: 169 PPEVFDYSRFSSKSDVWSFGVLMWEVFSE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.3 bits (225), Expect = 4e-20
Identities = 64/225 (28%), Positives = 97/225 (43%), Gaps = 49/225 (21%)
Query: 168 IGAGNFASVYK------GILFEGAPAVAIKVFN---FLHHDASKSFTVECEVMRNIIHRK 218
+G G+F V G L+ A+KV + + E ++ I H
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLY------AMKVLKKKKIIKRKEVEHTLTERNILSRINHPF 54
Query: 219 IIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLN-- 276
I+K + +Q + LV E+ P G L + H L+ R +
Sbjct: 55 IVK--LHYA---FQTEEKLYLVLEYAPGGEL--FSH--------------LSKEGRFSEE 93
Query: 277 ----IAIDVASALEYLH-LGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQ 331
A ++ ALEYLH LG I + D+KP NILL+ + + DFG+A+ L + +
Sbjct: 94 RARFYAAEIVLALEYLHSLG----IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSR 149
Query: 332 TSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRP 376
T++ GT Y+APE +G D +S G+LL EM TG P
Sbjct: 150 TNTF--CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 2e-19
Identities = 60/207 (28%), Positives = 102/207 (49%), Gaps = 23/207 (11%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACS 227
+GAG F V+ G + G VA+K ++F E ++M+ + H K++++ CS
Sbjct: 14 LGAGQFGEVWMG-TWNGTTKVAVKTLKPGTMSP-EAFLQEAQIMKKLRHDKLVQLYAVCS 71
Query: 228 RVD--YQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASAL 285
+ Y +V E+M GSL +++ + E K+ + P + +++A +A +
Sbjct: 72 EEEPIY-------IVTEYMSKGSLLDFLK--SGEGKKLRLP------QLVDMAAQIAEGM 116
Query: 286 EYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIA 345
YL H D+ NIL+ + + +ADFG+AR +E +E T+ G K + A
Sbjct: 117 AYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIE-DDEYTAREGAKFPIKWTA 172
Query: 346 PEYGMGHETSSYGDVYSFGILLLEMFT 372
PE + DV+SFGILL E+ T
Sbjct: 173 PEAANYGRFTIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 8e-19
Identities = 58/218 (26%), Positives = 96/218 (44%), Gaps = 21/218 (9%)
Query: 166 NLIGAGNFASVYKG---ILFEGAPA-VAIKVFNFLHHDASKS-FTVECEVMRNIIHRKII 220
+G G+F V L + VA+K N + +S F E E++R + H I+
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 221 KVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAID 280
K C + G L+ E++P+GSL +++ +RH+ +N L +
Sbjct: 70 KYKGVC---EKPGGRSLRLIMEYLPSGSLRDYL-------QRHRD--QINLKRLLLFSSQ 117
Query: 281 VASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGT 340
+ ++YL H D+ NIL+ E ++DFG+A+ L + +
Sbjct: 118 ICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGES 174
Query: 341 -TGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPS 377
+ APE + SS DV+SFG+ L E+FT PS
Sbjct: 175 PIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPS 212
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 2e-18
Identities = 60/218 (27%), Positives = 108/218 (49%), Gaps = 29/218 (13%)
Query: 165 ENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDAS--KSFTVECEVMRNIIHRKIIKV 222
++ +G G + VY+G+ + + VA+K L D + F E VM+ I H ++++
Sbjct: 11 KHKLGGGQYGEVYEGVWKKYSLTVAVKT---LKEDTMEVEEFLKEAAVMKEIKHPNLVQL 67
Query: 223 VTACSRVD--YQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAID 280
+ C+R Y ++ EFM G+L +++ ++ +N++ L +A
Sbjct: 68 LGVCTREPPFY-------IITEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQ 112
Query: 281 VASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGT 340
++SA+EYL K H D+ N L+ + VADFG++R + + T+ G K
Sbjct: 113 ISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFP 168
Query: 341 TGYIAPEYGMGHET-SSYGDVYSFGILLLEMFT-GLRP 376
+ APE + + S DV++FG+LL E+ T G+ P
Sbjct: 169 IKWTAPE-SLAYNKFSIKSDVWAFGVLLWEIATYGMSP 205
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 84.9 bits (211), Expect = 3e-18
Identities = 55/222 (24%), Positives = 89/222 (40%), Gaps = 36/222 (16%)
Query: 166 NLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDAS-KSFTV-ECEVMRNIIHRKIIKVV 223
IG G+F VY +K + + + + E ++++ + H IIK
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKY- 64
Query: 224 TACSRVDYQGNDFKALVYEFMPNGSLEEWIH-------PITEEDKRHKAPGNLNSLERLN 276
++ +V E+ G L + I P EE + L+
Sbjct: 65 ----YESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEE-------------QILD 107
Query: 277 IAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIG 336
+ + AL+YLH I H DIKP NI L + DFGI++ L +T + +
Sbjct: 108 WFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT-- 162
Query: 337 VKGTTGYIAPEY--GMGHETSSYGDVYSFGILLLEMFTGLRP 376
V GT Y++PE + S D++S G +L E+ T P
Sbjct: 163 VVGTPYYLSPELCQNKPYNYKS--DIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 5e-18
Identities = 75/265 (28%), Positives = 128/265 (48%), Gaps = 32/265 (12%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACS 227
+G G F V+ G + G VAIK + ++F E +VM+ + H K++++ S
Sbjct: 14 LGQGCFGEVWMGT-WNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 71
Query: 228 RVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEY 287
+ +V E+M GSL +++ E K + P + +++A +AS + Y
Sbjct: 72 E------EPIYIVTEYMSKGSLLDFLK--GEMGKYLRLP------QLVDMAAQIASGMAY 117
Query: 288 LHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPE 347
+ + H D++ +NIL+ + + VADFG+AR +E NE T+ G K + APE
Sbjct: 118 VE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPE 173
Query: 348 YGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQ--------SALPER 398
+ + DV+SFGILL E+ T G P M N + + V+ PE
Sbjct: 174 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV--NREVLDQVERGYRMPCPPECPES 231
Query: 399 VEEIVDTLFFKEIEEEETVYKYKKA 423
+ +++ + KE EE T ++Y +A
Sbjct: 232 LHDLMCQCWRKEPEERPT-FEYLQA 255
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 6e-18
Identities = 66/226 (29%), Positives = 112/226 (49%), Gaps = 27/226 (11%)
Query: 163 SSENLIGAGNFASVYKGILF---EGAPAVAIKVFNFLHHDASKS-FTVECEVMRNIIHRK 218
+ + +IGAG F V++GIL AVAIK + + + F E +M H
Sbjct: 8 TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHN 67
Query: 219 IIKVVTACSRVDYQGNDFK--ALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLN 276
II++ ++ FK ++ E+M NG+L++++ + D G +S + +
Sbjct: 68 IIRLEGVVTK-------FKPAMIITEYMENGALDKYLR---DHD------GEFSSYQLVG 111
Query: 277 IAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQT-SSI 335
+ +A+ ++YL H D+ NIL+N + V+DFG++R LE E T ++
Sbjct: 112 MLRGIAAGMKYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTS 168
Query: 336 GVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDM 380
G K + APE + +S DV+SFGI++ E+ + G RP DM
Sbjct: 169 GGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDM 214
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 8e-18
Identities = 75/250 (30%), Positives = 111/250 (44%), Gaps = 35/250 (14%)
Query: 137 PTPSISIDLDFPYVSYEALYSATKGFSS---ENLIGAGNFASVYKGILFEGAPAVAIKVF 193
P PS S + + SA K S N IG+G +VYK I A+KV
Sbjct: 48 PPPSSSSSSSSSSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVI 107
Query: 194 NFLHHDA-SKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEW 252
H D + E E++R++ H ++K C + + + L+ EFM GSLE
Sbjct: 108 YGNHEDTVRRQICREIEILRDVNHPNVVK----CHDMFDHNGEIQVLL-EFMDGGSLEG- 161
Query: 253 IHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEM 312
I +E ++A + S + YLH + I H DIKPSN+L+N
Sbjct: 162 -THIADE------------QFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAK 205
Query: 313 TACVADFGIARFLEATNEQ-TSSIGVKGTTGYIAPE-----YGMGHETSSYGDVYSFGIL 366
+ADFG++R L T + SS+ GT Y++PE G GD++S G+
Sbjct: 206 NVKIADFGVSRILAQTMDPCNSSV---GTIAYMSPERINTDLNHGAYDGYAGDIWSLGVS 262
Query: 367 LLEMFTGLRP 376
+LE + G P
Sbjct: 263 ILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 1e-17
Identities = 61/221 (27%), Positives = 99/221 (44%), Gaps = 30/221 (13%)
Query: 168 IGAGNFASVYKGILFEGAPA-----VAIKVF-NFLHHDASKSFTVECEVMRNIIHRKIIK 221
+G G F V+ G + P VA+K +DA K F E E++ N H I+K
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 222 VVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGN----LNSLERLNI 277
C+ D +V+E+M +G L +++ + K+P + L + L I
Sbjct: 73 FYGVCTE-----GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQI 127
Query: 278 AIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGV 337
A+ +AS + YL H D+ N L+ ++ + DFG++R + T+ V
Sbjct: 128 AVQIASGMVYLAS---QHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYR----V 180
Query: 338 KGTTGYIAPEYGMGHETSSYG------DVYSFGILLLEMFT 372
G T + P M E+ Y DV+SFG++L E+FT
Sbjct: 181 GGHT--MLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 1e-17
Identities = 58/220 (26%), Positives = 105/220 (47%), Gaps = 28/220 (12%)
Query: 168 IGAGNFASVYKGI-LFEGAPA---VAIKVF-NFLHHDASKSFTVECEVMRNIIHRKIIKV 222
+G+G F +VYKG+ + EG VAIKV A+K E VM ++ H ++++
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 223 VTAC--SRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAID 280
+ C S+V L+ + MP G L +++ + HK N+ S LN +
Sbjct: 75 LGICLSSQV--------QLITQLMPLGCLLDYV-------RNHK--DNIGSQYLLNWCVQ 117
Query: 281 VASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGT 340
+A + YL + + H D+ N+L+ + DFG+A+ L+ ++ + G K
Sbjct: 118 IAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVP 174
Query: 341 TGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDD 379
++A E + + DV+S+G+ + E+ T G +P +
Sbjct: 175 IKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEG 214
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 3e-17
Identities = 62/215 (28%), Positives = 104/215 (48%), Gaps = 27/215 (12%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKS---FTVECEVMRNIIHRKIIKVVT 224
+G G F V G + G VAIK+ + S S F E +VM + H K++++
Sbjct: 12 LGTGQFGVVKYG-KWRGQYDVAIKMIK----EGSMSEDEFIEEAKVMMKLSHEKLVQLYG 66
Query: 225 ACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASA 284
C++ Q + +V E+M NG L ++ E + P L L + DV
Sbjct: 67 VCTK---QRPIY--IVTEYMSNGCLLNYL----REHGKRFQPSQL-----LEMCKDVCEG 112
Query: 285 LEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYI 344
+ YL H D+ N L++D+ V+DFG++R++ +E TSS+G K +
Sbjct: 113 MAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYV-LDDEYTSSVGSKFPVRWS 168
Query: 345 APEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSD 378
PE + + SS DV++FG+L+ E+++ G P +
Sbjct: 169 PPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 3e-17
Identities = 61/208 (29%), Positives = 103/208 (49%), Gaps = 20/208 (9%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACS 227
+G G F V+ G + G VA+K + +SF E ++M+ + H K++++ S
Sbjct: 14 LGNGQFGEVWMG-TWNGNTKVAVKTLK-PGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS 71
Query: 228 RVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEY 287
+V E+M GSL +++ + + R NL +++A VA+ + Y
Sbjct: 72 EEPIY------IVTEYMSKGSLLDFL---KDGEGRALKLPNL-----VDMAAQVAAGMAY 117
Query: 288 LHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPE 347
+ + H D++ +NIL+ D + +ADFG+AR +E NE T+ G K + APE
Sbjct: 118 IE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIE-DNEYTARQGAKFPIKWTAPE 173
Query: 348 YGMGHETSSYGDVYSFGILLLEMFTGLR 375
+ + DV+SFGILL E+ T R
Sbjct: 174 AALYGRFTIKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 3e-17
Identities = 68/228 (29%), Positives = 103/228 (45%), Gaps = 36/228 (15%)
Query: 165 ENLIGAGNFASVYKGIL---FEGAPAVAIKVFNFLHHDASKS----FTVECEVMRNIIHR 217
E +IG G F V +G L + VAIK L +S F E +M H
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKT---LKAGSSDKQRLDFLTEASIMGQFDHP 65
Query: 218 KIIK---VVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLER 274
II+ VVT V ++ E+M NGSL++++ R G +
Sbjct: 66 NIIRLEGVVTKSRPV--------MIITEYMENGSLDKFL--------REND-GKFTVGQL 108
Query: 275 LNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSS 334
+ + +AS ++YL H D+ NIL+N + V+DFG++R LE + ++
Sbjct: 109 VGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTT 165
Query: 335 IGVKGTTGYIAPE-YGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDM 380
G K + APE TS+ DV+SFGI++ E+ + G RP DM
Sbjct: 166 KGGKIPIRWTAPEAIAYRKFTSA-SDVWSFGIVMWEVMSYGERPYWDM 212
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 5e-17
Identities = 62/219 (28%), Positives = 100/219 (45%), Gaps = 25/219 (11%)
Query: 168 IGAGNFASVYKGILFEGAP---AVAIKVFNFLHHDASKS-FTVECEVMRNIIHRKIIKVV 223
+G GNF SV KG+ + VA+K H A K F E VM + H I++++
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 224 TACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVAS 283
C +G LV E P G L +++ + +R +L +A VA
Sbjct: 63 GVC-----KGEPL-MLVMELAPLGPLLKYL-----KKRREIPVSDL-----KELAHQVAM 106
Query: 284 ALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQ-TSSIGVKGTTG 342
+ YL H D+ N+LL + A ++DFG++R L A ++ ++ +
Sbjct: 107 GMAYLE-SKH--FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLK 163
Query: 343 YIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDM 380
+ APE + SS DV+S+G+ L E F+ G +P +M
Sbjct: 164 WYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEM 202
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 8e-17
Identities = 61/221 (27%), Positives = 90/221 (40%), Gaps = 31/221 (14%)
Query: 166 NLIGAGNFASVYKGILFEGAPAVAIKVFNF--LHHDASKSFTVECEVMRNIIHRKIIKVV 223
N IG G F VY + + +A+K K E +V+ + H ++K
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVK-- 63
Query: 224 TACSRVDYQGNDFKALVYEFMP---NGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAID 280
V+ VY FM G+LEE + H + + + +
Sbjct: 64 --YYGVEVHREK----VYIFMEYCSGGTLEELLE--------HGRILDEHVIRVY--TLQ 107
Query: 281 VASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLE--ATNEQTSSIGVK 338
+ L YLH I H DIKP+NI L+ + DFG A L+ T +
Sbjct: 108 LLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLA 164
Query: 339 GTTGYIAPEYGMGHETSSYG---DVYSFGILLLEMFTGLRP 376
GT Y+APE G + +G D++S G ++LEM TG RP
Sbjct: 165 GTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.4 bits (202), Expect = 9e-17
Identities = 60/227 (26%), Positives = 98/227 (43%), Gaps = 39/227 (17%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTV--ECEVMRNIIHRKIIK---V 222
IG G + VYK + VA+K + T E ++++ + H I++ +
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEI 66
Query: 223 VTACSRVDYQGNDFKALVYEFMP---NGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAI 279
VT+ + G+ + +V+E+M G L+ TE +
Sbjct: 67 VTSKGK----GSIY--MVFEYMDHDLTGLLDSPEVKFTESQIKC-------------YMK 107
Query: 280 DVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKG 339
+ L+YLH I H DIK SNIL+N++ +ADFG+AR N + V
Sbjct: 108 QLLEGLQYLH-SNG--ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI- 163
Query: 340 TTGYIAPEYGMGHETSSYG---DVYSFGILLLEMFTG---LRPSDDM 380
T Y PE +G + YG D++S G +L E+F G + S ++
Sbjct: 164 TLWYRPPELLLG--ATRYGPEVDMWSVGCILAELFLGKPIFQGSTEL 208
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 1e-16
Identities = 60/208 (28%), Positives = 105/208 (50%), Gaps = 26/208 (12%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACS 227
+GAG F V+ G + G VAIK +F E +M+ + H +++++ +
Sbjct: 14 LGAGQFGEVWMG-YYNGHTKVAIKSLKQGSMSPE-AFLAEANLMKQLQHPRLVRLYAVVT 71
Query: 228 RVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEY 287
+ + ++ E+M NGSL +++ T E + +N L +++A +A + +
Sbjct: 72 Q------EPIYIITEYMENGSLVDFLK--TPEGIKLT----INKL--IDMAAQIAEGMAF 117
Query: 288 LHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPE 347
+ + H D++ +NIL+++ + +ADFG+AR +E NE T+ G K + APE
Sbjct: 118 IE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPE 173
Query: 348 ---YGMGHETSSYGDVYSFGILLLEMFT 372
YG S DV+SFGILL E+ T
Sbjct: 174 AINYGTFTIKS---DVWSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 2e-16
Identities = 69/229 (30%), Positives = 105/229 (45%), Gaps = 35/229 (15%)
Query: 165 ENLIGAGNFASVYKGILFEGAPA-----VAIKVFNFLHHDAS-KSFTVECEVMRNIIHRK 218
E +IGAG F V +G L P VAIK + + + F E +M H
Sbjct: 9 EEVIGAGEFGEVCRGRL--KLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPN 66
Query: 219 IIK---VVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERL 275
II VVT V ++ EFM NG+L+ ++ + G ++ +
Sbjct: 67 IIHLEGVVTKSRPV--------MIITEFMENGALDSFLR---------QNDGQFTVIQLV 109
Query: 276 NIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQ---T 332
+ +A+ ++YL + H D+ NIL+N + V+DFG++RFLE T
Sbjct: 110 GMLRGIAAGMKYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYT 166
Query: 333 SSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLE-MFTGLRPSDDM 380
SS+G K + APE + +S DV+S+GI++ E M G RP DM
Sbjct: 167 SSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 215
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 2e-16
Identities = 61/215 (28%), Positives = 102/215 (47%), Gaps = 25/215 (11%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIKVF--NFLHHDASKSFTVECEVMRNIIHRKIIKVVTA 225
IG+G F V+ G E VAIK + + + F E +VM + H K++++
Sbjct: 12 IGSGQFGLVWLGYWLEKR-KVAIKTIREGAM---SEEDFIEEAQVMMKLSHPKLVQLYGV 67
Query: 226 CSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASAL 285
C+ LV+EFM +G L +++ +R G + L + +DV +
Sbjct: 68 CTE-----RSPICLVFEFMEHGCLSDYL-----RAQR----GKFSQETLLGMCLDVCEGM 113
Query: 286 EYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIA 345
YL + H D+ N L+ + V+DFG+ RF+ ++ TSS G K + +
Sbjct: 114 AYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFV-LDDQYTSSTGTKFPVKWSS 169
Query: 346 PEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDD 379
PE + SS DV+SFG+L+ E+F+ G P ++
Sbjct: 170 PEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYEN 204
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 5e-16
Identities = 58/212 (27%), Positives = 91/212 (42%), Gaps = 24/212 (11%)
Query: 167 LIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTV---ECEV--MRNIIHRKIIK 221
L+G G F VY + +A+K F V ECE+ ++N+ H +I++
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 222 VVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDV 281
C R D + F E+MP GS+++ + KA G L +
Sbjct: 69 YY-GCLRDDETLSIF----MEYMPGGSVKDQL----------KAYGALTETVTRKYTRQI 113
Query: 282 ASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSI-GVKGT 340
+EYLH I H DIK +NIL + + DFG ++ L+ + + V GT
Sbjct: 114 LEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGT 170
Query: 341 TGYIAPEYGMGHETSSYGDVYSFGILLLEMFT 372
+++PE G DV+S G ++EM T
Sbjct: 171 PYWMSPEVISGEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 6e-16
Identities = 36/100 (36%), Positives = 47/100 (47%), Gaps = 6/100 (6%)
Query: 277 IAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIG 336
++ ALEYLH I H DIKP NILL+++ + DF IA + T +
Sbjct: 105 WICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTP---DTLTTS 158
Query: 337 VKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRP 376
GT GY+APE S D +S G+ E G RP
Sbjct: 159 TSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 8e-16
Identities = 68/223 (30%), Positives = 98/223 (43%), Gaps = 29/223 (13%)
Query: 162 FSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIK 221
F +G G++ SVYK I E VAIKV + + E +++ I+K
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPV--EEDLQEIIKEISILKQCDSPYIVK 62
Query: 222 VVTACSRVDYQGNDFKA----LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNI 277
Y G+ FK +V E+ GS+ + I IT + L E I
Sbjct: 63 ---------YYGSYFKNTDLWIVMEYCGAGSVSD-IMKITNK--------TLTEEEIAAI 104
Query: 278 AIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGV 337
LEYLH H DIK NILLN+E A +ADFG++ L T + ++ V
Sbjct: 105 LYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT--V 159
Query: 338 KGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDM 380
GT ++APE ++ D++S GI +EM G P D+
Sbjct: 160 IGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDI 202
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 8e-16
Identities = 72/259 (27%), Positives = 121/259 (46%), Gaps = 33/259 (12%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACS 227
+G G F V+ G + G VAIK ++F E ++M+ + H K++ + S
Sbjct: 14 LGQGCFGEVWMGT-WNGTTKVAIKTLK-PGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS 71
Query: 228 RVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRH-KAPGNLNSLERLNIAIDVASALE 286
+ +V EFM GSL +++ E D ++ K P + +++A +A +
Sbjct: 72 E------EPIYIVTEFMGKGSLLDFL---KEGDGKYLKLP------QLVDMAAQIADGMA 116
Query: 287 YLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAP 346
Y+ + H D++ +NIL+ D + +ADFG+AR +E NE T+ G K + AP
Sbjct: 117 YIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIE-DNEYTARQGAKFPIKWTAP 172
Query: 347 EYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQ--------SALPE 397
E + + DV+SFGILL E+ T G P M N + V+ PE
Sbjct: 173 EAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMV--NREVLEQVERGYRMPCPQGCPE 230
Query: 398 RVEEIVDTLFFKEIEEEET 416
+ E++ + K+ +E T
Sbjct: 231 SLHELMKLCWKKDPDERPT 249
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 1e-15
Identities = 62/218 (28%), Positives = 106/218 (48%), Gaps = 24/218 (11%)
Query: 167 LIGAGNFASVYKGILF-EGAPA---VAIKVFN-FLHHDASKSFTVECEVMRNIIHRKIIK 221
++G+G F +VYKGI EG VAIK+ N A+ F E +M ++ H +++
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 222 VVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDV 281
++ C Q LV + MP+G L +++H HK N+ S LN + +
Sbjct: 74 LLGVCLSPTIQ------LVTQLMPHGCLLDYVH-------EHK--DNIGSQLLLNWCVQI 118
Query: 282 ASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTT 341
A + YL + + H D+ N+L+ + DFG+AR LE ++ ++ G K
Sbjct: 119 AKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPI 175
Query: 342 GYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSD 378
++A E + + DV+S+G+ + E+ T G +P D
Sbjct: 176 KWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 1e-15
Identities = 60/231 (25%), Positives = 114/231 (49%), Gaps = 39/231 (16%)
Query: 168 IGAGNFASVYKGILF-----EGAPAVAIKVFNFLHH-DASKSFTVECEVMRNIIHRKIIK 221
+G G F VYKG L A +VAIK + F E E+M ++ H I+
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 222 VVTACSRVDYQGNDFKALVYEFMPNGSLEEWI---HPI-----TEEDKRHKAPGNLNSLE 273
++ C++ +++E++ +G L E++ P D+ K+ L+ +
Sbjct: 73 LLGVCTK-----EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSS--LDCSD 125
Query: 274 RLNIAIDVASALEYL---HLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATN- 329
L+IAI +A+ +EYL H H D+ N L+ + +T ++DFG++R + + +
Sbjct: 126 FLHIAIQIAAGMEYLSSHH------FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADY 179
Query: 330 ---EQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRP 376
+ S + V+ ++ PE + + ++ D++SFG++L E+F+ GL+P
Sbjct: 180 YRVQSKSLLPVR----WMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 4e-15
Identities = 62/220 (28%), Positives = 93/220 (42%), Gaps = 30/220 (13%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACS 227
IG+G + VYK VAIKV D + E +++ H I+ +
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS-- 68
Query: 228 RVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAI---DVASA 284
Y D +V E+ GSL++ I+ +T L L IA +
Sbjct: 69 ---YLRRDKLWIVMEYCGGGSLQD-IYQVTRG-----------PLSELQIAYVCRETLKG 113
Query: 285 LEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEAT-NEQTSSIGVKGTTGY 343
L YLH K H DIK +NILL ++ +ADFG++ L AT ++ S I GT +
Sbjct: 114 LAYLHETGK---IHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI---GTPYW 167
Query: 344 IAPEYGMGHETSSYG---DVYSFGILLLEMFTGLRPSDDM 380
+APE Y D+++ GI +E+ P D+
Sbjct: 168 MAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDL 207
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 4e-15
Identities = 63/208 (30%), Positives = 101/208 (48%), Gaps = 26/208 (12%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKS---FTVECEVMRNIIHRKIIKVVT 224
+G+G F V+ G + VAIK N + + S F E +VM + H K++++
Sbjct: 12 LGSGQFGVVHLG-KWRAQIKVAIKAIN----EGAMSEEDFIEEAKVMMKLSHPKLVQLYG 66
Query: 225 ACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASA 284
C++ Q + +V EFM NG L ++ R + G L+ L++ DV
Sbjct: 67 VCTQ---QKPLY--IVTEFMENGCLLNYL--------RQRQ-GKLSKDMLLSMCQDVCEG 112
Query: 285 LEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYI 344
+EYL + H D+ N L++ V+DFG+ R++ +E TSS G K +
Sbjct: 113 MEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYV-LDDEYTSSSGAKFPVKWS 168
Query: 345 APEYGMGHETSSYGDVYSFGILLLEMFT 372
PE + SS DV+SFG+L+ E+FT
Sbjct: 169 PPEVFNFSKYSSKSDVWSFGVLMWEVFT 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 5e-15
Identities = 69/226 (30%), Positives = 105/226 (46%), Gaps = 31/226 (13%)
Query: 165 ENLIGAGNFASVYKGIL-FEGAP--AVAIKVFNFLHHDASK-SFTVECEVMRNIIHRKII 220
E +IGAG F V G L G VAIK + + + F E +M H II
Sbjct: 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 221 K---VVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNI 277
VVT V +V E+M NGSL+ ++ ++H G ++ + +
Sbjct: 69 HLEGVVTKSKPV--------MIVTEYMENGSLDAFL-------RKHD--GQFTVIQLVGM 111
Query: 278 AIDVASALEYLH-LGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQT-SSI 335
+AS ++YL +G H D+ NIL+N + V+DFG++R LE E ++
Sbjct: 112 LRGIASGMKYLSDMG----YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTR 167
Query: 336 GVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLE-MFTGLRPSDDM 380
G K + APE + +S DV+S+GI++ E M G RP +M
Sbjct: 168 GGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEM 213
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 7e-15
Identities = 57/224 (25%), Positives = 90/224 (40%), Gaps = 39/224 (17%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIKVFNFLH---HDASKSFTVECEVMRNIIHRKIIKVVT 224
I G + V+ AIKV + E +++ ++K+
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 225 ACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVAS- 283
+ +QG LV E++P G L + N+ SL+ I +A
Sbjct: 61 S-----FQGKKNLYLVMEYLPGGDLASLLE-------------NVGSLDEDVARIYIAEI 102
Query: 284 --ALEYLH-LGCKPPIAHCDIKPSNILLNDEMTACVADFGIARF------LEATNEQTSS 334
ALEYLH G I H D+KP NIL++ + DFG+++ + +++
Sbjct: 103 VLALEYLHSNG----IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKED 158
Query: 335 IGVKGTTGYIAPEY--GMGHETSSYGDVYSFGILLLEMFTGLRP 376
+ GT YIAPE G GH + D +S G +L E G+ P
Sbjct: 159 KRIVGTPDYIAPEVILGQGHSKTV--DWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 7e-15
Identities = 77/323 (23%), Positives = 131/323 (40%), Gaps = 58/323 (17%)
Query: 168 IGAGNFASVYKGILFEGAPA-----VAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKV 222
+G G F V+ + +P VA+K A K F E E++ N+ H I+K
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 223 VTACSRVDYQGNDFKALVYEFMPNGSLEEWIHP------ITEEDKRHKAPGNLNSLERLN 276
C D D +V+E+M +G L +++ I + + +A G L + L+
Sbjct: 73 YGVC--GD---GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 127
Query: 277 IAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIG 336
IA +AS + YL H D+ N L+ + + DFG++R + +T+
Sbjct: 128 IASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGH 184
Query: 337 VKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQSAL 395
++ PE M + ++ DV+SFG++L E+FT G +P W Q +
Sbjct: 185 TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP-------------WFQLSN 231
Query: 396 PERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGER 455
E +E I + E V C + +I + C P +R
Sbjct: 232 TEVIECITQ----GRVLERPRV------------------CPKEVYDIMLGCWQREPQQR 269
Query: 456 MKINDVELGLRLIKKKLLETPVY 478
+ I ++ L + K TP+Y
Sbjct: 270 LNIKEIYKILHALGKA---TPIY 289
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.3 bits (186), Expect = 8e-15
Identities = 63/226 (27%), Positives = 94/226 (41%), Gaps = 34/226 (15%)
Query: 162 FSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIK 221
F+ IG G+F VYK I VAIKV + L + ++ E I+
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVID-LEEAEDEIEDIQQE----------IQ 51
Query: 222 VVTACSR---VDYQG---NDFK-ALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLER 274
++ C Y G K ++ E+ GS + + P G L+
Sbjct: 52 FLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKP-----------GKLDETYI 100
Query: 275 LNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSS 334
I +V LEYLH K H DIK +NILL++E +ADFG++ L +T +
Sbjct: 101 AFILREVLLGLEYLHEEGK---IHRDIKAANILLSEEGDVKLADFGVSGQLTST--MSKR 155
Query: 335 IGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDM 380
GT ++APE D++S GI +E+ G P D+
Sbjct: 156 NTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDL 201
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 9e-15
Identities = 54/220 (24%), Positives = 95/220 (43%), Gaps = 32/220 (14%)
Query: 168 IGAGNFASVYKGILF-----EGAPAVAIKVFNFLHHDASKS----FTVECEVMRNIIHRK 218
+G G+F VY+G+ E VAIK ++ +AS F E VM+
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKT---VNENASMRERIEFLNEASVMKEFNCHH 70
Query: 219 IIKVVTACSRVDYQGNDFKALV-YEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNI 277
+++++ S LV E M G L+ ++ E + + G + + +
Sbjct: 71 VVRLLGVVSTGQ------PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQM 124
Query: 278 AIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGV 337
A ++A + YL H D+ N ++ +++T + DFG+ R + T+
Sbjct: 125 AAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYR----- 176
Query: 338 KGTTG-----YIAPEYGMGHETSSYGDVYSFGILLLEMFT 372
KG G ++APE ++ DV+SFG++L EM T
Sbjct: 177 KGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 1e-14
Identities = 61/210 (29%), Positives = 104/210 (49%), Gaps = 34/210 (16%)
Query: 168 IGAGNFASV----YKGILFEGAPAVAIKVFNFLHHDAS-KSFTVECEVMRNIIHRKIIKV 222
IG G F V Y+G VA+K + +DA+ ++F E VM + H ++++
Sbjct: 14 IGKGEFGDVMLGDYRGN------KVAVKC---IKNDATAQAFLAEASVMTQLRHSNLVQL 64
Query: 223 VTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVA 282
+ V+ +G + +V E+M GSL +++ R + L L ++DV
Sbjct: 65 LGVI--VEEKGGLY--IVTEYMAKGSLVDYL--------RSRGRSVLGGDCLLKFSLDVC 112
Query: 283 SALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTG 342
A+EYL H D+ N+L++++ A V+DFG+ + +T + T + VK T
Sbjct: 113 EAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-QDTGKLPVKWT-- 166
Query: 343 YIAPEYGMGHETSSYGDVYSFGILLLEMFT 372
APE + S+ DV+SFGILL E+++
Sbjct: 167 --APEALREKKFSTKSDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-14
Identities = 64/224 (28%), Positives = 107/224 (47%), Gaps = 33/224 (14%)
Query: 165 ENLIGAGNFASVYKGILFEGAPAV--AIKVFN-FLHHDASKSFTVECEVMRNI-IHRKII 220
E++IG GNF V + ++ + + AIK+ F + + F E EV+ + H II
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 221 KVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHP--ITEED----KRHKAPGNLNSLER 274
++ AC Y + E+ P G+L +++ + E D K H L S +
Sbjct: 67 NLLGACENRGYL-----YIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL 121
Query: 275 LNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSS 334
L A DVA+ ++YL + H D+ N+L+ + + + +ADFG++R E
Sbjct: 122 LQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSRGEE-------- 170
Query: 335 IGVKGTTGYIAPEYGMGHETSSY------GDVYSFGILLLEMFT 372
+ VK T G + P M E+ +Y DV+SFG+LL E+ +
Sbjct: 171 VYVKKTMGRL-PVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 65/262 (24%), Positives = 124/262 (47%), Gaps = 31/262 (11%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACS 227
+GAG F V+ G + + VA+K + ++F E +M+ + H K++++ +
Sbjct: 14 LGAGQFGEVWMG-YYNNSTKVAVKTLK-PGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 71
Query: 228 RVD--YQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASAL 285
+ + Y ++ E+M GSL +++ ++E + P + ++ + +A +
Sbjct: 72 KEEPIY-------IITEYMAKGSLLDFLK--SDEGGKVLLP------KLIDFSAQIAEGM 116
Query: 286 EYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIA 345
Y+ + H D++ +N+L+++ + +ADFG+AR +E NE T+ G K + A
Sbjct: 117 AYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIE-DNEYTAREGAKFPIKWTA 172
Query: 346 PEYGMGHETSSYGDVYSFGILLLEMFT-------GLRPSDDMFKDNLNLQNWVQSALPER 398
PE + DV+SFGILL E+ T G+ SD M + P+
Sbjct: 173 PEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDE 232
Query: 399 VEEIVDTLFFKEIEEEETVYKY 420
+ +I+ T +KE EE + Y
Sbjct: 233 LYDIMKTC-WKEKAEERPTFDY 253
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 3e-14
Identities = 63/218 (28%), Positives = 91/218 (41%), Gaps = 29/218 (13%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIKVFNFLHHDAS-KSFTVECEVMRNIIHRKIIKVVTAC 226
IG G A VY I VAIK + S E + M H ++K
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYY--T 66
Query: 227 SRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAI---DVAS 283
S V D LV ++ GSL + + + P L+ IA +V
Sbjct: 67 SFVV---GDELWLVMPYLSGGSLLDIM--------KSSYPRGG--LDEAIIATVLKEVLK 113
Query: 284 ALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSI--GVKGTT 341
LEYLH H DIK NILL ++ + +ADFG++ L ++T + GT
Sbjct: 114 GLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTP 170
Query: 342 GYIAPEYGMGHETSSYG---DVYSFGILLLEMFTGLRP 376
++APE + + Y D++SFGI +E+ TG P
Sbjct: 171 CWMAPE--VMEQVHGYDFKADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 61/214 (28%), Positives = 105/214 (49%), Gaps = 27/214 (12%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACS 227
IG G F +V +G VA+K N +++F E VM + H+ +++++
Sbjct: 14 IGEGEFGAVLQGEYT--GQKVAVK--NIKCDVTAQAFLEETAVMTKLHHKNLVRLLGV-- 67
Query: 228 RVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEY 287
+ + G +V E M G+L ++ R + ++ ++ L ++DVA +EY
Sbjct: 68 -ILHNG---LYIVMELMSKGNLVNFL--------RTRGRALVSVIQLLQFSLDVAEGMEY 115
Query: 288 LHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPE 347
L + H D+ NIL++++ A V+DFG+AR + + S + VK T APE
Sbjct: 116 LE---SKKLVHRDLAARNILVSEDGVAKVSDFGLAR-VGSMGVDNSKLPVKWT----APE 167
Query: 348 YGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDM 380
+ SS DV+S+G+LL E+F+ G P M
Sbjct: 168 ALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKM 201
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 73.0 bits (180), Expect = 5e-14
Identities = 62/211 (29%), Positives = 91/211 (43%), Gaps = 30/211 (14%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACS 227
IG G VYK VAIK L + E +M++ H I+ +
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMR-LRKQNKELIINEILIMKDCKHPNIVDYYDS-- 83
Query: 228 RVDYQGNDFKALVYEFMPNGSLEEWI--HPITEEDKRHKAPGNLNSLERLNIAIDVASAL 285
Y D +V E+M GSL + I + + +N + + +V L
Sbjct: 84 ---YLVGDELWVVMEYMDGGSLTDIITQNFVR-----------MNEPQIAYVCREVLQGL 129
Query: 286 EYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIA 345
EYLH + H DIK NILL+ + + +ADFG A L T E++ V GT ++A
Sbjct: 130 EYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQL--TKEKSKRNSVVGTPYWMA 184
Query: 346 PEYGMGHETSSYG---DVYSFGILLLEMFTG 373
PE + YG D++S GI+ +EM G
Sbjct: 185 PEVIKRKD---YGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 58/219 (26%), Positives = 96/219 (43%), Gaps = 34/219 (15%)
Query: 167 LIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTAC 226
LIG G + +VY+G VA+K+ N + V ++ R + ++
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINL----DTPDDDVS-DIQREVALLSQLRQSQPP 62
Query: 227 SRVDYQGNDFKA----LVYEFMPNGSLEEWIH--PITEEDKRHKAPGNLNSLERLNIAID 280
+ Y G+ K ++ E+ GS+ + PI E ++ + I +
Sbjct: 63 NITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAE---KYISV----------IIRE 109
Query: 281 VASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGT 340
V AL+Y+H K + H DIK +NIL+ + + DFG+A L + + S+ GT
Sbjct: 110 VLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTF--VGT 164
Query: 341 TGYIAPEYGMGHETSSY---GDVYSFGILLLEMFTGLRP 376
++APE E Y D++S GI + EM TG P
Sbjct: 165 PYWMAPEVIT--EGKYYDTKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-13
Identities = 58/221 (26%), Positives = 96/221 (43%), Gaps = 22/221 (9%)
Query: 167 LIGAGNFASVYKGILFEGAPA---VAIKVFNFLHHDAS--KSFTVECEVMRNIIHRKIIK 221
++G G F SV +G L + + VA+K H S + F E M++ H ++K
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 222 VVTACSRV-DYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAID 280
++ C Q ++ FM +G L ++ P L L +D
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGG----LPEKLPLQTLLKFMVD 121
Query: 281 VASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIAR--FLEATNEQT--SSIG 336
+A +EYL H D+ N +L ++MT CVADFG+++ + Q + +
Sbjct: 122 IALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMP 178
Query: 337 VKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRP 376
VK +IA E +S DV++FG+ + E+ T G P
Sbjct: 179 VK----WIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 72/310 (23%), Positives = 121/310 (39%), Gaps = 64/310 (20%)
Query: 168 IGAGNFASVYKGILFEGAPA-----VAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKV 222
+G G F V+ P VA+K A + F E E++ + H+ I++
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 223 VTACSRVDYQGNDFKALVYEFMPNGSLEEWIHP------ITEEDKRHKAPGNLNSLERLN 276
C+ +V+E+M +G L ++ I + APG L + L
Sbjct: 73 YGVCTE-----GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGE-DVAPGQLTLGQMLA 126
Query: 277 IAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIG 336
IA +AS + YL H D+ N L+ + + DFG++R + +T+
Sbjct: 127 IASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR---- 179
Query: 337 VKGTT----GYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWV 391
V G T ++ PE + + ++ D++SFG++L E+FT G +P W
Sbjct: 180 VGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP-------------WY 226
Query: 392 QSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAEL 451
Q + E +E I +E+E T C + I C
Sbjct: 227 QLSNTEAIECITQG---RELERPRT-------------------CPPEVYAIMQGCWQRE 264
Query: 452 PGERMKINDV 461
P +RM I D+
Sbjct: 265 PQQRMVIKDI 274
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 67/212 (31%), Positives = 100/212 (47%), Gaps = 27/212 (12%)
Query: 167 LIGAGNFASVYKGILFEGAPAVAIKVFNF-LHHDASKSFTVECEVMRNIIHRKIIKVVTA 225
IG GNF VYKG+L +G VA+K L D + F E E+++ H I+K++
Sbjct: 2 KIGKGNFGDVYKGVL-KGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 226 CSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASAL 285
C V Q +V E +P GSL ++ K L + L +++D A+ +
Sbjct: 61 C--VQKQP---IYIVMELVPGGSLLTFLR---------KKKNRLTVKKLLQMSLDAAAGM 106
Query: 286 EYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGT-TGYI 344
EYL H D+ N L+ + ++DFG++R E T S G+K +
Sbjct: 107 EYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSR-EEEGGIYTVSDGLKQIPIKWT 162
Query: 345 APE---YGMGHETSSYGDVYSFGILLLEMFTG 373
APE YG +S DV+S+GILL E F+
Sbjct: 163 APEALNYG---RYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 2e-13
Identities = 63/227 (27%), Positives = 99/227 (43%), Gaps = 39/227 (17%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACS 227
+G GN +VYK +A+KV + E+ + I+ ++++ C
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVI---------PLDITVELQKQIMSE--LEILYKCD 57
Query: 228 R---VDYQGNDFK----ALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAID 280
+ + G F ++ EFM GSL D K P ++ L R IA+
Sbjct: 58 SPYIIGFYGAFFVENRISICTEFMDGGSL----------DVYRKIPEHV--LGR--IAVA 103
Query: 281 VASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGT 340
V L YL K I H D+KPSN+L+N + DFG++ L + +T GT
Sbjct: 104 VVKGLTYL-WSLK--ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYV----GT 156
Query: 341 TGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNL 387
Y+APE G + + DV+S GI +E+ G P + K+ +L
Sbjct: 157 NAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSL 203
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 5e-13
Identities = 62/232 (26%), Positives = 103/232 (44%), Gaps = 41/232 (17%)
Query: 167 LIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDAS---------KSFTVECEVMRNIIHR 217
LIG+G+F SVY G+ +A+K AS + E +++ + H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 218 KIIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERL-- 275
I++ + + D+ N F E++P GS+ ++ N + E
Sbjct: 67 NIVQYLGSSLDADHL-NIF----LEYVPGGSVAALLN-------------NYGAFEETLV 108
Query: 276 -NIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEA------T 328
N + L YLH I H DIK +NIL++++ ++DFGI++ LEA T
Sbjct: 109 RNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKT 165
Query: 329 NEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDM 380
N S+ +G+ ++APE + D++S G L++EM TG P D
Sbjct: 166 NGARPSL--QGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDC 215
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 6e-13
Identities = 65/241 (26%), Positives = 90/241 (37%), Gaps = 33/241 (13%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFT-VECEVMRNIIHRKIIKVVTAC 226
I G F SVY AIKV A T V+ E R I+ + A
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAE--RAIMMIQGESPYVAK 61
Query: 227 SRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALE 286
+Q D+ LV E++ G I K G L +V +E
Sbjct: 62 LYYSFQSKDYLYLVMEYLNGGDCASLI----------KTLGGLPEDWAKQYIAEVVLGVE 111
Query: 287 YLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAP 346
LH + I H DIKP N+L++ + DFG++R + GT Y+AP
Sbjct: 112 DLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK------FVGTPDYLAP 162
Query: 347 EYGMGHETSSYGDVYSFGILLLEMFTGLRP-----SDDMFKDNL-NLQNWVQSALPERVE 400
E +G D +S G ++ E G P D +F + L NW PE V+
Sbjct: 163 ETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINW-----PEEVK 217
Query: 401 E 401
E
Sbjct: 218 E 218
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 7e-13
Identities = 60/219 (27%), Positives = 98/219 (44%), Gaps = 27/219 (12%)
Query: 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVA---IKVFNFLHHDASKSFTVECEVMRNII 215
F E IG G F+ VYK I VA +++F + A + E ++++ +
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 216 HRKIIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERL 275
H +IK + + + N+ +V E G L I K K L ER
Sbjct: 61 HPNVIKYLAS-----FIENNELNIVLELADAGDLSRMI-------KHFKKQKRLIP-ERT 107
Query: 276 --NIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTS 333
+ + SALE++H I H DIKP+N+ + + D G+ RF +++ T+
Sbjct: 108 IWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTA 162
Query: 334 SIGVKGTTGYIAPE--YGMGHETSSYGDVYSFGILLLEM 370
+ + GT Y++PE + G+ S D++S G LL EM
Sbjct: 163 AHSLVGTPYYMSPERIHENGYNFKS--DIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 7e-13
Identities = 55/208 (26%), Positives = 100/208 (48%), Gaps = 20/208 (9%)
Query: 165 ENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVT 224
E +GAG F V+ + VA+K +F E VM+ + H K++K+
Sbjct: 11 EKKLGAGQFGEVWMAT-YNKHTKVAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVKLHA 68
Query: 225 ACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASA 284
++ + ++ EFM GSL +++ ++E + P + ++ + +A
Sbjct: 69 VVTK------EPIYIITEFMAKGSLLDFLK--SDEGSKQPLP------KLIDFSAQIAEG 114
Query: 285 LEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYI 344
+ ++ + H D++ +NIL++ + +ADFG+AR +E NE T+ G K +
Sbjct: 115 MAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIE-DNEYTAREGAKFPIKWT 170
Query: 345 APEYGMGHETSSYGDVYSFGILLLEMFT 372
APE + DV+SFGILL+E+ T
Sbjct: 171 APEAINFGSFTIKSDVWSFGILLMEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 8e-13
Identities = 55/218 (25%), Positives = 96/218 (44%), Gaps = 17/218 (7%)
Query: 168 IGAGNFASVYKGILFEGAPA-----VAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKV 222
+G G F V+ + P VA+K +A K F E E++ N+ H I+K
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 223 VTACSRVDYQGNDFKALVYEFMPNGSLEEWIH---PITEEDKRHKAPGNLNSLERLNIAI 279
C D +V+E+M +G L +++ P P L + L+IA
Sbjct: 73 YGVCVE-----GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ 127
Query: 280 DVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKG 339
+A+ + YL H D+ N L+ + + + DFG++R + +T+
Sbjct: 128 QIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTML 184
Query: 340 TTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRP 376
++ PE M + ++ DV+S G++L E+FT G +P
Sbjct: 185 PIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 9e-13
Identities = 62/224 (27%), Positives = 104/224 (46%), Gaps = 33/224 (14%)
Query: 165 ENLIGAGNFASVYKGILFEGA---PAVAIKVFNFLHHDASKSFTVECEVMRNI-IHRKII 220
+++IG GNF V K + + A ++ + D + F E EV+ + H II
Sbjct: 12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71
Query: 221 KVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHP--ITEEDKR----HKAPGNLNSLER 274
++ AC Y L E+ P+G+L +++ + E D + L+S +
Sbjct: 72 NLLGACEHRGYL-----YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126
Query: 275 LNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSS 334
L+ A DVA ++YL + H D+ NIL+ + A +ADFG++R E
Sbjct: 127 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQE-------- 175
Query: 335 IGVKGTTGYIAPEYGMGHETSSY------GDVYSFGILLLEMFT 372
+ VK T G + P M E+ +Y DV+S+G+LL E+ +
Sbjct: 176 VYVKKTMGRL-PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 9e-13
Identities = 54/224 (24%), Positives = 100/224 (44%), Gaps = 30/224 (13%)
Query: 167 LIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDAS--KSFTVECE---VMRNIIHRKIIK 221
L+G+G F +V+KGI ++ I V D S ++F + M ++ H I++
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73
Query: 222 VVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDV 281
++ C Q LV + P GSL + + ++H+ +L+ LN + +
Sbjct: 74 LLGICPGASLQ------LVTQLSPLGSLLDHV-------RQHR--DSLDPQRLLNWCVQI 118
Query: 282 ASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTT 341
A + YL + H ++ NILL + +ADFG+A L +++ K
Sbjct: 119 AKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPI 175
Query: 342 GYIAPEYGMGHETSSYGDVYSFGILLLEMFT-------GLRPSD 378
++A E + + DV+S+G+ + EM + G+RP +
Sbjct: 176 KWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE 219
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 46/135 (34%), Positives = 69/135 (51%), Gaps = 15/135 (11%)
Query: 242 EFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDI 301
E+M GSL++ + K + L + IA+ V L YLH K I H D+
Sbjct: 79 EYMDGGSLDKIL-------KEVQGRIPERILGK--IAVAVLKGLTYLHEKHK--IIHRDV 127
Query: 302 KPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVY 361
KPSNIL+N + DFG++ L + +T GT+ Y+APE G++ S D++
Sbjct: 128 KPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV----GTSSYMAPERIQGNDYSVKSDIW 183
Query: 362 SFGILLLEMFTGLRP 376
S G+ L+E+ TG P
Sbjct: 184 SLGLSLIELATGRFP 198
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 58/217 (26%), Positives = 96/217 (44%), Gaps = 23/217 (10%)
Query: 167 LIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTAC 226
L+G GNF V+KG L + P L + F E +++ H I+K++ C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 227 SRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALE 286
++ +V E +P G ++ +E L + + + A+D A+ +
Sbjct: 62 TQ-----RQPIYIVMELVPGGDFLSFLRKKKDE---------LKTKQLVKFALDAAAGMA 107
Query: 287 YLHL-GCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGT-TGYI 344
YL C H D+ N L+ + ++DFG++R + + SS G+K +
Sbjct: 108 YLESKNC----IHRDLAARNCLVGENNVLKISDFGMSR--QEDDGIYSSSGLKQIPIKWT 161
Query: 345 APEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDM 380
APE SS DV+S+GILL E F+ G+ P M
Sbjct: 162 APEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGM 198
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 61/214 (28%), Positives = 87/214 (40%), Gaps = 21/214 (9%)
Query: 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDA-SKSFTVECEVMRNIIHRK 218
+ + +G G SV K L A+K + K E E+ ++
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 219 IIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLER--LN 276
I+K A +D + + E+ GSL+ K+ K G E+
Sbjct: 61 IVKYYGAF--LDESSSSIGIAM-EYCEGGSLDSIY-------KKVKKRGGRIG-EKVLGK 109
Query: 277 IAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIG 336
IA V L YLH I H DIKPSNILL + + DFG++ E N +
Sbjct: 110 IAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSG--ELVNSLAGTF- 163
Query: 337 VKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEM 370
GT+ Y+APE G S DV+S G+ LLE+
Sbjct: 164 -TGTSFYMAPERIQGKPYSITSDVWSLGLTLLEV 196
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 2e-12
Identities = 50/167 (29%), Positives = 83/167 (49%), Gaps = 16/167 (9%)
Query: 207 ECEVMRNIIHRKIIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAP 266
E E++RN+ H I+K C+ + GN K L+ EF+P+GSL+E++ R+K
Sbjct: 56 EIEILRNLYHENIVKYKGICT--EDGGNGIK-LIMEFLPSGSLKEYL-------PRNKNK 105
Query: 267 GNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLE 326
NL L A+ + ++YL G + + H D+ N+L+ E + DFG+ + +E
Sbjct: 106 INLKQQ--LKYAVQICKGMDYL--GSRQYV-HRDLAARNVLVESEHQVKIGDFGLTKAIE 160
Query: 327 ATNE-QTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT 372
E T + + APE + + DV+SFG+ L E+ T
Sbjct: 161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 3e-12
Identities = 62/246 (25%), Positives = 110/246 (44%), Gaps = 36/246 (14%)
Query: 166 NLIGAGNFASVYKGILF------EGAPAVAIKVFNFLHHDASKS-FTVECEVMRNIIHRK 218
N +G+G F VY+G G VA+K D K F E +M N H
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 219 IIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSL-ERLNI 277
I+K++ C N+ + ++ E M G L ++ + + + L +L E L+I
Sbjct: 61 IVKLLGVCLL-----NEPQYIIMELMEGGDLLSYL----RDARVERFGPPLLTLKELLDI 111
Query: 278 AIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTAC-----VADFGIARFLEATN--- 329
+DVA YL + H D+ N L++++ + DFG+AR + ++
Sbjct: 112 CLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYR 168
Query: 330 -EQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNL 387
E + V+ ++APE + + ++ DV+SFG+L+ E+ T G +P + +N +
Sbjct: 169 KEGEGLLPVR----WMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPAL--NNQEV 222
Query: 388 QNWVQS 393
V +
Sbjct: 223 LQHVTA 228
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 3e-12
Identities = 66/225 (29%), Positives = 98/225 (43%), Gaps = 27/225 (12%)
Query: 167 LIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNII-HRKIIKVVTA 225
+IG G + VYK + VAIK+ + + D + E ++R H I A
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIKIMD-IIEDEEEEIKEEYNILRKYSNHPNIATFYGA 71
Query: 226 CSRVDYQGNDFKA-LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAI---DV 281
+ + GND + LV E GS +T+ K + G L+ IA +
Sbjct: 72 FIKKNPPGNDDQLWLVMELCGGGS-------VTDLVKGLRKKGK--RLKEEWIAYILRET 122
Query: 282 ASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQT-SSIGVKGT 340
L YLH + + H DIK NILL + DFG++ L++T + + I GT
Sbjct: 123 LRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI---GT 176
Query: 341 TGYIAPEYGMGHE--TSSY---GDVYSFGILLLEMFTGLRPSDDM 380
++APE E +SY DV+S GI +E+ G P DM
Sbjct: 177 PYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDM 221
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 5e-12
Identities = 60/225 (26%), Positives = 92/225 (40%), Gaps = 45/225 (20%)
Query: 167 LIGAGNFASVYKGILFEGAPAVAIKVFNFLHHD-----ASKSFTVECEVMRNIIHRKIIK 221
L+G+G+F SVY+G+ + A+K + A K E ++ + H I
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNI-- 64
Query: 222 VVTACSRVDYQGN---DFKALVY-EFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNI 277
V Y G + ++ E +P GSL K S I
Sbjct: 65 -------VQYLGTEREEDNLYIFLELVPGGSL-------------AKLLKKYGSFPEPVI 104
Query: 278 AI---DVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSS 334
+ + LEYLH H DIK +NIL++ +ADFG+A+ + + S
Sbjct: 105 RLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS- 160
Query: 335 IGVKGTTGYIAPEYGMGHETSSYG---DVYSFGILLLEMFTGLRP 376
KG+ ++APE + YG D++S G +LEM TG P
Sbjct: 161 --FKGSPYWMAPEVIA--QQGGYGLAADIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 6e-12
Identities = 63/223 (28%), Positives = 105/223 (47%), Gaps = 33/223 (14%)
Query: 166 NLIGAGNFASVYKGILFEGAPAV--AIKVFN-FLHHDASKSFTVECEVMRNIIHR-KIIK 221
++IG GNF V K + + + AIK + D + F E EV+ + H II
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 222 VVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHP--ITEED----KRHKAPGNLNSLERL 275
++ AC + + L E+ P+G+L +++ + E D + L+S + L
Sbjct: 61 LLGAC-----EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 115
Query: 276 NIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSI 335
+ A DVA ++YL + H D+ NIL+ + A +ADFG++R E +
Sbjct: 116 HFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQE--------V 164
Query: 336 GVKGTTGYIAPEYGMGHETSSY------GDVYSFGILLLEMFT 372
VK T G + P M E+ +Y DV+S+G+LL E+ +
Sbjct: 165 YVKKTMGRL-PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 1e-11
Identities = 61/219 (27%), Positives = 90/219 (41%), Gaps = 35/219 (15%)
Query: 167 LIGAGNFASVYKGILFEGAPAVAIKVFNFLHHD-ASKSFTV-ECEVMRNIIHRKIIKVVT 224
++G G + V K VAIK F D K + E +V+R + H I+ +
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 225 ACSRVD--YQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVA 282
A R Y LV+E++ LE +PG L + +
Sbjct: 68 AFRRKGRLY-------LVFEYVERTLLELL----------EASPGGLPPDAVRSYIWQLL 110
Query: 283 SALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQ--TSSIGVKGT 340
A+ Y H I H DIKP NIL+++ + DFG AR L A T + T
Sbjct: 111 QAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV---AT 164
Query: 341 TGYIAPEYGMGHETSSYG---DVYSFGILLLEMFTGLRP 376
Y APE +G ++YG DV++ G ++ E+ G P
Sbjct: 165 RWYRAPELLVG--DTNYGKPVDVWAIGCIMAELLDG-EP 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 60/224 (26%), Positives = 95/224 (42%), Gaps = 33/224 (14%)
Query: 167 LIGAGNFASVYKGILFEGAPAVAIKVFNF---LHHDASKSFTVECEVMRNIIHRKIIKVV 223
+G G F V+ A+KV + + E V++ + H II++
Sbjct: 8 TVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLF 67
Query: 224 TACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVAS 283
F ++ E++P G L ++ + G ++ L A ++
Sbjct: 68 WT-----EHDQRFLYMLMEYVPGGELFSYL----------RNSGRFSNSTGLFYASEIVC 112
Query: 284 ALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGY 343
ALEYLH I + D+KP NILL+ E + DFG A+ L ++T ++ GT Y
Sbjct: 113 ALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKL---RDRTWTLC--GTPEY 164
Query: 344 IAPEY--GMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNL 385
+APE GH + D ++ GIL+ EM G P F DN
Sbjct: 165 LAPEVIQSKGHNKAV--DWWALGILIYEMLVGYPP---FFDDNP 203
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 63/221 (28%), Positives = 91/221 (41%), Gaps = 33/221 (14%)
Query: 167 LIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDA--SKSFTVECEVMRNIIHRKIIKVVT 224
L+G G++ V K E VAIK F D K E +++ + H ++ ++
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 225 ACSRVD--YQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVA 282
R Y LV+EF+ + L D K P L+ +
Sbjct: 68 VFRRKKRLY-------LVFEFVDHTVL----------DDLEKYPNGLDESRVRKYLFQIL 110
Query: 283 SALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTG 342
+E+ H I H DIKP NIL++ + DFG AR L A E + T
Sbjct: 111 RGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTD--YVATRW 165
Query: 343 YIAPEYGMGHETSSYG---DVYSFGILLLEMFTG--LRPSD 378
Y APE +G + YG D+++ G L+ EM TG L P D
Sbjct: 166 YRAPELLVG--DTKYGRAVDIWAVGCLVTEMLTGEPLFPGD 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.0 bits (162), Expect = 1e-11
Identities = 58/225 (25%), Positives = 91/225 (40%), Gaps = 43/225 (19%)
Query: 162 FSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASK-SFTVEC--EV--MRNIIH 216
+ +G G + VYK + VA+K + D + E+ ++ + H
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKK---IRLDNEEEGIPSTALREISLLKELKH 57
Query: 217 RKIIK---VVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKR---HKAPGNLN 270
I+K V+ ++ LV+E+ + D + K PG L+
Sbjct: 58 PNIVKLLDVIHTERKL--------YLVFEYC-------------DMDLKKYLDKRPGPLS 96
Query: 271 SLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIAR-FLEATN 329
+I + L Y H I H D+KP NIL+N + +ADFG+AR F
Sbjct: 97 PNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR 153
Query: 330 EQTSSIGVKGTTGYIAPEYGMGHETSSYG-DVYSFGILLLEMFTG 373
T + V T Y APE +G + S D++S G + EM TG
Sbjct: 154 TYTHEV-V--TLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITG 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-11
Identities = 60/235 (25%), Positives = 95/235 (40%), Gaps = 46/235 (19%)
Query: 167 LIGAGNFASVYKGILFEGAPAVAIKV-------FNFLHHDASKSFTVECEVMRNIIHRKI 219
LIG G VY + VA+K L K F E ++ ++IH I
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLK----KRFLREAKIAADLIHPGI 64
Query: 220 IKVVTACSRVDYQGNDFKALVYEFMP---NGSLEEWIHPITEED---KRHKAPGNLNSLE 273
+ V + CS D VY MP +L+ + + +++ K ++ +
Sbjct: 65 VPVYSICSDGD--------PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAF- 115
Query: 274 RLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTS 333
L+I + + +EY+H + H D+KP NILL + D+G A F + E
Sbjct: 116 -LSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLL 171
Query: 334 SIGVK----------------GTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT 372
I V GT Y+APE +G S D+Y+ G++L +M T
Sbjct: 172 DIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 66.1 bits (162), Expect = 1e-11
Identities = 61/214 (28%), Positives = 91/214 (42%), Gaps = 32/214 (14%)
Query: 165 ENLIGAGNFASVYKGILFEGAPAVAIK---VFNFLHHDASKSFTV--ECEVMRNIIHRKI 219
+G G +A VYK E VAIK + +FT E ++++ + H I
Sbjct: 5 GKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNI 64
Query: 220 IKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHK-APGNLNSLERLNIA 278
I ++ + LV+EFM LE+ I DK P ++ S
Sbjct: 65 IGLLDV-----FGHKSNINLVFEFME-TDLEKVIK-----DKSIVLTPADIKS-----YM 108
Query: 279 IDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVK 338
+ LEYLH I H D+KP+N+L+ + +ADFG+AR + N + + V
Sbjct: 109 LMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV- 164
Query: 339 GTTGYIAPEYGMGHETSSYG---DVYSFGILLLE 369
T Y APE G YG D++S G + E
Sbjct: 165 -TRWYRAPELLFG--ARHYGVGVDMWSVGCIFAE 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 58/223 (26%), Positives = 102/223 (45%), Gaps = 24/223 (10%)
Query: 162 FSSENLIGAGNFASVYKGILF-EGAPA---VAIKVF-NFLHHDASKSFTVECEVMRNIIH 216
F ++G+G F +VYKG+ EG VAIK A+K E VM ++ +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 217 RKIIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLN 276
+ +++ C Q L+ + MP G L +++ + HK N+ S LN
Sbjct: 69 PHVCRLLGICLTSTVQ------LITQLMPFGCLLDYV-------REHKD--NIGSQYLLN 113
Query: 277 IAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIG 336
+ +A + YL + + H D+ N+L+ + DFG+A+ L A ++ + G
Sbjct: 114 WCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEG 170
Query: 337 VKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSD 378
K ++A E + + DV+S+G+ + E+ T G +P D
Sbjct: 171 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 65.3 bits (160), Expect = 2e-11
Identities = 55/229 (24%), Positives = 87/229 (37%), Gaps = 26/229 (11%)
Query: 152 YEALYSATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHD-ASKSFTV-ECE 209
YE L IG G+F +V K + K ++ + K V E
Sbjct: 2 YEVLE----------TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVN 51
Query: 210 VMRNIIHRKIIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNL 269
++R + H I V R+ + N +V E+ G L + I +E K +
Sbjct: 52 ILRELKHPNI---VRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKY------I 102
Query: 270 NSLERLNIAIDVASALEYLHLGCKPP--IAHCDIKPSNILLNDEMTACVADFGIARFLEA 327
I + AL H P + H D+KP+NI L+ + DFG+A+ L
Sbjct: 103 EEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGH 162
Query: 328 TNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRP 376
+ + GT Y++PE D++S G L+ E+ L P
Sbjct: 163 DSSFAKTY--VGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCA-LSP 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 59/235 (25%), Positives = 109/235 (46%), Gaps = 41/235 (17%)
Query: 168 IGAGNFASVYK----GIL-FEGAPAVAIKVFNFLHHDAS----KSFTVECEVMRNIIHRK 218
IG G F V++ G+L +E VA+K+ L +AS F E +M H
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKM---LKEEASADMQADFQREAALMAEFDHPN 69
Query: 219 IIKVVTACSRVDYQGNDFKALVYEFMPNGSLEE--------WIHPITEEDKRHKAPG--- 267
I+K++ C+ G L++E+M G L E ++ + G
Sbjct: 70 IVKLLGVCA----VGKPM-CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124
Query: 268 -NLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLE 326
L+ E+L IA VA+ + YL + H D+ N L+ + M +ADFG++R +
Sbjct: 125 LPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 181
Query: 327 ATN----EQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRP 376
+ + + +I ++ ++ PE + ++ DV+++G++L E+F+ G++P
Sbjct: 182 SADYYKASENDAIPIR----WMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQP 232
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 2e-11
Identities = 71/243 (29%), Positives = 105/243 (43%), Gaps = 44/243 (18%)
Query: 162 FSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTV--ECEVMRNIIHRKI 219
F IG G + VYK + VA+K + T E +++R + HR I
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNI 68
Query: 220 IK---VVTACSRVDYQGNDFKA------LVYEFMPN---GSLEEWIHPITEEDKRHKAPG 267
+ +VT DFK LV+E+M + G LE + +E+
Sbjct: 69 VNLKEIVTD----KQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSED-------- 116
Query: 268 NLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEA 327
++ S + + L Y H K H DIK SNILLN++ +ADFG+AR +
Sbjct: 117 HIKSFMK-----QLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNS 168
Query: 328 TNEQTSSIGVKGTTGYIAPEYGMGHETSSYG---DVYSFGILLLEMFTGLRPSDDMFKDN 384
+ + V T Y PE +G E YG DV+S G +L E+FT +P +F+ N
Sbjct: 169 EESRPYTNKVI-TLWYRPPELLLGEE--RYGPAIDVWSCGCILGELFTK-KP---IFQAN 221
Query: 385 LNL 387
L
Sbjct: 222 QEL 224
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 55/224 (24%), Positives = 92/224 (41%), Gaps = 36/224 (16%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACS 227
+G G F VYK E A K+ + + F VE +++ H I+ + A
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 228 RVDYQGNDFKALVY-EFMPNGSL----EEWIHPITEEDKRHKAPGNLNSLERLNIAIDVA 282
+ K + EF G+L E +TE R+ + +
Sbjct: 73 ------YENKLWILIEFCDGGALDSIMLELERGLTEPQIRY-------------VCRQML 113
Query: 283 SALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTG 342
AL +LH + H D+K NILL + +ADFG++ ++T ++ + GT
Sbjct: 114 EALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTF--IGTPY 168
Query: 343 YIAPEYGMGHETSS---Y---GDVYSFGILLLEMFTGLRPSDDM 380
++APE + ET Y D++S GI L+E+ P ++
Sbjct: 169 WMAPEV-VACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL 211
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 56/231 (24%), Positives = 103/231 (44%), Gaps = 26/231 (11%)
Query: 162 FSSENLIGAGNFASVYKGILFEGAPAVAIK---VFNFLHHDASKSFTVECEVMRNIIHRK 218
F E IG G F+ VY+ VA+K +F + A + E ++++ + H
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63
Query: 219 IIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERL--N 276
+IK + + + ++ +V E G L + I + ++ P ER
Sbjct: 64 VIKYLDS-----FIEDNELNIVLELADAGDLSQMIKYFKK--QKRLIP------ERTVWK 110
Query: 277 IAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIG 336
+ + SA+E++H + H DIKP+N+ + + D G+ RF +++ T++
Sbjct: 111 YFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHS 165
Query: 337 VKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNL 387
+ GT Y++PE + + D++S G LL EM P + D +NL
Sbjct: 166 LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP---FYGDKMNL 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 56/236 (23%), Positives = 102/236 (43%), Gaps = 40/236 (16%)
Query: 167 LIGAGNFASVYKGILFEGAPAVAIKVFNF----------LHHDASKSFTVECEVMRNIIH 216
LIG G + VY + +A+K D K+ E E ++++ H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 217 RKIIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLN 276
I++ + ++ ++ E++P GS+ + + G
Sbjct: 68 LNIVQYL-GFET----TEEYLSIFLEYVPGGSIGSCL----------RTYGRFEEQLVRF 112
Query: 277 IAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIG 336
V L YLH I H D+K N+L++ + ++DFGI++ + + ++
Sbjct: 113 FTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMS 169
Query: 337 VKGTTGYIAPE----YGMGHETSSYGDVYSFGILLLEMFTGLRP-SDD-----MFK 382
++G+ ++APE Y G+ S+ D++S G ++LEMF G RP SD+ MFK
Sbjct: 170 MQGSVFWMAPEVIHSYSQGY--SAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFK 223
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 40/107 (37%), Positives = 58/107 (54%), Gaps = 11/107 (10%)
Query: 277 IAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIG 336
IA+ + ALEYLH + H D+KPSN+L+N + DFGI+ +L + +T G
Sbjct: 108 IAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAG 165
Query: 337 VKGTTGYIAPEYGMGHETSSYG-----DVYSFGILLLEMFTGLRPSD 378
K Y+APE + E + G DV+S GI ++E+ TG P D
Sbjct: 166 CK---PYMAPER-INPELNQKGYDVKSDVWSLGITMIELATGRFPYD 208
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 56/218 (25%), Positives = 97/218 (44%), Gaps = 24/218 (11%)
Query: 167 LIGAGNFASVYKGILFEGAP----AVAIKVF-NFLHHDASKSFTVECEVMRNIIHRKIIK 221
++G+G F +VYKGI VAIKV A+K E VM + + +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 222 VVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDV 281
++ C Q LV + MP G L +++ + +K + S + LN + +
Sbjct: 74 LLGICLTSTVQ------LVTQLMPYGCLLDYV-------RENK--DRIGSQDLLNWCVQI 118
Query: 282 ASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTT 341
A + YL + + H D+ N+L+ + DFG+AR L+ + + G K
Sbjct: 119 AKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPI 175
Query: 342 GYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSD 378
++A E + + DV+S+G+ + E+ T G +P D
Sbjct: 176 KWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 3e-11
Identities = 54/219 (24%), Positives = 88/219 (40%), Gaps = 20/219 (9%)
Query: 162 FSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTV--ECEVMRNIIHRKI 219
F N IG G+F V+K + A+K + + + E V+ + I
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 220 IKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAI 279
I+ S +D +V E+ NG L + + + P + + R I I
Sbjct: 62 IRYYE--SFLDKG---KLNIVMEYAENGDLHKLLK------MQRGRPLPEDQVWRFFIQI 110
Query: 280 DVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKG 339
+ L +LH I H DIK N+ L+ + D G+A+ L ++I G
Sbjct: 111 LLG--LAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTI--VG 163
Query: 340 TTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSD 378
T Y++PE + DV++ G++L E TG P D
Sbjct: 164 TPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFD 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 4e-11
Identities = 55/215 (25%), Positives = 95/215 (44%), Gaps = 24/215 (11%)
Query: 167 LIGAGNFASVYKGILFEGAP---AVAIKVF-NFLHHDASKSFTVECEVMRNIIHRKIIKV 222
IG G F VY+G+ AVA+K N + F E +MR H I+K+
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 223 VTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVA 282
+ + + +V E P G L ++ + +K +L+ + + ++
Sbjct: 73 IGVIT------ENPVWIVMELAPLGELRSYL-------QVNKY--SLDLASLILYSYQLS 117
Query: 283 SALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTG 342
+AL YL H DI N+L++ + DFG++R+LE + +S G K
Sbjct: 118 TALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKG-KLPIK 173
Query: 343 YIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRP 376
++APE +S DV+ FG+ + E+ G++P
Sbjct: 174 WMAPESINFRRFTSASDVWMFGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 4e-11
Identities = 60/219 (27%), Positives = 89/219 (40%), Gaps = 22/219 (10%)
Query: 161 GFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNF-LHHDASKSFTV-ECEVMRNIIHRK 218
F +G G++ SVYK A+K + + V E ++ ++ H
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 219 IIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERL-NI 277
II A GN +V E+ P G L + I + K L + + I
Sbjct: 61 IISYKEAF----LDGNKL-CIVMEYAPFGDLSKAI-------SKRKKKRKLIPEQEIWRI 108
Query: 278 AIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGV 337
I + L+ LH + I H D+K +NILL + D GI++ L+ +T
Sbjct: 109 FIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKT----Q 161
Query: 338 KGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRP 376
GT Y+APE G S D++S G LL EM T P
Sbjct: 162 IGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 5e-11
Identities = 57/231 (24%), Positives = 103/231 (44%), Gaps = 26/231 (11%)
Query: 162 FSSENLIGAGNFASVYKGI-LFEGAPAV--AIKVFNFLHHDASKSFTVECEVMRNIIHRK 218
F E IG G F+ VY+ L +G P +++F+ + A E ++++ + H
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63
Query: 219 IIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERL--N 276
+IK + + N+ +V E G L I ++ + P E+
Sbjct: 64 VIKYYASF----IEDNELN-IVLELADAGDLSRMIKHFKKQ--KRLIP------EKTVWK 110
Query: 277 IAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIG 336
+ + SALE++H + H DIKP+N+ + + D G+ RF +++ T++
Sbjct: 111 YFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHS 165
Query: 337 VKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNL 387
+ GT Y++PE + + D++S G LL EM P + D +NL
Sbjct: 166 LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP---FYGDKMNL 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 5e-11
Identities = 62/250 (24%), Positives = 107/250 (42%), Gaps = 36/250 (14%)
Query: 167 LIGAGNFASVYKGILFEGAPA--VAIKVFNFLH-------HDASKSF---TVECEVMR-N 213
+G+G F VYK + + +A+K N + + KS E +++
Sbjct: 7 HLGSGAFGCVYK-VRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQ 65
Query: 214 IIHRKIIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLE 273
+ H I++ + ND +V + + L E H + ++K+ + E
Sbjct: 66 LRHPNIVRYYKT-----FLENDRLYIVMDLIEGAPLGE--HFNSLKEKKQRFTE-----E 113
Query: 274 RL-NIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQT 332
R+ NI + + AL YLH + I H D+ P+NI+L ++ + DFG+A+ ++
Sbjct: 114 RIWNIFVQMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQPES 168
Query: 333 SSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRP---SDDMFKDNLNLQN 389
V GT Y PE DV++FG +L +M T L+P S +M +
Sbjct: 169 KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCT-LQPPFYSTNMLSLATKIVE 227
Query: 390 WVQSALPERV 399
V LPE +
Sbjct: 228 AVYEPLPEGM 237
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 5e-11
Identities = 63/226 (27%), Positives = 97/226 (42%), Gaps = 34/226 (15%)
Query: 162 FSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIK 221
F+ IG G+F VYKGI VAIK+ + E E I ++I
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDL----------EEAEDEIEDIQQEI-T 54
Query: 222 VVTACSR---VDYQGNDFKA----LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLER 274
V++ C Y G+ K ++ E++ GS + + P G L
Sbjct: 55 VLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKP-----------GPLEETYI 103
Query: 275 LNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSS 334
I ++ L+YLH K H DIK +N+LL+++ +ADFG+A L T+ Q
Sbjct: 104 ATILREILKGLDYLHSERK---IHRDIKAANVLLSEQGDVKLADFGVAGQL--TDTQIKR 158
Query: 335 IGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDM 380
GT ++APE D++S GI +E+ G P+ D+
Sbjct: 159 NTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDL 204
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 5e-11
Identities = 39/100 (39%), Positives = 60/100 (60%), Gaps = 11/100 (11%)
Query: 280 DVASALEYLH-LGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVK 338
++A AL++LH LG I + D+KP NILL++E + DFG+++ E+ + + +
Sbjct: 106 ELALALDHLHSLG----IIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFC 159
Query: 339 GTTGYIAPEY--GMGHETSSYGDVYSFGILLLEMFTGLRP 376
GT Y+APE GH S+ D +SFG+L+ EM TG P
Sbjct: 160 GTVEYMAPEVVNRRGHTQSA--DWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 5e-11
Identities = 61/226 (26%), Positives = 98/226 (43%), Gaps = 34/226 (15%)
Query: 162 FSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIK 221
F+ IG G+F V+KGI VAIK+ + E E I ++I
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDL----------EEAEDEIEDIQQEI-T 54
Query: 222 VVTACSR---VDYQGNDFKA----LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLER 274
V++ C Y G+ K ++ E++ GS + + G + +
Sbjct: 55 VLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRA-----------GPFDEFQI 103
Query: 275 LNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSS 334
+ ++ L+YLH K H DIK +N+LL+++ +ADFG+A L T+ Q
Sbjct: 104 ATMLKEILKGLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQL--TDTQIKR 158
Query: 335 IGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDM 380
GT ++APE S D++S GI +E+ G P+ DM
Sbjct: 159 NTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDM 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 6e-11
Identities = 55/214 (25%), Positives = 87/214 (40%), Gaps = 22/214 (10%)
Query: 167 LIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTAC 226
++G G + VY +AIK + E + + HR I++ + +
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD 74
Query: 227 SRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALE 286
S N F + E +P GSL + K ++ + + L L+
Sbjct: 75 SE-----NGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQIL-------EGLK 122
Query: 287 YLHLGCKPPIAHCDIKPSNILLNDEMTAC-VADFGIARFLEATNEQTSSIGVKGTTGYIA 345
YLH I H DIK N+L+N ++DFG ++ L N T + GT Y+A
Sbjct: 123 YLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETF--TGTLQYMA 177
Query: 346 PEYGMGHETSSYG---DVYSFGILLLEMFTGLRP 376
PE + YG D++S G ++EM TG P
Sbjct: 178 PEV-IDKGPRGYGAPADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 63.7 bits (156), Expect = 6e-11
Identities = 58/224 (25%), Positives = 97/224 (43%), Gaps = 38/224 (16%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTV-----ECEVMRNIIHRKIIKV 222
+G G+F V A+K+ + K V E ++++I H ++ +
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSK--AKIVKLKQVEHVLNEKRILQSIRHPFLVNL 66
Query: 223 VTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVA 282
+ +Q + LV E++P G L + K + P + R A V
Sbjct: 67 YGS-----FQDDSNLYLVMEYVPGGELFSHL------RKSGRFP---EPVARFYAA-QVV 111
Query: 283 SALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTG 342
ALEYLH I + D+KP N+LL+ + + DFG A+ ++ +T ++ GT
Sbjct: 112 LALEYLH-SLD--IVYRDLKPENLLLDSDGYIKITDFGFAKRVK---GRTYTLC--GTPE 163
Query: 343 YIAPE--YGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDN 384
Y+APE G+ + D ++ GIL+ EM G P F D+
Sbjct: 164 YLAPEIILSKGYGKAV--DWWALGILIYEMLAGYPP----FFDD 201
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 8e-11
Identities = 62/226 (27%), Positives = 98/226 (43%), Gaps = 34/226 (15%)
Query: 162 FSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIK 221
F+ IG G+F V+KGI VAIK+ + E E I ++I
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDL----------EEAEDEIEDIQQEI-T 54
Query: 222 VVTACSR---VDYQGNDFKA----LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLER 274
V++ C Y G+ K ++ E++ GS + + P G L+ +
Sbjct: 55 VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-----------GPLDETQI 103
Query: 275 LNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSS 334
I ++ L+YLH K H DIK +N+LL++ +ADFG+A L T+ Q
Sbjct: 104 ATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKR 158
Query: 335 IGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDM 380
GT ++APE S D++S GI +E+ G P ++
Sbjct: 159 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSEL 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 8e-11
Identities = 58/210 (27%), Positives = 92/210 (43%), Gaps = 26/210 (12%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIK-VFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTAC 226
IG GNF V+ G L VA+K L D F E +++ H I++++ C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 227 SRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALE 286
++ +V E + G ++ R + P L E + + + A+ +E
Sbjct: 63 TQ-----KQPIYIVMELVQGGDFLTFL--------RTEGP-RLKVKELIQMVENAAAGME 108
Query: 287 YLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGT-TGYIA 345
YL H D+ N L+ ++ ++DFG++R E S+ G+K + A
Sbjct: 109 YLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSR-EEEDGVYASTGGMKQIPVKWTA 164
Query: 346 PE---YGMGHETSSYGDVYSFGILLLEMFT 372
PE YG SS DV+SFGILL E F+
Sbjct: 165 PEALNYG---RYSSESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 1e-10
Identities = 37/104 (35%), Positives = 51/104 (49%), Gaps = 9/104 (8%)
Query: 277 IAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIG 336
+ + + AL YL K + H D+KPSNILL+ + DFGI+ L + +T S
Sbjct: 119 MTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRS-- 174
Query: 337 VKGTTGYIAPE-YGMGHETSSY---GDVYSFGILLLEMFTGLRP 376
G Y+APE Y DV+S GI L+E+ TG P
Sbjct: 175 -AGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 1e-10
Identities = 58/209 (27%), Positives = 88/209 (42%), Gaps = 21/209 (10%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACS 227
IG G +VY I VAIK N + E VMR H I+ + +
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDS-- 84
Query: 228 RVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEY 287
Y D +V E++ GSL + + ++ G + ++ R + ALE+
Sbjct: 85 ---YLVGDELWVVMEYLAGGSLTDVVTETCMDE------GQIAAVCR-----ECLQALEF 130
Query: 288 LHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPE 347
LH + H DIK NILL + + + DFG + T EQ+ + GT ++APE
Sbjct: 131 LH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPE 185
Query: 348 YGMGHETSSYGDVYSFGILLLEMFTGLRP 376
D++S GI+ +EM G P
Sbjct: 186 VVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 55/224 (24%), Positives = 107/224 (47%), Gaps = 25/224 (11%)
Query: 168 IGAGNFASVYKGILF----EGAPAVAIKVF-NFLHHDASKSFTVECEVMRNIIHRKIIKV 222
+G F +YKG L+ + A VAIK + + F E +M + H I+ +
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 223 VTACSRVDYQGNDFKALVYEFMPNGSLEEWI---HPITE----EDKRHKAPGNLNSLERL 275
+ ++ +++E++ G L E++ P ++ D+ +L+ + L
Sbjct: 73 LGVVTQ-----EQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFL 127
Query: 276 NIAIDVASALEYL--HLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTS 333
+IAI +A+ +EYL H H D+ NIL+ +++ ++D G++R + + +
Sbjct: 128 HIAIQIAAGMEYLSSHF-----FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRV 182
Query: 334 SIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRP 376
++ PE M + SS D++SFG++L E+F+ GL+P
Sbjct: 183 QPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 61/196 (31%), Positives = 85/196 (43%), Gaps = 40/196 (20%)
Query: 242 EFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERL-NIAIDVASALEYLHLGCKPPIAHCD 300
EFM GSL D+ +K G + +E L IA+ V L YL+ I H D
Sbjct: 83 EFMDCGSL----------DRIYKKGGPI-PVEILGKIAVAVVEGLTYLYN--VHRIMHRD 129
Query: 301 IKPSNILLNDEMTACVADFGIARFLEATNEQTSSIG--VKGTTGYIAPEYGMGHETSSYG 358
IKPSNIL+N + DFG+ + E +SI GT+ Y++PE G + +
Sbjct: 130 IKPSNILVNSRGQIKLCDFGV------SGELINSIADTFVGTSTYMSPERIQGGKYTVKS 183
Query: 359 DVYSFGILLLEMFTGLRPSDDMFKDNLN----------LQNWVQ--------SALPERVE 400
DV+S GI ++E+ G P D+ LQ VQ S PE +
Sbjct: 184 DVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLR 243
Query: 401 EIVDTLFFKEIEEEET 416
+ VD K+ E T
Sbjct: 244 DFVDACLLKDPTERPT 259
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 3e-10
Identities = 56/218 (25%), Positives = 96/218 (44%), Gaps = 15/218 (6%)
Query: 162 FSSENLIGAGNFASVYKGILFE---GAPAVAIKVFN---FLHHDASKSFTVECEVMRNII 215
F+ ++G G F SV + L VA+K+ F D + F E M+
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEE-FLREAACMKEFD 59
Query: 216 HRKIIKVVTACSRVDYQGN-DFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLER 274
H +IK++ R +G ++ FM +G L H + + P L
Sbjct: 60 HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDL----HTFLLMSRIGEEPFTLPLQTL 115
Query: 275 LNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSS 334
+ ID+AS +EYL H D+ N +LN+ MT CVADFG+++ + + +
Sbjct: 116 VRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQG 172
Query: 335 IGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT 372
K ++A E + +++ DV++FG+ + E+ T
Sbjct: 173 CASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 3e-10
Identities = 56/220 (25%), Positives = 102/220 (46%), Gaps = 27/220 (12%)
Query: 168 IGAGNFASVYKGIL--FEGAPAVAIKVFNFLHHDAS--KSFTVECEVMRNIIHRKIIKVV 223
+G+GNF +V KG+ + VA+K+ ++D + E VM+ + + I++++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 224 TACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVAS 283
C + LV E G L +++ + +H N+ L V+
Sbjct: 63 GICEAESWM------LVMELAELGPLNKFL-----QKNKHVTEKNITELVH-----QVSM 106
Query: 284 ALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNE--QTSSIGVKGTT 341
++YL + H D+ N+LL + A ++DFG+++ L A + + G K
Sbjct: 107 GMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHG-KWPV 162
Query: 342 GYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDM 380
+ APE ++ SS DV+SFG+L+ E F+ G +P M
Sbjct: 163 KWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGM 202
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 4e-10
Identities = 54/212 (25%), Positives = 97/212 (45%), Gaps = 26/212 (12%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTV-ECEVMRNIIHRKIIK---VV 223
+G G +A+VYKG VA+K + + + S + E +M+ + H I++ V+
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67
Query: 224 TACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVAS 283
+++ LV+E+M + L++++ H G L+ + +
Sbjct: 68 HTENKL--------MLVFEYM-DKDLKKYM-------DTHGVRGALDPNTVKSFTYQLLK 111
Query: 284 ALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGY 343
+ + H + + H D+KP N+L+N +ADFG+AR S+ V T Y
Sbjct: 112 GIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV--TLWY 166
Query: 344 IAPEYGMGHETSSYG-DVYSFGILLLEMFTGL 374
AP+ +G T S D++S G ++ EM TG
Sbjct: 167 RAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 4e-10
Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 26/209 (12%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACS 227
+G G F VYK E A KV + + + VE E++ H I+K++ A
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF- 78
Query: 228 RVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEY 287
Y ++ EF P G+++ + E D+ P + I + AL+Y
Sbjct: 79 ---YWDGKLWIMI-EFCPGGAVDA---IMLELDRGLTEP------QIQVICRQMLEALQY 125
Query: 288 LHLGCKPPIAHCDIKPSNILLNDEMTACVADFGI-ARFLEATNEQTSSIGVKGTTGYIAP 346
LH I H D+K N+LL + +ADFG+ A+ ++ + S I GT ++AP
Sbjct: 126 LH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI---GTPYWMAP 179
Query: 347 EYGMGH--ETSSY---GDVYSFGILLLEM 370
E M + + Y D++S GI L+EM
Sbjct: 180 EVVMCETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 60.7 bits (148), Expect = 5e-10
Identities = 56/216 (25%), Positives = 87/216 (40%), Gaps = 32/216 (14%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIKVFNFLH---HDASKSFTVECEVMRNIIHRKIIKVVT 224
+G G F V + A+K H + E E++ H I+K+
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 225 ACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLN-SLERLNIAIDVAS 283
++ + ++ E+ G L + G + R IA V
Sbjct: 61 T-----FKDKKYIYMLMEYCLGGELWTILRDR----------GLFDEYTARFYIAC-VVL 104
Query: 284 ALEYLH-LGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTG 342
A EYLH G I + D+KP N+LL+ + DFG A+ L++ + + G T
Sbjct: 105 AFEYLHNRG----IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCG---TPE 157
Query: 343 YIAPEY--GMGHETSSYGDVYSFGILLLEMFTGLRP 376
Y+APE G++ S D +S GILL E+ TG P
Sbjct: 158 YVAPEIILNKGYDFSV--DYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 6e-10
Identities = 55/233 (23%), Positives = 105/233 (45%), Gaps = 34/233 (14%)
Query: 155 LYSATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVF-NFLHHDASKS----FTVECE 209
+ + + +L+ G F ++ GIL + P +VF + AS+ E
Sbjct: 1 IAISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESC 60
Query: 210 VMRNIIHRKIIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNL 269
++ + H+ I+ ++ C + + ++Y +M G+L+ ++ + R N
Sbjct: 61 LLYGLSHQNILPILHVCI----EDGEPPFVLYPYMNWGNLKLFL-----QQCRLGEANNP 111
Query: 270 NSL---ERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFL- 325
+L + +++AI +A + YLH K + H DI N ++++E+ + D ++R L
Sbjct: 112 QALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLF 168
Query: 326 ------EATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT 372
NE VK ++A E + E SS DV+SFG+LL E+ T
Sbjct: 169 PMDYHCLGDNENRP---VK----WMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 7e-10
Identities = 42/138 (30%), Positives = 66/138 (47%), Gaps = 11/138 (7%)
Query: 239 LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAH 298
LV M G L I+ + EE+ PG + S LE+LH + I +
Sbjct: 70 LVMTIMNGGDLRYHIYNVDEEN-----PG-FPEPRACFYTAQIISGLEHLH---QRRIIY 120
Query: 299 CDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYG 358
D+KP N+LL+++ ++D G+A +E + Q+ + G GT G++APE G E
Sbjct: 121 RDLKPENVLLDNDGNVRISDLGLA--VELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSV 178
Query: 359 DVYSFGILLLEMFTGLRP 376
D ++ G+ L EM P
Sbjct: 179 DYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 8e-10
Identities = 52/218 (23%), Positives = 92/218 (42%), Gaps = 31/218 (14%)
Query: 206 VECEVMRNIIHRKIIKVVTACSRV-----DYQGNDFKALVYEFMPNGSLEEWIHPITEED 260
VEC ++ R+++ + + +Q + V E++ G L + I
Sbjct: 39 VEC----TMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDL---MFHIQSSG 91
Query: 261 KRHKAPGNLNSLERLNI-AIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADF 319
+ R A ++ L++LH K I + D+K N+LL+ + +ADF
Sbjct: 92 RF--------DEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADF 140
Query: 320 GIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRP--- 376
G+ + E +S GT YIAPE G + + D +SFG+LL EM G P
Sbjct: 141 GMCK-ENMNGEGKAST-FCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHG 198
Query: 377 --SDDMFKDNLNLQNWVQSALPERVEEIVDTLFFKEIE 412
D++F LN + + + ++ + LF ++
Sbjct: 199 EDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPT 236
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 8e-10
Identities = 39/103 (37%), Positives = 50/103 (48%), Gaps = 8/103 (7%)
Query: 277 IAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIG 336
IA+ AL YL K I H D+KPSNILL+ + DFGI+ L + +T G
Sbjct: 112 IAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAG 169
Query: 337 VKGTTGYIAPEYGMGHETSSY---GDVYSFGILLLEMFTGLRP 376
+ Y+APE Y DV+S GI L E+ TG P
Sbjct: 170 CR---PYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 9e-10
Identities = 44/136 (32%), Positives = 61/136 (44%), Gaps = 15/136 (11%)
Query: 3 GNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTE- 61
GN G I SL + L+VLDLS N+ +G IPE L L+ LNL+ N+ +P
Sbjct: 451 GNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAAL 510
Query: 62 -GIFKNASATSVFGNNKLCGGIPEFQLPTCVSKKTKQNRSTLPLKLVIAIDCGLLVLTLA 120
G + ++ + N LC GIP L C L + I I G+ V L
Sbjct: 511 GGRLLHRASFNFTDNAGLC-GIP--GLRAC--------GPHLSVGAKIGIAFGVSVAFLF 559
Query: 121 LSSLFCRLMCMKKRGN 136
L + C + K+R N
Sbjct: 560 L--VICAMCWWKRRQN 573
|
Length = 623 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 9e-10
Identities = 54/215 (25%), Positives = 85/215 (39%), Gaps = 30/215 (13%)
Query: 167 LIGAGNFASVYKG----ILFEGAPAVAIKVFNFLH-HDASKSFTVECEVMRNIIHRKIIK 221
+G G+F V +G + P VA+K D F E +M ++ H +I+
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIP-VAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60
Query: 222 ---VVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIA 278
VV + +V E P GSL + + K +++L + A
Sbjct: 61 LYGVVLTHPLM---------MVTELAPLGSLLDRLR------KDALGHFLISTL--CDYA 103
Query: 279 IDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQ-TSSIGV 337
+ +A+ + YL H D+ NILL + + DFG+ R L + +
Sbjct: 104 VQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHL 160
Query: 338 KGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT 372
K + APE S DV+ FG+ L EMFT
Sbjct: 161 KVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 9e-10
Identities = 36/96 (37%), Positives = 55/96 (57%), Gaps = 5/96 (5%)
Query: 284 ALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGY 343
ALE LH K + + D+KP NILL+ + + DFG+ + +++T++ GT Y
Sbjct: 105 ALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC--GTPEY 159
Query: 344 IAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDD 379
+APE +GH + D ++ G+LL EM TGL P D
Sbjct: 160 LAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYD 195
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 9e-10
Identities = 63/225 (28%), Positives = 94/225 (41%), Gaps = 54/225 (24%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTV---------ECEVMRNIIHRK 218
IG+G + V I VAIK +F V E +++R+ H
Sbjct: 13 IGSGAYGVVCSAIDTRSGKKVAIK-------KIPHAFDVPTLAKRTLRELKILRHFKHDN 65
Query: 219 IIKVVTACSRVDYQGNDFKA--LVYEFMPNGSLEEWIH---PITEEDKRHKAPGNLNSLE 273
II + + G DFK +V + M + L IH P+TEE R+ L L
Sbjct: 66 IIAIRDI---LRPPGADFKDVYVVMDLMES-DLHHIIHSDQPLTEEHIRY----FLYQLL 117
Query: 274 RLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTS 333
R L+Y+H + H D+KPSN+L+N++ + DFG+AR L +S
Sbjct: 118 R---------GLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLS-----SS 160
Query: 334 SIGVKG-------TTGYIAPEYGMG-HETSSYGDVYSFGILLLEM 370
K T Y APE + E ++ D++S G + EM
Sbjct: 161 PTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEM 205
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 1e-09
Identities = 57/226 (25%), Positives = 99/226 (43%), Gaps = 31/226 (13%)
Query: 166 NLIGAGNFASVYKGILFEGAPA---VAIKVFNFLHHDASKS-FTVECEVMRNIIHRKIIK 221
+IG G+F VY G L + A+K N + F E +M++ H ++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 222 VVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDV 281
++ C + +G+ +V +M +G L +I + + +L + + V
Sbjct: 61 LLGIC--LPSEGSPL--VVLPYMKHGDLRNFI----RSETHNPTVKDL-----IGFGLQV 107
Query: 282 ASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIAR------FLEATNEQTSSI 335
A +EYL H D+ N +L++ T VADFG+AR + N + +
Sbjct: 108 AKGMEYL---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKL 164
Query: 336 GVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDM 380
VK ++A E + ++ DV+SFG+LL E+ T G P D+
Sbjct: 165 PVK----WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 206
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 40/101 (39%), Positives = 55/101 (54%), Gaps = 11/101 (10%)
Query: 280 DVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIAR-FLEATNEQTSSIGVK 338
++ ALE+LH K I + DIK NILL+ E + DFG+++ FL E+T S
Sbjct: 113 EIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFC-- 167
Query: 339 GTTGYIAPEYGMGHETSSYG---DVYSFGILLLEMFTGLRP 376
GT Y+APE G +G D +S GIL+ E+ TG P
Sbjct: 168 GTIEYMAPEIIRGK--GGHGKAVDWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 1e-09
Identities = 63/221 (28%), Positives = 99/221 (44%), Gaps = 40/221 (18%)
Query: 167 LIGAGNFASV----YKGILFEGAPAVAIKVFNFLHHDASKS---FTVECEVMRNIIHRKI 219
+G GNF SV Y + VA+K L H ++ F E E+++++ H I
Sbjct: 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVKK---LQHSTAEHLRDFEREIEILKSLQHDNI 67
Query: 220 IKVVTACSRVDYQGNDFKA------LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLE 273
+K Y+G + A LV E++P GSL +++ + R + L+ +
Sbjct: 68 VK---------YKGVCYSAGRRNLRLVMEYLPYGSLRDYL-----QKHRER----LDHRK 109
Query: 274 RLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNE--Q 331
L A + +EYL G K + H D+ NIL+ E + DFG+ + L E +
Sbjct: 110 LLLYASQICKGMEYL--GSKRYV-HRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYK 166
Query: 332 TSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT 372
G Y APE + S DV+SFG++L E+FT
Sbjct: 167 VREPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 1e-09
Identities = 57/211 (27%), Positives = 97/211 (45%), Gaps = 30/211 (14%)
Query: 167 LIGAGNFASVYKGILFEGAPAVAIKVFNF--LHHDASKSFTVECEVMRNIIHRKIIKVVT 224
++G G F V+ V IK + D + EC+V++ + H II
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNII---- 62
Query: 225 ACSRVDYQGN--DFKAL--VYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAID 280
+Y N + KAL V E+ P G+L E+I + + + L+ L+ +
Sbjct: 63 -----EYYENFLEDKALMIVMEYAPGGTLAEYI-----QKRCNSL---LDEDTILHFFVQ 109
Query: 281 VASALEYLHLGCKPPIAHCDIKPSNILLND-EMTACVADFGIARFLEATNEQTSSIGVKG 339
+ AL ++H I H D+K NILL+ +M + DFGI++ L + ++ + V G
Sbjct: 110 ILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSS---KSKAYTVVG 163
Query: 340 TTGYIAPEYGMGHETSSYGDVYSFGILLLEM 370
T YI+PE G + D+++ G +L E+
Sbjct: 164 TPCYISPELCEGKPYNQKSDIWALGCVLYEL 194
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 57/213 (26%), Positives = 99/213 (46%), Gaps = 30/213 (14%)
Query: 188 VAIKVFNFLHHDASKS----FTVECEVMRNI-IHRKIIKVVTACSRVDYQGNDFKALVYE 242
VA+K+ L DA++ E E+M+ I H+ II ++ AC+ Q +V E
Sbjct: 53 VAVKM---LKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT----QDGPLYVIV-E 104
Query: 243 FMPNGSLEEWIH----PITEE--DKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPI 296
+ G+L E++ P E + L+ + ++ A VA +EYL
Sbjct: 105 YASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL---ASKKC 161
Query: 297 AHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSS 356
H D+ N+L+ ++ +ADFG+AR + + + + ++APE +
Sbjct: 162 IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTH 221
Query: 357 YGDVYSFGILLLEMFT-------GLRPSDDMFK 382
DV+SFG+LL E+FT G+ P +++FK
Sbjct: 222 QSDVWSFGVLLWEIFTLGGSPYPGV-PVEELFK 253
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 1e-09
Identities = 57/229 (24%), Positives = 83/229 (36%), Gaps = 49/229 (21%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNII------HRKIIK 221
IG G + VYK VAIK S + +R I H IIK
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFE----SEGIPKTALREIKLLKELNHPNIIK 62
Query: 222 ---VVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIA 278
V + LV+EFM + L + I + + G SL + +
Sbjct: 63 LLDVFRHKGDL--------YLVFEFM-DTDLYKLI--------KDRQRGLPESLIK-SYL 104
Query: 279 IDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATN----EQTSS 334
+ L + H I H D+KP N+L+N E +ADFG+AR +
Sbjct: 105 YQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVV- 160
Query: 335 IGVKGTTGYIAPE--YGMGHETSSYGDVYSFGILLLEMFTG--LRPSDD 379
T Y APE G ++ D++S G + E+ + L P
Sbjct: 161 -----TRWYRAPELLLGDKGYSTPV-DIWSVGCIFAELLSRRPLFPGKS 203
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.5 bits (145), Expect = 2e-09
Identities = 60/226 (26%), Positives = 95/226 (42%), Gaps = 52/226 (23%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTV--ECEVMRNI-------IHRK 218
+G G F SVY E VAIK K F EC +R + H
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMK-------KKFYSWEECMNLREVKSLRKLNEHPN 59
Query: 219 IIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWI-----HPITEEDKRHKAPGNLNSLE 273
I+K+ ++ ND V+E+M G+L + + P +E R
Sbjct: 60 IVKLKEV-----FRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIR----------- 102
Query: 274 RLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTS 333
+I + L ++H K H D+KP N+L++ +ADFG+AR + + T
Sbjct: 103 --SIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTD 157
Query: 334 SIGVKGTTGYIAPEYGMGHETSSYG---DVYSFGILLLEMFTGLRP 376
+ T Y APE + +SY D+++ G ++ E++T LRP
Sbjct: 158 YV---STRWYRAPEILLRS--TSYSSPVDIWALGCIMAELYT-LRP 197
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.9 bits (146), Expect = 2e-09
Identities = 52/205 (25%), Positives = 89/205 (43%), Gaps = 43/205 (20%)
Query: 188 VAIK-VFNFLHH--DASKSFTVECEVMRNIIHRKIIK---VVTACSRVDYQGNDFKALVY 241
VAIK + N DA + E +++R++ H II ++ S D+ ND +V
Sbjct: 28 VAIKKISNVFDDLIDAKRILR-EIKLLRHLRHENIIGLLDILRPPSPEDF--NDV-YIVT 83
Query: 242 EFMPNGSLEEWIH---PITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAH 298
E M L + I P+T++ ++ + L+YLH + H
Sbjct: 84 ELMET-DLHKVIKSPQPLTDDHIQY-------------FLYQILRGLKYLH---SANVIH 126
Query: 299 CDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYI------APEYGMGH 352
D+KPSNIL+N + DFG+AR ++ ++ + T Y+ APE +
Sbjct: 127 RDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFL-----TEYVVTRWYRAPELLLSS 181
Query: 353 ETSSYG-DVYSFGILLLEMFTGLRP 376
+ D++S G + E+ T +P
Sbjct: 182 SRYTKAIDIWSVGCIFAELLTR-KP 205
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 59.5 bits (145), Expect = 2e-09
Identities = 39/100 (39%), Positives = 55/100 (55%), Gaps = 14/100 (14%)
Query: 284 ALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGY 343
AL+Y+H G + H D+KPSNILLN + +ADFG+AR L + E+ V T Y
Sbjct: 119 ALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSL-SELEENPENPV--LTDY 172
Query: 344 IA------PEYGMGHETSSYG-DVYSFGILLLEMFTGLRP 376
+A PE +G + G D++S G +L EM G +P
Sbjct: 173 VATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLG-KP 211
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 58/216 (26%), Positives = 90/216 (41%), Gaps = 22/216 (10%)
Query: 167 LIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTV---ECEV--MRNIIHRKIIK 221
L+G G F VY + +A K F S V ECE+ ++N+ H +I++
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 222 VVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDV 281
C R + + E+MP GS+++ + KA G L +
Sbjct: 69 YY-GCLR--DRAEKTLTIFMEYMPGGSVKDQL----------KAYGALTESVTRKYTRQI 115
Query: 282 ASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSI-GVKGT 340
+ YLH I H DIK +NIL + + DFG ++ L+ + I V GT
Sbjct: 116 LEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGT 172
Query: 341 TGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRP 376
+++PE G DV+S G ++EM T P
Sbjct: 173 PYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 53/210 (25%), Positives = 89/210 (42%), Gaps = 12/210 (5%)
Query: 168 IGAGNFASVYKGILF--EGAPAVAIKVFNF--LHHDASKSFTVECEVMRNIIHRKIIKVV 223
+G G F SV +G L + VA+K + F E M+ H +++++
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 224 TAC-SRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVA 282
C V+ +G ++ FM +G L H + P L + + D+A
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDL----HSFLLYSRLGDCPQYLPTQMLVKFMTDIA 122
Query: 283 SALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTG 342
S +EYL H D+ N +LN+ M CVADFG+++ + + K
Sbjct: 123 SGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVK 179
Query: 343 YIAPEYGMGHETSSYGDVYSFGILLLEMFT 372
+IA E ++ DV+SFG+ + E+ T
Sbjct: 180 WIAIESLADRVYTTKSDVWSFGVTMWEIAT 209
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 3e-09
Identities = 53/224 (23%), Positives = 94/224 (41%), Gaps = 42/224 (18%)
Query: 168 IGAGNFASVYKGILFE------GAPAVAIKV-FNFLH--HDASKSFTVECEVMRNIIHRK 218
+G G F ++YKG+L P + V L H S +F +M + H+
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 219 IIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIA 278
++K+ C R + +V E++ G L+ ++H + N++ +L++A
Sbjct: 63 LVKLYGVCVRDENI------MVEEYVKFGPLDVFLH---------REKNNVSLHWKLDVA 107
Query: 279 IDVASALEYLHLGCKPPIAHCDIKPSNILL-----NDEMTACV--ADFGIARFLEATNEQ 331
+ASAL YL + H ++ NIL+ N+ + +D GI + + E+
Sbjct: 108 KQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREER 164
Query: 332 TSSIGVKGTTGYIAPEY--GMGHETSSYGDVYSFGILLLEMFTG 373
I +IAPE + D +SFG LLE+ +
Sbjct: 165 VERI------PWIAPECIRNGQASLTIAADKWSFGTTLLEICSN 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 3e-09
Identities = 33/99 (33%), Positives = 47/99 (47%), Gaps = 6/99 (6%)
Query: 278 AIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGV 337
A + LE+LH + I + D+KP N+LL+D ++D G+A L+ G
Sbjct: 101 AAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELK---GGKKIKGR 154
Query: 338 KGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRP 376
GT GY+APE G D ++ G L EM G P
Sbjct: 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 57/216 (26%), Positives = 91/216 (42%), Gaps = 22/216 (10%)
Query: 167 LIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTV---ECEV--MRNIIHRKIIK 221
L+G G F VY + +A+K F S V ECE+ ++N++H +I++
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 222 VVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDV 281
C R D ++ E MP GS+++ + K+ G L +
Sbjct: 69 YY-GCLR-DPMERTL-SIFMEHMPGGSIKDQL----------KSYGALTENVTRKYTRQI 115
Query: 282 ASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATN-EQTSSIGVKGT 340
+ YLH I H DIK +NIL + + DFG ++ L+ T V GT
Sbjct: 116 LEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGT 172
Query: 341 TGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRP 376
+++PE G D++S G ++EM T P
Sbjct: 173 PYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 4e-09
Identities = 60/229 (26%), Positives = 101/229 (44%), Gaps = 41/229 (17%)
Query: 167 LIGAGNFASVYKGILF-----EGAPAVAIKVFNFLHHDAS----KSFTVECEVMRNI-IH 216
+G G F V K VA+K+ L DA+ E E+M+ I H
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKM---LKDDATEKDLSDLVSEMEMMKMIGKH 75
Query: 217 RKIIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIH---PITEE---DKRHKAPGNLN 270
+ II ++ C++ +G + +V E+ +G+L +++ P E D L
Sbjct: 76 KNIINLLGVCTQ---EGPLY--VVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLT 130
Query: 271 SLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIAR------- 323
+ ++ A VA +E+L H D+ N+L+ ++ +ADFG+AR
Sbjct: 131 QKDLVSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDY 187
Query: 324 FLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT 372
+ + TN + VK ++APE + DV+SFG+LL E+FT
Sbjct: 188 YRKTTN---GRLPVK----WMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 4e-09
Identities = 61/224 (27%), Positives = 98/224 (43%), Gaps = 27/224 (12%)
Query: 166 NLIGAGNFASVYKGILFEGAP------AVAIKVFNFLHHDASKS-FTVECEVMRNIIHRK 218
+G G F VY+G L+ G VA+K + +S F +E +M H+
Sbjct: 12 RALGHGAFGEVYEG-LYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQN 70
Query: 219 IIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIA 278
I++ V ++ + ++ E M G L+ ++ E R + P +L + L A
Sbjct: 71 IVR----LIGVSFERLP-RFILLELMAGGDLKSFLR---ENRPRPERPSSLTMKDLLFCA 122
Query: 279 IDVASALEYLHLGCKPPIAHCDIKPSNILLNDE---MTACVADFGIARFLEATNEQTSSI 335
DVA +YL + H DI N LL + A +ADFG+AR +
Sbjct: 123 RDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR--DIYRASYYRK 177
Query: 336 GVKGT--TGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRP 376
G + ++ PE + +S DV+SFG+LL E+F+ G P
Sbjct: 178 GGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMP 221
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.0 bits (141), Expect = 5e-09
Identities = 56/224 (25%), Positives = 90/224 (40%), Gaps = 37/224 (16%)
Query: 166 NLIGAGNFASVYKGILFEGAPAVAIKVFNF-LHHDASKSFTV-ECEVMRNII---HRKII 220
IG G + +VYK VA+K L + T+ E +++ + H I+
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIV 64
Query: 221 KVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEED-----KRHKAPGNLNSLERL 275
+++ C LV+E + ++D + PG L
Sbjct: 65 RLLDVCHGPRTDRELKLTLVFEHV-------------DQDLATYLSKCPKPG-LPPETIK 110
Query: 276 NIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSI 335
++ + +++LH I H D+KP NIL+ + +ADFG+AR TS
Sbjct: 111 DLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTS-- 165
Query: 336 GVKGTTGYIAPEYGMGHETSSYG---DVYSFGILLLEMFTGLRP 376
V T Y APE + SSY D++S G + E+F RP
Sbjct: 166 -VVVTLWYRAPEVLLQ---SSYATPVDMWSVGCIFAELFR-RRP 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 5e-09
Identities = 59/225 (26%), Positives = 102/225 (45%), Gaps = 31/225 (13%)
Query: 165 ENLIGAGNFASVYKGILFEGAPA-----VAIKVFNFLHHDASK-SFTVECEVMRNIIHRK 218
E ++G G F + +G L P+ VAI D + F E + H
Sbjct: 10 ERILGTGRFGELCRGCL--KLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSN 67
Query: 219 IIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIA 278
I+++ +R GN +V E+M NG+L+ ++ ++H+ G L + + + +
Sbjct: 68 IVRLEGVITR----GNTM-MIVTEYMSNGALDSFL-------RKHE--GQLVAGQLMGML 113
Query: 279 IDVASALEYL-HLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQT-SSIG 336
+AS ++YL +G H + +L+N ++ ++ F R E +E +++
Sbjct: 114 PGLASGMKYLSEMG----YVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMS 167
Query: 337 VKGTTGYIAPEYGMGHETSSYGDVYSFGILLLE-MFTGLRPSDDM 380
K + APE H SS DV+SFGI++ E M G RP DM
Sbjct: 168 GKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDM 212
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 6e-09
Identities = 67/225 (29%), Positives = 105/225 (46%), Gaps = 28/225 (12%)
Query: 157 SATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIH 216
S K + N+IG G+F VY+ I + + VAIK L K+ E +M+N+ H
Sbjct: 63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIK--KVLQDPQYKN--RELLIMKNLNH 118
Query: 217 RKIIKV----VTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKR--HKAPGNLN 270
II + T C + + + N F +V EF+P + +H + R H P L
Sbjct: 119 INIIFLKDYYYTECFKKN-EKNIFLNVVMEFIP-----QTVHKYMKHYARNNHALPLFLV 172
Query: 271 SLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLN-DEMTACVADFGIARFLEATN 329
L + + AL Y+H I H D+KP N+L++ + T + DFG A+ L A
Sbjct: 173 KL----YSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQ 225
Query: 330 EQTSSIGVKGTTGYIAPEYGMGHET-SSYGDVYSFGILLLEMFTG 373
S I + Y APE +G +++ D++S G ++ EM G
Sbjct: 226 RSVSYICSR---FYRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 7e-09
Identities = 53/230 (23%), Positives = 92/230 (40%), Gaps = 38/230 (16%)
Query: 168 IGAGNFASVYKGILFE-----GAPAVAIKVFNFLHHDASKS----FTVECEVMRNIIHRK 218
+G G F V K F G VA+K+ L +AS S E +++ + H
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKM---LKENASSSELRDLLSEFNLLKQVNHPH 64
Query: 219 IIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIA 278
+IK+ ACS+ + L+ E+ GSL ++ + R P L S N +
Sbjct: 65 VIKLYGACSQ-----DGPLLLIVEYAKYGSLRSFL-----RESRKVGPSYLGSDGNRNSS 114
Query: 279 IDVASALEYLHLG---------CKP-------PIAHCDIKPSNILLNDEMTACVADFGIA 322
L +G + + H D+ N+L+ + ++DFG++
Sbjct: 115 YLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLS 174
Query: 323 RFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT 372
R + + + ++A E H ++ DV+SFG+LL E+ T
Sbjct: 175 RDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 7e-09
Identities = 52/197 (26%), Positives = 89/197 (45%), Gaps = 37/197 (18%)
Query: 207 ECEVMRNI-IHRKIIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKA 265
E E+M+ I H+ II ++ AC+ Q LV E+ G+L E++ + +
Sbjct: 67 EMEMMKMIGKHKNIINLLGACT----QDGPLYVLV-EYASKGNLREYL-------RARRP 114
Query: 266 PG-------------NLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEM 312
PG L + ++ A VA +EYL H D+ N+L+ ++
Sbjct: 115 PGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDN 171
Query: 313 TACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT 372
+ADFG+AR + + + + ++APE + DV+SFG+LL E+FT
Sbjct: 172 VMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
Query: 373 -------GLRPSDDMFK 382
G+ P +++FK
Sbjct: 232 LGGSPYPGI-PVEELFK 247
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 7e-09
Identities = 31/90 (34%), Positives = 44/90 (48%), Gaps = 6/90 (6%)
Query: 281 VASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGT 340
+ L YLH I H D+K NI +ND C+ D G A+F + +G+ GT
Sbjct: 166 ILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV---APAFLGLAGT 219
Query: 341 TGYIAPEYGMGHETSSYGDVYSFGILLLEM 370
APE + +S D++S GI+L EM
Sbjct: 220 VETNAPEVLARDKYNSKADIWSAGIVLFEM 249
|
Length = 357 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 7e-09
Identities = 63/213 (29%), Positives = 93/213 (43%), Gaps = 34/213 (15%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACS 227
+G G F VYK E A KV + + + + VE +++ + H I+K++ A
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF- 71
Query: 228 RVDYQGNDFKALVYEFMPNGSLE----EWIHPITEEDKRHKAPGNLNSLERLNIAIDVAS 283
Y N+ L+ EF G+++ E P+TE R L
Sbjct: 72 ---YYENNLWILI-EFCAGGAVDAVMLELERPLTEPQIRVVCKQTLE------------- 114
Query: 284 ALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGY 343
AL YLH + I H D+K NIL + +ADFG++ T ++ S GT +
Sbjct: 115 ALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSF--IGTPYW 169
Query: 344 IAPEYGMGHETSS------YGDVYSFGILLLEM 370
+APE M ETS DV+S GI L+EM
Sbjct: 170 MAPEVVMC-ETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 8e-09
Identities = 55/223 (24%), Positives = 94/223 (42%), Gaps = 37/223 (16%)
Query: 168 IGAGNFASVYKGILFEGAPA-------VAIKVFNFLHHDASKSFTV----ECEVMRNIIH 216
+G G+F V L+ PA VA+K L + + T E +++ + H
Sbjct: 12 LGEGHFGKV---SLYCYDPANDGTGEMVAVKT---LKRECGQQNTSGWKKEINILKTLYH 65
Query: 217 RKIIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLN 276
I+K CS QG L+ E++P GSL +++ +H LN + L
Sbjct: 66 ENIVKYKGCCSE---QGGKGLQLIMEYVPLGSLRDYL-------PKH----KLNLAQLLL 111
Query: 277 IAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIG 336
A + + YLH H D+ N+LL+++ + DFG+A+ + + +
Sbjct: 112 FAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV-PEGHEYYRVR 167
Query: 337 VKGTTG--YIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPS 377
G + + A E ++ S DV+SFG+ L E+ T
Sbjct: 168 EDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSK 210
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 9e-09
Identities = 64/229 (27%), Positives = 102/229 (44%), Gaps = 27/229 (11%)
Query: 162 FSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIH-RKII 220
F ++G G + VYKG + AIKV + + D + +E +++ H R I
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMD-VTEDEEEEIKLEINMLKKYSHHRNIA 76
Query: 221 KVVTACSRVDYQGNDFKA-LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAI 279
A + G+D + LV EF GS +T+ K K N+L+ IA
Sbjct: 77 TYYGAFIKKSPPGHDDQLWLVMEFCGAGS-------VTDLVKNTKG----NALKEDWIAY 125
Query: 280 ---DVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIG 336
++ L +LH + H DIK N+LL + + DFG++ L+ T + ++
Sbjct: 126 ICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF- 181
Query: 337 VKGTTGYIAPEYGMGHET--SSY---GDVYSFGILLLEMFTGLRPSDDM 380
GT ++APE E ++Y D++S GI +EM G P DM
Sbjct: 182 -IGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDM 229
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 1e-08
Identities = 65/271 (23%), Positives = 101/271 (37%), Gaps = 74/271 (27%)
Query: 167 LIGAGNFASVY------KGILFEGAPAVAIKVFN---FLHHDASKSFTVECEVMRNIIHR 217
+IG G F V+ G ++ A+KV + + E +++ +
Sbjct: 8 VIGRGAFGEVWLVRDKDTGQVY------AMKVLRKSDMIKRNQIAHVRAERDILADADSP 61
Query: 218 KIIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEW--IHPITEEDKRHKAPGNLNSLERL 275
I+K+ + +Q + LV E+MP G L + E+ R
Sbjct: 62 WIVKLYYS-----FQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEE-----------TARF 105
Query: 276 NIAIDVASALEYLH-LGCKPPIAHCDIKPSNILLNDEMTACVADFGIA--------RFLE 326
IA ++ AL+ +H LG H DIKP NIL++ + +ADFG+ R
Sbjct: 106 YIA-ELVLALDSVHKLGF----IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY 160
Query: 327 ATNEQTSSIGVK-------------------GTTGYIAPEYGMGHETSSYG---DVYSFG 364
+ GT YIAPE G YG D +S G
Sbjct: 161 LNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTP---YGLECDWWSLG 217
Query: 365 ILLLEMFTGLRP--SDDMFKDNLNLQNWVQS 393
++L EM G P SD + + + NW +S
Sbjct: 218 VILYEMLYGFPPFYSDTLQETYNKIINWKES 248
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 1e-08
Identities = 51/198 (25%), Positives = 77/198 (38%), Gaps = 28/198 (14%)
Query: 187 AVAIKVFNFLHHDAS---KSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKALVYEF 243
VAIK+ + F E + + H I+ ++ + V+E+
Sbjct: 5 EVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGE----APPGLLFAVFEY 60
Query: 244 MPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKP 303
+P +L E A G L + E + + V AL H I H D+KP
Sbjct: 61 VPGRTLRE----------VLAADGALPAGETGRLMLQVLDALACAH---NQGIVHRDLKP 107
Query: 304 SNILL---NDEMTACVADFGIARFLEATNEQ-----TSSIGVKGTTGYIAPEYGMGHETS 355
NI++ A V DFGI L + T + V GT Y APE G +
Sbjct: 108 QNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVT 167
Query: 356 SYGDVYSFGILLLEMFTG 373
D+Y++G++ LE TG
Sbjct: 168 PNSDLYAWGLIFLECLTG 185
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 55/205 (26%), Positives = 98/205 (47%), Gaps = 32/205 (15%)
Query: 182 FEGAPA-VAIKVFNFLHHDASKS----FTVECEVMRNIIHRKIIKVVTACSRVDYQGNDF 236
F+G P VA+K+ L D +K+ F E ++M + + II+++ C +D
Sbjct: 40 FDGQPVLVAVKM---LRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVS-----DDP 91
Query: 237 KALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNI---AIDVASALEYLHLGCK 293
++ E+M NG L +++ E A N+ S+ N+ A+ +AS ++YL
Sbjct: 92 LCMITEYMENGDLNQFLSQREIESTFTHA-NNIPSVSIANLLYMAVQIASGMKYL---AS 147
Query: 294 PPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHE 353
H D+ N L+ + T +ADFG++R L + + ++G + P M E
Sbjct: 148 LNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYR----IQGRA--VLPIRWMAWE 201
Query: 354 T------SSYGDVYSFGILLLEMFT 372
+ ++ DV++FG+ L EMFT
Sbjct: 202 SILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 58/221 (26%), Positives = 102/221 (46%), Gaps = 29/221 (13%)
Query: 168 IGAGNFASVYKGI--LFEGAPAVAIKVFNFLHHDASKSFT----VECEVMRNIIHRKIIK 221
+G+GNF V KG+ + + VAIKV L ++ KS E E+M + + I++
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKV---LKNENEKSVRDEMMREAEIMHQLDNPYIVR 59
Query: 222 VVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDV 281
++ C LV E G L +++ K+ + + N +E ++ V
Sbjct: 60 MIGVCEAEALM------LVMEMASGGPLNKFL-----SGKKDEITVS-NVVELMH---QV 104
Query: 282 ASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEAT-NEQTSSIGVKGT 340
+ ++YL H D+ N+LL ++ A ++DFG+++ L A + + K
Sbjct: 105 SMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWP 161
Query: 341 TGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDM 380
+ APE + SS DV+S+GI + E F+ G +P M
Sbjct: 162 LKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKM 202
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 1e-08
Identities = 57/222 (25%), Positives = 91/222 (40%), Gaps = 34/222 (15%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIKVFNF--LHHDASKSFTVECEVMRNIIHRKIIKVVTA 225
IG G V+K E VA+K L E + ++ H ++K++
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD- 66
Query: 226 CSRVDYQGNDFKALVYEFMPNGSLEEWI----HPITEEDKRHKAPGNLNSLERLNIAIDV 281
V G+ F LV E+MP L E + P+ E + S R+ +
Sbjct: 67 ---VFPHGSGF-VLVMEYMP-SDLSEVLRDEERPLPEAQVK--------SYMRMLLK--- 110
Query: 282 ASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTT 341
+ Y+H I H D+KP+N+L++ + +ADFG+AR + S V T
Sbjct: 111 --GVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV-ATR 164
Query: 342 GYIAPE--YGMGHETSSYGDVYSFGILLLEMFTG--LRPSDD 379
Y APE YG D+++ G + E+ G L P ++
Sbjct: 165 WYRAPELLYGARKYDPGV-DLWAVGCIFAELLNGSPLFPGEN 205
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 60/228 (26%), Positives = 94/228 (41%), Gaps = 37/228 (16%)
Query: 207 ECEVMRNIIHRKIIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAP 266
E +++ + R ++ + A Y+ D LV M G L+ I+ H
Sbjct: 50 EKQILEKVNSRFVVSLAYA-----YETKDALCLVLTLMNGGDLKFHIY--------HMGE 96
Query: 267 GNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLE 326
+ A ++ LE LH + I + D+KP NILL+D ++D G+A +
Sbjct: 97 AGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLA--VH 151
Query: 327 ATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLN 386
QT G GT GY+APE + D ++ G LL EM G P
Sbjct: 152 VPEGQTIK-GRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP---------- 200
Query: 387 LQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIIL 434
Q + E VE +V KE++EE Y K +P + + ++L
Sbjct: 201 FQQRKKKIKREEVERLV-----KEVQEE---YSEKFSPDARSLCKMLL 240
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 59/213 (27%), Positives = 101/213 (47%), Gaps = 27/213 (12%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTV-ECEVMRNIIHRKIIKVVTAC 226
+G G +A+V+KG VA+K H + + + E +++N+ H I+ +
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLH--- 69
Query: 227 SRVDYQGNDFK-ALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAI-DVASA 284
D + LV+E++ + L++++ GNL S+ + I + +
Sbjct: 70 ---DIIHTERCLTLVFEYLDS-DLKQYLDNC----------GNLMSMHNVKIFMFQLLRG 115
Query: 285 LEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYI 344
L Y H K I H D+KP N+L+N++ +ADFG+AR + S+ V T Y
Sbjct: 116 LSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--TLWYR 170
Query: 345 APEYGMGH-ETSSYGDVYSFGILLLEMFTGLRP 376
P+ +G E S+ D++ G +L EM TG RP
Sbjct: 171 PPDVLLGSTEYSTPIDMWGVGCILYEMATG-RP 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 56.7 bits (136), Expect = 2e-08
Identities = 57/217 (26%), Positives = 91/217 (41%), Gaps = 21/217 (9%)
Query: 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKI 219
K ++ IG G +VY I VAIK N + E VMR + I
Sbjct: 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNI 78
Query: 220 IKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAI 279
+ + + Y D +V E++ GSL + + ++ G + ++ R
Sbjct: 79 VNYLDS-----YLVGDELWVVMEYLAGGSLTDVVTETCMDE------GQIAAVCR----- 122
Query: 280 DVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKG 339
+ AL++LH + H DIK NILL + + + DFG + T EQ+ + G
Sbjct: 123 ECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVG 177
Query: 340 TTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRP 376
T ++APE D++S GI+ +EM G P
Sbjct: 178 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 56.7 bits (136), Expect = 2e-08
Identities = 56/217 (25%), Positives = 91/217 (41%), Gaps = 21/217 (9%)
Query: 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKI 219
K ++ IG G +VY + VAI+ N + E VMR + I
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 79
Query: 220 IKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAI 279
+ + + Y D +V E++ GSL + + ++ G + ++ R
Sbjct: 80 VNYLDS-----YLVGDELWVVMEYLAGGSLTDVVTETCMDE------GQIAAVCR----- 123
Query: 280 DVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKG 339
+ ALE+LH + H DIK NILL + + + DFG + T EQ+ + G
Sbjct: 124 ECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVG 178
Query: 340 TTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRP 376
T ++APE D++S GI+ +EM G P
Sbjct: 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 57/209 (27%), Positives = 87/209 (41%), Gaps = 29/209 (13%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTV---ECEVMRNIIHRKIIKVVT 224
IG+G + VYK AIKV + + F V E +M++ H I+
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKL---EPGEDFAVVQQEIIMMKDCKHSNIVAYFG 73
Query: 225 ACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASA 284
+ Y D + EF GSL++ H G L+ + ++ +
Sbjct: 74 S-----YLRRDKLWICMEFCGGGSLQDIYH----------VTGPLSESQIAYVSRETLQG 118
Query: 285 LEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYI 344
L YLH K H DIK +NILL D +ADFG++ + AT + S GT ++
Sbjct: 119 LYYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSF--IGTPYWM 173
Query: 345 APEYGMGHETSSYG---DVYSFGILLLEM 370
APE Y D+++ GI +E+
Sbjct: 174 APEVAAVERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 74/289 (25%), Positives = 129/289 (44%), Gaps = 39/289 (13%)
Query: 168 IGAGNFASVYKGILF-----EGAPAVAIKVFNFLHHDASK----SFTVECEVMRNIIHRK 218
+G G+F VY+GI E VAIK N AS F E VM+
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVN---EAASMRERIEFLNEASVMKEFNCHH 70
Query: 219 IIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPI--TEEDKRHKAPGNLNSLERLN 276
+++++ S QG ++ E M G L+ ++ + E+ +AP +L + +
Sbjct: 71 VVRLLGVVS----QGQP-TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKM--IQ 123
Query: 277 IAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIG 336
+A ++A + YL+ H D+ N ++ ++ T + DFG+ R + T+ G
Sbjct: 124 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK--G 178
Query: 337 VKG--TTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQS 393
KG +++PE ++Y DV+SFG++L E+ T +P M + + L+ ++
Sbjct: 179 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQV-LRFVMEG 237
Query: 394 ALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICE 442
L ++ + D LF E+ Y K PS LE ++SI E
Sbjct: 238 GLLDKPDNCPDMLF--ELMRMCWQYNPKMRPS-------FLEIISSIKE 277
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 44/145 (30%), Positives = 72/145 (49%), Gaps = 18/145 (12%)
Query: 278 AIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGV 337
A ++ L++LH I + D+K NILL+ + +ADFG+ + + +T +
Sbjct: 102 AAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC- 157
Query: 338 KGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRP-----SDDMFK----DNLNLQ 388
GT YIAPE +G + ++ D +SFG+LL EM G P +++F+ DN
Sbjct: 158 -GTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYP 216
Query: 389 NWVQSALPERVEEIVDTLFFKEIEE 413
W L ++I+ LF +E E
Sbjct: 217 RW----LTREAKDILVKLFVREPER 237
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 55.9 bits (134), Expect = 3e-08
Identities = 53/217 (24%), Positives = 90/217 (41%), Gaps = 21/217 (9%)
Query: 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKI 219
K ++ IG G +V+ I VAIK N + E VM+ + + I
Sbjct: 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNI 78
Query: 220 IKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAI 279
+ + + + D +V E++ GSL + + ++ + A +
Sbjct: 79 VNFLDS-----FLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAA-----------VCR 122
Query: 280 DVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKG 339
+ ALE+LH + H DIK N+LL + + + DFG + T EQ+ + G
Sbjct: 123 ECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCA--QITPEQSKRSTMVG 177
Query: 340 TTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRP 376
T ++APE D++S GI+ +EM G P
Sbjct: 178 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 3e-08
Identities = 54/181 (29%), Positives = 79/181 (43%), Gaps = 24/181 (13%)
Query: 207 ECEVMRNIIHRKIIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAP 266
E ++R I H II++ + N F L+ +P + + + KR+ A
Sbjct: 133 EAHILRAINHPSIIQLKGT-----FTYNKFTCLI---LPRYKTDLYCY---LAAKRNIAI 181
Query: 267 GNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLE 326
++ ++ER V A++YLH + I H DIK NI +N C+ DFG A F
Sbjct: 182 CDILAIER-----SVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPV 233
Query: 327 ATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMF-KDNL 385
N G GT APE D++S GI+L EM T D +F KD L
Sbjct: 234 DIN-ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATC---HDSLFEKDGL 289
Query: 386 N 386
+
Sbjct: 290 D 290
|
Length = 391 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 35/100 (35%), Positives = 52/100 (52%), Gaps = 8/100 (8%)
Query: 280 DVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIAR-FLEATNEQTSSIGVK 338
++ ALE+LH K I + DIK NILL+ + DFG+++ F E E+ S
Sbjct: 113 EIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFC-- 167
Query: 339 GTTGYIAPEYGMGHET--SSYGDVYSFGILLLEMFTGLRP 376
GT Y+AP+ G + D +S G+L+ E+ TG P
Sbjct: 168 GTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.1 bits (136), Expect = 3e-08
Identities = 59/237 (24%), Positives = 98/237 (41%), Gaps = 52/237 (21%)
Query: 162 FSSENLIGAGNFASVYKGILFEGAPAVAIKV----FNFLHHDASKSFTVECEVMRNIIHR 217
+ + + +G+G + V + VAIK F H A +++ E +++++ H
Sbjct: 17 YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIH-AKRTYR-ELRLLKHMDHE 74
Query: 218 KII---KVVTACSRVDYQGNDFKA--LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSL 272
+I V T S + DF+ LV M L N+
Sbjct: 75 NVIGLLDVFTPASSL----EDFQDVYLVTHLM-GADL-----------------NNIVKC 112
Query: 273 ERLN------IAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLE 326
++L+ + + L+Y+H I H D+KPSNI +N++ + DFG+AR +
Sbjct: 113 QKLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTD 169
Query: 327 ATNEQTSSIGVKGTTGYIAPE--YGMGHETSSYGDVYSFGILLLEMFTG--LRPSDD 379
E T G T Y APE H + D++S G ++ E+ TG L P D
Sbjct: 170 D--EMT---GYVATRWYRAPEIMLNWMHYNQTV-DIWSVGCIMAELLTGKTLFPGSD 220
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 4e-08
Identities = 65/229 (28%), Positives = 102/229 (44%), Gaps = 27/229 (11%)
Query: 162 FSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIH-RKII 220
F L+G G + VYKG + AIKV + + D + E +++ H R I
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD-VTGDEEEEIKQEINMLKKYSHHRNIA 66
Query: 221 KVVTACSRVDYQGNDFKA-LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAI 279
A + + G D + LV EF GS+ + I K K N+L+ IA
Sbjct: 67 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI-------KNTKG----NTLKEEWIAY 115
Query: 280 ---DVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIG 336
++ L +LH + + H DIK N+LL + + DFG++ L+ T + ++
Sbjct: 116 ICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF- 171
Query: 337 VKGTTGYIAPEYGMGHET--SSY---GDVYSFGILLLEMFTGLRPSDDM 380
GT ++APE E ++Y D++S GI +EM G P DM
Sbjct: 172 -IGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 219
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 56/209 (26%), Positives = 96/209 (45%), Gaps = 24/209 (11%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTV--ECEVMRNIIHRKIIKVVTA 225
+G G++A+VYKGI VA+KV + + + FT E +++ + H I+ +
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVIS-MKTEEGVPFTAIREASLLKGLKHANIVLLHDI 71
Query: 226 CSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASAL 285
+ V+E+M + L +++ +H PG L+ + L
Sbjct: 72 I-----HTKETLTFVFEYM-HTDLAQYM-------IQH--PGGLHPYNVRLFMFQLLRGL 116
Query: 286 EYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIA 345
Y+H I H D+KP N+L++ +ADFG+AR ++ QT S V T Y
Sbjct: 117 AYIH---GQHILHRDLKPQNLLISYLGELKLADFGLAR-AKSIPSQTYSSEVV-TLWYRP 171
Query: 346 PEYGMGH-ETSSYGDVYSFGILLLEMFTG 373
P+ +G + SS D++ G + +EM G
Sbjct: 172 PDVLLGATDYSSALDIWGAGCIFIEMLQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 52/206 (25%), Positives = 84/206 (40%), Gaps = 23/206 (11%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACS 227
+G+G + VYK A+K+ D E +++ H I+ +
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGS-- 74
Query: 228 RVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEY 287
Y + + E+ GSL++ H G L+ L+ + + L Y
Sbjct: 75 ---YLSREKLWICMEYCGGGSLQDIYH----------VTGPLSELQIAYVCRETLQGLAY 121
Query: 288 LHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPE 347
LH K H DIK +NILL D +ADFG+A + AT + S GT ++APE
Sbjct: 122 LHSKGK---MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSF--IGTPYWMAPE 176
Query: 348 YGMGHETSSYG---DVYSFGILLLEM 370
+ Y D+++ GI +E+
Sbjct: 177 VAAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 5e-08
Identities = 52/199 (26%), Positives = 77/199 (38%), Gaps = 42/199 (21%)
Query: 277 IAIDVASALEYLHLGCKPPIAHCDIKPSNILLND--EMTACVADFGIARFLEATNEQTSS 334
I+I V L YL K I H D+KPSNIL+N E+ C DFG++ L + +S
Sbjct: 104 ISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLC--DFGVSGQL--IDSMANS 157
Query: 335 IGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSA 394
GT Y++PE G + D++S G+ L+EM G P +
Sbjct: 158 F--VGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYP--------------IPPP 201
Query: 395 LPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSI-------------- 440
+ +E + E E +E+ P S + I E L+ I
Sbjct: 202 DAKELEAMFGR-PVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFS 260
Query: 441 ---CEIGVACSAELPGERM 456
+ C + P ER
Sbjct: 261 DEFQDFVDKCLKKNPKERA 279
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 5e-08
Identities = 58/211 (27%), Positives = 90/211 (42%), Gaps = 34/211 (16%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHR-KIIKVVTAC 226
IG G+F +VY VAIK ++ + K E ++II + ++ +
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSY----SGKQSN---EKWQDIIKEVRFLQQLRHP 75
Query: 227 SRVDYQGNDFKA----LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVA 282
+ ++Y+G + LV E+ GS + + + HK P L +E I
Sbjct: 76 NTIEYKGCYLREHTAWLVMEYCL-GSASDIL-------EVHKKP--LQEVEIAAICHGAL 125
Query: 283 SALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTG 342
L YLH + H DIK NILL + T +ADFG A + N GT
Sbjct: 126 QGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSASLVSPANS------FVGTPY 176
Query: 343 YIAPEYGMGHETSSYG---DVYSFGILLLEM 370
++APE + + Y DV+S GI +E+
Sbjct: 177 WMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 5e-08
Identities = 59/218 (27%), Positives = 95/218 (43%), Gaps = 26/218 (11%)
Query: 167 LIGAGNFASVYKGILFEGAPAVAIKV--FNFLHHDASKSFT-VECEV--MRNIIHRKIIK 221
L+G G F VY + +A+K F+ + SK +ECE+ ++N+ H +I++
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 222 VVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDV 281
C R D + V E+MP GS+++ + KA G L +
Sbjct: 69 YY-GCLR-DPEEKKLSIFV-EYMPGGSIKDQL----------KAYGALTENVTRRYTRQI 115
Query: 282 ASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTT 341
+ YLH I H DIK +NIL + + DFG ++ ++ S G+K T
Sbjct: 116 LQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTI--CMSGTGIKSVT 170
Query: 342 G---YIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRP 376
G +++PE G DV+S ++EM T P
Sbjct: 171 GTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 6e-08
Identities = 37/105 (35%), Positives = 48/105 (45%), Gaps = 15/105 (14%)
Query: 277 IAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIG 336
+AID L Y+H DIKP N+LL+ +ADFG L A S++
Sbjct: 113 LAIDSVHQLGYVHR---------DIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVA 163
Query: 337 VKGTTGYIAPEY--GMGHETSSYG---DVYSFGILLLEMFTGLRP 376
V GT YI+PE M YG D +S G+ + EM G P
Sbjct: 164 V-GTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 6e-08
Identities = 35/96 (36%), Positives = 52/96 (54%), Gaps = 10/96 (10%)
Query: 284 ALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGY 343
ALE+LH K I + D+KP NILL+ + DFG+++ N+ T++ GTT Y
Sbjct: 108 ALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC--GTTEY 162
Query: 344 IAPEYGMGHETSSYG---DVYSFGILLLEMFTGLRP 376
+APE + + Y D +S G+L+ EM G P
Sbjct: 163 LAPEVLL--DEKGYTKHVDFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 7e-08
Identities = 53/224 (23%), Positives = 104/224 (46%), Gaps = 25/224 (11%)
Query: 168 IGAGNFASVYKGILFEGAP-----AVAIKVF-NFLHHDASKSFTVECEVMRNIIHRKIIK 221
+G F VYKG LF AP AVAIK + + F E + + H I+
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72
Query: 222 VVTACSRVDYQGNDFKALVYEFMPNGSLEEWI-----HP---ITEEDKRHKAPGNLNSLE 273
++ ++ ++++ + + L E++ H T++DK K+ L +
Sbjct: 73 LLGVVTK-----EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKS--TLEPAD 125
Query: 274 RLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTS 333
++I +A+ +E+L + H D+ N+L+ D++ ++D G+ R + A +
Sbjct: 126 FVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKL 182
Query: 334 SIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRP 376
+++PE M + S D++S+G++L E+F+ GL+P
Sbjct: 183 MGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 8e-08
Identities = 53/185 (28%), Positives = 82/185 (44%), Gaps = 41/185 (22%)
Query: 274 RLNIAIDVASALEYLH-LGCKPPIAHCDIKPSNILLNDEMTACVADFGIAR-FLEATNEQ 331
R+ IA ++ AL++LH LG I + DIK NILL+ E + DFG+++ FL E+
Sbjct: 108 RVYIA-EIVLALDHLHQLG----IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEER 162
Query: 332 TSSIGVKGTTGYIAPEYGMGHET--SSYGDVYSFGILLLEMFTGLRP------------- 376
S GT Y+APE G D +S G+L E+ TG P
Sbjct: 163 AYSFC--GTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEI 220
Query: 377 ------SDDMFKDNL--NLQNWVQSAL---PER------VEEIVDTLFFKEIEEEETVYK 419
S F + ++++Q L P++ +EI + FF+ I+ ++ K
Sbjct: 221 SRRILKSKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWDDLAAK 280
Query: 420 YKKAP 424
AP
Sbjct: 281 RIPAP 285
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 8e-08
Identities = 42/153 (27%), Positives = 70/153 (45%), Gaps = 13/153 (8%)
Query: 279 IDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVK 338
+ +A AL+YLH + I H D+K N+ L V D GIAR LE + S++
Sbjct: 109 VQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTL--I 163
Query: 339 GTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPE- 397
GT Y++PE + DV++ G + EM T L+ + + N + ++ LP
Sbjct: 164 GTPYYMSPELFSNKPYNYKSDVWALGCCVYEMAT-LKHAFNAKDMNSLVYRIIEGKLPPM 222
Query: 398 ------RVEEIVDTLFFKEIEEEETVYKYKKAP 424
+ E++ T+ K E+ +V + P
Sbjct: 223 PKDYSPELGELIATMLSKRPEKRPSVKSILRQP 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 8e-08
Identities = 56/215 (26%), Positives = 88/215 (40%), Gaps = 32/215 (14%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEV-----MRNIIHRKIIKV 222
IG G + +VYK VA+K ++ + EV + H I+++
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 223 VTAC--SRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKR---HKAPGNLNSLERL-N 276
+ C SR D + LV+E + ++D R K P E + +
Sbjct: 68 MDVCATSRTDRETK--VTLVFEHV-------------DQDLRTYLDKVPPPGLPAETIKD 112
Query: 277 IAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIG 336
+ L++LH C I H D+KP NIL+ +ADFG+AR Q +
Sbjct: 113 LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSC---QMALTP 166
Query: 337 VKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMF 371
V T Y APE + ++ D++S G + EMF
Sbjct: 167 VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 8e-08
Identities = 52/218 (23%), Positives = 97/218 (44%), Gaps = 28/218 (12%)
Query: 168 IGAGNFASVYKGI---LFEGAPA--VAIKVFNFLHHDASK----SFTVECEVMRNIIHRK 218
+G G+F VY+G + +G VA+K N AS F E VM+
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVN---ESASLRERIEFLNEASVMKGFTCHH 70
Query: 219 IIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPI--TEEDKRHKAPGNLNSLERLN 276
+++++ S+ +V E M +G L+ ++ + E+ + P L E +
Sbjct: 71 VVRLLGVVSK-----GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQ--EMIQ 123
Query: 277 IAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIG 336
+A ++A + YL+ H D+ N ++ + T + DFG+ R + T+ G
Sbjct: 124 MAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRK--G 178
Query: 337 VKG--TTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT 372
KG ++APE ++ D++SFG++L E+ +
Sbjct: 179 GKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 9e-08
Identities = 56/236 (23%), Positives = 103/236 (43%), Gaps = 38/236 (16%)
Query: 162 FSSENLI-----GAGNFASVYKGILF-------EGAPAVAIKVFNFLHHDAS----KSFT 205
F + L+ G G F V + + + VA+K+ L +A+
Sbjct: 9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKM---LKDNATDKDLADLI 65
Query: 206 VECEVMRNI-IHRKIIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIH---PITEED- 260
E E+M+ I H+ II ++ C++ +G + ++ E+ G+L E++ P +
Sbjct: 66 SEMELMKLIGKHKNIINLLGVCTQ---EGPLY--VIVEYAAKGNLREFLRARRPPGPDYT 120
Query: 261 ----KRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACV 316
K + + L ++ A VA +EYL H D+ N+L+ ++ +
Sbjct: 121 FDITKVPEEQLSFKDL--VSCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKI 175
Query: 317 ADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT 372
ADFG+AR + + + + ++APE + DV+SFGIL+ E+FT
Sbjct: 176 ADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 1e-07
Identities = 34/90 (37%), Positives = 46/90 (51%), Gaps = 14/90 (15%)
Query: 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPT 60
++ N GPI S+ L+ L LDLS N+LSGEIPE + + L+ L+L NNF IP
Sbjct: 267 LYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIP- 325
Query: 61 EGIFKNASATSV-------FGNNKLCGGIP 83
+ TS+ +NK G IP
Sbjct: 326 ------VALTSLPRLQVLQLWSNKFSGEIP 349
|
Length = 968 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 1e-07
Identities = 35/99 (35%), Positives = 50/99 (50%), Gaps = 5/99 (5%)
Query: 278 AIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGV 337
A ++ASAL YLH I + D+KP NILL+ + + DFG+ + ++ TS+
Sbjct: 102 AAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFC- 157
Query: 338 KGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRP 376
GT Y+APE D + G +L EM GL P
Sbjct: 158 -GTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 2e-07
Identities = 34/114 (29%), Positives = 54/114 (47%), Gaps = 10/114 (8%)
Query: 278 AIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGV 337
A ++ L++LH + I + D+K N+LL+ E +ADFG+ + E ++
Sbjct: 102 AAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCK--EGILGGVTTSTF 156
Query: 338 KGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRP-----SDDMFKDNLN 386
GT YIAPE D ++ G+LL EM G P D++F+ L
Sbjct: 157 CGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILE 210
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 2e-07
Identities = 58/233 (24%), Positives = 93/233 (39%), Gaps = 47/233 (20%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTV----ECEVMRNIIHRKIIKVV 223
+G G F VYK + VA+K L H+ F + E ++++ + H ++ ++
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALK--KILMHNEKDGFPITALREIKILKKLKHPNVVPLI 73
Query: 224 -TACSRVDYQGNDFKALVYEFMP------NGSLE-EWIHPITEEDKRHKAPGNLNSLERL 275
A R D + VY P +G LE + +TE +
Sbjct: 74 DMAVERPDKSKRK-RGSVYMVTPYMDHDLSGLLENPSVK-LTESQIK------------- 118
Query: 276 NIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSI 335
+ + + YLH + I H DIK +NIL++++ +ADFG+AR +
Sbjct: 119 CYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGG 175
Query: 336 GVKGTTGYI---------APEYGMGHETSSYG---DVYSFGILLLEMFTGLRP 376
G GT Y PE +G Y D++ G + EMFT RP
Sbjct: 176 GGGGTRKYTNLVVTRWYRPPELLLGER--RYTTAVDIWGIGCVFAEMFTR-RP 225
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 56/216 (25%), Positives = 97/216 (44%), Gaps = 30/216 (13%)
Query: 185 APAVAIKVFNFLHHDASKS----FTVECEVMRNI-IHRKIIKVVTACSRVDYQGNDFKAL 239
A VA+K+ L DA++ E E+M+ I H+ II ++ AC+ Q +
Sbjct: 47 AVTVAVKM---LKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT----QDGPLYVI 99
Query: 240 VYEFMPNGSLEEWIH---PITEE---DKRHKAPGNLNSLERLNIAIDVASALEYLHLGCK 293
V E+ G+L E++ P E D + + ++ VA +EYL
Sbjct: 100 V-EYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYL---AS 155
Query: 294 PPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHE 353
H D+ N+L+ + +ADFG+AR + + + + ++APE
Sbjct: 156 QKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRV 215
Query: 354 TSSYGDVYSFGILLLEMFT-------GLRPSDDMFK 382
+ DV+SFG+L+ E+FT G+ P +++FK
Sbjct: 216 YTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEELFK 250
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 2e-07
Identities = 37/114 (32%), Positives = 56/114 (49%), Gaps = 10/114 (8%)
Query: 278 AIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGV 337
A +V AL +LH + + + D+K NILL+ E +ADFG+ + E ++
Sbjct: 102 AAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCK--EGILNGVTTTTF 156
Query: 338 KGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRP-----SDDMFKDNLN 386
GT YIAPE E D ++ G+L+ EM G P DD+F+ L+
Sbjct: 157 CGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILH 210
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 41/138 (29%), Positives = 63/138 (45%), Gaps = 10/138 (7%)
Query: 278 AIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGV 337
A ++ SAL +LH I + D+K N+LL+ E +ADFG+ + E ++
Sbjct: 102 AAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGIFNGKTTSTF 156
Query: 338 KGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRP-----SDDMFKDNLNLQNWVQ 392
GT YIAPE D ++ G+LL EM G P DD+F+ LN +
Sbjct: 157 CGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYP 216
Query: 393 SALPERVEEIVDTLFFKE 410
+ L + +I+ K
Sbjct: 217 TWLSQDAVDILKAFMTKN 234
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 2e-07
Identities = 64/229 (27%), Positives = 101/229 (44%), Gaps = 33/229 (14%)
Query: 160 KGFSSENLIGAGNFASVYKGILFEGAPA--VAIKVFN---FLHHDASKSFTVECEVMRNI 214
K F ++L+G G+F V ++ E A A+KV L + F E +++
Sbjct: 1 KDFDVKSLVGRGHFGEVQ--VVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSIS 58
Query: 215 IHRKIIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLER 274
I ++ A +Q D LV E+ P G L ++ R++ + + +
Sbjct: 59 NSPWIPQLQYA-----FQDKDNLYLVMEYQPGGDLLSLLN-------RYEDQFD-EDMAQ 105
Query: 275 LNIAIDVASALEYLH-LGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTS 333
+A ++ A+ +H +G H DIKP N+L++ +ADFG A L A S
Sbjct: 106 FYLA-ELVLAIHSVHQMG----YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNS 160
Query: 334 SIGVKGTTGYIAPEY--GM-GHETSSYG---DVYSFGILLLEMFTGLRP 376
+ V GT YIAPE M G +YG D +S G++ EM G P
Sbjct: 161 KLPV-GTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.4 bits (129), Expect = 2e-07
Identities = 59/231 (25%), Positives = 96/231 (41%), Gaps = 32/231 (13%)
Query: 161 GFSSENLIGAGNFASVYKGILFEGAPA--VAIKVFNFLHHDA---SKSFTVECEVMRNII 215
+ E IG G + VYK G AIK F S+S E ++R +
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60
Query: 216 HRKIIKVVTACSRVDYQGNDFKA-LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSL-- 272
H ++ +V V + D L++++ + L + I + + P + SL
Sbjct: 61 HENVVSLV----EVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLW 115
Query: 273 ERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTAC----VADFGIARFLEAT 328
+ LN + YLH + H D+KP+NIL+ E + D G+AR A
Sbjct: 116 QILN-------GVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAP 165
Query: 329 NEQTSSI-GVKGTTGYIAPEYGMG--HETSSYGDVYSFGILLLEMFTGLRP 376
+ + + V T Y APE +G H T + D+++ G + E+ T L P
Sbjct: 166 LKPLADLDPVVVTIWYRAPELLLGARHYTKAI-DIWAIGCIFAELLT-LEP 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 31/94 (32%), Positives = 49/94 (52%), Gaps = 5/94 (5%)
Query: 279 IDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVK 338
+ SA+ Y+H K I H DIK NI L + DFGI++ L +E + + V
Sbjct: 108 FQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKIL--GSEYSMAETVV 162
Query: 339 GTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT 372
GT Y++PE G + + D+++ G +L E+ T
Sbjct: 163 GTPYYMSPELCQGVKYNFKSDIWALGCVLYELLT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 50/215 (23%), Positives = 90/215 (41%), Gaps = 23/215 (10%)
Query: 188 VAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKALVYEFMPNG 247
VA+K + + E +MR+ H ++ + + Y D +V EF+ G
Sbjct: 50 VAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNS-----YLVGDELWVVMEFLEGG 104
Query: 248 SLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNIL 307
+L + + +N + + + V AL YLH + H DIK +IL
Sbjct: 105 ALTDIV-----------THTRMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSIL 150
Query: 308 LNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILL 367
L + ++DFG + + E + GT ++APE + D++S GI++
Sbjct: 151 LTSDGRIKLSDFGFCA--QVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMV 208
Query: 368 LEMFTGLRPSDDMFKDNLNLQNWVQSALPERVEEI 402
+EM G P + + L ++ LP RV++
Sbjct: 209 IEMIDGEPPYFN--EPPLQAMRRIRDNLPPRVKDS 241
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 2e-07
Identities = 39/114 (34%), Positives = 57/114 (50%), Gaps = 20/114 (17%)
Query: 284 ALEYLHLGCKPPIAHCDIKPSNILLNDEMTAC---VADFGIARFLEATNEQTSSIG--VK 338
L+Y+H + H D+KPSN+LLN T C + DFG+AR + ++ T + V
Sbjct: 118 GLKYIH---SANVLHRDLKPSNLLLN---TNCDLKICDFGLARIADPEHDHTGFLTEYV- 170
Query: 339 GTTGYIAPEYGMGHETSSYG---DVYSFGILLLEMFTG--LRPSDDMFKDNLNL 387
T Y APE + + Y D++S G +L EM + L P D + LNL
Sbjct: 171 ATRWYRAPEIML--NSKGYTKAIDIWSVGCILAEMLSNRPLFPGKD-YLHQLNL 221
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 3e-07
Identities = 55/219 (25%), Positives = 92/219 (42%), Gaps = 27/219 (12%)
Query: 167 LIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTV------ECEVMRNIIHRKII 220
+G G F+S Y+ + +A+K ++ + +S+ V E +M + H II
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 221 KVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAID 280
+++ A + D N F E+M GS+ + G +N
Sbjct: 67 RMLGA-TCEDSHFNLF----VEWMAGGSVSHLLSKY----------GAFKEAVIINYTEQ 111
Query: 281 VASALEYLHLGCKPPIAHCDIKPSNILLNDEMTAC-VADFGIARFLEATNEQTSSIGVK- 338
+ L YLH + I H D+K +N+L++ +ADFG A L A +
Sbjct: 112 LLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQL 168
Query: 339 -GTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRP 376
GT ++APE G + DV+S G +++EM T P
Sbjct: 169 LGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 63/216 (29%), Positives = 101/216 (46%), Gaps = 34/216 (15%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACS 227
+GAGN V K + P+ I +H + + +RN I R++ +V+ C+
Sbjct: 13 LGAGNGGVVTK---VQHKPSGLIMARKLIHLEIKPA-------IRNQIIREL-QVLHECN 61
Query: 228 R---VDYQGNDFK----ALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAID 280
V + G + ++ E M GSL++ + +E KR P + L +++IA
Sbjct: 62 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQ----VLKEAKR--IPEEI--LGKVSIA-- 111
Query: 281 VASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGT 340
V L YL K I H D+KPSNIL+N + DFG++ L + +S GT
Sbjct: 112 VLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSF--VGT 165
Query: 341 TGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRP 376
Y++PE G S D++S G+ L+E+ G P
Sbjct: 166 RSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 39/114 (34%), Positives = 56/114 (49%), Gaps = 10/114 (8%)
Query: 278 AIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGV 337
A ++ASAL YLH I + D+KP NILL+ + + DFG+ + N TS+
Sbjct: 102 AAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFC- 157
Query: 338 KGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRP-----SDDMFKDNLN 386
GT Y+APE D + G +L EM GL P + +M+ + LN
Sbjct: 158 -GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN 210
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 63/222 (28%), Positives = 101/222 (45%), Gaps = 34/222 (15%)
Query: 162 FSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIK 221
F + +GAGN V+K P+ I +H + + +RN I R++ +
Sbjct: 7 FEKISELGAGNGGVVFK---VSHKPSGLIMARKLIHLEIKPA-------IRNQIIREL-Q 55
Query: 222 VVTACSR---VDYQGNDFK----ALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLER 274
V+ C+ V + G + ++ E M GSL++ + K + P + L +
Sbjct: 56 VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL------KKAGRIPEQI--LGK 107
Query: 275 LNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSS 334
++IA V L YL K I H D+KPSNIL+N + DFG++ L + +S
Sbjct: 108 VSIA--VIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANS 161
Query: 335 IGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRP 376
GT Y++PE G S D++S G+ L+EM G P
Sbjct: 162 F--VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 4e-07
Identities = 43/147 (29%), Positives = 67/147 (45%), Gaps = 16/147 (10%)
Query: 231 YQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHL 290
Y+ D LV M G L+ I+ + + + A ++ LE LH
Sbjct: 69 YETKDALCLVLTLMNGGDLKFHIY--------NMGNPGFDEERAVFYAAEITCGLEDLH- 119
Query: 291 GCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGM 350
+ I + D+KP NILL+D ++D G+A +E +T G GT GY+APE +
Sbjct: 120 --RERIVYRDLKPENILLDDYGHIRISDLGLA--VEIPEGETIR-GRVGTVGYMAPEV-V 173
Query: 351 GHETSSYG-DVYSFGILLLEMFTGLRP 376
+E ++ D + G L+ EM G P
Sbjct: 174 KNERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 4e-07
Identities = 35/108 (32%), Positives = 52/108 (48%), Gaps = 5/108 (4%)
Query: 278 AIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGV 337
A ++A L +LH I + D+K N++L+ E +ADFG+ + E ++
Sbjct: 107 AAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCK--ENIFGGKTTRTF 161
Query: 338 KGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNL 385
GT YIAPE D ++FG+LL EM G P D +D L
Sbjct: 162 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL 209
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 4e-07
Identities = 59/220 (26%), Positives = 99/220 (45%), Gaps = 26/220 (11%)
Query: 160 KGFSSENL--IGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTV--ECEVMRNII 215
K S E L +G G++A+VYKG VA+KV L + FT E +++ +
Sbjct: 3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIR-LQEEEGTPFTAIREASLLKGLK 61
Query: 216 HRKIIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERL 275
H I+ + + LV+E++ + L +++ K PG L+
Sbjct: 62 HANIVLLHDII-----HTKETLTLVFEYV-HTDLCQYMD---------KHPGGLHPENVK 106
Query: 276 NIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSI 335
+ L Y+H + I H D+KP N+L++D +ADFG+AR + S+
Sbjct: 107 LFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNE 163
Query: 336 GVKGTTGYIAPEYGMGH-ETSSYGDVYSFGILLLEMFTGL 374
V T Y P+ +G E S+ D++ G + +EM G+
Sbjct: 164 VV--TLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGV 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 4e-07
Identities = 34/99 (34%), Positives = 49/99 (49%), Gaps = 5/99 (5%)
Query: 278 AIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGV 337
A +VASA+ YLH I + D+KP NILL+ + + DFG+ + E + ++
Sbjct: 102 AAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTF 156
Query: 338 KGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRP 376
GT Y+APE D + G +L EM GL P
Sbjct: 157 CGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 5e-07
Identities = 58/227 (25%), Positives = 103/227 (45%), Gaps = 33/227 (14%)
Query: 155 LYSATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFN--FLHHDASKSFTVECEVMR 212
++ + ++S +G+G + SV I VAIK + F +K E +++
Sbjct: 10 VWELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLK 69
Query: 213 NIIHRKIIKV----VTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGN 268
++ H +I + +A S ++Q DF LV +M + HP++E+ ++
Sbjct: 70 HMQHENVIGLLDVFTSAVSGDEFQ--DF-YLVMPYMQTDLQKIMGHPLSEDKVQY----- 121
Query: 269 LNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEAT 328
+ + L+Y+H I H D+KP N+ +N++ + DFG+AR +A
Sbjct: 122 --------LVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA- 169
Query: 329 NEQTSSIGVKGTTGYIAPEYGMG--HETSSYGDVYSFGILLLEMFTG 373
E T G T Y APE + H + D++S G ++ EM TG
Sbjct: 170 -EMT---GYVVTRWYRAPEVILNWMHYNQTV-DIWSVGCIMAEMLTG 211
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 6e-07
Identities = 55/212 (25%), Positives = 96/212 (45%), Gaps = 25/212 (11%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACS 227
+G G +A+V+KG VA+K H + + C +R + K +K +
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAP-----CTAIREVSLLKDLKHANIVT 68
Query: 228 RVDYQGNDFK-ALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAI-DVASAL 285
D D LV+E++ + L++++ GN+ S+ + I + + L
Sbjct: 69 LHDIVHTDKSLTLVFEYL-DKDLKQYMDDC----------GNIMSMHNVKIFLYQILRGL 117
Query: 286 EYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIA 345
Y H + + H D+KP N+L+N+ +ADFG+AR + S+ V T Y
Sbjct: 118 AYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--TLWYRP 172
Query: 346 PEYGMG-HETSSYGDVYSFGILLLEMFTGLRP 376
P+ +G E S+ D++ G + EM +G RP
Sbjct: 173 PDVLLGSSEYSTQIDMWGVGCIFFEMASG-RP 203
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.9 bits (125), Expect = 6e-07
Identities = 68/252 (26%), Positives = 99/252 (39%), Gaps = 70/252 (27%)
Query: 167 LIGAGNFASVYKGILFEGAPAVAIKVF--------NFLHHDASKSFTVECEVMRNIIHRK 218
L+G G+ V+ L A+KV N + + E E++ + H
Sbjct: 8 LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLT-----EQEILATLDHPF 62
Query: 219 IIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLE--RLN 276
+ T + +Q + LV ++ P G L + PG S E R
Sbjct: 63 L---PTLYAS--FQTETYLCLVMDYCPGGELF---------RLLQRQPGKCLSEEVARFY 108
Query: 277 IAIDVASALEYLH-LGCKPPIAHCDIKPSNILLNDEMTACVADFGIA------------- 322
A +V ALEYLH LG I + D+KP NILL++ ++DF ++
Sbjct: 109 AA-EVLLALEYLHLLG----IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKA 163
Query: 323 ----------------RFLEATNEQTSSIGVKGTTGYIAPEY--GMGHETSSYGDVYSFG 364
F E + +++S V GT YIAPE G GH S D ++ G
Sbjct: 164 LRKGSRRSSVNSIPSETFSEEPSFRSNSF-V-GTEEYIAPEVISGDGH--GSAVDWWTLG 219
Query: 365 ILLLEMFTGLRP 376
ILL EM G P
Sbjct: 220 ILLYEMLYGTTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 6e-07
Identities = 61/246 (24%), Positives = 96/246 (39%), Gaps = 54/246 (21%)
Query: 166 NLIGAGNFASVYKGILFEGAPAVAIK------VFNFLHHDASK------SFTV--ECEVM 211
+G G + V K VAIK + N + D FT E ++M
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 212 RNIIHRKIIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHP---ITEEDKRHKAPGN 268
I H I+ +V Y DF LV + M L++ + +TE +
Sbjct: 75 NEIKHENIMGLVDV-----YVEGDFINLVMDIM-ASDLKKVVDRKIRLTESQVK------ 122
Query: 269 LNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIAR----- 323
I + + + L LH K H D+ P+NI +N + +ADFG+AR
Sbjct: 123 -------CILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYP 172
Query: 324 --FLEATNEQTSSIGVKGTTG-----YIAPEYGMGHETSSYG-DVYSFGILLLEMFTG-- 373
+ ++T + T+ Y APE MG E + D++S G + E+ TG
Sbjct: 173 PYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKP 232
Query: 374 LRPSDD 379
L P ++
Sbjct: 233 LFPGEN 238
|
Length = 335 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 7e-07
Identities = 39/136 (28%), Positives = 62/136 (45%), Gaps = 14/136 (10%)
Query: 278 AIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGV 337
A ++ASAL YLH I + D+KP NILL+ + + DFG+ + E + ++
Sbjct: 102 AAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCK--EGIAQSDTTTTF 156
Query: 338 KGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRP---------SDDMFKDNLNLQ 388
GT Y+APE + D + G +L EM GL P D++ L L+
Sbjct: 157 CGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLR 216
Query: 389 NWVQSALPERVEEIVD 404
+EE+++
Sbjct: 217 PGASLTAWSILEELLE 232
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 8e-07
Identities = 63/248 (25%), Positives = 105/248 (42%), Gaps = 30/248 (12%)
Query: 147 FPY----VSYEALYSATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASK 202
FPY + E+L T + IG G + VYK + A+K+ + + D +
Sbjct: 5 FPYNSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDE 63
Query: 203 SFTVECEVMRNII-HRKIIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDK 261
E +++++ H ++K + D LV E GS+ E + + +
Sbjct: 64 EIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQ 123
Query: 262 RHKAPGNLNSLERLNIAIDVASAL---EYLHLGCKPPIAHCDIKPSNILLNDEMTACVAD 318
R L+ I+ + AL ++LH I H D+K +NILL E + D
Sbjct: 124 R---------LDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVKLVD 171
Query: 319 FGIARFLEATN-EQTSSIGVKGTTGYIAPEYGMGHETSSYG-----DVYSFGILLLEMFT 372
FG++ L +T + +S+ GT ++APE + Y DV+S GI +E+
Sbjct: 172 FGVSAQLTSTRLRRNTSV---GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGD 228
Query: 373 GLRPSDDM 380
G P DM
Sbjct: 229 GDPPLFDM 236
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 8e-07
Identities = 31/99 (31%), Positives = 49/99 (49%), Gaps = 8/99 (8%)
Query: 277 IAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIG 336
+ + + L+YLH I H D+K SN+LL D+ +ADFG+AR + +
Sbjct: 113 LMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKV 169
Query: 337 VKGTTGYIAPE--YGMGHETSSYGDVYSFGILLLEMFTG 373
V T Y APE G T++ D+++ G +L E+
Sbjct: 170 V--TLWYRAPELLLGCTTYTTAI-DMWAVGCILAELLAH 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 8e-07
Identities = 54/194 (27%), Positives = 81/194 (41%), Gaps = 18/194 (9%)
Query: 238 ALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIA 297
ALV ++ G L + I R K E + I V A+ ++H +
Sbjct: 115 ALVLDYANAGDLRQEIK------SRAKTNRTFREHEAGLLFIQVLLAVHHVH---SKHMI 165
Query: 298 HCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSY 357
H DIK +NILL + DFG ++ AT GT Y+APE S
Sbjct: 166 HRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKK 225
Query: 358 GDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPERVEEIVDTLFFKEIEEEETV 417
D++S G+LL E+ T RP D N++ + L R + + ++ E++E T
Sbjct: 226 ADMFSLGVLLYELLTLKRPF-----DGENMEEVMHKTLAGRYDPLPPSI-SPEMQEIVTA 279
Query: 418 Y---KYKKAPSSST 428
K+ PSSS
Sbjct: 280 LLSSDPKRRPSSSK 293
|
Length = 496 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 9e-07
Identities = 62/241 (25%), Positives = 103/241 (42%), Gaps = 37/241 (15%)
Query: 162 FSSENL-----IGAGNFASVYKGILF-----EGAPAVAIKVFN-FLHHDASKSFTVECEV 210
F NL +GAG F V + + + VA+K+ H ++ E ++
Sbjct: 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKI 91
Query: 211 MRNI-IHRKIIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNL 269
M ++ H I+ ++ AC+ G ++ E+ G L ++ KR L
Sbjct: 92 MSHLGNHENIVNLLGACTI---GGPIL--VITEYCCYGDLLNFLR-----RKRESF---L 138
Query: 270 NSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATN 329
+ L+ + VA + +L K I H D+ N+LL + DFG+AR + N
Sbjct: 139 TLEDLLSFSYQVAKGMAFL--ASKNCI-HRDLAARNVLLTHGKIVKICDFGLAR--DIMN 193
Query: 330 EQTSSIGVKGTT----GYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDN 384
+ S+ VKG ++APE + DV+S+GILL E+F+ G P M D+
Sbjct: 194 D--SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS 251
Query: 385 L 385
Sbjct: 252 K 252
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 9e-07
Identities = 44/157 (28%), Positives = 70/157 (44%), Gaps = 20/157 (12%)
Query: 231 YQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHL 290
+Q + V EF+ G L I +DK G + A ++ L++LH
Sbjct: 65 FQTKEHLFFVMEFLNGGDLMFHI-----QDK-----GRFDLYRATFYAAEIVCGLQFLH- 113
Query: 291 GCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGM 350
I + D+K N++L+ + +ADFG+ + E + GT YIAPE
Sbjct: 114 --SKGIIYRDLKLDNVMLDRDGHIKIADFGMCK--ENVFGDNRASTFCGTPDYIAPEILQ 169
Query: 351 GHETSSYGDVYSFGILLLEMFTGLRP-----SDDMFK 382
G + + D +SFG+LL EM G P D++F+
Sbjct: 170 GLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFE 206
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 9e-07
Identities = 42/160 (26%), Positives = 64/160 (40%), Gaps = 39/160 (24%)
Query: 231 YQGNDFKALVYEFMPNGSL----------EEWIHPITEEDKRHKAPGNLNSLERLNIAID 280
+Q + + +V E+MP G L E+W T E + +A+D
Sbjct: 112 FQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAE---------------VVLALD 156
Query: 281 VASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGT 340
++ ++H D+KP N+LL+ +ADFG ++A V GT
Sbjct: 157 AIHSMGFIHR---------DVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV-GT 206
Query: 341 TGYIAPEYGMGH-ETSSYG---DVYSFGILLLEMFTGLRP 376
YI+PE YG D +S G+ L EM G P
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 1e-06
Identities = 29/87 (33%), Positives = 43/87 (49%), Gaps = 3/87 (3%)
Query: 283 SALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTG 342
SA++Y+H I H DIK N+L+N C+ DFG A F + G+ GT
Sbjct: 271 SAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVD 327
Query: 343 YIAPEYGMGHETSSYGDVYSFGILLLE 369
APE G + D++S G+++ E
Sbjct: 328 TNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 43/175 (24%), Positives = 69/175 (39%), Gaps = 40/175 (22%)
Query: 280 DVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKG 339
++ A EYLH I + D+KP N+LL+++ V DFG A+ ++T ++ G
Sbjct: 126 ELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAK---KVPDRTFTLC--G 177
Query: 340 TTGYIAPEY--GMGHETSSYGDVYSFGILLLEMFTGLRPSDD---------MFKDNLNLQ 388
T Y+APE GH + D ++ G+LL E G P D + L
Sbjct: 178 TPEYLAPEVIQSKGHGKAV--DWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFP 235
Query: 389 NWVQS-------------------ALPERVEEIVDTLFFKEIEEEETVYKYKKAP 424
NW L V ++ + +F ++ +Y AP
Sbjct: 236 NWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWDKLYARYYPAP 290
|
Length = 329 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 53/212 (25%), Positives = 99/212 (46%), Gaps = 25/212 (11%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTV-ECEVMRNIIHRKIIKVVTAC 226
+G G +A+VYKG VA+K H + + + E +++++ H I VT
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI---VTLH 70
Query: 227 SRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAI-DVASAL 285
+ + + LV+E++ + L++++ GN ++ + + + + L
Sbjct: 71 DIIHTEKS--LTLVFEYL-DKDLKQYLDDC----------GNSINMHNVKLFLFQLLRGL 117
Query: 286 EYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIA 345
Y H + + H D+KP N+L+N+ +ADFG+AR + S+ V T Y
Sbjct: 118 NYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--TLWYRP 172
Query: 346 PEYGMGH-ETSSYGDVYSFGILLLEMFTGLRP 376
P+ +G + S+ D++ G + EM TG RP
Sbjct: 173 PDILLGSTDYSTQIDMWGVGCIFYEMSTG-RP 203
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 59/221 (26%), Positives = 100/221 (45%), Gaps = 22/221 (9%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNII-HRKIIKVVTAC 226
IG G + V+K + + A+K+ + +H D + E +++ + H ++K
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMY 84
Query: 227 SRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALE 286
+ D + D LV E GS+ + + + +R +E IA + AL
Sbjct: 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGER---------MEEPIIAYILHEALM 135
Query: 287 YL-HLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATN-EQTSSIGVKGTTGYI 344
L HL I H D+K +NILL E + DFG++ L +T + +S+ GT ++
Sbjct: 136 GLQHLHVNKTI-HRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV---GTPFWM 191
Query: 345 APEYGMGHET--SSYG---DVYSFGILLLEMFTGLRPSDDM 380
APE + S+Y DV+S GI +E+ G P D+
Sbjct: 192 APEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADL 232
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 2e-06
Identities = 59/252 (23%), Positives = 101/252 (40%), Gaps = 57/252 (22%)
Query: 144 DLDFPYV----SYEALYSATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHD 199
+FP+ YE L IG G F V+K + VA+K L +
Sbjct: 2 QYEFPFCDEVSKYEKL----------AKIGQGTFGEVFKARHKKTKQIVALK--KVLMEN 49
Query: 200 ASKSFTV----ECEVMRNIIHRKIIKVVTACSRVDYQGNDFKA---LVYEFMPNGSLEEW 252
+ F + E ++++ + H ++ ++ C N +K LV+EF
Sbjct: 50 EKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFC-------- 101
Query: 253 IHPITEEDKRHKAPGNLN------SLERLNIAID-VASALEYLHLGCKPPIAHCDIKPSN 305
H G L+ +L + + + + L Y+H I H D+K +N
Sbjct: 102 ---------EHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAAN 149
Query: 306 ILLNDEMTACVADFGIAR-FLEATNEQTSSIGVKGTT-GYIAPEYGMGHETSSYG---DV 360
IL+ + +ADFG+AR F + N + + + T Y PE +G YG D+
Sbjct: 150 ILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGER--DYGPPIDM 207
Query: 361 YSFGILLLEMFT 372
+ G ++ EM+T
Sbjct: 208 WGAGCIMAEMWT 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 33/98 (33%), Positives = 51/98 (52%), Gaps = 5/98 (5%)
Query: 275 LNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSS 334
L+ + + AL+++H I H DIK NI L + T + DFGIAR L +T E +
Sbjct: 104 LDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART 160
Query: 335 IGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT 372
GT Y++PE ++ D+++ G +L EM T
Sbjct: 161 --CIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 60/267 (22%), Positives = 107/267 (40%), Gaps = 33/267 (12%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACS 227
IG G+ V + VA+K + + E +MR+ H ++++ +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNS-- 85
Query: 228 RVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEY 287
Y D +V EF+ G+L + + +N + + + V AL
Sbjct: 86 ---YLVGDELWVVMEFLEGGALTDIV-----------THTRMNEEQIAAVCLAVLKALSV 131
Query: 288 LHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPE 347
LH + H DIK +ILL + ++DFG + + E + GT ++APE
Sbjct: 132 LH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCA--QVSKEVPRRKSLVGTPYWMAPE 186
Query: 348 YGMGHETSSYGDVYSFGILLLEMFTGLRP--------SDDMFKDNL--NLQNWVQSALPE 397
D++S GI+++EM G P + M +DNL L+N + P
Sbjct: 187 LISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKN-LHKVSP- 244
Query: 398 RVEEIVDTLFFKEIEEEETVYKYKKAP 424
++ +D L ++ + T + K P
Sbjct: 245 SLKGFLDRLLVRDPAQRATAAELLKHP 271
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 33/108 (30%), Positives = 54/108 (50%), Gaps = 5/108 (4%)
Query: 278 AIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGV 337
A +++ L +LH + I + D+K N++L+ E +ADFG+ + E + ++
Sbjct: 107 AAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTF 161
Query: 338 KGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNL 385
GT YIAPE D +++G+LL EM G P D +D L
Sbjct: 162 CGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDEL 209
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 42/116 (36%), Positives = 60/116 (51%), Gaps = 18/116 (15%)
Query: 272 LERLNIAI-DVAS--------ALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIA 322
LER I + D A ALE+LH + I + D+KP NILL+ + + DFG+
Sbjct: 91 LEREGIFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLC 147
Query: 323 RFLEATNEQTSSIGVKGTTGYIAPEYGM--GHETSSYGDVYSFGILLLEMFTGLRP 376
+ E+ +E T + GT Y+APE M GH + D +S G L+ +M TG P
Sbjct: 148 K--ESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAV--DWWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 3e-06
Identities = 41/130 (31%), Positives = 66/130 (50%), Gaps = 23/130 (17%)
Query: 267 GNLNSLERLN------IAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFG 320
G L E+L+ + + L+Y+H I H D+KP N+ +N++ + DFG
Sbjct: 107 GKLMKHEKLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFG 163
Query: 321 IARFLEATNEQTSSIGVKGTTGYIAPEYGMG--HETSSYGDVYSFGILLLEMFTGLRPSD 378
+AR + +E T G T Y APE + H T + D++S G ++ EM TG +P
Sbjct: 164 LAR--QTDSEMT---GYVVTRWYRAPEVILNWMHYTQTV-DIWSVGCIMAEMLTG-KP-- 214
Query: 379 DMFK--DNLN 386
+FK D+L+
Sbjct: 215 -LFKGHDHLD 223
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 3e-06
Identities = 48/196 (24%), Positives = 85/196 (43%), Gaps = 35/196 (17%)
Query: 188 VAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKALVYEFMPNG 247
VA+K + + E +MR+ H I+++ ++ Y D +V EF+ G
Sbjct: 47 VAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSS-----YLVGDELWVVMEFLEGG 101
Query: 248 SLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNIL 307
+L + + +N + + + V AL +LH + H DIK +IL
Sbjct: 102 ALTDIV-----------THTRMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSIL 147
Query: 308 LNDEMTACVADFGI-ARFLEATNEQTSSIGVKGTTGYIAPE------YGMGHETSSYGDV 360
L + ++DFG A+ + + S +G T ++APE YG + D+
Sbjct: 148 LTSDGRVKLSDFGFCAQVSKEVPRRKSLVG---TPYWMAPEVISRLPYG------TEVDI 198
Query: 361 YSFGILLLEMFTGLRP 376
+S GI+++EM G P
Sbjct: 199 WSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 3e-06
Identities = 50/216 (23%), Positives = 90/216 (41%), Gaps = 28/216 (12%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIKVFNFLHHDAS----KSFTVECEVMRNIIHRKIIKVV 223
IG G F V ++ VA V L +AS F + + R + H I++ +
Sbjct: 3 IGNGWFGKVLLSEIYTD-TGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 224 TAC-SRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVA 282
C + Y LV+E+ G L+ ++ E+ R N L +A ++A
Sbjct: 62 GQCVEAIPY------LLVFEYCELGDLKSYLS--QEQWHR----RNSQLLLLQRMACEIA 109
Query: 283 SALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGI--ARFLE--ATNEQTSSIGVK 338
+ + ++H K H D+ N L ++T V D+GI +R+ E E + ++
Sbjct: 110 AGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLR 166
Query: 339 GTTGYIAPEYGMG---HETSSYGDVYSFGILLLEMF 371
+ E+ G E + +V++ G+ L E+F
Sbjct: 167 WLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 3e-06
Identities = 57/235 (24%), Positives = 101/235 (42%), Gaps = 39/235 (16%)
Query: 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIK--VFNFLHHDAS----KSFTVECEVMR 212
TKG ++G G + +VY G+ +G +A+K + + A+ + E ++++
Sbjct: 3 TKG----EVLGKGAYGTVYCGLTNQGQ-LIAVKQVELDTSNVLAAEKEYEKLQEEVDLLK 57
Query: 213 NIIHRKIIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSL 272
++ H I++ + C ++ ++ EF+P GS+ + G L
Sbjct: 58 SLKHVNIVQYLGTCLD-----DNTISIFMEFVPGGSISSIL----------NRFGPLPEP 102
Query: 273 ERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLE--ATNE 330
+ + YLH C + H DIK +N++L + DFG AR L +
Sbjct: 103 VFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG 159
Query: 331 QTSSI--GVKGTTGYIAPEYGMGHETSSYG---DVYSFGILLLEMFTGLRPSDDM 380
S++ + GT ++APE S YG D++S G + EM TG P M
Sbjct: 160 THSNMLKSMHGTPYWMAPEV---INESGYGRKSDIWSIGCTVFEMATGKPPLASM 211
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 3e-06
Identities = 63/219 (28%), Positives = 103/219 (47%), Gaps = 31/219 (14%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACS 227
+G GN+ SVYK + +A+K L D SK + E+ +I+H+ + +
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIR-LELDESKFNQIIMEL--DILHKAVSPYI---- 61
Query: 228 RVDYQGNDF-KALVY---EFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVAS 283
VD+ G F + VY E+M GSL++ + + + L R I V
Sbjct: 62 -VDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPE-----DVLRR--ITYAVVK 113
Query: 284 ALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGY 343
L++L + I H D+KP+N+L+N + DFG++ L A+ +T+ G Y
Sbjct: 114 GLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI----GCQSY 167
Query: 344 IAPEY---GMGHETSSY---GDVYSFGILLLEMFTGLRP 376
+APE G ++ +Y DV+S G+ +LEM G P
Sbjct: 168 MAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 53/195 (27%), Positives = 76/195 (38%), Gaps = 40/195 (20%)
Query: 231 YQGNDFKALVYEFMPNGSLEEWIH----PITEEDKRHKAPGNLNSLERLNIAIDVASALE 286
Y+ D LV M G L+ I+ P EE++ L A ++ LE
Sbjct: 69 YETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERA------------LFYAAEILCGLE 116
Query: 287 YLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAP 346
LH + + D+KP NILL+D ++D G+A + E S G GT GY+AP
Sbjct: 117 DLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIP---EGESIRGRVGTVGYMAP 170
Query: 347 EYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPERVEEIVDTL 406
E + D + G L+ EM G QS R E++
Sbjct: 171 EVLNNQRYTLSPDYWGLGCLIYEMIEG------------------QSPFRGRKEKVKREE 212
Query: 407 FFKEIEEEETVYKYK 421
+ + E E VY K
Sbjct: 213 VDRRVLETEEVYSAK 227
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 4e-06
Identities = 63/263 (23%), Positives = 100/263 (38%), Gaps = 47/263 (17%)
Query: 140 SISIDLDFPYVS-----------YEALYSATKGFSSE-------NLIGAGNFASVYKGIL 181
S+ +DLDFP + YE + + + +IG G F V
Sbjct: 5 SLVLDLDFPALRKNKNIDNFLNRYEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRH 64
Query: 182 FEGAPAVAIKV---FNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKA 238
A+K+ F + S F E ++M ++++ A +Q + +
Sbjct: 65 KSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCA-----FQDDKYLY 119
Query: 239 LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLH-LGCKPPIA 297
+V E+MP G L + +K K +V AL+ +H +G +
Sbjct: 120 MVMEYMPGGDLVNLMSNYDVPEKWAKF-----------YTAEVVLALDAIHSMG----LI 164
Query: 298 HCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSY 357
H D+KP N+LL+ +ADFG ++ T V GT YI+PE Y
Sbjct: 165 HRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-GTPDYISPEVLKSQGGDGY 223
Query: 358 ----GDVYSFGILLLEMFTGLRP 376
D +S G+ L EM G P
Sbjct: 224 YGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 4e-06
Identities = 31/99 (31%), Positives = 50/99 (50%), Gaps = 5/99 (5%)
Query: 280 DVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKG 339
+++ AL YLH + I + D+K N+LL+ E + D+G+ + E ++ G
Sbjct: 104 EISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCG 158
Query: 340 TTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSD 378
T YIAPE G + D ++ G+L+ EM G P D
Sbjct: 159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 4e-06
Identities = 62/225 (27%), Positives = 90/225 (40%), Gaps = 30/225 (13%)
Query: 162 FSSENLIGAGNFASVYKGILFEGAPAVAIKVFN---FLHHDASKSFTVECEVMRNIIHRK 218
F +IG G F V L A+K+ N L + F E +V+ N ++
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQW 62
Query: 219 IIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNS--LERLN 276
I + A +Q + LV ++ G L + + + P ++ L +
Sbjct: 63 ITTLHYA-----FQDENNLYLVMDYYVGGDLLTLLSKFED-----RLPEDMARFYLAEMV 112
Query: 277 IAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIG 336
IAID L Y+H DIKP NIL++ +ADFG L SS+
Sbjct: 113 IAIDSVHQLHYVHR---------DIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA 163
Query: 337 VKGTTGYIAPEY--GMGHETSSYG---DVYSFGILLLEMFTGLRP 376
V GT YI+PE M YG D +S G+ + EM G P
Sbjct: 164 V-GTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 4e-06
Identities = 36/123 (29%), Positives = 63/123 (51%), Gaps = 8/123 (6%)
Query: 278 AIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGV 337
A ++ AL +LH + I + D+K N+LL+ + + D+G+ + + TS+
Sbjct: 102 AAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFC- 157
Query: 338 KGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDN--LNLQNWVQSAL 395
GT YIAPE G E D ++ G+L+ EM G P D+ DN +N ++++ +
Sbjct: 158 -GTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPF-DIITDNPDMNTEDYLFQVI 215
Query: 396 PER 398
E+
Sbjct: 216 LEK 218
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 4e-06
Identities = 34/91 (37%), Positives = 46/91 (50%), Gaps = 7/91 (7%)
Query: 285 LEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYI 344
L+YLH I H DIKP N+L+N + DFG+AR E + + V T Y
Sbjct: 116 LKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV-TQYYR 171
Query: 345 APEYGMG--HETSSYGDVYSFGILLLEMFTG 373
APE MG H TS+ D++S G + E+
Sbjct: 172 APEILMGSRHYTSAV-DIWSVGCIFAELLGR 201
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 6e-06
Identities = 56/218 (25%), Positives = 93/218 (42%), Gaps = 32/218 (14%)
Query: 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKI 219
K F+ IG G+F +VY VAIK ++ +++ + ++++ + K
Sbjct: 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQ---DIIKEV---KF 78
Query: 220 IKVVTACSRVDYQGNDFKA----LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERL 275
++ + + ++Y+G + LV E+ GS + + + HK P L +E
Sbjct: 79 LQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLL-------EVHKKP--LQEVEIA 128
Query: 276 NIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSI 335
I L YLH + H DIK NILL + +ADFG A N
Sbjct: 129 AITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANS----- 180
Query: 336 GVKGTTGYIAPEYGMGHETSSYG---DVYSFGILLLEM 370
GT ++APE + + Y DV+S GI +E+
Sbjct: 181 -FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 7e-06
Identities = 58/231 (25%), Positives = 103/231 (44%), Gaps = 52/231 (22%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIKV----FNFLHHDASKSFTVECEVMRNIIHRKIIKVV 223
+G+G + SV + VA+K F + H A +++ E +++++ H +I
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH-AKRTYR-ELRLLKHMKHENVI--- 79
Query: 224 TACSRVDYQGNDFKALVYEFMPNGSLEEW--IHPITEEDKRHKAPGNLNSLERLNIAID- 280
L+ F P SLEE+ ++ +T H +LN++ + D
Sbjct: 80 --------------GLLDVFTPARSLEEFNDVYLVT-----HLMGADLNNIVKCQKLTDD 120
Query: 281 --------VASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQT 332
+ L+Y+H I H D+KPSN+ +N++ + DFG+AR T+++
Sbjct: 121 HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARH---TDDEM 174
Query: 333 SSIGVKGTTGYIAPEYGMG--HETSSYGDVYSFGILLLEMFTG--LRPSDD 379
+ G T Y APE + H + D++S G ++ E+ TG L P D
Sbjct: 175 T--GYVATRWYRAPEIMLNWMHYNQTV-DIWSVGCIMAELLTGRTLFPGTD 222
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 7e-06
Identities = 55/225 (24%), Positives = 93/225 (41%), Gaps = 51/225 (22%)
Query: 168 IGAGNFASV----YKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRN------IIHR 217
+G G+F V YK E P VAIK F + ++++ R
Sbjct: 38 LGTGSFGRVILATYKN---EDFPPVAIKRFE------------KSKIIKQKQVDHVFSER 82
Query: 218 KIIKVVTACSRVDYQGN----DFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLE 273
KI+ + V+ G+ + LV EF+ G ++ + + P ++
Sbjct: 83 KILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLR------RNKRFPNDVGCF- 135
Query: 274 RLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTS 333
A + EYL I + D+KP N+LL+ + + DFG A+ ++ T
Sbjct: 136 ---YAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD-----TR 184
Query: 334 SIGVKGTTGYIAPE--YGMGHETSSYGDVYSFGILLLEMFTGLRP 376
+ + GT YIAPE +GH ++ D ++ GI + E+ G P
Sbjct: 185 TYTLCGTPEYIAPEILLNVGHGKAA--DWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 7e-06
Identities = 50/178 (28%), Positives = 81/178 (45%), Gaps = 39/178 (21%)
Query: 269 LNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEAT 328
L +L+ L+ VA +E+L H D+ N+LL + DFG+AR +
Sbjct: 234 LTTLDLLSFTYQVARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHD 290
Query: 329 NEQTSSIGVKGTT----GYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKD 383
+ S KG+T ++APE + ++ DV+S+GILL E+F+ G P M
Sbjct: 291 SNYVS----KGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGM--- 343
Query: 384 NLNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQR--SIILECLNS 439
IVD+ F+ +I ++ Y+ K P +TQ I+++C NS
Sbjct: 344 ------------------IVDSTFYNKI---KSGYRMAK-PDHATQEVYDIMVKCWNS 379
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 7e-06
Identities = 42/134 (31%), Positives = 64/134 (47%), Gaps = 14/134 (10%)
Query: 256 ITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTAC 315
EED P +L+ L L + VA +++L K I H D+ N+LL D A
Sbjct: 198 KDEEDTEDSWPLDLDDL--LRFSSQVAQGMDFL--ASKNCI-HRDVAARNVLLTDGRVAK 252
Query: 316 VADFGIARFLEATNEQTSSIGVKGTT----GYIAPEYGMGHETSSYGDVYSFGILLLEMF 371
+ DFG+AR + S+ VKG ++APE + DV+S+GILL E+F
Sbjct: 253 ICDFGLARDI----MNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF 308
Query: 372 T-GLRPSDDMFKDN 384
+ G P + ++
Sbjct: 309 SLGKSPYPGILVNS 322
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 7e-06
Identities = 56/213 (26%), Positives = 84/213 (39%), Gaps = 38/213 (17%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIKVFNF---LHHDASKSFTVECEVMRNIIHRKIIKVVT 224
IG G+F +VY VA+K ++ ++ + E + ++ + H I
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTI---- 84
Query: 225 ACSRVDYQGNDFKA----LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAID 280
+Y+G K LV E+ GS + + + HK P L +E I
Sbjct: 85 -----EYKGCYLKEHTAWLVMEYCL-GSASDLL-------EVHKKP--LQEVEIAAITHG 129
Query: 281 VASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGT 340
L YLH H DIK NILL + +ADFG A N GT
Sbjct: 130 ALQGLAYLHSHNM---IHRDIKAGNILLTEPGQVKLADFGSASKSSPANS------FVGT 180
Query: 341 TGYIAPEYGMGHETSSYG---DVYSFGILLLEM 370
++APE + + Y DV+S GI +E+
Sbjct: 181 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 1e-05
Identities = 32/81 (39%), Positives = 42/81 (51%), Gaps = 2/81 (2%)
Query: 4 NLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTE-G 62
N G I L ++ LK + L NNLSGEIP + G L +L+L +NN IP+ G
Sbjct: 198 NQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLG 257
Query: 63 IFKNASATSVFGNNKLCGGIP 83
KN ++ NKL G IP
Sbjct: 258 NLKNLQYLFLY-QNKLSGPIP 277
|
Length = 968 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 1e-05
Identities = 33/100 (33%), Positives = 49/100 (49%), Gaps = 12/100 (12%)
Query: 284 ALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGY 343
+++LH I H D+KPSNI++ + T + DFG+AR T Y
Sbjct: 130 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYY 183
Query: 344 IAPE--YGMGHETSSYGDVYSFGILLLEMFTG--LRPSDD 379
APE GMG++ + D++S G ++ EM G L P D
Sbjct: 184 RAPEVILGMGYKENV--DIWSVGCIMGEMIRGTVLFPGTD 221
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 1e-05
Identities = 48/199 (24%), Positives = 91/199 (45%), Gaps = 28/199 (14%)
Query: 188 VAIKVFNFLHHDASKS----FTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKALVYEF 243
VA+K+ L DA+K+ F E +++ + II+++ C D ++ E+
Sbjct: 49 VAVKI---LRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVD-----EDPLCMITEY 100
Query: 244 MPNGSLEEWIHPITEEDKRHKAPGNLNSLER-----------LNIAIDVASALEYLHLGC 292
M NG L +++ +DK + GN L++A+ +AS ++YL
Sbjct: 101 MENGDLNQFLSSHHLDDK--EENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---S 155
Query: 293 KPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGH 352
H D+ N L+ + +T +ADFG++R L A + ++A E +
Sbjct: 156 SLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMG 215
Query: 353 ETSSYGDVYSFGILLLEMF 371
+ ++ DV++FG+ L E+
Sbjct: 216 KFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 59/271 (21%), Positives = 116/271 (42%), Gaps = 51/271 (18%)
Query: 162 FSSENL-----IGAGNFASVY----KGILFEGAPA-VAIKVFNFLHHDASKS-FTVECEV 210
F NL +G G F V+ KGI EG V +K + +S F E ++
Sbjct: 2 FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDM 61
Query: 211 MRNIIHRKIIKVVTACSRVD--YQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGN 268
R + H+ +++++ C + Y ++ E+ G L++++ T+ P
Sbjct: 62 FRKLSHKNVVRLLGLCREAEPHY-------MILEYTDLGDLKQFLR-ATKSKDEKLKPPP 113
Query: 269 LNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEAT 328
L++ +++ + +A +++L H D+ N L++ + V+ L +
Sbjct: 114 LSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVS------LLSLS 164
Query: 329 NEQTSS---------IGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRP-- 376
+ +S I ++ ++APE + S+ DV+SFG+L+ E+FT G P
Sbjct: 165 KDVYNSEYYKLRNALIPLR----WLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFY 220
Query: 377 --SDDMFKDNL---NLQNWVQSALPERVEEI 402
SD+ + L L+ V P R+ ++
Sbjct: 221 GLSDEEVLNRLQAGKLELPVPEGCPSRLYKL 251
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 50/198 (25%), Positives = 86/198 (43%), Gaps = 32/198 (16%)
Query: 188 VAIKVFNFLHHDASKS----FTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKALVYEF 243
VA+KV L DAS + F E +++ + I +++ C+ + ++ E+
Sbjct: 49 VAVKV---LRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTV-----DPPLCMIMEY 100
Query: 244 MPNGSLEEWIHPITEEDKRHKAPGNLNSLER---LNIAIDVASALEYLHLGCKPPIAHCD 300
M NG L +++ + N SL L +A +AS + YL H D
Sbjct: 101 MENGDLNQFLQ--KHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRD 155
Query: 301 IKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTT----GYIAPE--YGMGHET 354
+ N L+ T +ADFG++R L +++ V+G ++A E T
Sbjct: 156 LATRNCLVGKNYTIKIADFGMSRNLYSSDYYR----VQGRAPLPIRWMAWESVLLGKFTT 211
Query: 355 SSYGDVYSFGILLLEMFT 372
S DV++FG+ L E+ T
Sbjct: 212 KS--DVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 46.8 bits (112), Expect = 2e-05
Identities = 37/126 (29%), Positives = 54/126 (42%), Gaps = 10/126 (7%)
Query: 264 KAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMT-ACVADFGIA 322
K G L+ E I + AL LH K I H DIK N+L + + D+G+
Sbjct: 101 KKEGKLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLC 157
Query: 323 RFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFK 382
+ T S GT Y +PE GH D ++ G+L E+ TG P +
Sbjct: 158 K-----IIGTPSCY-DGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDED 211
Query: 383 DNLNLQ 388
+ L+L+
Sbjct: 212 EELDLE 217
|
Length = 267 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 37/114 (32%), Positives = 56/114 (49%), Gaps = 11/114 (9%)
Query: 279 IDVASALEYLHLGCKPPIAHCDIKPSNILLNDE-MTACVADFGIARFLEATNEQTSSIGV 337
+ ++ L+++H I H DIK NI L+ M A + DFGIAR L + E +
Sbjct: 108 VQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT--C 162
Query: 338 KGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWV 391
GT Y++PE ++ D++S G +L E+ T P F+ N NL V
Sbjct: 163 VGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHP----FEGN-NLHQLV 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 2e-05
Identities = 43/137 (31%), Positives = 67/137 (48%), Gaps = 28/137 (20%)
Query: 285 LEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYI 344
L+Y+H I H D+KPSN+ +N++ + DFG+AR +A +E T G T Y
Sbjct: 131 LKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLAR--QADDEMT---GYVATRWYR 182
Query: 345 APEYGMG--HETSSYGDVYSFGILLLEMFTG--LRPSDDMFKDNLNLQNWVQSALPERVE 400
APE + H + D++S G ++ E+ G L P +D + D L +R+
Sbjct: 183 APEIMLNWMHYNQTV-DIWSVGCIMAELLKGKALFPGND-YIDQL-----------KRIM 229
Query: 401 EIVDTL---FFKEIEEE 414
E+V T K+I E
Sbjct: 230 EVVGTPSPEVLKKISSE 246
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-05
Identities = 44/155 (28%), Positives = 68/155 (43%), Gaps = 15/155 (9%)
Query: 231 YQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHL 290
+Q D V E++ G L I + R K P + A ++A L +LH
Sbjct: 70 FQTMDRLYFVMEYVNGGDLMYQIQQV----GRFKEP------HAVFYAAEIAIGLFFLH- 118
Query: 291 GCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGM 350
I + D+K N++L+ E +ADFG+ + E + ++ GT YIAPE
Sbjct: 119 --SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENMWDGVTTKTFCGTPDYIAPEIIA 174
Query: 351 GHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNL 385
D ++FG+LL EM G P + +D L
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL 209
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-05
Identities = 60/216 (27%), Positives = 95/216 (43%), Gaps = 25/216 (11%)
Query: 162 FSSENLIGAGNFASVYKGILFEGAPAVAIKVF-NFLHHDASKSFTV-ECEVMRNIIHRKI 219
F ++G G + V K E VAIK F + ++ K T+ E +++R + I
Sbjct: 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENI 62
Query: 220 IKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAI 279
+++ A R +G + LV+E++ LE + EE P + S
Sbjct: 63 VELKEAFRR---RGKLY--LVFEYVEKNMLE-----LLEEMPNGVPPEKVRSY-----IY 107
Query: 280 DVASALEYLHLGCKPPIAHCDIKPSNILL--NDEMTACVADFGIARFLEATNEQTSSIGV 337
+ A+ + H K I H DIKP N+L+ ND + C DFG AR L + + V
Sbjct: 108 QLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLC--DFGFARNLSEGSNANYTEYV 162
Query: 338 KGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTG 373
T Y +PE +G D++S G +L E+ G
Sbjct: 163 -ATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 3e-05
Identities = 51/228 (22%), Positives = 88/228 (38%), Gaps = 32/228 (14%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASK----SFTVECEVMRNIIHRKIIKVV 223
IG G F V G G + A V L A+ F E + R + H +++ +
Sbjct: 3 IGNGWFGKVLLGEAHRGM-SKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61
Query: 224 TACSRV-DYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVA 282
C Y LV EF P G L+ ++ R +A +VA
Sbjct: 62 GQCIESIPY------LLVLEFCPLGDLKNYL-----RSNRGMVAQMAQKDVLQRMACEVA 110
Query: 283 SALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIA--RFLEATNEQTSSIGVKGT 340
S L +LH + H D+ N L +++ + D+G+A ++ E V
Sbjct: 111 SGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVP-- 165
Query: 341 TGYIAPEYG-------MGHETSSYGDVYSFGILLLEMFT-GLRPSDDM 380
++APE + + + +++S G+ + E+FT +P D+
Sbjct: 166 LRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDL 213
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 3e-05
Identities = 44/148 (29%), Positives = 65/148 (43%), Gaps = 18/148 (12%)
Query: 231 YQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNI--AIDVASALEYL 288
Y+ D LV M G L+ I+ + GN E+ I A ++ LE L
Sbjct: 69 YETKDALCLVLTIMNGGDLKFHIYNM----------GNPGFDEQRAIFYAAELCCGLEDL 118
Query: 289 HLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEY 348
+ I + D+KP NILL+D ++D G+A + E + G GT GY+APE
Sbjct: 119 Q---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIP---EGETVRGRVGTVGYMAPEV 172
Query: 349 GMGHETSSYGDVYSFGILLLEMFTGLRP 376
+ + D + G L+ EM G P
Sbjct: 173 INNEKYTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 4e-05
Identities = 30/81 (37%), Positives = 36/81 (44%), Gaps = 2/81 (2%)
Query: 4 NLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTE-G 62
N+ G I + LKVLDL N L G+IP L L+ L L+ N IP E G
Sbjct: 150 NMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELG 209
Query: 63 IFKNASATSVFGNNKLCGGIP 83
K+ G N L G IP
Sbjct: 210 QMKSLKWI-YLGYNNLSGEIP 229
|
Length = 968 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 4e-05
Identities = 31/101 (30%), Positives = 51/101 (50%), Gaps = 5/101 (4%)
Query: 278 AIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGV 337
+ +++ AL +LH I + D+K N+LL+ E + D+G+ + + TS+
Sbjct: 102 SAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFC- 157
Query: 338 KGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSD 378
GT YIAPE G + D ++ G+L+ EM G P D
Sbjct: 158 -GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 4e-05
Identities = 33/100 (33%), Positives = 47/100 (47%), Gaps = 15/100 (15%)
Query: 285 LEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYI 344
L+Y+H + H D+KPSNIL+N+ + DFG+AR + G T Y
Sbjct: 121 LKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARI-----QDPQMTGYVSTRYYR 172
Query: 345 APEYGMGHETSSYG---DVYSFGILLLEMFTG--LRPSDD 379
APE + + Y D++S G + EM G L P D
Sbjct: 173 APEIMLTWQ--KYDVEVDIWSAGCIFAEMLEGKPLFPGKD 210
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 4e-05
Identities = 42/158 (26%), Positives = 69/158 (43%), Gaps = 9/158 (5%)
Query: 217 RKIIKVVTACSRVD--YQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLER 274
R + + SRVD + L F P+ S +P E D K+P + L
Sbjct: 121 RGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGS--TNPPQETDDLWKSPLTMEDL-- 176
Query: 275 LNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSS 334
+ + VA +E+L H D+ NILL++ + DFG+AR + +
Sbjct: 177 ICYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRK 233
Query: 335 IGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT 372
+ ++APE ++ DV+SFG+LL E+F+
Sbjct: 234 GSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 4e-05
Identities = 50/197 (25%), Positives = 82/197 (41%), Gaps = 37/197 (18%)
Query: 204 FTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRH 263
+E VMR + H+ I++ + R + N ++ EF G L I K +
Sbjct: 59 LVIEVNVMRELKHKNIVRYI---DRFLNKANQKLYILMEFCDAGDLSRNIQ------KCY 109
Query: 264 KAPGNLNSLERLNIAIDVASALEYLHLGCKPP----IAHCDIKPSNIL------------ 307
K G + ++I + AL Y H P + H D+KP NI
Sbjct: 110 KMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169
Query: 308 -----LNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSY---GD 359
LN A + DFG+++ + + S + GT Y +PE + HET SY D
Sbjct: 170 AQANNLNGRPIAKIGDFGLSKNIGIESMAHSCV---GTPYYWSPEL-LLHETKSYDDKSD 225
Query: 360 VYSFGILLLEMFTGLRP 376
+++ G ++ E+ +G P
Sbjct: 226 MWALGCIIYELCSGKTP 242
|
Length = 1021 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 4e-05
Identities = 33/120 (27%), Positives = 55/120 (45%), Gaps = 7/120 (5%)
Query: 281 VASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGT 340
+ + +LH I + D+KP N+LL+D+ ++D G+A L+ T GT
Sbjct: 104 ITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQR---AGT 157
Query: 341 TGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPERVE 400
GY+APE S D ++ G + EM G P D K+ + + + L + V+
Sbjct: 158 NGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKD-HKEKVAKEELKRRTLEDEVK 216
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 4e-05
Identities = 31/100 (31%), Positives = 51/100 (51%), Gaps = 11/100 (11%)
Query: 280 DVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKG 339
++ SAL+YLH G I + D+K N++L+ + + DFG+ + E + + G
Sbjct: 103 EIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCK--EGITDAATMKTFCG 157
Query: 340 TTGYIAPEYGMGHETSSYG---DVYSFGILLLEMFTGLRP 376
T Y+APE E + YG D + G+++ EM G P
Sbjct: 158 TPEYLAPEV---LEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 4e-05
Identities = 46/164 (28%), Positives = 71/164 (43%), Gaps = 19/164 (11%)
Query: 207 ECEVMRNIIHRKIIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAP 266
E ++++ I HR II ++ A +K+ V MP + + T D+ P
Sbjct: 136 EIDILKTISHRAIINLIHAYR--------WKSTVCMVMPKYKCDLF----TYVDR--SGP 181
Query: 267 GNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLE 326
L + I + AL YLH I H D+K NI L++ A + DFG A L+
Sbjct: 182 LPLEQA--ITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLD 236
Query: 327 ATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEM 370
A + G GT +PE + D++S G++L EM
Sbjct: 237 AHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 4e-05
Identities = 31/100 (31%), Positives = 51/100 (51%), Gaps = 11/100 (11%)
Query: 280 DVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKG 339
++ SALEYLH + + DIK N++L+ + + DFG+ + E ++ + G
Sbjct: 103 EIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCG 157
Query: 340 TTGYIAPEYGMGHETSSYG---DVYSFGILLLEMFTGLRP 376
T Y+APE E + YG D + G+++ EM G P
Sbjct: 158 TPEYLAPEV---LEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 4e-05
Identities = 62/222 (27%), Positives = 96/222 (43%), Gaps = 35/222 (15%)
Query: 165 ENLIGAGNFASVYKGILFEGAPAVAIKVFN--FLHHDASKSFTVECEVMRNIIHRKIIKV 222
+ +IG G++ V I VAIK N F H + E +++R + H I+++
Sbjct: 5 QEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEI 64
Query: 223 ---VTACSRVDYQGNDFKAL--VYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNI 277
+ SR +FK + V+E M E +H + KA +L
Sbjct: 65 KHIMLPPSR-----REFKDIYVVFELM-----ESDLHQVI------KANDDLTPEHHQFF 108
Query: 278 AIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSI-- 335
+ AL+Y+H + H D+KP NIL N + + DFG+AR A N+ ++I
Sbjct: 109 LYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARV--AFNDTPTAIFW 163
Query: 336 -GVKGTTGYIAPEYGMGHETSSYG---DVYSFGILLLEMFTG 373
T Y APE G S Y D++S G + E+ TG
Sbjct: 164 TDYVATRWYRAPEL-CGSFFSKYTPAIDIWSIGCIFAEVLTG 204
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 5e-05
Identities = 38/140 (27%), Positives = 60/140 (42%), Gaps = 24/140 (17%)
Query: 239 LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLH-LGCKPPIA 297
LV+E+ H + E +++ P + I A+ + H C
Sbjct: 77 LVFEYCD--------HTVLNELEKN--PRGVPEHLIKKIIWQTLQAVNFCHKHNC----I 122
Query: 298 HCDIKPSNILLNDEMTACVADFGIARFLEAT-NEQTSSIGVKGTTGYIAPEYGMGHETSS 356
H D+KP NIL+ + + DFG AR L ++ T + T Y APE +G +
Sbjct: 123 HRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYV---ATRWYRAPELLVG--DTQ 177
Query: 357 YG---DVYSFGILLLEMFTG 373
YG DV++ G + E+ TG
Sbjct: 178 YGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 5e-05
Identities = 56/221 (25%), Positives = 99/221 (44%), Gaps = 43/221 (19%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTV--ECEVMRNIIHRKIIK---- 221
+G G++A+VYKG VA+K L H+ FT E +++++ H I+
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIR-LEHEEGAPFTAIREASLLKDLKHANIVTLHDI 71
Query: 222 VVTACSRVDYQGNDFKALVYEFMPNGSLEEWI--HPITEEDKRHKAPGNLNSLERLNIAI 279
+ T + LV+E++ + L++++ L N+ +
Sbjct: 72 IHTKKTLT---------LVFEYL-DTDLKQYMDDCG--------------GGLSMHNVRL 107
Query: 280 ---DVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIG 336
+ L Y H + + H D+KP N+L+++ +ADFG+AR ++ +T S
Sbjct: 108 FLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLAR-AKSVPSKTYSNE 163
Query: 337 VKGTTGYIAPEYGMGH-ETSSYGDVYSFGILLLEMFTGLRP 376
V T Y P+ +G E S+ D++ G + EM TG RP
Sbjct: 164 VV-TLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATG-RP 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 5e-05
Identities = 30/102 (29%), Positives = 52/102 (50%), Gaps = 12/102 (11%)
Query: 278 AIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGV 337
A ++ LE++H + + D+KP+NILL++ ++D G+A S
Sbjct: 103 ATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV--- 156
Query: 338 KGTTGYIAPEY---GMGHETSSYGDVYSFGILLLEMFTGLRP 376
GT GY+APE G +++S+ D +S G +L ++ G P
Sbjct: 157 -GTHGYMAPEVLQKGTAYDSSA--DWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 5e-05
Identities = 53/218 (24%), Positives = 94/218 (43%), Gaps = 32/218 (14%)
Query: 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKI 219
K FS IG G+F +VY + VAIK ++ +++ + ++++ + +
Sbjct: 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQ---DIIKEV---RF 68
Query: 220 IKVVTACSRVDYQGNDFKA----LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERL 275
++ + + + Y+G + LV E+ GS + + + HK P L +E
Sbjct: 69 LQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLL-------EVHKKP--LQEVEIA 118
Query: 276 NIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSI 335
+ L YLH + H D+K NILL++ + DFG A + N
Sbjct: 119 AVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX----- 170
Query: 336 GVKGTTGYIAPEYGMGHETSSYG---DVYSFGILLLEM 370
GT ++APE + + Y DV+S GI +E+
Sbjct: 171 -FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 6e-05
Identities = 52/237 (21%), Positives = 96/237 (40%), Gaps = 46/237 (19%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIKVFN--FLHH-DASKSFTVECEVMRNIIHRKIIKVVT 224
+G G + V+ + VA+K L + + E +++ ++K++
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 225 ACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLE----RLNIAID 280
A +Q +++ L E++P G ++ NL L R +A +
Sbjct: 69 A-----FQDDEYLYLAMEYVPGGDFRTLLN-------------NLGVLSEDHARFYMA-E 109
Query: 281 VASALEYLH-LGCKPPIAHCDIKPSNILLNDEMTACVADFGIAR-FLEATNEQTSSIGVK 338
+ A++ LH LG H D+KP N L++ + DFG+++ + N V
Sbjct: 110 MFEAVDALHELG----YIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANS------VV 159
Query: 339 GTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRP-----SDDMFKDNLNLQNW 390
G+ Y+APE G D +S G +L E G P ++ ++ NL+ W
Sbjct: 160 GSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWE---NLKYW 213
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 6e-05
Identities = 37/109 (33%), Positives = 48/109 (44%), Gaps = 23/109 (21%)
Query: 277 IAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIG 336
+AI L Y+H DIKP N+LL+ +ADFG + SS+
Sbjct: 113 LAIHSIHQLHYVHR---------DIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVA 163
Query: 337 VKGTTGYIAPEY------GMGHETSSYG---DVYSFGILLLEMFTGLRP 376
V GT YI+PE GMG YG D +S G+ + EM G P
Sbjct: 164 V-GTPDYISPEILQAMEDGMG----KYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 6e-05
Identities = 30/103 (29%), Positives = 53/103 (51%), Gaps = 12/103 (11%)
Query: 278 AIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGV 337
A ++ LE++H + + D+KP+NILL++ ++D G+A S
Sbjct: 103 AAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV--- 156
Query: 338 KGTTGYIAPEY---GMGHETSSYGDVYSFGILLLEMFTGLRPS 377
GT GY+APE G+ +++S+ D +S G +L ++ G P
Sbjct: 157 -GTHGYMAPEVLQKGVAYDSSA--DWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 7e-05
Identities = 28/89 (31%), Positives = 44/89 (49%), Gaps = 6/89 (6%)
Query: 4 NLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGI 63
N +G I + L++L L++N G +P+ G K L+NL+LS N F +P +
Sbjct: 438 NNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRK-- 494
Query: 64 FKNASATSV--FGNNKLCGGIPEFQLPTC 90
+ S NKL G IP+ +L +C
Sbjct: 495 LGSLSELMQLKLSENKLSGEIPD-ELSSC 522
|
Length = 968 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 7e-05
Identities = 51/215 (23%), Positives = 93/215 (43%), Gaps = 25/215 (11%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIKVFNFLHHDAS----KSFTVECEVMRNIIHRKIIKVV 223
IG G F V G + G + V L AS F E + R++ H +++ +
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQV-VVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 224 TACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVAS 283
C+ V LV EF P G L+ ++ + + P + +L+R+ A ++A
Sbjct: 62 GQCTEVTPY-----LLVMEFCPLGDLKGYLRSCRKAELM--TP-DPTTLQRM--ACEIAL 111
Query: 284 ALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGY 343
L +LH K H D+ N LL ++T + D+G++ + + + +
Sbjct: 112 GLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRW 168
Query: 344 IAPE-----YG--MGHETSSYGDVYSFGILLLEMF 371
IAPE +G + + + +V+S G+ + E+F
Sbjct: 169 IAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELF 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 7e-05
Identities = 36/112 (32%), Positives = 54/112 (48%), Gaps = 15/112 (13%)
Query: 284 ALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIAR-FLEATNEQTSSI-GVKGTT 341
L+Y+H + H D+KP N+L+N + + DFG+AR F E E + T
Sbjct: 117 GLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATR 173
Query: 342 GYIAPEYGMGHETSSYG-DVYSFGILLLEMFTGLRPSDDMFK-----DNLNL 387
Y APE + ++ + DV+S G +L E G +P +FK D LN
Sbjct: 174 WYRAPEIMLSFQSYTKAIDVWSVGCILAE-LLGRKP---VFKGKDYVDQLNQ 221
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 7e-05
Identities = 54/212 (25%), Positives = 94/212 (44%), Gaps = 25/212 (11%)
Query: 168 IGAGNFASVYKGI-LFEGAPAVAIKVFNFLHHDASKSFTV--ECEVMRNII---HRKIIK 221
IG G + V+K L G VA+K + + E V+R++ H +++
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 222 VVTAC--SRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAI 279
+ C SR D + LV+E + + L ++ + E PG + ++
Sbjct: 69 LFDVCTVSRTDRETK--LTLVFEHV-DQDLTTYLDKVPE-------PGVPTETIK-DMMF 117
Query: 280 DVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKG 339
+ L++LH + H D+KP NIL+ +ADFG+AR + + +S+ V
Sbjct: 118 QLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLAR-IYSFQMALTSVVV-- 171
Query: 340 TTGYIAPEYGMGHETSSYGDVYSFGILLLEMF 371
T Y APE + ++ D++S G + EMF
Sbjct: 172 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 9e-05
Identities = 42/171 (24%), Positives = 67/171 (39%), Gaps = 25/171 (14%)
Query: 207 ECEVMRNIIHRKIIKVVTACSRVDY-----QGNDFKALVYEFMPNGSLEEWIHPITEEDK 261
E + + H I+K+ Q DF +Y FM + + + P+ ++ +
Sbjct: 213 EILALGRLNHENILKIEEILRSEANTYMITQKYDFD--LYSFMYDEAFDWKDRPLLKQTR 270
Query: 262 RHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGI 321
I + A+EY+H + H DIK NI LN + + DFG
Sbjct: 271 A--------------IMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDFGT 313
Query: 322 ARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT 372
A E E G GT +PE G D++S G++LL+M +
Sbjct: 314 AMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 9e-05
Identities = 34/109 (31%), Positives = 47/109 (43%), Gaps = 22/109 (20%)
Query: 284 ALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIAR-------------FLEATNE 330
ALEYLH I H D+KP N+L+ + DFG+++ +E
Sbjct: 113 ALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTR 169
Query: 331 QTSSIGVKGTTGYIAPEYGMGHETSSYG---DVYSFGILLLEMFTGLRP 376
+ V GT YIAPE + YG D ++ GI+L E G P
Sbjct: 170 EFLDKQVCGTPEYIAPEVIL---RQGYGKPVDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 9e-05
Identities = 49/203 (24%), Positives = 88/203 (43%), Gaps = 42/203 (20%)
Query: 188 VAIKVFNFLHHDASKS----FTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKALVYEF 243
VA+K+ L DA+K+ F E ++M + II+++ C +D ++ E+
Sbjct: 49 VAVKM---LREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCIT-----SDPLCMITEY 100
Query: 244 MPNGSLEEWIHPITEEDKRHKAPGNLNSLER--------LNIAIDVASALEYLHLGCKPP 295
M NG L +++ RH+ + + +A +AS ++YL
Sbjct: 101 MENGDLNQFL-------SRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLN 150
Query: 296 IAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETS 355
H D+ N L+ T +ADFG++R L + + ++G + P M E+
Sbjct: 151 FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYR----IQGRA--VLPIRWMSWESI 204
Query: 356 SYG------DVYSFGILLLEMFT 372
G DV++FG+ L E+ T
Sbjct: 205 LLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 1e-04
Identities = 35/90 (38%), Positives = 47/90 (52%), Gaps = 3/90 (3%)
Query: 4 NLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGI 63
N F G I ++L+ L L+VL L N SGEIP+ L L L+LS NN IP EG+
Sbjct: 318 NNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIP-EGL 376
Query: 64 FKNASATS-VFGNNKLCGGIPEFQLPTCVS 92
+ + + +N L G IP+ L C S
Sbjct: 377 CSSGNLFKLILFSNSLEGEIPK-SLGACRS 405
|
Length = 968 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 28/78 (35%), Positives = 41/78 (52%), Gaps = 3/78 (3%)
Query: 296 IAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETS 355
I H D+KPSNI++ + T + DFG+AR TN + V T Y APE +G
Sbjct: 144 IIHRDLKPSNIVVKSDCTLKILDFGLAR-TACTNFMMTPYVV--TRYYRAPEVILGMGYK 200
Query: 356 SYGDVYSFGILLLEMFTG 373
D++S G ++ E+ G
Sbjct: 201 ENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 34/110 (30%), Positives = 49/110 (44%), Gaps = 12/110 (10%)
Query: 17 LRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNN 76
L LK LDLS N+LS ++P+ L+ L NL+LS N S +P E +A NN
Sbjct: 162 LPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKI-SDLPPEIELLSALEELDLSNN 219
Query: 77 KLCGGIPEFQLPTCVSKKTKQNRSTL---PLKLVIAIDCGLLVL-TLALS 122
+ +L + +S + L L+ + L L TL LS
Sbjct: 220 SI------IELLSSLSNLKNLSGLELSNNKLEDLPESIGNLSNLETLDLS 263
|
Length = 394 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 1e-04
Identities = 34/118 (28%), Positives = 58/118 (49%), Gaps = 5/118 (4%)
Query: 255 PITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTA 314
E D+ +K P L L ++ + VA +E+L + I H D+ NILL++
Sbjct: 158 EDEEGDELYKEPLTLEDL--ISYSFQVARGMEFL--ASRKCI-HRDLAARNILLSENNVV 212
Query: 315 CVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT 372
+ DFG+AR + + + ++APE ++ DV+SFG+LL E+F+
Sbjct: 213 KICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 44.5 bits (106), Expect = 1e-04
Identities = 30/94 (31%), Positives = 46/94 (48%), Gaps = 10/94 (10%)
Query: 283 SALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTG 342
S + +LH I H D+K SN+LLN+ + DFG+AR + + + + V T
Sbjct: 117 SGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV--TLW 171
Query: 343 YIAPEYGMGHETSSYG---DVYSFGILLLEMFTG 373
Y APE +G Y D++S G + E+ T
Sbjct: 172 YRAPELLLG--AKEYSTAIDMWSVGCIFAELLTK 203
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 2e-04
Identities = 32/82 (39%), Positives = 41/82 (50%), Gaps = 2/82 (2%)
Query: 4 NLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGI 63
N GPI SL L+ L+ L L QN LSG IP + + L +L+LS N+ IP I
Sbjct: 246 NNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVI 305
Query: 64 -FKNASATSVFGNNKLCGGIPE 84
+N +F NN G IP
Sbjct: 306 QLQNLEILHLFSNN-FTGKIPV 326
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 2e-04
Identities = 23/71 (32%), Positives = 36/71 (50%), Gaps = 3/71 (4%)
Query: 20 LKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSV--FGNNK 77
+ +DLS N+SG+I + ++Q +NLS+N IP + IF +S+ NN
Sbjct: 71 VVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIP-DDIFTTSSSLRYLNLSNNN 129
Query: 78 LCGGIPEFQLP 88
G IP +P
Sbjct: 130 FTGSIPRGSIP 140
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 2e-04
Identities = 31/82 (37%), Positives = 42/82 (51%), Gaps = 2/82 (2%)
Query: 3 GNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTE- 61
GN+ G I SL+ L L+ L L+ N L G+IP L K L+ + L +NN IP E
Sbjct: 173 GNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEI 232
Query: 62 GIFKNASATSVFGNNKLCGGIP 83
G + + + NN L G IP
Sbjct: 233 GGLTSLNHLDLVYNN-LTGPIP 253
|
Length = 968 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.2 bits (105), Expect = 2e-04
Identities = 30/100 (30%), Positives = 45/100 (45%), Gaps = 21/100 (21%)
Query: 296 IAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKG------TTGYIAPEYG 349
+ H D+KP N+L++ E +ADFG+AR + V+ T Y APE
Sbjct: 120 VLHRDLKPQNLLIDREGALKLADFGLARAF--------GVPVRTYTHEVVTLWYRAPEIL 171
Query: 350 MGHETSSYG-DVYSFGILLLEM------FTGLRPSDDMFK 382
+G S D++S G + EM F G D +F+
Sbjct: 172 LGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFR 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-04
Identities = 32/108 (29%), Positives = 56/108 (51%), Gaps = 11/108 (10%)
Query: 269 LNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEAT 328
L+ ++ + + VA+ +E+L H D+ N+L+ + + DFG+AR +
Sbjct: 236 LSYMDLVGFSYQVANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRD 292
Query: 329 NEQTSSIGVKGTT----GYIAPEYGMGHETSSYGDVYSFGILLLEMFT 372
+ S KG+T ++APE + ++ DV+SFGILL E+FT
Sbjct: 293 SNYIS----KGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 2e-04
Identities = 30/91 (32%), Positives = 43/91 (47%), Gaps = 10/91 (10%)
Query: 285 LEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYI 344
L+Y+H + H D+KPSN+LLN + DFG+AR + + V T Y
Sbjct: 121 LKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV--TRWYR 175
Query: 345 APEYGMGHETSSYG---DVYSFGILLLEMFT 372
APE + S Y DV+S G + E+
Sbjct: 176 APELLL--NCSEYTTAIDVWSVGCIFAELLG 204
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 39.4 bits (93), Expect = 2e-04
Identities = 20/42 (47%), Positives = 26/42 (61%)
Query: 13 SLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNF 54
+ L LKVLDLS NNL+ PE +G L++L+LS NN
Sbjct: 19 AFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 44/189 (23%), Positives = 81/189 (42%), Gaps = 21/189 (11%)
Query: 188 VAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKALVYEFMPNG 247
VA+K+ + + E +MR+ H+ ++++ + Y + ++ EF+ G
Sbjct: 49 VAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKS-----YLVGEELWVLMEFLQGG 103
Query: 248 SLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNIL 307
+L + + LN + + V AL YLH + H DIK +IL
Sbjct: 104 ALTDIVSQT-----------RLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSIL 149
Query: 308 LNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILL 367
L + ++DFG + + S+ GT ++APE + D++S GI++
Sbjct: 150 LTLDGRVKLSDFGFCAQISKDVPKRKSL--VGTPYWMAPEVISRTPYGTEVDIWSLGIMV 207
Query: 368 LEMFTGLRP 376
+EM G P
Sbjct: 208 IEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 3e-04
Identities = 42/149 (28%), Positives = 63/149 (42%), Gaps = 22/149 (14%)
Query: 231 YQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHL 290
+Q D V E+ G L IH + R A V L+YLH
Sbjct: 71 FQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVF-----------YAACVVLGLQYLH- 118
Query: 291 GCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGM 350
+ I + D+K N+LL+ E +ADFG+ + ++TS+ GT ++APE
Sbjct: 119 --ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFC--GTPEFLAPEVLT 174
Query: 351 GHETSSYG---DVYSFGILLLEMFTGLRP 376
+SY D + G+L+ EM G P
Sbjct: 175 E---TSYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 3e-04
Identities = 42/151 (27%), Positives = 61/151 (40%), Gaps = 21/151 (13%)
Query: 231 YQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLH- 289
+Q + + +V E+MP G L + + P R A +V AL+ +H
Sbjct: 112 FQDDRYLYMVMEYMPGGDLVNLM-------SNYDVPEKW---ARFYTA-EVVLALDAIHS 160
Query: 290 LGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYG 349
+G H D+KP N+LL+ +ADFG + V GT YI+PE
Sbjct: 161 MG----FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVL 215
Query: 350 MGHETSSY----GDVYSFGILLLEMFTGLRP 376
Y D +S G+ L EM G P
Sbjct: 216 KSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 43.4 bits (103), Expect = 3e-04
Identities = 58/225 (25%), Positives = 91/225 (40%), Gaps = 50/225 (22%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTV-ECEVMR------NIIHRKII 220
IG G F+ V K + AIK + + E + +R NI+ ++I
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNIL--RLI 64
Query: 221 KVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAID 280
+V+ D + ALV+E M + +L E I K K P L +
Sbjct: 65 EVL-----FDRKTGRL-ALVFELM-DMNLYELI-------KGRKRP--LPEKRVKSYMYQ 108
Query: 281 VASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGT 340
+ +L+++H + I H DIKP NIL+ D+ +ADFG R + + T I T
Sbjct: 109 LLKSLDHMH---RNGIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTEYI---ST 161
Query: 341 TGYIAPE---------YGMGHETSSYGDVYSFGILLLEMFTGLRP 376
Y APE M D+++ G + E+ + L P
Sbjct: 162 RWYRAPECLLTDGYYGPKM--------DIWAVGCVFFEILS-LFP 197
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 29/100 (29%), Positives = 51/100 (51%), Gaps = 10/100 (10%)
Query: 280 DVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKG 339
++ SAL+YLH + + + D+K N++L+ + + DFG+ + E + + G
Sbjct: 103 EIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCG 158
Query: 340 TTGYIAPEYGMGHETSSYG---DVYSFGILLLEMFTGLRP 376
T Y+APE E + YG D + G+++ EM G P
Sbjct: 159 TPEYLAPEV---LEDNDYGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|205079 pfam12799, LRR_4, Leucine Rich repeats (2 copies) | Back alignment and domain information |
|---|
Score = 38.6 bits (91), Expect = 3e-04
Identities = 13/38 (34%), Positives = 22/38 (57%), Gaps = 2/38 (5%)
Query: 20 LKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESM 57
L+ LDLS N ++ ++P L+ L+ L+LS N +
Sbjct: 3 LETLDLSNNQIT-DLPP-LSNLPNLETLDLSGNKITDL 38
|
Leucine rich repeats are short sequence motifs present in a number of proteins with diverse functions and cellular locations. These repeats are usually involved in protein-protein interactions. Each Leucine Rich Repeat is composed of a beta-alpha unit. These units form elongated non-globular structures. Leucine Rich Repeats are often flanked by cysteine rich domains. Length = 43 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 4e-04
Identities = 59/205 (28%), Positives = 91/205 (44%), Gaps = 40/205 (19%)
Query: 188 VAIKVFN--FLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKALVYEFMP 245
VAIK + F + +K E +M+ + H+ II L+ F P
Sbjct: 52 VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII-----------------GLLNVFTP 94
Query: 246 NGSLEEW--IHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHL-GCK----PPIAH 298
SLEE+ ++ + E NL + ++ + + S L Y L G K I H
Sbjct: 95 QKSLEEFQDVYIVME-----LMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIH 149
Query: 299 CDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPE--YGMGHETSS 356
D+KPSNI++ + T + DFG+AR + T + T Y APE GMG++ +
Sbjct: 150 RDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV---VTRYYRAPEVILGMGYKENV 206
Query: 357 YGDVYSFGILLLEMFTG--LRPSDD 379
D++S G ++ EM G L P D
Sbjct: 207 --DIWSVGCIMGEMIKGGVLFPGTD 229
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 4e-04
Identities = 38/154 (24%), Positives = 65/154 (42%), Gaps = 25/154 (16%)
Query: 165 ENLIGAGNFASVYKGILFEGA-------PAVAIKVFNFLHHDASKSFTVECEVMRNIIHR 217
E+L G G F ++KGI E V +KV + H + S+SF +M + H+
Sbjct: 1 ESL-GQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHK 59
Query: 218 KIIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNI 277
++ C D +V E++ GSL+ ++ K +N +L +
Sbjct: 60 HLVLNYGVC-----VCGDESIMVQEYVKFGSLDTYLK------KNKNL---INISWKLEV 105
Query: 278 AIDVASALEYLHLGCKPPIAHCDIKPSNILLNDE 311
A +A AL +L + H ++ N+LL E
Sbjct: 106 AKQLAWALHFLE---DKGLTHGNVCAKNVLLIRE 136
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 5e-04
Identities = 31/101 (30%), Positives = 50/101 (49%), Gaps = 12/101 (11%)
Query: 276 NIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIA-------RFLEAT 328
NI D+ + LEY+H + I+H DIKP NI+++ + D+GIA + +E +
Sbjct: 130 NIMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYS 186
Query: 329 NEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLE 369
EQ +GT Y + G + GD+ S G +L+
Sbjct: 187 KEQKDL--HRGTLYYAGLDAHNGACVTRRGDLESLGYCMLK 225
|
Length = 294 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 5e-04
Identities = 30/100 (30%), Positives = 51/100 (51%), Gaps = 11/100 (11%)
Query: 280 DVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKG 339
++ SAL YLH C + + D+K N++L+ + + DFG+ + E ++ + G
Sbjct: 103 EIVSALGYLH-SCD--VVYRDLKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCG 157
Query: 340 TTGYIAPEYGMGHETSSYG---DVYSFGILLLEMFTGLRP 376
T Y+APE E + YG D + G+++ EM G P
Sbjct: 158 TPEYLAPEV---LEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 5e-04
Identities = 50/205 (24%), Positives = 80/205 (39%), Gaps = 31/205 (15%)
Query: 188 VAIKVFNFLHHDASKSFTV---ECEVMRNIIHRKIIKVVTACSRVDYQGNDFKALVYEFM 244
VA+K N L + + + E R + H I+ VT S + ++ +V M
Sbjct: 28 VAVKKIN-LDSCSKEDLKLLQQEIITSRQLQHPNILPYVT--SFIV--DSEL-YVVSPLM 81
Query: 245 PNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLH-LGCKPPIAHCDIKP 303
GS E+ + K H G L L I DV +AL+Y+H G H +K
Sbjct: 82 AYGSCEDLL-------KTHFPEG-LPELAIAFILKDVLNALDYIHSKGF----IHRSVKA 129
Query: 304 SNILLNDEMTACVADFGIAR-FLEATNEQT----SSIGVKGTTGYIAPEYGMGHETSSYG 358
S+ILL+ + ++ + ++ Q +++PE + Y
Sbjct: 130 SHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEV-LQQNLQGYN 188
Query: 359 ---DVYSFGILLLEMFTGLRPSDDM 380
D+YS GI E+ G P DM
Sbjct: 189 EKSDIYSVGITACELANGHVPFKDM 213
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 6e-04
Identities = 30/82 (36%), Positives = 40/82 (48%), Gaps = 3/82 (3%)
Query: 3 GNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKF-LQNLNLSHNNFESMIPTE 61
G G I ++ L ++ ++LS N LSG IP+ + L+ LNLS+NNF IP
Sbjct: 78 GKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRG 137
Query: 62 GIFKNASATSVFGNNKLCGGIP 83
I T NN L G IP
Sbjct: 138 SIP--NLETLDLSNNMLSGEIP 157
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 6e-04
Identities = 30/82 (36%), Positives = 38/82 (46%), Gaps = 6/82 (7%)
Query: 4 NLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGI 63
N F G I P L+ LDLS N LSGEIP + F L+ L+L N IP
Sbjct: 128 NNFTGSIPRGSIP--NLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIP--NS 183
Query: 64 FKNASATSVF--GNNKLCGGIP 83
N ++ +N+L G IP
Sbjct: 184 LTNLTSLEFLTLASNQLVGQIP 205
|
Length = 968 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 6e-04
Identities = 39/158 (24%), Positives = 66/158 (41%), Gaps = 43/158 (27%)
Query: 239 LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAH 298
LV+E++ + L++++ D + PG + + +++ K +AH
Sbjct: 83 LVFEYL-DSDLKKFM------DSNGRGPGR---------PLPAKTIKSFMYQLLKG-VAH 125
Query: 299 C--------DIKPSNILLNDEMTAC-VADFGIARFLEATNEQTSSIGVKGTTG------Y 343
C D+KP N+L++ + +AD G+ R SI VK T Y
Sbjct: 126 CHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAF--------SIPVKSYTHEIVTLWY 177
Query: 344 IAPEYGMGHET-SSYGDVYSFGILLLEMFTG--LRPSD 378
APE +G S+ D++S G + EM L P D
Sbjct: 178 RAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGD 215
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 6e-04
Identities = 32/87 (36%), Positives = 44/87 (50%), Gaps = 7/87 (8%)
Query: 296 IAHCDIKPSNILLNDEMTACVADFGIAR-FLEATNEQTSSIGVKGTTGYIAPEYGMGHET 354
+ H D+KP N+L+N E +ADFG+AR F T + T Y APE +G +
Sbjct: 121 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV---VTLWYRAPEILLGCKY 177
Query: 355 SSYG-DVYSFGILLLEMFT--GLRPSD 378
S D++S G + EM T L P D
Sbjct: 178 YSTAVDIWSLGCIFAEMVTRRALFPGD 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 6e-04
Identities = 61/233 (26%), Positives = 94/233 (40%), Gaps = 44/233 (18%)
Query: 168 IGAGNFASVYKGIL------------FEGAPAVAIKVFNFLHHDASKSFTVECEVMRNII 215
+G G +Y GIL +E V +KV + H D S +F +MR +
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 216 HRKIIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERL 275
H+ I+ + C R N +V EF+ G L+ ++H ++ L + +
Sbjct: 63 HKHIVLLYGVCVR--DVEN---IMVEEFVEFGPLDLFMHRKSDV---------LTTPWKF 108
Query: 276 NIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEM--TAC-----VADFGIARFLEAT 328
+A +ASAL YL + H ++ NILL E C ++D GI + +
Sbjct: 109 KVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR 165
Query: 329 NEQTSSIGVKGTTGYIAPE-YGMGHETSSYGDVYSFGILLLEM-FTGLRPSDD 379
E I +IAPE S D +SFG L E+ + G P D
Sbjct: 166 QECVERI------PWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKD 212
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 7e-04
Identities = 27/95 (28%), Positives = 45/95 (47%), Gaps = 3/95 (3%)
Query: 278 AIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGV 337
+ VA +E+L H D+ NILL++ + DFG+AR + +
Sbjct: 185 SFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241
Query: 338 KGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT 372
+ ++APE + DV+SFG+LL E+F+
Sbjct: 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 7e-04
Identities = 61/232 (26%), Positives = 103/232 (44%), Gaps = 44/232 (18%)
Query: 153 EALYSATKGFSSENLIGAGN---FASVYKGILFEGAPAVAIKVFN--FLHHDASKSFTVE 207
++ ++ K + + IG+G + Y +L VAIK + F + +K E
Sbjct: 10 DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRE 66
Query: 208 CEVMRNIIHRKIIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEW--IHPITEEDKRHKA 265
+M+ + H+ II +L+ F P SLEE+ ++ + E
Sbjct: 67 LVLMKCVNHKNII-----------------SLLNVFTPQKSLEEFQDVYLVME-----LM 104
Query: 266 PGNLNSLERLNIAIDVASALEYLHL-GCK----PPIAHCDIKPSNILLNDEMTACVADFG 320
NL + ++ + + S L Y L G K I H D+KPSNI++ + T + DFG
Sbjct: 105 DANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG 164
Query: 321 IARFLEATNEQTSSIGVKGTTGYIAPE--YGMGHETSSYGDVYSFGILLLEM 370
+AR + T + T Y APE GMG++ + D++S G ++ EM
Sbjct: 165 LARTAGTSFMMTPYV---VTRYYRAPEVILGMGYKENV--DIWSVGCIMGEM 211
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 8e-04
Identities = 26/94 (27%), Positives = 49/94 (52%), Gaps = 10/94 (10%)
Query: 285 LEYLHLGCKPPIAHCDIKPSNILLN-DEMTACVADFGIARFLEATNEQTS--SIGVKGTT 341
L+Y+H + H D+KP+N+ +N +++ + DFG+AR ++ S G+ T
Sbjct: 127 LKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV-TK 182
Query: 342 GYIAPEYGMG--HETSSYGDVYSFGILLLEMFTG 373
Y +P + + T + D+++ G + EM TG
Sbjct: 183 WYRSPRLLLSPNNYTKAI-DMWAAGCIFAEMLTG 215
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 0.001
Identities = 40/174 (22%), Positives = 65/174 (37%), Gaps = 52/174 (29%)
Query: 239 LVYEFMPNGSLEEWI---HPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPP 295
L+ EF+P G + + +TEE+ + + +AID L ++H
Sbjct: 78 LIMEFLPGGDMMTLLMKKDTLTEEETQF-------YIAETVLAIDSIHQLGFIHR----- 125
Query: 296 IAHCDIKPSNILLNDEMTACVADFGIARFLEAT--------------------------- 328
DIKP N+LL+ + ++DFG+ L+
Sbjct: 126 ----DIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRK 181
Query: 329 ------NEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRP 376
N + + GT YIAPE M + D +S G+++ EM G P
Sbjct: 182 AETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 0.001
Identities = 26/86 (30%), Positives = 41/86 (47%), Gaps = 19/86 (22%)
Query: 296 IAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVK--------GTTGYIAPE 347
+ H D+KP N+L++++ +ADFG+AR + G+ T Y APE
Sbjct: 122 VLHRDLKPQNLLIDNKGVIKLADFGLAR----------AFGIPVRVYTHEVVTLWYRAPE 171
Query: 348 YGMGHETSSYG-DVYSFGILLLEMFT 372
+G S D++S G + EM T
Sbjct: 172 VLLGSPRYSTPVDIWSIGTIFAEMAT 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.002
Identities = 23/64 (35%), Positives = 29/64 (45%)
Query: 20 LKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLC 79
L+ LDLS+N SG +P L L L LS N IP E + +N+L
Sbjct: 477 LENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLS 536
Query: 80 GGIP 83
G IP
Sbjct: 537 GQIP 540
|
Length = 968 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.002
Identities = 27/84 (32%), Positives = 40/84 (47%), Gaps = 7/84 (8%)
Query: 296 IAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMG---H 352
+ H D+KP N+L+N +ADFG+AR S+ V T Y P+ G +
Sbjct: 120 VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV--TLWYRPPDVLFGAKLY 177
Query: 353 ETSSYGDVYSFGILLLEMFTGLRP 376
TS D++S G + E+ RP
Sbjct: 178 STSI--DMWSAGCIFAELANAGRP 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.002
Identities = 28/102 (27%), Positives = 46/102 (45%), Gaps = 5/102 (4%)
Query: 275 LNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSS 334
L + + ++++H + + H DIK NI L + DFG AR L T+ +
Sbjct: 103 LQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLL--TSPGAYA 157
Query: 335 IGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRP 376
GT Y+ PE ++ D++S G +L E+ T P
Sbjct: 158 CTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.002
Identities = 35/108 (32%), Positives = 55/108 (50%), Gaps = 11/108 (10%)
Query: 269 LNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEAT 328
L++ + L+ + VA + +L K I H D+ NILL + DFG+AR +
Sbjct: 211 LDTEDLLSFSYQVAKGMSFL--ASKNCI-HRDLAARNILLTHGRITKICDFGLAR--DIR 265
Query: 329 NEQTSSIGVKGTT----GYIAPEYGMGHETSSYGDVYSFGILLLEMFT 372
N+ S+ VKG ++APE + DV+S+GILL E+F+
Sbjct: 266 ND--SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.003
Identities = 61/270 (22%), Positives = 114/270 (42%), Gaps = 30/270 (11%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACS 227
+G G + VYK +G + S S E ++R + H +I A
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVI----ALQ 64
Query: 228 RVDYQGNDFKA-LVYEFMPNGSLEEW-IHPITEEDKRHKAPGNLNSLERLNIAIDVASAL 285
+V +D K L++++ + + W I K +K P L ++ + +
Sbjct: 65 KVFLSHSDRKVWLLFDYAEH---DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGI 121
Query: 286 EYLHLGCKPPIAHCDIKPSNILLNDEMT----ACVADFGIARFLEATNEQTSSIG-VKGT 340
YLH + H D+KP+NIL+ E +AD G AR + + + + V T
Sbjct: 122 HYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVT 178
Query: 341 TGYIAPEYGMG--HETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALP-- 396
Y APE +G H T + D+++ G + E+ T S+ +F Q ++++ P
Sbjct: 179 FWYRAPELLLGARHYTKAI-DIWAIGCIFAELLT----SEPIFHCR---QEDIKTSNPFH 230
Query: 397 -ERVEEIVDTLFFKEIEEEETVYKYKKAPS 425
++++ I + F ++ E + K + P+
Sbjct: 231 HDQLDRIFSVMGFPADKDWEDIRKMPEYPT 260
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 38.9 bits (91), Expect = 0.003
Identities = 31/134 (23%), Positives = 54/134 (40%), Gaps = 28/134 (20%)
Query: 196 LHHDASKSFTVECEV-MRNIIHRKIIKV--VTACSRVDYQGNDFKALVYEFMPNGSLEEW 252
++ K E EV + ++ RK + V V A D L+ E++ +L+E
Sbjct: 28 INPSREKGADREREVAILQLLARKGLPVPKVLASGESDGWS----YLLMEWIEGETLDE- 82
Query: 253 IHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIA--HCDIKPSNILLND 310
++ E+ +IA +A L LH P + H D+ P NIL++D
Sbjct: 83 ----------------VSEEEKEDIAEQLAELLAKLHQ--LPLLVLCHGDLHPGNILVDD 124
Query: 311 EMTACVADFGIARF 324
+ D+ A +
Sbjct: 125 GKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.003
Identities = 37/149 (24%), Positives = 65/149 (43%), Gaps = 13/149 (8%)
Query: 230 DYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLH 289
D++ +D L+ E+ G L + I +R K E + + AL+ +H
Sbjct: 133 DFKSDDKLLLIMEYGSGGDLNKQI------KQRLKEHLPFQEYEVGLLFYQIVLALDEVH 186
Query: 290 LGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVK--GTTGYIAPE 347
+ H D+K +NI L + DFG ++ + ++ + + GT Y+APE
Sbjct: 187 SRK---MMHRDLKSANIFLMPTGIIKLGDFGFSK--QYSDSVSLDVASSFCGTPYYLAPE 241
Query: 348 YGMGHETSSYGDVYSFGILLLEMFTGLRP 376
S D++S G++L E+ T RP
Sbjct: 242 LWERKRYSKKADMWSLGVILYELLTLHRP 270
|
Length = 478 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.003
Identities = 39/174 (22%), Positives = 64/174 (36%), Gaps = 52/174 (29%)
Query: 239 LVYEFMPNGSLEEWI---HPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPP 295
L+ EF+P G + + ++EE + + +AID L ++H
Sbjct: 78 LIMEFLPGGDMMTLLMKKDTLSEEATQF-------YIAETVLAIDAIHQLGFIHR----- 125
Query: 296 IAHCDIKPSNILLNDEMTACVADFGIARFLEAT--------------------------- 328
DIKP N+LL+ + ++DFG+ L+
Sbjct: 126 ----DIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRK 181
Query: 329 ------NEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRP 376
N + + GT YIAPE M + D +S G+++ EM G P
Sbjct: 182 AETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.003
Identities = 35/121 (28%), Positives = 52/121 (42%), Gaps = 17/121 (14%)
Query: 278 AIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEAT--NEQTSSI 335
A ++ AL+ LH + I D+ P+NILL+D + F +E + E ++
Sbjct: 91 AAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM 147
Query: 336 GVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGL-----RPSDDMFKDNLNLQNW 390
Y APE G E + D +S G +L E+ TG PS LN+ W
Sbjct: 148 -------YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGINTHTTLNIPEW 200
Query: 391 V 391
V
Sbjct: 201 V 201
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 873 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.98 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.98 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.98 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.98 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.98 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.98 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.98 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.98 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.98 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.98 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.97 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.96 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.96 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.96 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.96 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.96 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.94 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.94 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.92 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.92 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.92 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.92 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.91 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.9 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.89 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.87 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.85 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.84 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.8 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.79 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.79 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.78 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.78 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.78 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.76 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.76 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.72 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.71 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.71 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.7 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.7 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.68 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.65 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.65 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.64 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.61 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.61 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.59 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.59 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.54 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.52 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.46 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.38 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.34 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.26 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.22 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.14 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.11 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.08 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.06 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.05 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 98.94 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.94 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.91 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.89 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.86 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.82 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 98.81 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.76 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.73 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.69 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.68 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.48 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 98.48 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.42 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.34 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 98.33 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.23 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.08 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.04 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.04 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.02 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.96 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.96 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.9 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 97.89 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.84 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.8 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 97.78 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.77 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.71 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.61 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.6 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.51 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 97.49 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 97.49 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.46 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.4 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.31 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.29 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.28 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.22 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.17 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 97.15 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 97.15 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 97.1 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 97.05 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 97.03 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 97.01 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 96.95 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.93 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.81 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 96.81 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 96.78 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 96.73 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 96.72 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.63 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 96.44 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 96.43 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-51 Score=460.62 Aligned_cols=287 Identities=38% Similarity=0.638 Sum_probs=243.0
Q ss_pred CCCccCHHHHHHhhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeee
Q 002857 146 DFPYVSYEALYSATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTA 225 (873)
Q Consensus 146 ~~~~~s~~el~~at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~ 225 (873)
....|++++|..||++|+..++||+|+||.||+|... +++.||||++........++|.+|+++|++++|||+|+|+||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGy 139 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGY 139 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEE
Confidence 4667999999999999999999999999999999884 448999998875443314669999999999999999999999
Q ss_pred eecccccCCc-eEEEEEeecCCCChhhhcccccccccccCCCC-CCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCC
Q 002857 226 CSRVDYQGND-FKALVYEFMPNGSLEEWIHPITEEDKRHKAPG-NLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKP 303 (873)
Q Consensus 226 c~~~~~~~~~-~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~-~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKp 303 (873)
|.+ .+ +.+||||||++|+|.++|+. ... .++|.+|++||.++|+||+|||+.+.++|||||||+
T Consensus 140 C~e-----~~~~~~LVYEym~nGsL~d~L~~---------~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKs 205 (361)
T KOG1187|consen 140 CLE-----GGEHRLLVYEYMPNGSLEDHLHG---------KKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKS 205 (361)
T ss_pred Eec-----CCceEEEEEEccCCCCHHHHhCC---------CCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCH
Confidence 953 33 69999999999999999975 122 889999999999999999999998888999999999
Q ss_pred CCeeeCCCCCeEEecccccccccccccccccccc-ccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCccc-
Q 002857 304 SNILLNDEMTACVADFGIARFLEATNEQTSSIGV-KGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMF- 381 (873)
Q Consensus 304 sNILLd~~~~vKLsDFGla~~~~~~~~~~~~~~~-~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~- 381 (873)
+|||||+++++||+|||+|+..... ....... .||.+|+|||++..+..+.|+|||||||+|+||+||+.+.+...
T Consensus 206 sNILLD~~~~aKlsDFGLa~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~ 283 (361)
T KOG1187|consen 206 SNILLDEDFNAKLSDFGLAKLGPEG--DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRP 283 (361)
T ss_pred HHeeECCCCCEEccCccCcccCCcc--ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCC
Confidence 9999999999999999999765431 1111111 79999999999999999999999999999999999999987643
Q ss_pred ccchhhHHHHhhcCch-hHHHHhhhhhh-hhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHH
Q 002857 382 KDNLNLQNWVQSALPE-RVEEIVDTLFF-KEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKIN 459 (873)
Q Consensus 382 ~~~~~l~~~~~~~~~~-~l~elid~~L~-~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~ 459 (873)
.....+..|++..+.. .+.+++|+.+. ..+.. .+.+.++..++.+|++.+|++||+|.
T Consensus 284 ~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~--------------------~~~~~~~~~~a~~C~~~~~~~RP~m~ 343 (361)
T KOG1187|consen 284 RGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPD--------------------EKEVKKLAELALRCLRPDPKERPTMS 343 (361)
T ss_pred cccccHHHHHHHHHHCcchhheeCCCccCCCCCh--------------------HHHHHHHHHHHHHHcCcCCCcCcCHH
Confidence 3445688888777766 79999999886 32210 02356699999999999999999999
Q ss_pred HHHHHHHHHH
Q 002857 460 DVELGLRLIK 469 (873)
Q Consensus 460 EVl~~Le~i~ 469 (873)
||+++|+.+.
T Consensus 344 ~Vv~~L~~~~ 353 (361)
T KOG1187|consen 344 QVVKELEGIL 353 (361)
T ss_pred HHHHHHHhhc
Confidence 9999996653
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-49 Score=497.90 Aligned_cols=417 Identities=23% Similarity=0.360 Sum_probs=296.2
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCG 80 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G 80 (873)
|++|+++|.+|.++++|++|++|+|++|+|+|.+|..|..|++|+.|+|++|+|+|.+|..+.....+..+.+++|.+.|
T Consensus 506 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~ 585 (968)
T PLN00113 506 LSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHG 585 (968)
T ss_pred CcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCccee
Confidence 57899999999999999999999999999999999999999999999999999999999888777888888888888888
Q ss_pred CCCccccC-------------ccccccc------ccccCCCccceeehhhcchhhhhhhhhhhhhhhhhccccCCCCCCc
Q 002857 81 GIPEFQLP-------------TCVSKKT------KQNRSTLPLKLVIAIDCGLLVLTLALSSLFCRLMCMKKRGNPTPSI 141 (873)
Q Consensus 81 ~~p~~~~P-------------~~~~~~~------~~~~s~l~~~ivIai~~g~vv~~l~l~~l~~~~~~~~k~~~~~~~~ 141 (873)
.+|..... .|..... ...+......++++++++++++++++++ ++ +++.+++.......
T Consensus 586 ~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~ 663 (968)
T PLN00113 586 SLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLALVAF-GF-VFIRGRNNLELKRV 663 (968)
T ss_pred eCCCcchhcccChhhhcCCccccCCccccCCCCCccccccceeeeehhHHHHHHHHHHHHHH-HH-HHHHhhhccccccc
Confidence 76643110 0110000 0000111112222222222222222111 11 11121111111110
Q ss_pred c-----cC------CCCCccCHHHHHHhhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHH
Q 002857 142 S-----ID------LDFPYVSYEALYSATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEV 210 (873)
Q Consensus 142 ~-----~~------~~~~~~s~~el~~at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~i 210 (873)
. .. .....++++++. ..|...++||+|+||.||+|++..++..||||.++.... ....|+++
T Consensus 664 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~ 736 (968)
T PLN00113 664 ENEDGTWELQFFDSKVSKSITINDIL---SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS----IPSSEIAD 736 (968)
T ss_pred ccccccccccccccccchhhhHHHHH---hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc----ccHHHHHH
Confidence 0 00 001223444443 457788999999999999999988899999999864322 22456889
Q ss_pred HHhhhhccceeeeeeeecccccCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhh
Q 002857 211 MRNIIHRKIIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHL 290 (873)
Q Consensus 211 L~~L~HpNIV~llg~c~~~~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~ 290 (873)
+++++|||||+++|+|. .....++||||+++|+|.++++ .++|.++..|+.|||+||+|||+
T Consensus 737 l~~l~HpnIv~~~~~~~-----~~~~~~lv~Ey~~~g~L~~~l~-------------~l~~~~~~~i~~~ia~~L~yLH~ 798 (968)
T PLN00113 737 MGKLQHPNIVKLIGLCR-----SEKGAYLIHEYIEGKNLSEVLR-------------NLSWERRRKIAIGIAKALRFLHC 798 (968)
T ss_pred HhhCCCCCcceEEEEEE-----cCCCCEEEEeCCCCCcHHHHHh-------------cCCHHHHHHHHHHHHHHHHHhcc
Confidence 99999999999999974 3456899999999999999983 27899999999999999999997
Q ss_pred CCCCCeeeccCCCCCeeeCCCCCeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHH
Q 002857 291 GCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEM 370 (873)
Q Consensus 291 ~~s~gIvHrDLKpsNILLd~~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~EL 370 (873)
.++++|+||||||+||+++.++.+++. ||.+...... ....+|..|+|||++.+..++.++|||||||++|||
T Consensus 799 ~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el 871 (968)
T PLN00113 799 RCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIEL 871 (968)
T ss_pred CCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC------CCccccccccCcccccCCCCCcccchhhHHHHHHHH
Confidence 777899999999999999999988876 6655432211 123578999999999999999999999999999999
Q ss_pred HhCCCCCCcccccchhhHHHHhhcCch-hHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhc
Q 002857 371 FTGLRPSDDMFKDNLNLQNWVQSALPE-RVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSA 449 (873)
Q Consensus 371 lTGk~Pf~~~~~~~~~l~~~~~~~~~~-~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~ 449 (873)
+||+.||+........+..|+...... ....++|+.+..... ...+...++.+++.+||+
T Consensus 872 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~l~~~Cl~ 932 (968)
T PLN00113 872 LTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVS-------------------VNQNEIVEVMNLALHCTA 932 (968)
T ss_pred HhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCC-------------------ccHHHHHHHHHHHHhhCc
Confidence 999999976444444555665543332 333444443322110 011224468899999999
Q ss_pred cCcCCCCCHHHHHHHHHHHHH
Q 002857 450 ELPGERMKINDVELGLRLIKK 470 (873)
Q Consensus 450 ~dP~eRPTm~EVl~~Le~i~~ 470 (873)
.+|++||||.||+++|+.+..
T Consensus 933 ~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 933 TDPTARPCANDVLKTLESASR 953 (968)
T ss_pred CCchhCcCHHHHHHHHHHhhc
Confidence 999999999999999998754
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-44 Score=399.29 Aligned_cols=259 Identities=32% Similarity=0.468 Sum_probs=207.4
Q ss_pred CcceeecccCceEEEEEEEcCCCcE-EEEEEeeccCCcc--hhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEE
Q 002857 163 SSENLIGAGNFASVYKGILFEGAPA-VAIKVFNFLHHDA--SKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKAL 239 (873)
Q Consensus 163 ~~~~~LG~G~fG~VYkg~~~~~g~~-VAVK~l~~~~~~~--~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~L 239 (873)
...+.||.|+||+||+|.+ .|+. ||||++....... .+.|.+|+.+|.+++|||||+++|+|... ....+|
T Consensus 44 ~~~~~iG~G~~g~V~~~~~--~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~----~~~~~i 117 (362)
T KOG0192|consen 44 PIEEVLGSGSFGTVYKGKW--RGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSP----PGSLCI 117 (362)
T ss_pred hhhhhcccCCceeEEEEEe--CCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC----CCceEE
Confidence 3446699999999999998 3445 9999997543332 45899999999999999999999998532 226899
Q ss_pred EEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCC-eeeccCCCCCeeeCCCC-CeEEe
Q 002857 240 VYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPP-IAHCDIKPSNILLNDEM-TACVA 317 (873)
Q Consensus 240 V~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~g-IvHrDLKpsNILLd~~~-~vKLs 317 (873)
|||||++|+|.++|+. .....+++..++.|+.|||+||.||| +.+ |||||||++|||++.++ ++||+
T Consensus 118 VtEy~~~GsL~~~l~~--------~~~~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~KI~ 186 (362)
T KOG0192|consen 118 VTEYMPGGSLSVLLHK--------KRKRKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLKIA 186 (362)
T ss_pred EEEeCCCCcHHHHHhh--------cccCCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEEEC
Confidence 9999999999999964 14678999999999999999999999 777 99999999999999997 99999
Q ss_pred ccccccccccccccccccccccccccCCCcccC--CCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcC
Q 002857 318 DFGIARFLEATNEQTSSIGVKGTTGYIAPEYGM--GHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSAL 395 (873)
Q Consensus 318 DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~--~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~ 395 (873)
|||+++...... .......||..|||||++. ...|+.|+|||||||+||||+||+.||....... ..
T Consensus 187 DFGlsr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~--~~------- 255 (362)
T KOG0192|consen 187 DFGLSREKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQ--VA------- 255 (362)
T ss_pred CCccceeecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHH--HH-------
Confidence 999998764322 2233367999999999999 5699999999999999999999999998743311 00
Q ss_pred chhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHHHHhhhc
Q 002857 396 PERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLIKKKLLE 474 (873)
Q Consensus 396 ~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i~~~l~~ 474 (873)
..++..... |.. ..++...+..++.+||+.||+.||++.+|+.+|+.+......
T Consensus 256 ----~~v~~~~~R---------------p~~------p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 256 ----SAVVVGGLR---------------PPI------PKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred ----HHHHhcCCC---------------CCC------CccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 011100000 000 011455688999999999999999999999999999876654
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-43 Score=374.92 Aligned_cols=259 Identities=26% Similarity=0.309 Sum_probs=210.4
Q ss_pred ccCHHHHHHhhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCC-cchhHHHHHHHHHHhhhhccceeeeeeee
Q 002857 149 YVSYEALYSATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH-DASKSFTVECEVMRNIIHRKIIKVVTACS 227 (873)
Q Consensus 149 ~~s~~el~~at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~c~ 227 (873)
.+++.+|+ ..+.||+|..|+||+++++.+++.+|+|++..... ...+++.+|++++++.+||+||+++|.|.
T Consensus 75 ~i~~~dle-------~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~ 147 (364)
T KOG0581|consen 75 GISLSDLE-------RLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFY 147 (364)
T ss_pred ccCHHHhh-------hhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEE
Confidence 35556664 45899999999999999999999999999964433 34578999999999999999999999963
Q ss_pred cccccCCc-eEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCe
Q 002857 228 RVDYQGND-FKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNI 306 (873)
Q Consensus 228 ~~~~~~~~-~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNI 306 (873)
.+. ...|+||||++|||++++. ..+.+++...-+|+.+|++||.|||+ .++||||||||+||
T Consensus 148 -----~~~~~isI~mEYMDgGSLd~~~k----------~~g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNl 210 (364)
T KOG0581|consen 148 -----SNGEEISICMEYMDGGSLDDILK----------RVGRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNL 210 (364)
T ss_pred -----eCCceEEeehhhcCCCCHHHHHh----------hcCCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHe
Confidence 344 6999999999999999994 34679999999999999999999994 48999999999999
Q ss_pred eeCCCCCeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchh
Q 002857 307 LLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLN 386 (873)
Q Consensus 307 LLd~~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~ 386 (873)
|++..|.+||+|||.++.+... .....+||..|||||.+.+..|+.++||||||++++|+++|+.||.......
T Consensus 211 LvNskGeVKicDFGVS~~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~-- 284 (364)
T KOG0581|consen 211 LVNSKGEVKICDFGVSGILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPY-- 284 (364)
T ss_pred eeccCCCEEeccccccHHhhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCC--
Confidence 9999999999999999977543 3345679999999999999999999999999999999999999997631111
Q ss_pred hHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHH
Q 002857 387 LQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELG 464 (873)
Q Consensus 387 l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~ 464 (873)
....++++......+ |..+.. .+..++..++..||+.||.+||++.|+++.
T Consensus 285 ----------~~~~~Ll~~Iv~~pp------------P~lP~~-----~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 285 ----------LDIFELLCAIVDEPP------------PRLPEG-----EFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred ----------CCHHHHHHHHhcCCC------------CCCCcc-----cCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 122333333332221 111110 234468999999999999999999998753
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=388.08 Aligned_cols=254 Identities=29% Similarity=0.468 Sum_probs=207.7
Q ss_pred CcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEEEEe
Q 002857 163 SSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKALVYE 242 (873)
Q Consensus 163 ~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~LV~E 242 (873)
...+.||+|.||.||.|.+. +...||+|.++... ...+.|.+|+++|++|+|+|||+++|+|.. ++.++||||
T Consensus 209 ~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~-----~~piyIVtE 281 (468)
T KOG0197|consen 209 KLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTK-----QEPIYIVTE 281 (468)
T ss_pred HHHHHhcCCccceEEEEEEc-CCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEec-----CCceEEEEE
Confidence 45689999999999999984 44589999998653 334789999999999999999999999842 346899999
Q ss_pred ecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEeccccc
Q 002857 243 FMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIA 322 (873)
Q Consensus 243 y~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDFGla 322 (873)
||+.|+|.++|+. .....+...+.+.++.|||+||+||+ ++++|||||.++||||+++..+||+|||+|
T Consensus 282 ~m~~GsLl~yLr~--------~~~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLA 350 (468)
T KOG0197|consen 282 YMPKGSLLDYLRT--------REGGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLA 350 (468)
T ss_pred ecccCcHHHHhhh--------cCCCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEcccccc
Confidence 9999999999963 35677889999999999999999999 999999999999999999999999999999
Q ss_pred cccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHHHhhcCchhHHH
Q 002857 323 RFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQSALPERVEE 401 (873)
Q Consensus 323 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~~~~~~~~~l~e 401 (873)
+.... +.........-++.|.|||.+..+.++.|||||||||+||||+| |+.||..+...+ +.+
T Consensus 351 r~~~d-~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e--------------v~~ 415 (468)
T KOG0197|consen 351 RLIGD-DEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE--------------VLE 415 (468)
T ss_pred cccCC-CceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH--------------HHH
Confidence 95433 23333334446789999999999999999999999999999999 999987643221 111
Q ss_pred HhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHHHH
Q 002857 402 IVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLIKK 470 (873)
Q Consensus 402 lid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i~~ 470 (873)
.++.-.. .| .+..|+..+.+|+..||+.+|++|||+..+...|+.+..
T Consensus 416 ~le~GyR--------------lp-------~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 416 LLERGYR--------------LP-------RPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred HHhccCc--------------CC-------CCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 1111100 01 123467789999999999999999999999999887754
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=371.06 Aligned_cols=201 Identities=31% Similarity=0.518 Sum_probs=179.8
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeecc--CCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCce
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFL--HHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDF 236 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~ 236 (873)
..+|...+.||+|+||+||+|+++.++..||||.+... .....+.+..|+++|+.++|||||++++++ ..++.
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~-----~~~~~ 83 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCI-----EDDDF 83 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEE-----ecCCe
Confidence 45788889999999999999999999999999998754 444556789999999999999999999996 55678
Q ss_pred EEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCC-----
Q 002857 237 KALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDE----- 311 (873)
Q Consensus 237 ~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~----- 311 (873)
.+||||||.||+|.+||+ ..+.+++.....++.|||.||++|| +++||||||||.||||+..
T Consensus 84 i~lVMEyC~gGDLs~yi~----------~~~~l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~ 150 (429)
T KOG0595|consen 84 IYLVMEYCNGGDLSDYIR----------RRGRLPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDT 150 (429)
T ss_pred EEEEEEeCCCCCHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCC
Confidence 999999999999999995 3457999999999999999999999 9999999999999999764
Q ss_pred -CCeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcc
Q 002857 312 -MTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDM 380 (873)
Q Consensus 312 -~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~ 380 (873)
-.+||+|||+|+.+... .......|++.|||||+++.++|+.|+|+||+|+|||++++|+.||+..
T Consensus 151 ~~~LKIADFGfAR~L~~~---~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~ 217 (429)
T KOG0595|consen 151 SPVLKIADFGFARFLQPG---SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE 217 (429)
T ss_pred CceEEecccchhhhCCch---hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 46899999999988643 3334567999999999999999999999999999999999999999864
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=380.06 Aligned_cols=248 Identities=26% Similarity=0.370 Sum_probs=210.1
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeec---cCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCce
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNF---LHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDF 236 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~---~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~ 236 (873)
..|...++||+|||+.+|++++..+|+.||+|++.. ......+.+.+||+|.+.|+|||||+++++ |++.+.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~-----FEDs~n 92 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHF-----FEDSNN 92 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeE-----eecCCc
Confidence 568999999999999999999999999999999964 234455789999999999999999999999 477889
Q ss_pred EEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEE
Q 002857 237 KALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACV 316 (873)
Q Consensus 237 ~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKL 316 (873)
.|||.|+|++++|..+++ ..+.+++.++..++.||+.||.||| +.+|+|||||..|+||++++++||
T Consensus 93 VYivLELC~~~sL~el~K----------rrk~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKI 159 (592)
T KOG0575|consen 93 VYIVLELCHRGSLMELLK----------RRKPLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKI 159 (592)
T ss_pred eEEEEEecCCccHHHHHH----------hcCCCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEe
Confidence 999999999999999983 5678999999999999999999999 899999999999999999999999
Q ss_pred eccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCc
Q 002857 317 ADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALP 396 (873)
Q Consensus 317 sDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~ 396 (873)
+|||+|..+..... ......||+.|+|||++.....+..+||||+|||||-||+|++||+..
T Consensus 160 gDFGLAt~le~~~E--rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk---------------- 221 (592)
T KOG0575|consen 160 GDFGLATQLEYDGE--RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK---------------- 221 (592)
T ss_pred cccceeeeecCccc--ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc----------------
Confidence 99999998765432 233468999999999999999999999999999999999999999862
Q ss_pred hhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 397 ERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 397 ~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
.+.+..+..-..++. .|. ....+..+|+.++|+.||.+|||+.+|+.
T Consensus 222 -~vkety~~Ik~~~Y~----------~P~---------~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 222 -TVKETYNKIKLNEYS----------MPS---------HLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred -hHHHHHHHHHhcCcc----------ccc---------ccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 233333333222221 011 01123668999999999999999999875
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=395.11 Aligned_cols=267 Identities=22% Similarity=0.417 Sum_probs=217.7
Q ss_pred CCCcceeecccCceEEEEEEEcC-----CCcEEEEEEeeccCCc-chhHHHHHHHHHHhhhhccceeeeeeeecccccCC
Q 002857 161 GFSSENLIGAGNFASVYKGILFE-----GAPAVAIKVFNFLHHD-ASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGN 234 (873)
Q Consensus 161 ~f~~~~~LG~G~fG~VYkg~~~~-----~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~ 234 (873)
+....+.||+|.||+||+|+... ....||||.++..... ...+|++|+++|..|+|||||+|+|.|. .+
T Consensus 487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~-----~~ 561 (774)
T KOG1026|consen 487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCR-----EG 561 (774)
T ss_pred heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEc-----cC
Confidence 44556889999999999998643 3457999999876655 6689999999999999999999999994 46
Q ss_pred ceEEEEEeecCCCChhhhcccccccccccC----CCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCC
Q 002857 235 DFKALVYEFMPNGSLEEWIHPITEEDKRHK----APGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLND 310 (873)
Q Consensus 235 ~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~----~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~ 310 (873)
+.+++|+|||..|||.+||........... ....|+..+.+.||.|||.||.||- ++.+|||||..+|+||.+
T Consensus 562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVge 638 (774)
T KOG1026|consen 562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVGE 638 (774)
T ss_pred CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceecc
Confidence 679999999999999999975433222111 1455999999999999999999999 899999999999999999
Q ss_pred CCCeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHH
Q 002857 311 EMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQN 389 (873)
Q Consensus 311 ~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~ 389 (873)
+..+||+|||+++.....+.........-.++|||||.++.+++|++||||||||+|||++| |+.||.+..+++.
T Consensus 639 ~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EV---- 714 (774)
T KOG1026|consen 639 NLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEV---- 714 (774)
T ss_pred ceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHH----
Confidence 99999999999997765554443334456889999999999999999999999999999999 9999877543321
Q ss_pred HHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHHH
Q 002857 390 WVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLIK 469 (873)
Q Consensus 390 ~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i~ 469 (873)
+..+-+..+. ..++.|+.++..|+..||+.+|++||+++||-..|+...
T Consensus 715 ---------Ie~i~~g~lL----------------------~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~ 763 (774)
T KOG1026|consen 715 ---------IECIRAGQLL----------------------SCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWA 763 (774)
T ss_pred ---------HHHHHcCCcc----------------------cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHH
Confidence 1111111111 123457888999999999999999999999999999864
Q ss_pred H
Q 002857 470 K 470 (873)
Q Consensus 470 ~ 470 (873)
.
T Consensus 764 ~ 764 (774)
T KOG1026|consen 764 Q 764 (774)
T ss_pred h
Confidence 3
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=359.72 Aligned_cols=253 Identities=23% Similarity=0.301 Sum_probs=199.6
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCc-------chhHHHHHHHHHHhhhhccceeeeeeeecccc
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHD-------ASKSFTVECEVMRNIIHRKIIKVVTACSRVDY 231 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~-------~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~ 231 (873)
.+.|.+.+.||+|+||.|-+|..+.+++.||||+++..... ......+|+++|++|+|||||++++++
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f----- 245 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFF----- 245 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeee-----
Confidence 34577889999999999999999999999999999743211 223467999999999999999999995
Q ss_pred cCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCC
Q 002857 232 QGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDE 311 (873)
Q Consensus 232 ~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~ 311 (873)
...+..|+||||++||+|.+++- ..+.+.+..-..++.|++.|+.||| ++||+||||||+|||+..+
T Consensus 246 ~~~ds~YmVlE~v~GGeLfd~vv----------~nk~l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~ 312 (475)
T KOG0615|consen 246 EVPDSSYMVLEYVEGGELFDKVV----------ANKYLREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSND 312 (475)
T ss_pred ecCCceEEEEEEecCccHHHHHH----------hccccccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccC
Confidence 56677899999999999999983 3566777788999999999999999 9999999999999999755
Q ss_pred ---CCeEEeccccccccccccccccccccccccccCCCcccCCCCC---CcchhhHhHHHHHHHHHhCCCCCCcccccch
Q 002857 312 ---MTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHET---SSYGDVYSFGILLLEMFTGLRPSDDMFKDNL 385 (873)
Q Consensus 312 ---~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~---s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~ 385 (873)
..+||+|||+|+.... ........||+.|.|||++.+..+ ..+.|+||+|||||-+++|.+||.+...+..
T Consensus 313 ~e~~llKItDFGlAK~~g~---~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s 389 (475)
T KOG0615|consen 313 AEDCLLKITDFGLAKVSGE---GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS 389 (475)
T ss_pred CcceEEEecccchhhcccc---ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc
Confidence 7899999999998753 233445689999999999987643 3478999999999999999999987433321
Q ss_pred hhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 386 NLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 386 ~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
+. ..+....+.-. +.. ..+..++..+++.+||..||++|||+.|+++
T Consensus 390 -l~-----------eQI~~G~y~f~---------------p~~----w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 390 -LK-----------EQILKGRYAFG---------------PLQ----WDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred -HH-----------HHHhcCccccc---------------Chh----hhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 11 11111111110 001 1123446789999999999999999999865
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=350.29 Aligned_cols=260 Identities=24% Similarity=0.322 Sum_probs=205.2
Q ss_pred CCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC--CcchhHHHHHHHHHHhhhhccceeeeeeeecccccC-CceE
Q 002857 161 GFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH--HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQG-NDFK 237 (873)
Q Consensus 161 ~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~-~~~~ 237 (873)
+|.++++||+|.||.||++....++..||.|.++... .........|+.+|++|+|||||+++++- +.+ ...+
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~----f~~~~evl 95 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHS----FIEDNEVL 95 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHh----hhccchhh
Confidence 5788899999999999999999999999999987433 33446789999999999999999999852 233 3448
Q ss_pred EEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCC--eeeccCCCCCeeeCCCCCeE
Q 002857 238 ALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPP--IAHCDIKPSNILLNDEMTAC 315 (873)
Q Consensus 238 ~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~g--IvHrDLKpsNILLd~~~~vK 315 (873)
+|||||+.+|+|.+.++... +..+.+++..+|+++.|+++||.++|... +. |+||||||.||+|+.+|.+|
T Consensus 96 nivmE~c~~GDLsqmIk~~K------~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvK 168 (375)
T KOG0591|consen 96 NIVMELCDAGDLSQMIKHFK------KQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVK 168 (375)
T ss_pred HHHHHhhcccCHHHHHHHHH------hccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCcee
Confidence 99999999999999996532 34677999999999999999999999311 44 99999999999999999999
Q ss_pred EeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcC
Q 002857 316 VADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSAL 395 (873)
Q Consensus 316 LsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~ 395 (873)
|+|||+++++.... ......+||+.||+||.+....|+.||||||+||++|||..-+.||.+. ++.
T Consensus 169 LGDfGL~r~l~s~~--tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-----n~~------- 234 (375)
T KOG0591|consen 169 LGDFGLGRFLSSKT--TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-----NLL------- 234 (375)
T ss_pred eccchhHhHhcchh--HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-----cHH-------
Confidence 99999999886543 3344578999999999999999999999999999999999999999763 111
Q ss_pred chhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHH
Q 002857 396 PERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRL 467 (873)
Q Consensus 396 ~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~ 467 (873)
++....-..++. |.+ .+ -....+.+|+..|+..||+.||+...++..++.
T Consensus 235 -----~L~~KI~qgd~~-----------~~p---~~---~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 235 -----SLCKKIEQGDYP-----------PLP---DE---HYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred -----HHHHHHHcCCCC-----------CCc---HH---HhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 111111111110 000 01 112357789999999999999997555554443
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=370.68 Aligned_cols=267 Identities=24% Similarity=0.339 Sum_probs=208.3
Q ss_pred HHHHHhhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCC--cchhHHHHHHHHHHhhhhccceeeeeeeeccc
Q 002857 153 EALYSATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH--DASKSFTVECEVMRNIIHRKIIKVVTACSRVD 230 (873)
Q Consensus 153 ~el~~at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~ 230 (873)
++.....+.+.+...||+|.||+||+|.|.. .||||+++.... +..+.|.+|+.+|++-+|.||+-+.|+|..
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~-- 459 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN-- 459 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC--
Confidence 3333334455677899999999999999943 599999985543 345789999999999999999999999743
Q ss_pred ccCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCC
Q 002857 231 YQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLND 310 (873)
Q Consensus 231 ~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~ 310 (873)
+. ..||+.+|+|-+|+.+||. ....++..+.+.||.|||+||.||| .++|||||||+.||+|.+
T Consensus 460 ---p~-~AIiTqwCeGsSLY~hlHv---------~etkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~ 523 (678)
T KOG0193|consen 460 ---PP-LAIITQWCEGSSLYTHLHV---------QETKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHE 523 (678)
T ss_pred ---Cc-eeeeehhccCchhhhhccc---------hhhhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEcc
Confidence 33 4999999999999999974 3456888899999999999999999 999999999999999999
Q ss_pred CCCeEEeccccccccccccccccccccccccccCCCcccCCC---CCCcchhhHhHHHHHHHHHhCCCCCCcccccchhh
Q 002857 311 EMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGH---ETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNL 387 (873)
Q Consensus 311 ~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~---~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l 387 (873)
+++|||+|||++.....-..........|.+.|||||+++.+ +|+..+||||||+|+|||+||..||.....+.. +
T Consensus 524 ~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqI-i 602 (678)
T KOG0193|consen 524 DLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQI-I 602 (678)
T ss_pred CCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhhe-E
Confidence 999999999999654322222222234588999999998754 789999999999999999999999974222221 1
Q ss_pred HHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHH
Q 002857 388 QNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRL 467 (873)
Q Consensus 388 ~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~ 467 (873)
...-+..+..+ .......|.+++.+|+..||..++++||++.+|+.+|+.
T Consensus 603 fmVGrG~l~pd------------------------------~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~ 652 (678)
T KOG0193|consen 603 FMVGRGYLMPD------------------------------LSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEE 652 (678)
T ss_pred EEecccccCcc------------------------------chhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHH
Confidence 10000000000 011223567789999999999999999999999999988
Q ss_pred HHHh
Q 002857 468 IKKK 471 (873)
Q Consensus 468 i~~~ 471 (873)
+..+
T Consensus 653 l~~~ 656 (678)
T KOG0193|consen 653 LLPS 656 (678)
T ss_pred hhhc
Confidence 7554
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=359.40 Aligned_cols=271 Identities=23% Similarity=0.334 Sum_probs=203.9
Q ss_pred hcCCCcceeecccCceEEEEEEEc-----CCCcEEEEEEeeccCC-cchhHHHHHHHHHHhh-hhccceeeeeeeecccc
Q 002857 159 TKGFSSENLIGAGNFASVYKGILF-----EGAPAVAIKVFNFLHH-DASKSFTVECEVMRNI-IHRKIIKVVTACSRVDY 231 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~-----~~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L-~HpNIV~llg~c~~~~~ 231 (873)
.++|++.++||+|+||.||+|.+. .+++.||||+++.... ...+.+.+|+.++.++ +||||++++++|.
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~---- 81 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACT---- 81 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEec----
Confidence 467899999999999999999753 2356899999874332 2346789999999999 8999999999874
Q ss_pred cCCceEEEEEeecCCCChhhhccccccccc--------------------------------------------------
Q 002857 232 QGNDFKALVYEFMPNGSLEEWIHPITEEDK-------------------------------------------------- 261 (873)
Q Consensus 232 ~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~-------------------------------------------------- 261 (873)
..+...++||||+++|+|.+++........
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (338)
T cd05102 82 KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ 161 (338)
T ss_pred CCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence 334568999999999999999864211000
Q ss_pred --ccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEecccccccccccccccccccccc
Q 002857 262 --RHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKG 339 (873)
Q Consensus 262 --~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDFGla~~~~~~~~~~~~~~~~G 339 (873)
.......+++.+++.++.||++||+||| +.+|+||||||+|||++.++.+||+|||+++...............+
T Consensus 162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~ 238 (338)
T cd05102 162 ETDDLWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL 238 (338)
T ss_pred hccccccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCC
Confidence 0001235788899999999999999999 89999999999999999999999999999986543322222223346
Q ss_pred ccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHh
Q 002857 340 TTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQSALPERVEEIVDTLFFKEIEEEETVY 418 (873)
Q Consensus 340 t~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~ 418 (873)
+..|+|||++.+..++.++||||||+++|||++ |..||........ +.. .+.+...
T Consensus 239 ~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~-~~~-----------~~~~~~~----------- 295 (338)
T cd05102 239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE-FCQ-----------RLKDGTR----------- 295 (338)
T ss_pred CccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH-HHH-----------HHhcCCC-----------
Confidence 788999999999999999999999999999997 9999875321110 000 0000000
Q ss_pred hhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHHHH
Q 002857 419 KYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLIKK 470 (873)
Q Consensus 419 ~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i~~ 470 (873)
...|. .+...+.+|+.+||+.||++|||+.||+++|+.+..
T Consensus 296 --~~~~~---------~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 296 --MRAPE---------NATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred --CCCCC---------CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 00000 112357889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=380.46 Aligned_cols=270 Identities=26% Similarity=0.437 Sum_probs=218.2
Q ss_pred ccCHHHHHHhhcC---------CCcceeecccCceEEEEEEEcCCC---cEEEEEEeeccCC-cchhHHHHHHHHHHhhh
Q 002857 149 YVSYEALYSATKG---------FSSENLIGAGNFASVYKGILFEGA---PAVAIKVFNFLHH-DASKSFTVECEVMRNII 215 (873)
Q Consensus 149 ~~s~~el~~at~~---------f~~~~~LG~G~fG~VYkg~~~~~g---~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~ 215 (873)
.++|++-..|... ..+.++||.|.||.||+|+++..+ ..||||.++.... ....+|+.|+.||.+++
T Consensus 609 P~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFd 688 (996)
T KOG0196|consen 609 PHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFD 688 (996)
T ss_pred CccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCC
Confidence 3455554444433 356799999999999999997655 4699999986543 34568999999999999
Q ss_pred hccceeeeeeeecccccCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCC
Q 002857 216 HRKIIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPP 295 (873)
Q Consensus 216 HpNIV~llg~c~~~~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~g 295 (873)
||||++|.|+. ......+||+|||++|+|+.||+. ..+++++.+...++++||.||.||- +.+
T Consensus 689 HPNIIrLEGVV-----Tks~PvMIiTEyMENGsLDsFLR~---------~DGqftviQLVgMLrGIAsGMkYLs---dm~ 751 (996)
T KOG0196|consen 689 HPNIIRLEGVV-----TKSKPVMIITEYMENGSLDSFLRQ---------NDGQFTVIQLVGMLRGIASGMKYLS---DMN 751 (996)
T ss_pred CCcEEEEEEEE-----ecCceeEEEhhhhhCCcHHHHHhh---------cCCceEeehHHHHHHHHHHHhHHHh---hcC
Confidence 99999999994 455678999999999999999963 4577999999999999999999999 899
Q ss_pred eeeccCCCCCeeeCCCCCeEEeccccccccccccccc-cccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-C
Q 002857 296 IAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQT-SSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-G 373 (873)
Q Consensus 296 IvHrDLKpsNILLd~~~~vKLsDFGla~~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-G 373 (873)
+|||||.++|||++.+..+|++|||+++.+.++.... .+.+-.-.++|.|||.+...++|.+||||||||||||.++ |
T Consensus 752 YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyG 831 (996)
T KOG0196|consen 752 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYG 831 (996)
T ss_pred chhhhhhhhheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccC
Confidence 9999999999999999999999999999886554222 2222234678999999999999999999999999999888 9
Q ss_pred CCCCCcccccchhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcC
Q 002857 374 LRPSDDMFKDNLNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPG 453 (873)
Q Consensus 374 k~Pf~~~~~~~~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~ 453 (873)
.+||.++.+.+. +.. +.. .+..+|. ..|+..|.+|++.||+.|-.
T Consensus 832 ERPYWdmSNQdV-----------------Ika-Ie~---------gyRLPpP--------mDCP~aL~qLMldCWqkdR~ 876 (996)
T KOG0196|consen 832 ERPYWDMSNQDV-----------------IKA-IEQ---------GYRLPPP--------MDCPAALYQLMLDCWQKDRN 876 (996)
T ss_pred CCcccccchHHH-----------------HHH-HHh---------ccCCCCC--------CCCcHHHHHHHHHHHHHHhh
Confidence 999977544321 111 000 1111111 24778899999999999999
Q ss_pred CCCCHHHHHHHHHHHHH
Q 002857 454 ERMKINDVELGLRLIKK 470 (873)
Q Consensus 454 eRPTm~EVl~~Le~i~~ 470 (873)
+||.+.+|+..|.++..
T Consensus 877 ~RP~F~qiV~~lDklIr 893 (996)
T KOG0196|consen 877 RRPKFAQIVSTLDKLIR 893 (996)
T ss_pred cCCCHHHHHHHHHHHhc
Confidence 99999999999998754
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=335.00 Aligned_cols=277 Identities=21% Similarity=0.271 Sum_probs=209.0
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCC--cchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceE
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH--DASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFK 237 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~ 237 (873)
+.|+...++|+|+||.||+++++++|+.||||+|..... ...+-.++|+++|++++|+|+|.++.+| .....+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVF-----rrkrkl 76 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVF-----RRKRKL 76 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHH-----Hhccee
Confidence 457778899999999999999999999999999974433 2345688999999999999999999995 556789
Q ss_pred EEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEe
Q 002857 238 ALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVA 317 (873)
Q Consensus 238 ~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLs 317 (873)
+||+||++..-|. -|. .....++...+.+++.|+++|+.|+| ++++|||||||+||||+.++.+||+
T Consensus 77 hLVFE~~dhTvL~-eLe---------~~p~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLC 143 (396)
T KOG0593|consen 77 HLVFEYCDHTVLH-ELE---------RYPNGVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLC 143 (396)
T ss_pred EEEeeecchHHHH-HHH---------hccCCCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEec
Confidence 9999999874444 342 34667888999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccccccccccccccccCCCcccCC-CCCCcchhhHhHHHHHHHHHhCCCCCCccccc-chhhHHHHhhcC
Q 002857 318 DFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMG-HETSSYGDVYSFGILLLEMFTGLRPSDDMFKD-NLNLQNWVQSAL 395 (873)
Q Consensus 318 DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~-~~~l~~~~~~~~ 395 (873)
|||+|+.+... ....+.++.|..|+|||.+.+ -+|....||||+||++.||++|.+.|.+..+- ...........+
T Consensus 144 DFGFAR~L~~p--gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L 221 (396)
T KOG0593|consen 144 DFGFARTLSAP--GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNL 221 (396)
T ss_pred cchhhHhhcCC--cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHccc
Confidence 99999988642 233455678999999999988 58999999999999999999999988764332 111222222223
Q ss_pred chhHHHHhhhh-hhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 396 PERVEEIVDTL-FFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 396 ~~~l~elid~~-L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
.++...++... +... . .+.........+........-+++++..||+.||.+|++-+|++.
T Consensus 222 ~prhq~iF~~N~~F~G----v---~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 222 IPRHQSIFSSNPFFHG----V---RLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred CHHHHHHhccCCceee----e---ecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 33333333211 0000 0 000011111122223334456889999999999999999999873
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=343.98 Aligned_cols=247 Identities=24% Similarity=0.347 Sum_probs=206.7
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC---CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCc
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH---HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGND 235 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~ 235 (873)
.++|++.++||+|+||+||.++.+++++.+|+|++++.. ....+....|..+|.+++||.||+++-. |++.+
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ys-----FQt~~ 98 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYS-----FQTEE 98 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEe-----cccCC
Confidence 467999999999999999999999999999999997543 2345678899999999999999999877 58889
Q ss_pred eEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeE
Q 002857 236 FKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTAC 315 (873)
Q Consensus 236 ~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vK 315 (873)
.+|||+||+.||.|..+|+ ..+.+++..+.-++..|+.||.||| +.+||||||||+|||||++|+++
T Consensus 99 kLylVld~~~GGeLf~hL~----------~eg~F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~ 165 (357)
T KOG0598|consen 99 KLYLVLDYLNGGELFYHLQ----------REGRFSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIK 165 (357)
T ss_pred eEEEEEeccCCccHHHHHH----------hcCCcchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEE
Confidence 9999999999999999994 4678999999999999999999999 99999999999999999999999
Q ss_pred EeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHh---
Q 002857 316 VADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQ--- 392 (873)
Q Consensus 316 LsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~--- 392 (873)
|+|||+++..-... ..+....||+.|||||++.+..|+..+|.||+|+++|||++|.+||....... .......
T Consensus 166 LtDFgL~k~~~~~~--~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~-~~~~I~~~k~ 242 (357)
T KOG0598|consen 166 LTDFGLCKEDLKDG--DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKK-MYDKILKGKL 242 (357)
T ss_pred EeccccchhcccCC--CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHH-HHHHHhcCcC
Confidence 99999998543332 23334789999999999999999999999999999999999999997632211 1122222
Q ss_pred ----hcCchhHHHHhhhhhhhhhhHHH----HHhhhccCCCC
Q 002857 393 ----SALPERVEEIVDTLFFKEIEEEE----TVYKYKKAPSS 426 (873)
Q Consensus 393 ----~~~~~~l~elid~~L~~~~~~r~----~~~~i~~~p~~ 426 (873)
..+.....+++...+..++..|. ...+++.||..
T Consensus 243 ~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF 284 (357)
T KOG0598|consen 243 PLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFF 284 (357)
T ss_pred CCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCccc
Confidence 22455788999999999888773 34555566653
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=346.06 Aligned_cols=263 Identities=26% Similarity=0.323 Sum_probs=207.5
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcc-hhHHHHHHHHHHhhhhccceeeeeeeecccccCCceE
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDA-SKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFK 237 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~-~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~ 237 (873)
.+.|++..+||.|..++||+|+....++.||||+++...... .+.+.+|+..|+.++||||++++..| ..+..+
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sF-----vv~~~L 99 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSF-----VVDSEL 99 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEE-----Eeccee
Confidence 457899999999999999999999999999999998655443 48899999999999999999998875 556789
Q ss_pred EEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEe
Q 002857 238 ALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVA 317 (873)
Q Consensus 238 ~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLs 317 (873)
|+||.||.+||+.++++. .....+++..+..|++++++||.||| .+|.||||||+.||||+.+|.+||+
T Consensus 100 WvVmpfMa~GS~ldIik~--------~~~~Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLa 168 (516)
T KOG0582|consen 100 WVVMPFMAGGSLLDIIKT--------YYPDGLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLA 168 (516)
T ss_pred EEeehhhcCCcHHHHHHH--------HccccccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEc
Confidence 999999999999999975 34566999999999999999999999 8999999999999999999999999
Q ss_pred ccccccccccccccc-cc-cccccccccCCCcccCC--CCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhh
Q 002857 318 DFGIARFLEATNEQT-SS-IGVKGTTGYIAPEYGMG--HETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQS 393 (873)
Q Consensus 318 DFGla~~~~~~~~~~-~~-~~~~Gt~~Y~APE~l~~--~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~ 393 (873)
|||.+..+....... .. ...+||+.|||||+++. ..|+.|+||||||++..||.+|..||.....-..-+.. ++.
T Consensus 169 dFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~t-Lqn 247 (516)
T KOG0582|consen 169 DFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLT-LQN 247 (516)
T ss_pred CceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHH-hcC
Confidence 999987654433211 11 34579999999999654 47999999999999999999999999874332211111 111
Q ss_pred cCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 394 ALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 394 ~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
..+-..... +. .+........+.+++..||+.||.+|||+++++.
T Consensus 248 ~pp~~~t~~----~~---------------------~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 248 DPPTLLTSG----LD---------------------KDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred CCCCccccc----CC---------------------hHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 100000000 00 0001111235788999999999999999999875
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=386.31 Aligned_cols=269 Identities=23% Similarity=0.347 Sum_probs=214.7
Q ss_pred CCCcceeecccCceEEEEEEEcCCC-----cEEEEEEeecc-CCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCC
Q 002857 161 GFSSENLIGAGNFASVYKGILFEGA-----PAVAIKVFNFL-HHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGN 234 (873)
Q Consensus 161 ~f~~~~~LG~G~fG~VYkg~~~~~g-----~~VAVK~l~~~-~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~ 234 (873)
+.+..+.||+|.||.||+|....-. ..||||.++.. +.+...+|.+|..+|++++|||||+++|+|.. .
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~-----~ 767 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD-----S 767 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC-----C
Confidence 4456789999999999999986432 24899998754 34556789999999999999999999999842 5
Q ss_pred ceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCe
Q 002857 235 DFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTA 314 (873)
Q Consensus 235 ~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~v 314 (873)
...+|++|||++|+|..||+..+.. ..+...|+..+.+.|+.|||+|+.||+ ++++|||||.++|+||+....+
T Consensus 768 ~~~~i~leyM~gGDL~sflr~~r~~---~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~V 841 (1025)
T KOG1095|consen 768 GPPLILLEYMEGGDLLSFLRESRPA---PFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVV 841 (1025)
T ss_pred CCcEEEehhcccCcHHHHHHhcccc---cCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcE
Confidence 6689999999999999999753221 123677999999999999999999999 9999999999999999999999
Q ss_pred EEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHHHhh
Q 002857 315 CVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQS 393 (873)
Q Consensus 315 KLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~~~~ 393 (873)
||+|||+|+.+.............-...|||||.+..+.++.|+|||||||+|||++| |..||....+.+
T Consensus 842 KIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~--------- 912 (1025)
T KOG1095|consen 842 KIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE--------- 912 (1025)
T ss_pred EEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH---------
Confidence 9999999995544333222222234678999999999999999999999999999999 999997643221
Q ss_pred cCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHHHHhhh
Q 002857 394 ALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLIKKKLL 473 (873)
Q Consensus 394 ~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i~~~l~ 473 (873)
++...+... . .+.+..|++.+++|+..||+.+|++||++..|++.+..+.....
T Consensus 913 --------v~~~~~~gg--------R----------L~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~ 966 (1025)
T KOG1095|consen 913 --------VLLDVLEGG--------R----------LDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAAL 966 (1025)
T ss_pred --------HHHHHHhCC--------c----------cCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhc
Confidence 111011110 0 01123578889999999999999999999999999998877665
Q ss_pred cC
Q 002857 474 ET 475 (873)
Q Consensus 474 ~~ 475 (873)
..
T Consensus 967 ~~ 968 (1025)
T KOG1095|consen 967 GT 968 (1025)
T ss_pred cC
Confidence 44
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=351.50 Aligned_cols=274 Identities=23% Similarity=0.284 Sum_probs=207.9
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC--CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceE
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH--HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFK 237 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~ 237 (873)
+.|+.+++||+|.||.||+|++..+|+.||+|.++... ........+||.||++|+||||++|.+...+. .....
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~---~~~si 193 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSK---LSGSI 193 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEec---CCceE
Confidence 35667789999999999999999999999999987544 44456778999999999999999999986532 24679
Q ss_pred EEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEe
Q 002857 238 ALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVA 317 (873)
Q Consensus 238 ~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLs 317 (873)
|||+|||++ +|.-++. ...-.+++.++..++.||+.||.|+| .++|+|||||.+|||||.+|.+||+
T Consensus 194 YlVFeYMdh-DL~GLl~---------~p~vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKia 260 (560)
T KOG0600|consen 194 YLVFEYMDH-DLSGLLS---------SPGVKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIA 260 (560)
T ss_pred EEEEecccc-hhhhhhc---------CCCcccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEec
Confidence 999999987 8988884 34567999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccccccccccccccccCCCcccCCC-CCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCc
Q 002857 318 DFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGH-ETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALP 396 (873)
Q Consensus 318 DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~ 396 (873)
|||+|+++....... .+..+-|+.|+|||++.|. .|+.+.|+||.||||.||++|++.|.+..+-. .+...+.-.-.
T Consensus 261 DFGLAr~y~~~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEve-Ql~kIfklcGS 338 (560)
T KOG0600|consen 261 DFGLARFYTPSGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVE-QLHKIFKLCGS 338 (560)
T ss_pred cccceeeccCCCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHH-HHHHHHHHhCC
Confidence 999999887655443 3455689999999999986 79999999999999999999999987743211 11111110000
Q ss_pred --h-hHH--HHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHH
Q 002857 397 --E-RVE--EIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVE 462 (873)
Q Consensus 397 --~-~l~--elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl 462 (873)
+ .+. ++-.....+ ..++.....++.........++|+..+|..||.+|.|+.+++
T Consensus 339 P~e~~W~~~kLP~~~~~k-----------p~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL 398 (560)
T KOG0600|consen 339 PTEDYWPVSKLPHATIFK-----------PQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSAL 398 (560)
T ss_pred CChhccccccCCcccccC-----------CCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHh
Confidence 0 111 000000000 011112222222233344678899999999999999999764
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=347.13 Aligned_cols=259 Identities=27% Similarity=0.391 Sum_probs=200.0
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEE
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKAL 239 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~L 239 (873)
.++...+.||+|.||.||++...+++...|||..........+.+.+|+.+|++++|||||+++|..... ....+++
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~---~~~~~~i 93 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSR---ENDEYNI 93 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccc---cCeeeEe
Confidence 4567789999999999999999888999999998755433367799999999999999999999973221 1136899
Q ss_pred EEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCC-CCCeEEec
Q 002857 240 VYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLND-EMTACVAD 318 (873)
Q Consensus 240 V~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~-~~~vKLsD 318 (873)
.|||+++|+|.+++.. ....|++..+..++.||++||+||| +++|||+||||+|||++. ++.+||+|
T Consensus 94 ~mEy~~~GsL~~~~~~---------~g~~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaD 161 (313)
T KOG0198|consen 94 FMEYAPGGSLSDLIKR---------YGGKLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLAD 161 (313)
T ss_pred eeeccCCCcHHHHHHH---------cCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEecc
Confidence 9999999999999953 1226999999999999999999999 999999999999999999 79999999
Q ss_pred cccccccccc-cccccccccccccccCCCcccCCC-CCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCc
Q 002857 319 FGIARFLEAT-NEQTSSIGVKGTTGYIAPEYGMGH-ETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALP 396 (873)
Q Consensus 319 FGla~~~~~~-~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~ 396 (873)
||+++..... ..........||+.|||||++..+ ....++|||||||+++||+||+.||... .+. ..++
T Consensus 162 FG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-~~~---~~~~----- 232 (313)
T KOG0198|consen 162 FGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-FEE---AEAL----- 232 (313)
T ss_pred CccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-cch---HHHH-----
Confidence 9999876541 112223356799999999999964 3345899999999999999999998752 000 0000
Q ss_pred hhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHH
Q 002857 397 ERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLR 466 (873)
Q Consensus 397 ~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le 466 (873)
..+.. .. ..|..+ ........+++.+|++.+|++||||.++++.--
T Consensus 233 ---~~ig~----~~-----------~~P~ip------~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 233 ---LLIGR----ED-----------SLPEIP------DSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPF 278 (313)
T ss_pred ---HHHhc----cC-----------CCCCCC------cccCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence 00000 00 001000 011234678999999999999999999876543
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=339.57 Aligned_cols=262 Identities=23% Similarity=0.322 Sum_probs=203.1
Q ss_pred CccCHHHHHHhhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcc---hhHHHHHHHHHHhhhhccceeeee
Q 002857 148 PYVSYEALYSATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDA---SKSFTVECEVMRNIIHRKIIKVVT 224 (873)
Q Consensus 148 ~~~s~~el~~at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~---~~~f~~Ei~iL~~L~HpNIV~llg 224 (873)
..++.+++ +......||+|++|.||+|.+ +++.||||+++...... .+.|.+|+.+|++++||||++++|
T Consensus 13 ~~i~~~~i-----~~~~~~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g 85 (283)
T PHA02988 13 KCIESDDI-----DKYTSVLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYG 85 (283)
T ss_pred eecCHHHc-----CCCCCeEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEee
Confidence 44556666 223346899999999999988 68899999997544333 467889999999999999999999
Q ss_pred eeecccccCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCC-CCeeeccCCC
Q 002857 225 ACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCK-PPIAHCDIKP 303 (873)
Q Consensus 225 ~c~~~~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s-~gIvHrDLKp 303 (873)
++.... ......++||||+++|+|.+++.. ...+++...+.++.|++.||.||| . .+++||||||
T Consensus 86 ~~~~~~-~~~~~~~lv~Ey~~~g~L~~~l~~----------~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~Hrdlkp 151 (283)
T PHA02988 86 FIIDIV-DDLPRLSLILEYCTRGYLREVLDK----------EKDLSFKTKLDMAIDCCKGLYNLY---KYTNKPYKNLTS 151 (283)
T ss_pred eEEecc-cCCCceEEEEEeCCCCcHHHHHhh----------CCCCChhHHHHHHHHHHHHHHHHH---hcCCCCCCcCCh
Confidence 975311 223468999999999999999942 346889999999999999999999 5 4889999999
Q ss_pred CCeeeCCCCCeEEeccccccccccccccccccccccccccCCCcccCC--CCCCcchhhHhHHHHHHHHHhCCCCCCccc
Q 002857 304 SNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMG--HETSSYGDVYSFGILLLEMFTGLRPSDDMF 381 (873)
Q Consensus 304 sNILLd~~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~--~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~ 381 (873)
+|||+++++.+||+|||+++...... ....++..|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 152 ~nill~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~ 226 (283)
T PHA02988 152 VSFLVTENYKLKIICHGLEKILSSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT 226 (283)
T ss_pred hhEEECCCCcEEEcccchHhhhcccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC
Confidence 99999999999999999998653321 22357899999999876 689999999999999999999999997532
Q ss_pred ccchhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHH
Q 002857 382 KDNLNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDV 461 (873)
Q Consensus 382 ~~~~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EV 461 (873)
.. ++.+........ ...| ..+...+.+++.+||+.||++|||+.||
T Consensus 227 ~~-----------------~~~~~i~~~~~~--------~~~~---------~~~~~~l~~li~~cl~~dp~~Rps~~el 272 (283)
T PHA02988 227 TK-----------------EIYDLIINKNNS--------LKLP---------LDCPLEIKCIVEACTSHDSIKRPNIKEI 272 (283)
T ss_pred HH-----------------HHHHHHHhcCCC--------CCCC---------CcCcHHHHHHHHHHhcCCcccCcCHHHH
Confidence 11 111111100000 0000 0123458899999999999999999999
Q ss_pred HHHHHHHH
Q 002857 462 ELGLRLIK 469 (873)
Q Consensus 462 l~~Le~i~ 469 (873)
++.|+.+.
T Consensus 273 l~~l~~~~ 280 (283)
T PHA02988 273 LYNLSLYK 280 (283)
T ss_pred HHHHHHHH
Confidence 99999864
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=353.07 Aligned_cols=254 Identities=26% Similarity=0.398 Sum_probs=218.6
Q ss_pred HhhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeecc---CCcchhHHHHHHHHHHhh-hhccceeeeeeeeccccc
Q 002857 157 SATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFL---HHDASKSFTVECEVMRNI-IHRKIIKVVTACSRVDYQ 232 (873)
Q Consensus 157 ~at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~L-~HpNIV~llg~c~~~~~~ 232 (873)
...++|...+.||+|+|++|++|+.+.+++.+|||++.+. .....+-+..|-.+|.+| .||.|++|+-. |+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~T-----FQ 144 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFT-----FQ 144 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEE-----ee
Confidence 3456889999999999999999999999999999998632 233345677899999999 89999999987 47
Q ss_pred CCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCC
Q 002857 233 GNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEM 312 (873)
Q Consensus 233 ~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~ 312 (873)
+...+|+|+||+++|+|.++|+ ..+.|++.....++.+|+.||+||| +.|||||||||+|||||.||
T Consensus 145 D~~sLYFvLe~A~nGdll~~i~----------K~Gsfde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dm 211 (604)
T KOG0592|consen 145 DEESLYFVLEYAPNGDLLDLIK----------KYGSFDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDG 211 (604)
T ss_pred cccceEEEEEecCCCcHHHHHH----------HhCcchHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCC
Confidence 7788999999999999999994 4578999999999999999999999 99999999999999999999
Q ss_pred CeEEecccccccccccccc---------ccc--cccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCccc
Q 002857 313 TACVADFGIARFLEATNEQ---------TSS--IGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMF 381 (873)
Q Consensus 313 ~vKLsDFGla~~~~~~~~~---------~~~--~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~ 381 (873)
++||+|||.|+.+...... ... ...+||..|.+||++.....+..+|||+||||||+|+.|++||....
T Consensus 212 hikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~N 291 (604)
T KOG0592|consen 212 HIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAAN 291 (604)
T ss_pred cEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcccc
Confidence 9999999999988654321 111 34789999999999999999999999999999999999999998732
Q ss_pred -----ccchhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCch
Q 002857 382 -----KDNLNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSST 428 (873)
Q Consensus 382 -----~~~~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~ 428 (873)
...+.+..-+...+++...++++..|..++.+|.+.++++.||-...
T Consensus 292 eyliFqkI~~l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~ 343 (604)
T KOG0592|consen 292 EYLIFQKIQALDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEG 343 (604)
T ss_pred HHHHHHHHHHhcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCccccc
Confidence 23334444455667779999999999999999999999999997654
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=339.43 Aligned_cols=271 Identities=21% Similarity=0.326 Sum_probs=198.7
Q ss_pred cCCCcceeecccCceEEEEEEEcC----------------CCcEEEEEEeeccCC-cchhHHHHHHHHHHhhhhccceee
Q 002857 160 KGFSSENLIGAGNFASVYKGILFE----------------GAPAVAIKVFNFLHH-DASKSFTVECEVMRNIIHRKIIKV 222 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~----------------~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~l 222 (873)
++|.+.++||+|+||.||++.+.. ++..||+|++..... .....|.+|++++.+++|+||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 478889999999999999997632 234799999875432 234579999999999999999999
Q ss_pred eeeeecccccCCceEEEEEeecCCCChhhhcccccccccc---------cCCCCCCchhhhHHHHHHHHHHHHHHhhCCC
Q 002857 223 VTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKR---------HKAPGNLNSLERLNIAIDVASALEYLHLGCK 293 (873)
Q Consensus 223 lg~c~~~~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~---------~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s 293 (873)
++++. ..+..++||||+++|+|.+++......... ......+++..++.|+.||+.||+||| +
T Consensus 85 ~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~ 156 (304)
T cd05096 85 LGVCV-----DEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---S 156 (304)
T ss_pred EEEEe-----cCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---H
Confidence 99963 345689999999999999998532111000 112345788899999999999999999 8
Q ss_pred CCeeeccCCCCCeeeCCCCCeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-
Q 002857 294 PPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT- 372 (873)
Q Consensus 294 ~gIvHrDLKpsNILLd~~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT- 372 (873)
.+|+||||||+|||++.++.+||+|||+++.+.............++..|+|||++.+..++.++||||||+++|||++
T Consensus 157 ~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~ 236 (304)
T cd05096 157 LNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILML 236 (304)
T ss_pred CCccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHc
Confidence 9999999999999999999999999999986543322222223345788999999988899999999999999999987
Q ss_pred -CCCCCCcccccchhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccC
Q 002857 373 -GLRPSDDMFKDNLNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAEL 451 (873)
Q Consensus 373 -Gk~Pf~~~~~~~~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~d 451 (873)
+..||....... ....+ ........... ....+ ..++..+.+++.+||+.+
T Consensus 237 ~~~~p~~~~~~~~--~~~~~--------~~~~~~~~~~~---------~~~~~---------~~~~~~~~~li~~cl~~~ 288 (304)
T cd05096 237 CKEQPYGELTDEQ--VIENA--------GEFFRDQGRQV---------YLFRP---------PPCPQGLYELMLQCWSRD 288 (304)
T ss_pred cCCCCCCcCCHHH--HHHHH--------HHHhhhccccc---------cccCC---------CCCCHHHHHHHHHHccCC
Confidence 556765422111 11100 00000000000 00000 012345789999999999
Q ss_pred cCCCCCHHHHHHHHH
Q 002857 452 PGERMKINDVELGLR 466 (873)
Q Consensus 452 P~eRPTm~EVl~~Le 466 (873)
|++||||.||.+.|+
T Consensus 289 p~~RPs~~~i~~~l~ 303 (304)
T cd05096 289 CRERPSFSDIHAFLT 303 (304)
T ss_pred chhCcCHHHHHHHHh
Confidence 999999999998875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=341.63 Aligned_cols=284 Identities=20% Similarity=0.222 Sum_probs=200.4
Q ss_pred CCCcceeecccCceEEEEEEEcCCCcEEEEEEeecc--CCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEE
Q 002857 161 GFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFL--HHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKA 238 (873)
Q Consensus 161 ~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~ 238 (873)
+|++.++||+|+||.||+|++..++..||||+++.. .......+.+|++++++++||||+++++++...........+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 478899999999999999999889999999998642 222345688999999999999999999987543323334689
Q ss_pred EEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEec
Q 002857 239 LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVAD 318 (873)
Q Consensus 239 LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsD 318 (873)
+||||+. ++|.+++. ....+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|
T Consensus 81 lv~e~~~-~~L~~~l~----------~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~D 146 (338)
T cd07859 81 VVFELME-SDLHQVIK----------ANDDLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICD 146 (338)
T ss_pred EEEecCC-CCHHHHHH----------hcccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEcc
Confidence 9999995 68998884 2346899999999999999999999 89999999999999999999999999
Q ss_pred cccccccccccc-cccccccccccccCCCcccCC--CCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcC
Q 002857 319 FGIARFLEATNE-QTSSIGVKGTTGYIAPEYGMG--HETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSAL 395 (873)
Q Consensus 319 FGla~~~~~~~~-~~~~~~~~Gt~~Y~APE~l~~--~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~ 395 (873)
||+++....... ........||..|+|||++.+ ..++.++|||||||++|||+||+.||..... ......+....
T Consensus 147 fg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~--~~~~~~~~~~~ 224 (338)
T cd07859 147 FGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV--VHQLDLITDLL 224 (338)
T ss_pred CccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCCh--HHHHHHHHHHh
Confidence 999985432221 111233468999999999876 5789999999999999999999999965321 11111111111
Q ss_pred chhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 396 PERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 396 ~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
.....+......... .+.....+........ ..........+.+++.+||+.+|++|||+.||++
T Consensus 225 ~~~~~~~~~~i~~~~--~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 225 GTPSPETISRVRNEK--ARRYLSSMRKKQPVPF-SQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred CCCCHHHHHHhhhhh--HHHHHHhhcccCCCch-HHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 110000000000000 0000011111000000 0000112235778999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=320.88 Aligned_cols=277 Identities=21% Similarity=0.275 Sum_probs=209.3
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCC--cchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceE
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH--DASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFK 237 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~ 237 (873)
.+|...++||+|.||.||+|++..+|+.||||.++.... .-.....+||+.|+.++|+||+.+++++ ...+..
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F-----~~~~~l 76 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVF-----PHKSNL 76 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhc-----cCCCce
Confidence 467788999999999999999999999999999975432 2345789999999999999999999994 567778
Q ss_pred EEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEe
Q 002857 238 ALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVA 317 (873)
Q Consensus 238 ~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLs 317 (873)
.||+|||+. +|+..+++ ....++..++..++.++++||+|+| .+.|+||||||.|+|++.+|.+||+
T Consensus 77 ~lVfEfm~t-dLe~vIkd---------~~i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiA 143 (318)
T KOG0659|consen 77 SLVFEFMPT-DLEVVIKD---------KNIILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIA 143 (318)
T ss_pred EEEEEeccc-cHHHHhcc---------cccccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEee
Confidence 999999976 99999964 5677899999999999999999999 8999999999999999999999999
Q ss_pred ccccccccccccccccccccccccccCCCcccCCC-CCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCc
Q 002857 318 DFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGH-ETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALP 396 (873)
Q Consensus 318 DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~ 396 (873)
|||+|+.+...+.... ..+-|..|+|||.+.|. .|+...||||.|||+.||+-|.+-|.+.. +...+...+...-.
T Consensus 144 DFGLAr~f~~p~~~~~--~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~s-DidQL~~If~~LGT 220 (318)
T KOG0659|consen 144 DFGLARFFGSPNRIQT--HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDS-DIDQLSKIFRALGT 220 (318)
T ss_pred cccchhccCCCCcccc--cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCc-hHHHHHHHHHHcCC
Confidence 9999998866543332 23679999999998885 68999999999999999999987776532 22222222222211
Q ss_pred hhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHH
Q 002857 397 ERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELG 464 (873)
Q Consensus 397 ~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~ 464 (873)
+...++-+-.-..++ .++...|.... ......+....++++..++..||.+|+|++|++++
T Consensus 221 P~~~~WP~~~~lpdY------~~~~~~P~~~~-~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 221 PTPDQWPEMTSLPDY------VKIQQFPKPPL-NNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred CCcccCccccccccH------HHHhcCCCCcc-ccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 111111111111111 11111122111 11222334457899999999999999999998654
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=339.75 Aligned_cols=260 Identities=23% Similarity=0.404 Sum_probs=203.0
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcE----EEEEEeeccC-CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCC
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPA----VAIKVFNFLH-HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGN 234 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~----VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~ 234 (873)
.+|++.+.||+|+||.||+|++..++.. ||||+++... ....+.+.+|+.+++.++|+||++++|+|..
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~------ 80 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT------ 80 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC------
Confidence 4689999999999999999998666553 8999987443 2345678999999999999999999999742
Q ss_pred ceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCe
Q 002857 235 DFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTA 314 (873)
Q Consensus 235 ~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~v 314 (873)
...++|+||+++|+|.+++.. ....+++..++.++.||+.||+||| +.+|+||||||+|||++.++.+
T Consensus 81 ~~~~~v~e~~~~g~l~~~l~~---------~~~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~ 148 (316)
T cd05108 81 STVQLITQLMPFGCLLDYVRE---------HKDNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHV 148 (316)
T ss_pred CCceeeeecCCCCCHHHHHHh---------ccccCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcE
Confidence 246799999999999999853 2345888899999999999999999 8999999999999999999999
Q ss_pred EEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHHHhh
Q 002857 315 CVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQS 393 (873)
Q Consensus 315 KLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~~~~ 393 (873)
||+|||+++.+.............++..|+|||++.+..++.++||||||+++|||++ |+.||.......
T Consensus 149 kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~--------- 219 (316)
T cd05108 149 KITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--------- 219 (316)
T ss_pred EEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH---------
Confidence 9999999987654332222222335678999999999999999999999999999998 999986531111
Q ss_pred cCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHHHHhh
Q 002857 394 ALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLIKKKL 472 (873)
Q Consensus 394 ~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i~~~l 472 (873)
+..++.... ..+... .+...+.+++.+||+.+|++||++.+|+..|..+....
T Consensus 220 -----~~~~~~~~~--------------~~~~~~-------~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 220 -----ISSILEKGE--------------RLPQPP-------ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred -----HHHHHhCCC--------------CCCCCC-------CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 111111000 001000 01234778999999999999999999999998875443
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=351.26 Aligned_cols=257 Identities=24% Similarity=0.382 Sum_probs=208.7
Q ss_pred ccCHHHHHHhhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeec
Q 002857 149 YVSYEALYSATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSR 228 (873)
Q Consensus 149 ~~s~~el~~at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~ 228 (873)
.+.|++|. .++-||.|+.|.||+|++ .++.||||.++. .-..+|+-|++|+|+||+.+.|+|..
T Consensus 120 eiPFe~Is-------ELeWlGSGaQGAVF~Grl--~netVAVKKV~e-------lkETdIKHLRkLkH~NII~FkGVCtq 183 (904)
T KOG4721|consen 120 EIPFEEIS-------ELEWLGSGAQGAVFLGRL--HNETVAVKKVRE-------LKETDIKHLRKLKHPNIITFKGVCTQ 183 (904)
T ss_pred cCCHHHhh-------hhhhhccCcccceeeeec--cCceehhHHHhh-------hhhhhHHHHHhccCcceeeEeeeecC
Confidence 45666663 357899999999999988 567899998752 22458899999999999999999953
Q ss_pred ccccCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeee
Q 002857 229 VDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILL 308 (873)
Q Consensus 229 ~~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILL 308 (873)
..-++||||||..|-|..+|+ ....+.....+.+..+||.||.||| .+.|||||||+-||||
T Consensus 184 -----sPcyCIiMEfCa~GqL~~VLk----------a~~~itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLI 245 (904)
T KOG4721|consen 184 -----SPCYCIIMEFCAQGQLYEVLK----------AGRPITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILI 245 (904)
T ss_pred -----CceeEEeeeccccccHHHHHh----------ccCccCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEe
Confidence 456899999999999999995 3566778888999999999999999 8999999999999999
Q ss_pred CCCCCeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhH
Q 002857 309 NDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQ 388 (873)
Q Consensus 309 d~~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~ 388 (873)
..+..+||+|||.++..... .....+.||..|||||++.....++|.|||||||||||||||..||.+....
T Consensus 246 s~~d~VKIsDFGTS~e~~~~---STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss----- 317 (904)
T KOG4721|consen 246 SYDDVVKISDFGTSKELSDK---STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS----- 317 (904)
T ss_pred eccceEEeccccchHhhhhh---hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh-----
Confidence 99999999999999876443 2334567999999999999999999999999999999999999999774221
Q ss_pred HHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHH
Q 002857 389 NWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLI 468 (873)
Q Consensus 389 ~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i 468 (873)
..+|..-.. .+..|. ...|++.+.-|+++||+..|..||++.+|+..|+-.
T Consensus 318 AIIwGVGsN----------------------sL~Lpv-------PstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 318 AIIWGVGSN----------------------SLHLPV-------PSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred eeEEeccCC----------------------cccccC-------cccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 111111110 011111 235677788899999999999999999999999876
Q ss_pred HHhhhcCC
Q 002857 469 KKKLLETP 476 (873)
Q Consensus 469 ~~~l~~~~ 476 (873)
...+...+
T Consensus 369 ~pell~~t 376 (904)
T KOG4721|consen 369 SPELLSTT 376 (904)
T ss_pred CHHHhccc
Confidence 66665554
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=347.01 Aligned_cols=275 Identities=20% Similarity=0.207 Sum_probs=205.9
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcc-hhHHHHHHHHHHhhh-hccceeeeeeeecccccCCce
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDA-SKSFTVECEVMRNII-HRKIIKVVTACSRVDYQGNDF 236 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~-~~~f~~Ei~iL~~L~-HpNIV~llg~c~~~~~~~~~~ 236 (873)
.++|...++||.|.||.||+|+...++..||||.++..-... .-.-++|++.|++|+ |||||++..++. +.+..
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~----d~~~~ 84 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIR----DNDRI 84 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhh----ccCce
Confidence 467888999999999999999999999999999987443322 123467999999998 999999999863 23338
Q ss_pred EEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEE
Q 002857 237 KALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACV 316 (873)
Q Consensus 237 ~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKL 316 (873)
+++|||||+. +|++++++ ....+++..+..|+.||++||+|+| .+|+.||||||+|||+.....+||
T Consensus 85 L~fVfE~Md~-NLYqLmK~---------R~r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKi 151 (538)
T KOG0661|consen 85 LYFVFEFMDC-NLYQLMKD---------RNRLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKI 151 (538)
T ss_pred EeeeHHhhhh-hHHHHHhh---------cCCcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEe
Confidence 9999999966 99999964 3778999999999999999999999 999999999999999999999999
Q ss_pred eccccccccccccccccccccccccccCCCcccCC-CCCCcchhhHhHHHHHHHHHhCCCCCCcccccchh--hHHHHhh
Q 002857 317 ADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMG-HETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLN--LQNWVQS 393 (873)
Q Consensus 317 sDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~--l~~~~~~ 393 (873)
+|||+||.+.... ..+.++.|..|+|||++.. +-|+.+.||||+|||++|+.+-++.|.+..+-++- +-..+..
T Consensus 152 aDFGLARev~Skp---PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGt 228 (538)
T KOG0661|consen 152 ADFGLAREVRSKP---PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGT 228 (538)
T ss_pred cccccccccccCC---CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCC
Confidence 9999999775433 3455678999999998655 57899999999999999999999999774332211 1111110
Q ss_pred cCchhHH---HHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHH
Q 002857 394 ALPERVE---EIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELG 464 (873)
Q Consensus 394 ~~~~~l~---elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~ 464 (873)
-....+. .+...+ .-.+. +. ........+..+..+.++++.+|+++||++|||++|.++.
T Consensus 229 P~~~~~~eg~~La~~m-nf~~P------~~----~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 229 PDKDSWPEGYNLASAM-NFRFP------QV----KPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred CccccchhHHHHHHHh-ccCCC------cC----CCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 0000111 111110 00000 00 0011112222345568899999999999999999987653
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=330.26 Aligned_cols=277 Identities=19% Similarity=0.273 Sum_probs=198.1
Q ss_pred cCCCcceeecccCceEEEEEEEcC-CCcEEEEEEeeccCC--cchhHHHHHHHHHHhh---hhccceeeeeeeecccccC
Q 002857 160 KGFSSENLIGAGNFASVYKGILFE-GAPAVAIKVFNFLHH--DASKSFTVECEVMRNI---IHRKIIKVVTACSRVDYQG 233 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L---~HpNIV~llg~c~~~~~~~ 233 (873)
++|++.+.||+|+||.||+|++.. +++.||||+++.... .....+.+|+.+++.+ +||||++++++|.......
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 478899999999999999998754 578899999874332 2234567788887776 6999999999975433344
Q ss_pred CceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCC
Q 002857 234 NDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMT 313 (873)
Q Consensus 234 ~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~ 313 (873)
....++||||+. ++|.+++.. .....+++..++.|+.||+.||.||| +.+|+||||||+|||++.++.
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~--------~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~ 148 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDK--------VPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQ 148 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHh--------CCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCC
Confidence 567899999996 699998853 22345889999999999999999999 899999999999999999999
Q ss_pred eEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhh
Q 002857 314 ACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQS 393 (873)
Q Consensus 314 vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~ 393 (873)
+||+|||+++..... .......||..|+|||++.+..++.++|||||||++|||++|+.||....... .+...+..
T Consensus 149 ~kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~-~~~~i~~~ 224 (290)
T cd07862 149 IKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKILDV 224 (290)
T ss_pred EEEccccceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH-HHHHHHHH
Confidence 999999999865432 12233458999999999988899999999999999999999999997632211 11111100
Q ss_pred c---CchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 394 A---LPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 394 ~---~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
. .+..+..... +... .....+.. ............+.+++.+||+.||++|||+.|+++
T Consensus 225 ~~~~~~~~~~~~~~--~~~~--------~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 225 IGLPGEEDWPRDVA--LPRQ--------AFHSKSAQ-PIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hCCCChhhchhhhc--ccch--------hccCCCCC-CHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0 0000000000 0000 00000000 000111112345778999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=348.54 Aligned_cols=267 Identities=21% Similarity=0.316 Sum_probs=201.5
Q ss_pred hcCCCcceeecccCceEEEEEEEc-----CCCcEEEEEEeeccC-CcchhHHHHHHHHHHhh-hhccceeeeeeeecccc
Q 002857 159 TKGFSSENLIGAGNFASVYKGILF-----EGAPAVAIKVFNFLH-HDASKSFTVECEVMRNI-IHRKIIKVVTACSRVDY 231 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~-----~~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L-~HpNIV~llg~c~~~~~ 231 (873)
.++|++.+.||+|+||.||+|++. .++..||||+++... ....+.+.+|+.+|..+ +||||++++++|
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~----- 108 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGAC----- 108 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeee-----
Confidence 346888999999999999999752 346689999987432 23346788999999999 899999999996
Q ss_pred cCCceEEEEEeecCCCChhhhcccccccc---------------------------------------------------
Q 002857 232 QGNDFKALVYEFMPNGSLEEWIHPITEED--------------------------------------------------- 260 (873)
Q Consensus 232 ~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~--------------------------------------------------- 260 (873)
...+..++||||+++|+|.++++......
T Consensus 109 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 188 (375)
T cd05104 109 TVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS 188 (375)
T ss_pred ccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence 44567899999999999999985311000
Q ss_pred --------------cccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEeccccccccc
Q 002857 261 --------------KRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLE 326 (873)
Q Consensus 261 --------------~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDFGla~~~~ 326 (873)
........+++..++.|+.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++...
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~ 265 (375)
T cd05104 189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIR 265 (375)
T ss_pred cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceecc
Confidence 00011235788999999999999999999 8999999999999999999999999999998654
Q ss_pred cccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHHHhhcCchhHHHHhhh
Q 002857 327 ATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQSALPERVEEIVDT 405 (873)
Q Consensus 327 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~~~~~~~~~l~elid~ 405 (873)
............++..|+|||++.+..++.++||||||+++|||++ |..||....... .+.. .+..
T Consensus 266 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~-~~~~------------~~~~ 332 (375)
T cd05104 266 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS-KFYK------------MIKE 332 (375)
T ss_pred CcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH-HHHH------------HHHh
Confidence 3322222222335678999999999999999999999999999998 888886532211 1111 1110
Q ss_pred hhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHH
Q 002857 406 LFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRL 467 (873)
Q Consensus 406 ~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~ 467 (873)
.... ..|. ....++.+|+.+||+.||++||||.||+++|+.
T Consensus 333 ~~~~------------~~~~---------~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 333 GYRM------------LSPE---------CAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred CccC------------CCCC---------CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 0000 0000 012347899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=348.50 Aligned_cols=268 Identities=22% Similarity=0.346 Sum_probs=201.7
Q ss_pred cCCCcceeecccCceEEEEEEEcC-----CCcEEEEEEeeccC-CcchhHHHHHHHHHHhh-hhccceeeeeeeeccccc
Q 002857 160 KGFSSENLIGAGNFASVYKGILFE-----GAPAVAIKVFNFLH-HDASKSFTVECEVMRNI-IHRKIIKVVTACSRVDYQ 232 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~-----~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L-~HpNIV~llg~c~~~~~~ 232 (873)
++|++.+.||+|+||.||+|++.. ++..||||+++... ......+.+|+++++.+ +|+||++++++| .
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~-----~ 112 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGAC-----T 112 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEe-----c
Confidence 468889999999999999998643 33579999997443 22345688999999999 899999999986 4
Q ss_pred CCceEEEEEeecCCCChhhhccccccc-----------------------------------------------------
Q 002857 233 GNDFKALVYEFMPNGSLEEWIHPITEE----------------------------------------------------- 259 (873)
Q Consensus 233 ~~~~~~LV~Ey~~~GSL~~~L~~~~~~----------------------------------------------------- 259 (873)
.....++||||+++|+|.++++.....
T Consensus 113 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (374)
T cd05106 113 HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS 192 (374)
T ss_pred CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence 456789999999999999998531100
Q ss_pred -------ccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEeccccccccccccccc
Q 002857 260 -------DKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQT 332 (873)
Q Consensus 260 -------~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDFGla~~~~~~~~~~ 332 (873)
.........+++.++++|+.||+.||+||| +.+|+||||||+|||+++++++||+|||+++.........
T Consensus 193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~ 269 (374)
T cd05106 193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV 269 (374)
T ss_pred ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCccee
Confidence 000011235788899999999999999999 8999999999999999999999999999998654332211
Q ss_pred cccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHHHhhcCchhHHHHhhhhhhhhh
Q 002857 333 SSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQSALPERVEEIVDTLFFKEI 411 (873)
Q Consensus 333 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~~~~~~~~~l~elid~~L~~~~ 411 (873)
......++..|+|||++.+..++.++|||||||++|||++ |+.||....... . +..++.......
T Consensus 270 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-~------------~~~~~~~~~~~~- 335 (374)
T cd05106 270 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-K------------FYKMVKRGYQMS- 335 (374)
T ss_pred eccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH-H------------HHHHHHcccCcc-
Confidence 2222335678999999998899999999999999999997 999986532111 0 111111000000
Q ss_pred hHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHHH
Q 002857 412 EEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLIK 469 (873)
Q Consensus 412 ~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i~ 469 (873)
.|. .....+.+++.+||+.+|++|||+.+|+++|+++.
T Consensus 336 -----------~~~---------~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 336 -----------RPD---------FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred -----------CCC---------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 000 01234788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=332.48 Aligned_cols=200 Identities=24% Similarity=0.332 Sum_probs=172.3
Q ss_pred CCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC---CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceE
Q 002857 161 GFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH---HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFK 237 (873)
Q Consensus 161 ~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~ 237 (873)
.|+..+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.++++++|+||+++++++ ..++..
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~-----~~~~~~ 75 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAY-----ETKDAL 75 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEE-----ccCCeE
Confidence 3778899999999999999998899999999986432 22234678899999999999999999985 456679
Q ss_pred EEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEe
Q 002857 238 ALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVA 317 (873)
Q Consensus 238 ~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLs 317 (873)
++||||+++|+|.+++.. .....+++..++.++.|++.||+||| +.+|+||||||+|||+++++.+||+
T Consensus 76 ~lv~e~~~~g~L~~~~~~--------~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~ 144 (285)
T cd05631 76 CLVLTIMNGGDLKFHIYN--------MGNPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRIS 144 (285)
T ss_pred EEEEEecCCCcHHHHHHh--------hCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEe
Confidence 999999999999988742 22346889999999999999999999 8999999999999999999999999
Q ss_pred ccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCc
Q 002857 318 DFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDD 379 (873)
Q Consensus 318 DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~ 379 (873)
|||++....... ......||..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 145 Dfg~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~ 203 (285)
T cd05631 145 DLGLAVQIPEGE---TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRK 203 (285)
T ss_pred eCCCcEEcCCCC---eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCC
Confidence 999998653322 12234689999999999999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=347.72 Aligned_cols=250 Identities=23% Similarity=0.308 Sum_probs=205.7
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEE
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKAL 239 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~L 239 (873)
..|....+||+|..|.||.|....+++.||||++....+...+-+.+|+.+|+..+|+|||+++..+ ...+.+++
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sy-----lv~deLWV 347 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSY-----LVGDELWV 347 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHh-----cccceeEE
Confidence 4577778999999999999999999999999999988887778899999999999999999999985 34578999
Q ss_pred EEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEecc
Q 002857 240 VYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADF 319 (873)
Q Consensus 240 V~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDF 319 (873)
|||||++|+|.+.+. ...+++.++..|++++++||+||| .++|+|||||.+|||++.++.+||+||
T Consensus 348 VMEym~ggsLTDvVt-----------~~~~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDF 413 (550)
T KOG0578|consen 348 VMEYMEGGSLTDVVT-----------KTRMTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDF 413 (550)
T ss_pred EEeecCCCchhhhhh-----------cccccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeee
Confidence 999999999999984 344899999999999999999999 999999999999999999999999999
Q ss_pred ccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCchhH
Q 002857 320 GIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPERV 399 (873)
Q Consensus 320 Gla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~~l 399 (873)
|++..+..... .-...+||+.|||||++....|++|.||||||++++||+-|.+||-. +. .+...
T Consensus 414 GFcaqi~~~~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYln---E~-PlrAl--------- 478 (550)
T KOG0578|consen 414 GFCAQISEEQS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLN---EN-PLRAL--------- 478 (550)
T ss_pred eeeeccccccC--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccC---CC-hHHHH---------
Confidence 99987765443 22346799999999999999999999999999999999999999853 11 01100
Q ss_pred HHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 400 EEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 400 ~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
.++... .. |.... .+.....+.+++.+||+.|+++||++.|+|+
T Consensus 479 -yLIa~n--g~-------------P~lk~----~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 479 -YLIATN--GT-------------PKLKN----PEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred -HHHhhc--CC-------------CCcCC----ccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 000000 00 00000 0111234788999999999999999999975
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=331.67 Aligned_cols=251 Identities=29% Similarity=0.488 Sum_probs=190.9
Q ss_pred cceeecccCceEEEEEEEc----CCCcEEEEEEeeccCCc-chhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEE
Q 002857 164 SENLIGAGNFASVYKGILF----EGAPAVAIKVFNFLHHD-ASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKA 238 (873)
Q Consensus 164 ~~~~LG~G~fG~VYkg~~~----~~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~ 238 (873)
+.+.||.|.||.||+|.+. ..+..|+||+++..... ..+.|.+|++++++++||||++++|+|. ..+..+
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~-----~~~~~~ 77 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCI-----ENEPLF 77 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEE-----SSSSEE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccc-----cccccc
Confidence 4688999999999999997 34578999999654332 3678999999999999999999999984 344589
Q ss_pred EEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEec
Q 002857 239 LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVAD 318 (873)
Q Consensus 239 LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsD 318 (873)
+||||+++|+|.++|+. .....+++.+++.|+.||++||+||| +.+|+|+||+++|||++.++.+||+|
T Consensus 78 lv~e~~~~g~L~~~L~~--------~~~~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~ 146 (259)
T PF07714_consen 78 LVMEYCPGGSLDDYLKS--------KNKEPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSD 146 (259)
T ss_dssp EEEE--TTEBHHHHHHH--------TCTTTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEES
T ss_pred ccccccccccccccccc--------cccccccccccccccccccccccccc---cccccccccccccccccccccccccc
Confidence 99999999999999964 23567899999999999999999999 78999999999999999999999999
Q ss_pred cccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHHHhhcCch
Q 002857 319 FGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQSALPE 397 (873)
Q Consensus 319 FGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~~~~~~~~ 397 (873)
||+++...................|+|||.+....++.++||||||+++|||+| |+.||....... +..
T Consensus 147 f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~--~~~-------- 216 (259)
T PF07714_consen 147 FGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE--IIE-------- 216 (259)
T ss_dssp TTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH--HHH--------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--ccc--------
Confidence 999987632222222233457789999999998889999999999999999999 788886531111 111
Q ss_pred hHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHH
Q 002857 398 RVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGL 465 (873)
Q Consensus 398 ~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~L 465 (873)
.+.+.... +.. ..+...+.+++..||+.+|++||||.+|++.|
T Consensus 217 ---~~~~~~~~---------------~~~-------~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 217 ---KLKQGQRL---------------PIP-------DNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ---HHHTTEET---------------TSB-------TTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ---cccccccc---------------eec-------cchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 11000000 000 01133578899999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=330.21 Aligned_cols=265 Identities=24% Similarity=0.462 Sum_probs=203.1
Q ss_pred cCCCcceeecccCceEEEEEEEcCCC-----cEEEEEEeeccCC-cchhHHHHHHHHHHhhhhccceeeeeeeecccccC
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGA-----PAVAIKVFNFLHH-DASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQG 233 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g-----~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~ 233 (873)
++|++.+.||+|+||.||+|.+...+ ..||+|.++.... .....|.+|++++++++|+||+++++++ ..
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~-----~~ 79 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVC-----TK 79 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEE-----cC
Confidence 46788899999999999999876544 6799999874332 2345689999999999999999999986 34
Q ss_pred CceEEEEEeecCCCChhhhccccccccc------ccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCee
Q 002857 234 NDFKALVYEFMPNGSLEEWIHPITEEDK------RHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNIL 307 (873)
Q Consensus 234 ~~~~~LV~Ey~~~GSL~~~L~~~~~~~~------~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNIL 307 (873)
....+++|||+++|+|.+++........ .......+++.+++.++.|++.||.||| +.+|+|+||||+||+
T Consensus 80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil 156 (283)
T cd05048 80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCL 156 (283)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEE
Confidence 5678999999999999999954211000 0011256888999999999999999999 899999999999999
Q ss_pred eCCCCCeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchh
Q 002857 308 LNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLN 386 (873)
Q Consensus 308 Ld~~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~ 386 (873)
+++++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.......
T Consensus 157 ~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~-- 234 (283)
T cd05048 157 VGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE-- 234 (283)
T ss_pred EcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH--
Confidence 99999999999999986543322222233346788999999998899999999999999999998 999986532111
Q ss_pred hHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHH
Q 002857 387 LQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLR 466 (873)
Q Consensus 387 l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le 466 (873)
+...+.. ... .+ ....++..+.+|+.+||+.+|++||++.||++.|+
T Consensus 235 ------------~~~~i~~---~~~-----------~~-------~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~ 281 (283)
T cd05048 235 ------------VIEMIRS---RQL-----------LP-------CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLR 281 (283)
T ss_pred ------------HHHHHHc---CCc-----------CC-------CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHh
Confidence 1111100 000 00 00122446889999999999999999999999997
Q ss_pred H
Q 002857 467 L 467 (873)
Q Consensus 467 ~ 467 (873)
.
T Consensus 282 ~ 282 (283)
T cd05048 282 S 282 (283)
T ss_pred c
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=344.37 Aligned_cols=251 Identities=23% Similarity=0.308 Sum_probs=201.6
Q ss_pred HhhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeecc----CC-cchhHHHHHHHHHHhhh-hccceeeeeeeeccc
Q 002857 157 SATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFL----HH-DASKSFTVECEVMRNII-HRKIIKVVTACSRVD 230 (873)
Q Consensus 157 ~at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~----~~-~~~~~f~~Ei~iL~~L~-HpNIV~llg~c~~~~ 230 (873)
....+|.+.+.||+|+||+|++|.+..+++.||||+++.. .. ...+.+.+|+.++++++ ||||++++.++
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~---- 89 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVF---- 89 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEE----
Confidence 3456899999999999999999999999999999987643 11 23456778999999998 99999999995
Q ss_pred ccCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCC
Q 002857 231 YQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLND 310 (873)
Q Consensus 231 ~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~ 310 (873)
......++||||+.+|+|.+++. ..+.+.+.....++.|++.|++|+| +++|+||||||+|||+|.
T Consensus 90 -~t~~~~~ivmEy~~gGdL~~~i~----------~~g~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~ 155 (370)
T KOG0583|consen 90 -ATPTKIYIVMEYCSGGDLFDYIV----------NKGRLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDG 155 (370)
T ss_pred -ecCCeEEEEEEecCCccHHHHHH----------HcCCCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecC
Confidence 45666999999999999999994 3577888999999999999999999 999999999999999999
Q ss_pred C-CCeEEeccccccccccccccccccccccccccCCCcccCCCC-CC-cchhhHhHHHHHHHHHhCCCCCCcccccchhh
Q 002857 311 E-MTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHE-TS-SYGDVYSFGILLLEMFTGLRPSDDMFKDNLNL 387 (873)
Q Consensus 311 ~-~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~-~s-~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l 387 (873)
+ +++||+|||++.... ..........||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||++.. .
T Consensus 156 ~~~~~Kl~DFG~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~-----~ 228 (370)
T KOG0583|consen 156 NEGNLKLSDFGLSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN-----V 228 (370)
T ss_pred CCCCEEEeccccccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc-----H
Confidence 9 999999999999774 1222333467999999999999977 75 77999999999999999999998721 1
Q ss_pred HHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHH
Q 002857 388 QNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVE 462 (873)
Q Consensus 388 ~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl 462 (873)
.. +........+. -+.+.. ..++..++.+|+..+|.+|+|+.+|+
T Consensus 229 ~~------------l~~ki~~~~~~---------~p~~~~---------S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 229 PN------------LYRKIRKGEFK---------IPSYLL---------SPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred HH------------HHHHHhcCCcc---------CCCCcC---------CHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 11 11111111100 001100 12467899999999999999999998
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=328.04 Aligned_cols=280 Identities=20% Similarity=0.238 Sum_probs=201.4
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC--CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceE
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH--HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFK 237 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~ 237 (873)
++|++.+.||+|+||.||+|++..+++.||||+++... ....+.+.+|++++++++|+||+++++++ ...+..
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~ 75 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAF-----RRRGKL 75 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhE-----ecCCEE
Confidence 47899999999999999999998899999999987432 22346788999999999999999999985 456689
Q ss_pred EEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEe
Q 002857 238 ALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVA 317 (873)
Q Consensus 238 ~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLs 317 (873)
++||||++++.|..+.. ....+++..++.++.||+.||.||| +.+|+||||||+||+++.++.+||+
T Consensus 76 ~lv~e~~~~~~l~~~~~----------~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~ 142 (287)
T cd07848 76 YLVFEYVEKNMLELLEE----------MPNGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLC 142 (287)
T ss_pred EEEEecCCCCHHHHHHh----------cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEe
Confidence 99999999877765542 2346888999999999999999999 8999999999999999999999999
Q ss_pred ccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchh-hHHHHhhcCc
Q 002857 318 DFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLN-LQNWVQSALP 396 (873)
Q Consensus 318 DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~-l~~~~~~~~~ 396 (873)
|||+++....... .......|+..|+|||++.+..++.++|||||||++|||++|+.||......... ........++
T Consensus 143 Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 221 (287)
T cd07848 143 DFGFARNLSEGSN-ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLP 221 (287)
T ss_pred eccCccccccccc-ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCC
Confidence 9999987543221 1222346899999999999988999999999999999999999999763221110 0000111111
Q ss_pred hhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 397 ERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 397 ~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
....... ..++............+. .............+.+++.+||+.||++|||++|+++
T Consensus 222 ~~~~~~~----~~~~~~~~~~~~~~~~~~-~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 222 AEQMKLF----YSNPRFHGLRFPAVNHPQ-SLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred HHHHHhh----hccchhcccccCcccCcc-cHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 1110000 000000000000000000 0000011112346889999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=327.26 Aligned_cols=256 Identities=23% Similarity=0.377 Sum_probs=199.6
Q ss_pred cCCCcceeecccCceEEEEEEEc---CCCcEEEEEEeeccCC-cchhHHHHHHHHHHhhhhccceeeeeeeecccccCCc
Q 002857 160 KGFSSENLIGAGNFASVYKGILF---EGAPAVAIKVFNFLHH-DASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGND 235 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~---~~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~ 235 (873)
++|++.+.||+|+||.||+|.+. ..+..||+|+++.... .....+.+|+.++++++||||+++++++ ..++
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~ 79 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVI-----TRGN 79 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEE-----ecCC
Confidence 46888999999999999999875 3456899999875432 2345789999999999999999999986 3456
Q ss_pred eEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeE
Q 002857 236 FKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTAC 315 (873)
Q Consensus 236 ~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vK 315 (873)
..++||||+++|+|.+++.. ....+++.+++.++.||+.||+||| +.+++||||||+|||++.++.+|
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~---------~~~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~ 147 (266)
T cd05064 80 TMMIVTEYMSNGALDSFLRK---------HEGQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCK 147 (266)
T ss_pred CcEEEEEeCCCCcHHHHHHh---------CCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEE
Confidence 78999999999999999842 2346899999999999999999999 89999999999999999999999
Q ss_pred EeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHHHhhc
Q 002857 316 VADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQSA 394 (873)
Q Consensus 316 LsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~~~~~ 394 (873)
++|||.+........ .......++..|+|||++.+..++.++||||||+++||+++ |+.||....... ...
T Consensus 148 l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~--~~~----- 219 (266)
T cd05064 148 ISGFRRLQEDKSEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD--VIK----- 219 (266)
T ss_pred ECCCcccccccccch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH--HHH-----
Confidence 999998765322111 11112235678999999999999999999999999999875 999986532110 000
Q ss_pred CchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHH
Q 002857 395 LPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLI 468 (873)
Q Consensus 395 ~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i 468 (873)
.+.+.. ..+.. ..++..+.+++..||+.+|++||++.||.+.|+++
T Consensus 220 ------~~~~~~---------------~~~~~-------~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 220 ------AVEDGF---------------RLPAP-------RNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred ------HHHCCC---------------CCCCC-------CCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 010000 00000 11234578899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=337.02 Aligned_cols=199 Identities=26% Similarity=0.325 Sum_probs=173.5
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCC-cchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceE
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH-DASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFK 237 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~ 237 (873)
.++|++.+.||+|+||.||++++..++..||+|++..... .....+.+|+++|++++|+||+++++++ ..++..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~ 78 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF-----YSDGEI 78 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEE-----EECCEE
Confidence 3689999999999999999999998999999999875432 2345799999999999999999999986 345678
Q ss_pred EEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCC-CeeeccCCCCCeeeCCCCCeEE
Q 002857 238 ALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKP-PIAHCDIKPSNILLNDEMTACV 316 (873)
Q Consensus 238 ~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~-gIvHrDLKpsNILLd~~~~vKL 316 (873)
++||||+++|+|.+++.. ...+++..+..++.|++.||.||| +. +|+||||||+|||++.++.+||
T Consensus 79 ~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~~~~~i~~~l~~lH---~~~~ivH~dlkp~Nil~~~~~~~kl 145 (331)
T cd06649 79 SICMEHMDGGSLDQVLKE----------AKRIPEEILGKVSIAVLRGLAYLR---EKHQIMHRDVKPSNILVNSRGEIKL 145 (331)
T ss_pred EEEeecCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHh---hcCCEEcCCCChhhEEEcCCCcEEE
Confidence 999999999999999842 345888999999999999999999 54 6999999999999999999999
Q ss_pred eccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCc
Q 002857 317 ADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDD 379 (873)
Q Consensus 317 sDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~ 379 (873)
+|||+++...... .....|+..|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 146 ~Dfg~~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 204 (331)
T cd06649 146 CDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204 (331)
T ss_pred ccCcccccccccc----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 9999997653221 2234589999999999999999999999999999999999999965
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=352.86 Aligned_cols=262 Identities=26% Similarity=0.370 Sum_probs=206.1
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCc---E-EEEEEeec---cCCcchhHHHHHHHHHHhhhhccceeeeeeeecccc
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAP---A-VAIKVFNF---LHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDY 231 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~---~-VAVK~l~~---~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~ 231 (873)
.++....++||+|+||.||+|++...+. . ||||..+. ......++|++|+++|++++|||||+++|++.
T Consensus 156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~---- 231 (474)
T KOG0194|consen 156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV---- 231 (474)
T ss_pred ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc----
Confidence 4455566999999999999999876432 3 89999874 33455688999999999999999999999974
Q ss_pred cCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCC
Q 002857 232 QGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDE 311 (873)
Q Consensus 232 ~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~ 311 (873)
....++||||+|.||+|.++|+. ....++..+++.++.+.|.||+||| +.++|||||.++|+|++.+
T Consensus 232 -~~~Pl~ivmEl~~gGsL~~~L~k---------~~~~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~ 298 (474)
T KOG0194|consen 232 -LEEPLMLVMELCNGGSLDDYLKK---------NKKSLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKK 298 (474)
T ss_pred -CCCccEEEEEecCCCcHHHHHHh---------CCCCCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCC
Confidence 45678999999999999999953 3346999999999999999999999 9999999999999999999
Q ss_pred CCeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHH
Q 002857 312 MTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNW 390 (873)
Q Consensus 312 ~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~ 390 (873)
+.+||+|||+++.-... ........-...|+|||.+....++.++|||||||++||+++ |..||.+..... ...+
T Consensus 299 ~~vKISDFGLs~~~~~~--~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~--v~~k 374 (474)
T KOG0194|consen 299 GVVKISDFGLSRAGSQY--VMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYE--VKAK 374 (474)
T ss_pred CeEEeCccccccCCcce--eeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHH--HHHH
Confidence 99999999999854311 111111235789999999999999999999999999999999 888987642211 1111
Q ss_pred HhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHHHH
Q 002857 391 VQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLIKK 470 (873)
Q Consensus 391 ~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i~~ 470 (873)
+ ....+ .++... ..+..+..++.+||..+|++||||.+|.+.|+.+..
T Consensus 375 I---------------~~~~~----------r~~~~~-------~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~ 422 (474)
T KOG0194|consen 375 I---------------VKNGY----------RMPIPS-------KTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEK 422 (474)
T ss_pred H---------------HhcCc----------cCCCCC-------CCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHh
Confidence 1 00000 001110 123457788899999999999999999999999876
Q ss_pred hhh
Q 002857 471 KLL 473 (873)
Q Consensus 471 ~l~ 473 (873)
...
T Consensus 423 ~~~ 425 (474)
T KOG0194|consen 423 KKE 425 (474)
T ss_pred ccc
Confidence 554
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=335.79 Aligned_cols=279 Identities=29% Similarity=0.405 Sum_probs=208.7
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHh--hhhccceeeeeeeecccccCCceE
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRN--IIHRKIIKVVTACSRVDYQGNDFK 237 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~--L~HpNIV~llg~c~~~~~~~~~~~ 237 (873)
...+..++||+|+||.||+|.+ +++.||||+|.. +....|++|-+|++. ++|+||++++++-.... ....++
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t-~~~~ey 283 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGT-ADRMEY 283 (534)
T ss_pred CchhhHHHhhcCccceeehhhc--cCceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCC-ccccce
Confidence 3446678999999999999988 558999999973 445679999988875 48999999999843322 124478
Q ss_pred EEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCC------CCCeeeccCCCCCeeeCCC
Q 002857 238 ALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGC------KPPIAHCDIKPSNILLNDE 311 (873)
Q Consensus 238 ~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~------s~gIvHrDLKpsNILLd~~ 311 (873)
+||++|.++|+|.+||. ...++|....+|+..+++||+|||++. +++|+|||||++||||.+|
T Consensus 284 wLVt~fh~kGsL~dyL~-----------~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~D 352 (534)
T KOG3653|consen 284 WLVTEFHPKGSLCDYLK-----------ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKND 352 (534)
T ss_pred eEEeeeccCCcHHHHHH-----------hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccC
Confidence 99999999999999995 356899999999999999999999764 6789999999999999999
Q ss_pred CCeEEeccccccccccccccccccccccccccCCCcccCCCCC------CcchhhHhHHHHHHHHHhCCCCCCc--cccc
Q 002857 312 MTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHET------SSYGDVYSFGILLLEMFTGLRPSDD--MFKD 383 (873)
Q Consensus 312 ~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~------s~ksDVwSfGvvL~ELlTGk~Pf~~--~~~~ 383 (873)
+++.|+|||+|..+............+||.+|||||++.+.-. -.+.||||+|.|||||+++..-++. ..+-
T Consensus 353 lTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Y 432 (534)
T KOG3653|consen 353 LTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEY 432 (534)
T ss_pred CcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcc
Confidence 9999999999999887776666667889999999999877522 2458999999999999997655532 1111
Q ss_pred chhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHH-hhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHH
Q 002857 384 NLNLQNWVQSALPERVEEIVDTLFFKEIEEEETV-YKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVE 462 (873)
Q Consensus 384 ~~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~-~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl 462 (873)
...+...+. .++.+.++.+....+. .|+.+ ..+++| ..+..+.+.+..||+.||+.|-|+.=|.
T Consensus 433 qlpfe~evG--~hPt~e~mq~~VV~kK--~RP~~p~~W~~h-----------~~~~~l~et~EeCWDhDaeARLTA~Cv~ 497 (534)
T KOG3653|consen 433 QLPFEAEVG--NHPTLEEMQELVVRKK--QRPKIPDAWRKH-----------AGMAVLCETIEECWDHDAEARLTAGCVE 497 (534)
T ss_pred cCchhHHhc--CCCCHHHHHHHHHhhc--cCCCChhhhhcC-----------ccHHHHHHHHHHHcCCchhhhhhhHHHH
Confidence 112222221 1122222222221111 01110 011112 2245688999999999999999999999
Q ss_pred HHHHHHHH
Q 002857 463 LGLRLIKK 470 (873)
Q Consensus 463 ~~Le~i~~ 470 (873)
+++..+..
T Consensus 498 eR~~~l~~ 505 (534)
T KOG3653|consen 498 ERMAELMM 505 (534)
T ss_pred HHHHHHhc
Confidence 99987643
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=329.37 Aligned_cols=201 Identities=25% Similarity=0.369 Sum_probs=170.1
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCC-cchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEE
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH-DASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKA 238 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~ 238 (873)
++|.+.++||.|+||.||+|....+++.||+|+++.... .....+.+|+.++++++|+||+++++++ ......+
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~~ 79 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII-----HTERCLT 79 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEE-----cCCCeEE
Confidence 578999999999999999999988999999999874332 2345688999999999999999999985 4456789
Q ss_pred EEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEec
Q 002857 239 LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVAD 318 (873)
Q Consensus 239 LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsD 318 (873)
+||||+++ +|.+++.. ....+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|
T Consensus 80 lv~e~~~~-~l~~~l~~---------~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~D 146 (288)
T cd07871 80 LVFEYLDS-DLKQYLDN---------CGNLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLAD 146 (288)
T ss_pred EEEeCCCc-CHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECc
Confidence 99999975 99988842 2345788899999999999999999 89999999999999999999999999
Q ss_pred cccccccccccccccccccccccccCCCcccCC-CCCCcchhhHhHHHHHHHHHhCCCCCCcc
Q 002857 319 FGIARFLEATNEQTSSIGVKGTTGYIAPEYGMG-HETSSYGDVYSFGILLLEMFTGLRPSDDM 380 (873)
Q Consensus 319 FGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~ 380 (873)
||+++...... .......++..|+|||++.+ ..++.++|||||||++|||+||+.||...
T Consensus 147 fG~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~ 207 (288)
T cd07871 147 FGLARAKSVPT--KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGS 207 (288)
T ss_pred CcceeeccCCC--ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99997543222 11223457899999998865 56899999999999999999999999753
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=327.69 Aligned_cols=266 Identities=20% Similarity=0.343 Sum_probs=200.7
Q ss_pred hhcCCCcceeecccCceEEEEEEEcC-----CCcEEEEEEeeccCC-cchhHHHHHHHHHHhhhhccceeeeeeeecccc
Q 002857 158 ATKGFSSENLIGAGNFASVYKGILFE-----GAPAVAIKVFNFLHH-DASKSFTVECEVMRNIIHRKIIKVVTACSRVDY 231 (873)
Q Consensus 158 at~~f~~~~~LG~G~fG~VYkg~~~~-----~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~ 231 (873)
++++|++.+.||+|+||.||+|.+.. .+..||||+++.... ....++.+|+.+++.++|+||+++++++
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~----- 78 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV----- 78 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE-----
Confidence 56789999999999999999998642 346799999864322 2345688999999999999999999986
Q ss_pred cCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCC
Q 002857 232 QGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDE 311 (873)
Q Consensus 232 ~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~ 311 (873)
..+...++||||+++|+|.+++...............+++..++.++.|++.||+||| +.+++|+||||+||+++++
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~ 155 (277)
T cd05062 79 SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAED 155 (277)
T ss_pred cCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCC
Confidence 4456789999999999999998542111111111345678889999999999999999 8999999999999999999
Q ss_pred CCeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHH
Q 002857 312 MTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNW 390 (873)
Q Consensus 312 ~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~ 390 (873)
+.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||...... ....
T Consensus 156 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~--~~~~- 232 (277)
T cd05062 156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE--QVLR- 232 (277)
T ss_pred CCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHH-
Confidence 9999999999976543222221122345778999999998899999999999999999999 78888652111 0000
Q ss_pred HhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHH
Q 002857 391 VQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLR 466 (873)
Q Consensus 391 ~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le 466 (873)
.+....... .+ ..+...+.+++.+||+.+|++|||+.|++++|+
T Consensus 233 ----------~~~~~~~~~-------------~~---------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 233 ----------FVMEGGLLD-------------KP---------DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred ----------HHHcCCcCC-------------CC---------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 000000000 00 011335788999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=334.43 Aligned_cols=197 Identities=28% Similarity=0.412 Sum_probs=172.7
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC---CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCce
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH---HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDF 236 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~ 236 (873)
++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|++++++++||||+++++++ .+...
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~ 75 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTE-----HDQRF 75 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhh-----ccCCe
Confidence 47889999999999999999998889999999986432 22345688999999999999999999874 45678
Q ss_pred EEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEE
Q 002857 237 KALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACV 316 (873)
Q Consensus 237 ~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKL 316 (873)
.++||||+++|+|.+++.. ...+++..++.++.||+.||+||| +.+|+||||||+|||++.++.+||
T Consensus 76 ~~lv~e~~~~~~L~~~~~~----------~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl 142 (291)
T cd05612 76 LYMLMEYVPGGELFSYLRN----------SGRFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKL 142 (291)
T ss_pred EEEEEeCCCCCCHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEE
Confidence 9999999999999999842 346888999999999999999999 899999999999999999999999
Q ss_pred eccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCc
Q 002857 317 ADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDD 379 (873)
Q Consensus 317 sDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~ 379 (873)
+|||+++..... .....|+..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 143 ~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~ 200 (291)
T cd05612 143 TDFGFAKKLRDR-----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFD 200 (291)
T ss_pred EecCcchhccCC-----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 999999865321 1234589999999999998999999999999999999999999965
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=338.59 Aligned_cols=270 Identities=21% Similarity=0.317 Sum_probs=203.7
Q ss_pred cCCCcceeecccCceEEEEEEEcC-----CCcEEEEEEeeccC-CcchhHHHHHHHHHHhh-hhccceeeeeeeeccccc
Q 002857 160 KGFSSENLIGAGNFASVYKGILFE-----GAPAVAIKVFNFLH-HDASKSFTVECEVMRNI-IHRKIIKVVTACSRVDYQ 232 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~-----~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L-~HpNIV~llg~c~~~~~~ 232 (873)
++|++.+.||+|+||.||+|.+.. +++.||+|+++... ....+.+..|+.++.++ +|+||++++++|. .
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~----~ 82 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACT----K 82 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEe----c
Confidence 478899999999999999997543 34789999987432 22345678899999999 8999999999874 3
Q ss_pred CCceEEEEEeecCCCChhhhccccccccc---------------------------------------------------
Q 002857 233 GNDFKALVYEFMPNGSLEEWIHPITEEDK--------------------------------------------------- 261 (873)
Q Consensus 233 ~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~--------------------------------------------------- 261 (873)
.+...++||||+++|+|.++|........
T Consensus 83 ~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (337)
T cd05054 83 PGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEG 162 (337)
T ss_pred CCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhh
Confidence 45578999999999999999853111000
Q ss_pred ccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEecccccccccccccccccccccccc
Q 002857 262 RHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTT 341 (873)
Q Consensus 262 ~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~ 341 (873)
.......+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++.+.............++.
T Consensus 163 ~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd05054 163 DELYKEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 239 (337)
T ss_pred hHHhhcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCc
Confidence 0001236899999999999999999999 8999999999999999999999999999998764332222222344677
Q ss_pred ccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhh
Q 002857 342 GYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKY 420 (873)
Q Consensus 342 ~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i 420 (873)
.|+|||++.+..++.++|||||||++|||++ |..||....... .+ ...+......
T Consensus 240 ~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~-~~------------~~~~~~~~~~----------- 295 (337)
T cd05054 240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-EF------------CRRLKEGTRM----------- 295 (337)
T ss_pred cccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH-HH------------HHHHhccCCC-----------
Confidence 8999999999999999999999999999998 999986522111 00 0000000000
Q ss_pred ccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHHHH
Q 002857 421 KKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLIKK 470 (873)
Q Consensus 421 ~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i~~ 470 (873)
..+. .....+.+++.+||+.+|++||++.||++.|+.+.+
T Consensus 296 -~~~~---------~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 296 -RAPE---------YATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred -CCCc---------cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 0000 112357899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=322.35 Aligned_cols=256 Identities=25% Similarity=0.427 Sum_probs=202.4
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEE
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKAL 239 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~L 239 (873)
.+|++.+.||+|+||.||+|.+...++.||+|++... ....+.+.+|++++++++|+||+++++++. .....++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l 79 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT-----REPPFYI 79 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEc-----CCCCcEE
Confidence 3577889999999999999999888999999998743 233467899999999999999999999863 4556899
Q ss_pred EEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEecc
Q 002857 240 VYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADF 319 (873)
Q Consensus 240 V~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDF 319 (873)
||||+++++|.+++.. .....+++..++.++.|++.||+||| +.+++||||||+|||+++++.+||+||
T Consensus 80 v~e~~~~~~L~~~~~~--------~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df 148 (263)
T cd05052 80 ITEFMTYGNLLDYLRE--------CNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADF 148 (263)
T ss_pred EEEeCCCCcHHHHHHh--------CCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCC
Confidence 9999999999999853 23456899999999999999999999 899999999999999999999999999
Q ss_pred ccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHHHhhcCchh
Q 002857 320 GIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQSALPER 398 (873)
Q Consensus 320 Gla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~~~~~~~~~ 398 (873)
|+++....... .......++..|+|||++.+..++.++||||||+++|||++ |..||.....+. .
T Consensus 149 ~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~--~----------- 214 (263)
T cd05052 149 GLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--V----------- 214 (263)
T ss_pred cccccccccee-eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--H-----------
Confidence 99986543221 11112224668999999999999999999999999999998 999986521110 0
Q ss_pred HHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHH
Q 002857 399 VEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLI 468 (873)
Q Consensus 399 l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i 468 (873)
...+....... .+ ..+...+.+++.+||+.+|++|||+.+|+++|+.+
T Consensus 215 -~~~~~~~~~~~------------~~---------~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 215 -YELLEKGYRME------------RP---------EGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred -HHHHHCCCCCC------------CC---------CCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 00011000000 00 01123578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=346.12 Aligned_cols=260 Identities=24% Similarity=0.387 Sum_probs=213.7
Q ss_pred hhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceE
Q 002857 158 ATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFK 237 (873)
Q Consensus 158 at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~ 237 (873)
...+....++||.|.||.||.|.|++-.-.||||.++... -..++|+.|+.+|+.++|||+|+|+|+|.. +...
T Consensus 265 eRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~-----EpPF 338 (1157)
T KOG4278|consen 265 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTH-----EPPF 338 (1157)
T ss_pred cchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhcc-----CCCe
Confidence 3345566789999999999999999888899999998543 345899999999999999999999999953 4467
Q ss_pred EEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEe
Q 002857 238 ALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVA 317 (873)
Q Consensus 238 ~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLs 317 (873)
|||+|||.+|+|.+||+. -....++....+.++.||+.||.||. .+++|||||.++|+|+.++..+||+
T Consensus 339 YIiTEfM~yGNLLdYLRe--------cnr~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvA 407 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLRE--------CNRSEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVA 407 (1157)
T ss_pred EEEEecccCccHHHHHHH--------hchhhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEee
Confidence 999999999999999965 33445666778999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHHHhhcCc
Q 002857 318 DFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQSALP 396 (873)
Q Consensus 318 DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~~~~~~~ 396 (873)
|||+++++..+. ........-.+.|.|||-+....++.|+|||+|||+||||.| |..||.+....
T Consensus 408 DFGLsRlMtgDT-YTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlS------------- 473 (1157)
T KOG4278|consen 408 DFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS------------- 473 (1157)
T ss_pred ccchhhhhcCCc-eecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHH-------------
Confidence 999999886543 222223345788999999999999999999999999999999 99998763211
Q ss_pred hhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHHHH
Q 002857 397 ERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLIKK 470 (873)
Q Consensus 397 ~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i~~ 470 (873)
++.+++..-+. .+..+.|+.++++|++.||+++|.+||++.|+-+.++.+..
T Consensus 474 -qVY~LLEkgyR---------------------M~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 474 -QVYGLLEKGYR---------------------MDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred -HHHHHHhcccc---------------------ccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 12222222111 11234578889999999999999999999999999997643
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=321.21 Aligned_cols=265 Identities=24% Similarity=0.396 Sum_probs=201.6
Q ss_pred CCcceeecccCceEEEEEEEcCCC---cEEEEEEeeccCC--cchhHHHHHHHHHHhhhhccceeeeeeeecccc-cCCc
Q 002857 162 FSSENLIGAGNFASVYKGILFEGA---PAVAIKVFNFLHH--DASKSFTVECEVMRNIIHRKIIKVVTACSRVDY-QGND 235 (873)
Q Consensus 162 f~~~~~LG~G~fG~VYkg~~~~~g---~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~-~~~~ 235 (873)
|++.+.||+|+||.||+|.+..++ ..||||+++.... .....+.+|+++++.++|+||+++++++..... ....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 567889999999999999886543 7899999874322 234578999999999999999999998754321 2233
Q ss_pred eEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeE
Q 002857 236 FKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTAC 315 (873)
Q Consensus 236 ~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vK 315 (873)
..++||||+++|+|..++.... .......+++..++.++.|++.||+||| +.+|+||||||+||++++++.+|
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~----~~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~k 153 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSR----LGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVC 153 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhh----ccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEE
Confidence 5799999999999999985311 1122346899999999999999999999 89999999999999999999999
Q ss_pred EeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHHHhhc
Q 002857 316 VADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQSA 394 (873)
Q Consensus 316 LsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~~~~~ 394 (873)
|+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||...... .+..
T Consensus 154 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~--~~~~----- 226 (273)
T cd05035 154 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH--EIYD----- 226 (273)
T ss_pred ECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH--HHHH-----
Confidence 999999986644332222222335678999999988899999999999999999999 88888653211 0111
Q ss_pred CchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHH
Q 002857 395 LPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLI 468 (873)
Q Consensus 395 ~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i 468 (873)
.+.+.... ..+. .+...+.+++.+||+.||++|||+.||++.|+.+
T Consensus 227 ------~~~~~~~~-------------~~~~---------~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 227 ------YLRHGNRL-------------KQPE---------DCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred ------HHHcCCCC-------------CCCc---------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11100000 0000 1233588999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=338.27 Aligned_cols=242 Identities=20% Similarity=0.263 Sum_probs=192.5
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEeeccC---CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEEEEe
Q 002857 166 NLIGAGNFASVYKGILFEGAPAVAIKVFNFLH---HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKALVYE 242 (873)
Q Consensus 166 ~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~LV~E 242 (873)
+.||+|+||.||+++...+++.||||+++... ......+.+|+.++++++||||+++++++ ...+..+||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~-----~~~~~~~lv~e 75 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSF-----QTHDRLCFVME 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEE-----EcCCEEEEEEe
Confidence 46999999999999999999999999987432 23345678899999999999999999885 45678999999
Q ss_pred ecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEeccccc
Q 002857 243 FMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIA 322 (873)
Q Consensus 243 y~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDFGla 322 (873)
|+++|+|.+++. ....+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 76 ~~~~~~L~~~l~----------~~~~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a 142 (323)
T cd05571 76 YANGGELFFHLS----------RERVFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLC 142 (323)
T ss_pred CCCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCC
Confidence 999999999884 2456889999999999999999999 899999999999999999999999999998
Q ss_pred cccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCchhHHHH
Q 002857 323 RFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPERVEEI 402 (873)
Q Consensus 323 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~~l~el 402 (873)
+...... .......||..|+|||++.+..++.++|||||||++|||+||+.||....... +
T Consensus 143 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~-----------------~ 203 (323)
T cd05571 143 KEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-----------------L 203 (323)
T ss_pred cccccCC--CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH-----------------H
Confidence 7532211 12223568999999999999999999999999999999999999996521110 0
Q ss_pred hhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCC-----CHHHHHH
Q 002857 403 VDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERM-----KINDVEL 463 (873)
Q Consensus 403 id~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRP-----Tm~EVl~ 463 (873)
......... ..|. .....+.+++.+||+.||++|| ++.++++
T Consensus 204 ~~~~~~~~~----------~~p~---------~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 204 FELILMEEI----------RFPR---------TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred HHHHHcCCC----------CCCC---------CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 000000000 0000 0123477899999999999999 7888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=324.78 Aligned_cols=258 Identities=22% Similarity=0.333 Sum_probs=199.8
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCc----EEEEEEeeccCC-cchhHHHHHHHHHHhhhhccceeeeeeeecccccCC
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAP----AVAIKVFNFLHH-DASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGN 234 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~----~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~ 234 (873)
++|++.+.||+|+||.||+|.+..+++ .|++|.+..... ....++..|+.++++++|+||+++++++. +
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~------~ 80 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP------G 80 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC------C
Confidence 467788999999999999999877665 477777753322 23356788888999999999999999852 3
Q ss_pred ceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCe
Q 002857 235 DFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTA 314 (873)
Q Consensus 235 ~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~v 314 (873)
...++|+||+++|+|.+++.. ....+++..++.|+.||+.||+||| +.+++||||||+|||+++++.+
T Consensus 81 ~~~~~i~e~~~~gsL~~~l~~---------~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~ 148 (279)
T cd05111 81 ASLQLVTQLSPLGSLLDHVRQ---------HRDSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIV 148 (279)
T ss_pred CccEEEEEeCCCCcHHHHHHh---------cccCCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcE
Confidence 346899999999999999952 2346899999999999999999999 8999999999999999999999
Q ss_pred EEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHHHhh
Q 002857 315 CVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQS 393 (873)
Q Consensus 315 KLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~~~~ 393 (873)
||+|||+++...............++..|+|||++.+..++.++||||||+++|||+| |+.||......
T Consensus 149 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~---------- 218 (279)
T cd05111 149 QIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH---------- 218 (279)
T ss_pred EEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH----------
Confidence 9999999986644332222233457789999999998899999999999999999998 99998653211
Q ss_pred cCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHHHH
Q 002857 394 ALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLIKK 470 (873)
Q Consensus 394 ~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i~~ 470 (873)
.+.+++..... ...+. .+...+.+++.+||+.+|++|||+.|+++.|..+..
T Consensus 219 ----~~~~~~~~~~~------------~~~~~---------~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 219 ----EVPDLLEKGER------------LAQPQ---------ICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred ----HHHHHHHCCCc------------CCCCC---------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 11111110000 00000 012246778999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=337.83 Aligned_cols=254 Identities=19% Similarity=0.286 Sum_probs=200.3
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC---CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCce
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH---HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDF 236 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~ 236 (873)
++|++.+.||+|+||.||+|++..+++.||||+++... ......+.+|++++..++|+||+++++++ ...+.
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~-----~~~~~ 75 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAF-----QDDEY 75 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEE-----EcCCE
Confidence 46899999999999999999998889999999997432 23346788999999999999999999985 45678
Q ss_pred EEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEE
Q 002857 237 KALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACV 316 (873)
Q Consensus 237 ~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKL 316 (873)
.+|||||+++|+|.+++. ....+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||
T Consensus 76 ~~lv~e~~~g~~L~~~l~----------~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL 142 (333)
T cd05600 76 LYLAMEYVPGGDFRTLLN----------NLGVLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKL 142 (333)
T ss_pred EEEEEeCCCCCCHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEE
Confidence 999999999999999984 2346888999999999999999999 899999999999999999999999
Q ss_pred eccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCc
Q 002857 317 ADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALP 396 (873)
Q Consensus 317 sDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~ 396 (873)
+|||+++.... ......||..|+|||++.+..++.++|||||||++|||++|+.||........ ...+
T Consensus 143 ~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~--~~~i----- 210 (333)
T cd05600 143 TDFGLSKGIVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET--WENL----- 210 (333)
T ss_pred EeCcCCccccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHH--HHHH-----
Confidence 99999986533 22334689999999999999999999999999999999999999975321110 0000
Q ss_pred hhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHH
Q 002857 397 ERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELG 464 (873)
Q Consensus 397 ~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~ 464 (873)
.... ..+ ..|...... ......+.+++.+||+.+|++||++.||+..
T Consensus 211 ---~~~~-~~~--------------~~~~~~~~~---~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 211 ---KYWK-ETL--------------QRPVYDDPR---FNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred ---Hhcc-ccc--------------cCCCCCccc---cccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 0000 000 000000000 0112347789999999999999999998764
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=320.84 Aligned_cols=258 Identities=26% Similarity=0.418 Sum_probs=202.5
Q ss_pred hcCCCcceeecccCceEEEEEEEcCC---CcEEEEEEeeccCC-cchhHHHHHHHHHHhhhhccceeeeeeeecccccCC
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEG---APAVAIKVFNFLHH-DASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGN 234 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~---g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~ 234 (873)
.++|++.+.||+|+||.||+|.+... ...||||+++.... .....|..|+.++++++|+||+++++++ ...
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~ 77 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVV-----TKS 77 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEE-----ecC
Confidence 35789999999999999999998643 45799999874433 2345789999999999999999999985 445
Q ss_pred ceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCe
Q 002857 235 DFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTA 314 (873)
Q Consensus 235 ~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~v 314 (873)
+..++||||+++++|.+++.. ....+++..++.++.|++.||+||| +.+|+|+||||+|||+++++.+
T Consensus 78 ~~~~iv~e~~~~~~L~~~~~~---------~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~ 145 (266)
T cd05033 78 RPVMIITEYMENGSLDKFLRE---------NDGKFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVC 145 (266)
T ss_pred CceEEEEEcCCCCCHHHHHHh---------ccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCE
Confidence 678999999999999999853 2346899999999999999999999 8999999999999999999999
Q ss_pred EEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHHHhh
Q 002857 315 CVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQS 393 (873)
Q Consensus 315 KLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~~~~ 393 (873)
+|+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||....... ....
T Consensus 146 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~--~~~~--- 220 (266)
T cd05033 146 KVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD--VIKA--- 220 (266)
T ss_pred EECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH--HHHH---
Confidence 9999999987652222222222335678999999998899999999999999999998 999985421110 1010
Q ss_pred cCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHH
Q 002857 394 ALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLI 468 (873)
Q Consensus 394 ~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i 468 (873)
+.+. . ..+.. ..+...+.+++.+||+.+|++||++.||++.|+++
T Consensus 221 --------~~~~-~--------------~~~~~-------~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 221 --------VEDG-Y--------------RLPPP-------MDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred --------HHcC-C--------------CCCCC-------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0000 0 00000 01133578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=320.01 Aligned_cols=262 Identities=22% Similarity=0.329 Sum_probs=204.8
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC---CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCce
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH---HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDF 236 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~ 236 (873)
++|++.+.||+|+||.||+|+...+++.||||.++... ......+.+|+++++.++||||+++++++ ...+.
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~ 76 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSF-----IEDNE 76 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeE-----EECCe
Confidence 57899999999999999999998899999999876422 22335688999999999999999999985 34567
Q ss_pred EEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEE
Q 002857 237 KALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACV 316 (873)
Q Consensus 237 ~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKL 316 (873)
.++||||+++|+|.+++... ......+++..++.++.||+.||+||| +.+|+|+||||+||+++.++.++|
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l 147 (267)
T cd08228 77 LNIVLELADAGDLSQMIKYF------KKQKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKL 147 (267)
T ss_pred EEEEEEecCCCcHHHHHHHh------hhccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEE
Confidence 89999999999999988431 122345788899999999999999999 899999999999999999999999
Q ss_pred eccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCc
Q 002857 317 ADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALP 396 (873)
Q Consensus 317 sDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~ 396 (873)
+|||++........ ......++..|+|||.+.+..++.++||||||+++|||++|+.||.........+..
T Consensus 148 ~d~g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~------- 218 (267)
T cd08228 148 GDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQ------- 218 (267)
T ss_pred CccccceeccchhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHH-------
Confidence 99999986543221 112345888999999998888999999999999999999999998542111111111
Q ss_pred hhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHHH
Q 002857 397 ERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLIK 469 (873)
Q Consensus 397 ~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i~ 469 (873)
.+.. .. .+... .......+.+++.+||+.+|++||++.+|++.|+.++
T Consensus 219 -----~~~~---~~------------~~~~~-----~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 219 -----KIEQ---CD------------YPPLP-----TEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred -----HHhc---CC------------CCCCC-----hhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 0000 00 00000 0011335788999999999999999999999999763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=327.54 Aligned_cols=269 Identities=23% Similarity=0.422 Sum_probs=206.0
Q ss_pred cCCCcceeecccCceEEEEEEEc-----CCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCC
Q 002857 160 KGFSSENLIGAGNFASVYKGILF-----EGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGN 234 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~-----~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~ 234 (873)
++|.+.+.||+|+||.||++... .++..+|+|.+........+.+.+|++++++++|+||+++++++ ...
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~ 79 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVC-----VEG 79 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEE-----ecC
Confidence 46888999999999999999753 24567999998765555567899999999999999999999996 345
Q ss_pred ceEEEEEeecCCCChhhhcccccccc---cccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCC
Q 002857 235 DFKALVYEFMPNGSLEEWIHPITEED---KRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDE 311 (873)
Q Consensus 235 ~~~~LV~Ey~~~GSL~~~L~~~~~~~---~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~ 311 (873)
...++||||+++++|.+++....... ........+++.+++.++.|++.||+||| +.+|+||||||+|||++++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~ 156 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGEN 156 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccC
Confidence 67899999999999999985321100 00122345899999999999999999999 8999999999999999999
Q ss_pred CCeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHH
Q 002857 312 MTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNW 390 (873)
Q Consensus 312 ~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~ 390 (873)
+.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||+| |..||.......
T Consensus 157 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~------ 230 (288)
T cd05093 157 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE------ 230 (288)
T ss_pred CcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH------
Confidence 9999999999986543322222222335778999999998899999999999999999999 899986532111
Q ss_pred HhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHHHH
Q 002857 391 VQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLIKK 470 (873)
Q Consensus 391 ~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i~~ 470 (873)
+++........ ..+. .....+.+++.+||+.+|++|||+.||+..|+.+..
T Consensus 231 -----------~~~~i~~~~~~---------~~~~---------~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~ 281 (288)
T cd05093 231 -----------VIECITQGRVL---------QRPR---------TCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281 (288)
T ss_pred -----------HHHHHHcCCcC---------CCCC---------CCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 01100000000 0000 012347899999999999999999999999998865
Q ss_pred h
Q 002857 471 K 471 (873)
Q Consensus 471 ~ 471 (873)
.
T Consensus 282 ~ 282 (288)
T cd05093 282 A 282 (288)
T ss_pred h
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=323.64 Aligned_cols=264 Identities=25% Similarity=0.432 Sum_probs=202.9
Q ss_pred cCCCcceeecccCceEEEEEEEcC-----CCcEEEEEEeeccCCc-chhHHHHHHHHHHhhhhccceeeeeeeecccccC
Q 002857 160 KGFSSENLIGAGNFASVYKGILFE-----GAPAVAIKVFNFLHHD-ASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQG 233 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~-----~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~ 233 (873)
++|.+.+.||+|+||.||+|.+.. +++.||||+++..... ..+.+.+|+++|++++|+||+++++++ ..
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~ 79 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVC-----TE 79 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEE-----ec
Confidence 468888999999999999998743 3578999998755443 456899999999999999999999996 34
Q ss_pred CceEEEEEeecCCCChhhhccccccccc----ccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeC
Q 002857 234 NDFKALVYEFMPNGSLEEWIHPITEEDK----RHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLN 309 (873)
Q Consensus 234 ~~~~~LV~Ey~~~GSL~~~L~~~~~~~~----~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd 309 (873)
....++||||+++++|.+++........ .......+++.+++.++.||+.||+||| +.+|+||||||+||+++
T Consensus 80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~ 156 (280)
T cd05049 80 GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVG 156 (280)
T ss_pred CCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEc
Confidence 5678999999999999999964211000 0123456889999999999999999999 89999999999999999
Q ss_pred CCCCeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhH
Q 002857 310 DEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQ 388 (873)
Q Consensus 310 ~~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~ 388 (873)
.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||....... ..
T Consensus 157 ~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~--~~ 234 (280)
T cd05049 157 YDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE--VI 234 (280)
T ss_pred CCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH--HH
Confidence 999999999999976533222122223345788999999999999999999999999999999 999986432111 11
Q ss_pred HHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHH
Q 002857 389 NWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLR 466 (873)
Q Consensus 389 ~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le 466 (873)
.. +....+. .+. ......+.+++.+||+.+|++||++.||+++|+
T Consensus 235 ~~-----------~~~~~~~--------------~~~--------~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 235 EC-----------ITQGRLL--------------QRP--------RTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HH-----------HHcCCcC--------------CCC--------CCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 10 0000000 000 011235789999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=324.86 Aligned_cols=270 Identities=21% Similarity=0.303 Sum_probs=201.3
Q ss_pred CCcceeecccCceEEEEEEE----cCCCcEEEEEEeeccCC-cchhHHHHHHHHHHhhhhccceeeeeeeecccccCCce
Q 002857 162 FSSENLIGAGNFASVYKGIL----FEGAPAVAIKVFNFLHH-DASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDF 236 (873)
Q Consensus 162 f~~~~~LG~G~fG~VYkg~~----~~~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~ 236 (873)
|+..+.||+|+||+||++.. ..++..||+|+++.... .....+.+|++++++++|+||+++++++.. .....
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~ 82 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSE---QGGKG 82 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CCCce
Confidence 37889999999999988653 34677899999875432 234678899999999999999999998743 23456
Q ss_pred EEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEE
Q 002857 237 KALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACV 316 (873)
Q Consensus 237 ~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKL 316 (873)
.++||||+++++|.+++.. ..+++.+++.++.|++.||.||| +.+|+||||||+|||++.++.+||
T Consensus 83 ~~lv~e~~~~~~l~~~~~~-----------~~l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l 148 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPK-----------HKLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKI 148 (283)
T ss_pred EEEEecCCCCCCHHHHHHH-----------cCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEE
Confidence 8999999999999999842 34899999999999999999999 899999999999999999999999
Q ss_pred eccccccccccccccc-cccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcC
Q 002857 317 ADFGIARFLEATNEQT-SSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSAL 395 (873)
Q Consensus 317 sDFGla~~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~ 395 (873)
+|||+++......... ......++..|+|||.+.+..++.++||||||+++|||+||..||..................
T Consensus 149 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~ 228 (283)
T cd05080 149 GDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQM 228 (283)
T ss_pred eecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhccccccc
Confidence 9999998664322111 111223566799999998888999999999999999999999998653221111111110000
Q ss_pred -chhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHHH
Q 002857 396 -PERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLIK 469 (873)
Q Consensus 396 -~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i~ 469 (873)
...+.++++.... .+.. ..+...+.+++..||+.+|++|||+++|+++|+.+.
T Consensus 229 ~~~~~~~~~~~~~~--------------~~~~-------~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 229 TVVRLIELLERGMR--------------LPCP-------KNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred chhhhhhhhhcCCC--------------CCCC-------CCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 0011111111100 0000 012345889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=326.37 Aligned_cols=202 Identities=25% Similarity=0.413 Sum_probs=170.2
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCC-cchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceE
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH-DASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFK 237 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~ 237 (873)
.++|++.+.||+|+||.||+|+...+++.||||+++.... .....+.+|+.+++.++|+||+++++++ ......
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~ 78 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII-----HTKETL 78 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEE-----ecCCeE
Confidence 4689999999999999999999988899999999874432 2234678899999999999999999985 456679
Q ss_pred EEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEe
Q 002857 238 ALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVA 317 (873)
Q Consensus 238 ~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLs 317 (873)
++||||+. ++|.+++.. ....+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+
T Consensus 79 ~lv~e~~~-~~l~~~~~~---------~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~ 145 (303)
T cd07869 79 TLVFEYVH-TDLCQYMDK---------HPGGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLA 145 (303)
T ss_pred EEEEECCC-cCHHHHHHh---------CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEC
Confidence 99999995 688877742 2355888899999999999999999 8999999999999999999999999
Q ss_pred ccccccccccccccccccccccccccCCCcccCC-CCCCcchhhHhHHHHHHHHHhCCCCCCcc
Q 002857 318 DFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMG-HETSSYGDVYSFGILLLEMFTGLRPSDDM 380 (873)
Q Consensus 318 DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~ 380 (873)
|||+++...... .......++..|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 146 Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 207 (303)
T cd07869 146 DFGLARAKSVPS--HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGM 207 (303)
T ss_pred CCCcceeccCCC--ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999997543221 11223457899999998865 45788999999999999999999999764
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=323.17 Aligned_cols=274 Identities=24% Similarity=0.350 Sum_probs=203.0
Q ss_pred hcCCCcceeecccCceEEEEEEE----cCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCC
Q 002857 159 TKGFSSENLIGAGNFASVYKGIL----FEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGN 234 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~----~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~ 234 (873)
.++|++.+.||+|+||.||++.. ..++..||+|.+........+.+.+|++++++++|+||+++++++.. .+.
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~ 79 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYS---AGR 79 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEcc---CCC
Confidence 35788899999999999999974 34678999999876555556789999999999999999999998642 334
Q ss_pred ceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCe
Q 002857 235 DFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTA 314 (873)
Q Consensus 235 ~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~v 314 (873)
...++||||+++|+|.+++.. ....+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~---------~~~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~ 147 (284)
T cd05081 80 RNLRLVMEYLPYGSLRDYLQK---------HRERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRV 147 (284)
T ss_pred CceEEEEEecCCCCHHHHHHh---------cCcCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeE
Confidence 568999999999999999842 2345899999999999999999999 8999999999999999999999
Q ss_pred EEecccccccccccccccc-ccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhh
Q 002857 315 CVADFGIARFLEATNEQTS-SIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQS 393 (873)
Q Consensus 315 KLsDFGla~~~~~~~~~~~-~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~ 393 (873)
||+|||+++.......... .....++..|+|||++.+..++.++||||||+++|||++|..++...... +...+..
T Consensus 148 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~---~~~~~~~ 224 (284)
T cd05081 148 KIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE---FMRMMGN 224 (284)
T ss_pred EECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh---hhhhccc
Confidence 9999999987643322111 11122445699999999888999999999999999999988775432110 1110000
Q ss_pred cCc--hhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHH
Q 002857 394 ALP--ERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLI 468 (873)
Q Consensus 394 ~~~--~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i 468 (873)
... .....+.+. +.. ....+.. ..+...+.+++.+||+.+|++||||.||++.|+.+
T Consensus 225 ~~~~~~~~~~~~~~-~~~----------~~~~~~~-------~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 225 DKQGQMIVYHLIEL-LKN----------NGRLPAP-------PGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred ccccccchHHHHHH-Hhc----------CCcCCCC-------CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 000 000111000 000 0000000 01133588999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=339.40 Aligned_cols=194 Identities=29% Similarity=0.345 Sum_probs=167.5
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEE
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKAL 239 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~L 239 (873)
.+|++.+.||+|+||.||++.+..+++.||+|... ...+.+|+++|++++||||+++++++ ..+...++
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~~~l 160 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTF-----TYNKFTCL 160 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEE-----EECCeeEE
Confidence 57999999999999999999999999999999753 24578899999999999999999985 34567899
Q ss_pred EEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEecc
Q 002857 240 VYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADF 319 (873)
Q Consensus 240 V~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDF 319 (873)
|+|++. ++|..++. ....+++..++.|+.||+.||+||| +.+|+||||||+|||++.++.+||+||
T Consensus 161 v~e~~~-~~L~~~l~----------~~~~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DF 226 (391)
T PHA03212 161 ILPRYK-TDLYCYLA----------AKRNIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDF 226 (391)
T ss_pred EEecCC-CCHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeC
Confidence 999995 68888873 2346889999999999999999999 899999999999999999999999999
Q ss_pred ccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCc
Q 002857 320 GIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDD 379 (873)
Q Consensus 320 Gla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~ 379 (873)
|+++...... ........||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 227 G~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~ 285 (391)
T PHA03212 227 GAACFPVDIN-ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE 285 (391)
T ss_pred Cccccccccc-ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence 9997543221 1122345699999999999999999999999999999999999988643
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=337.62 Aligned_cols=197 Identities=24% Similarity=0.357 Sum_probs=173.3
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeecc---CCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCce
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFL---HHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDF 236 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~ 236 (873)
++|++.+.||+|+||.||+|++..+++.||||+++.. .....+.+.+|+.++++++||||+++++++ ..++.
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~ 92 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSF-----QDENR 92 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEE-----EcCCE
Confidence 5788999999999999999999989999999998743 223346788999999999999999999985 45678
Q ss_pred EEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEE
Q 002857 237 KALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACV 316 (873)
Q Consensus 237 ~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKL 316 (873)
.++||||+++|+|.+++.. ...+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||
T Consensus 93 ~~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl 159 (329)
T PTZ00263 93 VYFLLEFVVGGELFTHLRK----------AGRFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKV 159 (329)
T ss_pred EEEEEcCCCCChHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEE
Confidence 9999999999999999842 346788889999999999999999 899999999999999999999999
Q ss_pred eccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCc
Q 002857 317 ADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDD 379 (873)
Q Consensus 317 sDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~ 379 (873)
+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 160 ~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 217 (329)
T PTZ00263 160 TDFGFAKKVPDR-----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFD 217 (329)
T ss_pred eeccCceEcCCC-----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCC
Confidence 999999865332 1234689999999999999999999999999999999999999965
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=318.68 Aligned_cols=265 Identities=22% Similarity=0.400 Sum_probs=199.5
Q ss_pred CCcceeecccCceEEEEEEEcCCCc--EEEEEEeeccC--CcchhHHHHHHHHHHhhhhccceeeeeeeecccc-cCCce
Q 002857 162 FSSENLIGAGNFASVYKGILFEGAP--AVAIKVFNFLH--HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDY-QGNDF 236 (873)
Q Consensus 162 f~~~~~LG~G~fG~VYkg~~~~~g~--~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~-~~~~~ 236 (873)
|.+.+.||+|+||.||+|++..++. .||+|.++... ....+.+..|+++++.++|+||++++++|..... .....
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3567899999999999999876664 69999886432 3345678999999999999999999998743211 12235
Q ss_pred EEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEE
Q 002857 237 KALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACV 316 (873)
Q Consensus 237 ~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKL 316 (873)
.++||||+++|+|.+++.. .........+++..++.++.||+.||+||| +.+|+||||||+|||+++++.+||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl 153 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLY----SRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCV 153 (272)
T ss_pred cEEEEEeCCCCcHHHHHHH----hcccCCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEE
Confidence 7899999999999998742 111123455899999999999999999999 899999999999999999999999
Q ss_pred eccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHHHhhcC
Q 002857 317 ADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQSAL 395 (873)
Q Consensus 317 sDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~~~~~~ 395 (873)
+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |+.||...... .+...+
T Consensus 154 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~~~---- 227 (272)
T cd05075 154 ADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS--EIYDYL---- 227 (272)
T ss_pred CCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHH----
Confidence 99999987643322111122335678999999999999999999999999999999 88888652111 111100
Q ss_pred chhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHH
Q 002857 396 PERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLI 468 (873)
Q Consensus 396 ~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i 468 (873)
.. .. ..+... .+...+.+++.+||+.+|++|||+.+|++.|+.+
T Consensus 228 -------~~----~~-----------~~~~~~-------~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 228 -------RQ----GN-----------RLKQPP-------DCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred -------Hc----CC-----------CCCCCC-------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00 00 000000 1123478999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=334.89 Aligned_cols=192 Identities=27% Similarity=0.371 Sum_probs=167.1
Q ss_pred ecccCceEEEEEEEcCCCcEEEEEEeecc---CCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEEEEeec
Q 002857 168 IGAGNFASVYKGILFEGAPAVAIKVFNFL---HHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKALVYEFM 244 (873)
Q Consensus 168 LG~G~fG~VYkg~~~~~g~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~LV~Ey~ 244 (873)
||+|+||.||+|++..+++.||+|+++.. .......+..|+.++++++||||+++++++ ...+..++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv~e~~ 75 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSF-----QSPEKLYLVLAFI 75 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEE-----ecCCeEEEEEcCC
Confidence 79999999999999888999999998642 233446788899999999999999999885 4567899999999
Q ss_pred CCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEeccccccc
Q 002857 245 PNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARF 324 (873)
Q Consensus 245 ~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDFGla~~ 324 (873)
++|+|.+++.. ...+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 76 ~~g~L~~~l~~----------~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~ 142 (312)
T cd05585 76 NGGELFHHLQR----------EGRFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKL 142 (312)
T ss_pred CCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECccccc
Confidence 99999999842 346889999999999999999999 89999999999999999999999999999985
Q ss_pred cccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCc
Q 002857 325 LEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDD 379 (873)
Q Consensus 325 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~ 379 (873)
..... .......||..|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 143 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~ 195 (312)
T cd05585 143 NMKDD--DKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYD 195 (312)
T ss_pred CccCC--CccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCC
Confidence 43222 122335689999999999999999999999999999999999999965
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=326.35 Aligned_cols=268 Identities=25% Similarity=0.415 Sum_probs=205.7
Q ss_pred cCCCcceeecccCceEEEEEEEcC-----CCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCC
Q 002857 160 KGFSSENLIGAGNFASVYKGILFE-----GAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGN 234 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~-----~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~ 234 (873)
.+|.+.+.||+|+||.||+|.+.. ++..+++|.++.......+.+.+|++++++++|+||+++++++ ...
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~ 79 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVC-----GDG 79 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEE-----ccC
Confidence 357788999999999999998643 3456999998755555557799999999999999999999996 345
Q ss_pred ceEEEEEeecCCCChhhhccccccc------ccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeee
Q 002857 235 DFKALVYEFMPNGSLEEWIHPITEE------DKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILL 308 (873)
Q Consensus 235 ~~~~LV~Ey~~~GSL~~~L~~~~~~------~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILL 308 (873)
...++||||+++++|.+++...... .........+++..++.++.||+.||+||| +.+|+||||||+|||+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~ 156 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLV 156 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEE
Confidence 6789999999999999999542110 000112345899999999999999999999 8999999999999999
Q ss_pred CCCCCeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhh
Q 002857 309 NDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNL 387 (873)
Q Consensus 309 d~~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l 387 (873)
+.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||+| |+.||....... .
T Consensus 157 ~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~ 234 (291)
T cd05094 157 GANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE--V 234 (291)
T ss_pred ccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--H
Confidence 9999999999999976543322222223446788999999999999999999999999999999 999986532111 0
Q ss_pred HHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHH
Q 002857 388 QNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRL 467 (873)
Q Consensus 388 ~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~ 467 (873)
.. .+....... .+ ..++..+.+++.+||+.+|++|||+.+|+++|+.
T Consensus 235 ~~-----------~~~~~~~~~-------------~~---------~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~ 281 (291)
T cd05094 235 IE-----------CITQGRVLE-------------RP---------RVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHA 281 (291)
T ss_pred HH-----------HHhCCCCCC-------------CC---------ccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHH
Confidence 00 000000000 00 0113357899999999999999999999999999
Q ss_pred HHH
Q 002857 468 IKK 470 (873)
Q Consensus 468 i~~ 470 (873)
+..
T Consensus 282 ~~~ 284 (291)
T cd05094 282 LGK 284 (291)
T ss_pred HHh
Confidence 854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=342.82 Aligned_cols=269 Identities=22% Similarity=0.350 Sum_probs=203.4
Q ss_pred hcCCCcceeecccCceEEEEEEEcCC-----CcEEEEEEeeccCC-cchhHHHHHHHHHHhhh-hccceeeeeeeecccc
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEG-----APAVAIKVFNFLHH-DASKSFTVECEVMRNII-HRKIIKVVTACSRVDY 231 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~-----g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~-HpNIV~llg~c~~~~~ 231 (873)
.++|.+.++||+|+||.||+|++... +..||||+++.... ...+.+.+|+++|+++. ||||++++++|
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~----- 110 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGAC----- 110 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE-----
Confidence 45788999999999999999987432 34699999974332 23457899999999996 99999999996
Q ss_pred cCCceEEEEEeecCCCChhhhccccccccc--------------------------------------------------
Q 002857 232 QGNDFKALVYEFMPNGSLEEWIHPITEEDK-------------------------------------------------- 261 (873)
Q Consensus 232 ~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~-------------------------------------------------- 261 (873)
......+|||||+++|+|.++|+.......
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (400)
T cd05105 111 TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP 190 (400)
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence 445678999999999999999864210000
Q ss_pred ------------------------------------ccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCC
Q 002857 262 ------------------------------------RHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSN 305 (873)
Q Consensus 262 ------------------------------------~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsN 305 (873)
.......+++.+++.++.||+.||+||| +.+|+||||||+|
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~N 267 (400)
T cd05105 191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARN 267 (400)
T ss_pred hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHh
Confidence 0001235788899999999999999999 8999999999999
Q ss_pred eeeCCCCCeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccc
Q 002857 306 ILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDN 384 (873)
Q Consensus 306 ILLd~~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~ 384 (873)
||++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||.....+.
T Consensus 268 ill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~ 347 (400)
T cd05105 268 VLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS 347 (400)
T ss_pred EEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH
Confidence 9999999999999999986543322222223446788999999999899999999999999999997 999986532111
Q ss_pred hhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHH
Q 002857 385 LNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELG 464 (873)
Q Consensus 385 ~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~ 464 (873)
. + ...+.... ..+. ...+...+.+++.+||+.+|++|||+.+|+++
T Consensus 348 ~-~------------~~~~~~~~--------------~~~~-------~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~ 393 (400)
T cd05105 348 T-F------------YNKIKSGY--------------RMAK-------PDHATQEVYDIMVKCWNSEPEKRPSFLHLSDI 393 (400)
T ss_pred H-H------------HHHHhcCC--------------CCCC-------CccCCHHHHHHHHHHCccCHhHCcCHHHHHHH
Confidence 0 0 00000000 0000 00123457889999999999999999999999
Q ss_pred HHHHH
Q 002857 465 LRLIK 469 (873)
Q Consensus 465 Le~i~ 469 (873)
|+.+.
T Consensus 394 l~~l~ 398 (400)
T cd05105 394 VESLL 398 (400)
T ss_pred HHHHc
Confidence 99763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=351.99 Aligned_cols=254 Identities=19% Similarity=0.226 Sum_probs=201.3
Q ss_pred CCCcceeecccCceEEEEEEEcCC-CcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEE
Q 002857 161 GFSSENLIGAGNFASVYKGILFEG-APAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKAL 239 (873)
Q Consensus 161 ~f~~~~~LG~G~fG~VYkg~~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~L 239 (873)
.|.+.+.||+|+||.||+|....+ +..||+|.+..........+.+|+.+|+.++|||||++++++ ..++..+|
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~-----~~~~~~~l 142 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDF-----KSDDKLLL 142 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEE-----EECCEEEE
Confidence 388899999999999999988766 778999987654444456788899999999999999999996 44678999
Q ss_pred EEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEecc
Q 002857 240 VYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADF 319 (873)
Q Consensus 240 V~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDF 319 (873)
||||+++|+|.++|+.. ......+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+||
T Consensus 143 v~E~~~gg~L~~~l~~~------~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DF 213 (478)
T PTZ00267 143 IMEYGSGGDLNKQIKQR------LKEHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDF 213 (478)
T ss_pred EEECCCCCCHHHHHHHH------HhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeC
Confidence 99999999999988531 123456888999999999999999999 899999999999999999999999999
Q ss_pred ccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCchhH
Q 002857 320 GIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPERV 399 (873)
Q Consensus 320 Gla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~~l 399 (873)
|+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 214 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~----------------- 276 (478)
T PTZ00267 214 GFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ----------------- 276 (478)
T ss_pred cCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-----------------
Confidence 999876443322223345689999999999999999999999999999999999999965211
Q ss_pred HHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 400 EEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 400 ~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
.+++...+..... ..|. .....+.+++.+||+.+|++||++.+++.
T Consensus 277 ~~~~~~~~~~~~~---------~~~~---------~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 277 REIMQQVLYGKYD---------PFPC---------PVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred HHHHHHHHhCCCC---------CCCc---------cCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 1111111111100 0000 01234778999999999999999999975
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=324.43 Aligned_cols=267 Identities=21% Similarity=0.371 Sum_probs=202.8
Q ss_pred CCCcceeecccCceEEEEEEEcC-----CCcEEEEEEeeccCC-cchhHHHHHHHHHHhhhhccceeeeeeeecccccCC
Q 002857 161 GFSSENLIGAGNFASVYKGILFE-----GAPAVAIKVFNFLHH-DASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGN 234 (873)
Q Consensus 161 ~f~~~~~LG~G~fG~VYkg~~~~-----~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~ 234 (873)
+|++.+.||+|+||.||+|+... +...+|+|.+..... .....+.+|+.+++.++||||+++++.| ...
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~ 75 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGAC-----SQD 75 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEE-----ecC
Confidence 47788999999999999998743 335799998864432 2346789999999999999999999986 345
Q ss_pred ceEEEEEeecCCCChhhhcccccccc--------------cccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeecc
Q 002857 235 DFKALVYEFMPNGSLEEWIHPITEED--------------KRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCD 300 (873)
Q Consensus 235 ~~~~LV~Ey~~~GSL~~~L~~~~~~~--------------~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrD 300 (873)
+..++||||+.+|+|.+++....... ........+++.+++.++.|++.||+||| +.+|+|||
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~d 152 (290)
T cd05045 76 GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRD 152 (290)
T ss_pred CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhh
Confidence 56899999999999999985321100 00112346889999999999999999999 89999999
Q ss_pred CCCCCeeeCCCCCeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCc
Q 002857 301 IKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDD 379 (873)
Q Consensus 301 LKpsNILLd~~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~ 379 (873)
|||+|||+++++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||+| |..||..
T Consensus 153 ikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 232 (290)
T cd05045 153 LAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 232 (290)
T ss_pred hhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCC
Confidence 999999999999999999999986543322222223345778999999988889999999999999999999 9999865
Q ss_pred ccccchhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHH
Q 002857 380 MFKDNLNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKIN 459 (873)
Q Consensus 380 ~~~~~~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~ 459 (873)
.... .+.+.+....... .+ ..+...+.+++.+||+.+|++||++.
T Consensus 233 ~~~~--------------~~~~~~~~~~~~~------------~~---------~~~~~~~~~~i~~cl~~~P~~Rp~~~ 277 (290)
T cd05045 233 IAPE--------------RLFNLLKTGYRME------------RP---------ENCSEEMYNLMLTCWKQEPDKRPTFA 277 (290)
T ss_pred CCHH--------------HHHHHHhCCCCCC------------CC---------CCCCHHHHHHHHHHccCCcccCCCHH
Confidence 2111 1111111111000 00 01123578899999999999999999
Q ss_pred HHHHHHHHHHH
Q 002857 460 DVELGLRLIKK 470 (873)
Q Consensus 460 EVl~~Le~i~~ 470 (873)
||++.|+++..
T Consensus 278 ~i~~~l~~~~~ 288 (290)
T cd05045 278 DISKELEKMMV 288 (290)
T ss_pred HHHHHHHHHHh
Confidence 99999998753
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=338.46 Aligned_cols=249 Identities=25% Similarity=0.330 Sum_probs=204.7
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC-CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEE
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH-HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKA 238 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~ 238 (873)
..|+..+.||+|.||.||+|.+..+++.||+|++.... ....+++++|+.+|..++++||.+++|.+ ..+..++
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsy-----l~g~~Lw 87 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSY-----LKGTKLW 87 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhhe-----eecccHH
Confidence 45677799999999999999999999999999998543 34567899999999999999999999985 5567799
Q ss_pred EEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEec
Q 002857 239 LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVAD 318 (873)
Q Consensus 239 LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsD 318 (873)
++|||+.+|++.+.|+ ....+++..+.-|+++++.||.||| ..+.+|||||+.|||+..+|.+||+|
T Consensus 88 iiMey~~gGsv~~lL~----------~~~~~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~D 154 (467)
T KOG0201|consen 88 IIMEYCGGGSVLDLLK----------SGNILDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLAD 154 (467)
T ss_pred HHHHHhcCcchhhhhc----------cCCCCccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEe
Confidence 9999999999999994 3445588888999999999999999 89999999999999999999999999
Q ss_pred cccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCchh
Q 002857 319 FGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPER 398 (873)
Q Consensus 319 FGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~~ 398 (873)
||.+-.+....... ...+||+.|||||++.+..|+.|+||||||++.+||++|.+|+...... .....+.+..++.
T Consensus 155 fgVa~ql~~~~~rr--~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm--rvlflIpk~~PP~ 230 (467)
T KOG0201|consen 155 FGVAGQLTNTVKRR--KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM--RVLFLIPKSAPPR 230 (467)
T ss_pred cceeeeeechhhcc--ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc--eEEEeccCCCCCc
Confidence 99998775543332 4568999999999999889999999999999999999999999764331 1111111111110
Q ss_pred HHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 399 VEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 399 l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
.+. .....+.+++..||+.||+.||+|.++++
T Consensus 231 -----------------------------L~~----~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 231 -----------------------------LDG----DFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred -----------------------------ccc----ccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 000 11234778999999999999999999885
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=315.97 Aligned_cols=249 Identities=24% Similarity=0.371 Sum_probs=193.7
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEeeccC-CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEEEEeec
Q 002857 166 NLIGAGNFASVYKGILFEGAPAVAIKVFNFLH-HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKALVYEFM 244 (873)
Q Consensus 166 ~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~LV~Ey~ 244 (873)
+.||+|+||.||+|++..+++.||+|.+.... ......+.+|++++++++|+||++++++| ......++||||+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC-----TQKQPIYIVMELV 75 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEE-----cCCCCeEEEEeec
Confidence 36999999999999998889999999876432 23346799999999999999999999996 3456789999999
Q ss_pred CCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEeccccccc
Q 002857 245 PNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARF 324 (873)
Q Consensus 245 ~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDFGla~~ 324 (873)
++++|.+++.. ....+++.+++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++..
T Consensus 76 ~~~~L~~~~~~---------~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 143 (252)
T cd05084 76 QGGDFLTFLRT---------EGPRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSRE 143 (252)
T ss_pred cCCcHHHHHHh---------CCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCcc
Confidence 99999999842 2345889999999999999999999 89999999999999999999999999999875
Q ss_pred cccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHHHhhcCchhHHHHh
Q 002857 325 LEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQSALPERVEEIV 403 (873)
Q Consensus 325 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~~~~~~~~~l~eli 403 (873)
...............+..|+|||.+.+..++.++||||||+++|||++ |..||....... ....+
T Consensus 144 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~--------------~~~~~ 209 (252)
T cd05084 144 EEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ--------------TREAI 209 (252)
T ss_pred cccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH--------------HHHHH
Confidence 432211111111123567999999999999999999999999999998 888886421110 11111
Q ss_pred hhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHH
Q 002857 404 DTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLR 466 (873)
Q Consensus 404 d~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le 466 (873)
...... +.. ..+...+.+++.+||+.+|++|||+.+|+++|+
T Consensus 210 ~~~~~~--------------~~~-------~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 210 EQGVRL--------------PCP-------ELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HcCCCC--------------CCc-------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 110000 000 011335788999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=320.72 Aligned_cols=257 Identities=28% Similarity=0.452 Sum_probs=205.1
Q ss_pred hhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceE
Q 002857 158 ATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFK 237 (873)
Q Consensus 158 at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~ 237 (873)
...+|++.++||.|+||.||+|.+.. +..+|+|++..........+..|+.+++.++|+||+++++++ ......
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~ 77 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVC-----SVGEPV 77 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeE-----ecCCCe
Confidence 34578889999999999999999866 889999999866555567899999999999999999999986 345678
Q ss_pred EEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEe
Q 002857 238 ALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVA 317 (873)
Q Consensus 238 ~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLs 317 (873)
++||||+++++|.++++. .....+++.+++.++.||+.||+||| +.+|+|+||||+||++++++.+||+
T Consensus 78 ~lv~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~ 146 (261)
T cd05148 78 YIITELMEKGSLLAFLRS--------PEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVA 146 (261)
T ss_pred EEEEeecccCCHHHHHhc--------CCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEc
Confidence 999999999999999953 23456899999999999999999999 8999999999999999999999999
Q ss_pred ccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHHHhhcCc
Q 002857 318 DFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQSALP 396 (873)
Q Consensus 318 DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~~~~~~~ 396 (873)
|||++........ ......++..|+|||++.+..++.++||||||+++|+|++ |+.||....... ..
T Consensus 147 d~g~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~--~~-------- 214 (261)
T cd05148 147 DFGLARLIKEDVY--LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE--VY-------- 214 (261)
T ss_pred cccchhhcCCccc--cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH--HH--------
Confidence 9999986543221 1112346778999999988899999999999999999998 899986532110 00
Q ss_pred hhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHH
Q 002857 397 ERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLI 468 (873)
Q Consensus 397 ~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i 468 (873)
..+... . ..+.. ..+...+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 215 ---~~~~~~-~--------------~~~~~-------~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 215 ---DQITAG-Y--------------RMPCP-------AKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred ---HHHHhC-C--------------cCCCC-------CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 000000 0 00000 01133578999999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=353.54 Aligned_cols=267 Identities=24% Similarity=0.260 Sum_probs=207.0
Q ss_pred HHHHhhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC--CcchhHHHHHHHHHHhhhhccceeeeeeeecccc
Q 002857 154 ALYSATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH--HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDY 231 (873)
Q Consensus 154 el~~at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~ 231 (873)
+.....++|.+.+.||+|+||+||+|++..+++.||||++.... ......+.+|+.++..++|+||+++...+.....
T Consensus 26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~ 105 (496)
T PTZ00283 26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP 105 (496)
T ss_pred cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence 34455679999999999999999999998899999999987442 2334568889999999999999998877543211
Q ss_pred ---cCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeee
Q 002857 232 ---QGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILL 308 (873)
Q Consensus 232 ---~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILL 308 (873)
......++||||+++|+|.++|+. .......+++..+..|+.|++.||.||| +.+|+||||||+|||+
T Consensus 106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~------~~~~~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl 176 (496)
T PTZ00283 106 RNPENVLMIALVLDYANAGDLRQEIKS------RAKTNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILL 176 (496)
T ss_pred cCcccceEEEEEEeCCCCCcHHHHHHH------hhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEE
Confidence 111246899999999999999853 1123456889999999999999999999 8999999999999999
Q ss_pred CCCCCeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhH
Q 002857 309 NDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQ 388 (873)
Q Consensus 309 d~~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~ 388 (873)
+.++.+||+|||+++.+.............||..|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 177 ~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~------ 250 (496)
T PTZ00283 177 CSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM------ 250 (496)
T ss_pred eCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH------
Confidence 99999999999999876443222223345699999999999999999999999999999999999999965211
Q ss_pred HHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHH
Q 002857 389 NWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELG 464 (873)
Q Consensus 389 ~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~ 464 (873)
.++++..+..... +.. ......+.+++.+||+.+|++||++.+++..
T Consensus 251 -----------~~~~~~~~~~~~~-----------~~~-------~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 251 -----------EEVMHKTLAGRYD-----------PLP-------PSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred -----------HHHHHHHhcCCCC-----------CCC-------CCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 1111111111100 000 0112357789999999999999999999864
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=316.30 Aligned_cols=251 Identities=27% Similarity=0.380 Sum_probs=195.9
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEE
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKAL 239 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~L 239 (873)
++|++.+.||+|+||.||++.+. ++..+|+|.+.... .....+.+|++++++++||||+++++++ ......++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~i 76 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVC-----TQQKPLYI 76 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEE-----ccCCCEEE
Confidence 45788899999999999999874 45689999876332 2346789999999999999999999986 34567899
Q ss_pred EEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEecc
Q 002857 240 VYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADF 319 (873)
Q Consensus 240 V~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDF 319 (873)
||||+++|+|.++++. ....+++..++.++.|++.||+||| +.+|+|+||||+||++++++.+||+||
T Consensus 77 v~e~~~~~~L~~~~~~---------~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~ 144 (256)
T cd05114 77 VTEFMENGCLLNYLRQ---------RQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDF 144 (256)
T ss_pred EEEcCCCCcHHHHHHh---------CccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCC
Confidence 9999999999999852 2235889999999999999999999 899999999999999999999999999
Q ss_pred ccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHHHhhcCchh
Q 002857 320 GIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQSALPER 398 (873)
Q Consensus 320 Gla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~~~~~~~~~ 398 (873)
|+++....... .......++..|+|||++.+..++.++||||||+++|||++ |+.||...... .....
T Consensus 145 g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~--~~~~~-------- 213 (256)
T cd05114 145 GMTRYVLDDEY-TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY--EVVEM-------- 213 (256)
T ss_pred CCccccCCCce-eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH--HHHHH--------
Confidence 99986532221 11122335678999999988889999999999999999999 89998652111 11111
Q ss_pred HHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHH
Q 002857 399 VEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGL 465 (873)
Q Consensus 399 l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~L 465 (873)
+....... .|. .....+.+++.+||+.+|++||++.||++.|
T Consensus 214 ---i~~~~~~~-------------~~~---------~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 214 ---ISRGFRLY-------------RPK---------LASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred ---HHCCCCCC-------------CCC---------CCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 10000000 000 0122478999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=339.19 Aligned_cols=247 Identities=27% Similarity=0.406 Sum_probs=207.7
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCC--cchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceE
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH--DASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFK 237 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~ 237 (873)
++|.+.+.||+|.||.||||+.+.+.+.||+|.+.+... .+.+.+.+|++|+++++|||||.++.+ |+...+.
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~es-----fEt~~~~ 76 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLES-----FETSAHL 76 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHh-----hcccceE
Confidence 578889999999999999999999999999999875443 345679999999999999999999998 4778899
Q ss_pred EEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEe
Q 002857 238 ALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVA 317 (873)
Q Consensus 238 ~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLs 317 (873)
++|+||+.| +|..+|. ....+++..+..|+.|++.||.||| +.+|+|||+||.|||++..+++|++
T Consensus 77 ~vVte~a~g-~L~~il~----------~d~~lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~Klc 142 (808)
T KOG0597|consen 77 WVVTEYAVG-DLFTILE----------QDGKLPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLC 142 (808)
T ss_pred EEEehhhhh-hHHHHHH----------hccCCCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeec
Confidence 999999977 9999994 4678999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCch
Q 002857 318 DFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPE 397 (873)
Q Consensus 318 DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~ 397 (873)
|||+|+.+... ....+.+.||+.|||||+..+..|+..+|.||+|||+||+++|++||...
T Consensus 143 dFg~Ar~m~~~--t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~----------------- 203 (808)
T KOG0597|consen 143 DFGLARAMSTN--TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR----------------- 203 (808)
T ss_pred hhhhhhhcccC--ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH-----------------
Confidence 99999976542 33445678999999999999999999999999999999999999999541
Q ss_pred hHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 398 RVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 398 ~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
.+.+++...+.... +|+. .....+..++...|..||.+|-|-.+++.
T Consensus 204 si~~Lv~~I~~d~v------------~~p~-------~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 204 SITQLVKSILKDPV------------KPPS-------TASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred HHHHHHHHHhcCCC------------CCcc-------cccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 23333333332221 1111 11224778889999999999999998875
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=318.06 Aligned_cols=254 Identities=24% Similarity=0.417 Sum_probs=199.9
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEE
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKAL 239 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~L 239 (873)
++|++.++||+|+||.||+|.. .++..||+|.+.... ...+.+.+|+.++++++|+||+++++.+ ......++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l 78 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYY-NNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVV-----TKEEPIYI 78 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEe-cCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEE-----cCCCCcEE
Confidence 5688899999999999999986 456789999876433 2346899999999999999999999885 44567899
Q ss_pred EEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEecc
Q 002857 240 VYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADF 319 (873)
Q Consensus 240 V~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDF 319 (873)
||||+++|+|.++++. .....+++.+++.++.|++.||+||| +.+++|+||||+||+++.++.+||+||
T Consensus 79 v~e~~~~~~L~~~l~~--------~~~~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df 147 (261)
T cd05072 79 ITEYMAKGSLLDFLKS--------DEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADF 147 (261)
T ss_pred EEecCCCCcHHHHHHH--------hcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCC
Confidence 9999999999999853 23456888899999999999999999 899999999999999999999999999
Q ss_pred ccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHHHhhcCchh
Q 002857 320 GIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQSALPER 398 (873)
Q Consensus 320 Gla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~~~~~~~~~ 398 (873)
|+++....... .......++..|+|||++.+..++.++||||||+++|||+| |+.||....... ....+...
T Consensus 148 g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~--~~~~~~~~---- 220 (261)
T cd05072 148 GLARVIEDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD--VMSALQRG---- 220 (261)
T ss_pred ccceecCCCce-eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH--HHHHHHcC----
Confidence 99986543221 11122335678999999988889999999999999999998 999986521111 11110000
Q ss_pred HHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHH
Q 002857 399 VEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRL 467 (873)
Q Consensus 399 l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~ 467 (873)
. ..+.. ......+.+++.+||+.+|++||++.+|.+.|+.
T Consensus 221 --------~--------------~~~~~-------~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 221 --------Y--------------RMPRM-------ENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred --------C--------------CCCCC-------CCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0 00000 0112357889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=333.72 Aligned_cols=242 Identities=21% Similarity=0.279 Sum_probs=191.8
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEeecc---CCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEEEEe
Q 002857 166 NLIGAGNFASVYKGILFEGAPAVAIKVFNFL---HHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKALVYE 242 (873)
Q Consensus 166 ~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~LV~E 242 (873)
+.||+|+||.||++....++..||+|+++.. .......+.+|++++++++||||+++++++ ...+..+||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~-----~~~~~~~lv~E 75 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHDRLCFVME 75 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCEEEEEEe
Confidence 4699999999999999889999999998743 223345678899999999999999999985 45668999999
Q ss_pred ecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEeccccc
Q 002857 243 FMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIA 322 (873)
Q Consensus 243 y~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDFGla 322 (873)
|+++|+|..++. ....+++..++.++.||+.||+||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 76 ~~~~~~L~~~l~----------~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~ 142 (323)
T cd05595 76 YANGGELFFHLS----------RERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLC 142 (323)
T ss_pred CCCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHh
Confidence 999999998884 2346889999999999999999999 899999999999999999999999999998
Q ss_pred cccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCchhHHHH
Q 002857 323 RFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPERVEEI 402 (873)
Q Consensus 323 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~~l~el 402 (873)
+...... .......||..|+|||++.+..++.++|||||||++|||++|+.||....... +
T Consensus 143 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~-----------------~ 203 (323)
T cd05595 143 KEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-----------------L 203 (323)
T ss_pred ccccCCC--CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH-----------------H
Confidence 7532211 11223468999999999999999999999999999999999999996521110 0
Q ss_pred hhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCC-----CHHHHHH
Q 002857 403 VDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERM-----KINDVEL 463 (873)
Q Consensus 403 id~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRP-----Tm~EVl~ 463 (873)
......... ..|. .....+.+++.+||+.||++|| ++.++++
T Consensus 204 ~~~~~~~~~----------~~p~---------~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 204 FELILMEEI----------RFPR---------TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred HHHHhcCCC----------CCCC---------CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 000000000 0000 0123467899999999999998 7888765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=316.33 Aligned_cols=255 Identities=29% Similarity=0.430 Sum_probs=200.2
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEE
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKA 238 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~ 238 (873)
.++|++.+.||+|++|.||+|.+. +++.||+|.++... ...+.+.+|+.++++++|+||+++++++ ...+..+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 77 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVC-----TLEEPIY 77 (261)
T ss_pred hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEE-----ecCCCee
Confidence 457889999999999999999874 55789999987443 2346789999999999999999999985 3456789
Q ss_pred EEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEec
Q 002857 239 LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVAD 318 (873)
Q Consensus 239 LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsD 318 (873)
+||||+++++|.+++.. .....+++..+..++.|++.||.||| +.+|+||||||+||++++++.+||+|
T Consensus 78 lv~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d 146 (261)
T cd05068 78 IVTELMKYGSLLEYLQG--------GAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVAD 146 (261)
T ss_pred eeeecccCCcHHHHHhc--------cCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECC
Confidence 99999999999999853 22346899999999999999999999 89999999999999999999999999
Q ss_pred cccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHHHhhcCch
Q 002857 319 FGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQSALPE 397 (873)
Q Consensus 319 FGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~~~~~~~~ 397 (873)
||+++....... ........+..|+|||++.+..++.++||||||+++|||+| |+.||.......
T Consensus 147 fg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~------------- 212 (261)
T cd05068 147 FGLARVIKEDIY-EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE------------- 212 (261)
T ss_pred cceEEEccCCcc-cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH-------------
Confidence 999987642211 11112223468999999999999999999999999999999 999986531110
Q ss_pred hHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHH
Q 002857 398 RVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRL 467 (873)
Q Consensus 398 ~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~ 467 (873)
+...++.... .+.. ..+...+.+++.+||+.+|++||++.+|++.|+.
T Consensus 213 -~~~~~~~~~~--------------~~~~-------~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 213 -VLQQVDQGYR--------------MPCP-------PGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred -HHHHHHcCCC--------------CCCC-------CcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 0000110000 0000 0113357889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=321.10 Aligned_cols=260 Identities=23% Similarity=0.387 Sum_probs=202.1
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCc----EEEEEEeeccCC-cchhHHHHHHHHHHhhhhccceeeeeeeecccccC
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAP----AVAIKVFNFLHH-DASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQG 233 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~----~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~ 233 (873)
.++|+..++||+|+||.||+|++..+++ .||+|+++.... .....+.+|+.+++.++|+||+++++++.
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~------ 79 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICL------ 79 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEc------
Confidence 3578889999999999999999876665 489999874332 23467889999999999999999999873
Q ss_pred CceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCC
Q 002857 234 NDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMT 313 (873)
Q Consensus 234 ~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~ 313 (873)
....+++|||+++|+|.++++. ....+++..++.++.||+.||+||| +.+|+||||||+|||+++++.
T Consensus 80 ~~~~~l~~~~~~~g~l~~~l~~---------~~~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~ 147 (279)
T cd05109 80 TSTVQLVTQLMPYGCLLDYVRE---------NKDRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNH 147 (279)
T ss_pred CCCcEEEEEcCCCCCHHHHHhh---------ccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCc
Confidence 2346799999999999999853 2346899999999999999999999 899999999999999999999
Q ss_pred eEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHHHh
Q 002857 314 ACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQ 392 (873)
Q Consensus 314 vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~~~ 392 (873)
+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||...... .+.
T Consensus 148 ~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~---- 221 (279)
T cd05109 148 VKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR--EIP---- 221 (279)
T ss_pred EEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHH----
Confidence 99999999987643322211222235678999999998899999999999999999998 89998652211 111
Q ss_pred hcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHHHHh
Q 002857 393 SALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLIKKK 471 (873)
Q Consensus 393 ~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i~~~ 471 (873)
..+..... .+.. ..+...+.+++.+||+.||++||++.+++..|+.+...
T Consensus 222 --------~~~~~~~~--------------~~~~-------~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 222 --------DLLEKGER--------------LPQP-------PICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred --------HHHHCCCc--------------CCCC-------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 11111000 0000 01123477899999999999999999999999877543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=316.55 Aligned_cols=245 Identities=23% Similarity=0.328 Sum_probs=206.4
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC---CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCce
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH---HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDF 236 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~ 236 (873)
++|+..+.||.|+||.|.+++.+.++..+|+|+++... ....+...+|..+|+.+.||.++++.+.+ .+.+.
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~-----~d~~~ 118 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTF-----KDNSN 118 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEee-----ccCCe
Confidence 46778899999999999999999999999999997543 23345678899999999999999999985 56788
Q ss_pred EEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEE
Q 002857 237 KALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACV 316 (873)
Q Consensus 237 ~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKL 316 (873)
.+|||||++||.|..+|+ ..+.+++....-++.+|+.||+||| +.+|++|||||+|||||.+|.+||
T Consensus 119 lymvmeyv~GGElFS~Lr----------k~~rF~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKi 185 (355)
T KOG0616|consen 119 LYMVMEYVPGGELFSYLR----------KSGRFSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKI 185 (355)
T ss_pred EEEEEeccCCccHHHHHH----------hcCCCCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEE
Confidence 999999999999999994 4677999999999999999999999 999999999999999999999999
Q ss_pred eccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHH-----
Q 002857 317 ADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWV----- 391 (873)
Q Consensus 317 sDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~----- 391 (873)
+|||+|+.... .+....||+.|+|||+++...+..++|.|||||++|||+.|..||..... ...+.+.+
T Consensus 186 tDFGFAK~v~~-----rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~-~~iY~KI~~~~v~ 259 (355)
T KOG0616|consen 186 TDFGFAKRVSG-----RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP-IQIYEKILEGKVK 259 (355)
T ss_pred EeccceEEecC-----cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh-HHHHHHHHhCccc
Confidence 99999997643 24457899999999999999999999999999999999999999976433 22223332
Q ss_pred -hhcCchhHHHHhhhhhhhhhhHHHH-----HhhhccCCCCch
Q 002857 392 -QSALPERVEEIVDTLFFKEIEEEET-----VYKYKKAPSSST 428 (873)
Q Consensus 392 -~~~~~~~l~elid~~L~~~~~~r~~-----~~~i~~~p~~~~ 428 (873)
...+...+.+++...+..+...|.. ..+++.|||...
T Consensus 260 fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~ 302 (355)
T KOG0616|consen 260 FPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKG 302 (355)
T ss_pred CCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCccccc
Confidence 2334557889999888888777632 345778888653
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=314.05 Aligned_cols=262 Identities=23% Similarity=0.328 Sum_probs=206.0
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeecc---CCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCce
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFL---HHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDF 236 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~ 236 (873)
++|++.+.||+|+||.||+|....+++.||+|.++.. .....+.+.+|++++++++|+||+++++++ ...+.
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~-----~~~~~ 76 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASF-----IENNE 76 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeee-----ecCCe
Confidence 5799999999999999999999888999999988632 222346789999999999999999999986 34567
Q ss_pred EEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEE
Q 002857 237 KALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACV 316 (873)
Q Consensus 237 ~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKL 316 (873)
.++||||+++|+|.+++... ......+++.+++.++.+++.||.||| +.+|+||||+|+||+++.++.++|
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l 147 (267)
T cd08224 77 LNIVLELADAGDLSRMIKHF------KKQKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKL 147 (267)
T ss_pred EEEEEecCCCCCHHHHHHHh------cccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEE
Confidence 89999999999999998531 123455889999999999999999999 899999999999999999999999
Q ss_pred eccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCc
Q 002857 317 ADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALP 396 (873)
Q Consensus 317 sDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~ 396 (873)
+|||+++....... ......++..|+|||++.+..++.++||||||+++|+|++|+.||...... ..
T Consensus 148 ~d~~~~~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~-------- 214 (267)
T cd08224 148 GDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---LY-------- 214 (267)
T ss_pred eccceeeeccCCCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc---HH--------
Confidence 99999886543221 122345788999999999888999999999999999999999998542111 11
Q ss_pred hhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHHH
Q 002857 397 ERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLIK 469 (873)
Q Consensus 397 ~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i~ 469 (873)
++.+...... .+... . ......+.+++.+||+.+|++|||+.+|+++|+.+.
T Consensus 215 ----~~~~~~~~~~------------~~~~~--~---~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 215 ----SLCKKIEKCD------------YPPLP--A---DHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred ----HHHhhhhcCC------------CCCCC--h---hhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 1111100000 00000 0 011235778999999999999999999999999763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=340.39 Aligned_cols=264 Identities=21% Similarity=0.319 Sum_probs=211.1
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcch-hHHHHHHHHHHhhhhccceeeeeeeecccccCCceEE
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDAS-KSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKA 238 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~-~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~ 238 (873)
+...+.++||+|.||.|.++.. .++..||||+++....... .+|..|+++|.+++|||||+|+|+|. .++.++
T Consensus 538 s~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~-----~DePic 611 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCV-----QDDPLC 611 (807)
T ss_pred hheehhhhhcCcccceeEEEEe-cCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeee-----cCCchH
Confidence 3456678999999999999987 4578999999986655544 78999999999999999999999995 355689
Q ss_pred EEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEec
Q 002857 239 LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVAD 318 (873)
Q Consensus 239 LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsD 318 (873)
+|+|||++|+|.+||.. .....+.....+.|+.|||.||+||. +.++|||||.++|+|+|.++++||+|
T Consensus 612 mI~EYmEnGDLnqFl~a--------heapt~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiad 680 (807)
T KOG1094|consen 612 MITEYMENGDLNQFLSA--------HELPTAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIAD 680 (807)
T ss_pred HHHHHHhcCcHHHHHHh--------ccCcccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecC
Confidence 99999999999999964 12222566677889999999999999 89999999999999999999999999
Q ss_pred cccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh--CCCCCCcccccchhhHHHHhhcCc
Q 002857 319 FGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT--GLRPSDDMFKDNLNLQNWVQSALP 396 (873)
Q Consensus 319 FGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT--Gk~Pf~~~~~~~~~l~~~~~~~~~ 396 (873)
||+++-+............+-+++|||||.+..++++.+||||+|||++||+++ ...||....+++. .
T Consensus 681 fgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~v--v-------- 750 (807)
T KOG1094|consen 681 FGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQV--V-------- 750 (807)
T ss_pred cccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHH--H--------
Confidence 999997766665555555667899999999999999999999999999999876 7888876543321 1
Q ss_pred hhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHH
Q 002857 397 ERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLI 468 (873)
Q Consensus 397 ~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i 468 (873)
++..++++..-. +.++.. +.-|+..+.+++++||..+.++||++++|...|+..
T Consensus 751 en~~~~~~~~~~---------~~~l~~---------P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 751 ENAGEFFRDQGR---------QVVLSR---------PPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred HhhhhhcCCCCc---------ceeccC---------CCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 111122111100 011111 123566799999999999999999999999988763
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=330.01 Aligned_cols=200 Identities=27% Similarity=0.351 Sum_probs=173.0
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCC-cchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceE
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH-DASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFK 237 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~ 237 (873)
.++|++.++||+|+||.||++.+..++..+|+|++..... .....+.+|++++++++|+||++++++| ..++..
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~ 78 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF-----YSDGEI 78 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEE-----EECCEE
Confidence 4689999999999999999999988999999999875422 2345789999999999999999999996 345689
Q ss_pred EEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEe
Q 002857 238 ALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVA 317 (873)
Q Consensus 238 ~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLs 317 (873)
++||||+++|+|.+++.. ...+++..+..++.|++.||.|||+ ..+|+|+||||+|||++.++.+||+
T Consensus 79 ~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~ 146 (333)
T cd06650 79 SICMEHMDGGSLDQVLKK----------AGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLC 146 (333)
T ss_pred EEEEecCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEe
Confidence 999999999999999842 3457888999999999999999993 2479999999999999999999999
Q ss_pred ccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCc
Q 002857 318 DFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDD 379 (873)
Q Consensus 318 DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~ 379 (873)
|||++..+.... .....|+..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 147 Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 147 DFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred eCCcchhhhhhc----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 999997553221 1234589999999999998999999999999999999999999975
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=333.62 Aligned_cols=243 Identities=20% Similarity=0.276 Sum_probs=193.0
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEeecc---CCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEEEEe
Q 002857 166 NLIGAGNFASVYKGILFEGAPAVAIKVFNFL---HHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKALVYE 242 (873)
Q Consensus 166 ~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~LV~E 242 (873)
+.||+|+||.||++....+++.||||++... .......+.+|+.+++.++||||+++++++ ...+..++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~~lv~E 75 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSF-----QTKDRLCFVME 75 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-----EcCCEEEEEEe
Confidence 4699999999999999889999999999743 223446788899999999999999999885 45678999999
Q ss_pred ecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEeccccc
Q 002857 243 FMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIA 322 (873)
Q Consensus 243 y~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDFGla 322 (873)
|+++|+|.+++. ....+++.++..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 76 y~~~g~L~~~l~----------~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~ 142 (328)
T cd05593 76 YVNGGELFFHLS----------RERVFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLC 142 (328)
T ss_pred CCCCCCHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCC
Confidence 999999998884 2356899999999999999999999 899999999999999999999999999998
Q ss_pred cccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCchhHHHH
Q 002857 323 RFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPERVEEI 402 (873)
Q Consensus 323 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~~l~el 402 (873)
+...... .......||..|+|||++.+..++.++|||||||++|||++|+.||....... +
T Consensus 143 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~-----------------~ 203 (328)
T cd05593 143 KEGITDA--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-----------------L 203 (328)
T ss_pred ccCCCcc--cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH-----------------H
Confidence 7532211 12223468999999999999999999999999999999999999996521110 0
Q ss_pred hhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCC-----CHHHHHHH
Q 002857 403 VDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERM-----KINDVELG 464 (873)
Q Consensus 403 id~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRP-----Tm~EVl~~ 464 (873)
....+.... ..|. .....+.+++.+||+.||++|| ++.|+++.
T Consensus 204 ~~~~~~~~~----------~~p~---------~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 204 FELILMEDI----------KFPR---------TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred HHHhccCCc----------cCCC---------CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 000000000 0000 0122467899999999999997 88888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=321.19 Aligned_cols=263 Identities=24% Similarity=0.345 Sum_probs=200.0
Q ss_pred hhcCCCcceeecccCceEEEEEEEcC-----CCcEEEEEEeeccCC-cchhHHHHHHHHHHhhhhccceeeeeeeecccc
Q 002857 158 ATKGFSSENLIGAGNFASVYKGILFE-----GAPAVAIKVFNFLHH-DASKSFTVECEVMRNIIHRKIIKVVTACSRVDY 231 (873)
Q Consensus 158 at~~f~~~~~LG~G~fG~VYkg~~~~-----~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~ 231 (873)
.+++|.+.+.||+|+||.||+|.+.. .+..||+|.+..... .....|.+|+.++++++|+||+++++++.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~---- 79 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSF---- 79 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEc----
Confidence 35678999999999999999999876 667899998864332 23456899999999999999999999863
Q ss_pred cCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCC
Q 002857 232 QGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDE 311 (873)
Q Consensus 232 ~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~ 311 (873)
.....++||||+++++|.+++..... .......+++..++.++.||+.||+||| +.+++|+||||+|||++.+
T Consensus 80 -~~~~~~lv~e~~~g~~L~~~i~~~~~---~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~ 152 (277)
T cd05036 80 -ERLPRFILLELMAGGDLKSFLRENRP---RPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCK 152 (277)
T ss_pred -cCCCcEEEEecCCCCCHHHHHHHhCC---CCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEecc
Confidence 34567999999999999999854211 1112346899999999999999999999 8899999999999999865
Q ss_pred C---CeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhh
Q 002857 312 M---TACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNL 387 (873)
Q Consensus 312 ~---~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l 387 (873)
+ .+||+|||+++................+..|+|||++.+..++.++|||||||++|||++ |..||.......
T Consensus 153 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~--- 229 (277)
T cd05036 153 GPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE--- 229 (277)
T ss_pred CCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---
Confidence 4 699999999986633221111112234568999999999999999999999999999997 999986532111
Q ss_pred HHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHH
Q 002857 388 QNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLR 466 (873)
Q Consensus 388 ~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le 466 (873)
+.+.+....... .|. .+...+.+++.+||+.+|++||++.+|++.|+
T Consensus 230 -----------~~~~~~~~~~~~------------~~~---------~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 230 -----------VMEFVTGGGRLD------------PPK---------GCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred -----------HHHHHHcCCcCC------------CCC---------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 111111000000 000 11235788999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=319.07 Aligned_cols=279 Identities=20% Similarity=0.230 Sum_probs=197.9
Q ss_pred CCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCC--cchhHHHHHHHHHHhh---hhccceeeeeeeecccccCCc
Q 002857 161 GFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH--DASKSFTVECEVMRNI---IHRKIIKVVTACSRVDYQGND 235 (873)
Q Consensus 161 ~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L---~HpNIV~llg~c~~~~~~~~~ 235 (873)
+|++.+.||+|+||.||+|.+..+++.||+|.++.... .....+.+|+++++++ +|+||+++++++.........
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 47889999999999999999999999999999874322 2234567788887766 699999999987543333456
Q ss_pred eEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeE
Q 002857 236 FKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTAC 315 (873)
Q Consensus 236 ~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vK 315 (873)
..++||||+.+ +|.+++.. .....+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+|
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~--------~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~k 148 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDK--------VPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVK 148 (288)
T ss_pred eEEEEEccccc-CHHHHHHh--------cCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEE
Confidence 68999999974 89888843 22345899999999999999999999 89999999999999999999999
Q ss_pred EeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcC
Q 002857 316 VADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSAL 395 (873)
Q Consensus 316 LsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~ 395 (873)
|+|||+++...... ......+|..|+|||++.+..++.++|||||||++|||++|+.||....... .+........
T Consensus 149 l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~-~~~~~~~~~~ 224 (288)
T cd07863 149 LADFGLARIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD-QLGKIFDLIG 224 (288)
T ss_pred ECccCccccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH-HHHHHHHHhC
Confidence 99999998654322 1223457899999999998899999999999999999999999986532211 1111110000
Q ss_pred chhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 396 PERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 396 ~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
........ ..+.. . ......... ........+....+.+++.+||+.||++|||+.|++.
T Consensus 225 ~~~~~~~~-~~~~~--~----~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 225 LPPEDDWP-RDVTL--P----RGAFSPRGP-RPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred CCChhhCc-ccccc--c----ccccCCCCC-CchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00000000 00000 0 000000000 0001111122345789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=319.83 Aligned_cols=265 Identities=21% Similarity=0.346 Sum_probs=202.0
Q ss_pred hcCCCcceeecccCceEEEEEEEcCC-----CcEEEEEEeeccCC-cchhHHHHHHHHHHhhhhccceeeeeeeeccccc
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEG-----APAVAIKVFNFLHH-DASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQ 232 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~-----g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~ 232 (873)
.++|++.+.||+|+||.||+|.+... +..||+|.+..... .....+.+|+.+++.++|+||+++++++ .
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~ 79 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVV-----S 79 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEE-----c
Confidence 35788899999999999999988643 37899999864332 3345788999999999999999999996 3
Q ss_pred CCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCC
Q 002857 233 GNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEM 312 (873)
Q Consensus 233 ~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~ 312 (873)
.....++||||+++|+|.+++...............+++..++.++.||+.||.||| +.+|+|+||||+|||++.++
T Consensus 80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~ 156 (277)
T cd05032 80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDL 156 (277)
T ss_pred CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCC
Confidence 456789999999999999999642211111112345788999999999999999999 89999999999999999999
Q ss_pred CeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHHH
Q 002857 313 TACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWV 391 (873)
Q Consensus 313 ~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~~ 391 (873)
.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||+| |+.||....... ....
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~~~~- 233 (277)
T cd05032 157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE--VLKF- 233 (277)
T ss_pred CEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH--HHHH-
Confidence 999999999986543322222223346789999999988889999999999999999998 999986422111 1110
Q ss_pred hhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHH
Q 002857 392 QSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLR 466 (873)
Q Consensus 392 ~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le 466 (873)
+.+.... ..|. .+...+.+++.+||+.+|++|||+.+|++.|+
T Consensus 234 ----------~~~~~~~-------------~~~~---------~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 234 ----------VIDGGHL-------------DLPE---------NCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred ----------HhcCCCC-------------CCCC---------CCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 0000000 0000 01335789999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=312.33 Aligned_cols=250 Identities=22% Similarity=0.295 Sum_probs=200.5
Q ss_pred CCCcceeecccCceEEEEEEEcCCCcEEEEEEeecc--CCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEE
Q 002857 161 GFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFL--HHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKA 238 (873)
Q Consensus 161 ~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~ 238 (873)
+|+..+.||+|++|.||+|++..+++.|++|.+... .....+.+.+|++++++++|+||+++++++ ......+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 75 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESF-----LDKGKLN 75 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeee-----ccCCEEE
Confidence 477889999999999999999889999999998643 233456789999999999999999999985 4456899
Q ss_pred EEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEec
Q 002857 239 LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVAD 318 (873)
Q Consensus 239 LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsD 318 (873)
+||||+++++|.++++. .....+++..++.++.|++.||.||| +.+|+|+||||+||+++.++.++|+|
T Consensus 76 lv~e~~~~~~L~~~l~~--------~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~d 144 (256)
T cd08529 76 IVMEYAENGDLHKLLKM--------QRGRPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGD 144 (256)
T ss_pred EEEEeCCCCcHHHHHHH--------hcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcc
Confidence 99999999999999853 22456889999999999999999999 89999999999999999999999999
Q ss_pred cccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCchh
Q 002857 319 FGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPER 398 (873)
Q Consensus 319 FGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~~ 398 (873)
||+++.+..... ......++..|+|||++.+..++.++||||||+++|||++|+.||...... ...
T Consensus 145 f~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~---------- 210 (256)
T cd08529 145 LGVAKLLSDNTN--FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG--ALI---------- 210 (256)
T ss_pred cccceeccCccc--hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH--HHH----------
Confidence 999986643321 122345788999999999999999999999999999999999999653211 000
Q ss_pred HHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 399 VEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 399 l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
..+.. ... +... ......+.+++.+||+.+|++||++.+|++
T Consensus 211 -~~~~~----~~~------------~~~~------~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 211 -LKIIR----GVF------------PPVS------QMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred -HHHHc----CCC------------CCCc------cccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 00000 000 0000 011235789999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=319.47 Aligned_cols=269 Identities=21% Similarity=0.372 Sum_probs=207.1
Q ss_pred hcCCCcceeecccCceEEEEEEEcC----CCcEEEEEEeeccC-CcchhHHHHHHHHHHhhhhccceeeeeeeecccccC
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFE----GAPAVAIKVFNFLH-HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQG 233 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~----~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~ 233 (873)
.++|++.+.||+|+||.||+|.+.. .+..||+|++.... ......+.+|+.++++++|+||+++++++. ..
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~----~~ 80 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCI----ED 80 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe----cC
Confidence 4678899999999999999999865 25789999986432 233467889999999999999999999874 33
Q ss_pred CceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCC
Q 002857 234 NDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMT 313 (873)
Q Consensus 234 ~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~ 313 (873)
+...++++||+++|+|.+++...... .......+++.+++.++.||+.||+||| +.+++|+||||+||++++++.
T Consensus 81 ~~~~~~~~~~~~~~~L~~~l~~~~~~--~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~ 155 (280)
T cd05043 81 GEPPFVLYPYMNWGNLKLFLQQCRLG--EANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQ 155 (280)
T ss_pred CCCCEEEEEcCCCCcHHHHHHhcccc--ccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCc
Confidence 56789999999999999998541111 0112256899999999999999999999 899999999999999999999
Q ss_pred eEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHHHh
Q 002857 314 ACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQ 392 (873)
Q Consensus 314 vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~~~ 392 (873)
+||+|||+++.+.............++..|+|||++.+..++.++||||||+++||+++ |+.||.... ...+..++.
T Consensus 156 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--~~~~~~~~~ 233 (280)
T cd05043 156 VKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEID--PFEMAAYLK 233 (280)
T ss_pred EEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCC--HHHHHHHHH
Confidence 99999999986543322222222346778999999988889999999999999999999 999986521 111111111
Q ss_pred hcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHHHHh
Q 002857 393 SALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLIKKK 471 (873)
Q Consensus 393 ~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i~~~ 471 (873)
.. .. .+.. ..+...+.+++.+||+.+|++|||+.+|++.|+.+.++
T Consensus 234 ~~------------~~--------------~~~~-------~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 234 DG------------YR--------------LAQP-------INCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred cC------------CC--------------CCCC-------CcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 00 00 0000 01133578899999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=320.99 Aligned_cols=265 Identities=24% Similarity=0.412 Sum_probs=199.6
Q ss_pred cCCCcceeecccCceEEEEEEEc----CCCcEEEEEEeeccCC-cchhHHHHHHHHHHhhhhccceeeeeeeecccccCC
Q 002857 160 KGFSSENLIGAGNFASVYKGILF----EGAPAVAIKVFNFLHH-DASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGN 234 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~----~~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~ 234 (873)
++|++.+.||+|+||.||+|.+. ..+..||+|.+..... .....+.+|++++++++|+||+++++++ ..+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~ 79 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVV-----TQE 79 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEE-----ecC
Confidence 45788899999999999999853 3557899999874332 2336788999999999999999999985 445
Q ss_pred ceEEEEEeecCCCChhhhccccccc-------ccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCee
Q 002857 235 DFKALVYEFMPNGSLEEWIHPITEE-------DKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNIL 307 (873)
Q Consensus 235 ~~~~LV~Ey~~~GSL~~~L~~~~~~-------~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNIL 307 (873)
...++||||+++++|.+++...... .........+++.+++.++.|++.||+||| +.+|+||||||+|||
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nil 156 (283)
T cd05090 80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNIL 156 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEE
Confidence 6789999999999999998421100 000111345888999999999999999999 899999999999999
Q ss_pred eCCCCCeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchh
Q 002857 308 LNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLN 386 (873)
Q Consensus 308 Ld~~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~ 386 (873)
+++++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||...... .
T Consensus 157 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~--~ 234 (283)
T cd05090 157 IGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ--E 234 (283)
T ss_pred EcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH--H
Confidence 99999999999999986543322222223345778999999988889999999999999999999 98898642110 1
Q ss_pred hHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHH
Q 002857 387 LQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLR 466 (873)
Q Consensus 387 l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le 466 (873)
+.+.++.... ...+. .+...+.+++.+||+.+|++||++.+|+++|.
T Consensus 235 ------------~~~~~~~~~~------------~~~~~---------~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 281 (283)
T cd05090 235 ------------VIEMVRKRQL------------LPCSE---------DCPPRMYSLMTECWQEGPSRRPRFKDIHTRLR 281 (283)
T ss_pred ------------HHHHHHcCCc------------CCCCC---------CCCHHHHHHHHHHcccCcccCcCHHHHHHHhh
Confidence 1111110000 00000 11235778999999999999999999999886
Q ss_pred H
Q 002857 467 L 467 (873)
Q Consensus 467 ~ 467 (873)
.
T Consensus 282 ~ 282 (283)
T cd05090 282 S 282 (283)
T ss_pred c
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=333.66 Aligned_cols=248 Identities=26% Similarity=0.369 Sum_probs=189.2
Q ss_pred CCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCC-cchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEE
Q 002857 161 GFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH-DASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKAL 239 (873)
Q Consensus 161 ~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~L 239 (873)
+|+..++||+|+||.||+|++..+++.||||++..... .....+.+|++++++++|+||+++++++ ..++..++
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~l 149 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMF-----DHNGEIQV 149 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEe-----ccCCeEEE
Confidence 44567899999999999999988899999999864432 2346789999999999999999999985 45667899
Q ss_pred EEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEecc
Q 002857 240 VYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADF 319 (873)
Q Consensus 240 V~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDF 319 (873)
||||+++|+|.+.. .+++..+..|+.||+.||+||| +.+|+||||||+|||++.++.+||+||
T Consensus 150 v~e~~~~~~L~~~~--------------~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~Df 212 (353)
T PLN00034 150 LLEFMDGGSLEGTH--------------IADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADF 212 (353)
T ss_pred EEecCCCCcccccc--------------cCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccc
Confidence 99999999987543 2345678889999999999999 899999999999999999999999999
Q ss_pred ccccccccccccccccccccccccCCCcccCC-----CCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhc
Q 002857 320 GIARFLEATNEQTSSIGVKGTTGYIAPEYGMG-----HETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSA 394 (873)
Q Consensus 320 Gla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-----~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~ 394 (873)
|+++.+..... ......||..|+|||++.. ...+.++|||||||++|||++|+.||....... +.
T Consensus 213 G~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~--~~------ 282 (353)
T PLN00034 213 GVSRILAQTMD--PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD--WA------ 282 (353)
T ss_pred ccceecccccc--cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc--HH------
Confidence 99986543221 1223468999999998743 234568999999999999999999997321111 00
Q ss_pred CchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHH
Q 002857 395 LPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELG 464 (873)
Q Consensus 395 ~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~ 464 (873)
.+........ .+... ..+...+.+++.+||+.||++|||+.||++.
T Consensus 283 ------~~~~~~~~~~------------~~~~~------~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 283 ------SLMCAICMSQ------------PPEAP------ATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred ------HHHHHHhccC------------CCCCC------CccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000000 00000 0112357889999999999999999998763
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=323.51 Aligned_cols=291 Identities=22% Similarity=0.266 Sum_probs=214.7
Q ss_pred HHHHhhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEee--ccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccc
Q 002857 154 ALYSATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFN--FLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDY 231 (873)
Q Consensus 154 el~~at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~--~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~ 231 (873)
+...+...|...+.||+|+||.|..|.+..+++.||||.+. .......++..+|+++|+.++|+||+.++.+......
T Consensus 16 ~~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~ 95 (359)
T KOG0660|consen 16 ELFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSR 95 (359)
T ss_pred eEEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccc
Confidence 34445667777899999999999999999999999999986 4455566888999999999999999999999765333
Q ss_pred cCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCC
Q 002857 232 QGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDE 311 (873)
Q Consensus 232 ~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~ 311 (873)
..-...|+|+|+| .-+|.+.|+ ....|+......++.||++||.|+| +.+|+||||||+|+|++.+
T Consensus 96 ~~f~DvYiV~elM-etDL~~iik----------~~~~L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~ 161 (359)
T KOG0660|consen 96 DKFNDVYLVFELM-ETDLHQIIK----------SQQDLTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNAD 161 (359)
T ss_pred cccceeEEehhHH-hhHHHHHHH----------cCccccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccC
Confidence 4556789999999 559999994 3455999999999999999999999 9999999999999999999
Q ss_pred CCeEEeccccccccccccccccccccccccccCCCcccCC-CCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHH
Q 002857 312 MTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMG-HETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNW 390 (873)
Q Consensus 312 ~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~ 390 (873)
...||+|||+|+...........+..+.|..|+|||++.. ..|+...||||.|||+.||++|+..|.+.. ..+....
T Consensus 162 c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d--~v~Ql~l 239 (359)
T KOG0660|consen 162 CDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKD--YVHQLQL 239 (359)
T ss_pred CCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCc--hHHHHHH
Confidence 9999999999998765433333456778999999998654 589999999999999999999999997632 2222222
Q ss_pred HhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 391 VQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 391 ~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
+...+...-.+.+... ..+. .+..+......|..+ ............++|+.+||..||.+|+|++|.++
T Consensus 240 I~~~lGtP~~e~l~~i-~s~~-ar~yi~slp~~p~~~-f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 240 ILELLGTPSEEDLQKI-RSEK-ARPYIKSLPQIPKQP-FSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred HHHhcCCCCHHHHHHh-ccHH-HHHHHHhCCCCCCCC-HHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 2222222111111111 1000 011111111111111 11122233345779999999999999999998754
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=318.03 Aligned_cols=255 Identities=22% Similarity=0.287 Sum_probs=198.5
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEE
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKAL 239 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~L 239 (873)
++|++.+.||+|+||.||+|++..+++.||+|++..........+.+|+.++++++|+||+++++++ ..++..++
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~-----~~~~~~~i 83 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSY-----LSREKLWI 83 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEE-----EeCCEEEE
Confidence 4789999999999999999999889999999999755545556788999999999999999999986 34567899
Q ss_pred EEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEecc
Q 002857 240 VYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADF 319 (873)
Q Consensus 240 V~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDF 319 (873)
||||+++++|.++++. ...+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+||
T Consensus 84 v~e~~~~~~L~~~~~~----------~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~df 150 (267)
T cd06646 84 CMEYCGGGSLQDIYHV----------TGPLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADF 150 (267)
T ss_pred EEeCCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcC
Confidence 9999999999998842 345789999999999999999999 899999999999999999999999999
Q ss_pred ccccccccccccccccccccccccCCCcccC---CCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCc
Q 002857 320 GIARFLEATNEQTSSIGVKGTTGYIAPEYGM---GHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALP 396 (873)
Q Consensus 320 Gla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~---~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~ 396 (873)
|+++....... ......++..|+|||.+. ...++.++||||||+++|||++|+.||........ ...+
T Consensus 151 g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~-~~~~------ 221 (267)
T cd06646 151 GVAAKITATIA--KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-LFLM------ 221 (267)
T ss_pred ccceeeccccc--ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh-heee------
Confidence 99986532211 112345888999999874 34578899999999999999999999854211100 0000
Q ss_pred hhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHH
Q 002857 397 ERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGL 465 (873)
Q Consensus 397 ~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~L 465 (873)
....+. .+..... ......+.+++.+||+.+|++|||+++|++.|
T Consensus 222 ------~~~~~~--------------~~~~~~~----~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 222 ------SKSNFQ--------------PPKLKDK----TKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred ------ecCCCC--------------CCCCccc----cccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 000000 0000000 00123578899999999999999999998643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=327.16 Aligned_cols=260 Identities=22% Similarity=0.308 Sum_probs=200.2
Q ss_pred HHhhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC--------------CcchhHHHHHHHHHHhhhhcccee
Q 002857 156 YSATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH--------------HDASKSFTVECEVMRNIIHRKIIK 221 (873)
Q Consensus 156 ~~at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~--------------~~~~~~f~~Ei~iL~~L~HpNIV~ 221 (873)
....++|++.+.||+|.||.|-+|+...+++.||||++.+.. ....+...+||.+|++++|+|||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 345678999999999999999999999999999999985221 112257899999999999999999
Q ss_pred eeeeeecccccCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccC
Q 002857 222 VVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDI 301 (873)
Q Consensus 222 llg~c~~~~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDL 301 (873)
|+.+..+ ...+..|||+|||..|.+...= .....+++.+.+++++++..||+||| .++||||||
T Consensus 173 LiEvLDD---P~s~~~YlVley~s~G~v~w~p----------~d~~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDI 236 (576)
T KOG0585|consen 173 LIEVLDD---PESDKLYLVLEYCSKGEVKWCP----------PDKPELSEQQARKYLRDVVLGLEYLH---YQGIIHRDI 236 (576)
T ss_pred EEEeecC---cccCceEEEEEeccCCccccCC----------CCcccccHHHHHHHHHHHHHHHHHHH---hcCeecccc
Confidence 9998532 4566799999999988876532 12223999999999999999999999 999999999
Q ss_pred CCCCeeeCCCCCeEEeccccccccccccc---cccccccccccccCCCcccCCCC----CCcchhhHhHHHHHHHHHhCC
Q 002857 302 KPSNILLNDEMTACVADFGIARFLEATNE---QTSSIGVKGTTGYIAPEYGMGHE----TSSYGDVYSFGILLLEMFTGL 374 (873)
Q Consensus 302 KpsNILLd~~~~vKLsDFGla~~~~~~~~---~~~~~~~~Gt~~Y~APE~l~~~~----~s~ksDVwSfGvvL~ELlTGk 374 (873)
||+|+||++++++||+|||.+..+..... .......+||+.|+|||...++. .+.+.||||+||+||-|+.|+
T Consensus 237 KPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~ 316 (576)
T KOG0585|consen 237 KPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQ 316 (576)
T ss_pred chhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhcc
Confidence 99999999999999999999987633221 11223367999999999887742 356789999999999999999
Q ss_pred CCCCcccccchhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCC
Q 002857 375 RPSDDMFKDNLNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGE 454 (873)
Q Consensus 375 ~Pf~~~~~~~~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~e 454 (873)
.||.+.+ ..++.+...... +..|... +.-+.+.+|++++|+.||++
T Consensus 317 ~PF~~~~-----------------~~~l~~KIvn~p----------L~fP~~p-------e~~e~~kDli~~lL~KdP~~ 362 (576)
T KOG0585|consen 317 LPFFDDF-----------------ELELFDKIVNDP----------LEFPENP-------EINEDLKDLIKRLLEKDPEQ 362 (576)
T ss_pred CCcccch-----------------HHHHHHHHhcCc----------ccCCCcc-------cccHHHHHHHHHHhhcChhh
Confidence 9996521 112222221110 1111111 12335778999999999999
Q ss_pred CCCHHHHHHHH
Q 002857 455 RMKINDVELGL 465 (873)
Q Consensus 455 RPTm~EVl~~L 465 (873)
|.+..+|....
T Consensus 363 Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 363 RITLPDIKLHP 373 (576)
T ss_pred eeehhhheecc
Confidence 99999885443
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=316.13 Aligned_cols=261 Identities=22% Similarity=0.305 Sum_probs=204.5
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC---CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCce
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH---HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDF 236 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~ 236 (873)
++|++.+.||+|+||.||+|....+++.+|||.+.... ......+.+|+.+++.++|+||+++++++ ..++.
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~ 76 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASF-----IEDNE 76 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhhee-----EeCCe
Confidence 46888899999999999999998899999999876432 22335788999999999999999999986 34567
Q ss_pred EEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEE
Q 002857 237 KALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACV 316 (873)
Q Consensus 237 ~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKL 316 (873)
.++||||+++++|.+++... ......+++..++.++.||+.||.||| +.+|+|+||||+||+++.++.++|
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l 147 (267)
T cd08229 77 LNIVLELADAGDLSRMIKHF------KKQKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKL 147 (267)
T ss_pred EEEEEEecCCCCHHHHHHHh------hccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEE
Confidence 89999999999999988521 123456899999999999999999999 899999999999999999999999
Q ss_pred eccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCc
Q 002857 317 ADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALP 396 (873)
Q Consensus 317 sDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~ 396 (873)
+|||++........ ......++..|+|||++.+..++.++||||||+++|||++|..||.....+...+..
T Consensus 148 ~dfg~~~~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~------- 218 (267)
T cd08229 148 GDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK------- 218 (267)
T ss_pred CcchhhhccccCCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhh-------
Confidence 99999886543221 122345889999999998888999999999999999999999998642111100000
Q ss_pred hhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHH
Q 002857 397 ERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLI 468 (873)
Q Consensus 397 ~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i 468 (873)
...... .+... . ......+.+++.+||+.+|++||||.+|+++++++
T Consensus 219 --------~~~~~~------------~~~~~--~---~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 219 --------KIEQCD------------YPPLP--S---DHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred --------hhhcCC------------CCCCC--c---ccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 000000 00000 0 01233578899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=316.87 Aligned_cols=259 Identities=24% Similarity=0.296 Sum_probs=199.7
Q ss_pred HhhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhh-hhccceeeeeeeeccccc-CC
Q 002857 157 SATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNI-IHRKIIKVVTACSRVDYQ-GN 234 (873)
Q Consensus 157 ~at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~llg~c~~~~~~-~~ 234 (873)
.++..|++.+.||+|+||.||+|.+..+++.||+|++.... .....+..|+.++.++ +|+||+++++++...... ..
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 45678889999999999999999998899999999987543 3346788999999999 799999999997543211 13
Q ss_pred ceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCe
Q 002857 235 DFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTA 314 (873)
Q Consensus 235 ~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~v 314 (873)
...++||||+++|+|.+++.. .....+++..+..++.|++.||+||| +.+|+|+||||+||++++++.+
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~--------~~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~ 150 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKN--------TKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEV 150 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHh--------ccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCE
Confidence 468999999999999999853 22346889999999999999999999 8899999999999999999999
Q ss_pred EEeccccccccccccccccccccccccccCCCcccC-----CCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHH
Q 002857 315 CVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGM-----GHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQN 389 (873)
Q Consensus 315 KLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~-----~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~ 389 (873)
||+|||+++....... ......|+..|+|||++. +..++.++|||||||++|||++|+.||....... .
T Consensus 151 ~l~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~----~ 224 (272)
T cd06637 151 KLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR----A 224 (272)
T ss_pred EEccCCCceecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH----H
Confidence 9999999986533221 122345889999999986 3457889999999999999999999986421110 0
Q ss_pred HHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 390 WVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 390 ~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
.. .+... ... .... . .+...+.+++.+||+.+|.+|||+.||++
T Consensus 225 ~~---------~~~~~-~~~------------~~~~----~----~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 225 LF---------LIPRN-PAP------------RLKS----K----KWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred HH---------HHhcC-CCC------------CCCC----C----CcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 00 00000 000 0000 0 01234778999999999999999999864
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=318.01 Aligned_cols=273 Identities=24% Similarity=0.364 Sum_probs=204.5
Q ss_pred cCCCcceeecccCceEEEEEEEcC----CCcEEEEEEeeccCCc-chhHHHHHHHHHHhhhhccceeeeeeeecccccCC
Q 002857 160 KGFSSENLIGAGNFASVYKGILFE----GAPAVAIKVFNFLHHD-ASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGN 234 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~----~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~ 234 (873)
+.|+..+.||+|+||.||+|++.. ++..||||+++..... ..+.|.+|++++++++|+||+++++++.. ...
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~---~~~ 80 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEK---PGG 80 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeec---CCC
Confidence 357778999999999999998743 3788999999755443 45789999999999999999999998642 235
Q ss_pred ceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCe
Q 002857 235 DFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTA 314 (873)
Q Consensus 235 ~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~v 314 (873)
...++||||+++++|.+++.. ....+++..++.++.|++.||+||| +.+|+|+||||+||+++.++.+
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~---------~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~ 148 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQR---------HRDQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLV 148 (284)
T ss_pred CceEEEEecCCCCCHHHHHHh---------CccccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCE
Confidence 578999999999999999953 2336899999999999999999999 8999999999999999999999
Q ss_pred EEecccccccccccccc-ccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhh
Q 002857 315 CVADFGIARFLEATNEQ-TSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQS 393 (873)
Q Consensus 315 KLsDFGla~~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~ 393 (873)
+|+|||++......... .......++..|+|||.+.+..++.++||||||+++|||+||+.|+................
T Consensus 149 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~ 228 (284)
T cd05038 149 KISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQG 228 (284)
T ss_pred EEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccc
Confidence 99999999876532211 11112235667999999988899999999999999999999999986532211110000000
Q ss_pred -cCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHH
Q 002857 394 -ALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLI 468 (873)
Q Consensus 394 -~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i 468 (873)
.....+.+.+.... ..+. ...+..++.+++.+||+.+|++||||.||+++|+.+
T Consensus 229 ~~~~~~~~~~~~~~~--------------~~~~-------~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 229 QMIVTRLLELLKEGE--------------RLPR-------PPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred cccHHHHHHHHHcCC--------------cCCC-------CccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 00001111111000 0000 011234688999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=321.59 Aligned_cols=269 Identities=22% Similarity=0.364 Sum_probs=204.3
Q ss_pred hhcCCCcceeecccCceEEEEEEEcCC-----CcEEEEEEeeccCC-cchhHHHHHHHHHHhh-hhccceeeeeeeeccc
Q 002857 158 ATKGFSSENLIGAGNFASVYKGILFEG-----APAVAIKVFNFLHH-DASKSFTVECEVMRNI-IHRKIIKVVTACSRVD 230 (873)
Q Consensus 158 at~~f~~~~~LG~G~fG~VYkg~~~~~-----g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L-~HpNIV~llg~c~~~~ 230 (873)
..++|++.+.||+|+||.||++.+... ...+|+|++..... .....+.+|++++.++ +|+||+++++++
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~---- 85 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVC---- 85 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE----
Confidence 345788899999999999999987543 36899999874322 2345688999999999 899999999986
Q ss_pred ccCCceEEEEEeecCCCChhhhcccccccc------cccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCC
Q 002857 231 YQGNDFKALVYEFMPNGSLEEWIHPITEED------KRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPS 304 (873)
Q Consensus 231 ~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~------~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKps 304 (873)
..++..++||||+++|+|.++++...... ........+++..++.++.||+.||+||| +.+|+||||||+
T Consensus 86 -~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~ 161 (293)
T cd05053 86 -TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAAR 161 (293)
T ss_pred -cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCcccccccee
Confidence 34567899999999999999985421000 00123456899999999999999999999 899999999999
Q ss_pred CeeeCCCCCeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCccccc
Q 002857 305 NILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKD 383 (873)
Q Consensus 305 NILLd~~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~ 383 (873)
|||+++++.+||+|||+++.+.............++..|+|||++.+..++.++||||||+++|||++ |..||......
T Consensus 162 Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 241 (293)
T cd05053 162 NVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE 241 (293)
T ss_pred eEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH
Confidence 99999999999999999987644322222222335678999999988899999999999999999998 98888642111
Q ss_pred chhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 384 NLNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 384 ~~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
. +.+.+...... ..+ ..+...+.+++.+||+.+|++||||.||++
T Consensus 242 ~--------------~~~~~~~~~~~------------~~~---------~~~~~~~~~li~~~l~~~p~~Rps~~eil~ 286 (293)
T cd05053 242 E--------------LFKLLKEGYRM------------EKP---------QNCTQELYHLMRDCWHEVPSQRPTFKQLVE 286 (293)
T ss_pred H--------------HHHHHHcCCcC------------CCC---------CCCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 0 01111000000 000 011335789999999999999999999999
Q ss_pred HHHHHH
Q 002857 464 GLRLIK 469 (873)
Q Consensus 464 ~Le~i~ 469 (873)
.|+.+.
T Consensus 287 ~l~~~~ 292 (293)
T cd05053 287 DLDRML 292 (293)
T ss_pred HHHHhh
Confidence 998763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=320.79 Aligned_cols=200 Identities=25% Similarity=0.328 Sum_probs=171.8
Q ss_pred CCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCC---cchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceE
Q 002857 161 GFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH---DASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFK 237 (873)
Q Consensus 161 ~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~ 237 (873)
+|++.++||+|+||.||++.+..+++.||+|++..... .....+.+|+.++++++|+||+++++.+ ..++..
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~ 75 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY-----ETKDAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeee-----cCCCeE
Confidence 47888999999999999999988899999999864321 2234578899999999999999999985 445679
Q ss_pred EEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEe
Q 002857 238 ALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVA 317 (873)
Q Consensus 238 ~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLs 317 (873)
++||||+++|+|.+++.. .....+++..+..++.|++.||.||| +.+|+||||||+||++++++.++|+
T Consensus 76 ~lv~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~ 144 (285)
T cd05605 76 CLVLTLMNGGDLKFHIYN--------MGNPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRIS 144 (285)
T ss_pred EEEEeccCCCcHHHHHHh--------cCcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEe
Confidence 999999999999988843 22346899999999999999999999 8999999999999999999999999
Q ss_pred ccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCc
Q 002857 318 DFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDD 379 (873)
Q Consensus 318 DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~ 379 (873)
|||+++....... .....|+..|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 145 Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~ 203 (285)
T cd05605 145 DLGLAVEIPEGET---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQ 203 (285)
T ss_pred eCCCceecCCCCc---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCC
Confidence 9999986533221 1234589999999999988999999999999999999999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=329.35 Aligned_cols=270 Identities=20% Similarity=0.303 Sum_probs=201.4
Q ss_pred cCCCcceeecccCceEEEEEEEc-----CCCcEEEEEEeeccCC-cchhHHHHHHHHHHhh-hhccceeeeeeeeccccc
Q 002857 160 KGFSSENLIGAGNFASVYKGILF-----EGAPAVAIKVFNFLHH-DASKSFTVECEVMRNI-IHRKIIKVVTACSRVDYQ 232 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~-----~~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L-~HpNIV~llg~c~~~~~~ 232 (873)
++|.+.+.||+|+||.||+|.+. .+++.||||+++.... .....+.+|+.++.++ +|+||++++++|. .
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~----~ 82 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT----K 82 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceee----c
Confidence 57889999999999999999853 3567899999974332 2345688999999999 6899999999874 3
Q ss_pred CCceEEEEEeecCCCChhhhccccccccc---------------------------------------------------
Q 002857 233 GNDFKALVYEFMPNGSLEEWIHPITEEDK--------------------------------------------------- 261 (873)
Q Consensus 233 ~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~--------------------------------------------------- 261 (873)
.+...++||||+++|+|.++++.......
T Consensus 83 ~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (343)
T cd05103 83 PGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVE 162 (343)
T ss_pred CCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccch
Confidence 34567899999999999999853110000
Q ss_pred ------ccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEecccccccccccccccccc
Q 002857 262 ------RHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSI 335 (873)
Q Consensus 262 ------~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDFGla~~~~~~~~~~~~~ 335 (873)
.......+++.++..++.||++||+||| +.+|+||||||+|||++.++++||+|||+++............
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 239 (343)
T cd05103 163 EEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG 239 (343)
T ss_pred hhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcC
Confidence 0001134788889999999999999999 8999999999999999999999999999998653332222222
Q ss_pred ccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHHHhhcCchhHHHHhhhhhhhhhhHH
Q 002857 336 GVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQSALPERVEEIVDTLFFKEIEEE 414 (873)
Q Consensus 336 ~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~~~~~~~~~l~elid~~L~~~~~~r 414 (873)
...++..|+|||++.+..++.++||||||+++|||++ |..||....... .+...+.....
T Consensus 240 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------------~~~~~~~~~~~------ 300 (343)
T cd05103 240 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-------------EFCRRLKEGTR------ 300 (343)
T ss_pred CCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH-------------HHHHHHhccCC------
Confidence 2345678999999988899999999999999999997 998986521110 00000000000
Q ss_pred HHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHHHH
Q 002857 415 ETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLIKK 470 (873)
Q Consensus 415 ~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i~~ 470 (873)
...|.. ....+.+++..||+.+|++|||+.||++.|+.+.+
T Consensus 301 ------~~~~~~---------~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 301 ------MRAPDY---------TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred ------CCCCCC---------CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 000110 11247889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=333.98 Aligned_cols=254 Identities=22% Similarity=0.317 Sum_probs=200.4
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeecc---CCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCce
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFL---HHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDF 236 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~ 236 (873)
++|.+.+.||+|+||.||+|++..+++.||||+++.. .......+..|++++..++|+||+++++++ ..++.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~ 75 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSF-----QDEEH 75 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhe-----ecCCe
Confidence 4789999999999999999999888999999999743 223456788999999999999999999885 55678
Q ss_pred EEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEE
Q 002857 237 KALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACV 316 (873)
Q Consensus 237 ~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKL 316 (873)
.++||||+++|+|.+++.. ...+++..++.++.||+.||+||| ..+|+||||||+|||++.++.+||
T Consensus 76 ~~lv~e~~~~~~L~~~l~~----------~~~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL 142 (350)
T cd05573 76 LYLVMEYMPGGDLMNLLIR----------KDVFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKL 142 (350)
T ss_pred EEEEEcCCCCCCHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEe
Confidence 9999999999999999843 256889999999999999999999 899999999999999999999999
Q ss_pred ecccccccccccc---------------------------ccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHH
Q 002857 317 ADFGIARFLEATN---------------------------EQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLE 369 (873)
Q Consensus 317 sDFGla~~~~~~~---------------------------~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~E 369 (873)
+|||+++...... .........||..|+|||++.+..++.++|||||||++||
T Consensus 143 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~e 222 (350)
T cd05573 143 ADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYE 222 (350)
T ss_pred ecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhh
Confidence 9999998654332 0011223468999999999999999999999999999999
Q ss_pred HHhCCCCCCcccccchhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhc
Q 002857 370 MFTGLRPSDDMFKDNLNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSA 449 (873)
Q Consensus 370 LlTGk~Pf~~~~~~~~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~ 449 (873)
|++|+.||....... ....+.... .. ...|.... ....+.+++..|++
T Consensus 223 ll~g~~Pf~~~~~~~-------------~~~~i~~~~--~~----------~~~p~~~~-------~~~~~~~li~~ll~ 270 (350)
T cd05573 223 MLYGFPPFYSDTLQE-------------TYNKIINWK--ES----------LRFPPDPP-------VSPEAIDLICRLLC 270 (350)
T ss_pred hccCCCCCCCCCHHH-------------HHHHHhccC--Cc----------ccCCCCCC-------CCHHHHHHHHHHcc
Confidence 999999997532110 001111100 00 00011000 12347789999997
Q ss_pred cCcCCCCC-HHHHHHH
Q 002857 450 ELPGERMK-INDVELG 464 (873)
Q Consensus 450 ~dP~eRPT-m~EVl~~ 464 (873)
+|.+||+ +.|+++.
T Consensus 271 -dp~~R~~s~~~ll~h 285 (350)
T cd05573 271 -DPEDRLGSFEEIKSH 285 (350)
T ss_pred -ChhhcCCCHHHHhcC
Confidence 9999999 9998763
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=320.44 Aligned_cols=268 Identities=19% Similarity=0.318 Sum_probs=200.5
Q ss_pred hhcCCCcceeecccCceEEEEEEEcC-----CCcEEEEEEeeccCC-cchhHHHHHHHHHHhhhhccceeeeeeeecccc
Q 002857 158 ATKGFSSENLIGAGNFASVYKGILFE-----GAPAVAIKVFNFLHH-DASKSFTVECEVMRNIIHRKIIKVVTACSRVDY 231 (873)
Q Consensus 158 at~~f~~~~~LG~G~fG~VYkg~~~~-----~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~ 231 (873)
.+++|++.++||+|+||.||+|.... .+..||+|.++.... .....+.+|+.++++++|+||+++++++
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~----- 78 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVV----- 78 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE-----
Confidence 46789999999999999999997642 245799998764332 2234688899999999999999999985
Q ss_pred cCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCC
Q 002857 232 QGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDE 311 (873)
Q Consensus 232 ~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~ 311 (873)
......++||||+++|+|.+++...............+++..++.++.||+.||+||| +++|+||||||+|||++++
T Consensus 79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~ 155 (288)
T cd05061 79 SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHD 155 (288)
T ss_pred cCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCC
Confidence 3455789999999999999999642111111112344567788999999999999999 8999999999999999999
Q ss_pred CCeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHH
Q 002857 312 MTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNW 390 (873)
Q Consensus 312 ~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~ 390 (873)
+.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||.....+. ..
T Consensus 156 ~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~--~~-- 231 (288)
T cd05061 156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ--VL-- 231 (288)
T ss_pred CcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH--HH--
Confidence 9999999999986543222221222235678999999998899999999999999999999 788886421111 00
Q ss_pred HhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHH
Q 002857 391 VQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLI 468 (873)
Q Consensus 391 ~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i 468 (873)
..+.+...... + ..+...+.+++.+||+.+|++|||+.++++.|+..
T Consensus 232 ---------~~~~~~~~~~~-------------~---------~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 232 ---------KFVMDGGYLDQ-------------P---------DNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred ---------HHHHcCCCCCC-------------C---------CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 01111000000 0 01123588999999999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=332.54 Aligned_cols=283 Identities=20% Similarity=0.217 Sum_probs=199.0
Q ss_pred CCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC--CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEE
Q 002857 161 GFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH--HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKA 238 (873)
Q Consensus 161 ~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~ 238 (873)
+|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|+++++.++|+||+++++++...........+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4788999999999999999998899999999986432 22346788999999999999999999987432211223689
Q ss_pred EEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEec
Q 002857 239 LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVAD 318 (873)
Q Consensus 239 LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsD 318 (873)
+||||+. ++|.+++. ....+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|
T Consensus 81 lv~e~~~-~~l~~~~~----------~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~D 146 (372)
T cd07853 81 VVTELMQ-SDLHKIIV----------SPQPLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICD 146 (372)
T ss_pred EEeeccc-cCHHHHHh----------cCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEecc
Confidence 9999996 57888773 2456899999999999999999999 89999999999999999999999999
Q ss_pred cccccccccccccccccccccccccCCCcccCCC-CCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCch
Q 002857 319 FGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGH-ETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPE 397 (873)
Q Consensus 319 FGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~ 397 (873)
||+++....... .......++..|+|||++.+. .++.++|||||||++|||++|+.||....... ....+......
T Consensus 147 fg~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~i~~~~g~ 223 (372)
T cd07853 147 FGLARVEEPDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ--QLDLITDLLGT 223 (372)
T ss_pred ccceeecccCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHH--HHHHHHHHcCC
Confidence 999986543221 112234578899999998874 57899999999999999999999997632211 11111111111
Q ss_pred -hHHHHhhhhhhhhhhHHHHH-hhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHH
Q 002857 398 -RVEEIVDTLFFKEIEEEETV-YKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELG 464 (873)
Q Consensus 398 -~l~elid~~L~~~~~~r~~~-~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~ 464 (873)
...++... .. . .+... ......+...............+.+++.+||+.||++|||+.|+++.
T Consensus 224 ~~~~~~~~~-~~-~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 224 PSLEAMRSA-CE-G--ARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred CCHHHHHHh-hH-H--HHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 11111000 00 0 00000 00000010000000001113457899999999999999999998763
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=320.49 Aligned_cols=264 Identities=22% Similarity=0.372 Sum_probs=198.9
Q ss_pred CCCcceeecccCceEEEEEEEcCC-----CcEEEEEEeeccCCc-chhHHHHHHHHHHhhhhccceeeeeeeecccccCC
Q 002857 161 GFSSENLIGAGNFASVYKGILFEG-----APAVAIKVFNFLHHD-ASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGN 234 (873)
Q Consensus 161 ~f~~~~~LG~G~fG~VYkg~~~~~-----g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~ 234 (873)
+|.+.+.||+|+||.||+|.+..+ +..||||+++..... ....+.+|+.+++.++|+||+++++++ ...
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~-----~~~ 80 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVV-----TKE 80 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEE-----cCC
Confidence 467788999999999999987542 478999998744332 235688999999999999999999996 345
Q ss_pred ceEEEEEeecCCCChhhhccccccc------ccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeee
Q 002857 235 DFKALVYEFMPNGSLEEWIHPITEE------DKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILL 308 (873)
Q Consensus 235 ~~~~LV~Ey~~~GSL~~~L~~~~~~------~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILL 308 (873)
...++++||+++++|.+++...... .........+++..++.++.|++.||+||| +.+|+||||||+|||+
T Consensus 81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~ 157 (283)
T cd05091 81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLV 157 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEe
Confidence 5689999999999999998421100 001112345888899999999999999999 8999999999999999
Q ss_pred CCCCCeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhh
Q 002857 309 NDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNL 387 (873)
Q Consensus 309 d~~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l 387 (873)
++++.+||+|||+++...............+++.|+|||++.+..++.++||||||+++|||++ |..||...... ..
T Consensus 158 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--~~ 235 (283)
T cd05091 158 FDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ--DV 235 (283)
T ss_pred cCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH--HH
Confidence 9999999999999886543322222223346788999999988889999999999999999998 88887652111 01
Q ss_pred HHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHH
Q 002857 388 QNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRL 467 (873)
Q Consensus 388 ~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~ 467 (873)
. ..+.+.... +. ...+...+.+++..||+.+|++||++.+|+..|+.
T Consensus 236 ~-----------~~i~~~~~~---------------~~-------~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 236 I-----------EMIRNRQVL---------------PC-------PDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred H-----------HHHHcCCcC---------------CC-------CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 1 011110000 00 01123457889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=314.64 Aligned_cols=258 Identities=28% Similarity=0.466 Sum_probs=200.7
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCc---EEEEEEeeccC-CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCC
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAP---AVAIKVFNFLH-HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGN 234 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~---~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~ 234 (873)
+++|+..+.||+|+||.||+|++..++. .+|+|.++... ....+.+.+|++++++++|+||+++++++ ...
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~ 78 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVV-----TKF 78 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEE-----ccC
Confidence 3578889999999999999999865544 79999986442 23346789999999999999999999996 445
Q ss_pred ceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCe
Q 002857 235 DFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTA 314 (873)
Q Consensus 235 ~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~v 314 (873)
+..++||||+++++|.+++.. ....+++.+++.++.|++.||+||| +.+|+|+||||+||+++.++.+
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~---------~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~ 146 (268)
T cd05063 79 KPAMIITEYMENGALDKYLRD---------HDGEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLEC 146 (268)
T ss_pred CCcEEEEEcCCCCCHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcE
Confidence 678999999999999999842 2356899999999999999999999 8999999999999999999999
Q ss_pred EEeccccccccccccccccc-cccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHHHh
Q 002857 315 CVADFGIARFLEATNEQTSS-IGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQ 392 (873)
Q Consensus 315 KLsDFGla~~~~~~~~~~~~-~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~~~ 392 (873)
||+|||++............ .....+..|+|||++.+..++.++||||||+++|||++ |+.||...... ...
T Consensus 147 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~--~~~---- 220 (268)
T cd05063 147 KVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH--EVM---- 220 (268)
T ss_pred EECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH--HHH----
Confidence 99999999865432221111 11223457999999988889999999999999999998 99998642111 000
Q ss_pred hcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHH
Q 002857 393 SALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLI 468 (873)
Q Consensus 393 ~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i 468 (873)
..+... . ..|.. ..+...+.+++.+||+.+|++||++.+|++.|+++
T Consensus 221 -------~~i~~~-~--------------~~~~~-------~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 221 -------KAINDG-F--------------RLPAP-------MDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred -------HHHhcC-C--------------CCCCC-------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 011000 0 00100 01234578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=322.25 Aligned_cols=259 Identities=22% Similarity=0.343 Sum_probs=200.5
Q ss_pred cCCCcceeecccCceEEEEEEEc-----CCCcEEEEEEeeccCC-cchhHHHHHHHHHHhh-hhccceeeeeeeeccccc
Q 002857 160 KGFSSENLIGAGNFASVYKGILF-----EGAPAVAIKVFNFLHH-DASKSFTVECEVMRNI-IHRKIIKVVTACSRVDYQ 232 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~-----~~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L-~HpNIV~llg~c~~~~~~ 232 (873)
++|.+.+.||+|+||.||+|.+. ..+..||||+++.... ...+.+.+|+++++++ +|+||+++++++ .
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~-----~ 109 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGAC-----T 109 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEE-----e
Confidence 46889999999999999999753 2345799999875432 3345789999999999 799999999986 3
Q ss_pred CCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCC
Q 002857 233 GNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEM 312 (873)
Q Consensus 233 ~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~ 312 (873)
..+..++||||+++|+|.++++. .....+++.+++.++.||+.||+||| +.+|+|+||||+|||++.++
T Consensus 110 ~~~~~~lv~e~~~~~~L~~~i~~--------~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~ 178 (302)
T cd05055 110 IGGPILVITEYCCYGDLLNFLRR--------KRESFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGK 178 (302)
T ss_pred cCCceEEEEEcCCCCcHHHHHHh--------CCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCC
Confidence 45568999999999999999853 22234899999999999999999999 89999999999999999999
Q ss_pred CeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHHH
Q 002857 313 TACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWV 391 (873)
Q Consensus 313 ~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~~ 391 (873)
.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||+| |..||.......
T Consensus 179 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~------- 251 (302)
T cd05055 179 IVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS------- 251 (302)
T ss_pred eEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH-------
Confidence 999999999986543322111222345778999999999999999999999999999998 999986532111
Q ss_pred hhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHH
Q 002857 392 QSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLI 468 (873)
Q Consensus 392 ~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i 468 (873)
.+...++...... .+. .....+.+++.+||+.+|++|||+.||++.|+++
T Consensus 252 ------~~~~~~~~~~~~~------------~~~---------~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 252 ------KFYKLIKEGYRMA------------QPE---------HAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred ------HHHHHHHcCCcCC------------CCC---------CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 1111111100000 000 0022478899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=333.92 Aligned_cols=197 Identities=24% Similarity=0.376 Sum_probs=171.6
Q ss_pred cCCCcceeecccCceEEEEEEEcCCC-cEEEEEEeecc---CCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCc
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGA-PAVAIKVFNFL---HHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGND 235 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g-~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~ 235 (873)
++|++.+.||+|+||.||+|.+..++ ..||+|++... .....+.+.+|+.+++.++||||+++++++ ....
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~~ 104 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSF-----KDES 104 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEE-----EeCC
Confidence 46889999999999999999876554 68999998643 223346788999999999999999999996 4566
Q ss_pred eEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeE
Q 002857 236 FKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTAC 315 (873)
Q Consensus 236 ~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vK 315 (873)
..++||||+++|+|.+++.. ...+++..+..++.||+.||.||| +.+|+||||||+|||++.++++|
T Consensus 105 ~~~lv~Ey~~~g~L~~~i~~----------~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ik 171 (340)
T PTZ00426 105 YLYLVLEFVIGGEFFTFLRR----------NKRFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIK 171 (340)
T ss_pred EEEEEEeCCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEE
Confidence 89999999999999999842 346889999999999999999999 89999999999999999999999
Q ss_pred EeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCc
Q 002857 316 VADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDD 379 (873)
Q Consensus 316 LsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~ 379 (873)
|+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 172 L~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~ 230 (340)
T PTZ00426 172 MTDFGFAKVVDTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYA 230 (340)
T ss_pred EecCCCCeecCCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCC
Confidence 9999999865321 1234689999999999998899999999999999999999999975
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=325.28 Aligned_cols=279 Identities=24% Similarity=0.273 Sum_probs=207.4
Q ss_pred CCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEEE
Q 002857 161 GFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKALV 240 (873)
Q Consensus 161 ~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~LV 240 (873)
.|...+++|.|+||.||+|+...+++.||||..-... +--.+|+++|+++.|||||+++-++....-.+.-...||
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~----r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK----RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC----CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 4667799999999999999999999999999874322 233569999999999999999988765432212356799
Q ss_pred EeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCC-CCeEEecc
Q 002857 241 YEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDE-MTACVADF 319 (873)
Q Consensus 241 ~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~-~~vKLsDF 319 (873)
||||+. +|.++++... ..+..++...+.-+..||.+||+||| +.+|+||||||.|+|+|.+ +.+||+||
T Consensus 101 leymP~-tL~~~~r~~~------~~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDF 170 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYT------RANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDF 170 (364)
T ss_pred HHhchH-HHHHHHHHHh------hcCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccC
Confidence 999987 9999986421 23567888889999999999999999 8999999999999999965 89999999
Q ss_pred ccccccccccccccccccccccccCCCcccCCC-CCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCchh
Q 002857 320 GIARFLEATNEQTSSIGVKGTTGYIAPEYGMGH-ETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPER 398 (873)
Q Consensus 320 Gla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~~ 398 (873)
|.|+.+..+... .....|..|+|||.+.+. .|+.+.||||.|||+.||+-|++-|.+... .+....+-+.+...
T Consensus 171 GSAK~L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~--~dQL~eIik~lG~P 245 (364)
T KOG0658|consen 171 GSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSS--VDQLVEIIKVLGTP 245 (364)
T ss_pred CcceeeccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCH--HHHHHHHHHHhCCC
Confidence 999988665433 345678999999998886 799999999999999999999999987322 22222222222221
Q ss_pred HHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 399 VEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 399 l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
..+-+..+-.. +. .....+++.++|..... .....++++++.++++.+|.+|-++.|++.
T Consensus 246 t~e~I~~mn~~-y~-~~~~p~ik~~~~~~~~~---~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 246 TREDIKSMNPN-YT-EFKFPQIKAHPWHKVFF---KRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred CHHHHhhcCcc-cc-cccCcccccccceeecc---cCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 12222221111 11 12234456666643111 122345889999999999999999999874
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=322.84 Aligned_cols=263 Identities=24% Similarity=0.420 Sum_probs=202.4
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCc----EEEEEEeeccCC-cchhHHHHHHHHHHhhhhccceeeeeeeecccccCC
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAP----AVAIKVFNFLHH-DASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGN 234 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~----~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~ 234 (873)
++|+..+.||+|+||.||+|.+..++. .||+|++..... .....+.+|+.++++++|+||++++++|..
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~------ 80 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS------ 80 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC------
Confidence 467788999999999999999876665 578888864332 223468899999999999999999998732
Q ss_pred ceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCe
Q 002857 235 DFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTA 314 (873)
Q Consensus 235 ~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~v 314 (873)
...++|+||+++|+|.+++.. ....+++..++.++.||+.||+||| +.+|+|+||||+|||++.++.+
T Consensus 81 ~~~~~v~e~~~~g~l~~~~~~---------~~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~ 148 (303)
T cd05110 81 PTIQLVTQLMPHGCLLDYVHE---------HKDNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHV 148 (303)
T ss_pred CCceeeehhcCCCCHHHHHHh---------cccCCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCce
Confidence 235799999999999999852 2345788899999999999999999 8999999999999999999999
Q ss_pred EEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHHHhh
Q 002857 315 CVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQS 393 (873)
Q Consensus 315 KLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~~~~ 393 (873)
||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |+.||...... ...
T Consensus 149 kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~--~~~----- 221 (303)
T cd05110 149 KITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR--EIP----- 221 (303)
T ss_pred EEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHH-----
Confidence 9999999987643332222223345778999999998999999999999999999998 89998652111 111
Q ss_pred cCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHHHHhhh
Q 002857 394 ALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLIKKKLL 473 (873)
Q Consensus 394 ~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i~~~l~ 473 (873)
+++.... ..+... .+...+.+++..||..+|++||++.+|++.|+.+.....
T Consensus 222 -------~~~~~~~--------------~~~~~~-------~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~~ 273 (303)
T cd05110 222 -------DLLEKGE--------------RLPQPP-------ICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQ 273 (303)
T ss_pred -------HHHHCCC--------------CCCCCC-------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhchh
Confidence 1111000 000000 012247789999999999999999999999998866544
Q ss_pred cC
Q 002857 474 ET 475 (873)
Q Consensus 474 ~~ 475 (873)
..
T Consensus 274 ~~ 275 (303)
T cd05110 274 RY 275 (303)
T ss_pred hh
Confidence 33
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=327.99 Aligned_cols=197 Identities=25% Similarity=0.341 Sum_probs=167.5
Q ss_pred CCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC---CcchhHHHHHHHHH---HhhhhccceeeeeeeecccccCCc
Q 002857 162 FSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH---HDASKSFTVECEVM---RNIIHRKIIKVVTACSRVDYQGND 235 (873)
Q Consensus 162 f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL---~~L~HpNIV~llg~c~~~~~~~~~ 235 (873)
|.+.+.||+|+||.||+|.+..+++.||||+++... ....+.+..|++++ ++++||||+++++++ ...+
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~-----~~~~ 75 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACF-----QTED 75 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEE-----EcCC
Confidence 667899999999999999998899999999997432 22345677776665 456799999999985 4567
Q ss_pred eEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeE
Q 002857 236 FKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTAC 315 (873)
Q Consensus 236 ~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vK 315 (873)
..++||||+++|+|..+++ ...+++..++.++.||+.||.||| +.+|+||||||+|||++.++.+|
T Consensus 76 ~~~lv~E~~~~~~L~~~~~-----------~~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~k 141 (324)
T cd05589 76 HVCFVMEYAAGGDLMMHIH-----------TDVFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVK 141 (324)
T ss_pred EEEEEEcCCCCCcHHHHhh-----------cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEE
Confidence 8999999999999998873 245899999999999999999999 89999999999999999999999
Q ss_pred EeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCc
Q 002857 316 VADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDD 379 (873)
Q Consensus 316 LsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~ 379 (873)
|+|||+++...... .......|+..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 142 L~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~ 203 (324)
T cd05589 142 IADFGLCKEGMGFG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPG 203 (324)
T ss_pred eCcccCCccCCCCC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCC
Confidence 99999987532221 112235689999999999999999999999999999999999999965
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=313.74 Aligned_cols=254 Identities=27% Similarity=0.422 Sum_probs=199.0
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEE
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKAL 239 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~L 239 (873)
.+|++.++||+|+||.||+|++..+ ..||+|+++.... ..+.+.+|++++++++|+||+++++++ .....++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~------~~~~~~l 77 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVV------SEEPIYI 77 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEE------CCCCcEE
Confidence 5689999999999999999987544 5699999875332 346789999999999999999999874 2345789
Q ss_pred EEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEecc
Q 002857 240 VYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADF 319 (873)
Q Consensus 240 V~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDF 319 (873)
||||+++|+|.+++.. .....+++..++.++.|++.||+||| +.+|+|+||||+||++++++.+||+||
T Consensus 78 v~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~df 146 (262)
T cd05071 78 VTEYMSKGSLLDFLKG--------EMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADF 146 (262)
T ss_pred EEEcCCCCcHHHHHhh--------ccccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccC
Confidence 9999999999999953 22345789999999999999999999 899999999999999999999999999
Q ss_pred ccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHHHhhcCchh
Q 002857 320 GIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQSALPER 398 (873)
Q Consensus 320 Gla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~~~~~~~~~ 398 (873)
|.++.+..... .......++..|+|||+..+..++.++||||||+++|||+| |..||.......
T Consensus 147 g~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~-------------- 211 (262)
T cd05071 147 GLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-------------- 211 (262)
T ss_pred Cceeecccccc-ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH--------------
Confidence 99986643321 11222346778999999988899999999999999999999 888886532111
Q ss_pred HHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHH
Q 002857 399 VEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLI 468 (873)
Q Consensus 399 l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i 468 (873)
+.+...... ..+. ..++...+.+++.+||+.+|++||++.++++.|+..
T Consensus 212 ---~~~~~~~~~-----------~~~~-------~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 212 ---VLDQVERGY-----------RMPC-------PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred ---HHHHHhcCC-----------CCCC-------ccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 000000000 0000 011234578999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=318.56 Aligned_cols=270 Identities=21% Similarity=0.284 Sum_probs=207.4
Q ss_pred cCHHHHHHhhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhh-hhccceeeeeeeec
Q 002857 150 VSYEALYSATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNI-IHRKIIKVVTACSR 228 (873)
Q Consensus 150 ~s~~el~~at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~llg~c~~ 228 (873)
+.++.+..++++|++.+.||+|+||.||++.+..+++.+|+|+++... .....+.+|+.+++++ +|+||+++++++..
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 455677788999999999999999999999998899999999986432 2236788899999999 69999999998754
Q ss_pred ccccCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeee
Q 002857 229 VDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILL 308 (873)
Q Consensus 229 ~~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILL 308 (873)
.....+...++||||+++++|.++++.. ......+++..+..++.|++.||.||| +.+|+||||||+||++
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili 157 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGF------LKRGERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILL 157 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHh------hccCccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEE
Confidence 4444566799999999999999987531 122356888899999999999999999 8999999999999999
Q ss_pred CCCCCeEEeccccccccccccccccccccccccccCCCcccCC-----CCCCcchhhHhHHHHHHHHHhCCCCCCccccc
Q 002857 309 NDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMG-----HETSSYGDVYSFGILLLEMFTGLRPSDDMFKD 383 (873)
Q Consensus 309 d~~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-----~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~ 383 (873)
+.++.+||+|||+++...... .......|+..|+|||++.. ..++.++|||||||++|||++|+.||......
T Consensus 158 ~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~ 235 (286)
T cd06638 158 TTEGGVKLVDFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM 235 (286)
T ss_pred CCCCCEEEccCCceeecccCC--CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh
Confidence 999999999999998654321 11223458999999998753 45788999999999999999999998652110
Q ss_pred chhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 384 NLNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 384 ~~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
. . +..+.... ... . ..+. .....+.+++.+||+.+|++|||+.||++
T Consensus 236 ~----~---------~~~~~~~~-~~~---------~-~~~~---------~~~~~~~~li~~~l~~~p~~Rps~~ell~ 282 (286)
T cd06638 236 R----A---------LFKIPRNP-PPT---------L-HQPE---------LWSNEFNDFIRKCLTKDYEKRPTVSDLLQ 282 (286)
T ss_pred H----H---------HhhccccC-CCc---------c-cCCC---------CcCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 0 0 00000000 000 0 0000 01224778999999999999999999986
Q ss_pred H
Q 002857 464 G 464 (873)
Q Consensus 464 ~ 464 (873)
.
T Consensus 283 ~ 283 (286)
T cd06638 283 H 283 (286)
T ss_pred c
Confidence 4
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=334.76 Aligned_cols=202 Identities=23% Similarity=0.351 Sum_probs=173.9
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC---CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCce
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH---HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDF 236 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~ 236 (873)
++|++.+.||+|+||.||+|++..+++.||||+++... ......+.+|+++|..++|+||+++++++ ..+..
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~ 75 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSF-----QDENY 75 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-----EcCCe
Confidence 47899999999999999999999899999999997432 23345688899999999999999999985 55678
Q ss_pred EEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEE
Q 002857 237 KALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACV 316 (873)
Q Consensus 237 ~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKL 316 (873)
.+|||||+++|+|.+++.. ...+++..+..|+.||+.||+||| +.+|+||||||+|||++.++.+||
T Consensus 76 ~~lv~E~~~~g~L~~~l~~----------~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl 142 (364)
T cd05599 76 LYLIMEYLPGGDMMTLLMK----------KDTFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKL 142 (364)
T ss_pred EEEEECCCCCcHHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEE
Confidence 9999999999999999842 346899999999999999999999 899999999999999999999999
Q ss_pred eccccccccccccccc------------------------------------cccccccccccCCCcccCCCCCCcchhh
Q 002857 317 ADFGIARFLEATNEQT------------------------------------SSIGVKGTTGYIAPEYGMGHETSSYGDV 360 (873)
Q Consensus 317 sDFGla~~~~~~~~~~------------------------------------~~~~~~Gt~~Y~APE~l~~~~~s~ksDV 360 (873)
+|||+++.+....... ......||+.|+|||++.+..++.++||
T Consensus 143 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 222 (364)
T cd05599 143 SDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDW 222 (364)
T ss_pred eecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeee
Confidence 9999987543211000 0112358999999999999999999999
Q ss_pred HhHHHHHHHHHhCCCCCCc
Q 002857 361 YSFGILLLEMFTGLRPSDD 379 (873)
Q Consensus 361 wSfGvvL~ELlTGk~Pf~~ 379 (873)
|||||++|||++|..||..
T Consensus 223 wSlG~il~el~~G~~Pf~~ 241 (364)
T cd05599 223 WSLGVIMYEMLVGYPPFCS 241 (364)
T ss_pred ecchhHHHHhhcCCCCCCC
Confidence 9999999999999999975
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=318.84 Aligned_cols=264 Identities=24% Similarity=0.398 Sum_probs=201.0
Q ss_pred cCCCcceeecccCceEEEEEEEc-----CCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCC
Q 002857 160 KGFSSENLIGAGNFASVYKGILF-----EGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGN 234 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~-----~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~ 234 (873)
++|...++||+|+||.||++... ..+..+|+|.+..........+.+|++++++++|+||+++++++ ...
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~ 79 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVC-----TEG 79 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEE-----ecC
Confidence 46777899999999999999743 24568999998766555567899999999999999999999985 345
Q ss_pred ceEEEEEeecCCCChhhhcccccccc-----cccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeC
Q 002857 235 DFKALVYEFMPNGSLEEWIHPITEED-----KRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLN 309 (873)
Q Consensus 235 ~~~~LV~Ey~~~GSL~~~L~~~~~~~-----~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd 309 (873)
...++||||+++|+|.+++....... ........+++..++.++.||+.||+||| +.+|+||||||+|||++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~ 156 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVG 156 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEc
Confidence 66899999999999999986421100 00112246899999999999999999999 89999999999999999
Q ss_pred CCCCeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhH
Q 002857 310 DEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQ 388 (873)
Q Consensus 310 ~~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~ 388 (873)
+++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |+.||....... .
T Consensus 157 ~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~- 233 (280)
T cd05092 157 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE--A- 233 (280)
T ss_pred CCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH--H-
Confidence 999999999999975533221111222335678999999999999999999999999999998 899986422111 0
Q ss_pred HHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHH
Q 002857 389 NWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLR 466 (873)
Q Consensus 389 ~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le 466 (873)
...+...... ..+ ..+...+.+++.+||+.+|++||++.||++.|+
T Consensus 234 ----------~~~~~~~~~~-------------~~~---------~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 234 ----------IECITQGREL-------------ERP---------RTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred ----------HHHHHcCccC-------------CCC---------CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 0000000000 000 011234778999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=310.76 Aligned_cols=253 Identities=21% Similarity=0.314 Sum_probs=198.3
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCC-----cchhHHHHHHHHHHhhhhccceeeeeeeecccccCC
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH-----DASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGN 234 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~-----~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~ 234 (873)
++|.+.+.||+|++|.||+|....+++.||+|.+..... ...+.+.+|++++++++|+||+++++++ ..+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~ 76 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCL-----RDD 76 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE-----ccC
Confidence 578999999999999999999988899999999864321 1235688899999999999999999995 445
Q ss_pred ceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCe
Q 002857 235 DFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTA 314 (873)
Q Consensus 235 ~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~v 314 (873)
...++||||+++++|.+++.. ...+++..+..++.|++.||.||| +.+|+|+||+|+||++++++.+
T Consensus 77 ~~~~~v~e~~~~~~l~~~~~~----------~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~ 143 (263)
T cd06625 77 ETLSIFMEYMPGGSVKDQLKA----------YGALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNV 143 (263)
T ss_pred CeEEEEEEECCCCcHHHHHHH----------hCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCE
Confidence 689999999999999999842 345788899999999999999999 8999999999999999999999
Q ss_pred EEecccccccccccccccc-ccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhh
Q 002857 315 CVADFGIARFLEATNEQTS-SIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQS 393 (873)
Q Consensus 315 KLsDFGla~~~~~~~~~~~-~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~ 393 (873)
+|+|||+++.......... .....++..|+|||++.+..++.++||||||+++|||++|+.||....... .
T Consensus 144 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----~---- 215 (263)
T cd06625 144 KLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA----A---- 215 (263)
T ss_pred EEeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHH----H----
Confidence 9999999976543221111 123457889999999999999999999999999999999999986521110 0
Q ss_pred cCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHH
Q 002857 394 ALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELG 464 (873)
Q Consensus 394 ~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~ 464 (873)
............ .+ ......+.+++.+||+.+|++|||+.|+++.
T Consensus 216 -----~~~~~~~~~~~~------------~~---------~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 216 -----IFKIATQPTNPQ------------LP---------SHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred -----HHHHhccCCCCC------------CC---------ccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 000000000000 00 0112347789999999999999999998763
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=310.83 Aligned_cols=249 Identities=28% Similarity=0.427 Sum_probs=195.1
Q ss_pred eeecccCceEEEEEEEcCCC---cEEEEEEeeccCC-cchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEEEE
Q 002857 166 NLIGAGNFASVYKGILFEGA---PAVAIKVFNFLHH-DASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKALVY 241 (873)
Q Consensus 166 ~~LG~G~fG~VYkg~~~~~g---~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~LV~ 241 (873)
++||+|+||.||+|++...+ ..||+|.+..... ...+.+.+|+++++++.|+||+++++++. ....++||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------~~~~~~v~ 74 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK------GEPLMLVM 74 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc------CCceEEEE
Confidence 47999999999999876544 7899999875443 24467899999999999999999999852 34579999
Q ss_pred eecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEecccc
Q 002857 242 EFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGI 321 (873)
Q Consensus 242 Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDFGl 321 (873)
||+++|+|.+++.. ...+++..++.++.|++.||+||| ..+++|+||||+|||++.++.+||+|||+
T Consensus 75 e~~~~~~L~~~l~~----------~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~ 141 (257)
T cd05060 75 ELAPLGPLLKYLKK----------RREIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGM 141 (257)
T ss_pred EeCCCCcHHHHHHh----------CCCCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEeccccc
Confidence 99999999999943 236899999999999999999999 88999999999999999999999999999
Q ss_pred cccccccccccc-ccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHHHhhcCchhH
Q 002857 322 ARFLEATNEQTS-SIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQSALPERV 399 (873)
Q Consensus 322 a~~~~~~~~~~~-~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~~~~~~~~~l 399 (873)
++.......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||..... ..+..++....
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~--~~~~~~~~~~~---- 215 (257)
T cd05060 142 SRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG--AEVIAMLESGE---- 215 (257)
T ss_pred cceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH--HHHHHHHHcCC----
Confidence 986644332111 111224568999999998899999999999999999998 9999865321 11111111000
Q ss_pred HHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHH
Q 002857 400 EEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLI 468 (873)
Q Consensus 400 ~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i 468 (873)
..+.. ..+...+.+++.+||+.+|++||++.+|++.|+++
T Consensus 216 ----------------------~~~~~-------~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 216 ----------------------RLPRP-------EECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred ----------------------cCCCC-------CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 00000 01123578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=317.62 Aligned_cols=247 Identities=22% Similarity=0.268 Sum_probs=191.0
Q ss_pred ecccCceEEEEEEEcCCCcEEEEEEeeccC---CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEEEEeec
Q 002857 168 IGAGNFASVYKGILFEGAPAVAIKVFNFLH---HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKALVYEFM 244 (873)
Q Consensus 168 LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~LV~Ey~ 244 (873)
||+|+||.||++....+++.||+|.+.... ....+.+..|++++++++||||+++++++ ..+...++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~-----~~~~~~~lv~e~~ 75 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAF-----ESKTHLCLVMSLM 75 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEE-----ecCCeEEEEEecC
Confidence 799999999999998899999999986322 12234566799999999999999999885 4567899999999
Q ss_pred CCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEeccccccc
Q 002857 245 PNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARF 324 (873)
Q Consensus 245 ~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDFGla~~ 324 (873)
++++|.+++.. .....+++..++.++.||+.||+||| +.+|+||||||+||+++.++.++|+|||++..
T Consensus 76 ~g~~L~~~~~~--------~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~ 144 (277)
T cd05607 76 NGGDLKYHIYN--------VGERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVE 144 (277)
T ss_pred CCCCHHHHHHh--------ccccCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeee
Confidence 99999988843 23345888999999999999999999 89999999999999999999999999999976
Q ss_pred cccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCchhHHHHhh
Q 002857 325 LEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPERVEEIVD 404 (873)
Q Consensus 325 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~~l~elid 404 (873)
..... ......|+..|+|||++.+..++.++|||||||++|||++|+.||....... .. .++..
T Consensus 145 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~-~~------------~~~~~ 208 (277)
T cd05607 145 LKDGK---TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV-AK------------EELKR 208 (277)
T ss_pred cCCCc---eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh-hH------------HHHHH
Confidence 54322 1123458999999999999889999999999999999999999986521110 00 01111
Q ss_pred hhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHH
Q 002857 405 TLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELG 464 (873)
Q Consensus 405 ~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~ 464 (873)
..+..... .+. .....++.+++.+||+.||++||++.|+++.
T Consensus 209 ~~~~~~~~----------~~~--------~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ 250 (277)
T cd05607 209 RTLEDEVK----------FEH--------QNFTEESKDICRLFLAKKPEDRLGSREKNDD 250 (277)
T ss_pred Hhhccccc----------ccc--------ccCCHHHHHHHHHHhccCHhhCCCCccchhh
Confidence 11110000 000 0012347789999999999999999887643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=345.49 Aligned_cols=271 Identities=23% Similarity=0.296 Sum_probs=210.7
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhh-hccceeeeeeeeccc-ccC-Cc
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNII-HRKIIKVVTACSRVD-YQG-ND 235 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~-HpNIV~llg~c~~~~-~~~-~~ 235 (873)
..++++.++|.+|||+.||.|.+..++..||+|++-..+....+.+.+||++|++|. |+|||.+++...... ... .-
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 346678999999999999999998887999999987667777788999999999996 999999999422211 122 24
Q ss_pred eEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeE
Q 002857 236 FKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTAC 315 (873)
Q Consensus 236 ~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vK 315 (873)
+.+|+||||.+|+|-++|.. .-...|++.++++|+.|+++|+++|| .+..+|||||||-+||||+.+++.|
T Consensus 116 EvllLmEyC~gg~Lvd~mn~--------Rlq~~lte~eVLkIf~dv~~AVa~mH-~~~pPiIHRDLKiENvLls~~g~~K 186 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNT--------RLQTRLTEDEVLKIFYDVCEAVAAMH-YLKPPIIHRDLKIENVLLSADGNYK 186 (738)
T ss_pred EEEeehhhccCCcHHHHHHH--------HHhccCChHHHHHHHHHHHHHHHHHh-cCCCccchhhhhhhheEEcCCCCEE
Confidence 68999999999999999953 12334999999999999999999999 4578899999999999999999999
Q ss_pred Eeccccccccccccccc-------cccccccccccCCCccc---CCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccch
Q 002857 316 VADFGIARFLEATNEQT-------SSIGVKGTTGYIAPEYG---MGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNL 385 (873)
Q Consensus 316 LsDFGla~~~~~~~~~~-------~~~~~~Gt~~Y~APE~l---~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~ 385 (873)
|+|||.|.-........ ......-|+.|+|||++ .+..+++|+|||+|||+||-|+....||+....-
T Consensus 187 LCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l-- 264 (738)
T KOG1989|consen 187 LCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL-- 264 (738)
T ss_pred eCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce--
Confidence 99999986322111100 01122368999999974 5678999999999999999999999999863111
Q ss_pred hhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHH
Q 002857 386 NLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGL 465 (873)
Q Consensus 386 ~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~L 465 (873)
.|++. .+ ..|..+. ....|.+||..||+.||.+||++-+|++.+
T Consensus 265 ---------------aIlng----~Y----------~~P~~p~-------ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~ 308 (738)
T KOG1989|consen 265 ---------------AILNG----NY----------SFPPFPN-------YSDRLKDLIRTMLQPNPDERPNIYQVLEEI 308 (738)
T ss_pred ---------------eEEec----cc----------cCCCCcc-------HHHHHHHHHHHHhccCcccCCCHHHHHHHH
Confidence 11111 11 0111111 133588999999999999999999999999
Q ss_pred HHHHHhhhcCC
Q 002857 466 RLIKKKLLETP 476 (873)
Q Consensus 466 e~i~~~l~~~~ 476 (873)
-+|...-.+..
T Consensus 309 ~~l~~~~~~~~ 319 (738)
T KOG1989|consen 309 FELANKPCPIP 319 (738)
T ss_pred HHHhcCCCCcc
Confidence 98877555443
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=318.98 Aligned_cols=196 Identities=26% Similarity=0.343 Sum_probs=167.1
Q ss_pred ecccCceEEEEEEEcCCCcEEEEEEeeccCC---cchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEEEEeec
Q 002857 168 IGAGNFASVYKGILFEGAPAVAIKVFNFLHH---DASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKALVYEFM 244 (873)
Q Consensus 168 LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~LV~Ey~ 244 (873)
||+|+||+||++.+..+++.||+|.+..... ...+.+..|++++++++|+||+++.+++ ......++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAF-----QTKTDLCLVMTIM 75 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEE-----cCCCeEEEEEeCC
Confidence 7999999999999988999999999864322 2235678899999999999999999885 4566789999999
Q ss_pred CCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEeccccccc
Q 002857 245 PNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARF 324 (873)
Q Consensus 245 ~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDFGla~~ 324 (873)
++|+|.+++... ......+++..++.++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++.
T Consensus 76 ~~g~L~~~~~~~------~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~ 146 (280)
T cd05608 76 NGGDLRYHIYNV------DEENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVE 146 (280)
T ss_pred CCCCHHHHHHhc------cccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCcccee
Confidence 999999887431 123456899999999999999999999 89999999999999999999999999999976
Q ss_pred cccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCc
Q 002857 325 LEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDD 379 (873)
Q Consensus 325 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~ 379 (873)
+..... ......||..|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 147 ~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~ 199 (280)
T cd05608 147 LKDGQS--KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRA 199 (280)
T ss_pred cCCCCc--cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 543222 12234689999999999999999999999999999999999999965
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=310.87 Aligned_cols=250 Identities=24% Similarity=0.355 Sum_probs=196.7
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEE
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKAL 239 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~L 239 (873)
++|++.+.||+|+||.||++.. .+..||+|.++.. ...+.+.+|+.++++++|+|++++++++. ..+...++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----~~~~~~~l 77 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIV----EEKGGLYI 77 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEE----cCCCceEE
Confidence 4688899999999999999976 4678999998643 23467899999999999999999999753 34556899
Q ss_pred EEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEecc
Q 002857 240 VYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADF 319 (873)
Q Consensus 240 V~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDF 319 (873)
||||+++++|.++++. .....+++..++.++.||+.||+||| +.+|+||||||+||++++++.+||+||
T Consensus 78 v~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df 146 (256)
T cd05082 78 VTEYMAKGSLVDYLRS--------RGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDF 146 (256)
T ss_pred EEECCCCCcHHHHHHh--------cCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCC
Confidence 9999999999999853 22345889999999999999999999 899999999999999999999999999
Q ss_pred ccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHHHhhcCchh
Q 002857 320 GIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQSALPER 398 (873)
Q Consensus 320 Gla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~~~~~~~~~ 398 (873)
|+++...... ....++..|+|||++.+..++.++||||||+++|||++ |+.||...... .+...
T Consensus 147 g~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~--~~~~~-------- 211 (256)
T cd05082 147 GLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPR-------- 211 (256)
T ss_pred ccceeccccC-----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHH--HHHHH--------
Confidence 9987543221 12235678999999998899999999999999999998 99998642110 00000
Q ss_pred HHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHH
Q 002857 399 VEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLI 468 (873)
Q Consensus 399 l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i 468 (873)
+....... . ...+...+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 212 ----~~~~~~~~--------------~-------~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 212 ----VEKGYKMD--------------A-------PDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred ----HhcCCCCC--------------C-------CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 00000000 0 001233578899999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=330.80 Aligned_cols=243 Identities=21% Similarity=0.267 Sum_probs=191.7
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEeeccC---CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEEEEe
Q 002857 166 NLIGAGNFASVYKGILFEGAPAVAIKVFNFLH---HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKALVYE 242 (873)
Q Consensus 166 ~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~LV~E 242 (873)
+.||+|+||.||++....+++.||+|+++... ......+..|++++..++|+||+++++++ ...+..+||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~-----~~~~~~~lv~E 75 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF-----QTHDRLCFVME 75 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEE-----EcCCEEEEEEe
Confidence 46999999999999998899999999997432 23345678899999999999999999885 45678999999
Q ss_pred ecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCC-CCeeeccCCCCCeeeCCCCCeEEecccc
Q 002857 243 FMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCK-PPIAHCDIKPSNILLNDEMTACVADFGI 321 (873)
Q Consensus 243 y~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s-~gIvHrDLKpsNILLd~~~~vKLsDFGl 321 (873)
|+++|+|.+++. ....+++..+..++.||+.||+||| + .+|+||||||+|||++.++.+||+|||+
T Consensus 76 ~~~~~~L~~~l~----------~~~~l~~~~~~~~~~qi~~aL~~lH---~~~~ivHrDikp~NIll~~~~~~kL~Dfg~ 142 (325)
T cd05594 76 YANGGELFFHLS----------RERVFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGL 142 (325)
T ss_pred CCCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCCCCeEEECCCCCEEEecCCC
Confidence 999999998884 2356899999999999999999999 6 7999999999999999999999999999
Q ss_pred ccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCchhHHH
Q 002857 322 ARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPERVEE 401 (873)
Q Consensus 322 a~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~~l~e 401 (873)
++...... .......||..|+|||++.+..++.++|||||||++|||+||+.||.....+. .. .
T Consensus 143 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~--~~------------~ 206 (325)
T cd05594 143 CKEGIKDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK--LF------------E 206 (325)
T ss_pred CeecCCCC--cccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHH--HH------------H
Confidence 87532221 11223468999999999999999999999999999999999999996521110 00 0
Q ss_pred HhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCC-----CHHHHHHH
Q 002857 402 IVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERM-----KINDVELG 464 (873)
Q Consensus 402 lid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRP-----Tm~EVl~~ 464 (873)
.+ ..... ..|. .....+.+++.+||+.||++|+ ++.++++.
T Consensus 207 ~i---~~~~~----------~~p~---------~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 207 LI---LMEEI----------RFPR---------TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred HH---hcCCC----------CCCC---------CCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 00 00000 0000 0122467899999999999996 88888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=337.36 Aligned_cols=198 Identities=26% Similarity=0.392 Sum_probs=176.0
Q ss_pred CCCcceeecccCceEEEEEEEcCCCcEEEEEEeecc---CCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceE
Q 002857 161 GFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFL---HHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFK 237 (873)
Q Consensus 161 ~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~ 237 (873)
-|...+.||.|+-|.|-+|++..+|+.+|||++... .......+.+||-||+.|.||||++++++ +++..++
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydV-----we~~~~l 87 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDV-----WENKQHL 87 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeee-----eccCceE
Confidence 467889999999999999999999999999999754 22234568899999999999999999999 5788899
Q ss_pred EEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEe
Q 002857 238 ALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVA 317 (873)
Q Consensus 238 ~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLs 317 (873)
|||.||+++|-|.++|- ..+.+++.+..+++.||+.|+.|.| ..+|+||||||+|+|||..+++||+
T Consensus 88 ylvlEyv~gGELFdylv----------~kG~l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIA 154 (786)
T KOG0588|consen 88 YLVLEYVPGGELFDYLV----------RKGPLPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIA 154 (786)
T ss_pred EEEEEecCCchhHHHHH----------hhCCCCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeee
Confidence 99999999999999993 4678999999999999999999999 8999999999999999999999999
Q ss_pred ccccccccccccccccccccccccccCCCcccCCCCC-CcchhhHhHHHHHHHHHhCCCCCCc
Q 002857 318 DFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHET-SSYGDVYSFGILLLEMFTGLRPSDD 379 (873)
Q Consensus 318 DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~-s~ksDVwSfGvvL~ELlTGk~Pf~~ 379 (873)
|||+|.+-..+. .-...+|++.|.|||+++|..| ..++||||.|||||.||||+.||++
T Consensus 155 DFGMAsLe~~gk---lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD 214 (786)
T KOG0588|consen 155 DFGMASLEVPGK---LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD 214 (786)
T ss_pred ccceeecccCCc---cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC
Confidence 999998643322 2234579999999999999987 5679999999999999999999986
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=335.00 Aligned_cols=201 Identities=22% Similarity=0.326 Sum_probs=171.9
Q ss_pred CCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC---CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceE
Q 002857 161 GFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH---HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFK 237 (873)
Q Consensus 161 ~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~ 237 (873)
.|+..+.||+|+||+||+|++..+++.||||++.... ......+.+|++++++++|+||+++++++ .+.+..
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~-----~~~~~~ 76 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSF-----QDKDNL 76 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEE-----ecCCEE
Confidence 5888999999999999999999999999999997432 23345788999999999999999999985 456789
Q ss_pred EEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEe
Q 002857 238 ALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVA 317 (873)
Q Consensus 238 ~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLs 317 (873)
++||||+++|+|.+++.. ...+++..+..++.||+.||+||| ..+|+||||||+|||++.++++||+
T Consensus 77 ~lv~E~~~gg~L~~~l~~----------~~~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~ 143 (381)
T cd05626 77 YFVMDYIPGGDMMSLLIR----------MEVFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLT 143 (381)
T ss_pred EEEEecCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEe
Confidence 999999999999999842 345888889999999999999999 8999999999999999999999999
Q ss_pred ccccccccccccc---------------------------------------------cccccccccccccCCCcccCCC
Q 002857 318 DFGIARFLEATNE---------------------------------------------QTSSIGVKGTTGYIAPEYGMGH 352 (873)
Q Consensus 318 DFGla~~~~~~~~---------------------------------------------~~~~~~~~Gt~~Y~APE~l~~~ 352 (873)
|||+++.+..... ........||..|+|||++.+.
T Consensus 144 DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~ 223 (381)
T cd05626 144 DFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRK 223 (381)
T ss_pred eCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCC
Confidence 9999764311000 0001234699999999999988
Q ss_pred CCCcchhhHhHHHHHHHHHhCCCCCCc
Q 002857 353 ETSSYGDVYSFGILLLEMFTGLRPSDD 379 (873)
Q Consensus 353 ~~s~ksDVwSfGvvL~ELlTGk~Pf~~ 379 (873)
.++.++|||||||++|||+||+.||..
T Consensus 224 ~~~~~~DiwSlG~il~elltG~~Pf~~ 250 (381)
T cd05626 224 GYTQLCDWWSVGVILFEMLVGQPPFLA 250 (381)
T ss_pred CCCCccceeehhhHHHHHHhCCCCCcC
Confidence 999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=311.51 Aligned_cols=247 Identities=25% Similarity=0.390 Sum_probs=192.4
Q ss_pred eecccCceEEEEEEE--cCCCcEEEEEEeeccCC--cchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEEEEe
Q 002857 167 LIGAGNFASVYKGIL--FEGAPAVAIKVFNFLHH--DASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKALVYE 242 (873)
Q Consensus 167 ~LG~G~fG~VYkg~~--~~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~LV~E 242 (873)
.||+|+||.||+|.+ ..++..||+|+++.... ...+.+.+|+.++++++|+||+++++++. .+..++|||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~------~~~~~lv~e 75 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE------AESWMLVME 75 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc------CCCcEEEEe
Confidence 689999999999975 34678999999864432 23467899999999999999999999852 345789999
Q ss_pred ecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEeccccc
Q 002857 243 FMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIA 322 (873)
Q Consensus 243 y~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDFGla 322 (873)
|+++|+|.+++.. ...+++..++.++.|++.||+||| +++|+||||||+||+++.++.+||+|||++
T Consensus 76 ~~~~~~L~~~l~~----------~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~ 142 (257)
T cd05116 76 LAELGPLNKFLQK----------NKHVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLS 142 (257)
T ss_pred cCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccc
Confidence 9999999999842 346889999999999999999999 899999999999999999999999999999
Q ss_pred cccccccccc-cccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHHHhhcCchhHH
Q 002857 323 RFLEATNEQT-SSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQSALPERVE 400 (873)
Q Consensus 323 ~~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~~~~~~~~~l~ 400 (873)
+......... ......++..|+|||.+....++.++||||||+++|||+| |+.||...... ...
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~------------ 208 (257)
T cd05116 143 KALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN--EVT------------ 208 (257)
T ss_pred cccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--HHH------------
Confidence 8664332211 1112234578999999988889999999999999999998 99999753211 111
Q ss_pred HHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHH
Q 002857 401 EIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRL 467 (873)
Q Consensus 401 elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~ 467 (873)
+.+...... ..|. .+...+.+++.+||+.||++||++.+|.+.|+.
T Consensus 209 ~~i~~~~~~------------~~~~---------~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 209 QMIESGERM------------ECPQ---------RCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred HHHHCCCCC------------CCCC---------CCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 111110000 0000 112357899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=318.34 Aligned_cols=268 Identities=25% Similarity=0.406 Sum_probs=201.9
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCc--EEEEEEeeccC-CcchhHHHHHHHHHHhh-hhccceeeeeeeecccccCCc
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAP--AVAIKVFNFLH-HDASKSFTVECEVMRNI-IHRKIIKVVTACSRVDYQGND 235 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~--~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L-~HpNIV~llg~c~~~~~~~~~ 235 (873)
++|++.+.||+|+||.||+|.+..++. .+++|.++... ....+.+.+|++++.++ +||||+++++++ ....
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~-----~~~~ 76 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGAC-----ENRG 76 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEE-----ccCC
Confidence 578899999999999999998876654 47888887432 23346789999999999 799999999986 3455
Q ss_pred eEEEEEeecCCCChhhhccccccccc------ccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeC
Q 002857 236 FKALVYEFMPNGSLEEWIHPITEEDK------RHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLN 309 (873)
Q Consensus 236 ~~~LV~Ey~~~GSL~~~L~~~~~~~~------~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd 309 (873)
..++||||+++|+|.++++....... .......+++..++.|+.||+.||+||| +.+|+||||||+|||++
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~ 153 (297)
T cd05089 77 YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVG 153 (297)
T ss_pred cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEEC
Confidence 78999999999999999954111000 0112245889999999999999999999 89999999999999999
Q ss_pred CCCCeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhH
Q 002857 310 DEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQ 388 (873)
Q Consensus 310 ~~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~ 388 (873)
+++.+||+|||++....... .......+..|+|||++.+..++.++|||||||++|||+| |..||....... ..
T Consensus 154 ~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~--~~ 228 (297)
T cd05089 154 ENLASKIADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE--LY 228 (297)
T ss_pred CCCeEEECCcCCCcccccee---ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--HH
Confidence 99999999999986432111 1111123567999999988889999999999999999998 999986532111 00
Q ss_pred HHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHH
Q 002857 389 NWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLI 468 (873)
Q Consensus 389 ~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i 468 (873)
..+ ...+... .+ ..+...+.+|+.+||+.+|.+|||+.+|++.|+.+
T Consensus 229 -----------~~~-~~~~~~~------------~~---------~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 275 (297)
T cd05089 229 -----------EKL-PQGYRME------------KP---------RNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRM 275 (297)
T ss_pred -----------HHH-hcCCCCC------------CC---------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 000 0000000 00 01123477899999999999999999999999988
Q ss_pred HHhhh
Q 002857 469 KKKLL 473 (873)
Q Consensus 469 ~~~l~ 473 (873)
..+..
T Consensus 276 ~~~~~ 280 (297)
T cd05089 276 LEARK 280 (297)
T ss_pred HHhhc
Confidence 76553
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=305.99 Aligned_cols=272 Identities=23% Similarity=0.259 Sum_probs=215.7
Q ss_pred hhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceE
Q 002857 158 ATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFK 237 (873)
Q Consensus 158 at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~ 237 (873)
..++|.+.+.||+|||+.||+++...++..+|+|++.....+..+..++|++..++++||||+++++++....-....+.
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 45789999999999999999999888999999999987777778899999999999999999999998765444456679
Q ss_pred EEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEe
Q 002857 238 ALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVA 317 (873)
Q Consensus 238 ~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLs 317 (873)
||+++|...|||.+.+.. .......+++.+.+.|+.+|.+||++||.. ..+++||||||.|||+.+++.++|.
T Consensus 99 yll~Pyy~~Gsl~d~i~~------~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~ 171 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIER------LKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLM 171 (302)
T ss_pred EEEeehhccccHHHHHHH------HhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEE
Confidence 999999999999999953 113345799999999999999999999932 4459999999999999999999999
Q ss_pred ccccccccccccc-------cccccccccccccCCCcccC---CCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhh
Q 002857 318 DFGIARFLEATNE-------QTSSIGVKGTTGYIAPEYGM---GHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNL 387 (873)
Q Consensus 318 DFGla~~~~~~~~-------~~~~~~~~Gt~~Y~APE~l~---~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l 387 (873)
|||.+....-... .........|..|+|||.+. +...++++|||||||+||+|+.|..||+.....+.++
T Consensus 172 D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSl 251 (302)
T KOG2345|consen 172 DLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSL 251 (302)
T ss_pred eccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeE
Confidence 9999875432111 01122345799999999875 4467999999999999999999999998765544332
Q ss_pred HHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHH
Q 002857 388 QNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRL 467 (873)
Q Consensus 388 ~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~ 467 (873)
.-.+.. ..+. .|.... ..+.+.+++.+|++.||.+||++.+++..++.
T Consensus 252 aLAv~n-----------~q~s--------------~P~~~~-------yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~ 299 (302)
T KOG2345|consen 252 ALAVQN-----------AQIS--------------IPNSSR-------YSEALHQLIKSMLQVDPNQRPTIPELLSKLDD 299 (302)
T ss_pred EEeeec-----------cccc--------------cCCCCC-------ccHHHHHHHHHHhcCCcccCCCHHHHHHHHHh
Confidence 221110 0000 011000 13458899999999999999999999999886
Q ss_pred H
Q 002857 468 I 468 (873)
Q Consensus 468 i 468 (873)
+
T Consensus 300 L 300 (302)
T KOG2345|consen 300 L 300 (302)
T ss_pred h
Confidence 5
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=321.82 Aligned_cols=269 Identities=22% Similarity=0.347 Sum_probs=202.2
Q ss_pred cCCCcceeecccCceEEEEEEEcC-------CCcEEEEEEeeccC-CcchhHHHHHHHHHHhh-hhccceeeeeeeeccc
Q 002857 160 KGFSSENLIGAGNFASVYKGILFE-------GAPAVAIKVFNFLH-HDASKSFTVECEVMRNI-IHRKIIKVVTACSRVD 230 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~-------~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L-~HpNIV~llg~c~~~~ 230 (873)
++|.+.+.||+|+||.||+|.+.. ....+|+|+++... ......+..|+++++++ +|+||++++++|.
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~--- 94 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT--- 94 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe---
Confidence 578999999999999999998643 23479999987532 23345788899999999 7999999999963
Q ss_pred ccCCceEEEEEeecCCCChhhhccccccccc------ccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCC
Q 002857 231 YQGNDFKALVYEFMPNGSLEEWIHPITEEDK------RHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPS 304 (873)
Q Consensus 231 ~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~------~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKps 304 (873)
.....++||||+++|+|.+++........ .......+++.+++.++.|++.||+||| +.+++||||||+
T Consensus 95 --~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~ 169 (307)
T cd05098 95 --QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAAR 169 (307)
T ss_pred --cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHH
Confidence 45578999999999999999964111000 0012245889999999999999999999 899999999999
Q ss_pred CeeeCCCCCeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCccccc
Q 002857 305 NILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKD 383 (873)
Q Consensus 305 NILLd~~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~ 383 (873)
|||++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||.....+
T Consensus 170 Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~ 249 (307)
T cd05098 170 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 249 (307)
T ss_pred heEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH
Confidence 99999999999999999976543221111122234568999999998889999999999999999998 88888542111
Q ss_pred chhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 384 NLNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 384 ~~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
.+.+.+....... .+ ..+...+.+++.+||+.+|++||||.+|++
T Consensus 250 --------------~~~~~~~~~~~~~------------~~---------~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 294 (307)
T cd05098 250 --------------ELFKLLKEGHRMD------------KP---------SNCTNELYMMMRDCWHAVPSQRPTFKQLVE 294 (307)
T ss_pred --------------HHHHHHHcCCCCC------------CC---------CcCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 0111111000000 00 011235778999999999999999999999
Q ss_pred HHHHHHHh
Q 002857 464 GLRLIKKK 471 (873)
Q Consensus 464 ~Le~i~~~ 471 (873)
.|+.+...
T Consensus 295 ~l~~~~~~ 302 (307)
T cd05098 295 DLDRILAL 302 (307)
T ss_pred HHHHHHHH
Confidence 99998664
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=320.94 Aligned_cols=269 Identities=21% Similarity=0.331 Sum_probs=202.8
Q ss_pred hcCCCcceeecccCceEEEEEEEc-------CCCcEEEEEEeeccC-CcchhHHHHHHHHHHhh-hhccceeeeeeeecc
Q 002857 159 TKGFSSENLIGAGNFASVYKGILF-------EGAPAVAIKVFNFLH-HDASKSFTVECEVMRNI-IHRKIIKVVTACSRV 229 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~-------~~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L-~HpNIV~llg~c~~~ 229 (873)
.++|.+.+.||+|+||.||+|++. ..+..||+|.++... ......+.+|+.+++.+ +|+||+++++++
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~--- 90 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC--- 90 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEE---
Confidence 457888999999999999999753 134579999986432 23346789999999999 899999999986
Q ss_pred cccCCceEEEEEeecCCCChhhhccccccccc------ccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCC
Q 002857 230 DYQGNDFKALVYEFMPNGSLEEWIHPITEEDK------RHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKP 303 (873)
Q Consensus 230 ~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~------~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKp 303 (873)
......++||||+++|+|.+++........ .......+++.+++.++.||+.||.||| +.+|+||||||
T Consensus 91 --~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp 165 (304)
T cd05101 91 --TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAA 165 (304)
T ss_pred --ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeeccccc
Confidence 345678999999999999999964111000 0012346888999999999999999999 89999999999
Q ss_pred CCeeeCCCCCeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccc
Q 002857 304 SNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFK 382 (873)
Q Consensus 304 sNILLd~~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~ 382 (873)
+|||+++++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||.....
T Consensus 166 ~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 245 (304)
T cd05101 166 RNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 245 (304)
T ss_pred ceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH
Confidence 999999999999999999986644332222222345678999999998889999999999999999998 7888754211
Q ss_pred cchhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHH
Q 002857 383 DNLNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVE 462 (873)
Q Consensus 383 ~~~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl 462 (873)
. .+ .+.+..... +.. ...+...+.+++.+||+.+|++|||+.||+
T Consensus 246 ~-----~~---------~~~~~~~~~---------------~~~------~~~~~~~~~~li~~cl~~~p~~Rps~~e~l 290 (304)
T cd05101 246 E-----EL---------FKLLKEGHR---------------MDK------PANCTNELYMMMRDCWHAIPSHRPTFKQLV 290 (304)
T ss_pred H-----HH---------HHHHHcCCc---------------CCC------CCCCCHHHHHHHHHHcccChhhCCCHHHHH
Confidence 1 10 000000000 000 001234578899999999999999999999
Q ss_pred HHHHHHHH
Q 002857 463 LGLRLIKK 470 (873)
Q Consensus 463 ~~Le~i~~ 470 (873)
+.|+++..
T Consensus 291 ~~l~~~~~ 298 (304)
T cd05101 291 EDLDRILT 298 (304)
T ss_pred HHHHHHHH
Confidence 99998755
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=310.99 Aligned_cols=253 Identities=27% Similarity=0.432 Sum_probs=197.4
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEE
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKAL 239 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~L 239 (873)
++|++.++||+|+||.||+|.+. ++..||+|.++.... ..+.+.+|+.++++++|+|++++++++. ....++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~------~~~~~l 77 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS------EEPIYI 77 (260)
T ss_pred HHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC------CCCcEE
Confidence 46888999999999999999774 566799999875433 3467999999999999999999998842 345789
Q ss_pred EEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEecc
Q 002857 240 VYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADF 319 (873)
Q Consensus 240 V~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDF 319 (873)
||||+++++|.++++. .....+++.+++.++.|++.||+||| +.+|+|+||||+||++++++.++|+||
T Consensus 78 v~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~df 146 (260)
T cd05070 78 VTEYMSKGSLLDFLKD--------GEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADF 146 (260)
T ss_pred EEEecCCCcHHHHHHh--------cCCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCc
Confidence 9999999999999853 22345889999999999999999999 889999999999999999999999999
Q ss_pred ccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHHHhhcCchh
Q 002857 320 GIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQSALPER 398 (873)
Q Consensus 320 Gla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~~~~~~~~~ 398 (873)
|++..+..... .......++..|+|||++.+..++.++||||||+++|||++ |..||...... .....
T Consensus 147 g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--~~~~~-------- 215 (260)
T cd05070 147 GLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR--EVLEQ-------- 215 (260)
T ss_pred eeeeeccCccc-ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH--HHHHH--------
Confidence 99986543221 11112235678999999988889999999999999999999 88898652111 01110
Q ss_pred HHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHH
Q 002857 399 VEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRL 467 (873)
Q Consensus 399 l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~ 467 (873)
+ ..... .+.. ......+.+++.+||+.+|++|||+.++.+.|+.
T Consensus 216 ---~-~~~~~--------------~~~~-------~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 216 ---V-ERGYR--------------MPCP-------QDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred ---H-HcCCC--------------CCCC-------CcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0 00000 0000 0112357899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=339.76 Aligned_cols=204 Identities=22% Similarity=0.338 Sum_probs=168.4
Q ss_pred HHHHHhhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhc------cceeeeeee
Q 002857 153 EALYSATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHR------KIIKVVTAC 226 (873)
Q Consensus 153 ~el~~at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~Hp------NIV~llg~c 226 (873)
+++...+++|++.++||+|+||+||+|.+..+++.||||+++... .....+..|+++++.++|. +++++++++
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 445556789999999999999999999998889999999986432 2234567788888888665 478888876
Q ss_pred ecccccCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCC-CCeeeccCCCCC
Q 002857 227 SRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCK-PPIAHCDIKPSN 305 (873)
Q Consensus 227 ~~~~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s-~gIvHrDLKpsN 305 (873)
. ....+.++|||++ +++|.+++.. ...+++..+..|+.||+.||+||| . .+||||||||+|
T Consensus 201 ~----~~~~~~~iv~~~~-g~~l~~~l~~----------~~~l~~~~~~~i~~qi~~aL~yLH---~~~gIiHrDlKP~N 262 (467)
T PTZ00284 201 Q----NETGHMCIVMPKY-GPCLLDWIMK----------HGPFSHRHLAQIIFQTGVALDYFH---TELHLMHTDLKPEN 262 (467)
T ss_pred E----cCCceEEEEEecc-CCCHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHH---hcCCeecCCCCHHH
Confidence 3 2345789999988 7789888842 346899999999999999999999 6 599999999999
Q ss_pred eeeCCCC----------------CeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHH
Q 002857 306 ILLNDEM----------------TACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLE 369 (873)
Q Consensus 306 ILLd~~~----------------~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~E 369 (873)
||++.++ .+||+|||.+..... ......||..|+|||++.+..++.++|||||||++||
T Consensus 263 ILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~e 337 (467)
T PTZ00284 263 ILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYE 337 (467)
T ss_pred EEEecCCcccccccccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHH
Confidence 9998665 499999998864221 1234568999999999999999999999999999999
Q ss_pred HHhCCCCCCcc
Q 002857 370 MFTGLRPSDDM 380 (873)
Q Consensus 370 LlTGk~Pf~~~ 380 (873)
|++|+.||+..
T Consensus 338 lltG~~pf~~~ 348 (467)
T PTZ00284 338 LYTGKLLYDTH 348 (467)
T ss_pred HHhCCCCCCCC
Confidence 99999999763
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=318.53 Aligned_cols=271 Identities=21% Similarity=0.294 Sum_probs=197.5
Q ss_pred cCCCcceeecccCceEEEEEEEcCC--------------CcEEEEEEeeccC-CcchhHHHHHHHHHHhhhhccceeeee
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEG--------------APAVAIKVFNFLH-HDASKSFTVECEVMRNIIHRKIIKVVT 224 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~--------------g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~llg 224 (873)
++|++.+.||+|+||.||+++.... ...||+|.++... ......|.+|++++++++|+||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 5788999999999999999976432 2358999987432 223457899999999999999999999
Q ss_pred eeecccccCCceEEEEEeecCCCChhhhcccccccc--cccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCC
Q 002857 225 ACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEED--KRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIK 302 (873)
Q Consensus 225 ~c~~~~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~--~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLK 302 (873)
++ ......++||||+++++|.+++....... ........+++..++.++.|++.||+||| +.+++|+|||
T Consensus 85 ~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlk 156 (295)
T cd05097 85 VC-----VSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLA 156 (295)
T ss_pred EE-----cCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeeccccC
Confidence 96 34567899999999999999985311000 00011234788899999999999999999 8999999999
Q ss_pred CCCeeeCCCCCeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh--CCCCCCcc
Q 002857 303 PSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT--GLRPSDDM 380 (873)
Q Consensus 303 psNILLd~~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT--Gk~Pf~~~ 380 (873)
|+||++++++.+||+|||++................++..|+|||++.+..++.++||||||+++|||++ |..||...
T Consensus 157 p~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~ 236 (295)
T cd05097 157 TRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLL 236 (295)
T ss_pred hhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCccc
Confidence 9999999999999999999976543222112222345778999999988899999999999999999998 56677542
Q ss_pred cccchhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHH
Q 002857 381 FKDNLNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKIND 460 (873)
Q Consensus 381 ~~~~~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~E 460 (873)
..+. ..... .+..+...... ....+. ..+..+.+|+.+||+.+|++||++.+
T Consensus 237 ~~~~--~~~~~--------~~~~~~~~~~~---------~~~~~~---------~~~~~l~~li~~~l~~~p~~RPs~~~ 288 (295)
T cd05097 237 SDEQ--VIENT--------GEFFRNQGRQI---------YLSQTP---------LCPSPVFKLMMRCWSRDIKDRPTFNK 288 (295)
T ss_pred ChHH--HHHHH--------HHhhhhccccc---------cCCCCC---------CCCHHHHHHHHHHcCCCchhCcCHHH
Confidence 2111 00000 00000000000 000000 01235889999999999999999999
Q ss_pred HHHHHH
Q 002857 461 VELGLR 466 (873)
Q Consensus 461 Vl~~Le 466 (873)
|++.|+
T Consensus 289 i~~~l~ 294 (295)
T cd05097 289 IHHFLR 294 (295)
T ss_pred HHHHHh
Confidence 999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=320.17 Aligned_cols=277 Identities=18% Similarity=0.244 Sum_probs=197.5
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCC-cchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEE
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH-DASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKA 238 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~ 238 (873)
++|.+.+.||+|+||.||+|++..+++.||+|.++.... .....+.+|++++++++|+||+++++++ ..++..+
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~ 80 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV-----HTDKSLT 80 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEE-----eeCCeEE
Confidence 578899999999999999999988899999999874432 2335678899999999999999999986 3456789
Q ss_pred EEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEec
Q 002857 239 LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVAD 318 (873)
Q Consensus 239 LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsD 318 (873)
+||||+++ +|.+++.. ....+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|
T Consensus 81 lv~e~~~~-~l~~~~~~---------~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~D 147 (309)
T cd07872 81 LVFEYLDK-DLKQYMDD---------CGNIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLAD 147 (309)
T ss_pred EEEeCCCC-CHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECc
Confidence 99999975 88887742 2345788899999999999999999 89999999999999999999999999
Q ss_pred cccccccccccccccccccccccccCCCcccCC-CCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCch
Q 002857 319 FGIARFLEATNEQTSSIGVKGTTGYIAPEYGMG-HETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPE 397 (873)
Q Consensus 319 FGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~ 397 (873)
||+++....... ......++..|+|||++.+ ..++.++||||||+++|||+||+.||....... ....+...+..
T Consensus 148 fg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~--~~~~~~~~~~~ 223 (309)
T cd07872 148 FGLARAKSVPTK--TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVED--ELHLIFRLLGT 223 (309)
T ss_pred cccceecCCCcc--ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCC
Confidence 999975432221 1123357899999998765 468899999999999999999999997532211 11111111111
Q ss_pred hHHHHhhhhhhhhhhHHHHHhhhccCCCC-chhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 398 RVEEIVDTLFFKEIEEEETVYKYKKAPSS-STQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 398 ~l~elid~~L~~~~~~r~~~~~i~~~p~~-~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
...+......... ........... .............+.+++.+||+.||.+|||+.|+++
T Consensus 224 ~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 224 PTEETWPGISSND-----EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred CCHHHHhhhcchh-----hhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 0000000000000 00000000000 0000001112335778999999999999999999876
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=313.19 Aligned_cols=252 Identities=25% Similarity=0.373 Sum_probs=195.9
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEE
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKAL 239 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~L 239 (873)
++|.+.+.||+|+||.||+|.+. ++..||||.+.... .....+.+|+.++++++||||+++++++. .....++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l 76 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCT-----KQRPIYI 76 (256)
T ss_pred HHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEc-----cCCCcEE
Confidence 45788899999999999999874 45569999887433 23467999999999999999999999963 3456799
Q ss_pred EEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEecc
Q 002857 240 VYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADF 319 (873)
Q Consensus 240 V~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDF 319 (873)
||||+.+|+|.+++.. ....+++..++.++.||+.||+||| +.+|+|+||||+||+++.++.+||+||
T Consensus 77 v~e~~~~~~l~~~i~~---------~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~ 144 (256)
T cd05113 77 VTEYMSNGCLLNYLRE---------HGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDF 144 (256)
T ss_pred EEEcCCCCcHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCC
Confidence 9999999999999842 2236899999999999999999999 899999999999999999999999999
Q ss_pred ccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHHHhhcCchh
Q 002857 320 GIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQSALPER 398 (873)
Q Consensus 320 Gla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~~~~~~~~~ 398 (873)
|.++....... .......++..|+|||++.+..++.++||||||+++|||+| |+.||.......
T Consensus 145 g~~~~~~~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~-------------- 209 (256)
T cd05113 145 GLSRYVLDDEY-TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE-------------- 209 (256)
T ss_pred ccceecCCCce-eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH--------------
Confidence 99986533221 11222335678999999988889999999999999999999 999986422110
Q ss_pred HHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHH
Q 002857 399 VEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLR 466 (873)
Q Consensus 399 l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le 466 (873)
+.+....... .+.... ....+.+++.+||+.+|.+||++.+|+..|+
T Consensus 210 ---~~~~~~~~~~-----------~~~~~~-------~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 210 ---TVEKVSQGLR-----------LYRPHL-------ASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred ---HHHHHhcCCC-----------CCCCCC-------CCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 0010000000 000000 1235788999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=331.12 Aligned_cols=202 Identities=26% Similarity=0.299 Sum_probs=173.4
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC---CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCce
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH---HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDF 236 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~ 236 (873)
++|++.+.||+|+||.||++....+++.||+|+++... ....+.+.+|+.+++.++|+||+++++++ .....
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~-----~~~~~ 75 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAF-----QDKDN 75 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCe
Confidence 47899999999999999999999999999999997432 23445688999999999999999999885 45667
Q ss_pred EEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEE
Q 002857 237 KALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACV 316 (873)
Q Consensus 237 ~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKL 316 (873)
.+|||||+++|+|.+++.. ....+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||
T Consensus 76 ~~lv~e~~~~~~L~~~l~~---------~~~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL 143 (330)
T cd05601 76 LYLVMEYQPGGDLLSLLNR---------YEDQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKL 143 (330)
T ss_pred EEEEECCCCCCCHHHHHHH---------hcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEe
Confidence 9999999999999999853 2356889999999999999999999 899999999999999999999999
Q ss_pred eccccccccccccccccccccccccccCCCcccC------CCCCCcchhhHhHHHHHHHHHhCCCCCCc
Q 002857 317 ADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGM------GHETSSYGDVYSFGILLLEMFTGLRPSDD 379 (873)
Q Consensus 317 sDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~------~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~ 379 (873)
+|||++..+...... ......||..|+|||++. ...++.++|||||||++|||++|+.||..
T Consensus 144 ~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~ 211 (330)
T cd05601 144 ADFGSAARLTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHE 211 (330)
T ss_pred ccCCCCeECCCCCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCC
Confidence 999999866433221 222346899999999986 45678999999999999999999999965
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=311.32 Aligned_cols=250 Identities=27% Similarity=0.380 Sum_probs=194.8
Q ss_pred CCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEEE
Q 002857 161 GFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKALV 240 (873)
Q Consensus 161 ~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~LV 240 (873)
+|++.+.||+|+||.||+|.+. ++..+|+|++..... ....+.+|++++++++|+||+++++++ ......++|
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~lv 77 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVC-----TKQRPIFIV 77 (256)
T ss_pred HcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEE-----cCCCceEEE
Confidence 5778899999999999999875 566899999864322 335788999999999999999999985 445678999
Q ss_pred EeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEeccc
Q 002857 241 YEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFG 320 (873)
Q Consensus 241 ~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDFG 320 (873)
|||+++++|.+++.. ....+++..++.|+.||+.||+||| +.+|+||||||+||++++++.+||+|||
T Consensus 78 ~e~~~~~~L~~~l~~---------~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg 145 (256)
T cd05059 78 TEYMANGCLLNYLRE---------RKGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFG 145 (256)
T ss_pred EecCCCCCHHHHHHh---------cccCCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCcc
Confidence 999999999999852 2336899999999999999999999 8999999999999999999999999999
Q ss_pred cccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHHHhhcCchhH
Q 002857 321 IARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQSALPERV 399 (873)
Q Consensus 321 la~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~~~~~~~~~l 399 (873)
+++....... .......++..|+|||++.+..++.++||||||+++|||++ |+.||....... ....
T Consensus 146 ~~~~~~~~~~-~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~~--------- 213 (256)
T cd05059 146 LARYVLDDQY-TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE--VVES--------- 213 (256)
T ss_pred cceecccccc-cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH--HHHH---------
Confidence 9986532211 11112224567999999999999999999999999999999 899986521110 0000
Q ss_pred HHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHH
Q 002857 400 EEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGL 465 (873)
Q Consensus 400 ~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~L 465 (873)
+..... .+... .+...+.+++.+||+.+|++|||+.||++.|
T Consensus 214 ---~~~~~~--------------~~~~~-------~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 214 ---VSAGYR--------------LYRPK-------LAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred ---HHcCCc--------------CCCCC-------CCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 000000 00000 0133588999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=313.61 Aligned_cols=256 Identities=26% Similarity=0.438 Sum_probs=199.2
Q ss_pred CCCcceeecccCceEEEEEEEcCCCc---EEEEEEeeccC-CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCce
Q 002857 161 GFSSENLIGAGNFASVYKGILFEGAP---AVAIKVFNFLH-HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDF 236 (873)
Q Consensus 161 ~f~~~~~LG~G~fG~VYkg~~~~~g~---~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~ 236 (873)
+|++.+.||+|+||.||+|.+..+++ .||||+++... ......|..|+.++++++||||+++++++ ..+..
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~-----~~~~~ 79 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVV-----TKSRP 79 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEE-----CCCCc
Confidence 57788999999999999999876554 69999987542 33346899999999999999999999985 45667
Q ss_pred EEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEE
Q 002857 237 KALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACV 316 (873)
Q Consensus 237 ~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKL 316 (873)
.++||||+++|+|.+++.. ....+++.+++.++.|++.||.||| +.+++|+||||+||+++.++.+||
T Consensus 80 ~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl 147 (269)
T cd05065 80 VMIITEFMENGALDSFLRQ---------NDGQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKV 147 (269)
T ss_pred eEEEEecCCCCcHHHHHhh---------CCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEE
Confidence 8999999999999999853 2346899999999999999999999 899999999999999999999999
Q ss_pred eccccccccccccccccccc-c--ccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHHHh
Q 002857 317 ADFGIARFLEATNEQTSSIG-V--KGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQ 392 (873)
Q Consensus 317 sDFGla~~~~~~~~~~~~~~-~--~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~~~ 392 (873)
+|||+++............. . ..+..|+|||++.+..++.++||||||+++|||++ |..||...... ....++.
T Consensus 148 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~--~~~~~i~ 225 (269)
T cd05065 148 SDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ--DVINAIE 225 (269)
T ss_pred CCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH--HHHHHHH
Confidence 99999986543222111111 1 12457999999999999999999999999999987 99998653211 1111110
Q ss_pred hcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHH
Q 002857 393 SALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLI 468 (873)
Q Consensus 393 ~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i 468 (873)
. .. ..|.. .+++..+.+++..||+.+|++||++.+|+.+|+.+
T Consensus 226 ~------------~~--------------~~~~~-------~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 226 Q------------DY--------------RLPPP-------MDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred c------------CC--------------cCCCc-------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 00 00000 11233477899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=317.53 Aligned_cols=272 Identities=21% Similarity=0.308 Sum_probs=201.2
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCC----------------cEEEEEEeeccCC-cchhHHHHHHHHHHhhhhcccee
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGA----------------PAVAIKVFNFLHH-DASKSFTVECEVMRNIIHRKIIK 221 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g----------------~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~ 221 (873)
.++|++.+.||+|+||.||+|.+...+ ..||+|.+..... ...+.+.+|++++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 357899999999999999999875432 4689999875432 34567899999999999999999
Q ss_pred eeeeeecccccCCceEEEEEeecCCCChhhhcccccccccc-cCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeecc
Q 002857 222 VVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKR-HKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCD 300 (873)
Q Consensus 222 llg~c~~~~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~-~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrD 300 (873)
+++++ ..++..++||||+++++|.+++......... ......+++..++.++.|++.||+||| +.+|+|+|
T Consensus 84 ~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~d 155 (296)
T cd05051 84 LLGVC-----TVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRD 155 (296)
T ss_pred EEEEE-----ecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccc
Confidence 99986 3446789999999999999998542110000 112346899999999999999999999 89999999
Q ss_pred CCCCCeeeCCCCCeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh--CCCCCC
Q 002857 301 IKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT--GLRPSD 378 (873)
Q Consensus 301 LKpsNILLd~~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT--Gk~Pf~ 378 (873)
|||+||+++.++.++|+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||.
T Consensus 156 lkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~ 235 (296)
T cd05051 156 LATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYE 235 (296)
T ss_pred cchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCC
Confidence 999999999999999999999986543322222223446788999999988889999999999999999998 677775
Q ss_pred cccccchhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCH
Q 002857 379 DMFKDNLNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKI 458 (873)
Q Consensus 379 ~~~~~~~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm 458 (873)
...... ... .+.. .+... . .......+ ..+...+.+++.+||+.+|++|||+
T Consensus 236 ~~~~~~--~~~-----------~~~~-~~~~~-~----~~~~~~~~---------~~~~~~l~~li~~cl~~~p~~Rpt~ 287 (296)
T cd05051 236 HLTDQQ--VIE-----------NAGH-FFRDD-G----RQIYLPRP---------PNCPKDIYELMLECWRRDEEDRPTF 287 (296)
T ss_pred CcChHH--HHH-----------HHHh-ccccc-c----ccccCCCc---------cCCCHHHHHHHHHHhccChhcCCCH
Confidence 422111 000 0000 00000 0 00000000 0112358899999999999999999
Q ss_pred HHHHHHHH
Q 002857 459 NDVELGLR 466 (873)
Q Consensus 459 ~EVl~~Le 466 (873)
.||++.|+
T Consensus 288 ~el~~~L~ 295 (296)
T cd05051 288 REIHLFLQ 295 (296)
T ss_pred HHHHHHhc
Confidence 99998885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=308.52 Aligned_cols=251 Identities=26% Similarity=0.424 Sum_probs=200.3
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEE
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKA 238 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~ 238 (873)
.++|++.+.||.|+||.||+|.. .++.||+|.++.... ..+.+.+|+.++++++|+||+++++++ ......+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~ 76 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVV-----LQGNPLY 76 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEE-----cCCCCeE
Confidence 35788899999999999999987 478899999975544 457899999999999999999999985 3366789
Q ss_pred EEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEec
Q 002857 239 LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVAD 318 (873)
Q Consensus 239 LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsD 318 (873)
+||||+++++|.+++.. .....+++..++.++.|++.||.||| ..+|+|+||||+||+++.++.+||+|
T Consensus 77 ~v~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d 145 (256)
T cd05039 77 IVTEYMAKGSLVDYLRS--------RGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSD 145 (256)
T ss_pred EEEEecCCCcHHHHHHh--------cCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEcc
Confidence 99999999999999853 22236899999999999999999999 89999999999999999999999999
Q ss_pred cccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHHHhhcCch
Q 002857 319 FGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQSALPE 397 (873)
Q Consensus 319 FGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~~~~~~~~ 397 (873)
||.++....... ....+..|+|||++....++.++||||||+++|||++ |..||.......
T Consensus 146 ~g~~~~~~~~~~-----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------------- 207 (256)
T cd05039 146 FGLAKEASQGQD-----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD------------- 207 (256)
T ss_pred cccccccccccc-----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH-------------
Confidence 999986632211 2235678999999988899999999999999999997 999986421111
Q ss_pred hHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHH
Q 002857 398 RVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLI 468 (873)
Q Consensus 398 ~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i 468 (873)
+.+.+...... ..+ ......+.+++.+||+.+|++|||+.||+++|+.+
T Consensus 208 -~~~~~~~~~~~------------~~~---------~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 208 -VVPHVEKGYRM------------EAP---------EGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred -HHHHHhcCCCC------------CCc---------cCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 00100000000 000 01123578899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=326.14 Aligned_cols=199 Identities=26% Similarity=0.309 Sum_probs=169.2
Q ss_pred CCCcceeecccCceEEEEEEEcCCCcEEEEEEeecc---CCcchhHHHHHHHHHHhhhhc-cceeeeeeeecccccCCce
Q 002857 161 GFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFL---HHDASKSFTVECEVMRNIIHR-KIIKVVTACSRVDYQGNDF 236 (873)
Q Consensus 161 ~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~L~Hp-NIV~llg~c~~~~~~~~~~ 236 (873)
+|++.+.||+|+||.||+|++..+++.||||+++.. .....+.+..|++++..+.|+ +|+++++++ ...+.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~ 75 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QTMDR 75 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEE-----EcCCE
Confidence 578899999999999999999888999999998743 223446788899999999765 577787774 45667
Q ss_pred EEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEE
Q 002857 237 KALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACV 316 (873)
Q Consensus 237 ~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKL 316 (873)
.++||||+++|+|.+++.. ...+++..++.++.||+.||+||| +.+|+||||||+|||++.++.+||
T Consensus 76 ~~lv~E~~~~g~L~~~~~~----------~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL 142 (324)
T cd05587 76 LYFVMEYVNGGDLMYHIQQ----------VGKFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKI 142 (324)
T ss_pred EEEEEcCCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEE
Confidence 9999999999999998842 345888999999999999999999 899999999999999999999999
Q ss_pred eccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCc
Q 002857 317 ADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDD 379 (873)
Q Consensus 317 sDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~ 379 (873)
+|||+++...... .......||..|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 143 ~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~ 203 (324)
T cd05587 143 ADFGMCKENIFGG--KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG 203 (324)
T ss_pred eecCcceecCCCC--CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCC
Confidence 9999987432211 122234689999999999999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=331.34 Aligned_cols=202 Identities=24% Similarity=0.354 Sum_probs=173.9
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC---CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCce
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH---HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDF 236 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~ 236 (873)
++|++.+.||+|+||+||+|....+++.||||+++... ......+..|+.++.+++|+||+++++.+ .+...
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~-----~~~~~ 75 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSF-----QDKLN 75 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEE-----ecCCe
Confidence 47899999999999999999998899999999997432 22335688899999999999999999985 45678
Q ss_pred EEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEE
Q 002857 237 KALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACV 316 (873)
Q Consensus 237 ~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKL 316 (873)
.+|||||+++|+|.+++. ....+++..+..++.||+.||+||| +.+|+||||||+|||++.++++||
T Consensus 76 ~~lv~E~~~gg~L~~~l~----------~~~~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL 142 (363)
T cd05628 76 LYLIMEFLPGGDMMTLLM----------KKDTLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKL 142 (363)
T ss_pred EEEEEcCCCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEE
Confidence 999999999999999984 2456899999999999999999999 899999999999999999999999
Q ss_pred ecccccccccccccc---------------------------------ccccccccccccCCCcccCCCCCCcchhhHhH
Q 002857 317 ADFGIARFLEATNEQ---------------------------------TSSIGVKGTTGYIAPEYGMGHETSSYGDVYSF 363 (873)
Q Consensus 317 sDFGla~~~~~~~~~---------------------------------~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSf 363 (873)
+|||+++.+...... .......||..|+|||++.+..++.++|||||
T Consensus 143 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSl 222 (363)
T cd05628 143 SDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSL 222 (363)
T ss_pred eeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhh
Confidence 999999754321100 00123469999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCc
Q 002857 364 GILLLEMFTGLRPSDD 379 (873)
Q Consensus 364 GvvL~ELlTGk~Pf~~ 379 (873)
||++|||++|+.||..
T Consensus 223 Gvil~ell~G~~Pf~~ 238 (363)
T cd05628 223 GVIMYEMLIGYPPFCS 238 (363)
T ss_pred HHHHHHHHhCCCCCCC
Confidence 9999999999999975
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=311.99 Aligned_cols=257 Identities=23% Similarity=0.302 Sum_probs=198.9
Q ss_pred HHHhhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCC
Q 002857 155 LYSATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGN 234 (873)
Q Consensus 155 l~~at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~ 234 (873)
++.+++++.....||+|+||.||+|++..++..||+|.+........+.+.+|+.++++++|+||+++++++ ..+
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~ 77 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD-----SEN 77 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeee-----ccC
Confidence 455677788888999999999999999888999999998765555567899999999999999999999986 345
Q ss_pred ceEEEEEeecCCCChhhhcccccccccccCCCCCC--chhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCC-C
Q 002857 235 DFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNL--NSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLND-E 311 (873)
Q Consensus 235 ~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~L--s~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~-~ 311 (873)
+..++|+||+++++|.+++.. ....+ ++..+..++.||+.||+||| +.+|+||||||+||+++. +
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~ 145 (268)
T cd06624 78 GFFKIFMEQVPGGSLSALLRS---------KWGPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYS 145 (268)
T ss_pred CEEEEEEecCCCCCHHHHHHH---------hcccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCC
Confidence 678999999999999999853 11223 77888999999999999999 899999999999999986 6
Q ss_pred CCeEEeccccccccccccccccccccccccccCCCcccCCC--CCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHH
Q 002857 312 MTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGH--ETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQN 389 (873)
Q Consensus 312 ~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~--~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~ 389 (873)
+.++|+|||++........ ......++..|+|||++.+. .++.++||||||+++|+|++|+.||......... .
T Consensus 146 ~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~--~ 221 (268)
T cd06624 146 GVVKISDFGTSKRLAGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA--M 221 (268)
T ss_pred CeEEEecchhheecccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh--H
Confidence 7999999999976533221 11223478999999998664 3788999999999999999999998642111100 0
Q ss_pred HHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 390 WVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 390 ~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
+ ...... ..+... ......+.+++.+||+.+|++|||+.||++
T Consensus 222 ~-------------~~~~~~------------~~~~~~------~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 222 F-------------KVGMFK------------IHPEIP------ESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred h-------------hhhhhc------------cCCCCC------cccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 0 000000 000000 011234778999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=327.01 Aligned_cols=194 Identities=26% Similarity=0.326 Sum_probs=166.3
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEeecc---CCcchhHHHHHHHHHHhh-hhccceeeeeeeecccccCCceEEEEE
Q 002857 166 NLIGAGNFASVYKGILFEGAPAVAIKVFNFL---HHDASKSFTVECEVMRNI-IHRKIIKVVTACSRVDYQGNDFKALVY 241 (873)
Q Consensus 166 ~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~L-~HpNIV~llg~c~~~~~~~~~~~~LV~ 241 (873)
++||+|+||.||+|++..+++.||||+++.. .......+..|++++..+ +||||+++++++ ...+..++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~-----~~~~~~~lv~ 75 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCF-----QTKDRLFFVM 75 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCeEEEEE
Confidence 4699999999999999888999999998743 223345677899999876 799999999985 4566799999
Q ss_pred eecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEecccc
Q 002857 242 EFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGI 321 (873)
Q Consensus 242 Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDFGl 321 (873)
||+++|+|..++. ....+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 76 E~~~~~~L~~~l~----------~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~ 142 (321)
T cd05591 76 EYVNGGDLMFQIQ----------RSRKFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGM 142 (321)
T ss_pred eCCCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeeccc
Confidence 9999999998884 2346888999999999999999999 89999999999999999999999999999
Q ss_pred ccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCc
Q 002857 322 ARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDD 379 (873)
Q Consensus 322 a~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~ 379 (873)
++...... .......||..|+|||++.+..++.++||||||+++|||+||+.||..
T Consensus 143 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~ 198 (321)
T cd05591 143 CKEGILNG--VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEA 198 (321)
T ss_pred ceecccCC--ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCC
Confidence 87542221 122234689999999999998999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=307.20 Aligned_cols=257 Identities=26% Similarity=0.420 Sum_probs=200.3
Q ss_pred eeecccCceEEEEEEEcCC---CcEEEEEEeeccCCcc-hhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEEEE
Q 002857 166 NLIGAGNFASVYKGILFEG---APAVAIKVFNFLHHDA-SKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKALVY 241 (873)
Q Consensus 166 ~~LG~G~fG~VYkg~~~~~---g~~VAVK~l~~~~~~~-~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~LV~ 241 (873)
+.||+|+||.||+|.+... +..||+|+++...... .+.+.+|+++++.++|+||+++++++ ......++||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~lv~ 75 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVC-----TEEEPLYLVL 75 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeee-----cCCCceEEEE
Confidence 4699999999999999765 8899999997554433 57899999999999999999999986 3466789999
Q ss_pred eecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEecccc
Q 002857 242 EFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGI 321 (873)
Q Consensus 242 Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDFGl 321 (873)
||+++++|.+++....... .......+++..++.++.|++.||+||| +.+|+|+||||+||+++.++.+||+|||.
T Consensus 76 e~~~~~~L~~~l~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~ 151 (262)
T cd00192 76 EYMEGGDLLDYLRKSRPVF-PSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGL 151 (262)
T ss_pred EeccCCcHHHHHhhccccc-cccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEccccc
Confidence 9999999999995310000 0011367899999999999999999999 89999999999999999999999999999
Q ss_pred ccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHHHhhcCchhHH
Q 002857 322 ARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQSALPERVE 400 (873)
Q Consensus 322 a~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~~~~~~~~~l~ 400 (873)
+................++..|+|||.+....++.++||||||+++|||++ |..||...... .+. .
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~-----------~ 218 (262)
T cd00192 152 SRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE--EVL-----------E 218 (262)
T ss_pred ccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH--HHH-----------H
Confidence 987654432222334457889999999988889999999999999999999 69998763111 010 1
Q ss_pred HHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHH
Q 002857 401 EIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLR 466 (873)
Q Consensus 401 elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le 466 (873)
.+.+.... +. ...+...+.+++.+||+.+|++|||+.|++..|+
T Consensus 219 ~~~~~~~~---------------~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 219 YLRKGYRL---------------PK-------PEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred HHHcCCCC---------------CC-------CccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 11100000 00 0011335889999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=325.50 Aligned_cols=194 Identities=27% Similarity=0.372 Sum_probs=164.6
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEeeccC---CcchhHHHHHHHHHHhh-hhccceeeeeeeecccccCCceEEEEE
Q 002857 166 NLIGAGNFASVYKGILFEGAPAVAIKVFNFLH---HDASKSFTVECEVMRNI-IHRKIIKVVTACSRVDYQGNDFKALVY 241 (873)
Q Consensus 166 ~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L-~HpNIV~llg~c~~~~~~~~~~~~LV~ 241 (873)
+.||+|+||.||+|++..+++.||||+++... ....+.+..|..++..+ +||||+++++++ ..+...++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~-----~~~~~~~lv~ 75 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTF-----QTKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCEEEEEE
Confidence 46999999999999998889999999987432 22334566677777654 899999999885 4566899999
Q ss_pred eecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEecccc
Q 002857 242 EFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGI 321 (873)
Q Consensus 242 Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDFGl 321 (873)
||+++|+|.+++.. ...+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 76 e~~~gg~L~~~~~~----------~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~ 142 (316)
T cd05592 76 EYLNGGDLMFHIQS----------SGRFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGM 142 (316)
T ss_pred cCCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcC
Confidence 99999999998842 346888999999999999999999 89999999999999999999999999999
Q ss_pred ccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCc
Q 002857 322 ARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDD 379 (873)
Q Consensus 322 a~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~ 379 (873)
++...... .......||..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 143 a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~ 198 (316)
T cd05592 143 CKENMNGE--GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHG 198 (316)
T ss_pred CeECCCCC--CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCC
Confidence 97543222 222335689999999999999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=311.09 Aligned_cols=249 Identities=24% Similarity=0.355 Sum_probs=192.5
Q ss_pred eecccCceEEEEEEEc--CCCcEEEEEEeeccCCc-chhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEEEEee
Q 002857 167 LIGAGNFASVYKGILF--EGAPAVAIKVFNFLHHD-ASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKALVYEF 243 (873)
Q Consensus 167 ~LG~G~fG~VYkg~~~--~~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~LV~Ey 243 (873)
.||+|+||.||+|.+. .++..||+|++...... ..+.+.+|+.++++++|+||+++++++. ....++||||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~------~~~~~lv~e~ 75 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE------AEALMLVMEM 75 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc------CCCeEEEEEe
Confidence 3899999999999875 34567999998754332 3356899999999999999999999862 3457999999
Q ss_pred cCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEecccccc
Q 002857 244 MPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIAR 323 (873)
Q Consensus 244 ~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDFGla~ 323 (873)
+++|+|.+++.. ....+++..++.++.||+.||+||| +.+++||||||+|||++.++.+||+|||+++
T Consensus 76 ~~~~~L~~~l~~---------~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~ 143 (257)
T cd05115 76 ASGGPLNKFLSG---------KKDEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSK 143 (257)
T ss_pred CCCCCHHHHHHh---------CCCCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccc
Confidence 999999999842 2456899999999999999999999 8999999999999999999999999999998
Q ss_pred cccccccccc-ccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHHHhhcCchhHHH
Q 002857 324 FLEATNEQTS-SIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQSALPERVEE 401 (873)
Q Consensus 324 ~~~~~~~~~~-~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~~~~~~~~~l~e 401 (873)
.......... .....++..|+|||++.+..++.++||||||+++|||++ |..||....... .. .
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~------------~ 209 (257)
T cd05115 144 ALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE--VM------------S 209 (257)
T ss_pred cccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH--HH------------H
Confidence 6543322111 111223578999999988889999999999999999996 999987532111 11 1
Q ss_pred HhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHH
Q 002857 402 IVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLI 468 (873)
Q Consensus 402 lid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i 468 (873)
.+...... +.. ..+..++.+++.+||+.+|++||++.+|++.|+.+
T Consensus 210 ~~~~~~~~--------------~~~-------~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 210 FIEQGKRL--------------DCP-------AECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred HHHCCCCC--------------CCC-------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 11100000 000 01133577899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=325.99 Aligned_cols=204 Identities=24% Similarity=0.254 Sum_probs=170.1
Q ss_pred hhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeecc--CCcchhHHHHHHHHHHhhhhccceeeeeeeeccc-ccCC
Q 002857 158 ATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFL--HHDASKSFTVECEVMRNIIHRKIIKVVTACSRVD-YQGN 234 (873)
Q Consensus 158 at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~-~~~~ 234 (873)
..++|++.+.||+|+||.||++.+..++..||||++... .......+.+|+.+++.++||||+++++++.... ....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 457899999999999999999999888999999998643 2233467889999999999999999999864321 1122
Q ss_pred ceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCe
Q 002857 235 DFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTA 314 (873)
Q Consensus 235 ~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~v 314 (873)
...++||||+++ +|.+.++ ..+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~------------~~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~ 162 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIH------------MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTL 162 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHh------------ccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCE
Confidence 357999999965 6666552 23778888999999999999999 8999999999999999999999
Q ss_pred EEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcc
Q 002857 315 CVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDM 380 (873)
Q Consensus 315 KLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~ 380 (873)
||+|||+++...... ......+|..|+|||++.+..++.++||||||+++|||+||+.||...
T Consensus 163 kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 225 (359)
T cd07876 163 KILDFGLARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT 225 (359)
T ss_pred EEecCCCccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 999999997543221 122346899999999999999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=310.45 Aligned_cols=253 Identities=24% Similarity=0.418 Sum_probs=191.0
Q ss_pred eeecccCceEEEEEEEcC---CCcEEEEEEeeccC-CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEEEE
Q 002857 166 NLIGAGNFASVYKGILFE---GAPAVAIKVFNFLH-HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKALVY 241 (873)
Q Consensus 166 ~~LG~G~fG~VYkg~~~~---~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~LV~ 241 (873)
+.||+|+||.||+|.+.. ....||+|.+.... ....+.+.+|+.+++.++||||+++++++. ..+...++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~----~~~~~~~lv~ 76 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICL----PSEGSPLVVL 76 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEee----cCCCCcEEEE
Confidence 468999999999998753 34579999985332 234567889999999999999999999864 2345578999
Q ss_pred eecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEecccc
Q 002857 242 EFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGI 321 (873)
Q Consensus 242 Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDFGl 321 (873)
||+.+|+|.+++.. ....+++..++.++.||+.||+||| ..+|+||||||+|||+++++.+||+|||+
T Consensus 77 e~~~~~~L~~~~~~---------~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~ 144 (262)
T cd05058 77 PYMKHGDLRNFIRS---------ETHNPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGL 144 (262)
T ss_pred ecCCCCCHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCccc
Confidence 99999999999853 2334677788999999999999999 89999999999999999999999999999
Q ss_pred ccccccccc--cccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhC-CCCCCcccccchhhHHHHhhcCchh
Q 002857 322 ARFLEATNE--QTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTG-LRPSDDMFKDNLNLQNWVQSALPER 398 (873)
Q Consensus 322 a~~~~~~~~--~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTG-k~Pf~~~~~~~~~l~~~~~~~~~~~ 398 (873)
++....... ........++..|+|||++.+..++.++||||||+++|||++| ..||.... ...+...+
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~--~~~~~~~~------- 215 (262)
T cd05058 145 ARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD--SFDITVYL------- 215 (262)
T ss_pred cccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC--HHHHHHHH-------
Confidence 975432211 1111223467789999999888999999999999999999995 55554321 11111100
Q ss_pred HHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHHH
Q 002857 399 VEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLIK 469 (873)
Q Consensus 399 l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i~ 469 (873)
.... ..+.. ...+..+.+++..||+.+|++||++.||+..|+.+.
T Consensus 216 --------~~~~-----------~~~~~-------~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 216 --------LQGR-----------RLLQP-------EYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred --------hcCC-----------CCCCC-------CcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 0000 00000 001235788999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=310.29 Aligned_cols=254 Identities=25% Similarity=0.412 Sum_probs=199.5
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEE
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKA 238 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~ 238 (873)
.++|++.++||+|+||.||+|.. .+++.||+|.+..... ....+.+|+.++++++|+||+++++++ ..+..+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~-~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~------~~~~~~ 76 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVV------TQEPIY 76 (260)
T ss_pred hHHceeeeeeccCccceEEeeec-CCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEE------ccCCcE
Confidence 35788899999999999999986 4677899999874433 346789999999999999999999874 234589
Q ss_pred EEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEec
Q 002857 239 LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVAD 318 (873)
Q Consensus 239 LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsD 318 (873)
+||||+++++|.+++.. .....+++.+++.++.|++.||+||| +.+++|+||||+||++++++.++|+|
T Consensus 77 ~v~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~d 145 (260)
T cd05067 77 IITEYMENGSLVDFLKT--------PEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIAD 145 (260)
T ss_pred EEEEcCCCCCHHHHHHh--------cCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEcc
Confidence 99999999999999853 23456889999999999999999999 89999999999999999999999999
Q ss_pred cccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHHHhhcCch
Q 002857 319 FGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQSALPE 397 (873)
Q Consensus 319 FGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~~~~~~~~ 397 (873)
||++........ .......++..|+|||++.+..++.++||||||+++|||++ |+.||....... ...
T Consensus 146 fg~~~~~~~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~-------- 214 (260)
T cd05067 146 FGLARLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE--VIQ-------- 214 (260)
T ss_pred CcceeecCCCCc-ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH--HHH--------
Confidence 999986542221 11122345778999999988889999999999999999999 999996532110 000
Q ss_pred hHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHH
Q 002857 398 RVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRL 467 (873)
Q Consensus 398 ~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~ 467 (873)
.+..... .+.. .....++.+++.+||+.+|++|||+++|+..|+.
T Consensus 215 ----~~~~~~~--------------~~~~-------~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 215 ----NLERGYR--------------MPRP-------DNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred ----HHHcCCC--------------CCCC-------CCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 0000000 0000 0012358889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=316.15 Aligned_cols=273 Identities=23% Similarity=0.372 Sum_probs=201.5
Q ss_pred cCCCcceeecccCceEEEEEEE----cCCCcEEEEEEeeccC-CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCC
Q 002857 160 KGFSSENLIGAGNFASVYKGIL----FEGAPAVAIKVFNFLH-HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGN 234 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~----~~~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~ 234 (873)
+.|++.+.||+|+||.||++.+ ..++..||+|.++... ......+.+|++++++++|+||+++++++.. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~ 80 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTE---DGG 80 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEec---CCC
Confidence 3568889999999999999975 3467889999987443 2334679999999999999999999998743 224
Q ss_pred ceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCe
Q 002857 235 DFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTA 314 (873)
Q Consensus 235 ~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~v 314 (873)
...++||||+++++|.+++.. ....+++..++.++.||+.||+||| +.+|+||||||+||+++.++.+
T Consensus 81 ~~~~lv~e~~~g~~L~~~l~~---------~~~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~ 148 (284)
T cd05079 81 NGIKLIMEFLPSGSLKEYLPR---------NKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQV 148 (284)
T ss_pred CceEEEEEccCCCCHHHHHHh---------ccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCE
Confidence 568999999999999999842 2345899999999999999999999 8999999999999999999999
Q ss_pred EEecccccccccccccc-ccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhh
Q 002857 315 CVADFGIARFLEATNEQ-TSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQS 393 (873)
Q Consensus 315 KLsDFGla~~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~ 393 (873)
||+|||+++.+...... .......++..|+|||++.+..++.++||||||+++|||+|++.|+....... ......
T Consensus 149 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~---~~~~~~ 225 (284)
T cd05079 149 KIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLF---LKMIGP 225 (284)
T ss_pred EECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchh---hhhccc
Confidence 99999999866433221 11122346778999999988889999999999999999999887653311100 000000
Q ss_pred cCch-hHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHH
Q 002857 394 ALPE-RVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLI 468 (873)
Q Consensus 394 ~~~~-~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i 468 (873)
...+ .....+... ......+.. ..+...+.+|+.+||+.+|++|||+.+|++.|+.+
T Consensus 226 ~~~~~~~~~~~~~~-----------~~~~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 226 THGQMTVTRLVRVL-----------EEGKRLPRP-------PNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred ccccccHHHHHHHH-----------HcCccCCCC-------CCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 0000 011111000 000000100 01234588999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=327.62 Aligned_cols=252 Identities=21% Similarity=0.354 Sum_probs=207.5
Q ss_pred hhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC---CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCC
Q 002857 158 ATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH---HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGN 234 (873)
Q Consensus 158 at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~ 234 (873)
..++|++++.||+|+||.||+|+-+.+|..+|+|++++.. ....+.+..|-.+|...+++.||+|+-. |++.
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYs-----FQD~ 213 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYS-----FQDK 213 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEE-----ecCC
Confidence 4578999999999999999999999999999999998543 3445678889999999999999999987 5888
Q ss_pred ceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCe
Q 002857 235 DFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTA 314 (873)
Q Consensus 235 ~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~v 314 (873)
+.+||||||++||++..+|. ....|++.....++.+++.|+..|| ..|+|||||||+|+|||..|++
T Consensus 214 ~~LYLiMEylPGGD~mTLL~----------~~~~L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHi 280 (550)
T KOG0605|consen 214 EYLYLIMEYLPGGDMMTLLM----------RKDTLTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHI 280 (550)
T ss_pred CeeEEEEEecCCccHHHHHH----------hcCcCchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCE
Confidence 99999999999999999993 5678999999999999999999999 9999999999999999999999
Q ss_pred EEecccccccccccc---------------------ccc------------------------cccccccccccCCCccc
Q 002857 315 CVADFGIARFLEATN---------------------EQT------------------------SSIGVKGTTGYIAPEYG 349 (873)
Q Consensus 315 KLsDFGla~~~~~~~---------------------~~~------------------------~~~~~~Gt~~Y~APE~l 349 (873)
||+|||++.-+.... ... .....+||+.|||||++
T Consensus 281 KLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVl 360 (550)
T KOG0605|consen 281 KLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVL 360 (550)
T ss_pred eeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHH
Confidence 999999985332100 000 01135699999999999
Q ss_pred CCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccc--hhhHHHHhhc-------CchhHHHHhhhhhhhhhhHHHH---H
Q 002857 350 MGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDN--LNLQNWVQSA-------LPERVEEIVDTLFFKEIEEEET---V 417 (873)
Q Consensus 350 ~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~--~~l~~~~~~~-------~~~~l~elid~~L~~~~~~r~~---~ 417 (873)
.+..|+..+|.||+|||+||||.|-+||....... ..+..|-... ......+++...+. ++..|.. +
T Consensus 361 l~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~ 439 (550)
T KOG0605|consen 361 LGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGA 439 (550)
T ss_pred hcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccH
Confidence 99999999999999999999999999997743332 2344444221 22367888888887 5555544 6
Q ss_pred hhhccCCCCch
Q 002857 418 YKYKKAPSSST 428 (873)
Q Consensus 418 ~~i~~~p~~~~ 428 (873)
++++.||+...
T Consensus 440 ~EIK~HPfF~~ 450 (550)
T KOG0605|consen 440 EEIKKHPFFKG 450 (550)
T ss_pred HHHhcCCcccc
Confidence 78899998654
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=326.84 Aligned_cols=200 Identities=25% Similarity=0.337 Sum_probs=168.4
Q ss_pred CCCcceeecccCceEEEEEEEc---CCCcEEEEEEeeccC----CcchhHHHHHHHHHHhh-hhccceeeeeeeeccccc
Q 002857 161 GFSSENLIGAGNFASVYKGILF---EGAPAVAIKVFNFLH----HDASKSFTVECEVMRNI-IHRKIIKVVTACSRVDYQ 232 (873)
Q Consensus 161 ~f~~~~~LG~G~fG~VYkg~~~---~~g~~VAVK~l~~~~----~~~~~~f~~Ei~iL~~L-~HpNIV~llg~c~~~~~~ 232 (873)
+|++.+.||+|+||.||+++.. .+++.||+|++.... ....+.+..|+.++.++ +|+||+++++++ .
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-----~ 75 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAF-----Q 75 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEE-----e
Confidence 5788999999999999998764 467899999986421 22335678899999999 599999999884 4
Q ss_pred CCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCC
Q 002857 233 GNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEM 312 (873)
Q Consensus 233 ~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~ 312 (873)
.++..++||||+++|+|.+++.. ...+++..+..++.||+.||+||| +.+|+||||||+|||++.++
T Consensus 76 ~~~~~~lv~e~~~~g~L~~~l~~----------~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~ 142 (332)
T cd05614 76 TEAKLHLILDYVSGGEMFTHLYQ----------RDNFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEG 142 (332)
T ss_pred cCCEEEEEEeCCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCC
Confidence 56678999999999999999842 346889999999999999999999 89999999999999999999
Q ss_pred CeEEeccccccccccccccccccccccccccCCCcccCCC-CCCcchhhHhHHHHHHHHHhCCCCCCc
Q 002857 313 TACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGH-ETSSYGDVYSFGILLLEMFTGLRPSDD 379 (873)
Q Consensus 313 ~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELlTGk~Pf~~ 379 (873)
.+||+|||+++.+..... .......||..|+|||++.+. .++.++|||||||++|||+||+.||..
T Consensus 143 ~~kl~DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 209 (332)
T cd05614 143 HVVLTDFGLSKEFLSEEK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTL 209 (332)
T ss_pred CEEEeeCcCCccccccCC-CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCC
Confidence 999999999986533222 122235689999999998875 478899999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=313.58 Aligned_cols=279 Identities=20% Similarity=0.216 Sum_probs=204.0
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCc--chhHHHHHHHHHHhhhhccceeeeeeeecccccCCceE
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHD--ASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFK 237 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~ 237 (873)
+.|+..+.|++|.||.||+|+++.+++.||+|+++..... -.-.-++||.+|.+++|||||.+-.+... .+-+..
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG---~~~d~i 152 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVG---SNMDKI 152 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEec---ccccee
Confidence 4577789999999999999999999999999999854322 22356899999999999999999887543 334569
Q ss_pred EEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEe
Q 002857 238 ALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVA 317 (873)
Q Consensus 238 ~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLs 317 (873)
||||||++. +|..+|+. ....+...++.-+..|+++||+||| ...|+|||||++|+|+...|.+||+
T Consensus 153 y~VMe~~Eh-DLksl~d~---------m~q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKia 219 (419)
T KOG0663|consen 153 YIVMEYVEH-DLKSLMET---------MKQPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIA 219 (419)
T ss_pred eeeHHHHHh-hHHHHHHh---------ccCCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEec
Confidence 999999987 99999853 4467889999999999999999999 8999999999999999999999999
Q ss_pred ccccccccccccccccccccccccccCCCcccCCC-CCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCc
Q 002857 318 DFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGH-ETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALP 396 (873)
Q Consensus 318 DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~ 396 (873)
|||+|+.+.... ...+..+-|+.|+|||++.+. .|++..|+||+|||+.||+++++.|.+..+-++ +...+ ..+.
T Consensus 220 DFGLAR~ygsp~--k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQ-l~~If-~llG 295 (419)
T KOG0663|consen 220 DFGLAREYGSPL--KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQ-LDKIF-KLLG 295 (419)
T ss_pred ccchhhhhcCCc--ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHH-HHHHH-HHhC
Confidence 999999876542 233456689999999998886 689999999999999999999999977433211 11111 1110
Q ss_pred hhHHHHhhhhhhhhhhHHHHH--hhhccCCCCchhHHHHHH-HHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 397 ERVEEIVDTLFFKEIEEEETV--YKYKKAPSSSTQRSIILE-CLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 397 ~~l~elid~~L~~~~~~r~~~--~~i~~~p~~~~~~~~~~e-~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
..... ++..+.+-+.. ..+.++|.......+... ..+.-.+++...|..||.+|-|+.|.++
T Consensus 296 tPte~-----iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 296 TPSEA-----IWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred CCccc-----cCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 00000 00000000000 111222322221111000 1245668899999999999999998643
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=325.77 Aligned_cols=242 Identities=22% Similarity=0.315 Sum_probs=189.0
Q ss_pred eeecccCceEEEEEEEc---CCCcEEEEEEeeccC----CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEE
Q 002857 166 NLIGAGNFASVYKGILF---EGAPAVAIKVFNFLH----HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKA 238 (873)
Q Consensus 166 ~~LG~G~fG~VYkg~~~---~~g~~VAVK~l~~~~----~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~ 238 (873)
+.||+|+||.||+++.. ..++.||||+++... ......+.+|+.+|++++||||+++++++ ..++..+
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~-----~~~~~~~ 76 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAF-----QTGGKLY 76 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEE-----ecCCeEE
Confidence 68999999999999864 467899999987421 22335678899999999999999999985 4566789
Q ss_pred EEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEec
Q 002857 239 LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVAD 318 (873)
Q Consensus 239 LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsD 318 (873)
+||||+++|+|.+++. ....+.+..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|
T Consensus 77 lv~e~~~~~~L~~~~~----------~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~D 143 (323)
T cd05584 77 LILEYLSGGELFMHLE----------REGIFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTD 143 (323)
T ss_pred EEEeCCCCchHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEee
Confidence 9999999999999984 2345778888999999999999999 89999999999999999999999999
Q ss_pred cccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCchh
Q 002857 319 FGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPER 398 (873)
Q Consensus 319 FGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~~ 398 (873)
||+++...... .......||..|+|||++.+..++.++||||||+++|||++|+.||...... . .
T Consensus 144 fg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~-----~--------~ 208 (323)
T cd05584 144 FGLCKESIHEG--TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK-----K--------T 208 (323)
T ss_pred CcCCeecccCC--CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH-----H--------H
Confidence 99987542222 1122346899999999999988999999999999999999999999652111 0 0
Q ss_pred HHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCC-----CHHHHHH
Q 002857 399 VEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERM-----KINDVEL 463 (873)
Q Consensus 399 l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRP-----Tm~EVl~ 463 (873)
+..+....+ ..|. .....+.+++.+||+.+|++|| ++.+++.
T Consensus 209 ~~~~~~~~~--------------~~~~---------~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 209 IDKILKGKL--------------NLPP---------YLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred HHHHHcCCC--------------CCCC---------CCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 111111100 0000 0122477899999999999999 7777654
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=326.50 Aligned_cols=239 Identities=25% Similarity=0.301 Sum_probs=188.8
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEeecc---CCcchhHHHHHHHHHHhh-hhccceeeeeeeecccccCCceEEEEE
Q 002857 166 NLIGAGNFASVYKGILFEGAPAVAIKVFNFL---HHDASKSFTVECEVMRNI-IHRKIIKVVTACSRVDYQGNDFKALVY 241 (873)
Q Consensus 166 ~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~L-~HpNIV~llg~c~~~~~~~~~~~~LV~ 241 (873)
++||+|+||.||+|++..+++.||||+++.. .....+.+..|+.++..+ +||||+++++++ ...+..++||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~-----~~~~~~~iv~ 75 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCF-----QTPDRLFFVM 75 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEE-----EcCCEEEEEE
Confidence 4699999999999999889999999998743 223445678898888877 699999999985 4567899999
Q ss_pred eecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEecccc
Q 002857 242 EFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGI 321 (873)
Q Consensus 242 Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDFGl 321 (873)
||+++|+|.+++.. ...+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 76 Ey~~~g~L~~~i~~----------~~~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~ 142 (320)
T cd05590 76 EFVNGGDLMFHIQK----------SRRFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGM 142 (320)
T ss_pred cCCCCchHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCC
Confidence 99999999998842 346889999999999999999999 89999999999999999999999999999
Q ss_pred ccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCchhHHH
Q 002857 322 ARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPERVEE 401 (873)
Q Consensus 322 a~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~~l~e 401 (873)
++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 143 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~----------------- 203 (320)
T cd05590 143 CKEGIFNG--KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD----------------- 203 (320)
T ss_pred CeecCcCC--CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH-----------------
Confidence 87532221 12223468999999999999999999999999999999999999997532110
Q ss_pred HhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHH
Q 002857 402 IVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKIND 460 (873)
Q Consensus 402 lid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~E 460 (873)
+....+.... ..|. .....+.+++.+||+.||++||++.+
T Consensus 204 ~~~~i~~~~~----------~~~~---------~~~~~~~~li~~~L~~dP~~R~~~~~ 243 (320)
T cd05590 204 LFEAILNDEV----------VYPT---------WLSQDAVDILKAFMTKNPTMRLGSLT 243 (320)
T ss_pred HHHHHhcCCC----------CCCC---------CCCHHHHHHHHHHcccCHHHCCCCCC
Confidence 1111111000 0000 01224778999999999999999844
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=333.97 Aligned_cols=202 Identities=23% Similarity=0.315 Sum_probs=172.2
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeecc---CCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCce
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFL---HHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDF 236 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~ 236 (873)
++|++.+.||+|+||.||++....+++.||||++... .....+.+.+|++++++++||||+++++++ .++..
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~-----~~~~~ 75 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSF-----QDAQY 75 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEE-----EcCCe
Confidence 4788999999999999999999999999999998642 223346788899999999999999999985 45678
Q ss_pred EEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEE
Q 002857 237 KALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACV 316 (873)
Q Consensus 237 ~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKL 316 (873)
.+|||||+++|+|.+++.. ...+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||
T Consensus 76 ~~lv~E~~~gg~L~~~l~~----------~~~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl 142 (377)
T cd05629 76 LYLIMEFLPGGDLMTMLIK----------YDTFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKL 142 (377)
T ss_pred eEEEEeCCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEE
Confidence 9999999999999999842 346788889999999999999999 899999999999999999999999
Q ss_pred ecccccccccccccc---------------------------------------------ccccccccccccCCCcccCC
Q 002857 317 ADFGIARFLEATNEQ---------------------------------------------TSSIGVKGTTGYIAPEYGMG 351 (873)
Q Consensus 317 sDFGla~~~~~~~~~---------------------------------------------~~~~~~~Gt~~Y~APE~l~~ 351 (873)
+|||+++.+...... .......||+.|+|||++.+
T Consensus 143 ~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 222 (377)
T cd05629 143 SDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ 222 (377)
T ss_pred eecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc
Confidence 999999643211000 00012458999999999999
Q ss_pred CCCCcchhhHhHHHHHHHHHhCCCCCCc
Q 002857 352 HETSSYGDVYSFGILLLEMFTGLRPSDD 379 (873)
Q Consensus 352 ~~~s~ksDVwSfGvvL~ELlTGk~Pf~~ 379 (873)
..++.++|||||||++|||+||+.||..
T Consensus 223 ~~~~~~~DiwSlGvil~elltG~~Pf~~ 250 (377)
T cd05629 223 QGYGQECDWWSLGAIMFECLIGWPPFCS 250 (377)
T ss_pred CCCCCceeeEecchhhhhhhcCCCCCCC
Confidence 9999999999999999999999999965
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=309.78 Aligned_cols=253 Identities=26% Similarity=0.434 Sum_probs=197.0
Q ss_pred CCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchh--HHHHHHHHHHhhhhccceeeeeeeecccccCCceEEE
Q 002857 162 FSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASK--SFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKAL 239 (873)
Q Consensus 162 f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~--~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~L 239 (873)
|++.+.||+|+||+||++....+++.||+|++......... ....|+.++++++|+||+++++++ ......++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~-----~~~~~~~~ 75 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVF-----QDDNYLYI 75 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEE-----EESSEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccc-----cccccccc
Confidence 56789999999999999999999999999999855433322 345699999999999999999995 34677899
Q ss_pred EEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEecc
Q 002857 240 VYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADF 319 (873)
Q Consensus 240 V~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDF 319 (873)
||||+++++|.+++. ....+++..++.++.||++||+||| +.+|+|+||||+||+++.++.++|+||
T Consensus 76 v~~~~~~~~L~~~l~----------~~~~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Df 142 (260)
T PF00069_consen 76 VMEYCPGGSLQDYLQ----------KNKPLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDF 142 (260)
T ss_dssp EEEEETTEBHHHHHH----------HHSSBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSG
T ss_pred ccccccccccccccc----------ccccccccccccccccccccccccc---ccccccccccccccccccccccccccc
Confidence 999999999999994 2456899999999999999999999 889999999999999999999999999
Q ss_pred ccccccccccccccccccccccccCCCcccC-CCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCchh
Q 002857 320 GIARFLEATNEQTSSIGVKGTTGYIAPEYGM-GHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPER 398 (873)
Q Consensus 320 Gla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~-~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~~ 398 (873)
|.+..... .........++..|+|||++. +..++.++||||+|+++|+|++|..||....... .
T Consensus 143 g~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~--~----------- 207 (260)
T PF00069_consen 143 GSSVKLSE--NNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDD--Q----------- 207 (260)
T ss_dssp TTTEESTS--TTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHH--H-----------
T ss_pred cccccccc--cccccccccccccccccccccccccccccccccccccccccccccccccccccchh--h-----------
Confidence 99975411 122333456899999999998 7889999999999999999999999997631000 0
Q ss_pred HHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 399 VEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 399 l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
...+...+...... .. .. .......+.+++..||+.||++||++.++++
T Consensus 208 -~~~~~~~~~~~~~~-----~~----~~------~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 208 -LEIIEKILKRPLPS-----SS----QQ------SREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp -HHHHHHHHHTHHHH-----HT----TS------HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred -hhhhhhcccccccc-----cc----cc------cchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 01111111100000 00 00 0000135889999999999999999999874
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=317.87 Aligned_cols=250 Identities=22% Similarity=0.270 Sum_probs=199.7
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEE
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKAL 239 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~L 239 (873)
.+|+..+.||+|+||.||+|+...+++.||+|.+........+.+.+|+.+++.++|+||+++++.+. .+...++
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~-----~~~~~~l 94 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL-----VGDELWV 94 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEE-----eCCEEEE
Confidence 57888999999999999999988889999999998665555678999999999999999999999863 4567999
Q ss_pred EEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEecc
Q 002857 240 VYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADF 319 (873)
Q Consensus 240 V~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDF 319 (873)
||||+++++|.+++.. ..+++.+++.++.|++.||+||| +.+|+||||||+|||++.++.+||+||
T Consensus 95 v~e~~~~~~L~~~~~~-----------~~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~df 160 (296)
T cd06654 95 VMEYLAGGSLTDVVTE-----------TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDF 160 (296)
T ss_pred eecccCCCCHHHHHHh-----------cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECcc
Confidence 9999999999999842 34788899999999999999999 899999999999999999999999999
Q ss_pred ccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCchhH
Q 002857 320 GIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPERV 399 (873)
Q Consensus 320 Gla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~~l 399 (873)
|++........ ......++..|+|||++.+..++.++|||||||++|+|++|+.||........ +..+.
T Consensus 161 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~-~~~~~-------- 229 (296)
T cd06654 161 GFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-LYLIA-------- 229 (296)
T ss_pred ccchhcccccc--ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh-HHHHh--------
Confidence 99876533221 11223588899999999988899999999999999999999999965221110 00000
Q ss_pred HHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 400 EEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 400 ~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
... .+.... .......+.+++.+||+.+|++|||+.||+.
T Consensus 230 ---~~~-----------------~~~~~~----~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 230 ---TNG-----------------TPELQN----PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred ---cCC-----------------CCCCCC----ccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 000 000000 0011234778999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=316.38 Aligned_cols=265 Identities=23% Similarity=0.396 Sum_probs=200.6
Q ss_pred hcCCCcceeecccCceEEEEEEEcC-----CCcEEEEEEeeccCC-cchhHHHHHHHHHHhhhhccceeeeeeeeccccc
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFE-----GAPAVAIKVFNFLHH-DASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQ 232 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~-----~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~ 232 (873)
.++|++.+.||+|+||.||+|.+.. ++..||+|++..... .....+.+|+.++++++|+||+++++++ .
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~-----~ 78 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVC-----A 78 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEE-----c
Confidence 4678999999999999999998742 567899999874432 2346789999999999999999999986 3
Q ss_pred CCceEEEEEeecCCCChhhhccccccccc------------ccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeecc
Q 002857 233 GNDFKALVYEFMPNGSLEEWIHPITEEDK------------RHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCD 300 (873)
Q Consensus 233 ~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~------------~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrD 300 (873)
.+...++||||+++|+|.+++........ .......+++..++.++.||+.||+||| ..+++|||
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~d 155 (288)
T cd05050 79 VGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRD 155 (288)
T ss_pred CCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeeccc
Confidence 45578999999999999999963211000 0112245788999999999999999999 89999999
Q ss_pred CCCCCeeeCCCCCeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCc
Q 002857 301 IKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDD 379 (873)
Q Consensus 301 LKpsNILLd~~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~ 379 (873)
|||+|||++.++.++|+|||+++................+..|+|||.+.+..++.++|||||||++|||++ |..||..
T Consensus 156 l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~ 235 (288)
T cd05050 156 LATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYG 235 (288)
T ss_pred ccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999876533221111222235678999999988899999999999999999998 8888854
Q ss_pred ccccchhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHH
Q 002857 380 MFKDNLNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKIN 459 (873)
Q Consensus 380 ~~~~~~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~ 459 (873)
..... . ...+.+..+.. .+. .+...+.+++.+||+.+|++|||+.
T Consensus 236 ~~~~~-----~--------~~~~~~~~~~~-------------~~~---------~~~~~l~~li~~~l~~~p~~Rpt~~ 280 (288)
T cd05050 236 MAHEE-----V--------IYYVRDGNVLS-------------CPD---------NCPLELYNLMRLCWSKLPSDRPSFA 280 (288)
T ss_pred CCHHH-----H--------HHHHhcCCCCC-------------CCC---------CCCHHHHHHHHHHcccCcccCCCHH
Confidence 21110 0 00110000000 000 1123578899999999999999999
Q ss_pred HHHHHHH
Q 002857 460 DVELGLR 466 (873)
Q Consensus 460 EVl~~Le 466 (873)
||+..|+
T Consensus 281 el~~~l~ 287 (288)
T cd05050 281 SINRILQ 287 (288)
T ss_pred HHHHHhh
Confidence 9999886
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=333.09 Aligned_cols=269 Identities=20% Similarity=0.306 Sum_probs=201.9
Q ss_pred hcCCCcceeecccCceEEEEEEEcC-----CCcEEEEEEeeccCC-cchhHHHHHHHHHHhhh-hccceeeeeeeecccc
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFE-----GAPAVAIKVFNFLHH-DASKSFTVECEVMRNII-HRKIIKVVTACSRVDY 231 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~-----~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~-HpNIV~llg~c~~~~~ 231 (873)
.++|.+.++||+|+||.||+|++.. .++.||||+++.... ...+.+.+|+++|.++. |+||++++++|.
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~---- 111 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT---- 111 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc----
Confidence 3457788999999999999998642 346899999975432 22357889999999997 999999999963
Q ss_pred cCCceEEEEEeecCCCChhhhcccccccc---------------------------------------------------
Q 002857 232 QGNDFKALVYEFMPNGSLEEWIHPITEED--------------------------------------------------- 260 (873)
Q Consensus 232 ~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~--------------------------------------------------- 260 (873)
.....++||||+++|+|.++|+......
T Consensus 112 -~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (401)
T cd05107 112 -KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV 190 (401)
T ss_pred -cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence 4457899999999999999996421100
Q ss_pred -------------------------------------cccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCC
Q 002857 261 -------------------------------------KRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKP 303 (873)
Q Consensus 261 -------------------------------------~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKp 303 (873)
........+++..++.|+.||+.||+||| +.+|+||||||
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp 267 (401)
T cd05107 191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAA 267 (401)
T ss_pred chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCc
Confidence 00011235778889999999999999999 89999999999
Q ss_pred CCeeeCCCCCeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccc
Q 002857 304 SNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFK 382 (873)
Q Consensus 304 sNILLd~~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~ 382 (873)
+|||+++++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||.....
T Consensus 268 ~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~ 347 (401)
T cd05107 268 RNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM 347 (401)
T ss_pred ceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence 999999999999999999986533222122222346788999999998889999999999999999998 8889865321
Q ss_pred cchhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHH
Q 002857 383 DNLNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVE 462 (873)
Q Consensus 383 ~~~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl 462 (873)
... ..+.+...... ..|. .+...+.+++.+||+.+|.+||++.||+
T Consensus 348 ~~~-------------~~~~~~~~~~~------------~~p~---------~~~~~l~~li~~cl~~~P~~RPs~~ell 393 (401)
T cd05107 348 NEQ-------------FYNAIKRGYRM------------AKPA---------HASDEIYEIMQKCWEEKFEIRPDFSQLV 393 (401)
T ss_pred hHH-------------HHHHHHcCCCC------------CCCC---------CCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 110 01111100000 0010 0123578899999999999999999999
Q ss_pred HHHHHHH
Q 002857 463 LGLRLIK 469 (873)
Q Consensus 463 ~~Le~i~ 469 (873)
..|+.+.
T Consensus 394 ~~L~~~~ 400 (401)
T cd05107 394 HLVGDLL 400 (401)
T ss_pred HHHHHHh
Confidence 9998763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=317.84 Aligned_cols=271 Identities=20% Similarity=0.310 Sum_probs=198.7
Q ss_pred cCCCcceeecccCceEEEEEEEcC----------------CCcEEEEEEeeccC-CcchhHHHHHHHHHHhhhhccceee
Q 002857 160 KGFSSENLIGAGNFASVYKGILFE----------------GAPAVAIKVFNFLH-HDASKSFTVECEVMRNIIHRKIIKV 222 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~----------------~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~l 222 (873)
++|++.+.||+|+||.||++.+.. +...||+|+++... ......+.+|++++++++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 578999999999999999986432 34479999987442 2334678999999999999999999
Q ss_pred eeeeecccccCCceEEEEEeecCCCChhhhccccccccc-ccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccC
Q 002857 223 VTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDK-RHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDI 301 (873)
Q Consensus 223 lg~c~~~~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~-~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDL 301 (873)
++++ ...+..++||||+++|+|.+++........ .......+++.+++.++.||+.||+||| +.+|+|+||
T Consensus 85 ~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl 156 (296)
T cd05095 85 LAVC-----ITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDL 156 (296)
T ss_pred EEEE-----ecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeecccC
Confidence 9986 345568999999999999999864211100 0122345788899999999999999999 899999999
Q ss_pred CCCCeeeCCCCCeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh--CCCCCCc
Q 002857 302 KPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT--GLRPSDD 379 (873)
Q Consensus 302 KpsNILLd~~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT--Gk~Pf~~ 379 (873)
||+|||++.++.++|+|||+++.+.............++..|+|||...++.++.++||||||+++|||++ |..||..
T Consensus 157 kp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~ 236 (296)
T cd05095 157 ATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQ 236 (296)
T ss_pred ChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccc
Confidence 99999999999999999999986543322121222334678999999888889999999999999999998 7778754
Q ss_pred ccccchhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHH
Q 002857 380 MFKDNLNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKIN 459 (873)
Q Consensus 380 ~~~~~~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~ 459 (873)
..... .+. ............ .....+. .+...+.+++.+||+.||++||++.
T Consensus 237 ~~~~~-----~~~-----~~~~~~~~~~~~---------~~~~~~~---------~~~~~~~~li~~cl~~~p~~Rp~~~ 288 (296)
T cd05095 237 LSDEQ-----VIE-----NTGEFFRDQGRQ---------VYLPKPA---------LCPDSLYKLMLSCWRRNAKERPSFQ 288 (296)
T ss_pred cChHH-----HHH-----HHHHHHhhcccc---------ccCCCCC---------CCCHHHHHHHHHHcCCCcccCCCHH
Confidence 22111 000 000000000000 0000000 1223578999999999999999999
Q ss_pred HHHHHHH
Q 002857 460 DVELGLR 466 (873)
Q Consensus 460 EVl~~Le 466 (873)
||++.|+
T Consensus 289 ~i~~~l~ 295 (296)
T cd05095 289 EIHATLL 295 (296)
T ss_pred HHHHHHh
Confidence 9999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=324.48 Aligned_cols=199 Identities=26% Similarity=0.302 Sum_probs=169.3
Q ss_pred CCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC---CcchhHHHHHHHHHHhh-hhccceeeeeeeecccccCCce
Q 002857 161 GFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH---HDASKSFTVECEVMRNI-IHRKIIKVVTACSRVDYQGNDF 236 (873)
Q Consensus 161 ~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L-~HpNIV~llg~c~~~~~~~~~~ 236 (873)
+|++.+.||+|+||.||+|++..+++.||||+++... ......+..|..++..+ +|++|+++++++ ...+.
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~ 75 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCF-----QTMDR 75 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEE-----ecCCE
Confidence 5788999999999999999998889999999987432 22334567788888877 588899998885 45667
Q ss_pred EEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEE
Q 002857 237 KALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACV 316 (873)
Q Consensus 237 ~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKL 316 (873)
.++||||+++|+|.+++.. ...+++.+++.++.||+.||+||| +.+|+||||||+|||++.++.+||
T Consensus 76 ~~lv~E~~~~g~L~~~~~~----------~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL 142 (323)
T cd05616 76 LYFVMEYVNGGDLMYQIQQ----------VGRFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKI 142 (323)
T ss_pred EEEEEcCCCCCCHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEE
Confidence 9999999999999998842 345888999999999999999999 899999999999999999999999
Q ss_pred eccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCc
Q 002857 317 ADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDD 379 (873)
Q Consensus 317 sDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~ 379 (873)
+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 143 ~DfG~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~ 203 (323)
T cd05616 143 ADFGMCKENMWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG 203 (323)
T ss_pred ccCCCceecCCCC--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCC
Confidence 9999997532211 122235689999999999999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=312.85 Aligned_cols=254 Identities=24% Similarity=0.292 Sum_probs=197.8
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEE
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKA 238 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~ 238 (873)
.++|.+.+.||+|+||.||+|++..+++.||+|+++.........+.+|+.+++.++||||+++++.+ ...+..+
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~-----~~~~~~~ 82 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSY-----LRRDKLW 82 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEE-----EeCCEEE
Confidence 34788889999999999999999888999999998765545556788999999999999999999985 4466789
Q ss_pred EEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEec
Q 002857 239 LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVAD 318 (873)
Q Consensus 239 LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsD 318 (873)
+||||+++++|.+++.. ...+++.+++.++.|++.||.||| +.+|+|+||||+||+++.++.+||+|
T Consensus 83 lv~e~~~~~~L~~~~~~----------~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~d 149 (267)
T cd06645 83 ICMEFCGGGSLQDIYHV----------TGPLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLAD 149 (267)
T ss_pred EEEeccCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECc
Confidence 99999999999999842 346889999999999999999999 88999999999999999999999999
Q ss_pred cccccccccccccccccccccccccCCCcccC---CCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcC
Q 002857 319 FGIARFLEATNEQTSSIGVKGTTGYIAPEYGM---GHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSAL 395 (873)
Q Consensus 319 FGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~---~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~ 395 (873)
||++....... .......|+..|+|||++. ...++.++|||||||++|||++|+.||....... ......
T Consensus 150 fg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~-~~~~~~---- 222 (267)
T cd06645 150 FGVSAQITATI--AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR-ALFLMT---- 222 (267)
T ss_pred ceeeeEccCcc--cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh-hHHhhh----
Confidence 99987653221 1122346899999999874 4568899999999999999999999985422110 000000
Q ss_pred chhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 396 PERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 396 ~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
..... .+...... .....+.+++.+||+.+|++||++.+|++
T Consensus 223 --------~~~~~--------------~~~~~~~~----~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 223 --------KSNFQ--------------PPKLKDKM----KWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred --------ccCCC--------------CCcccccC----CCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 00000 00000000 01224678999999999999999999865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=327.04 Aligned_cols=204 Identities=24% Similarity=0.243 Sum_probs=170.7
Q ss_pred HhhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC--CcchhHHHHHHHHHHhhhhccceeeeeeeeccc-ccC
Q 002857 157 SATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH--HDASKSFTVECEVMRNIIHRKIIKVVTACSRVD-YQG 233 (873)
Q Consensus 157 ~at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~-~~~ 233 (873)
...++|++.+.||+|+||.||++.+...++.||||++.... ......+.+|+.+++.++|+||+++++++.... ...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 35678999999999999999999988889999999986432 233467888999999999999999999864321 122
Q ss_pred CceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCC
Q 002857 234 NDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMT 313 (873)
Q Consensus 234 ~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~ 313 (873)
....++||||+++ +|.+.+. ..+++..+..++.||+.||+||| +.+|+||||||+|||++.++.
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~------------~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~ 157 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQ------------MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCT 157 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHh------------hcCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCC
Confidence 3457999999965 6766662 23778889999999999999999 899999999999999999999
Q ss_pred eEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCc
Q 002857 314 ACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDD 379 (873)
Q Consensus 314 vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~ 379 (873)
+||+|||+++...... ......+|..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 158 ~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 220 (355)
T cd07874 158 LKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 220 (355)
T ss_pred EEEeeCcccccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999998653321 12234689999999999999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=307.09 Aligned_cols=255 Identities=24% Similarity=0.295 Sum_probs=201.9
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEE
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKA 238 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~ 238 (873)
.++|++.+.||.|+||.||+|....+++.+|+|++........+.+.+|++++++++|+||+++++++ ......+
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~ 76 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSY-----LRRDKLW 76 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEE-----EeCCEEE
Confidence 35789999999999999999999888899999999866555667899999999999999999999985 4466799
Q ss_pred EEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEec
Q 002857 239 LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVAD 318 (873)
Q Consensus 239 LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsD 318 (873)
++|||+++++|.+++.. ....+++.++..++.|++.||+||| ..+|+|+||+|+||++++++.+||+|
T Consensus 77 l~~e~~~~~~l~~~~~~---------~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d 144 (262)
T cd06613 77 IVMEYCGGGSLQDIYQV---------TRGPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLAD 144 (262)
T ss_pred EEEeCCCCCcHHHHHHh---------hccCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECc
Confidence 99999999999998842 2256889999999999999999999 89999999999999999999999999
Q ss_pred cccccccccccccccccccccccccCCCcccCCC---CCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcC
Q 002857 319 FGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGH---ETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSAL 395 (873)
Q Consensus 319 FGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~---~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~ 395 (873)
||++........ ......++..|+|||++.+. .++.++||||||+++|||+||+.||......... ..
T Consensus 145 ~g~~~~~~~~~~--~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~-~~------ 215 (262)
T cd06613 145 FGVSAQLTATIA--KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRAL-FL------ 215 (262)
T ss_pred cccchhhhhhhh--ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH-HH------
Confidence 999976543221 12234578899999998877 8899999999999999999999998653211100 00
Q ss_pred chhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 396 PERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 396 ~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
+....+. .+.... .......+.+++.+||+.+|.+|||+.+|+.
T Consensus 216 ------~~~~~~~--------------~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 216 ------ISKSNFP--------------PPKLKD----KEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred ------HHhccCC--------------Cccccc----hhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000000 000000 0111335789999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=319.06 Aligned_cols=266 Identities=26% Similarity=0.401 Sum_probs=199.0
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCc--EEEEEEeeccC-CcchhHHHHHHHHHHhh-hhccceeeeeeeecccccCCc
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAP--AVAIKVFNFLH-HDASKSFTVECEVMRNI-IHRKIIKVVTACSRVDYQGND 235 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~--~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L-~HpNIV~llg~c~~~~~~~~~ 235 (873)
++|++.+.||+|+||.||+|.+..++. .+|+|.++... ......+.+|++++.++ +|+||+++++++ ...+
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~-----~~~~ 81 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-----EHRG 81 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEE-----CCCC
Confidence 467888999999999999999877665 45777765332 23345788999999999 899999999986 4456
Q ss_pred eEEEEEeecCCCChhhhccccccccc------ccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeC
Q 002857 236 FKALVYEFMPNGSLEEWIHPITEEDK------RHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLN 309 (873)
Q Consensus 236 ~~~LV~Ey~~~GSL~~~L~~~~~~~~------~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd 309 (873)
..++||||+++|+|.++++....... .......+++.+++.++.||+.||+||| +.+|+||||||+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~ 158 (303)
T cd05088 82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVG 158 (303)
T ss_pred CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEec
Confidence 78999999999999999963110000 0012346889999999999999999999 89999999999999999
Q ss_pred CCCCeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhH
Q 002857 310 DEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQ 388 (873)
Q Consensus 310 ~~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~ 388 (873)
.++.+||+|||+++...... ......++..|+|||++.+..++.++||||||+++|||+| |..||....... ..
T Consensus 159 ~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~ 233 (303)
T cd05088 159 ENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--LY 233 (303)
T ss_pred CCCcEEeCccccCcccchhh---hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH--HH
Confidence 99999999999986432111 1111224667999999988889999999999999999998 999986421110 00
Q ss_pred HHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHH
Q 002857 389 NWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLI 468 (873)
Q Consensus 389 ~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i 468 (873)
. .+... .... .+. .....+.+++.+||+.+|++||++.+++.+|+.+
T Consensus 234 ~-----------~~~~~-~~~~------------~~~---------~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~ 280 (303)
T cd05088 234 E-----------KLPQG-YRLE------------KPL---------NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 280 (303)
T ss_pred H-----------HHhcC-CcCC------------CCC---------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0 00000 0000 000 0122477899999999999999999999999887
Q ss_pred HHh
Q 002857 469 KKK 471 (873)
Q Consensus 469 ~~~ 471 (873)
...
T Consensus 281 ~~~ 283 (303)
T cd05088 281 LEE 283 (303)
T ss_pred HHh
Confidence 543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=336.12 Aligned_cols=279 Identities=22% Similarity=0.276 Sum_probs=195.6
Q ss_pred hhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeeccccc---CC
Q 002857 158 ATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQ---GN 234 (873)
Q Consensus 158 at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~---~~ 234 (873)
...+|++.++||+|+||.||+|.+..+++.||||++.... ....+|+.+|+.++|+||+++++++....+. ..
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 3467999999999999999999998889999999885321 3346799999999999999999876432211 22
Q ss_pred ceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCC-C
Q 002857 235 DFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEM-T 313 (873)
Q Consensus 235 ~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~-~ 313 (873)
...++||||+++ +|.+++... ......+++..++.++.||+.||+||| +.+|+||||||+|||++.++ .
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~------~~~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~ 209 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHY------ARNNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHT 209 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHH------hhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCc
Confidence 357799999975 777776421 123456889999999999999999999 89999999999999999654 7
Q ss_pred eEEeccccccccccccccccccccccccccCCCcccCCC-CCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHh
Q 002857 314 ACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGH-ETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQ 392 (873)
Q Consensus 314 vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~ 392 (873)
+||+|||+++.+..... .....||..|+|||++.+. .++.++|||||||++|||+||..||....... .+...+.
T Consensus 210 vkL~DFGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~-~~~~i~~ 285 (440)
T PTZ00036 210 LKLCDFGSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD-QLVRIIQ 285 (440)
T ss_pred eeeeccccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHH
Confidence 99999999986643221 2234689999999988764 68999999999999999999999997632211 1111111
Q ss_pred hcCch---hHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 393 SALPE---RVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 393 ~~~~~---~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
..-.. .+.. ..+.+.. .....+ ...............++.+|+.+||+.||.+|||+.|++.
T Consensus 286 ~~~~p~~~~~~~-~~~~~~~-----~~~~~~---~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 286 VLGTPTEDQLKE-MNPNYAD-----IKFPDV---KPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred HhCCCCHHHHHH-hchhhhc-----ccCCcc---CchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 11000 1110 0000000 000000 0000000000112345789999999999999999999874
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=335.00 Aligned_cols=244 Identities=24% Similarity=0.313 Sum_probs=203.5
Q ss_pred hhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeecc---CCcchhHHHHHHHHHHhh-hhccceeeeeeeecccccC
Q 002857 158 ATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFL---HHDASKSFTVECEVMRNI-IHRKIIKVVTACSRVDYQG 233 (873)
Q Consensus 158 at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~L-~HpNIV~llg~c~~~~~~~ 233 (873)
..++|...++||+|.||+|+++..+.+++.+|||++++. ..++.+..+.|..|+... +||.+++++.. |+.
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~-----fQT 440 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSC-----FQT 440 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccc-----ccc
Confidence 456899999999999999999999999999999999854 345567888999998888 59999999988 588
Q ss_pred CceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCC
Q 002857 234 NDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMT 313 (873)
Q Consensus 234 ~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~ 313 (873)
.+++++||||+.||++..+. ....+++..+.-++..|+.||+||| .++||+||||.+|||||.+|+
T Consensus 441 ~~~l~fvmey~~Ggdm~~~~-----------~~~~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh 506 (694)
T KOG0694|consen 441 KEHLFFVMEYVAGGDLMHHI-----------HTDVFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGH 506 (694)
T ss_pred CCeEEEEEEecCCCcEEEEE-----------ecccccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCc
Confidence 99999999999999955544 3467999999999999999999999 899999999999999999999
Q ss_pred eEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhh
Q 002857 314 ACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQS 393 (873)
Q Consensus 314 vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~ 393 (873)
+||+|||+++..-. ....+....||+.|||||++.+..|+...|.|||||+||||+.|+.||.+..+
T Consensus 507 ~kiADFGlcKe~m~--~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddE----------- 573 (694)
T KOG0694|consen 507 VKIADFGLCKEGMG--QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDE----------- 573 (694)
T ss_pred EEecccccccccCC--CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCH-----------
Confidence 99999999985432 22345567899999999999999999999999999999999999999986322
Q ss_pred cCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCH
Q 002857 394 ALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKI 458 (873)
Q Consensus 394 ~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm 458 (873)
.++.|..+..++.- | . -+..+.+.|+.+.|..+|++|--+
T Consensus 574 ------ee~FdsI~~d~~~y----------P-----~----~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 574 ------EEVFDSIVNDEVRY----------P-----R----FLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred ------HHHHHHHhcCCCCC----------C-----C----cccHHHHHHHHHHhccCcccccCC
Confidence 23444444433210 0 0 112347789999999999999866
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=307.41 Aligned_cols=250 Identities=27% Similarity=0.284 Sum_probs=200.1
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEE
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKAL 239 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~L 239 (873)
++|+..+.||+|+||.||+|.+..+++.+|+|.++.... .+.+.+|++++++++|+||+++++++ ......++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~-----~~~~~~~l 75 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSY-----FKNTDLWI 75 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeee-----ecCCcEEE
Confidence 578999999999999999999988889999999874432 57899999999999999999999986 34577899
Q ss_pred EEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEecc
Q 002857 240 VYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADF 319 (873)
Q Consensus 240 V~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDF 319 (873)
++||+++++|.+++.. ....+++..++.++.|++.||.||| ..+|+|+||+|+||+++.++.+||+||
T Consensus 76 ~~e~~~~~~L~~~l~~---------~~~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~df 143 (256)
T cd06612 76 VMEYCGAGSVSDIMKI---------TNKTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADF 143 (256)
T ss_pred EEecCCCCcHHHHHHh---------CccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEccc
Confidence 9999999999999842 2456899999999999999999999 889999999999999999999999999
Q ss_pred ccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCchhH
Q 002857 320 GIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPERV 399 (873)
Q Consensus 320 Gla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~~l 399 (873)
|++........ ......++..|+|||++.+..++.++||||||+++|+|++|+.||......... .
T Consensus 144 g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~--~---------- 209 (256)
T cd06612 144 GVSGQLTDTMA--KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI--F---------- 209 (256)
T ss_pred ccchhcccCcc--ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh--h----------
Confidence 99986643321 122344788999999999889999999999999999999999998653211100 0
Q ss_pred HHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 400 EEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 400 ~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
. +........ . ........+.+++.+||+.+|++|||+.||++
T Consensus 210 -~-~~~~~~~~~---------------~----~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 210 -M-IPNKPPPTL---------------S----DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred -h-hccCCCCCC---------------C----chhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 0 000000000 0 00011235788999999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=309.28 Aligned_cols=251 Identities=18% Similarity=0.230 Sum_probs=199.1
Q ss_pred CCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC-CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEE
Q 002857 161 GFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH-HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKAL 239 (873)
Q Consensus 161 ~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~L 239 (873)
+|++.+.||+|+||.||++.+..+++.+|+|.++... ....+.+.+|+.++++++|+||+++++.+ ......++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l 75 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF-----EADGHLYI 75 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEE-----EECCEEEE
Confidence 4788899999999999999998899999999986432 33456788999999999999999999985 45678999
Q ss_pred EEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEecc
Q 002857 240 VYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADF 319 (873)
Q Consensus 240 V~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDF 319 (873)
||||+++|+|.+++.. .....+++...+.++.||+.||.||| +.+|+|+||||+||++++++.++|+||
T Consensus 76 v~e~~~~~~l~~~~~~--------~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~df 144 (255)
T cd08219 76 VMEYCDGGDLMQKIKL--------QRGKLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDF 144 (255)
T ss_pred EEeeCCCCcHHHHHHh--------ccCCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEccc
Confidence 9999999999998843 23345788899999999999999999 899999999999999999999999999
Q ss_pred ccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCchhH
Q 002857 320 GIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPERV 399 (873)
Q Consensus 320 Gla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~~l 399 (873)
|+++....... ......++..|+|||++.+..++.++||||||+++|+|++|+.||...... ...
T Consensus 145 g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~-----~~~-------- 209 (255)
T cd08219 145 GSARLLTSPGA--YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK-----NLI-------- 209 (255)
T ss_pred Ccceeeccccc--ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH-----HHH--------
Confidence 99976543221 122345888999999999888999999999999999999999999652111 000
Q ss_pred HHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHH
Q 002857 400 EEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELG 464 (873)
Q Consensus 400 ~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~ 464 (873)
..+ ..... .+.. ......+.+++.+||+.+|++|||+.||+..
T Consensus 210 ~~~----~~~~~-----------~~~~-------~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 210 LKV----CQGSY-----------KPLP-------SHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHH----hcCCC-----------CCCC-------cccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 000 00000 0000 0012246789999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=311.39 Aligned_cols=257 Identities=23% Similarity=0.395 Sum_probs=200.1
Q ss_pred cCCCcceeecccCceEEEEEEEcCC---CcEEEEEEeeccC-CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCc
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEG---APAVAIKVFNFLH-HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGND 235 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~---g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~ 235 (873)
++|++.++||+|+||.||+|.+... ...||||...... ....+.+.+|+.++++++|+||+++++++. ..
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~------~~ 79 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVIT------EN 79 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEc------CC
Confidence 4678889999999999999987543 3468999886544 334567999999999999999999999863 24
Q ss_pred eEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeE
Q 002857 236 FKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTAC 315 (873)
Q Consensus 236 ~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vK 315 (873)
..++||||+++|+|.+++.. ....+++..++.++.|++.||+||| +.+++|+||||+|||++.++.+|
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~ 147 (270)
T cd05056 80 PVWIVMELAPLGELRSYLQV---------NKYSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVK 147 (270)
T ss_pred CcEEEEEcCCCCcHHHHHHh---------CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeE
Confidence 46899999999999999942 2345899999999999999999999 89999999999999999999999
Q ss_pred EeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHHHhhc
Q 002857 316 VADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQSA 394 (873)
Q Consensus 316 LsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~~~~~ 394 (873)
|+|||+++......... .....++..|+|||.+....++.++||||||+++|||++ |..||....... ....+.
T Consensus 148 l~d~g~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~--~~~~~~-- 222 (270)
T cd05056 148 LGDFGLSRYLEDESYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND--VIGRIE-- 222 (270)
T ss_pred EccCceeeeccccccee-cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH--HHHHHH--
Confidence 99999998654432111 112234568999999988889999999999999999996 999986532111 000000
Q ss_pred CchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHHHH
Q 002857 395 LPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLIKK 470 (873)
Q Consensus 395 ~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i~~ 470 (873)
. .. ..+.. ..+...+.+++.+||..+|++|||+.++++.|+.++.
T Consensus 223 ---------~----~~-----------~~~~~-------~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 223 ---------N----GE-----------RLPMP-------PNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred ---------c----CC-----------cCCCC-------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 0 00 00000 0112357889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=312.47 Aligned_cols=258 Identities=22% Similarity=0.419 Sum_probs=201.5
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCc----EEEEEEeeccCC-cchhHHHHHHHHHHhhhhccceeeeeeeecccccCC
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAP----AVAIKVFNFLHH-DASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGN 234 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~----~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~ 234 (873)
.+|++.+.||+|+||.||+|.+..++. .||+|.+..... .....+.+|+.++++++|+||++++++|..
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------ 80 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS------ 80 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec------
Confidence 467888999999999999999866554 589998865433 234678899999999999999999999742
Q ss_pred ceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCe
Q 002857 235 DFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTA 314 (873)
Q Consensus 235 ~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~v 314 (873)
...++||||+++|+|.+++.. ....+++..++.++.||+.||+||| +.+|+|+||||+|||+++++.+
T Consensus 81 ~~~~~v~e~~~~g~L~~~l~~---------~~~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~ 148 (279)
T cd05057 81 SQVQLITQLMPLGCLLDYVRN---------HKDNIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHV 148 (279)
T ss_pred CceEEEEecCCCCcHHHHHHh---------ccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeE
Confidence 568999999999999999853 2345899999999999999999999 8999999999999999999999
Q ss_pred EEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHHHhh
Q 002857 315 CVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQS 393 (873)
Q Consensus 315 KLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~~~~ 393 (873)
||+|||+++...............++..|+|||.+....++.++||||||+++|||++ |+.||.......
T Consensus 149 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--------- 219 (279)
T cd05057 149 KITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE--------- 219 (279)
T ss_pred EECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH---------
Confidence 9999999987653322222222224578999999988889999999999999999999 999986532111
Q ss_pred cCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHHHH
Q 002857 394 ALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLIKK 470 (873)
Q Consensus 394 ~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i~~ 470 (873)
+.+.+.. .. ..+.... +...+.+++.+||..+|++||++.++++.|+.+..
T Consensus 220 -----~~~~~~~---~~-----------~~~~~~~-------~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 220 -----IPDLLEK---GE-----------RLPQPPI-------CTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred -----HHHHHhC---CC-----------CCCCCCC-------CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 1111110 00 0000000 11246789999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=314.25 Aligned_cols=270 Identities=23% Similarity=0.254 Sum_probs=207.2
Q ss_pred ccCHHHHHHhhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhh-hhccceeeeeeee
Q 002857 149 YVSYEALYSATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNI-IHRKIIKVVTACS 227 (873)
Q Consensus 149 ~~s~~el~~at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~llg~c~ 227 (873)
.++++++..++++|++.+.||+|+||.||++....+++.+|+|++.... .....+.+|+.++.++ +|+|++++++++.
T Consensus 11 ~~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~ 89 (291)
T cd06639 11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89 (291)
T ss_pred hhhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence 3556777788999999999999999999999998899999999986432 2346778899999999 8999999999976
Q ss_pred cccccCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCee
Q 002857 228 RVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNIL 307 (873)
Q Consensus 228 ~~~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNIL 307 (873)
..+.......++||||+++|+|.++++.. ......+++..++.++.|++.||.||| ..+|+|+||||+||+
T Consensus 90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~------~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nil 160 (291)
T cd06639 90 KADKLVGGQLWLVLELCNGGSVTELVKGL------LICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNIL 160 (291)
T ss_pred eccccCCCeeEEEEEECCCCcHHHHHHHh------hhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEE
Confidence 54333345789999999999999988531 122456889999999999999999999 889999999999999
Q ss_pred eCCCCCeEEeccccccccccccccccccccccccccCCCcccCCC-----CCCcchhhHhHHHHHHHHHhCCCCCCcccc
Q 002857 308 LNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGH-----ETSSYGDVYSFGILLLEMFTGLRPSDDMFK 382 (873)
Q Consensus 308 Ld~~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-----~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~ 382 (873)
++.++.+||+|||+++....... ......++..|+|||++... .++.++|||||||++|||++|+.||.....
T Consensus 161 i~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~ 238 (291)
T cd06639 161 LTTEGGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP 238 (291)
T ss_pred EcCCCCEEEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH
Confidence 99999999999999986543221 11234578899999987643 368899999999999999999999865311
Q ss_pred cchhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHH
Q 002857 383 DNLNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVE 462 (873)
Q Consensus 383 ~~~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl 462 (873)
.. .+. .+..... +.... ..+....+.+++.+||+.+|++||++.|++
T Consensus 239 ~~-~~~------------~~~~~~~----------------~~~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~il 285 (291)
T cd06639 239 VK-TLF------------KIPRNPP----------------PTLLH----PEKWCRSFNHFISQCLIKDFEARPSVTHLL 285 (291)
T ss_pred HH-HHH------------HHhcCCC----------------CCCCc----ccccCHHHHHHHHHHhhcChhhCcCHHHHh
Confidence 10 000 0000000 00000 001123478899999999999999999987
Q ss_pred H
Q 002857 463 L 463 (873)
Q Consensus 463 ~ 463 (873)
+
T Consensus 286 ~ 286 (291)
T cd06639 286 E 286 (291)
T ss_pred c
Confidence 5
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=319.76 Aligned_cols=270 Identities=21% Similarity=0.342 Sum_probs=202.4
Q ss_pred cCCCcceeecccCceEEEEEEEcC-------CCcEEEEEEeeccC-CcchhHHHHHHHHHHhh-hhccceeeeeeeeccc
Q 002857 160 KGFSSENLIGAGNFASVYKGILFE-------GAPAVAIKVFNFLH-HDASKSFTVECEVMRNI-IHRKIIKVVTACSRVD 230 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~-------~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L-~HpNIV~llg~c~~~~ 230 (873)
++|.+.+.||+|+||.||+|+... ....||+|+++... ......+..|+++++++ +|+||++++++|.
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~--- 88 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT--- 88 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc---
Confidence 467889999999999999997632 34579999987432 23345788999999999 6999999999863
Q ss_pred ccCCceEEEEEeecCCCChhhhcccccccc------cccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCC
Q 002857 231 YQGNDFKALVYEFMPNGSLEEWIHPITEED------KRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPS 304 (873)
Q Consensus 231 ~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~------~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKps 304 (873)
.....++||||+++|+|.+++....... ........+++.+++.++.||+.||.||| +.+|+||||||+
T Consensus 89 --~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~ 163 (314)
T cd05099 89 --QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAAR 163 (314)
T ss_pred --cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeeccccce
Confidence 4556899999999999999995421100 00112346899999999999999999999 899999999999
Q ss_pred CeeeCCCCCeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCccccc
Q 002857 305 NILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKD 383 (873)
Q Consensus 305 NILLd~~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~ 383 (873)
|||++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||......
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~ 243 (314)
T cd05099 164 NVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE 243 (314)
T ss_pred eEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999986543222111112234567999999998899999999999999999999 88888653111
Q ss_pred chhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 384 NLNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 384 ~~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
. +. +.+.. .. .+.. ...+...+.+++.+||+.+|++|||+.||++
T Consensus 244 ~--~~------------~~~~~---~~------------~~~~------~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 244 E--LF------------KLLRE---GH------------RMDK------PSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred H--HH------------HHHHc---CC------------CCCC------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 0 00 00000 00 0000 0011235778999999999999999999999
Q ss_pred HHHHHHHhh
Q 002857 464 GLRLIKKKL 472 (873)
Q Consensus 464 ~Le~i~~~l 472 (873)
.|+.+....
T Consensus 289 ~l~~~~~~~ 297 (314)
T cd05099 289 ALDKVLAAV 297 (314)
T ss_pred HHHHHHHHh
Confidence 999886654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=322.10 Aligned_cols=285 Identities=16% Similarity=0.227 Sum_probs=200.7
Q ss_pred HHHHhhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCC--cchhHHHHHHHHHHhhhhccceeeeeeeecccc
Q 002857 154 ALYSATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH--DASKSFTVECEVMRNIIHRKIIKVVTACSRVDY 231 (873)
Q Consensus 154 el~~at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~ 231 (873)
......++|++.+.||+|+||.||+|.+..+++.||||++..... ...+.+.+|+++|++++|+||+++++++.....
T Consensus 9 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07878 9 TVWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATS 88 (343)
T ss_pred HHhhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccc
Confidence 344567889999999999999999999988999999999864322 233567889999999999999999988643211
Q ss_pred -cCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCC
Q 002857 232 -QGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLND 310 (873)
Q Consensus 232 -~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~ 310 (873)
......+++++++ +++|.+++. ...+++..+..|+.||+.||.||| +.+|+||||||+|||++.
T Consensus 89 ~~~~~~~~~~~~~~-~~~l~~~~~-----------~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~ 153 (343)
T cd07878 89 IENFNEVYLVTNLM-GADLNNIVK-----------CQKLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNE 153 (343)
T ss_pred ccccCcEEEEeecC-CCCHHHHHh-----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECC
Confidence 1224578999988 779988773 245889999999999999999999 899999999999999999
Q ss_pred CCCeEEeccccccccccccccccccccccccccCCCcccCC-CCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHH
Q 002857 311 EMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMG-HETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQN 389 (873)
Q Consensus 311 ~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~ 389 (873)
++.+||+|||+++..... .....||..|+|||++.+ ..++.++|||||||++|||++|+.||...... ..+..
T Consensus 154 ~~~~kl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~ 227 (343)
T cd07878 154 DCELRILDFGLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI-DQLKR 227 (343)
T ss_pred CCCEEEcCCccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHH
Confidence 999999999999865332 223458999999999877 56899999999999999999999999653211 11111
Q ss_pred HHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 390 WVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 390 ~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
+. ........+......... . +.........+. .............+.+++.+||+.||++|||+.|+++
T Consensus 228 ~~-~~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 228 IM-EVVGTPSPEVLKKISSEH-A-RKYIQSLPHMPQ-QDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred HH-HHhCCCCHHHHHhcchhh-H-HHHhhccccccc-hhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 11 100000011111000000 0 000000000000 0000001111234678999999999999999999875
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=325.65 Aligned_cols=194 Identities=25% Similarity=0.317 Sum_probs=166.4
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEeeccC---CcchhHHHHHHHHHHhh-hhccceeeeeeeecccccCCceEEEEE
Q 002857 166 NLIGAGNFASVYKGILFEGAPAVAIKVFNFLH---HDASKSFTVECEVMRNI-IHRKIIKVVTACSRVDYQGNDFKALVY 241 (873)
Q Consensus 166 ~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L-~HpNIV~llg~c~~~~~~~~~~~~LV~ 241 (873)
+.||+|+||.||+|++..+++.||+|+++... ....+.+..|+.++.++ +||||+++++++ ...+..++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~-----~~~~~~~lv~ 75 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----QTESRLFFVI 75 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEE-----EeCCEEEEEE
Confidence 47999999999999999999999999997432 22345678899988877 899999999985 4567899999
Q ss_pred eecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEecccc
Q 002857 242 EFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGI 321 (873)
Q Consensus 242 Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDFGl 321 (873)
||+++|+|..++. ....+++..+..|+.||+.||+||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 76 E~~~~~~L~~~~~----------~~~~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~ 142 (329)
T cd05618 76 EYVNGGDLMFHMQ----------RQRKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGM 142 (329)
T ss_pred eCCCCCCHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCc
Confidence 9999999998873 2356899999999999999999999 89999999999999999999999999999
Q ss_pred ccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCc
Q 002857 322 ARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDD 379 (873)
Q Consensus 322 a~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~ 379 (873)
++...... .......||..|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 143 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~ 198 (329)
T cd05618 143 CKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred cccccCCC--CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCcc
Confidence 97532211 112235689999999999999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=323.60 Aligned_cols=242 Identities=24% Similarity=0.311 Sum_probs=190.7
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEeecc---CCcchhHHHHHHHHHHhh-hhccceeeeeeeecccccCCceEEEEE
Q 002857 166 NLIGAGNFASVYKGILFEGAPAVAIKVFNFL---HHDASKSFTVECEVMRNI-IHRKIIKVVTACSRVDYQGNDFKALVY 241 (873)
Q Consensus 166 ~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~L-~HpNIV~llg~c~~~~~~~~~~~~LV~ 241 (873)
+.||+|+||.||+|.+..+++.||||+++.. .......+..|++++..+ +||||+++++++ ...+..++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~-----~~~~~~~lv~ 75 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCF-----QTKDRLFFVM 75 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCEEEEEE
Confidence 4699999999999999888999999999743 223345678899999888 799999999985 4566899999
Q ss_pred eecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEecccc
Q 002857 242 EFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGI 321 (873)
Q Consensus 242 Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDFGl 321 (873)
||+++|+|..++.. ...+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 76 e~~~~~~L~~~~~~----------~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 142 (318)
T cd05570 76 EYVNGGDLMFHIQR----------SGRFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGM 142 (318)
T ss_pred cCCCCCCHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCC
Confidence 99999999988842 346899999999999999999999 89999999999999999999999999999
Q ss_pred ccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCchhHHH
Q 002857 322 ARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPERVEE 401 (873)
Q Consensus 322 a~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~~l~e 401 (873)
++...... .......|+..|+|||++.+..++.++|||||||++|||++|+.||....... .. ..
T Consensus 143 ~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~--~~-----------~~ 207 (318)
T cd05570 143 CKEGILGG--VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE--LF-----------QS 207 (318)
T ss_pred CeecCcCC--CcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH--HH-----------HH
Confidence 87432211 11223458999999999999999999999999999999999999996532110 00 00
Q ss_pred HhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCH-----HHHHH
Q 002857 402 IVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKI-----NDVEL 463 (873)
Q Consensus 402 lid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm-----~EVl~ 463 (873)
+.. ... ..|. .....+.+++.+||+.||++||++ .+++.
T Consensus 208 i~~----~~~----------~~~~---------~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 208 ILE----DEV----------RYPR---------WLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred HHc----CCC----------CCCC---------cCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 000 000 0000 012347789999999999999999 66543
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=325.82 Aligned_cols=204 Identities=24% Similarity=0.247 Sum_probs=171.0
Q ss_pred hhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC--CcchhHHHHHHHHHHhhhhccceeeeeeeeccc-ccCC
Q 002857 158 ATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH--HDASKSFTVECEVMRNIIHRKIIKVVTACSRVD-YQGN 234 (873)
Q Consensus 158 at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~-~~~~ 234 (873)
..++|.+.+.||+|+||.||++.+...++.||||++.... ......+.+|+.+++.++|+||+++++++.... ....
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 4578999999999999999999998889999999986432 233467889999999999999999999864321 1233
Q ss_pred ceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCe
Q 002857 235 DFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTA 314 (873)
Q Consensus 235 ~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~v 314 (873)
...++||||+++ +|.+++. ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~------------~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~ 165 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQ------------MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTL 165 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHH------------hcCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcE
Confidence 467999999965 7777662 23778889999999999999999 8999999999999999999999
Q ss_pred EEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcc
Q 002857 315 CVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDM 380 (873)
Q Consensus 315 KLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~ 380 (873)
||+|||+++...... ......+|..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 166 kL~DfG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 228 (364)
T cd07875 166 KILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 228 (364)
T ss_pred EEEeCCCccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Confidence 999999998653321 122345899999999999999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=324.63 Aligned_cols=194 Identities=25% Similarity=0.316 Sum_probs=167.1
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEeeccC---CcchhHHHHHHHHHHhh-hhccceeeeeeeecccccCCceEEEEE
Q 002857 166 NLIGAGNFASVYKGILFEGAPAVAIKVFNFLH---HDASKSFTVECEVMRNI-IHRKIIKVVTACSRVDYQGNDFKALVY 241 (873)
Q Consensus 166 ~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L-~HpNIV~llg~c~~~~~~~~~~~~LV~ 241 (873)
++||+|+||.||+|++..+++.||||+++... ....+.+..|+.++.++ +||||+++++++ ......+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~-----~~~~~~~lv~ 75 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCF-----QTESRLFFVI 75 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEE-----EcCCEEEEEE
Confidence 46999999999999999899999999997432 22345688899999998 799999999985 4566799999
Q ss_pred eecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEecccc
Q 002857 242 EFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGI 321 (873)
Q Consensus 242 Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDFGl 321 (873)
||+++|+|.+++. ....+++..++.++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 76 e~~~~g~L~~~~~----------~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~ 142 (329)
T cd05588 76 EFVSGGDLMFHMQ----------RQRKLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGM 142 (329)
T ss_pred eCCCCCCHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCcc
Confidence 9999999998883 2356899999999999999999999 89999999999999999999999999999
Q ss_pred ccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCc
Q 002857 322 ARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDD 379 (873)
Q Consensus 322 a~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~ 379 (873)
++...... .......||..|+|||++.+..++.++|||||||++|||+||+.||+.
T Consensus 143 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 198 (329)
T cd05588 143 CKEGIRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred ccccccCC--CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccc
Confidence 87432211 122235689999999999999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=312.20 Aligned_cols=251 Identities=26% Similarity=0.347 Sum_probs=194.5
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC-CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEE
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH-HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKA 238 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~ 238 (873)
++|+..++||+|+||.||+|.+..+++.||+|++.... ......+.+|++++++++||||+++++++. ..+..+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~ 75 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFF-----VENRIS 75 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEE-----ECCEEE
Confidence 36788899999999999999998899999999986442 233467889999999999999999999963 456789
Q ss_pred EEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEec
Q 002857 239 LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVAD 318 (873)
Q Consensus 239 LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsD 318 (873)
+||||+++++|..+. .+++..+..++.|++.||.||| +.+|+|+||||+|||++.++.++|+|
T Consensus 76 lv~e~~~~~~l~~~~--------------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~d 138 (279)
T cd06619 76 ICTEFMDGGSLDVYR--------------KIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCD 138 (279)
T ss_pred EEEecCCCCChHHhh--------------cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEee
Confidence 999999999997543 2567788899999999999999 89999999999999999999999999
Q ss_pred cccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCchh
Q 002857 319 FGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPER 398 (873)
Q Consensus 319 FGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~~ 398 (873)
||++...... ......++..|+|||++.+..++.++||||||+++|+|++|+.||.......... ....
T Consensus 139 fg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~-------~~~~ 207 (279)
T cd06619 139 FGVSTQLVNS----IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSL-------MPLQ 207 (279)
T ss_pred CCcceecccc----cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhccccccc-------chHH
Confidence 9999765322 1223468999999999999899999999999999999999999996532211100 0000
Q ss_pred H-HHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHH
Q 002857 399 V-EEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELG 464 (873)
Q Consensus 399 l-~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~ 464 (873)
. ..+.+.. .+.... . .....+.+++.+||+.+|++||++.|++..
T Consensus 208 ~~~~~~~~~----------------~~~~~~-~----~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 208 LLQCIVDED----------------PPVLPV-G----QFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred HHHHHhccC----------------CCCCCC-C----cCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 0 0000000 000000 0 012247789999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=332.16 Aligned_cols=255 Identities=22% Similarity=0.265 Sum_probs=197.3
Q ss_pred hhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeecc---CCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCC
Q 002857 158 ATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFL---HHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGN 234 (873)
Q Consensus 158 at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~ 234 (873)
..++|++.+.||+|+||.||+++...+++.||+|+++.. .......+.+|+.+++.++||||+++++++ ..+
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~-----~~~ 115 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAF-----QDD 115 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----ecC
Confidence 456899999999999999999999989999999998642 222335578899999999999999999885 556
Q ss_pred ceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCe
Q 002857 235 DFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTA 314 (873)
Q Consensus 235 ~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~v 314 (873)
...++||||+++|+|.+++.. ..+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~-----------~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~ 181 (370)
T cd05596 116 KYLYMVMEYMPGGDLVNLMSN-----------YDIPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHL 181 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHh-----------cCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCE
Confidence 789999999999999999842 24778888999999999999999 8999999999999999999999
Q ss_pred EEeccccccccccccccccccccccccccCCCcccCCC----CCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHH
Q 002857 315 CVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGH----ETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNW 390 (873)
Q Consensus 315 KLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~----~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~ 390 (873)
||+|||+++....... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||.......
T Consensus 182 kL~DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~------ 254 (370)
T cd05596 182 KLADFGTCMKMDANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG------ 254 (370)
T ss_pred EEEeccceeeccCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH------
Confidence 9999999986543221 112234689999999988653 47899999999999999999999997521110
Q ss_pred HhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCC--CCCHHHHHHH
Q 002857 391 VQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGE--RMKINDVELG 464 (873)
Q Consensus 391 ~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~e--RPTm~EVl~~ 464 (873)
....+.+..-. ...|... .....+.+++..||+.+|++ ||++.|++..
T Consensus 255 -------~~~~i~~~~~~------------~~~~~~~-------~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 255 -------TYSKIMDHKNS------------LTFPDDI-------EISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred -------HHHHHHcCCCc------------CCCCCcC-------CCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 11111110000 0001000 01234778999999999988 9999998654
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=307.63 Aligned_cols=253 Identities=27% Similarity=0.421 Sum_probs=196.6
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEE
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKAL 239 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~L 239 (873)
++|.+...||+|++|.||+|.+..+ ..||+|++.... ...+.+.+|++++++++|+|++++++++. ....++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~~~~~ 77 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS------EEPIYI 77 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc------CCCcEE
Confidence 4688889999999999999987544 469999876433 23467899999999999999999998842 345789
Q ss_pred EEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEecc
Q 002857 240 VYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADF 319 (873)
Q Consensus 240 V~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDF 319 (873)
||||+++|+|.++++. .....+++..++.++.|++.||+||| +.+|+|+||||+||++++++.++|+||
T Consensus 78 v~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~df 146 (260)
T cd05069 78 VTEFMGKGSLLDFLKE--------GDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADF 146 (260)
T ss_pred EEEcCCCCCHHHHHhh--------CCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCC
Confidence 9999999999999953 22345789999999999999999999 899999999999999999999999999
Q ss_pred ccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHHHhhcCchh
Q 002857 320 GIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQSALPER 398 (873)
Q Consensus 320 Gla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~~~~~~~~~ 398 (873)
|+++....... .......++..|+|||+..+..++.++||||||+++|||+| |+.||....... ...++...
T Consensus 147 g~~~~~~~~~~-~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~~~~~---- 219 (260)
T cd05069 147 GLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE--VLEQVERG---- 219 (260)
T ss_pred ccceEccCCcc-cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcC----
Confidence 99986533221 11122346778999999988899999999999999999999 899986532110 00100000
Q ss_pred HHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHH
Q 002857 399 VEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRL 467 (873)
Q Consensus 399 l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~ 467 (873)
.. .+.. ......+.+++.+||+.+|++||++.+|++.|+.
T Consensus 220 --------~~--------------~~~~-------~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 220 --------YR--------------MPCP-------QGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred --------CC--------------CCCC-------cccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 00 0000 0113357889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=332.32 Aligned_cols=203 Identities=23% Similarity=0.329 Sum_probs=172.3
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC---CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCce
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH---HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDF 236 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~ 236 (873)
++|++.+.||+|+||.||+|+...+++.||||++.... ......+.+|+++|++++|+||+++++.+ ..++.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~ 75 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSF-----QDKDN 75 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----EcCCE
Confidence 36899999999999999999999899999999986322 22345688999999999999999999985 55678
Q ss_pred EEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEE
Q 002857 237 KALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACV 316 (873)
Q Consensus 237 ~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKL 316 (873)
.++||||+++|+|.+++.. ...+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||
T Consensus 76 ~~lv~E~~~~g~L~~~i~~----------~~~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL 142 (376)
T cd05598 76 LYFVMDYIPGGDMMSLLIR----------LGIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKL 142 (376)
T ss_pred EEEEEeCCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEE
Confidence 9999999999999999842 345788888999999999999999 899999999999999999999999
Q ss_pred ecccccccccccc-----------------------------------------ccccccccccccccCCCcccCCCCCC
Q 002857 317 ADFGIARFLEATN-----------------------------------------EQTSSIGVKGTTGYIAPEYGMGHETS 355 (873)
Q Consensus 317 sDFGla~~~~~~~-----------------------------------------~~~~~~~~~Gt~~Y~APE~l~~~~~s 355 (873)
+|||++..+.... .........||..|+|||++.+..++
T Consensus 143 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 222 (376)
T cd05598 143 TDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYT 222 (376)
T ss_pred EeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCC
Confidence 9999975321000 00001134699999999999999999
Q ss_pred cchhhHhHHHHHHHHHhCCCCCCcc
Q 002857 356 SYGDVYSFGILLLEMFTGLRPSDDM 380 (873)
Q Consensus 356 ~ksDVwSfGvvL~ELlTGk~Pf~~~ 380 (873)
.++|||||||++|||++|+.||...
T Consensus 223 ~~~DiwSlGvilyell~G~~Pf~~~ 247 (376)
T cd05598 223 QLCDWWSVGVILYEMLVGQPPFLAD 247 (376)
T ss_pred cceeeeeccceeeehhhCCCCCCCC
Confidence 9999999999999999999999753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=309.97 Aligned_cols=257 Identities=21% Similarity=0.309 Sum_probs=186.6
Q ss_pred eeecccCceEEEEEEEcC--CCcEEEEEEeeccCC-cchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEEEEe
Q 002857 166 NLIGAGNFASVYKGILFE--GAPAVAIKVFNFLHH-DASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKALVYE 242 (873)
Q Consensus 166 ~~LG~G~fG~VYkg~~~~--~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~LV~E 242 (873)
+.||+|+||.||+|.+.. .+..+|+|.++.... .....+.+|+.++++++|+||+++++++. .....++|||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~e 75 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCT-----EVTPYLLVME 75 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEc-----CCCCcEEEEE
Confidence 368999999999998753 345799998865432 23357889999999999999999999863 4456899999
Q ss_pred ecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEeccccc
Q 002857 243 FMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIA 322 (873)
Q Consensus 243 y~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDFGla 322 (873)
|+++|+|.++++... ......+++..++.++.|++.||+||| +.+++|+||||+||+++.++++||+|||++
T Consensus 76 ~~~~g~L~~~l~~~~-----~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~ 147 (269)
T cd05087 76 FCPLGDLKGYLRSCR-----KAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLS 147 (269)
T ss_pred CCCCCcHHHHHHHhh-----hcccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCcccc
Confidence 999999999995311 112335677788899999999999999 899999999999999999999999999999
Q ss_pred cccccccccccccccccccccCCCcccCCC-------CCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHHHhhc
Q 002857 323 RFLEATNEQTSSIGVKGTTGYIAPEYGMGH-------ETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQSA 394 (873)
Q Consensus 323 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-------~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~~~~~ 394 (873)
+...............++..|+|||++.+. .++.++||||||+++|||++ |+.||........ ....
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~--~~~~--- 222 (269)
T cd05087 148 HNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV--LTYT--- 222 (269)
T ss_pred ccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH--HHHH---
Confidence 754332222222234567889999987642 35789999999999999996 9999965322110 0000
Q ss_pred CchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHH
Q 002857 395 LPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLR 466 (873)
Q Consensus 395 ~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le 466 (873)
+....... ..|... . .....+.+++..|| .+|++|||+.||+..|+
T Consensus 223 --------~~~~~~~~-----------~~~~~~--~----~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 223 --------VREQQLKL-----------PKPRLK--L----PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred --------hhcccCCC-----------CCCccC--C----CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 00000000 000000 0 01223667889999 58999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=323.64 Aligned_cols=238 Identities=24% Similarity=0.293 Sum_probs=185.4
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEeeccC---CcchhHHHHHHH-HHHhhhhccceeeeeeeecccccCCceEEEEE
Q 002857 166 NLIGAGNFASVYKGILFEGAPAVAIKVFNFLH---HDASKSFTVECE-VMRNIIHRKIIKVVTACSRVDYQGNDFKALVY 241 (873)
Q Consensus 166 ~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~---~~~~~~f~~Ei~-iL~~L~HpNIV~llg~c~~~~~~~~~~~~LV~ 241 (873)
+.||+|+||.||+|++..+++.||||++.... ......+..|.. +++.++||||+++++.+ ...+..++||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~-----~~~~~~~lv~ 75 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSF-----QTADKLYFVL 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEE-----EeCCEEEEEE
Confidence 46999999999999999899999999986432 222344555555 56788999999999885 4567899999
Q ss_pred eecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEecccc
Q 002857 242 EFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGI 321 (873)
Q Consensus 242 Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDFGl 321 (873)
||+++|+|.+++. ....+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 76 e~~~~g~L~~~l~----------~~~~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~ 142 (323)
T cd05575 76 DYVNGGELFFHLQ----------RERSFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGL 142 (323)
T ss_pred cCCCCCCHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCC
Confidence 9999999999884 2446888899999999999999999 89999999999999999999999999999
Q ss_pred ccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCchhHHH
Q 002857 322 ARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPERVEE 401 (873)
Q Consensus 322 a~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~~l~e 401 (873)
++...... .......||..|+|||++.+..++.++|||||||++|||++|+.||...... +
T Consensus 143 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~-----------------~ 203 (323)
T cd05575 143 CKEGIEHS--KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA-----------------E 203 (323)
T ss_pred CcccccCC--CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH-----------------H
Confidence 87532211 1223346899999999999999999999999999999999999999652111 1
Q ss_pred HhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHH
Q 002857 402 IVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKIN 459 (873)
Q Consensus 402 lid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~ 459 (873)
+.+..+..... ..+. ....+.+++.+||+.+|++||++.
T Consensus 204 ~~~~i~~~~~~---------~~~~----------~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 204 MYDNILNKPLR---------LKPN----------ISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred HHHHHHcCCCC---------CCCC----------CCHHHHHHHHHHhhcCHHhCCCCC
Confidence 11111111000 0000 122477899999999999999986
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=331.64 Aligned_cols=201 Identities=22% Similarity=0.332 Sum_probs=171.3
Q ss_pred CCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC---CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceE
Q 002857 161 GFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH---HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFK 237 (873)
Q Consensus 161 ~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~ 237 (873)
.|+..++||+|+||.||+|+...+++.||+|++.... ......+.+|++++++++|+||+++++.+ ..++..
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~-----~~~~~~ 76 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSF-----QDKDNL 76 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEE-----EeCCEE
Confidence 5888999999999999999999999999999986432 22345788999999999999999999985 456789
Q ss_pred EEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEe
Q 002857 238 ALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVA 317 (873)
Q Consensus 238 ~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLs 317 (873)
+|||||+++|+|.+++.. ...+++.....++.||+.||+||| +.+|+||||||+|||++.++.+||+
T Consensus 77 ~lv~E~~~gg~L~~~l~~----------~~~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~ 143 (382)
T cd05625 77 YFVMDYIPGGDMMSLLIR----------MGIFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLT 143 (382)
T ss_pred EEEEeCCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEe
Confidence 999999999999999842 345788889999999999999999 8999999999999999999999999
Q ss_pred ccccccccccccc---------------------------------------------cccccccccccccCCCcccCCC
Q 002857 318 DFGIARFLEATNE---------------------------------------------QTSSIGVKGTTGYIAPEYGMGH 352 (873)
Q Consensus 318 DFGla~~~~~~~~---------------------------------------------~~~~~~~~Gt~~Y~APE~l~~~ 352 (873)
|||+++.+..... ........||+.|+|||++.+.
T Consensus 144 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~ 223 (382)
T cd05625 144 DFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT 223 (382)
T ss_pred ECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCC
Confidence 9999753311000 0001124689999999999999
Q ss_pred CCCcchhhHhHHHHHHHHHhCCCCCCc
Q 002857 353 ETSSYGDVYSFGILLLEMFTGLRPSDD 379 (873)
Q Consensus 353 ~~s~ksDVwSfGvvL~ELlTGk~Pf~~ 379 (873)
.++.++|||||||++|||++|+.||..
T Consensus 224 ~~~~~~DiwSlGvil~elltG~~Pf~~ 250 (382)
T cd05625 224 GYTQLCDWWSVGVILYEMLVGQPPFLA 250 (382)
T ss_pred CCCCeeeEEechHHHHHHHhCCCCCCC
Confidence 999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=309.50 Aligned_cols=257 Identities=26% Similarity=0.417 Sum_probs=199.5
Q ss_pred cCCCcceeecccCceEEEEEEEcCCC---cEEEEEEeeccC-CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCc
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGA---PAVAIKVFNFLH-HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGND 235 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g---~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~ 235 (873)
.+|++.+.||+|+||.||+|.+..++ ..+|+|.++... ....+.+.+|+.++++++||||+++++++ ..++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~ 78 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVV-----TKSK 78 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEE-----ecCC
Confidence 46888999999999999999876443 379999886432 22346789999999999999999999986 3456
Q ss_pred eEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeE
Q 002857 236 FKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTAC 315 (873)
Q Consensus 236 ~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vK 315 (873)
..++||||+++++|.+++.. ....+++.+++.|+.|++.||+||| +.+++||||||+|||++.++.++
T Consensus 79 ~~~lv~e~~~~~~L~~~~~~---------~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~ 146 (267)
T cd05066 79 PVMIVTEYMENGSLDAFLRK---------HDGQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCK 146 (267)
T ss_pred ccEEEEEcCCCCCHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEE
Confidence 78999999999999999852 2346899999999999999999999 89999999999999999999999
Q ss_pred Eecccccccccccccccc-ccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHHHhh
Q 002857 316 VADFGIARFLEATNEQTS-SIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQS 393 (873)
Q Consensus 316 LsDFGla~~~~~~~~~~~-~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~~~~ 393 (873)
|+|||+++.......... .....++..|+|||++.+..++.++||||||+++||+++ |..||....... ....+
T Consensus 147 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~--~~~~~-- 222 (267)
T cd05066 147 VSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD--VIKAI-- 222 (267)
T ss_pred eCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH--HHHHH--
Confidence 999999987643322111 111223568999999998899999999999999999887 999986532110 11110
Q ss_pred cCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHH
Q 002857 394 ALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLI 468 (873)
Q Consensus 394 ~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i 468 (873)
.+. . ..+... .++..+.+++.+||+.+|.+||+|.+|++.|+++
T Consensus 223 ---------~~~-~--------------~~~~~~-------~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 223 ---------EEG-Y--------------RLPAPM-------DCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ---------hCC-C--------------cCCCCC-------CCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 000 0 000000 1123477899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=309.43 Aligned_cols=257 Identities=22% Similarity=0.293 Sum_probs=184.0
Q ss_pred eeecccCceEEEEEEEcC--CCcEEEEEEeeccCC-cchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEEEEe
Q 002857 166 NLIGAGNFASVYKGILFE--GAPAVAIKVFNFLHH-DASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKALVYE 242 (873)
Q Consensus 166 ~~LG~G~fG~VYkg~~~~--~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~LV~E 242 (873)
+.||+|+||.||+|.... ....+|+|.+..... .....+.+|+++++.++|+||+++++.+ ......++|||
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~-----~~~~~~~lv~e 75 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQC-----IESIPYLLVLE 75 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEE-----CCCCceEEEEE
Confidence 368999999999997643 335788888764332 2335688999999999999999999986 34567899999
Q ss_pred ecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEeccccc
Q 002857 243 FMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIA 322 (873)
Q Consensus 243 y~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDFGla 322 (873)
|+++|+|.+++.... .......++...+.++.||+.||+||| +.+|+||||||+|||+++++.+||+|||++
T Consensus 76 ~~~~g~L~~~l~~~~-----~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~ 147 (269)
T cd05042 76 FCPLGDLKNYLRSNR-----GMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLA 147 (269)
T ss_pred eCCCCcHHHHHHhcc-----ccccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEeccccc
Confidence 999999999995411 112234567788999999999999999 899999999999999999999999999998
Q ss_pred cccccccccccccccccccccCCCcccCC-------CCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHHHhhc
Q 002857 323 RFLEATNEQTSSIGVKGTTGYIAPEYGMG-------HETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQSA 394 (873)
Q Consensus 323 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-------~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~~~~~ 394 (873)
+...............++..|+|||++.. ..++.++||||||+++|||++ |..||....... .+..
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-~~~~----- 221 (269)
T cd05042 148 LEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ-VLKQ----- 221 (269)
T ss_pred cccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH-HHHH-----
Confidence 75433221111223345778999998643 456889999999999999999 788886432111 0000
Q ss_pred CchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHH
Q 002857 395 LPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLR 466 (873)
Q Consensus 395 ~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le 466 (873)
.+.... ...+..... ......+.+++..|| .||++|||++||++.|.
T Consensus 222 -------~~~~~~-------------~~~~~~~~~----~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 222 -------VVREQD-------------IKLPKPQLD----LKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred -------HhhccC-------------ccCCCCccc----ccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 000000 000000000 011234567888888 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=317.54 Aligned_cols=249 Identities=23% Similarity=0.322 Sum_probs=204.4
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCc---chhHHHHHHHHHHhhhhccceeeeeeeecccccCCc
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHD---ASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGND 235 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~---~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~ 235 (873)
..+|++.+.||+|.||.|-+|.....|+.||||.+++.... ..-.+.+||+||+.|+||||+.++.+ |++.+
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEV-----FENkd 126 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEV-----FENKD 126 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhh-----hcCCc
Confidence 34688889999999999999998889999999999754433 34468889999999999999999998 57888
Q ss_pred eEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeE
Q 002857 236 FKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTAC 315 (873)
Q Consensus 236 ~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vK 315 (873)
...|||||..+|.|++|+. ..+.|++.+...+++||..|+.|.| +++++|||||.+|||||+++++|
T Consensus 127 KIvivMEYaS~GeLYDYiS----------er~~LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiK 193 (668)
T KOG0611|consen 127 KIVIVMEYASGGELYDYIS----------ERGSLSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIK 193 (668)
T ss_pred eEEEEEEecCCccHHHHHH----------HhccccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCee
Confidence 9999999999999999994 4678999999999999999999999 99999999999999999999999
Q ss_pred EeccccccccccccccccccccccccccCCCcccCCCCC-CcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhc
Q 002857 316 VADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHET-SSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSA 394 (873)
Q Consensus 316 LsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~-s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~ 394 (873)
|+|||++.++.... ....+.|++.|.+||++.+..| .+..|-|||||+||-|+.|..||++...
T Consensus 194 IADFGLSNly~~~k---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh------------ 258 (668)
T KOG0611|consen 194 IADFGLSNLYADKK---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH------------ 258 (668)
T ss_pred eeccchhhhhcccc---HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH------------
Confidence 99999998875433 3345689999999999999887 5679999999999999999999987311
Q ss_pred CchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHH
Q 002857 395 LPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGL 465 (873)
Q Consensus 395 ~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~L 465 (873)
..++.+.-.+.+.+ ++. +....-|+.+||..||++|.|+.+|...-
T Consensus 259 -----k~lvrQIs~GaYrE---------P~~-----------PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 259 -----KRLVRQISRGAYRE---------PET-----------PSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred -----HHHHHHhhcccccC---------CCC-----------CchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 11222221121111 111 11244588999999999999999987643
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=321.50 Aligned_cols=194 Identities=27% Similarity=0.365 Sum_probs=165.1
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEeeccC---CcchhHHHHHHHHHHhh-hhccceeeeeeeecccccCCceEEEEE
Q 002857 166 NLIGAGNFASVYKGILFEGAPAVAIKVFNFLH---HDASKSFTVECEVMRNI-IHRKIIKVVTACSRVDYQGNDFKALVY 241 (873)
Q Consensus 166 ~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L-~HpNIV~llg~c~~~~~~~~~~~~LV~ 241 (873)
+.||+|+||.||+|++..+++.||||+++... ......+..|..++..+ +||||+++++++ ...+..++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~-----~~~~~~~lv~ 75 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTF-----QTKENLFFVM 75 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEE-----EeCCEEEEEE
Confidence 46999999999999998889999999987432 23345567788888764 899999999985 4566799999
Q ss_pred eecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEecccc
Q 002857 242 EFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGI 321 (873)
Q Consensus 242 Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDFGl 321 (873)
||+++|+|.+++.. ...+++.++..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 76 ey~~~g~L~~~l~~----------~~~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~ 142 (316)
T cd05619 76 EYLNGGDLMFHIQS----------CHKFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGM 142 (316)
T ss_pred eCCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCc
Confidence 99999999999842 346888899999999999999999 89999999999999999999999999999
Q ss_pred ccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCc
Q 002857 322 ARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDD 379 (873)
Q Consensus 322 a~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~ 379 (873)
++...... .......||..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 143 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~ 198 (316)
T cd05619 143 CKENMLGD--AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHG 198 (316)
T ss_pred ceECCCCC--CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCC
Confidence 87532211 112234689999999999999999999999999999999999999965
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=315.88 Aligned_cols=205 Identities=22% Similarity=0.281 Sum_probs=162.7
Q ss_pred ceeecccCceEEEEEEEcC--CCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEEEEe
Q 002857 165 ENLIGAGNFASVYKGILFE--GAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKALVYE 242 (873)
Q Consensus 165 ~~~LG~G~fG~VYkg~~~~--~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~LV~E 242 (873)
.++||+|+||.||+|++.. +++.||+|.+.... ....+.+|+++|++++||||+++++++.. ..+...++|||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~---~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLS---HADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEec---CCCcEEEEEEe
Confidence 4689999999999998753 56789999986432 23567899999999999999999998642 33456899999
Q ss_pred ecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeee----CCCCCeEEec
Q 002857 243 FMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILL----NDEMTACVAD 318 (873)
Q Consensus 243 y~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILL----d~~~~vKLsD 318 (873)
|+. ++|.+++...... ........+++..+..|+.||+.||+||| +.+|+||||||+|||+ +.++.+||+|
T Consensus 81 ~~~-~~l~~~~~~~~~~-~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~D 155 (317)
T cd07868 81 YAE-HDLWHIIKFHRAS-KANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIAD 155 (317)
T ss_pred ccC-CCHHHHHHhcccc-cccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEee
Confidence 985 5888887431111 11122346889999999999999999999 8999999999999999 4567999999
Q ss_pred ccccccccccccc-ccccccccccccCCCcccCCC-CCCcchhhHhHHHHHHHHHhCCCCCCc
Q 002857 319 FGIARFLEATNEQ-TSSIGVKGTTGYIAPEYGMGH-ETSSYGDVYSFGILLLEMFTGLRPSDD 379 (873)
Q Consensus 319 FGla~~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELlTGk~Pf~~ 379 (873)
||+++........ .......+|..|+|||++.+. .++.++|||||||++|||++|+.||..
T Consensus 156 fG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~ 218 (317)
T cd07868 156 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred cCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence 9999876433211 122335689999999998774 589999999999999999999999965
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=330.82 Aligned_cols=205 Identities=24% Similarity=0.327 Sum_probs=174.0
Q ss_pred HHHhhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeecc---CCcchhHHHHHHHHHHhhhhccceeeeeeeecccc
Q 002857 155 LYSATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFL---HHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDY 231 (873)
Q Consensus 155 l~~at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~ 231 (873)
+....++|++.+.||+|+||.||++++..+++.||+|++... .......+.+|+.+++.++||||+++++++
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~----- 112 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAF----- 112 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE-----
Confidence 334457899999999999999999999989999999998632 222345688999999999999999999985
Q ss_pred cCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCC
Q 002857 232 QGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDE 311 (873)
Q Consensus 232 ~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~ 311 (873)
..+...++||||+++|+|.+++.. ..+++..+..++.||+.||+||| +.+|+||||||+|||++.+
T Consensus 113 ~~~~~~~lv~Ey~~gg~L~~~l~~-----------~~~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~ 178 (370)
T cd05621 113 QDDKYLYMVMEYMPGGDLVNLMSN-----------YDVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKH 178 (370)
T ss_pred EcCCEEEEEEcCCCCCcHHHHHHh-----------cCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCC
Confidence 556789999999999999999842 24788889999999999999999 8999999999999999999
Q ss_pred CCeEEeccccccccccccccccccccccccccCCCcccCCC----CCCcchhhHhHHHHHHHHHhCCCCCCc
Q 002857 312 MTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGH----ETSSYGDVYSFGILLLEMFTGLRPSDD 379 (873)
Q Consensus 312 ~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~----~~s~ksDVwSfGvvL~ELlTGk~Pf~~ 379 (873)
+.+||+|||+++....... .......||..|+|||++.+. .++.++|||||||++|||++|+.||..
T Consensus 179 ~~~kL~DFG~a~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~ 249 (370)
T cd05621 179 GHLKLADFGTCMKMDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYA 249 (370)
T ss_pred CCEEEEecccceecccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCC
Confidence 9999999999986543221 112245699999999998754 378899999999999999999999965
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=313.44 Aligned_cols=199 Identities=25% Similarity=0.324 Sum_probs=171.2
Q ss_pred CCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCC---cchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEE
Q 002857 162 FSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH---DASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKA 238 (873)
Q Consensus 162 f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~ 238 (873)
|+..+.||+|+||+||+|.+..+++.||+|.+..... .....+.+|++++++++|+||+++.+.+ ..++..+
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~~ 76 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAY-----ETKDALC 76 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEE-----ecCCEEE
Confidence 6677899999999999999998999999999864322 2234578899999999999999998885 4566799
Q ss_pred EEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEec
Q 002857 239 LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVAD 318 (873)
Q Consensus 239 LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsD 318 (873)
+||||+++++|.+++.. .....+++..+..++.|++.||.||| +.+|+||||||+||++++++.+||+|
T Consensus 77 lv~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~D 145 (285)
T cd05632 77 LVLTIMNGGDLKFHIYN--------MGNPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISD 145 (285)
T ss_pred EEEEeccCccHHHHHHH--------hcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEec
Confidence 99999999999988843 22346899999999999999999999 89999999999999999999999999
Q ss_pred cccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCc
Q 002857 319 FGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDD 379 (873)
Q Consensus 319 FGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~ 379 (873)
||++....... ......|+..|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 146 fg~~~~~~~~~---~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~ 203 (285)
T cd05632 146 LGLAVKIPEGE---SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRG 203 (285)
T ss_pred CCcceecCCCC---cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCC
Confidence 99997653221 11234689999999999988999999999999999999999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=306.57 Aligned_cols=250 Identities=26% Similarity=0.379 Sum_probs=195.3
Q ss_pred eeecccCceEEEEEEEcC-CCc--EEEEEEeeccCC-cchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEEEE
Q 002857 166 NLIGAGNFASVYKGILFE-GAP--AVAIKVFNFLHH-DASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKALVY 241 (873)
Q Consensus 166 ~~LG~G~fG~VYkg~~~~-~g~--~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~LV~ 241 (873)
++||+|++|.||+|.+.. +++ .||||.+..... ...+.+.+|+.++++++|+||+++++++. . ...++||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~-~~~~~v~ 74 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVL-----T-HPLMMVT 74 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEc-----C-CeEEEEE
Confidence 468999999999999865 333 699999976555 45678999999999999999999999853 2 6789999
Q ss_pred eecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEecccc
Q 002857 242 EFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGI 321 (873)
Q Consensus 242 Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDFGl 321 (873)
||+++|+|.+++.. .....+++..++.++.|++.||+||| +.+++|+||||+||+++.++.+||+|||+
T Consensus 75 e~~~~~~L~~~l~~--------~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~ 143 (257)
T cd05040 75 ELAPLGSLLDRLRK--------DALGHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGL 143 (257)
T ss_pred EecCCCcHHHHHHh--------cccccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEeccccc
Confidence 99999999999853 11156899999999999999999999 89999999999999999999999999999
Q ss_pred cccccccccc-ccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHHHhhcCchhH
Q 002857 322 ARFLEATNEQ-TSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQSALPERV 399 (873)
Q Consensus 322 a~~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~~~~~~~~~l 399 (873)
++.+...... .......++..|+|||++.+..++.++||||||+++|||+| |+.||....... ....
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~--------- 212 (257)
T cd05040 144 MRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ--ILKK--------- 212 (257)
T ss_pred cccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH--HHHH---------
Confidence 9876442211 11122347789999999998899999999999999999999 999986431111 0000
Q ss_pred HHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHH
Q 002857 400 EEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLR 466 (873)
Q Consensus 400 ~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le 466 (873)
+ .. .. .....+ ...+..+.+++.+||+.+|++||++.+|++.|.
T Consensus 213 --~-~~---~~--------~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 213 --I-DK---EG--------ERLERP---------EACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred --H-Hh---cC--------CcCCCC---------ccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 0 00 00 000000 011335788999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=316.27 Aligned_cols=276 Identities=20% Similarity=0.258 Sum_probs=197.8
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC-CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEE
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH-HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKA 238 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~ 238 (873)
++|.+.+.||+|+||.||+|.+..+++.||+|.++... ......+.+|+.++++++|+||+++++++ ......+
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~-----~~~~~~~ 80 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII-----HTEKSLT 80 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEE-----ecCCeEE
Confidence 57889999999999999999998889999999987443 22335678899999999999999999995 4456789
Q ss_pred EEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEec
Q 002857 239 LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVAD 318 (873)
Q Consensus 239 LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsD 318 (873)
+||||++ ++|.+++.. ....+++..+..++.||+.||+||| +.+|+|+||||+|||++.++.+||+|
T Consensus 81 lv~e~~~-~~l~~~l~~---------~~~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~d 147 (301)
T cd07873 81 LVFEYLD-KDLKQYLDD---------CGNSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLAD 147 (301)
T ss_pred EEEeccc-cCHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECc
Confidence 9999997 589888842 2345788899999999999999999 89999999999999999999999999
Q ss_pred cccccccccccccccccccccccccCCCcccCCC-CCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCch
Q 002857 319 FGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGH-ETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPE 397 (873)
Q Consensus 319 FGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~ 397 (873)
||++........ ......++..|+|||++.+. .++.++||||||+++|||+||+.||...... .....+...+..
T Consensus 148 fg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~--~~~~~~~~~~~~ 223 (301)
T cd07873 148 FGLARAKSIPTK--TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVE--EQLHFIFRILGT 223 (301)
T ss_pred CcchhccCCCCC--cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHcCC
Confidence 999975432211 11223468899999987654 5788999999999999999999999753221 111111111111
Q ss_pred hHHHHhhhhhhhhhhHHHHHhhhccCCCCc-h-hHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 398 RVEEIVDTLFFKEIEEEETVYKYKKAPSSS-T-QRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 398 ~l~elid~~L~~~~~~r~~~~~i~~~p~~~-~-~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
.........+.... ... ...+... . ...........+.+++.+||+.||.+|||+.||++
T Consensus 224 ~~~~~~~~~~~~~~-----~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 224 PTEETWPGILSNEE-----FKS-YNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred CChhhchhhhcccc-----ccc-cccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00011000000000 000 0000000 0 00000112335778999999999999999999876
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=329.10 Aligned_cols=198 Identities=24% Similarity=0.280 Sum_probs=169.0
Q ss_pred hcCCCcceeecccCceEEEEEEEcC--CCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCce
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFE--GAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDF 236 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~--~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~ 236 (873)
..+|.+.+.||+|+||.||++.... .+..||+|.+... +.+.+|+++|++++|+||+++++++ .....
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~ 160 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAY-----RWKST 160 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeE-----eeCCE
Confidence 3579999999999999999997643 4578999987532 3457899999999999999999985 44567
Q ss_pred EEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEE
Q 002857 237 KALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACV 316 (873)
Q Consensus 237 ~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKL 316 (873)
.++|||++. ++|.+++. ....+++.+++.|+.||+.||.||| +.+|+||||||+|||++.++.+||
T Consensus 161 ~~lv~e~~~-~~l~~~l~----------~~~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l 226 (392)
T PHA03207 161 VCMVMPKYK-CDLFTYVD----------RSGPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVL 226 (392)
T ss_pred EEEEehhcC-CCHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEE
Confidence 899999995 68888873 2456899999999999999999999 899999999999999999999999
Q ss_pred eccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcc
Q 002857 317 ADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDM 380 (873)
Q Consensus 317 sDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~ 380 (873)
+|||+++.+.............||..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 227 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~ 290 (392)
T PHA03207 227 GDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGK 290 (392)
T ss_pred ccCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 9999998665443333333456999999999999999999999999999999999999999653
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=303.11 Aligned_cols=251 Identities=21% Similarity=0.283 Sum_probs=198.1
Q ss_pred CCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC--CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEE
Q 002857 161 GFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH--HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKA 238 (873)
Q Consensus 161 ~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~ 238 (873)
+|++.+.||+|++|.||++.+..+++.||+|.+.... ....+.+.+|++++++++|+|++++++.+. ......+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----~~~~~~~ 76 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWE----GEDGLLY 76 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeec----CCCCEEE
Confidence 5888999999999999999998889999999986432 234467889999999999999999998742 2344689
Q ss_pred EEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEec
Q 002857 239 LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVAD 318 (873)
Q Consensus 239 LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsD 318 (873)
+||||+++++|.+++.. .....+++.+++.++.+++.||+||| +.+|+||||||+||+++.++.++|+|
T Consensus 77 lv~e~~~~~~l~~~l~~--------~~~~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~d 145 (257)
T cd08223 77 IVMGFCEGGDLYHKLKE--------QKGKLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGD 145 (257)
T ss_pred EEecccCCCcHHHHHHH--------hcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEec
Confidence 99999999999999853 22345899999999999999999999 89999999999999999999999999
Q ss_pred cccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCchh
Q 002857 319 FGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPER 398 (873)
Q Consensus 319 FGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~~ 398 (873)
||++........ ......++..|+|||++.+..++.++||||||++++||++|+.||....... ..
T Consensus 146 f~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~-----~~------- 211 (257)
T cd08223 146 LGIARVLENQCD--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNS-----LV------- 211 (257)
T ss_pred ccceEEecccCC--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH-----HH-------
Confidence 999986643221 2223457899999999999999999999999999999999999986421110 00
Q ss_pred HHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 399 VEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 399 l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
..+....+ +... ......+.+++.+||+.+|++|||+.+++.
T Consensus 212 -~~~~~~~~----------------~~~~------~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 212 -YRIIEGKL----------------PPMP------KDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred -HHHHhcCC----------------CCCc------cccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00000000 0000 011234778999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=322.26 Aligned_cols=194 Identities=26% Similarity=0.346 Sum_probs=165.3
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEeeccC---CcchhHHHHHHHHHHhh-hhccceeeeeeeecccccCCceEEEEE
Q 002857 166 NLIGAGNFASVYKGILFEGAPAVAIKVFNFLH---HDASKSFTVECEVMRNI-IHRKIIKVVTACSRVDYQGNDFKALVY 241 (873)
Q Consensus 166 ~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L-~HpNIV~llg~c~~~~~~~~~~~~LV~ 241 (873)
++||+|+||.||+|++..+++.||+|+++... ......+..|..++... +|+||+++++++ ...+..++||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~~~lv~ 75 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTF-----QTKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEE-----EeCCEEEEEE
Confidence 46999999999999999899999999997432 23345667788888765 899999999985 4567899999
Q ss_pred eecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEecccc
Q 002857 242 EFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGI 321 (873)
Q Consensus 242 Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDFGl 321 (873)
||+++|+|.+++.. ...+++.++..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 76 E~~~~g~L~~~i~~----------~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~ 142 (316)
T cd05620 76 EFLNGGDLMFHIQD----------KGRFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGM 142 (316)
T ss_pred CCCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCC
Confidence 99999999998842 346888899999999999999999 89999999999999999999999999999
Q ss_pred ccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCc
Q 002857 322 ARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDD 379 (873)
Q Consensus 322 a~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~ 379 (873)
++...... .......||..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 143 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~ 198 (316)
T cd05620 143 CKENVFGD--NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHG 198 (316)
T ss_pred CeecccCC--CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCC
Confidence 87432211 122345689999999999999999999999999999999999999965
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=306.03 Aligned_cols=255 Identities=26% Similarity=0.445 Sum_probs=200.0
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEE
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKA 238 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~ 238 (873)
.++|.+.+.||+|+||.||+|.+. ++..||||.+..... ..+.+.+|+.++++++|+||+++++++ ......+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 77 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVC-----SEEEPIY 77 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeee-----ecCCceE
Confidence 467899999999999999999874 567899999874332 346799999999999999999999985 3446689
Q ss_pred EEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEec
Q 002857 239 LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVAD 318 (873)
Q Consensus 239 LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsD 318 (873)
+||||+++++|.+++.. .....+++.++..++.|++.||.||| +.+|+|+||||+||++++++.+||+|
T Consensus 78 ~v~e~~~~~~L~~~i~~--------~~~~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d 146 (261)
T cd05034 78 IVTEYMSKGSLLDFLKS--------GEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIAD 146 (261)
T ss_pred EEEeccCCCCHHHHHhc--------cccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECc
Confidence 99999999999999953 22346899999999999999999999 88999999999999999999999999
Q ss_pred cccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHHHhhcCch
Q 002857 319 FGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQSALPE 397 (873)
Q Consensus 319 FGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~~~~~~~~ 397 (873)
||+++...... .........+..|+|||.+.+..++.++||||||+++|||+| |+.||....... ..
T Consensus 147 ~g~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~--~~--------- 214 (261)
T cd05034 147 FGLARLIEDDE-YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE--VL--------- 214 (261)
T ss_pred cccceeccchh-hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH--HH---------
Confidence 99998654321 111112234678999999998889999999999999999999 999986521110 00
Q ss_pred hHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHH
Q 002857 398 RVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRL 467 (873)
Q Consensus 398 ~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~ 467 (873)
..+... +.. +.. ...+..+.+++.+||+.+|++||++.+|.+.|+.
T Consensus 215 --~~~~~~-~~~--------------~~~-------~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 215 --EQVERG-YRM--------------PRP-------PNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred --HHHHcC-CCC--------------CCC-------CCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 011000 000 000 0012357889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=335.34 Aligned_cols=260 Identities=23% Similarity=0.404 Sum_probs=211.3
Q ss_pred CcceeecccCceEEEEEEEcCCCc----EEEEEEeecc-CCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceE
Q 002857 163 SSENLIGAGNFASVYKGILFEGAP----AVAIKVFNFL-HHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFK 237 (873)
Q Consensus 163 ~~~~~LG~G~fG~VYkg~~~~~g~----~VAVK~l~~~-~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~ 237 (873)
...++||+|+||+||+|.|...++ +||||++... ..+...+++.|+-+|.+++|||+++++|+|.. ...
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~------s~~ 772 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCML------STL 772 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhccc------chH
Confidence 346899999999999999987665 6899988643 44456899999999999999999999999853 237
Q ss_pred EEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEe
Q 002857 238 ALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVA 317 (873)
Q Consensus 238 ~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLs 317 (873)
.||++||+.|+|.+|++. ....+-....+.|..|||+||.||| .+++|||||-++|||+..-.++||.
T Consensus 773 qlvtq~mP~G~LlDyvr~---------hr~~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkit 840 (1177)
T KOG1025|consen 773 QLVTQLMPLGCLLDYVRE---------HRDNIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKIT 840 (1177)
T ss_pred HHHHHhcccchHHHHHHH---------hhccccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEE
Confidence 899999999999999964 3456777889999999999999999 8999999999999999999999999
Q ss_pred ccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHHHhhcCc
Q 002857 318 DFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQSALP 396 (873)
Q Consensus 318 DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~~~~~~~ 396 (873)
|||+++.+..+..........-.+.|||=|.+....++.++|||||||++||++| |..|++....++
T Consensus 841 dfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e------------ 908 (1177)
T KOG1025|consen 841 DFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE------------ 908 (1177)
T ss_pred ecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH------------
Confidence 9999999877665555444556788999999999999999999999999999999 999998753322
Q ss_pred hhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHHHHhhhcC
Q 002857 397 ERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLIKKKLLET 475 (873)
Q Consensus 397 ~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i~~~l~~~ 475 (873)
+.+++.. .+ .+ .. +.-|...+..++.+||..|++.||+++++...+.++.......
T Consensus 909 --I~dlle~---ge--------RL-sq---------PpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardpqry 964 (1177)
T KOG1025|consen 909 --IPDLLEK---GE--------RL-SQ---------PPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDPQRY 964 (1177)
T ss_pred --hhHHHhc---cc--------cC-CC---------CCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCcceE
Confidence 1111110 00 00 01 1124556889999999999999999999999998875544433
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=326.51 Aligned_cols=239 Identities=23% Similarity=0.301 Sum_probs=188.1
Q ss_pred eeecccCceEEEEEEEc---CCCcEEEEEEeeccCC--cchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEEE
Q 002857 166 NLIGAGNFASVYKGILF---EGAPAVAIKVFNFLHH--DASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKALV 240 (873)
Q Consensus 166 ~~LG~G~fG~VYkg~~~---~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~LV 240 (873)
+.||+|+||.||++... .+++.||+|+++.... .....+..|+++|++++||||+++++++ ..++..++|
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~~lv 76 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAF-----QTEGKLYLI 76 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEE-----EcCCEEEEE
Confidence 67999999999998763 4678999999974322 2334577899999999999999999985 456789999
Q ss_pred EeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEeccc
Q 002857 241 YEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFG 320 (873)
Q Consensus 241 ~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDFG 320 (873)
|||+++|+|.+++. ....+++..++.++.||+.||+||| +.+|+||||||+|||++.++.+||+|||
T Consensus 77 ~e~~~~~~L~~~l~----------~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg 143 (318)
T cd05582 77 LDFLRGGDLFTRLS----------KEVMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFG 143 (318)
T ss_pred EcCCCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeecc
Confidence 99999999999984 2346899999999999999999999 8999999999999999999999999999
Q ss_pred cccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCchhHH
Q 002857 321 IARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPERVE 400 (873)
Q Consensus 321 la~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~~l~ 400 (873)
+++...... .......|+..|+|||++.+..++.++||||||+++|||+||+.||....... . ..
T Consensus 144 ~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~--~-----------~~ 208 (318)
T cd05582 144 LSKESIDHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE--T-----------MT 208 (318)
T ss_pred CCcccCCCC--CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHH--H-----------HH
Confidence 998643321 12223568999999999998889999999999999999999999997531110 0 01
Q ss_pred HHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHH
Q 002857 401 EIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKIND 460 (873)
Q Consensus 401 elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~E 460 (873)
.+....+ ..|. .....+.+++.+||+.||++||++.+
T Consensus 209 ~i~~~~~--------------~~p~---------~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 209 MILKAKL--------------GMPQ---------FLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred HHHcCCC--------------CCCC---------CCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 1100000 0000 01224678999999999999999665
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=312.18 Aligned_cols=239 Identities=23% Similarity=0.332 Sum_probs=183.6
Q ss_pred eecccCceEEEEEEEcCC------------------------CcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceee
Q 002857 167 LIGAGNFASVYKGILFEG------------------------APAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKV 222 (873)
Q Consensus 167 ~LG~G~fG~VYkg~~~~~------------------------g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~l 222 (873)
+||+|+||.||+|.+..+ ...||+|++..........+.+|+.++++++|+||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 699999999999986321 23589999875544445678899999999999999999
Q ss_pred eeeeecccccCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCC
Q 002857 223 VTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIK 302 (873)
Q Consensus 223 lg~c~~~~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLK 302 (873)
+++|. .....++||||+++|+|..++.. ....+++..++.++.||++||+||| +.+|+|||||
T Consensus 82 ~~~~~-----~~~~~~lv~ey~~~g~L~~~l~~---------~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlk 144 (274)
T cd05076 82 HGVCV-----RGSENIMVEEFVEHGPLDVCLRK---------EKGRVPVAWKITVAQQLASALSYLE---DKNLVHGNVC 144 (274)
T ss_pred EEEEE-----eCCceEEEEecCCCCcHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCC
Confidence 99974 35578999999999999998842 2456889999999999999999999 8999999999
Q ss_pred CCCeeeCCCC-------CeEEeccccccccccccccccccccccccccCCCcccCC-CCCCcchhhHhHHHHHHHHH-hC
Q 002857 303 PSNILLNDEM-------TACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMG-HETSSYGDVYSFGILLLEMF-TG 373 (873)
Q Consensus 303 psNILLd~~~-------~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELl-TG 373 (873)
|+|||++..+ .+||+|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|
T Consensus 145 p~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g 218 (274)
T cd05076 145 AKNILLARLGLAEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDG 218 (274)
T ss_pred cccEEEeccCcccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 9999997643 3799999998643221 12246788999998875 56899999999999999985 69
Q ss_pred CCCCCcccccchhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcC
Q 002857 374 LRPSDDMFKDNLNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPG 453 (873)
Q Consensus 374 k~Pf~~~~~~~~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~ 453 (873)
+.||....... ....+.... ..|.. ....+.+++.+||+.+|+
T Consensus 219 ~~p~~~~~~~~--------------~~~~~~~~~--------------~~~~~---------~~~~~~~li~~cl~~~p~ 261 (274)
T cd05076 219 EVPLKERTPSE--------------KERFYEKKH--------------RLPEP---------SCKELATLISQCLTYEPT 261 (274)
T ss_pred CCCccccChHH--------------HHHHHHhcc--------------CCCCC---------CChHHHHHHHHHcccChh
Confidence 99986532111 001110000 00100 012477899999999999
Q ss_pred CCCCHHHHHHHH
Q 002857 454 ERMKINDVELGL 465 (873)
Q Consensus 454 eRPTm~EVl~~L 465 (873)
+||||.+|++.|
T Consensus 262 ~Rps~~~il~~L 273 (274)
T cd05076 262 QRPSFRTILRDL 273 (274)
T ss_pred hCcCHHHHHHhh
Confidence 999999999877
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=308.70 Aligned_cols=201 Identities=21% Similarity=0.310 Sum_probs=168.7
Q ss_pred CCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC--CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEE
Q 002857 161 GFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH--HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKA 238 (873)
Q Consensus 161 ~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~ 238 (873)
+|++.+.||+|++|.||+|+...++..||||+++... ....+.+.+|+.++++++|+||+++++++ ..+...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 75 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVL-----MQESRLY 75 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEE-----eeCCeEE
Confidence 4788899999999999999998889999999986432 22346788999999999999999999996 4466789
Q ss_pred EEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEec
Q 002857 239 LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVAD 318 (873)
Q Consensus 239 LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsD 318 (873)
+||||++ ++|.+++.. ......+++..++.++.||+.||+||| +.+|+|+||||+|||++.++.+||+|
T Consensus 76 ~v~e~~~-~~l~~~~~~-------~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~d 144 (285)
T cd07861 76 LIFEFLS-MDLKKYLDS-------LPKGQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLAD 144 (285)
T ss_pred EEEecCC-CCHHHHHhc-------CCCCCcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECc
Confidence 9999997 689888743 122356899999999999999999999 89999999999999999999999999
Q ss_pred cccccccccccccccccccccccccCCCcccCCC-CCCcchhhHhHHHHHHHHHhCCCCCCc
Q 002857 319 FGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGH-ETSSYGDVYSFGILLLEMFTGLRPSDD 379 (873)
Q Consensus 319 FGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELlTGk~Pf~~ 379 (873)
||++....... .......++..|+|||++.+. .++.++||||||+++|||+||+.||..
T Consensus 145 fg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~ 204 (285)
T cd07861 145 FGLARAFGIPV--RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHG 204 (285)
T ss_pred ccceeecCCCc--ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 99997543221 111223468899999987654 578899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=308.84 Aligned_cols=274 Identities=22% Similarity=0.276 Sum_probs=199.4
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC--CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceE
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH--HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFK 237 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~ 237 (873)
++|+..+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|++++++++|+||+++++++ ......
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~ 75 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVF-----RRKRKL 75 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEE-----eeCCEE
Confidence 46888999999999999999998889999999986432 22335688999999999999999999985 446678
Q ss_pred EEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEe
Q 002857 238 ALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVA 317 (873)
Q Consensus 238 ~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLs 317 (873)
++||||+++++|..++. ....+++..++.++.||+.||+||| +.+|+||||||+||+++.++.+||+
T Consensus 76 ~~v~e~~~~~~l~~~~~----------~~~~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~ 142 (286)
T cd07847 76 HLVFEYCDHTVLNELEK----------NPRGVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLC 142 (286)
T ss_pred EEEEeccCccHHHHHHh----------CCCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEEC
Confidence 99999999998888763 2345899999999999999999999 8999999999999999999999999
Q ss_pred ccccccccccccccccccccccccccCCCcccCC-CCCCcchhhHhHHHHHHHHHhCCCCCCcccccch--hhHHHHhhc
Q 002857 318 DFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMG-HETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNL--NLQNWVQSA 394 (873)
Q Consensus 318 DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~--~l~~~~~~~ 394 (873)
|||++........ ......++..|+|||++.+ ..++.++||||||+++|||++|+.||........ .........
T Consensus 143 dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 220 (286)
T cd07847 143 DFGFARILTGPGD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDL 220 (286)
T ss_pred ccccceecCCCcc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 9999987644321 1122347889999999876 4578999999999999999999999975322111 001111111
Q ss_pred CchhHHHHhhhhhhhhhhHHHHHhhhccCCCCc---hhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 395 LPERVEEIVDTLFFKEIEEEETVYKYKKAPSSS---TQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 395 ~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~---~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
.. ...++.+..- +. .....|... ............+.+++.+||+.+|++||++.|++.
T Consensus 221 ~~-~~~~~~~~~~---~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 221 IP-RHQQIFSTNQ---FF------KGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred Ch-HHhhhccccc---cc------ccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 10 1111110000 00 000000000 000011112345889999999999999999998864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=334.11 Aligned_cols=196 Identities=22% Similarity=0.303 Sum_probs=167.8
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEE
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKA 238 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~ 238 (873)
..+|.+.+.||+|+||.||+|.+...++.||||... ...+.+|+++|++++|+|||++++++ ..++..+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~-----~~~~~~~ 236 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVR-----VVGGLTC 236 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEE-----EECCEEE
Confidence 457999999999999999999998889999999632 23567899999999999999999986 3456789
Q ss_pred EEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEec
Q 002857 239 LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVAD 318 (873)
Q Consensus 239 LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsD 318 (873)
||||++. ++|.+++.. ....+++.+++.|+.||+.||.||| +.+|+||||||+|||++.++.+||+|
T Consensus 237 lv~e~~~-~~L~~~l~~---------~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~D 303 (461)
T PHA03211 237 LVLPKYR-SDLYTYLGA---------RLRPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGD 303 (461)
T ss_pred EEEEccC-CCHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcc
Confidence 9999994 688888742 2346899999999999999999999 89999999999999999999999999
Q ss_pred cccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 002857 319 FGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSD 378 (873)
Q Consensus 319 FGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~ 378 (873)
||+++...............||..|+|||++.+..++.++|||||||+||||++|..++.
T Consensus 304 FGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf 363 (461)
T PHA03211 304 FGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLF 363 (461)
T ss_pred cCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcc
Confidence 999986643322222234569999999999999999999999999999999999887643
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=317.15 Aligned_cols=199 Identities=27% Similarity=0.344 Sum_probs=171.7
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCC-cchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEE
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH-DASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKA 238 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~ 238 (873)
++|++.+.||+|+||.||++.+..++..+|+|.++.... .....+.+|++++++++||||+++++++ ..++..+
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~ 75 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAF-----YSDGEIS 75 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----eeCCEEE
Confidence 468999999999999999999988899999999864322 2335688999999999999999999986 4567899
Q ss_pred EEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEec
Q 002857 239 LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVAD 318 (873)
Q Consensus 239 LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsD 318 (873)
+||||+++++|.++++. ...+++..+..++.||++||.|||+ ..+++|+||||+|||++.++.+||+|
T Consensus 76 lv~ey~~~~~L~~~l~~----------~~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~d 143 (308)
T cd06615 76 ICMEHMDGGSLDQVLKK----------AGRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCD 143 (308)
T ss_pred EEeeccCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEcc
Confidence 99999999999999842 3558888999999999999999993 25899999999999999999999999
Q ss_pred cccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCc
Q 002857 319 FGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDD 379 (873)
Q Consensus 319 FGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~ 379 (873)
||++....... .....++..|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 144 fg~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~ 200 (308)
T cd06615 144 FGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPP 200 (308)
T ss_pred CCCcccccccc----cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence 99987543221 1234588999999999888899999999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=311.00 Aligned_cols=274 Identities=22% Similarity=0.291 Sum_probs=199.1
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCC--cchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceE
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH--DASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFK 237 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~ 237 (873)
++|+..++||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+++++.++|+||+++++++ ..+...
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 75 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVF-----RRKKRL 75 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhc-----ccCCeE
Confidence 468889999999999999999988899999999864322 2345788999999999999999999985 456789
Q ss_pred EEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEe
Q 002857 238 ALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVA 317 (873)
Q Consensus 238 ~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLs 317 (873)
++||||+++++|..+.. ....+++.+++.++.||+.||+||| +.+|+|+||+|+||++++++.++|+
T Consensus 76 ~lv~e~~~~~~l~~~~~----------~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~ 142 (286)
T cd07846 76 YLVFEFVDHTVLDDLEK----------YPNGLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLC 142 (286)
T ss_pred EEEEecCCccHHHHHHh----------ccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEE
Confidence 99999999999988763 2345899999999999999999999 8899999999999999999999999
Q ss_pred ccccccccccccccccccccccccccCCCcccCCC-CCCcchhhHhHHHHHHHHHhCCCCCCcccccc--hhhHHHHhhc
Q 002857 318 DFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGH-ETSSYGDVYSFGILLLEMFTGLRPSDDMFKDN--LNLQNWVQSA 394 (873)
Q Consensus 318 DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~--~~l~~~~~~~ 394 (873)
|||++........ ......++..|+|||++.+. .++.++||||||+++|||++|+.||....... ..+..+.. .
T Consensus 143 dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~-~ 219 (286)
T cd07846 143 DFGFARTLAAPGE--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLG-N 219 (286)
T ss_pred eeeeeeeccCCcc--ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhC-C
Confidence 9999986543321 12234578899999998763 57889999999999999999999986422110 00111111 1
Q ss_pred CchhHHHHhhhhhhhhhhHHHHHhhhccCCCCc---hhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 395 LPERVEEIVDTLFFKEIEEEETVYKYKKAPSSS---TQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 395 ~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~---~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
+........+..... .....+... ............+.+++.+||+.+|++||++.+|++
T Consensus 220 ~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 220 LIPRHQEIFQKNPLF---------AGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred CchhhHHHhccchHh---------hccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 111111111100000 000001000 000001122346889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=304.40 Aligned_cols=252 Identities=22% Similarity=0.249 Sum_probs=201.1
Q ss_pred CCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC--CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEE
Q 002857 161 GFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH--HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKA 238 (873)
Q Consensus 161 ~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~ 238 (873)
+|+..+.||.|+||.||.++...+++.+++|.+.... ....+.+.+|++++++++|+||+++++++ ......+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~ 75 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHF-----MDDNTLL 75 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEE-----ecCCeEE
Confidence 5888999999999999999998899999999986432 33456789999999999999999999996 4466799
Q ss_pred EEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEec
Q 002857 239 LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVAD 318 (873)
Q Consensus 239 LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsD 318 (873)
+||||+++++|.+++.. .....+++.++..++.|++.||.||| +.+++|+||+|+||++++++.+||+|
T Consensus 76 ~~~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d 144 (256)
T cd08221 76 IEMEYANGGTLYDKIVR--------QKGQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGD 144 (256)
T ss_pred EEEEecCCCcHHHHHHh--------ccccCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECc
Confidence 99999999999999853 22456889999999999999999999 88999999999999999999999999
Q ss_pred cccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCchh
Q 002857 319 FGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPER 398 (873)
Q Consensus 319 FGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~~ 398 (873)
||++........ ......++..|+|||++.+..++.++||||||+++|||++|..||...... . .
T Consensus 145 ~~~~~~~~~~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~-----~--------~ 209 (256)
T cd08221 145 FGISKILGSEYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL-----N--------L 209 (256)
T ss_pred CcceEEcccccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH-----H--------H
Confidence 999986543321 222345899999999998888999999999999999999999998652110 0 0
Q ss_pred HHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHH
Q 002857 399 VEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGL 465 (873)
Q Consensus 399 l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~L 465 (873)
...+. ..... +.. ......+.+++.+||+.+|++||++.|+++.+
T Consensus 210 ~~~~~----~~~~~-----------~~~-------~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 210 VVKIV----QGNYT-----------PVV-------SVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred HHHHH----cCCCC-----------CCc-------cccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 11111 01000 000 01123477899999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=312.87 Aligned_cols=263 Identities=25% Similarity=0.265 Sum_probs=202.6
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC-CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEE
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH-HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKA 238 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~ 238 (873)
++|++.+.||+|+||+||++.+..+++.||+|++.... ....+.+.+|+++++.++|+||+++++++ ......+
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 79 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF-----LNENNIC 79 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeE-----ecCCEEE
Confidence 46788899999999999999998889999999986443 23346789999999999999999999996 3456789
Q ss_pred EEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEec
Q 002857 239 LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVAD 318 (873)
Q Consensus 239 LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsD 318 (873)
+||||+++++|.+++.. ...+++..+..++.+++.||.|||+ ..+++||||||+||++++++.++|+|
T Consensus 80 lv~e~~~~~~L~~~~~~----------~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d 147 (284)
T cd06620 80 MCMEFMDCGSLDRIYKK----------GGPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCD 147 (284)
T ss_pred EEEecCCCCCHHHHHHh----------ccCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEcc
Confidence 99999999999998842 3458899999999999999999993 35899999999999999999999999
Q ss_pred cccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCchh
Q 002857 319 FGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPER 398 (873)
Q Consensus 319 FGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~~ 398 (873)
||++....... .....++..|+|||++.+..++.++|||||||++|+|+||+.||........ .......
T Consensus 148 ~gl~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~------~~~~~~~ 217 (284)
T cd06620 148 FGVSGELINSI----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDD------GQDDPMG 217 (284)
T ss_pred CCcccchhhhc----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhh------hhhhhhH
Confidence 99987542221 1234589999999999888999999999999999999999999976332211 0000001
Q ss_pred HHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHH
Q 002857 399 VEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLR 466 (873)
Q Consensus 399 l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le 466 (873)
+.+++...+.... +... . .+....+.+++.+||+.||++|||+.||+.+..
T Consensus 218 ~~~~~~~~~~~~~------------~~~~--~---~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~ 268 (284)
T cd06620 218 ILDLLQQIVQEPP------------PRLP--S---SDFPEDLRDFVDACLLKDPTERPTPQQLCAMPP 268 (284)
T ss_pred HHHHHHHHhhccC------------CCCC--c---hhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 1122221111100 0000 0 012345788999999999999999999988654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=311.90 Aligned_cols=251 Identities=24% Similarity=0.313 Sum_probs=196.0
Q ss_pred CCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCC---cchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEE
Q 002857 162 FSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH---DASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKA 238 (873)
Q Consensus 162 f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~ 238 (873)
|+..+.||+|+||.||++.+..+++.||||.+..... .....+.+|+.++++++|+||+++++.+ ...+..+
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~~ 76 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAY-----ETKDALC 76 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEE-----ecCCEEE
Confidence 6778999999999999999999999999999864322 1234577899999999999999999985 3456799
Q ss_pred EEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEec
Q 002857 239 LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVAD 318 (873)
Q Consensus 239 LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsD 318 (873)
+||||+++++|.+++.. .....+++..++.++.|++.||.||| +.+|+||||||+||+++.++.++|+|
T Consensus 77 lv~e~~~g~~L~~~l~~--------~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~D 145 (285)
T cd05630 77 LVLTLMNGGDLKFHIYH--------MGEAGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISD 145 (285)
T ss_pred EEEEecCCCcHHHHHHH--------hcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEee
Confidence 99999999999998843 22345889999999999999999999 89999999999999999999999999
Q ss_pred cccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCchh
Q 002857 319 FGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPER 398 (873)
Q Consensus 319 FGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~~ 398 (873)
||++........ .....|+..|+|||++.+..++.++||||||+++|||++|+.||....... ... .
T Consensus 146 fg~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~-~~~---------~ 212 (285)
T cd05630 146 LGLAVHVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI-KRE---------E 212 (285)
T ss_pred ccceeecCCCcc---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccc-hHH---------H
Confidence 999976532221 123458999999999999999999999999999999999999997532110 000 0
Q ss_pred HHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCC-----HHHHHH
Q 002857 399 VEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMK-----INDVEL 463 (873)
Q Consensus 399 l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPT-----m~EVl~ 463 (873)
...+++... .. . + ......+.+++..||+.||++||| +.|+++
T Consensus 213 ~~~~~~~~~-~~---------~---~---------~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 213 VERLVKEVQ-EE---------Y---S---------EKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred HHhhhhhhh-hh---------c---C---------ccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 011100000 00 0 0 001224678999999999999999 788775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=308.29 Aligned_cols=258 Identities=26% Similarity=0.406 Sum_probs=193.2
Q ss_pred eeecccCceEEEEEEEcCCCc--EEEEEEeeccC-CcchhHHHHHHHHHHhh-hhccceeeeeeeecccccCCceEEEEE
Q 002857 166 NLIGAGNFASVYKGILFEGAP--AVAIKVFNFLH-HDASKSFTVECEVMRNI-IHRKIIKVVTACSRVDYQGNDFKALVY 241 (873)
Q Consensus 166 ~~LG~G~fG~VYkg~~~~~g~--~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L-~HpNIV~llg~c~~~~~~~~~~~~LV~ 241 (873)
+.||+|+||.||+|++..++. .+|+|.++... ....+.+.+|++++.++ +||||+++++++. .....++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~-----~~~~~~lv~ 75 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE-----HRGYLYLAI 75 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEe-----cCCCceEEE
Confidence 368999999999999877765 46888876432 33446788999999999 8999999999963 455689999
Q ss_pred eecCCCChhhhccccccccc------ccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeE
Q 002857 242 EFMPNGSLEEWIHPITEEDK------RHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTAC 315 (873)
Q Consensus 242 Ey~~~GSL~~~L~~~~~~~~------~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vK 315 (873)
||+++|+|.+++........ .......+++.+++.++.|++.||+||| +.+++||||||+|||+++++.+|
T Consensus 76 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~k 152 (270)
T cd05047 76 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAK 152 (270)
T ss_pred EeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEE
Confidence 99999999999854110000 0012245889999999999999999999 89999999999999999999999
Q ss_pred EeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHHHhhc
Q 002857 316 VADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQSA 394 (873)
Q Consensus 316 LsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~~~~~ 394 (873)
|+|||+++..... ........+..|+|||++....++.++||||||+++|||++ |..||....... ..
T Consensus 153 l~dfgl~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~--~~------ 221 (270)
T cd05047 153 IADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--LY------ 221 (270)
T ss_pred ECCCCCccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH--HH------
Confidence 9999998632211 11111224567999999988889999999999999999997 999986421110 00
Q ss_pred CchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHHH
Q 002857 395 LPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLIK 469 (873)
Q Consensus 395 ~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i~ 469 (873)
..+ ...... ..+. .+...+.+++.+||+.+|.+|||+.+|+..|+.+.
T Consensus 222 -----~~~-~~~~~~------------~~~~---------~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 222 -----EKL-PQGYRL------------EKPL---------NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred -----HHH-hCCCCC------------CCCC---------cCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 000 000000 0000 11234789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=310.22 Aligned_cols=266 Identities=23% Similarity=0.293 Sum_probs=204.6
Q ss_pred cCHHHHHHhhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhh-hhccceeeeeeeec
Q 002857 150 VSYEALYSATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNI-IHRKIIKVVTACSR 228 (873)
Q Consensus 150 ~s~~el~~at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~llg~c~~ 228 (873)
.++.++..+...|++.+.||.|+||.||+|.+..+++.||+|++.... .....+..|+.+++++ +|+||+++++++..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 456677778889999999999999999999998899999999986443 2345788899999999 79999999998743
Q ss_pred ccc-cCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCee
Q 002857 229 VDY-QGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNIL 307 (873)
Q Consensus 229 ~~~-~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNIL 307 (873)
... ......++||||+++|+|.+++.. .....+++..++.++.||+.||+||| +.+|+|+||+|+||+
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nil 153 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKN--------TKGNALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVL 153 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHH--------ccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEE
Confidence 211 234678999999999999999853 22345788889999999999999999 899999999999999
Q ss_pred eCCCCCeEEeccccccccccccccccccccccccccCCCcccC-----CCCCCcchhhHhHHHHHHHHHhCCCCCCcccc
Q 002857 308 LNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGM-----GHETSSYGDVYSFGILLLEMFTGLRPSDDMFK 382 (873)
Q Consensus 308 Ld~~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~-----~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~ 382 (873)
+++++.++|+|||++........ ......++..|+|||.+. +..++.++||||||+++|||++|+.||.....
T Consensus 154 i~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~ 231 (282)
T cd06636 154 LTENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHP 231 (282)
T ss_pred ECCCCCEEEeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCH
Confidence 99999999999999875532211 122345889999999875 34678899999999999999999999865211
Q ss_pred cchhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHH
Q 002857 383 DNLNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVE 462 (873)
Q Consensus 383 ~~~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl 462 (873)
... ...+... .+.... .......+.+++.+||+.||.+|||+.||+
T Consensus 232 ~~~-------------~~~~~~~-----------------~~~~~~----~~~~~~~~~~li~~cl~~~p~~Rp~~~ell 277 (282)
T cd06636 232 MRA-------------LFLIPRN-----------------PPPKLK----SKKWSKKFIDFIEGCLVKNYLSRPSTEQLL 277 (282)
T ss_pred Hhh-------------hhhHhhC-----------------CCCCCc----ccccCHHHHHHHHHHhCCChhhCcCHHHHh
Confidence 100 0000000 000000 001233588999999999999999999986
Q ss_pred H
Q 002857 463 L 463 (873)
Q Consensus 463 ~ 463 (873)
+
T Consensus 278 ~ 278 (282)
T cd06636 278 K 278 (282)
T ss_pred c
Confidence 4
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=320.89 Aligned_cols=199 Identities=25% Similarity=0.321 Sum_probs=168.8
Q ss_pred CCCcceeecccCceEEEEEEEcCCCcEEEEEEeecc---CCcchhHHHHHHHHHHhhh-hccceeeeeeeecccccCCce
Q 002857 161 GFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFL---HHDASKSFTVECEVMRNII-HRKIIKVVTACSRVDYQGNDF 236 (873)
Q Consensus 161 ~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~L~-HpNIV~llg~c~~~~~~~~~~ 236 (873)
+|+..+.||+|+||.||+|....+++.||+|+++.. .....+.+..|+.++..+. |++|+++++++ ...+.
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~ 75 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCF-----QTVDR 75 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEE-----ecCCE
Confidence 477889999999999999999889999999998743 2233456788999998886 56777788774 45667
Q ss_pred EEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEE
Q 002857 237 KALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACV 316 (873)
Q Consensus 237 ~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKL 316 (873)
.++||||+++|+|.+++. ....+++.+++.|+.||+.||+||| +.+|+||||||+|||++.++.+||
T Consensus 76 ~~lv~Ey~~~g~L~~~i~----------~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL 142 (323)
T cd05615 76 LYFVMEYVNGGDLMYHIQ----------QVGKFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKI 142 (323)
T ss_pred EEEEEcCCCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEE
Confidence 999999999999999884 2356899999999999999999999 899999999999999999999999
Q ss_pred eccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCc
Q 002857 317 ADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDD 379 (873)
Q Consensus 317 sDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~ 379 (873)
+|||+++...... .......||..|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 143 ~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~ 203 (323)
T cd05615 143 ADFGMCKEHMVDG--VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDG 203 (323)
T ss_pred eccccccccCCCC--ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCC
Confidence 9999987542221 112234589999999999998999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=319.72 Aligned_cols=268 Identities=22% Similarity=0.345 Sum_probs=201.7
Q ss_pred cCCCcceeecccCceEEEEEEEcCC-------CcEEEEEEeeccC-CcchhHHHHHHHHHHhh-hhccceeeeeeeeccc
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEG-------APAVAIKVFNFLH-HDASKSFTVECEVMRNI-IHRKIIKVVTACSRVD 230 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~-------g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L-~HpNIV~llg~c~~~~ 230 (873)
.+|.+.+.||+|+||.||+|.+... ...||+|+++... ....+.+.+|+++++++ +|+||++++++|.
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~--- 88 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT--- 88 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc---
Confidence 4688899999999999999986432 2368999887432 22346789999999999 8999999999963
Q ss_pred ccCCceEEEEEeecCCCChhhhcccccccc------cccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCC
Q 002857 231 YQGNDFKALVYEFMPNGSLEEWIHPITEED------KRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPS 304 (873)
Q Consensus 231 ~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~------~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKps 304 (873)
.....++||||+++|+|.++|....... ........+++.+++.++.||+.||+||| +.+|+||||||+
T Consensus 89 --~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~ 163 (334)
T cd05100 89 --QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAAR 163 (334)
T ss_pred --cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccc
Confidence 4557899999999999999985311100 00112345888999999999999999999 899999999999
Q ss_pred CeeeCCCCCeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCccccc
Q 002857 305 NILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKD 383 (873)
Q Consensus 305 NILLd~~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~ 383 (873)
|||++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||.....+
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 243 (334)
T cd05100 164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE 243 (334)
T ss_pred eEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 99999999999999999986543222212222334568999999999999999999999999999998 88888642111
Q ss_pred chhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 384 NLNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 384 ~~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
.+. ..+...... ..+ ..+...+.+++.+||+.+|++|||+.||++
T Consensus 244 -----~~~---------~~~~~~~~~------------~~~---------~~~~~~l~~li~~cl~~~p~~Rps~~ell~ 288 (334)
T cd05100 244 -----ELF---------KLLKEGHRM------------DKP---------ANCTHELYMIMRECWHAVPSQRPTFKQLVE 288 (334)
T ss_pred -----HHH---------HHHHcCCCC------------CCC---------CCCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 100 000000000 000 011235789999999999999999999999
Q ss_pred HHHHHHH
Q 002857 464 GLRLIKK 470 (873)
Q Consensus 464 ~Le~i~~ 470 (873)
.|+.+..
T Consensus 289 ~l~~~~~ 295 (334)
T cd05100 289 DLDRVLT 295 (334)
T ss_pred HHHHHhh
Confidence 9998864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=313.10 Aligned_cols=250 Identities=21% Similarity=0.289 Sum_probs=200.2
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEE
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKAL 239 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~L 239 (873)
.+|+..+.||.|+||.||+|....+++.||+|.+........+.+.+|+++++.++|+||+++++++ ......++
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~~l 93 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSF-----LVGDELFV 93 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeE-----ecCceEEE
Confidence 4689999999999999999999889999999999765555567889999999999999999999986 44667999
Q ss_pred EEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEecc
Q 002857 240 VYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADF 319 (873)
Q Consensus 240 V~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDF 319 (873)
||||+++++|.+++.. ..+++.+++.++.|++.||+||| +.+++|+||||+||+++.++.+||+||
T Consensus 94 v~e~~~~~~L~~~~~~-----------~~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~df 159 (296)
T cd06655 94 VMEYLAGGSLTDVVTE-----------TCMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDF 159 (296)
T ss_pred EEEecCCCcHHHHHHh-----------cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccC
Confidence 9999999999998832 34889999999999999999999 899999999999999999999999999
Q ss_pred ccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCchhH
Q 002857 320 GIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPERV 399 (873)
Q Consensus 320 Gla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~~l 399 (873)
|++......... .....++..|+|||.+.+..++.++|||||||++|+|++|+.||........ . ..+.....
T Consensus 160 g~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~-~-~~~~~~~~--- 232 (296)
T cd06655 160 GFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-L-YLIATNGT--- 232 (296)
T ss_pred ccchhccccccc--CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-H-HHHHhcCC---
Confidence 998865433221 1234588899999999988899999999999999999999999965321110 0 00000000
Q ss_pred HHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 400 EEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 400 ~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
+.+ ..+ ......+.+++.+||+.+|++|||+.+|+.
T Consensus 233 -----~~~--------------~~~---------~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 233 -----PEL--------------QNP---------EKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred -----ccc--------------CCc---------ccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 000 000 011234778999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=310.39 Aligned_cols=250 Identities=23% Similarity=0.290 Sum_probs=194.8
Q ss_pred CCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEEEE
Q 002857 162 FSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKALVY 241 (873)
Q Consensus 162 f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~LV~ 241 (873)
|++.+.||+|+||.||+|.+..++..+|+|.+........+.+.+|+++++.++|+||+++++++ ..+...++||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~-----~~~~~~~~v~ 81 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF-----YYENNLWILI 81 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEE-----eeCCEEEEEE
Confidence 56678999999999999999888999999998755545567789999999999999999999986 3456789999
Q ss_pred eecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEecccc
Q 002857 242 EFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGI 321 (873)
Q Consensus 242 Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDFGl 321 (873)
||+++++|..++.. ....+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 82 e~~~~~~l~~~~~~---------~~~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~ 149 (282)
T cd06643 82 EFCAGGAVDAVMLE---------LERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGV 149 (282)
T ss_pred EecCCCcHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEccccc
Confidence 99999999988742 2346899999999999999999999 89999999999999999999999999999
Q ss_pred ccccccccccccccccccccccCCCcccC-----CCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCc
Q 002857 322 ARFLEATNEQTSSIGVKGTTGYIAPEYGM-----GHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALP 396 (873)
Q Consensus 322 a~~~~~~~~~~~~~~~~Gt~~Y~APE~l~-----~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~ 396 (873)
+....... .......++..|+|||++. +..++.++|||||||++|||++|+.||........ .
T Consensus 150 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-~--------- 217 (282)
T cd06643 150 SAKNTRTI--QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV-L--------- 217 (282)
T ss_pred cccccccc--cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH-H---------
Confidence 87543221 1122345889999999874 34578899999999999999999999865221110 0
Q ss_pred hhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 397 ERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 397 ~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
..+.. ... +..... ......+.+++.+||+.+|.+||++.+|++
T Consensus 218 ---~~~~~----~~~------------~~~~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 218 ---LKIAK----SEP------------PTLAQP----SRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred ---HHHhh----cCC------------CCCCCc----cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000 000 000000 001234778999999999999999998753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=305.00 Aligned_cols=250 Identities=24% Similarity=0.357 Sum_probs=195.7
Q ss_pred CCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcc---------hhHHHHHHHHHHhhhhccceeeeeeeecccc
Q 002857 161 GFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDA---------SKSFTVECEVMRNIIHRKIIKVVTACSRVDY 231 (873)
Q Consensus 161 ~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~---------~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~ 231 (873)
+|.+...||+|++|.||+|....+++.||+|.+....... .+.+.+|+.++++++|+||+++++++
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~----- 75 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSS----- 75 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEE-----
Confidence 4677889999999999999988888999999886433221 24688899999999999999999985
Q ss_pred cCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCC
Q 002857 232 QGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDE 311 (873)
Q Consensus 232 ~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~ 311 (873)
......++||||+++++|.+++.. ...+++..+..++.|++.||+||| +.+++||||+|+||+++++
T Consensus 76 ~~~~~~~lv~e~~~~~~L~~~l~~----------~~~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~ 142 (267)
T cd06628 76 LDADHLNIFLEYVPGGSVAALLNN----------YGAFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNK 142 (267)
T ss_pred EeCCccEEEEEecCCCCHHHHHHh----------ccCccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCC
Confidence 345678999999999999999842 345788899999999999999999 8999999999999999999
Q ss_pred CCeEEeccccccccccccccc----cccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhh
Q 002857 312 MTACVADFGIARFLEATNEQT----SSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNL 387 (873)
Q Consensus 312 ~~vKLsDFGla~~~~~~~~~~----~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l 387 (873)
+.+||+|||+++......... ......++..|+|||++.+..++.++||||||+++|+|++|+.||.......
T Consensus 143 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--- 219 (267)
T cd06628 143 GGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ--- 219 (267)
T ss_pred CCEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH---
Confidence 999999999998664321111 1112347889999999998889999999999999999999999997521100
Q ss_pred HHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 388 QNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 388 ~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
....+..... +... ......+.+++.+||+.+|++||++.||++
T Consensus 220 ----------~~~~~~~~~~----------------~~~~------~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 220 ----------AIFKIGENAS----------------PEIP------SNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ----------HHHHHhccCC----------------CcCC------cccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 0000000000 0000 011234778999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=307.40 Aligned_cols=240 Identities=25% Similarity=0.351 Sum_probs=184.8
Q ss_pred eeecccCceEEEEEEEcCC------------CcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccC
Q 002857 166 NLIGAGNFASVYKGILFEG------------APAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQG 233 (873)
Q Consensus 166 ~~LG~G~fG~VYkg~~~~~------------g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~ 233 (873)
+.||+|+||.||+|++... ...||+|++..........+.+|+.+++.++||||+++++++. .
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~-----~ 75 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCV-----R 75 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEe-----c
Confidence 3689999999999986422 2358999987655555567899999999999999999999963 3
Q ss_pred CceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCC
Q 002857 234 NDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMT 313 (873)
Q Consensus 234 ~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~ 313 (873)
+...++||||+++|+|..+++. ....+++..++.|+.||+.||+||| +.+|+||||||+|||++.++.
T Consensus 76 ~~~~~lv~e~~~~~~l~~~~~~---------~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~ 143 (262)
T cd05077 76 DVENIMVEEFVEFGPLDLFMHR---------KSDVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGI 143 (262)
T ss_pred CCCCEEEEecccCCCHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCc
Confidence 4567999999999999988842 2345899999999999999999999 899999999999999987654
Q ss_pred -------eEEeccccccccccccccccccccccccccCCCcccC-CCCCCcchhhHhHHHHHHHHH-hCCCCCCcccccc
Q 002857 314 -------ACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGM-GHETSSYGDVYSFGILLLEMF-TGLRPSDDMFKDN 384 (873)
Q Consensus 314 -------vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~-~~~~s~ksDVwSfGvvL~ELl-TGk~Pf~~~~~~~ 384 (873)
++++|||++...... ....++..|+|||++. +..++.++|||||||++|||+ +|..||.......
T Consensus 144 ~~~~~~~~~l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~ 217 (262)
T cd05077 144 DGECGPFIKLSDPGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE 217 (262)
T ss_pred cCCCCceeEeCCCCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH
Confidence 899999998754321 1234788999999886 467899999999999999998 5888875421100
Q ss_pred hhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHH
Q 002857 385 LNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELG 464 (873)
Q Consensus 385 ~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~ 464 (873)
...+....... ..+ ....+.+|+.+||+.||.+||++.+|++.
T Consensus 218 --------------~~~~~~~~~~~------------~~~-----------~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 218 --------------KERFYEGQCML------------VTP-----------SCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred --------------HHHHHhcCccC------------CCC-----------ChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 00000000000 000 02347789999999999999999999887
Q ss_pred H
Q 002857 465 L 465 (873)
Q Consensus 465 L 465 (873)
|
T Consensus 261 ~ 261 (262)
T cd05077 261 I 261 (262)
T ss_pred c
Confidence 6
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=323.87 Aligned_cols=241 Identities=24% Similarity=0.289 Sum_probs=186.8
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEeecc---CCcchhHHHHHHH-HHHhhhhccceeeeeeeecccccCCceEEEEE
Q 002857 166 NLIGAGNFASVYKGILFEGAPAVAIKVFNFL---HHDASKSFTVECE-VMRNIIHRKIIKVVTACSRVDYQGNDFKALVY 241 (873)
Q Consensus 166 ~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~---~~~~~~~f~~Ei~-iL~~L~HpNIV~llg~c~~~~~~~~~~~~LV~ 241 (873)
+.||+|+||.||+|+...+++.||+|++... .......+..|.. +++.++||||+++++++ ...+..++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~-----~~~~~~~lv~ 75 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSF-----QTTEKLYFVL 75 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEE-----ecCCEEEEEE
Confidence 4699999999999999889999999998643 1223345556655 46778999999999885 4567899999
Q ss_pred eecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEecccc
Q 002857 242 EFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGI 321 (873)
Q Consensus 242 Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDFGl 321 (873)
||+++|+|..++. ....+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 76 e~~~~~~L~~~l~----------~~~~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~ 142 (325)
T cd05604 76 DFVNGGELFFHLQ----------RERSFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGL 142 (325)
T ss_pred cCCCCCCHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCC
Confidence 9999999998883 2456889999999999999999999 89999999999999999999999999999
Q ss_pred ccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCchhHHH
Q 002857 322 ARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPERVEE 401 (873)
Q Consensus 322 a~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~~l~e 401 (873)
++...... .......||..|+|||++.+..++.++|||||||++|||++|+.||...... +
T Consensus 143 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~-----------------~ 203 (325)
T cd05604 143 CKEGIAQS--DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA-----------------E 203 (325)
T ss_pred cccCCCCC--CCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH-----------------H
Confidence 87532211 1223456899999999999999999999999999999999999999652111 1
Q ss_pred HhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHH
Q 002857 402 IVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVE 462 (873)
Q Consensus 402 lid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl 462 (873)
+.+..+.... ...+. ....+.+++.+|++.+|.+||++.+.+
T Consensus 204 ~~~~~~~~~~---------~~~~~----------~~~~~~~ll~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 204 MYDNILHKPL---------VLRPG----------ASLTAWSILEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred HHHHHHcCCc---------cCCCC----------CCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence 1111111100 00010 012467899999999999999986443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=308.07 Aligned_cols=255 Identities=26% Similarity=0.398 Sum_probs=193.8
Q ss_pred eeecccCceEEEEEEEcCCC------cEEEEEEeeccC-CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEE
Q 002857 166 NLIGAGNFASVYKGILFEGA------PAVAIKVFNFLH-HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKA 238 (873)
Q Consensus 166 ~~LG~G~fG~VYkg~~~~~g------~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~ 238 (873)
+.||+|+||.||+|++.... ..+|||.+.... ......+.+|+.++++++|+||+++++++ ......+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 75 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVC-----LLNEPQY 75 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeee-----cCCCCeE
Confidence 46999999999999875433 689999876432 23456789999999999999999999986 3455689
Q ss_pred EEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCC-----C
Q 002857 239 LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEM-----T 313 (873)
Q Consensus 239 LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~-----~ 313 (873)
+||||+++++|.+++..... .......+++.+++.++.||+.||+||| +.+++|+||||+||+++.+. .
T Consensus 76 ~v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~ 149 (269)
T cd05044 76 IIMELMEGGDLLSYLRDARV---ERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRV 149 (269)
T ss_pred EEEeccCCCcHHHHHHHhhh---cccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcc
Confidence 99999999999999954111 0113345889999999999999999999 89999999999999999877 8
Q ss_pred eEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHHHh
Q 002857 314 ACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQ 392 (873)
Q Consensus 314 vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~~~ 392 (873)
++|+|||+++...............++..|+|||++.+..++.++||||||+++|||+| |+.||..... ......+
T Consensus 150 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~--~~~~~~~- 226 (269)
T cd05044 150 VKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN--QEVLQHV- 226 (269)
T ss_pred eEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH--HHHHHHH-
Confidence 99999999976533222111222345788999999999999999999999999999998 9999864211 1111100
Q ss_pred hcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHH
Q 002857 393 SALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLR 466 (873)
Q Consensus 393 ~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le 466 (873)
.... . . ..+ ......+.+++.+||+.+|++||++.+|++.|+
T Consensus 227 -----------~~~~--~---------~-~~~---------~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 227 -----------TAGG--R---------L-QKP---------ENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred -----------hcCC--c---------c-CCc---------ccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 0000 0 0 000 011335788999999999999999999999886
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=322.93 Aligned_cols=193 Identities=24% Similarity=0.359 Sum_probs=164.3
Q ss_pred hhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceE
Q 002857 158 ATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFK 237 (873)
Q Consensus 158 at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~ 237 (873)
...+|.+.+.||+|+||.||+|++..+++.||+|+... .....|+.++++++|+||+++++++ ......
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~ 132 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK------GTTLIEAMLLQNVNHPSVIRMKDTL-----VSGAIT 132 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc------cccHHHHHHHHhCCCCCCcChhheE-----EeCCee
Confidence 44689999999999999999999988889999998532 2345699999999999999999986 345678
Q ss_pred EEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEe
Q 002857 238 ALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVA 317 (873)
Q Consensus 238 ~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLs 317 (873)
++||||+. ++|.+++.. ....+++..++.|+.||+.||.||| +.+|+||||||+|||++.++.+||+
T Consensus 133 ~lv~e~~~-~~l~~~l~~---------~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~ 199 (357)
T PHA03209 133 CMVLPHYS-SDLYTYLTK---------RSRPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIG 199 (357)
T ss_pred EEEEEccC-CcHHHHHHh---------ccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEe
Confidence 99999994 688888742 3456899999999999999999999 8999999999999999999999999
Q ss_pred ccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCC
Q 002857 318 DFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPS 377 (873)
Q Consensus 318 DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf 377 (873)
|||+++..... .......||..|+|||++.+..++.++|||||||++|||+++..++
T Consensus 200 DfG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 200 DLGAAQFPVVA---PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred cCccccccccC---cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 99999753221 1122356899999999999999999999999999999999865553
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=309.56 Aligned_cols=271 Identities=18% Similarity=0.247 Sum_probs=195.3
Q ss_pred CCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC--CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEE
Q 002857 161 GFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH--HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKA 238 (873)
Q Consensus 161 ~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~ 238 (873)
+|++.+.||+|+||.||+|++..+++.||+|+++... ......+.+|++++++++|+||+++++++ .+....+
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~-----~~~~~~~ 75 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVL-----HSDKKLT 75 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHh-----ccCCceE
Confidence 4788899999999999999999899999999986432 22235678899999999999999999984 4566789
Q ss_pred EEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEec
Q 002857 239 LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVAD 318 (873)
Q Consensus 239 LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsD 318 (873)
+|+||+. ++|.+++.. ....+++..++.++.||++||.||| +.+|+||||||+||+++.++.+||+|
T Consensus 76 lv~e~~~-~~l~~~~~~---------~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d 142 (284)
T cd07839 76 LVFEYCD-QDLKKYFDS---------CNGDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLAD 142 (284)
T ss_pred EEEecCC-CCHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECc
Confidence 9999996 588887742 2356899999999999999999999 89999999999999999999999999
Q ss_pred cccccccccccccccccccccccccCCCcccCCC-CCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCch
Q 002857 319 FGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGH-ETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPE 397 (873)
Q Consensus 319 FGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~ 397 (873)
||+++....... ......++..|+|||++.+. .++.++||||||+++|||+||..|+.........+..........
T Consensus 143 fg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~ 220 (284)
T cd07839 143 FGLARAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTP 220 (284)
T ss_pred cchhhccCCCCC--CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCC
Confidence 999986533221 11233578899999988765 478999999999999999999998644222111111110000000
Q ss_pred ---hH---HHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 398 ---RV---EEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 398 ---~l---~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
.. .++.+.. .....+......+........+.+++.+||+.||.+|||+.|++.
T Consensus 221 ~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 221 TEESWPGVSKLPDYK------------PYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred ChHHhHHhhhccccc------------ccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 00 0000000 000000000000111112345778999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=302.13 Aligned_cols=248 Identities=28% Similarity=0.410 Sum_probs=193.6
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEeeccCCc-chhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEEEEeec
Q 002857 166 NLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHD-ASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKALVYEFM 244 (873)
Q Consensus 166 ~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~LV~Ey~ 244 (873)
++||+|+||.||++.+.. ++.||+|+++..... ....+.+|++++++++|+||+++++++ ......++||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~~v~e~~ 74 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC-----VQKQPIYIVMELV 74 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEE-----ecCCCeEEEEEcC
Confidence 469999999999999866 899999998754433 446799999999999999999999986 4456789999999
Q ss_pred CCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEeccccccc
Q 002857 245 PNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARF 324 (873)
Q Consensus 245 ~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDFGla~~ 324 (873)
++++|.+++.. ....+++..++.++.+++.||+||| +.+++||||||+|||++.++.+||+|||+++.
T Consensus 75 ~~~~l~~~l~~---------~~~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~ 142 (251)
T cd05041 75 PGGSLLTFLRK---------KKNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRE 142 (251)
T ss_pred CCCcHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeecccccc
Confidence 99999999842 2335788899999999999999999 89999999999999999999999999999986
Q ss_pred cccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHHHhhcCchhHHHHh
Q 002857 325 LEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQSALPERVEEIV 403 (873)
Q Consensus 325 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~~~~~~~~~l~eli 403 (873)
...............+..|+|||++.+..++.++||||||+++|||+| |..||....... ..+.+
T Consensus 143 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~--------------~~~~~ 208 (251)
T cd05041 143 EEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ--------------TRERI 208 (251)
T ss_pred ccCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH--------------HHHHH
Confidence 542221111112234667999999988899999999999999999999 888886532110 01111
Q ss_pred hhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHH
Q 002857 404 DTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLR 466 (873)
Q Consensus 404 d~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le 466 (873)
...... ..+ ......+.+++.+||+.+|++|||+.||++.|+
T Consensus 209 ~~~~~~------------~~~---------~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 209 ESGYRM------------PAP---------QLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred hcCCCC------------CCC---------ccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 100000 000 011235888999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=328.60 Aligned_cols=252 Identities=19% Similarity=0.260 Sum_probs=207.9
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCc--chhHHHHHHHHHHhhhhccceeeeeeeecccccCCce-
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHD--ASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDF- 236 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~- 236 (873)
++|...+++|+|+||.++..+++.+++.+|+|.+...... ..+...+|+.++++++|||||.+.+.+ ..++.
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~-----~~~~~~ 78 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSF-----EEDGQL 78 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccch-----hcCCce
Confidence 5788899999999999999999999999999998754432 334688999999999999999999984 44555
Q ss_pred EEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEE
Q 002857 237 KALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACV 316 (873)
Q Consensus 237 ~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKL 316 (873)
.+|||+|++||+|.+.|.. .+...+++..+..++.|++.|+.||| +..|+|||||+.||+++.+..+||
T Consensus 79 l~Ivm~Y~eGg~l~~~i~~--------~k~~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkL 147 (426)
T KOG0589|consen 79 LCIVMEYCEGGDLAQLIKE--------QKGVLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKL 147 (426)
T ss_pred EEEEEeecCCCCHHHHHHH--------HhhccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceee
Confidence 9999999999999999964 33567899999999999999999999 899999999999999999999999
Q ss_pred eccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCc
Q 002857 317 ADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALP 396 (873)
Q Consensus 317 sDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~ 396 (873)
+|||+|+.+.... .....+.||+.|+.||++.+.+|..|+|||||||++|||++-+++|....
T Consensus 148 gDfGlaK~l~~~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~--------------- 210 (426)
T KOG0589|consen 148 GDFGLAKILNPED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASN--------------- 210 (426)
T ss_pred cchhhhhhcCCch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccc---------------
Confidence 9999999886544 23345789999999999999999999999999999999999999997631
Q ss_pred hhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHH
Q 002857 397 ERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELG 464 (873)
Q Consensus 397 ~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~ 464 (873)
+..++........ .|.... ...++..++..||+.+|..||++.+++.+
T Consensus 211 --m~~Li~ki~~~~~-----------~Plp~~-------ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 211 --MSELILKINRGLY-----------SPLPSM-------YSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred --hHHHHHHHhhccC-----------CCCCcc-------ccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 1122222111110 011111 12347789999999999999999999987
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=305.28 Aligned_cols=204 Identities=25% Similarity=0.395 Sum_probs=171.7
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCC-----cchhHHHHHHHHHHhhhhccceeeeeeeecccccCC
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH-----DASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGN 234 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~-----~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~ 234 (873)
.+|+..+.||+|+||.||+|....++..||+|++..... .....+.+|+.++++++|+||+++++++.. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~ 78 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRD---RAE 78 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEc---CCC
Confidence 478899999999999999999988899999999864321 223568889999999999999999998632 224
Q ss_pred ceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCe
Q 002857 235 DFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTA 314 (873)
Q Consensus 235 ~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~v 314 (873)
...+++|||+++++|.+++.. ...+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+
T Consensus 79 ~~~~l~~e~~~~~~L~~~l~~----------~~~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~ 145 (266)
T cd06651 79 KTLTIFMEYMPGGSVKDQLKA----------YGALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNV 145 (266)
T ss_pred CEEEEEEeCCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCE
Confidence 568899999999999999842 345788899999999999999999 8999999999999999999999
Q ss_pred EEeccccccccccccc-cccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCc
Q 002857 315 CVADFGIARFLEATNE-QTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDD 379 (873)
Q Consensus 315 KLsDFGla~~~~~~~~-~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~ 379 (873)
||+|||+++....... ........++..|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 146 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~ 211 (266)
T cd06651 146 KLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAE 211 (266)
T ss_pred EEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccc
Confidence 9999999976532211 1111224578899999999998899999999999999999999999965
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=307.20 Aligned_cols=249 Identities=26% Similarity=0.320 Sum_probs=199.2
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC-CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEE
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH-HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKA 238 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~ 238 (873)
++|+..+.||.|++|.||+|++..+++.||+|++.... ......+.+|+++++.++|+||+++++++ .++...+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 75 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSF-----LKGSKLW 75 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEE-----EECCeEE
Confidence 36888899999999999999998899999999987543 33446788999999999999999999985 3456799
Q ss_pred EEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEec
Q 002857 239 LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVAD 318 (873)
Q Consensus 239 LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsD 318 (873)
+|+||+++++|.+++.. ..+++..++.++.|++.||.||| +.+++|+||+|+||++++++.++|+|
T Consensus 76 ~v~e~~~~~~L~~~~~~-----------~~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d 141 (274)
T cd06609 76 IIMEYCGGGSCLDLLKP-----------GKLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLAD 141 (274)
T ss_pred EEEEeeCCCcHHHHHhh-----------cCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcc
Confidence 99999999999999842 26889999999999999999999 89999999999999999999999999
Q ss_pred cccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCchh
Q 002857 319 FGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPER 398 (873)
Q Consensus 319 FGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~~ 398 (873)
||+++....... ......++..|+|||++.+..++.++||||||+++|||+||+.||....... ..
T Consensus 142 ~g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~--~~---------- 207 (274)
T cd06609 142 FGVSGQLTSTMS--KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR--VL---------- 207 (274)
T ss_pred cccceeeccccc--ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH--HH----------
Confidence 999987654321 1223457889999999999889999999999999999999999996532110 00
Q ss_pred HHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 399 VEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 399 l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
..+..... +.... . .....+.+++.+||..+|++|||+++|+.
T Consensus 208 --~~~~~~~~---------------~~~~~-~----~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 208 --FLIPKNNP---------------PSLEG-N----KFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred --HHhhhcCC---------------CCCcc-c----ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 00000000 00000 0 01234778999999999999999999876
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=304.22 Aligned_cols=250 Identities=22% Similarity=0.262 Sum_probs=199.4
Q ss_pred CCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC--CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEE
Q 002857 161 GFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH--HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKA 238 (873)
Q Consensus 161 ~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~ 238 (873)
+|++.+.||+|+||.||++....+++.||+|.+.... ....+++.+|+.++++++|+||+++++++ ...+..+
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~ 75 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESF-----EENGNLY 75 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeee-----cCCCeEE
Confidence 4788999999999999999998899999999987432 23346789999999999999999999985 4567899
Q ss_pred EEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEec
Q 002857 239 LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVAD 318 (873)
Q Consensus 239 LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsD 318 (873)
+||||+++++|.+++.. .....+++.+++.++.|++.||.||| +.+++|+||+|+|||++.++.++|+|
T Consensus 76 lv~e~~~~~~l~~~~~~--------~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d 144 (256)
T cd08218 76 IVMDYCEGGDLYKKINA--------QRGVLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGD 144 (256)
T ss_pred EEEecCCCCcHHHHHHh--------ccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEee
Confidence 99999999999998853 22345788899999999999999999 89999999999999999999999999
Q ss_pred cccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCchh
Q 002857 319 FGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPER 398 (873)
Q Consensus 319 FGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~~ 398 (873)
||++........ ......++..|+|||++.+..++.++||||||+++++|++|+.||.....
T Consensus 145 ~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~---------------- 206 (256)
T cd08218 145 FGIARVLNSTVE--LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM---------------- 206 (256)
T ss_pred ccceeecCcchh--hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH----------------
Confidence 999986543221 11234578899999999988999999999999999999999999864211
Q ss_pred HHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 399 VEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 399 l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
.++++..+..... ..+ ......+.+++.+||+.+|++||++.||++
T Consensus 207 -~~~~~~~~~~~~~---------~~~---------~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 207 -KNLVLKIIRGSYP---------PVS---------SHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred -HHHHHHHhcCCCC---------CCc---------ccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 1111111111100 000 011235788999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=313.79 Aligned_cols=251 Identities=22% Similarity=0.255 Sum_probs=199.9
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEE
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKA 238 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~ 238 (873)
..+|++.+.||+|+||.||+|....+++.||+|.+........+.+.+|+.+++.++|+||+++++++ ..+...+
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~ 92 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY-----LVGDELW 92 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEE-----ecCCEEE
Confidence 36789999999999999999998888999999999765555567789999999999999999999986 4466789
Q ss_pred EEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEec
Q 002857 239 LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVAD 318 (873)
Q Consensus 239 LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsD 318 (873)
+||||+++++|.+++.. ..+++.++..++.|++.||.||| +.+|+||||||+|||++.++.++|+|
T Consensus 93 lv~e~~~~~~L~~~~~~-----------~~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~D 158 (297)
T cd06656 93 VVMEYLAGGSLTDVVTE-----------TCMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTD 158 (297)
T ss_pred EeecccCCCCHHHHHHh-----------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECc
Confidence 99999999999999842 34788899999999999999999 89999999999999999999999999
Q ss_pred cccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCchh
Q 002857 319 FGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPER 398 (873)
Q Consensus 319 FGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~~ 398 (873)
||++........ ......++..|+|||.+.+..++.++||||||+++|+|++|+.||............ .
T Consensus 159 fg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~-~------- 228 (297)
T cd06656 159 FGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-A------- 228 (297)
T ss_pred CccceEccCCcc--CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeee-c-------
Confidence 999876533221 112345788999999999888999999999999999999999999652111100000 0
Q ss_pred HHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 399 VEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 399 l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
.... +.... .......+.+++.+||+.+|++||++.+|+.
T Consensus 229 --------~~~~-------------~~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 229 --------TNGT-------------PELQN----PERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred --------cCCC-------------CCCCC----ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 00000 0011234678999999999999999999876
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=305.97 Aligned_cols=256 Identities=22% Similarity=0.344 Sum_probs=197.5
Q ss_pred CCCcceeecccCceEEEEEEEcC-CCcEEEEEEeeccC----------CcchhHHHHHHHHHHh-hhhccceeeeeeeec
Q 002857 161 GFSSENLIGAGNFASVYKGILFE-GAPAVAIKVFNFLH----------HDASKSFTVECEVMRN-IIHRKIIKVVTACSR 228 (873)
Q Consensus 161 ~f~~~~~LG~G~fG~VYkg~~~~-~g~~VAVK~l~~~~----------~~~~~~f~~Ei~iL~~-L~HpNIV~llg~c~~ 228 (873)
+|++.+.||+|+||.||+|.+.. +++.+|+|.+.... ......+..|+.++.+ ++|+||+++++++
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~-- 78 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTF-- 78 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeE--
Confidence 47888999999999999999877 67899999875321 1223457788888875 7999999999986
Q ss_pred ccccCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeee
Q 002857 229 VDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILL 308 (873)
Q Consensus 229 ~~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILL 308 (873)
..++..++||||+++++|.+++.... .....+++..++.++.|++.||.|||+ ..+|+|+||+|+||++
T Consensus 79 ---~~~~~~~lv~e~~~~~~l~~~l~~~~------~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~ 147 (269)
T cd08528 79 ---LENDRLYIVMDLIEGAPLGEHFNSLK------EKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIML 147 (269)
T ss_pred ---ccCCeEEEEEecCCCCcHHHHHHHHH------hccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEE
Confidence 45678999999999999999884311 224568889999999999999999993 2689999999999999
Q ss_pred CCCCCeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhH
Q 002857 309 NDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQ 388 (873)
Q Consensus 309 d~~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~ 388 (873)
+.++.+||+|||++....... ......++..|+|||++.+..++.++||||||+++|||++|+.||......
T Consensus 148 ~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~----- 219 (269)
T cd08528 148 GEDDKVTITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML----- 219 (269)
T ss_pred CCCCcEEEecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH-----
Confidence 999999999999998654332 223345889999999999888999999999999999999999998642110
Q ss_pred HHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHH
Q 002857 389 NWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLR 466 (873)
Q Consensus 389 ~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le 466 (873)
.. ...+.+.... +... ......+.+++.+||+.||++||++.||.++|+
T Consensus 220 ~~--------~~~~~~~~~~---------------~~~~------~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 220 SL--------ATKIVEAVYE---------------PLPE------GMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred HH--------HHHHhhccCC---------------cCCc------ccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 00 0011110000 0000 001234778999999999999999999999885
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=322.05 Aligned_cols=241 Identities=24% Similarity=0.285 Sum_probs=185.5
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEeeccC---CcchhHHHHHHH-HHHhhhhccceeeeeeeecccccCCceEEEEE
Q 002857 166 NLIGAGNFASVYKGILFEGAPAVAIKVFNFLH---HDASKSFTVECE-VMRNIIHRKIIKVVTACSRVDYQGNDFKALVY 241 (873)
Q Consensus 166 ~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~---~~~~~~f~~Ei~-iL~~L~HpNIV~llg~c~~~~~~~~~~~~LV~ 241 (873)
+.||+|+||.||+|++..+++.||+|++.... ......+..|.. +++.++|+||+++++++ ...+..++||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~-----~~~~~~~lv~ 75 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF-----QTADKLYFVL 75 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEE-----EcCCeEEEEE
Confidence 46999999999999998899999999986432 122234444444 56788999999999885 4567799999
Q ss_pred eecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEecccc
Q 002857 242 EFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGI 321 (873)
Q Consensus 242 Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDFGl 321 (873)
||+++|+|.+++.. ...+++.....++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 76 e~~~~~~L~~~~~~----------~~~~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~ 142 (325)
T cd05602 76 DYINGGELFYHLQR----------ERCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGL 142 (325)
T ss_pred eCCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCC
Confidence 99999999999842 345778888899999999999999 89999999999999999999999999999
Q ss_pred ccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCchhHHH
Q 002857 322 ARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPERVEE 401 (873)
Q Consensus 322 a~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~~l~e 401 (873)
++...... .......||..|+|||++.+..++.++|||||||++|||++|+.||....... . ...
T Consensus 143 a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~-----------~~~ 207 (325)
T cd05602 143 CKENIEHN--GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE--M-----------YDN 207 (325)
T ss_pred CcccccCC--CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH--H-----------HHH
Confidence 97542211 12233568999999999999999999999999999999999999996521110 0 011
Q ss_pred HhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHH
Q 002857 402 IVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVE 462 (873)
Q Consensus 402 lid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl 462 (873)
+....+. ..+ .....+.+++.+||+.+|.+||++.+.+
T Consensus 208 i~~~~~~-------------~~~----------~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 208 ILNKPLQ-------------LKP----------NITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred HHhCCcC-------------CCC----------CCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 1110000 000 0122467899999999999999987543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=310.76 Aligned_cols=205 Identities=22% Similarity=0.289 Sum_probs=162.4
Q ss_pred ceeecccCceEEEEEEEcC--CCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEEEEe
Q 002857 165 ENLIGAGNFASVYKGILFE--GAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKALVYE 242 (873)
Q Consensus 165 ~~~LG~G~fG~VYkg~~~~--~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~LV~E 242 (873)
..+||+|+||.||+|+... .+..||+|.+.... ....+.+|++++++++|+||+++++++.. ..+...++|||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~---~~~~~~~lv~e 80 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLS---HSDRKVWLLFD 80 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEec---cCCCeEEEEEe
Confidence 3689999999999998754 45789999986432 23567899999999999999999998743 34557899999
Q ss_pred ecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeee----CCCCCeEEec
Q 002857 243 FMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILL----NDEMTACVAD 318 (873)
Q Consensus 243 y~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILL----d~~~~vKLsD 318 (873)
|+.+ +|.+++...... ........+++..++.|+.||+.||.||| +.+|+||||||+|||+ +.++.+||+|
T Consensus 81 ~~~~-~l~~~~~~~~~~-~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~D 155 (317)
T cd07867 81 YAEH-DLWHIIKFHRAS-KANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIAD 155 (317)
T ss_pred eeCC-cHHHHHHhhhcc-ccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEee
Confidence 9864 788777421111 01122346888999999999999999999 8999999999999999 5667999999
Q ss_pred ccccccccccccc-ccccccccccccCCCcccCCC-CCCcchhhHhHHHHHHHHHhCCCCCCc
Q 002857 319 FGIARFLEATNEQ-TSSIGVKGTTGYIAPEYGMGH-ETSSYGDVYSFGILLLEMFTGLRPSDD 379 (873)
Q Consensus 319 FGla~~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELlTGk~Pf~~ 379 (873)
||+++........ .......+|..|+|||++.+. .++.++|||||||++|||+||+.||..
T Consensus 156 fG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 156 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred ccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 9999876433211 122234689999999998764 579999999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=310.00 Aligned_cols=252 Identities=24% Similarity=0.283 Sum_probs=197.0
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEE
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKAL 239 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~L 239 (873)
+.|++.++||+|+||.||+|++..+++.||+|++........+.+.+|+++++.++|+||+++++.+ ..+...++
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l 86 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF-----YWDGKLWI 86 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEE-----EeCCeEEE
Confidence 5688899999999999999999888999999999766555567889999999999999999999985 34567899
Q ss_pred EEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEecc
Q 002857 240 VYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADF 319 (873)
Q Consensus 240 V~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDF 319 (873)
||||+++++|..++.. ....+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+||+||
T Consensus 87 v~e~~~~~~l~~~~~~---------~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~df 154 (292)
T cd06644 87 MIEFCPGGAVDAIMLE---------LDRGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADF 154 (292)
T ss_pred EEecCCCCcHHHHHHh---------hcCCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccC
Confidence 9999999999988742 2345899999999999999999999 899999999999999999999999999
Q ss_pred ccccccccccccccccccccccccCCCcccC-----CCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhc
Q 002857 320 GIARFLEATNEQTSSIGVKGTTGYIAPEYGM-----GHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSA 394 (873)
Q Consensus 320 Gla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~-----~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~ 394 (873)
|++....... .......++..|+|||++. ...++.++|||||||++|||++|+.||....... ..
T Consensus 155 g~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-~~------- 224 (292)
T cd06644 155 GVSAKNVKTL--QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-VL------- 224 (292)
T ss_pred ccceeccccc--cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH-HH-------
Confidence 9987542221 1122345788999999885 3456889999999999999999999986521100 00
Q ss_pred CchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 395 LPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 395 ~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
..+... . .+.... .......+.+++.+||+.+|++||++.||++
T Consensus 225 -----~~~~~~----~------------~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 225 -----LKIAKS----E------------PPTLSQ----PSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred -----HHHhcC----C------------CccCCC----CcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000000 0 000000 0011224778999999999999999998865
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=303.67 Aligned_cols=239 Identities=26% Similarity=0.380 Sum_probs=187.0
Q ss_pred eeecccCceEEEEEEEcCCC----------cEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCc
Q 002857 166 NLIGAGNFASVYKGILFEGA----------PAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGND 235 (873)
Q Consensus 166 ~~LG~G~fG~VYkg~~~~~g----------~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~ 235 (873)
+.||+|+||.||+|.+...+ ..|++|++...... ...+.+|+.++++++|+||+++++++.. .
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~ 73 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR------D 73 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec------C
Confidence 46999999999999997665 35888887644333 5789999999999999999999998642 4
Q ss_pred eEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCC---
Q 002857 236 FKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEM--- 312 (873)
Q Consensus 236 ~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~--- 312 (873)
..++||||+++|+|.+++.. ....+++..++.++.||+.||+||| +.+|+||||||+|||++.++
T Consensus 74 ~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~ 141 (259)
T cd05037 74 ENIMVEEYVKFGPLDVFLHR---------EKNNVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNE 141 (259)
T ss_pred CcEEEEEcCCCCcHHHHHHh---------hccCCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCcccc
Confidence 56899999999999999853 2226889999999999999999999 89999999999999999887
Q ss_pred ----CeEEeccccccccccccccccccccccccccCCCcccCCC--CCCcchhhHhHHHHHHHHHh-CCCCCCcccccch
Q 002857 313 ----TACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGH--ETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNL 385 (873)
Q Consensus 313 ----~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~--~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~ 385 (873)
.+||+|||++..... .....++..|+|||++.+. .++.++||||||+++|||++ |..||.......
T Consensus 142 ~~~~~~kl~Dfg~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~- 214 (259)
T cd05037 142 GYVPFIKLSDPGIPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE- 214 (259)
T ss_pred CCceeEEeCCCCccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh-
Confidence 799999999986533 1123467789999998876 78999999999999999999 577765431110
Q ss_pred hhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHH
Q 002857 386 NLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGL 465 (873)
Q Consensus 386 ~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~L 465 (873)
...+.. .... ...+. ...+.+++.+||+.+|.+|||+.||++.|
T Consensus 215 -~~~~~~-----------~~~~-------------~~~~~-----------~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 215 -KERFYQ-----------DQHR-------------LPMPD-----------CAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred -HHHHHh-----------cCCC-------------CCCCC-----------chHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 000000 0000 00000 13478899999999999999999999877
Q ss_pred H
Q 002857 466 R 466 (873)
Q Consensus 466 e 466 (873)
+
T Consensus 259 ~ 259 (259)
T cd05037 259 N 259 (259)
T ss_pred C
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=321.37 Aligned_cols=194 Identities=25% Similarity=0.330 Sum_probs=162.7
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEeeccC---CcchhHHHHHHH-HHHhhhhccceeeeeeeecccccCCceEEEEE
Q 002857 166 NLIGAGNFASVYKGILFEGAPAVAIKVFNFLH---HDASKSFTVECE-VMRNIIHRKIIKVVTACSRVDYQGNDFKALVY 241 (873)
Q Consensus 166 ~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~---~~~~~~f~~Ei~-iL~~L~HpNIV~llg~c~~~~~~~~~~~~LV~ 241 (873)
++||+|+||.||+|++..+++.||+|++.... ......+..|.. +++.++|+||+++++++ ...+..++||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~-----~~~~~~~lv~ 75 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSF-----QTAEKLYFVL 75 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEE-----EcCCEEEEEE
Confidence 47999999999999998899999999986432 222344555554 57888999999999885 4566899999
Q ss_pred eecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEecccc
Q 002857 242 EFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGI 321 (873)
Q Consensus 242 Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDFGl 321 (873)
||+++|+|..++. ....+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 76 e~~~~~~L~~~l~----------~~~~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 142 (321)
T cd05603 76 DYVNGGELFFHLQ----------RERCFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGL 142 (321)
T ss_pred cCCCCCCHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCC
Confidence 9999999998873 2346788889999999999999999 89999999999999999999999999999
Q ss_pred ccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCc
Q 002857 322 ARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDD 379 (873)
Q Consensus 322 a~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~ 379 (873)
++...... .......||..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 143 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 198 (321)
T cd05603 143 CKEGVEPE--ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYS 198 (321)
T ss_pred CccCCCCC--CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCC
Confidence 87532211 122334689999999999998999999999999999999999999965
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=301.22 Aligned_cols=258 Identities=19% Similarity=0.242 Sum_probs=201.9
Q ss_pred CCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC--CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEE
Q 002857 161 GFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH--HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKA 238 (873)
Q Consensus 161 ~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~ 238 (873)
+|++.+.||.|+||.||++.+..++..||+|++.... ....+.+..|++++++++|+||+++++++.. ..+...+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~~~ 77 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIID---RSNQTLY 77 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeec---CCCCEEE
Confidence 4788899999999999999998899999999986432 2334578899999999999999999997642 3355689
Q ss_pred EEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCC--CCCeeeccCCCCCeeeCCCCCeEE
Q 002857 239 LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGC--KPPIAHCDIKPSNILLNDEMTACV 316 (873)
Q Consensus 239 LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~--s~gIvHrDLKpsNILLd~~~~vKL 316 (873)
++|||+++++|.+++... ......+++..++.++.||+.||.|||..+ +.+|+|+||+|+||+++.++.+||
T Consensus 78 ~~~e~~~~~~L~~~l~~~------~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl 151 (265)
T cd08217 78 IVMEYCEGGDLAQLIQKC------KKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKL 151 (265)
T ss_pred EEehhccCCCHHHHHHHH------hhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEE
Confidence 999999999999998531 123456899999999999999999999443 678999999999999999999999
Q ss_pred eccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCc
Q 002857 317 ADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALP 396 (873)
Q Consensus 317 sDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~ 396 (873)
+|||++......... .....++..|+|||++.+..++.++||||||+++|+|++|+.||...... .+...
T Consensus 152 ~d~g~~~~~~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~------ 221 (265)
T cd08217 152 GDFGLAKILGHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL--QLASK------ 221 (265)
T ss_pred ecccccccccCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH--HHHHH------
Confidence 999999876543221 22345889999999999988999999999999999999999998753211 11110
Q ss_pred hhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHH
Q 002857 397 ERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELG 464 (873)
Q Consensus 397 ~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~ 464 (873)
+..... +... ......+.+++.+||+.+|++||++.+|++.
T Consensus 222 ------~~~~~~---------------~~~~------~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 222 ------IKEGKF---------------RRIP------YRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ------HhcCCC---------------CCCc------cccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 000000 0000 0112357899999999999999999999763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=305.98 Aligned_cols=255 Identities=21% Similarity=0.348 Sum_probs=194.7
Q ss_pred CCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCC---c-------chhHHHHHHHHHHhhhhccceeeeeeeeccc
Q 002857 161 GFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH---D-------ASKSFTVECEVMRNIIHRKIIKVVTACSRVD 230 (873)
Q Consensus 161 ~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~---~-------~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~ 230 (873)
+|...+.||+|+||.||+|....+++.||+|.++.... . ..+.+..|+.++++++|+||+++++++
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~---- 77 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFE---- 77 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEe----
Confidence 46778999999999999999888899999998753211 1 124578899999999999999999986
Q ss_pred ccCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCC
Q 002857 231 YQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLND 310 (873)
Q Consensus 231 ~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~ 310 (873)
...+..++||||+++++|.+++.. ...+++..+..++.||+.||.||| +.+++||||+|+||+++.
T Consensus 78 -~~~~~~~lv~e~~~~~~L~~~l~~----------~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~ 143 (272)
T cd06629 78 -TTEEYLSIFLEYVPGGSIGSCLRT----------YGRFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDA 143 (272)
T ss_pred -ccCCceEEEEecCCCCcHHHHHhh----------ccCCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcC
Confidence 345678999999999999999843 256888899999999999999999 899999999999999999
Q ss_pred CCCeEEeccccccccccccccccccccccccccCCCcccCCCC--CCcchhhHhHHHHHHHHHhCCCCCCcccccchhhH
Q 002857 311 EMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHE--TSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQ 388 (873)
Q Consensus 311 ~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~--~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~ 388 (873)
++.++|+|||+++...............++..|+|||.+.... ++.++||||||+++|||++|..||...... .
T Consensus 144 ~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~----~ 219 (272)
T cd06629 144 DGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI----A 219 (272)
T ss_pred CCeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH----H
Confidence 9999999999997654322222223345889999999987654 789999999999999999999998542110 0
Q ss_pred HHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 389 NWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 389 ~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
. ..++........ .+.. ...+....+.+++.+||+.+|++|||+.+|++
T Consensus 220 ~---------~~~~~~~~~~~~------------~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 220 A---------MFKLGNKRSAPP------------IPPD-----VSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred H---------HHHhhccccCCc------------CCcc-----ccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 0 000000000000 0000 00112345788999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=309.70 Aligned_cols=241 Identities=23% Similarity=0.339 Sum_probs=185.2
Q ss_pred eeecccCceEEEEEEEcCCCc-------EEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEE
Q 002857 166 NLIGAGNFASVYKGILFEGAP-------AVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKA 238 (873)
Q Consensus 166 ~~LG~G~fG~VYkg~~~~~g~-------~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~ 238 (873)
+.||+|+||.||+|.....+. .||+|.+........+.+.+|+.+++.++|+||+++++++. .+...+
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~-----~~~~~~ 75 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCV-----CGDESI 75 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEE-----eCCCcE
Confidence 369999999999998755433 48889886555455578899999999999999999999963 345689
Q ss_pred EEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCC-----
Q 002857 239 LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMT----- 313 (873)
Q Consensus 239 LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~----- 313 (873)
+||||+++|+|.++++. ....+++..++.++.||+.||+||| +.+|+||||||+|||++.++.
T Consensus 76 lv~e~~~~g~L~~~l~~---------~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~ 143 (258)
T cd05078 76 MVQEYVKFGSLDTYLKK---------NKNLINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGN 143 (258)
T ss_pred EEEecCCCCcHHHHHhc---------CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCC
Confidence 99999999999999953 2336889999999999999999999 899999999999999987765
Q ss_pred ---eEEeccccccccccccccccccccccccccCCCcccCCC-CCCcchhhHhHHHHHHHHHhCC-CCCCcccccchhhH
Q 002857 314 ---ACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGH-ETSSYGDVYSFGILLLEMFTGL-RPSDDMFKDNLNLQ 388 (873)
Q Consensus 314 ---vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELlTGk-~Pf~~~~~~~~~l~ 388 (873)
++++|||++...... ....++..|+|||++.+. .++.++||||||+++|||++|. .||.......
T Consensus 144 ~~~~~l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~---- 213 (258)
T cd05078 144 PPFIKLSDPGISITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK---- 213 (258)
T ss_pred CceEEecccccccccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH----
Confidence 589999988654321 123578899999998874 5789999999999999999985 5543311100
Q ss_pred HHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHH
Q 002857 389 NWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLR 466 (873)
Q Consensus 389 ~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le 466 (873)
...+.... ...|.. ...++.+++.+||+.+|++|||+.+|++.|+
T Consensus 214 ----------~~~~~~~~--------------~~~~~~---------~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 214 ----------KLQFYEDR--------------HQLPAP---------KWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ----------HHHHHHcc--------------ccCCCC---------CcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00000000 000110 0124788999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=301.01 Aligned_cols=247 Identities=26% Similarity=0.415 Sum_probs=191.3
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEeeccCCc-chhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEEEEeec
Q 002857 166 NLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHD-ASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKALVYEFM 244 (873)
Q Consensus 166 ~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~LV~Ey~ 244 (873)
++||+|+||.||+|.. .++..||+|+++..... ....+.+|++++++++|+||+++++++. .....++||||+
T Consensus 1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~ 74 (250)
T cd05085 1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT-----QRQPIYIVMELV 74 (250)
T ss_pred CccCCCCCceEEEEEe-cCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEe-----cCCccEEEEECC
Confidence 3699999999999986 46789999998754322 2346889999999999999999999863 445689999999
Q ss_pred CCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEeccccccc
Q 002857 245 PNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARF 324 (873)
Q Consensus 245 ~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDFGla~~ 324 (873)
++++|.+++.. ....+++..++.++.|++.||.||| +.+++|+||||+||+++.++.+||+|||++..
T Consensus 75 ~~~~L~~~~~~---------~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~ 142 (250)
T cd05085 75 PGGDFLSFLRK---------KKDELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQ 142 (250)
T ss_pred CCCcHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCcccee
Confidence 99999998842 2345789999999999999999999 89999999999999999999999999999975
Q ss_pred cccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHHHhhcCchhHHHHh
Q 002857 325 LEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQSALPERVEEIV 403 (873)
Q Consensus 325 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~~~~~~~~~l~eli 403 (873)
...... .......++..|+|||++.+..++.++||||||+++|||++ |..||....... ... .+
T Consensus 143 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~--~~~------------~~ 207 (250)
T cd05085 143 EDDGIY-SSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ--ARE------------QV 207 (250)
T ss_pred cccccc-ccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH--HHH------------HH
Confidence 432211 11111234678999999998899999999999999999999 999986531111 000 00
Q ss_pred hhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHH
Q 002857 404 DTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLR 466 (873)
Q Consensus 404 d~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le 466 (873)
...... ..+. .+...+.+++.+||+.+|++||++.||++.|.
T Consensus 208 ~~~~~~------------~~~~---------~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 208 EKGYRM------------SCPQ---------KCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HcCCCC------------CCCC---------CCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 000000 0000 11235788999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=303.46 Aligned_cols=204 Identities=24% Similarity=0.379 Sum_probs=170.9
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC-----CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCC
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH-----HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGN 234 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~-----~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~ 234 (873)
++|++.+.||+|+||.||+|.+..+++.||||.+.... ....+.+.+|+.++++++|+||+++++++.. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~ 78 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRD---PME 78 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEecc---CCC
Confidence 57899999999999999999998889999999886321 1223578889999999999999999997532 223
Q ss_pred ceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCe
Q 002857 235 DFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTA 314 (873)
Q Consensus 235 ~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~v 314 (873)
...++||||+++++|.+++.. ...+++...+.++.|++.||+||| +.+|+|+||||+||+++.++.+
T Consensus 79 ~~~~~v~e~~~~~~L~~~l~~----------~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~ 145 (265)
T cd06652 79 RTLSIFMEHMPGGSIKDQLKS----------YGALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNV 145 (265)
T ss_pred ceEEEEEEecCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCE
Confidence 467899999999999999842 234788889999999999999999 8999999999999999999999
Q ss_pred EEeccccccccccccc-cccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCc
Q 002857 315 CVADFGIARFLEATNE-QTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDD 379 (873)
Q Consensus 315 KLsDFGla~~~~~~~~-~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~ 379 (873)
+|+|||+++....... ........++..|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 146 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~ 211 (265)
T cd06652 146 KLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAE 211 (265)
T ss_pred EECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCc
Confidence 9999999986532211 1112234588999999999888899999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=318.30 Aligned_cols=201 Identities=20% Similarity=0.228 Sum_probs=165.2
Q ss_pred cceeeccc--CceEEEEEEEcCCCcEEEEEEeeccCC--cchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEE
Q 002857 164 SENLIGAG--NFASVYKGILFEGAPAVAIKVFNFLHH--DASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKAL 239 (873)
Q Consensus 164 ~~~~LG~G--~fG~VYkg~~~~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~L 239 (873)
+.++||+| +|++||++....+++.||||+++.... ...+.+.+|+++++.++||||+++++++ ..++..++
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~-----~~~~~~~l 76 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATF-----IADNELWV 76 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEE-----EECCEEEE
Confidence 45789999 789999999999999999999875432 2335678899999999999999999996 34567899
Q ss_pred EEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEecc
Q 002857 240 VYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADF 319 (873)
Q Consensus 240 V~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDF 319 (873)
||||+++|+|.+++.. .....+++..++.++.||+.||+||| +.+|+||||||+|||++.++.++++||
T Consensus 77 v~e~~~~~~l~~~~~~--------~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~ 145 (327)
T cd08227 77 VTSFMAYGSAKDLICT--------HFMDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGL 145 (327)
T ss_pred EEeccCCCcHHHHHHh--------hccCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEccc
Confidence 9999999999999843 12345889999999999999999999 899999999999999999999999999
Q ss_pred cccccccccccc-----ccccccccccccCCCcccCC--CCCCcchhhHhHHHHHHHHHhCCCCCCcc
Q 002857 320 GIARFLEATNEQ-----TSSIGVKGTTGYIAPEYGMG--HETSSYGDVYSFGILLLEMFTGLRPSDDM 380 (873)
Q Consensus 320 Gla~~~~~~~~~-----~~~~~~~Gt~~Y~APE~l~~--~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~ 380 (873)
+........... .......++..|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 213 (327)
T cd08227 146 RSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 213 (327)
T ss_pred chhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 875433211110 01112346778999999876 46899999999999999999999999763
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=302.62 Aligned_cols=259 Identities=25% Similarity=0.313 Sum_probs=201.3
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC-CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEE
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH-HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKA 238 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~ 238 (873)
++|++.+.||.|+||.||+|....++..+|+|++.... ....+.+.+|+++++.++|+||+++++.+ ......+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~ 75 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF-----VVGDELW 75 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEE-----eeCCEEE
Confidence 47899999999999999999988889999999986433 23457899999999999999999999985 4466789
Q ss_pred EEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEec
Q 002857 239 LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVAD 318 (873)
Q Consensus 239 LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsD 318 (873)
+||||+++++|.+++... .....+++.....++.|++.||+||| +.+|+||||+|+||++++++.++|+|
T Consensus 76 iv~e~~~~~~l~~~~~~~-------~~~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~d 145 (267)
T cd06610 76 LVMPYLSGGSLLDIMKSS-------YPRGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIAD 145 (267)
T ss_pred EEEeccCCCcHHHHHHHh-------cccCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcc
Confidence 999999999999998530 11246889999999999999999999 89999999999999999999999999
Q ss_pred cccccccccccccc--cccccccccccCCCcccCCC-CCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcC
Q 002857 319 FGIARFLEATNEQT--SSIGVKGTTGYIAPEYGMGH-ETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSAL 395 (873)
Q Consensus 319 FGla~~~~~~~~~~--~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~ 395 (873)
||++..+....... ......++..|+|||++... .++.++||||||+++|||++|+.||....... .+.......
T Consensus 146 f~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~-~~~~~~~~~- 223 (267)
T cd06610 146 FGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK-VLMLTLQND- 223 (267)
T ss_pred cchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh-hHHHHhcCC-
Confidence 99998665433221 22334588999999998877 78999999999999999999999996532111 011110000
Q ss_pred chhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 396 PERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 396 ~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
...+.. . .........+.+++.+||+.||++||++.+|++
T Consensus 224 --------~~~~~~----------------~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 224 --------PPSLET----------------G----ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred --------CCCcCC----------------c----cccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 000000 0 000112335788999999999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=296.57 Aligned_cols=250 Identities=22% Similarity=0.317 Sum_probs=205.0
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeecc---CCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCc
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFL---HHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGND 235 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~ 235 (873)
.++|++.+.||+|.||.||.|+.+.++-.||+|++-+. ..+...++.+|++|-+.|+||||+++++++ .+..
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~f-----hd~~ 95 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYF-----HDSK 95 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhhe-----eccc
Confidence 35789999999999999999999999999999998532 233457899999999999999999999995 5667
Q ss_pred eEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeE
Q 002857 236 FKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTAC 315 (873)
Q Consensus 236 ~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vK 315 (873)
..||++||..+|+|...|.. .....+++.....++.|+|.||.|+| .++||||||||+|+|++.++..|
T Consensus 96 riyLilEya~~gel~k~L~~--------~~~~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lk 164 (281)
T KOG0580|consen 96 RIYLILEYAPRGELYKDLQE--------GRMKRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELK 164 (281)
T ss_pred eeEEEEEecCCchHHHHHHh--------cccccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCee
Confidence 89999999999999999954 45667889999999999999999999 99999999999999999999999
Q ss_pred EeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcC
Q 002857 316 VADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSAL 395 (873)
Q Consensus 316 LsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~ 395 (873)
|+|||-+..-+.. .-....||+.|.+||...+...+...|+|++|++.||++.|.+||+....+. .+
T Consensus 165 iAdfGwsV~~p~~----kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e-tY-------- 231 (281)
T KOG0580|consen 165 IADFGWSVHAPSN----KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE-TY-------- 231 (281)
T ss_pred ccCCCceeecCCC----CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHH-HH--------
Confidence 9999998754321 2223579999999999999999999999999999999999999998643111 11
Q ss_pred chhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHH
Q 002857 396 PERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELG 464 (873)
Q Consensus 396 ~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~ 464 (873)
..+....+. .| ........+++..|+..+|.+|.+..||+..
T Consensus 232 ----krI~k~~~~--------------~p---------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 232 ----KRIRKVDLK--------------FP---------STISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred ----HHHHHcccc--------------CC---------cccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 111110000 00 0012246789999999999999999998764
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=307.07 Aligned_cols=261 Identities=25% Similarity=0.267 Sum_probs=200.1
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCC-cchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEE
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH-DASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKA 238 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~ 238 (873)
++|...+.||.|++|.||++.+..+++.+|+|++..... .....+.+|++++++++|+||+++++++.. ......+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~~~ 77 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLD---ESSSSIG 77 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEc---cCCCeEE
Confidence 468889999999999999999988899999999874433 344678999999999999999999998743 2345689
Q ss_pred EEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEec
Q 002857 239 LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVAD 318 (873)
Q Consensus 239 LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsD 318 (873)
+||||+++++|.+++... ......+++..+..|+.||+.||+||| ..+++|+||+|+||+++.++.++|+|
T Consensus 78 lv~e~~~~~~L~~~l~~~------~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~d 148 (287)
T cd06621 78 IAMEYCEGGSLDSIYKKV------KKRGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCD 148 (287)
T ss_pred EEEEecCCCCHHHHHHHH------HhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEee
Confidence 999999999999987431 123456888899999999999999999 89999999999999999999999999
Q ss_pred cccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCccccc---chhhHHHHhhcC
Q 002857 319 FGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKD---NLNLQNWVQSAL 395 (873)
Q Consensus 319 FGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~---~~~l~~~~~~~~ 395 (873)
||++........ ....++..|+|||.+.+..++.++||||||+++|||++|+.||...... ...+..++....
T Consensus 149 fg~~~~~~~~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 224 (287)
T cd06621 149 FGVSGELVNSLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMP 224 (287)
T ss_pred cccccccccccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCC
Confidence 999875432211 1234788999999999889999999999999999999999999753211 011111110000
Q ss_pred chhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 396 PERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 396 ~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
. ..+... +. ... .....+.+++.+||+.+|++|||+.||++
T Consensus 225 ~--------~~~~~~-------------~~--~~~----~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 225 N--------PELKDE-------------PG--NGI----KWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred c--------hhhccC-------------CC--CCC----chHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 0 000000 00 000 01235789999999999999999999876
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=305.18 Aligned_cols=265 Identities=25% Similarity=0.409 Sum_probs=198.1
Q ss_pred CCcceeecccCceEEEEEEEcC---CCcEEEEEEeeccC--CcchhHHHHHHHHHHhhhhccceeeeeeeeccccc-CCc
Q 002857 162 FSSENLIGAGNFASVYKGILFE---GAPAVAIKVFNFLH--HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQ-GND 235 (873)
Q Consensus 162 f~~~~~LG~G~fG~VYkg~~~~---~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~-~~~ 235 (873)
|.+.+.||+|+||.||+|.+.. ++..||||++.... ....+.+.+|++++++++||||+++++++...... ...
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 5677899999999999998753 46789999986432 23346788999999999999999999986432111 112
Q ss_pred eEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeE
Q 002857 236 FKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTAC 315 (873)
Q Consensus 236 ~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vK 315 (873)
..++++||+.+|+|.+++.... .......+++...+.++.||+.||+||| +.+|+||||||+||+++.++.+|
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~----~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~k 153 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSR----IGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVC 153 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhc----ccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEE
Confidence 3578999999999998874211 1122345788899999999999999999 88999999999999999999999
Q ss_pred EeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHHHhhc
Q 002857 316 VADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQSA 394 (873)
Q Consensus 316 LsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~~~~~ 394 (873)
|+|||+++...............++..|++||.+....++.++||||||+++|||++ |+.||..... ..+..++..
T Consensus 154 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~--~~~~~~~~~- 230 (273)
T cd05074 154 VADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN--SEIYNYLIK- 230 (273)
T ss_pred ECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH--HHHHHHHHc-
Confidence 999999986543322222222345678999999988889999999999999999999 8888864211 111111100
Q ss_pred CchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHH
Q 002857 395 LPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLI 468 (873)
Q Consensus 395 ~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i 468 (873)
. . .....+ .....+.+++.+||+.+|++||++.||++.|+.+
T Consensus 231 ----------~----~--------~~~~~~----------~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 231 ----------G----N--------RLKQPP----------DCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred ----------C----C--------cCCCCC----------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 0 000000 0123588999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=319.71 Aligned_cols=194 Identities=25% Similarity=0.314 Sum_probs=167.0
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEeeccC---CcchhHHHHHHHHHHhh-hhccceeeeeeeecccccCCceEEEEE
Q 002857 166 NLIGAGNFASVYKGILFEGAPAVAIKVFNFLH---HDASKSFTVECEVMRNI-IHRKIIKVVTACSRVDYQGNDFKALVY 241 (873)
Q Consensus 166 ~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L-~HpNIV~llg~c~~~~~~~~~~~~LV~ 241 (873)
+.||+|+||.||+|....+++.||+|+++... ....+.+..|+.++.++ +|+||+++++++ ......++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~ 75 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCF-----QTTSRLFLVI 75 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEE-----EeCCEEEEEE
Confidence 47999999999999999999999999997432 22345688899999888 699999999985 4566799999
Q ss_pred eecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEecccc
Q 002857 242 EFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGI 321 (873)
Q Consensus 242 Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDFGl 321 (873)
||+++|+|.+++. ....+++..++.++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 76 e~~~~~~L~~~~~----------~~~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~ 142 (327)
T cd05617 76 EYVNGGDLMFHMQ----------RQRKLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGM 142 (327)
T ss_pred eCCCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEecccc
Confidence 9999999998884 2346899999999999999999999 89999999999999999999999999999
Q ss_pred ccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCc
Q 002857 322 ARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDD 379 (873)
Q Consensus 322 a~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~ 379 (873)
++...... .......||..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 143 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~ 198 (327)
T cd05617 143 CKEGLGPG--DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 198 (327)
T ss_pred ceeccCCC--CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCc
Confidence 87532211 122235689999999999999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=313.99 Aligned_cols=271 Identities=25% Similarity=0.407 Sum_probs=200.5
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhh--hhccceeeeeeeecccccCCce
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNI--IHRKIIKVVTACSRVDYQGNDF 236 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L--~HpNIV~llg~c~~~~~~~~~~ 236 (873)
.++..+.+.||+|.||.||+|.| .|+.||||+|.. .+.+.+.+|.+|++.+ +|+||+.+++.-... ...-.+
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~s---rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~-~gs~TQ 283 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSS---RDERSWFRETEIYQTVMLRHENILGFIAADNKD-NGSWTQ 283 (513)
T ss_pred hheeEEEEEecCccccceeeccc--cCCceEEEEecc---cchhhhhhHHHHHHHHHhccchhhhhhhccccC-CCceEE
Confidence 35667789999999999999999 567899999973 3346788899998864 999999999873211 122347
Q ss_pred EEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCC-----CCCeeeccCCCCCeeeCCC
Q 002857 237 KALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGC-----KPPIAHCDIKPSNILLNDE 311 (873)
Q Consensus 237 ~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~-----s~gIvHrDLKpsNILLd~~ 311 (873)
++||++|.+.|||.|||. ...++....++++..+|.||+|||.+. ++.|.|||||+.|||+..+
T Consensus 284 LwLvTdYHe~GSL~DyL~-----------r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn 352 (513)
T KOG2052|consen 284 LWLVTDYHEHGSLYDYLN-----------RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN 352 (513)
T ss_pred EEEeeecccCCcHHHHHh-----------hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccC
Confidence 899999999999999994 356888999999999999999999753 7889999999999999999
Q ss_pred CCeEEecccccccccccccc--ccccccccccccCCCcccCCC------CCCcchhhHhHHHHHHHHHhC----------
Q 002857 312 MTACVADFGIARFLEATNEQ--TSSIGVKGTTGYIAPEYGMGH------ETSSYGDVYSFGILLLEMFTG---------- 373 (873)
Q Consensus 312 ~~vKLsDFGla~~~~~~~~~--~~~~~~~Gt~~Y~APE~l~~~------~~s~ksDVwSfGvvL~ELlTG---------- 373 (873)
+.+.|+|+|+|......... ......+||.+|||||++... .....+||||||.|+||++-.
T Consensus 353 ~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey 432 (513)
T KOG2052|consen 353 GTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEY 432 (513)
T ss_pred CcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhh
Confidence 99999999999866554221 222335699999999997653 123458999999999999753
Q ss_pred CCCCCcccccchhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcC
Q 002857 374 LRPSDDMFKDNLNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPG 453 (873)
Q Consensus 374 k~Pf~~~~~~~~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~ 453 (873)
+.||.+....+. .+.++.+-.-... ..|..+. +....+++..+.+++..||..||.
T Consensus 433 ~~Pyyd~Vp~DP------------s~eeMrkVVCv~~-----------~RP~ipn-rW~s~~~l~~m~klMkeCW~~Np~ 488 (513)
T KOG2052|consen 433 QLPYYDVVPSDP------------SFEEMRKVVCVQK-----------LRPNIPN-RWKSDPALRVMAKLMKECWYANPA 488 (513)
T ss_pred cCCcccCCCCCC------------CHHHHhcceeecc-----------cCCCCCc-ccccCHHHHHHHHHHHHhhcCCch
Confidence 344444222221 2222222111111 0111111 111234577899999999999999
Q ss_pred CCCCHHHHHHHHHHHHH
Q 002857 454 ERMKINDVELGLRLIKK 470 (873)
Q Consensus 454 eRPTm~EVl~~Le~i~~ 470 (873)
-|-|+--|-+.|.++.+
T Consensus 489 aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 489 ARLTALRIKKTLAKLSN 505 (513)
T ss_pred hhhHHHHHHHHHHHHhc
Confidence 99999988888887643
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=305.95 Aligned_cols=254 Identities=24% Similarity=0.323 Sum_probs=199.7
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCC-cchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEE
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH-DASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKA 238 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~ 238 (873)
++|+..+.||+|+||.||++.+..+++.||+|++..... ...+.+.+|++++++++|+||+++++.+ ......+
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~ 75 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF-----YNNGDIS 75 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheee-----ecCCEEE
Confidence 367788999999999999999988899999999875432 3446789999999999999999999986 3457899
Q ss_pred EEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCC-CCeeeccCCCCCeeeCCCCCeEEe
Q 002857 239 LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCK-PPIAHCDIKPSNILLNDEMTACVA 317 (873)
Q Consensus 239 LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s-~gIvHrDLKpsNILLd~~~~vKLs 317 (873)
+|+||+++++|.+++.. ....+++..+..++.|++.||+||| + .+++|+||||+||++++++.++|+
T Consensus 76 lv~e~~~~~~L~~~~~~---------~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~ 143 (265)
T cd06605 76 ICMEYMDGGSLDKILKE---------VQGRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLC 143 (265)
T ss_pred EEEEecCCCcHHHHHHH---------ccCCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEe
Confidence 99999999999999853 1256888899999999999999999 7 899999999999999999999999
Q ss_pred ccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCch
Q 002857 318 DFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPE 397 (873)
Q Consensus 318 DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~ 397 (873)
|||.+......... ...++..|+|||++.+..++.++||||||+++|+|++|+.||.........
T Consensus 144 d~g~~~~~~~~~~~----~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~----------- 208 (265)
T cd06605 144 DFGVSGQLVNSLAK----TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG----------- 208 (265)
T ss_pred ecccchhhHHHHhh----cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccccc-----------
Confidence 99998765332211 155888999999999999999999999999999999999998653211111
Q ss_pred hHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 398 RVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 398 ~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
..+.+...+... .+... .. .....+.+++.+||..+|++|||+.+++.
T Consensus 209 -~~~~~~~~~~~~------------~~~~~--~~---~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 209 -IFELLQYIVNEP------------PPRLP--SG---KFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred -HHHHHHHHhcCC------------CCCCC--hh---hcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 111111111110 00000 00 02335788999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=309.07 Aligned_cols=254 Identities=22% Similarity=0.294 Sum_probs=199.0
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEE
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKA 238 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~ 238 (873)
.++|++.+.||.|+||.||+|.+..++..||+|+++.......+.+..|++++++++|+||+++++++ ..+...+
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 78 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAY-----FYENKLW 78 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEE-----ecCCeEE
Confidence 45788999999999999999999888999999999765555567899999999999999999999985 4466789
Q ss_pred EEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEec
Q 002857 239 LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVAD 318 (873)
Q Consensus 239 LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsD 318 (873)
+||||+++++|.+++.. ....+++..++.++.|++.||.||| +.+|+|+||||+||+++.++.++|+|
T Consensus 79 lv~e~~~~~~L~~~~~~---------~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d 146 (280)
T cd06611 79 ILIEFCDGGALDSIMLE---------LERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLAD 146 (280)
T ss_pred EEeeccCCCcHHHHHHH---------hcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEcc
Confidence 99999999999999842 2346899999999999999999999 89999999999999999999999999
Q ss_pred cccccccccccccccccccccccccCCCcccC-----CCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhh
Q 002857 319 FGIARFLEATNEQTSSIGVKGTTGYIAPEYGM-----GHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQS 393 (873)
Q Consensus 319 FGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~-----~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~ 393 (873)
||++........ ......++..|+|||++. +..++.++||||||+++|||++|+.||....... .+
T Consensus 147 ~g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~-~~------ 217 (280)
T cd06611 147 FGVSAKNKSTLQ--KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR-VL------ 217 (280)
T ss_pred Cccchhhccccc--ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH-HH------
Confidence 999875433221 122345889999999875 3457789999999999999999999986531110 00
Q ss_pred cCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHH
Q 002857 394 ALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELG 464 (873)
Q Consensus 394 ~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~ 464 (873)
..+.. .. .+.... .......+.+++..||+.+|.+||++.+|++.
T Consensus 218 ------~~~~~----~~------------~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 218 ------LKILK----SE------------PPTLDQ----PSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred ------HHHhc----CC------------CCCcCC----cccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 00000 00 000000 00012247789999999999999999998653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=301.12 Aligned_cols=248 Identities=24% Similarity=0.349 Sum_probs=195.7
Q ss_pred CCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC-----CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCc
Q 002857 161 GFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH-----HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGND 235 (873)
Q Consensus 161 ~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~-----~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~ 235 (873)
+|+..+.||+|+||.||+|....++..||+|.+.... ....+.+.+|++++++++|+||+++++++ ..+.
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~ 75 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTE-----REED 75 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeE-----ecCC
Confidence 4677899999999999999998789999999986433 22346789999999999999999999985 4456
Q ss_pred eEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeE
Q 002857 236 FKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTAC 315 (873)
Q Consensus 236 ~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vK 315 (873)
..++||||+++++|.+++.. ...+++..+..++.||+.||+||| +.+|+|+||+|+||+++.++.+|
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~----------~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~k 142 (258)
T cd06632 76 NLYIFLELVPGGSLAKLLKK----------YGSFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVK 142 (258)
T ss_pred eEEEEEEecCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEE
Confidence 78999999999999999842 345889999999999999999999 89999999999999999999999
Q ss_pred EeccccccccccccccccccccccccccCCCcccCCCC-CCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhc
Q 002857 316 VADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHE-TSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSA 394 (873)
Q Consensus 316 LsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~-~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~ 394 (873)
|+|||++....... ......++..|+|||.+.... ++.++||||||+++|+|++|+.||....... ..
T Consensus 143 l~d~~~~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~-~~------- 211 (258)
T cd06632 143 LADFGMAKQVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA-AV------- 211 (258)
T ss_pred EccCccceeccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH-HH-------
Confidence 99999988654322 122345888999999987766 8999999999999999999999986532100 00
Q ss_pred CchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 395 LPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 395 ~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
..+... . ..+... ......+.+++.+||+.+|++||++.+++.
T Consensus 212 -----~~~~~~---~------------~~~~~~------~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 212 -----FKIGRS---K------------ELPPIP------DHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred -----HHHHhc---c------------cCCCcC------CCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 000000 0 000000 001234778999999999999999999874
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=346.39 Aligned_cols=270 Identities=23% Similarity=0.321 Sum_probs=203.1
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCC---cchhHHHHHHHHHHhhhhccceeeeeeeecccccCCce
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH---DASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDF 236 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~ 236 (873)
++|++.++||+|+||.||+|++..+++.||||+++.... ...+.+.+|++++++++||||+++++++ ..++.
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~-----~d~~~ 76 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSIC-----SDGDP 76 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEE-----eeCCE
Confidence 578999999999999999999988899999999874322 2245789999999999999999999986 34567
Q ss_pred EEEEEeecCCCChhhhcccccccc-cccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeE
Q 002857 237 KALVYEFMPNGSLEEWIHPITEED-KRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTAC 315 (873)
Q Consensus 237 ~~LV~Ey~~~GSL~~~L~~~~~~~-~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vK 315 (873)
.++||||+++|+|.+++....... ........+++..++.|+.||++||+||| +.+|+||||||+|||++.++.+|
T Consensus 77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vK 153 (932)
T PRK13184 77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVV 153 (932)
T ss_pred EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEE
Confidence 899999999999999985321110 00112345677888999999999999999 89999999999999999999999
Q ss_pred Eeccccccccccccc----------------cccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCc
Q 002857 316 VADFGIARFLEATNE----------------QTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDD 379 (873)
Q Consensus 316 LsDFGla~~~~~~~~----------------~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~ 379 (873)
|+|||+++....... ........||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 154 LiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~ 233 (932)
T PRK13184 154 ILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRR 233 (932)
T ss_pred EEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 999999986521110 0011124589999999999999999999999999999999999999965
Q ss_pred ccccchhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCC-CH
Q 002857 380 MFKDNLNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERM-KI 458 (873)
Q Consensus 380 ~~~~~~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRP-Tm 458 (873)
......... . .+ ..+.. ..+. .+.+..+.+++.+|++.||++|| ++
T Consensus 234 ~~~~ki~~~------------~----~i-~~P~~--------~~p~--------~~iP~~L~~LI~rcL~~DP~kR~ss~ 280 (932)
T PRK13184 234 KKGRKISYR------------D----VI-LSPIE--------VAPY--------REIPPFLSQIAMKALAVDPAERYSSV 280 (932)
T ss_pred cchhhhhhh------------h----hc-cChhh--------cccc--------ccCCHHHHHHHHHHccCChhhCcCHH
Confidence 211110000 0 00 00000 0000 01233577899999999999996 56
Q ss_pred HHHHHHHHHHHH
Q 002857 459 NDVELGLRLIKK 470 (873)
Q Consensus 459 ~EVl~~Le~i~~ 470 (873)
.++++.|+....
T Consensus 281 eeLl~~Le~~lq 292 (932)
T PRK13184 281 QELKQDLEPHLQ 292 (932)
T ss_pred HHHHHHHHHHHh
Confidence 777777776543
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=315.61 Aligned_cols=283 Identities=20% Similarity=0.245 Sum_probs=203.9
Q ss_pred hhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC-CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCce
Q 002857 158 ATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH-HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDF 236 (873)
Q Consensus 158 at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~ 236 (873)
.+++|++.++||+|+||.||+|++..+++.||||+++... ......+.+|+.++++++|+||+++++++....+.....
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 3578999999999999999999998899999999986432 233456888999999999999999999876544445567
Q ss_pred EEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEE
Q 002857 237 KALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACV 316 (873)
Q Consensus 237 ~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKL 316 (873)
.++|+||+.+ +|.+++. ...+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||
T Consensus 83 ~~lv~e~~~~-~l~~~~~-----------~~~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl 147 (336)
T cd07849 83 VYIVQELMET-DLYKLIK-----------TQHLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKI 147 (336)
T ss_pred EEEEehhccc-CHHHHHh-----------cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEE
Confidence 8999999964 8887763 245889999999999999999999 899999999999999999999999
Q ss_pred eccccccccccccccc-cccccccccccCCCcccCC-CCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhc
Q 002857 317 ADFGIARFLEATNEQT-SSIGVKGTTGYIAPEYGMG-HETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSA 394 (873)
Q Consensus 317 sDFGla~~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~ 394 (873)
+|||+++......... ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||..... ......+...
T Consensus 148 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~--~~~~~~~~~~ 225 (336)
T cd07849 148 CDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY--LHQLNLILGV 225 (336)
T ss_pred CcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHH
Confidence 9999998654322111 1123458899999998655 4689999999999999999999999965221 1111111111
Q ss_pred Cc----hhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHH
Q 002857 395 LP----ERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELG 464 (873)
Q Consensus 395 ~~----~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~ 464 (873)
+. +.+..+.+...... .......+.. ............+.+++.+||+.+|++|||+.|+++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 226 LGTPSQEDLNCIISLRARNY------IKSLPFKPKV-PWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred cCCCCHHHHHHhhchhhhhH------HhhcCcCCcc-cHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11 12222221111000 0000000000 0000111123458899999999999999999998775
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=304.15 Aligned_cols=262 Identities=24% Similarity=0.299 Sum_probs=201.6
Q ss_pred HhhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhh-hhccceeeeeeeecccc-cCC
Q 002857 157 SATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNI-IHRKIIKVVTACSRVDY-QGN 234 (873)
Q Consensus 157 ~at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~llg~c~~~~~-~~~ 234 (873)
.++++|++.+.||+|++|.||+|.+..+++.+++|++..... ..+.+.+|+.+++++ +|+||+++++++..... ...
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 357899999999999999999999988889999999875433 346799999999999 79999999999754332 235
Q ss_pred ceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCe
Q 002857 235 DFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTA 314 (873)
Q Consensus 235 ~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~v 314 (873)
...++||||+++++|.+++... ......+++..+..++.|++.||.||| +.+++|+||+|+||++++++.+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~ 152 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGL------RKKGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEV 152 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHH------hhcCCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeE
Confidence 5689999999999999998531 112456889999999999999999999 8999999999999999999999
Q ss_pred EEeccccccccccccccccccccccccccCCCcccCC-----CCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHH
Q 002857 315 CVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMG-----HETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQN 389 (873)
Q Consensus 315 KLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-----~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~ 389 (873)
||+|||++........ ......++..|+|||++.. ..++.++||||||+++|+|++|+.||....... .+
T Consensus 153 ~l~d~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~-- 227 (275)
T cd06608 153 KLVDFGVSAQLDSTLG--RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR-AL-- 227 (275)
T ss_pred EECCCccceecccchh--hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH-HH--
Confidence 9999999876533221 1223458899999998754 346788999999999999999999996421110 00
Q ss_pred HHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 390 WVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 390 ~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
..+..... +.... .......+.+++.+||..||++|||+.||++
T Consensus 228 ----------~~~~~~~~----------------~~~~~----~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 228 ----------FKIPRNPP----------------PTLKS----PENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred ----------HHhhccCC----------------CCCCc----hhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 01100000 00000 0111335778999999999999999999875
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=300.67 Aligned_cols=251 Identities=27% Similarity=0.440 Sum_probs=195.6
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEE
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKAL 239 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~L 239 (873)
.+|++.+.||+|+||.||+|.+. .+..+|+|++..... ....+.+|++++++++|+||+++++++ ......++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~~ 76 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVC-----TERSPICL 76 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEE-----ccCCceEE
Confidence 46788899999999999999875 467899998864332 346789999999999999999999985 44567899
Q ss_pred EEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEecc
Q 002857 240 VYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADF 319 (873)
Q Consensus 240 V~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDF 319 (873)
||||+++++|.+++.. ....+++..++.++.+++.||+||| +.+++|+||||+||+++.++.+||+||
T Consensus 77 v~e~~~~~~L~~~~~~---------~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~ 144 (256)
T cd05112 77 VFEFMEHGCLSDYLRA---------QRGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDF 144 (256)
T ss_pred EEEcCCCCcHHHHHHh---------CccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCC
Confidence 9999999999999842 2345788999999999999999999 889999999999999999999999999
Q ss_pred ccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHHHhhcCchh
Q 002857 320 GIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQSALPER 398 (873)
Q Consensus 320 Gla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~~~~~~~~~ 398 (873)
|+++....... .......++.+|+|||++.+..++.++||||||+++|||++ |+.||....... +..
T Consensus 145 g~~~~~~~~~~-~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--~~~--------- 212 (256)
T cd05112 145 GMTRFVLDDQY-TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE--VVE--------- 212 (256)
T ss_pred cceeecccCcc-cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH--HHH---------
Confidence 99875533211 11122235678999999998899999999999999999998 999986522110 000
Q ss_pred HHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHH
Q 002857 399 VEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGL 465 (873)
Q Consensus 399 l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~L 465 (873)
.+ ...... ..+.. ....+.+|+.+||+.+|++|||+.||+++|
T Consensus 213 --~~-~~~~~~------------~~~~~---------~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 213 --TI-NAGFRL------------YKPRL---------ASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred --HH-hCCCCC------------CCCCC---------CCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 00 000000 00000 023478899999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=308.16 Aligned_cols=248 Identities=25% Similarity=0.318 Sum_probs=196.9
Q ss_pred CCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC-CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEE
Q 002857 161 GFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH-HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKAL 239 (873)
Q Consensus 161 ~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~L 239 (873)
.|+..+.||+|+||.||+|.+..+++.||+|.++... ....+.+.+|++++++++|+||+++++++ ..+...++
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l 79 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY-----LKGTKLWI 79 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhccc-----ccCCceEE
Confidence 3566788999999999999998889999999987433 33446789999999999999999999985 45667899
Q ss_pred EEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEecc
Q 002857 240 VYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADF 319 (873)
Q Consensus 240 V~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDF 319 (873)
||||+++++|.+++. ...+++..+..++.||+.||.||| ..+++|+||+|+||++++++.++|+||
T Consensus 80 v~e~~~~~~L~~~~~-----------~~~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~df 145 (277)
T cd06642 80 IMEYLGGGSALDLLK-----------PGPLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADF 145 (277)
T ss_pred EEEccCCCcHHHHhh-----------cCCCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEccc
Confidence 999999999999883 235788999999999999999999 899999999999999999999999999
Q ss_pred ccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCchhH
Q 002857 320 GIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPERV 399 (873)
Q Consensus 320 Gla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~~l 399 (873)
|++..+..... ......++..|+|||++.+..++.++||||||+++|||+||+.||....... ...
T Consensus 146 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~---------- 211 (277)
T cd06642 146 GVAGQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR--VLF---------- 211 (277)
T ss_pred cccccccCcch--hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh--HHh----------
Confidence 99976543221 1122357889999999999889999999999999999999999986422111 000
Q ss_pred HHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHH
Q 002857 400 EEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELG 464 (873)
Q Consensus 400 ~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~ 464 (873)
.+..... +.. .......+.+++.+||+.+|++||+|.+|+..
T Consensus 212 --~~~~~~~---------------~~~------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 212 --LIPKNSP---------------PTL------EGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred --hhhcCCC---------------CCC------CcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 0000000 000 00112347789999999999999999999974
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=327.52 Aligned_cols=246 Identities=25% Similarity=0.345 Sum_probs=201.8
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEEEEeecC
Q 002857 166 NLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKALVYEFMP 245 (873)
Q Consensus 166 ~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~LV~Ey~~ 245 (873)
-+||+|.||+||.|++..+...+|||-+........+-+..||.+-++|+|.|||+++|.| ..+++.-|.||.++
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~-----senGf~kIFMEqVP 655 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSV-----SENGFFKIFMEQVP 655 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhcc-----CCCCeEEEEeecCC
Confidence 4799999999999999999999999999877666777899999999999999999999996 45668899999999
Q ss_pred CCChhhhcccccccccccCCCCCC--chhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeC-CCCCeEEeccccc
Q 002857 246 NGSLEEWIHPITEEDKRHKAPGNL--NSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLN-DEMTACVADFGIA 322 (873)
Q Consensus 246 ~GSL~~~L~~~~~~~~~~~~~~~L--s~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd-~~~~vKLsDFGla 322 (873)
||||.++|+. .-+++ ++.++-.+.+||++||.||| .+.|||||||-+|||++ -.|.+||+|||.+
T Consensus 656 GGSLSsLLrs---------kWGPlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTs 723 (1226)
T KOG4279|consen 656 GGSLSSLLRS---------KWGPLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTS 723 (1226)
T ss_pred CCcHHHHHHh---------ccCCCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccc
Confidence 9999999964 23344 67788889999999999999 89999999999999996 6899999999999
Q ss_pred cccccccccccccccccccccCCCcccCCC--CCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCchhHH
Q 002857 323 RFLEATNEQTSSIGVKGTTGYIAPEYGMGH--ETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPERVE 400 (873)
Q Consensus 323 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~--~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~~l~ 400 (873)
+.+..-+.- +....||+.|||||++..+ .|..++|||||||++.||.||++||-...... .
T Consensus 724 KRLAginP~--TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq---------------A 786 (1226)
T KOG4279|consen 724 KRLAGINPC--TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ---------------A 786 (1226)
T ss_pred hhhccCCcc--ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh---------------H
Confidence 987654432 3345699999999999876 58999999999999999999999996532111 0
Q ss_pred HHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 401 EIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 401 elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
.++. ..-++.||..+. +...+...++++|+.++|.+||+++++++
T Consensus 787 AMFk------------VGmyKvHP~iPe------elsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 787 AMFK------------VGMYKVHPPIPE------ELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred hhhh------------hcceecCCCCcH------HHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 1111 111345555433 23445778999999999999999998864
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=301.95 Aligned_cols=254 Identities=24% Similarity=0.389 Sum_probs=197.7
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEE
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKA 238 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~ 238 (873)
.++|++.+.||+|+||.||+|.+. ++..+|+|.+.... ...+.+.+|++++++++|+||+++++++. . ...+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~-~~~~ 76 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-----K-EPIY 76 (260)
T ss_pred ccceeEEeEecCccceEEEEEEec-CCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEc-----C-CCeE
Confidence 357889999999999999999864 55679999886432 23467899999999999999999999853 2 5679
Q ss_pred EEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEec
Q 002857 239 LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVAD 318 (873)
Q Consensus 239 LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsD 318 (873)
+||||+++++|.+++.. .....+++.+++.++.|++.||.||| +.+++|+||||+||+++.++.+||+|
T Consensus 77 ~v~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d 145 (260)
T cd05073 77 IITEFMAKGSLLDFLKS--------DEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIAD 145 (260)
T ss_pred EEEEeCCCCcHHHHHHh--------CCccccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECC
Confidence 99999999999999853 23446788899999999999999999 88999999999999999999999999
Q ss_pred cccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHHHhhcCch
Q 002857 319 FGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQSALPE 397 (873)
Q Consensus 319 FGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~~~~~~~~ 397 (873)
||.+........ .......++..|+|||++....++.++||||||+++|+|+| |+.||...... .....+
T Consensus 146 ~~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~~~~~~------ 216 (260)
T cd05073 146 FGLARVIEDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP--EVIRAL------ 216 (260)
T ss_pred CcceeeccCCCc-ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH--HHHHHH------
Confidence 999976543221 11222345678999999998889999999999999999999 99998652111 011110
Q ss_pred hHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHH
Q 002857 398 RVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRL 467 (873)
Q Consensus 398 ~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~ 467 (873)
..... .+.. ......+.+++.+||+.+|++||++.+|.+.|+.
T Consensus 217 ------~~~~~--------------~~~~-------~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 217 ------ERGYR--------------MPRP-------ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ------hCCCC--------------CCCc-------ccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 00000 0000 0112357889999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=299.16 Aligned_cols=252 Identities=27% Similarity=0.452 Sum_probs=197.0
Q ss_pred CCcceeecccCceEEEEEEEcCCC----cEEEEEEeeccCCc-chhHHHHHHHHHHhhhhccceeeeeeeecccccCCce
Q 002857 162 FSSENLIGAGNFASVYKGILFEGA----PAVAIKVFNFLHHD-ASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDF 236 (873)
Q Consensus 162 f~~~~~LG~G~fG~VYkg~~~~~g----~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~ 236 (873)
|++.+.||.|+||.||++++...+ ..||+|+++..... ..+.+..|+.++..++|+||+++++++ ...+.
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~ 75 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVC-----TEEEP 75 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEE-----cCCCe
Confidence 456789999999999999997655 88999999755433 557899999999999999999999986 34467
Q ss_pred EEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEE
Q 002857 237 KALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACV 316 (873)
Q Consensus 237 ~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKL 316 (873)
.++||||+++++|.+++.. .....+++.+++.++.|++.||+||| +.+++|+||||+||++++++.++|
T Consensus 76 ~~~i~e~~~~~~l~~~~~~--------~~~~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l 144 (258)
T smart00219 76 LMIVMEYMEGGDLLDYLRK--------NRPKELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKI 144 (258)
T ss_pred eEEEEeccCCCCHHHHHHh--------hhhccCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEE
Confidence 8999999999999999853 11222899999999999999999999 899999999999999999999999
Q ss_pred eccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHHHhhcC
Q 002857 317 ADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQSAL 395 (873)
Q Consensus 317 sDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~~~~~~ 395 (873)
+|||+++........... ...++..|+|||.+.+..++.++||||||++++||++ |..||...... .+...
T Consensus 145 ~dfg~~~~~~~~~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~--~~~~~----- 216 (258)
T smart00219 145 SDFGLSRDLYDDDYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNE--EVLEY----- 216 (258)
T ss_pred cccCCceecccccccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHH-----
Confidence 999999866543221111 2236789999999988889999999999999999998 78887642111 01110
Q ss_pred chhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHH
Q 002857 396 PERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGL 465 (873)
Q Consensus 396 ~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~L 465 (873)
+..... +... ......+.+++.+||+.+|++|||+.|+++.|
T Consensus 217 ------~~~~~~----------------~~~~------~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 217 ------LKKGYR----------------LPKP------ENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ------HhcCCC----------------CCCC------CcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 000000 0000 00233578899999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=324.98 Aligned_cols=208 Identities=24% Similarity=0.300 Sum_probs=176.2
Q ss_pred HHHHHHhhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeecc---CCcchhHHHHHHHHHHhhhhccceeeeeeeec
Q 002857 152 YEALYSATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFL---HHDASKSFTVECEVMRNIIHRKIIKVVTACSR 228 (873)
Q Consensus 152 ~~el~~at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~ 228 (873)
+.++....++|++.+.||+|+||.||++.+..+++.||+|++... .......+.+|+.+++.++||||+++++.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~-- 112 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF-- 112 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE--
Confidence 445556678999999999999999999999999999999998632 222335678899999999999999999985
Q ss_pred ccccCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeee
Q 002857 229 VDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILL 308 (873)
Q Consensus 229 ~~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILL 308 (873)
..+...++||||+++|+|.+++.. ..+++..+..++.||+.||+||| +.+|+||||||+|||+
T Consensus 113 ---~~~~~~~lv~Ey~~gg~L~~~~~~-----------~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll 175 (371)
T cd05622 113 ---QDDRYLYMVMEYMPGGDLVNLMSN-----------YDVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLL 175 (371)
T ss_pred ---EcCCEEEEEEcCCCCCcHHHHHHh-----------cCCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEE
Confidence 456789999999999999999842 24778888999999999999999 8999999999999999
Q ss_pred CCCCCeEEeccccccccccccccccccccccccccCCCcccCCC----CCCcchhhHhHHHHHHHHHhCCCCCCc
Q 002857 309 NDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGH----ETSSYGDVYSFGILLLEMFTGLRPSDD 379 (873)
Q Consensus 309 d~~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~----~~s~ksDVwSfGvvL~ELlTGk~Pf~~ 379 (873)
+.++.+||+|||+++....... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||..
T Consensus 176 ~~~~~ikL~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~ 249 (371)
T cd05622 176 DKSGHLKLADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA 249 (371)
T ss_pred CCCCCEEEEeCCceeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCC
Confidence 9999999999999986543221 112235699999999998754 378999999999999999999999975
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=301.97 Aligned_cols=251 Identities=21% Similarity=0.305 Sum_probs=193.8
Q ss_pred CCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCC------cchhHHHHHHHHHHhhhhccceeeeeeeecccccCC
Q 002857 161 GFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH------DASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGN 234 (873)
Q Consensus 161 ~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~------~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~ 234 (873)
+|...+.||+|+||.||+|.. .+++.+|||.++.... .....+.+|++++++++|+||+++++++ ...
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~ 74 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTC-----LDD 74 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEe-----ecC
Confidence 477889999999999999976 5678999998864321 1235688899999999999999999996 345
Q ss_pred ceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCe
Q 002857 235 DFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTA 314 (873)
Q Consensus 235 ~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~v 314 (873)
...++||||+++++|.+++.. ...+++..+..++.|++.||+||| +.+|+|+||+|+||++++++.+
T Consensus 75 ~~~~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~ 141 (265)
T cd06631 75 NTISIFMEFVPGGSISSILNR----------FGPLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGII 141 (265)
T ss_pred CeEEEEEecCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeE
Confidence 689999999999999999842 245788899999999999999999 8899999999999999999999
Q ss_pred EEeccccccccccccc----cccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHH
Q 002857 315 CVADFGIARFLEATNE----QTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNW 390 (873)
Q Consensus 315 KLsDFGla~~~~~~~~----~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~ 390 (873)
+|+|||++........ ........++..|+|||++.+..++.++||||||+++|||++|+.||........ .
T Consensus 142 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~-~--- 217 (265)
T cd06631 142 KLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA-M--- 217 (265)
T ss_pred EeccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH-H---
Confidence 9999999986532111 1112234588999999999988899999999999999999999999965211100 0
Q ss_pred HhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 391 VQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 391 ~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
..+.... . ..+... ......+.+++.+||+.+|++||++.||+.
T Consensus 218 ---------~~~~~~~--~------------~~~~~~------~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 218 ---------FYIGAHR--G------------LMPRLP------DSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred ---------HHhhhcc--C------------CCCCCC------CCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000000 0 000000 001234788999999999999999998864
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=302.58 Aligned_cols=247 Identities=26% Similarity=0.424 Sum_probs=194.1
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEE
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKAL 239 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~L 239 (873)
++|++.+.||+|+||.||++.. .++.||+|+++... ....+.+|+.++++++|+||+++++++. .+..++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~------~~~~~~ 75 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVIL------HNGLYI 75 (254)
T ss_pred HHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEc------CCCcEE
Confidence 4578899999999999999965 67789999986432 3467899999999999999999999863 233689
Q ss_pred EEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEecc
Q 002857 240 VYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADF 319 (873)
Q Consensus 240 V~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDF 319 (873)
||||+++++|.+++.. .....+++..++.++.|++.||.||| +.+++||||||+||+++.++.+||+||
T Consensus 76 v~e~~~~~~L~~~l~~--------~~~~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Df 144 (254)
T cd05083 76 VMELMSKGNLVNFLRT--------RGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDF 144 (254)
T ss_pred EEECCCCCCHHHHHHh--------cCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCC
Confidence 9999999999999853 22345788999999999999999999 899999999999999999999999999
Q ss_pred ccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHHHhhcCchh
Q 002857 320 GIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQSALPER 398 (873)
Q Consensus 320 Gla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~~~~~~~~~ 398 (873)
|+++...... .....+..|+|||++.+..++.++||||||+++|||++ |+.||.......
T Consensus 145 g~~~~~~~~~-----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-------------- 205 (254)
T cd05083 145 GLARVGSMGV-----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE-------------- 205 (254)
T ss_pred ccceeccccC-----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH--------------
Confidence 9987543211 11234578999999988899999999999999999998 999986532110
Q ss_pred HHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHH
Q 002857 399 VEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRL 467 (873)
Q Consensus 399 l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~ 467 (873)
..+.+...... .+. ......+.+++.+||+.+|++||++.+|++.|+.
T Consensus 206 ~~~~~~~~~~~-------------~~~--------~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 206 VKECVEKGYRM-------------EPP--------EGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred HHHHHhCCCCC-------------CCC--------CcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 01111100000 000 0113357889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=304.06 Aligned_cols=200 Identities=24% Similarity=0.341 Sum_probs=168.5
Q ss_pred CCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC--CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEE
Q 002857 161 GFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH--HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKA 238 (873)
Q Consensus 161 ~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~ 238 (873)
+|+..+.||.|++|.||+|++..+++.||||+++... ......+.+|++++++++|+||+++++++ .++...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 75 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKLY 75 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhc-----ccCCcEE
Confidence 5888999999999999999998889999999986432 22335788999999999999999999985 4566789
Q ss_pred EEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEec
Q 002857 239 LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVAD 318 (873)
Q Consensus 239 LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsD 318 (873)
+||||+. ++|.+++.. .....+++..++.++.|++.||+||| ..+++|+||+|+||+++.++.+||+|
T Consensus 76 ~v~e~~~-~~l~~~~~~--------~~~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~d 143 (284)
T cd07860 76 LVFEFLH-QDLKKFMDA--------SPLSGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLAD 143 (284)
T ss_pred EEeeccc-cCHHHHHHh--------CCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEee
Confidence 9999995 689888843 23456899999999999999999999 89999999999999999999999999
Q ss_pred cccccccccccccccccccccccccCCCcccCCCC-CCcchhhHhHHHHHHHHHhCCCCCCc
Q 002857 319 FGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHE-TSSYGDVYSFGILLLEMFTGLRPSDD 379 (873)
Q Consensus 319 FGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~-~s~ksDVwSfGvvL~ELlTGk~Pf~~ 379 (873)
||+++....... ......++..|+|||++.+.. ++.++||||||+++|||+||+.||..
T Consensus 144 fg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~ 203 (284)
T cd07860 144 FGLARAFGVPVR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPG 203 (284)
T ss_pred ccchhhcccCcc--ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 999876533221 122234688999999887654 58899999999999999999999965
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=305.92 Aligned_cols=274 Identities=18% Similarity=0.223 Sum_probs=199.7
Q ss_pred CCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC--CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEE
Q 002857 161 GFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH--HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKA 238 (873)
Q Consensus 161 ~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~ 238 (873)
+|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.++++++|+||+++++++ ..+...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~ 75 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVF-----PHGSGFV 75 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCeeE
Confidence 4788899999999999999998889999999987543 23346799999999999999999999985 4467789
Q ss_pred EEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEec
Q 002857 239 LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVAD 318 (873)
Q Consensus 239 LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsD 318 (873)
+||||+ +++|.+++.. ....+++.+++.++.||+.||+||| +.+|+|+||||+||+++.++.++|+|
T Consensus 76 ~v~e~~-~~~L~~~~~~---------~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~d 142 (286)
T cd07832 76 LVMEYM-PSDLSEVLRD---------EERPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIAD 142 (286)
T ss_pred EEeccc-CCCHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEee
Confidence 999999 9999999853 2356899999999999999999999 89999999999999999999999999
Q ss_pred cccccccccccccccccccccccccCCCcccCCC-CCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCch
Q 002857 319 FGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGH-ETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPE 397 (873)
Q Consensus 319 FGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~ 397 (873)
||++........ .......++..|+|||++.+. .++.++||||||+++|||+||..+|..... ......+...+..
T Consensus 143 fg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~--~~~~~~~~~~~~~ 219 (286)
T cd07832 143 FGLARLFSEEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND--IEQLAIVFRTLGT 219 (286)
T ss_pred eeecccccCCCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH--HHHHHHHHHHcCC
Confidence 999986644321 112234588999999998654 468999999999999999999877754221 1111111111110
Q ss_pred ----hHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 398 ----RVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 398 ----~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
...++.+. .+.. . . ... ............+....+.+++.+||+.+|++|||+++++.
T Consensus 220 ~~~~~~~~~~~~---~~~~--~-~-~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 220 PNEETWPGLTSL---PDYN--K-I-TFP-ESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred CChHHHhhccCc---chhh--c-c-cCC-CCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 00000000 0000 0 0 000 00000001111122356889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=299.87 Aligned_cols=249 Identities=23% Similarity=0.344 Sum_probs=197.0
Q ss_pred CCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC--CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEE
Q 002857 161 GFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH--HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKA 238 (873)
Q Consensus 161 ~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~ 238 (873)
+|+..+.||+|+||.||++....+++.+|||.+.... ......+.+|++++++++|+||+++++.+ ..++..+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~ 75 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENF-----LEDKALM 75 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeE-----ecCCEEE
Confidence 5788999999999999999998899999999986432 23356789999999999999999999884 4566799
Q ss_pred EEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCC-CCeEEe
Q 002857 239 LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDE-MTACVA 317 (873)
Q Consensus 239 LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~-~~vKLs 317 (873)
+||||+++++|.+++.. .....+++..++.++.+++.||+||| +.+|+|+||+|+||+++++ +.+||+
T Consensus 76 lv~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~ 144 (256)
T cd08220 76 IVMEYAPGGTLAEYIQK--------RCNSLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIG 144 (256)
T ss_pred EEEecCCCCCHHHHHHH--------hcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEc
Confidence 99999999999999953 22345889999999999999999999 8999999999999999854 468999
Q ss_pred ccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCch
Q 002857 318 DFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPE 397 (873)
Q Consensus 318 DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~ 397 (873)
|||++....... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||....... ..
T Consensus 145 d~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~--~~--------- 210 (256)
T cd08220 145 DFGISKILSSKS---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA--LV--------- 210 (256)
T ss_pred cCCCceecCCCc---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH--HH---------
Confidence 999998664322 1223457889999999998889999999999999999999999986521110 00
Q ss_pred hHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 398 RVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 398 ~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
..+....... .+ ......+.+++..||+.+|++|||+.|++.
T Consensus 211 --~~~~~~~~~~-------------~~---------~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 211 --LKIMSGTFAP-------------IS---------DRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred --HHHHhcCCCC-------------CC---------CCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 0000000000 00 001234778999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=307.25 Aligned_cols=209 Identities=22% Similarity=0.297 Sum_probs=170.2
Q ss_pred CCCcceeecccCceEEEEEEEcC--CCcEEEEEEeeccC---CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCc
Q 002857 161 GFSSENLIGAGNFASVYKGILFE--GAPAVAIKVFNFLH---HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGND 235 (873)
Q Consensus 161 ~f~~~~~LG~G~fG~VYkg~~~~--~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~ 235 (873)
+|++.+.||+|+||.||+|.+.. +++.||+|.+.... ......+.+|+.++++++||||+++++++.. ....
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~ 77 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLE---HADK 77 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeC---CCCc
Confidence 47888999999999999999987 78999999997533 3334678889999999999999999999743 2236
Q ss_pred eEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCC----C
Q 002857 236 FKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLND----E 311 (873)
Q Consensus 236 ~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~----~ 311 (873)
..++||||+++ +|.+++... .......+++..++.|+.||+.||+||| +.+|+||||||+|||++. +
T Consensus 78 ~~~lv~e~~~~-~l~~~~~~~-----~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~ 148 (316)
T cd07842 78 SVYLLFDYAEH-DLWQIIKFH-----RQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPER 148 (316)
T ss_pred eEEEEEeCCCc-CHHHHHHhh-----ccCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCcc
Confidence 79999999975 777766321 1112346889999999999999999999 899999999999999999 9
Q ss_pred CCeEEeccccccccccccc-cccccccccccccCCCcccCCC-CCCcchhhHhHHHHHHHHHhCCCCCCccc
Q 002857 312 MTACVADFGIARFLEATNE-QTSSIGVKGTTGYIAPEYGMGH-ETSSYGDVYSFGILLLEMFTGLRPSDDMF 381 (873)
Q Consensus 312 ~~vKLsDFGla~~~~~~~~-~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~ 381 (873)
+.+||+|||+++....... ........++..|+|||++.+. .++.++||||||+++|||++|+.||....
T Consensus 149 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 220 (316)
T cd07842 149 GVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGRE 220 (316)
T ss_pred ceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCc
Confidence 9999999999986543322 1122234578899999987764 57899999999999999999999997643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=317.14 Aligned_cols=202 Identities=26% Similarity=0.293 Sum_probs=171.7
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeecc---CCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCce
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFL---HHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDF 236 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~ 236 (873)
++|++.+.||+|+||.||+++...+++.||+|++... .....+.+.+|+.++..++|+||+++++++ ..++.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~ 75 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAF-----QDENN 75 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEE-----ecCCe
Confidence 4789999999999999999999888999999998642 222345688999999999999999999985 45678
Q ss_pred EEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEE
Q 002857 237 KALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACV 316 (873)
Q Consensus 237 ~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKL 316 (873)
.++||||+++|+|.+++.. ....+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||
T Consensus 76 ~~lv~e~~~g~~L~~~l~~---------~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl 143 (331)
T cd05597 76 LYLVMDYYVGGDLLTLLSK---------FEDRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRL 143 (331)
T ss_pred EEEEEecCCCCcHHHHHHH---------hcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEE
Confidence 9999999999999999842 2346888899999999999999999 899999999999999999999999
Q ss_pred eccccccccccccccccccccccccccCCCcccCC-----CCCCcchhhHhHHHHHHHHHhCCCCCCc
Q 002857 317 ADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMG-----HETSSYGDVYSFGILLLEMFTGLRPSDD 379 (873)
Q Consensus 317 sDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-----~~~s~ksDVwSfGvvL~ELlTGk~Pf~~ 379 (873)
+|||++..+...... ......||..|+|||++.. ..++.++|||||||++|||++|+.||..
T Consensus 144 ~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 210 (331)
T cd05597 144 ADFGSCLRLLADGTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred EECCceeecCCCCCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC
Confidence 999998765432211 1122458999999999863 4578899999999999999999999965
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=305.27 Aligned_cols=248 Identities=25% Similarity=0.335 Sum_probs=198.4
Q ss_pred CCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC-CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEE
Q 002857 161 GFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH-HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKAL 239 (873)
Q Consensus 161 ~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~L 239 (873)
.|+..+.||.|+||.||+|.+..++..||||++.... ......+.+|++++++++|+||+++++++ ..+...++
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l 79 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY-----LKGTKLWI 79 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EECCEEEE
Confidence 4677789999999999999998889999999987443 33456789999999999999999999986 44567999
Q ss_pred EEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEecc
Q 002857 240 VYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADF 319 (873)
Q Consensus 240 V~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDF 319 (873)
||||+++|+|.+++.. ..+++.+...++.|++.||+||| +.+++|+||+|+||+++.++.++|+||
T Consensus 80 v~e~~~~~~L~~~i~~-----------~~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~df 145 (277)
T cd06640 80 IMEYLGGGSALDLLRA-----------GPFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADF 145 (277)
T ss_pred EEecCCCCcHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEccc
Confidence 9999999999998842 34788889999999999999999 899999999999999999999999999
Q ss_pred ccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCchhH
Q 002857 320 GIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPERV 399 (873)
Q Consensus 320 Gla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~~l 399 (873)
|++........ ......++..|+|||++.+..++.++||||||+++|||+||+.||........
T Consensus 146 g~~~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-------------- 209 (277)
T cd06640 146 GVAGQLTDTQI--KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV-------------- 209 (277)
T ss_pred ccceeccCCcc--ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH--------------
Confidence 99976543221 12234578899999999888899999999999999999999999865321100
Q ss_pred HHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHH
Q 002857 400 EEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELG 464 (873)
Q Consensus 400 ~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~ 464 (873)
...+.... .+. ........+.+++.+||+.+|++||++.+|+..
T Consensus 210 ~~~~~~~~---------------~~~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 210 LFLIPKNN---------------PPT------LTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred hhhhhcCC---------------CCC------CchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 00000000 000 011223457899999999999999999999765
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=305.26 Aligned_cols=263 Identities=17% Similarity=0.338 Sum_probs=199.1
Q ss_pred cCCCcceeecccCceEEEEEEEcC-----CCcEEEEEEeeccCCc-chhHHHHHHHHHHhhhhccceeeeeeeecccccC
Q 002857 160 KGFSSENLIGAGNFASVYKGILFE-----GAPAVAIKVFNFLHHD-ASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQG 233 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~-----~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~ 233 (873)
++|++...||+|+||.||+|+... +.+.||+|.+...... ..+.+.+|++++++++|+||+++++++ ..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~ 79 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLC-----RE 79 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEE-----CC
Confidence 578889999999999999998753 3467999988654333 346799999999999999999999986 34
Q ss_pred CceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCC
Q 002857 234 NDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMT 313 (873)
Q Consensus 234 ~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~ 313 (873)
....++||||+++|+|.++++..... ........+++..++.++.||+.||+||| +.+|+||||||+||+++.++.
T Consensus 80 ~~~~~lv~e~~~~~~L~~~i~~~~~~-~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~ 155 (275)
T cd05046 80 AEPHYMILEYTDLGDLKQFLRATKSK-DEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQRE 155 (275)
T ss_pred CCcceEEEEecCCCcHHHHHHhcccc-cccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCc
Confidence 56689999999999999999541100 00011236899999999999999999999 899999999999999999999
Q ss_pred eEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHHHh
Q 002857 314 ACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQ 392 (873)
Q Consensus 314 vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~~~ 392 (873)
++|+|||+++...... ........++..|+|||.+.+..++.++||||||+++|+|++ |..||....... ...
T Consensus 156 ~~l~~~~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~--~~~--- 229 (275)
T cd05046 156 VKVSLLSLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE--VLN--- 229 (275)
T ss_pred EEEcccccccccCccc-ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH--HHH---
Confidence 9999999987543221 111222346778999999988889999999999999999999 788885422111 000
Q ss_pred hcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHH
Q 002857 393 SALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLR 466 (873)
Q Consensus 393 ~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le 466 (873)
.+....+ ++... ..+...+.+++.+||+.+|++||++.|++..|+
T Consensus 230 --------~~~~~~~----------------~~~~~-----~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 230 --------RLQAGKL----------------ELPVP-----EGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred --------HHHcCCc----------------CCCCC-----CCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 0000000 00000 011335888999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=310.44 Aligned_cols=257 Identities=21% Similarity=0.250 Sum_probs=198.4
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC---CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCce
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH---HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDF 236 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~ 236 (873)
++|++.+.||+|+||.||++.+...++.||+|.+.... ......+.+|+++++.++|+||+++++.+ ..++.
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~ 75 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSF-----ETKRH 75 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE-----ecCCE
Confidence 47889999999999999999998889999999987443 22345788999999999999999999985 45667
Q ss_pred EEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEE
Q 002857 237 KALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACV 316 (873)
Q Consensus 237 ~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKL 316 (873)
.++||||+++++|.+++.. ...+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||
T Consensus 76 ~~lv~e~~~g~~L~~~l~~----------~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l 142 (305)
T cd05609 76 LCMVMEYVEGGDCATLLKN----------IGALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKL 142 (305)
T ss_pred EEEEEecCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEE
Confidence 8999999999999999942 345888999999999999999999 899999999999999999999999
Q ss_pred eccccccccccccc-------------cccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCccccc
Q 002857 317 ADFGIARFLEATNE-------------QTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKD 383 (873)
Q Consensus 317 sDFGla~~~~~~~~-------------~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~ 383 (873)
+|||+++....... ........++..|+|||++.+..++.++||||||+++|||++|+.||......
T Consensus 143 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~ 222 (305)
T cd05609 143 TDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE 222 (305)
T ss_pred eeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 99999874211100 00111234788999999998888999999999999999999999998642111
Q ss_pred chhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 384 NLNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 384 ~~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
. +......... ..|... ......+.+++.+||+.+|++||++.++.+
T Consensus 223 -----~------------~~~~~~~~~~----------~~~~~~------~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ 269 (305)
T cd05609 223 -----E------------LFGQVISDDI----------EWPEGD------EALPADAQDLISRLLRQNPLERLGTGGAFE 269 (305)
T ss_pred -----H------------HHHHHHhccc----------CCCCcc------ccCCHHHHHHHHHHhccChhhccCccCHHH
Confidence 0 0000000000 000000 011234778999999999999999877766
Q ss_pred HHHH
Q 002857 464 GLRL 467 (873)
Q Consensus 464 ~Le~ 467 (873)
.|+.
T Consensus 270 ll~~ 273 (305)
T cd05609 270 VKQH 273 (305)
T ss_pred HHhC
Confidence 6654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=323.42 Aligned_cols=254 Identities=27% Similarity=0.432 Sum_probs=208.8
Q ss_pred CcceeecccCceEEEEEEEcCC----CcEEEEEEeec-cCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceE
Q 002857 163 SSENLIGAGNFASVYKGILFEG----APAVAIKVFNF-LHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFK 237 (873)
Q Consensus 163 ~~~~~LG~G~fG~VYkg~~~~~----g~~VAVK~l~~-~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~ 237 (873)
...++||.|.||.||+|++..- .-.||||..+. ...+..+.|+.|+.+|++++|||||+++|+|.+ ...
T Consensus 392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e------~P~ 465 (974)
T KOG4257|consen 392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE------QPM 465 (974)
T ss_pred cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec------cce
Confidence 4457899999999999987532 23589999875 344556789999999999999999999999864 348
Q ss_pred EEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEe
Q 002857 238 ALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVA 317 (873)
Q Consensus 238 ~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLs 317 (873)
+||||.++.|.|..||+. ....|+......++.||..||+||| +..+|||||..+|||+.....+||+
T Consensus 466 WivmEL~~~GELr~yLq~---------nk~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLa 533 (974)
T KOG4257|consen 466 WIVMELAPLGELREYLQQ---------NKDSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLA 533 (974)
T ss_pred eEEEecccchhHHHHHHh---------ccccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeec
Confidence 999999999999999963 4566888899999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHHHhhcCc
Q 002857 318 DFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQSALP 396 (873)
Q Consensus 318 DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~~~~~~~ 396 (873)
|||+++.+........+ ...-++.|||||.+.-.+++.+||||-|||.+||+++ |..||....+.+.
T Consensus 534 DFGLSR~~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV----------- 601 (974)
T KOG4257|consen 534 DFGLSRYLEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV----------- 601 (974)
T ss_pred ccchhhhccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccce-----------
Confidence 99999988665443333 3446788999999999999999999999999999998 9999987543321
Q ss_pred hhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHHHH
Q 002857 397 ERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLIKK 470 (873)
Q Consensus 397 ~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i~~ 470 (873)
+-..-.++ ..| .+..|+..|..|+.+||..+|.+||++.|+...|..+..
T Consensus 602 ------I~~iEnGe-----------RlP-------~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 602 ------IGHIENGE-----------RLP-------CPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred ------EEEecCCC-----------CCC-------CCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 10000000 011 123467789999999999999999999999999998876
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=302.76 Aligned_cols=256 Identities=20% Similarity=0.280 Sum_probs=182.1
Q ss_pred eeecccCceEEEEEEEcCCC--cEEEEEEeeccC-CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEEEEe
Q 002857 166 NLIGAGNFASVYKGILFEGA--PAVAIKVFNFLH-HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKALVYE 242 (873)
Q Consensus 166 ~~LG~G~fG~VYkg~~~~~g--~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~LV~E 242 (873)
+.||+|+||.||+|....+. ..+++|.++... ....+.+.+|+.+++.++||||+++++.|. .....++|||
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~-----~~~~~~lv~e 75 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCV-----EAIPYLLVFE 75 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEec-----CCCccEEEEe
Confidence 36999999999999764332 356677765433 234568999999999999999999999963 4556899999
Q ss_pred ecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEeccccc
Q 002857 243 FMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIA 322 (873)
Q Consensus 243 y~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDFGla 322 (873)
|+++|+|.++++.. ......+++..++.++.||+.||+||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 76 ~~~~~~L~~~l~~~------~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~ 146 (268)
T cd05086 76 YCELGDLKSYLSQE------QWHRRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIG 146 (268)
T ss_pred cCCCCcHHHHHHhh------hcccccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccc
Confidence 99999999999531 011234667778899999999999999 899999999999999999999999999998
Q ss_pred cccccccccccccccccccccCCCcccCC-------CCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHHHhhc
Q 002857 323 RFLEATNEQTSSIGVKGTTGYIAPEYGMG-------HETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQSA 394 (873)
Q Consensus 323 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-------~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~~~~~ 394 (873)
................++..|+|||++.. ..++.++||||||+++|||++ |..||....... .+...
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-~~~~~---- 221 (268)
T cd05086 147 PSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE-VLNHV---- 221 (268)
T ss_pred cccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHH----
Confidence 64322211112223457889999998753 245789999999999999997 566775421110 00000
Q ss_pred CchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHH
Q 002857 395 LPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLR 466 (873)
Q Consensus 395 ~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le 466 (873)
+.+....+.++.+.. + ....+.+++..|| .+|++||++.||++.|.
T Consensus 222 ~~~~~~~~~~~~~~~--------------~-----------~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 222 IKDQQVKLFKPQLEL--------------P-----------YSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred HhhcccccCCCccCC--------------C-----------CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 000000001110000 0 0124667888999 67999999999988773
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=306.89 Aligned_cols=281 Identities=21% Similarity=0.247 Sum_probs=202.5
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCC--cchhHHHHHHHHHHhhhhcc-ceeeeeeeeccc-ccCCc
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH--DASKSFTVECEVMRNIIHRK-IIKVVTACSRVD-YQGND 235 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpN-IV~llg~c~~~~-~~~~~ 235 (873)
..|...++||+|.||+||+|+.+.+|+.||+|.++.... .......+|+.+|++++|+| ||++++++.... +....
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 345666889999999999999999999999999985543 24456789999999999999 999999975432 12233
Q ss_pred eEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeE
Q 002857 236 FKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTAC 315 (873)
Q Consensus 236 ~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vK 315 (873)
..++||||+.. +|.+++.... .....++...+..++.||++||+||| +++|+||||||.||||+++|.+|
T Consensus 91 ~l~lvfe~~d~-DL~~ymd~~~------~~~~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lK 160 (323)
T KOG0594|consen 91 KLYLVFEFLDR-DLKKYMDSLP------KKPQGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLK 160 (323)
T ss_pred eEEEEEEeecc-cHHHHHHhcc------ccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEe
Confidence 78899999965 9999995411 11145666889999999999999999 99999999999999999999999
Q ss_pred EeccccccccccccccccccccccccccCCCcccCCC-CCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhc
Q 002857 316 VADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGH-ETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSA 394 (873)
Q Consensus 316 LsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~ 394 (873)
|+|||+|+.+.-.. ...+..++|..|+|||++.+. .|+...||||+|||+.||++++..|.+..+... +.......
T Consensus 161 laDFGlAra~~ip~--~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~q-l~~If~~l 237 (323)
T KOG0594|consen 161 LADFGLARAFSIPM--RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQ-LFRIFRLL 237 (323)
T ss_pred eeccchHHHhcCCc--ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHH-HHHHHHHc
Confidence 99999999654222 223445689999999999987 789999999999999999999999987544211 11111110
Q ss_pred Cch---hH---HHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHH
Q 002857 395 LPE---RV---EEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELG 464 (873)
Q Consensus 395 ~~~---~l---~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~ 464 (873)
-.+ .+ ..+.+... .+ ...+.................+++.+|++.+|++|.|+..++.+
T Consensus 238 GtP~e~~Wp~v~~~~~~k~--~f---------~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 238 GTPNEKDWPGVSSLPDYKA--PF---------PKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCCCccCCCCccccccccc--cC---------cCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 000 01 00000000 00 00000000011111111257789999999999999999988765
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=298.99 Aligned_cols=254 Identities=26% Similarity=0.322 Sum_probs=202.7
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCC-cchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEE
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH-DASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKA 238 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~ 238 (873)
++|++.+.||+|++|.||+|++..+++.||||++..... .....+.+|+.++.+++|+||+++++++ ......+
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~ 75 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF-----YKEGEIS 75 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEE-----ccCCeEE
Confidence 468889999999999999999988899999999875443 3457899999999999999999999985 4457899
Q ss_pred EEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCC-CCeeeccCCCCCeeeCCCCCeEEe
Q 002857 239 LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCK-PPIAHCDIKPSNILLNDEMTACVA 317 (873)
Q Consensus 239 LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s-~gIvHrDLKpsNILLd~~~~vKLs 317 (873)
+||||+++++|.+++.. ...+++..++.++.|+++||+||| + .+++|+||+|+||+++.++.++|+
T Consensus 76 lv~e~~~~~~L~~~l~~----------~~~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~ 142 (264)
T cd06623 76 IVLEYMDGGSLADLLKK----------VGKIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIA 142 (264)
T ss_pred EEEEecCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEc
Confidence 99999999999999942 256899999999999999999999 8 999999999999999999999999
Q ss_pred ccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCch
Q 002857 318 DFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPE 397 (873)
Q Consensus 318 DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~ 397 (873)
|||++.......... ....++..|+|||.+.+..++.++||||||+++|+|+||+.||....... .
T Consensus 143 df~~~~~~~~~~~~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~--~---------- 208 (264)
T cd06623 143 DFGISKVLENTLDQC--NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPS--F---------- 208 (264)
T ss_pred cCccceecccCCCcc--cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccC--H----------
Confidence 999998664332221 23457889999999999999999999999999999999999997632200 0
Q ss_pred hHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHH
Q 002857 398 RVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELG 464 (873)
Q Consensus 398 ~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~ 464 (873)
.+++....... ..+.... .....+.+++.+||+.+|++||++.|+++.
T Consensus 209 --~~~~~~~~~~~-----------~~~~~~~------~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 209 --FELMQAICDGP-----------PPSLPAE------EFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred --HHHHHHHhcCC-----------CCCCCcc------cCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 01111110000 0000000 012358889999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=305.20 Aligned_cols=203 Identities=25% Similarity=0.399 Sum_probs=169.2
Q ss_pred hhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCC-cchhHHHHHHHHHHhhhhccceeeeeeeecccccCCce
Q 002857 158 ATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH-DASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDF 236 (873)
Q Consensus 158 at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~ 236 (873)
++++|.+.+.||+|+||.||+|....++..||+|++..... .....+.+|+.+++.++|+||+++++++ ..+..
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~-----~~~~~ 77 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII-----HTKET 77 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEE-----ecCCe
Confidence 56889999999999999999999988899999999864432 2334678899999999999999999985 44567
Q ss_pred EEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEE
Q 002857 237 KALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACV 316 (873)
Q Consensus 237 ~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKL 316 (873)
.++||||+. ++|.+++.. ....+++..+..++.||+.||.||| +.+|+|+||||+|||++.++.+||
T Consensus 78 ~~lv~e~~~-~~l~~~~~~---------~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l 144 (291)
T cd07870 78 LTFVFEYMH-TDLAQYMIQ---------HPGGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKL 144 (291)
T ss_pred EEEEEeccc-CCHHHHHHh---------CCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEE
Confidence 899999995 677776632 2345778888999999999999999 889999999999999999999999
Q ss_pred eccccccccccccccccccccccccccCCCcccCCC-CCCcchhhHhHHHHHHHHHhCCCCCCcc
Q 002857 317 ADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGH-ETSSYGDVYSFGILLLEMFTGLRPSDDM 380 (873)
Q Consensus 317 sDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELlTGk~Pf~~~ 380 (873)
+|||+++....... ......++..|+|||++.+. .++.++||||||+++|||++|+.||+..
T Consensus 145 ~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~ 207 (291)
T cd07870 145 ADFGLARAKSIPSQ--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGV 207 (291)
T ss_pred eccccccccCCCCC--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCc
Confidence 99999975432211 11223478899999998764 5788999999999999999999999764
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=317.94 Aligned_cols=202 Identities=24% Similarity=0.286 Sum_probs=172.2
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeecc---CCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCce
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFL---HHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDF 236 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~ 236 (873)
++|++.+.||+|+||.||++++..+++.||+|++... .......+.+|+.++..++|+||+++++++ ...+.
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~-----~~~~~ 75 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAF-----QDENY 75 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCE
Confidence 4789999999999999999999889999999998642 222335588899999999999999999985 45678
Q ss_pred EEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEE
Q 002857 237 KALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACV 316 (873)
Q Consensus 237 ~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKL 316 (873)
.++||||+++|+|.+++.. ....+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||
T Consensus 76 ~~lv~Ey~~gg~L~~~l~~---------~~~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl 143 (331)
T cd05624 76 LYLVMDYYVGGDLLTLLSK---------FEDRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRL 143 (331)
T ss_pred EEEEEeCCCCCcHHHHHHH---------hcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEE
Confidence 9999999999999999952 2346888899999999999999999 899999999999999999999999
Q ss_pred eccccccccccccccccccccccccccCCCcccCC-----CCCCcchhhHhHHHHHHHHHhCCCCCCc
Q 002857 317 ADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMG-----HETSSYGDVYSFGILLLEMFTGLRPSDD 379 (873)
Q Consensus 317 sDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-----~~~s~ksDVwSfGvvL~ELlTGk~Pf~~ 379 (873)
+|||+++........ ......||..|+|||++.+ ..++.++||||||+++|||++|+.||..
T Consensus 144 ~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~ 210 (331)
T cd05624 144 ADFGSCLKMNQDGTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred EeccceeeccCCCce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccC
Confidence 999999765432221 1223458999999998875 4678899999999999999999999965
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=316.55 Aligned_cols=202 Identities=25% Similarity=0.289 Sum_probs=171.2
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeecc---CCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCce
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFL---HHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDF 236 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~ 236 (873)
++|++.++||+|+||.||++++..+++.||+|++... .......+.+|+.++..++|+||+++++++ .....
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~ 75 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAF-----QDENN 75 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEE-----ecCCE
Confidence 4788999999999999999999888999999998632 222334588899999999999999999985 45678
Q ss_pred EEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEE
Q 002857 237 KALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACV 316 (873)
Q Consensus 237 ~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKL 316 (873)
.++||||+++|+|.+++.. ....+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||
T Consensus 76 ~~lv~ey~~~g~L~~~l~~---------~~~~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL 143 (332)
T cd05623 76 LYLVMDYYVGGDLLTLLSK---------FEDRLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRL 143 (332)
T ss_pred EEEEEeccCCCcHHHHHHH---------hcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEE
Confidence 9999999999999999952 2346888899999999999999999 899999999999999999999999
Q ss_pred eccccccccccccccccccccccccccCCCcccC-----CCCCCcchhhHhHHHHHHHHHhCCCCCCc
Q 002857 317 ADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGM-----GHETSSYGDVYSFGILLLEMFTGLRPSDD 379 (873)
Q Consensus 317 sDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~-----~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~ 379 (873)
+|||+++.+..... .......||..|+|||++. ...++.++|||||||++|||++|+.||..
T Consensus 144 ~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~ 210 (332)
T cd05623 144 ADFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA 210 (332)
T ss_pred eecchheecccCCc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCC
Confidence 99999975433221 1122346899999999886 34678999999999999999999999965
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=303.53 Aligned_cols=253 Identities=22% Similarity=0.270 Sum_probs=191.1
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCC-cchhHHHHHHHH-HHhhhhccceeeeeeeecccccCCceE
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH-DASKSFTVECEV-MRNIIHRKIIKVVTACSRVDYQGNDFK 237 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~-~~~~~f~~Ei~i-L~~L~HpNIV~llg~c~~~~~~~~~~~ 237 (873)
++|++.+.||+|+||.||+|++..+++.||+|+++.... .....+..|+.+ ++.++|+||+++++++ ..+...
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~-----~~~~~~ 75 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGAL-----FREGDV 75 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEE-----ecCCcE
Confidence 478899999999999999999988999999999875432 233456667665 5566899999999986 345568
Q ss_pred EEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCC-CeeeccCCCCCeeeCCCCCeEE
Q 002857 238 ALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKP-PIAHCDIKPSNILLNDEMTACV 316 (873)
Q Consensus 238 ~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~-gIvHrDLKpsNILLd~~~~vKL 316 (873)
++||||++ |+|.+++... ......+++..++.++.||+.||+||| +. +++||||||+|||++.++.+||
T Consensus 76 ~lv~e~~~-~~l~~~l~~~------~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl 145 (283)
T cd06617 76 WICMEVMD-TSLDKFYKKV------YDKGLTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKL 145 (283)
T ss_pred EEEhhhhc-ccHHHHHHHh------ccCCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEE
Confidence 99999996 6888887431 122356899999999999999999999 65 9999999999999999999999
Q ss_pred eccccccccccccccccccccccccccCCCcccCC----CCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHh
Q 002857 317 ADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMG----HETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQ 392 (873)
Q Consensus 317 sDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~----~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~ 392 (873)
+|||++....... ......++..|+|||++.+ ..++.++||||||+++|||++|+.||........
T Consensus 146 ~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~------- 215 (283)
T cd06617 146 CDFGISGYLVDSV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQ------- 215 (283)
T ss_pred eeccccccccccc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHH-------
Confidence 9999998653221 1122457889999998765 4568899999999999999999999864211100
Q ss_pred hcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 393 SALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 393 ~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
.+.......... .+. ......+.+++.+||+.+|++||++.+|++
T Consensus 216 -----~~~~~~~~~~~~-------------~~~--------~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 216 -----QLKQVVEEPSPQ-------------LPA--------EKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred -----HHHHHHhcCCCC-------------CCc--------cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111111100000 000 011235788999999999999999999876
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=297.88 Aligned_cols=253 Identities=25% Similarity=0.363 Sum_probs=198.3
Q ss_pred CCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCc--chhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEE
Q 002857 161 GFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHD--ASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKA 238 (873)
Q Consensus 161 ~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~ 238 (873)
+|+..+.||+|+||.||+|....+++.||+|.++..... ..+.+..|++++++++|+||+++++++ ...+..+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~-----~~~~~~~ 75 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVE-----VHREKVY 75 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeE-----ecCCEEE
Confidence 578889999999999999999888999999998755443 557899999999999999999999985 4566789
Q ss_pred EEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEec
Q 002857 239 LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVAD 318 (873)
Q Consensus 239 LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsD 318 (873)
+|+||+++++|.+++.. ...+++..+..|+.+++.||.||| +.+|+|+||+|+||++++++.+||+|
T Consensus 76 lv~e~~~~~~L~~~~~~----------~~~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d 142 (264)
T cd06626 76 IFMEYCSGGTLEELLEH----------GRILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGD 142 (264)
T ss_pred EEEecCCCCcHHHHHhh----------cCCCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcc
Confidence 99999999999999842 345788899999999999999999 89999999999999999999999999
Q ss_pred ccccccccccccccc--ccccccccccCCCcccCCCC---CCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhh
Q 002857 319 FGIARFLEATNEQTS--SIGVKGTTGYIAPEYGMGHE---TSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQS 393 (873)
Q Consensus 319 FGla~~~~~~~~~~~--~~~~~Gt~~Y~APE~l~~~~---~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~ 393 (873)
||++........... .....++..|+|||++.+.. .+.++||||||+++|||++|+.||....... ........
T Consensus 143 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~-~~~~~~~~ 221 (264)
T cd06626 143 FGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF-QIMFHVGA 221 (264)
T ss_pred cccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH-HHHHHHhc
Confidence 999987644332111 11245788999999988766 8899999999999999999999996532110 00000000
Q ss_pred cCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 394 ALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 394 ~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
.. ....|.. ......+.+++.+||+.+|++|||+.|++.
T Consensus 222 ---------------~~---------~~~~~~~-------~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 222 ---------------GH---------KPPIPDS-------LQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred ---------------CC---------CCCCCcc-------cccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00 0000100 011234678999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=304.43 Aligned_cols=201 Identities=27% Similarity=0.360 Sum_probs=171.8
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC--CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceE
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH--HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFK 237 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~ 237 (873)
++|++.+.||+|+||.||+|.+..+++.||+|+++... ....+.+.+|++++++++|+||+++++++. .++..
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~ 75 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFR-----RKGRL 75 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEE-----ECCEE
Confidence 36889999999999999999998889999999986432 233467899999999999999999999963 46679
Q ss_pred EEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEe
Q 002857 238 ALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVA 317 (873)
Q Consensus 238 ~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLs 317 (873)
++||||++++.+..++. ....+++.+++.++.||+.||+||| ..+|+|+||+|+||++++++.+||+
T Consensus 76 ~iv~e~~~~~~l~~~~~----------~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~ 142 (288)
T cd07833 76 YLVFEYVERTLLELLEA----------SPGGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLC 142 (288)
T ss_pred EEEEecCCCCHHHHHHh----------cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEE
Confidence 99999999877776552 2345889999999999999999999 8899999999999999999999999
Q ss_pred ccccccccccccccccccccccccccCCCcccCCC-CCCcchhhHhHHHHHHHHHhCCCCCCc
Q 002857 318 DFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGH-ETSSYGDVYSFGILLLEMFTGLRPSDD 379 (873)
Q Consensus 318 DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELlTGk~Pf~~ 379 (873)
|||++......... ......++..|+|||++.+. .++.++||||||+++|+|++|+.||..
T Consensus 143 d~g~~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~ 204 (288)
T cd07833 143 DFGFARALRARPAS-PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPG 204 (288)
T ss_pred eeecccccCCCccc-cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99999876543321 22234578899999999888 889999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=321.75 Aligned_cols=250 Identities=22% Similarity=0.333 Sum_probs=196.0
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeecc---CCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCce
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFL---HHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDF 236 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~ 236 (873)
++|+..+.||+|+||.||++....+++.||||+++.. .......+..|+.++..++|+||+++++.+ ...+.
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~-----~~~~~ 75 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSF-----QDKRN 75 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCE
Confidence 4688999999999999999999989999999999743 223346788899999999999999999985 55678
Q ss_pred EEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEE
Q 002857 237 KALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACV 316 (873)
Q Consensus 237 ~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKL 316 (873)
.+|||||+++|+|.+++. ....+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||
T Consensus 76 ~~lv~E~~~gg~L~~~l~----------~~~~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL 142 (360)
T cd05627 76 LYLIMEFLPGGDMMTLLM----------KKDTLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKL 142 (360)
T ss_pred EEEEEeCCCCccHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEE
Confidence 999999999999999984 2456889999999999999999999 899999999999999999999999
Q ss_pred ecccccccccccccc---------------------------------ccccccccccccCCCcccCCCCCCcchhhHhH
Q 002857 317 ADFGIARFLEATNEQ---------------------------------TSSIGVKGTTGYIAPEYGMGHETSSYGDVYSF 363 (873)
Q Consensus 317 sDFGla~~~~~~~~~---------------------------------~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSf 363 (873)
+|||+++.+...... .......||..|+|||++.+..++.++|||||
T Consensus 143 ~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSl 222 (360)
T cd05627 143 SDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSL 222 (360)
T ss_pred eeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccc
Confidence 999998754321100 00113469999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCcccccch--hhHHHHh-------hcCchhHHHHhhhhhhhhhhHHH---HHhhhccCCCCch
Q 002857 364 GILLLEMFTGLRPSDDMFKDNL--NLQNWVQ-------SALPERVEEIVDTLFFKEIEEEE---TVYKYKKAPSSST 428 (873)
Q Consensus 364 GvvL~ELlTGk~Pf~~~~~~~~--~l~~~~~-------~~~~~~l~elid~~L~~~~~~r~---~~~~i~~~p~~~~ 428 (873)
||++|||+||+.||........ .+..|.. ..+.+...+++..++ .++..|. ...+++.|||...
T Consensus 223 Gvilyel~tG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~ 298 (360)
T cd05627 223 GVIMYEMLIGYPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFEG 298 (360)
T ss_pred cceeeecccCCCCCCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCCC
Confidence 9999999999999976332211 1111110 012345666776654 3555554 3567788888653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=304.59 Aligned_cols=275 Identities=22% Similarity=0.254 Sum_probs=196.9
Q ss_pred CCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCc-----chhHHHHHHHHHHhhhhccceeeeeeeecccccCCc
Q 002857 161 GFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHD-----ASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGND 235 (873)
Q Consensus 161 ~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~-----~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~ 235 (873)
+|+..+.||+|+||.||+|.+..+++.||||.++..... ....+..|++++++++|+||+++++++ ....
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~ 75 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVF-----GHKS 75 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhhee-----ecCC
Confidence 477889999999999999999888999999999754322 234577899999999999999999996 3466
Q ss_pred eEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeE
Q 002857 236 FKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTAC 315 (873)
Q Consensus 236 ~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vK 315 (873)
..++||||+ +|+|.+++.. ....+++..++.++.||++||+||| +.+|+|+||+|+||+++.++.+|
T Consensus 76 ~~~lv~e~~-~~~L~~~i~~---------~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~ 142 (298)
T cd07841 76 NINLVFEFM-ETDLEKVIKD---------KSIVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLK 142 (298)
T ss_pred EEEEEEccc-CCCHHHHHhc---------cCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEE
Confidence 789999999 8999999843 1236899999999999999999999 89999999999999999999999
Q ss_pred EeccccccccccccccccccccccccccCCCcccCC-CCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhc
Q 002857 316 VADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMG-HETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSA 394 (873)
Q Consensus 316 LsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~ 394 (873)
|+|||+++....... ......++..|+|||++.+ ..++.++||||||+++|||++|..+|...... ..+.......
T Consensus 143 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~-~~~~~~~~~~ 219 (298)
T cd07841 143 LADFGLARSFGSPNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI-DQLGKIFEAL 219 (298)
T ss_pred EccceeeeeccCCCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH-HHHHHHHHHc
Confidence 999999986644321 1122346788999998865 45789999999999999999997777542211 1111111000
Q ss_pred CchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 395 LPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 395 ~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
.........+..-.... ......+... ...........+.+++.+||+.+|++|||+.||+.
T Consensus 220 ~~~~~~~~~~~~~~~~~------~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 220 GTPTEENWPGVTSLPDY------VEFKPFPPTP-LKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred CCCchhhhhhccccccc------ccccccCCcc-hhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 00000000000000000 0000000000 01111222456889999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=346.74 Aligned_cols=261 Identities=19% Similarity=0.265 Sum_probs=198.1
Q ss_pred HHhhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC--CcchhHHHHHHHHHHhhhhccceeeeeeeecccccC
Q 002857 156 YSATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH--HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQG 233 (873)
Q Consensus 156 ~~at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~ 233 (873)
....++|.+.+.||+|+||.||+|.+..++..||+|++.... ......|..|+.+|++|+|||||++++++.. ..
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~d---e~ 85 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLN---KA 85 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEe---cC
Confidence 334578999999999999999999999999999999987432 2334678999999999999999999998642 33
Q ss_pred CceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCC----CCCeeeccCCCCCeeeC
Q 002857 234 NDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGC----KPPIAHCDIKPSNILLN 309 (873)
Q Consensus 234 ~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~----s~gIvHrDLKpsNILLd 309 (873)
....+|||||+++|+|.++|... ......+++..++.|+.||+.||+|||... ..+||||||||+||||+
T Consensus 86 ~~~lyIVMEY~~gGSL~~lL~k~------~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~ 159 (1021)
T PTZ00266 86 NQKLYILMEFCDAGDLSRNIQKC------YKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLS 159 (1021)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHH------hhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEee
Confidence 45789999999999999998531 122356899999999999999999999321 14599999999999996
Q ss_pred C-----------------CCCeEEeccccccccccccccccccccccccccCCCcccCC--CCCCcchhhHhHHHHHHHH
Q 002857 310 D-----------------EMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMG--HETSSYGDVYSFGILLLEM 370 (873)
Q Consensus 310 ~-----------------~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~--~~~s~ksDVwSfGvvL~EL 370 (873)
. ...+||+|||+++.+.... ......||+.|+|||++.+ ..++.++||||||||||||
T Consensus 160 s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYEL 236 (1021)
T PTZ00266 160 TGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYEL 236 (1021)
T ss_pred cCccccccccccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHH
Confidence 4 2358999999998653321 1223468999999999864 4588999999999999999
Q ss_pred HhCCCCCCcccccchhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhcc
Q 002857 371 FTGLRPSDDMFKDNLNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAE 450 (873)
Q Consensus 371 lTGk~Pf~~~~~~~~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~ 450 (873)
+||+.||..... ...++ ..+. ..+ ..+.. .....+.+|+..||+.
T Consensus 237 LTGk~PF~~~~~----~~qli---------~~lk----~~p----------~lpi~--------~~S~eL~dLI~~~L~~ 281 (1021)
T PTZ00266 237 CSGKTPFHKANN----FSQLI---------SELK----RGP----------DLPIK--------GKSKELNILIKNLLNL 281 (1021)
T ss_pred HHCCCCCCcCCc----HHHHH---------HHHh----cCC----------CCCcC--------CCCHHHHHHHHHHhcC
Confidence 999999964211 00000 0000 000 00000 0123478899999999
Q ss_pred CcCCCCCHHHHHH
Q 002857 451 LPGERMKINDVEL 463 (873)
Q Consensus 451 dP~eRPTm~EVl~ 463 (873)
+|.+||++.|++.
T Consensus 282 dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 282 SAKERPSALQCLG 294 (1021)
T ss_pred ChhHCcCHHHHhc
Confidence 9999999999984
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=304.74 Aligned_cols=254 Identities=22% Similarity=0.289 Sum_probs=195.6
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC-CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEE
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH-HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKA 238 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~ 238 (873)
++|++.+.||+|+||.||++.+..++..||+|.++... ......+.+|++++++++|+||+++++.+ ...+..+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~ 75 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF-----FIEGAVY 75 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhhe-----ecCCeEE
Confidence 36788999999999999999998889999999887432 22346788999999999999999999985 4467899
Q ss_pred EEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEec
Q 002857 239 LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVAD 318 (873)
Q Consensus 239 LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsD 318 (873)
+||||+++++|..++... .....+++..+..++.||+.||.|||+ +.+|+|+||||+||+++.++.+||+|
T Consensus 76 lv~e~~~~~~l~~~~~~~-------~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d 146 (286)
T cd06622 76 MCMEYMDAGSLDKLYAGG-------VATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCD 146 (286)
T ss_pred EEEeecCCCCHHHHHHhc-------cccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEee
Confidence 999999999999988530 113468999999999999999999993 35999999999999999999999999
Q ss_pred cccccccccccccccccccccccccCCCcccCCC------CCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHh
Q 002857 319 FGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGH------ETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQ 392 (873)
Q Consensus 319 FGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~------~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~ 392 (873)
||++..+.... .....++..|+|||++.+. .++.++|||||||++|||++|+.||....... ...
T Consensus 147 fg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~--- 217 (286)
T cd06622 147 FGVSGNLVASL----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN--IFA--- 217 (286)
T ss_pred cCCcccccCCc----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh--HHH---
Confidence 99997653221 1223478899999998554 35889999999999999999999996421110 000
Q ss_pred hcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 393 SALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 393 ~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
.+..+.+... +... ......+.+++.+||+.+|++||++.+++.
T Consensus 218 -----~~~~~~~~~~----------------~~~~------~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 218 -----QLSAIVDGDP----------------PTLP------SGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred -----HHHHHhhcCC----------------CCCC------cccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 0111111000 0000 012335778999999999999999998876
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=303.17 Aligned_cols=202 Identities=24% Similarity=0.374 Sum_probs=168.9
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCC-cchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceE
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH-DASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFK 237 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~ 237 (873)
-++|++.+.||+|++|.||+|....+++.||||.+..... .....+.+|++++++++|+||+++++++ ..+...
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~ 78 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDII-----HTKKTL 78 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEE-----ecCCeE
Confidence 3678999999999999999999988899999999874332 2234577899999999999999999985 456789
Q ss_pred EEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEe
Q 002857 238 ALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVA 317 (873)
Q Consensus 238 ~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLs 317 (873)
++||||+.+ +|.+++.. ....+++.....++.||+.||.||| +.+|+||||||+||+++.++.+||+
T Consensus 79 ~lv~e~~~~-~L~~~~~~---------~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~ 145 (291)
T cd07844 79 TLVFEYLDT-DLKQYMDD---------CGGGLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLA 145 (291)
T ss_pred EEEEecCCC-CHHHHHHh---------CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEEC
Confidence 999999975 99998842 2346888999999999999999999 8999999999999999999999999
Q ss_pred ccccccccccccccccccccccccccCCCcccCC-CCCCcchhhHhHHHHHHHHHhCCCCCCcc
Q 002857 318 DFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMG-HETSSYGDVYSFGILLLEMFTGLRPSDDM 380 (873)
Q Consensus 318 DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~ 380 (873)
|||+++...... .......++..|+|||++.+ ..++.++||||||+++|||++|+.||...
T Consensus 146 dfg~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~ 207 (291)
T cd07844 146 DFGLARAKSVPS--KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGS 207 (291)
T ss_pred ccccccccCCCC--ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999987542211 11122346788999998876 45789999999999999999999999653
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=308.81 Aligned_cols=252 Identities=26% Similarity=0.322 Sum_probs=196.7
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCc---chhHHHHHHHHHHhhhhccceeeeeeeecccccCCce
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHD---ASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDF 236 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~---~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~ 236 (873)
++|+..+.||+|+||.||+|....+++.||+|.+...... ..+.+..|+++++.++|+||+++++.+ .....
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~ 75 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASF-----QTETY 75 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeee-----ecCCE
Confidence 4688899999999999999999888999999998754322 345788999999999999999999985 45667
Q ss_pred EEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEE
Q 002857 237 KALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACV 316 (873)
Q Consensus 237 ~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKL 316 (873)
.++||||+.+++|.+++.. .....+++..+..++.||+.||+||| +.+++|+||||+||+++.++.++|
T Consensus 76 ~~lv~e~~~~~~L~~~~~~--------~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l 144 (316)
T cd05574 76 LCLVMDYCPGGELFRLLQR--------QPGKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIML 144 (316)
T ss_pred EEEEEEecCCCCHHHHHHh--------CCCCccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEE
Confidence 8999999999999999853 22356899999999999999999999 899999999999999999999999
Q ss_pred eccccccccccccccc---------------------------cccccccccccCCCcccCCCCCCcchhhHhHHHHHHH
Q 002857 317 ADFGIARFLEATNEQT---------------------------SSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLE 369 (873)
Q Consensus 317 sDFGla~~~~~~~~~~---------------------------~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~E 369 (873)
+|||++.......... ......|+..|+|||++.+..++.++||||||+++|+
T Consensus 145 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~ 224 (316)
T cd05574 145 SDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYE 224 (316)
T ss_pred eecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHH
Confidence 9999987543221100 1112357889999999999889999999999999999
Q ss_pred HHhCCCCCCcccccchhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhc
Q 002857 370 MFTGLRPSDDMFKDNLNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSA 449 (873)
Q Consensus 370 LlTGk~Pf~~~~~~~~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~ 449 (873)
|++|+.||....... .+..+.+.... .+... .....+.+++.+||+
T Consensus 225 l~~g~~pf~~~~~~~-------------~~~~~~~~~~~--------------~~~~~-------~~~~~~~~li~~~l~ 270 (316)
T cd05574 225 MLYGTTPFKGSNRDE-------------TFSNILKKEVT--------------FPGSP-------PVSSSARDLIRKLLV 270 (316)
T ss_pred HhhCCCCCCCCchHH-------------HHHHHhcCCcc--------------CCCcc-------ccCHHHHHHHHHHcc
Confidence 999999996532111 11111111000 00000 013358899999999
Q ss_pred cCcCCCCCHHHH
Q 002857 450 ELPGERMKINDV 461 (873)
Q Consensus 450 ~dP~eRPTm~EV 461 (873)
.+|++|||+...
T Consensus 271 ~~p~~R~s~~~~ 282 (316)
T cd05574 271 KDPSKRLGSKRG 282 (316)
T ss_pred CCHhHCCCchhh
Confidence 999999994333
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=309.69 Aligned_cols=248 Identities=20% Similarity=0.252 Sum_probs=194.8
Q ss_pred CcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEEEEe
Q 002857 163 SSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKALVYE 242 (873)
Q Consensus 163 ~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~LV~E 242 (873)
.....||+|+||.||++....++..||||.+........+.+.+|+.+++.++|+||+++++.+ ..++..++|||
T Consensus 25 ~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~-----~~~~~~~lv~e 99 (292)
T cd06658 25 DSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY-----LVGDELWVVME 99 (292)
T ss_pred hhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHhe-----ecCCeEEEEEe
Confidence 3346799999999999999888999999998765555567789999999999999999999985 44667899999
Q ss_pred ecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEeccccc
Q 002857 243 FMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIA 322 (873)
Q Consensus 243 y~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDFGla 322 (873)
|+++++|.+++.. ..+++.+++.++.||+.||+||| +.+|+||||||+||++++++.++|+|||++
T Consensus 100 ~~~~~~L~~~~~~-----------~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~ 165 (292)
T cd06658 100 FLEGGALTDIVTH-----------TRMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFC 165 (292)
T ss_pred CCCCCcHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcch
Confidence 9999999998732 34788999999999999999999 889999999999999999999999999998
Q ss_pred cccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCchhHHHH
Q 002857 323 RFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPERVEEI 402 (873)
Q Consensus 323 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~~l~el 402 (873)
........ ......++..|+|||++.+..++.++||||||+++|||++|+.||....... ....+ ...
T Consensus 166 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~--~~~~~--------~~~ 233 (292)
T cd06658 166 AQVSKEVP--KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ--AMRRI--------RDN 233 (292)
T ss_pred hhcccccc--cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHH--------Hhc
Confidence 75533221 1223458899999999988889999999999999999999999986421110 00000 000
Q ss_pred hhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHH
Q 002857 403 VDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELG 464 (873)
Q Consensus 403 id~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~ 464 (873)
....+.. . ......+.+++.+||+.+|++|||+.||++.
T Consensus 234 ~~~~~~~--------------------~---~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 234 LPPRVKD--------------------S---HKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred CCCcccc--------------------c---cccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 0000000 0 0012246789999999999999999998863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=317.99 Aligned_cols=192 Identities=27% Similarity=0.331 Sum_probs=160.5
Q ss_pred ecccCceEEEEEEEcCCCcEEEEEEeeccC---CcchhHHHHHHHHHHhh---hhccceeeeeeeecccccCCceEEEEE
Q 002857 168 IGAGNFASVYKGILFEGAPAVAIKVFNFLH---HDASKSFTVECEVMRNI---IHRKIIKVVTACSRVDYQGNDFKALVY 241 (873)
Q Consensus 168 LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L---~HpNIV~llg~c~~~~~~~~~~~~LV~ 241 (873)
||+|+||.||+|++..+++.||||++.... ......+..|..++.+. +||||++++..+ ......++||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~-----~~~~~~~lv~ 75 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSF-----QTDSDLYLVT 75 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEE-----ecCCeEEEEE
Confidence 799999999999998899999999986422 12233455677777665 699999999885 4567899999
Q ss_pred eecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEecccc
Q 002857 242 EFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGI 321 (873)
Q Consensus 242 Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDFGl 321 (873)
||+++|+|.+++. ....+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 76 e~~~~g~L~~~l~----------~~~~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~ 142 (330)
T cd05586 76 DYMSGGELFWHLQ----------KEGRFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGL 142 (330)
T ss_pred cCCCCChHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCc
Confidence 9999999999884 2456889999999999999999999 89999999999999999999999999999
Q ss_pred ccccccccccccccccccccccCCCcccCCC-CCCcchhhHhHHHHHHHHHhCCCCCCc
Q 002857 322 ARFLEATNEQTSSIGVKGTTGYIAPEYGMGH-ETSSYGDVYSFGILLLEMFTGLRPSDD 379 (873)
Q Consensus 322 a~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELlTGk~Pf~~ 379 (873)
++...... .......||..|+|||++.+. .++.++|||||||++|||+||+.||..
T Consensus 143 a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~ 199 (330)
T cd05586 143 SKANLTDN--KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYA 199 (330)
T ss_pred CcCCCCCC--CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCC
Confidence 97542222 112235689999999998765 479999999999999999999999965
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=300.59 Aligned_cols=254 Identities=23% Similarity=0.345 Sum_probs=196.7
Q ss_pred CCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCC------cchhHHHHHHHHHHhhhhccceeeeeeeecccccCC
Q 002857 161 GFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH------DASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGN 234 (873)
Q Consensus 161 ~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~------~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~ 234 (873)
+|+..+.||+|++|.||+|....+++.||+|++..... ...+.+.+|++++++++|+||+++++++ ...
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~ 75 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGAT-----CED 75 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhcee-----ccC
Confidence 47888999999999999999988999999999864321 1246789999999999999999999995 456
Q ss_pred ceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCC-C
Q 002857 235 DFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEM-T 313 (873)
Q Consensus 235 ~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~-~ 313 (873)
+..++||||+++++|.+++.. ...+++..++.++.||+.||.||| +.+++|+||+|+||+++.++ .
T Consensus 76 ~~~~~v~e~~~~~~L~~~l~~----------~~~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~ 142 (268)
T cd06630 76 SHFNLFVEWMAGGSVSHLLSK----------YGAFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQR 142 (268)
T ss_pred CeEEEEEeccCCCcHHHHHHH----------hCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCE
Confidence 678999999999999999842 346888999999999999999999 89999999999999998775 6
Q ss_pred eEEecccccccccccccc--ccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHH
Q 002857 314 ACVADFGIARFLEATNEQ--TSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWV 391 (873)
Q Consensus 314 vKLsDFGla~~~~~~~~~--~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~ 391 (873)
+||+|||++......... .......++..|+|||++.+..++.++||||||+++|+|++|..||....... .....
T Consensus 143 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~--~~~~~ 220 (268)
T cd06630 143 LRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN--HLALI 220 (268)
T ss_pred EEEcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcc--hHHHH
Confidence 999999999866433211 11123457889999999988889999999999999999999999986421110 00000
Q ss_pred hhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 392 QSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 392 ~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
..+..... .+.. .......+.+++.+||+.+|++||++.|++.
T Consensus 221 --------~~~~~~~~---------------~~~~------~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 221 --------FKIASATT---------------APSI------PEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred --------HHHhccCC---------------CCCC------chhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 00000000 0000 0011235778999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=323.28 Aligned_cols=197 Identities=26% Similarity=0.352 Sum_probs=171.1
Q ss_pred CCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhh-h-----ccceeeeeeeecccccCC
Q 002857 161 GFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNII-H-----RKIIKVVTACSRVDYQGN 234 (873)
Q Consensus 161 ~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~-H-----pNIV~llg~c~~~~~~~~ 234 (873)
+|.+.++||+|.||.|-+|.+..+++.||||+++... .-..+-+.|+.+|..|+ | -|+|++++++ ...
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F-----~fr 260 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYF-----YFR 260 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecc-----ccc
Confidence 7899999999999999999999999999999998543 33456778999999997 4 4899999995 567
Q ss_pred ceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCC--C
Q 002857 235 DFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDE--M 312 (873)
Q Consensus 235 ~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~--~ 312 (873)
++.|||+|.+. -+|+++|+. +.-..++...+..|+.||+.||.+|| ..+|||+||||+||||.+. .
T Consensus 261 ~HlciVfELL~-~NLYellK~--------n~f~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~ 328 (586)
T KOG0667|consen 261 NHLCIVFELLS-TNLYELLKN--------NKFRGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRS 328 (586)
T ss_pred cceeeeehhhh-hhHHHHHHh--------cCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcC
Confidence 89999999995 499999975 45567999999999999999999999 8999999999999999643 4
Q ss_pred CeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcc
Q 002857 313 TACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDM 380 (873)
Q Consensus 313 ~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~ 380 (873)
.+||+|||.|.+..... . ....+..|+|||++.|.+|+.+.||||||||+.||++|.+.|.+.
T Consensus 329 ~vKVIDFGSSc~~~q~v----y-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ 391 (586)
T KOG0667|consen 329 RIKVIDFGSSCFESQRV----Y-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGD 391 (586)
T ss_pred ceeEEecccccccCCcc----e-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCC
Confidence 89999999998653321 1 455788999999999999999999999999999999998888763
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=307.49 Aligned_cols=247 Identities=20% Similarity=0.248 Sum_probs=195.2
Q ss_pred cceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEEEEee
Q 002857 164 SENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKALVYEF 243 (873)
Q Consensus 164 ~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~LV~Ey 243 (873)
....||+|+||.||+|....+++.||+|++........+.+.+|+.+++.++||||+++++++ ..++..++||||
T Consensus 25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~-----~~~~~~~iv~e~ 99 (297)
T cd06659 25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY-----LVGEELWVLMEF 99 (297)
T ss_pred hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhhe-----eeCCeEEEEEec
Confidence 345799999999999999888999999998765555567789999999999999999999985 445678999999
Q ss_pred cCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEecccccc
Q 002857 244 MPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIAR 323 (873)
Q Consensus 244 ~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDFGla~ 323 (873)
+++++|.+++. ...+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++.
T Consensus 100 ~~~~~L~~~~~-----------~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~ 165 (297)
T cd06659 100 LQGGALTDIVS-----------QTRLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCA 165 (297)
T ss_pred CCCCCHHHHHh-----------hcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHh
Confidence 99999998773 235789999999999999999999 8999999999999999999999999999987
Q ss_pred ccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCchhHHHHh
Q 002857 324 FLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPERVEEIV 403 (873)
Q Consensus 324 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~~l~eli 403 (873)
....... ......++..|+|||++.+..++.++||||||+++|||++|+.||...... .....+...
T Consensus 166 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--~~~~~~~~~--------- 232 (297)
T cd06659 166 QISKDVP--KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV--QAMKRLRDS--------- 232 (297)
T ss_pred hcccccc--cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHhcc---------
Confidence 5533221 122345889999999999888999999999999999999999998642111 000000000
Q ss_pred hhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHH
Q 002857 404 DTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELG 464 (873)
Q Consensus 404 d~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~ 464 (873)
.. +.... .......+.+++.+||+.+|++||++.+|++.
T Consensus 233 ---~~---------------~~~~~----~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 233 ---PP---------------PKLKN----AHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred ---CC---------------CCccc----cCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00 00000 00012247789999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=304.83 Aligned_cols=197 Identities=26% Similarity=0.382 Sum_probs=173.3
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC---CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCce
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH---HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDF 236 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~ 236 (873)
++|++.+.||+|+||.||++.+..+++.||+|++.... ....+.+.+|++++++++|+||+++++++ ..+..
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~ 75 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSF-----QDDSN 75 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEE-----EcCCe
Confidence 47889999999999999999998889999999986432 23346788999999999999999999985 45667
Q ss_pred EEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEE
Q 002857 237 KALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACV 316 (873)
Q Consensus 237 ~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKL 316 (873)
.++||||+++++|.+++.. ...+++..+..++.||+.||.||| +.+|+|+||+|+|||++.++.+||
T Consensus 76 ~~~v~e~~~~~~L~~~~~~----------~~~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl 142 (290)
T cd05580 76 LYLVMEYVPGGELFSHLRK----------SGRFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKI 142 (290)
T ss_pred EEEEEecCCCCCHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEE
Confidence 9999999999999999842 356889999999999999999999 899999999999999999999999
Q ss_pred eccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCc
Q 002857 317 ADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDD 379 (873)
Q Consensus 317 sDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~ 379 (873)
+|||+++..... .....++..|+|||.+.+...+.++||||||+++|+|++|+.||..
T Consensus 143 ~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 200 (290)
T cd05580 143 TDFGFAKRVKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFD 200 (290)
T ss_pred eeCCCccccCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 999999865432 2234588999999999888889999999999999999999999865
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=310.08 Aligned_cols=286 Identities=20% Similarity=0.237 Sum_probs=203.1
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC--CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCce
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH--HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDF 236 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~ 236 (873)
.++|++.+.||+|+||.||+|....+++.||+|++.... ....+.+.+|+.+|++++|+||+++++++.... .....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~ 82 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG-ADFKD 82 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC-CCCce
Confidence 478999999999999999999998899999999987432 233467888999999999999999998764322 33457
Q ss_pred EEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEE
Q 002857 237 KALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACV 316 (873)
Q Consensus 237 ~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKL 316 (873)
.++||||+. ++|.+++. ....+++..+..++.||+.||+||| ..+|+||||||+||++++++.+||
T Consensus 83 ~~lv~e~~~-~~l~~~~~----------~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl 148 (334)
T cd07855 83 VYVVMDLME-SDLHHIIH----------SDQPLTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRI 148 (334)
T ss_pred EEEEEehhh-hhHHHHhc----------cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEe
Confidence 899999995 68998884 2345899999999999999999999 899999999999999999999999
Q ss_pred ecccccccccccccc--ccccccccccccCCCcccCC-CCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhh
Q 002857 317 ADFGIARFLEATNEQ--TSSIGVKGTTGYIAPEYGMG-HETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQS 393 (873)
Q Consensus 317 sDFGla~~~~~~~~~--~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~ 393 (873)
+|||+++........ .......++..|+|||++.+ ..++.++||||||+++|||++|+.||...... .....+..
T Consensus 149 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~--~~~~~~~~ 226 (334)
T cd07855 149 GDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYV--HQLKLILS 226 (334)
T ss_pred cccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChH--HHHHHHHH
Confidence 999999765432211 11123468899999998765 46889999999999999999999999653211 11111111
Q ss_pred cCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHH
Q 002857 394 ALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELG 464 (873)
Q Consensus 394 ~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~ 464 (873)
.......++.+........ ...+.....+. .............+.+++.+||+.+|.+|||+.+++..
T Consensus 227 ~~g~~~~~~~~~~~~~~~~--~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 227 VLGSPSEEVLNRIGSDRVR--KYIQNLPRKQP-VPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred HhCCChhHhhhhhchhhHH--HHHhhcccCCC-CCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 1111111111111000000 00000000000 00011111224568899999999999999999988763
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=299.25 Aligned_cols=275 Identities=21% Similarity=0.275 Sum_probs=198.1
Q ss_pred CCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC--CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEE
Q 002857 162 FSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH--HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKAL 239 (873)
Q Consensus 162 f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~L 239 (873)
|++.+.||+|+||.||+|++..+++.+|+|++.... ......+.+|++++++++|+|++++++++... .....++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~~~l 77 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSK---GKGSIYM 77 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecC---CCCcEEE
Confidence 567899999999999999998889999999998553 33345788999999999999999999996421 1367999
Q ss_pred EEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEecc
Q 002857 240 VYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADF 319 (873)
Q Consensus 240 V~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDF 319 (873)
||||+++ +|.+++.. ....+++..++.++.||+.||+||| ..+++|+||+|+||++++++.+||+||
T Consensus 78 v~e~~~~-~l~~~~~~---------~~~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~ 144 (287)
T cd07840 78 VFEYMDH-DLTGLLDS---------PEVKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADF 144 (287)
T ss_pred Eeccccc-cHHHHHhc---------cCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccc
Confidence 9999975 89888742 2256899999999999999999999 889999999999999999999999999
Q ss_pred ccccccccccccccccccccccccCCCcccCC-CCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCc--
Q 002857 320 GIARFLEATNEQTSSIGVKGTTGYIAPEYGMG-HETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALP-- 396 (873)
Q Consensus 320 Gla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~-- 396 (873)
|++........ .......++..|+|||.+.+ ..++.++||||||+++|||+||+.||....... .+.. +.....
T Consensus 145 g~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~-~~~~-~~~~~~~~ 221 (287)
T cd07840 145 GLARPYTKRNS-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELE-QLEK-IFELCGSP 221 (287)
T ss_pred cceeeccCCCc-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHH-HHHHhCCC
Confidence 99986644322 11223346788999997765 457899999999999999999999997532211 1111 111000
Q ss_pred --hhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHH-HHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 397 --ERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILE-CLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 397 --~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e-~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
.....+.+....... ....+........... +...+.+++.+||+.+|.+||++.++++
T Consensus 222 ~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 222 TDENWPGVSKLPWFENL--------KPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred chhhccccccchhhhhc--------cccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 000000000000000 0000000111111112 1456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=292.50 Aligned_cols=254 Identities=23% Similarity=0.332 Sum_probs=200.8
Q ss_pred CCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCC--cchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEE
Q 002857 161 GFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH--DASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKA 238 (873)
Q Consensus 161 ~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~ 238 (873)
+|+..+.||+|++|.||+|....+++.|++|++..... ...+.+.+|++++++++|+||+++++.+... .....+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~~~ 77 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDE---EKNTLN 77 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecC---CCCeEE
Confidence 47788999999999999999988899999999875442 3457899999999999999999999986321 126789
Q ss_pred EEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEec
Q 002857 239 LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVAD 318 (873)
Q Consensus 239 LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsD 318 (873)
+|+||+++++|.+++.. ...+++..++.++.|++.||+||| +.+++|+||+|+||+++.++.++|+|
T Consensus 78 lv~e~~~~~~L~~~~~~----------~~~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d 144 (260)
T cd06606 78 IFLEYVSGGSLSSLLKK----------FGKLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLAD 144 (260)
T ss_pred EEEEecCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcc
Confidence 99999999999999843 237899999999999999999999 89999999999999999999999999
Q ss_pred cccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCchh
Q 002857 319 FGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPER 398 (873)
Q Consensus 319 FGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~~ 398 (873)
||.+................++..|+|||.+.+...+.++||||||+++++|++|..||....... ...
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----~~~------- 213 (260)
T cd06606 145 FGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPM----AAL------- 213 (260)
T ss_pred cccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH----HHH-------
Confidence 999987654432111233458899999999988889999999999999999999999997632110 000
Q ss_pred HHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 399 VEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 399 l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
..+.. ... .+... ......+.+++.+|++.+|++||++.|++.
T Consensus 214 -~~~~~---~~~------------~~~~~------~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 214 -YKIGS---SGE------------PPEIP------EHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred -Hhccc---cCC------------CcCCC------cccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 00000 000 00000 011235788999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=296.74 Aligned_cols=250 Identities=22% Similarity=0.293 Sum_probs=196.9
Q ss_pred CCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC--CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEE
Q 002857 161 GFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH--HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKA 238 (873)
Q Consensus 161 ~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~ 238 (873)
+|++.+.||+|+||.||+|.+..++..||+|.+.... ....+.+.+|++++++++|+||+++++.+ ......+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~-----~~~~~~~ 75 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASF-----QENGRLF 75 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhhee-----ccCCeEE
Confidence 5788999999999999999999889999999986432 23346788999999999999999999985 4566899
Q ss_pred EEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCC-CeEEe
Q 002857 239 LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEM-TACVA 317 (873)
Q Consensus 239 LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~-~vKLs 317 (873)
+|+||+++++|.+++.. .....+++..++.++.|++.||.||| +.+|+|+||||+||++++++ .+||+
T Consensus 76 lv~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~ 144 (257)
T cd08225 76 IVMEYCDGGDLMKRINR--------QRGVLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLG 144 (257)
T ss_pred EEEecCCCCcHHHHHHh--------ccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEec
Confidence 99999999999999843 22345789999999999999999999 89999999999999999875 56999
Q ss_pred ccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCch
Q 002857 318 DFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPE 397 (873)
Q Consensus 318 DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~ 397 (873)
|||.+........ ......|+..|+|||++.+..++.++||||||+++|||++|..||..... ..++.
T Consensus 145 d~~~~~~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~----- 212 (257)
T cd08225 145 DFGIARQLNDSME--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL-----HQLVL----- 212 (257)
T ss_pred ccccchhccCCcc--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-----HHHHH-----
Confidence 9999986643221 11223588899999999888899999999999999999999999864211 11111
Q ss_pred hHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 398 RVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 398 ~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
.+....+.. ... .....+.+++.+||+.+|++|||+.||+.
T Consensus 213 ---~~~~~~~~~---------------~~~-------~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 213 ---KICQGYFAP---------------ISP-------NFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred ---HHhcccCCC---------------CCC-------CCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 111100000 000 01224778999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=300.16 Aligned_cols=248 Identities=25% Similarity=0.355 Sum_probs=195.5
Q ss_pred CCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC-CcchhHHHHHHHHHHhhh---hccceeeeeeeecccccCCce
Q 002857 161 GFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH-HDASKSFTVECEVMRNII---HRKIIKVVTACSRVDYQGNDF 236 (873)
Q Consensus 161 ~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~---HpNIV~llg~c~~~~~~~~~~ 236 (873)
.|+..+.||+|+||.||+|.+..+++.||+|.++... ......+.+|+.++++++ |+|++++++++ ..+..
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~-----~~~~~ 76 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSY-----LKGPR 76 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeee-----eeCCE
Confidence 4778899999999999999998899999999987442 334467889999999997 99999999986 34567
Q ss_pred EEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEE
Q 002857 237 KALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACV 316 (873)
Q Consensus 237 ~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKL 316 (873)
.++||||+++++|.+++.. ..+++..++.++.|++.||.||| ..+|+|+||+|+||+++.++.++|
T Consensus 77 ~~lv~e~~~~~~L~~~~~~-----------~~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l 142 (277)
T cd06917 77 LWIIMEYAEGGSVRTLMKA-----------GPIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKL 142 (277)
T ss_pred EEEEEecCCCCcHHHHHHc-----------cCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEE
Confidence 8999999999999998842 26889999999999999999999 899999999999999999999999
Q ss_pred eccccccccccccccccccccccccccCCCcccCCC-CCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcC
Q 002857 317 ADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGH-ETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSAL 395 (873)
Q Consensus 317 sDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~ 395 (873)
+|||++........ ......|+..|+|||++.+. .++.++||||||+++|+|++|+.||...... ....
T Consensus 143 ~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-----~~~~--- 212 (277)
T cd06917 143 CDFGVAALLNQNSS--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF-----RAMM--- 212 (277)
T ss_pred ccCCceeecCCCcc--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh-----hhhh---
Confidence 99999987644321 12234588899999988654 4688999999999999999999999652111 0000
Q ss_pred chhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 396 PERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 396 ~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
.+... . .+.... . .....+.+++.+||+.+|++||++.|++.
T Consensus 213 ------~~~~~---~------------~~~~~~-~----~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 213 ------LIPKS---K------------PPRLED-N----GYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred ------ccccC---C------------CCCCCc-c----cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 00000 0 000000 0 01235778999999999999999999976
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=311.74 Aligned_cols=204 Identities=25% Similarity=0.265 Sum_probs=171.0
Q ss_pred HhhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeecc--CCcchhHHHHHHHHHHhhhhccceeeeeeeeccc-ccC
Q 002857 157 SATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFL--HHDASKSFTVECEVMRNIIHRKIIKVVTACSRVD-YQG 233 (873)
Q Consensus 157 ~at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~-~~~ 233 (873)
...++|+..+.||+|+||.||+|....+++.||||++... .......+.+|+.++++++|+||+++++++.... +.+
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 3457899999999999999999999889999999998642 2233456788999999999999999999864321 122
Q ss_pred CceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCC
Q 002857 234 NDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMT 313 (873)
Q Consensus 234 ~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~ 313 (873)
....++||||+. ++|.+.+.. .+++..+..++.|++.||+||| ..+|+||||||+||+++.++.
T Consensus 93 ~~~~~lv~e~~~-~~l~~~~~~------------~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~ 156 (353)
T cd07850 93 FQDVYLVMELMD-ANLCQVIQM------------DLDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCT 156 (353)
T ss_pred cCcEEEEEeccC-CCHHHHHhh------------cCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCC
Confidence 345799999995 588887732 2788889999999999999999 899999999999999999999
Q ss_pred eEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCc
Q 002857 314 ACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDD 379 (873)
Q Consensus 314 vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~ 379 (873)
+||+|||+++....... .....++..|+|||++.+..++.++||||||+++|+|++|+.||..
T Consensus 157 ~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~ 219 (353)
T cd07850 157 LKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPG 219 (353)
T ss_pred EEEccCccceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCC
Confidence 99999999986533211 2233578899999999999999999999999999999999999965
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=304.81 Aligned_cols=251 Identities=23% Similarity=0.276 Sum_probs=199.1
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEE
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKAL 239 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~L 239 (873)
++|.+.+.||+|+||.||+|....++..||+|.+........+.+.+|+.++++++||||+++++++ ...+..++
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~-----~~~~~~~l 93 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSY-----LVGDELWV 93 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhhee-----eeCCcEEE
Confidence 5788899999999999999998888899999998755555557789999999999999999999986 34567899
Q ss_pred EEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEecc
Q 002857 240 VYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADF 319 (873)
Q Consensus 240 V~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDF 319 (873)
|+||+++++|.+++.. ..+++..+..++.|++.||.||| +.+++|+||||+||+++.++.+||+||
T Consensus 94 v~e~~~~~~L~~~~~~-----------~~l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~df 159 (293)
T cd06647 94 VMEYLAGGSLTDVVTE-----------TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDF 159 (293)
T ss_pred EEecCCCCcHHHHHhh-----------cCCCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccC
Confidence 9999999999999842 34788899999999999999999 899999999999999999999999999
Q ss_pred ccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCchhH
Q 002857 320 GIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPERV 399 (873)
Q Consensus 320 Gla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~~l 399 (873)
|++........ ......++..|+|||++.+..++.++||||||+++|+|++|+.||........ +.. +..
T Consensus 160 g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~-~~~-~~~------ 229 (293)
T cd06647 160 GFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-LYL-IAT------ 229 (293)
T ss_pred cceeccccccc--ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh-eee-hhc------
Confidence 99875543222 12234588899999999888899999999999999999999999965321110 000 000
Q ss_pred HHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHH
Q 002857 400 EEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELG 464 (873)
Q Consensus 400 ~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~ 464 (873)
... +.... .......+.+++.+||+.+|++||++.+++..
T Consensus 230 --------~~~-------------~~~~~----~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 230 --------NGT-------------PELQN----PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred --------CCC-------------CCCCC----ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 00000 00112347789999999999999999998864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=290.27 Aligned_cols=250 Identities=25% Similarity=0.328 Sum_probs=200.1
Q ss_pred CCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEEE
Q 002857 161 GFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKALV 240 (873)
Q Consensus 161 ~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~LV 240 (873)
+|+..+.||+|++|.||++.+..+++.+++|++..........+.+|++++++++|+||+++++++ ......+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~l~ 75 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSY-----LKKDELWIV 75 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEE-----ecCCeEEEE
Confidence 477889999999999999999888999999999765544567899999999999999999999985 345678999
Q ss_pred EeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEeccc
Q 002857 241 YEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFG 320 (873)
Q Consensus 241 ~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDFG 320 (873)
+||+++++|.+++.. ....+++..+..++.|++.||.||| ..+++||||+|+||++++++.++|+|||
T Consensus 76 ~e~~~~~~L~~~~~~---------~~~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~ 143 (253)
T cd05122 76 MEFCSGGSLKDLLKS---------TNQTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFG 143 (253)
T ss_pred EecCCCCcHHHHHhh---------cCCCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeecc
Confidence 999999999999843 2256899999999999999999999 8999999999999999999999999999
Q ss_pred cccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCchhHH
Q 002857 321 IARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPERVE 400 (873)
Q Consensus 321 la~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~~l~ 400 (873)
.+........ .....++..|+|||++.+..++.++||||||+++|+|++|+.||........ . .
T Consensus 144 ~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~------------~ 207 (253)
T cd05122 144 LSAQLSDTKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKA-L------------F 207 (253)
T ss_pred cccccccccc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHH-H------------H
Confidence 9986644321 2334588999999999888899999999999999999999999865311100 0 0
Q ss_pred HHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 401 EIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 401 elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
.. ...... ..+.. ......+.+++.+||+.+|++|||+.||++
T Consensus 208 ~~-~~~~~~------------~~~~~-------~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 208 KI-ATNGPP------------GLRNP-------EKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred HH-HhcCCC------------CcCcc-------cccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00 000000 00000 001234788999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=297.27 Aligned_cols=275 Identities=21% Similarity=0.228 Sum_probs=193.8
Q ss_pred CCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC-CcchhHHHHHHHHHHhhh-hccceeeeeeeecccccCCceEEE
Q 002857 162 FSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH-HDASKSFTVECEVMRNII-HRKIIKVVTACSRVDYQGNDFKAL 239 (873)
Q Consensus 162 f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~-HpNIV~llg~c~~~~~~~~~~~~L 239 (873)
|++.+.||+|+||.||+|+...+++.||+|+++... .........|+.++.++. |+||+++++++.. ...+..++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~---~~~~~~~l 77 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFD---RKTGRLAL 77 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEec---CCCCcEEE
Confidence 567889999999999999998889999999987432 222234567899999885 9999999999742 22367899
Q ss_pred EEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEecc
Q 002857 240 VYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADF 319 (873)
Q Consensus 240 V~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDF 319 (873)
||||++ |+|.+++.. ....+++.+++.++.||+.||+||| ..+|+||||+|+||+++. +.+||+||
T Consensus 78 v~e~~~-~~l~~~l~~---------~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~df 143 (282)
T cd07831 78 VFELMD-MNLYELIKG---------RKRPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADF 143 (282)
T ss_pred EEecCC-ccHHHHHHh---------ccCCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEec
Confidence 999996 588887742 2356899999999999999999999 899999999999999999 99999999
Q ss_pred ccccccccccccccccccccccccCCCcccCC-CCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCchh
Q 002857 320 GIARFLEATNEQTSSIGVKGTTGYIAPEYGMG-HETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPER 398 (873)
Q Consensus 320 Gla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~~ 398 (873)
|+++........ ....++..|+|||++.. ..++.++|||||||++|||++|+.||..... ..............
T Consensus 144 g~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~--~~~~~~~~~~~~~~ 218 (282)
T cd07831 144 GSCRGIYSKPPY---TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE--LDQIAKIHDVLGTP 218 (282)
T ss_pred ccccccccCCCc---CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCH--HHHHHHHHHHcCCC
Confidence 999865432221 22347889999997654 5578899999999999999999999965321 11112221111111
Q ss_pred HHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 399 VEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 399 l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
..++. ..+...... ...+.. ................+.+++.+||+.+|++||++.++++
T Consensus 219 ~~~~~-~~~~~~~~~---~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 219 DAEVL-KKFRKSRHM---NYNFPS-KKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred CHHHH-Hhhcccccc---cccCcc-cccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 11110 000000000 000000 0000001111223457899999999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=301.34 Aligned_cols=208 Identities=21% Similarity=0.298 Sum_probs=169.1
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC--CcchhHHHHHHHHHHhhhhccceeeeeeeecccc---cC
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH--HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDY---QG 233 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~---~~ 233 (873)
.++|++.++||+|+||.||+|....+++.||||.+.... ......+.+|++++++++||||++++++|..... ..
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 357999999999999999999998899999999986432 2223456789999999999999999998754321 12
Q ss_pred CceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCC
Q 002857 234 NDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMT 313 (873)
Q Consensus 234 ~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~ 313 (873)
....++||||+.+ +|.+++.. ....+++.+++.++.||+.||.||| +.+|+|+||||+||+++.++.
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~---------~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~ 157 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSN---------KNVKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGI 157 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHh---------cccCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCc
Confidence 3457999999964 88887742 2346899999999999999999999 889999999999999999999
Q ss_pred eEEecccccccccccccc--ccccccccccccCCCcccCCC-CCCcchhhHhHHHHHHHHHhCCCCCCc
Q 002857 314 ACVADFGIARFLEATNEQ--TSSIGVKGTTGYIAPEYGMGH-ETSSYGDVYSFGILLLEMFTGLRPSDD 379 (873)
Q Consensus 314 vKLsDFGla~~~~~~~~~--~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELlTGk~Pf~~ 379 (873)
+||+|||++..+...... .......++..|+|||++.+. .++.++||||||+++|||+||+.||..
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~ 226 (310)
T cd07865 158 LKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQG 226 (310)
T ss_pred EEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCC
Confidence 999999999865432211 111233578899999987665 478899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=298.28 Aligned_cols=199 Identities=23% Similarity=0.337 Sum_probs=167.3
Q ss_pred CCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC--CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEE
Q 002857 162 FSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH--HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKAL 239 (873)
Q Consensus 162 f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~L 239 (873)
|++.+.||.|++|.||+|.+..++..||+|++.... ......+.+|++++++++|+|++++++++ ..++..++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~-----~~~~~~~i 75 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVV-----HSENKLYL 75 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhhee-----ccCCeEEE
Confidence 567899999999999999998899999999987443 22335788999999999999999999996 44578999
Q ss_pred EEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEecc
Q 002857 240 VYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADF 319 (873)
Q Consensus 240 V~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDF 319 (873)
||||++ ++|.+++.. .....+++..++.++.|+++||+||| +.+++||||+|+||+++.++.++|+||
T Consensus 76 v~e~~~-~~l~~~~~~--------~~~~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df 143 (283)
T cd07835 76 VFEFLD-LDLKKYMDS--------SPLTGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADF 143 (283)
T ss_pred EEeccC-cCHHHHHhh--------CCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeec
Confidence 999995 699998843 12246899999999999999999999 899999999999999999999999999
Q ss_pred ccccccccccccccccccccccccCCCcccCCC-CCCcchhhHhHHHHHHHHHhCCCCCCc
Q 002857 320 GIARFLEATNEQTSSIGVKGTTGYIAPEYGMGH-ETSSYGDVYSFGILLLEMFTGLRPSDD 379 (873)
Q Consensus 320 Gla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELlTGk~Pf~~ 379 (873)
|+++....... ......++..|+|||++.+. .++.++||||||+++|||++|+.||..
T Consensus 144 ~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 202 (283)
T cd07835 144 GLARAFGVPVR--TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPG 202 (283)
T ss_pred ccccccCCCcc--ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 99975532211 11223468899999987664 568899999999999999999999965
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=300.47 Aligned_cols=283 Identities=17% Similarity=0.181 Sum_probs=196.5
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCC--cchhHHHHHHHHHHhhh-hccceeeeeeeecccccCCce
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH--DASKSFTVECEVMRNII-HRKIIKVVTACSRVDYQGNDF 236 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~-HpNIV~llg~c~~~~~~~~~~ 236 (873)
++|++.+.||+|+||.||+|.+..+++.||||+++.... .....+.+|+.+++++. |+||+++++++..........
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 468899999999999999999988999999999864322 23467888999999995 699999999875433222334
Q ss_pred EEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCC-CCCeE
Q 002857 237 KALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLND-EMTAC 315 (873)
Q Consensus 237 ~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~-~~~vK 315 (873)
.++||||+++ +|.+++... .......+++..++.++.||+.||.||| ..+|+||||||+||+++. ++.+|
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~-----~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~k 151 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSN-----GRGPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLK 151 (295)
T ss_pred EEEEeeccCc-CHHHHHHHh-----cccCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEE
Confidence 7999999985 898888431 1112346899999999999999999999 899999999999999998 88999
Q ss_pred EeccccccccccccccccccccccccccCCCcccCC-CCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhc
Q 002857 316 VADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMG-HETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSA 394 (873)
Q Consensus 316 LsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~ 394 (873)
|+|||+++.+..... ......++..|+|||++.+ ..++.++||||||+++|||++|..||....... .+.......
T Consensus 152 l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~~~~ 228 (295)
T cd07837 152 IADLGLGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ-QLLHIFKLL 228 (295)
T ss_pred EeecccceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHHHh
Confidence 999999975532211 1122346788999998765 457899999999999999999999986532111 111111000
Q ss_pred CchhHHHHhhhhhhhhhhHHHHHhhhccCCCCc--hhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 395 LPERVEEIVDTLFFKEIEEEETVYKYKKAPSSS--TQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 395 ~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~--~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
.... ...... ... .......+... ............+.+++.+||+.+|++||++.|++.
T Consensus 229 ~~~~-~~~~~~-~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 229 GTPT-EQVWPG-VSK-------LRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred CCCC-hhhCcc-hhh-------ccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0000 000000 000 00000000000 000111122346889999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=308.90 Aligned_cols=282 Identities=20% Similarity=0.211 Sum_probs=202.9
Q ss_pred hhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeecc--CCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCc
Q 002857 158 ATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFL--HHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGND 235 (873)
Q Consensus 158 at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~ 235 (873)
+.++|.+.+.||+|+||.||+|+...+++.||||.++.. .......+.+|+.+++.++|+||+++++++.........
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 356799999999999999999999889999999998643 223345678899999999999999999986543222334
Q ss_pred eEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeE
Q 002857 236 FKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTAC 315 (873)
Q Consensus 236 ~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vK 315 (873)
..++||||+. ++|.+++. ....+++..+..++.||+.||.||| +.+++||||||+||+++.++.+|
T Consensus 83 ~~~lv~e~~~-~~L~~~~~----------~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~k 148 (337)
T cd07858 83 DVYIVYELMD-TDLHQIIR----------SSQTLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLK 148 (337)
T ss_pred cEEEEEeCCC-CCHHHHHh----------cCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEE
Confidence 5899999995 68988873 2456899999999999999999999 89999999999999999999999
Q ss_pred EeccccccccccccccccccccccccccCCCcccCC-CCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhc
Q 002857 316 VADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMG-HETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSA 394 (873)
Q Consensus 316 LsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~ 394 (873)
|+|||+++...... .......++..|+|||.+.. ..++.++||||||+++|+|++|+.||...... .....+...
T Consensus 149 L~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~~~ 224 (337)
T cd07858 149 ICDFGLARTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYV--HQLKLITEL 224 (337)
T ss_pred ECcCccccccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChH--HHHHHHHHH
Confidence 99999998654322 11223457889999998765 46889999999999999999999999653211 111111111
Q ss_pred C----chhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHH
Q 002857 395 L----PERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELG 464 (873)
Q Consensus 395 ~----~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~ 464 (873)
. .+.+..+.+..... ........+.... ......+...+.+++.+||+.+|++|||+.|+++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 225 LGSPSEEDLGFIRNEKARR------YIRSLPYTPRQSF-ARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred hCCCChHHhhhcCchhhhH------HHHhcCcccccCH-HHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 1 11111111111100 0011101111100 01111234568899999999999999999999876
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=307.82 Aligned_cols=281 Identities=22% Similarity=0.294 Sum_probs=199.9
Q ss_pred hhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeecc--CCcchhHHHHHHHHHHhh-hhccceeeeeeeecccccCC
Q 002857 158 ATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFL--HHDASKSFTVECEVMRNI-IHRKIIKVVTACSRVDYQGN 234 (873)
Q Consensus 158 at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~L-~HpNIV~llg~c~~~~~~~~ 234 (873)
..++|++.+.||+|+||.||+|.+..+++.||||.+... .......+.+|+.+++++ +|+||+++++++.. .+.
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~---~~~ 81 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKA---END 81 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeecc---CCC
Confidence 356789999999999999999999888999999988532 223345677899999999 99999999998642 234
Q ss_pred ceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCe
Q 002857 235 DFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTA 314 (873)
Q Consensus 235 ~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~v 314 (873)
...++||||++ ++|.+++.. ..+++..++.++.||+.||+||| +.+|+|+||||+||+++.++.+
T Consensus 82 ~~~~lv~e~~~-~~L~~~~~~-----------~~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~ 146 (337)
T cd07852 82 KDIYLVFEYME-TDLHAVIRA-----------NILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRV 146 (337)
T ss_pred ceEEEEecccc-cCHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcE
Confidence 56899999997 599888742 26788899999999999999999 8999999999999999999999
Q ss_pred EEecccccccccccccc---ccccccccccccCCCcccCC-CCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHH
Q 002857 315 CVADFGIARFLEATNEQ---TSSIGVKGTTGYIAPEYGMG-HETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNW 390 (873)
Q Consensus 315 KLsDFGla~~~~~~~~~---~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~ 390 (873)
||+|||+++........ .......++..|+|||++.+ ..++.++||||||+++|||+||+.||........ ....
T Consensus 147 kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~-~~~~ 225 (337)
T cd07852 147 KLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQ-LEKI 225 (337)
T ss_pred EEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHH-HHHH
Confidence 99999999866443221 12223458899999998765 4578899999999999999999999965322111 1111
Q ss_pred Hhh--cCch-hHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHH
Q 002857 391 VQS--ALPE-RVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELG 464 (873)
Q Consensus 391 ~~~--~~~~-~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~ 464 (873)
... .... .+..+... +... ....+....... ...........+.+++.+||+.+|++|||+.++++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~-~~~~-----~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 226 IEVIGPPSAEDIESIKSP-FAAT-----MLDSLPSRPRKP-LDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHhCCCCHHHHHHHHhh-hHHH-----hhhhcccccccc-hhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 100 0000 11111000 0000 000000000000 001111124468899999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=297.96 Aligned_cols=247 Identities=23% Similarity=0.290 Sum_probs=197.2
Q ss_pred CCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCC---cchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceE
Q 002857 161 GFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH---DASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFK 237 (873)
Q Consensus 161 ~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~ 237 (873)
+|++.+.||.|+||.||+|.+..+++.||+|++..... ...+.+.+|++++++++||||+++++.+ ..+...
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 75 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSF-----QDEENM 75 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhh-----cCCCeE
Confidence 58889999999999999999988899999999974322 3457899999999999999999999884 556789
Q ss_pred EEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEe
Q 002857 238 ALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVA 317 (873)
Q Consensus 238 ~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLs 317 (873)
++|+||+.+++|.+++.. ...+++..+..|+.||++||.||| ..+++|+||+|+||++++++.++|+
T Consensus 76 ~lv~e~~~~~~L~~~l~~----------~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~ 142 (258)
T cd05578 76 YLVVDLLLGGDLRYHLSQ----------KVKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHIT 142 (258)
T ss_pred EEEEeCCCCCCHHHHHHh----------cCCcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEe
Confidence 999999999999999842 256889999999999999999999 8999999999999999999999999
Q ss_pred ccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCch
Q 002857 318 DFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPE 397 (873)
Q Consensus 318 DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~ 397 (873)
|||++....... ......++..|+|||++.+..++.++||||||+++|+|++|+.||....... ...
T Consensus 143 d~~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~------- 209 (258)
T cd05578 143 DFNIATKVTPDT---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI---RDQ------- 209 (258)
T ss_pred ecccccccCCCc---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH---HHH-------
Confidence 999998654322 2223458889999999988889999999999999999999999987532210 000
Q ss_pred hHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCH--HHH
Q 002857 398 RVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKI--NDV 461 (873)
Q Consensus 398 ~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm--~EV 461 (873)
+...... .. ...| ......+.+++.+||+.+|.+||++ +|+
T Consensus 210 -~~~~~~~---~~----------~~~~---------~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l 252 (258)
T cd05578 210 -IRAKQET---AD----------VLYP---------ATWSTEAIDAINKLLERDPQKRLGDNLKDL 252 (258)
T ss_pred -HHHHhcc---cc----------ccCc---------ccCcHHHHHHHHHHccCChhHcCCccHHHH
Confidence 0000000 00 0000 0112357889999999999999999 554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-33 Score=297.49 Aligned_cols=247 Identities=25% Similarity=0.347 Sum_probs=196.0
Q ss_pred CCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC-CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEEE
Q 002857 162 FSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH-HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKALV 240 (873)
Q Consensus 162 f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~LV 240 (873)
|+..+.||.|+||.||+|.+..++..||||++.... ....+.+.+|+.++++++|+||+++++++ ..+...++|
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv 80 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY-----LKDTKLWII 80 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEE-----EeCCeEEEE
Confidence 667789999999999999988889999999986432 23346788999999999999999999986 456678999
Q ss_pred EeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEeccc
Q 002857 241 YEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFG 320 (873)
Q Consensus 241 ~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDFG 320 (873)
|||+++++|.+++. ...+++..+..++.|++.||.||| ..+++|+||+|+||+++.++.++|+|||
T Consensus 81 ~e~~~~~~l~~~i~-----------~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg 146 (277)
T cd06641 81 MEYLGGGSALDLLE-----------PGPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFG 146 (277)
T ss_pred EEeCCCCcHHHHHh-----------cCCCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecc
Confidence 99999999999983 235789999999999999999999 8999999999999999999999999999
Q ss_pred cccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCchhHH
Q 002857 321 IARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPERVE 400 (873)
Q Consensus 321 la~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~~l~ 400 (873)
++........ ......++..|+|||++.+..++.++||||||+++|+|++|..||....... . .
T Consensus 147 ~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~--~------------~ 210 (277)
T cd06641 147 VAGQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK--V------------L 210 (277)
T ss_pred cceecccchh--hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH--H------------H
Confidence 9876543221 1122357889999999988889999999999999999999999986421110 0 0
Q ss_pred HHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHH
Q 002857 401 EIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELG 464 (873)
Q Consensus 401 elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~ 464 (873)
..+.. ... +.. .......+.+++.+||+.+|++||++.+++..
T Consensus 211 ~~~~~---~~~------------~~~------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 211 FLIPK---NNP------------PTL------EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred HHHhc---CCC------------CCC------CcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 00000 000 000 00112347789999999999999999999884
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=294.34 Aligned_cols=277 Identities=19% Similarity=0.232 Sum_probs=197.0
Q ss_pred CCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCC--cchhHHHHHHHHHHhh---hhccceeeeeeeecccccCCce
Q 002857 162 FSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH--DASKSFTVECEVMRNI---IHRKIIKVVTACSRVDYQGNDF 236 (873)
Q Consensus 162 f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L---~HpNIV~llg~c~~~~~~~~~~ 236 (873)
|++.+.||+|+||.||+|++..+++.||+|+++.... .....+.+|+.+++++ +|+||+++++++..........
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 5678999999999999999988899999999874322 2234577788887776 5999999999976543323335
Q ss_pred EEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEE
Q 002857 237 KALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACV 316 (873)
Q Consensus 237 ~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKL 316 (873)
.+++|||+. ++|.+++.. .....+++..++.++.||+.||+||| +.+++|+||+|+||+++.++.+||
T Consensus 81 ~~l~~e~~~-~~l~~~l~~--------~~~~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l 148 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSK--------CPKPGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKI 148 (287)
T ss_pred eEEEehhcc-cCHHHHHHH--------ccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEE
Confidence 899999997 489888743 12235899999999999999999999 899999999999999999999999
Q ss_pred eccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCc
Q 002857 317 ADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALP 396 (873)
Q Consensus 317 sDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~ 396 (873)
+|||++..+..... .....++..|+|||++.+..++.++||||||+++|||++|+.||...... ..+..+......
T Consensus 149 ~dfg~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~-~~~~~~~~~~~~ 224 (287)
T cd07838 149 ADFGLARIYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA-DQLDKIFDVIGL 224 (287)
T ss_pred eccCcceeccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH-HHHHHHHHHcCC
Confidence 99999987643321 12234788999999999999999999999999999999999998753221 111111111100
Q ss_pred hhHHHH-hhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 397 ERVEEI-VDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 397 ~~l~el-id~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
...... ....... ..+ .............+....+.+++.+||+.||++||++.|++.
T Consensus 225 ~~~~~~~~~~~~~~--------~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 225 PSEEEWPRNVSLPR--------SSF-PSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CChHhcCCCcccch--------hhc-ccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 000000 0000000 000 000000011112233456789999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=303.29 Aligned_cols=248 Identities=24% Similarity=0.307 Sum_probs=193.2
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCC---cchhHHHHHHHHHHhhhhccceeeeeeeecccccCCc
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH---DASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGND 235 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~ 235 (873)
.+.|+..+.||+|+||.||+|+...+++.||+|.+..... ...+.+.+|+++++.++||||++++++|. ...
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~-----~~~ 88 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYL-----REH 88 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEE-----eCC
Confidence 4568889999999999999999988899999999864322 22356889999999999999999999963 456
Q ss_pred eEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeE
Q 002857 236 FKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTAC 315 (873)
Q Consensus 236 ~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vK 315 (873)
..++||||+. |+|.+++.. ....+++..+..++.||+.||.||| +.+|+|+||+|+||++++++.+|
T Consensus 89 ~~~lv~e~~~-g~l~~~~~~---------~~~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~k 155 (307)
T cd06607 89 TAWLVMEYCL-GSASDILEV---------HKKPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVK 155 (307)
T ss_pred eEEEEHHhhC-CCHHHHHHH---------cccCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEE
Confidence 7899999996 577777632 2345899999999999999999999 89999999999999999999999
Q ss_pred EeccccccccccccccccccccccccccCCCcccC---CCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHh
Q 002857 316 VADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGM---GHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQ 392 (873)
Q Consensus 316 LsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~---~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~ 392 (873)
|+|||++...... ....++..|+|||++. ...++.++||||||+++|||+||+.||....... .
T Consensus 156 L~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~--~----- 222 (307)
T cd06607 156 LADFGSASLVSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--A----- 222 (307)
T ss_pred EeecCcceecCCC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH--H-----
Confidence 9999998764322 1235788999999874 3568899999999999999999999986521110 0
Q ss_pred hcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHH
Q 002857 393 SALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELG 464 (873)
Q Consensus 393 ~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~ 464 (873)
...+.. .. .+... .......+.+++.+||+.+|++||++.+|+..
T Consensus 223 ------~~~~~~----~~------------~~~~~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 223 ------LYHIAQ----ND------------SPTLS-----SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred ------HHHHhc----CC------------CCCCC-----chhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000000 00 00000 00123357889999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=302.25 Aligned_cols=264 Identities=20% Similarity=0.193 Sum_probs=184.7
Q ss_pred hcCCCcceeecccCceEEEEEEEcCC---CcEEEEEEeeccCCcch-----------hHHHHHHHHHHhhhhccceeeee
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEG---APAVAIKVFNFLHHDAS-----------KSFTVECEVMRNIIHRKIIKVVT 224 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~---g~~VAVK~l~~~~~~~~-----------~~f~~Ei~iL~~L~HpNIV~llg 224 (873)
.++|.+.++||+|+||.||+|.+..+ +..+|+|+......... .....+...+..+.|+||+++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 36799999999999999999998776 66778886543222110 01122333455568999999998
Q ss_pred eeecccccCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCC
Q 002857 225 ACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPS 304 (873)
Q Consensus 225 ~c~~~~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKps 304 (873)
.+.... ......+++++++.. ++.+.+.. ....++..++.|+.|++.||+||| +.+|+||||||+
T Consensus 91 ~~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~----------~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~ 155 (294)
T PHA02882 91 CGSFKR-CRMYYRFILLEKLVE-NTKEIFKR----------IKCKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPE 155 (294)
T ss_pred eeeEec-CCceEEEEEEehhcc-CHHHHHHh----------hccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHH
Confidence 753211 112245778887743 66665531 223467788999999999999999 899999999999
Q ss_pred CeeeCCCCCeEEecccccccccccccc-----ccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCc
Q 002857 305 NILLNDEMTACVADFGIARFLEATNEQ-----TSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDD 379 (873)
Q Consensus 305 NILLd~~~~vKLsDFGla~~~~~~~~~-----~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~ 379 (873)
|||++.++.++|+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 156 Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~ 235 (294)
T PHA02882 156 NIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKG 235 (294)
T ss_pred HEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCc
Confidence 999999999999999999866432211 111224599999999999999999999999999999999999999976
Q ss_pred ccccchhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHH
Q 002857 380 MFKDNLNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKIN 459 (873)
Q Consensus 380 ~~~~~~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~ 459 (873)
...... ..... ..+++........ ....+...+.+++..|++.+|++||++.
T Consensus 236 ~~~~~~-~~~~~-------~~~~~~~~~~~~~--------------------~~~~~~~~~~~~~~~~~~~~~~~rp~~~ 287 (294)
T PHA02882 236 FGHNGN-LIHAA-------KCDFIKRLHEGKI--------------------KIKNANKFIYDFIECVTKLSYEEKPDYD 287 (294)
T ss_pred cccchH-HHHHh-------HHHHHHHhhhhhh--------------------ccCCCCHHHHHHHHHHHhCCCCCCCCHH
Confidence 422111 11000 0111111110000 0011234588999999999999999999
Q ss_pred HHHHHH
Q 002857 460 DVELGL 465 (873)
Q Consensus 460 EVl~~L 465 (873)
+|++.|
T Consensus 288 ~l~~~~ 293 (294)
T PHA02882 288 ALIKIF 293 (294)
T ss_pred HHHHhh
Confidence 998876
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=300.08 Aligned_cols=249 Identities=20% Similarity=0.252 Sum_probs=196.2
Q ss_pred CCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEEE
Q 002857 161 GFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKALV 240 (873)
Q Consensus 161 ~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~LV 240 (873)
.|...+.||+|++|.||++....+++.||+|+++.......+.+.+|+.+++.++|+||+++++++ ...+..++|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~-----~~~~~~~~v 94 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSY-----LVGDELWVV 94 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEE-----EcCCeEEEE
Confidence 345568999999999999998888999999998755555556789999999999999999999985 345678999
Q ss_pred EeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEeccc
Q 002857 241 YEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFG 320 (873)
Q Consensus 241 ~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDFG 320 (873)
+||+++++|.+++.. ..+++..+..++.|++.||+||| +.+|+||||+|+||+++.++.++|+|||
T Consensus 95 ~e~~~~~~L~~~~~~-----------~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g 160 (285)
T cd06648 95 MEFLEGGALTDIVTH-----------TRMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFG 160 (285)
T ss_pred EeccCCCCHHHHHHh-----------CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEcccc
Confidence 999999999999832 45788899999999999999999 8999999999999999999999999999
Q ss_pred cccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCchhHH
Q 002857 321 IARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPERVE 400 (873)
Q Consensus 321 la~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~~l~ 400 (873)
++........ ......|+..|+|||.+.+..++.++||||||+++|||++|+.||...... ... .
T Consensus 161 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~--~~~-----------~ 225 (285)
T cd06648 161 FCAQVSKEVP--RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL--QAM-----------K 225 (285)
T ss_pred cchhhccCCc--ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH--HHH-----------H
Confidence 8875533221 122345889999999998888999999999999999999999998542110 000 0
Q ss_pred HHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 401 EIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 401 elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
.+. ... .+..... ......+.+++.+||+.+|++|||+.++++
T Consensus 226 ~~~-~~~---------------~~~~~~~----~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 226 RIR-DNL---------------PPKLKNL----HKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred HHH-hcC---------------CCCCccc----ccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 000 000 0000000 001235889999999999999999998875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=299.09 Aligned_cols=255 Identities=25% Similarity=0.283 Sum_probs=201.8
Q ss_pred HhhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCce
Q 002857 157 SATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDF 236 (873)
Q Consensus 157 ~at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~ 236 (873)
..++.|+..+.||+|++|.||+|.+..++..||+|++..... ..+.+.+|++++++++|+||+++++.+. ....
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~ 89 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYL-----VGDE 89 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEE-----ECCE
Confidence 456778889999999999999999987889999999975444 4567899999999999999999999863 3567
Q ss_pred EEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEE
Q 002857 237 KALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACV 316 (873)
Q Consensus 237 ~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKL 316 (873)
.++|+||+++++|.+++.. ....+++..++.++.|++.||+||| +.+|+|+||+|+||+++.++.++|
T Consensus 90 ~~lv~e~~~~~~L~~~l~~---------~~~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l 157 (286)
T cd06614 90 LWVVMEYMDGGSLTDIITQ---------NFVRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKL 157 (286)
T ss_pred EEEEEeccCCCcHHHHHHH---------hccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEE
Confidence 9999999999999999953 1137899999999999999999999 899999999999999999999999
Q ss_pred eccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCc
Q 002857 317 ADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALP 396 (873)
Q Consensus 317 sDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~ 396 (873)
+|||++........ ......++..|+|||++.+..++.++||||||+++|+|++|+.||....... ..
T Consensus 158 ~d~~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~-~~--------- 225 (286)
T cd06614 158 ADFGFAAQLTKEKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR-AL--------- 225 (286)
T ss_pred Cccchhhhhccchh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH-HH---------
Confidence 99999875543221 1122347889999999988889999999999999999999999986421110 00
Q ss_pred hhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHH
Q 002857 397 ERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELG 464 (873)
Q Consensus 397 ~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~ 464 (873)
..+..... +.... .......+.+++.+||+.+|.+|||+.+|++.
T Consensus 226 ---~~~~~~~~----------------~~~~~----~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 226 ---FLITTKGI----------------PPLKN----PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred ---HHHHhcCC----------------CCCcc----hhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 00000000 00000 01123357889999999999999999999763
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=301.14 Aligned_cols=209 Identities=25% Similarity=0.321 Sum_probs=170.9
Q ss_pred HhhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC--CcchhHHHHHHHHHHhhhhccceeeeeeeeccc----
Q 002857 157 SATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH--HDASKSFTVECEVMRNIIHRKIIKVVTACSRVD---- 230 (873)
Q Consensus 157 ~at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~---- 230 (873)
.+.++|++.+.||+|+||.||+|++..+++.||||+++... ......+.+|++++++++||||+++++++....
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 35678999999999999999999998889999999987433 223356788999999999999999999874321
Q ss_pred -ccCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeC
Q 002857 231 -YQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLN 309 (873)
Q Consensus 231 -~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd 309 (873)
.......++|+||+++ +|.+++.. ....+++..++.|+.||+.||+||| +.+|+|+||||+||+++
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~---------~~~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~ 150 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLES---------GLVHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLN 150 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhc---------CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEC
Confidence 1123478999999976 77777632 2346899999999999999999999 89999999999999999
Q ss_pred CCCCeEEeccccccccccccccccccccccccccCCCcccCCC-CCCcchhhHhHHHHHHHHHhCCCCCCc
Q 002857 310 DEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGH-ETSSYGDVYSFGILLLEMFTGLRPSDD 379 (873)
Q Consensus 310 ~~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELlTGk~Pf~~ 379 (873)
+++.+||+|||++........ .......++..|+|||.+.+. .++.++|||||||++|||++|+.||..
T Consensus 151 ~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~ 220 (302)
T cd07864 151 NKGQIKLADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQA 220 (302)
T ss_pred CCCcEEeCcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999986644322 111223467889999987653 578899999999999999999999965
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=296.48 Aligned_cols=273 Identities=21% Similarity=0.293 Sum_probs=198.0
Q ss_pred CCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCC-cchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEE
Q 002857 161 GFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH-DASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKAL 239 (873)
Q Consensus 161 ~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~L 239 (873)
+|++.+.||.|++|.||+|++..+++.||||+++.... .....+.+|++++++++|+||+++++++ ...+..+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~l 75 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI-----HTENKLML 75 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeE-----eeCCcEEE
Confidence 58889999999999999999988899999999875433 2346778899999999999999999996 34567899
Q ss_pred EEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEecc
Q 002857 240 VYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADF 319 (873)
Q Consensus 240 V~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDF 319 (873)
||||+++ +|.+++.. ......+++..+..++.||+.||+||| +.+|+||||||+||++++++.++|+||
T Consensus 76 v~e~~~~-~l~~~~~~-------~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~ 144 (284)
T cd07836 76 VFEYMDK-DLKKYMDT-------HGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADF 144 (284)
T ss_pred EEecCCc-cHHHHHHh-------cCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeec
Confidence 9999985 88888743 112346899999999999999999999 889999999999999999999999999
Q ss_pred ccccccccccccccccccccccccCCCcccCCC-CCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhh---cC
Q 002857 320 GIARFLEATNEQTSSIGVKGTTGYIAPEYGMGH-ETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQS---AL 395 (873)
Q Consensus 320 Gla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~---~~ 395 (873)
|+++....... ......++..|++||++.+. .++.++||||||+++|||++|+.||....... .+...... ..
T Consensus 145 g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~~ 221 (284)
T cd07836 145 GLARAFGIPVN--TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED-QLLKIFRIMGTPT 221 (284)
T ss_pred chhhhhcCCcc--ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhCCCC
Confidence 99975533211 11223468899999987664 56889999999999999999999997632211 11111100 00
Q ss_pred chhHHHHhhhhhhhhhhHHHHHhhhccCCCCc--hhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 396 PERVEEIVDTLFFKEIEEEETVYKYKKAPSSS--TQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 396 ~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~--~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
...+..+.+. .... ...+... ............+.+++.+|++.+|.+||++.||++
T Consensus 222 ~~~~~~~~~~---~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 222 ESTWPGISQL---PEYK--------PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred hhhHHHHhcC---chhc--------ccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0011111100 0000 0000000 001111122346789999999999999999999874
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-33 Score=299.94 Aligned_cols=203 Identities=23% Similarity=0.271 Sum_probs=169.3
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCC--cchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceE
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH--DASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFK 237 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~ 237 (873)
++|++.+.||+|+||.||+|.+..+++.+|+|.++.... .....+.+|+.++.+++||||+++++++.. ......
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~---~~~~~~ 81 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVG---SNLDKI 81 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEe---cCCCcE
Confidence 478889999999999999999988899999999874332 223457789999999999999999998642 223679
Q ss_pred EEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEe
Q 002857 238 ALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVA 317 (873)
Q Consensus 238 ~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLs 317 (873)
++||||+. ++|.+++.. ....+++..++.++.||+.||+||| +.+|+|+||||+||+++.++.+||+
T Consensus 82 ~lv~e~~~-~~L~~~~~~---------~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~ 148 (293)
T cd07843 82 YMVMEYVE-HDLKSLMET---------MKQPFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKIC 148 (293)
T ss_pred EEEehhcC-cCHHHHHHh---------ccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEe
Confidence 99999997 499988842 2236899999999999999999999 8899999999999999999999999
Q ss_pred ccccccccccccccccccccccccccCCCcccCCC-CCCcchhhHhHHHHHHHHHhCCCCCCcc
Q 002857 318 DFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGH-ETSSYGDVYSFGILLLEMFTGLRPSDDM 380 (873)
Q Consensus 318 DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELlTGk~Pf~~~ 380 (873)
|||+++....... ......++..|+|||++.+. .++.++||||||+++|||++|..||...
T Consensus 149 d~g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~ 210 (293)
T cd07843 149 DFGLAREYGSPLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGK 210 (293)
T ss_pred ecCceeeccCCcc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999986644321 11233478899999988765 4689999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=321.88 Aligned_cols=252 Identities=24% Similarity=0.327 Sum_probs=201.6
Q ss_pred CcceeecccCceEEEEEEEcCC-C--cEEEEEEeeccCCc-chhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEE
Q 002857 163 SSENLIGAGNFASVYKGILFEG-A--PAVAIKVFNFLHHD-ASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKA 238 (873)
Q Consensus 163 ~~~~~LG~G~fG~VYkg~~~~~-g--~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~ 238 (873)
...++||+|.||.|++|.|..- | -.||||.++..... ...+|++|+.+|.+|+|+|+|+|||+.. +....
T Consensus 113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl------~qp~m 186 (1039)
T KOG0199|consen 113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVL------DQPAM 186 (1039)
T ss_pred HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeec------cchhh
Confidence 4458999999999999999643 3 35899999865444 5689999999999999999999999942 35578
Q ss_pred EEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEec
Q 002857 239 LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVAD 318 (873)
Q Consensus 239 LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsD 318 (873)
+|||.++.|||.+.|+. .....|-....-.++.|||.||.||. .+++|||||..+||||-..-.+||+|
T Consensus 187 MV~ELaplGSLldrLrk--------a~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~D 255 (1039)
T KOG0199|consen 187 MVFELAPLGSLLDRLRK--------AKKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICD 255 (1039)
T ss_pred HHhhhcccchHHHHHhh--------ccccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeec
Confidence 99999999999999964 24456777788899999999999999 99999999999999999999999999
Q ss_pred ccccccccccccccc-ccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHHHhhcCc
Q 002857 319 FGIARFLEATNEQTS-SIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQSALP 396 (873)
Q Consensus 319 FGla~~~~~~~~~~~-~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~~~~~~~ 396 (873)
||+.+.+........ .....-.+.|.|||.+....++.+||||+|||+||||+| |..||.+....
T Consensus 256 FGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~------------- 322 (1039)
T KOG0199|consen 256 FGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI------------- 322 (1039)
T ss_pred ccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH-------------
Confidence 999998765543322 222335778999999999999999999999999999999 88888663211
Q ss_pred hhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHH
Q 002857 397 ERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLR 466 (873)
Q Consensus 397 ~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le 466 (873)
.+.+.+|. ++ .+ .....|.+.++++++.||..+|++|||+..|.+.+-
T Consensus 323 -qIL~~iD~---~e---------rL---------pRPk~csedIY~imk~cWah~paDRptFsair~~~~ 370 (1039)
T KOG0199|consen 323 -QILKNIDA---GE---------RL---------PRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLV 370 (1039)
T ss_pred -HHHHhccc---cc---------cC---------CCCCCChHHHHHHHHHhccCCccccccHHHHHHhHH
Confidence 11222220 10 00 011246778999999999999999999999985543
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=301.05 Aligned_cols=203 Identities=25% Similarity=0.314 Sum_probs=168.6
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCc--chhHHHHHHHHHHhhhhccceeeeeeeecccccCCce
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHD--ASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDF 236 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~ 236 (873)
.++|++.+.||+|+||.||+|.+..+++.||+|+++..... ....+.+|+.++++++|+||+++++++.. ...+.
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~ 82 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVG---KHLDS 82 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEec---CCCCe
Confidence 46799999999999999999999888999999998743322 23456789999999999999999998642 22356
Q ss_pred EEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEE
Q 002857 237 KALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACV 316 (873)
Q Consensus 237 ~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKL 316 (873)
.++||||+.+ +|.+++.. ....+++.+++.++.||+.||+||| +.+++||||||+||++++++.+||
T Consensus 83 ~~lv~e~~~~-~l~~~l~~---------~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL 149 (309)
T cd07845 83 IFLVMEYCEQ-DLASLLDN---------MPTPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKI 149 (309)
T ss_pred EEEEEecCCC-CHHHHHHh---------cccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEE
Confidence 8999999964 88888742 2356899999999999999999999 899999999999999999999999
Q ss_pred eccccccccccccccccccccccccccCCCcccCC-CCCCcchhhHhHHHHHHHHHhCCCCCCc
Q 002857 317 ADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMG-HETSSYGDVYSFGILLLEMFTGLRPSDD 379 (873)
Q Consensus 317 sDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELlTGk~Pf~~ 379 (873)
+|||++........ ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus 150 ~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~ 211 (309)
T cd07845 150 ADFGLARTYGLPAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPG 211 (309)
T ss_pred CccceeeecCCccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCC
Confidence 99999986643221 1122235788999998866 4578999999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=296.09 Aligned_cols=251 Identities=22% Similarity=0.331 Sum_probs=210.1
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeec--cCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCce
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNF--LHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDF 236 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~--~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~ 236 (873)
+++|++.+.||+|.|+.||+..+..+|+.+|+|+++. ......+++.+|+.|-+.|+||||++|...+ .....
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti-----~~~~~ 84 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEESF 84 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhh-----cccce
Confidence 4678888999999999999999999999999999863 3344668899999999999999999999884 56778
Q ss_pred EEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCC---CCC
Q 002857 237 KALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLND---EMT 313 (873)
Q Consensus 237 ~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~---~~~ 313 (873)
.+||+|+|.|++|..-|- ....+++...-..+.||+++|.|.| .++|||||+||+|+||-. .--
T Consensus 85 ~ylvFe~m~G~dl~~eIV----------~R~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~ 151 (355)
T KOG0033|consen 85 HYLVFDLVTGGELFEDIV----------AREFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAA 151 (355)
T ss_pred eEEEEecccchHHHHHHH----------HHHHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCc
Confidence 999999999999976552 1245677788889999999999999 899999999999999953 346
Q ss_pred eEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccc---------
Q 002857 314 ACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDN--------- 384 (873)
Q Consensus 314 vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~--------- 384 (873)
+||+|||+|..+. ......+.+||++|||||++...+|+..+|||+-|||||-|+.|..||.+.....
T Consensus 152 vKL~~FGvAi~l~---~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~ 228 (355)
T KOG0033|consen 152 VKLADFGLAIEVN---DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGA 228 (355)
T ss_pred eeecccceEEEeC---CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccc
Confidence 8999999999776 3344556789999999999999999999999999999999999999997732211
Q ss_pred hhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhH
Q 002857 385 LNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQR 430 (873)
Q Consensus 385 ~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~ 430 (873)
.++..-.|..+.+..++++..|+.-++.+|.+..+.++|||.....
T Consensus 229 yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r~ 274 (355)
T KOG0033|consen 229 YDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNRE 274 (355)
T ss_pred cCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcchH
Confidence 1222223556667889999999999999999999999999976544
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=290.09 Aligned_cols=252 Identities=23% Similarity=0.318 Sum_probs=200.8
Q ss_pred CCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCC--cchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEE
Q 002857 161 GFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH--DASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKA 238 (873)
Q Consensus 161 ~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~ 238 (873)
+|++.+.||.|+||.||++.+..++..||+|++..... ...+.+.+|++++++++|+|++++++.+ ......+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~-----~~~~~~~ 75 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESF-----EEKGKLC 75 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEE-----ecCCEEE
Confidence 57888999999999999999988899999999875433 4456789999999999999999999985 3457899
Q ss_pred EEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEec
Q 002857 239 LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVAD 318 (873)
Q Consensus 239 LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsD 318 (873)
+|+||+++++|.+++... ......+++..+..++.+++.||.||| +.+++|+||+|+||+++.++.++|+|
T Consensus 76 lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d 146 (258)
T cd08215 76 IVMEYADGGDLSQKIKKQ------KKEGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGD 146 (258)
T ss_pred EEEEecCCCcHHHHHHHh------hccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECC
Confidence 999999999999998531 112467899999999999999999999 88999999999999999999999999
Q ss_pred cccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCchh
Q 002857 319 FGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPER 398 (873)
Q Consensus 319 FGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~~ 398 (873)
||++....... .......++..|+|||.+.+..++.++||||||+++|+|++|+.||......
T Consensus 147 ~~~~~~~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~--------------- 209 (258)
T cd08215 147 FGISKVLSSTV--DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL--------------- 209 (258)
T ss_pred ccceeecccCc--ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH---------------
Confidence 99998664432 1222345888999999998888999999999999999999999998653111
Q ss_pred HHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 399 VEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 399 l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
++.......... ..+. .....+.+++.+||+.+|++|||+.||++
T Consensus 210 --~~~~~~~~~~~~---------~~~~---------~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 210 --ELALKILKGQYP---------PIPS---------QYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred --HHHHHHhcCCCC---------CCCC---------CCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 011110000000 0000 11235788999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=310.26 Aligned_cols=252 Identities=23% Similarity=0.322 Sum_probs=205.9
Q ss_pred hhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCc---chhHHHHHHHHHHhhh-hccceeeeeeeecccccC
Q 002857 158 ATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHD---ASKSFTVECEVMRNII-HRKIIKVVTACSRVDYQG 233 (873)
Q Consensus 158 at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~---~~~~f~~Ei~iL~~L~-HpNIV~llg~c~~~~~~~ 233 (873)
....|++.+.||+|.||.||+++.+.+|+.+|+|++.+.... ....+.+|+++|+++. |||||.+.+.+ +.
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~-----e~ 107 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAF-----ED 107 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEE-----Ec
Confidence 345688889999999999999999999999999999754433 3368999999999998 99999999995 56
Q ss_pred CceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCC--
Q 002857 234 NDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDE-- 311 (873)
Q Consensus 234 ~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~-- 311 (873)
....++|||++.||.|.+.|.. . .+++.....++.||+.+++||| +.+|+||||||+|+|+...
T Consensus 108 ~~~~~lvmEL~~GGeLfd~i~~--------~---~~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~ 173 (382)
T KOG0032|consen 108 PDSVYLVMELCEGGELFDRIVK--------K---HYSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDE 173 (382)
T ss_pred CCeEEEEEEecCCchHHHHHHH--------c---cCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccC
Confidence 6789999999999999999953 1 3999999999999999999999 8999999999999999633
Q ss_pred --CCeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHH
Q 002857 312 --MTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQN 389 (873)
Q Consensus 312 --~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~ 389 (873)
+.+|++|||++..... .......+||+.|+|||++....|+..+||||+||++|.|++|..||..........
T Consensus 174 ~~~~ik~~DFGla~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-- 248 (382)
T KOG0032|consen 174 GSGRIKLIDFGLAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-- 248 (382)
T ss_pred CCCcEEEeeCCCceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH--
Confidence 5799999999998755 233445789999999999999999999999999999999999999998743322111
Q ss_pred HHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 390 WVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 390 ~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
.+....+ .+...+|... ...+.+++..++..||.+|+|+.++++
T Consensus 249 -----------~i~~~~~-----------~f~~~~w~~i--------s~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 249 -----------AILRGDF-----------DFTSEPWDDI--------SESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred -----------HHHcCCC-----------CCCCCCcccc--------CHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 1111111 1122233222 234678999999999999999999887
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=297.78 Aligned_cols=201 Identities=21% Similarity=0.296 Sum_probs=165.7
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCC--cchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceE
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH--DASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFK 237 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~ 237 (873)
++|++.+.||+|++|.||+|.+..+++.||+|.+..... ...+.+.+|++++++++|+||+++++++ ......
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 76 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVV-----HSEKRL 76 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEE-----ecCCeE
Confidence 578999999999999999999988899999999864322 2335788999999999999999999996 456689
Q ss_pred EEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCC-CCCeEE
Q 002857 238 ALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLND-EMTACV 316 (873)
Q Consensus 238 ~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~-~~~vKL 316 (873)
++||||++ ++|.+++.. .....+++.....++.||+.||+||| +.+|+|+||+|+||+++. ++.+||
T Consensus 77 ~lv~e~~~-~~l~~~~~~--------~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl 144 (294)
T PLN00009 77 YLVFEYLD-LDLKKHMDS--------SPDFAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKL 144 (294)
T ss_pred EEEEeccc-ccHHHHHHh--------CCCCCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEE
Confidence 99999996 588877732 22334577888899999999999999 899999999999999985 567999
Q ss_pred eccccccccccccccccccccccccccCCCcccCCC-CCCcchhhHhHHHHHHHHHhCCCCCCc
Q 002857 317 ADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGH-ETSSYGDVYSFGILLLEMFTGLRPSDD 379 (873)
Q Consensus 317 sDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELlTGk~Pf~~ 379 (873)
+|||++....... .......++..|+|||++.+. .++.++||||||+++|+|+||+.||..
T Consensus 145 ~dfg~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~ 206 (294)
T PLN00009 145 ADFGLARAFGIPV--RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPG 206 (294)
T ss_pred cccccccccCCCc--cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9999997653321 111223568899999988664 578999999999999999999999965
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=300.85 Aligned_cols=258 Identities=24% Similarity=0.243 Sum_probs=191.2
Q ss_pred CCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC-CcchhHHHHHHHHHHhhh-hccceeeeeeeecccccCCceEE
Q 002857 161 GFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH-HDASKSFTVECEVMRNII-HRKIIKVVTACSRVDYQGNDFKA 238 (873)
Q Consensus 161 ~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~-HpNIV~llg~c~~~~~~~~~~~~ 238 (873)
+|...+.||+|+||.||++.+..+++.||+|.+.... ......+.+|+.++.++. |+||+++++++ ..+...+
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~-----~~~~~~~ 79 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGAL-----FREGDCW 79 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEE-----ecCCcEE
Confidence 4556789999999999999999899999999986433 234467889999999996 99999999985 3456788
Q ss_pred EEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEec
Q 002857 239 LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVAD 318 (873)
Q Consensus 239 LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsD 318 (873)
++|||+.. +|.++.... .......+++..+..++.+++.||+|||+ ..+|+||||||+||+++.++.+||+|
T Consensus 80 ~~~e~~~~-~l~~l~~~~-----~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~d 151 (288)
T cd06616 80 ICMELMDI-SLDKFYKYV-----YEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCD 151 (288)
T ss_pred EEEecccC-CHHHHHHHH-----HHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEee
Confidence 99999864 665543210 01223568999999999999999999993 35999999999999999999999999
Q ss_pred cccccccccccccccccccccccccCCCcccCCC---CCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcC
Q 002857 319 FGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGH---ETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSAL 395 (873)
Q Consensus 319 FGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~---~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~ 395 (873)
||+++.+..... .....++..|+|||++.+. .++.++||||||+++|||++|+.||..... ...
T Consensus 152 fg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----~~~------ 218 (288)
T cd06616 152 FGISGQLVDSIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS----VFD------ 218 (288)
T ss_pred cchhHHhccCCc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch----HHH------
Confidence 999976543221 1223578899999998776 689999999999999999999999864210 000
Q ss_pred chhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHH
Q 002857 396 PERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELG 464 (873)
Q Consensus 396 ~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~ 464 (873)
.+..+.. ... +.... .........+.+++.+||+.+|++|||+.+|+..
T Consensus 219 --~~~~~~~----~~~------------~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 219 --QLTQVVK----GDP------------PILSN--SEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred --HHhhhcC----CCC------------CcCCC--cCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0011000 000 00000 0001123458899999999999999999998763
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=293.57 Aligned_cols=272 Identities=21% Similarity=0.208 Sum_probs=199.1
Q ss_pred CCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCc--chhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEE
Q 002857 162 FSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHD--ASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKAL 239 (873)
Q Consensus 162 f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~L 239 (873)
|++.+.||+|++|.||+|....+++.+|+|.++..... ....+.+|++++++++|+||+++++++ ..+...++
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~~ 75 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVF-----RHKGDLYL 75 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhh-----ccCCCEEE
Confidence 56778999999999999999888999999998744322 346788999999999999999999985 44577899
Q ss_pred EEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEecc
Q 002857 240 VYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADF 319 (873)
Q Consensus 240 V~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDF 319 (873)
||||+++ +|.+++.. ....+++..++.++.||+.||.||| ..+|+|+||||+||+++.++.+||+||
T Consensus 76 v~e~~~~-~l~~~l~~---------~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df 142 (283)
T cd05118 76 VFEFMDT-DLYKLIKD---------RQRGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADF 142 (283)
T ss_pred EEeccCC-CHHHHHHh---------hcccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeee
Confidence 9999975 88888742 2357899999999999999999999 899999999999999999999999999
Q ss_pred ccccccccccccccccccccccccCCCcccCCC-CCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCch-
Q 002857 320 GIARFLEATNEQTSSIGVKGTTGYIAPEYGMGH-ETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPE- 397 (873)
Q Consensus 320 Gla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~- 397 (873)
|.+....... .......++..|+|||.+.+. .++.++||||||+++|+|+||+.||....... ........+..
T Consensus 143 ~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~--~~~~~~~~~~~~ 218 (283)
T cd05118 143 GLARSFGSPV--RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEID--QLFKIFRTLGTP 218 (283)
T ss_pred eeeEecCCCc--ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHcCCC
Confidence 9998664432 112224578889999998876 78999999999999999999999986532211 11111111000
Q ss_pred ---hHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 398 ---RVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 398 ---~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
.+..+.+...... .......... ..........++.+++..||+.+|.+||++.+++.
T Consensus 219 ~~~~~~~~~~~~~~~~------~~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 219 DPEVWPKFTSLARNYK------FSFPKKAGMP--LPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred chHhcccchhhhhhhh------hhhccccccC--HHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0011100000000 0000000000 01122234567899999999999999999999875
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=304.38 Aligned_cols=278 Identities=19% Similarity=0.228 Sum_probs=195.6
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC--CcchhHHHHHHHHHHhhhhccceeeeeeeecccc-cCCc
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH--HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDY-QGND 235 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~-~~~~ 235 (873)
.++|.+.+.||+|+||.||+|++..+++.||||++.... ......+.+|++++++++|+||+++++++..... ....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 478999999999999999999998889999999986432 2223568899999999999999999998743221 1224
Q ss_pred eEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeE
Q 002857 236 FKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTAC 315 (873)
Q Consensus 236 ~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vK 315 (873)
..++|+||+.. +|..++ ...+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+|
T Consensus 94 ~~~lv~e~~~~-~l~~~~------------~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~k 157 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIM------------GHPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELK 157 (342)
T ss_pred eEEEEeccccc-CHHHHH------------cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEE
Confidence 56999999964 676654 134788899999999999999999 89999999999999999999999
Q ss_pred EeccccccccccccccccccccccccccCCCcccCC-CCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHh--
Q 002857 316 VADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMG-HETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQ-- 392 (873)
Q Consensus 316 LsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~-- 392 (873)
|+|||+++..... .....++..|+|||++.+ ..++.++|||||||++|||++|+.||....... .+...+.
T Consensus 158 L~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~-~~~~~~~~~ 231 (342)
T cd07879 158 ILDFGLARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILKVT 231 (342)
T ss_pred EeeCCCCcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhc
Confidence 9999999754321 123457889999999876 468899999999999999999999997532111 1111110
Q ss_pred hcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHH
Q 002857 393 SALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELG 464 (873)
Q Consensus 393 ~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~ 464 (873)
......+.+.++....... .......+. .............+.+++.+||+.||++||++.||+..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h 297 (342)
T cd07879 232 GVPGPEFVQKLEDKAAKSY-----IKSLPKYPR-KDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEH 297 (342)
T ss_pred CCCCHHHHHHhcccchHHH-----HhhcCCccc-chHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0001111111111100000 000000000 00000001112357899999999999999999999753
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=292.28 Aligned_cols=204 Identities=24% Similarity=0.368 Sum_probs=171.7
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeecc-----CCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCC
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFL-----HHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGN 234 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~-----~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~ 234 (873)
.+|++.+.||+|+||.||+|.+..+++.||+|++... .......+.+|++++++++|+||+++++++.. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~---~~~ 78 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRD---PEE 78 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEc---CCC
Confidence 4788999999999999999999888999999987532 12234578899999999999999999998632 224
Q ss_pred ceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCe
Q 002857 235 DFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTA 314 (873)
Q Consensus 235 ~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~v 314 (873)
...++|+||+++++|.+++.. ...+++...+.++.||+.||.||| +.+|+|+||||+||+++.++.+
T Consensus 79 ~~~~~v~e~~~~~~L~~~~~~----------~~~l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~ 145 (264)
T cd06653 79 KKLSIFVEYMPGGSIKDQLKA----------YGALTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNV 145 (264)
T ss_pred CEEEEEEEeCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCE
Confidence 568899999999999999842 245788899999999999999999 8999999999999999999999
Q ss_pred EEeccccccccccccc-cccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCc
Q 002857 315 CVADFGIARFLEATNE-QTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDD 379 (873)
Q Consensus 315 KLsDFGla~~~~~~~~-~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~ 379 (873)
+|+|||+++....... ........++..|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 146 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 211 (264)
T cd06653 146 KLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAE 211 (264)
T ss_pred EECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCc
Confidence 9999999986532111 1112234588999999999988899999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=294.58 Aligned_cols=247 Identities=23% Similarity=0.346 Sum_probs=193.0
Q ss_pred ecccCceEEEEEEEcCCCcEEEEEEeeccCC---cchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEEEEeec
Q 002857 168 IGAGNFASVYKGILFEGAPAVAIKVFNFLHH---DASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKALVYEFM 244 (873)
Q Consensus 168 LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~LV~Ey~ 244 (873)
||.|+||.||++++..+++.+|+|++..... ...+.+.+|++++++++|+||+++++.+ ..+...++||||+
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSF-----QGKKNLYLVMEYL 75 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHhe-----ecCcEEEEEEecC
Confidence 6899999999999988899999999864433 3456789999999999999999999874 4567789999999
Q ss_pred CCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEeccccccc
Q 002857 245 PNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARF 324 (873)
Q Consensus 245 ~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDFGla~~ 324 (873)
++++|.+++.. ...+++..++.++.||+.||+||| ..+++|+||+|+||++++++.++|+|||++..
T Consensus 76 ~~~~L~~~l~~----------~~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~ 142 (265)
T cd05579 76 PGGDLASLLEN----------VGSLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKV 142 (265)
T ss_pred CCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchh
Confidence 99999999842 236899999999999999999999 89999999999999999999999999999875
Q ss_pred cccccc------cccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCchh
Q 002857 325 LEATNE------QTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPER 398 (873)
Q Consensus 325 ~~~~~~------~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~~ 398 (873)
...... ........++..|+|||.......+.++||||||+++|||++|+.||.......
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-------------- 208 (265)
T cd05579 143 GLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE-------------- 208 (265)
T ss_pred cccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH--------------
Confidence 433211 112223457889999999988889999999999999999999999986532110
Q ss_pred HHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHH
Q 002857 399 VEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLR 466 (873)
Q Consensus 399 l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le 466 (873)
+.+....... ++.... .....+.+++.+||+.+|++|||+.+|.+.|+
T Consensus 209 ---~~~~~~~~~~------------~~~~~~-----~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 209 ---IFQNILNGKI------------EWPEDV-----EVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred ---HHHHHhcCCc------------CCCccc-----cCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 0110000000 000000 01235788999999999999999977666554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=296.71 Aligned_cols=243 Identities=21% Similarity=0.259 Sum_probs=182.6
Q ss_pred eecccCceEEEEEEEcCCCcEEEEEEeeccCC---cchhHHHHHHHHHHhh---hhccceeeeeeeecccccCCceEEEE
Q 002857 167 LIGAGNFASVYKGILFEGAPAVAIKVFNFLHH---DASKSFTVECEVMRNI---IHRKIIKVVTACSRVDYQGNDFKALV 240 (873)
Q Consensus 167 ~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~L---~HpNIV~llg~c~~~~~~~~~~~~LV 240 (873)
.||+|+||.||++....+++.+|+|.+..... .....+.+|..+++.+ +|+||+.+++++ ..++..++|
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv 75 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAF-----HTPDKLCFI 75 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEE-----ecCCeEEEE
Confidence 48999999999999988899999999864322 1223345555444443 699999999885 345678999
Q ss_pred EeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEeccc
Q 002857 241 YEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFG 320 (873)
Q Consensus 241 ~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDFG 320 (873)
|||+++|+|.+++.. ...+++..+..|+.|++.||+||| +.+|+|+||||+|||+++++.++|+|||
T Consensus 76 ~e~~~~~~L~~~i~~----------~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg 142 (279)
T cd05633 76 LDLMNGGDLHYHLSQ----------HGVFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLG 142 (279)
T ss_pred EecCCCCCHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCC
Confidence 999999999998842 346899999999999999999999 8999999999999999999999999999
Q ss_pred cccccccccccccccccccccccCCCcccCC-CCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCchhH
Q 002857 321 IARFLEATNEQTSSIGVKGTTGYIAPEYGMG-HETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPERV 399 (873)
Q Consensus 321 la~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~~l 399 (873)
++....... .....|+..|+|||.+.+ ..++.++||||||+++|||++|..||......... .+
T Consensus 143 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-----------~~ 207 (279)
T cd05633 143 LACDFSKKK----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-----------EI 207 (279)
T ss_pred cceeccccC----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-----------HH
Confidence 987543221 122458999999998864 56889999999999999999999999653221100 00
Q ss_pred HHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCC-----CHHHHHHH
Q 002857 400 EEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERM-----KINDVELG 464 (873)
Q Consensus 400 ~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRP-----Tm~EVl~~ 464 (873)
...... .... .+ ......+.+++.+||+.||++|| |++|+++.
T Consensus 208 ~~~~~~-~~~~------------~~---------~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 208 DRMTLT-VNVE------------LP---------DSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred HHHhhc-CCcC------------Cc---------cccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 000000 0000 00 01123577899999999999999 58887653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=288.19 Aligned_cols=248 Identities=28% Similarity=0.392 Sum_probs=198.6
Q ss_pred CCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCC--cchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEE
Q 002857 161 GFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH--DASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKA 238 (873)
Q Consensus 161 ~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~ 238 (873)
+|++.+.||+|++|.||+|+...+++.||+|.+..... .....+.+|++++++++|+|++++++++ ......+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~ 75 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSI-----ETSDSLY 75 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEE-----EeCCEEE
Confidence 47888999999999999999988889999999875543 3456799999999999999999999985 3456789
Q ss_pred EEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEec
Q 002857 239 LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVAD 318 (873)
Q Consensus 239 LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsD 318 (873)
+||||+++++|.+++.. ...+++..+..++.|++.||.||| +.+|+||||+|+||+++.++.++|+|
T Consensus 76 ~v~e~~~~~~L~~~~~~----------~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d 142 (254)
T cd06627 76 IILEYAENGSLRQIIKK----------FGPFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLAD 142 (254)
T ss_pred EEEecCCCCcHHHHHHh----------ccCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEec
Confidence 99999999999999842 356899999999999999999999 89999999999999999999999999
Q ss_pred cccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCchh
Q 002857 319 FGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPER 398 (873)
Q Consensus 319 FGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~~ 398 (873)
||++......... .....++..|+|||...+...+.++||||||+++|+|++|+.||...... ...
T Consensus 143 ~~~~~~~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~----~~~-------- 208 (254)
T cd06627 143 FGVATKLNDVSKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM----AAL-------- 208 (254)
T ss_pred cccceecCCCccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH----HHH--------
Confidence 9999876543321 12345788999999988888899999999999999999999998652110 000
Q ss_pred HHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 399 VEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 399 l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
..... . .++... ......+.+++.+||+.+|++|||+.+++.
T Consensus 209 -~~~~~----~------------~~~~~~------~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 209 -FRIVQ----D------------DHPPLP------EGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred -HHHhc----c------------CCCCCC------CCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 00000 0 000000 001234778999999999999999999864
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=291.16 Aligned_cols=253 Identities=23% Similarity=0.377 Sum_probs=201.5
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCc----c----hhHHHHHHHHHHhh-hhccceeeeeeeecc
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHD----A----SKSFTVECEVMRNI-IHRKIIKVVTACSRV 229 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~----~----~~~f~~Ei~iL~~L-~HpNIV~llg~c~~~ 229 (873)
-+.|...+.||.|..+.|-+..++.++..+|+|++...... . .+.-.+|+.||+++ .||+|+++.++
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~---- 91 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDV---- 91 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeee----
Confidence 35678889999999999999999999999999998632211 1 23456799999998 69999999999
Q ss_pred cccCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeC
Q 002857 230 DYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLN 309 (873)
Q Consensus 230 ~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd 309 (873)
++.+.+.++|+|.|+.|.|.++|. ....+++.....|++|+..|+.||| ...||||||||+|||+|
T Consensus 92 -yes~sF~FlVFdl~prGELFDyLt----------s~VtlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILld 157 (411)
T KOG0599|consen 92 -YESDAFVFLVFDLMPRGELFDYLT----------SKVTLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLD 157 (411)
T ss_pred -ccCcchhhhhhhhcccchHHHHhh----------hheeecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeec
Confidence 477888999999999999999994 4567999999999999999999999 99999999999999999
Q ss_pred CCCCeEEeccccccccccccccccccccccccccCCCcccCC------CCCCcchhhHhHHHHHHHHHhCCCCCCccccc
Q 002857 310 DEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMG------HETSSYGDVYSFGILLLEMFTGLRPSDDMFKD 383 (873)
Q Consensus 310 ~~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~------~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~ 383 (873)
++.++||+|||++..+..+.. .....||++|+|||.+.- ..|+...|+||.|||||.|+.|.+||... .
T Consensus 158 dn~~i~isDFGFa~~l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR--k 232 (411)
T KOG0599|consen 158 DNMNIKISDFGFACQLEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR--K 232 (411)
T ss_pred cccceEEeccceeeccCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH--H
Confidence 999999999999998866543 345679999999998642 36888999999999999999999999541 1
Q ss_pred chhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 384 NLNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 384 ~~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
+.- ++...+.+.+ ++..+.|. +......+++.+||+.||.+|.|++|++.
T Consensus 233 Qml---------------MLR~ImeGky-------qF~speWa--------dis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 233 QML---------------MLRMIMEGKY-------QFRSPEWA--------DISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred HHH---------------HHHHHHhccc-------ccCCcchh--------hccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 110 1111111111 11111121 12335778999999999999999999885
Q ss_pred H
Q 002857 464 G 464 (873)
Q Consensus 464 ~ 464 (873)
.
T Consensus 283 H 283 (411)
T KOG0599|consen 283 H 283 (411)
T ss_pred C
Confidence 3
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=290.28 Aligned_cols=250 Identities=24% Similarity=0.286 Sum_probs=199.3
Q ss_pred CCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC--CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEE
Q 002857 161 GFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH--HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKA 238 (873)
Q Consensus 161 ~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~ 238 (873)
+|++.++||+|+||.||+++...+++.+|+|.+.... ......+.+|++++++++|+||+++++++ ......+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~ 75 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAF-----LDGNKLC 75 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhh-----ccCCEEE
Confidence 5788999999999999999998889999999987432 23345788899999999999999999885 4457899
Q ss_pred EEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEec
Q 002857 239 LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVAD 318 (873)
Q Consensus 239 LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsD 318 (873)
+||||+++++|.+++... ......+++..++.++.|++.||+||| +.+++|+||+|+||+++.++.+||+|
T Consensus 76 ~v~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d 146 (256)
T cd08530 76 IVMEYAPFGDLSKAISKR------KKKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGD 146 (256)
T ss_pred EEehhcCCCCHHHHHHHH------HhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEee
Confidence 999999999999998531 122456889999999999999999999 89999999999999999999999999
Q ss_pred cccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCchh
Q 002857 319 FGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPER 398 (873)
Q Consensus 319 FGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~~ 398 (873)
||+++..... ......++..|+|||.+.+..++.++|+||||+++|||++|+.||...... .+...
T Consensus 147 ~g~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~--~~~~~-------- 212 (256)
T cd08530 147 LGISKVLKKN----MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ--DLRYK-------- 212 (256)
T ss_pred ccchhhhccC----CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHH--------
Confidence 9999876543 112234788999999999989999999999999999999999999653211 00000
Q ss_pred HHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 399 VEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 399 l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
+. ... .+... ......+.+++.+||+.+|++||++.|+++
T Consensus 213 ----~~---~~~------------~~~~~------~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 213 ----VQ---RGK------------YPPIP------PIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred ----Hh---cCC------------CCCCc------hhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00 000 00000 012335789999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=291.22 Aligned_cols=192 Identities=26% Similarity=0.363 Sum_probs=166.6
Q ss_pred ecccCceEEEEEEEcCCCcEEEEEEeeccC---CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEEEEeec
Q 002857 168 IGAGNFASVYKGILFEGAPAVAIKVFNFLH---HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKALVYEFM 244 (873)
Q Consensus 168 LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~LV~Ey~ 244 (873)
||.|+||.||++++..+++.||+|++.... ....+.+.+|++++++++|+||+++++++ ..+...++||||+
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTF-----KDKKYIYMLMEYC 75 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeE-----EcCCccEEEEecC
Confidence 699999999999998889999999986432 23346799999999999999999999985 4566789999999
Q ss_pred CCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEeccccccc
Q 002857 245 PNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARF 324 (873)
Q Consensus 245 ~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDFGla~~ 324 (873)
++++|.+++.. ...+++..+..++.||+.||+||| +.+++|+||+|+||+++.++.++|+|||+++.
T Consensus 76 ~~~~L~~~l~~----------~~~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~ 142 (262)
T cd05572 76 LGGELWTILRD----------RGLFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKK 142 (262)
T ss_pred CCCcHHHHHhh----------cCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccc
Confidence 99999999942 345888999999999999999999 89999999999999999999999999999986
Q ss_pred cccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcc
Q 002857 325 LEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDM 380 (873)
Q Consensus 325 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~ 380 (873)
..... ......++..|+|||++.+..++.++||||||+++|+|++|..||...
T Consensus 143 ~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 195 (262)
T cd05572 143 LKSGQ---KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGED 195 (262)
T ss_pred cCccc---ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCC
Confidence 64332 122345788999999998888999999999999999999999999753
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=297.08 Aligned_cols=208 Identities=21% Similarity=0.327 Sum_probs=169.2
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCc--chhHHHHHHHHHHhhhhccceeeeeeeecccc---cC
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHD--ASKSFTVECEVMRNIIHRKIIKVVTACSRVDY---QG 233 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~---~~ 233 (873)
.++|++.++||+|+||.||+|++..+++.||||++...... ....+.+|++++++++|+||+++++++..... ..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 57899999999999999999999888999999998643222 23467889999999999999999987643221 12
Q ss_pred CceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCC
Q 002857 234 NDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMT 313 (873)
Q Consensus 234 ~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~ 313 (873)
....++||||+.+ +|...+.. ....+++.++..++.||++||+||| +.+|+|+||||+||++++++.
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~---------~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~ 153 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN---------PSVKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGI 153 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc---------cccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCC
Confidence 3457999999965 67776632 2346899999999999999999999 899999999999999999999
Q ss_pred eEEeccccccccccccccc---------cccccccccccCCCcccCCC-CCCcchhhHhHHHHHHHHHhCCCCCCc
Q 002857 314 ACVADFGIARFLEATNEQT---------SSIGVKGTTGYIAPEYGMGH-ETSSYGDVYSFGILLLEMFTGLRPSDD 379 (873)
Q Consensus 314 vKLsDFGla~~~~~~~~~~---------~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELlTGk~Pf~~ 379 (873)
+||+|||+++......... ......++..|+|||++.+. .++.++||||||+++|||++|+.||..
T Consensus 154 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~ 229 (311)
T cd07866 154 LKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQG 229 (311)
T ss_pred EEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCC
Confidence 9999999998654322111 11234568889999987654 578999999999999999999999975
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=302.65 Aligned_cols=249 Identities=26% Similarity=0.305 Sum_probs=204.1
Q ss_pred CCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEEEE
Q 002857 162 FSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKALVY 241 (873)
Q Consensus 162 f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~LV~ 241 (873)
|.+..+||+|+||.||+|.++..|..||||.+... ....++..|+.+|++.+.+++|+++|.+ .....+++||
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSY-----FK~sDLWIVM 107 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSY-----FKHSDLWIVM 107 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhh-----ccCCceEeeh
Confidence 56678999999999999999999999999987533 3567899999999999999999999985 4566799999
Q ss_pred eecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEecccc
Q 002857 242 EFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGI 321 (873)
Q Consensus 242 Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDFGl 321 (873)
|||..|++.+.++ ..++.|++.++..|+.+.++||+||| ...-||||||+.||||+.+|.+||+|||.
T Consensus 108 EYCGAGSiSDI~R---------~R~K~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGV 175 (502)
T KOG0574|consen 108 EYCGAGSISDIMR---------ARRKPLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGV 175 (502)
T ss_pred hhcCCCcHHHHHH---------HhcCCccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccc
Confidence 9999999999995 35778999999999999999999999 78899999999999999999999999999
Q ss_pred ccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCchhHHH
Q 002857 322 ARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPERVEE 401 (873)
Q Consensus 322 a~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~~l~e 401 (873)
|-.+..... ....+.||+.|||||++..-.|..++||||||++..||.-|++||.+...-. .
T Consensus 176 AGQLTDTMA--KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR----------------A 237 (502)
T KOG0574|consen 176 AGQLTDTMA--KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMR----------------A 237 (502)
T ss_pred cchhhhhHH--hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccc----------------e
Confidence 976644322 2234679999999999999999999999999999999999999997742210 0
Q ss_pred HhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHH
Q 002857 402 IVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELG 464 (873)
Q Consensus 402 lid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~ 464 (873)
++ ++.. ..+|.......+ ...+-++++.||-.+|++|-|+.++++.
T Consensus 238 IF--MIPT-----------~PPPTF~KPE~W----S~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 238 IF--MIPT-----------KPPPTFKKPEEW----SSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred eE--eccC-----------CCCCCCCChHhh----hhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 00 0000 111222222222 3458899999999999999999988763
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=301.10 Aligned_cols=285 Identities=20% Similarity=0.223 Sum_probs=202.4
Q ss_pred CCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC--CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEE
Q 002857 161 GFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH--HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKA 238 (873)
Q Consensus 161 ~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~ 238 (873)
+|++.+.||.|+||.||+|+...+++.||||++.... ....+.+.+|+++++.++|+||+++++++...........+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5788999999999999999998889999999987543 33456799999999999999999999986432212224689
Q ss_pred EEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEec
Q 002857 239 LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVAD 318 (873)
Q Consensus 239 LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsD 318 (873)
+||||++ ++|.+++.. ...+++..++.++.||+.||+||| +.+|+||||||+|||++.++.++|+|
T Consensus 81 lv~e~~~-~~l~~~l~~----------~~~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~d 146 (330)
T cd07834 81 IVTELME-TDLHKVIKS----------PQPLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICD 146 (330)
T ss_pred EEecchh-hhHHHHHhC----------CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcc
Confidence 9999997 489888842 347899999999999999999999 89999999999999999999999999
Q ss_pred cccccccccccc-cccccccccccccCCCcccCCC-CCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCc
Q 002857 319 FGIARFLEATNE-QTSSIGVKGTTGYIAPEYGMGH-ETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALP 396 (873)
Q Consensus 319 FGla~~~~~~~~-~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~ 396 (873)
||++........ ........++..|+|||++.+. .++.++||||||+++|+|++|+.||....... ....+.....
T Consensus 147 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~--~~~~i~~~~~ 224 (330)
T cd07834 147 FGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYID--QLNLIVEVLG 224 (330)
T ss_pred cCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHH--HHHHHHHhcC
Confidence 999987644321 0112234578899999999887 78999999999999999999999997643211 1111111110
Q ss_pred hhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHH
Q 002857 397 ERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELG 464 (873)
Q Consensus 397 ~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~ 464 (873)
....+........... ........... .............+.+++.+||+.+|++|||+.+++..
T Consensus 225 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 225 TPSEEDLKFITSEKAR--NYLKSLPKKPK-KPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred CCChhHhhhccccchh--hHHhhcccCCc-chhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0000000000000000 00000000000 00011111224468899999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=295.24 Aligned_cols=193 Identities=26% Similarity=0.347 Sum_probs=165.1
Q ss_pred ecccCceEEEEEEEcCCCcEEEEEEeeccC---CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEEEEeec
Q 002857 168 IGAGNFASVYKGILFEGAPAVAIKVFNFLH---HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKALVYEFM 244 (873)
Q Consensus 168 LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~LV~Ey~ 244 (873)
||+|+||+||++....+++.||+|++.... ......+..|++++++++||||+++++.+ ...+..++||||+
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAF-----ETKDDLCLVMTLM 75 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEE-----ecCCeEEEEEecC
Confidence 699999999999998889999999986432 22335678899999999999999999885 4456789999999
Q ss_pred CCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEeccccccc
Q 002857 245 PNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARF 324 (873)
Q Consensus 245 ~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDFGla~~ 324 (873)
++++|.+++.. .....+++..++.++.|++.||.||| ..+++||||+|+||+++.++.+||+|||++..
T Consensus 76 ~~~~L~~~l~~--------~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~ 144 (277)
T cd05577 76 NGGDLKYHIYN--------VGEPGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVE 144 (277)
T ss_pred CCCcHHHHHHH--------cCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhh
Confidence 99999999853 22246899999999999999999999 89999999999999999999999999999976
Q ss_pred cccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCc
Q 002857 325 LEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDD 379 (873)
Q Consensus 325 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~ 379 (873)
..... ......++..|+|||++.+..++.++||||||+++|+|++|+.||..
T Consensus 145 ~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 196 (277)
T cd05577 145 LKGGK---KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQ 196 (277)
T ss_pred hccCC---ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCC
Confidence 54321 12233578899999999888899999999999999999999999965
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=299.62 Aligned_cols=248 Identities=24% Similarity=0.292 Sum_probs=192.4
Q ss_pred CCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCC---cchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEE
Q 002857 162 FSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH---DASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKA 238 (873)
Q Consensus 162 f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~ 238 (873)
|+..+.||+|+||.||+|++..++..||+|.+..... .....+.+|++++++++|+|++++++++ ..+...+
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~~ 101 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCY-----LREHTAW 101 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEE-----eeCCeEE
Confidence 6677899999999999999988899999999864322 2235688899999999999999999986 3456789
Q ss_pred EEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEec
Q 002857 239 LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVAD 318 (873)
Q Consensus 239 LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsD 318 (873)
+||||+. |+|.+++.. ....+++.++..++.||+.||.||| +.+|+||||+|+||+++.++.+||+|
T Consensus 102 lv~e~~~-g~l~~~~~~---------~~~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~d 168 (317)
T cd06635 102 LVMEYCL-GSASDLLEV---------HKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLAD 168 (317)
T ss_pred EEEeCCC-CCHHHHHHH---------hcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEec
Confidence 9999996 588777632 2345899999999999999999999 89999999999999999999999999
Q ss_pred cccccccccccccccccccccccccCCCcccC---CCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcC
Q 002857 319 FGIARFLEATNEQTSSIGVKGTTGYIAPEYGM---GHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSAL 395 (873)
Q Consensus 319 FGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~---~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~ 395 (873)
||++...... ....++..|+|||++. ...++.++|||||||++|||++|+.||....... .
T Consensus 169 fg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-~--------- 232 (317)
T cd06635 169 FGSASIASPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-A--------- 232 (317)
T ss_pred CCCccccCCc------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHH-H---------
Confidence 9998754321 2235788999999874 4568899999999999999999999986421110 0
Q ss_pred chhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHH
Q 002857 396 PERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRL 467 (873)
Q Consensus 396 ~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~ 467 (873)
...+..... .+... ......+.+++.+||+.+|++||++.+|+..+..
T Consensus 233 ---~~~~~~~~~---------------~~~~~------~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~ 280 (317)
T cd06635 233 ---LYHIAQNES---------------PTLQS------NEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV 280 (317)
T ss_pred ---HHHHHhccC---------------CCCCC------ccccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence 001110000 00000 0112347789999999999999999999876543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=301.60 Aligned_cols=281 Identities=20% Similarity=0.219 Sum_probs=199.3
Q ss_pred HHHHhhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeecc--CCcchhHHHHHHHHHHhhhhccceeeeeeeecccc
Q 002857 154 ALYSATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFL--HHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDY 231 (873)
Q Consensus 154 el~~at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~ 231 (873)
++..++++|++.+.||.|+||.||+|....+++.||||++... .....+.+..|++++++++||||+++++++.
T Consensus 4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~---- 79 (328)
T cd07856 4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFI---- 79 (328)
T ss_pred ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEe----
Confidence 4556789999999999999999999999889999999987532 2223467889999999999999999999863
Q ss_pred cCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCC
Q 002857 232 QGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDE 311 (873)
Q Consensus 232 ~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~ 311 (873)
......++|+||+ +++|.+++. ...+++.....++.||+.||+||| +.+|+||||+|+|||++++
T Consensus 80 ~~~~~~~lv~e~~-~~~L~~~~~-----------~~~~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~ 144 (328)
T cd07856 80 SPLEDIYFVTELL-GTDLHRLLT-----------SRPLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINEN 144 (328)
T ss_pred cCCCcEEEEeehh-ccCHHHHHh-----------cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCC
Confidence 2345688999998 568988873 234677888899999999999999 8999999999999999999
Q ss_pred CCeEEeccccccccccccccccccccccccccCCCcccCC-CCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHH
Q 002857 312 MTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMG-HETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNW 390 (873)
Q Consensus 312 ~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~ 390 (873)
+.+||+|||++...... .....++..|+|||++.+ ..++.++||||||+++|||+||+.||...... .....
T Consensus 145 ~~~~l~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~--~~~~~ 217 (328)
T cd07856 145 CDLKICDFGLARIQDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHV--NQFSI 217 (328)
T ss_pred CCEEeCccccccccCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHH
Confidence 99999999999754321 122346888999998766 56899999999999999999999999653211 11111
Q ss_pred HhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 391 VQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 391 ~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
+...+.....++.+........ .............. .+........+.+++.+||+.+|++|||+.+++.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~ 287 (328)
T cd07856 218 ITDLLGTPPDDVINTICSENTL--RFVQSLPKREPVPF-SEKFKNADPSAIDLLEKMLVFDPQKRISAAEALA 287 (328)
T ss_pred HHHHhCCCCHHHHHhccchhhH--HHHhhccccCCCcH-HHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 1111110011111111100000 00000000000000 0111112346889999999999999999998754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-32 Score=291.63 Aligned_cols=251 Identities=21% Similarity=0.266 Sum_probs=190.4
Q ss_pred HHHHHHhhcCCCcceee--cccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhh-hhccceeeeeeeec
Q 002857 152 YEALYSATKGFSSENLI--GAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNI-IHRKIIKVVTACSR 228 (873)
Q Consensus 152 ~~el~~at~~f~~~~~L--G~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~llg~c~~ 228 (873)
..++....++|++.+.+ |+|+||.||+++...++..+|+|++....... .|+.....+ +|+||+++++.+
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~-- 78 (267)
T PHA03390 6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSV-- 78 (267)
T ss_pred HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEE--
Confidence 34455556677777776 99999999999998899999999986432221 123222223 699999999986
Q ss_pred ccccCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeee
Q 002857 229 VDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILL 308 (873)
Q Consensus 229 ~~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILL 308 (873)
...+..++||||+++++|.+++.. ...+++.+++.++.||++||.||| +.+++||||||+||++
T Consensus 79 ---~~~~~~~iv~e~~~~~~L~~~l~~----------~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~ 142 (267)
T PHA03390 79 ---TTLKGHVLIMDYIKDGDLFDLLKK----------EGKLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLY 142 (267)
T ss_pred ---ecCCeeEEEEEcCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEE
Confidence 345679999999999999999842 237899999999999999999999 8999999999999999
Q ss_pred CCCC-CeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhh
Q 002857 309 NDEM-TACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNL 387 (873)
Q Consensus 309 d~~~-~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l 387 (873)
+.++ .++|+|||+++..... ....++..|+|||++.+..++.++||||||+++|||++|+.||.....+....
T Consensus 143 ~~~~~~~~l~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~ 216 (267)
T PHA03390 143 DRAKDRIYLCDYGLCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDL 216 (267)
T ss_pred eCCCCeEEEecCccceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhH
Confidence 9988 9999999998765322 12357899999999999899999999999999999999999997533222111
Q ss_pred HHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCC-HHHHHH
Q 002857 388 QNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMK-INDVEL 463 (873)
Q Consensus 388 ~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPT-m~EVl~ 463 (873)
..+.... . .. .+.. ......+.+++.+||+.+|.+||+ ++|+++
T Consensus 217 ~~~~~~~---------~----~~------------~~~~-------~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 217 ESLLKRQ---------Q----KK------------LPFI-------KNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred HHHHHhh---------c----cc------------CCcc-------cccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 1111100 0 00 0000 011234788999999999999996 587763
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-32 Score=297.13 Aligned_cols=197 Identities=23% Similarity=0.245 Sum_probs=158.4
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEeecc--CCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEEEEee
Q 002857 166 NLIGAGNFASVYKGILFEGAPAVAIKVFNFL--HHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKALVYEF 243 (873)
Q Consensus 166 ~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~LV~Ey 243 (873)
+.+|.|+ .||.++...+++.||||+++.. .....+.+.+|++++++++|+||+++++++ ...+..+++|||
T Consensus 8 ~~~~~~~--~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~-----~~~~~~~~~~e~ 80 (314)
T cd08216 8 KCFEDLM--IVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF-----IVDSELYVVSPL 80 (314)
T ss_pred HhhcCCc--eEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhhee-----ecCCeEEEEEec
Confidence 3344444 4555555568899999998754 334456899999999999999999999985 456678999999
Q ss_pred cCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEecccccc
Q 002857 244 MPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIAR 323 (873)
Q Consensus 244 ~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDFGla~ 323 (873)
+++|+|.+++.. .....+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||.+.
T Consensus 81 ~~~~~l~~~l~~--------~~~~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~ 149 (314)
T cd08216 81 MAYGSCEDLLKT--------HFPEGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSV 149 (314)
T ss_pred cCCCCHHHHHHH--------hcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccce
Confidence 999999999853 22345788899999999999999999 8999999999999999999999999999987
Q ss_pred cccccccc-----ccccccccccccCCCcccCCC--CCCcchhhHhHHHHHHHHHhCCCCCCcc
Q 002857 324 FLEATNEQ-----TSSIGVKGTTGYIAPEYGMGH--ETSSYGDVYSFGILLLEMFTGLRPSDDM 380 (873)
Q Consensus 324 ~~~~~~~~-----~~~~~~~Gt~~Y~APE~l~~~--~~s~ksDVwSfGvvL~ELlTGk~Pf~~~ 380 (873)
.+...... .......++..|+|||++... .++.++||||||+++|||++|+.||...
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~ 213 (314)
T cd08216 150 SMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDM 213 (314)
T ss_pred eeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence 55322111 111233477889999998763 5889999999999999999999999763
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=292.01 Aligned_cols=199 Identities=25% Similarity=0.324 Sum_probs=166.5
Q ss_pred CCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCc-chhHHHHHHHHHHhhh-hccceeeeeeeecccccCCceEEE
Q 002857 162 FSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHD-ASKSFTVECEVMRNII-HRKIIKVVTACSRVDYQGNDFKAL 239 (873)
Q Consensus 162 f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~-HpNIV~llg~c~~~~~~~~~~~~L 239 (873)
|++.+.||+|++|.||+|+...+++.||||.+...... ......+|+..+.+++ |+||+++++++ ..++..++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~-----~~~~~~~l 75 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVF-----RENDELYF 75 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHh-----hcCCcEEE
Confidence 56789999999999999999888899999998643322 2234567999999998 99999999985 44678899
Q ss_pred EEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEecc
Q 002857 240 VYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADF 319 (873)
Q Consensus 240 V~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDF 319 (873)
||||+ +|+|.+++.. .....+++.+++.++.|++.+|.||| +.+++|+||+|+||++++++.++|+||
T Consensus 76 v~e~~-~~~l~~~~~~--------~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~ 143 (283)
T cd07830 76 VFEYM-EGNLYQLMKD--------RKGKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADF 143 (283)
T ss_pred EEecC-CCCHHHHHHh--------cccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeec
Confidence 99999 8899998853 22356899999999999999999999 899999999999999999999999999
Q ss_pred ccccccccccccccccccccccccCCCcccCC-CCCCcchhhHhHHHHHHHHHhCCCCCCcc
Q 002857 320 GIARFLEATNEQTSSIGVKGTTGYIAPEYGMG-HETSSYGDVYSFGILLLEMFTGLRPSDDM 380 (873)
Q Consensus 320 Gla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~ 380 (873)
|+++....... .....++..|+|||++.+ ..++.++||||||+++|||++|+.||...
T Consensus 144 ~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~ 202 (283)
T cd07830 144 GLAREIRSRPP---YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGS 202 (283)
T ss_pred ccceeccCCCC---cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCC
Confidence 99986543221 122457889999998754 45789999999999999999999998653
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=297.21 Aligned_cols=245 Identities=20% Similarity=0.254 Sum_probs=193.2
Q ss_pred ceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEEEEeec
Q 002857 165 ENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKALVYEFM 244 (873)
Q Consensus 165 ~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~LV~Ey~ 244 (873)
..+||+|+||.||++....+++.||||.+..........+.+|+.+++.++|+||+++++++ ..++..++||||+
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv~e~~ 99 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY-----LVGDELWVVMEFL 99 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEE-----EeCCEEEEEEecC
Confidence 36799999999999999889999999998655444556789999999999999999999985 4466899999999
Q ss_pred CCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEeccccccc
Q 002857 245 PNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARF 324 (873)
Q Consensus 245 ~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDFGla~~ 324 (873)
++++|.+++. ...+++.....++.|++.||+||| +.+++||||+|+||+++.++.++|+|||++..
T Consensus 100 ~~~~L~~~~~-----------~~~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~ 165 (292)
T cd06657 100 EGGALTDIVT-----------HTRMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQ 165 (292)
T ss_pred CCCcHHHHHh-----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEccccccee
Confidence 9999999873 234788899999999999999999 88999999999999999999999999999875
Q ss_pred cccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCchhHHHHhh
Q 002857 325 LEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPERVEEIVD 404 (873)
Q Consensus 325 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~~l~elid 404 (873)
..... .......++..|+|||++.+..++.++||||||+++|||++|..||...... .... .+.
T Consensus 166 ~~~~~--~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~--~~~~------------~~~ 229 (292)
T cd06657 166 VSKEV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--KAMK------------MIR 229 (292)
T ss_pred ccccc--ccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHH------------HHH
Confidence 53322 1122345889999999998888899999999999999999999998642111 0000 000
Q ss_pred hhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 405 TLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 405 ~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
..+..... ........+.+++.+||+.+|.+||++.+|+.
T Consensus 230 ~~~~~~~~-------------------~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 230 DNLPPKLK-------------------NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred hhCCcccC-------------------CcccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 00000000 00011224678999999999999999999876
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=300.60 Aligned_cols=199 Identities=22% Similarity=0.277 Sum_probs=161.6
Q ss_pred eeeccc--CceEEEEEEEcCCCcEEEEEEeeccCC--cchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEEEE
Q 002857 166 NLIGAG--NFASVYKGILFEGAPAVAIKVFNFLHH--DASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKALVY 241 (873)
Q Consensus 166 ~~LG~G--~fG~VYkg~~~~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~LV~ 241 (873)
..||+| +||+||++.+..+++.||||++..... ...+.+.+|+.+++.++|+||+++++++ ..++..++||
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~-----~~~~~~~~v~ 78 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVF-----TTGSWLWVIS 78 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeE-----ecCCceEEEE
Confidence 456776 999999999988999999999874332 2346788999999999999999999996 4466789999
Q ss_pred eecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEecccc
Q 002857 242 EFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGI 321 (873)
Q Consensus 242 Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDFGl 321 (873)
||+.+++|.+++.. .....+++..+..++.||+.||+||| +.+|+||||||+|||++.++.++++||+.
T Consensus 79 e~~~~~~l~~~l~~--------~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~ 147 (328)
T cd08226 79 PFMAYGSANSLLKT--------YFPEGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSH 147 (328)
T ss_pred ecccCCCHHHHHHh--------hcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHH
Confidence 99999999999853 12345888999999999999999999 89999999999999999999999999986
Q ss_pred ccccccccccc-----cccccccccccCCCcccCCC--CCCcchhhHhHHHHHHHHHhCCCCCCcc
Q 002857 322 ARFLEATNEQT-----SSIGVKGTTGYIAPEYGMGH--ETSSYGDVYSFGILLLEMFTGLRPSDDM 380 (873)
Q Consensus 322 a~~~~~~~~~~-----~~~~~~Gt~~Y~APE~l~~~--~~s~ksDVwSfGvvL~ELlTGk~Pf~~~ 380 (873)
+.......... ......++..|+|||++.+. .++.++||||||+++|||++|+.||...
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~ 213 (328)
T cd08226 148 LYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDM 213 (328)
T ss_pred HhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 54332211110 00112246679999998764 4789999999999999999999999764
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=290.57 Aligned_cols=245 Identities=24% Similarity=0.288 Sum_probs=185.9
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEeeccCC---cchhHHHHHHHHH-HhhhhccceeeeeeeecccccCCceEEEEE
Q 002857 166 NLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH---DASKSFTVECEVM-RNIIHRKIIKVVTACSRVDYQGNDFKALVY 241 (873)
Q Consensus 166 ~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~---~~~~~f~~Ei~iL-~~L~HpNIV~llg~c~~~~~~~~~~~~LV~ 241 (873)
+.||+|+||.||+|....+++.||||++..... .....+..|..++ ...+|+|++++++++ ..++..++||
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~ 76 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF-----QSKDYLYLVM 76 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeE-----EcCCeEEEEE
Confidence 579999999999999988899999999864322 1223344555544 345899999999985 4566899999
Q ss_pred eecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEecccc
Q 002857 242 EFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGI 321 (873)
Q Consensus 242 Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDFGl 321 (873)
||+++++|.+++.. ...+++..+..++.||+.||.||| +.+|+||||+|+||++++++.+||+|||+
T Consensus 77 e~~~~~~L~~~l~~----------~~~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~ 143 (260)
T cd05611 77 EYLNGGDCASLIKT----------LGGLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGL 143 (260)
T ss_pred eccCCCCHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeeccc
Confidence 99999999999842 345888999999999999999999 89999999999999999999999999999
Q ss_pred ccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCchhHHH
Q 002857 322 ARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPERVEE 401 (873)
Q Consensus 322 a~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~~l~e 401 (873)
++.... .....++..|+|||.+.+..++.++||||||+++|||+||..||....... . ...
T Consensus 144 ~~~~~~------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-----~--------~~~ 204 (260)
T cd05611 144 SRNGLE------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA-----V--------FDN 204 (260)
T ss_pred ceeccc------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH-----H--------HHH
Confidence 875432 122357889999999988888999999999999999999999996532110 0 000
Q ss_pred HhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHH
Q 002857 402 IVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLR 466 (873)
Q Consensus 402 lid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le 466 (873)
+....... +. . ....+...+.+++.+||+.+|++||++.++.+.|.
T Consensus 205 ~~~~~~~~--------------~~--~---~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 205 ILSRRINW--------------PE--E---VKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred HHhcccCC--------------CC--c---ccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 00000000 00 0 00012345789999999999999998876655443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=296.48 Aligned_cols=250 Identities=24% Similarity=0.348 Sum_probs=205.8
Q ss_pred CCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC---CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceE
Q 002857 161 GFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH---HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFK 237 (873)
Q Consensus 161 ~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~ 237 (873)
+|+..+.||.|.-|+||++.+..++..+|+|++.+.. .....+.+.|-+||+.++||.+..||+. ++.+...
T Consensus 78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~-----fet~~~~ 152 (459)
T KOG0610|consen 78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYAS-----FETDKYS 152 (459)
T ss_pred HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhe-----eecccee
Confidence 4567799999999999999999888999999997443 3344678889999999999999999998 4678889
Q ss_pred EEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEe
Q 002857 238 ALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVA 317 (873)
Q Consensus 238 ~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLs 317 (873)
+||||||+||+|..+++. +..+.+++..+.-++..|+-||+||| ..|||.|||||+||||.++|++-|+
T Consensus 153 cl~meyCpGGdL~~Lrqk--------Qp~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLs 221 (459)
T KOG0610|consen 153 CLVMEYCPGGDLHSLRQK--------QPGKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLS 221 (459)
T ss_pred EEEEecCCCccHHHHHhh--------CCCCccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEee
Confidence 999999999999999864 56778999999999999999999999 8999999999999999999999999
Q ss_pred ccccccccccc---------------------------------cc---------------------ccccccccccccc
Q 002857 318 DFGIARFLEAT---------------------------------NE---------------------QTSSIGVKGTTGY 343 (873)
Q Consensus 318 DFGla~~~~~~---------------------------------~~---------------------~~~~~~~~Gt~~Y 343 (873)
||.++...... .. ...+...+||-.|
T Consensus 222 DFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEY 301 (459)
T KOG0610|consen 222 DFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEY 301 (459)
T ss_pred eccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccccc
Confidence 99987532110 00 0011235699999
Q ss_pred CCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhc--------CchhHHHHhhhhhhhhhhHHH
Q 002857 344 IAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSA--------LPERVEEIVDTLFFKEIEEEE 415 (873)
Q Consensus 344 ~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~--------~~~~l~elid~~L~~~~~~r~ 415 (873)
+|||++.+...+.+.|.|+|||+||||+.|..||.+...+. .+...+.+. +.....+++...|.+++..|.
T Consensus 302 lAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~-Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRl 380 (459)
T KOG0610|consen 302 LAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKE-TLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRL 380 (459)
T ss_pred ccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchh-hHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhh
Confidence 99999999999999999999999999999999998854433 233333221 223689999999999998887
Q ss_pred H----HhhhccCCCCc
Q 002857 416 T----VYKYKKAPSSS 427 (873)
Q Consensus 416 ~----~~~i~~~p~~~ 427 (873)
. ..+++.||-..
T Consensus 381 g~~rGA~eIK~HpFF~ 396 (459)
T KOG0610|consen 381 GSKRGAAEIKRHPFFE 396 (459)
T ss_pred ccccchHHhhcCcccc
Confidence 7 56777777543
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=320.81 Aligned_cols=204 Identities=22% Similarity=0.241 Sum_probs=156.9
Q ss_pred hhcCCCcceeecccCceEEEEEEEcCCC-cEEEEE------------------EeeccCCcchhHHHHHHHHHHhhhhcc
Q 002857 158 ATKGFSSENLIGAGNFASVYKGILFEGA-PAVAIK------------------VFNFLHHDASKSFTVECEVMRNIIHRK 218 (873)
Q Consensus 158 at~~f~~~~~LG~G~fG~VYkg~~~~~g-~~VAVK------------------~l~~~~~~~~~~f~~Ei~iL~~L~HpN 218 (873)
..++|++.+.||+|+||.||++.++... ..+++| .+. ........+.+|+.+|++++|+|
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCC
Confidence 3578999999999999999998764322 122222 111 11122356889999999999999
Q ss_pred ceeeeeeeecccccCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeee
Q 002857 219 IIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAH 298 (873)
Q Consensus 219 IV~llg~c~~~~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvH 298 (873)
|+++++++ ...+..++|++++. ++|.+++.... ..........+...|+.||+.||+||| +.+|||
T Consensus 225 Iv~l~~~~-----~~~~~~~lv~e~~~-~~l~~~l~~~~-----~~~~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiH 290 (501)
T PHA03210 225 ILKIEEIL-----RSEANTYMITQKYD-FDLYSFMYDEA-----FDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIH 290 (501)
T ss_pred cCcEeEEE-----EECCeeEEEEeccc-cCHHHHHhhcc-----ccccccccHHHHHHHHHHHHHHHHHHH---hCCeec
Confidence 99999996 44567899999984 57777764311 111222345667889999999999999 899999
Q ss_pred ccCCCCCeeeCCCCCeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCC
Q 002857 299 CDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPS 377 (873)
Q Consensus 299 rDLKpsNILLd~~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf 377 (873)
|||||+|||++.++.+||+|||+++.+..... .......||..|+|||++.+..++.++|||||||++|||++|..++
T Consensus 291 rDLKP~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p 368 (501)
T PHA03210 291 RDIKLENIFLNCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCP 368 (501)
T ss_pred CCCCHHHEEECCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 99999999999999999999999987643322 1222356999999999999999999999999999999999987543
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-33 Score=313.32 Aligned_cols=244 Identities=25% Similarity=0.302 Sum_probs=193.1
Q ss_pred CCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCc---chhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEE
Q 002857 162 FSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHD---ASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKA 238 (873)
Q Consensus 162 f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~---~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~ 238 (873)
|+.++.||.|+||.||-|++..+.+.||||.++....+ ...++..|+..|.+++|||+|.+-|+| -.+...|
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCy-----Lre~TaW 102 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCY-----LREHTAW 102 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCccccccee-----eccchHH
Confidence 55668899999999999999999999999998744333 335789999999999999999999985 4456689
Q ss_pred EEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEec
Q 002857 239 LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVAD 318 (873)
Q Consensus 239 LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsD 318 (873)
|||||| -||-.|+|.- ..+++.+.++..|..+.+.||+||| +.+.||||||+.||||++.|.+||+|
T Consensus 103 LVMEYC-lGSAsDlleV---------hkKplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaD 169 (948)
T KOG0577|consen 103 LVMEYC-LGSASDLLEV---------HKKPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLAD 169 (948)
T ss_pred HHHHHH-hccHHHHHHH---------HhccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeecc
Confidence 999999 4588888742 3567888999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccccccccccccccccCCCcccCC---CCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcC
Q 002857 319 FGIARFLEATNEQTSSIGVKGTTGYIAPEYGMG---HETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSAL 395 (873)
Q Consensus 319 FGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~---~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~ 395 (873)
||.|.+.... ..++||+.|||||++.. ++|+-|.||||||++..||.-.++|+-.+.. ...+...+...
T Consensus 170 FGSAsi~~PA------nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA-MSALYHIAQNe- 241 (948)
T KOG0577|consen 170 FGSASIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-MSALYHIAQNE- 241 (948)
T ss_pred ccchhhcCch------hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH-HHHHHHHHhcC-
Confidence 9999876432 34679999999998754 6899999999999999999999999644210 00011111000
Q ss_pred chhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 396 PERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 396 ~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
.+.+.. .++ ...+.+++..||+.-|.+|||..+++.
T Consensus 242 --------sPtLqs--------------------~eW----S~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 242 --------SPTLQS--------------------NEW----SDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred --------CCCCCC--------------------chh----HHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 000100 111 234788999999999999999988764
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.4e-33 Score=315.35 Aligned_cols=246 Identities=24% Similarity=0.374 Sum_probs=194.7
Q ss_pred ceeecccCceEEEEEEEcCCCcEEEEEEee--c--cCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEEE
Q 002857 165 ENLIGAGNFASVYKGILFEGAPAVAIKVFN--F--LHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKALV 240 (873)
Q Consensus 165 ~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~--~--~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~LV 240 (873)
..+||+|+|-+||+|.+..+|..||=-.++ . ......+.|..|+.+|+.|+|+|||+++.+... ..+...-+|
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d---~~n~~in~i 121 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVD---TDNKTINFI 121 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheec---CCCceeeee
Confidence 467999999999999998888877743332 1 223344789999999999999999999998653 234568899
Q ss_pred EeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeC-CCCCeEEecc
Q 002857 241 YEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLN-DEMTACVADF 319 (873)
Q Consensus 241 ~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd-~~~~vKLsDF 319 (873)
+|.+..|+|..|++ ..+.++...+..|++||++||.|||.. .++|||||||-+||+|+ .-|.+||+|+
T Consensus 122 TEL~TSGtLr~Y~k----------k~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDL 190 (632)
T KOG0584|consen 122 TELFTSGTLREYRK----------KHRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDL 190 (632)
T ss_pred eecccCCcHHHHHH----------HhccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecch
Confidence 99999999999994 345678889999999999999999965 79999999999999997 4589999999
Q ss_pred ccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCchhH
Q 002857 320 GIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPERV 399 (873)
Q Consensus 320 Gla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~~l 399 (873)
|+|...... ....+.||+.|||||+.. ..|++..||||||+.|+||+|+..||..-.....-+.+.....-+..+
T Consensus 191 GLAtl~r~s----~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl 265 (632)
T KOG0584|consen 191 GLATLLRKS----HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAAL 265 (632)
T ss_pred hHHHHhhcc----ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHh
Confidence 999976432 223367999999999876 789999999999999999999999997643333333332222222233
Q ss_pred HHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 400 EEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 400 ~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
..+-|+ ++.+||.+|+.. .++|||+.|++.
T Consensus 266 ~kV~dP---------------------------------evr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 266 SKVKDP---------------------------------EVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred hccCCH---------------------------------HHHHHHHHHhcC-chhccCHHHHhh
Confidence 322221 367899999999 999999999875
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.5e-32 Score=295.73 Aligned_cols=252 Identities=22% Similarity=0.288 Sum_probs=190.7
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCC-cchhHHHHHHHHHHhhh-hccceeeeeeeecccccCCceE
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH-DASKSFTVECEVMRNII-HRKIIKVVTACSRVDYQGNDFK 237 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~-HpNIV~llg~c~~~~~~~~~~~ 237 (873)
++|++.+.||+|+||.||+|.+..+++.||||+++.... .....+..|+.++.+.. |+||+++++++ ......
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~ 89 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYF-----ITDSDV 89 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheee-----ecCCeE
Confidence 567889999999999999999987799999999975432 23456777888777775 99999999996 345678
Q ss_pred EEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCC-CCeeeccCCCCCeeeCCCCCeEE
Q 002857 238 ALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCK-PPIAHCDIKPSNILLNDEMTACV 316 (873)
Q Consensus 238 ~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s-~gIvHrDLKpsNILLd~~~~vKL 316 (873)
++||||+. ++|.+++.. ....+++..+..|+.||+.||+||| + .+|+||||+|+||++++++.+||
T Consensus 90 ~~v~e~~~-~~l~~l~~~---------~~~~l~~~~~~~i~~~i~~~l~~lH---~~~~i~H~dl~p~nill~~~~~~kL 156 (296)
T cd06618 90 FICMELMS-TCLDKLLKR---------IQGPIPEDILGKMTVAIVKALHYLK---EKHGVIHRDVKPSNILLDASGNVKL 156 (296)
T ss_pred EEEeeccC-cCHHHHHHH---------hcCCCCHHHHHHHHHHHHHHHHHHH---hhCCEecCCCcHHHEEEcCCCCEEE
Confidence 99999985 477776632 2346889999999999999999999 5 59999999999999999999999
Q ss_pred eccccccccccccccccccccccccccCCCcccCCCC----CCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHh
Q 002857 317 ADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHE----TSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQ 392 (873)
Q Consensus 317 sDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~----~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~ 392 (873)
+|||++..+...... ....++..|+|||++.+.. ++.++||||||+++|||++|+.||.........+
T Consensus 157 ~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~----- 228 (296)
T cd06618 157 CDFGISGRLVDSKAK---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVL----- 228 (296)
T ss_pred CccccchhccCCCcc---cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHH-----
Confidence 999999765432211 2234788999999987654 7889999999999999999999986421111000
Q ss_pred hcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHH
Q 002857 393 SALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELG 464 (873)
Q Consensus 393 ~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~ 464 (873)
..+...... ..+... ....++.+++.+||+.+|++||++.+|+..
T Consensus 229 -------~~~~~~~~~-------------~~~~~~-------~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 229 -------TKILQEEPP-------------SLPPNE-------GFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred -------HHHhcCCCC-------------CCCCCC-------CCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 011110000 000000 012357889999999999999999999765
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=297.16 Aligned_cols=204 Identities=22% Similarity=0.258 Sum_probs=166.6
Q ss_pred CCCcceeecccCceEEEEEEEcCC--CcEEEEEEeeccC--CcchhHHHHHHHHHHhh-hhccceeeeeeeecccccCCc
Q 002857 161 GFSSENLIGAGNFASVYKGILFEG--APAVAIKVFNFLH--HDASKSFTVECEVMRNI-IHRKIIKVVTACSRVDYQGND 235 (873)
Q Consensus 161 ~f~~~~~LG~G~fG~VYkg~~~~~--g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L-~HpNIV~llg~c~~~~~~~~~ 235 (873)
+|++.+.||+|+||.||+++.... +..||||++.... ....+.+.+|+.+++++ +|+||+++++.+... .....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVF-PGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeec-cccCC
Confidence 478889999999999999999877 8899999986432 22345788899999999 599999999875321 12334
Q ss_pred eEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeE
Q 002857 236 FKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTAC 315 (873)
Q Consensus 236 ~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vK 315 (873)
..++++||+. ++|.+++. ....+++..++.++.||+.||.||| +.+|+||||||+|||++.++.+|
T Consensus 80 ~~~~~~e~~~-~~L~~~l~----------~~~~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~k 145 (332)
T cd07857 80 ELYLYEELME-ADLHQIIR----------SGQPLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELK 145 (332)
T ss_pred cEEEEEeccc-CCHHHHHh----------cCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEE
Confidence 5788999885 68998883 2456889999999999999999999 89999999999999999999999
Q ss_pred Eecccccccccccccc--ccccccccccccCCCcccCC-CCCCcchhhHhHHHHHHHHHhCCCCCCc
Q 002857 316 VADFGIARFLEATNEQ--TSSIGVKGTTGYIAPEYGMG-HETSSYGDVYSFGILLLEMFTGLRPSDD 379 (873)
Q Consensus 316 LsDFGla~~~~~~~~~--~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELlTGk~Pf~~ 379 (873)
|+|||+++.+...... .......|+..|+|||++.+ ..++.++||||||+++|+|++|+.||..
T Consensus 146 l~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~ 212 (332)
T cd07857 146 ICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKG 212 (332)
T ss_pred eCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCC
Confidence 9999999865432211 11223468999999998765 4689999999999999999999999875
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.5e-32 Score=290.76 Aligned_cols=249 Identities=26% Similarity=0.394 Sum_probs=197.6
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeecc---CCcchhHHHHHHHHHHhhh-hccceeeeeeeecccccCCc
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFL---HHDASKSFTVECEVMRNII-HRKIIKVVTACSRVDYQGND 235 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~L~-HpNIV~llg~c~~~~~~~~~ 235 (873)
++|.+.+.||+|+||.||+|+...+++.||+|++... .....+.+..|++++++++ |+||+++++++ ..++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~ 75 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTF-----QDEE 75 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHh-----cCCc
Confidence 4788999999999999999999889999999998642 2233467889999999998 99999999984 4567
Q ss_pred eEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeE
Q 002857 236 FKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTAC 315 (873)
Q Consensus 236 ~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vK 315 (873)
..++||||+++++|.+++.. ...+++..++.|+.|++.||.||| +.+++|+||+|+||+++.++.++
T Consensus 76 ~~~lv~e~~~~~~L~~~l~~----------~~~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~ 142 (280)
T cd05581 76 NLYFVLEYAPNGELLQYIRK----------YGSLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIK 142 (280)
T ss_pred eEEEEEcCCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEE
Confidence 89999999999999999842 346999999999999999999999 89999999999999999999999
Q ss_pred Eecccccccccccccc------------------ccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCC
Q 002857 316 VADFGIARFLEATNEQ------------------TSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPS 377 (873)
Q Consensus 316 LsDFGla~~~~~~~~~------------------~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf 377 (873)
|+|||++......... .......++..|+|||.+....++.++||||||++++++++|+.||
T Consensus 143 l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~ 222 (280)
T cd05581 143 ITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPF 222 (280)
T ss_pred ecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCC
Confidence 9999999865433211 1122335788999999988888999999999999999999999999
Q ss_pred CcccccchhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCC
Q 002857 378 DDMFKDNLNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMK 457 (873)
Q Consensus 378 ~~~~~~~~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPT 457 (873)
....... .+..+.+.. ...|. .....+.+++.+||+.+|++||+
T Consensus 223 ~~~~~~~-------------~~~~~~~~~--------------~~~~~---------~~~~~~~~li~~~l~~~p~~R~~ 266 (280)
T cd05581 223 RGSNEYL-------------TFQKILKLE--------------YSFPP---------NFPPDAKDLIEKLLVLDPQDRLG 266 (280)
T ss_pred CCccHHH-------------HHHHHHhcC--------------CCCCC---------ccCHHHHHHHHHHhcCCHhhCCC
Confidence 7532100 001110000 00000 01234788999999999999999
Q ss_pred H----HHHH
Q 002857 458 I----NDVE 462 (873)
Q Consensus 458 m----~EVl 462 (873)
+ .+++
T Consensus 267 ~~~~~~~ll 275 (280)
T cd05581 267 VNEGYDELK 275 (280)
T ss_pred cccCHHHHh
Confidence 9 6654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.2e-33 Score=308.25 Aligned_cols=252 Identities=21% Similarity=0.276 Sum_probs=196.2
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEee--ccCCcchhHHHHHHHHHHhh-hhccceeeeeeeecccccCCce
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFN--FLHHDASKSFTVECEVMRNI-IHRKIIKVVTACSRVDYQGNDF 236 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~--~~~~~~~~~f~~Ei~iL~~L-~HpNIV~llg~c~~~~~~~~~~ 236 (873)
..|++.++||.||.+.||++.. .+.+.+|+|.+. ..+.+....|.+|++.|.+| .|.+||+|++|- ..++.
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~-s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYE-----v~d~~ 434 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLN-SDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYE-----VTDGY 434 (677)
T ss_pred chhhHHHhhcCCCcceeeeeec-CCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeee-----ccCce
Confidence 4688999999999999999965 555677887665 33445567899999999999 599999999993 45788
Q ss_pred EEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEE
Q 002857 237 KALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACV 316 (873)
Q Consensus 237 ~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKL 316 (873)
+|+||||-+ .+|.++|.. ....+....+..+..|++.++.++| ..||||-||||.|+|+- .|.+||
T Consensus 435 lYmvmE~Gd-~DL~kiL~k---------~~~~~~~~~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLlV-kG~LKL 500 (677)
T KOG0596|consen 435 LYMVMECGD-IDLNKILKK---------KKSIDPDWFLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLLV-KGRLKL 500 (677)
T ss_pred EEEEeeccc-ccHHHHHHh---------ccCCCchHHHHHHHHHHHHHHHHHH---HhceeecCCCcccEEEE-eeeEEe
Confidence 999999874 499999953 2222332378899999999999999 89999999999999986 468999
Q ss_pred eccccccccccccccccccccccccccCCCcccCCC-----------CCCcchhhHhHHHHHHHHHhCCCCCCcccccch
Q 002857 317 ADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGH-----------ETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNL 385 (873)
Q Consensus 317 sDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-----------~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~ 385 (873)
+|||+|..+..+.........+||+.||+||.+... +.+.+|||||+|||||+|+.|+.||.......
T Consensus 501 IDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~- 579 (677)
T KOG0596|consen 501 IDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQI- 579 (677)
T ss_pred eeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHH-
Confidence 999999988777666666677899999999987643 25688999999999999999999997531110
Q ss_pred hhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 386 NLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 386 ~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
..+..+.++...-++. .+|. ..+++++++.||+.||++|||+.|+++
T Consensus 580 -----------aKl~aI~~P~~~Iefp---------~~~~-----------~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 580 -----------AKLHAITDPNHEIEFP---------DIPE-----------NDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred -----------HHHHhhcCCCcccccc---------CCCC-----------chHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 1233444432211111 1111 123889999999999999999999875
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.8e-32 Score=290.13 Aligned_cols=242 Identities=19% Similarity=0.246 Sum_probs=182.4
Q ss_pred eecccCceEEEEEEEcCCCcEEEEEEeeccCCc---chhHHHHHHHHHH---hhhhccceeeeeeeecccccCCceEEEE
Q 002857 167 LIGAGNFASVYKGILFEGAPAVAIKVFNFLHHD---ASKSFTVECEVMR---NIIHRKIIKVVTACSRVDYQGNDFKALV 240 (873)
Q Consensus 167 ~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~---~~~~f~~Ei~iL~---~L~HpNIV~llg~c~~~~~~~~~~~~LV 240 (873)
.||+|+||.||+|....+++.||+|.+...... ....+..|..+++ ...|+||+++++++ ...+..++|
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~-----~~~~~~~~v 75 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-----HTPDKLSFI 75 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeee-----ecCCEEEEE
Confidence 489999999999999888999999998643221 1223444544443 44799999999885 456678999
Q ss_pred EeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEeccc
Q 002857 241 YEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFG 320 (873)
Q Consensus 241 ~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDFG 320 (873)
|||+++|+|.+++. ....+++..++.|+.|+++||.||| +.+|+||||||+||+++.++.+||+|||
T Consensus 76 ~e~~~g~~L~~~l~----------~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg 142 (278)
T cd05606 76 LDLMNGGDLHYHLS----------QHGVFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLG 142 (278)
T ss_pred EecCCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCc
Confidence 99999999998883 2356899999999999999999999 8999999999999999999999999999
Q ss_pred cccccccccccccccccccccccCCCcccCCC-CCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCchhH
Q 002857 321 IARFLEATNEQTSSIGVKGTTGYIAPEYGMGH-ETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPERV 399 (873)
Q Consensus 321 la~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~~l 399 (873)
++..+.... .....|+..|+|||++.++ .++.++||||||+++|||++|+.||.......... .
T Consensus 143 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~-----------~ 207 (278)
T cd05606 143 LACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-----------I 207 (278)
T ss_pred CccccCccC----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH-----------H
Confidence 987553321 1223589999999998754 68999999999999999999999997532111000 0
Q ss_pred HHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCC-----CHHHHHH
Q 002857 400 EEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERM-----KINDVEL 463 (873)
Q Consensus 400 ~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRP-----Tm~EVl~ 463 (873)
.... .... ..... .....+.+++.+|++.+|.+|| ++.++++
T Consensus 208 ~~~~---~~~~------------~~~~~-------~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 208 DRMT---LTMA------------VELPD-------SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred HHHh---hccC------------CCCCC-------cCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 0000 0000 00000 0123477899999999999999 8988864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=299.03 Aligned_cols=283 Identities=18% Similarity=0.211 Sum_probs=200.1
Q ss_pred HHHHhhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCC--cchhHHHHHHHHHHhhhhccceeeeeeeecccc
Q 002857 154 ALYSATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH--DASKSFTVECEVMRNIIHRKIIKVVTACSRVDY 231 (873)
Q Consensus 154 el~~at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~ 231 (873)
.+....++|++.+.||+|+||.||+|....++..||||++..... ...+.+.+|++++++++|+||+++++++.....
T Consensus 9 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07880 9 TIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLS 88 (343)
T ss_pred hhhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcc
Confidence 345567889999999999999999999988999999999854322 223568899999999999999999998643211
Q ss_pred -cCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCC
Q 002857 232 -QGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLND 310 (873)
Q Consensus 232 -~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~ 310 (873)
......++||||+ +++|.+++. ...+++..++.++.||+.||+||| +.+|+||||||+||+++.
T Consensus 89 ~~~~~~~~lv~e~~-~~~l~~~~~-----------~~~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~ 153 (343)
T cd07880 89 LDRFHDFYLVMPFM-GTDLGKLMK-----------HEKLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNE 153 (343)
T ss_pred ccccceEEEEEecC-CCCHHHHHh-----------cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcC
Confidence 1123468999999 779988873 235889999999999999999999 899999999999999999
Q ss_pred CCCeEEeccccccccccccccccccccccccccCCCcccCC-CCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHH
Q 002857 311 EMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMG-HETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQN 389 (873)
Q Consensus 311 ~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~ 389 (873)
++.+||+|||++...... .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||....... .+..
T Consensus 154 ~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~-~~~~ 227 (343)
T cd07880 154 DCELKILDFGLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLD-QLME 227 (343)
T ss_pred CCCEEEeecccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHH
Confidence 999999999999865322 123357889999998876 458899999999999999999999997532111 1111
Q ss_pred HHhh--cCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 390 WVQS--ALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 390 ~~~~--~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
.... ..+..+.+.+.......+ .... ..................+.+++.+|++.||++|||+.+++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 228 IMKVTGTPSKEFVQKLQSEDAKNY-----VKKL-PRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HHHhcCCCCHHHHHhhcchhHHHH-----HHhc-cccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 1110 001111111110000000 0000 000000001111122345789999999999999999999874
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5e-32 Score=301.63 Aligned_cols=284 Identities=19% Similarity=0.248 Sum_probs=197.0
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeeccc--------
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVD-------- 230 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~-------- 230 (873)
..+|.+.+.||.|+||.||+|....+++.||+|.+........+.+.+|++++++++|+||+++++.+....
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 368999999999999999999998899999999987665566678999999999999999999998754321
Q ss_pred -ccCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeC
Q 002857 231 -YQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLN 309 (873)
Q Consensus 231 -~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd 309 (873)
+......++||||++ ++|.+++. ...+++..++.++.||+.||.||| +.+|+||||||+||+++
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~-----------~~~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~ 148 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLE-----------QGPLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFIN 148 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHH-----------cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEc
Confidence 111235789999997 58888773 235888999999999999999999 89999999999999998
Q ss_pred -CCCCeEEeccccccccccccccc-cccccccccccCCCcccCC-CCCCcchhhHhHHHHHHHHHhCCCCCCcccccchh
Q 002857 310 -DEMTACVADFGIARFLEATNEQT-SSIGVKGTTGYIAPEYGMG-HETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLN 386 (873)
Q Consensus 310 -~~~~vKLsDFGla~~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~ 386 (873)
+++.+||+|||+++......... ......++..|+|||.+.. ..++.++|||||||++|||++|+.||....... .
T Consensus 149 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~-~ 227 (342)
T cd07854 149 TEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELE-Q 227 (342)
T ss_pred CCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-H
Confidence 45678999999997653321111 1122347889999997654 568889999999999999999999997532211 1
Q ss_pred hHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 387 LQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 387 l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
....... .+....+.....+.. ...... ... ..+.. ...........++.+++.+||+.||++|||+.||+.
T Consensus 228 ~~~~~~~-~~~~~~~~~~~~~~~-~~~~~~-~~~-~~~~~-~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 228 MQLILES-VPVVREEDRNELLNV-IPSFVR-NDG-GEPRR-PLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred HHHHHHh-cCCCChHHhhhhhhh-hhhhhh-hcc-cccCC-CHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 1111110 000000000000000 000000 000 00000 001111112345789999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.8e-32 Score=292.99 Aligned_cols=256 Identities=21% Similarity=0.266 Sum_probs=194.8
Q ss_pred CCCcceeecccCceEEEEEEEc---CCCcEEEEEEeeccC----CcchhHHHHHHHHHHhh-hhccceeeeeeeeccccc
Q 002857 161 GFSSENLIGAGNFASVYKGILF---EGAPAVAIKVFNFLH----HDASKSFTVECEVMRNI-IHRKIIKVVTACSRVDYQ 232 (873)
Q Consensus 161 ~f~~~~~LG~G~fG~VYkg~~~---~~g~~VAVK~l~~~~----~~~~~~f~~Ei~iL~~L-~HpNIV~llg~c~~~~~~ 232 (873)
+|++.+.||+|++|.||+++.. .+++.||||+++... ....+.+.+|++++.++ +|+||+++++.+ .
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-----~ 75 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAF-----Q 75 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheee-----e
Confidence 4778899999999999999864 356789999987432 22345688999999999 599999999874 4
Q ss_pred CCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCC
Q 002857 233 GNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEM 312 (873)
Q Consensus 233 ~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~ 312 (873)
.+...++||||+++|+|.+++.. ...+++..+..++.|+++||.||| ..+++||||+|+||+++.++
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~~~~----------~~~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~ 142 (288)
T cd05583 76 TDTKLHLILDYVNGGELFTHLYQ----------REHFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEG 142 (288)
T ss_pred cCCEEEEEEecCCCCcHHHHHhh----------cCCcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCC
Confidence 56678999999999999999842 345888899999999999999999 89999999999999999999
Q ss_pred CeEEeccccccccccccccccccccccccccCCCcccCCCC--CCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHH
Q 002857 313 TACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHE--TSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNW 390 (873)
Q Consensus 313 ~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~--~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~ 390 (873)
.++|+|||+++....... .......++..|+|||.+.+.. .+.++||||||+++|||++|..||....... .
T Consensus 143 ~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-~---- 216 (288)
T cd05583 143 HVVLTDFGLSKEFLAEEE-ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN-S---- 216 (288)
T ss_pred CEEEEECccccccccccc-cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc-h----
Confidence 999999999886543321 1122345789999999987665 7889999999999999999999985321110 0
Q ss_pred HhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHH
Q 002857 391 VQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRL 467 (873)
Q Consensus 391 ~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~ 467 (873)
..++......... ..+. .....+.+++.+||+.+|++|||+.+|.+.|+.
T Consensus 217 --------~~~~~~~~~~~~~----------~~~~---------~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 217 --------QSEISRRILKSKP----------PFPK---------TMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred --------HHHHHHHHHccCC----------CCCc---------ccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 0011110000000 0000 012246789999999999999999988887764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.3e-32 Score=298.19 Aligned_cols=274 Identities=20% Similarity=0.246 Sum_probs=193.6
Q ss_pred hcCCC-cceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcc--------------hhHHHHHHHHHHhhhhccceeee
Q 002857 159 TKGFS-SENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDA--------------SKSFTVECEVMRNIIHRKIIKVV 223 (873)
Q Consensus 159 t~~f~-~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~--------------~~~f~~Ei~iL~~L~HpNIV~ll 223 (873)
.++|. +.+.||+|+||.||+|.+..+++.||||+++...... ...+.+|++++++++|+||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 34565 3577999999999999998889999999986432221 12578899999999999999999
Q ss_pred eeeecccccCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCC
Q 002857 224 TACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKP 303 (873)
Q Consensus 224 g~c~~~~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKp 303 (873)
+++ ..++..++||||+. |+|.+++. ....+++.....++.|++.||+||| +.+|+|+||+|
T Consensus 87 ~~~-----~~~~~~~lv~e~~~-~~l~~~l~----------~~~~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~ 147 (335)
T PTZ00024 87 DVY-----VEGDFINLVMDIMA-SDLKKVVD----------RKIRLTESQVKCILLQILNGLNVLH---KWYFMHRDLSP 147 (335)
T ss_pred EEE-----ecCCcEEEEEeccc-cCHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccH
Confidence 985 44567899999996 69998883 2345889999999999999999999 89999999999
Q ss_pred CCeeeCCCCCeEEecccccccccccc------------ccccccccccccccCCCcccCCC-CCCcchhhHhHHHHHHHH
Q 002857 304 SNILLNDEMTACVADFGIARFLEATN------------EQTSSIGVKGTTGYIAPEYGMGH-ETSSYGDVYSFGILLLEM 370 (873)
Q Consensus 304 sNILLd~~~~vKLsDFGla~~~~~~~------------~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSfGvvL~EL 370 (873)
+||+++.++.+||+|||+++...... .........++..|+|||++.+. .++.++||||||+++|||
T Consensus 148 ~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el 227 (335)
T PTZ00024 148 ANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAEL 227 (335)
T ss_pred HHeEECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHH
Confidence 99999999999999999997654111 00111123467889999998764 468999999999999999
Q ss_pred HhCCCCCCcccccchhhHHHHhhcCch----hHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHH
Q 002857 371 FTGLRPSDDMFKDNLNLQNWVQSALPE----RVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVA 446 (873)
Q Consensus 371 lTGk~Pf~~~~~~~~~l~~~~~~~~~~----~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~ 446 (873)
+||+.||....... ....+...... .+.+..+..... .. ..................+.+++.+
T Consensus 228 ~tg~~p~~~~~~~~--~~~~i~~~~~~~~~~~~~~~~~~~~~~---------~~-~~~~~~~~~~~~~~~~~~~~~li~~ 295 (335)
T PTZ00024 228 LTGKPLFPGENEID--QLGRIFELLGTPNEDNWPQAKKLPLYT---------EF-TPRKPKDLKTIFPNASDDAIDLLQS 295 (335)
T ss_pred HhCCCCCCCCCHHH--HHHHHHHHhCCCchhhCcchhhccccc---------cc-CcCCcccHHHhCcCCChHHHHHHHH
Confidence 99999997532211 11111100000 000000000000 00 0000000001111123457899999
Q ss_pred hhccCcCCCCCHHHHHH
Q 002857 447 CSAELPGERMKINDVEL 463 (873)
Q Consensus 447 CL~~dP~eRPTm~EVl~ 463 (873)
||+.+|++|||+.||+.
T Consensus 296 ~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 296 LLKLNPLERISAKEALK 312 (335)
T ss_pred HcCCCchhccCHHHHhc
Confidence 99999999999999875
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=299.11 Aligned_cols=287 Identities=16% Similarity=0.216 Sum_probs=202.9
Q ss_pred CHHHHHHhhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC--CcchhHHHHHHHHHHhhhhccceeeeeeeec
Q 002857 151 SYEALYSATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH--HDASKSFTVECEVMRNIIHRKIIKVVTACSR 228 (873)
Q Consensus 151 s~~el~~at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~ 228 (873)
...++..++++|++.+.||+|+||.||+|....+++.||+|+++... ....+.+.+|+.++++++|+||+++++++..
T Consensus 8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~ 87 (345)
T cd07877 8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 87 (345)
T ss_pred HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence 34667788999999999999999999999988889999999986432 2234568889999999999999999998643
Q ss_pred cc-ccCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCee
Q 002857 229 VD-YQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNIL 307 (873)
Q Consensus 229 ~~-~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNIL 307 (873)
.. +......+++++++ +++|.+++. ...+++..+..++.||++||+||| +.+|+||||||+||+
T Consensus 88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~-----------~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl 152 (345)
T cd07877 88 ARSLEEFNDVYLVTHLM-GADLNNIVK-----------CQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLA 152 (345)
T ss_pred cccccccccEEEEehhc-ccCHHHHHh-----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEE
Confidence 22 12234567888877 789988873 235889999999999999999999 899999999999999
Q ss_pred eCCCCCeEEeccccccccccccccccccccccccccCCCcccCC-CCCCcchhhHhHHHHHHHHHhCCCCCCcccccchh
Q 002857 308 LNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMG-HETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLN 386 (873)
Q Consensus 308 Ld~~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~ 386 (873)
+++++.+||+|||+++..... .....++..|+|||++.+ ..++.++||||||+++|||++|+.||...... ..
T Consensus 153 l~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~-~~ 226 (345)
T cd07877 153 VNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQ 226 (345)
T ss_pred EcCCCCEEEeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HH
Confidence 999999999999999754321 123457889999998766 46888999999999999999999999653211 11
Q ss_pred hHHHHhhc--CchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHH
Q 002857 387 LQNWVQSA--LPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELG 464 (873)
Q Consensus 387 l~~~~~~~--~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~ 464 (873)
+....... ....+...+.... .+.........+..... +........+.+++..|++.+|.+||++.+++..
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 227 LKLILRLVGTPGAELLKKISSES-----ARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHHHHHHhCCCCHHHHhhcccHh-----HHHHHHHhcccCCcchh-hhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 11111100 0011110000000 00000010011110000 0000112357899999999999999999988754
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.8e-32 Score=288.04 Aligned_cols=270 Identities=21% Similarity=0.273 Sum_probs=196.6
Q ss_pred CCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC--CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEE
Q 002857 162 FSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH--HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKAL 239 (873)
Q Consensus 162 f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~L 239 (873)
|+..+.||+|++|.||+|+...+++.||+|++.... ....+.+..|++++++++|+||+++++++ ......++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~~ 75 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVI-----HTERKLYL 75 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhh-----hcCCceEE
Confidence 566788999999999999998889999999987543 33346788999999999999999999985 44577999
Q ss_pred EEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEecc
Q 002857 240 VYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADF 319 (873)
Q Consensus 240 V~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDF 319 (873)
||||++ ++|.+++.. ....+++..++.++.|++.||+||| ..+|+||||+|+||++++++.+||+||
T Consensus 76 v~e~~~-~~l~~~i~~---------~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~ 142 (282)
T cd07829 76 VFEYCD-MDLKKYLDK---------RPGPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADF 142 (282)
T ss_pred EecCcC-cCHHHHHHh---------hccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecC
Confidence 999997 599999853 1246899999999999999999999 889999999999999999999999999
Q ss_pred ccccccccccccccccccccccccCCCcccCCC-CCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcC---
Q 002857 320 GIARFLEATNEQTSSIGVKGTTGYIAPEYGMGH-ETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSAL--- 395 (873)
Q Consensus 320 Gla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~--- 395 (873)
|+++....... ......++..|+|||++.+. .++.++||||||+++|||++|+.||...... .....+....
T Consensus 143 g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~--~~~~~~~~~~~~~ 218 (282)
T cd07829 143 GLARAFGIPLR--TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEI--DQLFKIFQILGTP 218 (282)
T ss_pred CcccccCCCcc--ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHH--HHHHHHHHHhCCC
Confidence 99986543221 11223457789999998776 7899999999999999999999998653211 1111111100
Q ss_pred -chhHHHHhhhh-hhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 396 -PERVEEIVDTL-FFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 396 -~~~l~elid~~-L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
......+.+-. ..... ... +. .............+.+++..||+.+|++||++.+|+.
T Consensus 219 ~~~~~~~~~~~~~~~~~~------~~~---~~-~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 219 TEESWPGVTKLPDYKPTF------PKF---PP-KDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cHHHHHhhcccccccccc------ccc---Cc-cchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 00111110000 00000 000 00 0000001111345889999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=293.94 Aligned_cols=248 Identities=23% Similarity=0.282 Sum_probs=191.0
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC---CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCce
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH---HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDF 236 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~ 236 (873)
+.|+..+.||+|+||.||+|++..++..||+|.+.... ......+.+|+++++.++|+|++++++++. ....
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~ 89 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL-----REHT 89 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEE-----cCCe
Confidence 34667789999999999999998889999999986422 223356888999999999999999999863 4567
Q ss_pred EEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEE
Q 002857 237 KALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACV 316 (873)
Q Consensus 237 ~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKL 316 (873)
.++||||+. |+|.+++.. ....+++.++..++.|++.||.||| +.+++||||+|+||+++.++.+||
T Consensus 90 ~~lv~e~~~-~~l~~~~~~---------~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl 156 (308)
T cd06634 90 AWLVMEYCL-GSASDLLEV---------HKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKL 156 (308)
T ss_pred eEEEEEccC-CCHHHHHHH---------cCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEE
Confidence 899999996 688877632 2345788999999999999999999 899999999999999999999999
Q ss_pred eccccccccccccccccccccccccccCCCcccC---CCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhh
Q 002857 317 ADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGM---GHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQS 393 (873)
Q Consensus 317 sDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~---~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~ 393 (873)
+|||++...... ....++..|+|||++. ...++.++|||||||++|||++|+.||....... ..
T Consensus 157 ~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~------ 223 (308)
T cd06634 157 GDFGSASIMAPA------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-AL------ 223 (308)
T ss_pred CCcccceeecCc------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH-HH------
Confidence 999998765322 2235788999999874 3567889999999999999999999985421110 00
Q ss_pred cCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHH
Q 002857 394 ALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGL 465 (873)
Q Consensus 394 ~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~L 465 (873)
..+..... +... . ......+.+++.+||+.+|++||++.+|+...
T Consensus 224 ------~~~~~~~~----------------~~~~--~---~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 224 ------YHIAQNES----------------PALQ--S---GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred ------HHHhhcCC----------------CCcC--c---ccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 00000000 0000 0 01123477899999999999999999987653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-33 Score=310.69 Aligned_cols=251 Identities=24% Similarity=0.297 Sum_probs=199.9
Q ss_pred CCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEEE
Q 002857 161 GFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKALV 240 (873)
Q Consensus 161 ~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~LV 240 (873)
.|.+...||.|+||.||+|..+.++-..|-|++........++|+-||+||....||+||+|++.| ...+.++|+
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ay-----y~enkLwil 107 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAY-----YFENKLWIL 107 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHH-----hccCceEEE
Confidence 356678899999999999999888888899999877777889999999999999999999999984 446678999
Q ss_pred EeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEeccc
Q 002857 241 YEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFG 320 (873)
Q Consensus 241 ~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDFG 320 (873)
.|||.||.++.++-. -...|.+.++.-++.|++.||.||| ++.|||||||+.|||++-+|.++|+|||
T Consensus 108 iEFC~GGAVDaimlE---------L~r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFG 175 (1187)
T KOG0579|consen 108 IEFCGGGAVDAIMLE---------LGRVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFG 175 (1187)
T ss_pred EeecCCchHhHHHHH---------hccccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeeccc
Confidence 999999999988743 3567999999999999999999999 9999999999999999999999999999
Q ss_pred cccccccccccccccccccccccCCCcccC-----CCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcC
Q 002857 321 IARFLEATNEQTSSIGVKGTTGYIAPEYGM-----GHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSAL 395 (873)
Q Consensus 321 la~~~~~~~~~~~~~~~~Gt~~Y~APE~l~-----~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~ 395 (873)
.+....... .....+.||+.|||||+.+ ..+|+.++||||||++|.||.-+.+|...... ..
T Consensus 176 VSAKn~~t~--qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp-----MR------ 242 (1187)
T KOG0579|consen 176 VSAKNKSTR--QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP-----MR------ 242 (1187)
T ss_pred ccccchhHH--hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch-----HH------
Confidence 986432221 1223467999999999864 46899999999999999999999999654211 00
Q ss_pred chhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 396 PERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 396 ~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
++-..-..+ +|.......+ ...+.+++..||..||..||+++++++
T Consensus 243 ------VllKiaKSe------------PPTLlqPS~W----s~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 243 ------VLLKIAKSE------------PPTLLQPSHW----SRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred ------HHHHHhhcC------------CCcccCcchh----hhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 000000011 1111111112 224778999999999999999999874
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=292.76 Aligned_cols=244 Identities=24% Similarity=0.303 Sum_probs=188.4
Q ss_pred CCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCC---cchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEE
Q 002857 162 FSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH---DASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKA 238 (873)
Q Consensus 162 f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~ 238 (873)
|...+.||+|+||.||+|++..+++.||+|++..... .....+.+|++++++++|+|++++++++ ......+
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~ 97 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCY-----LKEHTAW 97 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEE-----EeCCEEE
Confidence 5556889999999999999988899999999864322 2335688899999999999999999996 3456789
Q ss_pred EEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEec
Q 002857 239 LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVAD 318 (873)
Q Consensus 239 LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsD 318 (873)
+||||+. |+|.+++.. ....+++.+++.++.||+.||.||| +.+|+|+||+|+||+++.++.+||+|
T Consensus 98 lv~e~~~-~~l~~~l~~---------~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~d 164 (313)
T cd06633 98 LVMEYCL-GSASDLLEV---------HKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLAD 164 (313)
T ss_pred EEEecCC-CCHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEee
Confidence 9999995 578777732 2345889999999999999999999 89999999999999999999999999
Q ss_pred cccccccccccccccccccccccccCCCcccC---CCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcC
Q 002857 319 FGIARFLEATNEQTSSIGVKGTTGYIAPEYGM---GHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSAL 395 (873)
Q Consensus 319 FGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~---~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~ 395 (873)
||++..... .....++..|+|||++. ...++.++||||||+++|||++|..||....... ...
T Consensus 165 fg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~--~~~------ 230 (313)
T cd06633 165 FGSASKSSP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--ALY------ 230 (313)
T ss_pred cCCCcccCC------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH--HHH------
Confidence 999864321 12345788999999974 4568889999999999999999999986521100 000
Q ss_pred chhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 396 PERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 396 ~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
.+.. .. .+... . ......+.+++.+||+.+|++||++.+++.
T Consensus 231 -----~~~~----~~------------~~~~~--~---~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 231 -----HIAQ----ND------------SPTLQ--S---NEWTDSFRGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred -----HHHh----cC------------CCCCC--c---cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 00 00000 0 001224778999999999999999999875
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=288.42 Aligned_cols=200 Identities=24% Similarity=0.340 Sum_probs=166.6
Q ss_pred CCCcceeecccCceEEEEEEEc---CCCcEEEEEEeeccC----CcchhHHHHHHHHHHhh-hhccceeeeeeeeccccc
Q 002857 161 GFSSENLIGAGNFASVYKGILF---EGAPAVAIKVFNFLH----HDASKSFTVECEVMRNI-IHRKIIKVVTACSRVDYQ 232 (873)
Q Consensus 161 ~f~~~~~LG~G~fG~VYkg~~~---~~g~~VAVK~l~~~~----~~~~~~f~~Ei~iL~~L-~HpNIV~llg~c~~~~~~ 232 (873)
+|++.+.||+|+||.||++... .++..||+|+++... ....+.+.+|++++.++ +|+||+++++.+ .
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-----~ 75 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF-----Q 75 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEe-----e
Confidence 4788899999999999999874 367899999987432 22346688899999999 599999999874 4
Q ss_pred CCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCC
Q 002857 233 GNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEM 312 (873)
Q Consensus 233 ~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~ 312 (873)
.+...++||||+++++|.+++.. ...+++..+..++.||+.||.||| +.+++||||+|+|||++.++
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~l~~----------~~~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~ 142 (290)
T cd05613 76 TDTKLHLILDYINGGELFTHLSQ----------RERFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNG 142 (290)
T ss_pred cCCeEEEEEecCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCC
Confidence 45678999999999999999842 345788889999999999999999 89999999999999999999
Q ss_pred CeEEeccccccccccccccccccccccccccCCCcccCCC--CCCcchhhHhHHHHHHHHHhCCCCCCc
Q 002857 313 TACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGH--ETSSYGDVYSFGILLLEMFTGLRPSDD 379 (873)
Q Consensus 313 ~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~--~~s~ksDVwSfGvvL~ELlTGk~Pf~~ 379 (873)
.+||+|||+++....... .......|+..|+|||++.+. .++.++||||||+++|+|++|+.||..
T Consensus 143 ~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~ 210 (290)
T cd05613 143 HVVLTDFGLSKEFHEDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTV 210 (290)
T ss_pred CEEEeeCccceecccccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCc
Confidence 999999999986543221 112234588999999998753 467899999999999999999999863
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-32 Score=296.88 Aligned_cols=247 Identities=21% Similarity=0.304 Sum_probs=200.0
Q ss_pred CCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcc--hhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEE
Q 002857 161 GFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDA--SKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKA 238 (873)
Q Consensus 161 ~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~--~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~ 238 (873)
=|...+.||+|.|+.|-+|++.-+|..||||++.+..-+. ...+.+|+..|+.++|||||+||.+ ......+|
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEV-----iDTQTKly 93 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEV-----IDTQTKLY 93 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeeh-----hcccceEE
Confidence 3667788999999999999998899999999998654443 3578899999999999999999998 35677899
Q ss_pred EEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeC-CCCCeEEe
Q 002857 239 LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLN-DEMTACVA 317 (873)
Q Consensus 239 LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd-~~~~vKLs 317 (873)
||+|.-.+|+|.+||.. ....+.+....+++.||+.|+.|.| ...+|||||||+||.+- .-|-+||.
T Consensus 94 LiLELGD~GDl~DyImK---------He~Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLT 161 (864)
T KOG4717|consen 94 LILELGDGGDLFDYIMK---------HEEGLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLT 161 (864)
T ss_pred EEEEecCCchHHHHHHh---------hhccccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEee
Confidence 99999999999999953 4567899999999999999999999 89999999999999876 55799999
Q ss_pred ccccccccccccccccccccccccccCCCcccCCCCCC-cchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCc
Q 002857 318 DFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETS-SYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALP 396 (873)
Q Consensus 318 DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s-~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~ 396 (873)
|||++..+...... ....|++.|-|||++.+..|+ ++.||||||||||-|+.|+.||+...+.
T Consensus 162 DFGFSNkf~PG~kL---~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS------------- 225 (864)
T KOG4717|consen 162 DFGFSNKFQPGKKL---TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS------------- 225 (864)
T ss_pred eccccccCCCcchh---hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch-------------
Confidence 99999877655433 235699999999999999875 5689999999999999999999763222
Q ss_pred hhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 397 ERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 397 ~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
+.+.-|.|-.+.. | .....+..+|+..||..||++|.+.+||+.
T Consensus 226 ETLTmImDCKYtv--------------P---------shvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 226 ETLTMIMDCKYTV--------------P---------SHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred hhhhhhhcccccC--------------c---------hhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 1222333322211 0 112234667888899999999999888764
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-32 Score=299.93 Aligned_cols=282 Identities=18% Similarity=0.238 Sum_probs=197.9
Q ss_pred HhhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeecc--CCcchhHHHHHHHHHHhhhhccceeeeeeeecccc-cC
Q 002857 157 SATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFL--HHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDY-QG 233 (873)
Q Consensus 157 ~at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~-~~ 233 (873)
...++|++.+.||+|++|.||+|++..+++.||||++... .....+.+.+|+.++++++|+||+++++++..... ..
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 4567899999999999999999999888999999998643 22233567889999999999999999987532211 12
Q ss_pred CceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCC
Q 002857 234 NDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMT 313 (873)
Q Consensus 234 ~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~ 313 (873)
....++|+||+ +++|.+++. ...+++..++.++.||++||+||| +.+|+||||||+||++++++.
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~-----------~~~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~ 156 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVK-----------CQKLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCE 156 (343)
T ss_pred cccEEEEEecC-CCCHHHHHh-----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCC
Confidence 23489999998 669999883 245899999999999999999999 899999999999999999999
Q ss_pred eEEeccccccccccccccccccccccccccCCCcccCC-CCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHh
Q 002857 314 ACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMG-HETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQ 392 (873)
Q Consensus 314 vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~ 392 (873)
+||+|||++...... .....++..|+|||.+.+ ..++.++||||||+++|||+||+.||...... .....+.
T Consensus 157 ~kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~--~~~~~i~ 229 (343)
T cd07851 157 LKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI--DQLKRIM 229 (343)
T ss_pred EEEcccccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHH
Confidence 999999999865332 123357889999998765 36789999999999999999999999653211 1111111
Q ss_pred hcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 393 SALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 393 ~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
........++......... ............... ..........+.+++.+||+.+|++|||+.||+.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~-~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 230 NLVGTPDEELLQKISSESA--RNYIQSLPQMPKKDF-KEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred HhcCCCCHHHHhhccchhH--HHHHHhccccCCCCH-HHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 1111000111111000000 000000000000000 0000111346889999999999999999999864
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=320.43 Aligned_cols=271 Identities=23% Similarity=0.351 Sum_probs=205.2
Q ss_pred HhhcCCCcceeecccCceEEEEEEEcC-------CCcEEEEEEeeccCC-cchhHHHHHHHHHHhh-hhccceeeeeeee
Q 002857 157 SATKGFSSENLIGAGNFASVYKGILFE-------GAPAVAIKVFNFLHH-DASKSFTVECEVMRNI-IHRKIIKVVTACS 227 (873)
Q Consensus 157 ~at~~f~~~~~LG~G~fG~VYkg~~~~-------~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L-~HpNIV~llg~c~ 227 (873)
...++..+.+.||+|.||.|++|.... ....||||.++.... .+.+.+..|+++|+.+ +|+||+.++|+|.
T Consensus 293 ~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t 372 (609)
T KOG0200|consen 293 IPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACT 372 (609)
T ss_pred echhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeec
Confidence 334455666799999999999998541 145799999975433 4557899999999999 6999999999985
Q ss_pred cccccCCceEEEEEeecCCCChhhhccccccccccc----CCC--CCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccC
Q 002857 228 RVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRH----KAP--GNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDI 301 (873)
Q Consensus 228 ~~~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~----~~~--~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDL 301 (873)
. .+..++|+||+..|+|.++|+......... ... ..++....+.++.|||.||+||+ +.++|||||
T Consensus 373 ~-----~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDL 444 (609)
T KOG0200|consen 373 Q-----DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDL 444 (609)
T ss_pred c-----CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhh
Confidence 3 567899999999999999997533000000 011 24889999999999999999999 899999999
Q ss_pred CCCCeeeCCCCCeEEecccccccccccccccccccc-ccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCc
Q 002857 302 KPSNILLNDEMTACVADFGIARFLEATNEQTSSIGV-KGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDD 379 (873)
Q Consensus 302 KpsNILLd~~~~vKLsDFGla~~~~~~~~~~~~~~~-~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~ 379 (873)
.++|||+..+..+||+|||+|+.............. .-...|||||.+....++.|||||||||+||||+| |..||..
T Consensus 445 AaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~ 524 (609)
T KOG0200|consen 445 AARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPG 524 (609)
T ss_pred hhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCC
Confidence 999999999999999999999965443322211110 13556999999999999999999999999999999 8899865
Q ss_pred ccccchhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHH
Q 002857 380 MFKDNLNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKIN 459 (873)
Q Consensus 380 ~~~~~~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~ 459 (873)
.... ..+.+++... .. .+.+..|..++.++++.||+.+|++||++.
T Consensus 525 ~~~~-~~l~~~l~~G------------~r---------------------~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~ 570 (609)
T KOG0200|consen 525 IPPT-EELLEFLKEG------------NR---------------------MEQPEHCSDEIYDLMKSCWNADPEDRPTFS 570 (609)
T ss_pred CCcH-HHHHHHHhcC------------CC---------------------CCCCCCCCHHHHHHHHHHhCCCcccCCCHH
Confidence 2101 0111111100 00 011223455788999999999999999999
Q ss_pred HHHHHHHHHH
Q 002857 460 DVELGLRLIK 469 (873)
Q Consensus 460 EVl~~Le~i~ 469 (873)
++++.|+...
T Consensus 571 ~~~~~~~~~l 580 (609)
T KOG0200|consen 571 ECVEFFEKHL 580 (609)
T ss_pred HHHHHHHHHH
Confidence 9999999853
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=284.28 Aligned_cols=251 Identities=20% Similarity=0.267 Sum_probs=191.9
Q ss_pred CCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC-----CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCc
Q 002857 161 GFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH-----HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGND 235 (873)
Q Consensus 161 ~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~-----~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~ 235 (873)
+|.+.++||+|+||.||++.+...+..+++|+++... ......+..|+.++++++||||+++++++ ....
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~ 75 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASF-----LERD 75 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHH-----hcCC
Confidence 4788899999999999999987776677777765322 22334577899999999999999999985 4456
Q ss_pred eEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeE
Q 002857 236 FKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTAC 315 (873)
Q Consensus 236 ~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vK 315 (873)
..++||||+++++|.+++... ......+++..++.++.|++.||.||| +.+++|+||+|+||++++ +.+|
T Consensus 76 ~~~lv~e~~~~~~l~~~~~~~------~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~ 145 (260)
T cd08222 76 AFCIITEYCEGRDLDCKLEEL------KHTGKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLK 145 (260)
T ss_pred ceEEEEEeCCCCCHHHHHHHH------hhcccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEe
Confidence 789999999999999988531 123457899999999999999999999 899999999999999985 5699
Q ss_pred EeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcC
Q 002857 316 VADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSAL 395 (873)
Q Consensus 316 LsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~ 395 (873)
|+|||+++....... ......++..|+|||.+.+..++.++||||||+++|+|++|..||..... ....
T Consensus 146 l~d~g~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~-----~~~~---- 214 (260)
T cd08222 146 IGDFGVSRLLMGSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF-----LSVV---- 214 (260)
T ss_pred ecccCceeecCCCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-----HHHH----
Confidence 999999986543221 12234578899999999888889999999999999999999999864211 0000
Q ss_pred chhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 396 PERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 396 ~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
..+.. .. .+.. .......+.+++.+||+.+|++||++.|+++
T Consensus 215 ----~~~~~----~~------------~~~~------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 215 ----LRIVE----GP------------TPSL------PETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred ----HHHHc----CC------------CCCC------cchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 00000 00 0000 0011235778999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-32 Score=310.45 Aligned_cols=204 Identities=29% Similarity=0.397 Sum_probs=173.0
Q ss_pred CcceeecccCceEEEEEEEcCCCcEEEEEEeeccC-CcchhHHHHHHHHHHhhhhccceeeeeeeeccc-ccCCceEEEE
Q 002857 163 SSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH-HDASKSFTVECEVMRNIIHRKIIKVVTACSRVD-YQGNDFKALV 240 (873)
Q Consensus 163 ~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~-~~~~~~~~LV 240 (873)
...+.||+|+||.||+|+++.+|+.||||.++... ....+...+|+++|++++|+|||+++++-.... ..-.....+|
T Consensus 16 ~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlv 95 (732)
T KOG4250|consen 16 EMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLV 95 (732)
T ss_pred eehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEE
Confidence 44578999999999999999999999999998543 334567899999999999999999999732111 0113457899
Q ss_pred EeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeC--CCC--CeEE
Q 002857 241 YEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLN--DEM--TACV 316 (873)
Q Consensus 241 ~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd--~~~--~vKL 316 (873)
||||.+|||...|.. ..+...|++.+.+.++.+++.||.||| ..+|+||||||.||++- .++ ..||
T Consensus 96 mEyC~gGsL~~~L~~-------PEN~~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKL 165 (732)
T KOG4250|consen 96 MEYCSGGSLRKVLNS-------PENAYGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKL 165 (732)
T ss_pred EeecCCCcHHHHhcC-------cccccCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEee
Confidence 999999999999964 245678999999999999999999999 89999999999999983 333 5799
Q ss_pred eccccccccccccccccccccccccccCCCcccCC-CCCCcchhhHhHHHHHHHHHhCCCCCCc
Q 002857 317 ADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMG-HETSSYGDVYSFGILLLEMFTGLRPSDD 379 (873)
Q Consensus 317 sDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELlTGk~Pf~~ 379 (873)
+|||.|+.++.+. .....+||..|.+||++.. ..|+...|.|||||++||.+||..||..
T Consensus 166 tDfG~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p 226 (732)
T KOG4250|consen 166 TDFGAARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIP 226 (732)
T ss_pred ecccccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCc
Confidence 9999999876543 4456789999999999984 7888899999999999999999999976
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-32 Score=322.71 Aligned_cols=260 Identities=20% Similarity=0.235 Sum_probs=187.0
Q ss_pred HhhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC-CcchhHHHHHHHHHHhhhhccceeeeeeeecccc----
Q 002857 157 SATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH-HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDY---- 231 (873)
Q Consensus 157 ~at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~---- 231 (873)
.-.++|++..+||+||||.||+++.+-+|+.+|||++.... ......+.+|+.+|++|+|||||+++....+..-
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 34567889999999999999999999999999999987443 3344678889999999999999999753322100
Q ss_pred ---------------------------------------------------c----------------------------
Q 002857 232 ---------------------------------------------------Q---------------------------- 232 (873)
Q Consensus 232 ---------------------------------------------------~---------------------------- 232 (873)
.
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence 0
Q ss_pred -----------------------CC--------ceEEEEEeecCCCChhhhcccccccccccCCCCCC-chhhhHHHHHH
Q 002857 233 -----------------------GN--------DFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNL-NSLERLNIAID 280 (873)
Q Consensus 233 -----------------------~~--------~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~L-s~~~~l~Ia~q 280 (873)
.+ ..+||-||||+.-+|.++++. +... .....++++.+
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~----------N~~~~~~d~~wrLFre 705 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRR----------NHFNSQRDEAWRLFRE 705 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHh----------cccchhhHHHHHHHHH
Confidence 00 235677888888777777742 1111 35567899999
Q ss_pred HHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEecccccccccc----------------ccccccccccccccccC
Q 002857 281 VASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEA----------------TNEQTSSIGVKGTTGYI 344 (873)
Q Consensus 281 Ia~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDFGla~~~~~----------------~~~~~~~~~~~Gt~~Y~ 344 (873)
|+.||+|+| +.+||||||||.||+||++..+||+|||+|..... .......+..+||..|+
T Consensus 706 IlEGLaYIH---~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYv 782 (1351)
T KOG1035|consen 706 ILEGLAYIH---DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYV 782 (1351)
T ss_pred HHHHHHHHH---hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeee
Confidence 999999999 89999999999999999999999999999986220 00111234567999999
Q ss_pred CCcccCCC---CCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhc
Q 002857 345 APEYGMGH---ETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYK 421 (873)
Q Consensus 345 APE~l~~~---~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~ 421 (873)
|||++.+. .|+.|+|+||+|||++||+. ||....+....+ ..+-+..+...
T Consensus 783 APEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL------------~~LR~g~iP~~----------- 836 (1351)
T KOG1035|consen 783 APELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASIL------------TNLRKGSIPEP----------- 836 (1351)
T ss_pred cHHHhcccccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHH------------HhcccCCCCCC-----------
Confidence 99998875 49999999999999999985 565532221111 11111111110
Q ss_pred cCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 422 KAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 422 ~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
..........-..++.++++.||.+||||.|++.
T Consensus 837 --------~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 837 --------ADFFDPEHPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred --------cccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 0000000112357999999999999999999873
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=279.12 Aligned_cols=237 Identities=27% Similarity=0.346 Sum_probs=189.3
Q ss_pred ecccCceEEEEEEEcCCCcEEEEEEeeccCC---cchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEEEEeec
Q 002857 168 IGAGNFASVYKGILFEGAPAVAIKVFNFLHH---DASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKALVYEFM 244 (873)
Q Consensus 168 LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~LV~Ey~ 244 (873)
||+|+||.||++.+..+++.+|+|+++.... .....+..|++++++++|+||+++++.+ ..+...++||||+
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~~v~e~~ 75 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAF-----QTEEKLYLVLEYA 75 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHe-----ecCCeeEEEEecC
Confidence 6999999999999988899999999874432 2345789999999999999999999884 5677899999999
Q ss_pred CCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEeccccccc
Q 002857 245 PNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARF 324 (873)
Q Consensus 245 ~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDFGla~~ 324 (873)
++++|.+++.. ...+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++..
T Consensus 76 ~~~~L~~~l~~----------~~~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~ 142 (250)
T cd05123 76 PGGELFSHLSK----------EGRFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKE 142 (250)
T ss_pred CCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCccee
Confidence 99999999842 336899999999999999999999 89999999999999999999999999999986
Q ss_pred cccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCchhHHHHhh
Q 002857 325 LEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPERVEEIVD 404 (873)
Q Consensus 325 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~~l~elid 404 (873)
..... .......++..|+|||...+...+.++||||||+++|+|++|+.||...... .. ...+..
T Consensus 143 ~~~~~--~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~--~~-----------~~~~~~ 207 (250)
T cd05123 143 LSSEG--SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK--EI-----------YEKILK 207 (250)
T ss_pred cccCC--CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH--HH-----------HHHHhc
Confidence 54332 1223345788999999998888999999999999999999999999653210 00 001110
Q ss_pred hhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHH
Q 002857 405 TLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKIND 460 (873)
Q Consensus 405 ~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~E 460 (873)
..+ ..+.. ....+.+++.+||..+|++||++.+
T Consensus 208 ~~~--------------~~~~~---------~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 208 DPL--------------RFPEF---------LSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCC--------------CCCCC---------CCHHHHHHHHHHhcCCHhhCCCccc
Confidence 000 00000 0234778999999999999999955
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-33 Score=330.98 Aligned_cols=256 Identities=23% Similarity=0.311 Sum_probs=198.4
Q ss_pred HHhhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeecc--CCcchhHHHHHHHHHHhhhhccceeeeeeeecccccC
Q 002857 156 YSATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFL--HHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQG 233 (873)
Q Consensus 156 ~~at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~ 233 (873)
...+-+++...+||.|.||.||.|...++|...|+|-++.. .....+.+.+|+.+|..|+|||+|+++|+- .+
T Consensus 1231 snV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVE-----vH 1305 (1509)
T KOG4645|consen 1231 SNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVE-----VH 1305 (1509)
T ss_pred ccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCcee-----ec
Confidence 34456777889999999999999999999999999987633 244557789999999999999999999983 44
Q ss_pred CceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCC
Q 002857 234 NDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMT 313 (873)
Q Consensus 234 ~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~ 313 (873)
.+..+|.||||++|+|.+++.. ....++.....+..|++.|++||| +.|||||||||.||+|+.+|.
T Consensus 1306 Rekv~IFMEyC~~GsLa~ll~~----------gri~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~ 1372 (1509)
T KOG4645|consen 1306 REKVYIFMEYCEGGSLASLLEH----------GRIEDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGL 1372 (1509)
T ss_pred HHHHHHHHHHhccCcHHHHHHh----------cchhhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCc
Confidence 5678999999999999999842 445666667778899999999999 899999999999999999999
Q ss_pred eEEeccccccccccccc--cccccccccccccCCCcccCCC---CCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhH
Q 002857 314 ACVADFGIARFLEATNE--QTSSIGVKGTTGYIAPEYGMGH---ETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQ 388 (873)
Q Consensus 314 vKLsDFGla~~~~~~~~--~~~~~~~~Gt~~Y~APE~l~~~---~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~ 388 (873)
+|++|||.|..+..... ........||+.|||||++.+. ....++||||+|||++||+||++||.....+- .+.
T Consensus 1373 iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~-aIM 1451 (1509)
T KOG4645|consen 1373 IKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEW-AIM 1451 (1509)
T ss_pred EEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchh-HHH
Confidence 99999999987755421 1122345699999999999875 35667999999999999999999987632221 111
Q ss_pred HHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 389 NWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 389 ~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
..+ .... .|..+. ....+-.+++..||+.||++|.++.|+++
T Consensus 1452 y~V--------------~~gh-------------~Pq~P~------~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1452 YHV--------------AAGH-------------KPQIPE------RLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred hHH--------------hccC-------------CCCCch------hhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 111 0100 011110 11223457999999999999998886654
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=279.03 Aligned_cols=208 Identities=24% Similarity=0.289 Sum_probs=173.8
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCC----cEEEEEEeeccCC--cchhHHHHHHHHHHhhhhccceeeeeeeeccccc
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGA----PAVAIKVFNFLHH--DASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQ 232 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g----~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~ 232 (873)
...|+....||+|.||.||+|.-.++. +.+|||.++.... .-.....+|+.+++.++|+||+.|..++. .
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl----~ 98 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFL----S 98 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHh----c
Confidence 356888999999999999999655432 3689999975432 23457889999999999999999999863 3
Q ss_pred CCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCC-
Q 002857 233 GNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDE- 311 (873)
Q Consensus 233 ~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~- 311 (873)
.+...+|++||.+. +|.+.|+-+.. .....++...+..|+.||+.|+.||| ++=|+||||||.|||+..+
T Consensus 99 ~d~~v~l~fdYAEh-DL~~II~fHr~-----~~~~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdg 169 (438)
T KOG0666|consen 99 HDKKVWLLFDYAEH-DLWHIIKFHRA-----SKAKQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDG 169 (438)
T ss_pred cCceEEEEehhhhh-hHHHHHHHhcc-----chhccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccC
Confidence 36779999999987 99999965322 33467899999999999999999999 8899999999999999877
Q ss_pred ---CCeEEeccccccccccccccc-cccccccccccCCCcccCCC-CCCcchhhHhHHHHHHHHHhCCCCCCc
Q 002857 312 ---MTACVADFGIARFLEATNEQT-SSIGVKGTTGYIAPEYGMGH-ETSSYGDVYSFGILLLEMFTGLRPSDD 379 (873)
Q Consensus 312 ---~~vKLsDFGla~~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELlTGk~Pf~~ 379 (873)
|.+||+|||+++++...-... ....++-|+.|+|||++.+. .||.+.||||.|||+.||+|-++.|..
T Consensus 170 perG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g 242 (438)
T KOG0666|consen 170 PERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG 242 (438)
T ss_pred CccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence 899999999999886544322 34456789999999999886 689999999999999999999988876
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-31 Score=316.88 Aligned_cols=146 Identities=25% Similarity=0.380 Sum_probs=129.2
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCC---cchhHHHHHHHHHHhhhhccceeeeeeeecccccCCce
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH---DASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDF 236 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~ 236 (873)
++|.+.++||+|+||.||+|.+..+++.||||+++.... .....+..|+.++..++|+||+++++++ .....
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~~~ 78 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL-----QSANN 78 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEE-----EECCE
Confidence 678999999999999999999988899999999874322 2236788899999999999999999875 44567
Q ss_pred EEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEE
Q 002857 237 KALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACV 316 (873)
Q Consensus 237 ~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKL 316 (873)
.+|||||+.+++|.+++.. ...+++..++.|+.||+.||+||| ..+|+||||||+|||++.++.+||
T Consensus 79 ~~lVmEy~~g~~L~~li~~----------~~~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL 145 (669)
T cd05610 79 VYLVMEYLIGGDVKSLLHI----------YGYFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKL 145 (669)
T ss_pred EEEEEeCCCCCCHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEE
Confidence 9999999999999999842 345788899999999999999999 889999999999999999999999
Q ss_pred ecccccc
Q 002857 317 ADFGIAR 323 (873)
Q Consensus 317 sDFGla~ 323 (873)
+|||+++
T Consensus 146 ~DFGls~ 152 (669)
T cd05610 146 TDFGLSK 152 (669)
T ss_pred EeCCCCc
Confidence 9999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=301.50 Aligned_cols=249 Identities=24% Similarity=0.330 Sum_probs=200.1
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcc--hhHHHHHHHHHHhhhhccceeeeeeeecccccCCce
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDA--SKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDF 236 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~--~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~ 236 (873)
+..|.+...||+|.|+.|.+|++..++..||||++++..-.. ...+.+|+++|..++|||||+++.+. .....
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~-----~t~~~ 129 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVI-----ETEAT 129 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeee-----eecce
Confidence 457889999999999999999999999999999997544332 24588999999999999999999984 55678
Q ss_pred EEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEE
Q 002857 237 KALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACV 316 (873)
Q Consensus 237 ~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKL 316 (873)
+++||||+.+|.+.++|. ....+.+.....++.|+.+|++|+| .+.|||||||++||||+.++++||
T Consensus 130 lylV~eya~~ge~~~yl~----------~~gr~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikI 196 (596)
T KOG0586|consen 130 LYLVMEYASGGELFDYLV----------KHGRMKEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKI 196 (596)
T ss_pred eEEEEEeccCchhHHHHH----------hcccchhhhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceee
Confidence 999999999999999994 3455666888999999999999999 899999999999999999999999
Q ss_pred eccccccccccccccccccccccccccCCCcccCCCCC-CcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcC
Q 002857 317 ADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHET-SSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSAL 395 (873)
Q Consensus 317 sDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~-s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~ 395 (873)
+|||++.++.... ......|++.|.|||++.+..| ++++|+||+|++||-|+.|..||++..-
T Consensus 197 aDfgfS~~~~~~~---~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l------------- 260 (596)
T KOG0586|consen 197 ADFGFSTFFDYGL---MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL------------- 260 (596)
T ss_pred eccccceeecccc---cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccc-------------
Confidence 9999999886433 2334679999999999999865 6789999999999999999999986321
Q ss_pred chhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHH
Q 002857 396 PERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELG 464 (873)
Q Consensus 396 ~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~ 464 (873)
.++-++.+...+. .|. - .....-+++.+++-.+|.+|+++++|.+.
T Consensus 261 ----k~Lr~rvl~gk~r----------Ip~-----~----ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 261 ----KELRPRVLRGKYR----------IPF-----Y----MSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred ----ccccchheeeeec----------ccc-----e----eechhHHHHHHhhccCccccCCHHHhhhh
Confidence 1111111211110 000 0 01124568888888999999999988653
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=287.68 Aligned_cols=202 Identities=25% Similarity=0.339 Sum_probs=177.8
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeecc---CCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCc
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFL---HHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGND 235 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~ 235 (873)
.+.|..-++||+||||.||-.+.+.+|+.+|.|.+.+. ........++|-.||++++.+.||.+--. |+..+
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYA-----feTkd 258 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYA-----FETKD 258 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeee-----ecCCC
Confidence 35678889999999999999999999999999988532 23334567889999999999999998766 47788
Q ss_pred eEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeE
Q 002857 236 FKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTAC 315 (873)
Q Consensus 236 ~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vK 315 (873)
.++||+..|.||+|.-+|.. .....+++..++-++.+|+.||++|| ..+||.|||||+|||||+.|+++
T Consensus 259 ~LClVLtlMNGGDLkfHiyn--------~g~~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvR 327 (591)
T KOG0986|consen 259 ALCLVLTLMNGGDLKFHIYN--------HGNPGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVR 327 (591)
T ss_pred ceEEEEEeecCCceeEEeec--------cCCCCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeE
Confidence 99999999999999999864 34578999999999999999999999 89999999999999999999999
Q ss_pred EeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCc
Q 002857 316 VADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDD 379 (873)
Q Consensus 316 LsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~ 379 (873)
|+|+|+|..+...... ...+||.+|||||++.+..|+...|.|||||+||||+.|+.||..
T Consensus 328 ISDLGLAvei~~g~~~---~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~ 388 (591)
T KOG0986|consen 328 ISDLGLAVEIPEGKPI---RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQ 388 (591)
T ss_pred eeccceEEecCCCCcc---ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhh
Confidence 9999999877654332 233799999999999999999999999999999999999999975
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=280.74 Aligned_cols=277 Identities=19% Similarity=0.282 Sum_probs=218.1
Q ss_pred HHHHHhhcCCCcceeecccCceEEEEEEEcCC-----CcEEEEEEeeccC-CcchhHHHHHHHHHHhhhhccceeeeeee
Q 002857 153 EALYSATKGFSSENLIGAGNFASVYKGILFEG-----APAVAIKVFNFLH-HDASKSFTVECEVMRNIIHRKIIKVVTAC 226 (873)
Q Consensus 153 ~el~~at~~f~~~~~LG~G~fG~VYkg~~~~~-----g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~llg~c 226 (873)
+++.....+++...++-+|.||.||+|.|++. .+.|-+|.++... +-....+..|.-++..+.|||+..+.+++
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ 356 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS 356 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence 45555567788889999999999999988653 3456777765332 23345688888888889999999999998
Q ss_pred ecccccCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCe
Q 002857 227 SRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNI 306 (873)
Q Consensus 227 ~~~~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNI 306 (873)
. ++....+++|.++.-|+|..||...... .......++..+...++.|++.|++||| +.+|||.||.++|+
T Consensus 357 i----e~~~~P~V~y~~~~~gNLK~FL~~Cr~~--~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNC 427 (563)
T KOG1024|consen 357 I----EDYATPFVLYPATGVGNLKSFLQICRGD--DPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNC 427 (563)
T ss_pred e----eccCcceEEEeccCcchHHHHHHHhccC--CCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcc
Confidence 6 4566789999999999999999743322 1245567888899999999999999999 99999999999999
Q ss_pred eeCCCCCeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccch
Q 002857 307 LLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNL 385 (873)
Q Consensus 307 LLd~~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~ 385 (873)
+||+...+||+|=.+++.+...+......+...+..||+||.+....|+.++|||||||+||||+| |+.|+......+
T Consensus 428 vIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE- 506 (563)
T KOG1024|consen 428 VIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE- 506 (563)
T ss_pred eehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH-
Confidence 999999999999999997766554444444456889999999999999999999999999999999 999986632211
Q ss_pred hhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHH
Q 002857 386 NLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGL 465 (873)
Q Consensus 386 ~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~L 465 (873)
...+ +.+.+. ...+-+|+++|..++.-||...|++||+++|++.-|
T Consensus 507 -m~~y----------------lkdGyR-----------------laQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cL 552 (563)
T KOG1024|consen 507 -MEHY----------------LKDGYR-----------------LAQPFNCPDELFTVMACCWALLPEERPSFSQLVICL 552 (563)
T ss_pred -HHHH----------------Hhccce-----------------ecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHH
Confidence 1111 111100 011235788899999999999999999999999999
Q ss_pred HHHHHhhh
Q 002857 466 RLIKKKLL 473 (873)
Q Consensus 466 e~i~~~l~ 473 (873)
.+....+.
T Consensus 553 seF~~qlt 560 (563)
T KOG1024|consen 553 SEFHTQLT 560 (563)
T ss_pred HHHHHHHh
Confidence 98765543
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-30 Score=297.72 Aligned_cols=266 Identities=22% Similarity=0.310 Sum_probs=213.7
Q ss_pred cCHHHHHHhhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhh-hhccceeeeeeeec
Q 002857 150 VSYEALYSATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNI-IHRKIIKVVTACSR 228 (873)
Q Consensus 150 ~s~~el~~at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~llg~c~~ 228 (873)
+.++.+-.-++-|++.+.||+|.+|.||+++.+.+++.+|+|++.... +..+++..|.++|+.. .|||++.++|++..
T Consensus 9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k 87 (953)
T KOG0587|consen 9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIK 87 (953)
T ss_pred cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence 445555666788999999999999999999999999999999987543 3347788899999988 79999999999987
Q ss_pred ccccCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeee
Q 002857 229 VDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILL 308 (873)
Q Consensus 229 ~~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILL 308 (873)
.....+++++||||||.+||..|+++. .....+.|..+..|++.+++||++|| ...++|||||-.|||+
T Consensus 88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn--------~~g~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLL 156 (953)
T KOG0587|consen 88 KDPGNGDQLWLVMEFCGGGSVTDLVKN--------TKGNRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLL 156 (953)
T ss_pred ecCCCCCeEEEEeeccCCccHHHHHhh--------hcccchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEE
Confidence 766778899999999999999999975 22667999999999999999999999 8999999999999999
Q ss_pred CCCCCeEEeccccccccccccccccccccccccccCCCcccCCC-----CCCcchhhHhHHHHHHHHHhCCCCCCccccc
Q 002857 309 NDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGH-----ETSSYGDVYSFGILLLEMFTGLRPSDDMFKD 383 (873)
Q Consensus 309 d~~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-----~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~ 383 (873)
+.++.+||.|||.+..+...... .....||+.|||||++.-. .|+.++|+||||++..||.-|.+|+-++..-
T Consensus 157 T~e~~VKLvDFGvSaQldsT~gr--RnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm 234 (953)
T KOG0587|consen 157 TENAEVKLVDFGVSAQLDSTVGR--RNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM 234 (953)
T ss_pred eccCcEEEeeeeeeeeeeccccc--ccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh
Confidence 99999999999999877553322 2235699999999997643 5778899999999999999999998764211
Q ss_pred chhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCch-hHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHH
Q 002857 384 NLNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSST-QRSIILECLNSICEIGVACSAELPGERMKINDVE 462 (873)
Q Consensus 384 ~~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~-~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl 462 (873)
- .+ +.....+|.... ...+ .+++.+++..||..|-++||++.+++
T Consensus 235 r----------------aL--------------F~IpRNPPPkLkrp~kW----s~~FndFIs~cL~Kd~e~RP~~~~ll 280 (953)
T KOG0587|consen 235 R----------------AL--------------FLIPRNPPPKLKRPKKW----SKKFNDFISTCLVKDYEQRPSTEELL 280 (953)
T ss_pred h----------------hh--------------ccCCCCCCccccchhhH----HHHHHHHHHHHHhhccccCcchhhhc
Confidence 0 00 000111111111 1112 34588899999999999999999887
Q ss_pred H
Q 002857 463 L 463 (873)
Q Consensus 463 ~ 463 (873)
+
T Consensus 281 ~ 281 (953)
T KOG0587|consen 281 K 281 (953)
T ss_pred c
Confidence 4
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=281.24 Aligned_cols=279 Identities=19% Similarity=0.231 Sum_probs=202.9
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhh--c----cceeeeeeeeccccc
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIH--R----KIIKVVTACSRVDYQ 232 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~H--p----NIV~llg~c~~~~~~ 232 (873)
+++|.+...+|+|.||.|-+..+...+..||||+++..... .+..+-|+++|+++.+ | -+|++.+| ++
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kY-reAa~iEi~vLqki~~~DP~g~~rcv~m~~w-----Fd 161 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKY-REAALIEIEVLQKINESDPNGKFRCVQMRDW-----FD 161 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHH-hhHHHHHHHHHHHHHhcCCCCceEEEeeehh-----hh
Confidence 78999999999999999999999888999999999854332 3556779999999943 2 26777777 45
Q ss_pred CCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCC--
Q 002857 233 GNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLND-- 310 (873)
Q Consensus 233 ~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~-- 310 (873)
-.++.+||+|.+ |-|+.++|.. +....++..++..|+.|++++++||| +.+++|.||||+|||+.+
T Consensus 162 yrghiCivfell-G~S~~dFlk~--------N~y~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~ 229 (415)
T KOG0671|consen 162 YRGHICIVFELL-GLSTFDFLKE--------NNYIPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSE 229 (415)
T ss_pred ccCceEEEEecc-ChhHHHHhcc--------CCccccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccc
Confidence 678899999988 6699999964 55677899999999999999999999 999999999999999831
Q ss_pred ------------------CCCeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh
Q 002857 311 ------------------EMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT 372 (873)
Q Consensus 311 ------------------~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT 372 (873)
+..+||+|||.|.+-.... ..++.|..|+|||++.+-.++.++||||+||||.||.|
T Consensus 230 ~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~Elyt 304 (415)
T KOG0671|consen 230 YFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYT 304 (415)
T ss_pred eEEEeccCCccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeec
Confidence 3468999999998643322 34568999999999999999999999999999999999
Q ss_pred CCCCCCcccc-cchhhHHHHhhcCchhHHHHhhhhhhhhhhHHHH-----------HhhhccCCCCch-hHHHHHHHHHH
Q 002857 373 GLRPSDDMFK-DNLNLQNWVQSALPERVEEIVDTLFFKEIEEEET-----------VYKYKKAPSSST-QRSIILECLNS 439 (873)
Q Consensus 373 Gk~Pf~~~~~-~~~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~-----------~~~i~~~p~~~~-~~~~~~e~~~~ 439 (873)
|...|..-.+ +...+.+.+...++.. ++.......+-.+.. .......+.+.. ......+...+
T Consensus 305 G~~LFqtHen~EHLaMMerIlGp~P~~---mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~ 381 (415)
T KOG0671|consen 305 GETLFQTHENLEHLAMMERILGPIPSR---MIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQ 381 (415)
T ss_pred cceecccCCcHHHHHHHHHhhCCCcHH---HhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhH
Confidence 9999976331 2222223232222222 111110000000000 011111111111 01111233456
Q ss_pred HHHHHHHhhccCcCCCCCHHHHHH
Q 002857 440 ICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 440 L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
|.+|+..+|..||.+|+|+.|++.
T Consensus 382 LfDLl~~mL~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 382 LFDLLRRMLEFDPARRITLREALS 405 (415)
T ss_pred HHHHHHHHHccCccccccHHHHhc
Confidence 999999999999999999999764
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-31 Score=270.38 Aligned_cols=249 Identities=22% Similarity=0.265 Sum_probs=189.0
Q ss_pred CcceeecccCceEEEEEEEcCCCcEEEEEEeecc-CCcchhHHHHHHHHHHhhh-hccceeeeeeeecccccCCceEEEE
Q 002857 163 SSENLIGAGNFASVYKGILFEGAPAVAIKVFNFL-HHDASKSFTVECEVMRNII-HRKIIKVVTACSRVDYQGNDFKALV 240 (873)
Q Consensus 163 ~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~-~~~~~~~f~~Ei~iL~~L~-HpNIV~llg~c~~~~~~~~~~~~LV 240 (873)
+....||.|..|.|++++.+.++...|||.+... ..++.++++..+.++..-+ .|.||+.+|+|. .+...++-
T Consensus 95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi-----~n~dV~Ic 169 (391)
T KOG0983|consen 95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFI-----TNTDVFIC 169 (391)
T ss_pred hhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEe-----eCchHHHH
Confidence 4557899999999999999999999999998643 3445577888888877664 899999999964 44557788
Q ss_pred EeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEeccc
Q 002857 241 YEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFG 320 (873)
Q Consensus 241 ~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDFG 320 (873)
||.|. .-++.+|+. ....+++...-++...+++||.||-+ +++|+|||+||+|||+|+.|++||+|||
T Consensus 170 MelMs-~C~ekLlkr---------ik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFG 237 (391)
T KOG0983|consen 170 MELMS-TCAEKLLKR---------IKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFG 237 (391)
T ss_pred HHHHH-HHHHHHHHH---------hcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeeccc
Confidence 89883 355666532 34558888888999999999999996 7899999999999999999999999999
Q ss_pred cccccccccccccccccccccccCCCcccCC---CCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCch
Q 002857 321 IARFLEATNEQTSSIGVKGTTGYIAPEYGMG---HETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPE 397 (873)
Q Consensus 321 la~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~---~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~ 397 (873)
++-.+..... .+...|-+.|||||.+.- ..|+.++||||||++|+||.||+.||.....+-..+.+.+
T Consensus 238 IsGrlvdSkA---htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvl------ 308 (391)
T KOG0983|consen 238 ISGRLVDSKA---HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVL------ 308 (391)
T ss_pred ccceeecccc---cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHH------
Confidence 9976644332 233468999999998764 3789999999999999999999999987433321111111
Q ss_pred hHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 398 RVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 398 ~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
+ .++ |....... ....+.+++..||+.|+.+||...++++
T Consensus 309 ------n----~eP------------P~L~~~~g----FSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 309 ------N----EEP------------PLLPGHMG----FSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred ------h----cCC------------CCCCcccC----cCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 1 110 10000000 1224788999999999999999998765
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=262.88 Aligned_cols=239 Identities=27% Similarity=0.345 Sum_probs=188.7
Q ss_pred CceEEEEEEEcCCCcEEEEEEeeccCCcc-hhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEEEEeecCCCChh
Q 002857 172 NFASVYKGILFEGAPAVAIKVFNFLHHDA-SKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKALVYEFMPNGSLE 250 (873)
Q Consensus 172 ~fG~VYkg~~~~~g~~VAVK~l~~~~~~~-~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~LV~Ey~~~GSL~ 250 (873)
+||.||+|++..+++.+|+|++....... .+.+.+|++.+++++|+||+++++++. .....++||||+++++|.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~l~~e~~~~~~L~ 75 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFE-----DEDKLYLVMEYCDGGDLF 75 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhhee-----eCCEEEEEEeCCCCCCHH
Confidence 58999999998888999999997554444 678999999999999999999999863 346789999999999999
Q ss_pred hhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEeccccccccccccc
Q 002857 251 EWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNE 330 (873)
Q Consensus 251 ~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDFGla~~~~~~~~ 330 (873)
+++.. ...+++..++.++.+++.+|.||| ..+|+|+||+|+||+++.++.++|+|||.+.......
T Consensus 76 ~~~~~----------~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~- 141 (244)
T smart00220 76 DLLKK----------RGRLSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG- 141 (244)
T ss_pred HHHHh----------ccCCCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeecccc-
Confidence 99843 222888999999999999999999 8899999999999999999999999999998765432
Q ss_pred cccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCchhHHHHhhhhhhhh
Q 002857 331 QTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPERVEEIVDTLFFKE 410 (873)
Q Consensus 331 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~~l~elid~~L~~~ 410 (873)
......++..|++||.+.+..++.++||||||+++++|++|..||...... ..... .+. ...
T Consensus 142 --~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~-~~~~~------------~~~---~~~ 203 (244)
T smart00220 142 --LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL-LELFK------------KIG---KPK 203 (244)
T ss_pred --ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHH------------HHh---ccC
Confidence 222345788999999998888999999999999999999999998652111 00111 000 000
Q ss_pred hhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 411 IEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 411 ~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
.. .... . ......+.+++.+||..+|++||++.++++
T Consensus 204 ~~------------~~~~-~---~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 204 PP------------FPPP-E---WKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred CC------------Cccc-c---ccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 00 0000 0 001235888999999999999999999976
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-30 Score=270.71 Aligned_cols=181 Identities=22% Similarity=0.190 Sum_probs=152.9
Q ss_pred cCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEEEEeecCCCChh
Q 002857 171 GNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKALVYEFMPNGSLE 250 (873)
Q Consensus 171 G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~LV~Ey~~~GSL~ 250 (873)
|.+|.||++.+..+++.||+|++.... .+..|...+....||||+++++++ ......++||||+++|+|.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~e~~~~~~L~ 73 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYI-----VSEDSVFLVLQHAEGGKLW 73 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhhe-----ecCCeEEEEEecCCCCCHH
Confidence 899999999999999999999986432 234455555666799999999985 4567799999999999999
Q ss_pred hhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEeccccccccccccc
Q 002857 251 EWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNE 330 (873)
Q Consensus 251 ~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDFGla~~~~~~~~ 330 (873)
+++.. ...+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||.+.......
T Consensus 74 ~~l~~----------~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~- 139 (237)
T cd05576 74 SHISK----------FLNIPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC- 139 (237)
T ss_pred HHHHH----------hcCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc-
Confidence 99842 234889999999999999999999 8999999999999999999999999999886543321
Q ss_pred cccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCc
Q 002857 331 QTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDD 379 (873)
Q Consensus 331 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~ 379 (873)
....++..|+|||++.+..++.++||||||+++|||++|+.|+..
T Consensus 140 ----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~ 184 (237)
T cd05576 140 ----DGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVEC 184 (237)
T ss_pred ----ccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhc
Confidence 123356789999999888899999999999999999999988643
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=299.73 Aligned_cols=213 Identities=21% Similarity=0.209 Sum_probs=145.1
Q ss_pred hhcCCCcceeecccCceEEEEEEEcCC----CcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeec-cccc
Q 002857 158 ATKGFSSENLIGAGNFASVYKGILFEG----APAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSR-VDYQ 232 (873)
Q Consensus 158 at~~f~~~~~LG~G~fG~VYkg~~~~~----g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~-~~~~ 232 (873)
..++|++.++||+|+||.||+|++..+ +..||||++..... .+.+..| .+....+.+++.++..+.. ....
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 567899999999999999999999888 88999998753221 1111111 1122222333332222111 1113
Q ss_pred CCceEEEEEeecCCCChhhhccccccc----c------cccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCC
Q 002857 233 GNDFKALVYEFMPNGSLEEWIHPITEE----D------KRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIK 302 (873)
Q Consensus 233 ~~~~~~LV~Ey~~~GSL~~~L~~~~~~----~------~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLK 302 (873)
.+...+|||||+.+++|.++++..... . .............+..|+.||+.||+||| +.+|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCcCC
Confidence 456789999999999999998531100 0 00000111223446689999999999999 8999999999
Q ss_pred CCCeeeCC-CCCeEEeccccccccccccccccccccccccccCCCcccCCC----------------------CCCcchh
Q 002857 303 PSNILLND-EMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGH----------------------ETSSYGD 359 (873)
Q Consensus 303 psNILLd~-~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~----------------------~~s~ksD 359 (873)
|+|||++. ++.+||+|||+++.+...... ......+++.|+|||.+... .++.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCcccccccccc-CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999985 579999999999865432221 22345689999999965322 2345679
Q ss_pred hHhHHHHHHHHHhCCCCCC
Q 002857 360 VYSFGILLLEMFTGLRPSD 378 (873)
Q Consensus 360 VwSfGvvL~ELlTGk~Pf~ 378 (873)
||||||+||||+++..+++
T Consensus 362 VwSlGviL~el~~~~~~~~ 380 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSD 380 (566)
T ss_pred cHHHHHHHHHHHhCcCCCc
Confidence 9999999999999877654
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-30 Score=269.31 Aligned_cols=255 Identities=22% Similarity=0.366 Sum_probs=207.3
Q ss_pred CHHHHHHhhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhh-hhccceeeeeeeecc
Q 002857 151 SYEALYSATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNI-IHRKIIKVVTACSRV 229 (873)
Q Consensus 151 s~~el~~at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~llg~c~~~ 229 (873)
.+++++..|. +.||+|+|+.|-.++...++..+|||++.+.......+..+|++++.+. .|+||++|+.+
T Consensus 74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLief---- 144 (463)
T KOG0607|consen 74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEF---- 144 (463)
T ss_pred hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHH----
Confidence 4678888774 7899999999999999999999999999877666678899999999999 59999999999
Q ss_pred cccCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeC
Q 002857 230 DYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLN 309 (873)
Q Consensus 230 ~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd 309 (873)
|+++...|||||-|.||+|..+|+ ....+++.+.-.+.++||.||.||| .++|.||||||+|||..
T Consensus 145 -FEdd~~FYLVfEKm~GGplLshI~----------~~~~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~ 210 (463)
T KOG0607|consen 145 -FEDDTRFYLVFEKMRGGPLLSHIQ----------KRKHFNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCE 210 (463)
T ss_pred -hcccceEEEEEecccCchHHHHHH----------HhhhccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeec
Confidence 477888999999999999999995 3567899999999999999999999 99999999999999986
Q ss_pred CCC---CeEEecccccccccccccc-----ccccccccccccCCCcccC---C--CCCCcchhhHhHHHHHHHHHhCCCC
Q 002857 310 DEM---TACVADFGIARFLEATNEQ-----TSSIGVKGTTGYIAPEYGM---G--HETSSYGDVYSFGILLLEMFTGLRP 376 (873)
Q Consensus 310 ~~~---~vKLsDFGla~~~~~~~~~-----~~~~~~~Gt~~Y~APE~l~---~--~~~s~ksDVwSfGvvL~ELlTGk~P 376 (873)
... -+||+||.+..-......- ......+|+..|||||+.. + ..|+.+.|.||||||||-|++|..|
T Consensus 211 ~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpP 290 (463)
T KOG0607|consen 211 SPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPP 290 (463)
T ss_pred CCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCC
Confidence 544 4799999987543322211 1122346889999999743 2 3688999999999999999999999
Q ss_pred CCcccccc------------------------hhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCch
Q 002857 377 SDDMFKDN------------------------LNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSST 428 (873)
Q Consensus 377 f~~~~~~~------------------------~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~ 428 (873)
|.+.-..+ ..+.+.-|..+....++++...+..+...+....++..|||...
T Consensus 291 FvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~ 366 (463)
T KOG0607|consen 291 FVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQR 366 (463)
T ss_pred ccCccCCcCCccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccc
Confidence 97632211 12223334555667788899999888888888888899998654
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-30 Score=286.58 Aligned_cols=244 Identities=24% Similarity=0.377 Sum_probs=201.3
Q ss_pred ceeecccCceEEEEEEEcCCCcEEEEEEeeccC--CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEEEEe
Q 002857 165 ENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH--HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKALVYE 242 (873)
Q Consensus 165 ~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~LV~E 242 (873)
.++||.|.||+||-|+++++|+.||||++.+.. ......+.+|+.||++++||.||.+--.| +..+..++|||
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~-----ET~ervFVVME 643 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMF-----ETPERVFVVME 643 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEee-----cCCceEEEEeh
Confidence 579999999999999999999999999997542 33346799999999999999999998774 67788999999
Q ss_pred ecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCC---CCeEEecc
Q 002857 243 FMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDE---MTACVADF 319 (873)
Q Consensus 243 y~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~---~~vKLsDF 319 (873)
-+. |+..+.|-. ...+.|++..-..++.||+.||.||| .++|+|.||||+||||.+. -.+||+||
T Consensus 644 Kl~-GDMLEMILS--------sEkgRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDF 711 (888)
T KOG4236|consen 644 KLH-GDMLEMILS--------SEKGRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDF 711 (888)
T ss_pred hhc-chHHHHHHH--------hhcccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeeccc
Confidence 995 566555532 35677888888899999999999999 8999999999999999643 37999999
Q ss_pred ccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccc--cch-----hhHHHHh
Q 002857 320 GIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFK--DNL-----NLQNWVQ 392 (873)
Q Consensus 320 Gla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~--~~~-----~l~~~~~ 392 (873)
|+|+++.... ....++||+.|+|||++....|...-|+||.|||+|--++|..||....+ ++. .+..--|
T Consensus 712 GfARiIgEks---FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMyPp~PW 788 (888)
T KOG4236|consen 712 GFARIIGEKS---FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMYPPNPW 788 (888)
T ss_pred cceeecchhh---hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhccccccCCCch
Confidence 9999886532 23457899999999999999999999999999999999999999975321 111 1112225
Q ss_pred hcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCch
Q 002857 393 SALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSST 428 (873)
Q Consensus 393 ~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~ 428 (873)
..+.+...++++..+.....+|.++.+-+.|||...
T Consensus 789 ~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~ 824 (888)
T KOG4236|consen 789 SEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQD 824 (888)
T ss_pred hhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhc
Confidence 556667889999999998889999998899998654
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-30 Score=309.03 Aligned_cols=255 Identities=24% Similarity=0.315 Sum_probs=204.6
Q ss_pred HHHHHHhhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeec---cCCcchhHHHHHHHHHHhhhhccceeeeeeeec
Q 002857 152 YEALYSATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNF---LHHDASKSFTVECEVMRNIIHRKIIKVVTACSR 228 (873)
Q Consensus 152 ~~el~~at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~---~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~ 228 (873)
..++....++|.+.++||+|+||.|..++++.+++.+|+|++++ .......-|..|-.+|..-+.+=|+.+.-.
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyA--- 143 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYA--- 143 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHH---
Confidence 34556667899999999999999999999999999999999985 334455679999999998888889998766
Q ss_pred ccccCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeee
Q 002857 229 VDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILL 308 (873)
Q Consensus 229 ~~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILL 308 (873)
|+++.++|+|||||+||+|-.+|.. ...+++.....++..|+.||.-|| +.|+|||||||+||||
T Consensus 144 --FQD~~~LYlVMdY~pGGDlltLlSk----------~~~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLl 208 (1317)
T KOG0612|consen 144 --FQDERYLYLVMDYMPGGDLLTLLSK----------FDRLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLL 208 (1317)
T ss_pred --hcCccceEEEEecccCchHHHHHhh----------cCCChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEe
Confidence 5889999999999999999999942 237899999999999999999999 9999999999999999
Q ss_pred CCCCCeEEeccccccccccccccccccccccccccCCCcccCC-----CCCCcchhhHhHHHHHHHHHhCCCCCCcccc-
Q 002857 309 NDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMG-----HETSSYGDVYSFGILLLEMFTGLRPSDDMFK- 382 (873)
Q Consensus 309 d~~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-----~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~- 382 (873)
|..|++||+|||.+-.+..+.... ....+||+-|++||++.. +.|+..+|.||+||++|||+.|..||....-
T Consensus 209 d~~GHikLADFGsClkm~~dG~V~-s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslv 287 (1317)
T KOG0612|consen 209 DKSGHIKLADFGSCLKMDADGTVR-SSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLV 287 (1317)
T ss_pred cccCcEeeccchhHHhcCCCCcEE-eccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHH
Confidence 999999999999998776544333 334679999999998753 5789999999999999999999999965210
Q ss_pred ----c------chhhHHHHhhcCchhHHHHhhhhhhhhhhHHHH---HhhhccCCCCch
Q 002857 383 ----D------NLNLQNWVQSALPERVEEIVDTLFFKEIEEEET---VYKYKKAPSSST 428 (873)
Q Consensus 383 ----~------~~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~---~~~i~~~p~~~~ 428 (873)
. ...+.. ...+++...+++...+... +.|.. +.+++.||....
T Consensus 288 eTY~KIm~hk~~l~FP~--~~~VSeeakdLI~~ll~~~-e~RLgrngiedik~HpFF~g 343 (1317)
T KOG0612|consen 288 ETYGKIMNHKESLSFPD--ETDVSEEAKDLIEALLCDR-EVRLGRNGIEDIKNHPFFEG 343 (1317)
T ss_pred HHHHHHhchhhhcCCCc--ccccCHHHHHHHHHHhcCh-hhhcccccHHHHHhCccccC
Confidence 1 111110 1124557778887776542 33333 677788887543
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-31 Score=269.11 Aligned_cols=283 Identities=18% Similarity=0.245 Sum_probs=203.5
Q ss_pred CCCcceeecccCceEEEEEEEcCCCcEEEEEEee--ccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccC---Cc
Q 002857 161 GFSSENLIGAGNFASVYKGILFEGAPAVAIKVFN--FLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQG---ND 235 (873)
Q Consensus 161 ~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~--~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~---~~ 235 (873)
.|.-..+||+|.||.||+|+..++++.||+|+.- .....-.....+|+++|..++|+|++.++..|....-.. ..
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 4556689999999999999999999999998653 233334456789999999999999999999996543221 23
Q ss_pred eEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeE
Q 002857 236 FKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTAC 315 (873)
Q Consensus 236 ~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vK 315 (873)
..+|||.+++. +|.-+|. .....++..++.+++.++..||.|+| ...|+|||+|+.|+||+.++.+|
T Consensus 98 t~ylVf~~ceh-DLaGlLs---------n~~vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilk 164 (376)
T KOG0669|consen 98 TFYLVFDFCEH-DLAGLLS---------NRKVRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILK 164 (376)
T ss_pred eeeeeHHHhhh-hHHHHhc---------CccccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEE
Confidence 47999999977 8888884 23467889999999999999999999 89999999999999999999999
Q ss_pred Eeccccccccccccc--cccccccccccccCCCcccCCC-CCCcchhhHhHHHHHHHHHhCCCCCCcccccc-hhhHHHH
Q 002857 316 VADFGIARFLEATNE--QTSSIGVKGTTGYIAPEYGMGH-ETSSYGDVYSFGILLLEMFTGLRPSDDMFKDN-LNLQNWV 391 (873)
Q Consensus 316 LsDFGla~~~~~~~~--~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~-~~l~~~~ 391 (873)
|+|||+++.+..... ....+..+-|+.|++||.+.+. .|+++.|||.-|||+.||+||.+-+.+..+.. ..+....
T Consensus 165 lADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~L 244 (376)
T KOG0669|consen 165 LADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQL 244 (376)
T ss_pred eeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHH
Confidence 999999986644332 2223344579999999998875 68999999999999999999998887643322 1111111
Q ss_pred hhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHH------HHHHHHHHhhccCcCCCCCHHHHHHH
Q 002857 392 QSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLN------SICEIGVACSAELPGERMKINDVELG 464 (873)
Q Consensus 392 ~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~------~L~~L~~~CL~~dP~eRPTm~EVl~~ 464 (873)
-..+.. ..+.+.+.-+..+.+...|....+...+.+..+ ..++++..++..||.+|+++.+++..
T Consensus 245 cGs~tk--------evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 245 CGSITK--------EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred hccCCc--------ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 111111 000111111111111111222222222222232 57789999999999999999988743
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-30 Score=270.96 Aligned_cols=252 Identities=23% Similarity=0.295 Sum_probs=207.2
Q ss_pred HhhcCCCcc-eeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhh-hhccceeeeeeeecccccCC
Q 002857 157 SATKGFSSE-NLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNI-IHRKIIKVVTACSRVDYQGN 234 (873)
Q Consensus 157 ~at~~f~~~-~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~llg~c~~~~~~~~ 234 (873)
..|++|++. ++||-|-.|.|.....+.+++.+|+|++.. .....+|+++--.. .|+|||.+++++.. .+.+.
T Consensus 58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-----s~KARrEVeLHw~~s~h~~iV~IidVyeN-s~~~r 131 (400)
T KOG0604|consen 58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-----SPKARREVELHWMASGHPHIVSIIDVYEN-SYQGR 131 (400)
T ss_pred cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-----CHHHHhHhhhhhhhcCCCceEEeehhhhh-hccCc
Confidence 356677664 689999999999999999999999999852 24456788765544 69999999999743 34566
Q ss_pred ceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeC---CC
Q 002857 235 DFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLN---DE 311 (873)
Q Consensus 235 ~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd---~~ 311 (873)
.-+++|||.|+||.|.+.+++ .....+++.+.-.|+.||+.|+.||| +.+|.||||||+|+|.. .|
T Consensus 132 kcLLiVmE~meGGeLfsriq~--------~g~~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~n 200 (400)
T KOG0604|consen 132 KCLLIVMECMEGGELFSRIQD--------RGDQAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPN 200 (400)
T ss_pred eeeEeeeecccchHHHHHHHH--------cccccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCC
Confidence 678899999999999999964 45567999999999999999999999 99999999999999996 45
Q ss_pred CCeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCccccc--------
Q 002857 312 MTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKD-------- 383 (873)
Q Consensus 312 ~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~-------- 383 (873)
-.+||+|||+|+...... ......-|+.|.|||++...+|+...|+||+||++|-|+.|.+||......
T Consensus 201 a~lKLtDfGFAK~t~~~~---~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~ 277 (400)
T KOG0604|consen 201 APLKLTDFGFAKETQEPG---DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKR 277 (400)
T ss_pred cceEecccccccccCCCc---cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHh
Confidence 579999999999654322 222345799999999999999999999999999999999999999753221
Q ss_pred -----chhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCch
Q 002857 384 -----NLNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSST 428 (873)
Q Consensus 384 -----~~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~ 428 (873)
...+..--|..+.+..++++..+|..++.+|.++.++..|||...
T Consensus 278 rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~ 327 (400)
T KOG0604|consen 278 RIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQ 327 (400)
T ss_pred HhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcc
Confidence 112333345566678899999999999999999999999999765
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-30 Score=270.58 Aligned_cols=201 Identities=23% Similarity=0.285 Sum_probs=175.7
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC---CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCc
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH---HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGND 235 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~ 235 (873)
-++|..+++||+|.||.|.+++.+.+++.+|||++++.. .+....-..|-.+|+..+||.+..+--. ++..+
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYs-----FQt~d 241 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYS-----FQTQD 241 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhh-----hccCc
Confidence 367899999999999999999999999999999998543 2333456778899999999999887554 57888
Q ss_pred eEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeE
Q 002857 236 FKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTAC 315 (873)
Q Consensus 236 ~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vK 315 (873)
.+++||||..||.|.-+|. ....+++.....+-..|+.||.||| +++||.||||.+|.|||.+|++|
T Consensus 242 rlCFVMeyanGGeLf~HLs----------rer~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIK 308 (516)
T KOG0690|consen 242 RLCFVMEYANGGELFFHLS----------RERVFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIK 308 (516)
T ss_pred eEEEEEEEccCceEeeehh----------hhhcccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceE
Confidence 9999999999999998883 4567888888889999999999999 89999999999999999999999
Q ss_pred EeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCc
Q 002857 316 VADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDD 379 (873)
Q Consensus 316 LsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~ 379 (873)
|+|||+.+.--. .........||+.|+|||++....|....|.|.+|||+|||+.|+.||..
T Consensus 309 itDFGLCKE~I~--~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn 370 (516)
T KOG0690|consen 309 ITDFGLCKEEIK--YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYN 370 (516)
T ss_pred eeecccchhccc--ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccc
Confidence 999999984322 22334457899999999999999999999999999999999999999975
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=286.72 Aligned_cols=240 Identities=23% Similarity=0.247 Sum_probs=190.7
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhh-hhccceeeeeeeecccccCCceE
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNI-IHRKIIKVVTACSRVDYQGNDFK 237 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~llg~c~~~~~~~~~~~ 237 (873)
++.|.....+|.|+|+.|-.+.+..+++..++|++.... .+..+|+.++... +|+||+++.+.+ .++.+.
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~-----~~~~~~ 391 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVY-----EDGKEI 391 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeeccee-----cCCcee
Confidence 667888888999999999999999999999999997542 3345677777666 799999999995 567789
Q ss_pred EEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeee-CCCCCeEE
Q 002857 238 ALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILL-NDEMTACV 316 (873)
Q Consensus 238 ~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILL-d~~~~vKL 316 (873)
++|||.+.++-|.+.+.. ..... ..+..|+.+|+.|+.||| .++||||||||+|||+ ++.++++|
T Consensus 392 ~~v~e~l~g~ell~ri~~----------~~~~~-~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrl 457 (612)
T KOG0603|consen 392 YLVMELLDGGELLRRIRS----------KPEFC-SEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRL 457 (612)
T ss_pred eeeehhccccHHHHHHHh----------cchhH-HHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEE
Confidence 999999999988877732 22233 677889999999999999 8999999999999999 69999999
Q ss_pred eccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCc
Q 002857 317 ADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALP 396 (873)
Q Consensus 317 sDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~ 396 (873)
+|||.++..... ....+-|..|.|||++....|++++|+||||++||+|++|+.||.....+ .
T Consensus 458 tyFG~a~~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-~----------- 520 (612)
T KOG0603|consen 458 TYFGFWSELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-I----------- 520 (612)
T ss_pred EEechhhhCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-H-----------
Confidence 999999876543 22234688999999999999999999999999999999999999763322 1
Q ss_pred hhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 397 ERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 397 ~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
++........+. ........+|+.+||+.||.+||+|.++..
T Consensus 521 ----ei~~~i~~~~~s---------------------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 521 ----EIHTRIQMPKFS---------------------ECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred ----HHHHhhcCCccc---------------------cccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 111111001000 111234678999999999999999998753
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.7e-31 Score=270.33 Aligned_cols=255 Identities=24% Similarity=0.240 Sum_probs=190.8
Q ss_pred cceeecccCceEEEEEEEcCCCcEEEEEEeeccCC-cchhHHHHHHHHHHhh-hhccceeeeeeeecccccCCceEEEEE
Q 002857 164 SENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH-DASKSFTVECEVMRNI-IHRKIIKVVTACSRVDYQGNDFKALVY 241 (873)
Q Consensus 164 ~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L-~HpNIV~llg~c~~~~~~~~~~~~LV~ 241 (873)
.+..||.|+||+|++-.++..|+..|||+++.... .+.++++.|.+...+- +.||||+++|.+ ..++..++-|
T Consensus 68 dlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~-----F~EGdcWiCM 142 (361)
T KOG1006|consen 68 DLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGAL-----FSEGDCWICM 142 (361)
T ss_pred HHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhh-----hcCCceeeeH
Confidence 34789999999999999999999999999985544 4557788888875554 789999999996 3455689999
Q ss_pred eecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEecccc
Q 002857 242 EFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGI 321 (873)
Q Consensus 242 Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDFGl 321 (873)
|.|. .||+.+-+... ..+...+++.-.-.|..-.+.||.||-+ ...|||||+||+|||||..|.+||+|||+
T Consensus 143 ELMd-~SlDklYk~vy-----~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGI 214 (361)
T KOG1006|consen 143 ELMD-ISLDKLYKRVY-----SVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGI 214 (361)
T ss_pred HHHh-hhHHHHHHHHH-----HHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccc
Confidence 9995 47766543211 1345668888888999999999999986 67999999999999999999999999999
Q ss_pred ccccccccccccccccccccccCCCcccCCC--CCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCchhH
Q 002857 322 ARFLEATNEQTSSIGVKGTTGYIAPEYGMGH--ETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPERV 399 (873)
Q Consensus 322 a~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~--~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~~l 399 (873)
+-.+... ...+..+|-..|||||.+... .|+.+|||||||++|+|+.||+.||..... +-+++
T Consensus 215 cGqLv~S---iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s------------vfeql 279 (361)
T KOG1006|consen 215 CGQLVDS---IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS------------VFEQL 279 (361)
T ss_pred hHhHHHH---HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH------------HHHHH
Confidence 9765432 223345689999999988653 589999999999999999999999865211 00111
Q ss_pred HHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 400 EEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 400 ~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
..++. ++ |........-.+....+++++..||..|-.+||...++.+
T Consensus 280 ~~Vv~----gd-------------pp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 280 CQVVI----GD-------------PPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred HHHHc----CC-------------CCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 11111 11 1100001110112335889999999999999999998764
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.2e-30 Score=276.21 Aligned_cols=205 Identities=26% Similarity=0.413 Sum_probs=172.5
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeec--cCCcc-----hhHHHHHHHHHHhhhhccceeeeeeeeccccc
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNF--LHHDA-----SKSFTVECEVMRNIIHRKIIKVVTACSRVDYQ 232 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~--~~~~~-----~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~ 232 (873)
++|-.+++||+|||+.||+|.+....+.||||+-.. ...+. .+...+|..|-+.|+||.||++++++. .
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfs----l 538 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFS----L 538 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeee----e
Confidence 456678999999999999999988899999998642 22222 244678999999999999999999974 3
Q ss_pred CCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeC---
Q 002857 233 GNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLN--- 309 (873)
Q Consensus 233 ~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd--- 309 (873)
+.+..|-|+||++|.+|+-||+ ..+.+++.+...|+.||+.||.||.+. +.+|||-||||.||||-
T Consensus 539 DtdsFCTVLEYceGNDLDFYLK----------QhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~Gt 607 (775)
T KOG1151|consen 539 DTDSFCTVLEYCEGNDLDFYLK----------QHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGT 607 (775)
T ss_pred ccccceeeeeecCCCchhHHHH----------hhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCc
Confidence 4556799999999999999994 467799999999999999999999954 89999999999999995
Q ss_pred CCCCeEEecccccccccccccc-----ccccccccccccCCCcccCCC----CCCcchhhHhHHHHHHHHHhCCCCCCc
Q 002857 310 DEMTACVADFGIARFLEATNEQ-----TSSIGVKGTTGYIAPEYGMGH----ETSSYGDVYSFGILLLEMFTGLRPSDD 379 (873)
Q Consensus 310 ~~~~vKLsDFGla~~~~~~~~~-----~~~~~~~Gt~~Y~APE~l~~~----~~s~ksDVwSfGvvL~ELlTGk~Pf~~ 379 (873)
.-|.+||.|||++++++.+... ..+....||..|++||.+.-+ +++.|.||||.|||+|..+.|+.||..
T Consensus 608 acGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGh 686 (775)
T KOG1151|consen 608 ACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGH 686 (775)
T ss_pred ccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCC
Confidence 4578999999999998765432 123345699999999976543 578899999999999999999999976
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-28 Score=283.06 Aligned_cols=218 Identities=20% Similarity=0.241 Sum_probs=158.0
Q ss_pred hhcCCCcceeecccCceEEEEEEEc----------------CCCcEEEEEEeeccCCcchh--------------HHHHH
Q 002857 158 ATKGFSSENLIGAGNFASVYKGILF----------------EGAPAVAIKVFNFLHHDASK--------------SFTVE 207 (873)
Q Consensus 158 at~~f~~~~~LG~G~fG~VYkg~~~----------------~~g~~VAVK~l~~~~~~~~~--------------~f~~E 207 (873)
..++|++.++||+|+||.||+|.+. ..++.||||+++.......+ .+..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 4678999999999999999999752 23567999998644332222 34457
Q ss_pred HHHHHhhhhccc-----eeeeeeeeccc---ccCCceEEEEEeecCCCChhhhcccccccc--------------cccCC
Q 002857 208 CEVMRNIIHRKI-----IKVVTACSRVD---YQGNDFKALVYEFMPNGSLEEWIHPITEED--------------KRHKA 265 (873)
Q Consensus 208 i~iL~~L~HpNI-----V~llg~c~~~~---~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~--------------~~~~~ 265 (873)
+.++.+++|.++ ++++++|.... ....+..+|||||+++|+|.++|+...... .....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777888876654 67788764321 112456899999999999999996421000 00011
Q ss_pred CCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEeccccccccccccccccccccccccccCC
Q 002857 266 PGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIA 345 (873)
Q Consensus 266 ~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~A 345 (873)
...+++..++.|+.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++........ ......+++.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeC
Confidence 234677889999999999999999 889999999999999999999999999999755332211 1112235789999
Q ss_pred CcccCCCCC----------------------CcchhhHhHHHHHHHHHhCCC-CCCc
Q 002857 346 PEYGMGHET----------------------SSYGDVYSFGILLLEMFTGLR-PSDD 379 (873)
Q Consensus 346 PE~l~~~~~----------------------s~ksDVwSfGvvL~ELlTGk~-Pf~~ 379 (873)
||.+..... ..+.||||+||+++||++|.. ||..
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~ 435 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVAN 435 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccc
Confidence 998754321 234699999999999999875 6643
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=269.58 Aligned_cols=201 Identities=26% Similarity=0.317 Sum_probs=171.7
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC---CcchhHHHHHHHHHHhh-hhccceeeeeeeecccccCCc
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH---HDASKSFTVECEVMRNI-IHRKIIKVVTACSRVDYQGND 235 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L-~HpNIV~llg~c~~~~~~~~~ 235 (873)
.+|..+.+||+|+||.|.+|..+.+.+.+|||++++.- .+..+--+.|-++|... +-|.++++... ++.-+
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHSc-----FQTmD 423 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSC-----FQTMD 423 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHH-----hhhhh
Confidence 47889999999999999999988889999999997432 22333456677777766 56778888776 46677
Q ss_pred eEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeE
Q 002857 236 FKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTAC 315 (873)
Q Consensus 236 ~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vK 315 (873)
.+++||||+.||+|--+|+ +-+.+.+....-+|..||-||-||| +++||.||||.+|||||.+|++|
T Consensus 424 RLyFVMEyvnGGDLMyhiQ----------Q~GkFKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiK 490 (683)
T KOG0696|consen 424 RLYFVMEYVNGGDLMYHIQ----------QVGKFKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIK 490 (683)
T ss_pred heeeEEEEecCchhhhHHH----------HhcccCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceE
Confidence 8999999999999998884 4567888899999999999999999 99999999999999999999999
Q ss_pred EeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcc
Q 002857 316 VADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDM 380 (873)
Q Consensus 316 LsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~ 380 (873)
|+|||+++.--. ....+....||+.|+|||++...+|+...|.|||||+||||+.|++||++.
T Consensus 491 i~DFGmcKEni~--~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGe 553 (683)
T KOG0696|consen 491 IADFGMCKENIF--DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE 553 (683)
T ss_pred eeeccccccccc--CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCC
Confidence 999999984222 233445578999999999999999999999999999999999999999874
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-28 Score=237.94 Aligned_cols=199 Identities=23% Similarity=0.336 Sum_probs=168.1
Q ss_pred CCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC--CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEE
Q 002857 161 GFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH--HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKA 238 (873)
Q Consensus 161 ~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~ 238 (873)
+|...++||+|.||+||+|+.+++++.||+|+++... ........+|+-+|+.++|+|||++++.. ..+...-
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvl-----hsdkklt 77 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL-----HSDKKLT 77 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhh-----ccCceeE
Confidence 4566789999999999999999999999999987443 33346789999999999999999999983 4567789
Q ss_pred EEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEec
Q 002857 239 LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVAD 318 (873)
Q Consensus 239 LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsD 318 (873)
||+||+.. +|..+... -++.++......++.|+++||.|.| ++++.||||||.|.|++.+|+.||+|
T Consensus 78 lvfe~cdq-dlkkyfds---------lng~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelklad 144 (292)
T KOG0662|consen 78 LVFEFCDQ-DLKKYFDS---------LNGDLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLAD 144 (292)
T ss_pred EeHHHhhH-HHHHHHHh---------cCCcCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecc
Confidence 99999955 88888742 4567888899999999999999999 89999999999999999999999999
Q ss_pred cccccccccccccccccccccccccCCCcccCCC-CCCcchhhHhHHHHHHHHHh-CCCCCCc
Q 002857 319 FGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGH-ETSSYGDVYSFGILLLEMFT-GLRPSDD 379 (873)
Q Consensus 319 FGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~ 379 (873)
||+++.+.-.. ......+-|..|++|.++.+. -|++..|+||-|||+.|+.. |++.|.+
T Consensus 145 fglarafgipv--rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg 205 (292)
T KOG0662|consen 145 FGLARAFGIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG 205 (292)
T ss_pred cchhhhcCCce--EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCC
Confidence 99999764322 222334579999999999886 47888999999999999997 6655655
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.5e-28 Score=264.39 Aligned_cols=137 Identities=20% Similarity=0.312 Sum_probs=118.0
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhh-----h---ccceeeeeeeeccc
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNII-----H---RKIIKVVTACSRVD 230 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~-----H---pNIV~llg~c~~~~ 230 (873)
..+|.+.++||.|.|++||++.+..+.+.||+|+.+... .-.+..+.||++|++++ | .+||+|++.|....
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 368999999999999999999999999999999987443 23366788999999994 3 46999999986543
Q ss_pred ccCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeee
Q 002857 231 YQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILL 308 (873)
Q Consensus 231 ~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILL 308 (873)
.++.+.++|+|++ |-+|..+|.. ...+.++...+.+|+.||+.||.|||.. -+|||.||||+|||+
T Consensus 156 -pNG~HVCMVfEvL-GdnLLklI~~--------s~YrGlpl~~VK~I~~qvL~GLdYLH~e--cgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 156 -PNGQHVCMVFEVL-GDNLLKLIKY--------SNYRGLPLSCVKEICRQVLTGLDYLHRE--CGIIHTDLKPENVLL 221 (590)
T ss_pred -CCCcEEEEEehhh-hhHHHHHHHH--------hCCCCCcHHHHHHHHHHHHHHHHHHHHh--cCccccCCCcceeee
Confidence 6788999999999 6699999853 4567899999999999999999999984 599999999999998
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.7e-28 Score=255.27 Aligned_cols=201 Identities=24% Similarity=0.316 Sum_probs=176.4
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeecc---CCcchhHHHHHHHHHHhh-hhccceeeeeeeecccccCCc
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFL---HHDASKSFTVECEVMRNI-IHRKIIKVVTACSRVDYQGND 235 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~L-~HpNIV~llg~c~~~~~~~~~ 235 (873)
++|..+.+||+|+|++|.+++++++.+.+|+|++++. ..+..+..+.|-.+..+. +||.+|-+..+ ++.+.
T Consensus 250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhsc-----fqtes 324 (593)
T KOG0695|consen 250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSC-----FQTES 324 (593)
T ss_pred ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhh-----hcccc
Confidence 6789999999999999999999999999999999743 333456677888888776 79999999887 57788
Q ss_pred eEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeE
Q 002857 236 FKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTAC 315 (873)
Q Consensus 236 ~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vK 315 (873)
.+++|.||++||+|--+++ ....|++.....+...|..||.||| ++|||.||||..|||+|..|++|
T Consensus 325 rlffvieyv~ggdlmfhmq----------rqrklpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghik 391 (593)
T KOG0695|consen 325 RLFFVIEYVNGGDLMFHMQ----------RQRKLPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIK 391 (593)
T ss_pred eEEEEEEEecCcceeeehh----------hhhcCcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCcee
Confidence 8999999999999987773 4667999999999999999999999 99999999999999999999999
Q ss_pred EeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcc
Q 002857 316 VADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDM 380 (873)
Q Consensus 316 LsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~ 380 (873)
|.|||+.+.--.. ...+....||+.|+|||++.+..|....|.|++||+++||+.|+.||+-.
T Consensus 392 ltdygmcke~l~~--gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdiv 454 (593)
T KOG0695|consen 392 LTDYGMCKEGLGP--GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIV 454 (593)
T ss_pred ecccchhhcCCCC--CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCccee
Confidence 9999999853322 23344578999999999999999999999999999999999999999763
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-28 Score=242.44 Aligned_cols=203 Identities=25% Similarity=0.312 Sum_probs=167.6
Q ss_pred CCCcceeecccCceEEEEEEEcCCCcEEEEEEeecc-CCcchhHHHHHHHHHHhh-hhccceeeeeeeecccccCCceEE
Q 002857 161 GFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFL-HHDASKSFTVECEVMRNI-IHRKIIKVVTACSRVDYQGNDFKA 238 (873)
Q Consensus 161 ~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~-~~~~~~~f~~Ei~iL~~L-~HpNIV~llg~c~~~~~~~~~~~~ 238 (873)
+......||+|++|.|-+-++..+|...|+|.+... ..+..++.++|+.+..+- ..|.+|.++|.. ......+
T Consensus 47 ~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~-----~regdvw 121 (282)
T KOG0984|consen 47 DLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGAL-----FREGDVW 121 (282)
T ss_pred hhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhh-----hccccEE
Confidence 344557899999999999999999999999998743 334456788888876654 789999999973 5566789
Q ss_pred EEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEec
Q 002857 239 LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVAD 318 (873)
Q Consensus 239 LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsD 318 (873)
+.||.|.- ||+.+-.. .......+++..+-+|+..|.+||.|||+ +..+||||+||+|||++.+|++||+|
T Consensus 122 IcME~M~t-Sldkfy~~------v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCD 192 (282)
T KOG0984|consen 122 ICMELMDT-SLDKFYRK------VLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICD 192 (282)
T ss_pred EeHHHhhh-hHHHHHHH------HHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcc
Confidence 99999954 88877643 23456778999999999999999999996 78999999999999999999999999
Q ss_pred cccccccccccccccccccccccccCCCcccCC----CCCCcchhhHhHHHHHHHHHhCCCCCCcc
Q 002857 319 FGIARFLEATNEQTSSIGVKGTTGYIAPEYGMG----HETSSYGDVYSFGILLLEMFTGLRPSDDM 380 (873)
Q Consensus 319 FGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~----~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~ 380 (873)
||++-.+.... ..+...|--.|||||.+.. ..|+.||||||||+++.||.+++.||+..
T Consensus 193 FGIsG~L~dSi---Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 193 FGISGYLVDSI---AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred cccceeehhhh---HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 99998764432 2223458889999998764 37899999999999999999999999763
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-28 Score=282.98 Aligned_cols=246 Identities=23% Similarity=0.364 Sum_probs=185.1
Q ss_pred CCcceeecccCce-EEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhh-hhccceeeeeeeecccccCCceEEE
Q 002857 162 FSSENLIGAGNFA-SVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNI-IHRKIIKVVTACSRVDYQGNDFKAL 239 (873)
Q Consensus 162 f~~~~~LG~G~fG-~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~llg~c~~~~~~~~~~~~L 239 (873)
|...+++|.|..| .||+|.. .++.||||++- .+......+|+..|+.- +|||||++++. -.+..+.||
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll---~e~~~~A~rEi~lL~eSD~H~NviRyyc~-----E~d~qF~YI 580 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY--EGREVAVKRLL---EEFFDFAQREIQLLQESDEHPNVIRYYCS-----EQDRQFLYI 580 (903)
T ss_pred eccHHHcccCCCCcEEEEEee--CCceehHHHHh---hHhHHHHHHHHHHHHhccCCCceEEEEee-----ccCCceEEE
Confidence 4455789999887 5899988 67899999874 22334678899999888 69999999887 366789999
Q ss_pred EEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCC---C--CCe
Q 002857 240 VYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLND---E--MTA 314 (873)
Q Consensus 240 V~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~---~--~~v 314 (873)
..|.|.. +|++++... .. ..........+.++.|++.||+||| +.+||||||||.||||+. + ..+
T Consensus 581 alELC~~-sL~dlie~~-~~-----d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra 650 (903)
T KOG1027|consen 581 ALELCAC-SLQDLIESS-GL-----DVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRA 650 (903)
T ss_pred EehHhhh-hHHHHHhcc-cc-----chhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeE
Confidence 9999965 999999642 00 1111111456788999999999999 899999999999999975 2 579
Q ss_pred EEecccccccccccccc-ccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhC-CCCCCcccccchhhHHHHh
Q 002857 315 CVADFGIARFLEATNEQ-TSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTG-LRPSDDMFKDNLNLQNWVQ 392 (873)
Q Consensus 315 KLsDFGla~~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTG-k~Pf~~~~~~~~~l~~~~~ 392 (873)
+|+|||+++.+..+... .......||-+|+|||++....-+.+.||||||||+|+.++| .+||.+....+.++..-..
T Consensus 651 ~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~ 730 (903)
T KOG1027|consen 651 KISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNY 730 (903)
T ss_pred EecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCcc
Confidence 99999999988665432 223456699999999999999888999999999999999994 9999874433322211000
Q ss_pred hcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHH
Q 002857 393 SALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVE 462 (873)
Q Consensus 393 ~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl 462 (873)
. +.. + .+. .++ +..+|+.+|++++|..||++.+|+
T Consensus 731 ~-----L~~-----L---------------~~~--------~d~--eA~dLI~~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 731 T-----LVH-----L---------------EPL--------PDC--EAKDLISRMLNPDPQLRPSATDVL 765 (903)
T ss_pred c-----eee-----e---------------ccC--------chH--HHHHHHHHhcCCCcccCCCHHHHh
Confidence 0 000 0 000 011 356899999999999999999997
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-26 Score=232.61 Aligned_cols=211 Identities=28% Similarity=0.457 Sum_probs=179.3
Q ss_pred ecccCceEEEEEEEcCCCcEEEEEEeeccCCc-chhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEEEEeecCC
Q 002857 168 IGAGNFASVYKGILFEGAPAVAIKVFNFLHHD-ASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKALVYEFMPN 246 (873)
Q Consensus 168 LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~LV~Ey~~~ 246 (873)
||+|.+|.||++....+++.+++|++...... ..+.+.+|++.++.++|++|+++++++ ......+++|||+.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~-----~~~~~~~~~~e~~~~ 75 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF-----EDENHLYLVMEYCEG 75 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeee-----ecCCeEEEEEecCCC
Confidence 68999999999999777899999998754332 346799999999999999999999995 334678999999999
Q ss_pred CChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCC-CCCeEEecccccccc
Q 002857 247 GSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLND-EMTACVADFGIARFL 325 (873)
Q Consensus 247 GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~-~~~vKLsDFGla~~~ 325 (873)
++|.+++.. ....+++..++.++.+++++|+||| +.+++|+||+|.||+++. ++.++|+|||.+...
T Consensus 76 ~~l~~~~~~---------~~~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~ 143 (215)
T cd00180 76 GSLKDLLKE---------NEGKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLL 143 (215)
T ss_pred CcHHHHHHh---------ccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEc
Confidence 999999843 1146889999999999999999999 889999999999999999 899999999999865
Q ss_pred ccccccccccccccccccCCCcccCCC-CCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCchhHHHHhh
Q 002857 326 EATNEQTSSIGVKGTTGYIAPEYGMGH-ETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPERVEEIVD 404 (873)
Q Consensus 326 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~~l~elid 404 (873)
..... ......+...|++||.+... ..+.++|+|++|+++++|
T Consensus 144 ~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------- 187 (215)
T cd00180 144 TSDKS--LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------- 187 (215)
T ss_pred cCCcc--hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------
Confidence 43321 12234478899999998877 888999999999999999
Q ss_pred hhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHH
Q 002857 405 TLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELG 464 (873)
Q Consensus 405 ~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~ 464 (873)
..+.+++..|++.+|++||++.++++.
T Consensus 188 ---------------------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ---------------------------------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ---------------------------------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 025678999999999999999998864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-28 Score=253.59 Aligned_cols=285 Identities=19% Similarity=0.210 Sum_probs=197.4
Q ss_pred CCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC--CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEE
Q 002857 162 FSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH--HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKAL 239 (873)
Q Consensus 162 f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~L 239 (873)
.+..+.||-|+||.||..++..+|+.||+|.+...- -...+.+.+|+++|..++|.|++..+++-......--.+.|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 345688999999999999999999999999885322 223477899999999999999999988743211111124678
Q ss_pred EEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEecc
Q 002857 240 VYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADF 319 (873)
Q Consensus 240 V~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDF 319 (873)
|+|.|.. +|.++| .....|+...+.-++.||++||.||| +.+|.||||||.|.|++.+...||+||
T Consensus 135 ~TELmQS-DLHKII----------VSPQ~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDF 200 (449)
T KOG0664|consen 135 LTELMQS-DLHKII----------VSPQALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDF 200 (449)
T ss_pred HHHHHHh-hhhhee----------ccCCCCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEeccc
Confidence 8898854 888877 35677888899999999999999999 899999999999999999999999999
Q ss_pred ccccccccccccccccccccccccCCCcccCCC-CCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCch-
Q 002857 320 GIARFLEATNEQTSSIGVKGTTGYIAPEYGMGH-ETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPE- 397 (873)
Q Consensus 320 Gla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~- 397 (873)
|+++..+.+..... +..+-|..|+|||++++. .|+.+.||||.|||+.||+..+..|..... ....+.+...+..
T Consensus 201 GLARvee~d~~~hM-TqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~P--iqQL~lItdLLGTP 277 (449)
T KOG0664|consen 201 GLARTWDQRDRLNM-THEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGP--IEQLQMIIDLLGTP 277 (449)
T ss_pred ccccccchhhhhhh-HHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccCh--HHHHHHHHHHhCCC
Confidence 99997655443333 334568899999999986 689999999999999999999888865321 1112222222222
Q ss_pred hHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHH--HHHHHHHHHHHHhhccCcCCCCCHHHHHHHHH
Q 002857 398 RVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIIL--ECLNSICEIGVACSAELPGERMKINDVELGLR 466 (873)
Q Consensus 398 ~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~--e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le 466 (873)
.++++ ...-.+. +.-......+.|.......... ..-.+.+.+...++..||.+|.+..+.+..+.
T Consensus 278 s~EaM-r~ACEGA--k~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 278 SQEAM-KYACEGA--KNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred cHHHH-HHHhhhh--HHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 11111 1100000 0000011122222221111110 11123556777889999999999888766543
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.2e-27 Score=239.08 Aligned_cols=278 Identities=17% Similarity=0.254 Sum_probs=199.2
Q ss_pred hhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhh-hccceeeeeeeecccccCCce
Q 002857 158 ATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNII-HRKIIKVVTACSRVDYQGNDF 236 (873)
Q Consensus 158 at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~-HpNIV~llg~c~~~~~~~~~~ 236 (873)
..++|++.+++|+|.++.||.|....+.+.++||+++.. ..+.+.+|++||..|. ||||++++++..+ .....
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~D---p~Skt 109 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKD---PESKT 109 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcC---ccccC
Confidence 457899999999999999999998889999999999743 3467899999999997 9999999998543 34556
Q ss_pred EEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCC-CCCeE
Q 002857 237 KALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLND-EMTAC 315 (873)
Q Consensus 237 ~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~-~~~vK 315 (873)
..||+||+.+.+...+- ..|+...+...+.++++||.|.| +.||+|||+||+|+++|. .-..+
T Consensus 110 paLiFE~v~n~Dfk~ly-------------~tl~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLr 173 (338)
T KOG0668|consen 110 PSLIFEYVNNTDFKQLY-------------PTLTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLR 173 (338)
T ss_pred chhHhhhhccccHHHHh-------------hhhchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceee
Confidence 88999999997777654 34677788999999999999999 999999999999999995 45799
Q ss_pred EeccccccccccccccccccccccccccCCCcccCCC-CCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhc
Q 002857 316 VADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGH-ETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSA 394 (873)
Q Consensus 316 LsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~ 394 (873)
|+|+|+|.++........ .+.+..|.-||.+... .|+..-|+|||||++..|+..+.||-........+.+.+.-.
T Consensus 174 lIDWGLAEFYHp~~eYnV---RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVL 250 (338)
T KOG0668|consen 174 LIDWGLAEFYHPGKEYNV---RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVL 250 (338)
T ss_pred eeecchHhhcCCCceeee---eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHh
Confidence 999999998866543332 2356778899998775 578888999999999999999999865433333333333222
Q ss_pred CchhHHHHhhhh-hhhhhhHHHHHhhhccCCCCc----hhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 395 LPERVEEIVDTL-FFKEIEEEETVYKYKKAPSSS----TQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 395 ~~~~l~elid~~-L~~~~~~r~~~~~i~~~p~~~----~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
-...+...++.- +.-++.-...+.....-+|.. ...... ..+.++++...|..|-++|+|+.|.+.
T Consensus 251 Gt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~---~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 251 GTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLV---SPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred ChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccC---ChHHHHHHHHHHhhccccccchHHHhc
Confidence 222222221111 000000000000001111110 000000 134678999999999999999998764
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.1e-26 Score=233.70 Aligned_cols=199 Identities=30% Similarity=0.444 Sum_probs=170.1
Q ss_pred CCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCc-chhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEEE
Q 002857 162 FSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHD-ASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKALV 240 (873)
Q Consensus 162 f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~LV 240 (873)
|.+.+.||.|++|.||++....+++.+|+|.+...... ..+.+.+|++.+.+++|+|++++++++ ......+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~-----~~~~~~~~v 75 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVF-----EDPEPLYLV 75 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeee-----ecCCceEEE
Confidence 56778999999999999999877899999999765444 567899999999999999999999985 344678999
Q ss_pred EeecCCCChhhhcccccccccccCCCCC-CchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEecc
Q 002857 241 YEFMPNGSLEEWIHPITEEDKRHKAPGN-LNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADF 319 (873)
Q Consensus 241 ~Ey~~~GSL~~~L~~~~~~~~~~~~~~~-Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDF 319 (873)
+||+++++|.+++.. ... +++..+..++.+++.+|.||| ..+++|+||+++||+++.++.++|+||
T Consensus 76 ~e~~~~~~L~~~~~~----------~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~ 142 (225)
T smart00221 76 MEYCEGGDLFDYLRK----------KGGKLSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADF 142 (225)
T ss_pred EeccCCCCHHHHHHh----------cccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeC
Confidence 999999999999853 122 788999999999999999999 789999999999999999999999999
Q ss_pred ccccccccccccccccccccccccCCCccc-CCCCCCcchhhHhHHHHHHHHHhCCCCCCc
Q 002857 320 GIARFLEATNEQTSSIGVKGTTGYIAPEYG-MGHETSSYGDVYSFGILLLEMFTGLRPSDD 379 (873)
Q Consensus 320 Gla~~~~~~~~~~~~~~~~Gt~~Y~APE~l-~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~ 379 (873)
|.+......... ......++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus 143 g~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 143 GLARFIHRDLAA-LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ceeeEecCcccc-cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 999876443211 12234577889999998 666788899999999999999999999955
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-27 Score=262.80 Aligned_cols=246 Identities=20% Similarity=0.293 Sum_probs=197.8
Q ss_pred CCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC---CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceE
Q 002857 161 GFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH---HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFK 237 (873)
Q Consensus 161 ~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~ 237 (873)
+++....||-|+||.|=++........+|+|++++.+ ....+.+..|-.||...+.+.||++|-. |.+..+.
T Consensus 421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrT-----frd~kyv 495 (732)
T KOG0614|consen 421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRT-----FRDSKYV 495 (732)
T ss_pred hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHH-----hccchhh
Confidence 4455678999999999999886555568999887543 3344668889999999999999999988 4667789
Q ss_pred EEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEe
Q 002857 238 ALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVA 317 (873)
Q Consensus 238 ~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLs 317 (873)
|++||-|-||.|...|+ ..+.++..+...++..+.+|++||| .++||.|||||+|.|||.+|-+||.
T Consensus 496 YmLmEaClGGElWTiLr----------dRg~Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLV 562 (732)
T KOG0614|consen 496 YMLMEACLGGELWTILR----------DRGSFDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLV 562 (732)
T ss_pred hhhHHhhcCchhhhhhh----------hcCCcccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEe
Confidence 99999999999999994 4677888999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccch------hhHHHH
Q 002857 318 DFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNL------NLQNWV 391 (873)
Q Consensus 318 DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~------~l~~~~ 391 (873)
|||+|+.+.... .+....||+.|.|||++.+...+...|.||||+++|||+||.+||.....-.. .+..|.
T Consensus 563 DFGFAKki~~g~---KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~ 639 (732)
T KOG0614|consen 563 DFGFAKKIGSGR---KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIE 639 (732)
T ss_pred ehhhHHHhccCC---ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhh
Confidence 999999875533 33456899999999999999999999999999999999999999986322110 111111
Q ss_pred -hhcCchhHHHHhhhhhhhhhhHHHH-----HhhhccCCCCc
Q 002857 392 -QSALPERVEEIVDTLFFKEIEEEET-----VYKYKKAPSSS 427 (873)
Q Consensus 392 -~~~~~~~l~elid~~L~~~~~~r~~-----~~~i~~~p~~~ 427 (873)
...+.....+++...-..++.+|.. +.++++|.|..
T Consensus 640 ~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~ 681 (732)
T KOG0614|consen 640 FPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFE 681 (732)
T ss_pred cccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhh
Confidence 2334446677777777777777655 45667776643
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.1e-27 Score=261.81 Aligned_cols=204 Identities=22% Similarity=0.325 Sum_probs=172.2
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC---CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCce
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH---HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDF 236 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~ 236 (873)
.-|..++.||-|+||.|.++.-.++...+|+|.+++.+ .........|-.||...+.+=||+|+-. |++.+.
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyyS-----FQDkdn 703 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYS-----FQDKDN 703 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEE-----eccCCc
Confidence 45778899999999999999888888889999987432 2334567889999999999999999877 578889
Q ss_pred EEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEE
Q 002857 237 KALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACV 316 (873)
Q Consensus 237 ~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKL 316 (873)
+|+||+|++||++-.+|- ..+.+.+.....++..+..|+++.| +.|+|||||||+|||||.+|++||
T Consensus 704 LYFVMdYIPGGDmMSLLI----------rmgIFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKL 770 (1034)
T KOG0608|consen 704 LYFVMDYIPGGDMMSLLI----------RMGIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKL 770 (1034)
T ss_pred eEEEEeccCCccHHHHHH----------HhccCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceee
Confidence 999999999999999983 4567888888889999999999999 999999999999999999999999
Q ss_pred ecccccccc---------cccccc-------------------------------ccccccccccccCCCcccCCCCCCc
Q 002857 317 ADFGIARFL---------EATNEQ-------------------------------TSSIGVKGTTGYIAPEYGMGHETSS 356 (873)
Q Consensus 317 sDFGla~~~---------~~~~~~-------------------------------~~~~~~~Gt~~Y~APE~l~~~~~s~ 356 (873)
.|||++.-+ ...+.. ......+||..|+|||++....++.
T Consensus 771 TDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q 850 (1034)
T KOG0608|consen 771 TDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQ 850 (1034)
T ss_pred eeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccc
Confidence 999997532 111100 0012346999999999999999999
Q ss_pred chhhHhHHHHHHHHHhCCCCCCccc
Q 002857 357 YGDVYSFGILLLEMFTGLRPSDDMF 381 (873)
Q Consensus 357 ksDVwSfGvvL~ELlTGk~Pf~~~~ 381 (873)
-+|.||.|||||||+.|+.||-...
T Consensus 851 ~cdwws~gvil~em~~g~~pf~~~t 875 (1034)
T KOG0608|consen 851 LCDWWSVGVILYEMLVGQPPFLADT 875 (1034)
T ss_pred cchhhHhhHHHHHHhhCCCCccCCC
Confidence 9999999999999999999997643
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-26 Score=259.75 Aligned_cols=198 Identities=23% Similarity=0.302 Sum_probs=169.6
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCC--------cchhHHHHHHHHHHhhh---hccceeeeeeee
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH--------DASKSFTVECEVMRNII---HRKIIKVVTACS 227 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~--------~~~~~f~~Ei~iL~~L~---HpNIV~llg~c~ 227 (873)
..+|+..+.||.|+||.|++|+++.+...|+||.+.+..- ......-.||+||..++ |+||++++.+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf-- 637 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF-- 637 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe--
Confidence 3468889999999999999999999999999998864321 11123567999999997 9999999999
Q ss_pred cccccCCceEEEEEeecC-CCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCe
Q 002857 228 RVDYQGNDFKALVYEFMP-NGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNI 306 (873)
Q Consensus 228 ~~~~~~~~~~~LV~Ey~~-~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNI 306 (873)
|+++++.+|+||-.. +.+|.++|. ....+++.+...|+.||+-|+++|| +++|||||||-+||
T Consensus 638 ---FEddd~yyl~te~hg~gIDLFd~IE----------~kp~m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenv 701 (772)
T KOG1152|consen 638 ---FEDDDYYYLETEVHGEGIDLFDFIE----------FKPRMDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENV 701 (772)
T ss_pred ---eecCCeeEEEecCCCCCcchhhhhh----------ccCccchHHHHHHHHHHHhcccccc---ccCceecccccccE
Confidence 477889999999763 558999993 4677999999999999999999999 99999999999999
Q ss_pred eeCCCCCeEEeccccccccccccccccccccccccccCCCcccCCCCCC-cchhhHhHHHHHHHHHhCCCCCC
Q 002857 307 LLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETS-SYGDVYSFGILLLEMFTGLRPSD 378 (873)
Q Consensus 307 LLd~~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s-~ksDVwSfGvvL~ELlTGk~Pf~ 378 (873)
.++.+|-+||+|||.|.....+. ....+||..|.|||++.+.+|- ..-|||++|++||.++....||.
T Consensus 702 ivd~~g~~klidfgsaa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 702 IVDSNGFVKLIDFGSAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred EEecCCeEEEeeccchhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 99999999999999998654332 2345799999999999998874 44799999999999999998875
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-25 Score=244.66 Aligned_cols=285 Identities=24% Similarity=0.287 Sum_probs=201.3
Q ss_pred HHhhcCCCcceeecccCceEEEEEEEcC---CCcEEEEEEeeccCCcchhHHHHHHHHHHhh-hhccceeeeeeeecccc
Q 002857 156 YSATKGFSSENLIGAGNFASVYKGILFE---GAPAVAIKVFNFLHHDASKSFTVECEVMRNI-IHRKIIKVVTACSRVDY 231 (873)
Q Consensus 156 ~~at~~f~~~~~LG~G~fG~VYkg~~~~---~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~llg~c~~~~~ 231 (873)
....+.|...++||+|.|++||++++.. ..+.||+|.+.... ....+.+|+++|..+ -+.||+++.++ +
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~-----~ 104 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGC-----F 104 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhh-----h
Confidence 3455678899999999999999999877 67899999986443 335789999999999 58999999998 4
Q ss_pred cCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCC-
Q 002857 232 QGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLND- 310 (873)
Q Consensus 232 ~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~- 310 (873)
..++...+|+||+++-...+++.. ++...+..+++.+..||+++| ..|||||||||+|+|.+.
T Consensus 105 rnnd~v~ivlp~~~H~~f~~l~~~-------------l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~ 168 (418)
T KOG1167|consen 105 RNNDQVAIVLPYFEHDRFRDLYRS-------------LSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRR 168 (418)
T ss_pred ccCCeeEEEecccCccCHHHHHhc-------------CCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccc
Confidence 678889999999999888888743 667789999999999999999 999999999999999984
Q ss_pred CCCeEEecccccccccccc-------------cc-----------------------------ccccccccccccCCCcc
Q 002857 311 EMTACVADFGIARFLEATN-------------EQ-----------------------------TSSIGVKGTTGYIAPEY 348 (873)
Q Consensus 311 ~~~vKLsDFGla~~~~~~~-------------~~-----------------------------~~~~~~~Gt~~Y~APE~ 348 (873)
.+.-.|.|||+|...+... .. .......||++|+|||+
T Consensus 169 t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEv 248 (418)
T KOG1167|consen 169 TQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEV 248 (418)
T ss_pred cCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHH
Confidence 4678999999997321110 00 00012359999999999
Q ss_pred cCCC-CCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCchh---HHHHhhh--hhh-hh----hhHHHHH
Q 002857 349 GMGH-ETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPER---VEEIVDT--LFF-KE----IEEEETV 417 (873)
Q Consensus 349 l~~~-~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~~---l~elid~--~L~-~~----~~~r~~~ 417 (873)
+... ..++++||||-|||++-+++++.||-....+-..+.+.+...-... ...+.+. .+. .+ ...+...
T Consensus 249 L~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f 328 (418)
T KOG1167|consen 249 LFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNF 328 (418)
T ss_pred HhhccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhch
Confidence 8764 5789999999999999999999998765555444444432222211 1111111 000 00 0000000
Q ss_pred -----hhhccCCCCchhHHHHHHH-HHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 418 -----YKYKKAPSSSTQRSIILEC-LNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 418 -----~~i~~~p~~~~~~~~~~e~-~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
..+.+............++ ...+++++.+|+..||.+|.|++|.+.
T Consensus 329 ~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 329 ETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred hccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 0011101100011111122 226889999999999999999998764
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-25 Score=247.14 Aligned_cols=206 Identities=23% Similarity=0.255 Sum_probs=173.2
Q ss_pred HHhhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhh------hccceeeeeeeecc
Q 002857 156 YSATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNII------HRKIIKVVTACSRV 229 (873)
Q Consensus 156 ~~at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~------HpNIV~llg~c~~~ 229 (873)
+....+|.+....|+|-|++|.+|.+...+..||||++.... ...+.=+.|++||++|+ --|+++|+-.
T Consensus 428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~---- 502 (752)
T KOG0670|consen 428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLFRH---- 502 (752)
T ss_pred hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHH----
Confidence 345678999999999999999999998888999999997542 22355678999999995 3578888776
Q ss_pred cccCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeC
Q 002857 230 DYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLN 309 (873)
Q Consensus 230 ~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd 309 (873)
|...+++|||+|-+ ..+|.++|+. ...+..|....+..++.|+.-||..|- .-+|+|.||||.|||++
T Consensus 503 -F~hknHLClVFE~L-slNLRevLKK-------yG~nvGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVN 570 (752)
T KOG0670|consen 503 -FKHKNHLCLVFEPL-SLNLREVLKK-------YGRNVGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVN 570 (752)
T ss_pred -hhhcceeEEEehhh-hchHHHHHHH-------hCcccceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEec
Confidence 46678999999988 5599999964 355677889999999999999999999 89999999999999998
Q ss_pred CC-CCeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccc
Q 002857 310 DE-MTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFK 382 (873)
Q Consensus 310 ~~-~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~ 382 (873)
+. ..+||+|||.|....... .+.+.-+..|.|||++.|-.|+...|+||.||+||||.||+..|.+..+
T Consensus 571 E~k~iLKLCDfGSA~~~~ene----itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TN 640 (752)
T KOG0670|consen 571 ESKNILKLCDFGSASFASENE----ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTN 640 (752)
T ss_pred cCcceeeeccCcccccccccc----ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCc
Confidence 65 578999999998664332 2223456789999999999999999999999999999999999987544
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.8e-26 Score=258.17 Aligned_cols=254 Identities=23% Similarity=0.301 Sum_probs=200.4
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEE
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKA 238 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~ 238 (873)
.++|.....+|.|.||.|||+++...++..|+|+++........-.++|+-+++..+|+|||.++|.+ ...+..+
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsy-----lr~dklw 88 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSY-----LRRDKLW 88 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhh-----hhhcCcE
Confidence 45788899999999999999999999999999999988888888899999999999999999999985 4566789
Q ss_pred EEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEec
Q 002857 239 LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVAD 318 (873)
Q Consensus 239 LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsD 318 (873)
+.|||+.+|+|++.-+ ....+++.++..+++..++||+||| +.+-+|||||-.|||+++.+.+|++|
T Consensus 89 icMEycgggslQdiy~----------~TgplselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaD 155 (829)
T KOG0576|consen 89 ICMEYCGGGSLQDIYH----------VTGPLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLAD 155 (829)
T ss_pred EEEEecCCCcccceee----------ecccchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecc
Confidence 9999999999999874 3678999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccccccccccccccccCCCcccC---CCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcC
Q 002857 319 FGIARFLEATNEQTSSIGVKGTTGYIAPEYGM---GHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSAL 395 (873)
Q Consensus 319 FGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~---~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~ 395 (873)
||.+-.+.... .......||+.|||||+.. .+.|..++|||+.|+...|+---+.|-.+....
T Consensus 156 fgvsaqitati--~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm------------ 221 (829)
T KOG0576|consen 156 FGVSAQITATI--AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM------------ 221 (829)
T ss_pred cCchhhhhhhh--hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH------------
Confidence 99987654322 2223457999999999753 467899999999999999998877774331110
Q ss_pred chhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 396 PERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 396 ~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
+..-+......+ +|.......+ .+.+-++++.|+-.+|++|||+..++.
T Consensus 222 --r~l~LmTkS~~q-------------pp~lkDk~kw----s~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 222 --RALFLMTKSGFQ-------------PPTLKDKTKW----SEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred --HHHHHhhccCCC-------------CCcccCCccc----hHHHHHHHHHHhcCCCccCCChhhhee
Confidence 011111111000 0000000011 123678999999999999999987653
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.9e-25 Score=227.52 Aligned_cols=255 Identities=20% Similarity=0.266 Sum_probs=187.5
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhh-hhccceeeeeeeecccccCCceEE
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNI-IHRKIIKVVTACSRVDYQGNDFKA 238 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~llg~c~~~~~~~~~~~~ 238 (873)
+.|.+.+.||+|.||.+-++.+++..+.+|+|-+... ....++|.+|..---.| .|.||+.-+..- |+..+...
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~va----Fqt~d~Yv 98 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVA----FQTSDAYV 98 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHH----hhcCceEE
Confidence 4588899999999999999999999999999988633 33457888888654445 589999987763 67778899
Q ss_pred EEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeC--CCCCeEE
Q 002857 239 LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLN--DEMTACV 316 (873)
Q Consensus 239 LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd--~~~~vKL 316 (873)
+++||++.|+|.+-+. ...+-+.....++.|++.||.||| +.++||||||.+||||- +...+||
T Consensus 99 F~qE~aP~gdL~snv~-----------~~GigE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKl 164 (378)
T KOG1345|consen 99 FVQEFAPRGDLRSNVE-----------AAGIGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKL 164 (378)
T ss_pred EeeccCccchhhhhcC-----------cccccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEe
Confidence 9999999999998773 355777788999999999999999 99999999999999994 4458999
Q ss_pred eccccccccccccccccccccccccccCCCcccCC---C--CCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHH
Q 002857 317 ADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMG---H--ETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWV 391 (873)
Q Consensus 317 sDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~---~--~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~ 391 (873)
+|||+.+..... ......+..|.+||.... + ...+.+|||.||++++.++||+.||+...-.+..+..|.
T Consensus 165 cDFG~t~k~g~t-----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~ 239 (378)
T KOG1345|consen 165 CDFGLTRKVGTT-----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWE 239 (378)
T ss_pred eecccccccCce-----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHH
Confidence 999999754322 122335678999997543 2 356779999999999999999999986444444444433
Q ss_pred hhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHH
Q 002857 392 QSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLR 466 (873)
Q Consensus 392 ~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le 466 (873)
.-.-.. .+.+.+.+ ......+.++..+-+..++++|=-..++..+-.
T Consensus 240 ~w~~rk------~~~~P~~F----------------------~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk 286 (378)
T KOG1345|consen 240 QWLKRK------NPALPKKF----------------------NPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRK 286 (378)
T ss_pred HHhccc------CccCchhh----------------------cccCHHHHHHHHHhcCCcccccchhHHHHHHHH
Confidence 211000 00010000 001224667788889999999955555555443
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.8e-25 Score=234.92 Aligned_cols=201 Identities=25% Similarity=0.269 Sum_probs=166.3
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeec--cCCcchhHHHHHHHHHHhhhhccceeeeeeeecccc-cCCc
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNF--LHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDY-QGND 235 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~--~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~-~~~~ 235 (873)
..+|.....+|.|.- .|-.|.+.-.++.||+|.+.. ......++..+|..++..++|+||++++.++..... ..-.
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 456777888999988 777887777889999998752 233445778999999999999999999998753321 1223
Q ss_pred eEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeE
Q 002857 236 FKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTAC 315 (873)
Q Consensus 236 ~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vK 315 (873)
..++|||+|. ++|.+.++ -.++-.++..|+.|++.|++||| +.+|+||||||+||++..+..+|
T Consensus 95 e~y~v~e~m~-~nl~~vi~------------~elDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lK 158 (369)
T KOG0665|consen 95 EVYLVMELMD-ANLCQVIL------------MELDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLK 158 (369)
T ss_pred hHHHHHHhhh-hHHHHHHH------------HhcchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhhee
Confidence 5799999995 58988874 23566788999999999999999 99999999999999999999999
Q ss_pred EeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCc
Q 002857 316 VADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDD 379 (873)
Q Consensus 316 LsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~ 379 (873)
|.|||+|+.-... ...+..+.|..|+|||++.+..+.+..||||.||++.||++|+..|.+
T Consensus 159 i~dfg~ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g 219 (369)
T KOG0665|consen 159 ILDFGLARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPG 219 (369)
T ss_pred eccchhhcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecC
Confidence 9999999854322 234456789999999999999999999999999999999999988874
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=1e-23 Score=211.52 Aligned_cols=171 Identities=22% Similarity=0.246 Sum_probs=125.5
Q ss_pred CChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEeccccccccc
Q 002857 247 GSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLE 326 (873)
Q Consensus 247 GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDFGla~~~~ 326 (873)
|+|.++++. ....+++.+++.|+.||+.||+||| +.+ ||+|||++.++.+|+ ||+++...
T Consensus 1 GsL~~~l~~---------~~~~l~~~~~~~i~~qi~~~L~~lH---~~~------kp~Nil~~~~~~~~~--fG~~~~~~ 60 (176)
T smart00750 1 VSLADILEV---------RGRPLNEEEIWAVCLQCLRALRELH---RQA------KSGNILLTWDGLLKL--DGSVAFKT 60 (176)
T ss_pred CcHHHHHHH---------hCCCCCHHHHHHHHHHHHHHHHHHH---hcC------CcccEeEcCccceee--ccceEeec
Confidence 688888842 2456999999999999999999999 555 999999999999999 99998654
Q ss_pred cccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCchhHHHHhhhh
Q 002857 327 ATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPERVEEIVDTL 406 (873)
Q Consensus 327 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~~l~elid~~ 406 (873)
... ..||..|+|||++.+..++.++|||||||++|||+||+.||........ .+..++...
T Consensus 61 ~~~-------~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~------------~~~~~~~~~ 121 (176)
T smart00750 61 PEQ-------SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSA------------ILEILLNGM 121 (176)
T ss_pred ccc-------CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcH------------HHHHHHHHh
Confidence 321 2588999999999999999999999999999999999999865321111 111111111
Q ss_pred hhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHHHH
Q 002857 407 FFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLIKK 470 (873)
Q Consensus 407 L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i~~ 470 (873)
.......+ .. .....+ ...+.+++.+||+.+|++||++.|+++.+..+..
T Consensus 122 ~~~~~~~~------------~~-~~~~~~-~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 122 PADDPRDR------------SN-LESVSA-ARSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred ccCCcccc------------cc-HHHHHh-hhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 11100000 00 000000 1258899999999999999999999999987654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.8e-24 Score=261.95 Aligned_cols=154 Identities=19% Similarity=0.344 Sum_probs=115.5
Q ss_pred Hhhhh-ccceeeeeeeecccc--cCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHH
Q 002857 212 RNIIH-RKIIKVVTACSRVDY--QGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYL 288 (873)
Q Consensus 212 ~~L~H-pNIV~llg~c~~~~~--~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yL 288 (873)
+.++| .||++++++|..... ......++++||+ +++|.++|.. ....+++.+++.|+.||++||+||
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~---------~~~~~~~~~~~~i~~qi~~al~~l 96 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN---------PDRSVDAFECFHVFRQIVEIVNAA 96 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc---------ccccccHHHHHHHHHHHHHHHHHH
Confidence 34566 688888888632211 1223567788887 6699999942 235689999999999999999999
Q ss_pred hhCCCCCeeeccCCCCCeeeCC-------------------CCCeEEeccccccccccccc--------------ccccc
Q 002857 289 HLGCKPPIAHCDIKPSNILLND-------------------EMTACVADFGIARFLEATNE--------------QTSSI 335 (873)
Q Consensus 289 H~~~s~gIvHrDLKpsNILLd~-------------------~~~vKLsDFGla~~~~~~~~--------------~~~~~ 335 (873)
| +++|+||||||+||||+. ++.+||+|||+++....... .....
T Consensus 97 H---~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (793)
T PLN00181 97 H---SQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQI 173 (793)
T ss_pred H---hCCeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCccccc
Confidence 9 899999999999999954 45566777777654211000 00011
Q ss_pred ccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 002857 336 GVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSD 378 (873)
Q Consensus 336 ~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~ 378 (873)
...||+.|||||++.+..++.++|||||||+||||++|..|+.
T Consensus 174 ~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~ 216 (793)
T PLN00181 174 LAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSRE 216 (793)
T ss_pred ccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchh
Confidence 1347888999999999999999999999999999999988764
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.9e-22 Score=221.94 Aligned_cols=178 Identities=19% Similarity=0.170 Sum_probs=135.3
Q ss_pred HHhhcCCCcceeecccCceEEEEEEEcC-CCcEEEEEEeeccC-----CcchhHHHHHHHHHHhhhhccceeeeeeeecc
Q 002857 156 YSATKGFSSENLIGAGNFASVYKGILFE-GAPAVAIKVFNFLH-----HDASKSFTVECEVMRNIIHRKIIKVVTACSRV 229 (873)
Q Consensus 156 ~~at~~f~~~~~LG~G~fG~VYkg~~~~-~g~~VAVK~l~~~~-----~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~ 229 (873)
.....+|.+.+.||+|+||+||+|.+.. +++.||||++.... ....+.|.+|+++|++++|+|++..+...
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--- 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--- 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence 3445789999999999999999998875 67788999875321 12245689999999999999999643321
Q ss_pred cccCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccC-CCCCeee
Q 002857 230 DYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDI-KPSNILL 308 (873)
Q Consensus 230 ~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDL-KpsNILL 308 (873)
+..+|||||+++++|.... . .. ...++.++++||.||| +.+|+|||| ||+|||+
T Consensus 91 -----~~~~LVmE~~~G~~L~~~~-~----------~~------~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv 145 (365)
T PRK09188 91 -----GKDGLVRGWTEGVPLHLAR-P----------HG------DPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLM 145 (365)
T ss_pred -----CCcEEEEEccCCCCHHHhC-c----------cc------hHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEE
Confidence 2469999999999996321 0 00 1467899999999999 899999999 9999999
Q ss_pred CCCCCeEEecccccccccccccccc------ccccccccccCCCcccCCCC------CCcchhhH
Q 002857 309 NDEMTACVADFGIARFLEATNEQTS------SIGVKGTTGYIAPEYGMGHE------TSSYGDVY 361 (873)
Q Consensus 309 d~~~~vKLsDFGla~~~~~~~~~~~------~~~~~Gt~~Y~APE~l~~~~------~s~ksDVw 361 (873)
+.++.+||+|||+++.+........ .....+++.|+|||++...+ .+..+|-|
T Consensus 146 ~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 146 GPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred cCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 9999999999999997654331111 13456889999999987543 23346666
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.7e-20 Score=204.62 Aligned_cols=264 Identities=22% Similarity=0.252 Sum_probs=193.4
Q ss_pred CCCcceeecccCceEEEEEEEcCCC-cEEEEEEeeccCCcchhHHHHHHHHHHhhhh----ccceeeeeeeecccccCCc
Q 002857 161 GFSSENLIGAGNFASVYKGILFEGA-PAVAIKVFNFLHHDASKSFTVECEVMRNIIH----RKIIKVVTACSRVDYQGND 235 (873)
Q Consensus 161 ~f~~~~~LG~G~fG~VYkg~~~~~g-~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~H----pNIV~llg~c~~~~~~~~~ 235 (873)
+|.+.++||+|+||.||++....++ ..+|+|.-..........+..|+.++..+.+ +++..++.... ..+.
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~----~~~~ 94 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR----STED 94 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc----CCCc
Confidence 8999999999999999999986653 6789998765433333378889999999973 57888877621 3566
Q ss_pred eEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCC----
Q 002857 236 FKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDE---- 311 (873)
Q Consensus 236 ~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~---- 311 (873)
+.++||+.+ |.+|.++... .....++..+.+.|+.|++.+|.+|| +.|++||||||.|+++...
T Consensus 95 ~~~iVM~l~-G~sL~dl~~~--------~~~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~ 162 (322)
T KOG1164|consen 95 FNFIVMSLL-GPSLEDLRKR--------NPPGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSE 162 (322)
T ss_pred eeEEEEecc-CccHHHHHHh--------CCCCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcc
Confidence 789999988 7799998743 22578999999999999999999999 9999999999999999854
Q ss_pred -CCeEEeccccccccc--ccccc----c-c-ccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccc
Q 002857 312 -MTACVADFGIARFLE--ATNEQ----T-S-SIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFK 382 (873)
Q Consensus 312 -~~vKLsDFGla~~~~--~~~~~----~-~-~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~ 382 (873)
..+.|.|||+++.+. ..... . . .....||..|.++....+...+.+.|+||++.++.|++.|..||.....
T Consensus 163 ~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~ 242 (322)
T KOG1164|consen 163 VRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEM 242 (322)
T ss_pred cceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccc
Confidence 469999999998322 22111 1 1 2235699999999999999999999999999999999999999865322
Q ss_pred cchhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHH
Q 002857 383 DNLNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVE 462 (873)
Q Consensus 383 ~~~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl 462 (873)
... ... +........... ... ..+..+.++...+-..+..++|....+.
T Consensus 243 ~~~-~~~---------~~~~~~~~~~~~------------~~~---------~~~~~~~~~~~~~~~~~~~~~Pdy~~~~ 291 (322)
T KOG1164|consen 243 TDL-KSK---------FEKDPRKLLTDR------------FGD---------LKPEEFAKILEYIDSLDYEDKPDYEKLA 291 (322)
T ss_pred cch-HHH---------HHHHhhhhcccc------------ccC---------CChHHHHHHHHHhhccCCcCCCCHHHHH
Confidence 110 000 000000000000 000 0122355566666668999999999999
Q ss_pred HHHHHHHHh
Q 002857 463 LGLRLIKKK 471 (873)
Q Consensus 463 ~~Le~i~~~ 471 (873)
..|+.....
T Consensus 292 ~~l~~~~~~ 300 (322)
T KOG1164|consen 292 ELLKDVFDS 300 (322)
T ss_pred HHHHHHHHh
Confidence 998876544
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.7e-20 Score=193.65 Aligned_cols=260 Identities=28% Similarity=0.380 Sum_probs=191.3
Q ss_pred CCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCc---chhHHHHHHHHHHhhhhc-cceeeeeeeecccccCCceE
Q 002857 162 FSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHD---ASKSFTVECEVMRNIIHR-KIIKVVTACSRVDYQGNDFK 237 (873)
Q Consensus 162 f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~---~~~~f~~Ei~iL~~L~Hp-NIV~llg~c~~~~~~~~~~~ 237 (873)
|.....||.|+||.||++.+. ..+++|.+...... ....+.+|+.+++.+.|+ +++++...+ ......
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~ 73 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFF-----QDEGSL 73 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEE-----ecCCEE
Confidence 667889999999999999885 78999998744333 357899999999999988 799999985 334447
Q ss_pred EEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCC-CeEE
Q 002857 238 ALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEM-TACV 316 (873)
Q Consensus 238 ~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~-~vKL 316 (873)
+++++++.+++|.+++.... .. ..+.......++.|++.++.|+| ..+++|||+||+||+++... .+++
T Consensus 74 ~~~~~~~~~~~l~~~~~~~~------~~-~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l 143 (384)
T COG0515 74 YLVMEYVDGGSLEDLLKKIG------RK-GPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKL 143 (384)
T ss_pred EEEEecCCCCcHHHHHHhcc------cc-cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEE
Confidence 99999999999997764200 00 36888899999999999999999 88999999999999999888 7999
Q ss_pred eccccccccccccccc----cccccccccccCCCcccCC---CCCCcchhhHhHHHHHHHHHhCCCCCCccccc--chhh
Q 002857 317 ADFGIARFLEATNEQT----SSIGVKGTTGYIAPEYGMG---HETSSYGDVYSFGILLLEMFTGLRPSDDMFKD--NLNL 387 (873)
Q Consensus 317 sDFGla~~~~~~~~~~----~~~~~~Gt~~Y~APE~l~~---~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~--~~~l 387 (873)
.|||.++.+....... ......|+..|+|||.+.+ .......|+||+|++++++++|..||...... ....
T Consensus 144 ~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~ 223 (384)
T COG0515 144 IDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQT 223 (384)
T ss_pred eccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHH
Confidence 9999998554433221 2345679999999999987 57888999999999999999999997653221 0011
Q ss_pred HHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHH
Q 002857 388 QNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELG 464 (873)
Q Consensus 388 ~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~ 464 (873)
...+...... ..... ...... ......+.+++..++..+|..|.++.+....
T Consensus 224 ~~~~~~~~~~--------~~~~~--------------~~~~~~---~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 224 LKIILELPTP--------SLASP--------------LSPSNP---ELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred HHHHHhcCCc--------ccccc--------------cCcccc---chhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 1111000000 00000 000000 0112346788999999999999999987665
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=6.3e-22 Score=204.72 Aligned_cols=247 Identities=20% Similarity=0.327 Sum_probs=183.1
Q ss_pred cceeecccCceEEEEEEEcCCCcEEEEEEeecc--CCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEEEE
Q 002857 164 SENLIGAGNFASVYKGILFEGAPAVAIKVFNFL--HHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKALVY 241 (873)
Q Consensus 164 ~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~LV~ 241 (873)
...+|.+...|..|+|+|.. ..+++|+++.. .....++|..|.-.|+-+.||||+.++|.|. ......+|.
T Consensus 194 l~tkl~e~hsgelwrgrwqg--ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacn-----sppnlv~is 266 (448)
T KOG0195|consen 194 LITKLAESHSGELWRGRWQG--NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACN-----SPPNLVIIS 266 (448)
T ss_pred hhhhhccCCCcccccccccC--cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhcc-----CCCCceEee
Confidence 34678889999999999944 35777887632 2333478999999999999999999999984 456789999
Q ss_pred eecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEe--cc
Q 002857 242 EFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVA--DF 319 (873)
Q Consensus 242 Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLs--DF 319 (873)
.||+.|+|+..|++ ......+..+..+++.+||+|++|||+- .+-|..--|.+..|++|++.+++|+ |-
T Consensus 267 q~mp~gslynvlhe--------~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~ 337 (448)
T KOG0195|consen 267 QYMPFGSLYNVLHE--------QTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADT 337 (448)
T ss_pred eeccchHHHHHHhc--------CccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccc
Confidence 99999999999986 4455678889999999999999999942 4555566799999999999999885 32
Q ss_pred ccccccccccccccccccccccccCCCcccCCCCC---CcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCc
Q 002857 320 GIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHET---SSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALP 396 (873)
Q Consensus 320 Gla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~---s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~ 396 (873)
-++. ......-.+.||+||.++..+- -..+|+|||++++|||.|...||.+...-+......+
T Consensus 338 kfsf---------qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkial----- 403 (448)
T KOG0195|consen 338 KFSF---------QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIAL----- 403 (448)
T ss_pred eeee---------eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhh-----
Confidence 2221 1112234678999999887643 4568999999999999999999987433221111000
Q ss_pred hhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHHH
Q 002857 397 ERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLIK 469 (873)
Q Consensus 397 ~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i~ 469 (873)
+-+...+ +|- ....+.+++.-|+++||.+||.+..|+-.|++++
T Consensus 404 ----eglrv~i---------------ppg----------is~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 404 ----EGLRVHI---------------PPG----------ISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred ----ccccccC---------------CCC----------ccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 0000000 010 1224778999999999999999999999998763
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.8e-20 Score=220.98 Aligned_cols=254 Identities=22% Similarity=0.236 Sum_probs=184.1
Q ss_pred cceeecccCceEEEEEEEcCCCcEEEEEEeecc--CCcc----hhHHHHHHHHHHhhhhccceeeeeeeecccccCCceE
Q 002857 164 SENLIGAGNFASVYKGILFEGAPAVAIKVFNFL--HHDA----SKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFK 237 (873)
Q Consensus 164 ~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~--~~~~----~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~ 237 (873)
...++|.|.+|.|+........+..+.|.+... .... ...+..|+-+-..+.|+|++..+..+. +....
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~-----~~~~~ 396 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQ-----EIDGI 396 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHh-----hcccc
Confidence 467899999998888877666666666654311 1111 122555777777889999988777643 22233
Q ss_pred EEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEe
Q 002857 238 ALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVA 317 (873)
Q Consensus 238 ~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLs 317 (873)
.-+|||+++ +|..++.. ...+...++-.++.|+..|+.||| ..||.|||||++|++++.++.+||+
T Consensus 397 ~~~mE~~~~-Dlf~~~~~----------~~~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~ 462 (601)
T KOG0590|consen 397 LQSMEYCPY-DLFSLVMS----------NGKLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKII 462 (601)
T ss_pred hhhhhcccH-HHHHHHhc----------ccccchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEe
Confidence 344999999 99999842 346788889999999999999999 9999999999999999999999999
Q ss_pred cccccccccccccc--ccccccccccccCCCcccCCCCCCcc-hhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhc
Q 002857 318 DFGIARFLEATNEQ--TSSIGVKGTTGYIAPEYGMGHETSSY-GDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSA 394 (873)
Q Consensus 318 DFGla~~~~~~~~~--~~~~~~~Gt~~Y~APE~l~~~~~s~k-sDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~ 394 (873)
|||.+..+...... .......|+-.|+|||++.+..|.+. .||||.|+++..|++|+.||......+..+
T Consensus 463 Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~------- 535 (601)
T KOG0590|consen 463 DFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF------- 535 (601)
T ss_pred ecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-------
Confidence 99999876554443 45556789999999999999998776 799999999999999999997643332211
Q ss_pred CchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 395 LPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 395 ~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
.+.....-... .+ .........+.+...++.++|+.+|.+|-|+.+|++
T Consensus 536 -----~~~~~~~~~~~-----------~~----~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 536 -----KTNNYSDQRNI-----------FE----GPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred -----hhhcccccccc-----------cc----ChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 00000000000 00 001112233445677999999999999999999875
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.2e-18 Score=178.45 Aligned_cols=274 Identities=21% Similarity=0.258 Sum_probs=199.8
Q ss_pred HHHHHHhhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhh-ccceeeeeeeeccc
Q 002857 152 YEALYSATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIH-RKIIKVVTACSRVD 230 (873)
Q Consensus 152 ~~el~~at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~H-pNIV~llg~c~~~~ 230 (873)
.+++..+ ..|.+.++||.|+||.+|.|....+|+.||||+=+... ....+..|.++...|+| ..|..+..+
T Consensus 8 ~~~~iv~-gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y----- 79 (341)
T KOG1163|consen 8 LEELIVG-GKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHY----- 79 (341)
T ss_pred hhhheec-cceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhh-----
Confidence 3444333 57999999999999999999999999999999854322 23568889999999976 445555444
Q ss_pred ccCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCC
Q 002857 231 YQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLND 310 (873)
Q Consensus 231 ~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~ 310 (873)
..+..+-.+||+.+ |.||++++.- -...++..+++-++-|++.-++|+| .+++|||||||+|.|..-
T Consensus 80 ~~e~~ynvlVMdLL-GPsLEdLfnf---------C~R~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGl 146 (341)
T KOG1163|consen 80 GTEKDYNVLVMDLL-GPSLEDLFNF---------CSRRFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGL 146 (341)
T ss_pred ccccccceeeeecc-CccHHHHHHH---------HhhhhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeecc
Confidence 24566778999998 8899998742 3566888999999999999999999 899999999999999974
Q ss_pred C---CCeEEeccccccccccccc-----cccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccc
Q 002857 311 E---MTACVADFGIARFLEATNE-----QTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFK 382 (873)
Q Consensus 311 ~---~~vKLsDFGla~~~~~~~~-----~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~ 382 (873)
+ ..+.|+|||+|+.+.+... ........||..|.+-....+...+.+.|+=|+|.+|..+.-|..||++...
T Consensus 147 grh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka 226 (341)
T KOG1163|consen 147 GRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKA 226 (341)
T ss_pred ccccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccch
Confidence 3 4688999999987654332 1223345699999998888888888999999999999999999999987432
Q ss_pred c--chhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHH
Q 002857 383 D--NLNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKIND 460 (873)
Q Consensus 383 ~--~~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~E 460 (873)
. .+.+.......+...+.. +.+. .+.++.-.+.-|-..--++-|.-.-
T Consensus 227 ~tk~QKyEkI~EkK~s~~ie~-----LC~G-------------------------~P~EF~myl~Y~R~L~F~E~Pdy~y 276 (341)
T KOG1163|consen 227 ATKKQKYEKISEKKMSTPIEV-----LCKG-------------------------FPAEFAMYLNYCRGLGFEEKPDYMY 276 (341)
T ss_pred hhHHHHHHHHHHhhcCCCHHH-----HhCC-------------------------CcHHHHHHHHHHhhcCCCCCCcHHH
Confidence 2 111111111111111111 1111 1234566777888888888998887
Q ss_pred HHHHHHHHHHhhhcCC
Q 002857 461 VELGLRLIKKKLLETP 476 (873)
Q Consensus 461 Vl~~Le~i~~~l~~~~ 476 (873)
+.+.++.+...+....
T Consensus 277 lrqlFriLfr~ln~~~ 292 (341)
T KOG1163|consen 277 LRQLFRILFRTLNHQY 292 (341)
T ss_pred HHHHHHHHHhhccccC
Confidence 7777777766555443
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.4e-18 Score=181.90 Aligned_cols=200 Identities=22% Similarity=0.329 Sum_probs=167.4
Q ss_pred CCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhh-hccceeeeeeeecccccCCceEEE
Q 002857 161 GFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNII-HRKIIKVVTACSRVDYQGNDFKAL 239 (873)
Q Consensus 161 ~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~-HpNIV~llg~c~~~~~~~~~~~~L 239 (873)
+|.+.++||+|.||.++.|+..-+++.||||.=.. .....++..|....+.|. .++|..++-| .+.+.+-.|
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr--kS~APQLrdEYr~YKlL~g~~GIP~vYYF-----GqeG~~NiL 101 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR--KSEAPQLRDEYRTYKLLGGTEGIPQVYYF-----GQEGKYNIL 101 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccc--cCCcchHHHHHHHHHHHcCCCCCCceeee-----ccccchhhh
Confidence 68899999999999999999989999999997432 223467888999999885 5788887765 355667789
Q ss_pred EEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCC-----CCCe
Q 002857 240 VYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLND-----EMTA 314 (873)
Q Consensus 240 V~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~-----~~~v 314 (873)
|+|.+ |-||+|+.. --...++..+++.||.|++.-++|+| .+.+|.|||||+|+||.. ...+
T Consensus 102 VidLL-GPSLEDLFD---------~CgR~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~I 168 (449)
T KOG1165|consen 102 VIDLL-GPSLEDLFD---------LCGRRFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVI 168 (449)
T ss_pred hhhhh-CcCHHHHHH---------HhcCcccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceE
Confidence 99988 789999873 23567999999999999999999999 899999999999999974 3468
Q ss_pred EEecccccccccccccc-----ccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcc
Q 002857 315 CVADFGIARFLEATNEQ-----TSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDM 380 (873)
Q Consensus 315 KLsDFGla~~~~~~~~~-----~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~ 380 (873)
.|+|||+|+.+...... .......||.+||+-....+...+.+-|+=|+|-++...|-|..||.+.
T Consensus 169 hiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGL 239 (449)
T KOG1165|consen 169 HIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL 239 (449)
T ss_pred EEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccc
Confidence 99999999987544321 1223456999999999999999999999999999999999999999874
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=5.6e-19 Score=181.63 Aligned_cols=139 Identities=16% Similarity=0.155 Sum_probs=107.4
Q ss_pred ceeecccCceEEEEEEEcCCCcEEEEEEeeccCCc--c-------hhH-----------------HHHHHHHHHhhhhcc
Q 002857 165 ENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHD--A-------SKS-----------------FTVECEVMRNIIHRK 218 (873)
Q Consensus 165 ~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~--~-------~~~-----------------f~~Ei~iL~~L~HpN 218 (873)
...||+|+||.||+|... +|+.||||+++..... . ... ...|++++.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 468999999999999885 8899999999743211 1 112 234999999999887
Q ss_pred ceeeeeeeecccccCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHH-hhCCCCCee
Q 002857 219 IIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYL-HLGCKPPIA 297 (873)
Q Consensus 219 IV~llg~c~~~~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yL-H~~~s~gIv 297 (873)
+.....+. . . ..+|||||+++++|...+. ....+++.....++.|++.+|.|| | ..+|+
T Consensus 81 v~~p~~~~-----~-~-~~~iVmE~i~g~~l~~~~~----------~~~~~~~~~~~~i~~qi~~~L~~l~H---~~gii 140 (190)
T cd05147 81 IPCPEPIL-----L-K-SHVLVMEFIGDDGWAAPRL----------KDAPLSESKARELYLQVIQIMRILYQ---DCRLV 140 (190)
T ss_pred CCCCcEEE-----e-c-CCEEEEEEeCCCCCcchhh----------hcCCCCHHHHHHHHHHHHHHHHHHHH---hCCcc
Confidence 74433221 1 1 2389999999877765431 134578889999999999999999 6 78999
Q ss_pred eccCCCCCeeeCCCCCeEEecccccccc
Q 002857 298 HCDIKPSNILLNDEMTACVADFGIARFL 325 (873)
Q Consensus 298 HrDLKpsNILLd~~~~vKLsDFGla~~~ 325 (873)
||||||+|||++ ++.++|+|||+|...
T Consensus 141 HrDlkP~NIli~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 141 HADLSEYNLLYH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred cCCCCHHHEEEE-CCcEEEEEccccccC
Confidence 999999999998 478999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.8e-19 Score=186.88 Aligned_cols=176 Identities=9% Similarity=0.082 Sum_probs=133.6
Q ss_pred hhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhH---------HHHHHHHHHhhhhccceeeeeeeec
Q 002857 158 ATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKS---------FTVECEVMRNIIHRKIIKVVTACSR 228 (873)
Q Consensus 158 at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~---------f~~Ei~iL~~L~HpNIV~llg~c~~ 228 (873)
...+|...++||.|+||.||++.. ++..+|||++.......... +.+|+..+.+++|++|..+..++..
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 467899999999999999999755 46689999997544333222 6889999999999999999887542
Q ss_pred ccc---cCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCC
Q 002857 229 VDY---QGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSN 305 (873)
Q Consensus 229 ~~~---~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsN 305 (873)
... ......+|||||++|.+|.++.. ++. ....+++.+|..|| ..+++|||++|+|
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------------~~~----~~~~~i~~~l~~lH---~~gi~H~Dikp~N 165 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE--------------ISE----DVKAKIKASIESLH---QHGMVSGDPHKGN 165 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh--------------ccH----HHHHHHHHHHHHHH---HcCCccCCCChHH
Confidence 211 11345899999999999988641 111 34669999999999 8999999999999
Q ss_pred eeeCCCCCeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHH
Q 002857 306 ILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMF 371 (873)
Q Consensus 306 ILLd~~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELl 371 (873)
|+++.++ ++|+|||............ .++....+..++||||||+++.-+.
T Consensus 166 ili~~~g-i~liDfg~~~~~~e~~a~d--------------~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 166 FIVSKNG-LRIIDLSGKRCTAQRKAKD--------------RIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEeCCC-EEEEECCCcccccchhhHH--------------HHHHHhHhcccccccceeEeehHHH
Confidence 9999988 9999999887543211110 0333445667899999999987654
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.8e-19 Score=204.32 Aligned_cols=218 Identities=25% Similarity=0.329 Sum_probs=160.7
Q ss_pred HHhhhhccceeeeeeeecccccCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhh
Q 002857 211 MRNIIHRKIIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHL 290 (873)
Q Consensus 211 L~~L~HpNIV~llg~c~~~~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~ 290 (873)
|+.+.|.|+.+++|.+. ++...++|.+|+..|+|.+.+.. ....++|.....++++|+.||+|||+
T Consensus 1 l~~l~h~n~~~f~g~~~-----~~~~~~~i~~~c~rGsl~D~i~~---------~~~~~d~~F~~s~~rdi~~Gl~ylh~ 66 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASV-----DGPEMIVIWEYCSRGSLLDILSN---------EDIKLDYFFILSFIRDISKGLAYLHN 66 (484)
T ss_pred CcccchhhhhhheeeEe-----cCCceEEEEeeecCccHHhHHhc---------cccCccHHHHHHHHHHHHHHHHHHhc
Confidence 35688999999999974 34778999999999999999952 46779999999999999999999994
Q ss_pred CCCCCeeeccCCCCCeeeCCCCCeEEeccccccccccccccccccccccccccCCCcccCCC-------CCCcchhhHhH
Q 002857 291 GCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGH-------ETSSYGDVYSF 363 (873)
Q Consensus 291 ~~s~gIvHrDLKpsNILLd~~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-------~~s~ksDVwSf 363 (873)
++-..|+.|+++|+++|..+.+||+|||+..+..............-...|.|||.+... ..+.++|||||
T Consensus 67 --s~i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~ 144 (484)
T KOG1023|consen 67 --SPIGYHGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSF 144 (484)
T ss_pred --CcceeeeeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehH
Confidence 233399999999999999999999999999876532222222223356789999998764 14677999999
Q ss_pred HHHHHHHHhCCCCCCcccccchhhHHHHhhcCchhHHHHhhhhhh-hhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHH
Q 002857 364 GILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPERVEEIVDTLFF-KEIEEEETVYKYKKAPSSSTQRSIILECLNSICE 442 (873)
Q Consensus 364 GvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~~l~elid~~L~-~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~ 442 (873)
|++++|+++.+.||+........ .+++..... .... -+|..... .+....+..
T Consensus 145 ~ii~~ei~~r~~~~~~~~~~~~~-------------~eii~~~~~~~~~~---------~rP~i~~~----~e~~~~l~~ 198 (484)
T KOG1023|consen 145 GIIMYEILFRSGPFDLRNLVEDP-------------DEIILRVKKGGSNP---------FRPSIELL----NELPPELLL 198 (484)
T ss_pred HHHHHHHHhccCccccccccCCh-------------HHHHHHHHhcCCCC---------cCcchhhh----hhcchHHHH
Confidence 99999999999999763322211 111111000 0000 01111110 133446889
Q ss_pred HHHHhhccCcCCCCCHHHHHHHHHHHHH
Q 002857 443 IGVACSAELPGERMKINDVELGLRLIKK 470 (873)
Q Consensus 443 L~~~CL~~dP~eRPTm~EVl~~Le~i~~ 470 (873)
++..||..+|++||++.+|-..++.+..
T Consensus 199 l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 199 LVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred HHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 9999999999999999999988887644
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.6e-18 Score=174.51 Aligned_cols=140 Identities=17% Similarity=0.137 Sum_probs=109.1
Q ss_pred ceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcc--------------------------hhHHHHHHHHHHhhhhcc
Q 002857 165 ENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDA--------------------------SKSFTVECEVMRNIIHRK 218 (873)
Q Consensus 165 ~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~--------------------------~~~f~~Ei~iL~~L~HpN 218 (873)
...||+|+||.||+|.+. +|+.||||+++...... ...+..|++.+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 468999999999999876 89999999987542110 112357899999999998
Q ss_pred ceeeeeeeecccccCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCC-CCee
Q 002857 219 IIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCK-PPIA 297 (873)
Q Consensus 219 IV~llg~c~~~~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s-~gIv 297 (873)
+.....+.. . ..+|||||++++++..... ....++......++.|++.+|.+|| . .+|+
T Consensus 81 i~~p~~~~~-----~--~~~lVmE~~~g~~~~~~~l----------~~~~~~~~~~~~i~~~l~~~l~~lH---~~~giv 140 (190)
T cd05145 81 VPVPEPILL-----K--KNVLVMEFIGDDGSPAPRL----------KDVPLEEEEAEELYEQVVEQMRRLY---QEAGLV 140 (190)
T ss_pred CCCceEEEe-----c--CCEEEEEEecCCCchhhhh----------hhccCCHHHHHHHHHHHHHHHHHHH---HhCCEe
Confidence 754443311 1 2489999999886543321 1234677889999999999999999 6 8999
Q ss_pred eccCCCCCeeeCCCCCeEEeccccccccc
Q 002857 298 HCDIKPSNILLNDEMTACVADFGIARFLE 326 (873)
Q Consensus 298 HrDLKpsNILLd~~~~vKLsDFGla~~~~ 326 (873)
||||||+|||++ ++.++|+|||++....
T Consensus 141 HrDlkP~NIll~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 141 HGDLSEYNILYH-DGKPYIIDVSQAVELD 168 (190)
T ss_pred cCCCChhhEEEE-CCCEEEEEcccceecC
Confidence 999999999999 8899999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=6e-19 Score=209.80 Aligned_cols=251 Identities=20% Similarity=0.201 Sum_probs=176.8
Q ss_pred CCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC-CcchhHHHHHHHH--HHhhhhccceeeeeeeecccccCCceE
Q 002857 161 GFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH-HDASKSFTVECEV--MRNIIHRKIIKVVTACSRVDYQGNDFK 237 (873)
Q Consensus 161 ~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~-~~~~~~f~~Ei~i--L~~L~HpNIV~llg~c~~~~~~~~~~~ 237 (873)
+|...+.||.+.|=+|.+|++.+ | .|+||++-+.. .-..+.|.++++- ...++|||.+++.-+ ...+...
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G-~vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~-----~~t~kAA 96 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-G-LVVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKV-----LVTDKAA 96 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-c-eEEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHH-----HHhhHHH
Confidence 56778899999999999998754 3 49999986443 3334555554444 444589999998765 2345556
Q ss_pred EEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEe
Q 002857 238 ALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVA 317 (873)
Q Consensus 238 ~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLs 317 (873)
|||-+|..+ +|+|.| ...+-|...+.+.|+.|++.||...| ..+|+|||||.+||||+.-..+.|+
T Consensus 97 ylvRqyvkh-nLyDRl----------STRPFL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~Lt 162 (1431)
T KOG1240|consen 97 YLVRQYVKH-NLYDRL----------STRPFLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLT 162 (1431)
T ss_pred HHHHHHHhh-hhhhhh----------ccchHHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhh
Confidence 788888855 999988 34667888899999999999999999 9999999999999999999999999
Q ss_pred cccccccc--ccccccccc---cccccccccCCCcccCCC----------C-CCcchhhHhHHHHHHHHHh-CCCCCCcc
Q 002857 318 DFGIARFL--EATNEQTSS---IGVKGTTGYIAPEYGMGH----------E-TSSYGDVYSFGILLLEMFT-GLRPSDDM 380 (873)
Q Consensus 318 DFGla~~~--~~~~~~~~~---~~~~Gt~~Y~APE~l~~~----------~-~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~ 380 (873)
||..-+.. ..++..... ..-..-..|+|||.+... . .+++.||||+||++.||++ |+++|+-.
T Consensus 163 DFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS 242 (1431)
T KOG1240|consen 163 DFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS 242 (1431)
T ss_pred cccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH
Confidence 99876532 222211111 111244579999975431 2 6788999999999999999 78888641
Q ss_pred cccchhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHH
Q 002857 381 FKDNLNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKIND 460 (873)
Q Consensus 381 ~~~~~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~E 460 (873)
.+..+-... ......+ +.++ +. ..+..+++.|++.||.+|-++.+
T Consensus 243 -----QL~aYr~~~-~~~~e~~--------------Le~I-------------ed--~~~Rnlil~Mi~rdPs~RlSAed 287 (1431)
T KOG1240|consen 243 -----QLLAYRSGN-ADDPEQL--------------LEKI-------------ED--VSLRNLILSMIQRDPSKRLSAED 287 (1431)
T ss_pred -----HHHhHhccC-ccCHHHH--------------HHhC-------------cC--ccHHHHHHHHHccCchhccCHHH
Confidence 111111000 0000000 0010 00 13667999999999999999999
Q ss_pred HHHHHHH
Q 002857 461 VELGLRL 467 (873)
Q Consensus 461 Vl~~Le~ 467 (873)
.++.-++
T Consensus 288 yL~~yrG 294 (1431)
T KOG1240|consen 288 YLQKYRG 294 (1431)
T ss_pred HHHhhhc
Confidence 9988443
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.9e-17 Score=200.98 Aligned_cols=201 Identities=23% Similarity=0.252 Sum_probs=159.9
Q ss_pred HHHHhhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhh---hccceeeeeeeeccc
Q 002857 154 ALYSATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNII---HRKIIKVVTACSRVD 230 (873)
Q Consensus 154 el~~at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~---HpNIV~llg~c~~~~ 230 (873)
+++.-...|.+.+.||+|+||+||+|...+ ++.||+|+=+. ....+|.--.+++.+|+ -+-|..+...
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P---~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a----- 762 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKP---PNPWEFYICLQVMERLKPQMLPSIMHISSA----- 762 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecC---CCceeeeehHHHHHhhchhhhcchHHHHHH-----
Confidence 334445678889999999999999999865 99999998542 23345666666777776 1223333222
Q ss_pred ccCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeC-
Q 002857 231 YQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLN- 309 (873)
Q Consensus 231 ~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd- 309 (873)
+...+.-+||+||.+.|+|.+++ +..+.++|...+.|+.|+++-+++|| ..+||||||||+|.||.
T Consensus 763 ~~~~~~S~lv~ey~~~Gtlld~~----------N~~~~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~ 829 (974)
T KOG1166|consen 763 HVFQNASVLVSEYSPYGTLLDLI----------NTNKVMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRR 829 (974)
T ss_pred HccCCcceeeeeccccccHHHhh----------ccCCCCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeec
Confidence 12244568999999999999999 35778999999999999999999999 89999999999999994
Q ss_pred ------CCCCeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCC
Q 002857 310 ------DEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRP 376 (873)
Q Consensus 310 ------~~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~P 376 (873)
+..-++|+|||.+-.+.--.+......+++|-.+-.+|+..|..++..+|-|.|+.+++-||.|+.-
T Consensus 830 ~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 830 EICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred ccCCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 3346899999999765444444555667899999999999999999999999999999999999743
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=5.4e-17 Score=167.74 Aligned_cols=187 Identities=13% Similarity=0.040 Sum_probs=137.7
Q ss_pred CCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcc----hhHHHHHHHHHHhhh-hccceeeeeeeecccccCCce
Q 002857 162 FSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDA----SKSFTVECEVMRNII-HRKIIKVVTACSRVDYQGNDF 236 (873)
Q Consensus 162 f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~----~~~f~~Ei~iL~~L~-HpNIV~llg~c~~~~~~~~~~ 236 (873)
+.+...|++|+||+||.+.. .+.+++.+.+.....-. ...+.+|+++|++|. |+++.+++++ ..
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~---------~~ 72 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW---------DG 72 (218)
T ss_pred cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE---------cC
Confidence 34568899999999997754 67788888776433211 125789999999995 5889999886 13
Q ss_pred EEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccC-CCCCeeeCCCCCeE
Q 002857 237 KALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDI-KPSNILLNDEMTAC 315 (873)
Q Consensus 237 ~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDL-KpsNILLd~~~~vK 315 (873)
.+++|||+.|.+|.+.+.. ....++.|++.+|.++| ..+|+|||| ||+|||++.++.++
T Consensus 73 ~~lvmeyI~G~~L~~~~~~-----------------~~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~ 132 (218)
T PRK12274 73 RHLDRSYLAGAAMYQRPPR-----------------GDLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPA 132 (218)
T ss_pred EEEEEeeecCccHHhhhhh-----------------hhHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEE
Confidence 6899999999898764410 11357889999999999 899999999 79999999999999
Q ss_pred Eecccccccccccccc----c-------cccccccccccCCCcccCCC-CCC-cchhhHhHHHHHHHHHhCCCCCCc
Q 002857 316 VADFGIARFLEATNEQ----T-------SSIGVKGTTGYIAPEYGMGH-ETS-SYGDVYSFGILLLEMFTGLRPSDD 379 (873)
Q Consensus 316 LsDFGla~~~~~~~~~----~-------~~~~~~Gt~~Y~APE~l~~~-~~s-~ksDVwSfGvvL~ELlTGk~Pf~~ 379 (873)
|+|||++......... . ...-...++.|++|+...-. ..+ ...+.++-|.-+|.++|+..++-.
T Consensus 133 LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 133 VIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred EEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 9999999855432210 0 01112256777777743221 222 456888999999999999888643
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.71 E-value=2.6e-17 Score=177.94 Aligned_cols=207 Identities=19% Similarity=0.279 Sum_probs=133.1
Q ss_pred CCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCC---cchhHHHHHHHHHHhhh----------hccceeeeeeeec
Q 002857 162 FSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH---DASKSFTVECEVMRNII----------HRKIIKVVTACSR 228 (873)
Q Consensus 162 f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~L~----------HpNIV~llg~c~~ 228 (873)
+.....||.|+++.||.+++..+++.+|||++..... ...+++.+|.-....+. |-.++--++...-
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 3456899999999999999999999999999864332 23355666654444421 2222222121110
Q ss_pred c---c-c---cCCc-----eEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCe
Q 002857 229 V---D-Y---QGND-----FKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPI 296 (873)
Q Consensus 229 ~---~-~---~~~~-----~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gI 296 (873)
. . + .+.. ..+++|+-+ .++|.+++....... .....+....++.+..|+++.+++|| ..|+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~---~~~~~l~~~arl~lT~Q~I~lvA~Lh---~~Gl 166 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRA---QTHSPLAFAARLSLTVQMIRLVANLH---SYGL 166 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHT---TTSHHHHHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcc---cccchhHHHHHHHHHHHHHHHHHHHh---hcce
Confidence 0 0 0 0011 236788887 559988874322111 11234556677888899999999999 8999
Q ss_pred eeccCCCCCeeeCCCCCeEEeccccccccccccccccccccccccccCCCcccCC--------CCCCcchhhHhHHHHHH
Q 002857 297 AHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMG--------HETSSYGDVYSFGILLL 368 (873)
Q Consensus 297 vHrDLKpsNILLd~~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~--------~~~s~ksDVwSfGvvL~ 368 (873)
+|+||+|+|++++.+|.++|+||+........... ...+..|.+||.... -.++.+.|.|++|+++|
T Consensus 167 VHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly 241 (288)
T PF14531_consen 167 VHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLY 241 (288)
T ss_dssp EEST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHH
T ss_pred EecccceeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHH
Confidence 99999999999999999999999887654322111 234578999997533 25788999999999999
Q ss_pred HHHhCCCCCCcc
Q 002857 369 EMFTGLRPSDDM 380 (873)
Q Consensus 369 ELlTGk~Pf~~~ 380 (873)
.|++|..||+..
T Consensus 242 ~lWC~~lPf~~~ 253 (288)
T PF14531_consen 242 SLWCGRLPFGLS 253 (288)
T ss_dssp HHHHSS-STCCC
T ss_pred HHHHccCCCCCC
Confidence 999999999764
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=3.2e-17 Score=177.70 Aligned_cols=203 Identities=21% Similarity=0.233 Sum_probs=139.4
Q ss_pred hhccceeeeeeeeccc----------------------ccCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchh
Q 002857 215 IHRKIIKVVTACSRVD----------------------YQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSL 272 (873)
Q Consensus 215 ~HpNIV~llg~c~~~~----------------------~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~ 272 (873)
+|||||++.++|.+.- +.++..+|+||...+. +|.++|- ....+..
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~-----------~~~~s~r 341 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLW-----------TRHRSYR 341 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHh-----------cCCCchH
Confidence 4999999998765431 1234567899998865 8999883 2345666
Q ss_pred hhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeee--CCCC--CeEEeccccccccccccc----cccccccccccccC
Q 002857 273 ERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILL--NDEM--TACVADFGIARFLEATNE----QTSSIGVKGTTGYI 344 (873)
Q Consensus 273 ~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILL--d~~~--~vKLsDFGla~~~~~~~~----~~~~~~~~Gt~~Y~ 344 (873)
...-|+.|+++|+.||| .++|.|||||++|||+ |+|. ...|+|||.+-.-+...- ........|...-|
T Consensus 342 ~~~~~laQlLEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lm 418 (598)
T KOG4158|consen 342 TGRVILAQLLEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLM 418 (598)
T ss_pred HHHHHHHHHHHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceec
Confidence 78889999999999999 9999999999999998 4554 567899998743221110 11111234778899
Q ss_pred CCcccCCCC------CCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHh
Q 002857 345 APEYGMGHE------TSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPERVEEIVDTLFFKEIEEEETVY 418 (873)
Q Consensus 345 APE~l~~~~------~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~ 418 (873)
|||+....+ ...|+|.|+.|.+.||+++...||....+-..+...+-
T Consensus 419 APEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yq--------------------------- 471 (598)
T KOG4158|consen 419 APEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQ--------------------------- 471 (598)
T ss_pred chhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhh---------------------------
Confidence 999876532 35689999999999999999999965211111111100
Q ss_pred hhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHH
Q 002857 419 KYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLR 466 (873)
Q Consensus 419 ~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le 466 (873)
+- ..|. ..+.++..+.+++..-|+.||++||+..-....|+
T Consensus 472 e~-qLPa------lp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 472 ES-QLPA------LPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred hh-hCCC------CcccCChHHHHHHHHHhcCCccccCCccHHHhHHH
Confidence 00 0011 11123344678899999999999999876666665
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.2e-16 Score=166.74 Aligned_cols=140 Identities=20% Similarity=0.257 Sum_probs=106.6
Q ss_pred CCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhh-----hhccceeeeeeeecccccCCce
Q 002857 162 FSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNI-----IHRKIIKVVTACSRVDYQGNDF 236 (873)
Q Consensus 162 f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L-----~HpNIV~llg~c~~~~~~~~~~ 236 (873)
+...++||+|+||.||. +..++.. +||++........+.+.+|+.+++.+ .||||++++|++... .+.+.
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~--~g~g~ 78 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETD--CGTGY 78 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeC--CCCeE
Confidence 34568999999999996 5555555 69988755444567899999999999 579999999996431 11123
Q ss_pred -EEEEEee--cCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHH-HHHhhCCCCCeeeccCCCCCeeeCC--
Q 002857 237 -KALVYEF--MPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASAL-EYLHLGCKPPIAHCDIKPSNILLND-- 310 (873)
Q Consensus 237 -~~LV~Ey--~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL-~yLH~~~s~gIvHrDLKpsNILLd~-- 310 (873)
..+|+|| +.+|+|.+++.. ..+++. ..++.+++.++ +||| +.+|+||||||+|||++.
T Consensus 79 v~~~I~e~~G~~~~tL~~~l~~-----------~~~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~ 142 (210)
T PRK10345 79 VYDVIADFDGKPSITLTEFAEQ-----------CRYEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRIS 142 (210)
T ss_pred EEEEEecCCCCcchhHHHHHHc-----------ccccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccC
Confidence 3478999 557999999942 124444 45678888888 9999 899999999999999973
Q ss_pred --CCCeEEeccccc
Q 002857 311 --EMTACVADFGIA 322 (873)
Q Consensus 311 --~~~vKLsDFGla 322 (873)
+..++|+||+.+
T Consensus 143 ~~~~~~~LiDg~G~ 156 (210)
T PRK10345 143 ESEVIPVVCDNIGE 156 (210)
T ss_pred CCCCcEEEEECCCC
Confidence 348999995444
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.68 E-value=3.1e-16 Score=166.82 Aligned_cols=142 Identities=18% Similarity=0.169 Sum_probs=110.7
Q ss_pred CCCcceeecccCceEEEEEE-EcCCCcEEEEEEeeccCCc------------------------chhHHHHHHHHHHhhh
Q 002857 161 GFSSENLIGAGNFASVYKGI-LFEGAPAVAIKVFNFLHHD------------------------ASKSFTVECEVMRNII 215 (873)
Q Consensus 161 ~f~~~~~LG~G~fG~VYkg~-~~~~g~~VAVK~l~~~~~~------------------------~~~~f~~Ei~iL~~L~ 215 (873)
.|.+.+.||+|+||.||+|. ...+|+.||||+++..... ....+..|++++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47788999999999999998 5678999999998743210 0123568999999997
Q ss_pred hcc--ceeeeeeeecccccCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCC
Q 002857 216 HRK--IIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCK 293 (873)
Q Consensus 216 HpN--IV~llg~c~~~~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s 293 (873)
+.. +.+++++ ...+|||||+++++|...+. ....+...+...++.||+.+|++|| .
T Consensus 109 ~~~i~~p~~~~~---------~~~~lV~E~~~g~~L~~~~~----------~~~~~~~~~~~~i~~qi~~~l~~LH---~ 166 (237)
T smart00090 109 EAGVPVPKPIAW---------RRNVLVMEFIGGDGLPAPRL----------KDVEPEEEEEFELYDDILEEMRKLY---K 166 (237)
T ss_pred hcCCCCCeeeEe---------cCceEEEEEecCCccccccc----------ccCCcchHHHHHHHHHHHHHHHHHH---h
Confidence 633 3344433 12479999999988876542 1223455567899999999999999 8
Q ss_pred CC-eeeccCCCCCeeeCCCCCeEEecccccccc
Q 002857 294 PP-IAHCDIKPSNILLNDEMTACVADFGIARFL 325 (873)
Q Consensus 294 ~g-IvHrDLKpsNILLd~~~~vKLsDFGla~~~ 325 (873)
.+ |+||||||+||+++ ++.++|+|||.+...
T Consensus 167 ~g~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 167 EGELVHGDLSEYNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred cCCEEeCCCChhhEEEE-CCCEEEEEChhhhcc
Confidence 89 99999999999999 889999999998753
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.65 E-value=2e-17 Score=189.33 Aligned_cols=187 Identities=26% Similarity=0.299 Sum_probs=153.0
Q ss_pred eecccCceEEEEEEE---cCCCcEEEEEEeeccCCc--chhHHHHHHHHHHhhh-hccceeeeeeeecccccCCceEEEE
Q 002857 167 LIGAGNFASVYKGIL---FEGAPAVAIKVFNFLHHD--ASKSFTVECEVMRNII-HRKIIKVVTACSRVDYQGNDFKALV 240 (873)
Q Consensus 167 ~LG~G~fG~VYkg~~---~~~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~-HpNIV~llg~c~~~~~~~~~~~~LV 240 (873)
.+|+|.||.|++..- .+.+..+|+|+++..... .......|..++..++ ||.+|++.-. ++.+...+++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhya-----fqt~~kl~l~ 75 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYA-----FQTDGKLYLI 75 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeee-----eccccchhHh
Confidence 379999999987542 234667889988643221 1124566888888886 9999999776 4667789999
Q ss_pred EeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEeccc
Q 002857 241 YEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFG 320 (873)
Q Consensus 241 ~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDFG 320 (873)
++|..+|.|...+. ....+++.....+...++-+++++| +.+|+|||+|++||+++.+|++++.|||
T Consensus 76 ld~~rgg~lft~l~----------~~~~f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfg 142 (612)
T KOG0603|consen 76 LDFLRGGDLFTRLS----------KEVMFDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFG 142 (612)
T ss_pred hhhcccchhhhccc----------cCCchHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCch
Confidence 99999999998873 3556777777888889999999999 9999999999999999999999999999
Q ss_pred cccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCc
Q 002857 321 IARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDD 379 (873)
Q Consensus 321 la~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~ 379 (873)
+++..-..... .||..|||||++. .....+|.||||++++||+||..||..
T Consensus 143 lske~v~~~~~------cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 143 LSKEAVKEKIA------CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred hhhHhHhhhhc------ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 99865432221 6899999999988 457789999999999999999999976
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.2e-15 Score=157.40 Aligned_cols=146 Identities=18% Similarity=0.171 Sum_probs=113.5
Q ss_pred HHHHHHhhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCc----------------------chhHHHHHHH
Q 002857 152 YEALYSATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHD----------------------ASKSFTVECE 209 (873)
Q Consensus 152 ~~el~~at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~----------------------~~~~f~~Ei~ 209 (873)
++++......|.+.+.||+|+||.||++.. .+++.||||++...... ....+..|+.
T Consensus 7 ~~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 85 (198)
T cd05144 7 LHTLVKRGVVESLGNQIGVGKESDVYLALD-PDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFA 85 (198)
T ss_pred HHHHHHcCchhhcCCccccCcceEEEEEEc-CCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHH
Confidence 345555555588889999999999999987 47899999987643210 0123677899
Q ss_pred HHHhhhhcc--ceeeeeeeecccccCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHH
Q 002857 210 VMRNIIHRK--IIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEY 287 (873)
Q Consensus 210 iL~~L~HpN--IV~llg~c~~~~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~y 287 (873)
++..+.|.+ +...++. ...++||||+++++|.++... .....++.+++.++.+
T Consensus 86 ~l~~l~~~~i~v~~~~~~---------~~~~lv~e~~~g~~L~~~~~~----------------~~~~~~~~~i~~~l~~ 140 (198)
T cd05144 86 ALKALYEEGFPVPKPIDW---------NRHAVVMEYIDGVELYRVRVL----------------EDPEEVLDEILEEIVK 140 (198)
T ss_pred HHHHHHHcCCCCCceeec---------CCceEEEEEeCCcchhhcccc----------------ccHHHHHHHHHHHHHH
Confidence 999998874 4444432 235899999999999875420 2456789999999999
Q ss_pred HhhCCCCCeeeccCCCCCeeeCCCCCeEEeccccccccc
Q 002857 288 LHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLE 326 (873)
Q Consensus 288 LH~~~s~gIvHrDLKpsNILLd~~~~vKLsDFGla~~~~ 326 (873)
+| ..+|+||||||+||++++++.++|+|||++....
T Consensus 141 lh---~~gi~H~Dl~p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 141 AY---KHGIIHGDLSEFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred HH---HCCCCcCCCCcccEEEcCCCcEEEEECCccccCC
Confidence 99 8999999999999999999999999999996543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.2e-15 Score=158.05 Aligned_cols=134 Identities=22% Similarity=0.273 Sum_probs=109.2
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEeeccCCc--------chhHHHHHHHHHHhhhhccceeeeeeeecccccCCceE
Q 002857 166 NLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHD--------ASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFK 237 (873)
Q Consensus 166 ~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~--------~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~ 237 (873)
+.||+|++|.||+|.+ .+..|++|+....... ....+.+|++++..+.|++|.....++. .....
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~-----~~~~~ 74 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFV-----DPENF 74 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEE-----eCCCC
Confidence 5799999999999987 5667999986532211 1235788999999999999877666542 23457
Q ss_pred EEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEe
Q 002857 238 ALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVA 317 (873)
Q Consensus 238 ~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLs 317 (873)
++||||++|++|.+++.. . .+ .+..++.+++.+|.+|| ..+++|+|++|.|||++ ++.++|+
T Consensus 75 ~lv~e~~~G~~L~~~~~~----------~---~~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~li 136 (211)
T PRK14879 75 IIVMEYIEGEPLKDLINS----------N---GM-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLI 136 (211)
T ss_pred EEEEEEeCCcCHHHHHHh----------c---cH-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEE
Confidence 899999999999998842 1 11 78899999999999999 89999999999999999 7899999
Q ss_pred ccccccc
Q 002857 318 DFGIARF 324 (873)
Q Consensus 318 DFGla~~ 324 (873)
|||.+..
T Consensus 137 Df~~a~~ 143 (211)
T PRK14879 137 DFGLAEF 143 (211)
T ss_pred ECCcccC
Confidence 9999864
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.61 E-value=2.7e-15 Score=177.78 Aligned_cols=145 Identities=19% Similarity=0.274 Sum_probs=112.2
Q ss_pred CHHHHHHhhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEee--ccCC------cchhHHHHHHHHHHhhhhccceee
Q 002857 151 SYEALYSATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFN--FLHH------DASKSFTVECEVMRNIIHRKIIKV 222 (873)
Q Consensus 151 s~~el~~at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~--~~~~------~~~~~f~~Ei~iL~~L~HpNIV~l 222 (873)
++.........|...+.||+|+||.||+|.+... .+++|+.. .... ...+.+.+|++++.+++|++++..
T Consensus 324 ~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p 401 (535)
T PRK09605 324 TWIKEEEVKRRKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTP 401 (535)
T ss_pred eeccccccccccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCee
Confidence 3444444455667789999999999999987443 34444321 1111 112468899999999999999887
Q ss_pred eeeeecccccCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCC
Q 002857 223 VTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIK 302 (873)
Q Consensus 223 lg~c~~~~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLK 302 (873)
..++. .....++||||+++++|.+++. ....++.+++++|.||| +.+|+|||||
T Consensus 402 ~~~~~-----~~~~~~lv~E~~~g~~L~~~l~------------------~~~~~~~~i~~~L~~lH---~~giiHrDlk 455 (535)
T PRK09605 402 VIYDV-----DPEEKTIVMEYIGGKDLKDVLE------------------GNPELVRKVGEIVAKLH---KAGIVHGDLT 455 (535)
T ss_pred EEEEE-----eCCCCEEEEEecCCCcHHHHHH------------------HHHHHHHHHHHHHHHHH---hCCCccCCCC
Confidence 76642 2345689999999999999872 35679999999999999 8999999999
Q ss_pred CCCeeeCCCCCeEEeccccccc
Q 002857 303 PSNILLNDEMTACVADFGIARF 324 (873)
Q Consensus 303 psNILLd~~~~vKLsDFGla~~ 324 (873)
|+|||+ +++.++|+|||+++.
T Consensus 456 p~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 456 TSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred hHHEEE-ECCcEEEEeCccccc
Confidence 999999 677999999999975
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.61 E-value=2.9e-15 Score=153.88 Aligned_cols=130 Identities=22% Similarity=0.273 Sum_probs=102.5
Q ss_pred eecccCceEEEEEEEcCCCcEEEEEEeeccCCc--------chhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEE
Q 002857 167 LIGAGNFASVYKGILFEGAPAVAIKVFNFLHHD--------ASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKA 238 (873)
Q Consensus 167 ~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~--------~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~ 238 (873)
.||+|+||.||+|.+ ++..|++|+....... ....+.+|++++..++|+++.....++. .....+
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~-----~~~~~~ 73 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDV-----DPDNKT 73 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEE-----ECCCCE
Confidence 489999999999985 5678999986532111 1245778999999999887554443321 233468
Q ss_pred EEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEec
Q 002857 239 LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVAD 318 (873)
Q Consensus 239 LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsD 318 (873)
+||||++|++|.+++.. .. ..++.+++.+|.+|| ..+++|||++|.||+++ ++.++++|
T Consensus 74 lv~e~~~g~~l~~~~~~----------~~-------~~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liD 132 (199)
T TIGR03724 74 IVMEYIEGKPLKDVIEE----------GN-------DELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLID 132 (199)
T ss_pred EEEEEECCccHHHHHhh----------cH-------HHHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEE
Confidence 99999999999998732 00 078999999999999 89999999999999999 88999999
Q ss_pred cccccc
Q 002857 319 FGIARF 324 (873)
Q Consensus 319 FGla~~ 324 (873)
||+++.
T Consensus 133 fg~a~~ 138 (199)
T TIGR03724 133 FGLGKY 138 (199)
T ss_pred CCCCcC
Confidence 999874
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.1e-15 Score=182.48 Aligned_cols=167 Identities=28% Similarity=0.375 Sum_probs=124.5
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEE
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKA 238 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~ 238 (873)
..+|+.+++|..|+||.||..+++.+.+.+|+|+-+.. -|+ +||..+.+- .+
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~------------lil-----Rnilt~a~n-----------pf 133 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQN------------LIL-----RNILTFAGN-----------PF 133 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcccccc------------hhh-----hccccccCC-----------cc
Confidence 35788999999999999999999888889999653211 011 223333322 23
Q ss_pred EEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEec
Q 002857 239 LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVAD 318 (873)
Q Consensus 239 LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsD 318 (873)
.| |+-...++ ..+.++. +++.+++||| +.+|+|||+||+|.||+.-|++|+.|
T Consensus 134 vv------gDc~tllk----------~~g~lPv--------dmvla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTD 186 (1205)
T KOG0606|consen 134 VV------GDCATLLK----------NIGPLPV--------DMVLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTD 186 (1205)
T ss_pred ee------chhhhhcc----------cCCCCcc--------hhhHHhHhhc---cCCeecCCCCCCcceeeecccccccc
Confidence 33 44444442 2222322 2288999999 99999999999999999999999999
Q ss_pred ccccccccccc-------------ccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcc
Q 002857 319 FGIARFLEATN-------------EQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDM 380 (873)
Q Consensus 319 FGla~~~~~~~-------------~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~ 380 (873)
||+++..-... .......+.||+.|+|||++....|....|.|++|+|+||.+-|..||...
T Consensus 187 fgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGd 261 (1205)
T KOG0606|consen 187 FGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD 261 (1205)
T ss_pred hhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCC
Confidence 99987532211 112233567999999999999999999999999999999999999999764
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.59 E-value=3.8e-16 Score=176.04 Aligned_cols=124 Identities=27% Similarity=0.471 Sum_probs=106.4
Q ss_pred eEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeE
Q 002857 236 FKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTAC 315 (873)
Q Consensus 236 ~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vK 315 (873)
..+|.|+++...+|.+||.. .......++...+.++.|++.|+.| ++.+|+|+||.||++..+..+|
T Consensus 330 ~lyI~Mn~c~~~tledWl~r-------r~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~k 396 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRR-------RRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLK 396 (516)
T ss_pred chhhhhhhhhhhhHHHHhhC-------CCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhh
Confidence 47899999999999999953 1234556788899999999999999 5899999999999999999999
Q ss_pred Eecccccccccccc----ccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh
Q 002857 316 VADFGIARFLEATN----EQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT 372 (873)
Q Consensus 316 LsDFGla~~~~~~~----~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT 372 (873)
|+|||+........ .....+...||..||+||.+.+..|+.|+||||||+||+||++
T Consensus 397 IgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 397 IGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred hhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 99999987654433 1223445679999999999999999999999999999999997
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.54 E-value=3.6e-14 Score=144.16 Aligned_cols=135 Identities=19% Similarity=0.238 Sum_probs=97.6
Q ss_pred ceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcc--hhHH----------------------HHHHHHHHhhhhcc--
Q 002857 165 ENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDA--SKSF----------------------TVECEVMRNIIHRK-- 218 (873)
Q Consensus 165 ~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~--~~~f----------------------~~Ei~iL~~L~HpN-- 218 (873)
.+.||+|+||.||+|.+. +++.||||+++...... ...+ ..|...+.++.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 468999999999999875 78899999987432211 1111 34566666665443
Q ss_pred ceeeeeeeecccccCCceEEEEEeecCCCChhhh-cccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCC-CCe
Q 002857 219 IIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEW-IHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCK-PPI 296 (873)
Q Consensus 219 IV~llg~c~~~~~~~~~~~~LV~Ey~~~GSL~~~-L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s-~gI 296 (873)
+.+.++. ...++||||++++++... +.. .... .....++.+++.++.++| . .+|
T Consensus 81 ~~~~~~~---------~~~~lv~e~~~g~~~~~~~l~~-----------~~~~-~~~~~~~~~~~~~l~~lh---~~~~i 136 (187)
T cd05119 81 VPKPIDL---------NRHVLVMEFIGGDGIPAPRLKD-----------VRLL-EDPEELYDQILELMRKLY---REAGL 136 (187)
T ss_pred CCceEec---------CCCEEEEEEeCCCCccChhhhh-----------hhhc-ccHHHHHHHHHHHHHHHh---hccCc
Confidence 3444433 135899999999654322 211 0001 567889999999999999 7 999
Q ss_pred eeccCCCCCeeeCCCCCeEEecccccccc
Q 002857 297 AHCDIKPSNILLNDEMTACVADFGIARFL 325 (873)
Q Consensus 297 vHrDLKpsNILLd~~~~vKLsDFGla~~~ 325 (873)
+|+||||+||+++ ++.++|+|||.+...
T Consensus 137 vH~Dl~p~Nili~-~~~~~liDfg~a~~~ 164 (187)
T cd05119 137 VHGDLSEYNILVD-DGKVYIIDVPQAVEI 164 (187)
T ss_pred CcCCCChhhEEEE-CCcEEEEECcccccc
Confidence 9999999999999 899999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.3e-13 Score=132.47 Aligned_cols=135 Identities=21% Similarity=0.261 Sum_probs=110.0
Q ss_pred cceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhh--ccceeeeeeeecccccCCceEEEEE
Q 002857 164 SENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIH--RKIIKVVTACSRVDYQGNDFKALVY 241 (873)
Q Consensus 164 ~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~H--pNIV~llg~c~~~~~~~~~~~~LV~ 241 (873)
+.+.||+|.++.||++... +..+++|....... ...+..|+.++..++| .++.+++++. ...+..+++|
T Consensus 2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~-----~~~~~~~~v~ 72 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASG-----ESDGWSYLLM 72 (155)
T ss_pred cceecccccccceEEEEec--CCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEc-----CCCCccEEEE
Confidence 4578999999999999873 36899999864432 4678999999999987 4888888874 3346789999
Q ss_pred eecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEecccc
Q 002857 242 EFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGI 321 (873)
Q Consensus 242 Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDFGl 321 (873)
||++++.+..+ +......++.+++++|++||.....+++|+||+|+||+++..+.++++|||.
T Consensus 73 e~~~g~~~~~~-----------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~ 135 (155)
T cd05120 73 EWIEGETLDEV-----------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEY 135 (155)
T ss_pred EecCCeecccC-----------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEeccc
Confidence 99988766542 3446678999999999999943335799999999999999989999999999
Q ss_pred ccc
Q 002857 322 ARF 324 (873)
Q Consensus 322 a~~ 324 (873)
+..
T Consensus 136 ~~~ 138 (155)
T cd05120 136 AGY 138 (155)
T ss_pred ccC
Confidence 874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.46 E-value=4.5e-13 Score=142.81 Aligned_cols=140 Identities=11% Similarity=0.108 Sum_probs=104.6
Q ss_pred ceeec-ccCceEEEEEEEcCCCcEEEEEEeeccC-------------CcchhHHHHHHHHHHhhhhccc--eeeeeeeec
Q 002857 165 ENLIG-AGNFASVYKGILFEGAPAVAIKVFNFLH-------------HDASKSFTVECEVMRNIIHRKI--IKVVTACSR 228 (873)
Q Consensus 165 ~~~LG-~G~fG~VYkg~~~~~g~~VAVK~l~~~~-------------~~~~~~f~~Ei~iL~~L~HpNI--V~llg~c~~ 228 (873)
...|| .||.|+||.+.. ++..+|||++.... ......+.+|++++.+++|++| ++.+++...
T Consensus 36 ~~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~ 113 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV 113 (239)
T ss_pred CceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence 35788 899999999876 46789999885211 1122467889999999999885 667766422
Q ss_pred ccccCCceEEEEEeecCC-CChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCee
Q 002857 229 VDYQGNDFKALVYEFMPN-GSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNIL 307 (873)
Q Consensus 229 ~~~~~~~~~~LV~Ey~~~-GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNIL 307 (873)
.. ......++|||++++ .+|.+++.. ..++. ..+.+|+.+|.+|| ..||+||||||.|||
T Consensus 114 ~~-~~~~~~~lV~e~l~G~~~L~~~l~~-----------~~l~~----~~~~~i~~~l~~lH---~~GI~HrDlkp~NIL 174 (239)
T PRK01723 114 RH-GLFYRADILIERIEGARDLVALLQE-----------APLSE----EQWQAIGQLIARFH---DAGVYHADLNAHNIL 174 (239)
T ss_pred ec-CcceeeeEEEEecCCCCCHHHHHhc-----------CCCCH----HHHHHHHHHHHHHH---HCCCCCCCCCchhEE
Confidence 11 111124699999997 689888732 12332 24678999999999 899999999999999
Q ss_pred eCCCCCeEEecccccccc
Q 002857 308 LNDEMTACVADFGIARFL 325 (873)
Q Consensus 308 Ld~~~~vKLsDFGla~~~ 325 (873)
++.++.++|+|||.+...
T Consensus 175 v~~~~~v~LIDfg~~~~~ 192 (239)
T PRK01723 175 LDPDGKFWLIDFDRGELR 192 (239)
T ss_pred EcCCCCEEEEECCCcccC
Confidence 999889999999998753
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.38 E-value=7.6e-14 Score=166.31 Aligned_cols=253 Identities=23% Similarity=0.298 Sum_probs=185.2
Q ss_pred cCCCcceeecccCceEEEEEEEcC-CCcEEEEEEeeccC--CcchhHHHHHHHHHHhhh-hccceeeeeeeecccccCCc
Q 002857 160 KGFSSENLIGAGNFASVYKGILFE-GAPAVAIKVFNFLH--HDASKSFTVECEVMRNII-HRKIIKVVTACSRVDYQGND 235 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~-HpNIV~llg~c~~~~~~~~~ 235 (873)
..|...+.||+|.|+.|-...... ....+|+|.+.... ....+....|..+-..+. |.|++++++. ....+
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~-----~~~~~ 94 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEP-----SSSPR 94 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCc-----cCCCc
Confidence 456677889999999998876533 34456777665432 222344455777777776 9999999998 35677
Q ss_pred eEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCC-Ce
Q 002857 236 FKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEM-TA 314 (873)
Q Consensus 236 ~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~-~v 314 (873)
..+++++|..++++.+.+.. ......+....-.++.|+..++.|+|. ..++.|+||||+|.+++..+ ..
T Consensus 95 ~~~~~~~~s~g~~~f~~i~~--------~~~~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l 164 (601)
T KOG0590|consen 95 SYLLSLSYSDGGSLFSKISH--------PDSTGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSAL 164 (601)
T ss_pred ccccccCccccccccccccc--------CCccCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcc
Confidence 88999999999999988721 122245666778899999999999995 57999999999999999999 99
Q ss_pred EEecccccccccc-cccccccccccc-ccccCCCcccCCC-CCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHH
Q 002857 315 CVADFGIARFLEA-TNEQTSSIGVKG-TTGYIAPEYGMGH-ETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWV 391 (873)
Q Consensus 315 KLsDFGla~~~~~-~~~~~~~~~~~G-t~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~ 391 (873)
+++|||+|..+.. ...........| ++.|+|||...+. ...+..|+||.|+++.-+++|..|++........+..|.
T Consensus 165 ~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~ 244 (601)
T KOG0590|consen 165 KIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWK 244 (601)
T ss_pred cCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeec
Confidence 9999999987765 333334444567 9999999998884 456778999999999999999999877544444434443
Q ss_pred hh----------cCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCc
Q 002857 392 QS----------ALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSS 427 (873)
Q Consensus 392 ~~----------~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~ 427 (873)
.. .+......++...+......+.+..++...+|..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~ 290 (601)
T KOG0590|consen 245 SNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLS 290 (601)
T ss_pred ccccccccCccccCChhhhhcccccccCCchhcccccccccccccc
Confidence 22 2333556666666665566666666655555543
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.5e-12 Score=139.30 Aligned_cols=160 Identities=22% Similarity=0.375 Sum_probs=122.8
Q ss_pred HHHHhhhhccceeeeeeeecccccCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHH
Q 002857 209 EVMRNIIHRKIIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYL 288 (873)
Q Consensus 209 ~iL~~L~HpNIV~llg~c~~~~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yL 288 (873)
.-|-++.|.|||++..|..+..+.+.....++.|||..|+|.++|+.. ......+......+|+.||..||.||
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt------~~~~~a~~~~~wkkw~tqIlsal~yL 192 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRT------KKNQKALFQKAWKKWCTQILSALSYL 192 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHH------HHhhhhhhHHHHHHHHHHHHhhhhhh
Confidence 345566899999999998776666777889999999999999999642 13345677777889999999999999
Q ss_pred hhCCCCCeeeccCCCCCeeeCCCCCeEEecccccccccc--ccccccccccccccccCCCcccCCCCCCcchhhHhHHHH
Q 002857 289 HLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEA--TNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGIL 366 (873)
Q Consensus 289 H~~~s~gIvHrDLKpsNILLd~~~~vKLsDFGla~~~~~--~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvv 366 (873)
| .|.++|+|+++.-+-|++..++-+||+----...... ...........+-++|.|||+-.....+..+|||+||+.
T Consensus 193 h-s~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmc 271 (458)
T KOG1266|consen 193 H-SCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMC 271 (458)
T ss_pred h-ccCCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHH
Confidence 9 5699999999999999999999888753211111000 001111222346789999999887788889999999999
Q ss_pred HHHHHhCCC
Q 002857 367 LLEMFTGLR 375 (873)
Q Consensus 367 L~ELlTGk~ 375 (873)
.+||..+..
T Consensus 272 AlemailEi 280 (458)
T KOG1266|consen 272 ALEMAILEI 280 (458)
T ss_pred HHHHHHhee
Confidence 999988754
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.26 E-value=1.9e-11 Score=141.25 Aligned_cols=142 Identities=20% Similarity=0.230 Sum_probs=99.9
Q ss_pred ceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcch----------------------------------------hHH
Q 002857 165 ENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDAS----------------------------------------KSF 204 (873)
Q Consensus 165 ~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~----------------------------------------~~f 204 (873)
.+.||.|++|.||+|++. +|+.||||+.+....... -+|
T Consensus 122 ~~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf 200 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL 200 (437)
T ss_pred CcceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence 368999999999999874 688999999753211000 024
Q ss_pred HHHHHHHHhhh----hccceeeeeeeecccccCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHH
Q 002857 205 TVECEVMRNII----HRKIIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAID 280 (873)
Q Consensus 205 ~~Ei~iL~~L~----HpNIV~llg~c~~~~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~q 280 (873)
.+|+..+.++. |.+-+.+-.++. ......+|||||++|++|.+++.. ..... .+..++..
T Consensus 201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~----~~~~~~vLvmE~i~G~~L~~~~~~---------~~~~~---~~~~ia~~ 264 (437)
T TIGR01982 201 RREAANASELGENFKNDPGVYVPEVYW----DRTSERVLTMEWIDGIPLSDIAAL---------DEAGL---DRKALAEN 264 (437)
T ss_pred HHHHHHHHHHHHhcCCCCCEEeCCEeh----hhcCCceEEEEeECCcccccHHHH---------HhcCC---CHHHHHHH
Confidence 45565555553 333344333332 123346899999999999987632 00111 34567777
Q ss_pred HHH-HHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEeccccccccc
Q 002857 281 VAS-ALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLE 326 (873)
Q Consensus 281 Ia~-gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDFGla~~~~ 326 (873)
++. .+..+| ..+++|+|++|.||+++.++.++|+|||++..+.
T Consensus 265 ~~~~~l~ql~---~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 265 LARSFLNQVL---RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred HHHHHHHHHH---hCCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 777 468889 8899999999999999999999999999997654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.22 E-value=7.4e-11 Score=117.53 Aligned_cols=127 Identities=17% Similarity=0.134 Sum_probs=95.8
Q ss_pred ceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhcccee-eeeeeecccccCCceEEEEEee
Q 002857 165 ENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIK-VVTACSRVDYQGNDFKALVYEF 243 (873)
Q Consensus 165 ~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~-llg~c~~~~~~~~~~~~LV~Ey 243 (873)
.+.|+.|.++.||+++. .+..|++|+...... ....+..|+++++.+.+.+++. ++.+. ....++||||
T Consensus 3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~-------~~~~~lv~e~ 72 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD-------PETGVLITEF 72 (170)
T ss_pred eeecCCcccCceEEEEE--CCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe-------CCCCeEEEEe
Confidence 36789999999999986 467899999754322 2345788999999997766554 44431 1234799999
Q ss_pred cCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCC-----eeeccCCCCCeeeCCCCCeEEec
Q 002857 244 MPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPP-----IAHCDIKPSNILLNDEMTACVAD 318 (873)
Q Consensus 244 ~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~g-----IvHrDLKpsNILLd~~~~vKLsD 318 (873)
+++.++.+.. .....++.+++++|+.|| ..+ ++|+|++|.||+++ ++.++++|
T Consensus 73 i~G~~l~~~~------------------~~~~~~~~~l~~~l~~LH---~~~~~~~~~~HgD~~~~Nil~~-~~~~~liD 130 (170)
T cd05151 73 IEGSELLTED------------------FSDPENLEKIAKLLKKLH---SSPLPDLVPCHNDLLPGNFLLD-DGRLWLID 130 (170)
T ss_pred cCCCcccccc------------------ccCHHHHHHHHHHHHHHh---CCCCCCceeecCCCCcCcEEEE-CCeEEEEe
Confidence 9998776421 012346789999999999 565 59999999999999 66899999
Q ss_pred ccccc
Q 002857 319 FGIAR 323 (873)
Q Consensus 319 FGla~ 323 (873)
||.+.
T Consensus 131 f~~a~ 135 (170)
T cd05151 131 WEYAG 135 (170)
T ss_pred ccccc
Confidence 99886
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.14 E-value=4.7e-11 Score=137.45 Aligned_cols=200 Identities=26% Similarity=0.280 Sum_probs=153.4
Q ss_pred CCCcceeecc--cCceEEEEEEE--cCCCcEEEEEEeeccC--CcchhHHHHHHHHHHhh-hhccceeeeeeeecccccC
Q 002857 161 GFSSENLIGA--GNFASVYKGIL--FEGAPAVAIKVFNFLH--HDASKSFTVECEVMRNI-IHRKIIKVVTACSRVDYQG 233 (873)
Q Consensus 161 ~f~~~~~LG~--G~fG~VYkg~~--~~~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L-~HpNIV~llg~c~~~~~~~ 233 (873)
.|.+...+|. |.+|.||.+.. ..++..+|+|.-+.-. ......-.+|+....++ .|+|.++.... +.+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~-----~e~ 189 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPA-----WEG 189 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcc-----ccc
Confidence 4566788999 99999999988 7788899999843222 22333445566666666 49999995554 466
Q ss_pred CceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHH----HHHHHhhCCCCCeeeccCCCCCeeeC
Q 002857 234 NDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVAS----ALEYLHLGCKPPIAHCDIKPSNILLN 309 (873)
Q Consensus 234 ~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~----gL~yLH~~~s~gIvHrDLKpsNILLd 309 (873)
.+..++-+|++ +.+|.++.+. ....++....+.++.+... ||.++| ...|+|-|+||.||++.
T Consensus 190 ~~~lfiqtE~~-~~sl~~~~~~---------~~~~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~ 256 (524)
T KOG0601|consen 190 SGILFIQTELC-GESLQSYCHT---------PCNFLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTT 256 (524)
T ss_pred CCcceeeeccc-cchhHHhhhc---------ccccCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecc
Confidence 77788888887 5688888753 3344677778888888888 999999 99999999999999999
Q ss_pred CC-CCeEEecccccccccccccccc---ccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCc
Q 002857 310 DE-MTACVADFGIARFLEATNEQTS---SIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDD 379 (873)
Q Consensus 310 ~~-~~vKLsDFGla~~~~~~~~~~~---~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~ 379 (873)
.+ ...+++|||+...+....-... .....|...|++||...+ .++..+|||++|.++++..++......
T Consensus 257 ~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~ 329 (524)
T KOG0601|consen 257 SDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSV 329 (524)
T ss_pred cccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccC
Confidence 99 8999999999987765442211 122357788999998654 478889999999999999998776543
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.11 E-value=6.9e-11 Score=142.49 Aligned_cols=84 Identities=30% Similarity=0.407 Sum_probs=73.0
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCG 80 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G 80 (873)
|++|.|+|.+|.+|+.|++|+.|+|++|+|+|.+|..++.|++|+.|+|++|+|+|.+|..+..+..+..+++++|.|.|
T Consensus 425 L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g 504 (623)
T PLN03150 425 LDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSG 504 (623)
T ss_pred CCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccc
Confidence 57888888899889999999999999999988899888899999999999999998888888888888888888888888
Q ss_pred CCCc
Q 002857 81 GIPE 84 (873)
Q Consensus 81 ~~p~ 84 (873)
.+|.
T Consensus 505 ~iP~ 508 (623)
T PLN03150 505 RVPA 508 (623)
T ss_pred cCCh
Confidence 7664
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.2e-09 Score=112.72 Aligned_cols=137 Identities=20% Similarity=0.177 Sum_probs=98.0
Q ss_pred ceeecccCceEEEEEEEcC------CCcEEEEEEeeccC----------------------CcchhHHH----HHHHHHH
Q 002857 165 ENLIGAGNFASVYKGILFE------GAPAVAIKVFNFLH----------------------HDASKSFT----VECEVMR 212 (873)
Q Consensus 165 ~~~LG~G~fG~VYkg~~~~------~g~~VAVK~l~~~~----------------------~~~~~~f~----~Ei~iL~ 212 (873)
...||.|.-+.||.|.... .+..+|||+++... ....+.+. +|+..|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3578999999999997543 24789999975210 01112233 7999999
Q ss_pred hhhh--ccceeeeeeeecccccCCceEEEEEeecCCCChhh-hcccccccccccCCCCCCchhhhHHHHHHHHHHHHHH-
Q 002857 213 NIIH--RKIIKVVTACSRVDYQGNDFKALVYEFMPNGSLEE-WIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYL- 288 (873)
Q Consensus 213 ~L~H--pNIV~llg~c~~~~~~~~~~~~LV~Ey~~~GSL~~-~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yL- 288 (873)
++.. -++.+++++ ...+|||||+.+..+.. .|+ ...++..+...+..+++.+|..|
T Consensus 82 rl~~~Gv~vP~pi~~---------~~~~lvME~Ig~~~~~~~~Lk-----------d~~~~~~~~~~i~~~i~~~l~~l~ 141 (197)
T cd05146 82 RMQKAGIPCPEVVVL---------KKHVLVMSFIGDDQVPAPKLK-----------DAKLNDEEMKNAYYQVLSMMKQLY 141 (197)
T ss_pred HHHHcCCCCCeEEEe---------cCCEEEEEEcCCCCccchhhh-----------ccccCHHHHHHHHHHHHHHHHHHH
Confidence 9864 456666654 23589999997654422 121 12244455677889999999999
Q ss_pred hhCCCCCeeeccCCCCCeeeCCCCCeEEecccccccc
Q 002857 289 HLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFL 325 (873)
Q Consensus 289 H~~~s~gIvHrDLKpsNILLd~~~~vKLsDFGla~~~ 325 (873)
| ..+||||||++.|||++ ++.+.|+|||.+...
T Consensus 142 H---~~glVHGDLs~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 142 K---ECNLVHADLSEYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred H---hCCeecCCCCHHHEEEE-CCcEEEEECCCceeC
Confidence 7 78999999999999997 467999999988754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.06 E-value=4.6e-10 Score=131.94 Aligned_cols=148 Identities=16% Similarity=0.148 Sum_probs=94.8
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCc----------------------------------chh---
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHD----------------------------------ASK--- 202 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~----------------------------------~~~--- 202 (873)
..|+. +.||.|++|.||+|+++.+|+.||||+.+..-.. ..+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 34665 7899999999999999877999999998632100 001
Q ss_pred ---HHHHHHHHHHhhh----hccceeeeeeeecccccCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhH
Q 002857 203 ---SFTVECEVMRNII----HRKIIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERL 275 (873)
Q Consensus 203 ---~f~~Ei~iL~~L~----HpNIV~llg~c~~~~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l 275 (873)
+|.+|+..+.+++ +.+.+.+-.++. .-....+|||||++|+.|.++-.- . .... .+.
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~----d~st~~VLvmE~i~G~~l~d~~~l--------~-~~g~---d~~ 262 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYW----DYCSETVMVMERMYGIPVSDVAAL--------R-AAGT---DMK 262 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeec----ccCCCceEEEeeecCccHHhHHHH--------H-hcCC---CHH
Confidence 2444554455543 333333333321 123457899999999999875310 0 0111 122
Q ss_pred HHHHHHHHH-HHHHhhCCCCCeeeccCCCCCeeeCCCC----CeEEecccccccccc
Q 002857 276 NIAIDVASA-LEYLHLGCKPPIAHCDIKPSNILLNDEM----TACVADFGIARFLEA 327 (873)
Q Consensus 276 ~Ia~qIa~g-L~yLH~~~s~gIvHrDLKpsNILLd~~~----~vKLsDFGla~~~~~ 327 (873)
.++...+.. +.-++ ..|++|+|++|.||+++.++ .+++.|||++..+..
T Consensus 263 ~la~~~v~~~~~Qif---~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 263 LLAERGVEVFFTQVF---RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHHHHHHHHHHHHH---hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 233333322 22334 57999999999999999888 999999999987654
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.05 E-value=2.7e-09 Score=124.28 Aligned_cols=171 Identities=16% Similarity=0.173 Sum_probs=127.8
Q ss_pred EEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEEEEeecCCCChhhhccccc
Q 002857 178 KGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPIT 257 (873)
Q Consensus 178 kg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~LV~Ey~~~GSL~~~L~~~~ 257 (873)
.|..+.++.+|.|..++...........+-++.|+.++||||++++.. +...+..|||+|.+. -|..++..
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t-----~e~~~~~ylvTErV~--Pl~~~lk~-- 100 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDT-----TEEEGTLYLVTERVR--PLETVLKE-- 100 (690)
T ss_pred ccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhh-----hcccCceEEEeeccc--cHHHHHHH--
Confidence 466667888999998876555444567788899999999999999987 456678999999884 46666643
Q ss_pred ccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEecccccccccccccccccccc
Q 002857 258 EEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGV 337 (873)
Q Consensus 258 ~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDFGla~~~~~~~~~~~~~~~ 337 (873)
+.....-..+.||+.||.|||+ ..+++|++|.-..|+++..|..||++|.++........ .....
T Consensus 101 -----------l~~~~v~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~ 165 (690)
T KOG1243|consen 101 -----------LGKEEVCLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSL 165 (690)
T ss_pred -----------hHHHHHHHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccc
Confidence 2244566788999999999996 56899999999999999999999999998864432221 11111
Q ss_pred ccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCC
Q 002857 338 KGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGL 374 (873)
Q Consensus 338 ~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk 374 (873)
.--..|..|+.+.... -..|.|-||++++|++.|.
T Consensus 166 ~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 166 YLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred hhhhcccChhhcCccc--cchhhhhHHHHHHHHhCcc
Confidence 2233466676543322 3469999999999999993
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.94 E-value=8.1e-10 Score=133.30 Aligned_cols=82 Identities=35% Similarity=0.454 Sum_probs=69.9
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccc-cCcccc-ccccccc
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFK-NASATS-VFGNNKL 78 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~-~~l~~~-~l~nN~L 78 (873)
|++|+|+|.+|..++.|++|+.|+|++|+|+|.+|..+++|++|+.|+|++|+|+|.+|..+... ..+..+ +.+|..+
T Consensus 449 Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~~N~~l 528 (623)
T PLN03150 449 LSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGL 528 (623)
T ss_pred CCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceEEecCCccc
Confidence 68999999999999999999999999999999999999999999999999999999999886532 122233 3456678
Q ss_pred CCCC
Q 002857 79 CGGI 82 (873)
Q Consensus 79 ~G~~ 82 (873)
||.+
T Consensus 529 c~~p 532 (623)
T PLN03150 529 CGIP 532 (623)
T ss_pred cCCC
Confidence 8743
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.94 E-value=1e-08 Score=106.15 Aligned_cols=145 Identities=19% Similarity=0.222 Sum_probs=105.9
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEeeccCC-cchhHHHHHHHHHHhhhhc--cceeeeeeeecccccCCceEEEEEe
Q 002857 166 NLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH-DASKSFTVECEVMRNIIHR--KIIKVVTACSRVDYQGNDFKALVYE 242 (873)
Q Consensus 166 ~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~Hp--NIV~llg~c~~~~~~~~~~~~LV~E 242 (873)
+.|+.|..+.||++... +|+.+++|+...... .....+..|+++++.+.+. ++.+++.+..... ..+..++|||
T Consensus 4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~--~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPS--VLGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEec-CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCC--ccCCceEEEE
Confidence 57899999999999873 357899999764322 1346789999999999763 4566777642211 1135689999
Q ss_pred ecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhC-------------------------------
Q 002857 243 FMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLG------------------------------- 291 (873)
Q Consensus 243 y~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~------------------------------- 291 (873)
|+++.++.+.+. ...++..++..++.+++++|.+||..
T Consensus 81 ~i~G~~l~~~~~-----------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (223)
T cd05154 81 RVDGRVLRDRLL-----------RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDAS 149 (223)
T ss_pred EeCCEecCCCCC-----------CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhh
Confidence 999988887652 02355666777777777777777731
Q ss_pred ----------------------CCCCeeeccCCCCCeeeCC--CCCeEEeccccccc
Q 002857 292 ----------------------CKPPIAHCDIKPSNILLND--EMTACVADFGIARF 324 (873)
Q Consensus 292 ----------------------~s~gIvHrDLKpsNILLd~--~~~vKLsDFGla~~ 324 (873)
....++|+|+.+.||+++. ++.+.|+||+.+..
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 150 RTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred cccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 1256799999999999998 66789999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.91 E-value=2.8e-08 Score=110.09 Aligned_cols=283 Identities=16% Similarity=0.151 Sum_probs=169.6
Q ss_pred CcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhh-hhccceeeeeeeeccc--ccCCceEEE
Q 002857 163 SSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNI-IHRKIIKVVTACSRVD--YQGNDFKAL 239 (873)
Q Consensus 163 ~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~llg~c~~~~--~~~~~~~~L 239 (873)
.....||+|+-+.+|-.-.. ...+-|++..-...... +.++.|... .||-+-.-+.+-...- -.......+
T Consensus 14 ~~gr~LgqGgea~ly~l~e~---~d~VAKIYh~Pppa~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf 87 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEV---RDQVAKIYHAPPPAAQA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF 87 (637)
T ss_pred CCCccccCCccceeeecchh---hchhheeecCCCchHHH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence 34578999999999975321 22345776533322211 223333333 4554333121110000 012223667
Q ss_pred EEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEecc
Q 002857 240 VYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADF 319 (873)
Q Consensus 240 V~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDF 319 (873)
+|..+.+. +=++.+...+.+...-...+|...+..++.+|.+.+-|| ..|.+-||+.++|+|+.++..+.|.|=
T Consensus 88 lmP~v~g~---~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~lVsd~~~V~LVds 161 (637)
T COG4248 88 LMPKVSGK---EPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH---EHGHVVGDVNQNSFLVSDDSKVVLVDS 161 (637)
T ss_pred ecccCCCc---cchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH---hcCCcccccCccceeeecCceEEEEcc
Confidence 88887664 222222223444556678899999999999999999999 889999999999999999999999985
Q ss_pred ccccccccccccccccccccccccCCCcccC-----CCCCCcchhhHhHHHHHHHHHhC-CCCCCcccccchhhHHHHhh
Q 002857 320 GIARFLEATNEQTSSIGVKGTTGYIAPEYGM-----GHETSSYGDVYSFGILLLEMFTG-LRPSDDMFKDNLNLQNWVQS 393 (873)
Q Consensus 320 Gla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~-----~~~~s~ksDVwSfGvvL~ELlTG-k~Pf~~~~~~~~~l~~~~~~ 393 (873)
..-.+. .........+|...|.+||.-. +..-+...|-|.+||++++|+.| ++||.+......
T Consensus 162 Dsfqi~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~-------- 230 (637)
T COG4248 162 DSFQIN---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISD-------- 230 (637)
T ss_pred cceeec---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCC--------
Confidence 433322 1222233346888999999643 44567789999999999999986 999987432110
Q ss_pred cCchhHH-HHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhcc--CcCCCCCHHHHHHHHHHHHH
Q 002857 394 ALPERVE-EIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAE--LPGERMKINDVELGLRLIKK 470 (873)
Q Consensus 394 ~~~~~l~-elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~--dP~eRPTm~EVl~~Le~i~~ 470 (873)
-+...+ +|-...+....+.+. ..+..|...... . .+..+..+..+|+.. ++.-|||++.++..|..++.
T Consensus 231 -ap~p~E~~Ia~g~f~ya~~~~~---g~~p~P~~~P~~-~---Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~ 302 (637)
T COG4248 231 -APNPLETDIAHGRFAYASDQRR---GLKPPPRSIPLS-M---LPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQ 302 (637)
T ss_pred -CCCcchhhhhcceeeechhccC---CCCCCCCCCChh-h---cCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHH
Confidence 011111 222222111111000 011111111111 1 122355677788865 36789999999999999999
Q ss_pred hhhcCC
Q 002857 471 KLLETP 476 (873)
Q Consensus 471 ~l~~~~ 476 (873)
.+.+..
T Consensus 303 ~L~~C~ 308 (637)
T COG4248 303 QLKKCT 308 (637)
T ss_pred hhhhhh
Confidence 887653
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.89 E-value=1.1e-09 Score=126.44 Aligned_cols=200 Identities=23% Similarity=0.197 Sum_probs=146.8
Q ss_pred HHHhhcCCCcceeecccCceEEEEEEEc-CCCcEEEEEEeeccCCcchhH--HHHHHHHHHhh-hhccceeeeeeeeccc
Q 002857 155 LYSATKGFSSENLIGAGNFASVYKGILF-EGAPAVAIKVFNFLHHDASKS--FTVECEVMRNI-IHRKIIKVVTACSRVD 230 (873)
Q Consensus 155 l~~at~~f~~~~~LG~G~fG~VYkg~~~-~~g~~VAVK~l~~~~~~~~~~--f~~Ei~iL~~L-~HpNIV~llg~c~~~~ 230 (873)
...-+.+|.....||.|.|+.|+..... .++..+++|.+.........+ -..|+.+...+ .|.++++....
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~----- 334 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSS----- 334 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCC-----
Confidence 3344567899999999999999998765 678889999876443332222 23455555555 58888876554
Q ss_pred ccCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCC
Q 002857 231 YQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLND 310 (873)
Q Consensus 231 ~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~ 310 (873)
+......++-.||++++++...+. ....+++..++.+..|++.++.++| ++.++|+|+||+||++..
T Consensus 335 W~~~r~~~ip~e~~~~~s~~l~~~----------~~~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~ 401 (524)
T KOG0601|consen 335 WSQLRQGYIPLEFCEGGSSSLRSV----------TSQMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISN 401 (524)
T ss_pred ccccccccCchhhhcCcchhhhhH----------HHHhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeecc
Confidence 344556679999999998876651 2345777789999999999999999 999999999999999987
Q ss_pred C-CCeEEecccccccccccccccccccccccccc-CCCcccCCCCCCcchhhHhHHHHHHHHHhCCCC
Q 002857 311 E-MTACVADFGIARFLEATNEQTSSIGVKGTTGY-IAPEYGMGHETSSYGDVYSFGILLLEMFTGLRP 376 (873)
Q Consensus 311 ~-~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y-~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~P 376 (873)
+ +.-+++|||.+..+...... ....+..| .+++......+-.+.|+||||..+.|.+++..-
T Consensus 402 ~~~~~~~~~~~~~t~~~~~~~~----~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~l 465 (524)
T KOG0601|consen 402 DGFFSKLGDFGCWTRLAFSSGV----FHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPL 465 (524)
T ss_pred chhhhhccccccccccceeccc----ccccccccccchhhccccccccccccccccccccccccCccc
Confidence 6 88999999998642211110 01122333 355556666788999999999999999998644
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.86 E-value=3.6e-08 Score=111.78 Aligned_cols=182 Identities=17% Similarity=0.168 Sum_probs=137.9
Q ss_pred CceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEEEEeecCC-CChh
Q 002857 172 NFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKALVYEFMPN-GSLE 250 (873)
Q Consensus 172 ~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~LV~Ey~~~-GSL~ 250 (873)
...+.|++....+|..+++|++.............-+++++++.|.|||++..++.... .++.-++|||+|.++ ++|.
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~t-F~D~SlvlvYDYyP~s~TL~ 366 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYT-FGDLSLVLVYDYYPSSPTLY 366 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhc-cCcceEEEEEecCCCCchHH
Confidence 45688999998899999999995443333334455688999999999999999876333 345568999999986 5787
Q ss_pred hhcccccccc-----cccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEecccccccc
Q 002857 251 EWIHPITEED-----KRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFL 325 (873)
Q Consensus 251 ~~L~~~~~~~-----~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDFGla~~~ 325 (873)
++-....... .....+..+++..+|.++.|+..||.++| +.|+.-+-|.+++||++.+.+++|+..|+...+
T Consensus 367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl 443 (655)
T KOG3741|consen 367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH---SSGLACKTLDLKKILVTGKMRIRISGCGIMDVL 443 (655)
T ss_pred HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH---hcCceeecccHhHeEeeCcceEEEecccceeee
Confidence 7665322221 11234556788999999999999999999 889999999999999999999999999988766
Q ss_pred ccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCC
Q 002857 326 EATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRP 376 (873)
Q Consensus 326 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~P 376 (873)
..+.. |-+.. -.+-|.=.||.+++-|.||...
T Consensus 444 ~~d~~----------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 444 QEDPT----------------EPLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred cCCCC----------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 44331 11111 2346888999999999999654
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.82 E-value=3.3e-08 Score=99.83 Aligned_cols=129 Identities=22% Similarity=0.306 Sum_probs=95.3
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEeeccC--Cc------chhHHHHHHHHHHhhhhc--cceeeeeeeecccccCCc
Q 002857 166 NLIGAGNFASVYKGILFEGAPAVAIKVFNFLH--HD------ASKSFTVECEVMRNIIHR--KIIKVVTACSRVDYQGND 235 (873)
Q Consensus 166 ~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~--~~------~~~~f~~Ei~iL~~L~Hp--NIV~llg~c~~~~~~~~~ 235 (873)
..+++|+-+.+|.+.+. |..+++|.=.... .. ....-.+|+.+|.+++-- +...++.+ +..
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dv-------D~~ 72 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDV-------DPD 72 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEE-------cCC
Confidence 46889999999999773 3346666422111 11 123567799999988643 33344443 344
Q ss_pred eEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeE
Q 002857 236 FKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTAC 315 (873)
Q Consensus 236 ~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vK 315 (873)
...|+|||++|-.|.++|.. . +..++..|-.-+.-|| ..+|+|+||.++||++..+. +.
T Consensus 73 ~~~I~me~I~G~~lkd~l~~----------~-------~~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~ 131 (204)
T COG3642 73 NGLIVMEYIEGELLKDALEE----------A-------RPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IY 131 (204)
T ss_pred CCEEEEEEeCChhHHHHHHh----------c-------chHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EE
Confidence 56899999999999988842 1 3668888888899999 99999999999999998765 99
Q ss_pred Eeccccccc
Q 002857 316 VADFGIARF 324 (873)
Q Consensus 316 LsDFGla~~ 324 (873)
++|||++.+
T Consensus 132 ~IDfGLg~~ 140 (204)
T COG3642 132 FIDFGLGEF 140 (204)
T ss_pred EEECCcccc
Confidence 999999974
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=98.81 E-value=4e-09 Score=133.76 Aligned_cols=84 Identities=37% Similarity=0.504 Sum_probs=80.1
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCG 80 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G 80 (873)
|++|+++|.+|..|.+|++|+.|+|++|+++|.+|..+.+|++|++|+|++|.|+|.+|..+..+..+..+++++|.+.|
T Consensus 482 ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 561 (968)
T PLN00113 482 LSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSG 561 (968)
T ss_pred CcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccc
Confidence 68999999999999999999999999999999999999999999999999999999999998888999999999999998
Q ss_pred CCCc
Q 002857 81 GIPE 84 (873)
Q Consensus 81 ~~p~ 84 (873)
..|.
T Consensus 562 ~~p~ 565 (968)
T PLN00113 562 EIPK 565 (968)
T ss_pred cCCh
Confidence 7764
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.76 E-value=5.6e-08 Score=97.82 Aligned_cols=143 Identities=22% Similarity=0.249 Sum_probs=99.6
Q ss_pred cceeecccCceEEEEEEEcCCCcEEEEEE-eecc-------CCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCc
Q 002857 164 SENLIGAGNFASVYKGILFEGAPAVAIKV-FNFL-------HHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGND 235 (873)
Q Consensus 164 ~~~~LG~G~fG~VYkg~~~~~g~~VAVK~-l~~~-------~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~ 235 (873)
...+|-+|+-+.|+++.+ .|+..+||. +.+. ..-..++..+|+++|.++.--.|.--.-++ .+..
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~-----~D~~ 83 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIF-----IDTY 83 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEE-----EecC
Confidence 568899999999999987 567767764 3211 111235678899999998643332222221 1223
Q ss_pred eEEEEEeecCC-CChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCC--
Q 002857 236 FKALVYEFMPN-GSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEM-- 312 (873)
Q Consensus 236 ~~~LV~Ey~~~-GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~-- 312 (873)
.-.|+|||+++ -++.+++... ............++..|-+.+.-|| ..+|+||||..+||+|..++
T Consensus 84 ~~~i~ME~~~g~~~vk~~i~~~--------~~~~~~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~ 152 (229)
T KOG3087|consen 84 GGQIYMEFIDGASTVKDFILST--------MEDESEDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQ 152 (229)
T ss_pred CCeEEEEeccchhHHHHHHHHH--------ccCcccchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCc
Confidence 34799999976 4788887531 1122222233788999999999999 89999999999999996544
Q ss_pred -CeEEeccccccc
Q 002857 313 -TACVADFGIARF 324 (873)
Q Consensus 313 -~vKLsDFGla~~ 324 (873)
.+.++|||++..
T Consensus 153 ~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 153 ITPILIDFGLSSV 165 (229)
T ss_pred CceEEEeecchhc
Confidence 568999999864
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.73 E-value=2.8e-09 Score=128.60 Aligned_cols=205 Identities=21% Similarity=0.324 Sum_probs=142.4
Q ss_pred hhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC---CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCC
Q 002857 158 ATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH---HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGN 234 (873)
Q Consensus 158 at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~ 234 (873)
..++|.+.+-+-.|.++.++.+.-...+...++|+..... ....+....+-.++-..+||-++...-- +.-.
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s-----~~~r 876 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPS-----FPCR 876 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCC-----CCCC
Confidence 4466777788889999999987665555555555543211 1111222222222222233444443322 2345
Q ss_pred ceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCe
Q 002857 235 DFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTA 314 (873)
Q Consensus 235 ~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~v 314 (873)
....||++|+.+++|...|+. ....+..-....+..+..+++||| ...++|+|++|.|+|...+++.
T Consensus 877 sP~~L~~~~~~~~~~~Skl~~----------~~~~saepaRs~i~~~vqs~e~L~---s~~r~h~~~~p~~~l~~~~gh~ 943 (1205)
T KOG0606|consen 877 SPLPLVGHYLNGGDLPSKLHN----------SGCLSAEPARSPILERVQSLESLH---SSLRKHRDLKPDSLLIAYDGHR 943 (1205)
T ss_pred CCcchhhHHhccCCchhhhhc----------CCCcccccccchhHHHHhhhhccc---cchhhcccccccchhhcccCCc
Confidence 567899999999999999864 234555555667778889999999 7779999999999999999999
Q ss_pred EEeccccccccccc---------------------c--------ccccccccccccccCCCcccCCCCCCcchhhHhHHH
Q 002857 315 CVADFGIARFLEAT---------------------N--------EQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGI 365 (873)
Q Consensus 315 KLsDFGla~~~~~~---------------------~--------~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGv 365 (873)
+++|||........ . .........+|..|.+||...+......+|.|++|+
T Consensus 944 ~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~ 1023 (1205)
T KOG0606|consen 944 PLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGV 1023 (1205)
T ss_pred ccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhh
Confidence 99999843221100 0 001123456899999999999999999999999999
Q ss_pred HHHHHHhCCCCCCcc
Q 002857 366 LLLEMFTGLRPSDDM 380 (873)
Q Consensus 366 vL~ELlTGk~Pf~~~ 380 (873)
+++|.++|..||+..
T Consensus 1024 ~l~e~l~g~pp~na~ 1038 (1205)
T KOG0606|consen 1024 CLFEVLTGIPPFNAE 1038 (1205)
T ss_pred hhhhhhcCCCCCCCc
Confidence 999999999999874
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.69 E-value=2.1e-07 Score=101.02 Aligned_cols=146 Identities=14% Similarity=0.083 Sum_probs=100.2
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEeeccCCc-----------chhHHHHHHHHHHhhhhccc--eeeeeeeeccccc
Q 002857 166 NLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHD-----------ASKSFTVECEVMRNIIHRKI--IKVVTACSRVDYQ 232 (873)
Q Consensus 166 ~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~-----------~~~~f~~Ei~iL~~L~HpNI--V~llg~c~~~~~~ 232 (873)
+.+-.-....|++..+ +|+.+.||........ ....+.+|...+.++...+| ..++++.......
T Consensus 28 e~v~~~~~rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~ 105 (268)
T PRK15123 28 EVFRELEGRRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP 105 (268)
T ss_pred cEEecCCCceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence 4444444455777765 6678999977422211 11247899999999864443 3445553211111
Q ss_pred CCceEEEEEeecCCC-ChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCC-
Q 002857 233 GNDFKALVYEFMPNG-SLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLND- 310 (873)
Q Consensus 233 ~~~~~~LV~Ey~~~G-SL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~- 310 (873)
.....+||||++++- +|.+++... .....+...+..++.+++..+.-|| ..||+|+|++++|||++.
T Consensus 106 ~~~~s~LVte~l~~~~sL~~~~~~~--------~~~~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~ 174 (268)
T PRK15123 106 ATRTSFIITEDLAPTISLEDYCADW--------ATNPPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLP 174 (268)
T ss_pred ccceeEEEEeeCCCCccHHHHHHhh--------cccCCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEecc
Confidence 123578999999876 899887421 1123445667789999999999999 899999999999999975
Q ss_pred ------CCCeEEeccccccc
Q 002857 311 ------EMTACVADFGIARF 324 (873)
Q Consensus 311 ------~~~vKLsDFGla~~ 324 (873)
+..+.|+||+.++.
T Consensus 175 ~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 175 FPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred ccCCCCCceEEEEECCcccc
Confidence 46899999998863
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.68 E-value=1.2e-07 Score=97.58 Aligned_cols=125 Identities=22% Similarity=0.259 Sum_probs=82.0
Q ss_pred EEEEEEEcCCCcEEEEEEeeccC-------------Cc-------------chhHHHHHHHHHHhhhhc--cceeeeeee
Q 002857 175 SVYKGILFEGAPAVAIKVFNFLH-------------HD-------------ASKSFTVECEVMRNIIHR--KIIKVVTAC 226 (873)
Q Consensus 175 ~VYkg~~~~~g~~VAVK~l~~~~-------------~~-------------~~~~f~~Ei~iL~~L~Hp--NIV~llg~c 226 (873)
.||.|.. .++..+|||+.+... .. ......+|.+.|.++..- ++.+++.+-
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 4899976 567799999975210 00 012467799999999654 566666551
Q ss_pred ecccccCCceEEEEEeecC--CCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHH-HhhCCCCCeeeccCCC
Q 002857 227 SRVDYQGNDFKALVYEFMP--NGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEY-LHLGCKPPIAHCDIKP 303 (873)
Q Consensus 227 ~~~~~~~~~~~~LV~Ey~~--~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~y-LH~~~s~gIvHrDLKp 303 (873)
...|||||++ |..+..+.. ..++......++.+++..+.. +| ..+|+||||.+
T Consensus 80 ---------~~~ivME~I~~~G~~~~~l~~------------~~~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~ 135 (188)
T PF01163_consen 80 ---------RNVIVMEYIGEDGVPLPRLKD------------VDLSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSE 135 (188)
T ss_dssp ---------TTEEEEE--EETTEEGGCHHH------------CGGGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-ST
T ss_pred ---------CCEEEEEecCCCccchhhHHh------------ccccchhHHHHHHHHHHHHHHHHH---hcCceecCCCh
Confidence 2379999998 544544331 112244567788899886665 57 88999999999
Q ss_pred CCeeeCCCCCeEEecccccccc
Q 002857 304 SNILLNDEMTACVADFGIARFL 325 (873)
Q Consensus 304 sNILLd~~~~vKLsDFGla~~~ 325 (873)
.|||++++ .+.|+|||.+...
T Consensus 136 ~NIlv~~~-~~~iIDf~qav~~ 156 (188)
T PF01163_consen 136 YNILVDDG-KVYIIDFGQAVDS 156 (188)
T ss_dssp TSEEEETT-CEEE--GTTEEET
T ss_pred hhEEeecc-eEEEEecCcceec
Confidence 99999988 9999999988643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.48 E-value=6.8e-07 Score=95.32 Aligned_cols=134 Identities=21% Similarity=0.210 Sum_probs=97.5
Q ss_pred CCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCC----------------------cchhHHHHHHHHHHhhhhc--
Q 002857 162 FSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH----------------------DASKSFTVECEVMRNIIHR-- 217 (873)
Q Consensus 162 f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~----------------------~~~~~f~~Ei~iL~~L~Hp-- 217 (873)
..+.+.||.|.-+.||.|.. ..|..+|||.-+.... -.....++|.++|.+|...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~-~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAID-PKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEEC-CCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 34568999999999999977 4678999997531100 0113467799999998654
Q ss_pred cceeeeeeeecccccCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCee
Q 002857 218 KIIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIA 297 (873)
Q Consensus 218 NIV~llg~c~~~~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIv 297 (873)
.|.+.+++ +...+||||++|--|...- ++....-.|+..|+.-+..+- ..|||
T Consensus 172 ~VP~P~~~---------nRHaVvMe~ieG~eL~~~r---------------~~~en~~~il~~il~~~~~~~---~~GiV 224 (304)
T COG0478 172 KVPKPIAW---------NRHAVVMEYIEGVELYRLR---------------LDVENPDEILDKILEEVRKAY---RRGIV 224 (304)
T ss_pred CCCCcccc---------ccceeeeehcccceeeccc---------------CcccCHHHHHHHHHHHHHHHH---HcCcc
Confidence 66666665 3568999999885554321 123344456666666666555 57899
Q ss_pred eccCCCCCeeeCCCCCeEEecccccc
Q 002857 298 HCDIKPSNILLNDEMTACVADFGIAR 323 (873)
Q Consensus 298 HrDLKpsNILLd~~~~vKLsDFGla~ 323 (873)
|+|+..-||+++++|.+.++||-.+.
T Consensus 225 HGDlSefNIlV~~dg~~~vIDwPQ~v 250 (304)
T COG0478 225 HGDLSEFNILVTEDGDIVVIDWPQAV 250 (304)
T ss_pred ccCCchheEEEecCCCEEEEeCcccc
Confidence 99999999999999999999997664
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.48 E-value=2.7e-08 Score=98.38 Aligned_cols=75 Identities=24% Similarity=0.327 Sum_probs=36.8
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCccccccccccc
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKL 78 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L 78 (873)
||+|+|+ .+|+.|..|.+|+.|+|++|+++ .+|.++++|+.|+.|+++-|.|. .+|..++.+..+..+++..|+|
T Consensus 40 LSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldltynnl 114 (264)
T KOG0617|consen 40 LSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLTYNNL 114 (264)
T ss_pred cccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhcccccc
Confidence 3455555 45555555555555555555555 45555555555555555544444 3444444444444444444433
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.42 E-value=4.5e-06 Score=86.96 Aligned_cols=159 Identities=17% Similarity=0.136 Sum_probs=109.7
Q ss_pred HHHHHHhhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC------CcchhHHHHHHHHHHhhhhc--cceeee
Q 002857 152 YEALYSATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH------HDASKSFTVECEVMRNIIHR--KIIKVV 223 (873)
Q Consensus 152 ~~el~~at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~------~~~~~~f~~Ei~iL~~L~Hp--NIV~ll 223 (873)
++.+......+-..---|+||.+.|++-.. +|..+-+|.-.... .-....|.+|+..|.++... .+.+.+
T Consensus 10 f~~~w~~~~~wve~pN~~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv 87 (216)
T PRK09902 10 FNHWWATEGDWVEEPNYRRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV 87 (216)
T ss_pred HHHHHhCCCceecCCCcCCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc
Confidence 344444443443333457799999999765 34467788643111 22456899999999999643 344444
Q ss_pred eeeecccccCCceEEEEEeecCC-CChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCC
Q 002857 224 TACSRVDYQGNDFKALVYEFMPN-GSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIK 302 (873)
Q Consensus 224 g~c~~~~~~~~~~~~LV~Ey~~~-GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLK 302 (873)
++........-..+||+|-+.+ -+|.+++.. ......+...+..++.+|+..++-|| ..++.|+|+.
T Consensus 88 -f~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~--------~~~~~~~~~~k~~il~~va~~ia~LH---~~Gv~Hgdly 155 (216)
T PRK09902 88 -FGEAVKIEGEWRALLVTEDMAGFISIADWYAQ--------HAVSPYSDEVRQAMLKAVALAFKKMH---SVNRQHGCCY 155 (216)
T ss_pred -eeeeeccCCceEEEEEEEeCCCCccHHHHHhc--------CCcCCcchHHHHHHHHHHHHHHHHHH---HCCCcCCCCC
Confidence 3322212223457899998864 488888743 12234577778899999999999999 8999999999
Q ss_pred CCCeeeCCCCC--eEEeccccccc
Q 002857 303 PSNILLNDEMT--ACVADFGIARF 324 (873)
Q Consensus 303 psNILLd~~~~--vKLsDFGla~~ 324 (873)
+.|||++.++. ++++||.-++.
T Consensus 156 ~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 156 VRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred HhheeecCCCCeeEEEEEhhccch
Confidence 99999986666 99999987763
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.34 E-value=3.6e-06 Score=87.84 Aligned_cols=110 Identities=22% Similarity=0.282 Sum_probs=84.0
Q ss_pred hHHHHHHHHHHhhhhc--cceeeeeeeecccccCCceEEEEEeecCCC-ChhhhcccccccccccCCCCCCchhhhHHHH
Q 002857 202 KSFTVECEVMRNIIHR--KIIKVVTACSRVDYQGNDFKALVYEFMPNG-SLEEWIHPITEEDKRHKAPGNLNSLERLNIA 278 (873)
Q Consensus 202 ~~f~~Ei~iL~~L~Hp--NIV~llg~c~~~~~~~~~~~~LV~Ey~~~G-SL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia 278 (873)
....+|...+.++... ...+.+++..... ......+||+|++++- +|.+++.. ...++......++
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~-~~~~~s~lite~l~~~~~L~~~~~~----------~~~~~~~~~~~ll 124 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRK-GGGYRSYLITEALPGAQDLRDLLQQ----------WEQLDPSQRRELL 124 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcC-CCceeEEEEEEeCCCcccHHHHHHh----------hcccchhhHHHHH
Confidence 4678899988888543 3455566543221 1123468999999874 79998842 1125666788999
Q ss_pred HHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCC---CeEEecccccccc
Q 002857 279 IDVASALEYLHLGCKPPIAHCDIKPSNILLNDEM---TACVADFGIARFL 325 (873)
Q Consensus 279 ~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~---~vKLsDFGla~~~ 325 (873)
.+++..++-|| ..+|+|+|+++.|||++.+. .+.|+||+.++..
T Consensus 125 ~~l~~~i~~lH---~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 125 RALARLIAKLH---DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHHHHHHH---HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99999999999 89999999999999999876 8999999988753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.33 E-value=9.6e-08 Score=94.56 Aligned_cols=67 Identities=31% Similarity=0.290 Sum_probs=54.6
Q ss_pred CCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCCCC
Q 002857 14 LSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCGGI 82 (873)
Q Consensus 14 l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G~~ 82 (873)
+.++.+++.|-||+|.|+ .+|+.++.|.+|++|++++|+++ .+|.++..+..+..+.++-|+|.-.+
T Consensus 29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~~lp 95 (264)
T KOG0617|consen 29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLNILP 95 (264)
T ss_pred ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhhcCc
Confidence 566778888888888888 88888888888888888888888 67777778888888888888877544
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.23 E-value=4.1e-07 Score=106.74 Aligned_cols=98 Identities=24% Similarity=0.439 Sum_probs=76.6
Q ss_pred HHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEecccccccccccccc-------ccccccccccccCCCcccC
Q 002857 278 AIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQ-------TSSIGVKGTTGYIAPEYGM 350 (873)
Q Consensus 278 a~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDFGla~~~~~~~~~-------~~~~~~~Gt~~Y~APE~l~ 350 (873)
+.+++.||.|+|. +.++||++|.|++|.++..+..||+.|+++......... ....-..-...|.|||++.
T Consensus 105 l~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 3445599999996 789999999999999999999999999988654432110 1111122467899999999
Q ss_pred CCCCCcchhhHhHHHHHHHHHh-CCCCC
Q 002857 351 GHETSSYGDVYSFGILLLEMFT-GLRPS 377 (873)
Q Consensus 351 ~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf 377 (873)
+...+.++|+||+|+++|.+.. |+.-+
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~ 210 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSII 210 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchh
Confidence 9889999999999999999994 55444
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.08 E-value=1.5e-06 Score=72.43 Aligned_cols=58 Identities=34% Similarity=0.426 Sum_probs=26.8
Q ss_pred CCCeEeCCCCcCCCccc-ccccCCCCcceecccCCCccCCCCcccccccCcccccccccc
Q 002857 19 GLKVLDLSQNNLSGEIP-EFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNK 77 (873)
Q Consensus 19 ~L~~L~Ls~N~LsG~iP-~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~ 77 (873)
+|+.|+|++|+|+ .|| ..|..+++|++|+|++|+|+...|..+..+..+..+++++|.
T Consensus 2 ~L~~L~l~~n~l~-~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 2 NLESLDLSNNKLT-EIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp TESEEEETSSTES-EECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred cCcEEECCCCCCC-ccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 3444455555444 333 344444555555555555544444444444444444444443
|
... |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.04 E-value=5.8e-05 Score=80.08 Aligned_cols=154 Identities=18% Similarity=0.171 Sum_probs=102.4
Q ss_pred CccCHHHHHHhhcCCCcceeec---ccCceEEEEEEEcCCCcEEEEEEeeccCCcch-----------------------
Q 002857 148 PYVSYEALYSATKGFSSENLIG---AGNFASVYKGILFEGAPAVAIKVFNFLHHDAS----------------------- 201 (873)
Q Consensus 148 ~~~s~~el~~at~~f~~~~~LG---~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~----------------------- 201 (873)
-..+++.|....++..+..+.| .|.-+.||+|.. .++..||||+++.......
T Consensus 33 D~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv 111 (268)
T COG1718 33 DKRTLETLRRLLSRGVITELVGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLV 111 (268)
T ss_pred hhHHHHHHHHHhcCCceeeeEeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHH
Confidence 3456677777777777766555 567779999965 5678999999863221110
Q ss_pred -hHHHHHHHHHHhhh--hccceeeeeeeecccccCCceEEEEEeecCCCC-hhhhcccccccccccCCCCCCchhhhHHH
Q 002857 202 -KSFTVECEVMRNII--HRKIIKVVTACSRVDYQGNDFKALVYEFMPNGS-LEEWIHPITEEDKRHKAPGNLNSLERLNI 277 (873)
Q Consensus 202 -~~f~~Ei~iL~~L~--HpNIV~llg~c~~~~~~~~~~~~LV~Ey~~~GS-L~~~L~~~~~~~~~~~~~~~Ls~~~~l~I 277 (873)
.....|..-|.++. +-.+.+-+++. .-.|||||+.... -.-.| ....+...+...+
T Consensus 112 ~~W~~kEf~NL~R~~eAGVrvP~Pi~~~---------~nVLvMEfIg~~g~pAP~L-----------kDv~~e~~e~~~~ 171 (268)
T COG1718 112 FAWARKEFRNLKRAYEAGVRVPEPIAFR---------NNVLVMEFIGDDGLPAPRL-----------KDVPLELEEAEGL 171 (268)
T ss_pred HHHHHHHHHHHHHHHHcCCCCCCceeec---------CCeEEEEeccCCCCCCCCc-----------ccCCcCchhHHHH
Confidence 11344666666663 34444445441 2479999996531 11111 1122223356778
Q ss_pred HHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEecccccccc
Q 002857 278 AIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFL 325 (873)
Q Consensus 278 a~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDFGla~~~ 325 (873)
..++++.+.-|-. ..++||+||+.=|||+. ++.+.|+|||.|...
T Consensus 172 ~~~~v~~~~~l~~--~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~ 216 (268)
T COG1718 172 YEDVVEYMRRLYK--EAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTI 216 (268)
T ss_pred HHHHHHHHHHHHH--hcCcccccchhhheEEE-CCeEEEEECcccccc
Confidence 8888999888872 48999999999999999 889999999998754
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.04 E-value=4.9e-05 Score=79.71 Aligned_cols=142 Identities=13% Similarity=0.131 Sum_probs=95.1
Q ss_pred hhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhH---------HHHHHHHHHhhhhc---cceeeeee
Q 002857 158 ATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKS---------FTVECEVMRNIIHR---KIIKVVTA 225 (873)
Q Consensus 158 at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~---------f~~Ei~iL~~L~Hp---NIV~llg~ 225 (873)
...+|...+++-......|.+-.. ++..+++|..+.......+. ..+++..+.+++.. ....++..
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 456788888888888888877655 67889999887543332222 23344444455332 22232332
Q ss_pred eecccccCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCC
Q 002857 226 CSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSN 305 (873)
Q Consensus 226 c~~~~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsN 305 (873)
.....+.-....+|||||++|..|.++.. ++. .++..|++++.-|| ..|++|+|..|.|
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------------i~e----~~~~ki~~~ikqlH---~~G~~HGD~hpgN 165 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIED--------------IDE----DLAEKIVEAIKQLH---KHGFYHGDPHPGN 165 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccchh--------------cCH----HHHHHHHHHHHHHH---HcCCccCCCCcCc
Confidence 22222222344679999999988877541 111 35677888899999 8999999999999
Q ss_pred eeeCCCCCeEEecccccc
Q 002857 306 ILLNDEMTACVADFGIAR 323 (873)
Q Consensus 306 ILLd~~~~vKLsDFGla~ 323 (873)
+++++++ ++++||+..+
T Consensus 166 Flv~~~~-i~iID~~~k~ 182 (229)
T PF06176_consen 166 FLVSNNG-IRIIDTQGKR 182 (229)
T ss_pred EEEECCc-EEEEECcccc
Confidence 9999654 9999998765
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.02 E-value=2.2e-06 Score=71.41 Aligned_cols=54 Identities=35% Similarity=0.434 Sum_probs=47.0
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCc
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNF 54 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~L 54 (873)
|++|+|+..-+..|..+++|++|+|++|+|+..-|..|.+|++|+.|+|++|+|
T Consensus 8 l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 8 LSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp ETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 578999944446788999999999999999965557999999999999999986
|
... |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.96 E-value=8.5e-05 Score=77.11 Aligned_cols=151 Identities=19% Similarity=0.271 Sum_probs=86.1
Q ss_pred ceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhcc--ceeeeeeeecccccCCceEEEEEe
Q 002857 165 ENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRK--IIKVVTACSRVDYQGNDFKALVYE 242 (873)
Q Consensus 165 ~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpN--IV~llg~c~~~~~~~~~~~~LV~E 242 (873)
.+.|+.|..+.||+..... ..+++|..... .....+..|+.+++.+.... +.+++.++.. .......+++|+
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~--~~~~~~~~~~~~ 75 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTS--DEFNGFPYLLME 75 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEE--TEETSEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeeccc--ccccccceEEEE
Confidence 3679999999999998743 58999997533 34567889999999996543 4566664322 122345799999
Q ss_pred ecCCCChhh----------------hcccccccccccCCCCCCchhh---------hHHH------------HHHHHH-H
Q 002857 243 FMPNGSLEE----------------WIHPITEEDKRHKAPGNLNSLE---------RLNI------------AIDVAS-A 284 (873)
Q Consensus 243 y~~~GSL~~----------------~L~~~~~~~~~~~~~~~Ls~~~---------~l~I------------a~qIa~-g 284 (873)
++++..+.. .+...... . .....+.+.. .... ...+.+ .
T Consensus 76 ~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~--~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (239)
T PF01636_consen 76 YIPGRPLDDELSPEQRPELLRQLGRALAQLHQV--P-PPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERL 152 (239)
T ss_dssp EESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHS--H-TTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHH
T ss_pred Eeccccccccccccccccccccchhhhhhcccc--c-ccccccccccccccccccccccccccccchhhhhhhHHHHHHH
Confidence 999988877 11100000 0 0001111000 0000 111222 2
Q ss_pred HHHHhh----CCCCCeeeccCCCCCeeeC-CCCCeEEeccccccc
Q 002857 285 LEYLHL----GCKPPIAHCDIKPSNILLN-DEMTACVADFGIARF 324 (873)
Q Consensus 285 L~yLH~----~~s~gIvHrDLKpsNILLd-~~~~vKLsDFGla~~ 324 (873)
+..++. .....++|+|+.+.|||++ +++.+.|+||+.+..
T Consensus 153 ~~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 153 LQELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred HHHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 333331 1257799999999999999 666668999988753
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.96 E-value=3e-05 Score=91.16 Aligned_cols=142 Identities=19% Similarity=0.234 Sum_probs=92.2
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEeeccCC----------------------c----ch--------------hHHH
Q 002857 166 NLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH----------------------D----AS--------------KSFT 205 (873)
Q Consensus 166 ~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~----------------------~----~~--------------~~f~ 205 (873)
+.|+.++-|.||+|++. +|+.||||+.+..-. . .. -++.
T Consensus 131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 67999999999999985 589999998641110 0 00 0134
Q ss_pred HHHHHHHhhh----hccceeeeeeeecccccCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHH
Q 002857 206 VECEVMRNII----HRKIIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDV 281 (873)
Q Consensus 206 ~Ei~iL~~L~----HpNIV~llg~c~~~~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qI 281 (873)
+|+.-+.+++ +..-+++=.++ ++-.....|+|||++|-.+.+...- ....++ +..|+..+
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~----we~t~~~VLtmE~i~Gi~i~d~~~l---------~~~g~d---~k~ia~~~ 273 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVY----WEYTTRRVLTMEWIDGIKISDIAAL---------KSAGID---RKELAELL 273 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceee----hhccCCcEEEEEeeCCEecccHHHH---------HhcCCC---HHHHHHHH
Confidence 4555555542 22222232332 2223457899999999988887521 112333 34455555
Q ss_pred HHHH-HHHhhCCCCCeeeccCCCCCeeeCCCCCeEEecccccccccc
Q 002857 282 ASAL-EYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEA 327 (873)
Q Consensus 282 a~gL-~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDFGla~~~~~ 327 (873)
+++. ..+- ..++.|.|..|.||+++.++.+-+.|||+...+..
T Consensus 274 ~~~f~~q~~---~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 274 VRAFLRQLL---RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred HHHHHHHHH---hcCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 5542 2222 45899999999999999999999999999876654
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.90 E-value=0.00015 Score=76.89 Aligned_cols=146 Identities=15% Similarity=0.158 Sum_probs=82.5
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccc--eeeeeeeecccccCCceEEEEEee
Q 002857 166 NLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKI--IKVVTACSRVDYQGNDFKALVYEF 243 (873)
Q Consensus 166 ~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNI--V~llg~c~~~~~~~~~~~~LV~Ey 243 (873)
..||+|..+.||+. .+..+++|...... ......+|.++++.+..-.+ .+.+++. ...+...+|||+
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~-----~~~~~~glv~e~ 75 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLV-----EDGGRLGLIYEL 75 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEE-----ecCCeeeeeeee
Confidence 57899999999984 23457889876422 33567899999999975444 5556553 234456789999
Q ss_pred cCCCC-hhhhccccc----------cc--ccccCC-CCCCchhhhHH-HHH----------HHHHH-HHHHhh-CCCCCe
Q 002857 244 MPNGS-LEEWIHPIT----------EE--DKRHKA-PGNLNSLERLN-IAI----------DVASA-LEYLHL-GCKPPI 296 (873)
Q Consensus 244 ~~~GS-L~~~L~~~~----------~~--~~~~~~-~~~Ls~~~~l~-Ia~----------qIa~g-L~yLH~-~~s~gI 296 (873)
++|.+ +...+.... .. ...+.- ........... +.. .+... ..+|.. .....+
T Consensus 76 i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~ 155 (226)
T TIGR02172 76 IVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTC 155 (226)
T ss_pred cCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCce
Confidence 99863 222221000 00 000000 00001000000 000 01111 122221 114567
Q ss_pred eeccCCCCCeeeCCCCCeEEecccccc
Q 002857 297 AHCDIKPSNILLNDEMTACVADFGIAR 323 (873)
Q Consensus 297 vHrDLKpsNILLd~~~~vKLsDFGla~ 323 (873)
+|+|+.|.||++++++ +.|+||+.+.
T Consensus 156 ~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 156 LHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred EecCCCCCcEEEcCCC-cEEEechhcC
Confidence 8999999999999888 9999999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=97.89 E-value=9e-06 Score=63.58 Aligned_cols=37 Identities=38% Similarity=0.620 Sum_probs=33.6
Q ss_pred CCCCeEeCCCCcCCCcccccccCCCCcceecccCCCcc
Q 002857 18 RGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFE 55 (873)
Q Consensus 18 ~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Ls 55 (873)
++|++|+|++|+|+ .||..|++|++|+.|+|++|+|+
T Consensus 1 ~~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 1 KNLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp TT-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred CcceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence 58999999999999 89999999999999999999999
|
... |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.84 E-value=4.8e-05 Score=78.39 Aligned_cols=105 Identities=22% Similarity=0.225 Sum_probs=83.2
Q ss_pred HHHHHHHHhhhh-ccceeeeeeeecccccCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHH
Q 002857 205 TVECEVMRNIIH-RKIIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVAS 283 (873)
Q Consensus 205 ~~Ei~iL~~L~H-pNIV~llg~c~~~~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~ 283 (873)
..|.-+|+.+++ +++.+++|+|. .++|.||...+++...-.. ...-...+|..|.+||.++++
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG---------~~~v~E~~~~~~~~~~~~~-------l~~~~~~~w~~R~~iA~~lL~ 70 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG---------RFYVVEYVGAGSLYGIYRP-------LSQFLQSPWEQRAKIALQLLE 70 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC---------CEEEEEeecCccccccccc-------cccccccCHHHHHHHHHHHHH
Confidence 458888888876 69999999994 3789999987766532100 011234689999999999999
Q ss_pred HHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEecccccccc
Q 002857 284 ALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFL 325 (873)
Q Consensus 284 gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDFGla~~~ 325 (873)
.+.+|++.....+.-.|++++|+-+++++++|++|...+...
T Consensus 71 ~l~~l~~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 71 LLEELDHGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred HHHHHhcCCCCcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 999999765566888999999999999999999999877644
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.80 E-value=4.3e-06 Score=97.35 Aligned_cols=185 Identities=18% Similarity=0.140 Sum_probs=132.5
Q ss_pred CCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhcc-ceeeeeeeecccccCCceEEEE
Q 002857 162 FSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRK-IIKVVTACSRVDYQGNDFKALV 240 (873)
Q Consensus 162 f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpN-IV~llg~c~~~~~~~~~~~~LV 240 (873)
+...+-+++|+++++||.+.......+ .+.+... ....-++++|.+++||| .+..++- ++.+...+++
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d-----~~~E~~~~i~ 312 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLED-----YDGEDYLWIP 312 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-----hhhHHHHHHHHHccCCCCccccccc-----CCcccccchh
Confidence 334466889999999998654333222 4444311 45566899999999999 5555554 3567788999
Q ss_pred EeecCCC-ChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEecc
Q 002857 241 YEFMPNG-SLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADF 319 (873)
Q Consensus 241 ~Ey~~~G-SL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDF 319 (873)
++++.++ +-..... .....+...+...+.+.-.++|+||| +..=+|+| ||+..+ ...|..||
T Consensus 313 ~~i~s~~rs~~~~~~---------~se~~~~~~~~~~~~r~et~~l~~l~---~~~~~~~d----~~l~s~-~~~~~~~~ 375 (829)
T KOG0576|consen 313 MRICSTGRSSALEMT---------VSEIALEQYQFAYPLRKETRPLAELH---SSYKVHRD----NILGSE-EEVKLLDF 375 (829)
T ss_pred hhhhcCCccccccCC---------hhhHhhhhhhhhhhhhhhcccccccc---cccccCcc----cccccc-cccccccc
Confidence 9999877 2222211 12233445566677788889999999 55568998 777765 68899999
Q ss_pred ccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCC
Q 002857 320 GIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPS 377 (873)
Q Consensus 320 Gla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf 377 (873)
+....+.... ......++..|+|||+.....+..+-|+|+.|+--.++.-|-.|-
T Consensus 376 ~v~~~L~~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 376 AVPPQLTRTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred cCCcccCccc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 9988765543 223345899999999999999999999999999877777777664
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=97.78 E-value=7.3e-06 Score=94.42 Aligned_cols=81 Identities=35% Similarity=0.321 Sum_probs=68.0
Q ss_pred CCCcccc-CcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCccc-ccccCcccccccccccC
Q 002857 2 HGNLFEG-PIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEG-IFKNASATSVFGNNKLC 79 (873)
Q Consensus 2 s~N~L~G-~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~-~~~~~l~~~~l~nN~L~ 79 (873)
..|+|.. -||++|..|.-|++||||+|+|+ +.|..+-.-+++-+||||+|++. .||..+ ..+.-+-++++++|+|.
T Consensus 86 R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe 163 (1255)
T KOG0444|consen 86 RDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRLE 163 (1255)
T ss_pred hccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhccccchhh
Confidence 4577763 39999999999999999999999 99999999999999999999999 677763 34555667788999888
Q ss_pred CCCCc
Q 002857 80 GGIPE 84 (873)
Q Consensus 80 G~~p~ 84 (873)
..||+
T Consensus 164 ~LPPQ 168 (1255)
T KOG0444|consen 164 MLPPQ 168 (1255)
T ss_pred hcCHH
Confidence 77664
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.77 E-value=0.00029 Score=74.91 Aligned_cols=75 Identities=16% Similarity=0.138 Sum_probs=50.7
Q ss_pred ecccCc-eEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhh-hccceeeeeeeecccccCCceEEEEEeecC
Q 002857 168 IGAGNF-ASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNII-HRKIIKVVTACSRVDYQGNDFKALVYEFMP 245 (873)
Q Consensus 168 LG~G~f-G~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~-HpNIV~llg~c~~~~~~~~~~~~LV~Ey~~ 245 (873)
|..|.. ..||+... .+..++||+..... ...+..|++++..+. +--+.+++++. ...+..++|||+++
T Consensus 6 ~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~-----~~~~~~~lv~e~i~ 75 (244)
T cd05150 6 VTEGQSGATVYRLDG--KNPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYG-----SDDGRAWLLTSAVP 75 (244)
T ss_pred cCCCCCcCeEEEEcC--CCCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEE-----ecCCccEEEEEeeC
Confidence 444555 78999864 34678889875332 346788999999884 33455666653 22345789999999
Q ss_pred CCChhhh
Q 002857 246 NGSLEEW 252 (873)
Q Consensus 246 ~GSL~~~ 252 (873)
|.+|...
T Consensus 76 G~~l~~~ 82 (244)
T cd05150 76 GVPAAAL 82 (244)
T ss_pred CccHhHh
Confidence 9877654
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.00048 Score=71.61 Aligned_cols=135 Identities=21% Similarity=0.285 Sum_probs=92.9
Q ss_pred CcceeecccCceEEEEEEEcCCCcEEEEEEeeccC----------------CcchhHHHHHHHHHHhhh------hccce
Q 002857 163 SSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH----------------HDASKSFTVECEVMRNII------HRKII 220 (873)
Q Consensus 163 ~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~----------------~~~~~~f~~Ei~iL~~L~------HpNIV 220 (873)
+....||+|+.=.||.- +......||+..... ....++..+|+.-...+. +.+|.
T Consensus 4 ~~~~~i~~G~~R~cy~H---P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~ 80 (199)
T PF10707_consen 4 SESDLIAQGGERDCYQH---PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIP 80 (199)
T ss_pred CCCcccccCCCceEEEC---CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccc
Confidence 34578999999999973 456678899987554 223467788888777776 88999
Q ss_pred eeeeeeecccccCCceEEEEEeecCCC------ChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCC
Q 002857 221 KVVTACSRVDYQGNDFKALVYEFMPNG------SLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKP 294 (873)
Q Consensus 221 ~llg~c~~~~~~~~~~~~LV~Ey~~~G------SL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~ 294 (873)
+++|+. +.+....+|+|.+.+. +|.+++.. ..++. ...+.+.+ -..||- ..
T Consensus 81 r~~G~v-----eT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-----------~~~~~-~~~~~L~~---f~~~l~---~~ 137 (199)
T PF10707_consen 81 RFYGFV-----ETNLGLGLVVELIRDADGNISPTLEDYLKE-----------GGLTE-ELRQALDE---FKRYLL---DH 137 (199)
T ss_pred cEeEEE-----ecCCceEEEEEEEECCCCCcCccHHHHHHc-----------CCccH-HHHHHHHH---HHHHHH---Hc
Confidence 999994 4556678999987542 56777632 23444 33333333 345555 56
Q ss_pred CeeeccCCCCCeeeCCC--C--CeEEec-ccccc
Q 002857 295 PIAHCDIKPSNILLNDE--M--TACVAD-FGIAR 323 (873)
Q Consensus 295 gIvHrDLKpsNILLd~~--~--~vKLsD-FGla~ 323 (873)
.|+.+||+|+||++... + .+.|+| ||-..
T Consensus 138 ~Iv~~dl~~~NIv~~~~~~~~~~lvlIDG~G~~~ 171 (199)
T PF10707_consen 138 HIVIRDLNPHNIVVQRRDSGEFRLVLIDGLGEKE 171 (199)
T ss_pred CCeecCCCcccEEEEecCCCceEEEEEeCCCCcc
Confidence 79999999999999632 2 577777 55544
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.00072 Score=84.84 Aligned_cols=83 Identities=13% Similarity=0.163 Sum_probs=57.0
Q ss_pred ceeecccCceEEEEEEEcCCC--cEEEEEEeeccC-CcchhHHHHHHHHHHhhh-hccc--eeeeeeeecccccCCceEE
Q 002857 165 ENLIGAGNFASVYKGILFEGA--PAVAIKVFNFLH-HDASKSFTVECEVMRNII-HRKI--IKVVTACSRVDYQGNDFKA 238 (873)
Q Consensus 165 ~~~LG~G~fG~VYkg~~~~~g--~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~-HpNI--V~llg~c~~~~~~~~~~~~ 238 (873)
...|+.|.+..+|+.....++ ..+++|+..... ......+.+|+++|+.+. |.+| .+++.+|.... ..+..+
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~--v~G~~f 120 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDAS--VIGTAF 120 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCC--cCCCce
Confidence 577899999999998764432 367777754322 122357889999999995 6654 77787764321 123568
Q ss_pred EEEeecCCCCh
Q 002857 239 LVYEFMPNGSL 249 (873)
Q Consensus 239 LV~Ey~~~GSL 249 (873)
+||||+++..+
T Consensus 121 lVME~v~G~~~ 131 (822)
T PLN02876 121 YIMEYLEGRIF 131 (822)
T ss_pred EEEEecCCccc
Confidence 99999988654
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.0003 Score=71.18 Aligned_cols=130 Identities=18% Similarity=0.209 Sum_probs=89.6
Q ss_pred CcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEEEEe
Q 002857 163 SSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKALVYE 242 (873)
Q Consensus 163 ~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~LV~E 242 (873)
...+.|++|.+|.||++.+ .+..+|+|+-+. ......+..|+++|..++-.++.+=+-++ +.-++.||
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~--ds~r~~l~kEakiLeil~g~~~~p~vy~y--------g~~~i~me 92 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEW--RGGEVALKVRRR--DSPRRNLEKEAKILEILAGEGVTPEVYFY--------GEDFIRME 92 (201)
T ss_pred hhhhhhhcccccEEEEeec--cCceEEEEEecC--CcchhhHHHHHHHHHHhhhcCCCceEEEe--------chhhhhhh
Confidence 4467899999999999988 455899998553 23346899999999999877766533332 12346699
Q ss_pred ecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCC-CCCeeeCCCCCeEEecccc
Q 002857 243 FMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIK-PSNILLNDEMTACVADFGI 321 (873)
Q Consensus 243 y~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLK-psNILLd~~~~vKLsDFGl 321 (873)
|+.|-.|.++-.. .+ .+-+..+++.-.-|- ..||-|+.|. |..++|..+..+.|+||..
T Consensus 93 ~i~G~~L~~~~~~-------------~~----rk~l~~vlE~a~~LD---~~GI~H~El~~~~k~vlv~~~~~~iIDFd~ 152 (201)
T COG2112 93 YIDGRPLGKLEIG-------------GD----RKHLLRVLEKAYKLD---RLGIEHGELSRPWKNVLVNDRDVYIIDFDS 152 (201)
T ss_pred hhcCcchhhhhhc-------------cc----HHHHHHHHHHHHHHH---HhccchhhhcCCceeEEecCCcEEEEEccc
Confidence 9998888776421 01 223344555544455 6788888886 4445555555999999999
Q ss_pred ccc
Q 002857 322 ARF 324 (873)
Q Consensus 322 a~~ 324 (873)
|+.
T Consensus 153 At~ 155 (201)
T COG2112 153 ATF 155 (201)
T ss_pred hhh
Confidence 874
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.00092 Score=70.93 Aligned_cols=77 Identities=8% Similarity=0.150 Sum_probs=46.8
Q ss_pred eeecccCce-EEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhc---cceeeeeeeecccccCCceEEEEE
Q 002857 166 NLIGAGNFA-SVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHR---KIIKVVTACSRVDYQGNDFKALVY 241 (873)
Q Consensus 166 ~~LG~G~fG-~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~Hp---NIV~llg~c~~~~~~~~~~~~LV~ 241 (873)
+.|+.|+.. .||+. + ..+++|+.+.. .....+..|+++|..+... .+.++++.... .......++||
T Consensus 3 ~~~~~gG~~n~vy~~----~-~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~--~~~~~~~~~l~ 73 (235)
T cd05155 3 EPVDSGGTDNATFRL----G-DDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEP--GEGYPWPWSVY 73 (235)
T ss_pred eeccCCCcccceEEc----C-CceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCC--ccCCCcceEEE
Confidence 467777766 58975 1 24777875532 2345789999999988532 33444443211 01112458899
Q ss_pred eecCCCChhh
Q 002857 242 EFMPNGSLEE 251 (873)
Q Consensus 242 Ey~~~GSL~~ 251 (873)
++++|.++.+
T Consensus 74 ~~i~G~~l~~ 83 (235)
T cd05155 74 RWLEGETATA 83 (235)
T ss_pred EeecCCCCCc
Confidence 9999977753
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=97.49 E-value=1.8e-05 Score=91.23 Aligned_cols=75 Identities=28% Similarity=0.329 Sum_probs=40.3
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCccccccccccc
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKL 78 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L 78 (873)
||.|+|. .+|..+.+|.+|+.|+||+|+|+ ++-...+...+|+.||||.|+|+ .+|..+.-++.+..+++.||+|
T Consensus 229 lS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL 303 (1255)
T KOG0444|consen 229 LSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKL 303 (1255)
T ss_pred ccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcc
Confidence 3555555 55666666666665555555555 44444444455555555555555 4555544444445555555543
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=97.49 E-value=3.3e-05 Score=85.63 Aligned_cols=79 Identities=37% Similarity=0.397 Sum_probs=60.1
Q ss_pred CCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcc--------------------
Q 002857 2 HGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTE-------------------- 61 (873)
Q Consensus 2 s~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~-------------------- 61 (873)
++|.++ .+|..+..+++|..|+|++|.|. .+|.+++.+..|+.||||+|.|. .+|..
T Consensus 420 snn~is-fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~v 496 (565)
T KOG0472|consen 420 SNNKIS-FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSV 496 (565)
T ss_pred hcCccc-cchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhcccccccc
Confidence 444444 88899999999999999999998 89999999999999999999887 45543
Q ss_pred ----cccccCcccccccccccCCCCC
Q 002857 62 ----GIFKNASATSVFGNNKLCGGIP 83 (873)
Q Consensus 62 ----~~~~~~l~~~~l~nN~L~G~~p 83 (873)
+..+..+..++++||.+...||
T Consensus 497 d~~~l~nm~nL~tLDL~nNdlq~IPp 522 (565)
T KOG0472|consen 497 DPSGLKNMRNLTTLDLQNNDLQQIPP 522 (565)
T ss_pred ChHHhhhhhhcceeccCCCchhhCCh
Confidence 3334455666677777665544
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.00059 Score=80.35 Aligned_cols=162 Identities=19% Similarity=0.210 Sum_probs=99.6
Q ss_pred CCCccCHHHHHHhh------------cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcc-------------
Q 002857 146 DFPYVSYEALYSAT------------KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDA------------- 200 (873)
Q Consensus 146 ~~~~~s~~el~~at------------~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~------------- 200 (873)
..|.++++|+...- ..|+ .+.||.-+.|.||+|+.+. |+.||||+-+..-...
T Consensus 136 ~~Pp~~~ee~~~i~e~ElG~~ie~if~~f~-~~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~ 213 (538)
T KOG1235|consen 136 QAPPFPWEEAFKIFEEELGAPIEDIFSEFD-EEPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAK 213 (538)
T ss_pred cCCCCCHHHHHHHHHHHhCCCHHHHHHhcC-cchhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHH
Confidence 45667777765432 2232 3679999999999999865 8999999843111000
Q ss_pred ------------------------hhHHHHHHHHHHhh----hhccc---eeeeeeeecccccCCceEEEEEeecCCCCh
Q 002857 201 ------------------------SKSFTVECEVMRNI----IHRKI---IKVVTACSRVDYQGNDFKALVYEFMPNGSL 249 (873)
Q Consensus 201 ------------------------~~~f~~Ei~iL~~L----~HpNI---V~llg~c~~~~~~~~~~~~LV~Ey~~~GSL 249 (873)
.-+|.+|++-..++ .|-+. |.+-.++ +.-.....|+||||+|..+
T Consensus 214 ~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy----~~~st~RVLtME~~~G~~i 289 (538)
T KOG1235|consen 214 VLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAKNAERFRENFKDFSLLTYVLVPKVY----WDLSTKRVLTMEYVDGIKI 289 (538)
T ss_pred HHHHhCcCCchhhHHHHHHhhhHhhcchHHHHHhHHHHHHHHHhcccccceeCCeeh----hhcCcceEEEEEecCCccC
Confidence 01245555544443 35551 1122222 2233467999999999988
Q ss_pred hhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCC----CCCeEEecccccccc
Q 002857 250 EEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLND----EMTACVADFGIARFL 325 (873)
Q Consensus 250 ~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~----~~~vKLsDFGla~~~ 325 (873)
.+.-.- ....++.. .|+..+.++... +-...|++|.|-.|.||+++. ++.+.+-|||+...+
T Consensus 290 ~Dl~~i---------~~~gi~~~---~i~~~l~~~~~~--qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i 355 (538)
T KOG1235|consen 290 NDLDAI---------DKRGISPH---DILNKLVEAYLE--QIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI 355 (538)
T ss_pred CCHHHH---------HHcCCCHH---HHHHHHHHHHHH--HHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence 776421 12233333 455555444322 222468999999999999983 678999999998765
Q ss_pred cc
Q 002857 326 EA 327 (873)
Q Consensus 326 ~~ 327 (873)
..
T Consensus 356 s~ 357 (538)
T KOG1235|consen 356 SH 357 (538)
T ss_pred cH
Confidence 43
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.0023 Score=66.50 Aligned_cols=130 Identities=21% Similarity=0.355 Sum_probs=92.9
Q ss_pred cCCCcceeecccCc-eEEEEEEEcCCCcEEEEEEeec---cCC------------------cchhHHHHHHHHHHhhh--
Q 002857 160 KGFSSENLIGAGNF-ASVYKGILFEGAPAVAIKVFNF---LHH------------------DASKSFTVECEVMRNII-- 215 (873)
Q Consensus 160 ~~f~~~~~LG~G~f-G~VYkg~~~~~g~~VAVK~l~~---~~~------------------~~~~~f~~Ei~iL~~L~-- 215 (873)
.+++..+.||.|.. |.||++.. +|+.+|+|+++. ... .....|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 67888999999999 99999988 677999999431 000 11235889999999885
Q ss_pred -hccc--eeeeeeeeccc---c----------cCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHH
Q 002857 216 -HRKI--IKVVTACSRVD---Y----------QGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAI 279 (873)
Q Consensus 216 -HpNI--V~llg~c~~~~---~----------~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~ 279 (873)
+.++ |+.+||..-.. . .......||.||++... .....-+.
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------------------~~~~~~~~ 171 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------------------PLQIRDIP 171 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------------------ccchhHHH
Confidence 3455 89999863210 0 11223567777765422 11233456
Q ss_pred HHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEeccccc
Q 002857 280 DVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIA 322 (873)
Q Consensus 280 qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDFGla 322 (873)
+|.+-|..|| ..+|+-+|+++.|.. .-||+|||.+
T Consensus 172 ~~~~dl~~~~---k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 172 QMLRDLKILH---KLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHHHHHHH---HCCeeeccCcccccc-----CCEEEecccC
Confidence 7778889999 999999999999987 5689999864
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.31 E-value=0.0033 Score=69.45 Aligned_cols=81 Identities=11% Similarity=0.012 Sum_probs=57.1
Q ss_pred CcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhh---ccceeeeeeeecccccCCceEEE
Q 002857 163 SSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIH---RKIIKVVTACSRVDYQGNDFKAL 239 (873)
Q Consensus 163 ~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~H---pNIV~llg~c~~~~~~~~~~~~L 239 (873)
...+.||.|..+.||+... .++ .+++|..+. ......+..|++.|+.|.- -.+.+++++|... ...+..+|
T Consensus 17 ~~~~~i~~G~~~~vy~~~~-~~~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~--~~~g~~~L 90 (297)
T PRK10593 17 SRVECISEQPYAALWALYD-SQG-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHE--QSPGPDVL 90 (297)
T ss_pred heeeecCCccceeEEEEEc-CCC-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccC--CcCCCeEE
Confidence 3457899999999999854 233 477777542 1133589999999999853 3677888876321 22355799
Q ss_pred EEeecCCCCh
Q 002857 240 VYEFMPNGSL 249 (873)
Q Consensus 240 V~Ey~~~GSL 249 (873)
|||+++++++
T Consensus 91 VmE~i~G~~~ 100 (297)
T PRK10593 91 LLERLRGVSV 100 (297)
T ss_pred EEeccCCEec
Confidence 9999998765
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.0034 Score=66.27 Aligned_cols=76 Identities=21% Similarity=0.247 Sum_probs=49.3
Q ss_pred ceeecccCceEEEEEEEcC-CCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccce-eeeeeeecccccCCceEEEEEe
Q 002857 165 ENLIGAGNFASVYKGILFE-GAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKII-KVVTACSRVDYQGNDFKALVYE 242 (873)
Q Consensus 165 ~~~LG~G~fG~VYkg~~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV-~llg~c~~~~~~~~~~~~LV~E 242 (873)
.+.|..|-...+|+..... ++..|++|+...... ..-...+|+.++..+...+++ ++++.. . ..+|||
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~-----~----~~~l~e 72 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATF-----Q----NGLIYE 72 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEe-----C----CcEEEE
Confidence 3567888888999986532 256889998764322 223345799999998654443 343331 1 148999
Q ss_pred ecCCCChh
Q 002857 243 FMPNGSLE 250 (873)
Q Consensus 243 y~~~GSL~ 250 (873)
|++|.++.
T Consensus 73 ~i~G~~l~ 80 (235)
T cd05157 73 FIPGRTLE 80 (235)
T ss_pred eeCCCcCC
Confidence 99987663
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.28 E-value=0.0015 Score=70.12 Aligned_cols=144 Identities=8% Similarity=0.047 Sum_probs=79.1
Q ss_pred eecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccce-eeeeeeecccccCCceEEEEEeecC
Q 002857 167 LIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKII-KVVTACSRVDYQGNDFKALVYEFMP 245 (873)
Q Consensus 167 ~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV-~llg~c~~~~~~~~~~~~LV~Ey~~ 245 (873)
.+..|-...+|+.. .++..+++|+.........-...+|.++++.+....++ +++... . .++||||++
T Consensus 3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~-------~--~~~v~e~i~ 71 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN-------E--HWLLVEWLE 71 (256)
T ss_pred cCCCcCcCCeEEEE--eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe-------C--CEEEEEecc
Confidence 35567788999886 35667889986533222112468899999999654443 344331 1 268999999
Q ss_pred CCChhhh-------ccccc-----ccccccCCCCCCchhhh-HHHHH---------HHHHHHHHHhh-----CCCCCeee
Q 002857 246 NGSLEEW-------IHPIT-----EEDKRHKAPGNLNSLER-LNIAI---------DVASALEYLHL-----GCKPPIAH 298 (873)
Q Consensus 246 ~GSL~~~-------L~~~~-----~~~~~~~~~~~Ls~~~~-l~Ia~---------qIa~gL~yLH~-----~~s~gIvH 298 (873)
|..+... +.... -+... .....++...+ ..... .+...+..+-. .....++|
T Consensus 72 G~~~~~~~~~~~~~~~~la~~l~~lH~~~-~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H 150 (256)
T TIGR02721 72 GEVITLDQFVALDLLLELAALLHQLHSQP-RFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLH 150 (256)
T ss_pred CcccccccccCchhHHHHHHHHHHHhCCC-CCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeec
Confidence 8766431 00000 00000 00111111111 11111 11111222211 11346899
Q ss_pred ccCCCCCeeeCCCCCeEEecccccc
Q 002857 299 CDIKPSNILLNDEMTACVADFGIAR 323 (873)
Q Consensus 299 rDLKpsNILLd~~~~vKLsDFGla~ 323 (873)
+|+.|.||++++++ +.|+||..+.
T Consensus 151 ~Dl~~~Nil~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 151 MDVHAYNLVVTPQG-LKLIDWEYAS 174 (256)
T ss_pred CCCCcCcEEEeCCC-CEEEeccccC
Confidence 99999999999877 7899998875
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.22 E-value=0.0022 Score=70.26 Aligned_cols=154 Identities=15% Similarity=0.112 Sum_probs=88.1
Q ss_pred ceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhcc--ceeeeeeeeccc-ccCCceEEEEE
Q 002857 165 ENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRK--IIKVVTACSRVD-YQGNDFKALVY 241 (873)
Q Consensus 165 ~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpN--IV~llg~c~~~~-~~~~~~~~LV~ 241 (873)
.+.|..|....+|+... ++..+++|+... .....+..|++++..+.+.. +.+++....... ...++..++|+
T Consensus 19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~ 93 (296)
T cd05153 19 FEGISAGIENTNYFVTT--DSGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV 93 (296)
T ss_pred eecccCccccceEEEEe--CCCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence 46677888889999764 334688898764 23456778999999886543 444443211000 01234568999
Q ss_pred eecCCCChhhh----c----------ccccccccc-cCCCCCCchhhhH----------HHHHHHHHHHHHHhh----CC
Q 002857 242 EFMPNGSLEEW----I----------HPITEEDKR-HKAPGNLNSLERL----------NIAIDVASALEYLHL----GC 292 (873)
Q Consensus 242 Ey~~~GSL~~~----L----------~~~~~~~~~-~~~~~~Ls~~~~l----------~Ia~qIa~gL~yLH~----~~ 292 (873)
+|++|..+... + |.....-.. ........|.... .....+..++.++.. ..
T Consensus 94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~ 173 (296)
T cd05153 94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL 173 (296)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence 99998765430 1 100000000 0001111222111 111223344444442 22
Q ss_pred CCCeeeccCCCCCeeeCCCCCeEEecccccc
Q 002857 293 KPPIAHCDIKPSNILLNDEMTACVADFGIAR 323 (873)
Q Consensus 293 s~gIvHrDLKpsNILLd~~~~vKLsDFGla~ 323 (873)
..+++|+|+.|.|||++++..+.|+||+.+.
T Consensus 174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 174 PRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 4679999999999999998778899998875
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.17 E-value=0.0058 Score=70.16 Aligned_cols=77 Identities=19% Similarity=0.171 Sum_probs=54.1
Q ss_pred ceeecccCceEEEEEEEcCCCcEEEEEEeecc-------CCcchhHHHHHHHHHHhhh---hccceeeeeeeecccccCC
Q 002857 165 ENLIGAGNFASVYKGILFEGAPAVAIKVFNFL-------HHDASKSFTVECEVMRNII---HRKIIKVVTACSRVDYQGN 234 (873)
Q Consensus 165 ~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~-------~~~~~~~f~~Ei~iL~~L~---HpNIV~llg~c~~~~~~~~ 234 (873)
.+.||.|.+..||++....+++.|+||.-... ..-..+.+..|.+.|..+. ..++.+++.+ +.
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~-------D~ 103 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY-------DE 103 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE-------CC
Confidence 36799999999999988544468999984311 1223466788899888873 2456777776 23
Q ss_pred ceEEEEEeecCCCC
Q 002857 235 DFKALVYEFMPNGS 248 (873)
Q Consensus 235 ~~~~LV~Ey~~~GS 248 (873)
+..++||||+++..
T Consensus 104 ~~~~lVME~L~~~~ 117 (401)
T PRK09550 104 ELAVTVMEDLSDHK 117 (401)
T ss_pred CCCEEEEecCCCcc
Confidence 44689999998743
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=97.15 E-value=0.00019 Score=73.04 Aligned_cols=75 Identities=32% Similarity=0.407 Sum_probs=27.6
Q ss_pred CCCCccccCcCcCCC-CCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCccc-ccccCccccccccccc
Q 002857 1 MHGNLFEGPIGLSLS-PLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEG-IFKNASATSVFGNNKL 78 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~-~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~-~~~~~l~~~~l~nN~L 78 (873)
|.+|.++ .| ..++ .|++|+.||||+|.|+ .|+ .|..|+.|+.|+|++|.|+. +...+ .....+..+++++|.+
T Consensus 26 L~~n~I~-~I-e~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~L~~L~L~~N~I 100 (175)
T PF14580_consen 26 LRGNQIS-TI-ENLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRISS-ISEGLDKNLPNLQELYLSNNKI 100 (175)
T ss_dssp ------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S--CHHHHHH-TT--EEE-TTS--
T ss_pred ccccccc-cc-cchhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCCc-cccchHHhCCcCCEEECcCCcC
Confidence 4677777 34 3576 5889999999999999 675 58889999999999999994 44333 2456788899999988
Q ss_pred CC
Q 002857 79 CG 80 (873)
Q Consensus 79 ~G 80 (873)
..
T Consensus 101 ~~ 102 (175)
T PF14580_consen 101 SD 102 (175)
T ss_dssp -S
T ss_pred CC
Confidence 64
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=97.15 E-value=8.7e-05 Score=82.38 Aligned_cols=75 Identities=20% Similarity=0.227 Sum_probs=53.1
Q ss_pred CcCcCCCCCCCCCeEeCCCCcCCCc----------------------cccccc-CCCCcceecccCCCccCCCCcccccc
Q 002857 9 PIGLSLSPLRGLKVLDLSQNNLSGE----------------------IPEFLA-GFKFLQNLNLSHNNFESMIPTEGIFK 65 (873)
Q Consensus 9 ~iP~~l~~L~~L~~L~Ls~N~LsG~----------------------iP~~l~-~L~~L~~L~LS~N~Lsg~iP~~~~~~ 65 (873)
+||+++|.|.+|.-|+|..|.|. . +|+++. +|++|.+|||..|+|+ .+|..+..+
T Consensus 197 tlP~~lg~l~~L~~LyL~~Nki~-~lPef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clL 274 (565)
T KOG0472|consen 197 TLPPELGGLESLELLYLRRNKIR-FLPEFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLL 274 (565)
T ss_pred cCChhhcchhhhHHHHhhhcccc-cCCCCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccc-cCchHHHHh
Confidence 56666666666666666666555 4 444333 6777888888888888 678877777
Q ss_pred cCcccccccccccCCCCCcc
Q 002857 66 NASATSVFGNNKLCGGIPEF 85 (873)
Q Consensus 66 ~~l~~~~l~nN~L~G~~p~~ 85 (873)
..+..++++||.+++.+++.
T Consensus 275 rsL~rLDlSNN~is~Lp~sL 294 (565)
T KOG0472|consen 275 RSLERLDLSNNDISSLPYSL 294 (565)
T ss_pred hhhhhhcccCCccccCCccc
Confidence 88888888888888766543
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=97.10 E-value=0.00034 Score=71.23 Aligned_cols=76 Identities=29% Similarity=0.320 Sum_probs=34.0
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccc-cCCCCcceecccCCCccCCCC-cccccccCccccccccccc
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFL-AGFKFLQNLNLSHNNFESMIP-TEGIFKNASATSVFGNNKL 78 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l-~~L~~L~~L~LS~N~Lsg~iP-~~~~~~~~l~~~~l~nN~L 78 (873)
|++|.|+ .|+ .|..|++|+.|+|++|+|+ .|.+.+ ..+++|+.|+|++|+|...-- ..+...+.+..+.+.+|.+
T Consensus 49 Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv 125 (175)
T PF14580_consen 49 LSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPV 125 (175)
T ss_dssp -TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GG
T ss_pred CCCCCCc-ccc-CccChhhhhhcccCCCCCC-ccccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcc
Confidence 6889999 565 4888999999999999999 777655 469999999999999984211 1233456677788888877
Q ss_pred C
Q 002857 79 C 79 (873)
Q Consensus 79 ~ 79 (873)
|
T Consensus 126 ~ 126 (175)
T PF14580_consen 126 C 126 (175)
T ss_dssp G
T ss_pred c
Confidence 6
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.05 E-value=8.2e-05 Score=85.82 Aligned_cols=79 Identities=19% Similarity=0.075 Sum_probs=55.0
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLC 79 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~ 79 (873)
|..|+++.---..+.+|++|+.|+||+|.+.-.-++++.-.++|+.|+||+|+|+...+.++..+..+..+.++.|.+.
T Consensus 276 L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~ 354 (873)
T KOG4194|consen 276 LETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSID 354 (873)
T ss_pred cccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchH
Confidence 3456666444555677777777777777777666677777777777777777777666666666666777777777654
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.03 E-value=8e-05 Score=71.95 Aligned_cols=53 Identities=28% Similarity=0.422 Sum_probs=29.2
Q ss_pred CCCCccccCcCcCCCCC-CCCCeEeCCCCcCCCcccccccCCCCcceecccCCCcc
Q 002857 1 MHGNLFEGPIGLSLSPL-RGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFE 55 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L-~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Ls 55 (873)
|++|.|. .+|..|... +.++.|||++|.|+ .+|.+++.++.|+.||+++|.|.
T Consensus 60 ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~ 113 (177)
T KOG4579|consen 60 LSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN 113 (177)
T ss_pred cccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc
Confidence 3455555 455555433 35555555555555 55555555555555555555555
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.01 E-value=0.00017 Score=83.30 Aligned_cols=81 Identities=19% Similarity=0.152 Sum_probs=64.9
Q ss_pred CCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCCC
Q 002857 2 HGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCGG 81 (873)
Q Consensus 2 s~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G~ 81 (873)
..|.++.---..|..|.++++|+|+.|+++..--.++.+|++|+.||||+|.+...-+++|.+...+..+++++|.++-.
T Consensus 253 qrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l 332 (873)
T KOG4194|consen 253 QRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRL 332 (873)
T ss_pred hhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccC
Confidence 45666644455678888999999999999844456888899999999999999888888888888888899999888754
Q ss_pred C
Q 002857 82 I 82 (873)
Q Consensus 82 ~ 82 (873)
.
T Consensus 333 ~ 333 (873)
T KOG4194|consen 333 D 333 (873)
T ss_pred C
Confidence 4
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=96.95 E-value=0.00012 Score=84.34 Aligned_cols=53 Identities=26% Similarity=0.423 Sum_probs=38.1
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCcc
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFE 55 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Ls 55 (873)
++||+|+ .+|.+++.+..|..||.|.|++. .+|+.++.|.+|+.|++..|++.
T Consensus 150 ~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~ 202 (722)
T KOG0532|consen 150 VSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE 202 (722)
T ss_pred EecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh
Confidence 4677777 78888887778888888888887 77777777766665555555555
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.013 Score=64.95 Aligned_cols=169 Identities=15% Similarity=0.106 Sum_probs=87.2
Q ss_pred cCHHHHHHhhcCCCc-----ceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhcc--ceee
Q 002857 150 VSYEALYSATKGFSS-----ENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRK--IIKV 222 (873)
Q Consensus 150 ~s~~el~~at~~f~~-----~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpN--IV~l 222 (873)
++.+++......|.+ .+.|+.|....+|+... .++ .+++|++. ....+.+..|+.++..|.... +.+.
T Consensus 7 ls~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t-~~g-~~vLK~~~---~~~~~~l~~~~~~l~~L~~~glpvP~~ 81 (319)
T PRK05231 7 VSDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTT-TQG-EYVLTLFE---RLTAEDLPFFLGLMQHLAARGVPVPAP 81 (319)
T ss_pred CCHHHHHHHHHhcCCchhhccchhccccccceEEEEe-CCC-cEEEEEec---cCChHHhHHHHHHHHHHHHCCCCCCcc
Confidence 344555444445543 34566777789999865 333 68889875 122345556777777775333 3333
Q ss_pred eeeeeccc-ccCCceEEEEEeecCCCChhh-----------hc---ccccccc-cccCCCCCCch-hhhHH---------
Q 002857 223 VTACSRVD-YQGNDFKALVYEFMPNGSLEE-----------WI---HPITEED-KRHKAPGNLNS-LERLN--------- 276 (873)
Q Consensus 223 lg~c~~~~-~~~~~~~~LV~Ey~~~GSL~~-----------~L---~~~~~~~-~~~~~~~~Ls~-~~~l~--------- 276 (873)
+....... ....+..+++++|++|..+.. .| |.....- ........+.| .....
T Consensus 82 i~~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (319)
T PRK05231 82 VARRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADE 161 (319)
T ss_pred eeCCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChh
Confidence 32110000 012345789999999875421 11 1100000 00000111212 11111
Q ss_pred ---HHHH-HHHHHHHHhh----CCCCCeeeccCCCCCeeeCCCCCeEEecccccc
Q 002857 277 ---IAID-VASALEYLHL----GCKPPIAHCDIKPSNILLNDEMTACVADFGIAR 323 (873)
Q Consensus 277 ---Ia~q-Ia~gL~yLH~----~~s~gIvHrDLKpsNILLd~~~~vKLsDFGla~ 323 (873)
.+.+ +...+..+.. ....+++|+|+.+.|||++.+...-|+||+.+.
T Consensus 162 ~~~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 162 QAALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred HHHHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 1111 1112233321 135689999999999999977666899999875
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.81 E-value=0.021 Score=63.17 Aligned_cols=154 Identities=16% Similarity=0.120 Sum_probs=85.2
Q ss_pred ceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhcc--ceeeeeeeeccc-ccCCceEEEEE
Q 002857 165 ENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRK--IIKVVTACSRVD-YQGNDFKALVY 241 (873)
Q Consensus 165 ~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpN--IV~llg~c~~~~-~~~~~~~~LV~ 241 (873)
.+.++.|....+|+... .++ .+++|+..... .......|++++..|.... +.+++....... ....+..++|+
T Consensus 27 i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~ 102 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTT-DVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLV 102 (307)
T ss_pred ccccCCccccceEEEEe-CCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEE
Confidence 45677777789999764 334 57788865321 2345667888888885333 344444211000 11235578999
Q ss_pred eecCCCChhhh--------------cccccccccccCCC---CCCchhhhH------------HHHHHHHHHHHHHhh--
Q 002857 242 EFMPNGSLEEW--------------IHPITEEDKRHKAP---GNLNSLERL------------NIAIDVASALEYLHL-- 290 (873)
Q Consensus 242 Ey~~~GSL~~~--------------L~~~~~~~~~~~~~---~~Ls~~~~l------------~Ia~qIa~gL~yLH~-- 290 (873)
+|++|..+... +|.... ....... ..-.|.... .....+...+++|..
T Consensus 103 e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~-~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~ 181 (307)
T TIGR00938 103 EFLQGLSVGRPTAMHCRPVGEVLAWMHLAGA-HFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFW 181 (307)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHhhhc-cCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhh
Confidence 99998654311 111000 0000000 001111100 111223344555542
Q ss_pred --CCCCCeeeccCCCCCeeeCCCCCeEEecccccc
Q 002857 291 --GCKPPIAHCDIKPSNILLNDEMTACVADFGIAR 323 (873)
Q Consensus 291 --~~s~gIvHrDLKpsNILLd~~~~vKLsDFGla~ 323 (873)
....+++|+|+.+.||+++.++...|+||+.+.
T Consensus 182 ~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 182 PRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred hhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 235789999999999999988777899999875
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=96.81 E-value=0.00075 Score=83.03 Aligned_cols=33 Identities=36% Similarity=0.467 Sum_probs=19.0
Q ss_pred CCCeEeCCCCcCCCcccccccCCCCcceecccCCCcc
Q 002857 19 GLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFE 55 (873)
Q Consensus 19 ~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Ls 55 (873)
+|+.|+|++|+|+ .+|..+ ++|+.|+||+|+|+
T Consensus 383 ~L~~LdLs~N~Lt-~LP~l~---s~L~~LdLS~N~Ls 415 (788)
T PRK15387 383 GLKELIVSGNRLT-SLPVLP---SELKELMVSGNRLT 415 (788)
T ss_pred ccceEEecCCccc-CCCCcc---cCCCEEEccCCcCC
Confidence 5666666666666 455432 34555566666555
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.78 E-value=0.00025 Score=85.88 Aligned_cols=80 Identities=28% Similarity=0.240 Sum_probs=66.8
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccc-cccCCCCcceecccCCCccCCCCcccccccCcccccccccccC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPE-FLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLC 79 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~-~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~ 79 (873)
|.+|+|+...=+.|-+..+|++|+||+|+|. ++|+ .+.+|..|+.|+||+|.|+ .+|..+.....+..+...+|+|.
T Consensus 366 lanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~ 443 (1081)
T KOG0618|consen 366 LANNHLTDSCFPVLVNFKHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL 443 (1081)
T ss_pred HhcCcccccchhhhccccceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee
Confidence 4688998776666889999999999999998 8884 7888999999999999999 78888887788888888888777
Q ss_pred CCC
Q 002857 80 GGI 82 (873)
Q Consensus 80 G~~ 82 (873)
..|
T Consensus 444 ~fP 446 (1081)
T KOG0618|consen 444 SFP 446 (1081)
T ss_pred ech
Confidence 443
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=96.73 E-value=0.0027 Score=79.18 Aligned_cols=200 Identities=16% Similarity=0.173 Sum_probs=130.0
Q ss_pred HHHHHHHHHhhhhccceeeeeeeecccccCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHH
Q 002857 204 FTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVAS 283 (873)
Q Consensus 204 f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~ 283 (873)
...|++.+.++.|+|++.++.|-.+.... +-...+..+++..-++...+. ....++....+.+..++..
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~-g~~~~v~~~~~s~~~~~~~~q----------~v~~i~~~~~r~~~~~~~~ 297 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFR-GIVLDVLQEICSKVELRSLLQ----------SVGSIPLETLRILHQKLLE 297 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcc-hHHHHHHHhhcCccchHHHHh----------hccccCHHHHHHHHHHHhh
Confidence 44567778889999999999884332111 112234456677777777763 3456777788889999999
Q ss_pred HHHHHhhCCCCCeeeccCCCC---CeeeCCCCCeEEe--ccccccccccccccccccccccccccCCCcccCCCCCCc--
Q 002857 284 ALEYLHLGCKPPIAHCDIKPS---NILLNDEMTACVA--DFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSS-- 356 (873)
Q Consensus 284 gL~yLH~~~s~gIvHrDLKps---NILLd~~~~vKLs--DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~-- 356 (873)
||+|+| +....|.-|..+ +-..+.++...++ ||+..+.+...... ....-+..|.++|.........
T Consensus 298 GL~~~h---~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~~~~r 371 (1351)
T KOG1035|consen 298 GLAYLH---SLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNADEDLKENTAKKSR 371 (1351)
T ss_pred hHHHHH---HhccceeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCccccccccccccccchhhh
Confidence 999999 555555555555 4455666777777 99988766443221 1223456678888776655444
Q ss_pred chhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHH
Q 002857 357 YGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILEC 436 (873)
Q Consensus 357 ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~ 436 (873)
..|+|.+|..+..+..|..+-... .....+++...
T Consensus 372 ~~dL~~lgll~~~~~~~~~i~~~~----------------~~~~~~l~~~~----------------------------- 406 (1351)
T KOG1035|consen 372 LTDLWCLGLLLLQLSQGEDISEKS----------------AVPVSLLDVLS----------------------------- 406 (1351)
T ss_pred hhHHHHHHHHHhhhhhcCcccccc----------------cchhhhhcccc-----------------------------
Confidence 379999999999999886542210 00011111000
Q ss_pred HHHHHHHHHHhhccCcCCCCCHHHHHHHH
Q 002857 437 LNSICEIGVACSAELPGERMKINDVELGL 465 (873)
Q Consensus 437 ~~~L~~L~~~CL~~dP~eRPTm~EVl~~L 465 (873)
...+......|+..++++|+++.+++...
T Consensus 407 ~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~ 435 (1351)
T KOG1035|consen 407 TSELLDALPKCLDEDSEERLSALELLTHP 435 (1351)
T ss_pred chhhhhhhhhhcchhhhhccchhhhhhch
Confidence 00245567789999999999999987754
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=96.72 E-value=0.00025 Score=81.88 Aligned_cols=77 Identities=25% Similarity=0.249 Sum_probs=38.5
Q ss_pred CCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCCC
Q 002857 2 HGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCGG 81 (873)
Q Consensus 2 s~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G~ 81 (873)
+.|++. ++|.++..+..|+.|.|.+|.+. .||..+.+|..|++|||+.|+|+ .+|..+.+ --+..+.+.||+|...
T Consensus 83 srNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~-lpLkvli~sNNkl~~l 158 (722)
T KOG0532|consen 83 SRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCD-LPLKVLIVSNNKLTSL 158 (722)
T ss_pred cccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhc-CcceeEEEecCccccC
Confidence 445555 55555555555555555555555 55555555555555555555555 33333222 2233444555555443
Q ss_pred C
Q 002857 82 I 82 (873)
Q Consensus 82 ~ 82 (873)
+
T Consensus 159 p 159 (722)
T KOG0532|consen 159 P 159 (722)
T ss_pred C
Confidence 3
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.63 E-value=0.021 Score=62.73 Aligned_cols=76 Identities=22% Similarity=0.257 Sum_probs=50.3
Q ss_pred eeecccCceEEEEEEEcCC------CcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccce-eeeeeeecccccCCceEE
Q 002857 166 NLIGAGNFASVYKGILFEG------APAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKII-KVVTACSRVDYQGNDFKA 238 (873)
Q Consensus 166 ~~LG~G~fG~VYkg~~~~~------g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV-~llg~c~~~~~~~~~~~~ 238 (873)
+.|..|-...+|+.....+ ++.+++|+..... .......+|++++..+....+. ++++++ . + .
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~-----~-~---~ 73 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIF-----P-N---G 73 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEe-----C-C---C
Confidence 4566777779999875331 5789999976433 2334678899999998644443 445442 1 1 3
Q ss_pred EEEeecCCCChhh
Q 002857 239 LVYEFMPNGSLEE 251 (873)
Q Consensus 239 LV~Ey~~~GSL~~ 251 (873)
+|+||++|..+..
T Consensus 74 ~v~e~i~G~~l~~ 86 (302)
T cd05156 74 RIEEFIPSRTLTT 86 (302)
T ss_pred chhheeCCCcCCH
Confidence 6899999877653
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=96.44 E-value=0.00086 Score=72.16 Aligned_cols=69 Identities=25% Similarity=0.175 Sum_probs=43.6
Q ss_pred cCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccC
Q 002857 8 GPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLC 79 (873)
Q Consensus 8 G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~ 79 (873)
|.+-..+-..+-|+.||||+|.++ .|-+++.-++.+++|+||+|.|.. +-. ++++..+..+++++|.|+
T Consensus 274 G~~~~~~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~-v~n-La~L~~L~~LDLS~N~Ls 342 (490)
T KOG1259|consen 274 GSALVSADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRT-VQN-LAELPQLQLLDLSGNLLA 342 (490)
T ss_pred CceEEecchHhhhhhccccccchh-hhhhhhhhccceeEEeccccceee-ehh-hhhcccceEeecccchhH
Confidence 333333444566677777777777 677777777777777777777762 222 556666667777777665
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.43 E-value=0.00043 Score=67.02 Aligned_cols=78 Identities=22% Similarity=0.269 Sum_probs=66.5
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCG 80 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G 80 (873)
|++|.|+ .+|.++..++.|+.|||++|.|. ..|.-+..|.+|-.|+.-+|.+. .||..+..........++|+.+.+
T Consensus 84 l~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~dl~~s~~~al~~lgnepl~~ 160 (177)
T KOG4579|consen 84 LANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDVDLFYSSLPALIKLGNEPLGD 160 (177)
T ss_pred cchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcHHHhccccHHHHHhcCCcccc
Confidence 5789999 79999999999999999999999 89999999999999999999998 778774444445566678887776
Q ss_pred C
Q 002857 81 G 81 (873)
Q Consensus 81 ~ 81 (873)
.
T Consensus 161 ~ 161 (177)
T KOG4579|consen 161 E 161 (177)
T ss_pred c
Confidence 4
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 873 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 8e-33 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-31 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-21 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-21 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-20 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-20 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-20 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 5e-20 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-19 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 7e-18 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-16 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-16 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-16 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-16 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-16 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-16 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-16 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 5e-16 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 6e-16 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 6e-16 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 7e-16 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 7e-16 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 8e-16 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 8e-16 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 9e-16 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 9e-16 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-15 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-15 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-15 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-15 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-15 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-15 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-15 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-15 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-15 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-15 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-15 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 4e-15 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 4e-15 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-15 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-15 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 9e-15 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 9e-15 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-14 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-14 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-14 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-14 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-14 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-14 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-14 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-14 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-14 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-14 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-14 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-14 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-14 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-14 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-14 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-14 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-14 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-14 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-14 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-14 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-14 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-14 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-14 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-14 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-14 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-14 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-14 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-14 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-14 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-14 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-14 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 4e-14 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 5e-14 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 5e-14 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 6e-14 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-14 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-14 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 9e-14 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 9e-14 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 9e-14 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-13 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-13 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-13 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-13 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-13 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-13 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-13 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-13 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-13 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-13 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-13 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-13 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-13 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-13 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-13 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-13 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-13 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-13 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-13 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-13 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-13 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-13 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-13 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-13 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-13 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-13 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-13 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-13 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-13 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-13 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-13 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-13 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-13 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-13 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-13 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-13 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-13 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-13 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-13 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 4e-13 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 5e-13 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-13 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 5e-13 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-13 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-13 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-13 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 5e-13 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 5e-13 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 5e-13 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 5e-13 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 6e-13 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 6e-13 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 6e-13 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 6e-13 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 6e-13 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 6e-13 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 6e-13 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 7e-13 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 7e-13 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 8e-13 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 8e-13 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 8e-13 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 9e-13 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 9e-13 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 9e-13 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-12 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-12 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-12 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-12 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-12 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-12 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-12 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-12 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-12 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-12 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-12 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-12 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-12 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-12 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-12 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-12 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-12 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-12 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-12 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-12 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-12 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-12 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 5e-12 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 5e-12 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 5e-12 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-12 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 7e-12 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-12 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-11 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-11 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-11 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-11 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-11 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-11 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-11 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-11 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-11 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-11 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-11 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-11 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-11 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-11 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-11 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 4e-11 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-11 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-11 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-11 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 4e-11 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-11 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-11 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 4e-11 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-11 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 5e-11 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-11 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 5e-11 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 5e-11 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 5e-11 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 5e-11 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-11 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 5e-11 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-11 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 6e-11 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 6e-11 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 6e-11 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 6e-11 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 6e-11 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 6e-11 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 6e-11 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-11 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 7e-11 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 7e-11 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 7e-11 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-11 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 7e-11 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-11 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 7e-11 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 8e-11 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 8e-11 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 8e-11 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 8e-11 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 8e-11 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-11 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-11 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-10 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-10 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-10 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-10 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-10 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-10 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-10 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-10 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-10 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-10 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-10 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-10 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-10 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-10 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-10 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-10 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-10 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-10 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-10 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-10 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-10 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-10 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-10 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-10 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 4e-10 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 4e-10 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-10 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 4e-10 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-10 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 4e-10 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 4e-10 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-10 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 5e-10 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 5e-10 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 5e-10 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 5e-10 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 5e-10 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 5e-10 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 5e-10 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 5e-10 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 5e-10 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 6e-10 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 6e-10 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 6e-10 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-10 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 6e-10 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 6e-10 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-10 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 6e-10 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 6e-10 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 7e-10 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 8e-10 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 8e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 9e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 9e-10 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 9e-10 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-09 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-09 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-09 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-09 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-09 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-09 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-09 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-09 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-09 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-09 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 5e-09 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 5e-09 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 5e-09 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 6e-09 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 6e-09 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-09 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 6e-09 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 7e-09 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 9e-09 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 9e-09 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 9e-09 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-08 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-08 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-08 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-08 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-08 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-08 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-08 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-08 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-08 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-08 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-08 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-08 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-08 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-08 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-08 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-08 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-08 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-08 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-08 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-08 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-08 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-08 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-08 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-08 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-08 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-08 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-08 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-08 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-08 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-08 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-08 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-08 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-08 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-08 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-08 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-08 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-08 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-08 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-08 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-08 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-08 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-08 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-08 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-08 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-08 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-08 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-08 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-08 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-08 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-08 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-08 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-08 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-08 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-08 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-08 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-08 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-08 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-08 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-08 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-08 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 4e-08 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-08 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-08 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-08 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-08 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 4e-08 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-08 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-08 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 5e-08 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 5e-08 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-08 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 5e-08 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 6e-08 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 6e-08 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-08 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 6e-08 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-08 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 6e-08 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 7e-08 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-08 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 7e-08 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-08 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 7e-08 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 8e-08 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 8e-08 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-08 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 8e-08 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 8e-08 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-08 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 8e-08 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 9e-08 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 9e-08 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 9e-08 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-08 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 9e-08 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-07 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-07 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-07 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-07 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-07 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-07 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-07 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-07 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-07 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-07 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-07 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-07 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-07 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-07 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-07 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-07 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-07 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-07 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-07 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-07 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-07 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-07 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-07 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-07 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-07 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-07 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-07 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-07 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-07 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-07 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-07 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-07 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-07 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-07 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-07 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-07 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-07 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-07 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-07 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-07 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-07 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-07 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-07 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-07 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-07 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-07 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-07 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-07 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-07 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-07 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-07 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-07 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-07 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-07 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-07 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-07 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-07 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-07 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-07 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-07 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-07 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-07 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-07 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-07 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 4e-07 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-07 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-07 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-07 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 4e-07 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-07 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-07 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 4e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-07 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 5e-07 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 5e-07 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 5e-07 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 5e-07 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 5e-07 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 5e-07 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 5e-07 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 5e-07 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 5e-07 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 5e-07 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 5e-07 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-07 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 5e-07 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 5e-07 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 5e-07 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-07 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 5e-07 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 5e-07 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 6e-07 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 6e-07 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-07 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 6e-07 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-07 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 6e-07 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-07 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 6e-07 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 6e-07 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 6e-07 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-07 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 6e-07 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 7e-07 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 7e-07 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 7e-07 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 7e-07 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 7e-07 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 7e-07 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 7e-07 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 7e-07 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-07 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 8e-07 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-07 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 8e-07 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 8e-07 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 8e-07 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 8e-07 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 9e-07 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-06 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-06 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-06 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-06 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-06 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-06 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-06 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-06 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-06 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-06 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-06 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-06 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-06 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-06 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-06 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-06 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-06 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-06 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-06 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-06 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-06 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-06 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-06 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-06 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-06 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-06 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-06 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-06 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-06 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-06 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-06 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-06 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-06 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-06 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-06 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-06 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-06 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-06 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-06 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-06 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-06 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-06 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-06 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 4e-06 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-06 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 4e-06 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 4e-06 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 4e-06 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-06 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 4e-06 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-06 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-06 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 5e-06 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 5e-06 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 5e-06 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-06 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 5e-06 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 5e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-06 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-06 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-06 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 5e-06 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 5e-06 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 5e-06 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 5e-06 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 5e-06 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 5e-06 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 5e-06 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 5e-06 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 5e-06 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 5e-06 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-06 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-06 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 6e-06 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 6e-06 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 6e-06 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 6e-06 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 6e-06 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 6e-06 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-06 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-06 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 6e-06 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 6e-06 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 6e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 6e-06 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 6e-06 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-06 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 6e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 7e-06 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 7e-06 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 7e-06 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 7e-06 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 7e-06 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 7e-06 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 8e-06 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 8e-06 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 8e-06 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 8e-06 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 8e-06 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 8e-06 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 8e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-06 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 8e-06 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 9e-06 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 9e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 9e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-05 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-05 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-05 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-05 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-05 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-05 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-05 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-05 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-05 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-05 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-05 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-05 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-05 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-05 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-05 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-05 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-05 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-05 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-05 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-05 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-05 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-05 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-05 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-05 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-05 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-05 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-05 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-05 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-05 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-05 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-05 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-05 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-05 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-05 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-05 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-05 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-05 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-05 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-05 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-05 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-05 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-05 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-05 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-05 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-05 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-05 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-05 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-05 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-05 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-05 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-05 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-05 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-05 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-05 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-05 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-05 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-05 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-05 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-05 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-05 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-05 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-05 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-05 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-05 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-05 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-05 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-05 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-05 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-05 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-05 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-05 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-05 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-05 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-05 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-05 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-05 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-05 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-05 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-05 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-05 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-05 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-05 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-05 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-05 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-05 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-05 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-05 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-05 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-05 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-05 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-05 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-05 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-05 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 4e-05 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-05 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-05 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-05 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 4e-05 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-05 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-05 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-05 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-05 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 4e-05 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 4e-05 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 4e-05 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-05 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 4e-05 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-05 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 4e-05 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 4e-05 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-05 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-05 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-05 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 4e-05 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-05 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-05 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 5e-05 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 5e-05 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 5e-05 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 5e-05 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-05 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 5e-05 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 5e-05 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 5e-05 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 5e-05 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 5e-05 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 5e-05 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-05 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 5e-05 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 5e-05 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 5e-05 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-05 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 5e-05 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 5e-05 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 5e-05 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 5e-05 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 5e-05 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 5e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-05 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-05 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 5e-05 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 5e-05 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 5e-05 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-05 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-05 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 6e-05 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 6e-05 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 6e-05 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 6e-05 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 6e-05 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-05 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 6e-05 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 6e-05 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 6e-05 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 6e-05 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 6e-05 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 6e-05 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-05 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 6e-05 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 6e-05 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-05 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-05 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 6e-05 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 6e-05 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 6e-05 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 6e-05 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 6e-05 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-05 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-05 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 6e-05 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 6e-05 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 6e-05 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 6e-05 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 7e-05 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 7e-05 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 7e-05 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 7e-05 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 7e-05 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 7e-05 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 7e-05 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-05 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 7e-05 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 7e-05 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 8e-05 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 8e-05 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 8e-05 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-05 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 8e-05 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 8e-05 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 8e-05 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 8e-05 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 8e-05 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 8e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 9e-05 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 9e-05 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 9e-05 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 9e-05 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 9e-05 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 9e-05 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 9e-05 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 9e-05 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-04 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-04 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-04 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 1e-04 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-04 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-04 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-04 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-04 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-04 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 1e-04 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-04 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-04 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-04 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-04 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-04 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-04 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-04 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-04 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-04 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-04 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-04 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-04 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-04 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-04 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-04 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-04 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-04 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-04 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-04 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-04 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-04 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-04 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-04 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-04 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-04 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-04 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-04 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-04 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-04 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-04 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-04 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-04 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-04 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-04 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-04 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 2e-04 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-04 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-04 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-04 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-04 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 3e-04 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-04 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-04 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-04 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-04 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-04 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-04 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-04 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-04 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-04 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-04 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-04 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-04 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-04 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-04 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-04 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-04 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-04 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-04 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-04 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-04 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-04 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-04 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-04 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-04 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-04 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-04 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 3e-04 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-04 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-04 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-04 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-04 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-04 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-04 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-04 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 3e-04 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-04 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-04 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 3e-04 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-04 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-04 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 4e-04 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 4e-04 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 4e-04 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 5e-04 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 5e-04 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 5e-04 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 5e-04 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 5e-04 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 5e-04 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 5e-04 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-04 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 6e-04 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-04 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 6e-04 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 7e-04 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 7e-04 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 8e-04 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 8e-04 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 8e-04 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 8e-04 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 8e-04 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 8e-04 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 8e-04 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 8e-04 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 9e-04 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 9e-04 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 9e-04 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 9e-04 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 230 bits (588), Expect = 1e-68
Identities = 95/317 (29%), Positives = 158/317 (49%), Gaps = 41/317 (12%)
Query: 151 SYEALYSATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKS-FTVECE 209
S L A+ FS++N++G G F VYKG L +G VA+K + F E E
Sbjct: 21 SLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTL-VAVKRLKEERTQGGELQFQTEVE 79
Query: 210 VMRNIIHRKIIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNL 269
++ +HR ++++ C + + LVY +M NGS+ + +R ++ L
Sbjct: 80 MISMAVHRNLLRLRGFCM----TPTE-RLLVYPYMANGSVASCLR------ERPESQPPL 128
Query: 270 NSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATN 329
+ +R IA+ A L YLH C P I H D+K +NILL++E A V DFG+A+ ++ +
Sbjct: 129 DWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 188
Query: 330 EQTSSIGVKGTTGYIAPEYGM-GHETSSYGDVYSFGILLLEMFTGLRPSDDMF---KDNL 385
++ V+GT G+IAPEY G + DV+ +G++LLE+ TG R D D++
Sbjct: 189 THVTT-AVRGTIGHIAPEYLSTGKSSEK-TDVFGYGVMLLELITGQRAFDLARLANDDDV 246
Query: 386 NLQNWVQSALPE-RVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIG 444
L +WV+ L E ++E +VD ++EE + + ++
Sbjct: 247 MLLDWVKGLLKEKKLEALVDVDLQGNYKDEE---------------------VEQLIQVA 285
Query: 445 VACSAELPGERMKINDV 461
+ C+ P ER K+++V
Sbjct: 286 LLCTQSSPMERPKMSEV 302
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 220 bits (564), Expect = 2e-65
Identities = 91/333 (27%), Positives = 138/333 (41%), Gaps = 44/333 (13%)
Query: 134 RGNPTPSISIDLDFPYVSYEALYSATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVF 193
+ S + + V L AT F + LIG G F VYKG+L +GA VA+K
Sbjct: 13 NDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAK-VALKRR 71
Query: 194 NFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWI 253
+ F E E + H ++ ++ C + L+Y++M NG+L+ +
Sbjct: 72 TPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEM-----ILIYKYMENGNLKRHL 126
Query: 254 HPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMT 313
+ +++ +RL I I A L YLH I H D+K NILL++
Sbjct: 127 Y------GSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFV 177
Query: 314 ACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGM-GH--ETSSYGDVYSFGILLLEM 370
+ DFGI++ ++ S VKGT GYI PEY + G E S DVYSFG++L E+
Sbjct: 178 PKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKS---DVYSFGVVLFEV 234
Query: 371 FTGLRPSDDMF-KDNLNLQNWVQSALPER-VEEIVDTLFFKEIEEEETVYKYKKAPSSST 428
++ +NL W + +E+IVD +
Sbjct: 235 LCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVD---------------------PNL 273
Query: 429 QRSIILECLNSICEIGVACSAELPGERMKINDV 461
I E L + V C A +R + DV
Sbjct: 274 ADKIRPESLRKFGDTAVKCLALSSEDRPSMGDV 306
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 3e-58
Identities = 70/268 (26%), Positives = 115/268 (42%), Gaps = 29/268 (10%)
Query: 151 SYEALYSATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEV 210
E LY + + G F V+K L VA+K+F + S E
Sbjct: 15 GTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEY--VAVKIF-PIQDKQSWQNEYEVYS 71
Query: 211 MRNIIHRKIIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLN 270
+ + H I++ + A R D L+ F GSL +++ + ++
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDL-WLITAFHEKGSLSDFLK-------ANV----VS 119
Query: 271 SLERLNIAIDVASALEYLH-------LGCKPPIAHCDIKPSNILLNDEMTACVADFGIAR 323
E +IA +A L YLH G KP I+H DIK N+LL + +TAC+ADFG+A
Sbjct: 120 WNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLAL 179
Query: 324 FLEATNEQTSSIGVKGTTGYIAPEY---GMGHETSSY--GDVYSFGILLLEMFTGLRPSD 378
EA + G GT Y+APE + + ++ D+Y+ G++L E+ + +D
Sbjct: 180 KFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAAD 239
Query: 379 DMFKDN-LNLQNWVQSALP-ERVEEIVD 404
+ L + + E ++E+V
Sbjct: 240 GPVDEYMLPFEEEIGQHPSLEDMQEVVV 267
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 7e-58
Identities = 82/267 (30%), Positives = 127/267 (47%), Gaps = 33/267 (12%)
Query: 151 SYEALYSATKGFSSE------NLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDAS--- 201
S+ L + T F N +G G F VYKG + VA+K + +
Sbjct: 16 SFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTT-VAVKKLAAMVDITTEEL 73
Query: 202 -KSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEED 260
+ F E +VM H +++++ S G+D LVY +MPNGSL + +
Sbjct: 74 KQQFDQEIKVMAKCQHENLVELLGFSS----DGDD-LCLVYVYMPNGSLLDRLS-----C 123
Query: 261 KRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFG 320
P L+ R IA A+ + +LH + H DIK +NILL++ TA ++DFG
Sbjct: 124 LDGTPP--LSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFG 178
Query: 321 IARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETS-SYGDVYSFGILLLEMFTGLRPSDD 379
+AR E + + + GTT Y+APE G T S D+YSFG++LLE+ TGL D+
Sbjct: 179 LARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKS--DIYSFGVVLLEIITGLPAVDE 236
Query: 380 MFKDNLNLQNWVQSALPER--VEEIVD 404
++ L + + E +E+ +D
Sbjct: 237 H-REPQLLLDIKEEIEDEEKTIEDYID 262
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 2e-50
Identities = 70/273 (25%), Positives = 113/273 (41%), Gaps = 43/273 (15%)
Query: 145 LDFPYVSYEALYSATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSF 204
++ LIG G + +VYKG L E VA+KVF+F + ++F
Sbjct: 1 MEAAASEPSL---DLDNLKLLELIGRGRYGAVYKGSLDERP--VAVKVFSFANR---QNF 52
Query: 205 TVECEVMR--NIIHRKIIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKR 262
E + R + H I + + RV G LV E+ PNGSL +++ T
Sbjct: 53 INEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----- 107
Query: 263 HKAPGNLNSLERLNIAIDVASALEYLH------LGCKPPIAHCDIKPSNILLNDEMTACV 316
+ + +A V L YLH KP I+H D+ N+L+ ++ T +
Sbjct: 108 ------SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVI 161
Query: 317 ADFGIARFLEAT------NEQTSSIGVKGTTGYIAPEYGMG-------HETSSYGDVYSF 363
+DFG++ L E ++I GT Y+APE G D+Y+
Sbjct: 162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYAL 221
Query: 364 GILLLEMF---TGLRPSDDMFKDNLNLQNWVQS 393
G++ E+F T L P + + + + Q V +
Sbjct: 222 GLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGN 254
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 7e-49
Identities = 64/218 (29%), Positives = 111/218 (50%), Gaps = 19/218 (8%)
Query: 165 ENLIGAGNFASVYKGILFEGAPAVAIKVFNF--LHHDASKSFTVECEVMRNIIHRKIIKV 222
+ IGAG+F +V++ + G+ VA+K+ H + F E +M+ + H I+
Sbjct: 42 KEKIGAGSFGTVHRAE-WHGSD-VAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLF 99
Query: 223 VTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVA 282
+ A + Q + ++V E++ GSL +H + A L+ RL++A DVA
Sbjct: 100 MGAVT----QPPNL-SIVTEYLSRGSLYRLLH-------KSGAREQLDERRRLSMAYDVA 147
Query: 283 SALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTG 342
+ YLH PPI H ++K N+L++ + T V DFG++R +T + GT
Sbjct: 148 KGMNYLH-NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSK--SAAGTPE 204
Query: 343 YIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDM 380
++APE ++ DVYSFG++L E+ T +P ++
Sbjct: 205 WMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNL 242
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 5e-48
Identities = 60/217 (27%), Positives = 92/217 (42%), Gaps = 24/217 (11%)
Query: 165 ENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVT 224
E ++G G F V K + VAIK K+F VE + + H I+K+
Sbjct: 13 EEVVGRGAFGVVCKAK-WRAKD-VAIKQIE--SESERKAFIVELRQLSRVNHPNIVKLYG 68
Query: 225 ACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASA 284
AC LV E+ GSL +H + + ++ + +
Sbjct: 69 ACLNPVC-------LVMEYAEGGSLYNVLH-------GAEPLPYYTAAHAMSWCLQCSQG 114
Query: 285 LEYLHLGCKPPIAHCDIKPSNILLNDEMTAC-VADFGIARFLEATNEQTSSIGVKGTTGY 343
+ YLH + H D+KP N+LL T + DFG A + QT KG+ +
Sbjct: 115 VAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI-----QTHMTNNKGSAAW 169
Query: 344 IAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDM 380
+APE G S DV+S+GI+L E+ T +P D++
Sbjct: 170 MAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEI 206
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 6e-48
Identities = 44/221 (19%), Positives = 90/221 (40%), Gaps = 26/221 (11%)
Query: 165 ENLIGAGNFASVYKGILFEGAPAVAIKVFNF--LHHDASKSFTVECEVMRNIIHRKIIKV 222
+ + ++KG ++G + +KV S+ F EC +R H ++ V
Sbjct: 15 LTKLNENHSGELWKGR-WQGND-IVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPV 72
Query: 223 VTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVA 282
+ AC L+ +MP GSL +H ++ + + A+D+A
Sbjct: 73 LGACQS---PPAPHPTLITHWMPYGSLYNVLH--------EGTNFVVDQSQAVKFALDMA 121
Query: 283 SALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTG 342
+ +LH +P I + +++++++MTA ++ + ++ G
Sbjct: 122 RGMAFLH-TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSP-------GRMYAPA 173
Query: 343 YIAPEYGMGHETSSYG---DVYSFGILLLEMFTGLRPSDDM 380
++APE + D++SF +LL E+ T P D+
Sbjct: 174 WVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADL 214
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 4e-47
Identities = 65/231 (28%), Positives = 97/231 (41%), Gaps = 38/231 (16%)
Query: 165 ENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDAS-------KSFTVECEVMRNIIHR 217
E IG G F V+KG L + VAIK + + F E +M N+ H
Sbjct: 24 EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 218 KIIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNI 277
I+K+ +V EF+P G L + + +L +
Sbjct: 84 NIVKLYGLMHNPPR-------MVMEFVPCGDLYHRLL---------DKAHPIKWSVKLRL 127
Query: 278 AIDVASALEYLHLGCKPPIAHCDIKPSNILL-----NDEMTACVADFGIARFLEATNEQT 332
+D+A +EY+ PPI H D++ NI L N + A VADFG+++
Sbjct: 128 MLDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-----SVH 181
Query: 333 SSIGVKGTTGYIAPEYGMGHETSSYG---DVYSFGILLLEMFTGLRPSDDM 380
S G+ G ++APE +G E SY D YSF ++L + TG P D+
Sbjct: 182 SVSGLLGNFQWMAPE-TIGAEEESYTEKADTYSFAMILYTILTGEGPFDEY 231
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 6e-45
Identities = 53/231 (22%), Positives = 99/231 (42%), Gaps = 32/231 (13%)
Query: 165 ENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNII--HRKIIKV 222
+G G + V++G ++G VA+K+F+ KS+ E E+ ++ H I+
Sbjct: 13 LECVGKGRYGEVWRGS-WQGEN-VAVKIFS---SRDEKSWFRETELYNTVMLRHENILGF 67
Query: 223 VTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVA 282
+ + + L+ + GSL +++ L+++ L I + +A
Sbjct: 68 IASDMTSRHSSTQL-WLITHYHEMGSLYDYLQ-------LTT----LDTVSCLRIVLSIA 115
Query: 283 SALEYLH-----LGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNE--QTSSI 335
S L +LH KP IAH D+K NIL+ C+AD G+A + +
Sbjct: 116 SGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNN 175
Query: 336 GVKGTTGYIAPE------YGMGHETSSYGDVYSFGILLLEMFTGLRPSDDM 380
GT Y+APE ++ D+++FG++L E+ + + +
Sbjct: 176 PRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIV 226
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 2e-44
Identities = 57/218 (26%), Positives = 98/218 (44%), Gaps = 26/218 (11%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIKVFNF--LHHDASKSFTVECEVMRNIIHRKIIKVVTA 225
IG+G+F +VYKG VA+K+ N ++F E V+R H I+ +
Sbjct: 32 IGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 226 CSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASAL 285
+ A+V ++ SL +H + + ++IA A +
Sbjct: 89 STAPQL------AIVTQWCEGSSLYHHLH---------ASETKFEMKKLIDIARQTARGM 133
Query: 286 EYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIA 345
+YLH I H D+K +NI L+++ T + DFG+A + + G+ ++A
Sbjct: 134 DYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMA 190
Query: 346 PEYGMGHETSSYG---DVYSFGILLLEMFTGLRPSDDM 380
PE +++ Y DVY+FGI+L E+ TG P ++
Sbjct: 191 PEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNI 228
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 1e-43
Identities = 57/231 (24%), Positives = 99/231 (42%), Gaps = 32/231 (13%)
Query: 165 ENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEV--MRNIIHRKIIKV 222
+ IG G F V++G VA+K+F+ +S+ E E+ + H I+
Sbjct: 47 QESIGKGRFGEVWRGKWRGEE--VAVKIFSSREE---RSWFREAEIYQTVMLRHENILGF 101
Query: 223 VTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVA 282
+ A ++ + LV ++ +GSL ++++ R+ + + +A+ A
Sbjct: 102 IAADNKDNGTWTQL-WLVSDYHEHGSLFDYLN-------RYT----VTVEGMIKLALSTA 149
Query: 283 SALEYLH-----LGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNE--QTSSI 335
S L +LH KP IAH D+K NIL+ T C+AD G+A ++ + +
Sbjct: 150 SGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPN 209
Query: 336 GVKGTTGYIAPE-----YGMGHETSSY-GDVYSFGILLLEMFTGLRPSDDM 380
GT Y+APE M H S D+Y+ G++ E+
Sbjct: 210 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 260
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 2e-43
Identities = 58/229 (25%), Positives = 88/229 (38%), Gaps = 32/229 (13%)
Query: 165 ENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEV--MRNIIHRKIIKV 222
IG G + V+ G VA+KVF S+ E E+ + H I+
Sbjct: 42 VKQIGKGRYGEVWMGKWRGEK--VAVKVF---FTTEEASWFRETEIYQTVLMRHENILGF 96
Query: 223 VTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVA 282
+ A + L+ ++ NGSL +++ L++ L +A
Sbjct: 97 IAADIKGTGSWTQL-YLITDYHENGSLYDYLK-------STT----LDAKSMLKLAYSSV 144
Query: 283 SALEYLH-----LGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQT--SSI 335
S L +LH KP IAH D+K NIL+ T C+AD G+A + +
Sbjct: 145 SGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPN 204
Query: 336 GVKGTTGYIAPE-----YGMGHETSS-YGDVYSFGILLLEMFTGLRPSD 378
GT Y+ PE H S D+YSFG++L E+
Sbjct: 205 TRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGG 253
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 9e-43
Identities = 60/229 (26%), Positives = 97/229 (42%), Gaps = 36/229 (15%)
Query: 165 ENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDAS----KSFTVECEVMRNIIHRKII 220
E +IG G F VY+ + G VA+K + ++ E ++ + H II
Sbjct: 12 EEIIGIGGFGKVYRAF-WIGDE-VAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69
Query: 221 KVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAID 280
+ C + LV EF G L + + P ++ +N A+
Sbjct: 70 ALRGVCLK-----EPNLCLVMEFARGGPLNRVLS-------GKRIPPDI----LVNWAVQ 113
Query: 281 VASALEYLHLGCKPPIAHCDIKPSNILLNDEMTAC--------VADFGIARFLEATNEQT 332
+A + YLH PI H D+K SNIL+ ++ + DFG+AR +T
Sbjct: 114 IARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW----HRT 169
Query: 333 SSIGVKGTTGYIAPEYGMGHETSSYG-DVYSFGILLLEMFTGLRPSDDM 380
+ + G ++APE + S G DV+S+G+LL E+ TG P +
Sbjct: 170 TKMSAAGAYAWMAPE-VIRASMFSKGSDVWSYGVLLWELLTGEVPFRGI 217
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 7e-42
Identities = 54/228 (23%), Positives = 87/228 (38%), Gaps = 29/228 (12%)
Query: 165 ENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVT 224
++G G F K E + +K + ++F E +VMR + H ++K +
Sbjct: 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIG 74
Query: 225 ACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASA 284
Y+ + E++ G+L I +R++ A D+AS
Sbjct: 75 VL----YKDKRL-NFITEYIKGGTLRGII---------KSMDSQYPWSQRVSFAKDIASG 120
Query: 285 LEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQT------------ 332
+ YLH I H D+ N L+ + VADFG+AR + Q
Sbjct: 121 MAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRK 177
Query: 333 SSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDM 380
V G ++APE G DV+SFGI+L E+ + D
Sbjct: 178 KRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDY 225
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 4e-41
Identities = 45/230 (19%), Positives = 74/230 (32%), Gaps = 35/230 (15%)
Query: 165 ENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDAS--KSFTVECEVMRNIIHRKIIKV 222
LIG G F VY G VAI++ + + K+F E R H ++
Sbjct: 38 GELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF 94
Query: 223 VTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVA 282
+ AC A++ +L + A L+ + IA ++
Sbjct: 95 MGACMS-----PPHLAIITSLCKGRTLYSVVR---------DAKIVLDVNKTRQIAQEIV 140
Query: 283 SALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSS---IGVKG 339
+ YLH I H D+K N+ D + DFG+ G
Sbjct: 141 KGMGYLH---AKGILHKDLKSKNVFY-DNGKVVITDFGLFSISGVLQAGRREDKLRIQNG 196
Query: 340 TTGYIAPE------YGMGHETSSYG---DVYSFGILLLEMFTGLRPSDDM 380
++APE + + DV++ G + E+ P
Sbjct: 197 WLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ 246
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 4e-31
Identities = 59/221 (26%), Positives = 108/221 (48%), Gaps = 27/221 (12%)
Query: 165 ENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDAS--KSFTVECEVMRNIIHRKIIKV 222
++ +G G + VY+G+ + + VA+K L D + F E VM+ I H ++++
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKT---LKEDTMEVEEFLKEAAVMKEIKHPNLVQL 281
Query: 223 VTACSRVD--YQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAID 280
+ C+R Y ++ EFM G+L +++ R ++++ L +A
Sbjct: 282 LGVCTREPPFY-------IITEFMTYGNLLDYL--------RECNRQEVSAVVLLYMATQ 326
Query: 281 VASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGT 340
++SA+EYL K H ++ N L+ + VADFG++R + + T+ G K
Sbjct: 327 ISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFP 382
Query: 341 TGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDM 380
+ APE ++ S DV++FG+LL E+ T G+ P +
Sbjct: 383 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 423
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 59/218 (27%), Positives = 93/218 (42%), Gaps = 30/218 (13%)
Query: 167 LIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDAS--KSFTVECEVMRNIIHRKIIKVVT 224
IG G+F +VYKG+ E VA S + F E E+++ + H I++
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY- 91
Query: 225 ACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERL--NIAIDVA 282
+G LV E M +G+L+ ++ KR K ++ + +
Sbjct: 92 DSWESTVKGKKCIVLVTELMTSGTLKTYL-------KRFKVMK-----IKVLRSWCRQIL 139
Query: 283 SALEYLHLGCKPPIAHCDIKPSNILLNDEMTAC-VADFGIARFLEATNEQTSSIGVKGTT 341
L++LH PPI H D+K NI + + + D G+A A+ + V GT
Sbjct: 140 KGLQFLH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA----VIGTP 194
Query: 342 GYIAPEYGMGHETSSYG---DVYSFGILLLEMFTGLRP 376
++APE Y DVY+FG+ +LEM T P
Sbjct: 195 EFMAPEMY----EEKYDESVDVYAFGMCMLEMATSEYP 228
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-30
Identities = 62/220 (28%), Positives = 90/220 (40%), Gaps = 36/220 (16%)
Query: 167 LIGAGNFASVYKG---ILFEGAPAVAIKVFNF-LHHDAS--KSFTVECEVMRNIIHRKII 220
+G G ++VY IL VAIK K F E + H+ I+
Sbjct: 18 KLGGGGMSTVYLAEDTILNI---KVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIV 74
Query: 221 KVVTACSRVDY-QGNDFKA--LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNI 277
+ + LV E++ +L E+I + G L+ +N
Sbjct: 75 SM--------IDVDEEDDCYYLVMEYIEGPTLSEYIE----------SHGPLSVDTAINF 116
Query: 278 AIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFL-EATNEQTSSIG 336
+ +++ H I H DIKP NIL++ T + DFGIA+ L E + QT+
Sbjct: 117 TNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNH-- 171
Query: 337 VKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRP 376
V GT Y +PE G T D+YS GI+L EM G P
Sbjct: 172 VLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPP 211
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 28/90 (31%), Positives = 40/90 (44%), Gaps = 5/90 (5%)
Query: 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPT 60
+ N +G + + L LDL N + G +P+ L KFL +LN+S NN IP
Sbjct: 228 LAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ 286
Query: 61 EGIFKNASATSVFGNNKLCGGIPEFQLPTC 90
G + ++ N LCG LP C
Sbjct: 287 GGNLQRFDVSAYANNKCLCGSP----LPAC 312
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 76.4 bits (189), Expect = 3e-15
Identities = 26/84 (30%), Positives = 42/84 (50%), Gaps = 2/84 (2%)
Query: 2 HGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTE 61
N GPI +++ L L L ++ N+SG IP+FL+ K L L+ S+N +P
Sbjct: 85 GINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPS 144
Query: 62 GIFKNASATSV-FGNNKLCGGIPE 84
I + + F N++ G IP+
Sbjct: 145 -ISSLPNLVGITFDGNRISGAIPD 167
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 76.0 bits (188), Expect = 5e-15
Identities = 24/85 (28%), Positives = 33/85 (38%), Gaps = 1/85 (1%)
Query: 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPT 60
+ G I LS ++ L LD S N LSG +P ++ L + N IP
Sbjct: 108 ITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPD 167
Query: 61 E-GIFKNASATSVFGNNKLCGGIPE 84
G F + N+L G IP
Sbjct: 168 SYGSFSKLFTSMTISRNRLTGKIPP 192
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 5e-13
Identities = 19/87 (21%), Positives = 36/87 (41%), Gaps = 6/87 (6%)
Query: 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPT 60
+ N G I + + L L +DLS+N L G+ K Q ++L+ N+ +
Sbjct: 181 ISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK 239
Query: 61 EGIFKNASATSVF--GNNKLCGGIPEF 85
+ + NN++ G +P+
Sbjct: 240 ---VGLSKNLNGLDLRNNRIYGTLPQG 263
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 3e-12
Identities = 20/87 (22%), Positives = 32/87 (36%), Gaps = 4/87 (4%)
Query: 1 MHGNLFEGPIGLSLSPLRGL-KVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIP 59
GN G I S L + +S+N L+G+IP A L ++LS N E
Sbjct: 156 FDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDAS 214
Query: 60 TEGIFKNASATSVF-GNNKLCGGIPEF 85
+ + + N L + +
Sbjct: 215 VL-FGSDKNTQKIHLAKNSLAFDLGKV 240
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 50.2 bits (121), Expect = 1e-06
Identities = 23/86 (26%), Positives = 34/86 (39%), Gaps = 5/86 (5%)
Query: 4 NLFEGPIGLSLSPLRGLKVLDLSQNNLSGE--IPEFLAGFKFLQNLNLSH-NNFESMIPT 60
+ G + + + + LDLS NL IP LA +L L + NN IP
Sbjct: 36 RTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPP 95
Query: 61 EGIFKNASATSV-FGNNKLCGGIPEF 85
I K + + + G IP+F
Sbjct: 96 A-IAKLTQLHYLYITHTNVSGAIPDF 120
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 4e-29
Identities = 54/223 (24%), Positives = 95/223 (42%), Gaps = 26/223 (11%)
Query: 165 ENLIGAGNFASVYKGILFEGAPA----VAIKVFNFLHHDASKS-FTVECEVMRNIIHRKI 219
++G+G F +V+KG+ + V IKV S T + ++ H I
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77
Query: 220 IKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAI 279
++++ C Q LV +++P GSL + + ++H+ G L LN +
Sbjct: 78 VRLLGLCPGSSLQ------LVTQYLPLGSLLDHV-------RQHR--GALGPQLLLNWGV 122
Query: 280 DVASALEYLH-LGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVK 338
+A + YL G H ++ N+LL VADFG+A L ++Q K
Sbjct: 123 QIAKGMYYLEEHGM----VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAK 178
Query: 339 GTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDM 380
++A E + + DV+S+G+ + E+ T G P +
Sbjct: 179 TPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGL 221
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 7e-29
Identities = 55/226 (24%), Positives = 97/226 (42%), Gaps = 32/226 (14%)
Query: 165 ENLIGAGNFASVYKGILFEGAP----AVAIKVFNFLHHDASKS----FTVECEVMRNIIH 216
++G+G F +VYKG+ VAIK L S E VM ++ +
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE---LREATSPKANKEILDEAYVMASVDN 76
Query: 217 RKIIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLN 276
+ +++ C Q L+ + MP G L +++ + HK N+ S LN
Sbjct: 77 PHVCRLLGICLTSTVQ------LITQLMPFGCLLDYV-------REHK--DNIGSQYLLN 121
Query: 277 IAIDVASALEYL-HLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSI 335
+ +A + YL H D+ N+L+ + DFG+A+ L A ++ +
Sbjct: 122 WCVQIAKGMNYLEDRRL----VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 177
Query: 336 GVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDM 380
G K ++A E + + DV+S+G+ + E+ T G +P D +
Sbjct: 178 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 223
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 60/226 (26%), Positives = 108/226 (47%), Gaps = 37/226 (16%)
Query: 165 ENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDAS--KSFTVECEVMRNIIHRKIIKV 222
++ +G G + VY+G+ + + VA+K L D + F E VM+ I H ++++
Sbjct: 18 KHKLGGGQYGEVYEGVWKKYSLTVAVKT---LKEDTMEVEEFLKEAAVMKEIKHPNLVQL 74
Query: 223 VTACSRVD--YQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAID 280
+ C+R Y ++ EFM G+L +++ R ++++ L +A
Sbjct: 75 LGVCTREPPFY-------IITEFMTYGNLLDYL--------RECNRQEVSAVVLLYMATQ 119
Query: 281 VASALEYL-HLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIG--- 336
++SA+EYL H D+ N L+ + VADFG++R + + T+ G
Sbjct: 120 ISSAMEYLEKKNF----IHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKF 174
Query: 337 -VKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDM 380
+K T APE ++ S DV++FG+LL E+ T G+ P +
Sbjct: 175 PIKWT----APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 216
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-28
Identities = 57/225 (25%), Positives = 88/225 (39%), Gaps = 39/225 (17%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKS----FTVECEVMRNIIHRKIIKVV 223
IG GNF V+ G L VA+K F E +++ H I++++
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKS---CRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178
Query: 224 TACSRVD--YQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDV 281
C++ Y +V E + G ++ L L + D
Sbjct: 179 GVCTQKQPIY-------IVMELVQGGDFLTFLR---------TEGARLRVKTLLQMVGDA 222
Query: 282 ASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIG----- 336
A+ +EYL H D+ N L+ ++ ++DFG++R +S G
Sbjct: 223 AAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEA-DGVYAASGGLRQVP 278
Query: 337 VKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDM 380
VK T APE SS DV+SFGILL E F+ G P ++
Sbjct: 279 VKWT----APEALNYGRYSSESDVWSFGILLWETFSLGASPYPNL 319
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 2e-28
Identities = 47/216 (21%), Positives = 80/216 (37%), Gaps = 33/216 (15%)
Query: 167 LIGAGNFASVYKG--ILFEGAPAVAIKVFNFLHH----DASKSFTVECEVMRNIIHRKII 220
I G +Y G P V +K L H +A E + + ++H I+
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRP-VVLKG---LVHSGDAEAQAMAMAERQFLAEVVHPSIV 142
Query: 221 KVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAID 280
++ D G+ +V E++ SL+ L E + ++
Sbjct: 143 QIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG------------QKLPVAEAIAYLLE 190
Query: 281 VASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGT 340
+ AL YLH + + D+KP NI+L +E + D G + + + GT
Sbjct: 191 ILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGY------LYGT 240
Query: 341 TGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRP 376
G+ APE T + D+Y+ G L + L
Sbjct: 241 PGFQAPEIVRTGPTVA-TDIYTVGRTLAALTLDLPT 275
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-28
Identities = 54/224 (24%), Positives = 97/224 (43%), Gaps = 25/224 (11%)
Query: 165 ENLIGAGNFASVYKGILFEGAP---AVAIKVFNFLHHDAS--KSFTVECEVMRNIIHRKI 219
++G G F SV +G L + VA+K + + F E M++ H +
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 220 IKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAI 279
I+++ C + QG ++ FM G L ++ + P ++ L +
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLL----YSRLETGPKHIPLQTLLKFMV 154
Query: 280 DVASALEYL-HLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVK 338
D+A +EYL + H D+ N +L D+MT CVADFG+++ + + + +
Sbjct: 155 DIALGMEYLSNRNF----LHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYR-----Q 205
Query: 339 GTTGYI-----APEYGMGHETSSYGDVYSFGILLLEMFT-GLRP 376
G + A E +S DV++FG+ + E+ T G+ P
Sbjct: 206 GRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-28
Identities = 56/219 (25%), Positives = 101/219 (46%), Gaps = 25/219 (11%)
Query: 165 ENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDAS--KSFTVECEVMRNIIHRKIIKV 222
E +GAG F V+ VA+K + + ++F E VM+ + H K++K+
Sbjct: 193 EKKLGAGQFGEVWMATY-NKHTKVAVKT---MKPGSMSVEAFLAEANVMKTLQHDKLVKL 248
Query: 223 VTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVA 282
++ + ++ EFM GSL +++ + + ++ + +A
Sbjct: 249 HAVVTK------EPIYIITEFMAKGSLLDFL--------KSDEGSKQPLPKLIDFSAQIA 294
Query: 283 SALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTG 342
+ ++ + H D++ +NIL++ + +ADFG+AR +E NE T+ G K
Sbjct: 295 EGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIE-DNEYTAREGAKFPIK 350
Query: 343 YIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDM 380
+ APE + DV+SFGILL+E+ T G P M
Sbjct: 351 WTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM 389
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 59/224 (26%), Positives = 92/224 (41%), Gaps = 38/224 (16%)
Query: 167 LIGAGNFASVYKG---ILFEGAPAVAIKVFNF-LHHDAS--KSFTVECEVMRNIIHRKII 220
++G G + V+ VA+KV L D S F E + + H I+
Sbjct: 19 ILGFGGMSEVHLARDLRD--HRD-VAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIV 75
Query: 221 KVVTACSRVDY-QGNDFKA------LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLE 273
V Y G +V E++ +L + +H G +
Sbjct: 76 AV--------YDTGEAETPAGPLPYIVMEYVDGVTLRDIVH----------TEGPMTPKR 117
Query: 274 RLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFL-EATNEQT 332
+ + D AL + H + I H D+KP+NI+++ V DFGIAR + ++ N T
Sbjct: 118 AIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVT 174
Query: 333 SSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRP 376
+ V GT Y++PE G + DVYS G +L E+ TG P
Sbjct: 175 QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 4e-28
Identities = 60/218 (27%), Positives = 103/218 (47%), Gaps = 27/218 (12%)
Query: 165 ENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDAS-KSFTVECEVMRNIIHRKIIKVV 223
IG G F V G + G VA+K + +DA+ ++F E VM + H +++++
Sbjct: 198 LQTIGKGEFGDVMLGD-YRGNK-VAVKC---IKNDATAQAFLAEASVMTQLRHSNLVQLL 252
Query: 224 TACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVAS 283
+ +V E+M GSL +++ R + L L ++DV
Sbjct: 253 GVIV----EEKGGLYIVTEYMAKGSLVDYL--------RSRGRSVLGGDCLLKFSLDVCE 300
Query: 284 ALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGY 343
A+EYL H D+ N+L++++ A V+DFG+ + ++ + T + VK T
Sbjct: 301 AMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE-ASSTQDTGKLPVKWT--- 353
Query: 344 IAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDM 380
APE + S+ DV+SFGILL E+++ G P +
Sbjct: 354 -APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 390
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 7e-28
Identities = 64/219 (29%), Positives = 103/219 (47%), Gaps = 25/219 (11%)
Query: 165 ENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKS--FTVECEVMRNIIHRKIIKV 222
E +G G F V+ G G VAIK L F E +VM+ + H K++++
Sbjct: 189 EVKLGQGCFGEVWMGTW-NGTTRVAIKT---LKPGTMSPEAFLQEAQVMKKLRHEKLVQL 244
Query: 223 VTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVA 282
S + +V E+M GSL +++ + + L + +++A +A
Sbjct: 245 YAVVSE------EPIYIVTEYMSKGSLLDFL--------KGETGKYLRLPQLVDMAAQIA 290
Query: 283 SALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTG 342
S + Y+ + H D++ +NIL+ + + VADFG+AR +E NE T+ G K
Sbjct: 291 SGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIK 346
Query: 343 YIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDM 380
+ APE + + DV+SFGILL E+ T G P M
Sbjct: 347 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 385
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 9e-28
Identities = 49/222 (22%), Positives = 78/222 (35%), Gaps = 36/222 (16%)
Query: 165 ENLIGAGNFASVYKG---ILFEGAPAVAIKVFNF-LHHDAS--KSFTVECEVMRNIIHRK 218
L+G G VY+ + VA+K+ + L D E +
Sbjct: 39 RRLVGRGGMGDVYEAEDTVRER---IVALKLMSETLSSDPVFRTRMQREARTAGRLQEPH 95
Query: 219 IIKVVTACSRVDY---QGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERL 275
++ + D+ G + + + L + + G L +
Sbjct: 96 VVPIH------DFGEIDGQLY--VDMRLINGVDLAAML----------RRQGPLAPPRAV 137
Query: 276 NIAIDVASALEYLH-LGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSS 334
I + SAL+ H G H D+KP NIL++ + A + DFGIA T
Sbjct: 138 AIVRQIGSALDAAHAAG----ATHRDVKPENILVSADDFAYLVDFGIASATTDEK-LTQL 192
Query: 335 IGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRP 376
GT Y+APE + D+Y+ +L E TG P
Sbjct: 193 GNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPP 234
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 2e-27
Identities = 56/242 (23%), Positives = 97/242 (40%), Gaps = 35/242 (14%)
Query: 162 FSSENLIGAGNFASVYKGI-LFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKII 220
F LIG+G F V+K +G IK + + A + E + + + H I+
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKT-YVIKRVKYNNEKAER----EVKALAKLDHVNIV 67
Query: 221 KVVTACSRVDYQGNDFKA-----------LVYEFMPNGSLEEWIHPITEEDKRHKAPGNL 269
DY + EF G+LE+WI KR L
Sbjct: 68 HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIE------KRRGEK--L 119
Query: 270 NSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATN 329
+ + L + + ++Y+H + + D+KPSNI L D + DFG+ L+
Sbjct: 120 DKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG 176
Query: 330 EQTSSIGVKGTTGYIAPE--YGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNL 387
++T S GT Y++PE + D+Y+ G++L E+ + + K +L
Sbjct: 177 KRTRSK---GTLRYMSPEQISSQDYGKEV--DLYALGLILAELLHVCDTAFETSKFFTDL 231
Query: 388 QN 389
++
Sbjct: 232 RD 233
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 55/223 (24%), Positives = 96/223 (43%), Gaps = 32/223 (14%)
Query: 168 IGAGNFASVYKGILFEGAP----AVAIKVFNFLHHDASKS----FTVECEVMRNIIHRKI 219
+G+G F +VYKG+ VAIK L S E VM ++ + +
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKE---LREATSPKANKEILDEAYVMASVDNPHV 79
Query: 220 IKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAI 279
+++ C Q L+ + MP G L +++ + HK N+ S LN +
Sbjct: 80 CRLLGICLTSTVQ------LITQLMPFGCLLDYV-------REHK--DNIGSQYLLNWCV 124
Query: 280 DVASALEYL-HLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVK 338
+A + YL H D+ N+L+ + DFG+A+ L A ++ + G K
Sbjct: 125 QIAKGMNYLEDRRL----VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 180
Query: 339 GTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDM 380
++A E + + DV+S+G+ + E+ T G +P D +
Sbjct: 181 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 223
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 62/226 (27%), Positives = 95/226 (42%), Gaps = 39/226 (17%)
Query: 165 ENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDAS--KSFTVECEVMRNIIHRKIIKV 222
IG+G F V+ G VAIK + A + F E EVM + H K++++
Sbjct: 13 VQEIGSGQFGLVHLGYW-LNKDKVAIKT---IREGAMSEEDFIEEAEVMMKLSHPKLVQL 68
Query: 223 VTACSRVD--YQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAID 280
C LV EFM +G L +++ G + L + +D
Sbjct: 69 YGVCLEQAPIC-------LVTEFMEHGCLSDYLR---------TQRGLFAAETLLGMCLD 112
Query: 281 VASALEYL-HLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIG--- 336
V + YL H D+ N L+ + V+DFG+ RF+ ++ TSS G
Sbjct: 113 VCEGMAYLEEACV----IHRDLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKF 167
Query: 337 -VKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDM 380
VK +PE SS DV+SFG+L+ E+F+ G P ++
Sbjct: 168 PVKWA----SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR 209
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 4e-27
Identities = 55/228 (24%), Positives = 93/228 (40%), Gaps = 38/228 (16%)
Query: 165 ENLIGAGNFASVYKGILF---EGAPAVAIKVFNFLHHDAS----KSFTVECEVMRNIIHR 217
IG G F V++GI A AVAIK + S + F E MR H
Sbjct: 20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKT---CKNCTSDSVREKFLQEALTMRQFDHP 76
Query: 218 KIIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNI 277
I+K++ + ++ E G L ++ + K +L+ +
Sbjct: 77 HIVKLIGVITENPVW------IIMELCTLGELRSFL-------QVRK--YSLDLASLILY 121
Query: 278 AIDVASALEYL-HLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIG 336
A +++AL YL H DI N+L++ + DFG++R++E + +S G
Sbjct: 122 AYQLSTALAYLESKRF----VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG 177
Query: 337 ---VKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDM 380
+K APE +S DV+ FG+ + E+ G++P +
Sbjct: 178 KLPIKWM----APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 221
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 4e-27
Identities = 58/221 (26%), Positives = 91/221 (41%), Gaps = 36/221 (16%)
Query: 167 LIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTAC 226
++G G + VY G +AIK S+ E + +++ H+ I
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNI------- 81
Query: 227 SRVDYQGNDFKA----LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERL--NIAID 280
V Y G+ + + E +P GSL + R K G L E+
Sbjct: 82 --VQYLGSFSENGFIKIFMEQVPGGSLSALL--------RSKW-GPLKDNEQTIGFYTKQ 130
Query: 281 VASALEYLHLGCKPPIAHCDIKPSNILLNDEMTAC-VADFGIARFLEATNEQTSSIGVKG 339
+ L+YLH I H DIK N+L+N ++DFG ++ L N T + G
Sbjct: 131 ILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTG 185
Query: 340 TTGYIAPE----YGMGHETSSYGDVYSFGILLLEMFTGLRP 376
T Y+APE G+ ++ D++S G ++EM TG P
Sbjct: 186 TLQYMAPEIIDKGPRGYGKAA--DIWSLGCTIIEMATGKPP 224
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 5e-27
Identities = 59/219 (26%), Positives = 101/219 (46%), Gaps = 29/219 (13%)
Query: 165 ENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDAS-KSFTVECEVMRNIIHRKIIKVV 223
IG G F V G VA+K + +DA+ ++F E VM + H +++++
Sbjct: 26 LQTIGKGEFGDVMLGDYRG--NKVAVKC---IKNDATAQAFLAEASVMTQLRHSNLVQLL 80
Query: 224 TACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVAS 283
+ +V E+M GSL +++ R + L L ++DV
Sbjct: 81 GVIV----EEKGGLYIVTEYMAKGSLVDYL--------RSRGRSVLGGDCLLKFSLDVCE 128
Query: 284 ALEYL-HLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTG 342
A+EYL H D+ N+L++++ A V+DFG+ + ++ + T + VK T
Sbjct: 129 AMEYLEGNNF----VHRDLAARNVLVSEDNVAKVSDFGLTKE-ASSTQDTGKLPVKWT-- 181
Query: 343 YIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDM 380
APE + S+ DV+SFGILL E+++ G P +
Sbjct: 182 --APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 218
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 5e-27
Identities = 63/219 (28%), Positives = 102/219 (46%), Gaps = 25/219 (11%)
Query: 165 ENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKS--FTVECEVMRNIIHRKIIKV 222
E +G G F V+ G VAIK L F E +VM+ + H K++++
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTR-VAIKT---LKPGTMSPEAFLQEAQVMKKLRHEKLVQL 327
Query: 223 VTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVA 282
S + +V E+M GSL +++ + + L + +++A +A
Sbjct: 328 YAVVSE------EPIYIVTEYMSKGSLLDFL--------KGETGKYLRLPQLVDMAAQIA 373
Query: 283 SALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTG 342
S + Y+ + H D++ +NIL+ + + VADFG+AR +E NE T+ G K
Sbjct: 374 SGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIK 429
Query: 343 YIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDM 380
+ APE + + DV+SFGILL E+ T G P M
Sbjct: 430 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 468
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 6e-27
Identities = 68/309 (22%), Positives = 116/309 (37%), Gaps = 64/309 (20%)
Query: 110 IDCGLLVLTLALSSLFCR--------------LMCMKKRGNPTPSISIDLDFPYV----- 150
ID ++ A S R L +K+G + ++S+ Y
Sbjct: 314 IDGYCRLVNGATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDE 373
Query: 151 --SYEALYSATKGFSSENL-----IGAGNFASVYKGILF---EGAPAVAIKVFNFLHHDA 200
+Y + E + IG G F V++GI A AVAIK +
Sbjct: 374 EDTYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKT---CKNCT 430
Query: 201 SKS----FTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPI 256
S S F E MR H I+K++ + ++ E G L ++
Sbjct: 431 SDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVW------IIMELCTLGELRSFL--- 481
Query: 257 TEEDKRHKAPGNLNSLERLNIAIDVASALEYLH-LGCKPPIAHCDIKPSNILLNDEMTAC 315
+ K +L+ + A +++AL YL H DI N+L++
Sbjct: 482 ----QVRK--FSLDLASLILYAYQLSTALAYLESKRF----VHRDIAARNVLVSSNDCVK 531
Query: 316 VADFGIARFLEATNEQTSSIG---VKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT 372
+ DFG++R++E + +S G +K APE +S DV+ FG+ + E+
Sbjct: 532 LGDFGLSRYMEDSTYYKASKGKLPIKWM----APESINFRRFTSASDVWMFGVCMWEILM 587
Query: 373 -GLRPSDDM 380
G++P +
Sbjct: 588 HGVKPFQGV 596
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 6e-27
Identities = 61/232 (26%), Positives = 101/232 (43%), Gaps = 43/232 (18%)
Query: 165 ENLIGAGNFASVYKGIL---FEGAPAVAIKVFNFLHHDAS----KSFTVECEVMRNIIHR 217
E +IG+G+ V G L + VAIK L + + F E +M H
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKA---LKAGYTERQRRDFLSEASIMGQFDHP 110
Query: 218 KIIKVVTACSRVD--YQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERL 275
II++ +R +V E+M NGSL+ ++ + H G ++ +
Sbjct: 111 NIIRLEGVVTRGRLAM-------IVTEYMENGSLDTFL-------RTHD--GQFTIMQLV 154
Query: 276 NIAIDVASALEYL-HLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSS 334
+ V + + YL LG H D+ N+L++ + V+DFG++R LE + +
Sbjct: 155 GMLRGVGAGMRYLSDLGY----VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYT 210
Query: 335 -----IGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDM 380
I ++ T APE SS DV+SFG+++ E+ G RP +M
Sbjct: 211 TTGGKIPIRWT----APEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNM 258
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 8e-27
Identities = 53/226 (23%), Positives = 93/226 (41%), Gaps = 37/226 (16%)
Query: 165 ENLIGAGNFASVYKGILFEGAPA---VAIKVFNFLHHDASKS----FTVECEVMRNIIHR 217
+IG G+F VY G L + A+K L+ F E +M++ H
Sbjct: 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS---LNRITDIGEVSQFLTEGIIMKDFSHP 150
Query: 218 KIIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNI 277
++ ++ C R + +V +M +G L +I R++ N + +
Sbjct: 151 NVLSLLGICLRSEGS----PLVVLPYMKHGDLRNFI--------RNETH-NPTVKDLIGF 197
Query: 278 AIDVASALEYL-HLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIG 336
+ VA +++L H D+ N +L+++ T VADFG+AR + +
Sbjct: 198 GLQVAKGMKFLASKKF----VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV--- 250
Query: 337 VKGTTGYI-----APEYGMGHETSSYGDVYSFGILLLEMFT-GLRP 376
T + A E + ++ DV+SFG+LL E+ T G P
Sbjct: 251 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 8e-27
Identities = 55/225 (24%), Positives = 95/225 (42%), Gaps = 32/225 (14%)
Query: 168 IGAGNFASVYKGILFEGAP---AVAIKVFNFLHHDAS-----KSFTVECEVMRNIIHRKI 219
+G G F SV + L + VA+K+ L D + F E M+ H +
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKM---LKADIIASSDIEEFLREAACMKEFDHPHV 87
Query: 220 IKVVTACSRVDYQGNDFKAL-VYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIA 278
K+V R +G + + FM +G L ++ + + P NL +
Sbjct: 88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLL----ASRIGENPFNLPLQTLVRFM 143
Query: 279 IDVASALEYL-HLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGV 337
+D+A +EYL H D+ N +L ++MT CVADFG++R + + +
Sbjct: 144 VDIACGMEYLSSRNF----IHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYR----- 194
Query: 338 KGTTGYI-----APEYGMGHETSSYGDVYSFGILLLEMFT-GLRP 376
+G + A E + + + DV++FG+ + E+ T G P
Sbjct: 195 QGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 8e-27
Identities = 59/239 (24%), Positives = 93/239 (38%), Gaps = 33/239 (13%)
Query: 167 LIGAGNFASVYKGILFEGAPAVAIKVFN-FLHHDASKSFTVECEVMRNIIHRKIIKVVTA 225
++G G A+V++G + AIKVFN E EV++ + H+ I+K+
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 226 CSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASAL 285
+ K L+ EF P GSL + + L E L + DV +
Sbjct: 76 ---EEETTTRHKVLIMEFCPCGSLYTVL-------EEPSNAYGLPESEFLIVLRDVVGGM 125
Query: 286 EYLHLGCKPPIAHCDIKPSNILL----NDEMTACVADFGIARFLEATNEQTSSIGVKGTT 341
+L + I H +IKP NI+ + + + DFG AR LE + S GT
Sbjct: 126 NHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY---GTE 179
Query: 342 GYIAPE-----YGMGHETSSYG---DVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQ 392
Y+ P+ YG D++S G+ TG P F+ + +
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP----FRPFEGPRRNKE 234
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 8e-27
Identities = 60/224 (26%), Positives = 107/224 (47%), Gaps = 35/224 (15%)
Query: 165 ENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDAS--KSFTVECEVMRNIIHRKIIKV 222
+GAG F V+ G G VA+K L + +F E +M+ + H++++++
Sbjct: 18 VERLGAGQFGEVWMGYY-NGHTKVAVKS---LKQGSMSPDAFLAEANLMKQLQHQRLVRL 73
Query: 223 VTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVA 282
++ + ++ E+M NGSL +++ + + L + L++A +A
Sbjct: 74 YAVVTQ------EPIYIITEYMENGSLVDFL--------KTPSGIKLTINKLLDMAAQIA 119
Query: 283 SALEYL-HLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIG----V 337
+ ++ H D++ +NIL++D ++ +ADFG+AR +E NE T+ G +
Sbjct: 120 EGMAFIEERNY----IHRDLRAANILVSDTLSCKIADFGLARLIED-NEYTAREGAKFPI 174
Query: 338 KGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDM 380
K T APE + DV+SFGILL E+ T G P M
Sbjct: 175 KWT----APEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM 214
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 53/227 (23%), Positives = 81/227 (35%), Gaps = 32/227 (14%)
Query: 165 ENLIGAGNFASVYKGILFEGAPA---VAIKVFN---FLHHDASKSFTVECEVMRNIIHRK 218
+G G+F V +G + VA+K +A F E M ++ HR
Sbjct: 23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 219 IIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIA 278
+I++ + +V E P GSL + + K G+ A
Sbjct: 83 LIRLYGVVLTPPMK------MVTELAPLGSLLDRLR---------KHQGHFLLGTLSRYA 127
Query: 279 IDVASALEYL---HLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQ-TSS 334
+ VA + YL H D+ N+LL + DFG+ R L ++
Sbjct: 128 VQVAEGMGYLESKRF------IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQ 181
Query: 335 IGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDM 380
K + APE S D + FG+ L EMFT G P +
Sbjct: 182 EHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL 228
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 54/227 (23%), Positives = 90/227 (39%), Gaps = 39/227 (17%)
Query: 165 ENLIGAGNFASVYKGILFEGAPA---VAIKVFNFLHHDASKS----FTVECEVMRNIIHR 217
+IG G+F VY G L + A+K L+ F E +M++ H
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS---LNRITDIGEVSQFLTEGIIMKDFSHP 86
Query: 218 KIIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNI 277
++ ++ C R + +V +M +G L +I N + +
Sbjct: 87 NVLSLLGICLRSEGS----PLVVLPYMKHGDLRNFIR---------NETHNPTVKDLIGF 133
Query: 278 AIDVASALEYLH-LGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATN---EQTS 333
+ VA ++YL H D+ N +L+++ T VADFG+AR +
Sbjct: 134 GLQVAKGMKYLASKKF----VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNK 189
Query: 334 SIG---VKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRP 376
+ VK A E + ++ DV+SFG+LL E+ T G P
Sbjct: 190 TGAKLPVKWM----ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 232
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 60/254 (23%), Positives = 101/254 (39%), Gaps = 25/254 (9%)
Query: 129 MCMKKRGNPTPSISIDLDFPYVSYEALYSATKGFSSENLIGAGNFASVYKGILFEGAPAV 188
M + +G P + + + Y+ F E IG G F+ VY+ V
Sbjct: 1 MDEQSQGMQGPPVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPV 60
Query: 189 AIK---VFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKALVYEFMP 245
A+K +F+ + A E ++++ + H +IK + + ++ +V E
Sbjct: 61 ALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYAS-----FIEDNELNIVLELAD 115
Query: 246 NGSLEEWIHPITEEDKRHKAPGNLNSLER-LNIAIDVASALEYLHLGCKPPIAHCDIKPS 304
G L I K K L + + SALE++H + H DIKP+
Sbjct: 116 AGDLSRMI-------KHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPA 165
Query: 305 NILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPE--YGMGHETSSYGDVYS 362
N+ + + D G+ RF + S + GT Y++PE + G+ S D++S
Sbjct: 166 NVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPERIHENGYNFKS--DIWS 221
Query: 363 FGILLLEMFTGLRP 376
G LL EM P
Sbjct: 222 LGCLLYEMAALQSP 235
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 52/225 (23%), Positives = 93/225 (41%), Gaps = 31/225 (13%)
Query: 165 ENLIGAGNFASVYKGIL--FEGAPAVAIKVFNFLHHDASKS----FTVECEVMRNIIHRK 218
+ +G GNF SV +G+ + VAIKV L K+ E ++M + +
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKV---LKQGTEKADTEEMMREAQIMHQLDNPY 71
Query: 219 IIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIA 278
I++++ C LV E G L +++ + + +
Sbjct: 72 IVRLIGVCQAEALM------LVMEMAGGGPLHKFL-------VGKR--EEIPVSNVAELL 116
Query: 279 IDVASALEYL-HLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQ-TSSIG 336
V+ ++YL H D+ N+LL + A ++DFG+++ L A + T+
Sbjct: 117 HQVSMGMKYLEEKNF----VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA 172
Query: 337 VKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDM 380
K + APE + SS DV+S+G+ + E + G +P M
Sbjct: 173 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM 217
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 26/262 (9%), Positives = 66/262 (25%), Gaps = 42/262 (16%)
Query: 167 LIGAGNFASVYKGILFEGAPAVAIKVFN---FLHHDASKSFTVECEVMRNIIHRKIIKVV 223
+ G+ + V+ E A+KVF + ++ +
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 224 TACS-----------------RVDYQGNDFKA----LVYEFMPNGSLEEWIHPITEEDKR 262
++ +D+ L+ + LE + D
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAA-SVDLELLFSTL---DFV 184
Query: 263 HKAPGNLNSLERLNIAIDVASALEYLH-LGCKPPIAHCDIKPSNILLNDEMTACVADFGI 321
+ G+ L + + L G + H P N+ + + + D
Sbjct: 185 YVFRGDEGILALHILTAQLIRLAANLQSKG----LVHGHFTPDNLFIMPDGRLMLGDVSA 240
Query: 322 ARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYG---DVYSFGILLLEMFTGLRPSD 378
+ + Y E+ + T+++ + + G+ + ++ P
Sbjct: 241 LW---KVGTRGPASS--VPVTYAPREF-LNASTATFTHALNAWQLGLSIYRVWCLFLPFG 294
Query: 379 DMFKDNLNLQNWVQSALPERVE 400
+ +P
Sbjct: 295 LVTPGIKGSWKRPSLRVPGTDS 316
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 115 bits (288), Expect = 1e-26
Identities = 66/340 (19%), Positives = 119/340 (35%), Gaps = 36/340 (10%)
Query: 58 IPTEGIFKNASATSVFGNNKLCGGIPEFQLPTCVSKKTKQNRSTLPLKLVIAIDC----- 112
IP F + K G I + S + + + P
Sbjct: 223 IPEGTKFDTLWQLVEYLKLKADGLIYCLKEACPNSSASNASGAAAPTLPAHPSTLTHPQR 282
Query: 113 GLLVLTLALSSLFCRLMCMKKRGNPTPSISIDLDFPYVSYEALYSATKGFSSENL----- 167
+ L + + + P P + + P+ E L +NL
Sbjct: 283 RIDTLNSDGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIADI 342
Query: 168 -IGAGNFASVYKGIL--FEGAPAVAIKVFNFLHHDASKS-FTVECEVMRNIIHRKIIKVV 223
+G GNF SV +G+ + VAIKV A E ++M + + I++++
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 224 TACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVAS 283
C LV E G L +++ + + + V+
Sbjct: 403 GVCQAEALM------LVMEMAGGGPLHKFL-------VGKR--EEIPVSNVAELLHQVSM 447
Query: 284 ALEYL-HLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQ-TSSIGVKGTT 341
++YL H ++ N+LL + A ++DFG+++ L A + T+ K
Sbjct: 448 GMKYLEEKNF----VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL 503
Query: 342 GYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDM 380
+ APE + SS DV+S+G+ + E + G +P M
Sbjct: 504 KWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM 543
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-26
Identities = 61/232 (26%), Positives = 103/232 (44%), Gaps = 43/232 (18%)
Query: 165 ENLIGAGNFASVYKGIL---FEGAPAVAIKVFNFLHHDAS----KSFTVECEVMRNIIHR 217
+ ++GAG F V G L + +VAIK L + + F E +M H
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKT---LKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 218 KIIKVVTACSRVD--YQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERL 275
II++ ++ +V E+M NGSL+ ++ K ++ +
Sbjct: 107 NIIRLEGVVTKSKPVM-------IVTEYMENGSLDSFLR---------KHDAQFTVIQLV 150
Query: 276 NIAIDVASALEYL-HLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSS 334
+ +AS ++YL +G H D+ NIL+N + V+DFG+ R LE E +
Sbjct: 151 GMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYT 206
Query: 335 -----IGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDM 380
I ++ T +PE + +S DV+S+GI+L E+ + G RP +M
Sbjct: 207 TRGGKIPIRWT----SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM 254
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 53/237 (22%), Positives = 87/237 (36%), Gaps = 26/237 (10%)
Query: 165 ENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVT 224
+G G F+ V A+K + E ++ R H I+++V
Sbjct: 34 IQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVA 93
Query: 225 ACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASA 284
C R ++ L+ F G+L I ++ L + L + + +
Sbjct: 94 YCLRERGAKHEAW-LLLPFFKRGTLWNEI------ERLKDKGNFLTEDQILWLLLGICRG 146
Query: 285 LEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSS-------IGV 337
LE +H AH D+KP+NILL DE + D G E +
Sbjct: 147 LEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQ 203
Query: 338 KGTTGYIAPE------YGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQ 388
+ T Y APE + + E + DV+S G +L M G P D +F+ ++
Sbjct: 204 RCTISYRAPELFSVQSHCVIDERT---DVWSLGCVLYAMMFGEGPYDMVFQKGDSVA 257
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 3e-26
Identities = 43/302 (14%), Positives = 92/302 (30%), Gaps = 67/302 (22%)
Query: 167 LIGAGNFASVYKGILFEGAPAVAIKVFNF---LHHDASKSFTVECEVMRNIIHRKIIKVV 223
++G + + + E + + V F +A K E +R + K K
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 224 TACSRV-------------------DYQGNDFKALVYEFMP--NGSLEEWIHPITEEDKR 262
R + + + + P +L+ + +
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 263 HKAPGNLNSLERLNIAIDVASALEYLH-LGCKPPIAHCDIKPSNILLNDEMTACVADFGI 321
HK+ + RL + + V L LH G + H ++P +I+L+ + F
Sbjct: 205 HKSLVHH---ARLQLTLQVIRLLASLHHYG----LVHTYLRPVDIVLDQRGGVFLTGFEH 257
Query: 322 ARFLEATNEQTSSIGVKGTTGYIAPEY-------GMGHETSSYG---DVYSFGILLLEMF 371
A+ G+ PE H + D ++ G+ + ++
Sbjct: 258 LVRDGASAV------SPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW 311
Query: 372 TGLRP--SDDM-------FKDNLNLQNWVQSAL-------PER---VEEIVDTLFFKEIE 412
P D F+ N+ V++ L E + ++T ++++
Sbjct: 312 CADLPNTDDAALGGSEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLR 371
Query: 413 EE 414
E
Sbjct: 372 TE 373
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-26
Identities = 64/232 (27%), Positives = 100/232 (43%), Gaps = 40/232 (17%)
Query: 165 ENLIGAGNFASVYKGILFEGAPA--VAIKVFNFLHHDASKS----FTVECEVMRNII-HR 217
+++IG GNF V K + + AIK + ASK F E EV+ + H
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKR---MKEYASKDDHRDFAGELEVLCKLGHHP 86
Query: 218 KIIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEW------IHPITEEDKRHKAPGNLNS 271
II ++ AC Y L E+ P+G+L ++ + + L+S
Sbjct: 87 NIINLLGACEHRGYL-----YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 141
Query: 272 LERLNIAIDVASALEYL-HLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNE 330
+ L+ A DVA ++YL H D+ NIL+ + A +ADFG++R E
Sbjct: 142 QQLLHFAADVARGMDYLSQKQFI----HRDLAARNILVGENYVAKIADFGLSRGQEVY-- 195
Query: 331 QTSSIGVKGTTGYI-----APEYGMGHETSSYGDVYSFGILLLEMFT-GLRP 376
VK T G + A E ++ DV+S+G+LL E+ + G P
Sbjct: 196 ------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 4e-26
Identities = 67/278 (24%), Positives = 103/278 (37%), Gaps = 34/278 (12%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIKVFNF-LHHDASKSFTVECEVMRNIIHRKIIKVV-TA 225
+G G F V + I + VAIK L + + +E ++M+ + H ++
Sbjct: 22 LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81
Query: 226 CSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASAL 285
ND L E+ G L ++++ + + L + D++SAL
Sbjct: 82 DGLQKLAPNDLPLLAMEYCEGGDLRKYLN-------QFENCCGLKEGPIRTLLSDISSAL 134
Query: 286 EYLHLGCKPPIAHCDIKPSNILLNDEMTAC---VADFGIARFLEATNEQTSSIGVKGTTG 342
YLH + I H D+KP NI+L + D G A+ L+ T + GT
Sbjct: 135 RYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFV---GTLQ 188
Query: 343 YIAPEYGMGHETSSYG---DVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPERV 399
Y+APE Y D +SFG L E TG RP F N W +
Sbjct: 189 YLAPELLEQK---KYTVTVDYWSFGTLAFECITGFRP----FLPNWQPVQWHGKVREKSN 241
Query: 400 EEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECL 437
E IV ++ K+ + S IL
Sbjct: 242 EHIVVY------DDLTGAVKFSSVLPTPNHLSGILAGK 273
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 59/229 (25%), Positives = 104/229 (45%), Gaps = 45/229 (19%)
Query: 165 ENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDAS--KSFTVECEVMRNIIHRKIIKV 222
+G G F V G G VAIK+ + + F E +VM N+ H K++++
Sbjct: 29 LKELGTGQFGVVKYGKW-RGQYDVAIKM---IKEGSMSEDEFIEEAKVMMNLSHEKLVQL 84
Query: 223 VTACSRVD--YQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAID 280
C++ + ++ E+M NG L ++ + + + + L + D
Sbjct: 85 YGVCTKQRPIF-------IITEYMANGCLLNYL-------REMR--HRFQTQQLLEMCKD 128
Query: 281 VASALEYL-HLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIG--- 336
V A+EYL H D+ N L+ND+ V+DFG++R++ +E TSS+G
Sbjct: 129 VCEAMEYLESKQF----LHRDLAARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKF 183
Query: 337 -VKGTTGYIAPE---YGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDM 380
V+ + PE Y SS D+++FG+L+ E+++ G P +
Sbjct: 184 PVRWS----PPEVLMYSK---FSSKSDIWAFGVLMWEIYSLGKMPYERF 225
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 5e-26
Identities = 59/239 (24%), Positives = 93/239 (38%), Gaps = 33/239 (13%)
Query: 167 LIGAGNFASVYKGILFEGAPAVAIKVFN-FLHHDASKSFTVECEVMRNIIHRKIIKVVTA 225
++G G A+V++G + AIKVFN E EV++ + H+ I+K+
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 226 CSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASAL 285
+ K L+ EF P GSL + + L E L + DV +
Sbjct: 76 ---EEETTTRHKVLIMEFCPCGSLYTVL-------EEPSNAYGLPESEFLIVLRDVVGGM 125
Query: 286 EYLHLGCKPPIAHCDIKPSNILL----NDEMTACVADFGIARFLEATNEQTSSIGVKGTT 341
+L + I H +IKP NI+ + + + DFG AR LE + S GT
Sbjct: 126 NHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY---GTE 179
Query: 342 GYIAPE-----YGMGHETSSYG---DVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQ 392
Y+ P+ YG D++S G+ TG P F+ + +
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP----FRPFEGPRRNKE 234
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 6e-26
Identities = 64/233 (27%), Positives = 110/233 (47%), Gaps = 44/233 (18%)
Query: 165 ENLIGAGNFASVYKGIL----FEGAPAVAIKVFNFLHHDAS----KSFTVECEVMRNIIH 216
+ +IGAG F VYKG+L + VAIK L + F E +M H
Sbjct: 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKT---LKAGYTEKQRVDFLGEAGIMGQFSH 105
Query: 217 RKIIKVVTACSRVD--YQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLER 274
II++ S+ ++ E+M NG+L++++ + G + L+
Sbjct: 106 HNIIRLEGVISKYKPMM-------IITEYMENGALDKFL-------REKD--GEFSVLQL 149
Query: 275 LNIAIDVASALEYL-HLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQT- 332
+ + +A+ ++YL ++ H D+ NIL+N + V+DFG++R LE E T
Sbjct: 150 VGMLRGIAAGMKYLANMNY----VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATY 205
Query: 333 SSIG----VKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDM 380
++ G ++ T APE + +S DV+SFGI++ E+ T G RP ++
Sbjct: 206 TTSGGKIPIRWT----APEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL 254
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 7e-26
Identities = 52/247 (21%), Positives = 91/247 (36%), Gaps = 40/247 (16%)
Query: 162 FSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIK 221
F ++G G F V K + AIK + + E ++ ++ H+ +++
Sbjct: 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLNHQYVVR 66
Query: 222 -----VVTACSRVDYQGNDFKALVY---EFMPNGSLEEWIHPITEEDKRHKAPGNLNSLE 273
+ K+ ++ E+ NG+L + IH N E
Sbjct: 67 YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIH---------SENLNQQRDE 117
Query: 274 RLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTS 333
+ + AL Y+H I H D+KP NI +++ + DFG+A+ + + +
Sbjct: 118 YWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILK 174
Query: 334 SIGVK------------GTTGYIAPEYGMGHETSSYG---DVYSFGILLLEMFTGLRPSD 378
GT Y+A E + T Y D+YS GI+ EM S
Sbjct: 175 LDSQNLPGSSDNLTSAIGTAMYVATE--VLDGTGHYNEKIDMYSLGIIFFEMIYP--FST 230
Query: 379 DMFKDNL 385
M + N+
Sbjct: 231 GMERVNI 237
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 7e-26
Identities = 58/226 (25%), Positives = 98/226 (43%), Gaps = 39/226 (17%)
Query: 165 ENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDAS--KSFTVECEVMRNIIHRKIIKV 222
+G+G F V G +G VA+K+ + + F E + M + H K++K
Sbjct: 13 LKELGSGQFGVVKLGKW-KGQYDVAVKM---IKEGSMSEDEFFQEAQTMMKLSHPKLVKF 68
Query: 223 VTACSRVD--YQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAID 280
CS+ Y +V E++ NG L ++ L + L + D
Sbjct: 69 YGVCSKEYPIY-------IVTEYISNGCLLNYLR---------SHGKGLEPSQLLEMCYD 112
Query: 281 VASALEYL-HLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIG--- 336
V + +L H D+ N L++ ++ V+DFG+ R++ ++ SS+G
Sbjct: 113 VCEGMAFLESHQF----IHRDLAARNCLVDRDLCVKVSDFGMTRYVL-DDQYVSSVGTKF 167
Query: 337 -VKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDM 380
VK + APE + SS DV++FGIL+ E+F+ G P D
Sbjct: 168 PVKWS----APEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLY 209
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 54/224 (24%), Positives = 91/224 (40%), Gaps = 33/224 (14%)
Query: 165 ENLIGAGNFASVYKGILF---EGAPAVAIKVFNFLHHDASKS-FTVECEVMRNIIHRKII 220
+ +IG G+F VY G + AIK + + F E +MR + H ++
Sbjct: 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85
Query: 221 KVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAID 280
++ ++ +M +G L ++I + + N + ++ +
Sbjct: 86 ALIGIML----PPEGLPHVLLPYMCHGDLLQFI-------RSPQ--RNPTVKDLISFGLQ 132
Query: 281 VASALEYL-HLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATN---EQTSSIG 336
VA +EYL H D+ N +L++ T VADFG+AR + Q
Sbjct: 133 VARGMEYLAEQKF----VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHA 188
Query: 337 ---VKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRP 376
VK T A E + ++ DV+SFG+LL E+ T G P
Sbjct: 189 RLPVKWT----ALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-25
Identities = 46/307 (14%), Positives = 100/307 (32%), Gaps = 76/307 (24%)
Query: 167 LIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKS----------------------- 203
++G + + + E + + V F S +
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 204 -----FTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITE 258
F +++++ +K+I+V R + + F +Y M +L+ + +
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVR-LDERDMWVLSRF--FLYPRM-QSNLQTFGEVLLS 195
Query: 259 EDKRHKAPGNLNSLERLNIAIDVASALEYLH-LGCKPPIAHCDIKPSNILLNDEMTACVA 317
H +L RL + + V L LH G + H ++P +I+L+ +
Sbjct: 196 HSSTH---KSLVHHARLQLTLQVIRLLASLHHYG----LVHTYLRPVDIVLDQRGGVFLT 248
Query: 318 DFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYG-----------DVYSFGIL 366
F SS + G+ PE T SY D ++ G++
Sbjct: 249 GFEHLV--RDGARVVSS----VSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302
Query: 367 LLEMFTGLRPSDD---------MFKDNLNLQNWVQSAL-------PER---VEEIVDTLF 407
+ ++ P +F+ N+ V++ L E + ++T
Sbjct: 303 IYWIWCADLPITKDAALGGSEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPE 362
Query: 408 FKEIEEE 414
++++ E
Sbjct: 363 YEQLRTE 369
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-25
Identities = 52/225 (23%), Positives = 93/225 (41%), Gaps = 37/225 (16%)
Query: 168 IGAGNFASVYKGIL--FEGAPAVAIKVF--NFLHHDASKSFTVECEVMRNIIHRKIIKVV 223
+G+GNF +V KG + VA+K+ E VM+ + + I++++
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 224 TACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVAS 283
C + LV E G L +++ + ++ + + V+
Sbjct: 85 GICEAESWM------LVMEMAELGPLNKYL----------QQNRHVKDKNIIELVHQVSM 128
Query: 284 ALEYL-HLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQ-TSSIG----V 337
++YL H D+ N+LL + A ++DFG+++ L A + V
Sbjct: 129 GMKYLEESNF----VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV 184
Query: 338 KGTTGYIAPEYGMGHET-SSYGDVYSFGILLLEMFT-GLRPSDDM 380
K APE + + SS DV+SFG+L+ E F+ G +P M
Sbjct: 185 KWY----APE-CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 224
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 2e-25
Identities = 45/300 (15%), Positives = 85/300 (28%), Gaps = 62/300 (20%)
Query: 136 NPTPSISIDLDFPYVSYEALYSATKGFSSENLIGAGNFASVYKGILFEGAPA-----VAI 190
P+I +F +K +L+G G FA VY+ + A +
Sbjct: 49 CKLPAIKPKTEFQL--------GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVL 100
Query: 191 KVFNFLHHDASKSFTVECEVMRNII-------HRKIIKVVTACSRVDYQGNDFKALVYEF 243
KV + E + ++ +K +A + + LV E
Sbjct: 101 KVQK-------PANPWEFYIGTQLMERLKPSMQHMFMKFYSA-----HLFQNGSVLVGEL 148
Query: 244 MPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKP 303
G+L I ++ + ++ A+ + +E +H I H DIKP
Sbjct: 149 YSYGTLLNAI-----NLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKP 200
Query: 304 SNILLNDEMTA-----------CVADFGIARFLEATNEQTSSIGVKGTTGYIAPE--YGM 350
N +L + + D G + ++ + T T+G+ E
Sbjct: 201 DNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNK 260
Query: 351 GHETSSYGDVYSFGILLLEMFTGLRP----SDDMFKDNLNLQNWVQSALPERVEEIVDTL 406
D + + M G K + + E +
Sbjct: 261 PWNYQI--DYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPH---LDMWNEFFHVM 315
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 50/228 (21%), Positives = 97/228 (42%), Gaps = 38/228 (16%)
Query: 165 ENLIGAGNFASVYKGILFEGAPA---VAIKVFNFLHHDASKS-FTVECEVMRNIIHRKII 220
++G G F VY+G+ VA+K +K F E +M+N+ H I+
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 221 KVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAID 280
K++ + ++ E P G L ++ +R+K +L L + ++
Sbjct: 77 KLIGIIEE------EPTWIIMELYPYGELGHYL-------ERNK--NSLKVLTLVLYSLQ 121
Query: 281 VASALEYL-HLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIG--- 336
+ A+ YL + C H DI NIL+ + DFG++R++E + +S+
Sbjct: 122 ICKAMAYLESINC----VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLP 177
Query: 337 VKGTTGYIAPE---YGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDM 380
+K +PE + ++ DV+ F + + E+ + G +P +
Sbjct: 178 IKWM----SPESINFRR---FTTASDVWMFAVCMWEILSFGKQPFFWL 218
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 2e-25
Identities = 54/240 (22%), Positives = 98/240 (40%), Gaps = 35/240 (14%)
Query: 162 FSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNI-IHRKII 220
F ++++G G ++ +F+ VA+K + E +++R H +I
Sbjct: 26 FCPKDVLGHGAEGTIVYRGMFDNRD-VAVKRILPECFSFADR---EVQLLRESDEHPNVI 81
Query: 221 KVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAID 280
+ C+ + F+ + E +L+E++ E K LE + +
Sbjct: 82 RYF--CT---EKDRQFQYIAIELCA-ATLQEYV-----EQKDF----AHLGLEPITLLQQ 126
Query: 281 VASALEYLH-LGCKPPIAHCDIKPSNILL-----NDEMTACVADFGIARFLEATNEQTSS 334
S L +LH L I H D+KP NIL+ + ++ A ++DFG+ + L S
Sbjct: 127 TTSGLAHLHSLN----IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSR 182
Query: 335 I-GVKGTTGYIAPEYGMGHETSSYG---DVYSFGILLLEMFT-GLRPSDDMFKDNLNLQN 389
GV GT G+IAPE + D++S G + + + G P + N+
Sbjct: 183 RSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILL 242
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 52/238 (21%), Positives = 92/238 (38%), Gaps = 50/238 (21%)
Query: 165 ENLIGAGNFASVYKGIL-------FEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHR 217
+G G F ++KG+ V +KV + H + S+SF +M + H+
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 218 KIIKVVTACSRVD--YQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERL 275
++ C D LV EF+ GSL+ ++ K++K +N L +L
Sbjct: 73 HLVLNYGVCVCGDENI-------LVQEFVKFGSLDTYL-------KKNK--NCINILWKL 116
Query: 276 NIAIDVASALEYL---HLGCKPPIAHCDIKPSNILLNDEMTAC--------VADFGIARF 324
+A +A+A+ +L L H ++ NILL E ++D GI+
Sbjct: 117 EVAKQLAAAMHFLEENTL------IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT 170
Query: 325 LEATNEQTSSIGVKGTTGYIAPE-YGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDM 380
+ + + PE + D +SFG L E+ + G +P +
Sbjct: 171 VL--PKDILQERIPWV----PPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSAL 222
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 4e-25
Identities = 44/215 (20%), Positives = 79/215 (36%), Gaps = 17/215 (7%)
Query: 167 LIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDAS--KSFTVECEVMRNIIHRKIIKVVT 224
IG G++ K + K ++ + + E ++R + H I++
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 225 ACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLER-LNIAIDVAS 283
+D +V E+ G L I + E L + +
Sbjct: 73 --RIIDRTNTTLY-IVMEYCEGGDLASVI-------TKGTKERQYLDEEFVLRVMTQLTL 122
Query: 284 ALEYLHLGCKPP--IAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTT 341
AL+ H + H D+KP+N+ L+ + + DFG+AR L + GT
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGTP 180
Query: 342 GYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRP 376
Y++PE + D++S G LL E+ + P
Sbjct: 181 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP 215
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 5e-25
Identities = 52/219 (23%), Positives = 86/219 (39%), Gaps = 34/219 (15%)
Query: 167 LIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDAS--KSFTVECEVMRNIIHRKIIKVVT 224
IG G+F E IK N + + E V+ N+ H I++
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 225 ACSRVDYQGNDFKALVYEFMPNGSLEEWI-----HPITEEDKRHKAPGNLNSLERLNIAI 279
+ ++ N +V ++ G L + I E+ + L+ +
Sbjct: 91 S-----FEENGSLYIVMDYCEGGDLFKRINAQKGVLFQED-------------QILDWFV 132
Query: 280 DVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKG 339
+ AL+++H I H DIK NI L + T + DFGIAR L +T E + G
Sbjct: 133 QICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIG 187
Query: 340 TTGYIAPE--YGMGHETSSYGDVYSFGILLLEMFTGLRP 376
T Y++PE + S D+++ G +L E+ T
Sbjct: 188 TPYYLSPEICENKPYNNKS--DIWALGCVLYELCTLKHA 224
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 6e-25
Identities = 53/239 (22%), Positives = 95/239 (39%), Gaps = 49/239 (20%)
Query: 165 ENLIGAGNFASVYKGILFEGAP-----AVAIKVFNFLHHDASKS----FTVECEVMRNII 215
+G F VYKG LF AP AVAIK L A F E + +
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKT---LKDKAEGPLREEFRHEAMLRARLQ 70
Query: 216 HRKIIKVVTACSRVD--YQGNDFKALVYEFMPNGSLEEW------IHPITEEDKRHKAPG 267
H ++ ++ ++ +++ + +G L E+ + D
Sbjct: 71 HPNVVCLLGVVTKDQPLS-------MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKS 123
Query: 268 NLNSLERLNIAIDVASALEYL-HLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLE 326
L + +++ +A+ +EYL H D+ N+L+ D++ ++D G+ R +
Sbjct: 124 ALEPPDFVHLVAQIAAGMEYLSSHHV----VHKDLATRNVLVYDKLNVKISDLGLFREVY 179
Query: 327 ATNEQTSSIGVKGTTGYI-----APE---YGMGHETSSYGDVYSFGILLLEMFT-GLRP 376
A + + APE YG S D++S+G++L E+F+ GL+P
Sbjct: 180 AADYYK-----LLGNSLLPIRWMAPEAIMYGK---FSIDSDIWSYGVVLWEVFSYGLQP 230
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 6e-25
Identities = 46/231 (19%), Positives = 91/231 (39%), Gaps = 32/231 (13%)
Query: 162 FSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTV-ECEVMRNIIHRKII 220
F +G G F V++ AIK + + ++ + E + + + H I+
Sbjct: 7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66
Query: 221 K----VVTACSRVDYQGNDFKALVY---EFMPNGSLEEWIHPITEEDKRHKAPGNLNSLE 273
+ + + Q + K +Y + +L++W+
Sbjct: 67 RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWM-------NGRCTIEERERSV 119
Query: 274 RLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTS 333
L+I + +A A+E+LH + H D+KPSNI + V DFG+ ++ E+ +
Sbjct: 120 CLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQT 176
Query: 334 SIGVK----------GTTGYIAPE--YGMGHETSSYGDVYSFGILLLEMFT 372
+ GT Y++PE +G + D++S G++L E+
Sbjct: 177 VLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKV--DIFSLGLILFELLY 225
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 7e-25
Identities = 48/226 (21%), Positives = 94/226 (41%), Gaps = 35/226 (15%)
Query: 168 IGAGNFASVYKGILFEGAP-----AVAIKVFNFLHHDASKS----FTVECEVMRNIIHRK 218
+G G+F VY+G+ VAIK ++ AS F E VM+
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKT---VNEAASMRERIEFLNEASVMKEFNCHH 89
Query: 219 IIKVVTACSRVD--YQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLN 276
+++++ S+ ++ E M G L+ ++ + + + + +
Sbjct: 90 VVRLLGVVSQGQPTL-------VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 142
Query: 277 IAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIG 336
+A ++A + YL+ H D+ N ++ ++ T + DFG+ R + +
Sbjct: 143 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY-----ETDYY 194
Query: 337 VKGTTGYI-----APEYGMGHETSSYGDVYSFGILLLEMFT-GLRP 376
KG G + +PE ++Y DV+SFG++L E+ T +P
Sbjct: 195 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 8e-25
Identities = 54/228 (23%), Positives = 94/228 (41%), Gaps = 35/228 (15%)
Query: 168 IGAGNFASVYKGILFEGAP-----AVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKV 222
+G G F V+ P VA+K A + F E E++ + H+ I++
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 223 VTACSRVD--YQGNDFKALVYEFMPNGSLEEWI-----HPITEEDKRHKAPGNLNSLERL 275
C+ +V+E+M +G L ++ APG L + L
Sbjct: 109 FGVCTEGRPLL-------MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLL 161
Query: 276 NIAIDVASALEYL-HLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSS 334
+A VA+ + YL L H D+ N L+ + + DFG++R + +T+
Sbjct: 162 AVASQVAAGMVYLAGLHF----VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR-- 215
Query: 335 IGVKGTTGYI-----APEYGMGHETSSYGDVYSFGILLLEMFT-GLRP 376
G + PE + + ++ DV+SFG++L E+FT G +P
Sbjct: 216 ---VGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 8e-25
Identities = 54/222 (24%), Positives = 92/222 (41%), Gaps = 37/222 (16%)
Query: 165 ENLIGAGNFASVYKGILF----EGAPAVAIKVFNFLHHDASKS----FTVECEVMRNIIH 216
+G G+F V VA+K L ++ + E E++RN+ H
Sbjct: 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKS---LKPESGGNHIADLKKEIEILRNLYH 82
Query: 217 RKIIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLN 276
I+K C+ G + L+ EF+P+GSL+E++ ++K +N ++L
Sbjct: 83 ENIVKYKGICTE---DGGNGIKLIMEFLPSGSLKEYL-------PKNK--NKINLKQQLK 130
Query: 277 IAIDVASALEYLH-LGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNE----- 330
A+ + ++YL H D+ N+L+ E + DFG+ + +E E
Sbjct: 131 YAVQICKGMDYLGSRQY----VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVK 186
Query: 331 QTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT 372
V APE M + DV+SFG+ L E+ T
Sbjct: 187 DDRDSPVFWY----APECLMQSKFYIASDVWSFGVTLHELLT 224
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-24
Identities = 32/88 (36%), Positives = 42/88 (47%), Gaps = 4/88 (4%)
Query: 3 GNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEG 62
N G I + LRGL +LDLS N L G IP+ ++ L ++LS+NN IP G
Sbjct: 665 HNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMG 724
Query: 63 IFKNASATSVFGNNKLCGGIPEFQLPTC 90
F+ N LCG + LP C
Sbjct: 725 QFETFPPAKFLNNPGLCG----YPLPRC 748
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 2e-16
Identities = 30/85 (35%), Positives = 38/85 (44%), Gaps = 2/85 (2%)
Query: 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPT 60
+ N F G I +LS L L LS N LSG IP L L++L L N E IP
Sbjct: 401 LQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQ 460
Query: 61 EGIFKNASATSV-FGNNKLCGGIPE 84
E + + ++ N L G IP
Sbjct: 461 E-LMYVKTLETLILDFNDLTGEIPS 484
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 2e-15
Identities = 29/86 (33%), Positives = 41/86 (47%), Gaps = 2/86 (2%)
Query: 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPT 60
+ N G I SL L L+ L L N L GEIP+ L K L+ L L N+ IP+
Sbjct: 425 LSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPS 484
Query: 61 EGIFKNASATSV-FGNNKLCGGIPEF 85
+ + + NN+L G IP++
Sbjct: 485 G-LSNCTNLNWISLSNNRLTGEIPKW 509
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 3e-15
Identities = 28/85 (32%), Positives = 38/85 (44%), Gaps = 2/85 (2%)
Query: 2 HGNLFEGPIGLSLSP-LRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPT 60
N F G I LS L LDLS N+ G +P F L++L LS NNF +P
Sbjct: 277 AENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPM 336
Query: 61 EGIFKNASATSVF-GNNKLCGGIPE 84
+ + K + N+ G +PE
Sbjct: 337 DTLLKMRGLKVLDLSFNEFSGELPE 361
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 2e-14
Identities = 26/94 (27%), Positives = 37/94 (39%), Gaps = 22/94 (23%)
Query: 3 GNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEG 62
++ G + + LD+S N LSG IP+ + +L LNL HN+ IP E
Sbjct: 617 SRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDE- 675
Query: 63 IFKNASATSVFGN-----------NKLCGGIPEF 85
G+ NKL G IP+
Sbjct: 676 ----------VGDLRGLNILDLSSNKLDGRIPQA 699
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 2e-14
Identities = 25/85 (29%), Positives = 37/85 (43%), Gaps = 4/85 (4%)
Query: 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPT 60
+ N G I + L L +L LS N+ SG IP L + L L+L+ N F IP
Sbjct: 497 LSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPA 556
Query: 61 EGIFKNASATSVFGNNKLCGGIPEF 85
+FK + + N + G +
Sbjct: 557 A-MFKQSGKIA---ANFIAGKRYVY 577
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 4e-14
Identities = 27/85 (31%), Positives = 40/85 (47%), Gaps = 2/85 (2%)
Query: 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIP-EFLAGFKFLQNLNLSHNNFESMIP 59
+ GN F G + L+ L LS NN SGE+P + L + L+ L+LS N F +P
Sbjct: 301 LSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELP 360
Query: 60 TEGIFKNASATSV-FGNNKLCGGIP 83
+AS ++ +N G I
Sbjct: 361 ESLTNLSASLLTLDLSSNNFSGPIL 385
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 5e-14
Identities = 28/89 (31%), Positives = 39/89 (43%), Gaps = 6/89 (6%)
Query: 1 MHGNLFEGPI--GLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMI 58
+ N F GPI L +P L+ L L N +G+IP L+ L +L+LS N I
Sbjct: 375 LSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTI 434
Query: 59 PTEGIFKNASATSVF--GNNKLCGGIPEF 85
P+ + S N L G IP+
Sbjct: 435 PSS--LGSLSKLRDLKLWLNMLEGEIPQE 461
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 2e-13
Identities = 30/92 (32%), Positives = 44/92 (47%), Gaps = 5/92 (5%)
Query: 3 GNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAG-FKFLQNLNLSHNNFESMIPTE 61
N F GPI PL+ L+ L L++N +GEIP+FL+G L L+LS N+F +P
Sbjct: 256 SNQFVGPI--PPLPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPF 313
Query: 62 GIFKNASATSV-FGNNKLCGGIPEFQLPTCVS 92
+ S+ +N G +P L
Sbjct: 314 -FGSCSLLESLALSSNNFSGELPMDTLLKMRG 344
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 3e-13
Identities = 36/127 (28%), Positives = 50/127 (39%), Gaps = 8/127 (6%)
Query: 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPT 60
+ N G I LS L + LS N L+GEIP+++ + L L LS+N+F IP
Sbjct: 473 LDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPA 532
Query: 61 EGIFKNASATSV-FGNNKLCGGIPE--FQLPTCVSKKTKQNRSTLPLKLVIAIDCGLLVL 117
E + S + N G IP F+ S K N + I D
Sbjct: 533 E-LGDCRSLIWLDLNTNLFNGTIPAAMFKQ----SGKIAANFIAGKRYVYIKNDGMKKEC 587
Query: 118 TLALSSL 124
A + L
Sbjct: 588 HGAGNLL 594
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 1e-12
Identities = 28/85 (32%), Positives = 39/85 (45%), Gaps = 3/85 (3%)
Query: 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPT 60
+ N F I L L+ LD+S N LSG+ ++ L+ LN+S N F IP
Sbjct: 207 VSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPP 265
Query: 61 EGIFKNASATSVFGNNKLCGGIPEF 85
K+ S+ NK G IP+F
Sbjct: 266 L-PLKSLQYLSL-AENKFTGEIPDF 288
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 67.2 bits (165), Expect = 1e-11
Identities = 17/82 (20%), Positives = 30/82 (36%), Gaps = 2/82 (2%)
Query: 4 NLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGI 63
F+G L+ L +++ G + L++S+N IP E I
Sbjct: 594 LEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKE-I 652
Query: 64 FKNASATSV-FGNNKLCGGIPE 84
+ G+N + G IP+
Sbjct: 653 GSMPYLFILNLGHNDISGSIPD 674
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 2e-11
Identities = 32/89 (35%), Positives = 36/89 (40%), Gaps = 7/89 (7%)
Query: 1 MHGNLFEGPIGLSLSPLRG-LKVLDLSQNNLSGEIPEFLAGF--KFLQNLNLSHNNFESM 57
+ N F G + SL+ L L LDLS NN SG I L LQ L L +N F
Sbjct: 350 LSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGK 409
Query: 58 IPTEGIFKNASATSV--FGNNKLCGGIPE 84
IP N S N L G IP
Sbjct: 410 IPPT--LSNCSELVSLHLSFNYLSGTIPS 436
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 3e-11
Identities = 21/88 (23%), Positives = 37/88 (42%), Gaps = 8/88 (9%)
Query: 1 MHGNLFEGPIGLSLSP---LRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESM 57
+ N G + LK L +S N +SG++ ++ L+ L++S NNF +
Sbjct: 158 LSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTG 215
Query: 58 IPTEGIFKNASATSV-FGNNKLCGGIPE 84
IP + ++ + NKL G
Sbjct: 216 IPF--LGDCSALQHLDISGNKLSGDFSR 241
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 3e-11
Identities = 20/82 (24%), Positives = 34/82 (41%), Gaps = 3/82 (3%)
Query: 4 NLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGI 63
N+ + SL L GL+ L LS ++++G + F L +L+LS N+ + T
Sbjct: 63 NVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGF-KCSASLTSLDLSRNSLSGPVTTLTS 121
Query: 64 FKNASATSVF--GNNKLCGGIP 83
+ S +N L
Sbjct: 122 LGSCSGLKFLNVSSNTLDFPGK 143
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 6e-11
Identities = 21/89 (23%), Positives = 35/89 (39%), Gaps = 8/89 (8%)
Query: 2 HGNLFEGPIGLS-LSPLRGLKVLDLSQNNLSGEIPEFLAGF---KFLQNLNLSHNNFESM 57
N + P +S L L+VLDLS N++SG L++L +S N
Sbjct: 134 SSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGD 193
Query: 58 IPTEGIFKNASATSV-FGNNKLCGGIPEF 85
+ + + + + +N GIP
Sbjct: 194 VD---VSRCVNLEFLDVSSNNFSTGIPFL 219
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 1e-10
Identities = 21/85 (24%), Positives = 31/85 (36%), Gaps = 4/85 (4%)
Query: 3 GNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEF--LAGFKFLQNLNLSHNNFESMIPT 60
+ G + L LDLS+N+LSG + L L+ LN+S N +
Sbjct: 86 NSHINGSV-SGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKV 144
Query: 61 EGIFKNASATSV-FGNNKLCGGIPE 84
G K S + N + G
Sbjct: 145 SGGLKLNSLEVLDLSANSISGANVV 169
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 2e-09
Identities = 15/87 (17%), Positives = 24/87 (27%), Gaps = 4/87 (4%)
Query: 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQN--NLSGEIPEFLAGFKFLQNLNLSHNNFESMI 58
+ N G + + K + N G E L N++ +
Sbjct: 565 IAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHT 624
Query: 59 PTEGIFKNASATSV-FGNNKLCGGIPE 84
N S + N L G IP+
Sbjct: 625 SPT-FDNNGSMMFLDMSYNMLSGYIPK 650
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 1e-07
Identities = 15/108 (13%), Positives = 32/108 (29%), Gaps = 24/108 (22%)
Query: 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNL--------------------SGEIPEFLAG 40
+ N F G I L R L LDL+ N +G+ ++
Sbjct: 521 LSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKN 580
Query: 41 FKFLQNLNLSHN--NFESMIPTEGIFKNASATSV-FGNNKLCGGIPEF 85
+ + + N F+ + + + + ++ + G
Sbjct: 581 DGMKKECHGAGNLLEFQGIRSEQ-LNRLSTRNPCNITSRVYGGHTSPT 627
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 2e-06
Identities = 12/70 (17%), Positives = 28/70 (40%), Gaps = 4/70 (5%)
Query: 20 LKVLDLSQNNLS---GEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNN 76
+ +DLS L+ + L L++L LS+++ + + ++ + N+
Sbjct: 52 VTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNS 111
Query: 77 KLCGGIPEFQ 86
L G +
Sbjct: 112 -LSGPVTTLT 120
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 54/223 (24%), Positives = 90/223 (40%), Gaps = 31/223 (13%)
Query: 165 ENLIGAGNFASVYKGILFEGAP----AVAIKVFNFLHHDASKSFTVECEVMRNIIHRKII 220
+ +G GNF SV VA+K D + F E ++++ + I+
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 87
Query: 221 KVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAID 280
K G LV E++P+G L +++ +RH+ L++ L +
Sbjct: 88 KYRGVSYG---PGRQSLRLVMEYLPSGCLRDFL-------QRHR--ARLDASRLLLYSSQ 135
Query: 281 VASALEYLH-LGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEA-TNEQTSSIG-- 336
+ +EYL C H D+ NIL+ E +ADFG+A+ L +
Sbjct: 136 ICKGMEYLGSRRC----VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQ 191
Query: 337 --VKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRP 376
+ APE + S DV+SFG++L E+FT +
Sbjct: 192 SPIFWY----APESLSDNIFSRQSDVWSFGVVLYELFTYCDKS 230
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 4e-24
Identities = 56/254 (22%), Positives = 93/254 (36%), Gaps = 40/254 (15%)
Query: 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDAS--KSFTVECEVMRNIIH- 216
+ +S IG+G + V++ + + AIK N D S+ E + +
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLNEKKQ-IYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 67
Query: 217 -RKIIKVVTACSRVDYQGNDFKALVYEFM--PNGSLEEWIHPITEEDKRHKAPGNLNSLE 273
KII++ DY+ D +Y M N L W+ K +++ E
Sbjct: 68 SDKIIRLY------DYEITDQY--IYMVMECGNIDLNSWL----------KKKKSIDPWE 109
Query: 274 RLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTS 333
R + ++ A+ +H + I H D+KP+N L+ + + DFGIA ++
Sbjct: 110 RKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVV 165
Query: 334 SIGVKGTTGYIAPE--------YGMGHETSSYG---DVYSFGILLLEMFTGLRPSDDMFK 382
GT Y+ PE G S DV+S G +L M G P +
Sbjct: 166 KDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN 225
Query: 383 DNLNLQNWVQSALP 396
L +
Sbjct: 226 QISKLHAIIDPNHE 239
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-24
Identities = 57/263 (21%), Positives = 97/263 (36%), Gaps = 45/263 (17%)
Query: 166 NLIGAGNFASVYKGILFEGAPAVAIKVFNF--LHHDASKSFTVECEVMRNIIH--RKIIK 221
IG+G + V++ + + AIK N + S+ E + + KII+
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQ-IYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 92
Query: 222 VVTACSRVDYQGNDFKALVYEFM--PNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAI 279
+ DY+ D +Y M N L W+ K +++ ER +
Sbjct: 93 LY------DYEITDQY--IYMVMECGNIDLNSWL----------KKKKSIDPWERKSYWK 134
Query: 280 DVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKG 339
++ A+ +H + I H D+KP+N L+ + + DFGIA ++ G
Sbjct: 135 NMLEAVHTIH---QHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVG 190
Query: 340 TTGYIAPE--------YGMGHETSSYG---DVYSFGILLLEMFTGLRPSDDMFKDNLNLQ 388
T Y+ PE G S DV+S G +L M G P + L
Sbjct: 191 TVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH 250
Query: 389 NWVQSA----LPERV-EEIVDTL 406
+ P+ +++ D L
Sbjct: 251 AIIDPNHEIEFPDIPEKDLQDVL 273
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 5e-24
Identities = 52/244 (21%), Positives = 99/244 (40%), Gaps = 36/244 (14%)
Query: 165 ENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNII-HRKIIKVV 223
++ G FA VY+ A+K + +++ E M+ + H I++
Sbjct: 33 RRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFC 92
Query: 224 TAC--SRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDV 281
+A + + + L+ + G L E++ K+ ++ G L+ L I
Sbjct: 93 SAASIGKEESDTGQAEFLLLTELCKGQLVEFL-------KKMESRGPLSCDTVLKIFYQT 145
Query: 282 ASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSS------- 334
A++++H KPPI H D+K N+LL+++ T + DFG A + + + S
Sbjct: 146 CRAVQHMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALV 204
Query: 335 ---IGVKGTTGYIAPE-------YGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDN 384
I T Y PE + +G + D+++ G +L + P F+D
Sbjct: 205 EEEITRNTTPMYRTPEIIDLYSNFPIGEKQ----DIWALGCILYLLCFRQHP----FEDG 256
Query: 385 LNLQ 388
L+
Sbjct: 257 AKLR 260
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 6e-24
Identities = 55/221 (24%), Positives = 90/221 (40%), Gaps = 36/221 (16%)
Query: 165 ENLIGAGNFASVYKGILFEGAP----AVAIKVFNFLHHDAS---KSFTVECEVMRNIIHR 217
+G GNF SV VA+K L H + F E E+++++ H
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKK---LQHSTEEHLRDFEREIEILKSLQHD 71
Query: 218 KIIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNI 277
I+K C G L+ E++P GSL +++ ++HK ++ ++ L
Sbjct: 72 NIVKYKGVCYS---AGRRNLKLIMEYLPYGSLRDYL-------QKHK--ERIDHIKLLQY 119
Query: 278 AIDVASALEYLH-LGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQ-TSSI 335
+ +EYL H D+ NIL+ +E + DFG+ + L E
Sbjct: 120 TSQICKGMEYLGTKRY----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKE 175
Query: 336 G----VKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT 372
+ APE + S DV+SFG++L E+FT
Sbjct: 176 PGESPIFWY----APESLTESKFSVASDVWSFGVVLYELFT 212
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 7e-24
Identities = 58/241 (24%), Positives = 95/241 (39%), Gaps = 51/241 (21%)
Query: 168 IGAGNFASVYKGILF-----EGAPAVAIKVFNFLHHDASKS----FTVECEVMRNIIHRK 218
+G G F V K F G VA+K+ L +AS S E V++ + H
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKM---LKENASPSELRDLLSEFNVLKQVNHPH 87
Query: 219 IIKVVTACSRVD--YQGNDFKALVYEFMPNGSLEEW--------------IHPITEEDKR 262
+IK+ ACS+ L+ E+ GSL +
Sbjct: 88 VIKLYGACSQDGPLL-------LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLD 140
Query: 263 HKAPGNLNSLERLNIAIDVASALEYL-HLGCKPPIAHCDIKPSNILLNDEMTACVADFGI 321
H L + ++ A ++ ++YL + + H D+ NIL+ + ++DFG+
Sbjct: 141 HPDERALTMGDLISFAWQISQGMQYLAEMKL---V-HRDLAARNILVAEGRKMKISDFGL 196
Query: 322 ARFLEATNEQTSSIGVKGTTGYI-----APEYGMGHETSSYGDVYSFGILLLEMFT-GLR 375
+R + + K + G I A E H ++ DV+SFG+LL E+ T G
Sbjct: 197 SRDVYEEDSYV-----KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN 251
Query: 376 P 376
P
Sbjct: 252 P 252
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 49/225 (21%), Positives = 76/225 (33%), Gaps = 39/225 (17%)
Query: 162 FSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDAS--KSFTVECEVMRNII-HRK 218
F + +G G++ V+K E A+K E + H
Sbjct: 59 FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPC 118
Query: 219 IIKVVTACSRVDYQGNDFKALVYEFMPNGSL----EEWIHPITEEDKRHKAPGNLNSLER 274
+++ A ++ L E SL E W + E +
Sbjct: 119 CVRLEQA-----WEEGGILYLQTELC-GPSLQQHCEAWGASLPEA-------------QV 159
Query: 275 LNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSS 334
D AL +LH + H D+KP+NI L + DFG+ L
Sbjct: 160 WGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV- 215
Query: 335 IGVKGTTGYIAPEYGMGHETSSYG---DVYSFGILLLEMFTGLRP 376
+G Y+APE G SYG DV+S G+ +LE+ +
Sbjct: 216 --QEGDPRYMAPELLQG----SYGTAADVFSLGLTILEVACNMEL 254
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 54/221 (24%), Positives = 90/221 (40%), Gaps = 36/221 (16%)
Query: 165 ENLIGAGNFASVYKGILFEGAP----AVAIKVFNFLHHDAS---KSFTVECEVMRNIIHR 217
+G GNF SV VA+K L H + F E E+++++ H
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKK---LQHSTEEHLRDFEREIEILKSLQHD 102
Query: 218 KIIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNI 277
I+K C + L+ E++P GSL +++ ++HK ++ ++ L
Sbjct: 103 NIVKYKGVCYSAGRRN---LKLIMEYLPYGSLRDYL-------QKHK--ERIDHIKLLQY 150
Query: 278 AIDVASALEYLH-LGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQ-TSSI 335
+ +EYL H D+ NIL+ +E + DFG+ + L E
Sbjct: 151 TSQICKGMEYLGTKRY----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKE 206
Query: 336 G----VKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT 372
+ APE + S DV+SFG++L E+FT
Sbjct: 207 PGESPIFWY----APESLTESKFSVASDVWSFGVVLYELFT 243
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 51/235 (21%), Positives = 91/235 (38%), Gaps = 45/235 (19%)
Query: 168 IGAGNFASVYKGILF-----EGAPAVAIKVFNFLHHDASKS----FTVECEVMRNII-HR 217
+G G F V + F VA+K+ L A+ S E +++ +I H
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKM---LKEGATHSEHRALMSELKILIHIGHHL 91
Query: 218 KIIKVVTACSRVD---YQGNDFKALVYEFMPNGSLEEWI------HPITEEDKRHKAPGN 268
++ ++ AC++ ++ EF G+L ++ +
Sbjct: 92 NVVNLLGACTKPGGPLM-------VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 144
Query: 269 LNSLERLNIAIDVASALEYL-HLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEA 327
L + + VA +E+L C H D+ NILL+++ + DFG+AR +
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIYK 200
Query: 328 TNEQTSSIGVKGTTGYI-----APEYGMGHETSSYGDVYSFGILLLEMFT-GLRP 376
+ + + APE + DV+SFG+LL E+F+ G P
Sbjct: 201 DPDYV-----RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-23
Identities = 55/255 (21%), Positives = 91/255 (35%), Gaps = 40/255 (15%)
Query: 166 NLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDAS--KSFTVECEVMRNIIH--RKIIK 221
IG+G + V++ + + AIK N D S+ E + + KII+
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQ-IYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 120
Query: 222 VVTACSRVDYQGNDFKALVYEFM--PNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAI 279
+ DY+ D +Y M N L W+ K +++ ER +
Sbjct: 121 LY------DYEITDQY--IYMVMECGNIDLNSWL----------KKKKSIDPWERKSYWK 162
Query: 280 DVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKG 339
++ A+ +H + I H D+KP+N L+ + + DFGIA ++ G
Sbjct: 163 NMLEAVHTIH---QHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVG 218
Query: 340 TTGYIAPE--------YGMGHETSSYG---DVYSFGILLLEMFTGLRPSDDMFKDNLNLQ 388
Y+ PE G S DV+S G +L M G P + L
Sbjct: 219 AVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH 278
Query: 389 NWVQSALPERVEEIV 403
+ +I
Sbjct: 279 AIIDPNHEIEFPDIP 293
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 56/230 (24%), Positives = 94/230 (40%), Gaps = 43/230 (18%)
Query: 168 IGAGNFASVYKGILFEGAP-----AVAIKVFNFLHHDASKS-FTVECEVMRNIIHRKIIK 221
+G G F VY+G + VA+K + + + F +E ++ H+ I++
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 222 VVTACSRVD--YQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAI 279
+ + + ++ E M G L+ ++ E R P +L L+ L++A
Sbjct: 98 CIGVSLQSLPRF-------ILMELMAGGDLKSFLR---ETRPRPSQPSSLAMLDLLHVAR 147
Query: 280 DVASALEYL-HLGCKPPIAHCDIKPSNILLN---DEMTACVADFGIARFLEATNEQTSSI 335
D+A +YL H DI N LL A + DFG+AR + +
Sbjct: 148 DIACGCQYLEENHF----IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR--- 200
Query: 336 GVKGTTGYI-----APE---YGMGHETSSYGDVYSFGILLLEMFT-GLRP 376
KG + PE G+ +S D +SFG+LL E+F+ G P
Sbjct: 201 --KGGCAMLPVKWMPPEAFMEGI---FTSKTDTWSFGVLLWEIFSLGYMP 245
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 67/303 (22%), Positives = 117/303 (38%), Gaps = 67/303 (22%)
Query: 113 GLLVLTLALSSLFCRLMCMKKRGNPT-PSISIDLDFPYVSYEALYSATKGFSSENL---- 167
+ + L++L L+ + NP + + L+ +S E + N+
Sbjct: 2 AMESAAVTLTTLPSELLLDRLHPNPMYQRMPLLLNPKLLSLE--------YPRNNIEYVR 53
Query: 168 -IGAGNFASVYKGILFEGAP-----AVAIKVFNFLHHDASKS----FTVECEVMRNIIHR 217
IG G F V++ P VA+K+ L +AS F E +M +
Sbjct: 54 DIGEGAFGRVFQARAPGLLPYEPFTMVAVKM---LKEEASADMQADFQREAALMAEFDNP 110
Query: 218 KIIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEW--------------IHPITEEDKRH 263
I+K++ C+ L++E+M G L E+ T
Sbjct: 111 NIVKLLGVCAVGKPM-----CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 165
Query: 264 KAPGNLNSLERLNIAIDVASALEYLH-LGCKPPIAHCDIKPSNILLNDEMTACVADFGIA 322
P L+ E+L IA VA+ + YL H D+ N L+ + M +ADFG++
Sbjct: 166 PGPPPLSCAEQLCIARQVAAGMAYLSERKF----VHRDLATRNCLVGENMVVKIADFGLS 221
Query: 323 RFLEATNEQTSSIGVKGTTGYI-----APE---YGMGHETSSYGDVYSFGILLLEMFT-G 373
R + + + I PE Y ++ DV+++G++L E+F+ G
Sbjct: 222 RNIYSADYYK-----ADGNDAIPIRWMPPESIFYNR---YTTESDVWAYGVVLWEIFSYG 273
Query: 374 LRP 376
L+P
Sbjct: 274 LQP 276
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-23
Identities = 59/236 (25%), Positives = 97/236 (41%), Gaps = 46/236 (19%)
Query: 168 IGAGNFASVYKGILF-------EGAPAVAIKVFNFLHHDASKS----FTVECEVMRNII- 215
+G G F V + A VA+K+ L DA++ E E+M+ I
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKM---LKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 216 HRKIIKVVTACSRVD--YQGNDFKALVYEFMPNGSLEEW------IHPITEEDKRHKAPG 267
H+ II ++ AC++ Y ++ E+ G+L E+ D
Sbjct: 100 HKNIINLLGACTQDGPLY-------VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 152
Query: 268 NLNSLERLNIAIDVASALEYL-HLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLE 326
+ + ++ +A +EYL C I H D+ N+L+ + +ADFG+AR +
Sbjct: 153 QMTFKDLVSCTYQLARGMEYLASQKC---I-HRDLAARNVLVTENNVMKIADFGLARDIN 208
Query: 327 ATNEQTSSIGVKGTTGYI-----APEYGMGHETSSYGDVYSFGILLLEMFT-GLRP 376
+ K T G + APE + DV+SFG+L+ E+FT G P
Sbjct: 209 NIDYYK-----KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-23
Identities = 61/272 (22%), Positives = 106/272 (38%), Gaps = 48/272 (17%)
Query: 131 MKKRGNPTPSISIDLDFPYVSYEALYSATKGFSSENL-----IGAGNFASVYKGILF--- 182
+ K T + ++ + + S K +N+ +G G F VY+G +
Sbjct: 37 LSKLRTSTIMTDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMP 96
Query: 183 --EGAPAVAIKVFNFLHHDASKS-FTVECEVMRNIIHRKIIKVVTACSRVD--YQGNDFK 237
VA+K + + + F +E ++ H+ I++ + + +
Sbjct: 97 NDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF------ 150
Query: 238 ALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYL-HLGCKPPI 296
++ E M G L+ ++ E R P +L L+ L++A D+A +YL
Sbjct: 151 -ILLELMAGGDLKSFLR---ETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHF---- 202
Query: 297 AHCDIKPSNILLN---DEMTACVADFGIARFLEATNEQTSSIGVKGTTGYI-----APE- 347
H DI N LL A + DFG+AR + KG + PE
Sbjct: 203 IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYR-----KGGCAMLPVKWMPPEA 257
Query: 348 --YGMGHETSSYGDVYSFGILLLEMFT-GLRP 376
G+ +S D +SFG+LL E+F+ G P
Sbjct: 258 FMEGI---FTSKTDTWSFGVLLWEIFSLGYMP 286
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-23
Identities = 58/221 (26%), Positives = 87/221 (39%), Gaps = 32/221 (14%)
Query: 162 FSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDAS--KSFTVECEVMRNIIHRKI 219
F + +GAGN V+K +A K+ + L + E +V+ I
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIH-LEIKPAIRNQIIRELQVLHECNSPYI 93
Query: 220 IKVVTACSRVDYQGNDFKA----LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERL 275
V + G + + E M GSL D+ K G +
Sbjct: 94 ---------VGFYGAFYSDGEISICMEHMDGGSL----------DQVLKKAGRIPEQILG 134
Query: 276 NIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSI 335
++I V L YL K I H D+KPSNIL+N + DFG++ L + +
Sbjct: 135 KVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS--- 189
Query: 336 GVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRP 376
GT Y++PE G S D++S G+ L+EM G P
Sbjct: 190 -FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 229
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 50/219 (22%), Positives = 78/219 (35%), Gaps = 35/219 (15%)
Query: 166 NLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTA 225
+G G+F V++ + A+K E + +I
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-----ELVACAGLSSPRI------ 112
Query: 226 CSRVDYQGNDFKA----LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDV 281
V G + + E + GSL + I K G L L
Sbjct: 113 ---VPLYGAVREGPWVNIFMELLEGGSLGQLI----------KQMGCLPEDRALYYLGQA 159
Query: 282 ASALEYLHLGCKPPIAHCDIKPSNILLNDEMTAC-VADFGIARFLEATNEQTSSIG---V 337
LEYLH I H D+K N+LL+ + + + DFG A L+ S + +
Sbjct: 160 LEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYI 216
Query: 338 KGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRP 376
GT ++APE MG + D++S ++L M G P
Sbjct: 217 PGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 3e-23
Identities = 59/232 (25%), Positives = 98/232 (42%), Gaps = 42/232 (18%)
Query: 168 IGAGNFASVYKGILFEGAP-----AVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKV 222
+G G F V+ + +P VA+K A K F E E++ N+ H I+K
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 223 VTACSRVD--YQGNDFKALVYEFMPNGSLEEW------IHPITEEDKRHKAPGNLNSLER 274
C D +V+E+M +G L ++ I + + +A G L +
Sbjct: 83 YGVCGDGDPLI-------MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQM 135
Query: 275 LNIAIDVASALEYL-HLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTS 333
L+IA +AS + YL H D+ N L+ + + DFG++R + +T+
Sbjct: 136 LHIASQIASGMVYLASQHF----VHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYR- 190
Query: 334 SIGVKGTTGYI-----APE---YGMGHETSSYGDVYSFGILLLEMFT-GLRP 376
G + PE Y ++ DV+SFG++L E+FT G +P
Sbjct: 191 ----VGGHTMLPIRWMPPESIMYRK---FTTESDVWSFGVILWEIFTYGKQP 235
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 4e-23
Identities = 58/236 (24%), Positives = 95/236 (40%), Gaps = 46/236 (19%)
Query: 168 IGAGNFASVYKGILFEGAP-------AVAIKVFNFLHHDASKS----FTVECEVMRNII- 215
+G G F V VA+K+ L DA++ E E+M+ I
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKM---LKDDATEKDLSDLVSEMEMMKMIGK 145
Query: 216 HRKIIKVVTACSRVD--YQGNDFKALVYEFMPNGSLEEW------IHPITEEDKRHKAPG 267
H+ II ++ AC++ Y ++ E+ G+L E+ D
Sbjct: 146 HKNIINLLGACTQDGPLY-------VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 198
Query: 268 NLNSLERLNIAIDVASALEYL-HLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLE 326
+ + ++ +A +EYL C I H D+ N+L+ + +ADFG+AR +
Sbjct: 199 QMTFKDLVSCTYQLARGMEYLASQKC---I-HRDLAARNVLVTENNVMKIADFGLARDIN 254
Query: 327 ATNEQTSSIGVKGTTGYI-----APEYGMGHETSSYGDVYSFGILLLEMFT-GLRP 376
+ K T G + APE + DV+SFG+L+ E+FT G P
Sbjct: 255 NIDYYK-----KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 5e-23
Identities = 54/232 (23%), Positives = 90/232 (38%), Gaps = 38/232 (16%)
Query: 168 IGAGNFASVYKGILF-----EGAPAVAIKVFNFLHHDASKS-FTVECEVMRNII-HRKII 220
+GAG F V + + + A VA+K+ H + E +V+ + H I+
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 221 KVVTACSRVD--YQGNDFKALVYEFMPNGSL--------EEWIHPITEEDKRHKAPGNLN 270
++ AC+ ++ E+ G L + +I T L+
Sbjct: 91 NLLGACTIGGPTL-------VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143
Query: 271 SLERLNIAIDVASALEYLH-LGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATN 329
+ L+ + VA + +L C I H D+ NILL + DFG+AR ++ +
Sbjct: 144 LEDLLSFSYQVAKGMAFLASKNC---I-HRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 330 EQTSSIG----VKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRP 376
VK APE + DV+S+GI L E+F+ G P
Sbjct: 200 NYVVKGNARLPVKWM----APESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 5e-23
Identities = 63/235 (26%), Positives = 100/235 (42%), Gaps = 44/235 (18%)
Query: 168 IGAGNFASVYKGILF-------EGAPAVAIKVFNFLHHDASKS----FTVECEVMRNII- 215
+G G F V VA+K+ L DA++ E E+M+ I
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKM---LKSDATEKDLSDLISEMEMMKMIGK 133
Query: 216 HRKIIKVVTACSRVD--YQGNDFKALVYEFMPNGSLEEW------IHPITEEDKRHKAPG 267
H+ II ++ AC++ Y ++ E+ G+L E+ + H
Sbjct: 134 HKNIINLLGACTQDGPLY-------VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 186
Query: 268 NLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEA 327
L+S + ++ A VA +EYL K I H D+ N+L+ ++ +ADFG+AR +
Sbjct: 187 QLSSKDLVSCAYQVARGMEYL--ASKKCI-HRDLAARNVLVTEDNVMKIADFGLARDIHH 243
Query: 328 TNEQTSSIGVKGTTGYI-----APEYGMGHETSSYGDVYSFGILLLEMFT-GLRP 376
+ K T G + APE + DV+SFG+LL E+FT G P
Sbjct: 244 IDYYK-----KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 99.6 bits (248), Expect = 9e-23
Identities = 49/293 (16%), Positives = 97/293 (33%), Gaps = 77/293 (26%)
Query: 162 FSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDAS-KSFTVECEVMRNIIHRKII 220
F +G G F V++ AIK + + + + E + + + H I+
Sbjct: 8 FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 67
Query: 221 KVVTACSRVDYQGNDF-------------------------------------------- 236
+ A +
Sbjct: 68 RYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQL 127
Query: 237 -----KALVY---EFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYL 288
K +Y + +L++W+ R + + L+I I +A A+E+L
Sbjct: 128 QPSSPKVYLYIQMQLCRKENLKDWM-------NRRCSLEDREHGVCLHIFIQIAEAVEFL 180
Query: 289 HLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVK---------- 338
H + H D+KPSNI + V DFG+ ++ E+ + +
Sbjct: 181 H---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQV 237
Query: 339 GTTGYIAPE--YGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQN 389
GT Y++PE +G + D++S G++L E+ + + +++N
Sbjct: 238 GTKLYMSPEQIHGNNYSHKV--DIFSLGLILFELLYSFSTQMERVRIITDVRN 288
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 1e-22
Identities = 55/231 (23%), Positives = 94/231 (40%), Gaps = 34/231 (14%)
Query: 165 ENLIGAGNFASVYKGILF-----EGAPAVAIKVFNFLHHDASKS-FTVECEVMRNII-HR 217
+GAG F V + F + VA+K+ H K E ++M ++ H
Sbjct: 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110
Query: 218 KIIKVVTACSRVD--YQGNDFKALVYEFMPNGSLEEWI----HPITEEDKRHKAPGNLNS 271
I+ ++ AC+ ++ E+ G L ++ + + A ++
Sbjct: 111 NIVNLLGACTHGGPVL-------VITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAST 163
Query: 272 LERLNIAIDVASALEYL-HLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNE 330
+ L+ + VA + +L C I H D+ N+LL + A + DFG+AR + +
Sbjct: 164 RDLLHFSSQVAQGMAFLASKNC---I-HRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN 219
Query: 331 QTSSIG----VKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRP 376
VK APE + DV+S+GILL E+F+ GL P
Sbjct: 220 YIVKGNARLPVKWM----APESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 2e-22
Identities = 52/216 (24%), Positives = 86/216 (39%), Gaps = 33/216 (15%)
Query: 168 IGAGNFASVYKGILFEGAPA----VAIKVFNFLHHDASKS-FTVECEVMRNIIHRKIIKV 222
+G G+F V VA+K +S + E +++R + H IIK
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 223 VTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVA 282
C LV E++P GSL +++ RH + + L A +
Sbjct: 99 KGCCEDAGAASL---QLVMEYVPLGSLRDYL-------PRHS----IGLAQLLLFAQQIC 144
Query: 283 SALEYLH-LGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNE--QTSSIG--- 336
+ YLH H D+ N+LL+++ + DFG+A+ + +E + G
Sbjct: 145 EGMAYLHAQHY----IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP 200
Query: 337 VKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT 372
V APE ++ DV+SFG+ L E+ T
Sbjct: 201 VFWY----APECLKEYKFYYASDVWSFGVTLYELLT 232
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-22
Identities = 51/253 (20%), Positives = 97/253 (38%), Gaps = 42/253 (16%)
Query: 162 FSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNII-HRKII 220
SE ++G G+ +V F+G P VA+K D + E +++ H +I
Sbjct: 17 VVSEKILGYGSSGTVVFQGSFQGRP-VAVKRMLIDFCDIALM---EIKLLTESDDHPNVI 72
Query: 221 KVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAID 280
+ CS + F + E N +L++ + ++ + +++
Sbjct: 73 RYY--CS---ETTDRFLYIALELC-NLNLQDLV---ESKNVSDENLKLQKEYNPISLLRQ 123
Query: 281 VASALEYLH-LGCKPPIAHCDIKPSNILLNDEMTAC-------------VADFGIARFLE 326
+AS + +LH L I H D+KP NIL++ ++DFG+ + L+
Sbjct: 124 IASGVAHLHSLK----IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLD 179
Query: 327 ATNEQTSSI--GVKGTTGYIAPEYGMGHETSS----YG---DVYSFGILLLEMFT-GLRP 376
+ + GT+G+ APE D++S G + + + G P
Sbjct: 180 SGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP 239
Query: 377 SDDMFKDNLNLQN 389
D + N+
Sbjct: 240 FGDKYSRESNIIR 252
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 6e-22
Identities = 59/281 (20%), Positives = 106/281 (37%), Gaps = 51/281 (18%)
Query: 131 MKKRGNPTPSISIDLDFPYVSYEALYSATKG-FSSENL-----IGAGNFASVYKGILF-- 182
+ + S D ++ YV + K F ENL +G+G F V +
Sbjct: 10 ESQLQMVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGI 69
Query: 183 ---EGAPAVAIKVFNFLHHDASKS-FTVECEVMRNII-HRKIIKVVTACSRVD--YQGND 235
+ VA+K+ + + E ++M + H I+ ++ AC+ Y
Sbjct: 70 SKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIY---- 125
Query: 236 FKALVYEFMPNGSL-------------EEWIHPITEEDKRHKAPGNLNSLERLNIAIDVA 282
L++E+ G L +E + + + + L + L A VA
Sbjct: 126 ---LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVA 182
Query: 283 SALEYL-HLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTT 341
+E+L C + H D+ N+L+ + DFG+AR + + +
Sbjct: 183 KGMEFLEFKSC---V-HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV-----VRGN 233
Query: 342 GYI-----APEYGMGHETSSYGDVYSFGILLLEMFT-GLRP 376
+ APE + DV+S+GILL E+F+ G+ P
Sbjct: 234 ARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 7e-22
Identities = 49/226 (21%), Positives = 86/226 (38%), Gaps = 43/226 (19%)
Query: 167 LIGAGNFASVYKGILFEGAPAVAIKVFN---FLHHDASKSFTVECEVMRNIIHRKIIK-- 221
+G G FA ++ + A K+ L + ++E + R++ H+ ++
Sbjct: 22 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 222 -VVTACSRVDYQGNDFKALVYEFMPNGSLEEWI---HPITEEDKRHKAPGNLNSLERLNI 277
V + +V E SL E +TE + R+
Sbjct: 82 GFFEDNDFV-F-------VVLELCRRRSLLELHKRRKALTEPEARY-------------Y 120
Query: 278 AIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNE--QTSSI 335
+ +YLH + + H D+K N+ LN+++ + DFG+A +E E +
Sbjct: 121 LRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC- 176
Query: 336 GVKGTTGYIAPE--YGMGHETSSYGDVYSFGILLLEMFTGLRPSDD 379
GT YIAPE GH DV+S G ++ + G P +
Sbjct: 177 ---GTPNYIAPEVLSKKGHSFEV--DVWSIGCIMYTLLVGKPPFET 217
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 7e-22
Identities = 49/226 (21%), Positives = 86/226 (38%), Gaps = 43/226 (19%)
Query: 167 LIGAGNFASVYKGILFEGAPAVAIKVFN---FLHHDASKSFTVECEVMRNIIHRKIIK-- 221
+G G FA ++ + A K+ L + ++E + R++ H+ ++
Sbjct: 48 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 222 -VVTACSRVDYQGNDFKALVYEFMPNGSLEEWI---HPITEEDKRHKAPGNLNSLERLNI 277
V + +V E SL E +TE + R+
Sbjct: 108 GFFEDNDFV-F-------VVLELCRRRSLLELHKRRKALTEPEARY-------------Y 146
Query: 278 AIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNE--QTSSI 335
+ +YLH + + H D+K N+ LN+++ + DFG+A +E E +
Sbjct: 147 LRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC- 202
Query: 336 GVKGTTGYIAPE--YGMGHETSSYGDVYSFGILLLEMFTGLRPSDD 379
GT YIAPE GH DV+S G ++ + G P +
Sbjct: 203 ---GTPNYIAPEVLSKKGHSFEV--DVWSIGCIMYTLLVGKPPFET 243
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 2e-21
Identities = 62/229 (27%), Positives = 100/229 (43%), Gaps = 27/229 (11%)
Query: 162 FSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNII-HRKII 220
F L+G G + VYKG + AIKV + + D + E +++ HR I
Sbjct: 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD-VTGDEEEEIKQEINMLKKYSHHRNIA 84
Query: 221 KVVTACSRVDYQGNDFKA-LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAI 279
A + + G D + LV EF GS+ + I N+L+ IA
Sbjct: 85 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG-----------NTLKEEWIAY 133
Query: 280 ---DVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIG 336
++ L +LH + + H DIK N+LL + + DFG++ L+ T + ++
Sbjct: 134 ICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-- 188
Query: 337 VKGTTGYIAPE--YGMGHETSSYG---DVYSFGILLLEMFTGLRPSDDM 380
GT ++APE + ++Y D++S GI +EM G P DM
Sbjct: 189 FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 237
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 3e-21
Identities = 47/220 (21%), Positives = 86/220 (39%), Gaps = 39/220 (17%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACS 227
+G G + V K +A+K TV + + ++ + +
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRA---------TVNSQEQKRLL--MDLDISMRTV 63
Query: 228 R----VDYQGNDFK----ALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERL--NI 277
V + G F+ + E M + SL+++ + ++ + E + I
Sbjct: 64 DCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIP--------EDILGKI 114
Query: 278 AIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGV 337
A+ + ALE+LH + H D+KPSN+L+N + DFGI+ +L +
Sbjct: 115 AVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA-- 170
Query: 338 KGTTGYIAPE-YGMGHETSSYG---DVYSFGILLLEMFTG 373
G Y+APE Y D++S GI ++E+
Sbjct: 171 -GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAIL 209
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 5e-21
Identities = 57/225 (25%), Positives = 86/225 (38%), Gaps = 34/225 (15%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACS 227
IG G + SV K + +A+K TV+ + + ++ + VV S
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRS---------TVDEKEQKQLL--MDLDVVMRSS 78
Query: 228 R----VDYQGNDFKA----LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAI 279
V + G F+ + E M + S +++ + + I +
Sbjct: 79 DCPYIVQFYGALFREGDCWICMELM-STSFDKFYKYVYS-----VLDDVIPEEILGKITL 132
Query: 280 DVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKG 339
AL +L K I H DIKPSNILL+ + DFGI+ L + +T G
Sbjct: 133 ATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDA---G 187
Query: 340 TTGYIAPE-YGMGHETSSYG---DVYSFGILLLEMFTGLRPSDDM 380
Y+APE Y DV+S GI L E+ TG P
Sbjct: 188 CRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKW 232
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 5e-21
Identities = 63/225 (28%), Positives = 96/225 (42%), Gaps = 25/225 (11%)
Query: 162 FSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKS-FTVECEVMRNIIHRKII 220
+ + +IG+G A V VAIK N S E + M H I+
Sbjct: 17 YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 76
Query: 221 KVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAI- 279
T+ + D LV + + GS+ + I I + + L+ IA
Sbjct: 77 SYYTS-----FVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGV-----LDESTIATI 126
Query: 280 --DVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGV 337
+V LEYLH K H D+K NILL ++ + +ADFG++ FL + T +
Sbjct: 127 LREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVR 183
Query: 338 K---GTTGYIAPEYGMGHETSSYG---DVYSFGILLLEMFTGLRP 376
K GT ++APE + + Y D++SFGI +E+ TG P
Sbjct: 184 KTFVGTPCWMAPE--VMEQVRGYDFKADIWSFGITAIELATGAAP 226
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 6e-21
Identities = 52/245 (21%), Positives = 97/245 (39%), Gaps = 46/245 (18%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIKVFN---------FLHHDASKSFTV--------ECEV 210
+ G F + + A+K + F + K E ++
Sbjct: 39 LNQGKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96
Query: 211 MRNIIHRKIIK---VVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPG 267
+ +I + + ++T V Y ++YE+M N S+ ++ DK +
Sbjct: 97 ITDIKNEYCLTCEGIITNYDEV-Y-------IIYEYMENDSILKFDEYFFVLDKNYTCF- 147
Query: 268 NLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEA 327
+ I V ++ Y+H + I H D+KPSNIL++ ++DFG + ++
Sbjct: 148 -IPIQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVD 204
Query: 328 TNEQTSSIGVKGTTGYIAPEYGMGHETSSYG---DVYSFGILLLEMFTGLRPSDDMFKDN 384
+ S +GT ++ PE+ E+S G D++S GI L MF + P F
Sbjct: 205 KKIKGS----RGTYEFMPPEFFSN-ESSYNGAKVDIWSLGICLYVMFYNVVP----FSLK 255
Query: 385 LNLQN 389
++L
Sbjct: 256 ISLVE 260
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 6e-21
Identities = 56/223 (25%), Positives = 86/223 (38%), Gaps = 36/223 (16%)
Query: 167 LIGAGNFASVYKGILFEGAPAVAIKVFN---FLHHDASKSFTVECEVMRNIIHRKIIK-- 221
L+G G+FA VY+ VAIK+ + + E ++ + H I++
Sbjct: 18 LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 222 -VVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAID 280
+ V Y LV E NG + ++ + E +
Sbjct: 78 NYFEDSNYV-Y-------LVLEMCHNGEMNRYLK---------NRVKPFSENEARHFMHQ 120
Query: 281 VASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNE--QTSSIGVK 338
+ + + YLH I H D+ SN+LL M +ADFG+A L+ +E T
Sbjct: 121 IITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC---- 173
Query: 339 GTTGYIAPE--YGMGHETSSYGDVYSFGILLLEMFTGLRPSDD 379
GT YI+PE H S DV+S G + + G P D
Sbjct: 174 GTPNYISPEIATRSAHGLES--DVWSLGCMFYTLLIGRPPFDT 214
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 55/225 (24%), Positives = 90/225 (40%), Gaps = 33/225 (14%)
Query: 162 FSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIK 221
++ IG G +VY + VAI+ N + E VMR + I+
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 222 VVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAI-- 279
+ + Y D +V E++ GSL + + ++ IA
Sbjct: 82 YLDS-----YLVGDELWVVMEYLAGGSLTDVVTE--------------TCMDEGQIAAVC 122
Query: 280 -DVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVK 338
+ ALE+LH + H DIK NILL + + + DFG + + S+ +
Sbjct: 123 RECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MV 177
Query: 339 GTTGYIAPEYGMGHETSSYG---DVYSFGILLLEMFTGLRPSDDM 380
GT ++APE +YG D++S GI+ +EM G P +
Sbjct: 178 GTPYWMAPEVVTR---KAYGPKVDIWSLGIMAIEMIEGEPPYLNE 219
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 3e-20
Identities = 50/222 (22%), Positives = 83/222 (37%), Gaps = 35/222 (15%)
Query: 166 NLIGAGNFASVYKGILFEGAPAVAIKVFN---FLHHDASKSFTVECEVMRNIIHRKIIK- 221
+G G F +VY + +A+KV E E+ ++ H I++
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 222 --VVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAI 279
+RV Y L+ E+ P G++ + + +
Sbjct: 75 YGYFHDATRV-Y-------LILEYAPLGTVYREL----------QKLSKFDEQRTATYIT 116
Query: 280 DVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKG 339
++A+AL Y H + H DIKP N+LL +ADFG + ++ G
Sbjct: 117 ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC----G 169
Query: 340 TTGYIAPE--YGMGHETSSYGDVYSFGILLLEMFTGLRPSDD 379
T Y+ PE G H+ D++S G+L E G P +
Sbjct: 170 TLDYLPPEMIEGRMHDEKV--DLWSLGVLCYEFLVGKPPFEA 209
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 3e-20
Identities = 51/224 (22%), Positives = 88/224 (39%), Gaps = 31/224 (13%)
Query: 162 FSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIK 221
S IG G+ V VA+K+ + + E +MR+ H +++
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 222 VVTACSRVDYQGNDFKALVYEFMPNGSLEEWIH--PITEEDKRHKAPGNLNSLERLNIAI 279
+ + Y + ++ EF+ G+L + + + EE IA
Sbjct: 107 MYKS-----YLVGEELWVLMEFLQGGALTDIVSQVRLNEEQ----------------IAT 145
Query: 280 ---DVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIG 336
V AL YLH + H DIK +ILL + ++DFG + + S
Sbjct: 146 VCEAVLQALAYLH---AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS-- 200
Query: 337 VKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDM 380
+ GT ++APE ++ D++S GI+++EM G P
Sbjct: 201 LVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSD 244
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 4e-20
Identities = 51/226 (22%), Positives = 80/226 (35%), Gaps = 39/226 (17%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACS 227
+G+G V+K + +A+K + E + I+ + VV
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRR---------SGNKEENKRIL--MDLDVVLKSH 81
Query: 228 R----VDYQGNDFKA----LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAI 279
V G + E M E+ + G + + +
Sbjct: 82 DCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKK---------RMQGPIPERILGKMTV 131
Query: 280 DVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKG 339
+ AL YL + H D+KPSNILL++ + DFGI+ L + S G
Sbjct: 132 AIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSA---G 186
Query: 340 TTGYIAPE--YGMGHETSSYG---DVYSFGILLLEMFTGLRPSDDM 380
Y+APE Y DV+S GI L+E+ TG P +
Sbjct: 187 CAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNC 232
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 5e-20
Identities = 59/233 (25%), Positives = 94/233 (40%), Gaps = 42/233 (18%)
Query: 162 FSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIK 221
+ +G G F VYK E A KV + + + VE E++ H I+K
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 222 VVTACSRVDYQGNDFKALVYEFMPNGSL----EEWIHPITEEDKRHKAPGNLNSLERLNI 277
++ A Y + ++ EF P G++ E +TE I
Sbjct: 81 LLGA-----YYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQ----------------I 119
Query: 278 AI---DVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQ-TS 333
+ + AL +LH I H D+K N+L+ E +ADFG++ T ++ S
Sbjct: 120 QVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS 176
Query: 334 SIGVKGTTGY-IAPE--YGMGHETSSYG---DVYSFGILLLEMFTGLRPSDDM 380
IG T Y +APE + + Y D++S GI L+EM P ++
Sbjct: 177 FIG----TPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL 225
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 91.9 bits (228), Expect = 6e-20
Identities = 43/226 (19%), Positives = 79/226 (34%), Gaps = 35/226 (15%)
Query: 169 GAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTV---ECEVMRNIIHRKIIKVVTA 225
G + +V V ++ N L +++ T E V + H I+
Sbjct: 36 GFEDLMTVNLARYKPTGEYVTVRRIN-LEACSNEMVTFLQGELHVSKLFNHPNIVPYRAT 94
Query: 226 CSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAI---DVA 282
+ ++ +V FM GS ++ I +N E IA V
Sbjct: 95 -----FIADNELWVVTSFMAYGSAKDLI--------CTHFMDGMN--ELA-IAYILQGVL 138
Query: 283 SALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVK---- 338
AL+Y+H H +K S+IL++ + ++ + + ++ +
Sbjct: 139 KALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYS 195
Query: 339 -GTTGYIAPEYGMGHETSSYG---DVYSFGILLLEMFTGLRPSDDM 380
+++PE + Y D+YS GI E+ G P DM
Sbjct: 196 VKVLPWLSPEV-LQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 240
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 1e-19
Identities = 52/220 (23%), Positives = 92/220 (41%), Gaps = 45/220 (20%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIKVFN---------FLHHDASKSFTVECEVMRNI-IHR 217
+G G + V + I A+K+ + + ++ E +++R + H
Sbjct: 25 LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 218 KIIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWI---HPITEEDKRHKAPGNLNSLER 274
II++ Y+ N F LV++ M G L +++ ++E++ R
Sbjct: 85 NIIQLKDT-----YETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRK----------- 128
Query: 275 LNIAIDVASALEYLH-LGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTS 333
I + + LH L I H D+KP NILL+D+M + DFG + L+ +
Sbjct: 129 --IMRALLEVICALHKLN----IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE 182
Query: 334 SIGVKGTTGYIAPE---YGMGHETSSYG---DVYSFGILL 367
GT Y+APE M YG D++S G+++
Sbjct: 183 VC---GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 1e-19
Identities = 55/223 (24%), Positives = 92/223 (41%), Gaps = 28/223 (12%)
Query: 162 FSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKS-FTVECEVMRNIIHRKII 220
F+ IG G+F V+KGI VAIK+ + + E V+ +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 221 KVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAI- 279
K + Y + ++ E++ GS + + P L+ IA
Sbjct: 84 KYYGS-----YLKDTKLWIIMEYLGGGSALDLLEP--------------GPLDETQIATI 124
Query: 280 --DVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGV 337
++ L+YLH H DIK +N+LL++ +ADFG+A L T + ++
Sbjct: 125 LREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--F 179
Query: 338 KGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDM 380
GT ++APE S D++S GI +E+ G P ++
Sbjct: 180 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL 222
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 2e-19
Identities = 42/250 (16%), Positives = 85/250 (34%), Gaps = 52/250 (20%)
Query: 162 FSSENLIGAGNFASVYKGI-LFEGAPAVAIKVFNFLHHDAS--KSFTVECEVMRNII-HR 217
F IG+G F SV+K + +G AIK + ++ E + H
Sbjct: 13 FHELEKIGSGEFGSVFKCVKRLDGC-IYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHS 71
Query: 218 KIIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNI 277
+++ +A + +D + E+ GSL + I + ++ E ++
Sbjct: 72 HVVRYFSA-----WAEDDHMLIQNEYCNGGSLADAI------SENYRIMSYFKEAELKDL 120
Query: 278 AIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACV-------------------AD 318
+ V L Y+H + H DIKPSNI ++ D
Sbjct: 121 LLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGD 177
Query: 319 FGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYG---DVYSFGILLLEMFTGLR 375
G + + + G + ++A E + E ++ D+++ + ++
Sbjct: 178 LGHVTRISSPQVEE------GDSRFLANE--VLQENYTHLPKADIFALALTVVCAAGAEP 229
Query: 376 P---SDDMFK 382
D +
Sbjct: 230 LPRNGDQWHE 239
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 2e-19
Identities = 56/237 (23%), Positives = 96/237 (40%), Gaps = 45/237 (18%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIKVFN--------FLHHDASKSFTVECEVMRNIIHRKI 219
+G+G V + VAI++ + D + + E E+++ + H I
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202
Query: 220 IKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWI---HPITEEDKRHKAPGNLNSLERLN 276
IK+ DY +V E M G L + + + E +
Sbjct: 203 IKIKNFFDAEDYY------IVLELMEGGELFDKVVGNKRLKEATCKL------------- 243
Query: 277 IAIDVASALEYLH-LGCKPPIAHCDIKPSNILLNDEMTAC---VADFGIARFLEATNEQT 332
+ A++YLH G I H D+KP N+LL+ + C + DFG ++ L T+
Sbjct: 244 YFYQMLLAVQYLHENG----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR 299
Query: 333 SSIGVKGTTGYIAPEYGMGHETSSYG---DVYSFGILLLEMFTGLRP-SDDMFKDNL 385
+ GT Y+APE + T+ Y D +S G++L +G P S+ + +L
Sbjct: 300 TLC---GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL 353
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 5e-19
Identities = 51/218 (23%), Positives = 88/218 (40%), Gaps = 44/218 (20%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIKVFN--------FLHHDASKSFTVECEVMRNIIHRKI 219
+G+G V + VAIK+ + D + + E E+++ + H I
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 220 IKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWI---HPITEEDKRHKAPGNLNSLERLN 276
IK+ + D+ +V E M G L + + + E +
Sbjct: 78 IKIKNF-----FDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKL------------- 118
Query: 277 IAIDVASALEYLH-LGCKPPIAHCDIKPSNILL---NDEMTACVADFGIARFLEATNEQT 332
+ A++YLH G I H D+KP N+LL ++ + DFG ++ L T+
Sbjct: 119 YFYQMLLAVQYLHENG----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR 174
Query: 333 SSIGVKGTTGYIAPEYGMGHETSSYG---DVYSFGILL 367
+ GT Y+APE + T+ Y D +S G++L
Sbjct: 175 TLC---GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 7e-19
Identities = 52/221 (23%), Positives = 85/221 (38%), Gaps = 35/221 (15%)
Query: 167 LIGAGNFASVYKGILFEGAPAVAIKVFN---FLHHDASKSFTVECEVMRNIIHRKIIK-- 221
+G G F +VY + +A+KV E E+ ++ H I++
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 222 -VVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAID 280
R+ Y L+ EF P G L + + + G + +
Sbjct: 81 NYFHDRKRI-Y-------LMLEFAPRGELYKEL----------QKHGRFDEQRSATFMEE 122
Query: 281 VASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGT 340
+A AL Y H + + H DIKP N+L+ + +ADFG + + +T GT
Sbjct: 123 LADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC----GT 175
Query: 341 TGYIAPE--YGMGHETSSYGDVYSFGILLLEMFTGLRPSDD 379
Y+ PE G H+ D++ G+L E G+ P D
Sbjct: 176 LDYLPPEMIEGKTHDEKV--DLWCAGVLCYEFLVGMPPFDS 214
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 1e-18
Identities = 52/224 (23%), Positives = 80/224 (35%), Gaps = 41/224 (18%)
Query: 165 ENLIGAGNFASVYKGILFEGAPAVAIKVFN--FLHHDASKSFTVECEVMRNIIHRKIIKV 222
+G+G + V AIK+ + ++ E V++ + H I+K+
Sbjct: 42 VKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKL 101
Query: 223 VTACSRVDYQGNDFKALVYEFMPNGSLEEWI---HPITEEDKRHKAPGNLNSLERLNIAI 279
++ LV E G L + I E D I
Sbjct: 102 YDF-----FEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAV-------------IIK 143
Query: 280 DVASALEYLH-LGCKPPIAHCDIKPSNILLNDEMTAC---VADFGIARFLEATNEQTSSI 335
V S + YLH I H D+KP N+LL + + DFG++ E + +
Sbjct: 144 QVLSGVTYLHKHN----IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERL 199
Query: 336 GVKGTTGYIAPEYGMGHETSSYG---DVYSFGILLLEMFTGLRP 376
GT YIAPE Y DV+S G++L + G P
Sbjct: 200 ---GTAYYIAPEVLRK----KYDEKCDVWSIGVILFILLAGYPP 236
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 5e-18
Identities = 55/222 (24%), Positives = 88/222 (39%), Gaps = 42/222 (18%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIKVFN---FLHHDASKSFTVECEVMRNIIHRKIIKVVT 224
+G G+F V A+KV + +S E ++++ + H I+K+
Sbjct: 34 LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93
Query: 225 ACSRVDYQGNDFKALVYEFMPNGSLEEWI---HPITEEDKRHKAPGNLNSLERLNIAIDV 281
++ + LV E G L + I +E D I V
Sbjct: 94 F-----FEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR-------------IIRQV 135
Query: 282 ASALEYLH-LGCKPPIAHCDIKPSNILLNDEMTAC---VADFGIARFLEATNEQTSSIGV 337
S + Y+H I H D+KP N+LL + + DFG++ EA+ + I
Sbjct: 136 LSGITYMHKNK----IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI-- 189
Query: 338 KGTTGYIAPEYGMGHETSSYG---DVYSFGILLLEMFTGLRP 376
GT YIAPE G +Y DV+S G++L + +G P
Sbjct: 190 -GTAYYIAPEVLHG----TYDEKCDVWSTGVILYILLSGCPP 226
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 5e-18
Identities = 49/222 (22%), Positives = 87/222 (39%), Gaps = 32/222 (14%)
Query: 162 FSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIK 221
S ++G G F V+K +A K+ + E VM + H +I+
Sbjct: 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQ 150
Query: 222 VVTACSRVDYQGNDFKALVYEFMPNGSLEEWI----HPITEEDKRHKAPGNLNSLERLNI 277
+ A ++ + LV E++ G L + I + +TE D
Sbjct: 151 LYDA-----FESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTIL-------------F 192
Query: 278 AIDVASALEYLH-LGCKPPIAHCDIKPSNILLNDEMTACV--ADFGIARFLEATNEQTSS 334
+ + ++H + I H D+KP NIL + + DFG+AR + + +
Sbjct: 193 MKQICEGIRHMHQMY----ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVN 248
Query: 335 IGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRP 376
GT ++APE S D++S G++ + +GL P
Sbjct: 249 F---GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP 287
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 5e-18
Identities = 64/222 (28%), Positives = 90/222 (40%), Gaps = 27/222 (12%)
Query: 162 FSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIK 221
F +G G++ SVYK I E VAIK + E +M+ ++K
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPV--ESDLQEIIKEISIMQQCDSPHVVK 88
Query: 222 VVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAI-- 279
+ Y N +V E+ GS+ + I +L IA
Sbjct: 89 YYGS-----YFKNTDLWIVMEYCGAGSVSDIIRLRN------------KTLTEDEIATIL 131
Query: 280 -DVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVK 338
LEYLH H DIK NILLN E A +ADFG+A L T + ++ V
Sbjct: 132 QSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT--VI 186
Query: 339 GTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDM 380
GT ++APE + D++S GI +EM G P D+
Sbjct: 187 GTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADI 228
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 84.5 bits (210), Expect = 6e-18
Identities = 53/217 (24%), Positives = 81/217 (37%), Gaps = 43/217 (19%)
Query: 165 ENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVT 224
++G+G F+ V+ A+K S E V++ I H I+ +
Sbjct: 14 MEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLED 73
Query: 225 ACSRVDYQGNDFKALVYEFMPNGSLEEWI---HPITEEDKRHKAPGNLNSLERLNIAIDV 281
Y+ LV + + G L + I TE+D + V
Sbjct: 74 I-----YESTTHYYLVMQLVSGGELFDRILERGVYTEKDASL-------------VIQQV 115
Query: 282 ASALEYLH-LGCKPPIAHCDIKPSNILL---NDEMTACVADFGIARFLEATNEQTSSIGV 337
SA++YLH G I H D+KP N+L + + DFG+++ + T
Sbjct: 116 LSAVKYLHENG----IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMST----A 167
Query: 338 KGTTGYIAPEYGMGHETSSYG---DVYSFG----ILL 367
GT GY+APE Y D +S G ILL
Sbjct: 168 CGTPGYVAPEVLAQK---PYSKAVDCWSIGVITYILL 201
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 9e-18
Identities = 48/216 (22%), Positives = 82/216 (37%), Gaps = 43/216 (19%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIKVFN--FLHHDASKSFTVECEVMRNIIHRKIIKVVTA 225
+G G F+ V + + A + N L + E + R + H I+++ +
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 226 CSRVDYQGNDFKALVYEFMPNGSLEEWI---HPITEEDKRHKAPGNLNSLERLNIAIDVA 282
L+++ + G L E I +E D H +
Sbjct: 79 -----ISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASH-------------CIQQIL 120
Query: 283 SALEYLH-LGCKPPIAHCDIKPSNILL---NDEMTACVADFGIARFLEATNEQTSSIGVK 338
A+ + H +G + H ++KP N+LL +ADFG+A +E + G
Sbjct: 121 EAVLHCHQMG----VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWF--GFA 174
Query: 339 GTTGYIAPEYGMGHETSSYG---DVYSFG----ILL 367
GT GY++PE YG D+++ G ILL
Sbjct: 175 GTPGYLSPEVLRK---DPYGKPVDLWACGVILYILL 207
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 1e-17
Identities = 50/216 (23%), Positives = 81/216 (37%), Gaps = 44/216 (20%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIKVFN--FLHHDASKSFTVECEVMRNIIHRKIIKVVTA 225
+G G F+ V + + A K+ N L + E + R + H I+++ +
Sbjct: 14 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73
Query: 226 CSRVDYQGNDFKALVYEFMPNGSLEEWI---HPITEEDKRHKAPGNLNSLERLNIAIDVA 282
Q F LV++ + G L E I +E D H +
Sbjct: 74 -----IQEESFHYLVFDLVTGGELFEDIVAREFYSEADASH-------------CIQQIL 115
Query: 283 SALEYLH-LGCKPPIAHCDIKPSNILL---NDEMTACVADFGIARFLEATNEQTSSIGVK 338
++ Y H G I H ++KP N+LL +ADFG+A + +
Sbjct: 116 ESIAYCHSNG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA--- 168
Query: 339 GTTGYIAPEYGMGHETSSYG---DVYSFG----ILL 367
GT GY++PE Y D+++ G ILL
Sbjct: 169 GTPGYLSPEVLKK---DPYSKPVDIWACGVILYILL 201
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 57/219 (26%), Positives = 92/219 (42%), Gaps = 34/219 (15%)
Query: 164 SENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNII-HRKIIKV 222
E+++G G A V I + A+K+ E E++ HR ++++
Sbjct: 17 QEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLEL 76
Query: 223 VTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVA 282
+ ++ D LV+E M GS+ IH + N LE + DVA
Sbjct: 77 IEF-----FEEEDRFYLVFEKMRGGSILSHIH----------KRRHFNELEASVVVQDVA 121
Query: 283 SALEYLH-LGCKPPIAHCDIKPSNILL---NDEMTACVADFGIARFLEATNEQTSSIGVK 338
SAL++LH G IAH D+KP NIL N + DF + ++ + + +
Sbjct: 122 SALDFLHNKG----IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPE 177
Query: 339 -----GTTGYIAPE--YGMGHETSSYG---DVYSFGILL 367
G+ Y+APE E S Y D++S G++L
Sbjct: 178 LLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 84.1 bits (208), Expect = 2e-17
Identities = 56/252 (22%), Positives = 90/252 (35%), Gaps = 53/252 (21%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIKVFN-----FLHHDASKSFTVECEVMRNIIHRKIIKV 222
IG G++ V I + AIK+ N ++ + E +M+ + H I ++
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 223 VTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERL------- 275
Y+ + LV E G L + ++ ++ A + +
Sbjct: 94 YEV-----YEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEE 148
Query: 276 -----------------------NIAIDVASALEYLH-LGCKPPIAHCDIKPSNILLNDE 311
NI + SAL YLH G I H DIKP N L +
Sbjct: 149 AINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG----ICHRDIKPENFLFSTN 204
Query: 312 MTACV--ADFGIARFLEATNEQTSSI--GVKGTTGYIAPEYGMGHETSSYG---DVYSFG 364
+ + DFG+++ N GT ++APE + SYG D +S G
Sbjct: 205 KSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPE-VLNTTNESYGPKCDAWSAG 263
Query: 365 ILLLEMFTGLRP 376
+LL + G P
Sbjct: 264 VLLHLLLMGAVP 275
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 2e-17
Identities = 54/224 (24%), Positives = 92/224 (41%), Gaps = 50/224 (22%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIKVFN--------FLHHDASKSFTVECEVMRNII-HRK 218
IG G + V + + A+K+ + ++ E ++R + H
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161
Query: 219 IIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWI----HPITEEDKRHKAPGNLNSLER 274
II ++ + Y+ + F LV++ M G L +++ ++E++ R
Sbjct: 162 IITLIDS-----YESSSFMFLVFDLMRKGELFDYLTEKVA-LSEKETRS----------- 204
Query: 275 LNIAIDVASALEYLH-LGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTS 333
I + A+ +LH I H D+KP NILL+D M ++DFG + LE +
Sbjct: 205 --IMRSLLEAVSFLHANN----IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRE 258
Query: 334 SIGVKGTTGYIAPE---YGMGHETSSYG---DVYSFG----ILL 367
GT GY+APE M YG D+++ G LL
Sbjct: 259 LC---GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLL 299
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 2e-17
Identities = 56/224 (25%), Positives = 89/224 (39%), Gaps = 41/224 (18%)
Query: 165 ENLIGAGNFASVYKGILFEGAPAVAIKVFN--FLHHDASKSFTVECEVMRNIIHRKIIKV 222
++G G+F V K A+KV N + + + E E+++ + H I+K+
Sbjct: 27 VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 223 VTACSRVDYQGNDFKALVYEFMPNGSLEEWI---HPITEEDKRHKAPGNLNSLERLNIAI 279
+ + +V E G L + I +E D I
Sbjct: 87 FEI-----LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR-------------IIK 128
Query: 280 DVASALEYLH-LGCKPPIAHCDIKPSNILLNDEMTAC---VADFGIARFLEATNEQTSSI 335
V S + Y+H I H D+KP NILL + C + DFG++ + + I
Sbjct: 129 QVFSGITYMHKHN----IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI 184
Query: 336 GVKGTTGYIAPEYGMGHETSSYG---DVYSFGILLLEMFTGLRP 376
GT YIAPE G +Y DV+S G++L + +G P
Sbjct: 185 ---GTAYYIAPEVLRG----TYDEKCDVWSAGVILYILLSGTPP 221
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 3e-17
Identities = 33/99 (33%), Positives = 48/99 (48%), Gaps = 9/99 (9%)
Query: 281 VASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGT 340
+ AL+YL I H D+KP NILL++ + DF IA L + T+ + GT
Sbjct: 124 LVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT---MAGT 177
Query: 341 TGYIAPEYGMGHETSSYG---DVYSFGILLLEMFTGLRP 376
Y+APE + + Y D +S G+ E+ G RP
Sbjct: 178 KPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 3e-17
Identities = 46/215 (21%), Positives = 83/215 (38%), Gaps = 30/215 (13%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACS 227
+G+G F V++ + K N + + E +M + H K+I + A
Sbjct: 59 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA-- 116
Query: 228 RVDYQGNDFKALVYEFMPNGSLEEWI----HPITEEDKRHKAPGNLNSLERLNIAIDVAS 283
++ L+ EF+ G L + I + ++E + +
Sbjct: 117 ---FEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVIN-------------YMRQACE 160
Query: 284 ALEYLHLGCKPPIAHCDIKPSNILLNDEMTACV--ADFGIARFLEATNEQTSSIGVKGTT 341
L+++H + I H DIKP NI+ + + V DFG+A L + T
Sbjct: 161 GLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---ATA 214
Query: 342 GYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRP 376
+ APE Y D+++ G+L + +GL P
Sbjct: 215 EFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP 249
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 3e-17
Identities = 53/219 (24%), Positives = 84/219 (38%), Gaps = 39/219 (17%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACS 227
IG G++ V + A K + F E E+M+++ H II++
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYET-- 74
Query: 228 RVDYQGNDFKALVYEFMPNGSLEEWI---HPITEEDKRHKAPGNLNSLERLNIAIDVASA 284
++ N LV E G L E + E D I DV SA
Sbjct: 75 ---FEDNTDIYLVMELCTGGELFERVVHKRVFRESDAAR-------------IMKDVLSA 118
Query: 285 LEYLH-LGCKPPIAHCDIKPSNILL---NDEMTACVADFGIARFLEATNEQTSSIGVKGT 340
+ Y H L +AH D+KP N L + + + DFG+A + + + GT
Sbjct: 119 VAYCHKLN----VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV---GT 171
Query: 341 TGYIAPEYGMGHETSSYG---DVYSFGILLLEMFTGLRP 376
Y++P+ G YG D +S G+++ + G P
Sbjct: 172 PYYVSPQVLEG----LYGPECDEWSAGVMMYVLLCGYPP 206
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 5e-17
Identities = 54/228 (23%), Positives = 84/228 (36%), Gaps = 36/228 (15%)
Query: 162 FSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH---HDASKSFTVECEVMRNIIHRK 218
FS IG G+F +VY + VAIK ++ ++ + E ++ + H
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 219 IIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIA 278
I+ Y LV E+ + D L +E IA
Sbjct: 116 TIQYRGC-----YLREHTAWLVMEYCLGSAS----------DLLEVHKKPLQEVE---IA 157
Query: 279 I---DVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSI 335
L YLH + H D+K NILL++ + DFG A + S +
Sbjct: 158 AVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM---APANSFV 211
Query: 336 GVKGTTGYIAPEYGMGHETSSYG---DVYSFGILLLEMFTGLRPSDDM 380
GT ++APE + + Y DV+S GI +E+ P +M
Sbjct: 212 ---GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 256
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 5e-17
Identities = 53/218 (24%), Positives = 86/218 (39%), Gaps = 35/218 (16%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIKVFN--FLHHDASKSFTVECEVMRNIIHRKIIKVVTA 225
+G G+F V K A+KV N + + + E E+++ + H I+K+
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 226 CSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASAL 285
+ + +V E G L + I + + I V S +
Sbjct: 90 -----LEDSSSFYIVGELYTGGELFDEI----------IKRKRFSEHDAARIIKQVFSGI 134
Query: 286 EYLH-LGCKPPIAHCDIKPSNILL---NDEMTACVADFGIARFLEATNEQTSSIGVKGTT 341
Y+H I H D+KP NILL + + DFG++ + + I GT
Sbjct: 135 TYMHKHN----IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI---GTA 187
Query: 342 GYIAPEYGMGHETSSYG---DVYSFGILLLEMFTGLRP 376
YIAPE G +Y DV+S G++L + +G P
Sbjct: 188 YYIAPEVLRG----TYDEKCDVWSAGVILYILLSGTPP 221
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 8e-17
Identities = 50/216 (23%), Positives = 81/216 (37%), Gaps = 44/216 (20%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIKVFN--FLHHDASKSFTVECEVMRNIIHRKIIKVVTA 225
+G G F+ V + + A K+ N L + E + R + H I+++ +
Sbjct: 37 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96
Query: 226 CSRVDYQGNDFKALVYEFMPNGSLEEWI---HPITEEDKRHKAPGNLNSLERLNIAIDVA 282
Q F LV++ + G L E I +E D H +
Sbjct: 97 -----IQEESFHYLVFDLVTGGELFEDIVAREFYSEADASH-------------CIQQIL 138
Query: 283 SALEYLH-LGCKPPIAHCDIKPSNILL---NDEMTACVADFGIARFLEATNEQTSSIGVK 338
++ Y H G I H ++KP N+LL +ADFG+A + +
Sbjct: 139 ESIAYCHSNG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA--- 191
Query: 339 GTTGYIAPEYGMGHETSSYG---DVYSFG----ILL 367
GT GY++PE Y D+++ G ILL
Sbjct: 192 GTPGYLSPEVLKK---DPYSKPVDIWACGVILYILL 224
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 1e-16
Identities = 59/235 (25%), Positives = 86/235 (36%), Gaps = 52/235 (22%)
Query: 165 ENLIGAGNFASVYKGILFEGAPAVAIKV-------------FNFLHHDASKSFTVECEVM 211
+G+G + V G AIKV N + E ++
Sbjct: 41 VRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLL 100
Query: 212 RNIIHRKIIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWI---HPITEEDKRHKAPGN 268
+++ H IIK+ ++ + LV EF G L E I H E D +
Sbjct: 101 KSLDHPNIIKLFDV-----FEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAAN----- 150
Query: 269 LNSLERLNIAIDVASALEYLH-LGCKPPIAHCDIKPSNILL---NDEMTACVADFGIARF 324
I + S + YLH I H DIKP NILL N + + DFG++ F
Sbjct: 151 --------IMKQILSGICYLHKHN----IVHRDIKPENILLENKNSLLNIKIVDFGLSSF 198
Query: 325 LEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYG---DVYSFGILLLEMFTGLRP 376
+ + GT YIAPE Y DV+S G+++ + G P
Sbjct: 199 FSKDYKLRDRL---GTAYYIAPEVLKK----KYNEKCDVWSCGVIMYILLCGYPP 246
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 49/217 (22%), Positives = 81/217 (37%), Gaps = 30/217 (13%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIKVFN-FLHHDASKSFTVECEVMRNIIHRKIIKVVTAC 226
+G+G F V+ IK N + E EV++++ H IIK+
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV- 88
Query: 227 SRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALE 286
++ +V E G L E I L+ + + +AL
Sbjct: 89 ----FEDYHNMYIVMETCEGGELLERI------VSAQARGKALSEGYVAELMKQMMNALA 138
Query: 287 YLH-LGCKPPIAHCDIKPSNILL---NDEMTACVADFGIARFLEATNEQTSSIGVKGTTG 342
Y H + H D+KP NIL + + DFG+A ++ T++ GT
Sbjct: 139 YFHSQH----VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAA---GTAL 191
Query: 343 YIAPEYGMGHETSSYG---DVYSFGILLLEMFTGLRP 376
Y+APE D++S G+++ + TG P
Sbjct: 192 YMAPEVFKR----DVTFKCDIWSAGVVMYFLLTGCLP 224
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 2e-16
Identities = 51/212 (24%), Positives = 82/212 (38%), Gaps = 43/212 (20%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVM-RNIIHRKIIKVVTAC 226
IG G+++ + I A+K+ + + + T E E++ R H II +
Sbjct: 30 IGVGSYSVCKRCIHKATNMEFAVKIID----KSKRDPTEEIEILLRYGQHPNIITLKDV- 84
Query: 227 SRVDYQGNDFKALVYEFMPNGSLEEWIH---PITEEDKRHKAPGNLNSLERLNIAIDVAS 283
Y + +V E M G L + I +E + + +
Sbjct: 85 ----YDDGKYVYVVTELMKGGELLDKILRQKFFSEREASA-------------VLFTITK 127
Query: 284 ALEYLH-LGCKPPIAHCDIKPSNILL----NDEMTACVADFGIARFLEATNEQTSSIGVK 338
+EYLH G + H D+KPSNIL + + + DFG A+ L A N
Sbjct: 128 TVEYLHAQG----VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLM--TPC 181
Query: 339 GTTGYIAPEYGMGHETSSYG---DVYSFGILL 367
T ++APE Y D++S G+LL
Sbjct: 182 YTANFVAPEVLERQ---GYDAACDIWSLGVLL 210
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 3e-16
Identities = 38/107 (35%), Positives = 57/107 (53%), Gaps = 13/107 (12%)
Query: 281 VASALEYLH-LGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKG 339
+ SALEYLH G I H D+KP NILLN++M + DFG A+ L ++Q + G
Sbjct: 139 IVSALEYLHGKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 194
Query: 340 TTGYIAPE--YGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDN 384
T Y++PE SS D+++ G ++ ++ GL P F+
Sbjct: 195 TAQYVSPELLTEKSACKSS--DLWALGCIIYQLVAGLPP----FRAG 235
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 7e-16
Identities = 42/216 (19%), Positives = 79/216 (36%), Gaps = 33/216 (15%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACS 227
+G G F V++ + K + E ++ HR I+ + +
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVK-VKGTDQVLVKKEISILNIARHRNILHLHES-- 69
Query: 228 RVDYQGNDFKALVYEFMPNGSLEEWI----HPITEEDKRHKAPGNLNSLERLNIAIDVAS 283
++ + +++EF+ + E I + E + V
Sbjct: 70 ---FESMEELVMIFEFISGLDIFERINTSAFELNEREIVS-------------YVHQVCE 113
Query: 284 ALEYLH-LGCKPPIAHCDIKPSNILLNDEMTACV--ADFGIARFLEATNEQTSSIGVKGT 340
AL++LH I H DI+P NI+ ++ + +FG AR L+ +
Sbjct: 114 ALQFLHSHN----IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF---TA 166
Query: 341 TGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRP 376
Y APE S+ D++S G L+ + +G+ P
Sbjct: 167 PEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP 202
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 80.7 bits (199), Expect = 8e-16
Identities = 47/211 (22%), Positives = 84/211 (39%), Gaps = 22/211 (10%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACS 227
+G G F V++ A K H ++ E + M + H ++ + A
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA-- 222
Query: 228 RVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEY 287
++ ++ ++YEFM G L E + E ++ E + V L +
Sbjct: 223 ---FEDDNEMVMIYEFMSGGELFEKV--ADEH-------NKMSEDEAVEYMRQVCKGLCH 270
Query: 288 LHLGCKPPIAHCDIKPSNILLNDEMTACV--ADFGIARFLEATNEQTSSIGVKGTTGYIA 345
+H + H D+KP NI+ + + + DFG+ L+ + GT + A
Sbjct: 271 MH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAA 324
Query: 346 PEYGMGHETSSYGDVYSFGILLLEMFTGLRP 376
PE G Y D++S G+L + +GL P
Sbjct: 325 PEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 355
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 9e-16
Identities = 49/259 (18%), Positives = 83/259 (32%), Gaps = 44/259 (16%)
Query: 131 MKKRGNPTPSISIDLDFPYVSYEALYSATKGFSSENLIGAGNFASVYKGILFEGAPAVAI 190
++ Y +S+ L G G FA V + I A
Sbjct: 5 HHHSSGVDLGTENLYFQSMENFNNFYI----LTSKEL-GRGKFAVVRQCISKSTGQEYAA 59
Query: 191 KVFN--FLHHDASKSFTVECEVMRNIIHR-KIIKVVTACSRVDYQGNDFKALVYEFMPNG 247
K D E V+ ++I + Y+ L+ E+ G
Sbjct: 60 KFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV-----YENTSEIILILEYAAGG 114
Query: 248 SLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLH-LGCKPPIAHCDIKPSNI 306
+ P + ++ + + + + + YLH I H D+KP NI
Sbjct: 115 EIFSLCLP--------ELAEMVSENDVIRLIKQILEGVYYLHQNN----IVHLDLKPQNI 162
Query: 307 LLNDEMTAC---VADFGIARFLEATNEQTSSIGVKGTTGYIAPE------YGMGHETSSY 357
LL+ + DFG++R + E + GT Y+APE T
Sbjct: 163 LLSSIYPLGDIKIVDFGMSRKIGHACELREIM---GTPEYLAPEILNYDPITT--AT--- 214
Query: 358 GDVYSFGILLLEMFTGLRP 376
D+++ GI+ + T P
Sbjct: 215 -DMWNIGIIAYMLLTHTSP 232
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 9e-16
Identities = 49/220 (22%), Positives = 83/220 (37%), Gaps = 33/220 (15%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIKVFN------FLHHDASKSFTVECEVMRNIIHRKIIK 221
+G+G FA V K A K + E ++R ++H II
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 222 VVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDV 281
+ Y+ L+ E + G L +++ +L+ E + +
Sbjct: 80 LHDV-----YENRTDVVLILELVSGGELFDFL----------AQKESLSEEEATSFIKQI 124
Query: 282 ASALEYLH-LGCKPPIAHCDIKPSNILLNDEMTAC----VADFGIARFLEATNEQTSSIG 336
+ YLH IAH D+KP NI+L D+ + DFG+A +E E +
Sbjct: 125 LDGVNYLHTKK----IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF- 179
Query: 337 VKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRP 376
GT ++APE D++S G++ + +G P
Sbjct: 180 --GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 48/220 (21%), Positives = 84/220 (38%), Gaps = 33/220 (15%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIKVFN------FLHHDASKSFTVECEVMRNIIHRKIIK 221
+G+G FA V K A K + + E ++R ++H +I
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 222 VVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDV 281
+ Y+ L+ E + G L +++ +L+ E + +
Sbjct: 80 LHDV-----YENRTDVVLILELVSGGELFDFL----------AQKESLSEEEATSFIKQI 124
Query: 282 ASALEYLH-LGCKPPIAHCDIKPSNILLNDEMTAC----VADFGIARFLEATNEQTSSIG 336
+ YLH IAH D+KP NI+L D+ + DFG+A +E E +
Sbjct: 125 LDGVNYLHTKK----IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF- 179
Query: 337 VKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRP 376
GT ++APE D++S G++ + +G P
Sbjct: 180 --GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 55/215 (25%), Positives = 82/215 (38%), Gaps = 44/215 (20%)
Query: 167 LIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTAC 226
+G G + VY+ A+KV K E V+ + H IIK+
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLK--KTVDKKIVRTEIGVLLRLSHPNIIKLKEI- 116
Query: 227 SRVDYQGNDFKALVYEFMPNGSLEEWI---HPITEEDKRHKAPGNLNSLERLNIAIDVAS 283
++ +LV E + G L + I +E D +
Sbjct: 117 ----FETPTEISLVLELVTGGELFDRIVEKGYYSERDAAD-------------AVKQILE 159
Query: 284 ALEYLH-LGCKPPIAHCDIKPSNILL---NDEMTACVADFGIARFLEATNEQTSSIGVKG 339
A+ YLH G I H D+KP N+L + +ADFG+++ +E + G
Sbjct: 160 AVAYLHENG----IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVC---G 212
Query: 340 TTGYIAPEYGMGHETSSYG---DVYSFG----ILL 367
T GY APE G +YG D++S G ILL
Sbjct: 213 TPGYCAPEILRG---CAYGPEVDMWSVGIITYILL 244
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 50/228 (21%), Positives = 82/228 (35%), Gaps = 46/228 (20%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIKV-----FNFLHHDASKSFTVECEVMRNIIHRKIIKV 222
IG G F+ V + I E A+K+ F +++ E + + H I+++
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 223 VTACSRVDYQGNDFKALVYEFMPNGSL-------EEWIHPITEEDKRHKAPGNLNSLERL 275
+ Y + +V+EFM L + +E H
Sbjct: 92 LET-----YSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASH------------ 134
Query: 276 NIAIDVASALEYLH-LGCKPPIAHCDIKPSNILL---NDEMTACVADFGIARFLEATNEQ 331
+ AL Y H I H D+KP +LL + + FG+A L +
Sbjct: 135 -YMRQILEALRYCHDNN----IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLV 189
Query: 332 TSSIGVKGTTGYIAPEYGMGHETSSYG---DVYSFGILLLEMFTGLRP 376
G GT ++APE YG DV+ G++L + +G P
Sbjct: 190 AG--GRVGTPHFMAPEVVKR---EPYGKPVDVWGCGVILFILLSGCLP 232
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 56/221 (25%), Positives = 89/221 (40%), Gaps = 36/221 (16%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEV--MRNIIHRKIIKV--V 223
IG GNFA V VAIK+ + + + + EV M+ + H I+K+ V
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 224 TACSRVDYQGNDFKALVYEFMPNGSLEEWI---HPITEEDKRHKAPGNLNSLERLNIAID 280
+ Y L+ E+ G + +++ + E++ R K
Sbjct: 83 IETEKTLY-------LIMEYASGGEVFDYLVAHGRMKEKEARSKF-------------RQ 122
Query: 281 VASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGI-ARFLEATNEQTSSIGVKG 339
+ SA++Y H I H D+K N+LL+ +M +ADFG F G
Sbjct: 123 IVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC----G 175
Query: 340 TTGYIAPEYGMGHE-TSSYGDVYSFGILLLEMFTGLRPSDD 379
Y APE G + DV+S G++L + +G P D
Sbjct: 176 APPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG 216
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 3e-15
Identities = 56/230 (24%), Positives = 83/230 (36%), Gaps = 45/230 (19%)
Query: 167 LIGAGNFASVYKGI-LFEGAPAVAIKVFN----FLHHDASKSFTVECEV--MRNIIHRK- 218
L+G+G F SVY GI + + P VAIK + V EV ++ +
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLP-VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 108
Query: 219 -IIKV--VTACSRVDYQGNDFKALVYEF-MPNGSLEEWIHPITEEDKRHKAPGNLNSLER 274
+I++ L+ E P L ++I G L
Sbjct: 109 GVIRLLDWFERPDSFV-------LILERPEPVQDLFDFI-------TER---GALQEELA 151
Query: 275 LNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLN-DEMTACVADFGIARFLEATNEQTS 333
+ V A+ + H + H DIK NIL++ + + DFG L+ T
Sbjct: 152 RSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF 208
Query: 334 SIGVKGTTGYIAPEYGMGHETSSYG----DVYSFGILLLEMFTGLRPSDD 379
GT Y PE+ H Y V+S GILL +M G P +
Sbjct: 209 D----GTRVYSPPEWIRYHR---YHGRSAAVWSLGILLYDMVCGDIPFEH 251
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 3e-15
Identities = 53/226 (23%), Positives = 85/226 (37%), Gaps = 45/226 (19%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIKVFN------FLHHDASKSFTVECEVMRNIIHRKIIK 221
+G+G FA V K A K + + E ++R I H II
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 222 VVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDV 281
+ ++ L+ E + G L +++ +L E +
Sbjct: 73 LHDI-----FENKTDVVLILELVSGGELFDFL----------AEKESLTEDEATQFLKQI 117
Query: 282 ASALEYLH-LGCKPPIAHCDIKPSNILL--NDEMTACV--ADFGIARFLEATNEQTSSIG 336
+ YLH IAH D+KP NI+L + + DFGIA +EA NE +
Sbjct: 118 LDGVHYLHSKR----IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF- 172
Query: 337 VKGTTGYIAPE------YGMGHETSSYGDVYSFGILLLEMFTGLRP 376
GT ++APE G+ E D++S G++ + +G P
Sbjct: 173 --GTPEFVAPEIVNYEPLGL--EA----DMWSIGVITYILLSGASP 210
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 4e-15
Identities = 49/220 (22%), Positives = 83/220 (37%), Gaps = 33/220 (15%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIKVFN------FLHHDASKSFTVECEVMRNIIHRKIIK 221
+G+G FA V K A K + + E +++ I H +I
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 222 VVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDV 281
+ Y+ L+ E + G L +++ +L E +
Sbjct: 79 LHEV-----YENKTDVILILELVAGGELFDFL----------AEKESLTEEEATEFLKQI 123
Query: 282 ASALEYLH-LGCKPPIAHCDIKPSNILLNDEMTA----CVADFGIARFLEATNEQTSSIG 336
+ + YLH L IAH D+KP NI+L D + DFG+A ++ NE +
Sbjct: 124 LNGVYYLHSLQ----IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF- 178
Query: 337 VKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRP 376
GT ++APE D++S G++ + +G P
Sbjct: 179 --GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 7e-15
Identities = 54/239 (22%), Positives = 91/239 (38%), Gaps = 52/239 (21%)
Query: 167 LIGAGNFASVYKGILFEGAPAVAIKVFN--FLHHDASKSFTV--ECEVMRNIIHRKIIK- 221
L+G G++ V + + E A+K+ L + V E +++R + H+ +I+
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 222 --VVTACSRVD-YQGNDFKALVYEFMPNGSLE--EWI--HPITEEDKRHKAPGNLNSLER 274
V+ + Y +V E+ G E + +
Sbjct: 72 VDVLYNEEKQKMY-------MVMEYCVCGMQEMLDSVPEKRFPVCQAHGYF--------- 115
Query: 275 LNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNE---- 330
+ LEYLH I H DIKP N+LL T ++ G+A L
Sbjct: 116 ----CQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTC 168
Query: 331 QTSSIGVKGTTGYIAPEYGMGHETSSYG----DVYSFGILLLEMFTGLRPSDDMFKDNL 385
+TS G+ + PE G +T + D++S G+ L + TGL P + DN+
Sbjct: 169 RTSQ----GSPAFQPPEIANGLDT--FSGFKVDIWSAGVTLYNITTGLYPFEG---DNI 218
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 9e-15
Identities = 67/232 (28%), Positives = 101/232 (43%), Gaps = 42/232 (18%)
Query: 162 FSSENLIGAGNFASVY------KGILFEGAPAVAIKVFN---FLHHDASKSFTVECEVMR 212
F +IG G F+ V G ++ A+K+ N L F E +V+
Sbjct: 63 FEILKVIGRGAFSEVAVVKMKQTGQVY------AMKIMNKWDMLKRGEVSCFREERDVLV 116
Query: 213 NIIHRKIIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSL 272
N R I ++ A +Q ++ LV E+ G L + +++ +R A +
Sbjct: 117 NGDRRWITQLHFA-----FQDENYLYLVMEYYVGGDL---LTLLSKFGERIPAE-----M 163
Query: 273 ERLNIAIDVASALEYLH-LGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQ 331
R +A ++ A++ +H LG H DIKP NILL+ +ADFG L A
Sbjct: 164 ARFYLA-EIVMAIDSVHRLG----YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTV 218
Query: 332 TSSIGVKGTTGYIAPE----YGMGHETSSYG---DVYSFGILLLEMFTGLRP 376
S + V GT Y++PE G G T SYG D ++ G+ EMF G P
Sbjct: 219 RSLVAV-GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 1e-14
Identities = 51/225 (22%), Positives = 88/225 (39%), Gaps = 41/225 (18%)
Query: 163 SSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNI-IHRKIIK 221
+ +G G+F+ K + + A A+K+ + + E ++ H I+K
Sbjct: 14 LKDKPLGEGSFSICRKCVHKKSNQAFAVKI---ISKRMEANTQKEITALKLCEGHPNIVK 70
Query: 222 VVTACSRVDYQGNDFKALVYEFMPNGSLEEWI---HPITEEDKRHKAPGNLNSLERLNIA 278
+ + LV E + G L E I +E + + I
Sbjct: 71 LHEV-----FHDQLHTFLVMELLNGGELFERIKKKKHFSETEASY-------------IM 112
Query: 279 IDVASALEYLH-LGCKPPIAHCDIKPSNILL---NDEMTACVADFGIARFLEATNEQTSS 334
+ SA+ ++H +G + H D+KP N+L ND + + DFG AR N+ +
Sbjct: 113 RKLVSAVSHMHDVG----VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT 168
Query: 335 IGVKGTTGYIAPEYGMGHETSSYG---DVYSFGILLLEMFTGLRP 376
T Y APE + Y D++S G++L M +G P
Sbjct: 169 PC--FTLHYAAPELLNQN---GYDESCDLWSLGVILYTMLSGQVP 208
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 1e-14
Identities = 57/232 (24%), Positives = 82/232 (35%), Gaps = 47/232 (20%)
Query: 167 LIGAGNFASVYKGI-LFEGAPAVAIKVFN----FLHHDASKSFTVECEV--MRNI----I 215
L+G G F +V+ G L + VAIKV S S T EV + +
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQ-VAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGG 96
Query: 216 HRKIIKV--VTACSRVDYQGNDFKALVYEF-MPNGSLEEWIHPITEEDKRHKAPGNLNSL 272
H +I++ LV E +P L ++I G L
Sbjct: 97 HPGVIRLLDWFETQEGFM-------LVLERPLPAQDLFDYI-------TEK---GPLGEG 139
Query: 273 ERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTAC-VADFGIARFLEATNEQ 331
V +A+++ H + H DIK NIL++ + DFG L
Sbjct: 140 PSRCFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYT 196
Query: 332 TSSIGVKGTTGYIAPEYGMGHETSSYG----DVYSFGILLLEMFTGLRPSDD 379
GT Y PE+ H+ Y V+S GILL +M G P +
Sbjct: 197 DFD----GTRVYSPPEWISRHQ---YHALPATVWSLGILLYDMVCGDIPFER 241
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 2e-14
Identities = 50/250 (20%), Positives = 88/250 (35%), Gaps = 64/250 (25%)
Query: 167 LIGAGNFASVYKGILFEGAPAVAIKVFN---FLHHDASKSFTV----------------- 206
IG G++ V A+KV + +
Sbjct: 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 207 ------ECEVMRNIIHRKIIK---VVTACSRVD-YQGNDFKALVYEFMPNGSLEEWIH-- 254
E +++ + H ++K V+ + Y +V+E + G + E
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLY-------MVFELVNQGPVMEVPTLK 132
Query: 255 PITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTA 314
P++E+ R D+ +EYLH I H DIKPSN+L+ ++
Sbjct: 133 PLSEDQARF-------------YFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHI 176
Query: 315 CVADFGIARFLEATNE--QTSSIGVKGTTGYIAPEYGMGHETSSYG---DVYSFGILLLE 369
+ADFG++ + ++ + GT ++APE G DV++ G+ L
Sbjct: 177 KIADFGVSNEFKGSDALLSNTV----GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYC 232
Query: 370 MFTGLRPSDD 379
G P D
Sbjct: 233 FVFGQCPFMD 242
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 25/220 (11%), Positives = 55/220 (25%), Gaps = 66/220 (30%)
Query: 167 LIGAGNFASVYKG---ILFEGAPAVAIKVFNFLHHDASKS------FTVECEVMRNIIHR 217
G ++ L VA+ + + I
Sbjct: 38 FHGGVPPLQFWQALDTAL--DRQ-VALTF---VDPQGVLPDDVLQETLSRTLRLSRIDKP 91
Query: 218 KIIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNI 277
+ +V+ V + +V E++ GSL+E + + + +
Sbjct: 92 GVARVLDV---VHTRAGGL--VVAEWIRGGSLQEVAD------------TSPSPVGAIRA 134
Query: 278 AIDVASALEYLH-LGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIG 336
+A+A + H G +A PS + ++ + +A
Sbjct: 135 MQSLAAAADAAHRAG----VALSIDHPSRVRVSIDGDVVLAYPATMP------------- 177
Query: 337 VKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRP 376
+ + D+ G L + P
Sbjct: 178 ----------------DANPQDDIRGIGASLYALLVNRWP 201
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 3e-14
Identities = 55/229 (24%), Positives = 88/229 (38%), Gaps = 41/229 (17%)
Query: 162 FSSENLIGAGNFASVY------KGILFEGAPAVAIKVFN---FLHHDASKSFTVECEVMR 212
+ +IG G F V ++ A+K+ + + S F E ++M
Sbjct: 71 YEVVKVIGRGAFGEVQLVRHKSTRKVY------AMKLLSKFEMIKRSDSAFFWEERDIMA 124
Query: 213 NIIHRKIIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSL 272
++++ A +Q + + +V E+MP G L + + P
Sbjct: 125 FANSPWVVQLFYA-----FQDDRYLYMVMEYMPGGDLVNLM-------SNYDVP---EKW 169
Query: 273 ERLNIAIDVASALEYLH-LGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQ 331
R A +V AL+ +H +G H D+KP N+LL+ +ADFG +
Sbjct: 170 ARFYTA-EVVLALDAIHSMG----FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV 224
Query: 332 TSSIGVKGTTGYIAPEYGMGH-ETSSYG---DVYSFGILLLEMFTGLRP 376
V GT YI+PE YG D +S G+ L EM G P
Sbjct: 225 RCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 6e-14
Identities = 61/231 (26%), Positives = 91/231 (39%), Gaps = 42/231 (18%)
Query: 162 FSSENLIGAGNFASVY------KGILFEGAPAVAIKVFN---FLHHDASKSFTVECEVMR 212
F +IG G F V +F A+K+ N L + F E +V+
Sbjct: 76 FEILKVIGRGAFGEVAVVKLKNADKVF------AMKILNKWEMLKRAETACFREERDVLV 129
Query: 213 NIIHRKIIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNL-NS 271
N + I + A +Q ++ LV ++ G L + K L
Sbjct: 130 NGDSKWITTLHYA-----FQDDNNLYLVMDYYVGGDLLTLLS---------KFEDRLPEE 175
Query: 272 LERLNIAIDVASALEYLH-LGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNE 330
+ R +A ++ A++ +H L H DIKP NIL++ +ADFG L
Sbjct: 176 MARFYLA-EMVIAIDSVHQLH----YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 230
Query: 331 QTSSIGVKGTTGYIAPE--YGMGHETSSYG---DVYSFGILLLEMFTGLRP 376
SS+ V GT YI+PE M YG D +S G+ + EM G P
Sbjct: 231 VQSSVAV-GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 6e-14
Identities = 53/238 (22%), Positives = 87/238 (36%), Gaps = 57/238 (23%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIKVFN--------FLHHDASKSFTVECEVMRNIIHRKI 219
+G+G F V+ + E V +K ++ T+E ++ + H I
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 220 IKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEE--------DK--RHKAPGNL 269
IKV + N + + + E+ RH L
Sbjct: 92 IKV------------------LDIFEN---QGFFQLVMEKHGSGLDLFAFIDRH---PRL 127
Query: 270 NSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATN 329
+ I + SA+ YL L I H DIK NI++ ++ T + DFG A +LE
Sbjct: 128 DEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK 184
Query: 330 E-QTSSIGVKGTTGYIAPEYGMGHETSSYG----DVYSFGILLLEMFTGLRPSDDMFK 382
T GT Y APE MG+ Y +++S G+ L + P ++ +
Sbjct: 185 LFYTFC----GTIEYCAPEVLMGNP---YRGPELEMWSLGVTLYTLVFEENPFCELEE 235
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 7e-14
Identities = 57/223 (25%), Positives = 93/223 (41%), Gaps = 37/223 (16%)
Query: 167 LIGAGNFASVYKGILFEGAPAVAIKVFN---FLHHDASKSFTVECEVMRNIIHRKIIKV- 222
+G G F V G VA+K+ N D E + ++ H IIK+
Sbjct: 18 TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY 77
Query: 223 -VTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDV 281
V + + +V E++ G L ++I G + +E + +
Sbjct: 78 QVISTPTDFF-------MVMEYVSGGELFDYI----------CKHGRVEEMEARRLFQQI 120
Query: 282 ASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNE-QTSSIGVKGT 340
SA++Y H + + H D+KP N+LL+ M A +ADFG++ + +TS G+
Sbjct: 121 LSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC----GS 173
Query: 341 TGYIAPEYGMGHETSSYG----DVYSFGILLLEMFTGLRPSDD 379
Y APE G Y D++S G++L + G P DD
Sbjct: 174 PNYAAPEVISGRL---YAGPEVDIWSCGVILYALLCGTLPFDD 213
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 1e-13
Identities = 55/241 (22%), Positives = 88/241 (36%), Gaps = 44/241 (18%)
Query: 167 LIGAGNFASVYKGILFEGAPAVAIKVFNFLHH-DASKSFTVECEVMRNIIHRKIIKV--V 223
+G G + V + AVA+K+ + D ++ E + + + H ++K
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 224 TACSRVDYQGNDFKALVYEFMPNGSLEEWI---HPITEEDKRHKAPGNLNSLERLNIAID 280
+ Y L E+ G L + I + E D + +L
Sbjct: 74 RREGNIQY-------LFLEYCSGGELFDRIEPDIGMPEPDAQRF-------FHQL----- 114
Query: 281 VASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNE----QTSSIG 336
+ + YLH I H DIKP N+LL++ ++DFG+A N
Sbjct: 115 -MAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-- 168
Query: 337 VKGTTGYIAPEYGMGHETSSYG----DVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQ 392
GT Y+APE E + DV+S GI+L M G P D +W +
Sbjct: 169 --GTLPYVAPELLKRRE---FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE 223
Query: 393 S 393
Sbjct: 224 K 224
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 74.2 bits (182), Expect = 1e-13
Identities = 28/99 (28%), Positives = 55/99 (55%), Gaps = 12/99 (12%)
Query: 281 VASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGT 340
+ LE++H + + D+KP+NILL++ ++D G+A + + ++ + GT
Sbjct: 301 IILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLAC--DFSKKKPHASV--GT 353
Query: 341 TGYIAPE---YGMGHETSSYGDVYSFGILLLEMFTGLRP 376
GY+APE G+ +++S+ D +S G +L ++ G P
Sbjct: 354 HGYMAPEVLQKGVAYDSSA--DWFSLGCMLFKLLRGHSP 390
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 46/226 (20%), Positives = 78/226 (34%), Gaps = 43/226 (19%)
Query: 164 SENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNII-HRKIIKV 222
S+ ++G G V + A+K+ S E + I+ +
Sbjct: 33 SKQVLGLGVNGKVLECFHRRTGQKCALKLL-----YDSPKARQEVDHHWQASGGPHIVCI 87
Query: 223 VTACSRVDYQGNDFKALVYEFMPNGSL-----EEWIHPITEEDKRHKAPGNLNSLERLNI 277
+ + + ++ E M G L E TE + I
Sbjct: 88 LDVYENMHHGKRCL-LIIMECMEGGELFSRIQERGDQAFTEREAAE-------------I 133
Query: 278 AIDVASALEYLH-LGCKPPIAHCDIKPSNILL---NDEMTACVADFGIARFLEATNEQTS 333
D+ +A+++LH IAH D+KP N+L + + DFG A+ QT
Sbjct: 134 MRDIGTAIQFLHSHN----IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQT- 188
Query: 334 SIGVKGTTGYIAPEYGMGHETSSYG---DVYSFGILLLEMFTGLRP 376
T Y+APE Y D++S G+++ + G P
Sbjct: 189 ---PCYTPYYVAPEVLGPE---KYDKSCDMWSLGVIMYILLCGFPP 228
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 57/236 (24%), Positives = 95/236 (40%), Gaps = 35/236 (14%)
Query: 149 YVSYEALYSA---TKGFSSENLIGAGNFASVYKGILFEGAPAVAIK-VFN-FLHHDASKS 203
+ S E S K + + IG+G V VAIK + F + +K
Sbjct: 11 FYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKR 70
Query: 204 FTVECEVMRNIIHRKIIK---VVTACSRVDYQGNDFKA--LVYEFMPNGSLEEWIH-PIT 257
E +M+ + H+ II V T ++ +F+ +V E M +L + I +
Sbjct: 71 AYRELVLMKCVNHKNIIGLLNVFTPQKSLE----EFQDVYIVMELMDA-NLCQVIQMELD 125
Query: 258 EEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVA 317
E + + + +++LH I H D+KPSNI++ + T +
Sbjct: 126 HERMSY-------------LLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKIL 169
Query: 318 DFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTG 373
DFG+AR + T + T Y APE +G D++S G ++ EM G
Sbjct: 170 DFGLARTAGTSFMMTPYV---VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 71.1 bits (174), Expect = 3e-13
Identities = 38/152 (25%), Positives = 66/152 (43%), Gaps = 7/152 (4%)
Query: 226 CSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASAL 285
R+D + + F+ SL + + +K L L + + VA +
Sbjct: 150 KRRLDSITSSQSSASSGFVEEKSLS-DVEEEEAPEDLYKDFLTLEHL--ICYSFQVAKGM 206
Query: 286 EYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIA 345
E+L + I H D+ NILL+++ + DFG+AR + + + ++A
Sbjct: 207 EFL--ASRKCI-HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 263
Query: 346 PEYGMGHETSSYGDVYSFGILLLEMFT-GLRP 376
PE + DV+SFG+LL E+F+ G P
Sbjct: 264 PETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 5e-13
Identities = 56/241 (23%), Positives = 89/241 (36%), Gaps = 44/241 (18%)
Query: 167 LIGAGNFASVYKGILFEGAPAVAIKVFNFLHH-DASKSFTVECEVMRNIIHRKIIKV--V 223
+G G + V + AVA+K+ + D ++ E + + + H ++K
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 224 TACSRVDYQGNDFKALVYEFMPNGSLEEWIHP---ITEEDKRHKAPGNLNSLERLNIAID 280
+ Y L E+ G L + I P + E D + +L
Sbjct: 74 RREGNIQY-------LFLEYCSGGELFDRIEPDIGMPEPDAQRF-------FHQL----- 114
Query: 281 VASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNE----QTSSIG 336
+ + YLH I H DIKP N+LL++ ++DFG+A N
Sbjct: 115 -MAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-- 168
Query: 337 VKGTTGYIAPEYGMGHETSSYG----DVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQ 392
GT Y+APE E + DV+S GI+L M G P D +W +
Sbjct: 169 --GTLPYVAPELLKRRE---FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE 223
Query: 393 S 393
Sbjct: 224 K 224
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 6e-13
Identities = 61/232 (26%), Positives = 98/232 (42%), Gaps = 49/232 (21%)
Query: 162 FSSENLIGAGNFASVYKGILFEGAPAVAIK-VFNFLHHDASKSFTV-ECEVMRNIIHRKI 219
++ +IG G+F VY+ L + VAIK V K F E ++MR + H I
Sbjct: 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD------KRFKNRELQIMRKLDHCNI 109
Query: 220 IKVVTA-CSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIA 278
+++ S + + + LV +++P E ++ + R K L + +
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVP-----ETVYRVARHYSRAKQT-----LPVIYVK 159
Query: 279 I---DVASALEYLH-LGCKPPIAHCDIKPSNILLNDEMTAC-VADFGIARFLEATNEQTS 333
+ + +L Y+H G I H DIKP N+LL+ + + DFG A+ L S
Sbjct: 160 LYMYQLFRSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 215
Query: 334 SIGVKGTTGYI------APEYGMGHETSSYG---DVYSFGILLLEMFTGLRP 376
YI APE G + Y DV+S G +L E+ G +P
Sbjct: 216 ---------YICSRYYRAPELIFG--ATDYTSSIDVWSAGCVLAELLLG-QP 255
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 6e-13
Identities = 50/162 (30%), Positives = 73/162 (45%), Gaps = 39/162 (24%)
Query: 281 VASALEYLH-LGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKG 339
+A AL++LH LG I + D+KP NILL++E + DFG+++ ++ S G
Sbjct: 135 LALALDHLHSLG----IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC--G 188
Query: 340 TTGYIAPE--YGMGHETSSYGDVYSFGILLLEMFTGLRP-----SDDMF----KDNLNLQ 388
T Y+APE GH S+ D +SFG+L+ EM TG P + K L +
Sbjct: 189 TVEYMAPEVVNRRGHTQSA--DWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP 246
Query: 389 NWVQS-------------------ALPERVEEIVDTLFFKEI 411
++ A P+ VEEI FF I
Sbjct: 247 QFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTI 288
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 71.4 bits (175), Expect = 6e-13
Identities = 42/153 (27%), Positives = 70/153 (45%), Gaps = 20/153 (13%)
Query: 239 LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAH 298
LV M G + I+ + E++ + P A + S LE+LH + I +
Sbjct: 262 LVMTIMNGGDIRYHIYNVDEDNPGFQEP-----RAIFYTA-QIVSGLEHLH---QRNIIY 312
Query: 299 CDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYG 358
D+KP N+LL+D+ ++D G+A E QT + G GT G++APE +G E
Sbjct: 313 RDLKPENVLLDDDGNVRISDLGLAV--ELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSV 370
Query: 359 DVYSFGILLLEMFTGLRP---------SDDMFK 382
D ++ G+ L EM P + ++ +
Sbjct: 371 DYFALGVTLYEMIAARGPFRARGEKVENKELKQ 403
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 9e-13
Identities = 43/162 (26%), Positives = 63/162 (38%), Gaps = 39/162 (24%)
Query: 281 VASALEYLH-LGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKG 339
++ AL +LH G I + D+KP NI+LN + + DFG+ + T + G
Sbjct: 130 ISMALGHLHQKG----IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFC--G 183
Query: 340 TTGYIAPE--YGMGHETSSYGDVYSFGILLLEMFTGLRP-----SDDMF----KDNLNLQ 388
T Y+APE GH + D +S G L+ +M TG P K LNL
Sbjct: 184 TIEYMAPEILMRSGHNRAV--DWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLP 241
Query: 389 NWVQS-------------------ALPERVEEIVDTLFFKEI 411
++ A P E+ FF+ I
Sbjct: 242 PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHI 283
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 9e-13
Identities = 49/225 (21%), Positives = 80/225 (35%), Gaps = 42/225 (18%)
Query: 165 ENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNII-HRKIIKVV 223
++G G V + A+K+ D K+ E E+ I+++V
Sbjct: 67 SQVLGLGINGKVLQIFNKRTQEKFALKMLQ----DCPKARR-EVELHWRASQCPHIVRIV 121
Query: 224 TACSRVDYQGNDFKALVYEFMPNGSL-----EEWIHPITEEDKRHKAPGNLNSLERLNIA 278
Y G +V E + G L + TE + I
Sbjct: 122 DVYEN-LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASE-------------IM 167
Query: 279 IDVASALEYLH-LGCKPPIAHCDIKPSNILL---NDEMTACVADFGIARFLEATNEQTSS 334
+ A++YLH + IAH D+KP N+L + DFG A+ + N T+
Sbjct: 168 KSIGEAIQYLHSIN----IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP 223
Query: 335 IGVKGTTGYIAPEYGMGHETSSYG---DVYSFGILLLEMFTGLRP 376
T Y+APE Y D++S G+++ + G P
Sbjct: 224 C---YTPYYVAPEVLGPE---KYDKSCDMWSLGVIMYILLCGYPP 262
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 1e-12
Identities = 48/226 (21%), Positives = 98/226 (43%), Gaps = 39/226 (17%)
Query: 167 LIGAGNFASVYKGILFEGAPAVAIKVF--NFLHHDASKSFTVECEVMRNI--------IH 216
+G G+F++V+ VA+K+ + ++ +A++ E ++++ +
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAE---DEIKLLQRVNDADNTKEDS 82
Query: 217 RKIIKVVTACSRVDYQGNDFK--ALVYEFMPNGSLEEWIHPITEEDKRHKAPG-NLNSLE 273
++ +++G + +V+E + +L I K+++ G L ++
Sbjct: 83 MGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALI-------KKYEHRGIPLIYVK 134
Query: 274 RLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTAC------VADFGIARFLEA 327
+ I+ + L+Y+H C I H DIKP N+L+ + +AD G A +
Sbjct: 135 Q--ISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW--Y 188
Query: 328 TNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTG 373
T+SI T Y +PE +G D++S L+ E+ TG
Sbjct: 189 DEHYTNSI---QTREYRSPEVLLGAPWGCGADIWSTACLIFELITG 231
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 2e-12
Identities = 52/252 (20%), Positives = 94/252 (37%), Gaps = 48/252 (19%)
Query: 149 YVSYEAL---YSATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFT 205
Y YE+ + + +G G ++ V++ I V +K+ K
Sbjct: 22 YWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK--PVKKKKIKR 79
Query: 206 VECEVMRNII-HRKIIK----VVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEED 260
E +++ N+ II V SR LV+E + N ++ +T+ D
Sbjct: 80 -EIKILENLRGGPNIITLADIVKDPVSRTPA-------LVFEHVNNTDFKQLYQTLTDYD 131
Query: 261 KRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTAC---VA 317
R + + + AL+Y H I H D+KP N++++ E +
Sbjct: 132 IRFY----MYEILK---------ALDYCH---SMGIMHRDVKPHNVMIDHE--HRKLRLI 173
Query: 318 DFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYG-DVYSFGILLLEMFTGLRP 376
D+G+A F E + + + PE + ++ Y D++S G +L M P
Sbjct: 174 DWGLAEFYHPGQEYNVRV---ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 230
Query: 377 SDDMF--KDNLN 386
F DN +
Sbjct: 231 ---FFHGHDNYD 239
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 2e-12
Identities = 45/161 (27%), Positives = 69/161 (42%), Gaps = 38/161 (23%)
Query: 281 VASALEYLH-LGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKG 339
+ASAL YLH L I + D+KP NILL+ + + DFG+ + N TS+ G
Sbjct: 148 IASALGYLHSLN----IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFC--G 201
Query: 340 TTGYIAPE--YGMGHETSSYGDVYSFGILLLEMFTGLRP-----SDDMFK----DNLNLQ 388
T Y+APE + ++ + D + G +L EM GL P + +M+ L L+
Sbjct: 202 TPEYLAPEVLHKQPYDRTV--DWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK 259
Query: 389 NWV----QSAL--------------PERVEEIVDTLFFKEI 411
+ + L + EI +FF I
Sbjct: 260 PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLI 300
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 2e-12
Identities = 34/162 (20%), Positives = 61/162 (37%), Gaps = 38/162 (23%)
Query: 281 VASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGT 340
+ SAL+YLH + + + D+K N++L+ + + DFG+ + + GT
Sbjct: 257 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC--GT 312
Query: 341 TGYIAPEYGMGHETSSYG---DVYSFGILLLEMFTGLRP-----SDDMF----KDNLNLQ 388
Y+APE + YG D + G+++ EM G P + +F + +
Sbjct: 313 PEYLAPEVLEDN---DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP 369
Query: 389 NWVQS-------------------ALPERVEEIVDTLFFKEI 411
+ E +EI+ FF I
Sbjct: 370 RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI 411
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 2e-12
Identities = 55/221 (24%), Positives = 83/221 (37%), Gaps = 38/221 (17%)
Query: 167 LIGAGNFASVY------KGILFEGAPAVAIKVFN---FLHHDASKSFTVECEVMRNIIHR 217
++G G F V G ++ A K E +++ + R
Sbjct: 191 VLGKGGFGEVCACQVRATGKMY------ACKKLEKKRIKKRKGEAMALNEKQILEKVNSR 244
Query: 218 KIIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNI 277
++ + A Y+ D LV M G L+ I+ G +
Sbjct: 245 FVVSLAYA-----YETKDALCLVLTLMNGGDLKFHIY-------HMGQAGFPEARAVFYA 292
Query: 278 AIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGV 337
A ++ LE LH + I + D+KP NILL+D ++D G+A QT G
Sbjct: 293 A-EICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAV--HVPEGQTIK-GR 345
Query: 338 KGTTGYIAPE--YGMGHETSSYGDVYSFGILLLEMFTGLRP 376
GT GY+APE + S D ++ G LL EM G P
Sbjct: 346 VGTVGYMAPEVVKNERYTFSP--DWWALGCLLYEMIAGQSP 384
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 3e-12
Identities = 57/223 (25%), Positives = 92/223 (41%), Gaps = 37/223 (16%)
Query: 167 LIGAGNFASVYKGILFEGAPAVAIKVFN---FLHHDASKSFTVECEVMRNIIHRKIIKV- 222
+G G F V G VA+K+ N D E + ++ H IIK+
Sbjct: 23 TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82
Query: 223 -VTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDV 281
V + + +V E++ G L ++I G L+ E + +
Sbjct: 83 QVISTPSDIF-------MVMEYVSGGELFDYI----------CKNGRLDEKESRRLFQQI 125
Query: 282 ASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNE-QTSSIGVKGT 340
S ++Y H + + H D+KP N+LL+ M A +ADFG++ + +TS G+
Sbjct: 126 LSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC----GS 178
Query: 341 TGYIAPEYGMGHETSSYG----DVYSFGILLLEMFTGLRPSDD 379
Y APE G Y D++S G++L + G P DD
Sbjct: 179 PNYAAPEVISGRL---YAGPEVDIWSSGVILYALLCGTLPFDD 218
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 3e-12
Identities = 39/107 (36%), Positives = 52/107 (48%), Gaps = 16/107 (14%)
Query: 281 VASALEYLH-LGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKG 339
V ALEYLH I + D+KP NILL+ + DFG A+++ T ++ G
Sbjct: 115 VCLALEYLHSKD----IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---TYTLC--G 165
Query: 340 TTGYIAPE--YGMGHETSSYGDVYSFGILLLEMFTGLRP--SDDMFK 382
T YIAPE + S D +SFGIL+ EM G P + K
Sbjct: 166 TPDYIAPEVVSTKPYNKSI--DWWSFGILIYEMLAGYTPFYDSNTMK 210
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 3e-12
Identities = 57/236 (24%), Positives = 94/236 (39%), Gaps = 35/236 (14%)
Query: 149 YVSYEALYSA---TKGFSSENLIGAGNFASVYKGILFEGAPAVAIK-VFN-FLHHDASKS 203
+ S E S K + + IG+G V VAIK + F + +K
Sbjct: 48 FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKR 107
Query: 204 FTVECEVMRNIIHRKIIK---VVTACSRVDYQGNDFKA--LVYEFMPNGSLEEWIH-PIT 257
E +M+ + H+ II V T ++ +F+ LV E M +L + I +
Sbjct: 108 AYRELVLMKCVNHKNIISLLNVFTPQKTLE----EFQDVYLVMELMDA-NLCQVIQMELD 162
Query: 258 EEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVA 317
E + + + +++LH I H D+KPSNI++ + T +
Sbjct: 163 HERMSY-------------LLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKIL 206
Query: 318 DFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTG 373
DFG+AR + T + T Y APE +G D++S G ++ EM
Sbjct: 207 DFGLARTAGTSFMMTPYV---VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 259
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 4e-12
Identities = 29/106 (27%), Positives = 51/106 (48%), Gaps = 14/106 (13%)
Query: 281 VASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGT 340
+ EYLH + + D+KP N+L++ + V DFG A+ ++ T ++ GT
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR---TWTLC--GT 201
Query: 341 TGYIAPE--YGMGHETSSYGDVYSFGILLLEMFTGLRP--SDDMFK 382
+APE G+ + D ++ G+L+ EM G P +D +
Sbjct: 202 PEALAPEIILSKGYNKAV--DWWALGVLIYEMAAGYPPFFADQPIQ 245
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 67.2 bits (165), Expect = 5e-12
Identities = 35/162 (21%), Positives = 63/162 (38%), Gaps = 39/162 (24%)
Query: 281 VASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGT 340
+ SALEYLH + + DIK N++L+ + + DFG+ + + + GT
Sbjct: 114 IVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC--GT 168
Query: 341 TGYIAPEYGMGHETSSYG---DVYSFGILLLEMFTGLRP-----SDDMFK----DNLNLQ 388
Y+APE + YG D + G+++ EM G P + +F+ + +
Sbjct: 169 PEYLAPEVLEDN---DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP 225
Query: 389 NWVQS-------------------ALPERVEEIVDTLFFKEI 411
+ P +E+++ FF I
Sbjct: 226 RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 5e-12
Identities = 43/169 (25%), Positives = 68/169 (40%), Gaps = 46/169 (27%)
Query: 281 VASALEYLH-LGCKPPIAHCDIKPSNILLNDEMTACVADFGIA-RFLEATNEQTSSIGVK 338
+ ALE+LH LG I + DIK NILL+ + DFG++ F+ E+
Sbjct: 168 IVLALEHLHKLG----IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC-- 221
Query: 339 GTTGYIAPE----YGMGHETSSYGDVYSFGILLLEMFTGLRP---------SDDMF---- 381
GT Y+AP+ GH+ + D +S G+L+ E+ TG P ++
Sbjct: 222 GTIEYMAPDIVRGGDSGHDKAV--DWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL 279
Query: 382 KDNLNLQNWVQS-------------------ALPERVEEIVDTLFFKEI 411
K + + P +EI + LFF++I
Sbjct: 280 KSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 328
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 6e-12
Identities = 23/91 (25%), Positives = 35/91 (38%), Gaps = 5/91 (5%)
Query: 4 NLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGI 63
NL P+ SL ++ L +L+ N L G++P F L +LNL++N IP
Sbjct: 316 NLKTFPVETSLQKMKKLGMLECLYNQLEGKLPAF-GSEIKLASLNLAYNQITE-IP-ANF 372
Query: 64 FKNASATSVF--GNNKLCGGIPEFQLPTCVS 92
+NKL F +
Sbjct: 373 CGFTEQVENLSFAHNKLKYIPNIFDAKSVSV 403
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 7e-10
Identities = 19/90 (21%), Positives = 30/90 (33%), Gaps = 8/90 (8%)
Query: 1 MHGNLFEG-PIGL-SLSPLRGLKV---LDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFE 55
+ N F P + S L+G + D N E PE + L L + N+
Sbjct: 520 LSYNSFSKFPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR 579
Query: 56 SMIPTEGIFKNASATSVFGNNKLCGGIPEF 85
+ E I N S + +N +
Sbjct: 580 K-VN-EKITPNISVLDI-KDNPNISIDLSY 606
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 2e-09
Identities = 15/88 (17%), Positives = 35/88 (39%), Gaps = 3/88 (3%)
Query: 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPT 60
N EG + + L L+L+ N ++ F + ++NL+ +HN + +
Sbjct: 337 CLYNQLEGKLP-AFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNI 395
Query: 61 EGIFKNASATSV-FGNNKLCGGIPEFQL 87
+ +++ F N++ G +
Sbjct: 396 FDAKSVSVMSAIDFSYNEI-GSVDGKNF 422
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 3e-09
Identities = 16/97 (16%), Positives = 30/97 (30%), Gaps = 8/97 (8%)
Query: 4 NLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGI 63
L L+ L +++ ++P FL +Q +N++ N S +
Sbjct: 235 AQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDD 294
Query: 64 FKNASATSV--------FGNNKLCGGIPEFQLPTCVS 92
++ + V G N L E L
Sbjct: 295 WQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKK 331
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 3e-09
Identities = 20/129 (15%), Positives = 42/129 (32%), Gaps = 4/129 (3%)
Query: 4 NLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPT--- 60
+++ G+SL+ + L L SG +P+ + L+ L L + +
Sbjct: 67 DMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGP 126
Query: 61 EGIFKNASATSVF-GNNKLCGGIPEFQLPTCVSKKTKQNRSTLPLKLVIAIDCGLLVLTL 119
+GI N S ++ S K ++ P + I + +
Sbjct: 127 KGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDT 186
Query: 120 ALSSLFCRL 128
+ L +
Sbjct: 187 QIGQLSNNI 195
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 7e-09
Identities = 16/92 (17%), Positives = 31/92 (33%), Gaps = 7/92 (7%)
Query: 8 GPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNA 67
P+ + + ++LS N +S E + L ++NL N + +N
Sbjct: 423 DPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENE 482
Query: 68 SATSV-------FGNNKLCGGIPEFQLPTCVS 92
+ + NKL +F+ T
Sbjct: 483 NFKNTYLLTSIDLRFNKLTKLSDDFRATTLPY 514
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 8e-09
Identities = 16/94 (17%), Positives = 28/94 (29%), Gaps = 13/94 (13%)
Query: 1 MHGNLFEG-PIGLSLSPLRGLKVLDLSQNNLSG-------EIPEFLAGFKFLQNLNLSHN 52
N + P + + +D S N + + + ++NLS+N
Sbjct: 384 FAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNN 443
Query: 53 NFESMIPTEGIFKNASATSV--FGNNKLCGGIPE 84
+F S S N L IP+
Sbjct: 444 QISKFPK--ELFSTGSPLSSINLMGNML-TEIPK 474
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 3e-08
Identities = 13/95 (13%), Positives = 35/95 (36%), Gaps = 11/95 (11%)
Query: 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNL--------SGEIPEFLAGFKFLQNLNLSHN 52
++ + L L +++++++ N + + +Q + + +N
Sbjct: 256 VYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYN 315
Query: 53 NFESMIPTEGIFKNASATSVF--GNNKLCGGIPEF 85
N ++ P E + + N+L G +P F
Sbjct: 316 NLKT-FPVETSLQKMKKLGMLECLYNQLEGKLPAF 349
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 2e-07
Identities = 12/67 (17%), Positives = 17/67 (25%), Gaps = 8/67 (11%)
Query: 2 HGNLFEG-PIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQ------NLNLSHNNF 54
N + L L +DLS N+ S P L+ + N
Sbjct: 496 RFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRT 554
Query: 55 ESMIPTE 61
P
Sbjct: 555 LREWPEG 561
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 3e-07
Identities = 10/92 (10%), Positives = 27/92 (29%), Gaps = 6/92 (6%)
Query: 2 HGNLFEGPIGLSLSPLRGLKVLDLSQNNLSG----EIPEFLAGFKFLQNLNLSHNNFESM 57
G G + ++ L L+VL L + P+ ++ + +++
Sbjct: 89 EGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKT 148
Query: 58 IPTEGIFKNASATSV--FGNNKLCGGIPEFQL 87
++ S ++ I +
Sbjct: 149 FVDYDPREDFSDLIKDCINSDPQQKSIKKSSR 180
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 9e-06
Identities = 7/62 (11%), Positives = 21/62 (33%), Gaps = 1/62 (1%)
Query: 2 HGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTE 61
+ + + I S + NN++ + + + L+ + ++ F + E
Sbjct: 167 NSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICE 225
Query: 62 GI 63
Sbjct: 226 AW 227
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 1e-04
Identities = 6/61 (9%), Positives = 15/61 (24%), Gaps = 5/61 (8%)
Query: 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPT 60
M + F + + K L ++ + + + +PT
Sbjct: 213 MGNSPFVAENICEA-----WENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPT 267
Query: 61 E 61
Sbjct: 268 F 268
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 1e-04
Identities = 9/73 (12%), Positives = 22/73 (30%), Gaps = 7/73 (9%)
Query: 13 SLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTE-GIFKNASATS 71
++ L L+ + + E + +N N + + K+ +
Sbjct: 201 AVMRLTKLRQFYMGNSPFVAENI-----CEAWENENSEYAQQYKTEDLKWDNLKDLTDVE 255
Query: 72 VFGNNKLCGGIPE 84
V+ L +P
Sbjct: 256 VYNCPNL-TKLPT 267
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 1e-04
Identities = 5/43 (11%), Positives = 14/43 (32%)
Query: 11 GLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNN 53
++ + VLD+ N ++ + L ++
Sbjct: 580 KVNEKITPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDK 622
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 9e-12
Identities = 56/232 (24%), Positives = 95/232 (40%), Gaps = 51/232 (21%)
Query: 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIK-VFN-FLHHDASKSFTVECEVMRNIIH 216
K + S +G+G + SV I VAIK + F +K E +++++ H
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQH 82
Query: 217 RKIIK---VVTACSRVDYQGNDFKA--LVYEFMPNGSLEEWIH-PITEEDKRHKAPGNLN 270
+I V T S + +F LV FM L++ + +EE ++
Sbjct: 83 ENVIGLLDVFTPASSLR----NFYDFYLVMPFMQT-DLQKIMGLKFSEEKIQY------- 130
Query: 271 SLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNE 330
+ + L+Y+H + H D+KP N+ +N++ + DFG+AR +A
Sbjct: 131 ------LVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAE-- 179
Query: 331 QTSSIGVKGTTGYI------APEYGMGHETSSYG---DVYSFGILLLEMFTG 373
TGY+ APE + Y D++S G ++ EM TG
Sbjct: 180 ---------MTGYVVTRWYRAPEVILSW--MHYNQTVDIWSVGCIMAEMLTG 220
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 1e-11
Identities = 14/61 (22%), Positives = 23/61 (37%)
Query: 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPT 60
+ E + + L L+VL++S NN LQ L+ S N+ +
Sbjct: 477 LSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQ 536
Query: 61 E 61
E
Sbjct: 537 E 537
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 6e-11
Identities = 26/88 (29%), Positives = 37/88 (42%), Gaps = 5/88 (5%)
Query: 1 MHGNLFEGPI-GLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIP 59
M GN F+ + LR L LDLSQ L P LQ LN+SHNNF S+
Sbjct: 452 MAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDT 511
Query: 60 TEGIFKNASA-TSV-FGNNKLCGGIPEF 85
+K ++ + + N + +
Sbjct: 512 --FPYKCLNSLQVLDYSLNHIMTSKKQE 537
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 1e-10
Identities = 16/87 (18%), Positives = 28/87 (32%), Gaps = 4/87 (4%)
Query: 1 MHGNLFEGPIGLS-LSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIP 59
+ + S LR L LD+S + G L+ L ++ N+F+
Sbjct: 403 FQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFL 462
Query: 60 TEGIFKNASATSV--FGNNKLCGGIPE 84
+ IF + +L P
Sbjct: 463 PD-IFTELRNLTFLDLSQCQLEQLSPT 488
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 2e-10
Identities = 18/85 (21%), Positives = 33/85 (38%), Gaps = 1/85 (1%)
Query: 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPT 60
+ GN + + S L L+ L + NL+ + K L+ LN++HN +S
Sbjct: 83 LTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLP 142
Query: 61 EGIFKNASATSV-FGNNKLCGGIPE 84
E + + +NK+
Sbjct: 143 EYFSNLTNLEHLDLSSNKIQSIYCT 167
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 2e-10
Identities = 15/66 (22%), Positives = 22/66 (33%), Gaps = 2/66 (3%)
Query: 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPT 60
+ N S L+VLDLS+ + L L L+ N +S+
Sbjct: 35 LSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLAL- 93
Query: 61 EGIFKN 66
G F
Sbjct: 94 -GAFSG 98
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 8e-10
Identities = 17/55 (30%), Positives = 23/55 (41%), Gaps = 1/55 (1%)
Query: 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAG-FKFLQNLNLSHNNF 54
M N F L L+VLD S N++ + L L LNL+ N+F
Sbjct: 501 MSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDF 555
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 4e-09
Identities = 19/83 (22%), Positives = 30/83 (36%), Gaps = 4/83 (4%)
Query: 4 NLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGI 63
F+G S LK LDLS N + FL G + L++L+ H+N + M +
Sbjct: 359 LSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFL-GLEQLEHLDFQHSNLKQMSE-FSV 416
Query: 64 FKNASATSV--FGNNKLCGGIPE 84
F + +
Sbjct: 417 FLSLRNLIYLDISHTHTRVAFNG 439
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 1e-08
Identities = 19/66 (28%), Positives = 28/66 (42%), Gaps = 6/66 (9%)
Query: 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPT 60
M N ++ P L S K LDLS N L F LQ L+LS +++
Sbjct: 15 MELNFYKIPDNLPFS----TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIED- 69
Query: 61 EGIFKN 66
G +++
Sbjct: 70 -GAYQS 74
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 2e-08
Identities = 19/86 (22%), Positives = 29/86 (33%), Gaps = 7/86 (8%)
Query: 4 NLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQN----LNLSHNNFESMIP 59
+ + S L L+ LDLS N + L + L+LS N + P
Sbjct: 135 LIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQP 194
Query: 60 TEGIFKNASATSVF-GNNKLCGGIPE 84
G FK + NN + +
Sbjct: 195 --GAFKEIRLHKLTLRNNFDSLNVMK 218
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 1e-07
Identities = 22/84 (26%), Positives = 31/84 (36%), Gaps = 7/84 (8%)
Query: 4 NLFEGPIGLSLSPLRGLKVLDLSQNNLS--GEIPEFLAGFKFLQNLNLSHNNFESMIPTE 61
+G S L L+ LDLS+N LS G + G L+ L+LS N +M
Sbjct: 333 TSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN- 391
Query: 62 GIFKNASATSV--FGNNKLCGGIP 83
F F ++ L
Sbjct: 392 --FLGLEQLEHLDFQHSNLKQMSE 413
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 6e-06
Identities = 14/88 (15%), Positives = 26/88 (29%), Gaps = 5/88 (5%)
Query: 2 HGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTE 61
+ + + I + L + L + + Q+L L + F
Sbjct: 266 YLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQFPT-- 321
Query: 62 GIFKNASATSVFGNNKLCGGIPEFQLPT 89
K+ F +NK E LP+
Sbjct: 322 LKLKSLK-RLTFTSNKGGNAFSEVDLPS 348
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 5e-05
Identities = 14/68 (20%), Positives = 23/68 (33%), Gaps = 2/68 (2%)
Query: 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPE-FLAGFKFLQNLNLSHNNFESMIP 59
+ N + +R L L L N S + + + G L+ L F +
Sbjct: 184 LSLNPMNFIQPGAFKEIR-LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGN 242
Query: 60 TEGIFKNA 67
E K+A
Sbjct: 243 LEKFDKSA 250
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 5e-04
Identities = 9/54 (16%), Positives = 18/54 (33%), Gaps = 6/54 (11%)
Query: 12 LSLSPLRGLKVLDLSQNNLS------GEIPEFLAGFKFLQNLNLSHNNFESMIP 59
S L GL L + + L+ +I + + + +L E +
Sbjct: 246 FDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD 299
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 1e-11
Identities = 58/223 (26%), Positives = 88/223 (39%), Gaps = 38/223 (17%)
Query: 167 LIGAGNFASVYKGILFEGAPAVAIKVFN---FLHHDASKSFTVECEVMRNIIHRKIIKV- 222
+G G+F V ++ VA+K + D E ++ + H IIK+
Sbjct: 16 TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLY 75
Query: 223 -VTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDV 281
V +V E+ G L ++I + E +
Sbjct: 76 DVITTPTDIV-------MVIEYA-GGELFDYI----------VEKKRMTEDEGRRFFQQI 117
Query: 282 ASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNE-QTSSIGVKGT 340
A+EY H + I H D+KP N+LL+D + +ADFG++ + N +TS G+
Sbjct: 118 ICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC----GS 170
Query: 341 TGYIAPEYGMGHETSSYG----DVYSFGILLLEMFTGLRPSDD 379
Y APE G Y DV+S GI+L M G P DD
Sbjct: 171 PNYAAPEVINGKL---YAGPEVDVWSCGIVLYVMLVGRLPFDD 210
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 1e-11
Identities = 40/161 (24%), Positives = 63/161 (39%), Gaps = 37/161 (22%)
Query: 281 VASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGT 340
+A L +L I + D+K N++L+ E +ADFG+ + T + GT
Sbjct: 130 IAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC--GT 184
Query: 341 TGYIAPE--YGMGHETSSYGDVYSFGILLLEMFTGLRP-----SDDMF----KDNLNLQN 389
YIAPE + S D ++FG+LL EM G P D++F + N+
Sbjct: 185 PDYIAPEIIAYQPYGKSV--DWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK 242
Query: 390 WVQS-------------------ALPERVEEIVDTLFFKEI 411
+ PE +I + FF+ I
Sbjct: 243 SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 283
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 2e-11
Identities = 36/109 (33%), Positives = 54/109 (49%), Gaps = 14/109 (12%)
Query: 281 VASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGT 340
+ SAL +LH I + D+K N+LL+ E +ADFG+ + T++ GT
Sbjct: 133 IISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFC--GT 187
Query: 341 TGYIAPE--YGMGHETSSYGDVYSFGILLLEMFTGLRP-----SDDMFK 382
YIAPE M + + D ++ G+LL EM G P DD+F+
Sbjct: 188 PDYIAPEILQEMLYGPAV--DWWAMGVLLYEMLCGHAPFEAENEDDLFE 234
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 2e-11
Identities = 53/243 (21%), Positives = 90/243 (37%), Gaps = 41/243 (16%)
Query: 150 VSYEALYSATKGFSSENLIGAGNFASVYKGILFEGAPAVAIK-VFNFLHHDASKSFTV-- 206
+ E F E + G G F +V G +VAIK V F
Sbjct: 13 AADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQ------DPRFRNRE 66
Query: 207 --ECEVMRNIIHRKIIKVVTA-CSRVDYQGND-FKALVYEFMPNGSLEEWIHPITEEDKR 262
+ + + H I+++ + + + D + +V E++P + +H R
Sbjct: 67 LQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP-----DTLHRCCRNYYR 121
Query: 263 HKAPGNLNSLERLNIAI---DVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACV--- 316
+ + I + + ++ LHL + H DIKP N+L+N+
Sbjct: 122 RQVA-----PPPILIKVFLFQLIRSIGCLHLPSVN-VCHRDIKPHNVLVNEAD--GTLKL 173
Query: 317 ADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYG---DVYSFGILLLEMFTG 373
DFG A+ L + + I + Y APE G+ Y D++S G + EM G
Sbjct: 174 CDFGSAKKLSPSEPNVAYI---CSRYYRAPELIFGN--QHYTTAVDIWSVGCIFAEMMLG 228
Query: 374 LRP 376
P
Sbjct: 229 -EP 230
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 2e-11
Identities = 60/235 (25%), Positives = 95/235 (40%), Gaps = 56/235 (23%)
Query: 162 FSSENLIGAGNFASVYKGILFEGAPAVAIK-VFNFLHHDASKSFTV-ECEVMRNIIHRKI 219
+++ +IG G+F V++ L E VAIK V K F E ++MR + H +
Sbjct: 42 YTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQD------KRFKNRELQIMRIVKHPNV 94
Query: 220 IKVVTACSRVDYQGNDFKA--LVYEFMPNGSLEEWIHPITEED-KRHKAPGNLNSLERLN 276
+ + A + D LV E++P E R +L
Sbjct: 95 VDLK-AFFYSNGDKKDEVFLNLVLEYVP-------------ETVYRA-----SRHYAKLK 135
Query: 277 IAIDVA----------SALEYLH-LGCKPPIAHCDIKPSNILLNDEMTAC-VADFGIARF 324
+ + +L Y+H +G I H DIKP N+LL+ + DFG A+
Sbjct: 136 QTMPMLLIKLYMYQLLRSLAYIHSIG----ICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191
Query: 325 LEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYG---DVYSFGILLLEMFTGLRP 376
L A S I + Y APE G ++Y D++S G ++ E+ G +P
Sbjct: 192 LIAGEPNVSYI---CSRYYRAPELIFG--ATNYTTNIDIWSTGCVMAELMQG-QP 240
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 2e-11
Identities = 45/157 (28%), Positives = 70/157 (44%), Gaps = 33/157 (21%)
Query: 281 VASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGT 340
+ L++LH I + D+K NILL+ + +ADFG+ + + +T++ GT
Sbjct: 127 IILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC--GT 181
Query: 341 TGYIAPE--YGMGHETSSYGDVYSFGILLLEMFTGLRP-----SDDMFK----DNLNLQN 389
YIAPE G + S D +SFG+LL EM G P +++F DN
Sbjct: 182 PDYIAPEILLGQKYNHS--VDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR 239
Query: 390 WV----QSAL-------PER----VEEIVDTLFFKEI 411
W+ + L PE+ +I F+EI
Sbjct: 240 WLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI 276
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 3e-11
Identities = 50/241 (20%), Positives = 93/241 (38%), Gaps = 42/241 (17%)
Query: 148 PYVSYEALYSATKGFSSENLIGAGNFASVYKGILFEGAPAVAIK-VFNFLHHDASKSFTV 206
P + ++ +++ + IG G + V VAIK + F H +
Sbjct: 15 PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR 74
Query: 207 ECEVMRNIIHRKIIK---VVTACSRVDYQGNDFKALVYEFMPNGSLEEWIH--PITEEDK 261
E +++ H II ++ A + D +V + M L + + ++ +
Sbjct: 75 EIKILLRFRHENIIGINDIIRAPTIEQM--KDV-YIVQDLMET-DLYKLLKTQHLSNDHI 130
Query: 262 RHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGI 321
+ + L+Y+H + H D+KPSN+LLN + DFG+
Sbjct: 131 CY-------------FLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGL 174
Query: 322 ARFLEATNEQTSSIGVKGTTGYI------APEYGMGHETSSYG---DVYSFGILLLEMFT 372
AR + ++ T + T Y+ APE + + Y D++S G +L EM +
Sbjct: 175 ARVADPDHDHTGFL-----TEYVATRWYRAPEIMLN--SKGYTKSIDIWSVGCILAEMLS 227
Query: 373 G 373
Sbjct: 228 N 228
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 6e-11
Identities = 32/98 (32%), Positives = 50/98 (51%), Gaps = 9/98 (9%)
Query: 281 VASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGT 340
++ AL YLH + I + D+K N+LL+ E + D+G+ + + TS+ GT
Sbjct: 119 ISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC--GT 173
Query: 341 TGYIAPE--YGMGHETSSYGDVYSFGILLLEMFTGLRP 376
YIAPE G + S D ++ G+L+ EM G P
Sbjct: 174 PNYIAPEILRGEDYGFSV--DWWALGVLMFEMMAGRSP 209
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 6e-11
Identities = 53/222 (23%), Positives = 85/222 (38%), Gaps = 29/222 (13%)
Query: 168 IGAGNFASVYKGILFEGAPA--VAIKVFNFLHHDASKSFTVECEV--MRNIIHRKIIKVV 223
+G G + VYK +G A+K S + E+ +R + H +I +
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIE----GTGISMSACREIALLRELKHPNVISLQ 84
Query: 224 TACSRVDYQGNDFKA-LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVA 282
+V D K L++++ + L I K +K P L ++ +
Sbjct: 85 ----KVFLSHADRKVWLLFDYAEH-DLWHIIKFHRAS-KANKKPVQLPRGMVKSLLYQIL 138
Query: 283 SALEYLHLGCKPPIAHCDIKPSNILLNDEMTAC----VADFGIAR-FLEATNEQTSSIGV 337
+ YLH + H D+KP+NIL+ E +AD G AR F V
Sbjct: 139 DGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 195
Query: 338 KGTTGYIAPEYGMGHETSSYG---DVYSFGILLLEMFTGLRP 376
T Y APE +G Y D+++ G + E+ T P
Sbjct: 196 VVTFWYRAPELLLGARH--YTKAIDIWAIGCIFAELLTS-EP 234
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 8e-11
Identities = 49/228 (21%), Positives = 95/228 (41%), Gaps = 42/228 (18%)
Query: 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIK-VFNFLHH--DASKSFTVECEVMRNII 215
+ + + + +G+G + SV + VA+K + A +++ E +++++
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK 86
Query: 216 HRKIIK---VVTACSRVDYQGNDFKA--LVYEFMPNGSLEEWIH--PITEEDKRHKAPGN 268
H +I V T ++ +F LV M L + +T++ +
Sbjct: 87 HENVIGLLDVFTPARSLE----EFNDVYLVTHLMGA-DLNNIVKCQKLTDDHVQF----- 136
Query: 269 LNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEAT 328
+ + L+Y+H I H D+KPSN+ +N++ + DFG+AR
Sbjct: 137 --------LIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR--HTA 183
Query: 329 NEQTSSIGVKGTTGYIAPEYGMGHETSSYG---DVYSFGILLLEMFTG 373
+E T + T Y APE + Y D++S G ++ E+ TG
Sbjct: 184 DEMTGYV---ATRWYRAPEIMLNW--MHYNQTVDIWSVGCIMAELLTG 226
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 9e-11
Identities = 22/91 (24%), Positives = 33/91 (36%), Gaps = 6/91 (6%)
Query: 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPT 60
+ N F+ L LK++DL NNL+ L++LNL N S+
Sbjct: 543 LESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKK 602
Query: 61 --EGIFKNASATSVFGNNKL---CGGIPEFQ 86
F+N + + N C I F
Sbjct: 603 VFGPAFRNLTELDM-RFNPFDCTCESIAWFV 632
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 3e-10
Identities = 12/67 (17%), Positives = 21/67 (31%), Gaps = 1/67 (1%)
Query: 1 MHGNLFEGPI-GLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIP 59
+ N + G L + + LS N A LQ L L +++
Sbjct: 412 LGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDS 471
Query: 60 TEGIFKN 66
+ F+
Sbjct: 472 SPSPFQP 478
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 8e-10
Identities = 15/85 (17%), Positives = 31/85 (36%), Gaps = 4/85 (4%)
Query: 4 NLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGI 63
S L+ L+ L++ N++ G G L+ L+LS++ T
Sbjct: 315 ASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNET 374
Query: 64 FKNASATSV----FGNNKLCGGIPE 84
F + + + + NK+ +
Sbjct: 375 FVSLAHSPLHILNLTKNKISKIESD 399
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 9e-10
Identities = 15/66 (22%), Positives = 22/66 (33%), Gaps = 2/66 (3%)
Query: 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPT 60
+ N + + L LD+ N +S PE L+ LNL HN +
Sbjct: 32 LTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSD- 90
Query: 61 EGIFKN 66
F
Sbjct: 91 -KTFAF 95
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 1e-09
Identities = 18/86 (20%), Positives = 25/86 (29%), Gaps = 4/86 (4%)
Query: 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPT 60
+ N + + L L L N++ K L L+LSHN S
Sbjct: 80 LQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKL- 138
Query: 61 EGIFKNASATSV--FGNNKLCGGIPE 84
G NNK+ E
Sbjct: 139 -GTQVQLENLQELLLSNNKIQALKSE 163
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 2e-09
Identities = 17/93 (18%), Positives = 29/93 (31%), Gaps = 6/93 (6%)
Query: 1 MHGNLFEGPIGLSLSPLRG--LKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMI 58
+ + + L+ L +LDLS NNL+ + A L+ L +NN + +
Sbjct: 229 LSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLF 288
Query: 59 PTEGIFKNASATSV--FGNNKLCGGIPEFQLPT 89
+ I LP
Sbjct: 289 S--HSLHGLFNVRYLNLKRSFTKQSISLASLPK 319
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 3e-09
Identities = 17/90 (18%), Positives = 30/90 (33%), Gaps = 7/90 (7%)
Query: 1 MHGNLFEG--PIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMI 58
+ N + L + LK L+LS N + P L L L++ +
Sbjct: 152 LSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSL 211
Query: 59 PTEGIFKNASATSV----FGNNKLCGGIPE 84
E + + TS+ N++L
Sbjct: 212 T-EKLCLELANTSIRNLSLSNSQLSTTSNT 240
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 4e-09
Identities = 14/68 (20%), Positives = 24/68 (35%), Gaps = 2/68 (2%)
Query: 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPT 60
+ + G L L L +L+L N E L+ ++L NN ++
Sbjct: 519 LWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPA- 577
Query: 61 EGIFKNAS 68
+F N
Sbjct: 578 -SVFNNQV 584
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 5e-09
Identities = 14/67 (20%), Positives = 26/67 (38%), Gaps = 1/67 (1%)
Query: 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPE-FLAGFKFLQNLNLSHNNFESMIP 59
+ N + LK L+L +N ++ + F F+ L L++ N F+
Sbjct: 567 LGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCE 626
Query: 60 TEGIFKN 66
+ F N
Sbjct: 627 SIAWFVN 633
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 5e-09
Identities = 22/86 (25%), Positives = 35/86 (40%), Gaps = 2/86 (2%)
Query: 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPT 60
+ N + + L LDLS N LS + LQ L LS+N +++
Sbjct: 104 LMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSE 163
Query: 61 E-GIFKNASATSV-FGNNKLCGGIPE 84
E IF N+S + +N++ P
Sbjct: 164 ELDIFANSSLKKLELSSNQIKEFSPG 189
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 7e-09
Identities = 18/61 (29%), Positives = 28/61 (45%), Gaps = 2/61 (3%)
Query: 1 MHGNLFEGPIGL--SLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMI 58
+ + PLR L +LDLS NN++ + L G + L+ L+L HNN +
Sbjct: 461 LRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLW 520
Query: 59 P 59
Sbjct: 521 K 521
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 1e-08
Identities = 25/95 (26%), Positives = 34/95 (35%), Gaps = 12/95 (12%)
Query: 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLS--------GEIPEFLAGFKFLQNLNLSHN 52
+ N L L L++LDL NNL+ G FL G L LNL N
Sbjct: 487 LSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESN 546
Query: 53 NFESMIPTEGIFKNASATSV--FGNNKLCGGIPEF 85
F+ + +FK+ + G N L
Sbjct: 547 GFDEIPV--EVFKDLFELKIIDLGLNNLNTLPASV 579
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 1e-08
Identities = 16/66 (24%), Positives = 23/66 (34%), Gaps = 2/66 (3%)
Query: 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPT 60
+ N L LKVL+L N LS + A L L+L N+ + +
Sbjct: 56 VGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKN- 114
Query: 61 EGIFKN 66
F
Sbjct: 115 -NPFVK 119
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 5e-08
Identities = 16/81 (19%), Positives = 28/81 (34%), Gaps = 5/81 (6%)
Query: 3 GNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIP-EFLAGFKFLQNLNLSHNNFESMIPTE 61
N + S L L+VLDL N + E+ + G + + + LS+N + +
Sbjct: 390 KNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTR-- 447
Query: 62 GIFKNASATSV--FGNNKLCG 80
F + L
Sbjct: 448 NSFALVPSLQRLMLRRVALKN 468
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 1e-07
Identities = 11/65 (16%), Positives = 23/65 (35%), Gaps = 3/65 (4%)
Query: 16 PLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSV--F 73
L +L+L++N +S + + L+ L+L N + ++
Sbjct: 379 AHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELT-GQEWRGLENIFEIYL 437
Query: 74 GNNKL 78
NK
Sbjct: 438 SYNKY 442
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 3e-07
Identities = 13/66 (19%), Positives = 24/66 (36%), Gaps = 6/66 (9%)
Query: 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPT 60
H L + P L + VL+L+ N L + L +L++ N + P
Sbjct: 12 SHLKLTQVPDDL----PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEP- 66
Query: 61 EGIFKN 66
+ +
Sbjct: 67 -ELCQK 71
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 1e-06
Identities = 19/89 (21%), Positives = 26/89 (29%), Gaps = 8/89 (8%)
Query: 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLA----GFKFLQNLNLSHNNFES 56
M N G + L LK L LS + S L LNL+ N
Sbjct: 336 MEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISK 395
Query: 57 MIPTEGIFKNASATSV--FGNNKLCGGIP 83
+ F V G N++ +
Sbjct: 396 IES--DAFSWLGHLEVLDLGLNEIGQELT 422
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 3e-06
Identities = 16/90 (17%), Positives = 27/90 (30%), Gaps = 9/90 (10%)
Query: 1 MHGNLFEGPIGLSLS---PLRGLKVLDLSQNNLSGEIPEFLAGFKF--LQNLNLSHNNFE 55
++ + L ++ L LS + LS G K+ L L+LS+NN
Sbjct: 202 LNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLN 261
Query: 56 SMIPTEGIFKNASATSV--FGNNKLCGGIP 83
+ F N +
Sbjct: 262 VVGN--DSFAWLPQLEYFFLEYNNIQHLFS 289
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 6e-06
Identities = 13/75 (17%), Positives = 27/75 (36%), Gaps = 11/75 (14%)
Query: 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQN---------NLSGEIPEFLAGFKFLQNLNLSH 51
+ N + SL L ++ L+L ++ +L K L++LN+
Sbjct: 279 LEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMED 338
Query: 52 NNFESMIPTEGIFKN 66
N+ + +F
Sbjct: 339 NDIPGIKS--NMFTG 351
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 5e-04
Identities = 12/47 (25%), Positives = 20/47 (42%), Gaps = 5/47 (10%)
Query: 20 LKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKN 66
+V D S L+ ++P+ L + LNL+HN + F
Sbjct: 6 HEVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAAN--FTR 47
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 9e-11
Identities = 51/245 (20%), Positives = 86/245 (35%), Gaps = 78/245 (31%)
Query: 168 IGAGNFASVYKG-------------ILF----EGAPAVA---IKVFNFLHHDASKSFTVE 207
IG G F V+K +L EG P A IK+ L H
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH--------- 75
Query: 208 CEVMRNIIHRKIIKVVTACSRVDYQGNDFKALVYEFMPN---GSLEEWIHPITEEDKRHK 264
N++ +I++ + + LV++F + G L + T + +
Sbjct: 76 ----ENVV--NLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKR- 128
Query: 265 APGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARF 324
+ + + L Y+H + I H D+K +N+L+ + +ADFG+AR
Sbjct: 129 ------------VMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARA 173
Query: 325 LEATNEQTSSIGVKGTTG----------YIAPEYGMGHETSSYG---DVYSFGILLLEMF 371
S+ Y PE +G YG D++ G ++ EM+
Sbjct: 174 F--------SLAKNSQPNRYTNRVVTLWYRPPELLLGERD--YGPPIDLWGAGCIMAEMW 223
Query: 372 TGLRP 376
T P
Sbjct: 224 TR-SP 227
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 9e-11
Identities = 54/222 (24%), Positives = 78/222 (35%), Gaps = 37/222 (16%)
Query: 167 LIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKV--VT 224
IG+GNF VA+K E R++ H I++ V
Sbjct: 27 DIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQR-EIINHRSLRHPNIVRFKEVI 85
Query: 225 ACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASA 284
++ E+ G L E I G + E + S
Sbjct: 86 LTPTHLA-------IIMEYASGGELYERI----------CNAGRFSEDEARFFFQQLLSG 128
Query: 285 LEYLHLGCKPPIAHCDIKPSNILLNDEMTAC---VADFGIARFLEATNEQTSSIGVKGTT 341
+ Y H I H D+K N LL D A + DFG ++ ++ S++ GT
Sbjct: 129 VSYCH---SMQICHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTV---GTP 181
Query: 342 GYIAPEYGMGHETSSYG----DVYSFGILLLEMFTGLRPSDD 379
YIAPE + E Y DV+S G+ L M G P +D
Sbjct: 182 AYIAPEVLLRQE---YDGKIADVWSCGVTLYVMLVGAYPFED 220
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 1e-10
Identities = 43/239 (17%), Positives = 86/239 (35%), Gaps = 52/239 (21%)
Query: 162 FSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH-DASKSFTVECEVMRNIIHRKII 220
+ +G G V+ + + VAIK + E +++R + H I+
Sbjct: 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR-EIKIIRRLDHDNIV 71
Query: 221 K---VVTACSRVDYQG----NDFKA--LVYEFMPNGSLEEWIH--PITEEDKRHKAPGNL 269
K ++ + + +V E+M L + P+ EE R
Sbjct: 72 KVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQGPLLEEHARL------ 124
Query: 270 NSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTAC---VADFGIARFLE 326
+ L+Y+H + H D+KP+N+ +N E + DFG+AR ++
Sbjct: 125 -------FMYQLLRGLKYIHSA---NVLHRDLKPANLFINTE--DLVLKIGDFGLARIMD 172
Query: 327 ATNEQTSSIGVKGTTGYI------APEYGMGHETSSYG---DVYSFGILLLEMFTGLRP 376
+ + + +P + ++Y D+++ G + EM TG +
Sbjct: 173 PHYSHKGHL-----SEGLVTKWYRSPRLLLS--PNNYTKAIDMWAAGCIFAEMLTG-KT 223
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 1e-10
Identities = 32/98 (32%), Positives = 50/98 (51%), Gaps = 9/98 (9%)
Query: 281 VASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGT 340
++ AL YLH + I + D+K N+LL+ E + D+G+ + + TS+ GT
Sbjct: 162 ISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC--GT 216
Query: 341 TGYIAPE--YGMGHETSSYGDVYSFGILLLEMFTGLRP 376
YIAPE G + S D ++ G+L+ EM G P
Sbjct: 217 PNYIAPEILRGEDYGFSV--DWWALGVLMFEMMAGRSP 252
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 1e-10
Identities = 52/215 (24%), Positives = 92/215 (42%), Gaps = 34/215 (15%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIK-VFN-FLHHDASKSFTVECEVMRNIIHRKIIKVVTA 225
+G+G + +V + VAIK ++ F +K E +++++ H +I ++
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 92
Query: 226 CSRVDYQGNDFKA--LVYEFMPNGSLEEWIH--PITEEDKRHKAPGNLNSLERLNIAIDV 281
D +DF LV FM L + + + E+ + + +
Sbjct: 93 -FTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEKLGEDRIQF-------------LVYQM 137
Query: 282 ASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTT 341
L Y+H I H D+KP N+ +N++ + DFG+AR +A +E T + T
Sbjct: 138 LKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR--QADSEMTGYV---VTR 189
Query: 342 GYIAPEYGMGHETSSYG---DVYSFGILLLEMFTG 373
Y APE + Y D++S G ++ EM TG
Sbjct: 190 WYRAPEVILNW--MRYTQTVDIWSVGCIMAEMITG 222
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 1e-10
Identities = 52/244 (21%), Positives = 97/244 (39%), Gaps = 40/244 (16%)
Query: 150 VSYEALYSATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFN-FLHHDASKSFTVEC 208
+ +Y+ + F ++L+G G + V VAIK F + E
Sbjct: 1 MPKRIVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREI 60
Query: 209 EVMRNIIHRKIIK---VVTACSRVDYQGNDFKALVYEFMPNGSLEEWIH--PITEEDKRH 263
+++++ H II + S ++ N+ ++ E M L I ++++ ++
Sbjct: 61 KILKHFKHENIITIFNIQRPDSFENF--NEV-YIIQELMQT-DLHRVISTQMLSDDHIQY 116
Query: 264 KAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIAR 323
A++ LH + H D+KPSN+L+N V DFG+AR
Sbjct: 117 -------------FIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLAR 160
Query: 324 FLEATNEQTSSIGVKGT--TGYI------APEYGMGHETSSYG---DVYSFGILLLEMFT 372
++ + S + + ++ APE + + Y DV+S G +L E+F
Sbjct: 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTS--AKYSRAMDVWSCGCILAELFL 218
Query: 373 GLRP 376
RP
Sbjct: 219 R-RP 221
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 63.9 bits (155), Expect = 1e-10
Identities = 41/164 (25%), Positives = 65/164 (39%), Gaps = 37/164 (22%)
Query: 278 AIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGV 337
A ++A L +L I + D+K N++L+ E +ADFG+ + T +
Sbjct: 448 AAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC- 503
Query: 338 KGTTGYIAPE--YGMGHETSSYGDVYSFGILLLEMFTGLRP-----SDDMF----KDNLN 386
GT YIAPE + S D ++FG+LL EM G P D++F + N+
Sbjct: 504 -GTPDYIAPEIIAYQPYGKSV--DWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA 560
Query: 387 LQNWVQS-------------------ALPERVEEIVDTLFFKEI 411
+ PE +I + FF+ I
Sbjct: 561 YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 604
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 29/100 (29%), Positives = 47/100 (47%), Gaps = 8/100 (8%)
Query: 277 IAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTAC--VADFGIARFLEATNEQTSS 334
A + +AL +L + I HCD+KP NILL + + + DFG + ++
Sbjct: 162 FAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ---LGQRIYQ 217
Query: 335 IGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGL 374
+ Y +PE +G D++S G +L+EM TG
Sbjct: 218 YIQ--SRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 52/256 (20%), Positives = 93/256 (36%), Gaps = 59/256 (23%)
Query: 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIK-VFNFLHHDASKSFTV-ECEVMRNIIH 216
+K +S +G G+F V + E A+K V + E ++M+ + H
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQD------PRYKNRELDIMKVLDH 59
Query: 217 RKIIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLN 276
IIK+V + + P+ + + N + + LN
Sbjct: 60 VNIIKLVDY-----FYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLN 114
Query: 277 IAID-------------------------------VASALEYLH-LGCKPPIAHCDIKPS 304
+ ++ + A+ ++H LG I H DIKP
Sbjct: 115 VIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG----ICHRDIKPQ 170
Query: 305 NILLNDEMTAC-VADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYG---DV 360
N+L+N + + DFG A+ L + + I + Y APE +G + Y D+
Sbjct: 171 NLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYI---CSRFYRAPELMLG--ATEYTPSIDL 225
Query: 361 YSFGILLLEMFTGLRP 376
+S G + E+ G +P
Sbjct: 226 WSIGCVFGELILG-KP 240
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 31/100 (31%), Positives = 48/100 (48%), Gaps = 10/100 (10%)
Query: 277 IAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTA--CVADFGIARFLEATNEQTSS 334
A + L+ LH K I HCD+KP NILL + + V DFG + + +++ +
Sbjct: 205 FAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE---HQRVYT 258
Query: 335 IGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGL 374
+ Y APE +G D++S G +L E+ TG
Sbjct: 259 YIQ--SRFYRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 4e-10
Identities = 51/246 (20%), Positives = 85/246 (34%), Gaps = 47/246 (19%)
Query: 149 YVSYEALYSATKGFSSENLIGAGNFASVYKGILFEGAPAVAIK--VFNFLHHDASKSFTV 206
L++ ++ + I +G++ +V G+ EG P VAIK +
Sbjct: 11 RDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIP-VAIKRVFNTVSDGRTVNILSD 69
Query: 207 ---------ECEVMRNIIHRKIIK---VVTACSRVDYQGNDFKALVYEFMPNGSLEEWIH 254
E ++ + H I+ + + LV E M L + IH
Sbjct: 70 SFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAM--HKL-YLVTELMRT-DLAQVIH 125
Query: 255 ----PITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLND 310
I+ + ++ + L LH + H D+ P NILL D
Sbjct: 126 DQRIVISPQHIQY-------------FMYHILLGLHVLHEAG---VVHRDLHPGNILLAD 169
Query: 311 EMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYG---DVYSFGILL 367
+ DF +AR A +T + Y APE M + D++S G ++
Sbjct: 170 NNDITICDFNLAREDTADANKTHYV---THRWYRAPELVMQF--KGFTKLVDMWSAGCVM 224
Query: 368 LEMFTG 373
EMF
Sbjct: 225 AEMFNR 230
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 6e-10
Identities = 17/67 (25%), Positives = 28/67 (41%), Gaps = 1/67 (1%)
Query: 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEI-PEFLAGFKFLQNLNLSHNNFESMIP 59
+ N FE +S S L L + N E+ L + L+ L+LSH++ E+
Sbjct: 308 LSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDC 367
Query: 60 TEGIFKN 66
+N
Sbjct: 368 CNLQLRN 374
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 2e-09
Identities = 20/89 (22%), Positives = 33/89 (37%), Gaps = 6/89 (6%)
Query: 1 MHGNLFEGPIGL---SLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESM 57
+ GN F SL L L++L LS +LS K + +++LSHN S
Sbjct: 456 LQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSS 515
Query: 58 IPTEGIFKNASATSVF-GNNKLCGGIPEF 85
+ + +N + +P
Sbjct: 516 SI--EALSHLKGIYLNLASNHISIILPSL 542
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 9e-09
Identities = 15/66 (22%), Positives = 23/66 (34%), Gaps = 2/66 (3%)
Query: 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPT 60
+ N +LS + LK L Q +S L K L++L L N+ S+
Sbjct: 88 LTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKL- 146
Query: 61 EGIFKN 66
Sbjct: 147 -PKGFP 151
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 6e-08
Identities = 20/64 (31%), Positives = 29/64 (45%), Gaps = 3/64 (4%)
Query: 3 GNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEG 62
+ F + GL+ LDL+ +LS E+P L G L+ L LS N FE++
Sbjct: 263 KHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQ--I 319
Query: 63 IFKN 66
N
Sbjct: 320 SASN 323
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 8e-08
Identities = 14/54 (25%), Positives = 20/54 (37%), Gaps = 1/54 (1%)
Query: 13 SLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKN 66
L L LK L LS N + F L +L++ N + G +N
Sbjct: 296 GLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELG-TGCLEN 348
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 1e-07
Identities = 16/57 (28%), Positives = 22/57 (38%), Gaps = 1/57 (1%)
Query: 13 SLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIP-TEGIFKNAS 68
L LKVL+LS + L + G LQ+LNL N+F +
Sbjct: 420 PFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLG 476
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 1e-07
Identities = 14/59 (23%), Positives = 22/59 (37%), Gaps = 1/59 (1%)
Query: 8 GPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKN 66
L L L L+ L+LS N E L+ L+L+ + + F+N
Sbjct: 366 DCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDA-QSPFQN 423
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 2e-07
Identities = 12/66 (18%), Positives = 19/66 (28%), Gaps = 2/66 (3%)
Query: 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPT 60
N+ + S L L LDL++ + + L L L+ N M
Sbjct: 40 FSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAE- 98
Query: 61 EGIFKN 66
Sbjct: 99 -TALSG 103
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 3e-07
Identities = 12/65 (18%), Positives = 18/65 (27%), Gaps = 2/65 (3%)
Query: 2 HGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTE 61
+ L L L+ N L L+G K L++L S+
Sbjct: 65 TRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDF-- 122
Query: 62 GIFKN 66
N
Sbjct: 123 IPLHN 127
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 1e-06
Identities = 26/129 (20%), Positives = 44/129 (34%), Gaps = 9/129 (6%)
Query: 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQN--LNLSHNNFESMI 58
+ N P LKVLD N + E ++ + N LNL+ N+ +
Sbjct: 136 LGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIE 195
Query: 59 PTEGIFKNASATSV-FGNNKL----CGGIPEFQLPTCVSKKTKQNRSTLPLKLVIAIDCG 113
P G F +A S+ FG + G+ + + + V C
Sbjct: 196 P--GAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCE 253
Query: 114 LLVLTLALS 122
+ V ++ L
Sbjct: 254 MSVESINLQ 262
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 2e-06
Identities = 22/69 (31%), Positives = 31/69 (44%), Gaps = 5/69 (7%)
Query: 1 MHGNLFEGPIGL-SLSPLRGLKVLDLSQNNL--SGEIPEFLAGFKFLQNLNLSHNNFESM 57
+ GN +G L L L+ LDLS +++ S L LQ+LNLS+N S+
Sbjct: 332 IKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSL 391
Query: 58 IPTEGIFKN 66
FK
Sbjct: 392 KT--EAFKE 398
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 3e-06
Identities = 13/67 (19%), Positives = 24/67 (35%), Gaps = 3/67 (4%)
Query: 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPE-FLAGFKFLQNLNLSHNNFESMIP 59
+ N + L++LDL+ L + + L+ LNLSH+ +
Sbjct: 383 LSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSE 442
Query: 60 TEGIFKN 66
+F
Sbjct: 443 --QLFDG 447
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 3e-06
Identities = 9/59 (15%), Positives = 19/59 (32%)
Query: 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIP 59
+ L + L+ L L N++S + L+ L+ +N +
Sbjct: 112 FIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSK 170
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 5e-06
Identities = 13/66 (19%), Positives = 22/66 (33%), Gaps = 6/66 (9%)
Query: 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPT 60
+ L E P L S + L+ S N L + L L+L+ +
Sbjct: 20 ENLGLNEIPGTLPNS----TECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHE- 74
Query: 61 EGIFKN 66
F++
Sbjct: 75 -DTFQS 79
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 8e-06
Identities = 14/55 (25%), Positives = 26/55 (47%), Gaps = 1/55 (1%)
Query: 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFE 55
+ N +LS L+G+ L+L+ N++S +P L + +NL N +
Sbjct: 507 LSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLD 560
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 5e-05
Identities = 8/59 (13%), Positives = 18/59 (30%), Gaps = 2/59 (3%)
Query: 1 MHGNLFEGPIGLSLSPLRG--LKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESM 57
E L ++ ++L ++ F LQ L+L+ + +
Sbjct: 235 FEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSEL 293
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 1e-04
Identities = 12/65 (18%), Positives = 23/65 (35%), Gaps = 4/65 (6%)
Query: 4 NLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKF--LQNLNLSHNNFESMIPTE 61
NL GL S ++ L + + P G ++++NL + F ++
Sbjct: 214 NLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISS-- 271
Query: 62 GIFKN 66
F
Sbjct: 272 NTFHC 276
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 60.2 bits (147), Expect = 6e-10
Identities = 48/223 (21%), Positives = 87/223 (39%), Gaps = 33/223 (14%)
Query: 162 FSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTV--ECEVMRNIIHRKI 219
+ IG G + +V+K E VA+K D + E +++ + H+ I
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 220 IK---VVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLN 276
++ V+ + ++ LV+EF L+++ G+L+ +
Sbjct: 64 VRLHDVLHSDKKL-T-------LVFEFCDQ-DLKKYFD---------SCNGDLDPEIVKS 105
Query: 277 IAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIG 336
+ L + H + H D+KP N+L+N +A+FG+AR S+
Sbjct: 106 FLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEV 162
Query: 337 VKGTTGYIAPEYGMGHETSSYG---DVYSFGILLLEMFTGLRP 376
V T Y P+ G Y D++S G + E+ RP
Sbjct: 163 V--TLWYRPPDVLFG--AKLYSTSIDMWSAGCIFAELANAGRP 201
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 61.4 bits (149), Expect = 1e-09
Identities = 15/63 (23%), Positives = 26/63 (41%)
Query: 4 NLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGI 63
LS S L+ L ++L ++P+FL LQ+LN++ N S +
Sbjct: 477 AKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKAD 536
Query: 64 FKN 66
+
Sbjct: 537 WTR 539
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 1e-09
Identities = 24/87 (27%), Positives = 31/87 (35%), Gaps = 8/87 (9%)
Query: 1 MHGNLFEG-PIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIP 59
M N E P SL + L +LD N + + F L +L L +N E IP
Sbjct: 555 MGYNNLEEFPASASLQKMVKLGLLDCVHNKVR-HLEAF-GTNVKLTDLKLDYNQIEE-IP 611
Query: 60 TEGIFKNASATSVF--GNNKLCGGIPE 84
E +NKL IP
Sbjct: 612 -EDFCAFTDQVEGLGFSHNKL-KYIPN 636
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 58.3 bits (141), Expect = 8e-09
Identities = 11/84 (13%), Positives = 29/84 (34%)
Query: 4 NLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGI 63
+++ G+ L + L L+ G +P+ + L+ L+ ++ G
Sbjct: 309 DMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGD 368
Query: 64 FKNASATSVFGNNKLCGGIPEFQL 87
+ S +++ + L
Sbjct: 369 EELTPDMSEERKHRIRMHYKKMFL 392
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 55.7 bits (134), Expect = 6e-08
Identities = 13/97 (13%), Positives = 30/97 (30%), Gaps = 13/97 (13%)
Query: 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSG---------EIPEFLAGFKFLQNLNLSH 51
++ + L L L+ L+++ N + + +Q + +
Sbjct: 498 LYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGY 557
Query: 52 NNFESMIPTEGIFKNASATSVF--GNNKLCGGIPEFQ 86
NN E P + + +NK+ + F
Sbjct: 558 NNLEE-FPASASLQKMVKLGLLDCVHNKV-RHLEAFG 592
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 55.3 bits (133), Expect = 7e-08
Identities = 17/91 (18%), Positives = 28/91 (30%), Gaps = 11/91 (12%)
Query: 2 HGNLFEG-PIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKF-----LQNLNLSHNNFE 55
N + P + + + +D S N + E + LS+N +
Sbjct: 627 SHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQ 686
Query: 56 SMIPTEGIFKNASATSV--FGNNKLCGGIPE 84
+F S S NN + IPE
Sbjct: 687 KFPT--ELFATGSPISTIILSNNLM-TSIPE 714
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 1e-07
Identities = 14/84 (16%), Positives = 27/84 (32%), Gaps = 6/84 (7%)
Query: 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPT 60
GN ++ L L + N++ ++ E L L L+++ N S+ T
Sbjct: 789 AEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKL--TPQLYILDIADNPNISIDVT 845
Query: 61 EGIFKNASATSVF---GNNKLCGG 81
+ V + G
Sbjct: 846 SVCPYIEAGMYVLLYDKTQDIRGC 869
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 54.1 bits (130), Expect = 2e-07
Identities = 11/55 (20%), Positives = 17/55 (30%), Gaps = 1/55 (1%)
Query: 7 EGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTE 61
+ + LS N + E A + + LS+N S IP
Sbjct: 662 NISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTS-IPEN 715
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 1e-06
Identities = 17/97 (17%), Positives = 27/97 (27%), Gaps = 13/97 (13%)
Query: 1 MHGNLFEG-PIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSH------NN 53
+ N + L L +D+S N S P L+ + H N
Sbjct: 735 LRFNKLTSLSDDFRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAEGNR 793
Query: 54 FESMIPTEGIFKNASATSVF--GNNKLCGGIPEFQLP 88
PT + G+N + + E P
Sbjct: 794 ILRQWPTG--ITTCPSLIQLQIGSNDI-RKVDEKLTP 827
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 12/71 (16%), Positives = 23/71 (32%), Gaps = 7/71 (9%)
Query: 1 MHGNLFEG-PIGL-SLSPLRGLKV---LDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFE 55
+ N F P + S L+ + D N + + P + L L + N+
Sbjct: 760 VSYNCFSSFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR 819
Query: 56 SMIPTEGIFKN 66
+ E +
Sbjct: 820 K-VD-EKLTPQ 828
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 2e-06
Identities = 8/73 (10%), Positives = 19/73 (26%), Gaps = 8/73 (10%)
Query: 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLS-------GEIPEFLAGFKFLQNLNLSHNN 53
+ N + + + + LS N ++ L ++L N
Sbjct: 680 LSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNK 739
Query: 54 FESMIPTEGIFKN 66
S + +
Sbjct: 740 LTS-LSDDFRATT 751
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 4e-06
Identities = 20/75 (26%), Positives = 28/75 (37%), Gaps = 6/75 (8%)
Query: 13 SLSPLRGLKVLDLSQNNLSGEIP-EFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATS 71
+ L L L N + EIP +F A ++ L SHN + IP K+
Sbjct: 590 AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKY-IPNIFNAKSVYVMG 647
Query: 72 V--FGNNKLCGGIPE 84
F NK+ G
Sbjct: 648 SVDFSYNKI-GSEGR 661
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 46.4 bits (110), Expect = 4e-05
Identities = 4/49 (8%), Positives = 13/49 (26%)
Query: 13 SLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTE 61
+ + + + K L ++ L + + +P
Sbjct: 462 YDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDF 510
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 1e-09
Identities = 16/80 (20%), Positives = 27/80 (33%), Gaps = 4/80 (5%)
Query: 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPT 60
+ E L L++L++S NNL L L+ S N E+
Sbjct: 480 LSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKG- 538
Query: 61 EGIFKNASATSVF--GNNKL 78
+ + + F NN +
Sbjct: 539 -ILQHFPKSLAFFNLTNNSV 557
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 1e-08
Identities = 14/69 (20%), Positives = 24/69 (34%), Gaps = 2/69 (2%)
Query: 1 MHGNLFEGPIGLS-LSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIP 59
+ + S L L LD+S N + G L L ++ N+F+
Sbjct: 406 FQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTL 465
Query: 60 TEGIFKNAS 68
+F N +
Sbjct: 466 -SNVFANTT 473
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 1e-08
Identities = 18/70 (25%), Positives = 26/70 (37%), Gaps = 3/70 (4%)
Query: 1 MHGNLF-EGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIP 59
M GN F + + + L LDLS+ L LQ LN+SHNN +
Sbjct: 455 MAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDS 514
Query: 60 TEGIFKNASA 69
+ +
Sbjct: 515 --SHYNQLYS 522
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 2e-08
Identities = 18/66 (27%), Positives = 26/66 (39%), Gaps = 2/66 (3%)
Query: 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPT 60
+ N + S S L+ LDLS+ + + G L NL L+ N +S P
Sbjct: 39 LSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSP- 97
Query: 61 EGIFKN 66
G F
Sbjct: 98 -GSFSG 102
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 3e-08
Identities = 13/56 (23%), Positives = 18/56 (32%)
Query: 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFES 56
M N + L L LD S N + K L NL++N+
Sbjct: 504 MSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVAC 559
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 4e-08
Identities = 16/66 (24%), Positives = 25/66 (37%), Gaps = 1/66 (1%)
Query: 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPT 60
+ GN + S S L L+ L + L+ + L+ LN++HN S
Sbjct: 87 LTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHS-CKL 145
Query: 61 EGIFKN 66
F N
Sbjct: 146 PAYFSN 151
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 1e-07
Identities = 12/66 (18%), Positives = 19/66 (28%), Gaps = 2/66 (3%)
Query: 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPT 60
+ E + L L L L+ N + P +G L+NL S+
Sbjct: 63 LSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLES- 121
Query: 61 EGIFKN 66
Sbjct: 122 -FPIGQ 126
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 2e-06
Identities = 17/135 (12%), Positives = 36/135 (26%), Gaps = 16/135 (11%)
Query: 4 NLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQN----LNLSHNNFESMIP 59
+ + S L L +DLS N + L + L++S N + +
Sbjct: 139 FIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQD 198
Query: 60 TEGIFKNASATSV-FGNNKLCGGIPEFQLPTCVSKKTKQ---------NRSTLPLKLVIA 109
F+ + N I + L + + ++
Sbjct: 199 --QAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIME 256
Query: 110 IDCGLLVLTLALSSL 124
C + + L+
Sbjct: 257 GLCDVTIDEFRLTYT 271
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 5e-06
Identities = 17/66 (25%), Positives = 25/66 (37%), Gaps = 6/66 (9%)
Query: 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPT 60
M L + P + S K +DLS N L + F LQ L+LS E++
Sbjct: 19 MDQKLSKVPDDIPSS----TKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIED- 73
Query: 61 EGIFKN 66
+
Sbjct: 74 -KAWHG 78
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 1e-05
Identities = 15/68 (22%), Positives = 24/68 (35%), Gaps = 4/68 (5%)
Query: 1 MHGNLFE--GPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMI 58
+ N G S L+ LDLS N + G + LQ+L+ H+ +
Sbjct: 357 LSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTL-KRV 414
Query: 59 PTEGIFKN 66
F +
Sbjct: 415 TEFSAFLS 422
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 9e-05
Identities = 16/80 (20%), Positives = 21/80 (26%), Gaps = 8/80 (10%)
Query: 11 GLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASAT 70
L LK L L+ N S I L L+LS N + +
Sbjct: 321 QFPTLDLPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGC--CSYSDLGTN 376
Query: 71 SV----FGNNKLCGGIPEFQ 86
S+ N F
Sbjct: 377 SLRHLDLSFNGAIIMSANFM 396
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 2e-04
Identities = 20/80 (25%), Positives = 28/80 (35%), Gaps = 8/80 (10%)
Query: 12 LSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKF--LQNLNLSHNNFESMIPTEGIFKNASA 69
L L LDLS+N LS + L++L+LS N M F
Sbjct: 344 FKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIM---SANFMGLEE 400
Query: 70 TSV--FGNNKLCGGIPEFQL 87
F ++ L + EF
Sbjct: 401 LQHLDFQHSTL-KRVTEFSA 419
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 10/82 (12%), Positives = 23/82 (28%), Gaps = 8/82 (9%)
Query: 12 LSLSPLRGL-----KVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKN 66
S + GL L+ N + + ++L+ + + + +
Sbjct: 250 FEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYL--EDVPKHF 307
Query: 67 ASATSVFGNNKLCGGIPEFQLP 88
+ +L P LP
Sbjct: 308 KWQSLSIIRCQLK-QFPTLDLP 328
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 59.5 bits (145), Expect = 2e-09
Identities = 60/217 (27%), Positives = 95/217 (43%), Gaps = 30/217 (13%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTV--ECEVMRNIIHRKIIK---V 222
+G G +A+VYKG+ VA+K L + T E +M+ + H I++ V
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEVK-LDSEEGTPSTAIREISLMKELKHENIVRLYDV 71
Query: 223 VTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVA 282
+ +++ LV+EFM N L++++ + P L +
Sbjct: 72 IHTENKL-T-------LVFEFMDN-DLKKYM----DSRTVGNTPRGLELNLVKYFQWQLL 118
Query: 283 SALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTG 342
L + H I H D+KP N+L+N + DFG+AR SS V T
Sbjct: 119 QGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV--TLW 173
Query: 343 YIAPEYGMGHETSSYG---DVYSFGILLLEMFTGLRP 376
Y AP+ MG + +Y D++S G +L EM TG +P
Sbjct: 174 YRAPDVLMG--SRTYSTSIDIWSCGCILAEMITG-KP 207
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 58.3 bits (142), Expect = 3e-09
Identities = 53/223 (23%), Positives = 89/223 (39%), Gaps = 35/223 (15%)
Query: 162 FSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTV--ECEVMRNIIHRKI 219
+ +G G + VYK +G VA+K D T E +++ + H I
Sbjct: 23 YQKLEKVGEGTYGVVYKAKDSQGR-IVALKRIRLDAEDEGIPSTAIREISLLKELHHPNI 81
Query: 220 IK---VVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLN 276
+ V+ + + LV+EFM L++ + + L +
Sbjct: 82 VSLIDVIHSERCL-T-------LVFEFMEK-DLKKVLD---------ENKTGLQDSQIKI 123
Query: 277 IAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIG 336
+ + + H + I H D+KP N+L+N + +ADFG+AR +
Sbjct: 124 YLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEV 180
Query: 337 VKGTTGYIAPEYGMGHETSSYG---DVYSFGILLLEMFTGLRP 376
V T Y AP+ MG + Y D++S G + EM TG +P
Sbjct: 181 V--TLWYRAPDVLMG--SKKYSTSVDIWSIGCIFAEMITG-KP 218
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 4e-09
Identities = 50/267 (18%), Positives = 97/267 (36%), Gaps = 55/267 (20%)
Query: 149 YVSYEALYSATKGFSSENLIGAGNFASVYKGILFEGAPAVAIK-VFN-FLHH-DASKSFT 205
Y + ++LIG G++ VY VAIK V F D +
Sbjct: 15 YFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILR 74
Query: 206 VECEVMRNIIHRKIIK---VVTACSRVDYQGNDFKALVYEFMPNGSLEEWIH---PITEE 259
E ++ + II+ ++ + + ++ +V E + L++ +TEE
Sbjct: 75 -EITILNRLKSDYIIRLYDLIIPDDLLKF--DEL-YIVLEIADS-DLKKLFKTPIFLTEE 129
Query: 260 DKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADF 319
+ I ++ ++H I H D+KP+N LLN + + V DF
Sbjct: 130 HIKT-------------ILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDF 173
Query: 320 GIARFLEATNEQTSSIGVKGT--------------TGYI------APEYGMGHETSSYG- 358
G+AR + + + ++ T ++ APE + +Y
Sbjct: 174 GLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQ--ENYTK 231
Query: 359 --DVYSFGILLLEMFTGLRPSDDMFKD 383
D++S G + E+ L+ + +
Sbjct: 232 SIDIWSTGCIFAELLNMLQSHINDPTN 258
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 6e-09
Identities = 61/221 (27%), Positives = 93/221 (42%), Gaps = 39/221 (17%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKS---FTV--ECEVMRNIIHRKIIK- 221
+G G FA+VYK VAIK H +K T E ++++ + H II
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 222 --VVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAI 279
S + LV++FM LE I +++ P ++ + +
Sbjct: 78 LDAFGHKSNI-S-------LVFDFMET-DLEVII----KDNSLVLTPSHIKAY-----ML 119
Query: 280 DVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIAR-FLEATNEQTSSIGVK 338
LEYLH I H D+KP+N+LL++ +ADFG+A+ F T + V
Sbjct: 120 MTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-V- 174
Query: 339 GTTGYIAPEYGMGHETSSYG---DVYSFGILLLEMFTGLRP 376
T Y APE G YG D+++ G +L E+ P
Sbjct: 175 -TRWYRAPELLFG--ARMYGVGVDMWAVGCILAELLLR-VP 211
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 6e-09
Identities = 51/223 (22%), Positives = 93/223 (41%), Gaps = 35/223 (15%)
Query: 162 FSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTV--ECEVMRNIIHRKI 219
+ + +G G +A+VYKG VA+K L H+ T E +++++ H I
Sbjct: 4 YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIR-LEHEEGAPCTAIREVSLLKDLKHANI 62
Query: 220 IK---VVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLN 276
+ ++ + LV+E++ L++++ +N
Sbjct: 63 VTLHDIIHTEKSL-T-------LVFEYLDK-DLKQYLD---------DCGNIINMHNVKL 104
Query: 277 IAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIG 336
+ L Y H + + H D+KP N+L+N+ +ADFG+AR + +
Sbjct: 105 FLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEV 161
Query: 337 VKGTTGYIAPEYGMGHETSSYG---DVYSFGILLLEMFTGLRP 376
V T Y P+ +G ++ Y D++ G + EM TG RP
Sbjct: 162 V--TLWYRPPDILLG--STDYSTQIDMWGVGCIFYEMATG-RP 199
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 7e-09
Identities = 57/222 (25%), Positives = 90/222 (40%), Gaps = 35/222 (15%)
Query: 166 NLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNI---------IH 216
IG G + +VYK VA+K + + + +R + H
Sbjct: 15 AEIGVGAYGTVYKARDPHSGHFVALKSVR-VPNGGGGGGGLPISTVREVALLRRLEAFEH 73
Query: 217 RKIIKV--VTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLER 274
++++ V A SR D + LV+E + L ++ + PG L +
Sbjct: 74 PNVVRLMDVCATSRTDREIKVT--LVFEHVDQ-DLRTYL-------DKAPPPG-LPAETI 122
Query: 275 LNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSS 334
++ L++LH C I H D+KP NIL+ T +ADFG+AR T
Sbjct: 123 KDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPV 179
Query: 335 IGVKGTTGYIAPEYGMGHETSSYG---DVYSFGILLLEMFTG 373
+ V T Y APE + S+Y D++S G + EMF
Sbjct: 180 V-V--TLWYRAPEVLLQ---STYATPVDMWSVGCIFAEMFRR 215
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 9e-09
Identities = 37/115 (32%), Positives = 54/115 (46%), Gaps = 28/115 (24%)
Query: 284 ALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGT--- 340
++YLH G + H D+KPSNILLN E VADFG++R T++I +
Sbjct: 121 VIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENT 177
Query: 341 ----------TGYI------APEYGMGHETSSYG---DVYSFGILLLEMFTGLRP 376
T Y+ APE +G + Y D++S G +L E+ G +P
Sbjct: 178 ENFDDDQPILTDYVATRWYRAPEILLGS--TKYTKGIDMWSLGCILGEILCG-KP 229
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 56.0 bits (136), Expect = 2e-08
Identities = 48/223 (21%), Positives = 84/223 (37%), Gaps = 46/223 (20%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTV--ECEVMRNIIHRKIIK---V 222
IG G++ V+K + VAIK F D E +++ + H ++ V
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 223 VTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVA 282
R+ + LV+E+ + ++ + + +R + S I
Sbjct: 71 FRRKRRL-H-------LVFEYCDH-TVLHEL----DRYQRGVPEHLVKS-----ITWQTL 112
Query: 283 SALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTG 342
A+ + H K H D+KP NIL+ + DFG AR L +
Sbjct: 113 QAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLL--------TGPSDYYDD 161
Query: 343 YI------APEYGMGHETSSYG---DVYSFGILLLEMFTGLRP 376
+ +PE +G + YG DV++ G + E+ +G P
Sbjct: 162 EVATRWYRSPELLVG--DTQYGPPVDVWAIGCVFAELLSG-VP 201
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 2e-08
Identities = 51/225 (22%), Positives = 89/225 (39%), Gaps = 46/225 (20%)
Query: 166 NLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTV--ECEVMRNIIHRKIIKVV 223
L+G G++ V K + VAIK F D E ++++ + H ++ ++
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLL 90
Query: 224 TACSRVDYQGNDFKALVYEFMPN---GSLEEWIHPITEEDKRHKAPGNLNSLERLNIAID 280
C + + + LV+EF+ + LE + + + + +
Sbjct: 91 EVCKK---KKRWY--LVFEFVDHTILDDLELFPNGLDYQVVQ-------------KYLFQ 132
Query: 281 VASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGT 340
+ + + + H I H DIKP NIL++ + DFG AR L + +
Sbjct: 133 IINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTL--------AAPGEVY 181
Query: 341 TGYI------APEYGMGHETSSYG---DVYSFGILLLEMFTGLRP 376
+ APE +G YG DV++ G L+ EMF G P
Sbjct: 182 DDEVATRWYRAPELLVG--DVKYGKAVDVWAIGCLVTEMFMG-EP 223
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 55.6 bits (135), Expect = 2e-08
Identities = 55/217 (25%), Positives = 88/217 (40%), Gaps = 35/217 (16%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTV--ECEVMRNIIHRKIIK---V 222
IG G + VYK G A+K D T E +++ + H I+K V
Sbjct: 10 IGEGTYGVVYKAQNNYGE-TFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 223 VTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVA 282
+ R+ LV+E + L++ + G L S+ + + +
Sbjct: 69 IHTKKRL-V-------LVFEHLDQ-DLKKLLD---------VCEGGLESVTAKSFLLQLL 110
Query: 283 SALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTG 342
+ + Y H + H D+KP N+L+N E +ADFG+AR + + V T
Sbjct: 111 NGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV--TLW 165
Query: 343 YIAPEYGMGHETSSYG---DVYSFGILLLEMFTGLRP 376
Y AP+ MG + Y D++S G + EM G P
Sbjct: 166 YRAPDVLMG--SKKYSTTIDIWSVGCIFAEMVNG-TP 199
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 2e-08
Identities = 56/234 (23%), Positives = 89/234 (38%), Gaps = 56/234 (23%)
Query: 166 NLIGAGNFASVYKG--------------ILF----EGAPAVAIKVFNFLHHDASKSFTVE 207
IG G + V+K + EG P I+ L H
Sbjct: 17 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH--------- 67
Query: 208 CEVMRNIIHRKIIKV--VTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKA 265
+ H ++++ V SR D + LV+E + L ++ +
Sbjct: 68 ---LETFEHPNVVRLFDVCTVSRTDRETKLT--LVFEHVDQ-DLTTYL-------DKVPE 114
Query: 266 PGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFL 325
PG + + ++ + L++LH + H D+KP NIL+ +ADFG+AR
Sbjct: 115 PG-VPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIY 170
Query: 326 EATNEQTSSIGVKGTTGYIAPEYGMGHETSSYG---DVYSFGILLLEMFTGLRP 376
TS + V T Y APE + SSY D++S G + EMF +P
Sbjct: 171 SFQMALTSVV-V--TLWYRAPEVLLQ---SSYATPVDLWSVGCIFAEMFRR-KP 217
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 56.8 bits (136), Expect = 3e-08
Identities = 69/520 (13%), Positives = 124/520 (23%), Gaps = 206/520 (39%)
Query: 395 LPERVEEIVDTLFFKEIEEEE-TVYKYK------KAPSSSTQRSIILECLNSICEIGVAC 447
L + VD K++++ ++ + + + + + L
Sbjct: 22 LSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTL---------- 71
Query: 448 SAELPGERMKINDVELGLRLIKKKLLETPVYEEKQTINMPLSRGKEGY-------CNDEE 500
E M VE LR+ K L+ E++Q S Y ND +
Sbjct: 72 --LSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQP-----SMMTRMYIEQRDRLYNDNQ 124
Query: 501 --TPYSAGGLSVVTSDDPETSDAVREESDSSEAKAERHGKKSSCCQCLQENRSSEMDVCI 558
Y+ V+ + +R Q L E R ++
Sbjct: 125 VFAKYN------VSR--LQPYLKLR--------------------QALLELRPAK----- 151
Query: 559 FCDAMYCCNCVVKAMGSMPEGRTC---AACVGSRLDVCMPTSSNGIG--SSGESNSPN-- 611
N ++ + G+T C+ ++ M I + NSP
Sbjct: 152 --------NVLIDGVLGS--GKTWVALDVCLSYKVQCKMD---FKIFWLNLKNCNSPETV 198
Query: 612 -------CHDNLPVNNELPDDSNDGTNAGFHDYMNPANSESGESGASSH----------- 653
+ P D H S ++
Sbjct: 199 LEMLQKLLYQIDPNWTSRSD----------HSSNIKLRIHSIQAELRRLLKSKPYENCLL 248
Query: 654 ---SVSS----EVF--SCKEKGFNEEEAPGHGHVRKPSVITFRDPDPSDAVYEESDYSEF 704
+V + F SCK ++T R +D + + +
Sbjct: 249 VLLNVQNAKAWNAFNLSCK------------------ILLTTRFKQVTDFL-SAATTTHI 289
Query: 705 ESIHEKPKAVRKGKKGSCYRCLKGNRFTKKEFCFVCGARYCSSCVLWAMDSMPEGRIC-- 762
H T E + +P +
Sbjct: 290 SLDHH-----SMT-------------LTPDE-----VKSLLLKYLDCRPQDLPR-EVLTT 325
Query: 763 ----VTCIGFRL-DASKRLSLWKCSGMPKGLLTETEVKQIMRSEISCKANQLPRDRVFVN 817
++ I + D WK K + I+ S + N L
Sbjct: 326 NPRRLSIIAESIRDGLATWDNWKHVNCDK-------LTTIIESSL----NVL-------- 366
Query: 818 GEPLSKRE----LVILLSCPN----PPKKLNCGTYWYDKV 849
EP R+ L + P P L W+D +
Sbjct: 367 -EPAEYRKMFDRLSVF---PPSAHIPTILL--SLIWFDVI 400
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 51.4 bits (122), Expect = 1e-06
Identities = 69/369 (18%), Positives = 120/369 (32%), Gaps = 126/369 (34%)
Query: 2 HGNLFEGPIGLSLSPLRGL--KVLDLSQNNLSGEI----P-----------EFLAGFKFL 44
H +L + L+ ++ L K LD +L E+ P + LA +
Sbjct: 288 HISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNW 347
Query: 45 QNLNLSHNNFESMI--------PTE--GIFKNASATSVFGNNKLCGGIPEFQLPTCVSKK 94
+++N + ++I P E +F SVF + IP
Sbjct: 348 KHVN--CDKLTTIIESSLNVLEPAEYRKMFD---RLSVFPPSAH---IPT---------- 389
Query: 95 TKQNRSTLPL--KLVIAIDCGLLVLTLALSSLFCRLMCMKKRGNPT----PSISIDLDFP 148
L L VI D ++V L SL ++K+ + PSI ++L
Sbjct: 390 -----ILLSLIWFDVIKSDVMVVVNKLHKYSL------VEKQPKESTISIPSIYLELKVK 438
Query: 149 YVSYEAL-------YSATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFL-HHDA 200
+ AL Y+ K F S++LI + Y ++ + HH
Sbjct: 439 LENEYALHRSIVDHYNIPKTFDSDDLIP--PYLDQY--------------FYSHIGHHLK 482
Query: 201 SKSFTVECEVMRNI------IHRKIIKVVTACSRVDYQGNDFKAL-VYE-FMPNGSLEEW 252
+ + R + + +KI TA + N + L Y+ +
Sbjct: 483 NIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPY--------- 533
Query: 253 IHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNIL---LN 309
I + D ERL AI L++L + + K +++L L
Sbjct: 534 ---ICDND---------PKYERLVNAI-----LDFLP-KIEENLICS--KYTDLLRIALM 573
Query: 310 DEMTACVAD 318
E A +
Sbjct: 574 AEDEAIFEE 582
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 4e-08
Identities = 34/165 (20%), Positives = 53/165 (32%), Gaps = 33/165 (20%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNII-HRKIIKVVTAC 226
+G G V + A+K+ E E+ I+++V
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDVY 80
Query: 227 SRVDYQGNDFKALVYEFMPNGSL-----EEWIHPITEEDKRHKAPGNLNSLERLNIAIDV 281
Y G +V E + G L + TE + I +
Sbjct: 81 EN-LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASE-------------IMKSI 126
Query: 282 ASALEYLH-LGCKPPIAHCDIKPSNILL---NDEMTACVADFGIA 322
A++YLH + IAH D+KP N+L + DFG A
Sbjct: 127 GEAIQYLHSIN----IAHRDVKPENLLYTSKRPNAILKLTDFGFA 167
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 55.6 bits (134), Expect = 4e-08
Identities = 50/254 (19%), Positives = 96/254 (37%), Gaps = 50/254 (19%)
Query: 162 FSSENLIGAGNFASVYKGILFEGAPAVAIK-VFN-FLHH-DASKSFTVECEVMRNIIHRK 218
+ +LIG G++ V + VAIK + F D + E ++ + H
Sbjct: 55 YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILR-EIAILNRLNHDH 113
Query: 219 IIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIH---PITEEDKRHKAPGNLNSLERL 275
++KV+ D + D +V E + ++ +TE +
Sbjct: 114 VVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVYLTELHIKT------------ 160
Query: 276 NIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSI 335
+ ++ ++Y+H I H D+KP+N L+N + + V DFG+AR ++ S +
Sbjct: 161 -LLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQL 216
Query: 336 GVKGT-------------------TGYI------APEYGMGHETSSYG-DVYSFGILLLE 369
+ TG++ APE + E + DV+S G + E
Sbjct: 217 PISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAE 276
Query: 370 MFTGLRPSDDMFKD 383
+ ++ + D
Sbjct: 277 LLNMIKENVAYHAD 290
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 7e-08
Identities = 30/117 (25%), Positives = 47/117 (40%), Gaps = 27/117 (23%)
Query: 276 NIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVA------------------ 317
++A + AL +LH + + H D+KP NIL + +
Sbjct: 127 HMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRV 183
Query: 318 -DFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTG 373
DFG A F +E ++I T Y PE + + DV+S G +L E + G
Sbjct: 184 ADFGSATF---DHEHHTTIVA--TRHYRPPEVILELGWAQPCDVWSIGCILFEYYRG 235
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 8e-08
Identities = 48/222 (21%), Positives = 87/222 (39%), Gaps = 40/222 (18%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTV--ECEVMRNIIHRKIIK---V 222
+G G + VYK I VAIK H + T E +++ + HR II+ V
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSV 101
Query: 223 VTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVA 282
+ R+ + L++E+ N L++++ +++ + +
Sbjct: 102 IHHNHRL-H-------LIFEYAEN-DLKKYMD----------KNPDVSMRVIKSFLYQLI 142
Query: 283 SALEYLHLGCKPPIAHCDIKPSNILLNDEMTAC-----VADFGIARFLEATNEQTSSIGV 337
+ + + H H D+KP N+LL+ + + DFG+AR Q + +
Sbjct: 143 NGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII 199
Query: 338 KGTTGYIAPEYGMGHETSSYG---DVYSFGILLLEMFTGLRP 376
T Y PE +G + Y D++S + EM P
Sbjct: 200 --TLWYRPPEILLG--SRHYSTSVDIWSIACIWAEMLMK-TP 236
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 2e-07
Identities = 29/117 (24%), Positives = 45/117 (38%), Gaps = 27/117 (23%)
Query: 276 NIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVA------------------ 317
+A + ++ +LH + H D+KP NIL
Sbjct: 122 KMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKV 178
Query: 318 -DFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTG 373
DFG A + +E S++ T Y APE + S DV+S G +L+E + G
Sbjct: 179 VDFGSATY---DDEHHSTLVS--TRHYRAPEVILALGWSQPCDVWSIGCILIEYYLG 230
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 5e-07
Identities = 34/175 (19%), Positives = 62/175 (35%), Gaps = 35/175 (20%)
Query: 167 LIGAGNFASVYKGILFEGAPAVAIKV--------------FNFLHHDASKSFTVECEVMR 212
IG+G F +Y A V F A K + +
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 213 NIIHRKIIKVVTACSRVDYQGNDFKALVYEFMPNG-SLEEWIHPITEEDKRHKAPGNLNS 271
+ + I +++G ++ +V E + G L++ I+ ++
Sbjct: 104 QLDYLGIPLFY-GSGLTEFKGRSYRFMVMERL--GIDLQK----ISGQNGTF-------K 149
Query: 272 LER-LNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACV--ADFGIAR 323
L + I + LEY+H + H DIK +N+LL + V AD+G++
Sbjct: 150 KSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 7e-07
Identities = 8/72 (11%), Positives = 23/72 (31%), Gaps = 5/72 (6%)
Query: 17 LRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSV--FG 74
K+ ++ ++L + ++ L+LS N + + +
Sbjct: 9 GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISA--ADLAPFTKLELLNLS 66
Query: 75 NNKLCGGIPEFQ 86
+N L + +
Sbjct: 67 SNVL-YETLDLE 77
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 8e-07
Identities = 15/56 (26%), Positives = 26/56 (46%), Gaps = 2/56 (3%)
Query: 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFES 56
+ GN L+P L++L+LS N L E + L+ L+L++N +
Sbjct: 41 LSGNPLSQISAADLAPFTKLELLNLSSNVLY-ETLDL-ESLSTLRTLDLNNNYVQE 94
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 18/116 (15%), Positives = 34/116 (29%), Gaps = 5/116 (4%)
Query: 13 SLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSV 72
LK LDLS N L+ + + ++L +N I + + + +
Sbjct: 186 GQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVL-IE-KALRFSQNLEHF 242
Query: 73 -FGNNKLCGGIPEFQLPTCVSKKTKQNRSTLPLKLVIAIDCGLLVLTLALSSLFCR 127
N G +T ++ L +C + L + C
Sbjct: 243 DLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTL-GHYGAYCCE 297
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 17/47 (36%), Positives = 20/47 (42%)
Query: 13 SLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIP 59
+K LDLS N LS LA F L+ LNLS N +
Sbjct: 29 LRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD 75
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 49.8 bits (119), Expect = 3e-06
Identities = 19/115 (16%), Positives = 33/115 (28%), Gaps = 3/115 (2%)
Query: 10 IGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASA 69
+G G+ + L N L I + L + L++ +L N F + KN
Sbjct: 206 MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRV 264
Query: 70 TSVFGNNKLCGGIPEFQLPTCVSKKTKQNRSTLPLKLVIAIDCGLLVLTLALSSL 124
+V + C + L L+ L +L
Sbjct: 265 QTVAKQT--VKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHAL 317
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 3e-06
Identities = 10/55 (18%), Positives = 23/55 (41%), Gaps = 1/55 (1%)
Query: 12 LSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKN 66
+S S +G K + L+ N ++ +Q L+L N ++ + + +
Sbjct: 114 VSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDT-VNFAELAAS 167
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 47.9 bits (114), Expect = 1e-05
Identities = 8/54 (14%), Positives = 20/54 (37%), Gaps = 5/54 (9%)
Query: 13 SLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKN 66
L ++ L + NN+S + + + +N+ L++N +
Sbjct: 94 ELLVGPSIETLHAANNNIS-RVSC--SRGQGKKNIYLANNKITMLRD--LDEGC 142
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 3e-05
Identities = 13/62 (20%), Positives = 22/62 (35%), Gaps = 2/62 (3%)
Query: 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSG-EIPEFLAGFKFLQNLNLSHNNFESMIP 59
+ N L ++ LDL N + E A L++LNL +N +
Sbjct: 127 LANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD-VK 185
Query: 60 TE 61
+
Sbjct: 186 GQ 187
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 51.1 bits (122), Expect = 7e-07
Identities = 18/69 (26%), Positives = 23/69 (33%), Gaps = 7/69 (10%)
Query: 1 MHGNLFEGPIGLSLS----PLRGLKVLDLSQNN---LSGEIPEFLAGFKFLQNLNLSHNN 53
+ N G GL + L+VL L SG A LQ L+LSHN+
Sbjct: 180 LSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNS 239
Query: 54 FESMIPTEG 62
Sbjct: 240 LRDAAGAPS 248
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 1e-05
Identities = 15/60 (25%), Positives = 19/60 (31%), Gaps = 4/60 (6%)
Query: 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLA----GFKFLQNLNLSHNNFES 56
+ + L LDLS N GE A F LQ L L + E+
Sbjct: 156 IAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMET 215
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 16/65 (24%), Positives = 26/65 (40%), Gaps = 4/65 (6%)
Query: 2 HGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTE 61
H +L + S L L+LS L ++P+ L L L+LS+N + P+
Sbjct: 237 HNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL--PAKLSVLDLSYNRLDR-NPSP 292
Query: 62 GIFKN 66
Sbjct: 293 DELPQ 297
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 14/35 (40%), Positives = 16/35 (45%), Gaps = 2/35 (5%)
Query: 20 LKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNF 54
L VLDLS N L P + NL+L N F
Sbjct: 276 LSVLDLSYNRLD-RNP-SPDELPQVGNLSLKGNPF 308
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 3e-04
Identities = 14/48 (29%), Positives = 19/48 (39%)
Query: 12 LSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIP 59
L GLKVL ++Q + E + F L L+LS N
Sbjct: 143 LQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERG 190
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 9e-07
Identities = 38/125 (30%), Positives = 53/125 (42%), Gaps = 37/125 (29%)
Query: 276 NIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTAC-------------------- 315
I++ AL YL K + H D+KP NILL+D
Sbjct: 141 LYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTK 197
Query: 316 -----VADFGIARFLEATNEQTSSIGVKGTTGYIAPE--YGMGHETSSYGDVYSFGILLL 368
+ DFG A F ++ SI T Y APE +G + SS D++SFG +L
Sbjct: 198 STGIKLIDFGCATF---KSDYHGSIIN--TRQYRAPEVILNLGWDVSS--DMWSFGCVLA 250
Query: 369 EMFTG 373
E++TG
Sbjct: 251 ELYTG 255
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 9e-07
Identities = 8/72 (11%), Positives = 23/72 (31%), Gaps = 5/72 (6%)
Query: 17 LRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSV--FG 74
K+ ++ ++L + ++ L+LS N + + +
Sbjct: 9 GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISA--ADLAPFTKLELLNLS 66
Query: 75 NNKLCGGIPEFQ 86
+N L + +
Sbjct: 67 SNVL-YETLDLE 77
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 15/56 (26%), Positives = 26/56 (46%), Gaps = 2/56 (3%)
Query: 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFES 56
+ GN L+P L++L+LS N L E + L+ L+L++N +
Sbjct: 41 LSGNPLSQISAADLAPFTKLELLNLSSNVLY-ETLDL-ESLSTLRTLDLNNNYVQE 94
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 3e-06
Identities = 14/67 (20%), Positives = 24/67 (35%), Gaps = 1/67 (1%)
Query: 10 IGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASA 69
+G G+ + L N L I + L + L++ +L N F + KN
Sbjct: 206 MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRV 264
Query: 70 TSVFGNN 76
+V
Sbjct: 265 QTVAKQT 271
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 3e-06
Identities = 15/77 (19%), Positives = 27/77 (35%), Gaps = 5/77 (6%)
Query: 13 SLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSV 72
LK LDLS N L+ + + ++L +N I + + + +
Sbjct: 186 GQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVL-IE-KALRFSQNLEHF 242
Query: 73 -FGNNKL-CGGIPEFQL 87
N CG + +F
Sbjct: 243 DLRGNGFHCGTLRDFFS 259
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 4e-06
Identities = 17/47 (36%), Positives = 20/47 (42%)
Query: 13 SLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIP 59
+K LDLS N LS LA F L+ LNLS N +
Sbjct: 29 LRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD 75
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 1e-05
Identities = 9/54 (16%), Positives = 23/54 (42%), Gaps = 5/54 (9%)
Query: 13 SLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKN 66
L ++ L + NN+S + + + +N+ L++N +M+ +
Sbjct: 94 ELLVGPSIETLHAANNNIS-RVS--CSRGQGKKNIYLANNKI-TMLR-DLDEGC 142
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 2e-05
Identities = 10/55 (18%), Positives = 23/55 (41%), Gaps = 1/55 (1%)
Query: 12 LSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKN 66
+S S +G K + L+ N ++ +Q L+L N ++ + + +
Sbjct: 114 VSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDT-VNFAELAAS 167
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 3e-05
Identities = 13/62 (20%), Positives = 22/62 (35%), Gaps = 2/62 (3%)
Query: 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSG-EIPEFLAGFKFLQNLNLSHNNFESMIP 59
+ N L ++ LDL N + E A L++LNL +N +
Sbjct: 127 LANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD-VK 185
Query: 60 TE 61
+
Sbjct: 186 GQ 187
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 1e-06
Identities = 13/53 (24%), Positives = 20/53 (37%), Gaps = 1/53 (1%)
Query: 14 LSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKN 66
LR L LD+S + G L+ L ++ N+F+ IF
Sbjct: 417 FLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFL-PDIFTE 468
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 27/92 (29%), Positives = 36/92 (39%), Gaps = 8/92 (8%)
Query: 1 MHGN-LFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIP 59
M GN E + + LR L LDLSQ L P LQ LN++ N +S +P
Sbjct: 452 MAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKS-VP 510
Query: 60 TEGIFKNASATSVF--GNNKL---CGGIPEFQ 86
+GIF ++ N C I
Sbjct: 511 -DGIFDRLTSLQKIWLHTNPWDCSCPRIDYLS 541
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 4e-06
Identities = 15/54 (27%), Positives = 24/54 (44%), Gaps = 1/54 (1%)
Query: 13 SLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKN 66
+ S L L+ L + NL+ + K L+ LN++HN +S F N
Sbjct: 95 AFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS-FKLPEYFSN 147
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 6e-06
Identities = 13/69 (18%), Positives = 24/69 (34%), Gaps = 3/69 (4%)
Query: 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEI-PEFLAGFKFLQNLNLSHNNFESMIP 59
+ + L L+VL ++ N+ P+ + L L+LS E +
Sbjct: 428 ISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQ-LS 486
Query: 60 TEGIFKNAS 68
F + S
Sbjct: 487 -PTAFNSLS 494
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 1e-05
Identities = 15/66 (22%), Positives = 22/66 (33%), Gaps = 2/66 (3%)
Query: 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPT 60
+ N S L+VLDLS+ + L L L+ N +S+
Sbjct: 35 LSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLAL- 93
Query: 61 EGIFKN 66
G F
Sbjct: 94 -GAFSG 98
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 1e-05
Identities = 16/61 (26%), Positives = 28/61 (45%), Gaps = 2/61 (3%)
Query: 6 FEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFK 65
F+G S LK LDLS N + + G + L++L+ H+N + + +F
Sbjct: 361 FKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQ-MSEFSVFL 418
Query: 66 N 66
+
Sbjct: 419 S 419
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 14/60 (23%), Positives = 29/60 (48%), Gaps = 1/60 (1%)
Query: 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNL-SGEIPEFLAGFKFLQNLNLSHNNFESMIP 59
+ L+ LK L+++ N + S ++PE+ + L++L+LS N +S+
Sbjct: 107 AVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYC 166
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 7e-05
Identities = 11/54 (20%), Positives = 17/54 (31%), Gaps = 2/54 (3%)
Query: 13 SLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKN 66
+ L L L L+ N + +G LQ L N S+ +
Sbjct: 71 AYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLEN--FPIGH 122
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 9e-05
Identities = 20/66 (30%), Positives = 27/66 (40%), Gaps = 6/66 (9%)
Query: 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPT 60
M N ++ P L S K LDLS N L F LQ L+LS I
Sbjct: 15 MELNFYKIPDNLPFS----TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEI-QTIE- 68
Query: 61 EGIFKN 66
+G +++
Sbjct: 69 DGAYQS 74
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 1e-04
Identities = 19/86 (22%), Positives = 28/86 (32%), Gaps = 7/86 (8%)
Query: 4 NLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQN----LNLSHNNFESMIP 59
+ + S L L+ LDLS N + L + L+LS N + P
Sbjct: 135 LIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQP 194
Query: 60 TEGIFKNASATS-VFGNNKLCGGIPE 84
G FK NN + +
Sbjct: 195 --GAFKEIRLHKLTLRNNFDSLNVMK 218
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 6e-04
Identities = 14/52 (26%), Positives = 22/52 (42%), Gaps = 5/52 (9%)
Query: 17 LRGLKVLDLSQNNLSGEIPE--FLAGFKFLQNLNLSHNNFESMIPTEGIFKN 66
L L+ LD +NL ++ E + L L++SH + GIF
Sbjct: 395 LEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTRVAFN--GIFNG 443
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 7e-04
Identities = 20/70 (28%), Positives = 30/70 (42%), Gaps = 7/70 (10%)
Query: 13 SLSPLRGLKVLDLSQNNLS--GEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASAT 70
S L L+ LDLS+N LS G + G L+ L+LS N + + + F
Sbjct: 342 SEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSN--FLGLEQL 398
Query: 71 SV--FGNNKL 78
F ++ L
Sbjct: 399 EHLDFQHSNL 408
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 14/56 (25%), Positives = 19/56 (33%), Gaps = 3/56 (5%)
Query: 13 SLSPLRGLKVLDLSQNNLSGEI--PEFLAGFKFLQNLNLSHNNFESMIPTEGIFKN 66
+ L L L L LS + + K L L+LS N S + F
Sbjct: 92 AFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRS-LYLHPSFGK 146
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 9e-06
Identities = 13/54 (24%), Positives = 22/54 (40%)
Query: 13 SLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKN 66
+ L L++LDL + + P+ G L L L + +G F+N
Sbjct: 68 AFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRN 121
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 3e-05
Identities = 12/55 (21%), Positives = 20/55 (36%), Gaps = 3/55 (5%)
Query: 13 SLSPLRGLKVLDLSQNNLSGEI-PEFLAGFKFLQNLNLSHNNFESMIPTEGIFKN 66
S L L++L+L I E L+ L+L + + P F+
Sbjct: 43 SFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHP--DAFQG 95
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 4e-05
Identities = 11/57 (19%), Positives = 24/57 (42%)
Query: 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESM 57
+ NL + L + +DL +N+++ + + LQ L+L N ++
Sbjct: 321 LSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTI 377
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 4e-05
Identities = 13/54 (24%), Positives = 22/54 (40%), Gaps = 2/54 (3%)
Query: 13 SLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKN 66
+ L L+VL+LS N L G + ++L N+ + + FK
Sbjct: 309 AFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAII--QDQTFKF 360
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 5e-05
Identities = 21/85 (24%), Positives = 33/85 (38%), Gaps = 7/85 (8%)
Query: 1 MHGNLFEG-PIGLSLSPLRGLKVLDLSQNNLSG-EIPEFLAGFKFLQNLNLSHNNFESMI 58
+ N E I L + L++L L+QN S + + L+ L L N +
Sbjct: 408 LSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAW 467
Query: 59 PTE---GIFKNASATSV--FGNNKL 78
TE +F+ S V +N L
Sbjct: 468 ETELCWDVFEGLSHLQVLYLNHNYL 492
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 45.6 bits (108), Expect = 7e-05
Identities = 13/54 (24%), Positives = 22/54 (40%), Gaps = 1/54 (1%)
Query: 13 SLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKN 66
L L+VL L+ N L+ P + L+ L+L+ N + + N
Sbjct: 475 VFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTV-LSHNDLPAN 527
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 44.8 bits (106), Expect = 1e-04
Identities = 13/65 (20%), Positives = 21/65 (32%), Gaps = 4/65 (6%)
Query: 16 PLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASA--TSVF 73
++ LDLS + K L+ LNL++N + + F
Sbjct: 264 ARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKI--ADEAFYGLDNLQVLNL 321
Query: 74 GNNKL 78
N L
Sbjct: 322 SYNLL 326
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 2e-04
Identities = 12/50 (24%), Positives = 17/50 (34%), Gaps = 1/50 (2%)
Query: 17 LRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKN 66
L + L LS N + + LQ L L I + F+N
Sbjct: 23 LNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTID-KEAFRN 71
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 42.9 bits (101), Expect = 4e-04
Identities = 15/55 (27%), Positives = 22/55 (40%), Gaps = 7/55 (12%)
Query: 17 LRGLKVLDLSQNNLSGEI-----PEFLAGFKFLQNLNLSHNNFESMIPTEGIFKN 66
L+ L L +N L + G LQ L L+HN S+ G+F +
Sbjct: 450 NPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSL--PPGVFSH 502
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 49.5 bits (119), Expect = 2e-06
Identities = 16/47 (34%), Positives = 21/47 (44%)
Query: 13 SLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIP 59
L+ L L L L+ N L E E + G L L LS N+ + P
Sbjct: 282 VLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP 328
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 45.6 bits (109), Expect = 4e-05
Identities = 9/47 (19%), Positives = 21/47 (44%), Gaps = 1/47 (2%)
Query: 13 SLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIP 59
L+ L + L+L N+ ++ L+ L L ++ + + + P
Sbjct: 127 PLANLTKMYSLNLGANHNLSDLSP-LSNMTGLNYLTVTESKVKDVTP 172
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 44.1 bits (105), Expect = 1e-04
Identities = 13/47 (27%), Positives = 25/47 (53%), Gaps = 2/47 (4%)
Query: 13 SLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIP 59
LS + GL L ++++ + P +A L +L+L++N E + P
Sbjct: 150 PLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP 194
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 43.7 bits (104), Expect = 2e-04
Identities = 14/47 (29%), Positives = 24/47 (51%), Gaps = 2/47 (4%)
Query: 13 SLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIP 59
+L L L+ L L+++N+S LA + +LNL N+ S +
Sbjct: 105 ALQNLTNLRELYLNEDNISD--ISPLANLTKMYSLNLGANHNLSDLS 149
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 43.7 bits (104), Expect = 2e-04
Identities = 9/47 (19%), Positives = 19/47 (40%), Gaps = 2/47 (4%)
Query: 13 SLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIP 59
+ L + L ++ ++ I + L+ LNL+ N + P
Sbjct: 39 TQEELESITKLVVAGEKVA-SIQG-IEYLTNLEYLNLNGNQITDISP 83
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 43.3 bits (103), Expect = 2e-04
Identities = 11/49 (22%), Positives = 21/49 (42%), Gaps = 2/49 (4%)
Query: 13 SLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTE 61
++ L LK+L++ N +S L L +L L++N +
Sbjct: 260 AVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEV 306
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 42.5 bits (101), Expect = 4e-04
Identities = 10/47 (21%), Positives = 18/47 (38%), Gaps = 2/47 (4%)
Query: 13 SLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIP 59
L+ L L N ++ P +A L +L + +N + P
Sbjct: 194 PLASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP 238
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 42.5 bits (101), Expect = 4e-04
Identities = 11/53 (20%), Positives = 22/53 (41%), Gaps = 2/53 (3%)
Query: 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNN 53
++ N + L L L LSQN+++ P LA + + + ++
Sbjct: 294 LNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQV 344
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 42.5 bits (101), Expect = 4e-04
Identities = 11/47 (23%), Positives = 20/47 (42%), Gaps = 2/47 (4%)
Query: 13 SLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIP 59
+ L L+ L+L+ N ++ P L+ L NL + N +
Sbjct: 61 GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDISA 105
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 42.5 bits (101), Expect = 4e-04
Identities = 12/46 (26%), Positives = 19/46 (41%), Gaps = 2/46 (4%)
Query: 14 LSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIP 59
LS L L L + N ++ L L+ L L+ +N + P
Sbjct: 84 LSNLVKLTNLYIGTNKIT--DISALQNLTNLRELYLNEDNISDISP 127
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 3e-06
Identities = 18/57 (31%), Positives = 26/57 (45%), Gaps = 3/57 (5%)
Query: 10 IGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKN 66
+ L P+ LKVLDLS N+L + F L+NL L HN+ + +
Sbjct: 287 LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVT-LK-LSTHHT 340
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 6e-06
Identities = 13/66 (19%), Positives = 24/66 (36%), Gaps = 4/66 (6%)
Query: 4 NLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIP-EFLAGFKFLQNLNLSHNNFESMIPTEG 62
+ G L K++ + + ++P L F+ ++ LNL+ E I
Sbjct: 31 QTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEE-ID-TY 87
Query: 63 IFKNAS 68
F A
Sbjct: 88 AFAYAH 93
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 1e-05
Identities = 16/70 (22%), Positives = 33/70 (47%), Gaps = 4/70 (5%)
Query: 10 IGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASA 69
+ + L+ L L N++ + L+ L+NL LSHN+++ +F+N +
Sbjct: 310 VERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWDC-NSLRALFRNVAR 365
Query: 70 TSVFGNNKLC 79
+V ++ C
Sbjct: 366 PAVDDADQHC 375
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 12/67 (17%), Positives = 28/67 (41%), Gaps = 4/67 (5%)
Query: 13 SLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSV 72
++ L+ L +S N L + + L+ L+LSHN+ + + ++
Sbjct: 267 PFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLH-VE-RNQPQFDRLENL 323
Query: 73 F-GNNKL 78
+ +N +
Sbjct: 324 YLDHNSI 330
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 8e-05
Identities = 13/55 (23%), Positives = 21/55 (38%), Gaps = 4/55 (7%)
Query: 12 LSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKN 66
+ L +L L NNL+ + + L ++LS+N E I F
Sbjct: 220 VRGPVNVELTILKLQHNNLT-DTAWL-LNYPGLVEVDLSYNELEK-IM-YHPFVK 270
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 1e-04
Identities = 13/54 (24%), Positives = 21/54 (38%), Gaps = 2/54 (3%)
Query: 13 SLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKN 66
+ + ++ L + N + P L L L N+ S +P GIF N
Sbjct: 88 AFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSS-LP-RGIFHN 139
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 1e-04
Identities = 13/58 (22%), Positives = 24/58 (41%), Gaps = 4/58 (6%)
Query: 13 SLSPLRGLKVLDLSQNNLSGEIP-EFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASA 69
L R +++L+L+ + EI A +Q L + N +P +F+N
Sbjct: 64 LLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAI-RYLP-PHVFQNVPL 118
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 1e-04
Identities = 11/44 (25%), Positives = 20/44 (45%), Gaps = 3/44 (6%)
Query: 13 SLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFES 56
+L+ ++ LD S N+++ + + L L L HNN
Sbjct: 200 TLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLTD 240
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 13/45 (28%), Positives = 20/45 (44%), Gaps = 2/45 (4%)
Query: 13 SLSPLRGLKVLDLSQNNLSGEIPEF-LAGFKFLQNLNLSHNNFES 56
L GL +DLS N L +I + L+ L +S+N +
Sbjct: 243 WLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLVA 286
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 3e-04
Identities = 14/55 (25%), Positives = 19/55 (34%), Gaps = 4/55 (7%)
Query: 13 SLSPLRGLKVLDLSQNNLSGEIP-EFLAGFKFLQNLNLSHNNFESMIPTEGIFKN 66
L L +S NNL I + LQNL LS N + + +
Sbjct: 136 IFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLTH-VD-LSLIPS 187
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 3e-04
Identities = 16/55 (29%), Positives = 26/55 (47%), Gaps = 4/55 (7%)
Query: 13 SLSPLRGLKVLDLSQNNLSGEIPEFL-AGFKFLQNLNLSHNNFESMIPTEGIFKN 66
+ L VL L +N+LS +P + L L++S+NN E I + F+
Sbjct: 112 VFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLER-IE-DDTFQA 163
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 5e-04
Identities = 11/44 (25%), Positives = 20/44 (45%), Gaps = 3/44 (6%)
Query: 13 SLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFES 56
+ L+ L LS N L+ + L+ L + N+S+N +
Sbjct: 160 TFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLLST 200
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 3e-06
Identities = 23/82 (28%), Positives = 30/82 (36%), Gaps = 5/82 (6%)
Query: 13 SLSPLRGLKVLDLSQNNLSGEI---PEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASA 69
L+ L+ LDLS+N + E + LQ L LS N+ SM T I
Sbjct: 329 FSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKN 388
Query: 70 -TSV-FGNNKLCGGIPEFQLPT 89
TS+ N Q P
Sbjct: 389 LTSLDISRNTFHPMPDSCQWPE 410
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 4e-06
Identities = 14/58 (24%), Positives = 24/58 (41%), Gaps = 3/58 (5%)
Query: 9 PIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKN 66
G L L+ L LD+S+N +P+ + ++ LNLS + I +
Sbjct: 378 KTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRVV--KTCIPQT 432
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 1e-05
Identities = 16/54 (29%), Positives = 26/54 (48%), Gaps = 1/54 (1%)
Query: 13 SLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKN 66
+ L L+ LDLS N+LS + L+ LNL N +++ + +F N
Sbjct: 69 AFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQT-LGVTSLFPN 121
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 4e-05
Identities = 4/65 (6%), Positives = 22/65 (33%), Gaps = 2/65 (3%)
Query: 4 NLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGI 63
+ + L ++ L + Q L ++ + + ++ + + ++ +
Sbjct: 272 SESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLV--PCSF 329
Query: 64 FKNAS 68
++
Sbjct: 330 SQHLK 334
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 6e-05
Identities = 12/67 (17%), Positives = 21/67 (31%)
Query: 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPT 60
+ + S L +K + + + + F K L+ L+LS N
Sbjct: 293 IPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLK 352
Query: 61 EGIFKNA 67
K A
Sbjct: 353 NSACKGA 359
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 1e-04
Identities = 10/64 (15%), Positives = 17/64 (26%), Gaps = 3/64 (4%)
Query: 4 NLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPE-FLAGFKFLQNLNLSHNNFESMIPTEG 62
+ L L+ L + EI AG L L + + +
Sbjct: 109 PYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQS--Q 166
Query: 63 IFKN 66
K+
Sbjct: 167 SLKS 170
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 12/54 (22%), Positives = 23/54 (42%), Gaps = 2/54 (3%)
Query: 13 SLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKN 66
L L+VL L + ++ + L++L+LS N+ S+ + F
Sbjct: 45 DLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSL--SSSWFGP 96
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 16/63 (25%), Positives = 25/63 (39%), Gaps = 6/63 (9%)
Query: 4 NLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGI 63
+ P GL+ + +K LDLS N ++ L LQ L L + + I
Sbjct: 16 SFTSIPSGLTAA----MKSLDLSFNKITYIGHGDLRACANLQVLILKSSRI-NTIE-GDA 69
Query: 64 FKN 66
F +
Sbjct: 70 FYS 72
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 5e-04
Identities = 17/125 (13%), Positives = 35/125 (28%), Gaps = 5/125 (4%)
Query: 2 HGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTE 61
+ F + + L L L++ +L + L + + +L L + ++
Sbjct: 132 NVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLE-- 189
Query: 62 GIFKNASA--TSVFGNNKLCGGIPEFQLPTCVSKKTKQNRSTLPLKLVIAIDCGLLVLTL 119
S+ + L LP + + L LL L
Sbjct: 190 IFADILSSVRYLELRDTNLA-RFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLR 248
Query: 120 ALSSL 124
+ L
Sbjct: 249 YILEL 253
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 6e-04
Identities = 17/55 (30%), Positives = 26/55 (47%), Gaps = 5/55 (9%)
Query: 12 LSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKN 66
+ + L+VLD+S NNL FL LQ L +S N ++ +P +F
Sbjct: 425 VKTCIPQTLEVLDVSNNNLD-SFSLFL---PRLQELYISRNKLKT-LPDASLFPV 474
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 4e-06
Identities = 13/66 (19%), Positives = 24/66 (36%), Gaps = 4/66 (6%)
Query: 4 NLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIP-EFLAGFKFLQNLNLSHNNFESMIPTEG 62
+ G L K++ + + ++P L F+ ++ LNL+ E I
Sbjct: 37 QTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEE-ID-TY 93
Query: 63 IFKNAS 68
F A
Sbjct: 94 AFAYAH 99
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 49.2 bits (117), Expect = 5e-06
Identities = 18/57 (31%), Positives = 26/57 (45%), Gaps = 3/57 (5%)
Query: 10 IGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKN 66
+ L P+ LKVLDLS N+L + F L+NL L HN+ + +
Sbjct: 293 LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVT-LK-LSTHHT 346
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 1e-05
Identities = 12/67 (17%), Positives = 28/67 (41%), Gaps = 4/67 (5%)
Query: 13 SLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSV 72
++ L+ L +S N L + + L+ L+LSHN+ + + ++
Sbjct: 273 PFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLH-VE-RNQPQFDRLENL 329
Query: 73 F-GNNKL 78
+ +N +
Sbjct: 330 YLDHNSI 336
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 46.5 bits (110), Expect = 4e-05
Identities = 13/55 (23%), Positives = 21/55 (38%), Gaps = 4/55 (7%)
Query: 12 LSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKN 66
+ L +L L NNL+ + + L ++LS+N E I F
Sbjct: 226 VRGPVNVELTILKLQHNNLT-DTAWL-LNYPGLVEVDLSYNELEK-IM-YHPFVK 276
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 9e-05
Identities = 13/55 (23%), Positives = 22/55 (40%), Gaps = 4/55 (7%)
Query: 13 SLSPLRGLKVLDLSQNNLSGEIPE-FLAGFKFLQNLNLSHNNFESMIPTEGIFKN 66
+ + ++ L + N + +P L L L N+ S +P GIF N
Sbjct: 94 AFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSS-LP-RGIFHN 145
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 1e-04
Identities = 13/58 (22%), Positives = 25/58 (43%), Gaps = 4/58 (6%)
Query: 13 SLSPLRGLKVLDLSQNNLSGEIPEF-LAGFKFLQNLNLSHNNFESMIPTEGIFKNASA 69
L R +++L+L+ + EI + A +Q L + N +P +F+N
Sbjct: 70 LLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAI-RYLP-PHVFQNVPL 124
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 44.5 bits (105), Expect = 1e-04
Identities = 14/54 (25%), Positives = 19/54 (35%), Gaps = 4/54 (7%)
Query: 14 LSPLRGLKVLDLSQNNLSGEIP-EFLAGFKFLQNLNLSHNNFESMIPTEGIFKN 66
L L +S NNL I + LQNL LS N + + +
Sbjct: 143 FHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLTH-VD-LSLIPS 193
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 11/44 (25%), Positives = 20/44 (45%), Gaps = 3/44 (6%)
Query: 13 SLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFES 56
+L+ ++ LD S N+++ + + L L L HNN
Sbjct: 206 TLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLTD 246
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 16/55 (29%), Positives = 25/55 (45%), Gaps = 4/55 (7%)
Query: 13 SLSPLRGLKVLDLSQNNLSGEIP-EFLAGFKFLQNLNLSHNNFESMIPTEGIFKN 66
+ L VL L +N+LS +P L L++S+NN E I + F+
Sbjct: 118 VFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLER-IE-DDTFQA 169
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 43.8 bits (103), Expect = 3e-04
Identities = 13/46 (28%), Positives = 21/46 (45%), Gaps = 2/46 (4%)
Query: 13 SLSPLRGLKVLDLSQNNLSGEIPEF-LAGFKFLQNLNLSHNNFESM 57
L GL +DLS N L +I + L+ L +S+N ++
Sbjct: 249 WLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLVAL 293
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 43.0 bits (101), Expect = 4e-04
Identities = 11/44 (25%), Positives = 20/44 (45%), Gaps = 3/44 (6%)
Query: 13 SLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFES 56
+ L+ L LS N L+ + L+ L + N+S+N +
Sbjct: 166 TFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLLST 206
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 4e-06
Identities = 52/223 (23%), Positives = 87/223 (39%), Gaps = 43/223 (19%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACS 227
IG GNF + G VAIK L S++ + E + K + +
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIK----LEPMKSRAPQLHLEY-------RFYKQLGSGD 65
Query: 228 ---RVDYQG--NDFKALVYEFMPNG-SLEEWIHPITEEDKRHKAPGNLNSLER-LNIAID 280
+V Y G + A+V E + G SLE D SL+ L IAI
Sbjct: 66 GIPQVYYFGPCGKYNAMVLELL--GPSLE---------DLFDLCDRTF-SLKTVLMIAIQ 113
Query: 281 VASALEYLHLGCKPPIAHCDIKPSNILL-----NDEMTACVADFGIA-RFLEATNEQ--- 331
+ S +EY+H + + D+KP N L+ + + DF +A +++ ++
Sbjct: 114 LISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIP 170
Query: 332 -TSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTG 373
+ GT Y++ +G E S D+ + G + + G
Sbjct: 171 YREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRG 213
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 5e-06
Identities = 19/54 (35%), Positives = 23/54 (42%), Gaps = 3/54 (5%)
Query: 13 SLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKN 66
SLS L L+ L L N LS +P L K LQ + L NN + F
Sbjct: 236 SLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITK-VG-VNDFCP 286
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 19/54 (35%), Positives = 28/54 (51%), Gaps = 5/54 (9%)
Query: 13 SLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKN 66
+ SPLR L+ L +S+N+L EIP L L L + N +P +G+F
Sbjct: 97 AFSPLRKLQKLYISKNHLV-EIPPNL--PSSLVELRIHDNRI-RKVP-KGVFSG 145
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 8e-06
Identities = 47/242 (19%), Positives = 81/242 (33%), Gaps = 39/242 (16%)
Query: 167 LIGAGNFASVYKGILFEGAP-----AVAIKV-----------FNFLHHDASKSFTVECEV 210
IG G F +Y + +KV F A +
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 211 MRNIIHRKIIKVVTACSRVDYQGNDFKALVYEFMPNG-SLEEWIHPITEEDKRHKAPGNL 269
R + + + K D G ++ ++ + G L+
Sbjct: 102 TRKLKYLGVPKYW-GSGLHDKNGKSYRFMIMDRF--GSDLQ---------KIYEANAKRF 149
Query: 270 NSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACV--ADFGIA-RFLE 326
+ L +++ + LEY+H + H DIK SN+LLN + V D+G+A R+
Sbjct: 150 SRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCP 206
Query: 327 ATNEQ----TSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFK 382
+ GT + + + G S GD+ G +++ TG P +D K
Sbjct: 207 EGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK 266
Query: 383 DN 384
D
Sbjct: 267 DP 268
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 1e-05
Identities = 54/264 (20%), Positives = 91/264 (34%), Gaps = 77/264 (29%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNI-----IHRKIIKV 222
+G G+F++V+ +G VA+KV H + E +++++ V
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETA-LDEIRLLKSVRNSDPNDPNREMV 103
Query: 223 VTACSRVDYQGNDFK--ALVYEFMPNG-SLEEWIHPITEEDKRHKAPGNLNSLERL-NIA 278
V G + +V+E + G L +WI K+ L + I
Sbjct: 104 VQLLDDFKISGVNGTHICMVFEVL--GHHLLKWII---------KSNYQGLPLPCVKKII 152
Query: 279 IDVASALEYLHLGCKPPIAHCDIKPSNILLN----------------------------- 309
V L+YLH C+ I H DIKP NILL+
Sbjct: 153 QQVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAV 210
Query: 310 --------------------DEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYG 349
+++ +AD G A ++ T I T Y + E
Sbjct: 211 STAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVH--KHFTEDI---QTRQYRSLEVL 265
Query: 350 MGHETSSYGDVYSFGILLLEMFTG 373
+G ++ D++S + E+ TG
Sbjct: 266 IGSGYNTPADIWSTACMAFELATG 289
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 1e-05
Identities = 11/41 (26%), Positives = 21/41 (51%)
Query: 13 SLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNN 53
+LS L L +LD+S + I + + +++LS+N
Sbjct: 107 NLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNG 147
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 5e-05
Identities = 12/48 (25%), Positives = 25/48 (52%)
Query: 14 LSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTE 61
+S L L+ L + +++ + L+G L L++SH+ + I T+
Sbjct: 84 ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTK 131
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 1e-05
Identities = 15/44 (34%), Positives = 25/44 (56%), Gaps = 1/44 (2%)
Query: 13 SLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFES 56
SL+ L+ L L+ N L ++P LA K++Q + L +NN +
Sbjct: 235 SLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISA 277
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 3e-04
Identities = 10/54 (18%), Positives = 21/54 (38%), Gaps = 5/54 (9%)
Query: 13 SLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKN 66
+ ++ L + ++ N++ IP+ L L L+L N + K
Sbjct: 166 AFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITK-VD-AASLKG 214
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 5e-04
Identities = 16/54 (29%), Positives = 22/54 (40%), Gaps = 2/54 (3%)
Query: 13 SLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKN 66
L+ L L L N +S P A L+ L LS N + +P E + K
Sbjct: 71 DFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKE-LP-EKMPKT 122
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 46/223 (20%), Positives = 82/223 (36%), Gaps = 43/223 (19%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACS 227
IG G+F +++G VAIK S + + E + K++ C+
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKF----EPRRSDAPQLRDEY-------RTYKLLAGCT 66
Query: 228 ---RVDYQG--NDFKALVYEFMPNG-SLEEWIHPITEEDKRHKAPGNLNSLER-LNIAID 280
V Y G LV + + G SLE D S++ A
Sbjct: 67 GIPNVYYFGQEGLHNVLVIDLL--GPSLE---------DLLDLCGRKF-SVKTVAMAAKQ 114
Query: 281 VASALEYLHLGCKPPIAHCDIKPSNILL-----NDEMTACVADFGIA-RFLEATNEQ--- 331
+ + ++ +H + + + DIKP N L+ + V DFG+ + + +Q
Sbjct: 115 MLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIP 171
Query: 332 -TSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTG 373
+ GT Y++ +G E S D+ + G + + G
Sbjct: 172 YREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRG 214
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 54/223 (24%), Positives = 87/223 (39%), Gaps = 39/223 (17%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACS 227
IG+G+F +Y G VAIK+ +K + E KI K++
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKL----ECVKTKHPQLHIES-------KIYKMMQGGV 65
Query: 228 ---RVDYQG--NDFKALVYEFMPNG-SLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDV 281
+ + G D+ +V E + G SLE D + + L +A +
Sbjct: 66 GIPTIRWCGAEGDYNVMVMELL--GPSLE---------DLFNFCSRKFSLKTVLLLADQM 114
Query: 282 ASALEYLHLGCKPPIAHCDIKPSNILL---NDEMTACVADFGIA-RFLEATNEQ----TS 333
S +EY+H H D+KP N L+ + DFG+A ++ +A Q
Sbjct: 115 ISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRE 171
Query: 334 SIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRP 376
+ + GT Y + +G E S D+ S G +L+ G P
Sbjct: 172 NKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 2e-05
Identities = 14/54 (25%), Positives = 25/54 (46%), Gaps = 2/54 (3%)
Query: 13 SLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKN 66
S LK LDLS N + + G + L++L+ H+N + + +F +
Sbjct: 73 SDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQ-MSEFSVFLS 124
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 9e-05
Identities = 13/66 (19%), Positives = 25/66 (37%), Gaps = 2/66 (3%)
Query: 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPT 60
+ E + + L L+VL++S NN LQ L+ S N+ +
Sbjct: 182 LSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMT-SK- 239
Query: 61 EGIFKN 66
+ ++
Sbjct: 240 KQELQH 245
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 1e-04
Identities = 13/53 (24%), Positives = 20/53 (37%), Gaps = 1/53 (1%)
Query: 14 LSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKN 66
LR L LD+S + G L+ L ++ N+F+ IF
Sbjct: 122 FLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFL-PDIFTE 173
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 5e-04
Identities = 19/58 (32%), Positives = 27/58 (46%), Gaps = 4/58 (6%)
Query: 13 SLSPLRGLKVLDLSQNNLSGEIPE-FLAGFKFLQNLNLSHNNFESMIPTEGIFKNASA 69
+ LR L LDLSQ L ++ LQ LN+SHNNF + +K ++
Sbjct: 170 IFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNF-FSLD-TFPYKCLNS 224
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 8e-04
Identities = 11/54 (20%), Positives = 20/54 (37%), Gaps = 3/54 (5%)
Query: 14 LSPLRGLKVLDLSQNNLSGEIPE-FLAGFKFLQNLNLSHNNFESMIPTEGIFKN 66
+ L L+VL ++ N+ + L L+LS E + F +
Sbjct: 146 FNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQ-LS-PTAFNS 197
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 3e-05
Identities = 28/182 (15%), Positives = 55/182 (30%), Gaps = 42/182 (23%)
Query: 165 ENLIGAGNFASVYKGILFEGAPA--------VAIKVFNFLHHDASKSFTVECEVMRNIIH 216
++ N +Y+ ++K L + F E +
Sbjct: 47 KSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK----LDAKDGRLF-NEQNFFQRAAK 101
Query: 217 RKIIKVVTACSRVDYQG-----------NDFKALVYEFMPNG-SLEEWIHPITEEDKRHK 264
+ + ++ LV + G SL+
Sbjct: 102 PLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQ---------SALDV 150
Query: 265 APGNLNSLER-LNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACV--ADFGI 321
+P ++ S L +A + ALE+LH + H ++ NI ++ E + V A +G
Sbjct: 151 SPKHVLSERSVLQVACRLLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQVTLAGYGF 207
Query: 322 AR 323
A
Sbjct: 208 AF 209
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 4e-05
Identities = 17/57 (29%), Positives = 29/57 (50%), Gaps = 5/57 (8%)
Query: 10 IGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKN 66
+ +LS L+ K L LS NN+ +I L+G + L+ L+L N + + E +
Sbjct: 40 MDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIKKI---ENLDAV 91
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 19/66 (28%), Positives = 33/66 (50%), Gaps = 5/66 (7%)
Query: 14 LSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVF 73
LS + L++L L +N + +I A L+ L +S+N S+ GI K + ++
Sbjct: 66 LSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL---SGIEKLVNLRVLY 121
Query: 74 -GNNKL 78
NNK+
Sbjct: 122 MSNNKI 127
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 46.1 bits (109), Expect = 4e-05
Identities = 11/45 (24%), Positives = 20/45 (44%), Gaps = 4/45 (8%)
Query: 17 LRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTE 61
+ L L++ NLS +P+ L + L ++ N S +P
Sbjct: 58 INQFSELQLNRLNLS-SLPDNL--PPQITVLEITQNALIS-LPEL 98
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 16/67 (23%), Positives = 28/67 (41%), Gaps = 11/67 (16%)
Query: 17 LRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSV---- 72
L+VL + N L+ +PE L+ L++S N ES +P +N +
Sbjct: 159 PTSLEVLSVRNNQLT-FLPELPES---LEALDVSTNLLES-LP-AVPVRNHHSEETEIFF 212
Query: 73 -FGNNKL 78
N++
Sbjct: 213 RCRENRI 219
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 4e-05
Identities = 16/44 (36%), Positives = 22/44 (50%)
Query: 14 LSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESM 57
L L LK L+LS N +SG + L +LNLS N + +
Sbjct: 60 LPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDL 103
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 6e-05
Identities = 10/47 (21%), Positives = 20/47 (42%), Gaps = 2/47 (4%)
Query: 13 SLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIP 59
+ L L ++ S N L+ P L L ++ +++N + P
Sbjct: 63 GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP 107
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 7e-05
Identities = 16/47 (34%), Positives = 23/47 (48%), Gaps = 2/47 (4%)
Query: 13 SLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIP 59
+L+ L L LDL+ N +S P L+G L L L N ++ P
Sbjct: 238 TLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP 282
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 1e-04
Identities = 15/76 (19%), Positives = 24/76 (31%), Gaps = 6/76 (7%)
Query: 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPT 60
+ N SL+ L + L N +S P LA + L L+ + +
Sbjct: 338 FYNNKVSDVS--SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVN 393
Query: 61 EGIFKNASATSVFGNN 76
N S + N
Sbjct: 394 --YKANVSIPNTVKNV 407
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 1e-04
Identities = 8/48 (16%), Positives = 18/48 (37%), Gaps = 2/48 (4%)
Query: 12 LSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIP 59
+S + L + L + + + + L +N S+N + P
Sbjct: 40 VSQTDLDQVTTLQADRLGIK--SIDGVEYLNNLTQINFSNNQLTDITP 85
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 2e-04
Identities = 16/66 (24%), Positives = 26/66 (39%), Gaps = 5/66 (7%)
Query: 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPT 60
++ N E +S L+ L L L NN+S P ++ LQ L +N + +
Sbjct: 294 LNENQLEDISPIS--NLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD-VSS 348
Query: 61 EGIFKN 66
N
Sbjct: 349 LANLTN 354
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 3e-04
Identities = 14/48 (29%), Positives = 23/48 (47%), Gaps = 2/48 (4%)
Query: 12 LSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIP 59
L+ L L+ LD+S N +S LA L++L ++N + P
Sbjct: 171 KPLANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITP 216
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 3e-04
Identities = 12/46 (26%), Positives = 19/46 (41%), Gaps = 2/46 (4%)
Query: 14 LSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIP 59
L L L + ++ N ++ P LA L L L +N + P
Sbjct: 86 LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP 129
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 4e-04
Identities = 15/47 (31%), Positives = 22/47 (46%), Gaps = 2/47 (4%)
Query: 13 SLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIP 59
L+ L L L+L++N L P ++ K L L L NN + P
Sbjct: 282 PLAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP 326
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 4e-04
Identities = 12/47 (25%), Positives = 20/47 (42%), Gaps = 2/47 (4%)
Query: 13 SLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIP 59
L+ L L+ L + N +S P L L L+L+ N + +
Sbjct: 194 VLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDIGT 238
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 5e-04
Identities = 20/59 (33%), Positives = 24/59 (40%), Gaps = 4/59 (6%)
Query: 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIP 59
+ N LS L L L L N +S P LAG L NL L+ N E + P
Sbjct: 250 LANNQISNLAPLS--GLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP 304
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 6e-04
Identities = 14/47 (29%), Positives = 21/47 (44%), Gaps = 2/47 (4%)
Query: 13 SLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIP 59
L L L L L+ N L LA L +L+L++N ++ P
Sbjct: 216 PLGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP 260
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 9e-04
Identities = 19/88 (21%), Positives = 28/88 (31%), Gaps = 7/88 (7%)
Query: 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPT 60
M+ N L+ L L L L N ++ P L L L LS N +
Sbjct: 97 MNNNQIADITPLA--NLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDI--- 149
Query: 61 EGIFKNASATSVFGNNKLCGGIPEFQLP 88
+ S + N++ P L
Sbjct: 150 SALSGLTSLQQLSFGNQVTDLKPLANLT 177
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 45.3 bits (106), Expect = 6e-05
Identities = 35/247 (14%), Positives = 70/247 (28%), Gaps = 44/247 (17%)
Query: 158 ATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKV--------FNFLHHDASKSFTVECE 209
T+ IG G F V++ I VAIK+ N H + E
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIADHT--PVAIKIIAIEGPDLVNGSHQKTFEEILPEII 75
Query: 210 VMRNIIH---------------RKIIKVVTACSRV---DYQGNDFKALVYEFMPNGSLEE 251
+ + + + V + + + + P+ ++
Sbjct: 76 ISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDD 135
Query: 252 WIHPITE-----EDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNI 306
+ + E D + +I + ++L H D+ N+
Sbjct: 136 QLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNV 193
Query: 307 LLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGIL 366
LL + N ++S+I G I +Y + V+ +
Sbjct: 194 LLKKTSLKKLHYTL--------NGKSSTIPSCGLQVSII-DYTLSRLERDGIVVFCDVSM 244
Query: 367 LLEMFTG 373
++FTG
Sbjct: 245 DEDLFTG 251
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 45.1 bits (106), Expect = 9e-05
Identities = 16/44 (36%), Positives = 21/44 (47%), Gaps = 1/44 (2%)
Query: 13 SLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFES 56
L L + LDLS N L +P LA + L+ L S N E+
Sbjct: 458 HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN 500
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 1e-04
Identities = 15/44 (34%), Positives = 22/44 (50%)
Query: 14 LSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESM 57
L L LK L+LS+N + G + L +LNLS N + +
Sbjct: 67 LPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDI 110
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 1e-04
Identities = 11/47 (23%), Positives = 22/47 (46%), Gaps = 5/47 (10%)
Query: 13 SLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIP 59
L LK++D+ N+L ++P+ L+ + +N E +P
Sbjct: 148 ELQNSSFLKIIDVDNNSLK-KLPDLPPS---LEFIAAGNNQLEE-LP 189
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 51/220 (23%), Positives = 87/220 (39%), Gaps = 39/220 (17%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACS 227
IG+G+F +Y G + VAIK + + E KI +++ +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHP-QLLYES-------KIYRILQGGT 63
Query: 228 ---RVDYQG--NDFKALVYEFMPNG-SLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDV 281
V + G D+ LV + + G SLE D + L+ L +A +
Sbjct: 64 GIPNVRWFGVEGDYNVLVMDLL--GPSLE---------DLFNFCSRKLSLKTVLMLADQM 112
Query: 282 ASALEYLHLGCKPPIAHCDIKPSNILL---NDEMTACVADFGIA-RFLEATNEQ----TS 333
+ +E++H H DIKP N L+ + DFG+A ++ + + Q
Sbjct: 113 INRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRE 169
Query: 334 SIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTG 373
+ + GT Y + +G E S D+ S G +L+ G
Sbjct: 170 NKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRG 209
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 11/52 (21%), Positives = 18/52 (34%)
Query: 15 SPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKN 66
S + LD S N L+ + E L+ L L N + + +
Sbjct: 321 SKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQ 372
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 42.9 bits (101), Expect = 4e-04
Identities = 20/66 (30%), Positives = 32/66 (48%), Gaps = 5/66 (7%)
Query: 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPT 60
M N+ + +KVLDL N + IP+ + + LQ LN++ N +S +P
Sbjct: 406 MSSNIL--TDTIFRCLPPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKS-VP- 460
Query: 61 EGIFKN 66
+GIF
Sbjct: 461 DGIFDR 466
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 14/54 (25%), Positives = 19/54 (35%), Gaps = 1/54 (1%)
Query: 13 SLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKN 66
S R L +L L N L+ G L+ L+LS N + F
Sbjct: 51 SFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVD-PATFHG 103
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 3e-04
Identities = 11/49 (22%), Positives = 23/49 (46%), Gaps = 1/49 (2%)
Query: 13 SLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTE 61
++ GL+ L L++N L +P +A L+ L++ + +P
Sbjct: 122 TMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEP 169
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 3e-04
Identities = 10/58 (17%), Positives = 18/58 (31%), Gaps = 2/58 (3%)
Query: 4 NLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTE 61
L L + G L+L L + P+ LQ++ + +P
Sbjct: 67 ALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLME-LPDT 122
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 42.2 bits (100), Expect = 5e-04
Identities = 11/49 (22%), Positives = 21/49 (42%), Gaps = 2/49 (4%)
Query: 13 SLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTE 61
L L+ + + L E+P+ + F L+ L L+ N + +P
Sbjct: 99 QAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLRA-LPAS 145
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 7e-04
Identities = 11/49 (22%), Positives = 18/49 (36%)
Query: 13 SLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTE 61
++ L L+ LDL P G L+ L L + +P +
Sbjct: 224 AIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLD 272
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 7e-04
Identities = 11/49 (22%), Positives = 20/49 (40%), Gaps = 1/49 (2%)
Query: 13 SLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTE 61
S++ L+ LK L + + LS + + L+ L+L P
Sbjct: 201 SIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPI 248
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 3e-04
Identities = 16/67 (23%), Positives = 26/67 (38%), Gaps = 2/67 (2%)
Query: 13 SLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSV 72
+LS L GL VL L N++ L+ L +SH + + + TS+
Sbjct: 171 ALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMT-PNCLYGLNLTSL 229
Query: 73 -FGNNKL 78
+ L
Sbjct: 230 SITHCNL 236
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 3e-04
Identities = 12/54 (22%), Positives = 23/54 (42%), Gaps = 2/54 (3%)
Query: 13 SLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKN 66
S L LKVL++S + L +L+++H N + +P ++
Sbjct: 195 SFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTA-VP-YLAVRH 246
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 4e-04
Identities = 14/58 (24%), Positives = 24/58 (41%), Gaps = 4/58 (6%)
Query: 13 SLSPLRGLKVLDLSQNNLSGEIPEF-LAGFKFLQNLNLSHNNFESMIPTEGIFKNASA 69
+ L+ L+L++N +S + L+ L L N + IP G+F S
Sbjct: 51 EFASFPHLEELELNENIVS-AVEPGAFNNLFNLRTLGLRSNRLKL-IP-LGVFTGLSN 105
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 3e-04
Identities = 15/55 (27%), Positives = 21/55 (38%), Gaps = 4/55 (7%)
Query: 13 SLSPLRGLKVLDLSQNNLSGEIP-EFLAGFKFLQNLNLSHNNFESMIPTEGIFKN 66
+ + L L L+L N L+ IP L+ L L +N IP F
Sbjct: 118 AFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPI-ESIP-SYAFNR 169
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 4e-04
Identities = 17/55 (30%), Positives = 23/55 (41%), Gaps = 4/55 (7%)
Query: 13 SLSPLRGLKVLDLSQNNLSGEIPE-FLAGFKFLQNLNLSHNNFESMIPTEGIFKN 66
+ + L L L+L N L+ IP L+ L L +N ES IP F
Sbjct: 107 AFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIES-IP-SYAFNR 158
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 6e-04
Identities = 11/45 (24%), Positives = 21/45 (46%), Gaps = 4/45 (8%)
Query: 17 LRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTE 61
G VL++ ++ L+ +P+ L + L + NN S +P
Sbjct: 39 NNGNAVLNVGESGLT-TLPDCL--PAHITTLVIPDNNLTS-LPAL 79
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 42.2 bits (99), Expect = 6e-04
Identities = 17/47 (36%), Positives = 28/47 (59%), Gaps = 3/47 (6%)
Query: 20 LKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKN 66
+KVLDL N + IP+ + + LQ LN++ N +S +P +G+F
Sbjct: 452 VKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKS-VP-DGVFDR 495
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 6e-04
Identities = 10/44 (22%), Positives = 17/44 (38%)
Query: 14 LSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESM 57
LR LK L ++ N + L L L++N+ +
Sbjct: 60 FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVEL 103
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 7e-04
Identities = 9/45 (20%), Positives = 18/45 (40%), Gaps = 2/45 (4%)
Query: 12 LSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFES 56
+S L L LD ++++ ++ L L + NN +
Sbjct: 36 ISEEQLATLTSLDCHNSSIT-DMTGI-EKLTGLTKLICTSNNITT 78
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 873 | |||
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.98 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.93 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.9 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.85 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.74 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.57 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.23 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.08 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.06 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 98.98 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.86 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 98.84 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 98.84 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 98.8 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 98.77 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 98.75 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 98.72 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 98.72 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.71 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 98.69 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 98.68 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 98.66 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 98.66 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 98.65 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 98.65 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 98.64 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 98.63 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 98.63 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 98.61 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 98.61 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 98.59 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 98.59 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 98.58 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 98.55 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 98.54 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 98.53 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 98.52 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 98.5 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 98.5 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 98.5 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 98.49 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 98.47 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 98.46 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 98.46 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 98.45 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 98.45 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 98.44 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 98.43 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 98.43 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 98.43 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 98.4 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 98.4 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 98.38 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 98.38 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 98.36 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 98.36 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 98.36 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.35 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 98.34 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 98.34 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 98.33 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 98.32 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 98.29 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 98.29 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 98.28 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 98.27 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 98.27 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 98.26 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 98.25 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 98.25 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 98.24 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 98.23 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 98.22 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 98.22 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 98.22 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 98.21 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 98.21 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 98.21 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 98.21 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 98.21 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.2 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 98.2 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.19 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 98.18 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 98.17 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 98.17 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 98.17 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 98.15 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 98.15 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 98.14 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.14 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 98.14 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 98.13 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 98.11 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 98.11 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 98.11 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 98.1 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 98.1 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 98.09 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 98.09 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 98.08 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 98.08 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 98.08 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 98.06 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 98.04 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 98.04 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 98.04 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 98.04 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 98.03 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 98.03 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 98.03 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.03 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 98.0 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 97.99 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 97.99 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 97.99 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 97.95 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.95 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.85 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 97.82 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 97.82 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 97.79 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 97.77 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 97.76 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 97.76 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 97.76 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 97.74 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 97.74 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 97.73 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 97.73 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.71 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 97.7 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 97.7 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 97.69 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 97.66 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 97.65 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 97.6 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 97.6 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 97.59 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 97.59 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 97.57 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 97.55 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 97.54 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 97.53 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 97.53 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 97.5 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 97.47 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 97.47 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 97.47 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 97.46 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 97.44 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.41 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 97.38 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.36 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 97.35 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.28 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 97.09 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.02 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 96.97 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.81 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.81 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 96.78 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.57 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.49 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 96.4 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.39 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 96.29 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.26 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.24 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 95.88 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.59 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.3 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 95.17 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 94.86 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 94.61 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 94.43 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 94.33 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.01 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 93.62 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 93.45 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 92.87 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 91.63 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 91.41 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 90.89 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 90.05 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 88.91 |
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-51 Score=453.65 Aligned_cols=268 Identities=23% Similarity=0.383 Sum_probs=204.5
Q ss_pred cCCCcceeecccCceEEEEEEEcC-----CCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCC
Q 002857 160 KGFSSENLIGAGNFASVYKGILFE-----GAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGN 234 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~-----~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~ 234 (873)
++|.+.++||+|+||.||+|++.. +++.||||+++.......++|.+|+++|++++|||||+++|+| .+.
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~-----~~~ 115 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVC-----TEG 115 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----CSS
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EEC
Confidence 456788999999999999998753 5789999999866666667899999999999999999999997 345
Q ss_pred ceEEEEEeecCCCChhhhccccccccc-----ccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeC
Q 002857 235 DFKALVYEFMPNGSLEEWIHPITEEDK-----RHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLN 309 (873)
Q Consensus 235 ~~~~LV~Ey~~~GSL~~~L~~~~~~~~-----~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd 309 (873)
+..+||||||++|+|.++|+....... .......++|.+++.|+.|||+||+||| +++||||||||+||||+
T Consensus 116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl~ 192 (329)
T 4aoj_A 116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVG 192 (329)
T ss_dssp SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEE
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEEC
Confidence 678999999999999999964221100 1123457999999999999999999999 89999999999999999
Q ss_pred CCCCeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhH
Q 002857 310 DEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQ 388 (873)
Q Consensus 310 ~~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~ 388 (873)
+++++||+|||+++...............||+.|||||++.+..++.++|||||||+||||+| |+.||.......
T Consensus 193 ~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~---- 268 (329)
T 4aoj_A 193 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE---- 268 (329)
T ss_dssp TTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH----
T ss_pred CCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH----
Confidence 999999999999997655444444445679999999999999999999999999999999999 899997632111
Q ss_pred HHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHH
Q 002857 389 NWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLI 468 (873)
Q Consensus 389 ~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i 468 (873)
+++...... ..+.+ ..++..+.+|+.+||+.||++||||.||++.|+.+
T Consensus 269 -------------~~~~i~~g~-----------~~~~p-------~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l 317 (329)
T 4aoj_A 269 -------------AIDCITQGR-----------ELERP-------RACPPEVYAIMRGCWQREPQQRHSIKDVHARLQAL 317 (329)
T ss_dssp -------------HHHHHHHTC-----------CCCCC-------TTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHH
T ss_pred -------------HHHHHHcCC-----------CCCCc-------ccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 111110000 00000 11234588999999999999999999999999988
Q ss_pred HH
Q 002857 469 KK 470 (873)
Q Consensus 469 ~~ 470 (873)
.+
T Consensus 318 ~~ 319 (329)
T 4aoj_A 318 AQ 319 (329)
T ss_dssp HH
T ss_pred hh
Confidence 65
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-51 Score=449.01 Aligned_cols=269 Identities=23% Similarity=0.407 Sum_probs=212.6
Q ss_pred cCCCcceeecccCceEEEEEEEcC-----CCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCC
Q 002857 160 KGFSSENLIGAGNFASVYKGILFE-----GAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGN 234 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~-----~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~ 234 (873)
++|.+.+.||+|+||+||+|++.. ++..||||+++.......++|.+|+++|++++|||||+++|+| .++
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~-----~~~ 87 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVC-----VEG 87 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----CSS
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEE-----eeC
Confidence 467888999999999999998753 5778999999866666667899999999999999999999997 345
Q ss_pred ceEEEEEeecCCCChhhhcccccccc---cccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCC
Q 002857 235 DFKALVYEFMPNGSLEEWIHPITEED---KRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDE 311 (873)
Q Consensus 235 ~~~~LV~Ey~~~GSL~~~L~~~~~~~---~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~ 311 (873)
+..+||||||++|+|.++|+...... ........++|.+++.|+.|||+||+||| +++||||||||+||||+++
T Consensus 88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDlKp~NILl~~~ 164 (299)
T 4asz_A 88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGEN 164 (299)
T ss_dssp SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGG
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccCHhhEEECCC
Confidence 67899999999999999996421100 01123567999999999999999999999 8999999999999999999
Q ss_pred CCeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHH
Q 002857 312 MTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNW 390 (873)
Q Consensus 312 ~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~ 390 (873)
+++||+|||+|+...............||+.|||||++.+..++.++|||||||+||||+| |+.||.......
T Consensus 165 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~------ 238 (299)
T 4asz_A 165 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE------ 238 (299)
T ss_dssp GCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH------
T ss_pred CcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH------
Confidence 9999999999997655443333444569999999999999999999999999999999999 899997632111
Q ss_pred HhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHHHH
Q 002857 391 VQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLIKK 470 (873)
Q Consensus 391 ~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i~~ 470 (873)
++....... ....| ..++.++.+|+.+||+.||++||||+||++.|+.+.+
T Consensus 239 -----------~~~~i~~~~---------~~~~p---------~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~ 289 (299)
T 4asz_A 239 -----------VIECITQGR---------VLQRP---------RTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289 (299)
T ss_dssp -----------HHHHHHHTC---------CCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----------HHHHHHcCC---------CCCCC---------ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 111110000 00001 0123458899999999999999999999999998765
Q ss_pred h
Q 002857 471 K 471 (873)
Q Consensus 471 ~ 471 (873)
.
T Consensus 290 ~ 290 (299)
T 4asz_A 290 A 290 (299)
T ss_dssp H
T ss_pred c
Confidence 3
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-51 Score=446.25 Aligned_cols=262 Identities=25% Similarity=0.411 Sum_probs=201.1
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCC--cchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceE
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH--DASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFK 237 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~ 237 (873)
++|.+.++||+|+||+||+|++. ..||||+++.... ...+.|.+|+++|++++|||||+++|+|. .+..
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~------~~~~ 106 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT------KDNL 106 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC------SSSC
T ss_pred HHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE------CCeE
Confidence 56788899999999999999863 2599999874432 33467999999999999999999999863 2347
Q ss_pred EEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEe
Q 002857 238 ALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVA 317 (873)
Q Consensus 238 ~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLs 317 (873)
+||||||++|+|.++|+. ....++|.+++.|+.|||+||+||| +++||||||||+||||++++++||+
T Consensus 107 ~iVmEy~~gGsL~~~l~~---------~~~~l~~~~~~~i~~qia~gL~yLH---~~~IiHRDlKp~NILl~~~~~~Ki~ 174 (307)
T 3omv_A 107 AIVTQWCEGSSLYKHLHV---------QETKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIG 174 (307)
T ss_dssp EEEEECCSSCBHHHHHHT---------SCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCSSSEEEETTEEEEEC
T ss_pred EEEEEcCCCCCHHHHHhh---------cCCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCccCHHHEEECCCCcEEEe
Confidence 999999999999999953 3456999999999999999999999 8999999999999999999999999
Q ss_pred ccccccccccccccccccccccccccCCCcccCC---CCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhc
Q 002857 318 DFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMG---HETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSA 394 (873)
Q Consensus 318 DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~---~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~ 394 (873)
|||+|+...............||+.|||||++.+ ..|+.++|||||||+||||+||+.||........ +..
T Consensus 175 DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~-~~~----- 248 (307)
T 3omv_A 175 DFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQ-IIF----- 248 (307)
T ss_dssp CCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH-HHH-----
T ss_pred eccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHH-HHH-----
Confidence 9999987654433333445679999999999864 4689999999999999999999999975322111 111
Q ss_pred CchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHHHHhh
Q 002857 395 LPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLIKKKL 472 (873)
Q Consensus 395 ~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i~~~l 472 (873)
++.... ..|... .....++..+.+|+.+||+.||++||||.||++.|+.++..+
T Consensus 249 -------~~~~~~--------------~~p~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l 302 (307)
T 3omv_A 249 -------MVGRGY--------------ASPDLS---KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL 302 (307)
T ss_dssp -------HHHTTC--------------CCCCST---TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred -------HHhcCC--------------CCCCcc---cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence 110000 000000 000123445889999999999999999999999999886544
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-50 Score=444.02 Aligned_cols=265 Identities=22% Similarity=0.385 Sum_probs=207.4
Q ss_pred CCCcceeecccCceEEEEEEEc-----CCCcEEEEEEeeccCC-cchhHHHHHHHHHHhhhhccceeeeeeeecccccCC
Q 002857 161 GFSSENLIGAGNFASVYKGILF-----EGAPAVAIKVFNFLHH-DASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGN 234 (873)
Q Consensus 161 ~f~~~~~LG~G~fG~VYkg~~~-----~~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~ 234 (873)
++++.++||+|+||+||+|++. .+++.||||+++.... ...++|.+|+.+|++++|||||+++|+|. .+
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-----~~ 101 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVT-----KD 101 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SS
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEE-----EC
Confidence 4566789999999999999874 3567899999975433 34578999999999999999999999973 45
Q ss_pred ceEEEEEeecCCCChhhhcccccccc------cccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeee
Q 002857 235 DFKALVYEFMPNGSLEEWIHPITEED------KRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILL 308 (873)
Q Consensus 235 ~~~~LV~Ey~~~GSL~~~L~~~~~~~------~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILL 308 (873)
+..+||||||++|+|.++|+...... ........++|.+++.|+.|||+||+||| +.+||||||||+||||
T Consensus 102 ~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLK~~NILl 178 (308)
T 4gt4_A 102 QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLV 178 (308)
T ss_dssp SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCccccceEE
Confidence 66899999999999999996411100 00112356999999999999999999999 8999999999999999
Q ss_pred CCCCCeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhh
Q 002857 309 NDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNL 387 (873)
Q Consensus 309 d~~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l 387 (873)
++++++||+|||+++...............||+.|||||++.+..++.++|||||||+||||+| |+.||....... +
T Consensus 179 ~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~--~ 256 (308)
T 4gt4_A 179 YDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD--V 256 (308)
T ss_dssp CGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH--H
T ss_pred CCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH--H
Confidence 9999999999999997755444444445679999999999999999999999999999999999 899997632211 1
Q ss_pred HHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHH
Q 002857 388 QNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRL 467 (873)
Q Consensus 388 ~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~ 467 (873)
.. .+. ... ..|.+ ..++..+.+|+.+||+.||++||||.||++.|+.
T Consensus 257 ~~------------~i~---~~~-----------~~~~p-------~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a 303 (308)
T 4gt4_A 257 VE------------MIR---NRQ-----------VLPCP-------DDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRA 303 (308)
T ss_dssp HH------------HHH---TTC-----------CCCCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred HH------------HHH---cCC-----------CCCCc-------ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 11 110 000 00110 1234458899999999999999999999999985
Q ss_pred H
Q 002857 468 I 468 (873)
Q Consensus 468 i 468 (873)
+
T Consensus 304 ~ 304 (308)
T 4gt4_A 304 W 304 (308)
T ss_dssp S
T ss_pred c
Confidence 3
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-49 Score=432.56 Aligned_cols=282 Identities=23% Similarity=0.313 Sum_probs=201.4
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEE
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKAL 239 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~L 239 (873)
++|.+.++||+|+||+||+|++ +|+.||||+++.... ....+..|+..+.+++|||||+++|+|.... ......+|
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~-~~~~~~~l 78 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecC-CCceEEEE
Confidence 4577889999999999999988 578999999964321 1122344555667889999999999986422 12246899
Q ss_pred EEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCC-----CCCeeeccCCCCCeeeCCCCCe
Q 002857 240 VYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGC-----KPPIAHCDIKPSNILLNDEMTA 314 (873)
Q Consensus 240 V~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~-----s~gIvHrDLKpsNILLd~~~~v 314 (873)
||||+++|+|.++|+. ..++|..+++|+.|+|+||+|||+.+ .++||||||||+||||+.++++
T Consensus 79 V~Ey~~~gsL~~~l~~-----------~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~ 147 (303)
T 3hmm_A 79 VSDYHEHGSLFDYLNR-----------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC 147 (303)
T ss_dssp EEECCTTCBHHHHHHH-----------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCE
T ss_pred EecCCCCCcHHHHHHh-----------CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCE
Confidence 9999999999999953 35899999999999999999999321 2399999999999999999999
Q ss_pred EEecccccccccccccc--ccccccccccccCCCcccCCC------CCCcchhhHhHHHHHHHHHhCCCCCCcccccchh
Q 002857 315 CVADFGIARFLEATNEQ--TSSIGVKGTTGYIAPEYGMGH------ETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLN 386 (873)
Q Consensus 315 KLsDFGla~~~~~~~~~--~~~~~~~Gt~~Y~APE~l~~~------~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~ 386 (873)
||+|||+|+........ .......||+.|||||++.+. .++.++|||||||+||||+||+.||.........
T Consensus 148 Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p 227 (303)
T 3hmm_A 148 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 227 (303)
T ss_dssp EECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCT
T ss_pred EEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcccccccc
Confidence 99999999876544322 122345799999999998764 4678999999999999999999887653222211
Q ss_pred hHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHH
Q 002857 387 LQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLR 466 (873)
Q Consensus 387 l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le 466 (873)
+..+.... ....++........ ..|..+... ...+++..+.+|+.+||+.||++||||.||++.|+
T Consensus 228 ~~~~~~~~--~~~~~~~~~~~~~~-----------~rp~~p~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 293 (303)
T 3hmm_A 228 YYDLVPSD--PSVEEMRKVVCEQK-----------LRPNIPNRW-QSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293 (303)
T ss_dssp TTTTSCSS--CCHHHHHHHHTTSC-----------CCCCCCGGG-GSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHH
T ss_pred chhccccc--chHHHHHHHHhccc-----------CCCCCCccc-cchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHH
Confidence 11111100 01111111111100 001111100 11234567889999999999999999999999999
Q ss_pred HHHH
Q 002857 467 LIKK 470 (873)
Q Consensus 467 ~i~~ 470 (873)
.|.+
T Consensus 294 ~l~~ 297 (303)
T 3hmm_A 294 QLSQ 297 (303)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 8865
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=436.28 Aligned_cols=278 Identities=20% Similarity=0.275 Sum_probs=215.9
Q ss_pred HHHHHhhcCCCcceeecccCceEEEEEEEcCC-----CcEEEEEEeeccCC-cchhHHHHHHHHHHhhhh-ccceeeeee
Q 002857 153 EALYSATKGFSSENLIGAGNFASVYKGILFEG-----APAVAIKVFNFLHH-DASKSFTVECEVMRNIIH-RKIIKVVTA 225 (873)
Q Consensus 153 ~el~~at~~f~~~~~LG~G~fG~VYkg~~~~~-----g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~H-pNIV~llg~ 225 (873)
++.+...++|++.+.||+|+||.||+|++... ++.||||+++.... ...+.|.+|+++|.+++| ||||+++|+
T Consensus 57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~ 136 (353)
T 4ase_A 57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 136 (353)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEE
Confidence 34444567899999999999999999998653 36899999975433 334679999999999965 899999999
Q ss_pred eecccccCCceEEEEEeecCCCChhhhccccccccc------ccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeec
Q 002857 226 CSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDK------RHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHC 299 (873)
Q Consensus 226 c~~~~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~------~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHr 299 (873)
|. ..+...+||||||++|+|.++|+....... .......+++.+++.|+.|||+||+||| +++||||
T Consensus 137 ~~----~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH---~~~iiHR 209 (353)
T 4ase_A 137 CT----KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHR 209 (353)
T ss_dssp EC----CTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred EE----ecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---hCCeecC
Confidence 74 334568999999999999999964221100 0112456899999999999999999999 8999999
Q ss_pred cCCCCCeeeCCCCCeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCC
Q 002857 300 DIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSD 378 (873)
Q Consensus 300 DLKpsNILLd~~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~ 378 (873)
||||+|||+++++++||+|||+|+.+.............||+.|||||++.+..++.++|||||||+||||+| |+.||.
T Consensus 210 DLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~ 289 (353)
T 4ase_A 210 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 289 (353)
T ss_dssp CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred ccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999997755544444455679999999999999999999999999999999998 999997
Q ss_pred cccccchhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCH
Q 002857 379 DMFKDNLNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKI 458 (873)
Q Consensus 379 ~~~~~~~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm 458 (873)
....... + ...+..... ...|. .+..++.+++.+||+.||++||||
T Consensus 290 ~~~~~~~-~------------~~~i~~g~~------------~~~p~---------~~~~~~~~li~~c~~~dP~~RPt~ 335 (353)
T 4ase_A 290 GVKIDEE-F------------CRRLKEGTR------------MRAPD---------YTTPEMYQTMLDCWHGEPSQRPTF 335 (353)
T ss_dssp TCCCSHH-H------------HHHHHHTCC------------CCCCT---------TCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred CCCHHHH-H------------HHHHHcCCC------------CCCCc---------cCCHHHHHHHHHHcCcChhHCcCH
Confidence 6322110 1 111110000 00010 123357889999999999999999
Q ss_pred HHHHHHHHHHHHh
Q 002857 459 NDVELGLRLIKKK 471 (873)
Q Consensus 459 ~EVl~~Le~i~~~ 471 (873)
.||++.|+.+.+.
T Consensus 336 ~eil~~L~~llq~ 348 (353)
T 4ase_A 336 SELVEHLGNLLQA 348 (353)
T ss_dssp HHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHH
Confidence 9999999988653
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-49 Score=435.67 Aligned_cols=251 Identities=22% Similarity=0.273 Sum_probs=199.7
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCC--cchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceE
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH--DASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFK 237 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~ 237 (873)
++|++.+.||+|+||+||+|++..+++.||||+++.... ...+.+.+|+++|++++|||||++++++ .+++..
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~-----~~~~~~ 98 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESF-----EENGSL 98 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----EETTEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEE-----EECCEE
Confidence 689999999999999999999999999999999975432 3346799999999999999999999995 456789
Q ss_pred EEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEe
Q 002857 238 ALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVA 317 (873)
Q Consensus 238 ~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLs 317 (873)
+|||||+++|+|.++|.. .....+++.+++.|+.||+.||+||| +++||||||||+||||+.++++||+
T Consensus 99 yiVmEy~~gg~L~~~i~~--------~~~~~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~ 167 (350)
T 4b9d_A 99 YIVMDYCEGGDLFKRINA--------QKGVLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLG 167 (350)
T ss_dssp EEEEECCTTCBHHHHHHH--------TTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCEEEC
T ss_pred EEEEeCCCCCcHHHHHHH--------cCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEc
Confidence 999999999999999953 23456788999999999999999999 8999999999999999999999999
Q ss_pred ccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCch
Q 002857 318 DFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPE 397 (873)
Q Consensus 318 DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~ 397 (873)
|||+|+.+.... .......||+.|||||++.+..|+.++|||||||+||||+||+.||......
T Consensus 168 DFGla~~~~~~~--~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~-------------- 231 (350)
T 4b9d_A 168 DFGIARVLNSTV--ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMK-------------- 231 (350)
T ss_dssp STTEESCCCHHH--HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH--------------
T ss_pred ccccceeecCCc--ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--------------
Confidence 999998764322 1223457999999999999999999999999999999999999999753211
Q ss_pred hHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 398 RVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 398 ~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
+++...+...+. +... .....+.+|+.+||+.||++|||+.|+++
T Consensus 232 ---~~~~~i~~~~~~-----------~~~~-------~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 232 ---NLVLKIISGSFP-----------PVSL-------HYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp ---HHHHHHHHTCCC-----------CCCT-------TSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---HHHHHHHcCCCC-----------CCCc-------cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111111111100 0000 01234778999999999999999999976
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-48 Score=430.17 Aligned_cols=250 Identities=21% Similarity=0.262 Sum_probs=205.5
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEE
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKAL 239 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~L 239 (873)
+.|+..++||+|+||+||+|+++.+++.||||+++.......+.+.+|+++|++++|||||++++++ ..++..+|
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~-----~~~~~~~i 148 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY-----LVGDELWV 148 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEE-----EETTEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEEEE
Confidence 4688999999999999999999999999999999876666667899999999999999999999995 45678999
Q ss_pred EEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEecc
Q 002857 240 VYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADF 319 (873)
Q Consensus 240 V~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDF 319 (873)
||||+++|+|.+++.. ..+++.++..|+.||+.||+||| +++||||||||+||||+.++++||+||
T Consensus 149 vmEy~~gg~L~~~l~~-----------~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DF 214 (346)
T 4fih_A 149 VMEFLEGGALTDIVTH-----------TRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDF 214 (346)
T ss_dssp EECCCTTEEHHHHHHH-----------SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCC
T ss_pred EEeCCCCCcHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEecC
Confidence 9999999999999842 35899999999999999999999 899999999999999999999999999
Q ss_pred ccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCchhH
Q 002857 320 GIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPERV 399 (873)
Q Consensus 320 Gla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~~l 399 (873)
|+|+.+..... ......||+.|||||++.+..|+.++|||||||++|||++|+.||...... .....
T Consensus 215 Gla~~~~~~~~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~--~~~~~--------- 281 (346)
T 4fih_A 215 GFCAQVSKEVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--KAMKM--------- 281 (346)
T ss_dssp TTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHH---------
T ss_pred cCceecCCCCC--cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--HHHHH---------
Confidence 99987654322 233467999999999999999999999999999999999999999753111 11111
Q ss_pred HHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 400 EEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 400 ~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
+.+. . .+...... .....+.+|+.+||+.||++|||+.|+++
T Consensus 282 --i~~~-~---------------~~~~~~~~----~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 282 --IRDN-L---------------PPRLKNLH----KVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp --HHHS-S---------------CCCCSCGG----GSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --HHcC-C---------------CCCCCccc----cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1100 0 00000000 11234778999999999999999998754
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=417.80 Aligned_cols=249 Identities=24% Similarity=0.349 Sum_probs=195.0
Q ss_pred CcceeecccCceEEEEEEEcCCCcEEEEEEeeccC--CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEEE
Q 002857 163 SSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH--HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKALV 240 (873)
Q Consensus 163 ~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~LV 240 (873)
...++||+|+||+||+|.+..++..||||++.... ....+.|.+|+++|++++|||||++++++.... ......+||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~-~~~~~~~lv 107 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIVLV 107 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEE-TTEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeecc-CCCcEEEEE
Confidence 56678999999999999999999999999997432 233467999999999999999999999874321 234568999
Q ss_pred EeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCC--eeeccCCCCCeeeC-CCCCeEEe
Q 002857 241 YEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPP--IAHCDIKPSNILLN-DEMTACVA 317 (873)
Q Consensus 241 ~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~g--IvHrDLKpsNILLd-~~~~vKLs 317 (873)
|||+++|+|.++|+. ...+++..+..|+.||+.||+||| +++ ||||||||+||||+ .++.+||+
T Consensus 108 mEy~~gg~L~~~l~~----------~~~l~~~~~~~~~~qi~~aL~ylH---~~~~~IiHRDlKp~NILl~~~~g~vKl~ 174 (290)
T 3fpq_A 108 TELMTSGTLKTYLKR----------FKVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIG 174 (290)
T ss_dssp EECCCSCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCCCCCGGGEEESSTTSCEEEC
T ss_pred EeCCCCCCHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCCCEEecccChhheeEECCCCCEEEE
Confidence 999999999999953 356899999999999999999999 666 99999999999998 47899999
Q ss_pred ccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCch
Q 002857 318 DFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPE 397 (873)
Q Consensus 318 DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~ 397 (873)
|||+|+.... .......||+.|||||++.+ .|+.++|||||||+||||+||+.||....... .+...+.
T Consensus 175 DFGla~~~~~----~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~-~~~~~i~----- 243 (290)
T 3fpq_A 175 DLGLATLKRA----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA-QIYRRVT----- 243 (290)
T ss_dssp CTTGGGGCCT----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-HHHHHHT-----
T ss_pred eCcCCEeCCC----CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH-HHHHHHH-----
Confidence 9999986432 22334679999999999865 69999999999999999999999996532111 1111100
Q ss_pred hHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 398 RVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 398 ~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
.......+. . ....++.+|+.+||+.||++|||+.|+++
T Consensus 244 ------~~~~~~~~~-----------------~----~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 244 ------SGVKPASFD-----------------K----VAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp ------TTCCCGGGG-----------------G----CCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ------cCCCCCCCC-----------------c----cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000000 0 01124778999999999999999999864
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-48 Score=426.14 Aligned_cols=258 Identities=21% Similarity=0.265 Sum_probs=205.0
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEE
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKA 238 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~ 238 (873)
.+.|.+.++||+|+||.||+|+++.+++.||||+++... ...+|+.+|++++|||||++++++ .+++..+
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~-----~~~~E~~il~~l~HpnIV~l~~~~-----~~~~~~~ 126 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-----FRVEELVACAGLSSPRIVPLYGAV-----REGPWVN 126 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-----CCTHHHHTTTTCCCTTBCCEEEEE-----EETTEEE
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH-----hHHHHHHHHHhCCCCCCCcEEEEE-----EECCEEE
Confidence 356788899999999999999999999999999997432 235799999999999999999995 4567899
Q ss_pred EEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCC-CeEEe
Q 002857 239 LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEM-TACVA 317 (873)
Q Consensus 239 LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~-~vKLs 317 (873)
|||||+++|+|.++|+. ...+++.+++.|+.||+.||+||| +++||||||||+||||+.++ ++||+
T Consensus 127 ivmEy~~gg~L~~~l~~----------~~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~ 193 (336)
T 4g3f_A 127 IFMELLEGGSLGQLIKQ----------MGCLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALC 193 (336)
T ss_dssp EEECCCTTCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEEC
T ss_pred EEEeccCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEe
Confidence 99999999999999953 346999999999999999999999 89999999999999999887 69999
Q ss_pred cccccccccccccc---ccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhc
Q 002857 318 DFGIARFLEATNEQ---TSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSA 394 (873)
Q Consensus 318 DFGla~~~~~~~~~---~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~ 394 (873)
|||+|+.+...... .......||+.|||||++.+..|+.++|||||||++|||+||+.||........ +
T Consensus 194 DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-~------- 265 (336)
T 4g3f_A 194 DFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL-C------- 265 (336)
T ss_dssp CCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC-H-------
T ss_pred eCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH-H-------
Confidence 99999976543221 122235699999999999999999999999999999999999999976332211 0
Q ss_pred CchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHHHHhh
Q 002857 395 LPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLIKKKL 472 (873)
Q Consensus 395 ~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i~~~l 472 (873)
..+... .+. ....| ..+...+.+++.+||+.||++|||+.||++.|.......
T Consensus 266 -----~~i~~~----~~~-------~~~~~---------~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~ 318 (336)
T 4g3f_A 266 -----LKIASE----PPP-------IREIP---------PSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEV 318 (336)
T ss_dssp -----HHHHHS----CCG-------GGGSC---------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred -----HHHHcC----CCC-------chhcC---------ccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhh
Confidence 111110 000 00000 011234778999999999999999999999998876654
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-48 Score=424.92 Aligned_cols=251 Identities=24% Similarity=0.357 Sum_probs=207.4
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeecc---CCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCce
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFL---HHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDF 236 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~ 236 (873)
++|++.+.||+|+||+||+|++..+++.||||+++.. .....+.+.+|+++|++++|||||++++++ .+++.
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~~~ 106 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF-----QDDEK 106 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeCCE
Confidence 5799999999999999999999999999999999743 234457799999999999999999999995 56778
Q ss_pred EEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEE
Q 002857 237 KALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACV 316 (873)
Q Consensus 237 ~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKL 316 (873)
.+|||||+++|+|.++|.. .+.+++.++..|+.||+.||+||| +++|+||||||+||||+.++++||
T Consensus 107 ~yivmEy~~gG~L~~~i~~----------~~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl 173 (311)
T 4aw0_A 107 LYFGLSYAKNGELLKYIRK----------IGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQI 173 (311)
T ss_dssp EEEEECCCTTEEHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEE
T ss_pred EEEEEecCCCCCHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEE
Confidence 9999999999999999942 356999999999999999999999 899999999999999999999999
Q ss_pred eccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCc
Q 002857 317 ADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALP 396 (873)
Q Consensus 317 sDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~ 396 (873)
+|||+|+.+.............||+.|||||++.+..|+.++||||+||++|||+||+.||......
T Consensus 174 ~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~------------- 240 (311)
T 4aw0_A 174 TDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEG------------- 240 (311)
T ss_dssp CCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-------------
T ss_pred EEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-------------
Confidence 9999999875544444445568999999999999999999999999999999999999999753211
Q ss_pred hhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHH
Q 002857 397 ERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELG 464 (873)
Q Consensus 397 ~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~ 464 (873)
+++...+...+. .|. ....++.+|+.+||+.||++|||+.|++..
T Consensus 241 ----~~~~~i~~~~~~----------~p~---------~~s~~~~dli~~lL~~dp~~R~t~~e~~~~ 285 (311)
T 4aw0_A 241 ----LIFAKIIKLEYD----------FPE---------KFFPKARDLVEKLLVLDATKRLGCEEMEGY 285 (311)
T ss_dssp ----HHHHHHHHTCCC----------CCT---------TCCHHHHHHHHHHSCSSGGGSTTSGGGTCH
T ss_pred ----HHHHHHHcCCCC----------CCc---------ccCHHHHHHHHHHccCCHhHCcChHHHcCC
Confidence 111111111100 010 011246789999999999999999987543
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-47 Score=431.56 Aligned_cols=250 Identities=21% Similarity=0.271 Sum_probs=205.7
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEE
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKAL 239 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~L 239 (873)
+.|++.++||+|+||.||+|+++.+++.||||+++.......+.+.+|+.+|++++|||||++++++ ..++..||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~-----~~~~~~~i 225 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY-----LVGDELWV 225 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEE-----EETTEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEE-----EECCEEEE
Confidence 5699999999999999999999999999999999876666677899999999999999999999995 45678999
Q ss_pred EEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEecc
Q 002857 240 VYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADF 319 (873)
Q Consensus 240 V~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDF 319 (873)
|||||++|+|.++++. ..+++.++..|+.||+.||+||| +++||||||||+||||+.++.+||+||
T Consensus 226 VmEy~~gG~L~~~i~~-----------~~l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~DF 291 (423)
T 4fie_A 226 VMEFLEGGALTDIVTH-----------TRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDF 291 (423)
T ss_dssp EEECCTTEEHHHHHHH-----------SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEECCC
T ss_pred EEeCCCCCcHHHHHhc-----------cCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEecC
Confidence 9999999999999842 34899999999999999999999 899999999999999999999999999
Q ss_pred ccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCchhH
Q 002857 320 GIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPERV 399 (873)
Q Consensus 320 Gla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~~l 399 (873)
|+|+.+..... .....+||+.|||||++.+..|+.++|||||||++|||++|+.||...... .....+.....
T Consensus 292 Gla~~~~~~~~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~--~~~~~i~~~~~--- 364 (423)
T 4fie_A 292 GFCAQVSKEVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--KAMKMIRDNLP--- 364 (423)
T ss_dssp TTCEECCSSCC--CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHHHSCC---
T ss_pred ccceECCCCCc--cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--HHHHHHHcCCC---
Confidence 99987654322 233467999999999999999999999999999999999999999652111 11111100000
Q ss_pred HHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 400 EEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 400 ~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
+...... .....+.+|+.+||+.||++|||+.|+++
T Consensus 365 ------------------------~~~~~~~----~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 365 ------------------------PRLKNLH----KVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp ------------------------CCCSCTT----SSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ------------------------CCCcccc----cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0000000 01234778999999999999999998754
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=406.89 Aligned_cols=246 Identities=24% Similarity=0.314 Sum_probs=187.9
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC---CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCce
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH---HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDF 236 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~ 236 (873)
++|++.+.||+|+||+||+|++..+++.||||+++... ....+.+.+|+++|++++|||||++++++ ...+.
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~~~ 87 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVI-----KSKDE 87 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSSE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEE-----EECCE
Confidence 58999999999999999999999999999999997432 23346799999999999999999999995 56778
Q ss_pred EEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEE
Q 002857 237 KALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACV 316 (873)
Q Consensus 237 ~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKL 316 (873)
.+|||||+ +|+|.++|.. ...+++.++..++.||+.||+||| +++|+||||||+|||++.++++||
T Consensus 88 ~~ivmEy~-~g~L~~~l~~----------~~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl 153 (275)
T 3hyh_A 88 IIMVIEYA-GNELFDYIVQ----------RDKMSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKI 153 (275)
T ss_dssp EEEEEECC-CEEHHHHHHH----------SCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEE
T ss_pred EEEEEeCC-CCCHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEE
Confidence 99999999 6899999842 456999999999999999999999 899999999999999999999999
Q ss_pred eccccccccccccccccccccccccccCCCcccCCCCC-CcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcC
Q 002857 317 ADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHET-SSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSAL 395 (873)
Q Consensus 317 sDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~-s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~ 395 (873)
+|||+|+...... ......||+.|||||++.+..+ +.++|||||||++|||+||+.||......
T Consensus 154 ~DFGla~~~~~~~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~------------ 218 (275)
T 3hyh_A 154 ADFGLSNIMTDGN---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP------------ 218 (275)
T ss_dssp CCSSCC------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------------
T ss_pred eecCCCeecCCCC---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH------------
Confidence 9999998654322 2234579999999999998876 57999999999999999999999752111
Q ss_pred chhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 396 PERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 396 ~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
++........+ ..|. . ....+.+++.+||+.||++|||+.|+++
T Consensus 219 -----~~~~~i~~~~~----------~~p~--~-------~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 219 -----VLFKNISNGVY----------TLPK--F-------LSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp -----HHHHHHHHTCC----------CCCT--T-------SCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -----HHHHHHHcCCC----------CCCC--C-------CCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 11111110000 0010 0 1224778999999999999999999875
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-46 Score=405.74 Aligned_cols=257 Identities=20% Similarity=0.309 Sum_probs=187.1
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCc-chhHHHHHHHHHHhhhhccceeeeeeeecccc-------
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHD-ASKSFTVECEVMRNIIHRKIIKVVTACSRVDY------- 231 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~------- 231 (873)
++|++.+.||+|+||+||+|+++.+++.||||+++..... ..+.+.+|+++|++++|||||++++++.....
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 4689999999999999999999999999999999754433 34678999999999999999999998754221
Q ss_pred cCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCC
Q 002857 232 QGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDE 311 (873)
Q Consensus 232 ~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~ 311 (873)
......+|||||+++|+|.+++... ......++..++.|+.||+.||+||| +++||||||||+||||+.+
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~-------~~~~~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~ 154 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGR-------CTIEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMD 154 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTC-------CSGGGSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTT
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhc-------CCCChhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCC
Confidence 1233579999999999999999530 11123455668899999999999999 8999999999999999999
Q ss_pred CCeEEeccccccccccccccc----------cccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCccc
Q 002857 312 MTACVADFGIARFLEATNEQT----------SSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMF 381 (873)
Q Consensus 312 ~~vKLsDFGla~~~~~~~~~~----------~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~ 381 (873)
+++||+|||+|+.+....... ......||+.|||||++.+..|+.++|||||||++|||++ ||....
T Consensus 155 ~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~ 231 (299)
T 4g31_A 155 DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM 231 (299)
T ss_dssp CCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH
T ss_pred CcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc
Confidence 999999999998765432211 1223569999999999999999999999999999999996 775421
Q ss_pred ccchhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHH
Q 002857 382 KDNLNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDV 461 (873)
Q Consensus 382 ~~~~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EV 461 (873)
.... .+..+.+.. ... ...+....+.+|+.+||+.||++|||+.||
T Consensus 232 ~~~~------------~~~~~~~~~------------------~p~----~~~~~~~~~~~li~~~L~~dP~~Rps~~ei 277 (299)
T 4g31_A 232 ERVR------------TLTDVRNLK------------------FPP----LFTQKYPCEYVMVQDMLSPSPMERPEAINI 277 (299)
T ss_dssp HHHH------------HHHHHHTTC------------------CCH----HHHHHCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHH------------HHHHHhcCC------------------CCC----CCcccCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 1000 000110000 000 011112235679999999999999999998
Q ss_pred HH
Q 002857 462 EL 463 (873)
Q Consensus 462 l~ 463 (873)
++
T Consensus 278 l~ 279 (299)
T 4g31_A 278 IE 279 (299)
T ss_dssp HT
T ss_pred hc
Confidence 65
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=411.07 Aligned_cols=200 Identities=26% Similarity=0.354 Sum_probs=167.9
Q ss_pred cCCCcceeecccCceEEEEEEEc---CCCcEEEEEEeeccC--CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCC
Q 002857 160 KGFSSENLIGAGNFASVYKGILF---EGAPAVAIKVFNFLH--HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGN 234 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~---~~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~ 234 (873)
++|++.+.||+|+||+||+|+.. .+++.||||+++... ......+.+|+++|++++|||||++++++ .++
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~ 98 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAF-----QTE 98 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEE-----EET
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEE-----EEC
Confidence 57999999999999999999874 357899999996432 22335688999999999999999999995 456
Q ss_pred ceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCe
Q 002857 235 DFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTA 314 (873)
Q Consensus 235 ~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~v 314 (873)
+..+|||||+++|+|.++|.. ...+++.++..|+.||+.||+||| +++|+||||||+|||++.++++
T Consensus 99 ~~~~ivmEy~~gg~L~~~l~~----------~~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~v 165 (304)
T 3ubd_A 99 GKLYLILDFLRGGDLFTRLSK----------EVMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHI 165 (304)
T ss_dssp TEEEEEECCCTTCEEHHHHHH----------HCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTSCE
T ss_pred CEEEEEEEcCCCCCHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCCCE
Confidence 789999999999999999942 356899999999999999999999 8999999999999999999999
Q ss_pred EEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCc
Q 002857 315 CVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDD 379 (873)
Q Consensus 315 KLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~ 379 (873)
||+|||+|+....... ......||+.|||||++.+..++.++|||||||++|||+||+.||..
T Consensus 166 Kl~DFGla~~~~~~~~--~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~ 228 (304)
T 3ubd_A 166 KLTDFGLSKESIDHEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQG 228 (304)
T ss_dssp EEESSEEEEC-----C--CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred EecccccceeccCCCc--cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCC
Confidence 9999999986543222 22345799999999999999999999999999999999999999975
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-44 Score=405.20 Aligned_cols=208 Identities=24% Similarity=0.286 Sum_probs=176.3
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCC--cchhHHHHHHHHHHhhhhccceeeeeeeecc-cccCCc
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH--DASKSFTVECEVMRNIIHRKIIKVVTACSRV-DYQGND 235 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~-~~~~~~ 235 (873)
.++|++.+.||+|+||+||+|++..+|+.||||+++.... ...+.+.+|+++|++++|||||++++++... .+.+.+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 3679999999999999999999999999999999974432 2345788999999999999999999987532 234556
Q ss_pred eEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeE
Q 002857 236 FKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTAC 315 (873)
Q Consensus 236 ~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vK 315 (873)
..+|||||++ |+|.++|. ....+++.++..|+.||+.||+||| +.+||||||||+|||++.++.+|
T Consensus 133 ~~~ivmE~~~-g~L~~~i~----------~~~~l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~~~K 198 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIH----------SSQPLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELK 198 (398)
T ss_dssp CEEEEEECCS-EEHHHHHT----------SSSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEE
T ss_pred EEEEEEeCCC-CCHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCCCCCEE
Confidence 7999999995 68999984 3467999999999999999999999 89999999999999999999999
Q ss_pred Eecccccccccccc--ccccccccccccccCCCcccCCC-CCCcchhhHhHHHHHHHHHhCCCCCCcc
Q 002857 316 VADFGIARFLEATN--EQTSSIGVKGTTGYIAPEYGMGH-ETSSYGDVYSFGILLLEMFTGLRPSDDM 380 (873)
Q Consensus 316 LsDFGla~~~~~~~--~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELlTGk~Pf~~~ 380 (873)
|+|||+|+.+.... .........||+.|||||++.+. .++.++||||+||++|||++|+.||...
T Consensus 199 i~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~ 266 (398)
T 4b99_A 199 IGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGK 266 (398)
T ss_dssp ECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCS
T ss_pred EeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCC
Confidence 99999998764332 12223456799999999998875 5689999999999999999999999763
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=389.05 Aligned_cols=201 Identities=23% Similarity=0.333 Sum_probs=169.7
Q ss_pred HhhcCCCcceeecccCceEEEEEEEc---CCCcEEEEEEeeccCCcchhHHHHHHHHHHhh-hhccceeeeeeeeccccc
Q 002857 157 SATKGFSSENLIGAGNFASVYKGILF---EGAPAVAIKVFNFLHHDASKSFTVECEVMRNI-IHRKIIKVVTACSRVDYQ 232 (873)
Q Consensus 157 ~at~~f~~~~~LG~G~fG~VYkg~~~---~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~llg~c~~~~~~ 232 (873)
...++|++.++||+|+||+||+|+++ .+++.||||++... .....+.+|+++|+.+ +|||||++++++ .
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~-----~ 90 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCF-----R 90 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEE-----E
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEE-----E
Confidence 45688999999999999999999875 35678999998643 2345788999999998 699999999985 5
Q ss_pred CCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCC-
Q 002857 233 GNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDE- 311 (873)
Q Consensus 233 ~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~- 311 (873)
..+..+|||||+++|+|.+++. .+++.++..++.||+.||+||| +.+|+||||||+|||++.+
T Consensus 91 ~~~~~~lvmE~~~g~~L~~~~~-------------~l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl~~~~ 154 (361)
T 4f9c_A 91 KNDHVVIAMPYLEHESFLDILN-------------SLSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRL 154 (361)
T ss_dssp ETTEEEEEEECCCCCCHHHHHT-------------TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTT
T ss_pred ECCEEEEEEeCCCcccHHHHHc-------------CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEEeCCC
Confidence 5678999999999999999883 3788899999999999999999 8999999999999999876
Q ss_pred CCeEEecccccccccccccc--------------------------ccccccccccccCCCcccCCC-CCCcchhhHhHH
Q 002857 312 MTACVADFGIARFLEATNEQ--------------------------TSSIGVKGTTGYIAPEYGMGH-ETSSYGDVYSFG 364 (873)
Q Consensus 312 ~~vKLsDFGla~~~~~~~~~--------------------------~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSfG 364 (873)
+.+||+|||+|+........ ......+||+.|+|||++.+. .++.++||||+|
T Consensus 155 ~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG 234 (361)
T 4f9c_A 155 KKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAG 234 (361)
T ss_dssp TEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHH
T ss_pred CeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhH
Confidence 79999999999865432110 111234699999999998876 589999999999
Q ss_pred HHHHHHHhCCCCCCcc
Q 002857 365 ILLLEMFTGLRPSDDM 380 (873)
Q Consensus 365 vvL~ELlTGk~Pf~~~ 380 (873)
|++|||+||+.||...
T Consensus 235 ~il~ell~G~~Pf~~~ 250 (361)
T 4f9c_A 235 VIFLSLLSGRYPFYKA 250 (361)
T ss_dssp HHHHHHHHTCSSSSCC
T ss_pred HHHHHHHHCCCCCCCC
Confidence 9999999999999653
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=379.53 Aligned_cols=285 Identities=30% Similarity=0.463 Sum_probs=222.6
Q ss_pred cCHHHHHHhhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecc
Q 002857 150 VSYEALYSATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRV 229 (873)
Q Consensus 150 ~s~~el~~at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~ 229 (873)
+++.++..++++|++.+.||+|+||.||+|++ .+++.||||++........+.+.+|++++++++||||+++++++
T Consensus 29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~--- 104 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFC--- 104 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEEC---
T ss_pred ecHHHHHHHHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEE---
Confidence 34445667889999999999999999999986 46889999998866666678899999999999999999999996
Q ss_pred cccCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeC
Q 002857 230 DYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLN 309 (873)
Q Consensus 230 ~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd 309 (873)
...+..++||||+++|+|.+++... ......+++.+++.|+.||+.||+||| +.+|+||||||+|||++
T Consensus 105 --~~~~~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~ 173 (321)
T 2qkw_B 105 --DERNEMILIYKYMENGNLKRHLYGS------DLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLD 173 (321)
T ss_dssp --CCTTCCEEEEECCTTCBTGGGSSSS------CCCSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCSTTEEEC
T ss_pred --cCCCeEEEEEEcCCCCcHHHHHhcc------CCCccccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCCHHHEEEC
Confidence 4456789999999999999999531 122346899999999999999999999 89999999999999999
Q ss_pred CCCCeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCccccc-chhhH
Q 002857 310 DEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKD-NLNLQ 388 (873)
Q Consensus 310 ~~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~-~~~l~ 388 (873)
.++.+||+|||+++...............||..|+|||++.+..++.++||||||+++|||+||+.||...... .....
T Consensus 174 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~ 253 (321)
T 2qkw_B 174 ENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLA 253 (321)
T ss_dssp TTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHH
T ss_pred CCCCEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHH
Confidence 99999999999998654333323333456899999999998889999999999999999999999999763322 12222
Q ss_pred HHHhhcCc-hhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHH
Q 002857 389 NWVQSALP-ERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRL 467 (873)
Q Consensus 389 ~~~~~~~~-~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~ 467 (873)
.|...... ..+..++++.+.. ....++...+.+++.+||+.||++|||+.||++.|+.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 312 (321)
T 2qkw_B 254 EWAVESHNNGQLEQIVDPNLAD---------------------KIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEY 312 (321)
T ss_dssp HHTHHHHTTTCCCSSSSSSCTT---------------------CSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHhhhccccccHHHhcChhhcc---------------------ccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 22211100 0111111111110 0112345678899999999999999999999999998
Q ss_pred HHH
Q 002857 468 IKK 470 (873)
Q Consensus 468 i~~ 470 (873)
+.+
T Consensus 313 ~l~ 315 (321)
T 2qkw_B 313 ALR 315 (321)
T ss_dssp HHH
T ss_pred Hhh
Confidence 764
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=375.64 Aligned_cols=287 Identities=33% Similarity=0.548 Sum_probs=224.7
Q ss_pred CCccCHHHHHHhhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCC-cchhHHHHHHHHHHhhhhccceeeeee
Q 002857 147 FPYVSYEALYSATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH-DASKSFTVECEVMRNIIHRKIIKVVTA 225 (873)
Q Consensus 147 ~~~~s~~el~~at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~ 225 (873)
...+++.++..++++|++.+.||+|+||.||+|.+ .+++.||||++..... .....+.+|++++++++||||++++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 95 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 95 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence 46789999999999999999999999999999975 4688999999875432 233478999999999999999999999
Q ss_pred eecccccCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCC
Q 002857 226 CSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSN 305 (873)
Q Consensus 226 c~~~~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsN 305 (873)
+ ......++||||+++|+|.++++. .......+++..++.|+.||+.||+|||..+..+|+||||||+|
T Consensus 96 ~-----~~~~~~~lv~e~~~~~~L~~~l~~------~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~N 164 (326)
T 3uim_A 96 C-----MTPTERLLVYPYMANGSVASCLRE------RPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAAN 164 (326)
T ss_dssp E-----CCSSCCEEEEECCTTCBHHHHHHC------CSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGG
T ss_pred E-----ecCCceEEEEEeccCCCHHHHHHh------ccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhh
Confidence 6 345667999999999999999954 11234569999999999999999999993222399999999999
Q ss_pred eeeCCCCCeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCccc---c
Q 002857 306 ILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMF---K 382 (873)
Q Consensus 306 ILLd~~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~---~ 382 (873)
||++.++.+||+|||+++....... .......||..|+|||++.+..++.++||||||+++|||+||+.||+... .
T Consensus 165 il~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 243 (326)
T 3uim_A 165 ILLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAND 243 (326)
T ss_dssp EEECTTCCEEECCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTT
T ss_pred EEECCCCCEEeccCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccc
Confidence 9999999999999999987643322 22334559999999999988889999999999999999999999996421 1
Q ss_pred cchhhHHHHhhcCch-hHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHH
Q 002857 383 DNLNLQNWVQSALPE-RVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDV 461 (873)
Q Consensus 383 ~~~~l~~~~~~~~~~-~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EV 461 (873)
.......|+...... .+..+.+..+.... ..+....+.+++.+||+.||++|||+.||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~l~~li~~cl~~dP~~Rps~~el 302 (326)
T 3uim_A 244 DDVMLLDWVKGLLKEKKLEALVDVDLQGNY---------------------KDEEVEQLIQVALLCTQSSPMERPKMSEV 302 (326)
T ss_dssp SCSBHHHHHTTTTSSCCSTTSSCTTCTTSC---------------------CHHHHHHHHHHHHHHTCSCGGGSCCHHHH
T ss_pred cchhHHHHHHHHhhchhhhhhcChhhcccc---------------------CHHHHHHHHHHHHHHhCcCCccCCCHHHH
Confidence 222334444333322 22222222221111 12335578999999999999999999999
Q ss_pred HHHHHH
Q 002857 462 ELGLRL 467 (873)
Q Consensus 462 l~~Le~ 467 (873)
+++|+.
T Consensus 303 l~~L~~ 308 (326)
T 3uim_A 303 VRMLEG 308 (326)
T ss_dssp HHHHHT
T ss_pred HHHhcC
Confidence 999985
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=369.08 Aligned_cols=267 Identities=24% Similarity=0.385 Sum_probs=215.0
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEE
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKA 238 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~ 238 (873)
.++|.+.++||+|+||.||+|.+..+++.||+|++........+.+.+|++++++++||||+++++++. .+...+
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~~~ 83 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY-----KDKRLN 83 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETTEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEe-----cCCeeE
Confidence 357889999999999999999999999999999987655566678999999999999999999999963 456789
Q ss_pred EEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEec
Q 002857 239 LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVAD 318 (873)
Q Consensus 239 LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsD 318 (873)
+||||+++|+|.+++.. ....+++.+++.|+.||+.||+||| +.+|+||||||+|||++.++.+||+|
T Consensus 84 lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~D 151 (310)
T 3s95_A 84 FITEYIKGGTLRGIIKS---------MDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVAD 151 (310)
T ss_dssp EEEECCTTCBHHHHHHH---------CCTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEECC
T ss_pred EEEEecCCCcHHHHHHh---------ccCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEEee
Confidence 99999999999999953 3456899999999999999999999 89999999999999999999999999
Q ss_pred cccccccccccccc------------cccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchh
Q 002857 319 FGIARFLEATNEQT------------SSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLN 386 (873)
Q Consensus 319 FGla~~~~~~~~~~------------~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~ 386 (873)
||+++......... ......||+.|+|||++.+..++.++||||||+++|||++|..||.........
T Consensus 152 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~ 231 (310)
T 3s95_A 152 FGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMD 231 (310)
T ss_dssp CTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTT
T ss_pred cccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHH
Confidence 99998764432211 111346999999999999999999999999999999999999998653322211
Q ss_pred hHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHH
Q 002857 387 LQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLR 466 (873)
Q Consensus 387 l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le 466 (873)
... ......+...... +...+.+++.+||+.||++|||+.||++.|+
T Consensus 232 ~~~--------~~~~~~~~~~~~~-------------------------~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~ 278 (310)
T 3s95_A 232 FGL--------NVRGFLDRYCPPN-------------------------CPPSFFPITVRCCDLDPEKRPSFVKLEHWLE 278 (310)
T ss_dssp SSB--------CHHHHHHHTCCTT-------------------------CCTTHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred Hhh--------hhhccccccCCCC-------------------------CCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 100 1111111111110 1224778999999999999999999999999
Q ss_pred HHHHhhhcC
Q 002857 467 LIKKKLLET 475 (873)
Q Consensus 467 ~i~~~l~~~ 475 (873)
.++..+...
T Consensus 279 ~l~~~~~~~ 287 (310)
T 3s95_A 279 TLRMHLAGH 287 (310)
T ss_dssp HHHHHHHHC
T ss_pred HHHHhccCc
Confidence 998877543
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=406.80 Aligned_cols=253 Identities=21% Similarity=0.297 Sum_probs=205.3
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEE
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKA 238 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~ 238 (873)
.++|++.+.||+|+||.||+|+++.+|+.||||++........+.+.+|+++|+.++|||||++++++ ......+
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~-----~~~~~~~ 230 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF-----EDDNEMV 230 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEE-----ECSSEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEE-----EECCEEE
Confidence 36899999999999999999999999999999999866555567899999999999999999999995 5677899
Q ss_pred EEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCC--CCeEE
Q 002857 239 LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDE--MTACV 316 (873)
Q Consensus 239 LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~--~~vKL 316 (873)
||||||++|+|.++|.. ....+++.++..|+.||+.||+||| +++|+||||||+|||++.+ +.+||
T Consensus 231 iv~E~~~gg~L~~~i~~---------~~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl 298 (573)
T 3uto_A 231 MIYEFMSGGELFEKVAD---------EHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKL 298 (573)
T ss_dssp EEEECCCCCBHHHHHTC---------TTSCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEE
T ss_pred EEEeecCCCcHHHHHHH---------hCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEE
Confidence 99999999999999842 3456999999999999999999999 8999999999999999854 89999
Q ss_pred eccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCc
Q 002857 317 ADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALP 396 (873)
Q Consensus 317 sDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~ 396 (873)
+|||+|+.+.... ......||+.|||||++.+..|+.++|||||||++|||++|+.||....... .
T Consensus 299 ~DFG~a~~~~~~~---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~--~--------- 364 (573)
T 3uto_A 299 IDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE--T--------- 364 (573)
T ss_dssp CCCSSCEECCTTS---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH--H---------
T ss_pred eeccceeEccCCC---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH--H---------
Confidence 9999999775432 2234569999999999999999999999999999999999999997632211 0
Q ss_pred hhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 397 ERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 397 ~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
+..+....... + ..... .....+.+|+.+||+.||++|||+.|+++
T Consensus 365 --~~~i~~~~~~~--------------~-~~~~~----~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 365 --LRNVKSCDWNM--------------D-DSAFS----GISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp --HHHHHTTCCCC--------------C-SGGGT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --HHHHHhCCCCC--------------C-ccccc----CCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 01111100000 0 00000 01224678999999999999999998754
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-41 Score=362.00 Aligned_cols=283 Identities=30% Similarity=0.461 Sum_probs=221.7
Q ss_pred CCCccCHHHHHHhhcCCCcc------eeecccCceEEEEEEEcCCCcEEEEEEeeccC----CcchhHHHHHHHHHHhhh
Q 002857 146 DFPYVSYEALYSATKGFSSE------NLIGAGNFASVYKGILFEGAPAVAIKVFNFLH----HDASKSFTVECEVMRNII 215 (873)
Q Consensus 146 ~~~~~s~~el~~at~~f~~~------~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~----~~~~~~f~~Ei~iL~~L~ 215 (873)
....|++.++..++++|... +.||+|+||.||+|.+ +++.||||++.... ....+.+.+|++++++++
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 88 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ 88 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC
Confidence 45789999999999999887 8999999999999976 67899999986432 233467999999999999
Q ss_pred hccceeeeeeeecccccCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCC
Q 002857 216 HRKIIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPP 295 (873)
Q Consensus 216 HpNIV~llg~c~~~~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~g 295 (873)
||||+++++++ ...+..++||||+++|+|.+++.. ......+++..++.|+.||+.||+||| +.+
T Consensus 89 h~~i~~~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~-------~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~ 153 (307)
T 2nru_A 89 HENLVELLGFS-----SDGDDLCLVYVYMPNGSLLDRLSC-------LDGTPPLSWHMRCKIAQGAANGINFLH---ENH 153 (307)
T ss_dssp CTTBCCEEEEE-----CSSSSCEEEEECCTTCBHHHHHHT-------GGGCCCCCHHHHHHHHHHHHHHHHHHH---HTT
T ss_pred CCCeEEEEEEE-----ecCCceEEEEEecCCCcHHHHHHh-------ccCCCCCCHHHHHHHHHHHHHHHHHHh---cCC
Confidence 99999999996 445678999999999999999853 122456899999999999999999999 899
Q ss_pred eeeccCCCCCeeeCCCCCeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCC
Q 002857 296 IAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLR 375 (873)
Q Consensus 296 IvHrDLKpsNILLd~~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~ 375 (873)
|+||||||+|||++.++.+||+|||+++...............||..|+|||++.+ .++.++||||||+++|||++|+.
T Consensus 154 i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~ 232 (307)
T 2nru_A 154 HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLP 232 (307)
T ss_dssp EECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCC
T ss_pred eecCCCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCC
Confidence 99999999999999999999999999987654333333334568999999998765 58899999999999999999999
Q ss_pred CCCcccccchhhHHHHhhc--CchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcC
Q 002857 376 PSDDMFKDNLNLQNWVQSA--LPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPG 453 (873)
Q Consensus 376 Pf~~~~~~~~~l~~~~~~~--~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~ 453 (873)
||....... .+..+.... ....+.+.++..+... .......+.+++.+||+.+|+
T Consensus 233 p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~l~~li~~cl~~~p~ 289 (307)
T 2nru_A 233 AVDEHREPQ-LLLDIKEEIEDEEKTIEDYIDKKMNDA----------------------DSTSVEAMYSVASQCLHEKKN 289 (307)
T ss_dssp SBCTTBSSS-BTTHHHHHHHTTSCCHHHHSCSSCSCC----------------------CHHHHHHHHHHHHHHTCSSTT
T ss_pred CcccCcchH-HHHHHHHHhhhhhhhhhhhcccccccc----------------------chHHHHHHHHHHHHHcCCCcc
Confidence 997643221 111111100 0112222222221110 112345688999999999999
Q ss_pred CCCCHHHHHHHHHHHH
Q 002857 454 ERMKINDVELGLRLIK 469 (873)
Q Consensus 454 eRPTm~EVl~~Le~i~ 469 (873)
+|||+.+|++.|+.+.
T Consensus 290 ~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 290 KRPDIKKVQQLLQEMT 305 (307)
T ss_dssp TSCCHHHHHHHHHHHC
T ss_pred cCcCHHHHHHHHHHHh
Confidence 9999999999999874
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=373.30 Aligned_cols=281 Identities=25% Similarity=0.362 Sum_probs=210.3
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEE
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKA 238 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~ 238 (873)
.++|++.++||+|+||.||+|++. ++.||||++.... .....+..|+.++++++||||+++++++.... ......+
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~~~~~~ 98 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGT-SVDVDLW 98 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCC-CCCceEE
Confidence 468999999999999999999874 7899999996433 22345667899999999999999999975422 2244579
Q ss_pred EEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCC----------CeeeccCCCCCeee
Q 002857 239 LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKP----------PIAHCDIKPSNILL 308 (873)
Q Consensus 239 LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~----------gIvHrDLKpsNILL 308 (873)
+||||+++|+|.++++. ..+++..++.|+.||+.||+||| +. +|+||||||+|||+
T Consensus 99 lv~e~~~~g~L~~~l~~-----------~~~~~~~~~~i~~qi~~al~~LH---~~~~~l~~~~~~~ivH~Dlkp~Nill 164 (322)
T 3soc_A 99 LITAFHEKGSLSDFLKA-----------NVVSWNELCHIAETMARGLAYLH---EDIPGLKDGHKPAISHRDIKSKNVLL 164 (322)
T ss_dssp EEEECCTTCBHHHHHHH-----------CCBCHHHHHHHHHHHHHHHHHHT---CCEEEETTEEECEEECSCCSGGGEEE
T ss_pred EEEecCCCCCHHHHHHh-----------cCCCHHHHHHHHHHHHHHHHHHH---hhccccccccCCCEEeCCCChHhEEE
Confidence 99999999999999942 34899999999999999999999 77 99999999999999
Q ss_pred CCCCCeEEeccccccccccccccccccccccccccCCCcccCCC-----CCCcchhhHhHHHHHHHHHhCCCCCCccccc
Q 002857 309 NDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGH-----ETSSYGDVYSFGILLLEMFTGLRPSDDMFKD 383 (873)
Q Consensus 309 d~~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-----~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~ 383 (873)
+.++.+||+|||+++...............||..|+|||++.+. .++.++||||||+++|||+||+.||......
T Consensus 165 ~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~ 244 (322)
T 3soc_A 165 KNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE 244 (322)
T ss_dssp CTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCC
T ss_pred CCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcch
Confidence 99999999999999876554433334445799999999998873 5667899999999999999999999764332
Q ss_pred ch-hhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHH
Q 002857 384 NL-NLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVE 462 (873)
Q Consensus 384 ~~-~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl 462 (873)
.. .+...... .....++.+..... ...|...... ....+...+.+|+.+||+.||++|||+.||+
T Consensus 245 ~~~~~~~~~~~--~~~~~~~~~~~~~~-----------~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~Rps~~ell 310 (322)
T 3soc_A 245 YMLPFEEEIGQ--HPSLEDMQEVVVHK-----------KKRPVLRDYW-QKHAGMAMLCETIEECWDHDAEARLSAGCVG 310 (322)
T ss_dssp CCCTTHHHHCS--SCCHHHHHHHHTTS-----------CCCCCCCGGG-GSSHHHHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred hccchhhhhcc--CCchhhhhhhhhcc-----------cCCCCccccc-cccchHHHHHHHHHHHccCChhhCcCHHHHH
Confidence 11 11111110 01111111111111 0011111100 0112345688999999999999999999999
Q ss_pred HHHHHHHHh
Q 002857 463 LGLRLIKKK 471 (873)
Q Consensus 463 ~~Le~i~~~ 471 (873)
+.|+.|++.
T Consensus 311 ~~L~~l~~~ 319 (322)
T 3soc_A 311 ERITQMQRL 319 (322)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHH
Confidence 999998764
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=400.95 Aligned_cols=198 Identities=23% Similarity=0.329 Sum_probs=170.9
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC---CcchhHHHHH---HHHHHhhhhccceeeeeeeecccccC
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH---HDASKSFTVE---CEVMRNIIHRKIIKVVTACSRVDYQG 233 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~---~~~~~~f~~E---i~iL~~L~HpNIV~llg~c~~~~~~~ 233 (873)
++|++.++||+|+||.||+|+++.+++.||||+++... ......+.+| +.+++.++|||||++++++ .+
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f-----~~ 263 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-----HT 263 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE-----EC
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEE-----EE
Confidence 67999999999999999999999999999999996321 2222334444 5566677899999999985 66
Q ss_pred CceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCC
Q 002857 234 NDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMT 313 (873)
Q Consensus 234 ~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~ 313 (873)
.+..+|||||++||+|.++|.. ...+++..+..++.||+.||+||| +.+||||||||+||||+.+++
T Consensus 264 ~~~lylVmEy~~GGdL~~~l~~----------~~~l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~ 330 (689)
T 3v5w_A 264 PDKLSFILDLMNGGDLHYHLSQ----------HGVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGH 330 (689)
T ss_dssp SSEEEEEECCCCSCBHHHHHHH----------HCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSC
T ss_pred CCEEEEEEecCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCC
Confidence 7789999999999999999942 356999999999999999999999 999999999999999999999
Q ss_pred eEEeccccccccccccccccccccccccccCCCcccCC-CCCCcchhhHhHHHHHHHHHhCCCCCCc
Q 002857 314 ACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMG-HETSSYGDVYSFGILLLEMFTGLRPSDD 379 (873)
Q Consensus 314 vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELlTGk~Pf~~ 379 (873)
+||+|||+|+.+.... ....+||+.|||||++.+ ..|+.++|||||||+||||++|+.||..
T Consensus 331 vKL~DFGlA~~~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~ 393 (689)
T 3v5w_A 331 VRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ 393 (689)
T ss_dssp EEECCCTTCEECSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCG
T ss_pred EEecccceeeecCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999998764332 234579999999999975 5799999999999999999999999975
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=363.55 Aligned_cols=278 Identities=23% Similarity=0.369 Sum_probs=208.0
Q ss_pred hcCCCcceeecccCceEEEEEEE----cCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCC
Q 002857 159 TKGFSSENLIGAGNFASVYKGIL----FEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGN 234 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~----~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~ 234 (873)
.++|++.+.||+|+||.||+|++ ..+++.||||++........+.+.+|++++++++||||+++++++.. ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~~ 85 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYS---AGR 85 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECH---HHH
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CCC
Confidence 46789999999999999999984 45789999999986655556789999999999999999999998743 223
Q ss_pred ceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCe
Q 002857 235 DFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTA 314 (873)
Q Consensus 235 ~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~v 314 (873)
...++||||+++|+|.+++.. ....+++.+++.|+.||+.||+||| +.+|+||||||+|||++.++.+
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~ 153 (295)
T 3ugc_A 86 RNLKLIMEYLPYGSLRDYLQK---------HKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRV 153 (295)
T ss_dssp TSCEEEEECCTTCBHHHHHHH---------CGGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEE
T ss_pred CceEEEEEeCCCCCHHHHHHh---------cccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEEEcCCCeE
Confidence 457999999999999999953 2335899999999999999999999 8999999999999999999999
Q ss_pred EEecccccccccccccc-ccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhh
Q 002857 315 CVADFGIARFLEATNEQ-TSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQS 393 (873)
Q Consensus 315 KLsDFGla~~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~ 393 (873)
||+|||+++........ .......++..|+|||++.+..++.++||||||+++|||+||..|+.....+ .......
T Consensus 154 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~---~~~~~~~ 230 (295)
T 3ugc_A 154 KIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE---FMRMIGN 230 (295)
T ss_dssp EECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH---HHHHHCT
T ss_pred EEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH---HHhhhcC
Confidence 99999999876443221 1222334778899999999999999999999999999999999998653211 1111111
Q ss_pred cCch--hHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHHHHh
Q 002857 394 ALPE--RVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLIKKK 471 (873)
Q Consensus 394 ~~~~--~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i~~~ 471 (873)
.... ....+.+.... ....+... .+...+.+++.+||+.||++|||+.||++.|+.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~-----------~~~~~~~~-------~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 231 DKQGQMIVFHLIELLKN-----------NGRLPRPD-------GCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp TCCTHHHHHHHHHHHHT-----------TCCCCCCT-------TCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ccccchhHHHHHHHHhc-----------cCcCCCCc-------CcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 1000 00111111000 00111111 1234588999999999999999999999999998775
Q ss_pred h
Q 002857 472 L 472 (873)
Q Consensus 472 l 472 (873)
+
T Consensus 293 l 293 (295)
T 3ugc_A 293 M 293 (295)
T ss_dssp -
T ss_pred c
Confidence 4
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=372.56 Aligned_cols=283 Identities=19% Similarity=0.254 Sum_probs=216.2
Q ss_pred ccCHHHHHHhhcCCCcceeecccCceEEEEEEE-----cCCCcEEEEEEeeccCC-cchhHHHHHHHHHHhh-hhcccee
Q 002857 149 YVSYEALYSATKGFSSENLIGAGNFASVYKGIL-----FEGAPAVAIKVFNFLHH-DASKSFTVECEVMRNI-IHRKIIK 221 (873)
Q Consensus 149 ~~s~~el~~at~~f~~~~~LG~G~fG~VYkg~~-----~~~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L-~HpNIV~ 221 (873)
.+...+.....++|.+.+.||+|+||.||+|++ ..+++.||||+++.... ...+.+.+|++++.++ +||||++
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence 345566666788999999999999999999985 34568999999975432 2346799999999999 7999999
Q ss_pred eeeeeecccccCCceEEEEEeecCCCChhhhccccccccc----------------------------------------
Q 002857 222 VVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDK---------------------------------------- 261 (873)
Q Consensus 222 llg~c~~~~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~---------------------------------------- 261 (873)
+++++. ..+...++||||+++|+|.++++.......
T Consensus 91 ~~~~~~----~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (359)
T 3vhe_A 91 LLGACT----KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSG 166 (359)
T ss_dssp EEEEEC----STTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------
T ss_pred eeeeee----cCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccc
Confidence 999974 334558999999999999999964211000
Q ss_pred ----------------ccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEecccccccc
Q 002857 262 ----------------RHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFL 325 (873)
Q Consensus 262 ----------------~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDFGla~~~ 325 (873)
.......+++..++.|+.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++..
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 243 (359)
T 3vhe_A 167 FVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDI 243 (359)
T ss_dssp -----------------CTTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCT
T ss_pred cccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEeccceeee
Confidence 0001223899999999999999999999 889999999999999999999999999999876
Q ss_pred ccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHHHhhcCchhHHHHhh
Q 002857 326 EATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQSALPERVEEIVD 404 (873)
Q Consensus 326 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~~~~~~~~~l~elid 404 (873)
.............||..|+|||++.+..++.++||||||+++|||+| |+.||........ +...+.
T Consensus 244 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-------------~~~~~~ 310 (359)
T 3vhe_A 244 YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-------------FCRRLK 310 (359)
T ss_dssp TSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH-------------HHHHHH
T ss_pred cccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH-------------HHHHHH
Confidence 54433333444568999999999999999999999999999999999 9999976322211 011110
Q ss_pred hhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHHHHhh
Q 002857 405 TLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLIKKKL 472 (873)
Q Consensus 405 ~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i~~~l 472 (873)
..... ..|. .+...+.+++..||+.||++|||+.||++.|+.+.+..
T Consensus 311 ~~~~~------------~~~~---------~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 311 EGTRM------------RAPD---------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 357 (359)
T ss_dssp HTCCC------------CCCT---------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred cCCCC------------CCCC---------CCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence 00000 0000 01234788999999999999999999999999987643
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=357.08 Aligned_cols=269 Identities=24% Similarity=0.403 Sum_probs=202.6
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHh--hhhccceeeeeeeecccccCCce
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRN--IIHRKIIKVVTACSRVDYQGNDF 236 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~--L~HpNIV~llg~c~~~~~~~~~~ 236 (873)
.++|++.+.||+|+||.||+|++ +++.||||++... ....+..|.+++.. ++||||+++++++... ......
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~-~~~~~~ 80 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTS-RHSSTQ 80 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEE-ETTEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccc-cCCCce
Confidence 56899999999999999999987 6889999998632 34567778888777 7999999999987542 233556
Q ss_pred EEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCC-----CCCeeeccCCCCCeeeCCC
Q 002857 237 KALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGC-----KPPIAHCDIKPSNILLNDE 311 (873)
Q Consensus 237 ~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~-----s~gIvHrDLKpsNILLd~~ 311 (873)
.++||||+++|+|.++++ ...+++..++.|+.||+.||+|||... +.+|+||||||+|||++.+
T Consensus 81 ~~lv~e~~~~g~L~~~l~-----------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~ 149 (301)
T 3q4u_A 81 LWLITHYHEMGSLYDYLQ-----------LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKN 149 (301)
T ss_dssp EEEEECCCTTCBHHHHHT-----------TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTT
T ss_pred eEEehhhccCCCHHHHHh-----------hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCC
Confidence 899999999999999994 246899999999999999999999321 5799999999999999999
Q ss_pred CCeEEeccccccccccccccc--cccccccccccCCCcccCCC------CCCcchhhHhHHHHHHHHHhC----------
Q 002857 312 MTACVADFGIARFLEATNEQT--SSIGVKGTTGYIAPEYGMGH------ETSSYGDVYSFGILLLEMFTG---------- 373 (873)
Q Consensus 312 ~~vKLsDFGla~~~~~~~~~~--~~~~~~Gt~~Y~APE~l~~~------~~s~ksDVwSfGvvL~ELlTG---------- 373 (873)
+.+||+|||+++......... ......||..|+|||++.+. .++.++||||||+++|||+||
T Consensus 150 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~ 229 (301)
T 3q4u_A 150 GQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDY 229 (301)
T ss_dssp SCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred CCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccc
Confidence 999999999998664433221 12234699999999998876 456799999999999999999
Q ss_pred CCCCCcccccchhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcC
Q 002857 374 LRPSDDMFKDNLNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPG 453 (873)
Q Consensus 374 k~Pf~~~~~~~~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~ 453 (873)
+.||............. ...+. .. ...+.... ......+...+.+++.+||+.||+
T Consensus 230 ~~pf~~~~~~~~~~~~~---------~~~~~---~~-----------~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~ 285 (301)
T 3q4u_A 230 KPPFYDVVPNDPSFEDM---------RKVVC---VD-----------QQRPNIPN-RWFSDPTLTSLAKLMKECWYQNPS 285 (301)
T ss_dssp CCTTTTTSCSSCCHHHH---------HHHHT---TS-----------CCCCCCCG-GGGGSHHHHHHHHHHHHHCCSSGG
T ss_pred cccccccCCCCcchhhh---------hHHHh---cc-----------CCCCCCCh-hhccCccHHHHHHHHHHHhhcChh
Confidence 67765432221111110 01000 00 00000000 001112355688999999999999
Q ss_pred CCCCHHHHHHHHHHH
Q 002857 454 ERMKINDVELGLRLI 468 (873)
Q Consensus 454 eRPTm~EVl~~Le~i 468 (873)
+|||+.||++.|+.|
T Consensus 286 ~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 286 ARLTALRIKKTLTKI 300 (301)
T ss_dssp GSCCHHHHHHHHHHH
T ss_pred hCCCHHHHHHHHhcc
Confidence 999999999999976
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=360.04 Aligned_cols=251 Identities=22% Similarity=0.279 Sum_probs=204.1
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEE
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKA 238 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~ 238 (873)
.++|++.+.||+|+||.||+|.+..+++.||||++........+.+.+|+.++++++||||+++++++ ...+..+
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~~ 93 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY-----LVGDELW 93 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEE-----EETTEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEE-----EECCEEE
Confidence 46899999999999999999999889999999999866666667899999999999999999999986 3456789
Q ss_pred EEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEec
Q 002857 239 LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVAD 318 (873)
Q Consensus 239 LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsD 318 (873)
+||||+++|+|.+++.. ..+++.+++.++.||+.||+||| +.+|+||||||+|||++.++.+||+|
T Consensus 94 lv~e~~~~~~L~~~~~~-----------~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~D 159 (297)
T 3fxz_A 94 VVMEYLAGGSLTDVVTE-----------TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTD 159 (297)
T ss_dssp EEEECCTTCBHHHHHHH-----------SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECC
T ss_pred EEEECCCCCCHHHHHhh-----------cCCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCCCEEEee
Confidence 99999999999999842 24889999999999999999999 88999999999999999999999999
Q ss_pred cccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCchh
Q 002857 319 FGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPER 398 (873)
Q Consensus 319 FGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~~ 398 (873)
||+++....... ......||..|+|||++.+..++.++||||||+++|||+||+.||........ +.
T Consensus 160 fg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~---------- 226 (297)
T 3fxz_A 160 FGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-LY---------- 226 (297)
T ss_dssp CTTCEECCSTTC--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HH----------
T ss_pred CCCceecCCccc--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HH----------
Confidence 999986644322 22345699999999999999999999999999999999999999965321110 00
Q ss_pred HHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 399 VEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 399 l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
.+.... .+...... .....+.+++.+||+.||++|||+.|+++
T Consensus 227 --~~~~~~----------------~~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 227 --LIATNG----------------TPELQNPE----KLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp --HHHHHC----------------SCCCSCGG----GSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --HHHhCC----------------CCCCCCcc----ccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 000000 00000000 11234778999999999999999999865
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=360.41 Aligned_cols=263 Identities=21% Similarity=0.249 Sum_probs=211.3
Q ss_pred CCccCHHHHHHhhcC----------CCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhh
Q 002857 147 FPYVSYEALYSATKG----------FSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIH 216 (873)
Q Consensus 147 ~~~~s~~el~~at~~----------f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~H 216 (873)
.+.++++++..+++. |...+.||+|+||.||+|++..+++.||||++........+.+.+|+.++++++|
T Consensus 22 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h 101 (321)
T 2c30_A 22 SGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH 101 (321)
T ss_dssp ---CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCC
T ss_pred CCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCC
Confidence 456888999888865 6777899999999999999988899999999987666666789999999999999
Q ss_pred ccceeeeeeeecccccCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCe
Q 002857 217 RKIIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPI 296 (873)
Q Consensus 217 pNIV~llg~c~~~~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gI 296 (873)
+||+++++++. ..+..++||||+++|+|.+++. ...+++..++.++.||+.||+||| +.+|
T Consensus 102 ~niv~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~-----------~~~l~~~~~~~i~~qi~~~L~~LH---~~~i 162 (321)
T 2c30_A 102 FNVVEMYKSYL-----VGEELWVLMEFLQGGALTDIVS-----------QVRLNEEQIATVCEAVLQALAYLH---AQGV 162 (321)
T ss_dssp TTBCCEEEEEE-----ETTEEEEEECCCCSCBHHHHHT-----------TCCCCHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred CCcceEEEEEE-----ECCEEEEEEecCCCCCHHHHHH-----------hcCCCHHHHHHHHHHHHHHHHHHH---HCCe
Confidence 99999999963 4567899999999999999984 235899999999999999999999 8899
Q ss_pred eeccCCCCCeeeCCCCCeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCC
Q 002857 297 AHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRP 376 (873)
Q Consensus 297 vHrDLKpsNILLd~~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~P 376 (873)
+||||||+|||++.++.+||+|||+++....... ......||..|+|||++.+..++.++||||||+++|||++|+.|
T Consensus 163 vH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p 240 (321)
T 2c30_A 163 IHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPP 240 (321)
T ss_dssp ECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCT
T ss_pred ecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999986644322 22345699999999999999999999999999999999999999
Q ss_pred CCcccccchhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCC
Q 002857 377 SDDMFKDNLNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERM 456 (873)
Q Consensus 377 f~~~~~~~~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRP 456 (873)
|...... .... .+.+.. .+...... .....+.+++.+||+.||++||
T Consensus 241 f~~~~~~--~~~~-----------~~~~~~----------------~~~~~~~~----~~~~~l~~li~~~l~~dp~~Rp 287 (321)
T 2c30_A 241 YFSDSPV--QAMK-----------RLRDSP----------------PPKLKNSH----KVSPVLRDFLERMLVRDPQERA 287 (321)
T ss_dssp TTTSCHH--HHHH-----------HHHHSS----------------CCCCTTGG----GSCHHHHHHHHHHSCSSTTTSC
T ss_pred CCCCCHH--HHHH-----------HHhcCC----------------CCCcCccc----cCCHHHHHHHHHHccCChhhCc
Confidence 9653111 0000 000000 00000000 0123477899999999999999
Q ss_pred CHHHHHH
Q 002857 457 KINDVEL 463 (873)
Q Consensus 457 Tm~EVl~ 463 (873)
|+.||++
T Consensus 288 s~~ell~ 294 (321)
T 2c30_A 288 TAQELLD 294 (321)
T ss_dssp CHHHHHT
T ss_pred CHHHHhc
Confidence 9999876
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=368.79 Aligned_cols=277 Identities=18% Similarity=0.203 Sum_probs=208.6
Q ss_pred hhcCCCcceeecccCceEEEEEEEcCC-----CcEEEEEEeeccCCcc-----------hhHHHHHHHHHHhhhhcccee
Q 002857 158 ATKGFSSENLIGAGNFASVYKGILFEG-----APAVAIKVFNFLHHDA-----------SKSFTVECEVMRNIIHRKIIK 221 (873)
Q Consensus 158 at~~f~~~~~LG~G~fG~VYkg~~~~~-----g~~VAVK~l~~~~~~~-----------~~~f~~Ei~iL~~L~HpNIV~ 221 (873)
..++|.+.+.||+|+||.||+|.+..+ ++.||||++....... ...+..|+..+..++|+||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 356899999999999999999998664 4789999986433111 112334445556667999999
Q ss_pred eeeeeecccccCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccC
Q 002857 222 VVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDI 301 (873)
Q Consensus 222 llg~c~~~~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDL 301 (873)
+++++.... ......+|||||+ +++|.+++.. ....+++.+++.|+.||+.||+||| +.+|+||||
T Consensus 113 ~~~~~~~~~-~~~~~~~lv~e~~-g~~L~~~~~~---------~~~~l~~~~~~~i~~qi~~~l~~lH---~~~iiHrDl 178 (364)
T 3op5_A 113 YWGSGLHDK-NGKSYRFMIMDRF-GSDLQKIYEA---------NAKRFSRKTVLQLSLRILDILEYIH---EHEYVHGDI 178 (364)
T ss_dssp EEEEEEEEE-TTEEEEEEEEECE-EEEHHHHHHH---------TTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCC
T ss_pred EEeeeeecc-CCcceEEEEEeCC-CCCHHHHHHh---------ccCCCCHHHHHHHHHHHHHHHHHHH---HCCeEEecC
Confidence 999975421 2235689999999 9999999953 3456999999999999999999999 889999999
Q ss_pred CCCCeeeC--CCCCeEEeccccccccccccccc-----cccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCC
Q 002857 302 KPSNILLN--DEMTACVADFGIARFLEATNEQT-----SSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGL 374 (873)
Q Consensus 302 KpsNILLd--~~~~vKLsDFGla~~~~~~~~~~-----~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk 374 (873)
||+|||++ .++.+||+|||+++.+....... ......||+.|+|||++.+..++.++|||||||++|||+||+
T Consensus 179 kp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~ 258 (364)
T 3op5_A 179 KASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGH 258 (364)
T ss_dssp CGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSC
T ss_pred CHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCC
Confidence 99999999 88999999999998765432211 112345999999999999999999999999999999999999
Q ss_pred CCCCcccccchhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCC
Q 002857 375 RPSDDMFKDNLNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGE 454 (873)
Q Consensus 375 ~Pf~~~~~~~~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~e 454 (873)
.||....... .............+.++++..+... .++..+.+++..||+.+|++
T Consensus 259 ~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~li~~cl~~~p~~ 313 (364)
T 3op5_A 259 LPWEDNLKDP-KYVRDSKIRYRENIASLMDKCFPAA------------------------NAPGEIAKYMETVKLLDYTE 313 (364)
T ss_dssp CTTGGGTTCH-HHHHHHHHHHHHCHHHHHHHHSCTT------------------------CCCHHHHHHHHHHHTCCTTC
T ss_pred CCccccccCH-HHHHHHHHHhhhhHHHHHHHhcccc------------------------cCHHHHHHHHHHHhcCCCCC
Confidence 9997632221 2222222222223333333322110 01335788999999999999
Q ss_pred CCCHHHHHHHHHHHHHhhh
Q 002857 455 RMKINDVELGLRLIKKKLL 473 (873)
Q Consensus 455 RPTm~EVl~~Le~i~~~l~ 473 (873)
||++.+|++.|+.+.....
T Consensus 314 RP~~~~l~~~l~~~~~~~~ 332 (364)
T 3op5_A 314 KPLYENLRDILLQGLKAIG 332 (364)
T ss_dssp CCCHHHHHHHHHHHHHHTT
T ss_pred CCCHHHHHHHHHHHHHHcC
Confidence 9999999999999877664
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=370.25 Aligned_cols=271 Identities=21% Similarity=0.342 Sum_probs=209.9
Q ss_pred hcCCCcceeecccCceEEEEEEEc-------CCCcEEEEEEeeccCC-cchhHHHHHHHHHHhh-hhccceeeeeeeecc
Q 002857 159 TKGFSSENLIGAGNFASVYKGILF-------EGAPAVAIKVFNFLHH-DASKSFTVECEVMRNI-IHRKIIKVVTACSRV 229 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~-------~~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L-~HpNIV~llg~c~~~ 229 (873)
.++|.+.+.||+|+||.||+|++. .++..||||+++.... ...+.+.+|+++|+++ +||||++++++|
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~--- 156 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC--- 156 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEE---
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE---
Confidence 467899999999999999999874 2456799999975432 2346799999999999 899999999996
Q ss_pred cccCCceEEEEEeecCCCChhhhcccccccc------cccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCC
Q 002857 230 DYQGNDFKALVYEFMPNGSLEEWIHPITEED------KRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKP 303 (873)
Q Consensus 230 ~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~------~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKp 303 (873)
...+..++||||+++|+|.+++....... ........+++.+++.|+.||+.||+||| +.+|+||||||
T Consensus 157 --~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp 231 (370)
T 2psq_A 157 --TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAA 231 (370)
T ss_dssp --CSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCG
T ss_pred --ccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccch
Confidence 44567899999999999999996411100 00112346899999999999999999999 89999999999
Q ss_pred CCeeeCCCCCeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccc
Q 002857 304 SNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFK 382 (873)
Q Consensus 304 sNILLd~~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~ 382 (873)
+|||++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||+| |+.||.....
T Consensus 232 ~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~ 311 (370)
T 2psq_A 232 RNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 311 (370)
T ss_dssp GGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred hhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 999999999999999999987654433333334457889999999999999999999999999999999 9999975321
Q ss_pred cchhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHH
Q 002857 383 DNLNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVE 462 (873)
Q Consensus 383 ~~~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl 462 (873)
.. +. ..+...... ..| ..+...+.+++.+||+.+|++|||+.||+
T Consensus 312 ~~--~~------------~~~~~~~~~------------~~~---------~~~~~~l~~li~~~l~~dP~~Rpt~~ell 356 (370)
T 2psq_A 312 EE--LF------------KLLKEGHRM------------DKP---------ANCTNELYMMMRDCWHAVPSQRPTFKQLV 356 (370)
T ss_dssp GG--HH------------HHHHTTCCC------------CCC---------TTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HH--HH------------HHHhcCCCC------------CCC---------CCCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 11 11 111000000 000 01133578899999999999999999999
Q ss_pred HHHHHHHHhh
Q 002857 463 LGLRLIKKKL 472 (873)
Q Consensus 463 ~~Le~i~~~l 472 (873)
+.|+.+....
T Consensus 357 ~~L~~il~~~ 366 (370)
T 2psq_A 357 EDLDRILTLT 366 (370)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHHh
Confidence 9999987644
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=362.94 Aligned_cols=254 Identities=22% Similarity=0.338 Sum_probs=202.3
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCC-cchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceE
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH-DASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFK 237 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~ 237 (873)
.++|++.+.||+|+||.||+|++..+++.||||++..... ...+.+.+|+.+++.++||||+++++++ ..++..
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-----~~~~~~ 80 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR-----REGNIQ 80 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEE-----ECSSEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEE-----ecCCeE
Confidence 4689999999999999999999998999999999864332 2346789999999999999999999996 456778
Q ss_pred EEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEe
Q 002857 238 ALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVA 317 (873)
Q Consensus 238 ~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLs 317 (873)
++||||+++|+|.+++. ....+++.+++.|+.||+.||+||| +.+|+||||||+|||++.++.+||+
T Consensus 81 ~lv~e~~~~~~L~~~l~----------~~~~~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~ 147 (323)
T 3tki_A 81 YLFLEYCSGGELFDRIE----------PDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKIS 147 (323)
T ss_dssp EEEEECCTTEEGGGGSB----------TTTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEEC
T ss_pred EEEEEcCCCCcHHHHHh----------hcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCCEEEE
Confidence 99999999999999984 3456899999999999999999999 8999999999999999999999999
Q ss_pred ccccccccccccccccccccccccccCCCcccCCCCC-CcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCc
Q 002857 318 DFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHET-SSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALP 396 (873)
Q Consensus 318 DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~-s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~ 396 (873)
|||+++.+.............||..|+|||++.+..+ +.++||||||+++|||++|+.||.........+..+.....
T Consensus 148 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~- 226 (323)
T 3tki_A 148 DFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT- 226 (323)
T ss_dssp CCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCT-
T ss_pred EeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccc-
Confidence 9999987654433333344579999999999988765 77899999999999999999999764332222222111100
Q ss_pred hhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 397 ERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 397 ~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
.. .++ . .....+.+++.+||+.||++|||+.||++
T Consensus 227 -----------~~-------------~~~----~----~~~~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 227 -----------YL-------------NPW----K----KIDSAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp -----------TS-------------TTG----G----GSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -----------cC-------------Ccc----c----cCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 00 000 0 01234678999999999999999998864
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=377.07 Aligned_cols=262 Identities=25% Similarity=0.367 Sum_probs=208.2
Q ss_pred hhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCC-cchhHHHHHHHHHHhhhhccceeeeeeeecccccCCce
Q 002857 158 ATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH-DASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDF 236 (873)
Q Consensus 158 at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~ 236 (873)
..++|.+.+.||+|+||.||+|++..+++.||||+++.... .....|.+|+++|++++||||++++++| ...+.
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~~~ 186 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC-----TQKQP 186 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEE-----CSSSS
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-----ecCCC
Confidence 34678899999999999999999988899999999874432 2345789999999999999999999996 34556
Q ss_pred EEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEE
Q 002857 237 KALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACV 316 (873)
Q Consensus 237 ~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKL 316 (873)
.++||||+++|+|.++++. ....+++..++.++.||+.||+||| +.+|+||||||+|||++.++.+||
T Consensus 187 ~~lv~e~~~~g~L~~~l~~---------~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl 254 (377)
T 3cbl_A 187 IYIVMELVQGGDFLTFLRT---------EGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKI 254 (377)
T ss_dssp CEEEEECCTTCBHHHHHHH---------HGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEE
T ss_pred cEEEEEcCCCCCHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCcEEE
Confidence 8999999999999999953 2235889999999999999999999 899999999999999999999999
Q ss_pred eccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHHHhhcC
Q 002857 317 ADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQSAL 395 (873)
Q Consensus 317 sDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~~~~~~ 395 (873)
+|||+++...............++..|+|||++.+..++.++||||||+++|||+| |..||.......
T Consensus 255 ~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~----------- 323 (377)
T 3cbl_A 255 SDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ----------- 323 (377)
T ss_dssp CCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH-----------
T ss_pred CcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-----------
Confidence 99999986433221111112235778999999998899999999999999999999 999997532111
Q ss_pred chhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHHHHh
Q 002857 396 PERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLIKKK 471 (873)
Q Consensus 396 ~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i~~~ 471 (873)
..+.+.... ..+... .++..+.+++.+||+.||++|||+.+|++.|+.+++.
T Consensus 324 ---~~~~~~~~~--------------~~~~~~-------~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 324 ---TREFVEKGG--------------RLPCPE-------LCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp ---HHHHHHTTC--------------CCCCCT-------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---HHHHHHcCC--------------CCCCCC-------CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 111111100 000000 1233578899999999999999999999999998764
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=360.35 Aligned_cols=264 Identities=26% Similarity=0.370 Sum_probs=198.0
Q ss_pred HhhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCC--cchhHHHHHHHHHHhhhhccceeeeeeeecccccCC
Q 002857 157 SATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH--DASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGN 234 (873)
Q Consensus 157 ~at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~ 234 (873)
...++|++.+.||+|+||.||+|++ +++.||||++..... ...+.+.+|++++++++||||+++++++ ...
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~ 106 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV-----TQP 106 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----CST
T ss_pred CChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EEC
Confidence 3456889999999999999999987 678899999875432 2345789999999999999999999996 445
Q ss_pred ceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCC--eeeccCCCCCeeeCCCC
Q 002857 235 DFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPP--IAHCDIKPSNILLNDEM 312 (873)
Q Consensus 235 ~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~g--IvHrDLKpsNILLd~~~ 312 (873)
...++||||+++|+|.+++... .....+++..++.|+.||+.||+||| +.+ |+||||||+|||++.++
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~~~ 176 (309)
T 3p86_A 107 PNLSIVTEYLSRGSLYRLLHKS-------GAREQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRNLKSPNLLVDKKY 176 (309)
T ss_dssp TCCEEEEECCTTCBHHHHHHST-------THHHHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTTCCGGGEEECTTC
T ss_pred CceEEEEecCCCCcHHHHHhhc-------CCCCCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCCCChhhEEEeCCC
Confidence 6689999999999999999531 11123889999999999999999999 788 99999999999999999
Q ss_pred CeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHh
Q 002857 313 TACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQ 392 (873)
Q Consensus 313 ~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~ 392 (873)
.+||+|||+++...... .......||..|+|||++.+..++.++||||||+++|||+||+.||........ ..
T Consensus 177 ~~kL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~--~~--- 249 (309)
T 3p86_A 177 TVKVCDFGLSRLKASTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQV--VA--- 249 (309)
T ss_dssp CEEECCCC-------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHH--HH---
T ss_pred cEEECCCCCCccccccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HH---
Confidence 99999999998643321 122345689999999999999999999999999999999999999975321110 00
Q ss_pred hcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHHHHhh
Q 002857 393 SALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLIKKKL 472 (873)
Q Consensus 393 ~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i~~~l 472 (873)
.+.... ...+... .+...+.+++.+||+.+|++|||+.||++.|+.+.+..
T Consensus 250 --------~~~~~~--------------~~~~~~~-------~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 250 --------AVGFKC--------------KRLEIPR-------NLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp --------HHHHSC--------------CCCCCCT-------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred --------HHHhcC--------------CCCCCCc-------cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 000000 0000000 11234788999999999999999999999999886654
Q ss_pred h
Q 002857 473 L 473 (873)
Q Consensus 473 ~ 473 (873)
.
T Consensus 301 ~ 301 (309)
T 3p86_A 301 V 301 (309)
T ss_dssp -
T ss_pred C
Confidence 3
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=364.64 Aligned_cols=261 Identities=23% Similarity=0.394 Sum_probs=200.8
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcE----EEEEEeecc-CCcchhHHHHHHHHHHhhhhccceeeeeeeecccccC
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPA----VAIKVFNFL-HHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQG 233 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~----VAVK~l~~~-~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~ 233 (873)
.++|++.++||+|+||.||+|++..+++. ||+|.++.. .....+.+.+|+.++++++||||++++++|..
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----- 88 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT----- 88 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEES-----
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec-----
Confidence 35789999999999999999998777664 578877533 23445789999999999999999999999742
Q ss_pred CceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCC
Q 002857 234 NDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMT 313 (873)
Q Consensus 234 ~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~ 313 (873)
...++|+||+++|+|.+++.. ....+++..++.|+.||+.||+||| +.+|+||||||+|||++.++.
T Consensus 89 -~~~~~v~e~~~~g~L~~~l~~---------~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIll~~~~~ 155 (327)
T 3poz_A 89 -STVQLITQLMPFGCLLDYVRE---------HKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQH 155 (327)
T ss_dssp -SSEEEEEECCTTCBHHHHHHH---------STTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTE
T ss_pred -CCeEEEEEecCCCcHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCChheEEECCCCC
Confidence 237899999999999999953 3456899999999999999999999 889999999999999999999
Q ss_pred eEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHHHh
Q 002857 314 ACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQ 392 (873)
Q Consensus 314 vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~~~ 392 (873)
+||+|||+++...............+|..|+|||++.+..++.++||||||+++|||+| |+.||.......
T Consensus 156 ~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-------- 227 (327)
T 3poz_A 156 VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-------- 227 (327)
T ss_dssp EEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--------
T ss_pred EEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH--------
Confidence 99999999987755443333344557889999999999999999999999999999999 999997632211
Q ss_pred hcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHHHHhh
Q 002857 393 SALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLIKKKL 472 (873)
Q Consensus 393 ~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i~~~l 472 (873)
+...+..... .+... .+...+.+++.+||+.+|++|||+.||++.|+.+....
T Consensus 228 ------~~~~~~~~~~--------------~~~~~-------~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~ 280 (327)
T 3poz_A 228 ------ISSILEKGER--------------LPQPP-------ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 280 (327)
T ss_dssp ------HHHHHHTTCC--------------CCCCT-------TBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTSH
T ss_pred ------HHHHHHcCCC--------------CCCCc-------cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhhh
Confidence 1111111000 00000 01234788999999999999999999999999886543
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=363.67 Aligned_cols=261 Identities=23% Similarity=0.400 Sum_probs=205.0
Q ss_pred cCCCcceeecccCceEEEEEEEcCCC---cEEEEEEeeccC-CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCc
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGA---PAVAIKVFNFLH-HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGND 235 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g---~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~ 235 (873)
++|.+.+.||+|+||.||+|.+..++ ..||||+++... ....+.+.+|++++++++||||+++++++ ....
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~ 123 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVV-----TRGR 123 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----CGGG
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EeCC
Confidence 56888999999999999999987544 459999997542 23346799999999999999999999996 3456
Q ss_pred eEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeE
Q 002857 236 FKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTAC 315 (873)
Q Consensus 236 ~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vK 315 (873)
..++||||+++|+|.++++. ....+++.+++.|+.||+.||+||| +.+|+||||||+|||++.++.+|
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~k 191 (325)
T 3kul_A 124 LAMIVTEYMENGSLDTFLRT---------HDGQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCK 191 (325)
T ss_dssp CCEEEEECCTTCBHHHHHHT---------TTTCSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEE
T ss_pred ccEEEeeCCCCCcHHHHHHh---------cccCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECCCCCEE
Confidence 78999999999999999953 3456899999999999999999999 89999999999999999999999
Q ss_pred Eecccccccccccccc-ccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHHHhh
Q 002857 316 VADFGIARFLEATNEQ-TSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQS 393 (873)
Q Consensus 316 LsDFGla~~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~~~~ 393 (873)
|+|||+++........ .......+|..|+|||++.+..++.++||||||+++|||++ |+.||....... ...
T Consensus 192 l~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--~~~---- 265 (325)
T 3kul_A 192 VSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD--VIS---- 265 (325)
T ss_dssp ECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH--HHH----
T ss_pred ECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH--HHH----
Confidence 9999999876543221 12223346788999999998899999999999999999999 999996532111 000
Q ss_pred cCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHHHHhh
Q 002857 394 ALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLIKKKL 472 (873)
Q Consensus 394 ~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i~~~l 472 (873)
.+... . ..+... .+...+.+++..||+.||++|||+.||++.|+.+....
T Consensus 266 -------~~~~~-~--------------~~~~~~-------~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~ 315 (325)
T 3kul_A 266 -------SVEEG-Y--------------RLPAPM-------GCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP 315 (325)
T ss_dssp -------HHHTT-C--------------CCCCCT-------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred -------HHHcC-C--------------CCCCCC-------CcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence 00000 0 000000 11335788999999999999999999999999986543
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=346.71 Aligned_cols=268 Identities=17% Similarity=0.209 Sum_probs=211.5
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhh-hhccceeeeeeeecccccCCceE
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNI-IHRKIIKVVTACSRVDYQGNDFK 237 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~llg~c~~~~~~~~~~~ 237 (873)
.++|.+.+.||+|+||.||+|++..+++.||||++.... ..+.+.+|+.+++++ +|+|++++++++ ......
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~~~ 81 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFG-----QEGLHN 81 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEE-----EETTEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeec-----CCCcee
Confidence 467999999999999999999998899999999986432 335789999999999 799999999985 456678
Q ss_pred EEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCC----
Q 002857 238 ALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMT---- 313 (873)
Q Consensus 238 ~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~---- 313 (873)
++||||+ +++|.+++.. ....+++..++.|+.||+.||+||| +.+|+||||||+|||++.++.
T Consensus 82 ~lv~e~~-~~~L~~~l~~---------~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~ 148 (298)
T 1csn_A 82 VLVIDLL-GPSLEDLLDL---------CGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNAN 148 (298)
T ss_dssp EEEEECC-CCBHHHHHHH---------TTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTT
T ss_pred EEEEEec-CCCHHHHHHH---------hccCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCC
Confidence 9999999 9999999953 2345899999999999999999999 899999999999999987776
Q ss_pred -eEEecccccccccccccc-----ccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhh
Q 002857 314 -ACVADFGIARFLEATNEQ-----TSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNL 387 (873)
Q Consensus 314 -vKLsDFGla~~~~~~~~~-----~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l 387 (873)
+||+|||+++........ .......||..|+|||++.+..++.++||||||+++|||++|+.||.........
T Consensus 149 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~- 227 (298)
T 1csn_A 149 MIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNK- 227 (298)
T ss_dssp CEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHH-
T ss_pred eEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccH-
Confidence 999999999876543221 1223456999999999999999999999999999999999999999763221110
Q ss_pred HHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHH
Q 002857 388 QNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRL 467 (873)
Q Consensus 388 ~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~ 467 (873)
. .+..+......... ......+...+.+++.+||+.||++|||+.+|++.|+.
T Consensus 228 -~--------~~~~~~~~~~~~~~------------------~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~ 280 (298)
T 1csn_A 228 -Q--------KYERIGEKKQSTPL------------------RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSK 280 (298)
T ss_dssp -H--------HHHHHHHHHHHSCH------------------HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred -H--------HHHHHHhhccCccH------------------HHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHH
Confidence 0 00111110000000 00000123458899999999999999999999999999
Q ss_pred HHHhhhc
Q 002857 468 IKKKLLE 474 (873)
Q Consensus 468 i~~~l~~ 474 (873)
+.+.+..
T Consensus 281 ~~~~~~~ 287 (298)
T 1csn_A 281 VLERLNT 287 (298)
T ss_dssp HHHHTTC
T ss_pred HHHhcCC
Confidence 9876643
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=360.86 Aligned_cols=287 Identities=24% Similarity=0.333 Sum_probs=203.6
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHH--HhhhhccceeeeeeeecccccCCce
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVM--RNIIHRKIIKVVTACSRVDYQGNDF 236 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL--~~L~HpNIV~llg~c~~~~~~~~~~ 236 (873)
.++|++.+.||+|+||.||+|++ +++.||||+++.. ....+..|.+++ ..++|+||+++++.+..........
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred hHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 46899999999999999999977 6789999998743 234455555554 4589999999998765544455667
Q ss_pred EEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCC---------CeeeccCCCCCee
Q 002857 237 KALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKP---------PIAHCDIKPSNIL 307 (873)
Q Consensus 237 ~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~---------gIvHrDLKpsNIL 307 (873)
.+|||||+++|+|.+++.. ..+++..++.|+.||+.||+||| +. +|+||||||+|||
T Consensus 87 ~~lv~e~~~~g~L~~~l~~-----------~~~~~~~~~~i~~qi~~~L~~LH---~~~~~~~~~~~~ivH~Dikp~Nil 152 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSL-----------HTSDWVSSCRLAHSVTRGLAYLH---TELPRGDHYKPAISHRDLNSRNVL 152 (336)
T ss_dssp EEEEECCCTTCBHHHHHHH-----------CCBCHHHHHHHHHHHHHHHHHHH---CCBCCGGGCBCCEECSSCSGGGEE
T ss_pred EEEEEecCCCCcHHHHHhh-----------cccchhHHHHHHHHHHHHHHHHH---hhhccccccccceeecccccceEE
Confidence 8999999999999999943 23478899999999999999999 77 9999999999999
Q ss_pred eCCCCCeEEeccccccccccccc------cccccccccccccCCCcccCC-------CCCCcchhhHhHHHHHHHHHhCC
Q 002857 308 LNDEMTACVADFGIARFLEATNE------QTSSIGVKGTTGYIAPEYGMG-------HETSSYGDVYSFGILLLEMFTGL 374 (873)
Q Consensus 308 Ld~~~~vKLsDFGla~~~~~~~~------~~~~~~~~Gt~~Y~APE~l~~-------~~~s~ksDVwSfGvvL~ELlTGk 374 (873)
++.++.+||+|||+++.+..... ........||..|+|||++.+ ..++.++||||||+++|||+||.
T Consensus 153 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~ 232 (336)
T 3g2f_A 153 VKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232 (336)
T ss_dssp ECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTB
T ss_pred EcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcC
Confidence 99999999999999987643221 111223469999999999887 45677899999999999999998
Q ss_pred CCCCcccccchhhHHHHhhc-CchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcC
Q 002857 375 RPSDDMFKDNLNLQNWVQSA-LPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPG 453 (873)
Q Consensus 375 ~Pf~~~~~~~~~l~~~~~~~-~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~ 453 (873)
.||............+.... ......++. ..... ....+...........+...+.+|+.+||+.||+
T Consensus 233 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~----------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~ 301 (336)
T 3g2f_A 233 TDLFPGESVPEYQMAFQTEVGNHPTFEDMQ-VLVSR----------EKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAE 301 (336)
T ss_dssp GGGSTTSCCCCCCCTTHHHHCSSCCHHHHH-HHHTT----------SCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGG
T ss_pred CcCCCccchhHHHHhhhcccCCCchHHHHH-hhhcc----------cccCCCCCcccccccchHHHHHHHHHHHhcCChh
Confidence 77644221111000000000 000111110 00000 0000110000000112345688999999999999
Q ss_pred CCCCHHHHHHHHHHHHHhhhcC
Q 002857 454 ERMKINDVELGLRLIKKKLLET 475 (873)
Q Consensus 454 eRPTm~EVl~~Le~i~~~l~~~ 475 (873)
+|||+.||++.|+.+...+.+.
T Consensus 302 ~Rps~~e~l~~L~~ll~~~~~~ 323 (336)
T 3g2f_A 302 ARLTAQXAEERMAELMMIWERN 323 (336)
T ss_dssp GSCCHHHHHHHHHHHHHCCCC-
T ss_pred hCcchHHHHHHHHHHHHHHHhc
Confidence 9999999999999998877654
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=356.44 Aligned_cols=266 Identities=20% Similarity=0.233 Sum_probs=210.2
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhh-hhccceeeeeeeecccccCCceE
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNI-IHRKIIKVVTACSRVDYQGNDFK 237 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~llg~c~~~~~~~~~~~ 237 (873)
.++|.+.+.||+|+||.||+|++..+++.||||++.... ..+.+.+|+++++++ +|+||+++++++ ......
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~-----~~~~~~ 80 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFG-----PCGKYN 80 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEE-----EETTEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEE-----ecCCcc
Confidence 468999999999999999999998999999999987443 235789999999999 999999999985 346678
Q ss_pred EEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCC----
Q 002857 238 ALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMT---- 313 (873)
Q Consensus 238 ~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~---- 313 (873)
++||||+ +++|.+++.. ....+++..++.|+.||+.||+||| +.+|+||||||+|||++.++.
T Consensus 81 ~lv~e~~-~~~L~~~~~~---------~~~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~~ 147 (330)
T 2izr_A 81 AMVLELL-GPSLEDLFDL---------CDRTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQ 147 (330)
T ss_dssp EEEEECC-CCBHHHHHHH---------TTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCTT
T ss_pred EEEEEeC-CCCHHHHHHH---------cCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCCc
Confidence 9999999 9999999953 2457999999999999999999999 889999999999999998887
Q ss_pred -eEEeccccccccccccccc-----cccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhh
Q 002857 314 -ACVADFGIARFLEATNEQT-----SSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNL 387 (873)
Q Consensus 314 -vKLsDFGla~~~~~~~~~~-----~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l 387 (873)
+||+|||+++.+....... ......||..|+|||++.+..++.++||||||+++|||++|+.||........
T Consensus 148 ~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~-- 225 (330)
T 2izr_A 148 VIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTL-- 225 (330)
T ss_dssp SEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSH--
T ss_pred eEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccH--
Confidence 9999999998764432211 12345699999999999999999999999999999999999999976422211
Q ss_pred HHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHH
Q 002857 388 QNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRL 467 (873)
Q Consensus 388 ~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~ 467 (873)
... +..+......... .......+ .+.+++..||+.+|.+||++.+|++.|+.
T Consensus 226 ~~~--------~~~i~~~~~~~~~------------------~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~ 278 (330)
T 2izr_A 226 KER--------YQKIGDTKRATPI------------------EVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTD 278 (330)
T ss_dssp HHH--------HHHHHHHHHHSCH------------------HHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred HHH--------HHHHHhhhccCCH------------------HHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHH
Confidence 110 0111110000000 00000112 58899999999999999999999999998
Q ss_pred HHHhhh
Q 002857 468 IKKKLL 473 (873)
Q Consensus 468 i~~~l~ 473 (873)
+.....
T Consensus 279 ~~~~~~ 284 (330)
T 2izr_A 279 LFDRKG 284 (330)
T ss_dssp HHHHTT
T ss_pred HHHHcC
Confidence 877654
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=363.28 Aligned_cols=274 Identities=22% Similarity=0.381 Sum_probs=209.5
Q ss_pred HHhhcCCCcceeecccCceEEEEEEEcC-----CCcEEEEEEeeccCC-cchhHHHHHHHHHHhhhhccceeeeeeeecc
Q 002857 156 YSATKGFSSENLIGAGNFASVYKGILFE-----GAPAVAIKVFNFLHH-DASKSFTVECEVMRNIIHRKIIKVVTACSRV 229 (873)
Q Consensus 156 ~~at~~f~~~~~LG~G~fG~VYkg~~~~-----~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~ 229 (873)
....++|.+.+.||+|+||.||+|++.. +++.||||+++.... ...+.+.+|+.++++++||||+++++++
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~--- 119 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC--- 119 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE---
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE---
Confidence 3456789999999999999999999863 458999999975432 2346799999999999999999999996
Q ss_pred cccCCceEEEEEeecCCCChhhhcccccccc--------------cccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCC
Q 002857 230 DYQGNDFKALVYEFMPNGSLEEWIHPITEED--------------KRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPP 295 (873)
Q Consensus 230 ~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~--------------~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~g 295 (873)
...+..++||||+++|+|.+++....... ........+++.+++.|+.||+.||+||| +.+
T Consensus 120 --~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~~ 194 (343)
T 1luf_A 120 --AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERK 194 (343)
T ss_dssp --CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTT
T ss_pred --ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH---hCC
Confidence 44567899999999999999996421100 00011267899999999999999999999 899
Q ss_pred eeeccCCCCCeeeCCCCCeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CC
Q 002857 296 IAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GL 374 (873)
Q Consensus 296 IvHrDLKpsNILLd~~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk 374 (873)
|+||||||+|||++.++.+||+|||+++...............+|..|+|||++.+..++.++||||||+++|||+| |+
T Consensus 195 ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~ 274 (343)
T 1luf_A 195 FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 274 (343)
T ss_dssp CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred eecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCC
Confidence 99999999999999999999999999987644332233334568899999999988899999999999999999999 99
Q ss_pred CCCCcccccchhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCC
Q 002857 375 RPSDDMFKDNLNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGE 454 (873)
Q Consensus 375 ~Pf~~~~~~~~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~e 454 (873)
.||....... .. ..+.+.... ..|. .+...+.+++.+||+.||++
T Consensus 275 ~p~~~~~~~~--~~-----------~~~~~~~~~-------------~~~~---------~~~~~l~~li~~~l~~~p~~ 319 (343)
T 1luf_A 275 QPYYGMAHEE--VI-----------YYVRDGNIL-------------ACPE---------NCPLELYNLMRLCWSKLPAD 319 (343)
T ss_dssp CTTTTSCHHH--HH-----------HHHHTTCCC-------------CCCT---------TCCHHHHHHHHHHTCSSGGG
T ss_pred CcCCCCChHH--HH-----------HHHhCCCcC-------------CCCC---------CCCHHHHHHHHHHcccCccc
Confidence 9997532111 00 011110000 0000 11235788999999999999
Q ss_pred CCCHHHHHHHHHHHHHhh
Q 002857 455 RMKINDVELGLRLIKKKL 472 (873)
Q Consensus 455 RPTm~EVl~~Le~i~~~l 472 (873)
|||+.||++.|+.+.+.+
T Consensus 320 Rps~~~~~~~L~~~~~~~ 337 (343)
T 1luf_A 320 RPSFCSIHRILQRMCERA 337 (343)
T ss_dssp SCCHHHHHHHHHHTTC--
T ss_pred CCCHHHHHHHHHHHHhhh
Confidence 999999999999876544
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=363.72 Aligned_cols=249 Identities=22% Similarity=0.316 Sum_probs=201.9
Q ss_pred hhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC--CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCc
Q 002857 158 ATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH--HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGND 235 (873)
Q Consensus 158 at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~ 235 (873)
...+|.+.+.||+|+||.||+|++..+++.||||++.... ....+.+.+|+++|+.++||||+++++++ ...+
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~-----~~~~ 87 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVI-----ETEK 87 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSS
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EECC
Confidence 3568999999999999999999999999999999997543 23346788999999999999999999996 4567
Q ss_pred eEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeE
Q 002857 236 FKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTAC 315 (873)
Q Consensus 236 ~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vK 315 (873)
..++||||+++|+|.+++.. ...+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+|
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~----------~~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~k 154 (328)
T 3fe3_A 88 TLYLIMEYASGGEVFDYLVA----------HGRMKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIK 154 (328)
T ss_dssp EEEEEECCCTTCBHHHHHHH----------HCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEE
T ss_pred EEEEEEECCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCEE
Confidence 79999999999999999843 345889999999999999999999 89999999999999999999999
Q ss_pred EeccccccccccccccccccccccccccCCCcccCCCCCC-cchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhc
Q 002857 316 VADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETS-SYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSA 394 (873)
Q Consensus 316 LsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s-~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~ 394 (873)
|+|||+++...... ......||+.|+|||++.+..++ .++|||||||++|||++|+.||......
T Consensus 155 l~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~----------- 220 (328)
T 3fe3_A 155 IADFGFSNEFTVGG---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK----------- 220 (328)
T ss_dssp ECSTTCCGGGSSSC---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH-----------
T ss_pred EeeccCceecCCCC---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH-----------
Confidence 99999998654332 22345699999999999888765 7899999999999999999999763211
Q ss_pred CchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 395 LPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 395 ~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
++........+ ..|.. ....+.+++.+||+.||++|||+.|+++
T Consensus 221 ------~~~~~i~~~~~----------~~p~~---------~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 221 ------ELRERVLRGKY----------RIPFY---------MSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp ------HHHHHHHHCCC----------CCCTT---------SCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred ------HHHHHHHhCCC----------CCCCC---------CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 11111111100 00110 1224678999999999999999998865
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=346.96 Aligned_cols=258 Identities=28% Similarity=0.419 Sum_probs=206.4
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEE
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKA 238 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~ 238 (873)
.++|++.+.||+|+||.||+|.+. +++.||||++..... ..+.+.+|++++++++||||+++++++ ......+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 81 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVC-----LEQAPIC 81 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEE-----CSSSSEE
T ss_pred hhhceeeheecCCCccEEEEEEec-CCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEE-----ecCCceE
Confidence 357889999999999999999885 567899999975433 346799999999999999999999996 4456789
Q ss_pred EEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEec
Q 002857 239 LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVAD 318 (873)
Q Consensus 239 LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsD 318 (873)
+||||+++++|.+++.. ....+++..++.|+.|++.||+||| +.+|+||||||+|||++.++.+||+|
T Consensus 82 lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~D 149 (269)
T 4hcu_A 82 LVFEFMEHGCLSDYLRT---------QRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSD 149 (269)
T ss_dssp EEEECCTTCBHHHHHHT---------TTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECC
T ss_pred EEEEeCCCCcHHHHHHh---------cCcccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEcCCCCEEecc
Confidence 99999999999999953 3456899999999999999999999 89999999999999999999999999
Q ss_pred cccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHHHhhcCch
Q 002857 319 FGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQSALPE 397 (873)
Q Consensus 319 FGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~~~~~~~~ 397 (873)
||+++...... ........+|..|+|||++.+..++.++||||||+++|||++ |+.||....... ..
T Consensus 150 fg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~--~~--------- 217 (269)
T 4hcu_A 150 FGMTRFVLDDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VV--------- 217 (269)
T ss_dssp TTGGGGBCCHH-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HH---------
T ss_pred ccccccccccc-cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH--HH---------
Confidence 99998654322 112223456788999999998899999999999999999999 999997532111 00
Q ss_pred hHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHHHHh
Q 002857 398 RVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLIKKK 471 (873)
Q Consensus 398 ~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i~~~ 471 (873)
..+... ... ..+. . ....+.+++.+||+.||++|||+.|+++.|+.+.+.
T Consensus 218 --~~~~~~-~~~------------~~~~--~-------~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 218 --EDISTG-FRL------------YKPR--L-------ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp --HHHHTT-CCC------------CCCT--T-------SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred --HHHhcC-ccC------------CCCC--c-------CCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 111100 000 0000 0 123477899999999999999999999999998653
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=368.35 Aligned_cols=268 Identities=22% Similarity=0.328 Sum_probs=207.8
Q ss_pred hcCCCcceeecccCceEEEEEEEc-----CCCcEEEEEEeeccC-CcchhHHHHHHHHHHhhhhccceeeeeeeeccccc
Q 002857 159 TKGFSSENLIGAGNFASVYKGILF-----EGAPAVAIKVFNFLH-HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQ 232 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~-----~~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~ 232 (873)
.++|.+.+.||+|+||.||+|++. .+++.||||+++... ......+.+|+.++++++||||+++++++ .
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-----~ 144 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVS-----L 144 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----C
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEE-----e
Confidence 357889999999999999999953 456789999986432 33345789999999999999999999996 4
Q ss_pred CCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCC
Q 002857 233 GNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEM 312 (873)
Q Consensus 233 ~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~ 312 (873)
.....++||||+++|+|.+++.... ........+++.+++.|+.||+.||+||| +.+|+||||||+|||++.++
T Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~ 218 (367)
T 3l9p_A 145 QSLPRFILLELMAGGDLKSFLRETR---PRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPG 218 (367)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHS---CCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSS
T ss_pred cCCCCEEEEEeCCCCCHHHHHHhhc---cccCccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEEecCC
Confidence 4556799999999999999996411 11123456899999999999999999999 89999999999999999554
Q ss_pred ---CeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhH
Q 002857 313 ---TACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQ 388 (873)
Q Consensus 313 ---~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~ 388 (873)
.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||+| |..||....... +.
T Consensus 219 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~--~~ 296 (367)
T 3l9p_A 219 PGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE--VL 296 (367)
T ss_dssp TTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--HH
T ss_pred CCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HH
Confidence 599999999986644333333334568999999999998999999999999999999998 999997532111 11
Q ss_pred HHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHH
Q 002857 389 NWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLI 468 (873)
Q Consensus 389 ~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i 468 (873)
. .+...... +.. ..+...+.+|+.+||+.+|++|||+.||++.|+.+
T Consensus 297 ~------------~i~~~~~~--------------~~~-------~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 297 E------------FVTSGGRM--------------DPP-------KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp H------------HHHTTCCC--------------CCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred H------------HHHcCCCC--------------CCC-------ccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1 11000000 000 01123478899999999999999999999999988
Q ss_pred HHhh
Q 002857 469 KKKL 472 (873)
Q Consensus 469 ~~~l 472 (873)
....
T Consensus 344 ~~~~ 347 (367)
T 3l9p_A 344 TQDP 347 (367)
T ss_dssp HHCH
T ss_pred hhCh
Confidence 6543
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=350.71 Aligned_cols=260 Identities=25% Similarity=0.387 Sum_probs=202.5
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCC---cchhHHHHHHHHHHhhhhccceeeeeeeecccccCCc
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH---DASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGND 235 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~ 235 (873)
.++|++.+.||+|+||.||+|++..+++.||+|++..... ...+.+.+|+.++++++||||+++++++ ...+
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~-----~~~~ 84 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVD-----EEDD 84 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEE-----ECSS
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEee-----eeCC
Confidence 4679999999999999999999998999999999864332 2346789999999999999999999995 4567
Q ss_pred eEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeE
Q 002857 236 FKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTAC 315 (873)
Q Consensus 236 ~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vK 315 (873)
..++||||+++|+|.+++.. ...+++..++.++.||+.||+||| +.+|+||||||+|||++.++.+|
T Consensus 85 ~~~lv~e~~~g~~L~~~l~~----------~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~k 151 (294)
T 4eqm_A 85 CYYLVMEYIEGPTLSEYIES----------HGPLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLK 151 (294)
T ss_dssp EEEEEEECCCSCBHHHHHHH----------HCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEE
T ss_pred eEEEEEeCCCCCCHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEE
Confidence 89999999999999999943 346899999999999999999999 89999999999999999999999
Q ss_pred EeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcC
Q 002857 316 VADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSAL 395 (873)
Q Consensus 316 LsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~ 395 (873)
|+|||+++....... .......||+.|+|||++.+..++.++||||||+++|||+||+.||......... ...+....
T Consensus 152 l~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~-~~~~~~~~ 229 (294)
T 4eqm_A 152 IFDFGIAKALSETSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIA-IKHIQDSV 229 (294)
T ss_dssp ECCCSSSTTC--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHH-HHHHSSCC
T ss_pred EEeCCCccccccccc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHhhccC
Confidence 999999986643221 2223356899999999999999999999999999999999999999763221110 00000000
Q ss_pred chhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCC-CHHHHHHHHHHH
Q 002857 396 PERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERM-KINDVELGLRLI 468 (873)
Q Consensus 396 ~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRP-Tm~EVl~~Le~i 468 (873)
+.... ......+..+.+++.+||+.||++|| +++++.+.|+.+
T Consensus 230 ~~~~~------------------------------~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~ 273 (294)
T 4eqm_A 230 PNVTT------------------------------DVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSV 273 (294)
T ss_dssp CCHHH------------------------------HSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTS
T ss_pred CCcch------------------------------hcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHH
Confidence 00000 00001133578899999999999999 899999988865
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=368.70 Aligned_cols=261 Identities=26% Similarity=0.415 Sum_probs=195.8
Q ss_pred cCCCcceeecccCceEEEEEEEc---CCCcEEEEEEeeccC-CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCc
Q 002857 160 KGFSSENLIGAGNFASVYKGILF---EGAPAVAIKVFNFLH-HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGND 235 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~---~~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~ 235 (873)
++|++.+.||+|+||.||+|++. .++..||||+++... ....+.|.+|+.++++++||||+++++++ ....
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~ 119 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVV-----TKSK 119 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----CSSS
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----eeCC
Confidence 57899999999999999999876 456789999997543 23346799999999999999999999996 3456
Q ss_pred eEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeE
Q 002857 236 FKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTAC 315 (873)
Q Consensus 236 ~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vK 315 (873)
..++||||+++|+|.++++. ....+++.+++.|+.||+.||+||| +.+|+||||||+|||++.++.+|
T Consensus 120 ~~~lv~e~~~~~sL~~~l~~---------~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~k 187 (373)
T 2qol_A 120 PVMIVTEYMENGSLDSFLRK---------HDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCK 187 (373)
T ss_dssp SCEEEEECCTTCBHHHHHHT---------TTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEE
T ss_pred ceEEEEeCCCCCcHHHHHHh---------CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcCCCCEE
Confidence 78999999999999999953 3456899999999999999999999 88999999999999999999999
Q ss_pred Eeccccccccccccccc-cccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHHHhh
Q 002857 316 VADFGIARFLEATNEQT-SSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQS 393 (873)
Q Consensus 316 LsDFGla~~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~~~~ 393 (873)
|+|||+++......... ......++..|+|||++.+..++.++||||||+++|||++ |+.||.......
T Consensus 188 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~--------- 258 (373)
T 2qol_A 188 VSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD--------- 258 (373)
T ss_dssp ECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH---------
T ss_pred ECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH---------
Confidence 99999998765432211 1122335778999999999999999999999999999998 999996532111
Q ss_pred cCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHHHHhh
Q 002857 394 ALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLIKKKL 472 (873)
Q Consensus 394 ~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i~~~l 472 (873)
+...+..... .+... .+...+.+++.+||+.||++||++.||++.|+.+....
T Consensus 259 -----~~~~i~~~~~--------------~~~~~-------~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 259 -----VIKAVDEGYR--------------LPPPM-------DCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp -----HHHHHHTTEE--------------CCCCT-------TCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred -----HHHHHHcCCC--------------CCCCc-------cccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 1111111000 00000 11335889999999999999999999999999986643
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=357.11 Aligned_cols=258 Identities=22% Similarity=0.342 Sum_probs=203.4
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcE----EEEEEeeccC-CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCC
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPA----VAIKVFNFLH-HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGN 234 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~----VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~ 234 (873)
++|.+.+.||+|+||.||+|++..+++. ||+|++.... ......+.+|+.++++++||||+++++++. +
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------~ 86 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP------G 86 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC------B
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc------C
Confidence 5788999999999999999999877765 7788775332 334467889999999999999999999862 3
Q ss_pred ceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCe
Q 002857 235 DFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTA 314 (873)
Q Consensus 235 ~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~v 314 (873)
...++||||+++|+|.+++.. ....+++..++.|+.||+.||+||| +.+|+||||||+|||++.++.+
T Consensus 87 ~~~~~v~e~~~~~~L~~~l~~---------~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~ 154 (325)
T 3kex_A 87 SSLQLVTQYLPLGSLLDHVRQ---------HRGALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQV 154 (325)
T ss_dssp SSEEEEEECCTTCBSHHHHHS---------SGGGSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEESSSSCE
T ss_pred CccEEEEEeCCCCCHHHHHHH---------ccccCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEECCCCeE
Confidence 458999999999999999853 2346889999999999999999999 8899999999999999999999
Q ss_pred EEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHHHhh
Q 002857 315 CVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQS 393 (873)
Q Consensus 315 KLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~~~~ 393 (873)
||+|||+++...............+|..|+|||++.+..++.++||||||+++|||+| |+.||.......
T Consensus 155 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--------- 225 (325)
T 3kex_A 155 QVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE--------- 225 (325)
T ss_dssp EECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH---------
T ss_pred EECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH---------
Confidence 9999999998755444434445568889999999998899999999999999999999 999997632111
Q ss_pred cCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHHHH
Q 002857 394 ALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLIKK 470 (873)
Q Consensus 394 ~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i~~ 470 (873)
+.+.+...... ..+.. +...+.+++.+||+.||++|||+.||++.|+.+..
T Consensus 226 -----~~~~~~~~~~~------------~~~~~---------~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 226 -----VPDLLEKGERL------------AQPQI---------CTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp -----HHHHHHTTCBC------------CCCTT---------BCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred -----HHHHHHcCCCC------------CCCCc---------CcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 11111110000 00000 11236789999999999999999999999998744
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-40 Score=356.63 Aligned_cols=275 Identities=22% Similarity=0.362 Sum_probs=194.6
Q ss_pred HHhhcCCCcceeecccCceEEEEEEEcCCCc---EEEEEEeecc--CCcchhHHHHHHHHHHhhhhccceeeeeeeeccc
Q 002857 156 YSATKGFSSENLIGAGNFASVYKGILFEGAP---AVAIKVFNFL--HHDASKSFTVECEVMRNIIHRKIIKVVTACSRVD 230 (873)
Q Consensus 156 ~~at~~f~~~~~LG~G~fG~VYkg~~~~~g~---~VAVK~l~~~--~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~ 230 (873)
....++|++.+.||+|+||.||+|++..++. .||||+++.. .....+.+.+|++++++++||||+++++++....
T Consensus 19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 98 (323)
T 3qup_A 19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR 98 (323)
T ss_dssp BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence 3445789999999999999999998876654 8999998744 3344578999999999999999999999974321
Q ss_pred cc-CCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeC
Q 002857 231 YQ-GNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLN 309 (873)
Q Consensus 231 ~~-~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd 309 (873)
.. .....++||||+++|+|.+++.... .......+++.+++.|+.||+.||+||| +.+|+||||||+|||++
T Consensus 99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Dikp~NIli~ 171 (323)
T 3qup_A 99 AKGRLPIPMVILPFMKHGDLHAFLLASR----IGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLA 171 (323)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHHH----C---CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEC
T ss_pred cccCCCccEEEEEeccCCcHHHHHHhhh----ccccccccCHHHHHHHHHHHHHHHHHHH---cCCcccCCCCcceEEEc
Confidence 11 0112489999999999999995311 1122346899999999999999999999 88999999999999999
Q ss_pred CCCCeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhH
Q 002857 310 DEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQ 388 (873)
Q Consensus 310 ~~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~ 388 (873)
.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||....... ..
T Consensus 172 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--~~ 249 (323)
T 3qup_A 172 EDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE--IY 249 (323)
T ss_dssp TTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HH
T ss_pred CCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH--HH
Confidence 999999999999987654433333334457889999999999999999999999999999999 999997632211 11
Q ss_pred HHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHH
Q 002857 389 NWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLI 468 (873)
Q Consensus 389 ~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i 468 (873)
..+...... +... .+...+.+++.+||+.||++|||+.+|++.|+.+
T Consensus 250 -----------~~~~~~~~~---------------~~~~-------~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 296 (323)
T 3qup_A 250 -----------NYLIGGNRL---------------KQPP-------ECMEEVYDLMYQCWSADPKQRPSFTCLRMELENI 296 (323)
T ss_dssp -----------HHHHTTCCC---------------CCCT-------TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----------HHHhcCCCC---------------CCCC-------ccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 011100000 0000 1123578999999999999999999999999998
Q ss_pred HHhh
Q 002857 469 KKKL 472 (873)
Q Consensus 469 ~~~l 472 (873)
....
T Consensus 297 l~~~ 300 (323)
T 3qup_A 297 LGHL 300 (323)
T ss_dssp HHC-
T ss_pred HHHh
Confidence 7654
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=343.67 Aligned_cols=269 Identities=20% Similarity=0.290 Sum_probs=208.3
Q ss_pred hhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceE
Q 002857 158 ATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFK 237 (873)
Q Consensus 158 at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~ 237 (873)
..++|++.+.||+|+||.||+|++..+++.||||++.... ....+.+|+++++.++|++++..+.++. ......
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~----~~~~~~ 80 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCG----AEGDYN 80 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEE----EETTEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeec----CCCCce
Confidence 4578999999999999999999998999999999876432 2356899999999999999888888763 456678
Q ss_pred EEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeee---CCCCCe
Q 002857 238 ALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILL---NDEMTA 314 (873)
Q Consensus 238 ~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILL---d~~~~v 314 (873)
++||||+ +++|.+++.. ....+++..++.|+.||+.||+||| +.+|+||||||+|||+ +.++.+
T Consensus 81 ~lv~e~~-~~~L~~~~~~---------~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~~~~ 147 (296)
T 4hgt_A 81 VMVMELL-GPSLEDLFNF---------CSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLV 147 (296)
T ss_dssp EEEEECC-CCBHHHHHHH---------TTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECCGGGTTCE
T ss_pred EEEEEcc-CCCHHHHHHH---------hcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeeeeccCCCCeE
Confidence 9999999 9999999852 2446899999999999999999999 8999999999999999 788999
Q ss_pred EEecccccccccccccc-----ccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHH
Q 002857 315 CVADFGIARFLEATNEQ-----TSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQN 389 (873)
Q Consensus 315 KLsDFGla~~~~~~~~~-----~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~ 389 (873)
||+|||+++........ .......||..|+|||++.+..++.++||||||+++|||++|+.||.........
T Consensus 148 kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--- 224 (296)
T 4hgt_A 148 YIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR--- 224 (296)
T ss_dssp EECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSS---
T ss_pred EEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhh---
Confidence 99999999876543321 1223456899999999999999999999999999999999999999763222110
Q ss_pred HHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHHH
Q 002857 390 WVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLIK 469 (873)
Q Consensus 390 ~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i~ 469 (873)
..+..+....+..... .........+.+++..||+.+|++|||+.+|++.|+.+.
T Consensus 225 -------~~~~~~~~~~~~~~~~------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~ 279 (296)
T 4hgt_A 225 -------QKYERISEKKMSTPIE------------------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 279 (296)
T ss_dssp -------SHHHHHHHHHHHSCHH------------------HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred -------hhhhhhhcccccchhh------------------hhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHH
Confidence 0111111111100000 000011235889999999999999999999999999998
Q ss_pred Hhhh
Q 002857 470 KKLL 473 (873)
Q Consensus 470 ~~l~ 473 (873)
....
T Consensus 280 ~~~~ 283 (296)
T 4hgt_A 280 HRQG 283 (296)
T ss_dssp HHHT
T ss_pred HHhC
Confidence 7664
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=348.33 Aligned_cols=252 Identities=21% Similarity=0.310 Sum_probs=195.7
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCC--------------------------cchhHHHHHHHHHH
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH--------------------------DASKSFTVECEVMR 212 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~--------------------------~~~~~f~~Ei~iL~ 212 (873)
.++|++.+.||+|+||.||+|++..+++.||||++..... ...+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 4689999999999999999999999999999999864321 12356899999999
Q ss_pred hhhhccceeeeeeeecccccCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCC
Q 002857 213 NIIHRKIIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGC 292 (873)
Q Consensus 213 ~L~HpNIV~llg~c~~~~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~ 292 (873)
+++||||+++++++.. ......++||||+++++|.+++. ...+++.+++.++.||+.||+|||
T Consensus 92 ~l~h~~iv~~~~~~~~---~~~~~~~lv~e~~~~~~l~~~~~-----------~~~~~~~~~~~~~~qi~~~l~~lH--- 154 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDD---PNEDHLYMVFELVNQGPVMEVPT-----------LKPLSEDQARFYFQDLIKGIEYLH--- 154 (298)
T ss_dssp TCCCTTBCCEEEEEEC---SSSSEEEEEEECCTTCBSCCSSC-----------SSCCCHHHHHHHHHHHHHHHHHHH---
T ss_pred hCCCCCCCeEEEEEEc---CCCCEEEEEEecCCCCcHHHHhh-----------cCCCCHHHHHHHHHHHHHHHHHHH---
Confidence 9999999999999742 23567899999999999998762 346899999999999999999999
Q ss_pred CCCeeeccCCCCCeeeCCCCCeEEeccccccccccccccccccccccccccCCCcccCCCC---CCcchhhHhHHHHHHH
Q 002857 293 KPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHE---TSSYGDVYSFGILLLE 369 (873)
Q Consensus 293 s~gIvHrDLKpsNILLd~~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~---~s~ksDVwSfGvvL~E 369 (873)
+.+|+||||||+|||++.++.+||+|||+++....... ......||..|+|||++.+.. ++.++||||||+++||
T Consensus 155 ~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~ 232 (298)
T 2zv2_A 155 YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYC 232 (298)
T ss_dssp HTTEECCCCCGGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHH
T ss_pred HCCeeccCCCHHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHH
Confidence 88999999999999999999999999999987643321 223356999999999988765 4788999999999999
Q ss_pred HHhCCCCCCcccccchhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhc
Q 002857 370 MFTGLRPSDDMFKDNLNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSA 449 (873)
Q Consensus 370 LlTGk~Pf~~~~~~~~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~ 449 (873)
|++|+.||...... .+. ..+....+ ..+... .....+.+++.+||+
T Consensus 233 l~~g~~pf~~~~~~--~~~-----------~~~~~~~~--------------~~~~~~-------~~~~~l~~li~~~l~ 278 (298)
T 2zv2_A 233 FVFGQCPFMDERIM--CLH-----------SKIKSQAL--------------EFPDQP-------DIAEDLKDLITRMLD 278 (298)
T ss_dssp HHHSSCSSCCSSHH--HHH-----------HHHHHCCC--------------CCCSSS-------CCCHHHHHHHHHHTC
T ss_pred HHHCCCCCCCccHH--HHH-----------HHHhcccC--------------CCCCcc-------ccCHHHHHHHHHHhh
Confidence 99999999652111 000 00000000 001000 012347889999999
Q ss_pred cCcCCCCCHHHHHH
Q 002857 450 ELPGERMKINDVEL 463 (873)
Q Consensus 450 ~dP~eRPTm~EVl~ 463 (873)
.||++|||+.||++
T Consensus 279 ~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 279 KNPESRIVVPEIKL 292 (298)
T ss_dssp SCTTTSCCHHHHTT
T ss_pred cChhhCCCHHHHhc
Confidence 99999999999864
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=360.18 Aligned_cols=253 Identities=21% Similarity=0.285 Sum_probs=203.1
Q ss_pred hhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCc------chhHHHHHHHHHHhhhhccceeeeeeeecccc
Q 002857 158 ATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHD------ASKSFTVECEVMRNIIHRKIIKVVTACSRVDY 231 (873)
Q Consensus 158 at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~------~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~ 231 (873)
..++|.+.+.||+|+||.||+|++..+++.||||+++..... ..+.+.+|+.+|++++||||+++++++
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~----- 84 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVY----- 84 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEE-----
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEE-----
Confidence 356799999999999999999999999999999999754322 236789999999999999999999995
Q ss_pred cCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCC
Q 002857 232 QGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDE 311 (873)
Q Consensus 232 ~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~ 311 (873)
......++||||+++|+|.+++. ....+++..++.++.||+.||.||| +.+|+||||||+|||++.+
T Consensus 85 ~~~~~~~lv~e~~~gg~L~~~l~----------~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~ 151 (361)
T 2yab_A 85 ENRTDVVLILELVSGGELFDFLA----------QKESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDK 151 (361)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHT----------TCSCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCT
T ss_pred EeCCEEEEEEEcCCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCC
Confidence 45678999999999999999994 3456999999999999999999999 8999999999999999877
Q ss_pred C----CeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhh
Q 002857 312 M----TACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNL 387 (873)
Q Consensus 312 ~----~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l 387 (873)
+ .+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||....... .
T Consensus 152 ~~~~~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~--~ 226 (361)
T 2yab_A 152 NIPIPHIKLIDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE--T 226 (361)
T ss_dssp TSSSCCEEECCCSSCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH--H
T ss_pred CCCccCEEEEecCCceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH--H
Confidence 6 79999999998764432 2233569999999999999999999999999999999999999997532111 0
Q ss_pred HHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 388 QNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 388 ~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
. ..+...... +.. .........+.+++.+||+.||++|||+.|+++
T Consensus 227 ~-----------~~i~~~~~~--~~~-----------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 227 L-----------ANITAVSYD--FDE-----------------EFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp H-----------HHHHTTCCC--CCH-----------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred H-----------HHHHhcCCC--CCc-----------------hhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0 111110000 000 000111234778999999999999999999874
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=344.49 Aligned_cols=254 Identities=26% Similarity=0.384 Sum_probs=200.2
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcc-------hhHHHHHHHHHHhhhhccceeeeeeeecccc
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDA-------SKSFTVECEVMRNIIHRKIIKVVTACSRVDY 231 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~-------~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~ 231 (873)
.++|++.+.||+|+||.||+|++..+++.||||++....... .+.+.+|++++++++||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~---- 93 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMH---- 93 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEET----
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeec----
Confidence 468999999999999999999999999999999986433221 167899999999999999999999863
Q ss_pred cCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCC--eeeccCCCCCeeeC
Q 002857 232 QGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPP--IAHCDIKPSNILLN 309 (873)
Q Consensus 232 ~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~g--IvHrDLKpsNILLd 309 (873)
... ++||||+++|+|.+++.. ....+++..++.++.|++.||+||| +.+ |+||||||+|||++
T Consensus 94 -~~~--~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~ 158 (287)
T 4f0f_A 94 -NPP--RMVMEFVPCGDLYHRLLD---------KAHPIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQ 158 (287)
T ss_dssp -TTT--EEEEECCTTCBHHHHHHC---------TTSCCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEES
T ss_pred -CCC--eEEEEecCCCCHHHHHhc---------ccCCccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEe
Confidence 222 699999999999998842 3456899999999999999999999 788 99999999999998
Q ss_pred CCCC-----eEEeccccccccccccccccccccccccccCCCcccC--CCCCCcchhhHhHHHHHHHHHhCCCCCCcccc
Q 002857 310 DEMT-----ACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGM--GHETSSYGDVYSFGILLLEMFTGLRPSDDMFK 382 (873)
Q Consensus 310 ~~~~-----vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~--~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~ 382 (873)
.++. +||+|||+++.... ......||..|+|||++. ...++.++||||||+++|||++|+.||.....
T Consensus 159 ~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 233 (287)
T 4f0f_A 159 SLDENAPVCAKVADFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSY 233 (287)
T ss_dssp CCCTTCSCCEEECCCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred ccCCCCceeEEeCCCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccc
Confidence 7776 99999999975432 223356899999999984 45678999999999999999999999976432
Q ss_pred cchhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHH
Q 002857 383 DNLNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVE 462 (873)
Q Consensus 383 ~~~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl 462 (873)
......... ...... +... ..+...+.+++.+||+.||++|||+.||+
T Consensus 234 ~~~~~~~~~-----------~~~~~~---------------~~~~------~~~~~~l~~li~~~l~~dp~~Rps~~~ll 281 (287)
T 4f0f_A 234 GKIKFINMI-----------REEGLR---------------PTIP------EDCPPRLRNVIELCWSGDPKKRPHFSYIV 281 (287)
T ss_dssp CHHHHHHHH-----------HHSCCC---------------CCCC------TTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred cHHHHHHHH-----------hccCCC---------------CCCC------cccCHHHHHHHHHHhcCChhhCcCHHHHH
Confidence 221111111 000000 0000 01123578999999999999999999999
Q ss_pred HHHHHH
Q 002857 463 LGLRLI 468 (873)
Q Consensus 463 ~~Le~i 468 (873)
+.|+++
T Consensus 282 ~~L~~l 287 (287)
T 4f0f_A 282 KELSEL 287 (287)
T ss_dssp HHHHTC
T ss_pred HHHHhC
Confidence 999853
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=353.60 Aligned_cols=252 Identities=21% Similarity=0.293 Sum_probs=201.9
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCc------chhHHHHHHHHHHhhhhccceeeeeeeeccccc
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHD------ASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQ 232 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~------~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~ 232 (873)
.++|.+.+.||+|+||.||+|.+..+++.||||+++..... ..+.+.+|+.+|++++||||+++++++ .
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~ 84 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY-----E 84 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----E
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEE-----E
Confidence 35689999999999999999999989999999998754322 346799999999999999999999996 4
Q ss_pred CCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCC
Q 002857 233 GNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEM 312 (873)
Q Consensus 233 ~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~ 312 (873)
.....++||||+++|+|.+++. ....+++..++.|+.||+.||.||| +.+|+||||||+|||++.++
T Consensus 85 ~~~~~~lv~e~~~~~~L~~~l~----------~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~ 151 (326)
T 2y0a_A 85 NKTDVILILELVAGGELFDFLA----------EKESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRN 151 (326)
T ss_dssp CSSEEEEEEECCCSCBHHHHHT----------TSSCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSS
T ss_pred eCCEEEEEEEcCCCCCHHHHHH----------hcCCcCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecCC
Confidence 5667999999999999999984 2456899999999999999999999 89999999999999999877
Q ss_pred ----CeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhH
Q 002857 313 ----TACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQ 388 (873)
Q Consensus 313 ----~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~ 388 (873)
.+||+|||+++....... .....||+.|+|||++.+..++.++||||||+++|||++|+.||....... .
T Consensus 152 ~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~- 225 (326)
T 2y0a_A 152 VPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE--T- 225 (326)
T ss_dssp SSSCCEEECCCTTCEECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH--H-
T ss_pred CCCCCEEEEECCCCeECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH--H-
Confidence 899999999987643322 223469999999999999999999999999999999999999996532111 0
Q ss_pred HHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 389 NWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 389 ~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
+..+...... .. ..........+.+++.+||+.||++|||+.|+++
T Consensus 226 ----------~~~~~~~~~~--~~-----------------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 226 ----------LANVSAVNYE--FE-----------------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp ----------HHHHHHTCCC--CC-----------------HHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ----------HHHHHhcCCC--cC-----------------ccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0000000000 00 0000111234778999999999999999999976
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=350.41 Aligned_cols=260 Identities=24% Similarity=0.372 Sum_probs=191.8
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCC--cchhHHHHHHHHHHhhhhccceeeeeeeecccccCCce
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH--DASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDF 236 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~ 236 (873)
.++|++.+.||+|+||.||+|++. ..||||+++.... ...+.+.+|++++++++|+||+++++++ ....
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~------~~~~ 93 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS------TAPQ 93 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE------CSSS
T ss_pred ccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec------cCCc
Confidence 467999999999999999999753 3599999875433 2346799999999999999999999974 3445
Q ss_pred EEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEE
Q 002857 237 KALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACV 316 (873)
Q Consensus 237 ~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKL 316 (873)
.++||||+++++|.+++.. ....+++.+++.|+.||+.||+||| +.+|+||||||+|||++.++.+||
T Consensus 94 ~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl 161 (289)
T 3og7_A 94 LAIVTQWCEGSSLYHHLHA---------SETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKI 161 (289)
T ss_dssp CEEEEECCCEEEHHHHHTT---------C---CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEE
T ss_pred cEEEEEecCCCcHHHHHhh---------ccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEE
Confidence 7999999999999999853 3456899999999999999999999 899999999999999999999999
Q ss_pred eccccccccccccccccccccccccccCCCcccC---CCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhh
Q 002857 317 ADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGM---GHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQS 393 (873)
Q Consensus 317 sDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~---~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~ 393 (873)
+|||+++...............||..|+|||++. +..++.++||||||+++|||++|+.||........ +...+.
T Consensus 162 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~~- 239 (289)
T 3og7_A 162 GDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ-IIEMVG- 239 (289)
T ss_dssp CCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH-HHHHHH-
T ss_pred ccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH-HHHHhc-
Confidence 9999998654433233333456899999999986 56788999999999999999999999976322211 111100
Q ss_pred cCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHHH
Q 002857 394 ALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLIK 469 (873)
Q Consensus 394 ~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i~ 469 (873)
...+.... .. ....+...+.+++.+||+.+|++|||+.||++.|+.+.
T Consensus 240 ----------~~~~~~~~--------------~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 240 ----------RGSLSPDL--------------SK----VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp ----------HTSCCCCT--------------TS----SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred ----------ccccCcch--------------hh----ccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 00000000 00 00012345889999999999999999999999999863
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=352.04 Aligned_cols=272 Identities=21% Similarity=0.293 Sum_probs=210.0
Q ss_pred hcCCCcceeecccCceEEEEEEE-----cCCCcEEEEEEeeccCC-cchhHHHHHHHHHHhh-hhccceeeeeeeecccc
Q 002857 159 TKGFSSENLIGAGNFASVYKGIL-----FEGAPAVAIKVFNFLHH-DASKSFTVECEVMRNI-IHRKIIKVVTACSRVDY 231 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~-----~~~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L-~HpNIV~llg~c~~~~~ 231 (873)
.++|.+.+.||+|+||.||+|++ ..+++.||||+++.... ...+.+.+|+++++++ +||||+++++++
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~----- 96 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC----- 96 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEE-----
Confidence 46789999999999999999986 34678999999975433 2346799999999999 999999999996
Q ss_pred cCCceEEEEEeecCCCChhhhcccccccc--------cccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCC
Q 002857 232 QGNDFKALVYEFMPNGSLEEWIHPITEED--------KRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKP 303 (873)
Q Consensus 232 ~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~--------~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKp 303 (873)
...+..++||||+++|+|.+++....... ........+++..++.++.||+.||+||| +.+|+||||||
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp 173 (313)
T 1t46_A 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAA 173 (313)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSG
T ss_pred ecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCcc
Confidence 44567899999999999999996411000 00011235899999999999999999999 88999999999
Q ss_pred CCeeeCCCCCeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccc
Q 002857 304 SNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFK 382 (873)
Q Consensus 304 sNILLd~~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~ 382 (873)
+|||++.++.+||+|||+++...............+|..|+|||++.+..++.++||||||+++|||+| |+.||.....
T Consensus 174 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 253 (313)
T 1t46_A 174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (313)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred ceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence 999999999999999999987655433333334457889999999988899999999999999999999 9999976322
Q ss_pred cchhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHH
Q 002857 383 DNLNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVE 462 (873)
Q Consensus 383 ~~~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl 462 (873)
.. .....+...... +... .....+.+++.+||+.||++|||+.||+
T Consensus 254 ~~-------------~~~~~~~~~~~~--------------~~~~-------~~~~~l~~li~~~l~~dp~~Rps~~ell 299 (313)
T 1t46_A 254 DS-------------KFYKMIKEGFRM--------------LSPE-------HAPAEMYDIMKTCWDADPLKRPTFKQIV 299 (313)
T ss_dssp SH-------------HHHHHHHHTCCC--------------CCCT-------TSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred hh-------------HHHHHhccCCCC--------------CCcc-------cCCHHHHHHHHHHcCCCchhCcCHHHHH
Confidence 11 111111111000 0000 0123478899999999999999999999
Q ss_pred HHHHHHHHhh
Q 002857 463 LGLRLIKKKL 472 (873)
Q Consensus 463 ~~Le~i~~~l 472 (873)
+.|+.+....
T Consensus 300 ~~L~~~~~~~ 309 (313)
T 1t46_A 300 QLIEKQISES 309 (313)
T ss_dssp HHHHHHHHHT
T ss_pred HHHHHHHHHh
Confidence 9999886643
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=353.61 Aligned_cols=270 Identities=22% Similarity=0.366 Sum_probs=208.7
Q ss_pred hcCCCcceeecccCceEEEEEEEc-----CCCcEEEEEEeeccC-CcchhHHHHHHHHHHhhhhccceeeeeeeeccccc
Q 002857 159 TKGFSSENLIGAGNFASVYKGILF-----EGAPAVAIKVFNFLH-HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQ 232 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~-----~~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~ 232 (873)
.++|.+.+.||+|+||.||+|.+. .+++.||||+++... ....+.+.+|++++++++||||+++++++ .
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~ 96 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGAC-----S 96 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----C
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEE-----e
Confidence 567899999999999999999873 355899999997443 23346789999999999999999999996 4
Q ss_pred CCceEEEEEeecCCCChhhhcccccccc--------------cccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeee
Q 002857 233 GNDFKALVYEFMPNGSLEEWIHPITEED--------------KRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAH 298 (873)
Q Consensus 233 ~~~~~~LV~Ey~~~GSL~~~L~~~~~~~--------------~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvH 298 (873)
..+..++||||+++|+|.+++....... ........+++.+++.|+.||+.||+||| +.+|+|
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH 173 (314)
T 2ivs_A 97 QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVH 173 (314)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH---HTTEEC
T ss_pred cCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH---HCCCcc
Confidence 4567899999999999999996411100 00012245889999999999999999999 889999
Q ss_pred ccCCCCCeeeCCCCCeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCC
Q 002857 299 CDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPS 377 (873)
Q Consensus 299 rDLKpsNILLd~~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf 377 (873)
|||||+|||++.++.+||+|||+++...............+|..|+|||++.+..++.++||||||+++|||+| |+.||
T Consensus 174 ~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 253 (314)
T 2ivs_A 174 RDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 253 (314)
T ss_dssp CCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred cccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999999987654433333334457889999999998889999999999999999999 99999
Q ss_pred CcccccchhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCC
Q 002857 378 DDMFKDNLNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMK 457 (873)
Q Consensus 378 ~~~~~~~~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPT 457 (873)
....... +.+.+...... ..+. .+...+.+++.+||+.||++|||
T Consensus 254 ~~~~~~~--------------~~~~~~~~~~~------------~~~~---------~~~~~~~~li~~~l~~dp~~Rps 298 (314)
T 2ivs_A 254 PGIPPER--------------LFNLLKTGHRM------------ERPD---------NCSEEMYRLMLQCWKQEPDKRPV 298 (314)
T ss_dssp TTCCGGG--------------HHHHHHTTCCC------------CCCT---------TCCHHHHHHHHHHTCSSGGGSCC
T ss_pred CCCCHHH--------------HHHHhhcCCcC------------CCCc---------cCCHHHHHHHHHHccCChhhCcC
Confidence 7532211 11111100000 0000 11235788999999999999999
Q ss_pred HHHHHHHHHHHHHh
Q 002857 458 INDVELGLRLIKKK 471 (873)
Q Consensus 458 m~EVl~~Le~i~~~ 471 (873)
+.||++.|+.+..+
T Consensus 299 ~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 299 FADISKDLEKMMVK 312 (314)
T ss_dssp HHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHhh
Confidence 99999999998653
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=350.37 Aligned_cols=283 Identities=21% Similarity=0.246 Sum_probs=207.6
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC-CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceE
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH-HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFK 237 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~ 237 (873)
.++|.+.++||+|+||.||+|++..+++.||||+++... ....+.+.+|++++++++||||+++++++.. ......
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~~~~~ 84 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEE---TTTRHK 84 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC---TTTCCE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeec---CCCceE
Confidence 357899999999999999999999889999999997433 2345678899999999999999999998642 234478
Q ss_pred EEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeee----CCCCC
Q 002857 238 ALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILL----NDEMT 313 (873)
Q Consensus 238 ~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILL----d~~~~ 313 (873)
++||||+++|+|.+++... .....+++.+++.|+.||+.||+||| +.+|+||||||+|||+ +.++.
T Consensus 85 ~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~ 154 (319)
T 4euu_A 85 VLIMEFCPCGSLYTVLEEP-------SNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSV 154 (319)
T ss_dssp EEEEECCTTCBHHHHHHSG-------GGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCEE
T ss_pred EEEEeCCCCCCHHHHHHHh-------ccccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCce
Confidence 9999999999999999531 12334899999999999999999999 8999999999999999 78888
Q ss_pred eEEeccccccccccccccccccccccccccCCCcccC--------CCCCCcchhhHhHHHHHHHHHhCCCCCCcccccch
Q 002857 314 ACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGM--------GHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNL 385 (873)
Q Consensus 314 vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~--------~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~ 385 (873)
+||+|||+++....... .....||..|+|||++. +..++.++||||||+++|||+||+.||........
T Consensus 155 ~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~ 231 (319)
T 4euu_A 155 YKLTDFGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR 231 (319)
T ss_dssp EEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGG
T ss_pred EEEccCCCceecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccch
Confidence 99999999987644322 22346899999999875 57889999999999999999999999965322111
Q ss_pred --hh-HHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHH
Q 002857 386 --NL-QNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVE 462 (873)
Q Consensus 386 --~l-~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl 462 (873)
.. ...........+..+ .........+ ....+... .........+.+++.+||+.||++|||+.|++
T Consensus 232 ~~~~~~~~~~~~p~~~~~~~-~~~~~~~~~~------~~~~~~~~---~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell 301 (319)
T 4euu_A 232 NKEVMYKIITGKPSGAISGV-QKAENGPIDW------SGDMPVSC---SLSRGLQVLLTPVLANILEADQEKCWGFDQFF 301 (319)
T ss_dssp CHHHHHHHHHHCCTTCCEEE-ECSTTCCEEE------ESSCCTTC---SSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHH
T ss_pred hHHHHHHHhcCCCcccchhh-hcccCCcccc------CccCCccc---ccchhHHHHhHHHHHHhccCChhhhccHHHhh
Confidence 11 111100000000000 0000000000 00001000 11123345688999999999999999999999
Q ss_pred HHHHH
Q 002857 463 LGLRL 467 (873)
Q Consensus 463 ~~Le~ 467 (873)
+....
T Consensus 302 ~h~~d 306 (319)
T 4euu_A 302 AETSD 306 (319)
T ss_dssp HHHHH
T ss_pred hccHH
Confidence 88775
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=353.29 Aligned_cols=282 Identities=20% Similarity=0.271 Sum_probs=214.7
Q ss_pred cCHHHHHHhhcCCCcceeecccCceEEEEEEEc-----CCCcEEEEEEeeccCC-cchhHHHHHHHHHHhh-hhccceee
Q 002857 150 VSYEALYSATKGFSSENLIGAGNFASVYKGILF-----EGAPAVAIKVFNFLHH-DASKSFTVECEVMRNI-IHRKIIKV 222 (873)
Q Consensus 150 ~s~~el~~at~~f~~~~~LG~G~fG~VYkg~~~-----~~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L-~HpNIV~l 222 (873)
+.........++|.+.+.||+|+||.||+|++. .+++.||||+++.... ...+.+.+|++++.++ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 344555556789999999999999999999863 4568999999975433 2345789999999999 79999999
Q ss_pred eeeeecccccCCceEEEEEeecCCCChhhhcccccccccc------cCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCe
Q 002857 223 VTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKR------HKAPGNLNSLERLNIAIDVASALEYLHLGCKPPI 296 (873)
Q Consensus 223 lg~c~~~~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~------~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gI 296 (873)
++++. ..+...++||||+++|+|.+++......... ......+++..++.++.||+.||.||| +.+|
T Consensus 97 ~~~~~----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i 169 (316)
T 2xir_A 97 LGACT----KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKC 169 (316)
T ss_dssp EEEEC----CTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---HTTC
T ss_pred EEEEe----cCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---hCCc
Confidence 99974 3345589999999999999999641110000 001233899999999999999999999 8899
Q ss_pred eeccCCCCCeeeCCCCCeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCC
Q 002857 297 AHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLR 375 (873)
Q Consensus 297 vHrDLKpsNILLd~~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~ 375 (873)
+||||||+|||++.++.+||+|||+++...............+|..|+|||++.+..++.++||||||+++|||+| |+.
T Consensus 170 ~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~ 249 (316)
T 2xir_A 170 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 249 (316)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred ccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999987654433333334567899999999998999999999999999999998 999
Q ss_pred CCCcccccchhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCC
Q 002857 376 PSDDMFKDNLNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGER 455 (873)
Q Consensus 376 Pf~~~~~~~~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eR 455 (873)
||........ +. ..+...... ..+. .....+.+++.+||+.||++|
T Consensus 250 p~~~~~~~~~-~~------------~~~~~~~~~------------~~~~---------~~~~~l~~li~~~l~~dp~~R 295 (316)
T 2xir_A 250 PYPGVKIDEE-FC------------RRLKEGTRM------------RAPD---------YTTPEMYQTMLDCWHGEPSQR 295 (316)
T ss_dssp SSTTCCCSHH-HH------------HHHHHTCCC------------CCCT---------TCCHHHHHHHHHHTCSSGGGS
T ss_pred CCcccchhHH-HH------------HHhccCccC------------CCCC---------CCCHHHHHHHHHHcCCChhhC
Confidence 9975322111 00 000000000 0000 012247789999999999999
Q ss_pred CCHHHHHHHHHHHHHhh
Q 002857 456 MKINDVELGLRLIKKKL 472 (873)
Q Consensus 456 PTm~EVl~~Le~i~~~l 472 (873)
||+.||++.|+.+.+..
T Consensus 296 ps~~ell~~L~~~~~~~ 312 (316)
T 2xir_A 296 PTFSELVEHLGNLLQAN 312 (316)
T ss_dssp CCHHHHHHHHHHHHHHH
T ss_pred cCHHHHHHHHHHHHhhh
Confidence 99999999999987654
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=371.31 Aligned_cols=255 Identities=24% Similarity=0.353 Sum_probs=204.2
Q ss_pred hhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceE
Q 002857 158 ATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFK 237 (873)
Q Consensus 158 at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~ 237 (873)
..++|++.+.||+|+||.||+|.+ .++.||||+++... ..+.|.+|+++|++++||||+++++++. ......
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~--~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~----~~~~~~ 262 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIV----EEKGGL 262 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEE----CTTSCE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEe--cCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEE----cCCCce
Confidence 346788899999999999999988 46799999997543 4578999999999999999999999974 334468
Q ss_pred EEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEe
Q 002857 238 ALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVA 317 (873)
Q Consensus 238 ~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLs 317 (873)
+|||||+++|+|.++++. .....+++..++.++.||+.||+||| +.+|+||||||+|||++.++.+||+
T Consensus 263 ~iv~e~~~~g~L~~~l~~--------~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~ 331 (450)
T 1k9a_A 263 YIVTEYMAKGSLVDYLRS--------RGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVS 331 (450)
T ss_dssp EEEEECCTTCBHHHHHHH--------HCTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEEEC
T ss_pred EEEEEecCCCcHHHHHHh--------cCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEEEe
Confidence 999999999999999953 22345788999999999999999999 8999999999999999999999999
Q ss_pred ccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHHHhhcCc
Q 002857 318 DFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQSALP 396 (873)
Q Consensus 318 DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~~~~~~~ 396 (873)
|||+++...... ....++..|+|||++.+..++.++||||||+++|||+| |+.||....... ...
T Consensus 332 DfG~a~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~--~~~------- 397 (450)
T 1k9a_A 332 DFGLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVP------- 397 (450)
T ss_dssp CCTTCEECC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT--HHH-------
T ss_pred eCCCcccccccc-----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHH-------
Confidence 999998543211 12247889999999999999999999999999999999 999997632211 000
Q ss_pred hhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHHHHh
Q 002857 397 ERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLIKKK 471 (873)
Q Consensus 397 ~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i~~~ 471 (873)
.+... .. .+.. ..+...+.+|+.+||+.||++|||+.+|++.|+.++..
T Consensus 398 ----~i~~~-~~--------------~~~p-------~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 398 ----RVEKG-YK--------------MDAP-------DGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp ----HHHTT-CC--------------CCCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ----HHHcC-CC--------------CCCC-------CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 01000 00 0000 01234588999999999999999999999999998654
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=357.53 Aligned_cols=272 Identities=21% Similarity=0.313 Sum_probs=206.3
Q ss_pred hhcCCCcceeecccCceEEEEEEEc-----CCCcEEEEEEeecc-CCcchhHHHHHHHHHHhh-hhccceeeeeeeeccc
Q 002857 158 ATKGFSSENLIGAGNFASVYKGILF-----EGAPAVAIKVFNFL-HHDASKSFTVECEVMRNI-IHRKIIKVVTACSRVD 230 (873)
Q Consensus 158 at~~f~~~~~LG~G~fG~VYkg~~~-----~~g~~VAVK~l~~~-~~~~~~~f~~Ei~iL~~L-~HpNIV~llg~c~~~~ 230 (873)
..++|.+.+.||+|+||.||+|++. .++..||||+++.. .....+.+.+|+.+++++ +||||+++++++
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~---- 118 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC---- 118 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE----
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE----
Confidence 3568899999999999999999973 35668999999743 233457899999999999 899999999996
Q ss_pred ccCCceEEEEEeecCCCChhhhcccccccc-------------cccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCee
Q 002857 231 YQGNDFKALVYEFMPNGSLEEWIHPITEED-------------KRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIA 297 (873)
Q Consensus 231 ~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~-------------~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIv 297 (873)
...+..++||||+++|+|.+++....... ........+++..++.|+.||+.||+||| +.+|+
T Consensus 119 -~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~iv 194 (344)
T 1rjb_A 119 -TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCV 194 (344)
T ss_dssp -CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred -eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCcc
Confidence 34567899999999999999996411000 00011234899999999999999999999 89999
Q ss_pred eccCCCCCeeeCCCCCeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCC
Q 002857 298 HCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRP 376 (873)
Q Consensus 298 HrDLKpsNILLd~~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~P 376 (873)
||||||+|||++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||+| |..|
T Consensus 195 H~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 274 (344)
T 1rjb_A 195 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274 (344)
T ss_dssp ETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred cCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCC
Confidence 999999999999999999999999987655443333344557889999999988899999999999999999998 9999
Q ss_pred CCcccccchhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCC
Q 002857 377 SDDMFKDNLNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERM 456 (873)
Q Consensus 377 f~~~~~~~~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRP 456 (873)
|....... . +..++....... .+. .+...+.+++.+||+.||.+||
T Consensus 275 ~~~~~~~~-~------------~~~~~~~~~~~~------------~~~---------~~~~~l~~li~~~l~~dp~~Rp 320 (344)
T 1rjb_A 275 YPGIPVDA-N------------FYKLIQNGFKMD------------QPF---------YATEEIYIIMQSCWAFDSRKRP 320 (344)
T ss_dssp STTCCCSH-H------------HHHHHHTTCCCC------------CCT---------TCCHHHHHHHHHHTCSSGGGSC
T ss_pred cccCCcHH-H------------HHHHHhcCCCCC------------CCC---------CCCHHHHHHHHHHcCCCchhCc
Confidence 97632211 1 111111100000 000 0123478899999999999999
Q ss_pred CHHHHHHHHHHHHHh
Q 002857 457 KINDVELGLRLIKKK 471 (873)
Q Consensus 457 Tm~EVl~~Le~i~~~ 471 (873)
|+.||++.|+.+...
T Consensus 321 s~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 321 SFPNLTSFLGCQLAD 335 (344)
T ss_dssp CHHHHHHHHHHHC--
T ss_pred CHHHHHHHHHHHHHH
Confidence 999999999987543
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=355.71 Aligned_cols=253 Identities=20% Similarity=0.272 Sum_probs=203.8
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEE
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKA 238 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~ 238 (873)
.++|.+.+.||+|+||.||+|++..+++.||+|++... ......+.+|+.+++.++||||+++++++ ...+..+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-----~~~~~~~ 77 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESF-----ESMEELV 77 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEE-----EETTEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEE-----ecCCEEE
Confidence 57899999999999999999999999999999998743 23346788999999999999999999996 4466799
Q ss_pred EEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCC--CCCeEE
Q 002857 239 LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLND--EMTACV 316 (873)
Q Consensus 239 LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~--~~~vKL 316 (873)
+||||+++|+|.+++.. ....+++.+++.++.||+.||.||| +.+|+||||||+|||++. ++.+||
T Consensus 78 lv~e~~~g~~L~~~l~~---------~~~~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~~~~~~~~kl 145 (321)
T 1tki_A 78 MIFEFISGLDIFERINT---------SAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKI 145 (321)
T ss_dssp EEECCCCCCBHHHHHTS---------SSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEE
T ss_pred EEEEeCCCCCHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEccCCCCCEEE
Confidence 99999999999999842 3346899999999999999999999 899999999999999987 789999
Q ss_pred eccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCc
Q 002857 317 ADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALP 396 (873)
Q Consensus 317 sDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~ 396 (873)
+|||+++...... ......||+.|+|||++.+..++.++||||||+++|||++|..||....... .
T Consensus 146 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~--------- 211 (321)
T 1tki_A 146 IEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ--I--------- 211 (321)
T ss_dssp CCCTTCEECCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH--H---------
T ss_pred EECCCCeECCCCC---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH--H---------
Confidence 9999998764332 2233568999999999999889999999999999999999999997532111 0
Q ss_pred hhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHH
Q 002857 397 ERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELG 464 (873)
Q Consensus 397 ~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~ 464 (873)
+..+........ ..........+.+++.+||+.||++|||+.|+++.
T Consensus 212 --~~~i~~~~~~~~-------------------~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 212 --IENIMNAEYTFD-------------------EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp --HHHHHHTCCCCC-------------------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred --HHHHHcCCCCCC-------------------hhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 111111110000 00001113357889999999999999999999873
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=341.50 Aligned_cols=270 Identities=20% Similarity=0.285 Sum_probs=211.7
Q ss_pred hhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceE
Q 002857 158 ATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFK 237 (873)
Q Consensus 158 at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~ 237 (873)
..++|++.+.||+|+||.||+|++..+++.||||++.... ..+.+.+|+.++++++|++++..+.++. ......
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~----~~~~~~ 80 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCG----AEGDYN 80 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEE----EETTEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCcccccc----CCCCce
Confidence 3578999999999999999999998899999999987443 2357899999999999999888887763 346678
Q ss_pred EEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeee---CCCCCe
Q 002857 238 ALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILL---NDEMTA 314 (873)
Q Consensus 238 ~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILL---d~~~~v 314 (873)
++||||+ +++|.+++.. ....+++..++.|+.||+.||+||| +.+|+||||||+|||+ +.++.+
T Consensus 81 ~lv~e~~-~~~L~~~~~~---------~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~ 147 (296)
T 3uzp_A 81 VMVMELL-GPSLEDLFNF---------CSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLV 147 (296)
T ss_dssp EEEEECC-CCBHHHHHHH---------TTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCE
T ss_pred EEEEEec-CCCHHHHHHh---------hccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCeE
Confidence 9999999 9999999852 2346899999999999999999999 8999999999999999 488899
Q ss_pred EEeccccccccccccccc-----cccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHH
Q 002857 315 CVADFGIARFLEATNEQT-----SSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQN 389 (873)
Q Consensus 315 KLsDFGla~~~~~~~~~~-----~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~ 389 (873)
||+|||+++......... ......||..|+|||++.+..++.++||||||+++|||++|+.||.........
T Consensus 148 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--- 224 (296)
T 3uzp_A 148 YIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR--- 224 (296)
T ss_dssp EECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSS---
T ss_pred EEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhh---
Confidence 999999998765433211 123456999999999999999999999999999999999999999763221100
Q ss_pred HHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHHH
Q 002857 390 WVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLIK 469 (873)
Q Consensus 390 ~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i~ 469 (873)
..+..+....+..... .....+...+.+++.+||+.||++|||+.+|++.|+.+.
T Consensus 225 -------~~~~~~~~~~~~~~~~------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 279 (296)
T 3uzp_A 225 -------QKYERISEKKMSTPIE------------------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 279 (296)
T ss_dssp -------SHHHHHHHHHHHSCHH------------------HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred -------hhhhhhcccccCCchH------------------HHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHH
Confidence 0111111111100000 000011235889999999999999999999999999987
Q ss_pred Hhhhc
Q 002857 470 KKLLE 474 (873)
Q Consensus 470 ~~l~~ 474 (873)
.....
T Consensus 280 ~~~~~ 284 (296)
T 3uzp_A 280 HRQGF 284 (296)
T ss_dssp HHTTC
T ss_pred HhcCC
Confidence 76643
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=350.38 Aligned_cols=282 Identities=27% Similarity=0.360 Sum_probs=200.4
Q ss_pred HHHhhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhh--hhccceeeeeeeeccccc
Q 002857 155 LYSATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNI--IHRKIIKVVTACSRVDYQ 232 (873)
Q Consensus 155 l~~at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L--~HpNIV~llg~c~~~~~~ 232 (873)
-....++|++.+.||+|+||.||+|++ .++.||||++... ....+..|.+++..+ +|+||+++++++.... .
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~-~ 105 (337)
T 3mdy_A 32 QRTIAKQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGT-G 105 (337)
T ss_dssp HTTHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC-G
T ss_pred ccccccceEEEeEeecCCCeEEEEEEE--CCceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCC-C
Confidence 334457899999999999999999987 4889999998632 234556666666655 8999999999975321 1
Q ss_pred CCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCC--------CeeeccCCCC
Q 002857 233 GNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKP--------PIAHCDIKPS 304 (873)
Q Consensus 233 ~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~--------gIvHrDLKps 304 (873)
.....++||||+++|+|.++++. ..+++..++.|+.|++.||+||| +. +|+||||||+
T Consensus 106 ~~~~~~lv~e~~~~g~L~~~l~~-----------~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~~~~ivH~Dikp~ 171 (337)
T 3mdy_A 106 SWTQLYLITDYHENGSLYDYLKS-----------TTLDAKSMLKLAYSSVSGLCHLH---TEIFSTQGKPAIAHRDLKSK 171 (337)
T ss_dssp GGCEEEEEECCCTTCBHHHHHHH-----------CCBCHHHHHHHHHHHHHHHHHHH---SCBCSTTCBCCEECSCCCGG
T ss_pred CCCceEEEEeccCCCcHHHHhhc-----------cCCCHHHHHHHHHHHHHHHHHHH---HhhhhhccCCCEEecccchH
Confidence 22678999999999999999942 25899999999999999999999 67 9999999999
Q ss_pred CeeeCCCCCeEEeccccccccccccccc--cccccccccccCCCcccCCCCCCcc------hhhHhHHHHHHHHHhCCCC
Q 002857 305 NILLNDEMTACVADFGIARFLEATNEQT--SSIGVKGTTGYIAPEYGMGHETSSY------GDVYSFGILLLEMFTGLRP 376 (873)
Q Consensus 305 NILLd~~~~vKLsDFGla~~~~~~~~~~--~~~~~~Gt~~Y~APE~l~~~~~s~k------sDVwSfGvvL~ELlTGk~P 376 (873)
|||++.++.+||+|||+++.+....... ......||..|+|||++.+...+.+ +|||||||++|||+||..|
T Consensus 172 Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~ 251 (337)
T 3mdy_A 172 NILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVS 251 (337)
T ss_dssp GEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCB
T ss_pred HEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCc
Confidence 9999999999999999997654332211 1123469999999999988766655 9999999999999999544
Q ss_pred CCcccccchhhHHHHhhcCc-hhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCC
Q 002857 377 SDDMFKDNLNLQNWVQSALP-ERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGER 455 (873)
Q Consensus 377 f~~~~~~~~~l~~~~~~~~~-~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eR 455 (873)
+.........+......... ....+.+.. .. ..+.... .....++...+.+++.+||+.||++|
T Consensus 252 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~---~~-----------~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~R 316 (337)
T 3mdy_A 252 GGIVEEYQLPYHDLVPSDPSYEDMREIVCI---KK-----------LRPSFPN-RWSSDECLRQMGKLMTECWAHNPASR 316 (337)
T ss_dssp TTBCCCCCCTTTTTSCSSCCHHHHHHHHTT---SC-----------CCCCCCG-GGGGSHHHHHHHHHHHHHSCSSGGGS
T ss_pred ccccccccccHhhhcCCCCchhhhHHHHhh---hc-----------cCccccc-cchhhHHHHHHHHHHHHhhhhChhhC
Confidence 43211111100000000000 011111100 00 0010000 00112456678999999999999999
Q ss_pred CCHHHHHHHHHHHHHh
Q 002857 456 MKINDVELGLRLIKKK 471 (873)
Q Consensus 456 PTm~EVl~~Le~i~~~ 471 (873)
||+.||++.|+.+.+.
T Consensus 317 ps~~ell~~L~~l~~~ 332 (337)
T 3mdy_A 317 LTALRVKKTLAKMSES 332 (337)
T ss_dssp CCHHHHHHHHHHHHHT
T ss_pred CCHHHHHHHHHHHHhh
Confidence 9999999999998664
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=345.84 Aligned_cols=257 Identities=25% Similarity=0.388 Sum_probs=205.1
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEE
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKA 238 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~ 238 (873)
.++|++.+.||+|+||.||+|.+. ++..||||+++.... ..+.+.+|++++.+++||||+++++++ ......+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 79 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVC-----SKEYPIY 79 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSSSEE
T ss_pred hhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEE-----ccCCceE
Confidence 467899999999999999999874 567899999975433 346799999999999999999999996 4566789
Q ss_pred EEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEec
Q 002857 239 LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVAD 318 (873)
Q Consensus 239 LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsD 318 (873)
+||||+++++|.+++.. ....+++.+++.|+.||+.||+||| +.+|+||||||+|||++.++.+||+|
T Consensus 80 lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~D 147 (268)
T 3sxs_A 80 IVTEYISNGCLLNYLRS---------HGKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSD 147 (268)
T ss_dssp EEEECCTTCBHHHHHHH---------HGGGCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECC
T ss_pred EEEEccCCCcHHHHHHH---------cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEECCCCCEEEcc
Confidence 99999999999999953 2345899999999999999999999 89999999999999999999999999
Q ss_pred cccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHHHhhcCch
Q 002857 319 FGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQSALPE 397 (873)
Q Consensus 319 FGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~~~~~~~~ 397 (873)
||+++....... .......+|..|+|||++.+..++.++||||||+++|||+| |+.||........
T Consensus 148 fg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~------------ 214 (268)
T 3sxs_A 148 FGMTRYVLDDQY-VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEV------------ 214 (268)
T ss_dssp TTCEEECCTTCE-EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHH------------
T ss_pred Cccceecchhhh-hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHH------------
Confidence 999986644322 22233446778999999988889999999999999999999 9999975321110
Q ss_pred hHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHHHH
Q 002857 398 RVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLIKK 470 (873)
Q Consensus 398 ~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i~~ 470 (873)
...+..... ...|.. ....+.+++..||+.+|++|||+.||++.|+.+++
T Consensus 215 -~~~~~~~~~-------------~~~~~~---------~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 215 -VLKVSQGHR-------------LYRPHL---------ASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp -HHHHHTTCC-------------CCCCTT---------SCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred -HHHHHcCCC-------------CCCCCc---------ChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 000000000 000000 12247789999999999999999999999998754
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=350.79 Aligned_cols=258 Identities=21% Similarity=0.319 Sum_probs=196.3
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC-CcchhHHHHHHHHHHhhhhccceeeeeeeecccc------
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH-HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDY------ 231 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~------ 231 (873)
.++|++.+.||+|+||.||+|++..+++.||||+++... ....+.+.+|+++|++++||||+++++++.....
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 357899999999999999999998899999999997543 3345779999999999999999999998754210
Q ss_pred ----------------------------------------------cCCceEEEEEeecCCCChhhhcccccccccccCC
Q 002857 232 ----------------------------------------------QGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKA 265 (873)
Q Consensus 232 ----------------------------------------------~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~ 265 (873)
......++||||+++|+|.+++... ..
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-------~~ 157 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRR-------CS 157 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTC-------CS
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcc-------cC
Confidence 1122489999999999999999531 12
Q ss_pred CCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEecccccccccccccc----------cccc
Q 002857 266 PGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQ----------TSSI 335 (873)
Q Consensus 266 ~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDFGla~~~~~~~~~----------~~~~ 335 (873)
....++..++.|+.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++........ ....
T Consensus 158 ~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~ 234 (332)
T 3qd2_B 158 LEDREHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHT 234 (332)
T ss_dssp GGGSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCC
T ss_pred ccchhhHHHHHHHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhcccccccccccccc
Confidence 233456678999999999999999 899999999999999999999999999999876543211 1123
Q ss_pred ccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCchhHHHHhhhhhhhhhhHHH
Q 002857 336 GVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPERVEEIVDTLFFKEIEEEE 415 (873)
Q Consensus 336 ~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~~l~elid~~L~~~~~~r~ 415 (873)
...||..|+|||++.+..++.++||||||+++|||++|..|+... ... ...+....+.
T Consensus 235 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~----~~~-----------~~~~~~~~~~------- 292 (332)
T 3qd2_B 235 GQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER----VRI-----------ITDVRNLKFP------- 292 (332)
T ss_dssp SCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH----HHH-----------HHHHHTTCCC-------
T ss_pred ccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH----HHH-----------HHHhhccCCC-------
Confidence 346999999999999999999999999999999999987664221 000 0000000000
Q ss_pred HHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 416 TVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 416 ~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
.........+.+++.+||+.||++|||+.|+++
T Consensus 293 ---------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 293 ---------------LLFTQKYPQEHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp ---------------HHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred ---------------cccccCChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence 001112334678999999999999999999875
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=352.97 Aligned_cols=276 Identities=24% Similarity=0.392 Sum_probs=201.5
Q ss_pred HHHhhcCCCcceeecccCceEEEEEEEcC---CCcEEEEEEeeccCC--cchhHHHHHHHHHHhhhhccceeeeeeeecc
Q 002857 155 LYSATKGFSSENLIGAGNFASVYKGILFE---GAPAVAIKVFNFLHH--DASKSFTVECEVMRNIIHRKIIKVVTACSRV 229 (873)
Q Consensus 155 l~~at~~f~~~~~LG~G~fG~VYkg~~~~---~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~ 229 (873)
+....++|.+.+.||+|+||.||+|.+.. ++..||||+++.... ...+.+.+|+.++++++||||+++++++...
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 108 (313)
T 3brb_A 29 VVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEM 108 (313)
T ss_dssp TBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-
T ss_pred cccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeec
Confidence 33456788999999999999999998765 345899999874432 2346789999999999999999999997643
Q ss_pred cccCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeC
Q 002857 230 DYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLN 309 (873)
Q Consensus 230 ~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd 309 (873)
........++||||+++|+|.+++... ........+++..++.|+.||+.||.||| +.+|+||||||+|||++
T Consensus 109 ~~~~~~~~~~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~ 181 (313)
T 3brb_A 109 SSQGIPKPMVILPFMKYGDLHTYLLYS----RLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLR 181 (313)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHT----TBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEEC
T ss_pred cccCCcccEEEEecccCCCHHHHHHHh----hhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEc
Confidence 322233569999999999999998431 11123467999999999999999999999 89999999999999999
Q ss_pred CCCCeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhH
Q 002857 310 DEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQ 388 (873)
Q Consensus 310 ~~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~ 388 (873)
.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||....... ..
T Consensus 182 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~ 259 (313)
T 3brb_A 182 DDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE--MY 259 (313)
T ss_dssp TTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--HH
T ss_pred CCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH--HH
Confidence 999999999999987654332223333457889999999999999999999999999999999 888986532211 11
Q ss_pred HHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHH
Q 002857 389 NWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLI 468 (873)
Q Consensus 389 ~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i 468 (873)
. .+...... +.. ..+...+.+++.+||+.||++|||+.+|++.|+.+
T Consensus 260 ~-----------~~~~~~~~---------------~~~-------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l 306 (313)
T 3brb_A 260 D-----------YLLHGHRL---------------KQP-------EDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKL 306 (313)
T ss_dssp H-----------HHHTTCCC---------------CCB-------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred H-----------HHHcCCCC---------------CCC-------ccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0 01100000 000 01123578899999999999999999999999998
Q ss_pred HHhh
Q 002857 469 KKKL 472 (873)
Q Consensus 469 ~~~l 472 (873)
.+.+
T Consensus 307 ~~~l 310 (313)
T 3brb_A 307 LESL 310 (313)
T ss_dssp HHHC
T ss_pred HHhc
Confidence 7755
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=340.56 Aligned_cols=254 Identities=22% Similarity=0.338 Sum_probs=203.3
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC-CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceE
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH-HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFK 237 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~ 237 (873)
.++|++.+.||+|+||.||+|.+..+++.||||+++... ....+.+.+|+.++++++||||+++++++ ...+..
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 80 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR-----REGNIQ 80 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEE-----EETTEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEE-----EcCCEE
Confidence 357899999999999999999998899999999987433 33457789999999999999999999986 345678
Q ss_pred EEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEe
Q 002857 238 ALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVA 317 (873)
Q Consensus 238 ~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLs 317 (873)
++||||+++++|.+++. ....+++..++.++.||+.||+||| +.+|+||||||+||+++.++.+||+
T Consensus 81 ~lv~e~~~~~~L~~~l~----------~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~ 147 (276)
T 2yex_A 81 YLFLEYCSGGELFDRIE----------PDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKIS 147 (276)
T ss_dssp EEEEECCTTEEGGGGSB----------TTTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEEC
T ss_pred EEEEEecCCCcHHHHHh----------hccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEEccCCCEEEe
Confidence 99999999999999984 2456899999999999999999999 8999999999999999999999999
Q ss_pred ccccccccccccccccccccccccccCCCcccCCCCC-CcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCc
Q 002857 318 DFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHET-SSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALP 396 (873)
Q Consensus 318 DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~-s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~ 396 (873)
|||++................||..|+|||++.+..+ +.++||||||+++|||++|+.||.........+..+.....
T Consensus 148 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~- 226 (276)
T 2yex_A 148 DFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT- 226 (276)
T ss_dssp CCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCT-
T ss_pred eCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhccc-
Confidence 9999986644332222334568999999999988765 77899999999999999999999764332222222111000
Q ss_pred hhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 397 ERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 397 ~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
... ++ . .....+.+++.+||+.||++|||+.||++
T Consensus 227 -----------~~~-------------~~----~----~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 227 -----------YLN-------------PW----K----KIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp -----------TST-------------TG----G----GSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -----------ccC-------------ch----h----hcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 000 00 0 01224778999999999999999998864
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=359.98 Aligned_cols=272 Identities=24% Similarity=0.363 Sum_probs=211.5
Q ss_pred hcCCCcceeecccCceEEEEEEEcC-------CCcEEEEEEeeccCC-cchhHHHHHHHHHHhh-hhccceeeeeeeecc
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFE-------GAPAVAIKVFNFLHH-DASKSFTVECEVMRNI-IHRKIIKVVTACSRV 229 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~-------~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L-~HpNIV~llg~c~~~ 229 (873)
.++|.+.+.||+|+||.||+|++.. .+..||||+++.... .....+.+|+++++++ +||||+++++++
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~--- 144 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC--- 144 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE---
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee---
Confidence 4678999999999999999998753 235799999975432 2346789999999999 999999999996
Q ss_pred cccCCceEEEEEeecCCCChhhhcccccccc------cccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCC
Q 002857 230 DYQGNDFKALVYEFMPNGSLEEWIHPITEED------KRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKP 303 (873)
Q Consensus 230 ~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~------~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKp 303 (873)
...+..++||||+++|+|.+++....... ........+++.+++.|+.||+.||+||| +.+|+||||||
T Consensus 145 --~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp 219 (382)
T 3tt0_A 145 --TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAA 219 (382)
T ss_dssp --CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCG
T ss_pred --ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCc
Confidence 44566899999999999999996421100 00112356999999999999999999999 88999999999
Q ss_pred CCeeeCCCCCeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccc
Q 002857 304 SNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFK 382 (873)
Q Consensus 304 sNILLd~~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~ 382 (873)
+|||++.++.+||+|||+++...............+|..|+|||++.+..++.++||||||+++|||+| |..||.....
T Consensus 220 ~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~ 299 (382)
T 3tt0_A 220 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 299 (382)
T ss_dssp GGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred ceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987654433333344557889999999999999999999999999999999 9999865321
Q ss_pred cchhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHH
Q 002857 383 DNLNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVE 462 (873)
Q Consensus 383 ~~~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl 462 (873)
.. + .+.+....... .+. .+...+.+++.+||+.||++|||+.||+
T Consensus 300 ~~--~------------~~~~~~~~~~~------------~~~---------~~~~~l~~li~~~l~~dP~~Rps~~ell 344 (382)
T 3tt0_A 300 EE--L------------FKLLKEGHRMD------------KPS---------NCTNELYMMMRDCWHAVPSQRPTFKQLV 344 (382)
T ss_dssp HH--H------------HHHHHTTCCCC------------CCS---------SCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HH--H------------HHHHHcCCCCC------------CCc---------cCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 11 1 11111000000 000 1123578899999999999999999999
Q ss_pred HHHHHHHHhhh
Q 002857 463 LGLRLIKKKLL 473 (873)
Q Consensus 463 ~~Le~i~~~l~ 473 (873)
+.|+.+.....
T Consensus 345 ~~L~~~~~~~~ 355 (382)
T 3tt0_A 345 EDLDRIVALTS 355 (382)
T ss_dssp HHHHHHHHHSC
T ss_pred HHHHHHHHHHh
Confidence 99999876554
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=358.05 Aligned_cols=249 Identities=21% Similarity=0.275 Sum_probs=201.4
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeecc---CCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCc
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFL---HHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGND 235 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~ 235 (873)
.++|++.+.||+|+||.||+|+...+++.||||+++.. .......+.+|+.+|+.++||||+++++++ ...+
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~-----~~~~ 78 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHD 78 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE-----ECSS
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEE-----EeCC
Confidence 36799999999999999999999989999999999743 233456789999999999999999999985 4567
Q ss_pred eEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeE
Q 002857 236 FKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTAC 315 (873)
Q Consensus 236 ~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vK 315 (873)
..++||||+++|+|.+++.. ...+++..++.++.||+.||+||| +.+|+||||||+|||++.++++|
T Consensus 79 ~~~lv~E~~~gg~L~~~l~~----------~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vk 145 (337)
T 1o6l_A 79 RLCFVMEYANGGELFFHLSR----------ERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIK 145 (337)
T ss_dssp EEEEEEECCTTCBHHHHHHH----------HSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEE
T ss_pred EEEEEEeCCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCCEE
Confidence 89999999999999999842 346889999999999999999999 89999999999999999999999
Q ss_pred EeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcC
Q 002857 316 VADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSAL 395 (873)
Q Consensus 316 LsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~ 395 (873)
|+|||+++...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||......
T Consensus 146 L~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~------------ 211 (337)
T 1o6l_A 146 ITDFGLCKEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------------ 211 (337)
T ss_dssp ECCCTTCBCSCCTT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------------
T ss_pred EeeccchhhcccCC--CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH------------
Confidence 99999998543222 1223456999999999999999999999999999999999999999652111
Q ss_pred chhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCC-----CHHHHHH
Q 002857 396 PERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERM-----KINDVEL 463 (873)
Q Consensus 396 ~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRP-----Tm~EVl~ 463 (873)
++....+.... ..|. .....+.+++.+||+.||++|| ++.||++
T Consensus 212 -----~~~~~i~~~~~----------~~p~---------~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 212 -----RLFELILMEEI----------RFPR---------TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp -----HHHHHHHHCCC----------CCCT---------TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -----HHHHHHHcCCC----------CCCC---------CCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 01111110000 0010 0122477899999999999999 8888865
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=348.48 Aligned_cols=282 Identities=21% Similarity=0.226 Sum_probs=201.3
Q ss_pred hhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC-----CcchhHHHHHHHHHHhhh---hccceeeeeeeecc
Q 002857 158 ATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH-----HDASKSFTVECEVMRNII---HRKIIKVVTACSRV 229 (873)
Q Consensus 158 at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~-----~~~~~~f~~Ei~iL~~L~---HpNIV~llg~c~~~ 229 (873)
.+++|++.+.||+|+||.||+|++..+++.||||++.... ......+.+|++++++++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 4679999999999999999999998899999999987432 122356788988888876 99999999998643
Q ss_pred cccCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeC
Q 002857 230 DYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLN 309 (873)
Q Consensus 230 ~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd 309 (873)
........++||||+. |+|.+++.. .....+++.+++.|+.||+.||+||| +.+|+||||||+|||++
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~--------~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~ 154 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDK--------APPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVT 154 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHT--------CCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTTEEEC
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhh--------ccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEc
Confidence 3222336899999996 599999853 23345999999999999999999999 88999999999999999
Q ss_pred CCCCeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHH
Q 002857 310 DEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQN 389 (873)
Q Consensus 310 ~~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~ 389 (873)
.++.+||+|||+++...... ......||..|+|||++.+..++.++||||||+++|||++|+.||........ +..
T Consensus 155 ~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~ 230 (308)
T 3g33_A 155 SGGTVKLADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ-LGK 230 (308)
T ss_dssp TTSCEEECSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHH-HHH
T ss_pred CCCCEEEeeCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHH
Confidence 99999999999998664322 22345689999999999999999999999999999999999999976322211 111
Q ss_pred HHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 390 WVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 390 ~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
............+.. ... ... ..+.. ...........+....+.+++.+||+.||++|||+.|+++
T Consensus 231 i~~~~~~~~~~~~~~-~~~-~~~-----~~~~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 231 IFDLIGLPPEDDWPR-DVS-LPR-----GAFPP-RGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp HHHHHCCCCTTTSCS-SCS-SCG-----GGSCC-CCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHhCCCChhhccc-hhh-ccc-----cccCC-CCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 110000000000000 000 000 00000 0000001111122345789999999999999999999864
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=344.57 Aligned_cols=258 Identities=26% Similarity=0.396 Sum_probs=203.2
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEE
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKA 238 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~ 238 (873)
.++|++.+.||+|+||.||+|.+. ++..||||+++.... ..+.+.+|++++.+++|+||+++++++ ......+
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 95 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVC-----TKQRPIF 95 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEE-----CSSSSEE
T ss_pred HHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEE-----ecCCCeE
Confidence 467889999999999999999874 677899999975433 347799999999999999999999996 4566789
Q ss_pred EEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEec
Q 002857 239 LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVAD 318 (873)
Q Consensus 239 LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsD 318 (873)
+||||+++|+|.+++.. ....+++.+++.|+.||+.||+||| +.+|+||||||+|||++.++.+||+|
T Consensus 96 lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~D 163 (283)
T 3gen_A 96 IITEYMANGCLLNYLRE---------MRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSD 163 (283)
T ss_dssp EEECCCTTCBHHHHHHC---------GGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTSCEEECS
T ss_pred EEEeccCCCcHHHHHHH---------hccCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcCCCCEEEcc
Confidence 99999999999999953 2345899999999999999999999 89999999999999999999999999
Q ss_pred cccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHHHhhcCch
Q 002857 319 FGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQSALPE 397 (873)
Q Consensus 319 FGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~~~~~~~~ 397 (873)
||+++....... .......+|..|+|||++.+..++.++||||||+++|||+| |+.||....... ..
T Consensus 164 fg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~--~~--------- 231 (283)
T 3gen_A 164 FGLSRYVLDDEY-TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE--TA--------- 231 (283)
T ss_dssp TTGGGGBCCHHH-HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH--HH---------
T ss_pred cccccccccccc-ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhH--HH---------
Confidence 999986543221 12223446788999999998899999999999999999999 999997532111 00
Q ss_pred hHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHHHHh
Q 002857 398 RVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLIKKK 471 (873)
Q Consensus 398 ~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i~~~ 471 (873)
..+... ... ..+. . ....+.+++.+||+.+|++|||+.||++.|+.+.+.
T Consensus 232 --~~~~~~-~~~------------~~~~--~-------~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 232 --EHIAQG-LRL------------YRPH--L-------ASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp --HHHHTT-CCC------------CCCT--T-------CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --HHHhcc-cCC------------CCCC--c-------CCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 011000 000 0000 0 022477899999999999999999999999988653
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=351.56 Aligned_cols=274 Identities=23% Similarity=0.376 Sum_probs=205.6
Q ss_pred cCCCcceeecccCceEEEEEEE----cCCCcEEEEEEeeccC-CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCC
Q 002857 160 KGFSSENLIGAGNFASVYKGIL----FEGAPAVAIKVFNFLH-HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGN 234 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~----~~~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~ 234 (873)
+.|++.+.||+|+||.||+|++ ..+++.||||+++... ....+.+.+|++++++++|+||+++++++.. ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~ 97 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTE---DGG 97 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC------
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEec---CCC
Confidence 4588899999999999999984 5678999999997433 3344789999999999999999999999753 223
Q ss_pred ceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCe
Q 002857 235 DFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTA 314 (873)
Q Consensus 235 ~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~v 314 (873)
...++||||+++|+|.+++.. ....+++.+++.|+.||+.||+||| +.+|+||||||+|||++.++.+
T Consensus 98 ~~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~ 165 (302)
T 4e5w_A 98 NGIKLIMEFLPSGSLKEYLPK---------NKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQV 165 (302)
T ss_dssp CCEEEEEECCTTCBHHHHHHH---------HTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEE
T ss_pred ceEEEEEEeCCCCcHHHHHHh---------ccccCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEEEcCCCCE
Confidence 568999999999999999943 2345899999999999999999999 8999999999999999999999
Q ss_pred EEecccccccccccccc-ccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhh
Q 002857 315 CVADFGIARFLEATNEQ-TSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQS 393 (873)
Q Consensus 315 KLsDFGla~~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~ 393 (873)
||+|||+++........ .......+|..|+|||++.+..++.++||||||+++|||+||..|+...... .......
T Consensus 166 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~ 242 (302)
T 4e5w_A 166 KIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMAL---FLKMIGP 242 (302)
T ss_dssp EECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH---HHHHHCS
T ss_pred EECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhH---HhhccCC
Confidence 99999999876543321 2223345888899999999999999999999999999999999986542111 1111111
Q ss_pred cCch-hHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHHH
Q 002857 394 ALPE-RVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLIK 469 (873)
Q Consensus 394 ~~~~-~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i~ 469 (873)
.... ....+....... ...+... .+...+.+++.+||+.||++|||+.||++.|+.+.
T Consensus 243 ~~~~~~~~~~~~~~~~~-----------~~~~~~~-------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 243 THGQMTVTRLVNTLKEG-----------KRLPCPP-------NCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp CCGGGHHHHHHHHHHTT-----------CCCCCCT-------TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cccccCHHHHHHHHhcc-----------CCCCCCC-------CCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 1111 111111111000 0011100 11235889999999999999999999999999874
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=378.13 Aligned_cols=258 Identities=25% Similarity=0.421 Sum_probs=208.5
Q ss_pred hhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceE
Q 002857 158 ATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFK 237 (873)
Q Consensus 158 at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~ 237 (873)
..++|++.+.||+|+||.||+|++..++..||||+++... ...+.|.+|+.+|++++||||++++++| ......
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~-----~~~~~~ 291 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVC-----TREPPF 291 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSSSC
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEE-----ecCCcE
Confidence 3467888999999999999999998889999999997543 3457899999999999999999999997 345568
Q ss_pred EEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEe
Q 002857 238 ALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVA 317 (873)
Q Consensus 238 ~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLs 317 (873)
+|||||+++|+|.++|+. .....+++..++.|+.||+.||+||| +.+|+||||||+|||++.++.+||+
T Consensus 292 ~lv~E~~~~g~L~~~l~~--------~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~ 360 (495)
T 1opk_A 292 YIITEFMTYGNLLDYLRE--------CNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVA 360 (495)
T ss_dssp EEEEECCTTCBHHHHHHH--------SCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEEC
T ss_pred EEEEEccCCCCHHHHHHh--------cCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCCcEEEe
Confidence 999999999999999953 23456899999999999999999999 8999999999999999999999999
Q ss_pred ccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHHHhhcCc
Q 002857 318 DFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQSALP 396 (873)
Q Consensus 318 DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~~~~~~~ 396 (873)
|||+++...... ........++..|+|||++.+..++.++|||||||++|||+| |+.||.......
T Consensus 361 DFG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~------------ 427 (495)
T 1opk_A 361 DFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ------------ 427 (495)
T ss_dssp CTTCEECCTTCC-EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG------------
T ss_pred ecccceeccCCc-eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH------------
Confidence 999998764322 122223446789999999998899999999999999999999 999997532111
Q ss_pred hhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHH
Q 002857 397 ERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLI 468 (873)
Q Consensus 397 ~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i 468 (873)
+.+.+....... .| ..+...+.+|+.+||+.||++||||.+|++.|+.+
T Consensus 428 --~~~~~~~~~~~~------------~~---------~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~ 476 (495)
T 1opk_A 428 --VYELLEKDYRME------------RP---------EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 476 (495)
T ss_dssp --HHHHHHTTCCCC------------CC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred --HHHHHHcCCCCC------------CC---------CCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 111111110000 00 01233578899999999999999999999999875
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=358.34 Aligned_cols=275 Identities=19% Similarity=0.322 Sum_probs=211.5
Q ss_pred HHHHHhhcCCCcceeecccCceEEEEEEEc-----CCCcEEEEEEeeccCC-cchhHHHHHHHHHHhhhhccceeeeeee
Q 002857 153 EALYSATKGFSSENLIGAGNFASVYKGILF-----EGAPAVAIKVFNFLHH-DASKSFTVECEVMRNIIHRKIIKVVTAC 226 (873)
Q Consensus 153 ~el~~at~~f~~~~~LG~G~fG~VYkg~~~-----~~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~c 226 (873)
++.....++|.+.+.||+|+||.||+|++. .+++.||||++..... .....+.+|++++++++|+||+++++++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 97 (322)
T 1p4o_A 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV 97 (322)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence 344556788999999999999999999876 3467899999874432 2345689999999999999999999996
Q ss_pred ecccccCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCe
Q 002857 227 SRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNI 306 (873)
Q Consensus 227 ~~~~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNI 306 (873)
......++||||+++|+|.+++...............+++..++.|+.||+.||+||| +.+|+||||||+||
T Consensus 98 -----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~NI 169 (322)
T 1p4o_A 98 -----SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNC 169 (322)
T ss_dssp -----CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGE
T ss_pred -----ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCccCCCccceE
Confidence 4456789999999999999999642211111122356789999999999999999999 88999999999999
Q ss_pred eeCCCCCeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccch
Q 002857 307 LLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNL 385 (873)
Q Consensus 307 LLd~~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~ 385 (873)
|++.++.+||+|||+++...............+|..|+|||++.+..++.++||||||+++|||+| |+.||.......
T Consensus 170 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~- 248 (322)
T 1p4o_A 170 MVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ- 248 (322)
T ss_dssp EECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH-
T ss_pred EEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHH-
Confidence 999999999999999986644332222333457889999999998899999999999999999999 899986532111
Q ss_pred hhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHH
Q 002857 386 NLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGL 465 (873)
Q Consensus 386 ~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~L 465 (873)
.. ..+....+.. .+. .+...+.+++.+||+.||++|||+.||++.|
T Consensus 249 -~~-----------~~~~~~~~~~-------------~~~---------~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L 294 (322)
T 1p4o_A 249 -VL-----------RFVMEGGLLD-------------KPD---------NCPDMLFELMRMCWQYNPKMRPSFLEIISSI 294 (322)
T ss_dssp -HH-----------HHHHTTCCCC-------------CCT---------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred -HH-----------HHHHcCCcCC-------------CCC---------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 00 0011100000 000 1123478899999999999999999999999
Q ss_pred HHHHH
Q 002857 466 RLIKK 470 (873)
Q Consensus 466 e~i~~ 470 (873)
+.+..
T Consensus 295 ~~~~~ 299 (322)
T 1p4o_A 295 KEEME 299 (322)
T ss_dssp GGGSC
T ss_pred HHhhc
Confidence 87633
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=342.77 Aligned_cols=254 Identities=19% Similarity=0.314 Sum_probs=199.9
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCC--cchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceE
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH--DASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFK 237 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~ 237 (873)
++|.+.+.||+|+||.||+|++ .++.||||+++.... ...+.+.+|+.++++++||||+++++++.. ......
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~~~~~ 84 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQS---PPAPHP 84 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECT---TTSSSC
T ss_pred HHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEcc---CCCCCe
Confidence 5789999999999999999998 478899999975432 334679999999999999999999999743 223678
Q ss_pred EEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCC--eeeccCCCCCeeeCCCCCeE
Q 002857 238 ALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPP--IAHCDIKPSNILLNDEMTAC 315 (873)
Q Consensus 238 ~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~g--IvHrDLKpsNILLd~~~~vK 315 (873)
++||||+++|+|.+++.. .....+++..++.|+.||+.||+||| +.+ |+||||||+|||++.++.++
T Consensus 85 ~lv~e~~~~~~L~~~l~~--------~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~ 153 (271)
T 3kmu_A 85 TLITHWMPYGSLYNVLHE--------GTNFVVDQSQAVKFALDMARGMAFLH---TLEPLIPRHALNSRSVMIDEDMTAR 153 (271)
T ss_dssp EEEEECCTTCBHHHHHHS--------CSSCCCCHHHHHHHHHHHHHHHHHHT---TSSSCCTTCCCSGGGEEECTTSCEE
T ss_pred EeeecccCCCcHHHHHhh--------cccCCCCHHHHHHHHHHHHHHHHHHh---cCCCceecCCCccceEEEcCCccee
Confidence 999999999999999953 22346899999999999999999999 778 99999999999999999999
Q ss_pred EeccccccccccccccccccccccccccCCCcccCCCCCCc---chhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHh
Q 002857 316 VADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSS---YGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQ 392 (873)
Q Consensus 316 LsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~---ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~ 392 (873)
|+|||++..... ....||..|+|||++.+..++. ++||||||+++|||+||+.||........
T Consensus 154 l~~~~~~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------- 219 (271)
T 3kmu_A 154 ISMADVKFSFQS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI------- 219 (271)
T ss_dssp EEGGGSCCTTSC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH-------
T ss_pred EEeccceeeecc-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH-------
Confidence 999988764221 2245899999999988765544 79999999999999999999975322110
Q ss_pred hcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHHHH
Q 002857 393 SALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLIKK 470 (873)
Q Consensus 393 ~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i~~ 470 (873)
...+....... +... .+...+.+++..||+.||++|||+.||++.|+.+++
T Consensus 220 ------~~~~~~~~~~~--------------~~~~-------~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 220 ------GMKVALEGLRP--------------TIPP-------GISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp ------HHHHHHSCCCC--------------CCCT-------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred ------HHHHHhcCCCC--------------CCCC-------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 00000000000 0000 012347889999999999999999999999998743
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-39 Score=347.90 Aligned_cols=258 Identities=26% Similarity=0.372 Sum_probs=195.9
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEE
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKAL 239 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~L 239 (873)
++|++.+.||+|+||.||+|++ .++.||||++.. ....+.+.+|++++++++||||+++++++. +..++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-------~~~~l 76 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIES--ESERKAFIVELRQLSRVNHPNIVKLYGACL-------NPVCL 76 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSS--TTHHHHHHHHHHHHHHCCCTTBCCEEEBCT-------TTTEE
T ss_pred hHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecC--hhHHHHHHHHHHHHhcCCCCCcCeEEEEEc-------CCcEE
Confidence 5788999999999999999987 468899999863 234578999999999999999999999863 23689
Q ss_pred EEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCC-eEEec
Q 002857 240 VYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMT-ACVAD 318 (873)
Q Consensus 240 V~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~-vKLsD 318 (873)
||||+++|+|.++++.. .....+++..++.++.||++||+|||+....+|+||||||+|||++.++. +||+|
T Consensus 77 v~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~D 149 (307)
T 2eva_A 77 VMEYAEGGSLYNVLHGA-------EPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICD 149 (307)
T ss_dssp EEECCTTCBHHHHHHCS-------SSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECC
T ss_pred EEEcCCCCCHHHHHhcc-------CCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcc
Confidence 99999999999999531 11234788899999999999999999321289999999999999998886 79999
Q ss_pred cccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCchh
Q 002857 319 FGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPER 398 (873)
Q Consensus 319 FGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~~ 398 (873)
||++...... .....||..|+|||++.+..++.++||||||+++|||+||+.||..............
T Consensus 150 fg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~------- 217 (307)
T 2eva_A 150 FGTACDIQTH-----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAV------- 217 (307)
T ss_dssp CCC-----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHH-------
T ss_pred cccccccccc-----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHH-------
Confidence 9999755322 1233589999999999999999999999999999999999999975322211110000
Q ss_pred HHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHHHHhhh
Q 002857 399 VEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLIKKKLL 473 (873)
Q Consensus 399 l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i~~~l~ 473 (873)
.... ..+... .+...+.+++.+||+.||++|||+.||++.|+.+...+.
T Consensus 218 ----~~~~---------------~~~~~~-------~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 266 (307)
T 2eva_A 218 ----HNGT---------------RPPLIK-------NLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFP 266 (307)
T ss_dssp ----HTTC---------------CCCCBT-------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCC
T ss_pred ----hcCC---------------CCCccc-------ccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhcc
Confidence 0000 000000 112347789999999999999999999999999866553
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=356.44 Aligned_cols=211 Identities=26% Similarity=0.341 Sum_probs=181.7
Q ss_pred CCccCHHHHHHhhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhh-----hcccee
Q 002857 147 FPYVSYEALYSATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNII-----HRKIIK 221 (873)
Q Consensus 147 ~~~~s~~el~~at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~-----HpNIV~ 221 (873)
...+++++.....++|.+.++||+|+||.||+|++..+++.||||+++.. ......+..|+.+++.++ |+||++
T Consensus 22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~ 100 (360)
T 3llt_A 22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVK 100 (360)
T ss_dssp GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence 44566666667788999999999999999999999999999999998632 233466788999999996 999999
Q ss_pred eeeeeecccccCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccC
Q 002857 222 VVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDI 301 (873)
Q Consensus 222 llg~c~~~~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDL 301 (873)
+++++ ...+..+|||||+ +++|.+++.. .....+++..++.|+.||+.||+||| +.+|+||||
T Consensus 101 ~~~~~-----~~~~~~~lv~e~~-~~~L~~~~~~--------~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDl 163 (360)
T 3llt_A 101 YHGKF-----MYYDHMCLIFEPL-GPSLYEIITR--------NNYNGFHIEDIKLYCIEILKALNYLR---KMSLTHTDL 163 (360)
T ss_dssp EEEEE-----EETTEEEEEECCC-CCBHHHHHHH--------TTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCC
T ss_pred cccee-----eECCeeEEEEcCC-CCCHHHHHHh--------cCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCC
Confidence 99986 3456799999999 9999999953 23345899999999999999999999 899999999
Q ss_pred CCCCeeeCC-------------------------CCCeEEeccccccccccccccccccccccccccCCCcccCCCCCCc
Q 002857 302 KPSNILLND-------------------------EMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSS 356 (873)
Q Consensus 302 KpsNILLd~-------------------------~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ 356 (873)
||+|||++. ++.+||+|||+++..... .....||..|+|||++.+..++.
T Consensus 164 kp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~ 238 (360)
T 3llt_A 164 KPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDV 238 (360)
T ss_dssp SGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCT
T ss_pred CcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCC
Confidence 999999975 789999999999864332 12346899999999999999999
Q ss_pred chhhHhHHHHHHHHHhCCCCCCcc
Q 002857 357 YGDVYSFGILLLEMFTGLRPSDDM 380 (873)
Q Consensus 357 ksDVwSfGvvL~ELlTGk~Pf~~~ 380 (873)
++|||||||++|||+||+.||...
T Consensus 239 ~~DiwslG~il~ell~g~~pf~~~ 262 (360)
T 3llt_A 239 SSDMWSFGCVLAELYTGSLLFRTH 262 (360)
T ss_dssp THHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccchHHHHHHHHHHHHCCCCCCCC
Confidence 999999999999999999999763
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=347.60 Aligned_cols=200 Identities=23% Similarity=0.342 Sum_probs=170.5
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCC--cchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceE
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH--DASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFK 237 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~ 237 (873)
++|++.+.||+|+||.||+|++..+++.||||+++.... .....+.+|+.++++++||||+++++++ ..+...
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~ 76 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL-----HSDKKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEE-----EETTEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEE-----EeCCEE
Confidence 578999999999999999999999999999999974432 2346788999999999999999999996 446689
Q ss_pred EEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEe
Q 002857 238 ALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVA 317 (873)
Q Consensus 238 ~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLs 317 (873)
++||||+++ +|.+++. .....+++..++.|+.||+.||+||| +.+|+||||||+|||++.++.+||+
T Consensus 77 ~lv~e~~~~-~l~~~~~---------~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~ 143 (292)
T 3o0g_A 77 TLVFEFCDQ-DLKKYFD---------SCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLA 143 (292)
T ss_dssp EEEEECCSE-EHHHHHH---------HTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEEC
T ss_pred EEEEecCCC-CHHHHHH---------hCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEe
Confidence 999999975 6665553 23456899999999999999999999 8899999999999999999999999
Q ss_pred ccccccccccccccccccccccccccCCCcccCCCC-CCcchhhHhHHHHHHHHHhCCCCCCc
Q 002857 318 DFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHE-TSSYGDVYSFGILLLEMFTGLRPSDD 379 (873)
Q Consensus 318 DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~-~s~ksDVwSfGvvL~ELlTGk~Pf~~ 379 (873)
|||+++...... .......||..|+|||++.+.. ++.++||||||+++|||++|..||..
T Consensus 144 Dfg~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~ 204 (292)
T 3o0g_A 144 NFGLARAFGIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 204 (292)
T ss_dssp CCTTCEECCSCC--SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC
T ss_pred ecccceecCCcc--ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcC
Confidence 999998664322 2223346899999999988765 79999999999999999999888643
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=350.26 Aligned_cols=268 Identities=22% Similarity=0.257 Sum_probs=206.9
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEE
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKA 238 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~ 238 (873)
.++|++.+.||+|+||.||++....+++.||||++........+.+.+|++++++++||||+++++++.... ......+
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~~ 106 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRER-GAKHEAW 106 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEE-TTEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEecc-CCCceeE
Confidence 467999999999999999999998899999999987655556678999999999999999999999975321 2345789
Q ss_pred EEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEec
Q 002857 239 LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVAD 318 (873)
Q Consensus 239 LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsD 318 (873)
+||||+++|+|.+++... ......+++.+++.|+.||+.||+||| +.+|+||||||+|||++.++.+||+|
T Consensus 107 lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~d 177 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERL------KDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMD 177 (317)
T ss_dssp EEEECCTTCBHHHHHHHH------HTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECC
T ss_pred EEEEeCCCCcHHHHHHHH------HhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCCEEEEe
Confidence 999999999999998531 123567899999999999999999999 88999999999999999999999999
Q ss_pred ccccccccccccc-------ccccccccccccCCCcccCCCC---CCcchhhHhHHHHHHHHHhCCCCCCcccccchhhH
Q 002857 319 FGIARFLEATNEQ-------TSSIGVKGTTGYIAPEYGMGHE---TSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQ 388 (873)
Q Consensus 319 FGla~~~~~~~~~-------~~~~~~~Gt~~Y~APE~l~~~~---~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~ 388 (873)
||+++........ .......||..|+|||++.+.. ++.++||||||+++|||++|+.||...........
T Consensus 178 fg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~ 257 (317)
T 2buj_A 178 LGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVA 257 (317)
T ss_dssp CSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHH
T ss_pred cCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhh
Confidence 9998764322111 0112345799999999987654 68999999999999999999999964221111111
Q ss_pred HHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHH
Q 002857 389 NWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLI 468 (873)
Q Consensus 389 ~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i 468 (873)
. .+.... ..+... .....+.+++.+||+.||++|||+.||++.|+.+
T Consensus 258 ~------------~~~~~~--------------~~~~~~-------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~ 304 (317)
T 2buj_A 258 L------------AVQNQL--------------SIPQSP-------RHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEAL 304 (317)
T ss_dssp H------------HHHCC----------------CCCCT-------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred H------------HhhccC--------------CCCccc-------cCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhc
Confidence 1 000000 001000 0123478899999999999999999999999976
Q ss_pred H
Q 002857 469 K 469 (873)
Q Consensus 469 ~ 469 (873)
.
T Consensus 305 ~ 305 (317)
T 2buj_A 305 Q 305 (317)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-40 Score=357.78 Aligned_cols=278 Identities=22% Similarity=0.314 Sum_probs=210.3
Q ss_pred cCCCcceeecccCceEEEEEEE----cCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCc
Q 002857 160 KGFSSENLIGAGNFASVYKGIL----FEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGND 235 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~----~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~ 235 (873)
++|++.+.||+|+||.||+|++ ..+++.||||++........+.+.+|++++++++|+||+++++++.. ....
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~ 99 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYG---PGRQ 99 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC---SSSC
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEec---CCCc
Confidence 5789999999999999999984 56788999999986655556779999999999999999999998642 3456
Q ss_pred eEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeE
Q 002857 236 FKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTAC 315 (873)
Q Consensus 236 ~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vK 315 (873)
..++||||+++++|.+++.. ....+++..++.|+.||+.||+||| +.+|+||||||+|||++.++.+|
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~k 167 (327)
T 3lxl_A 100 SLRLVMEYLPSGCLRDFLQR---------HRARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVK 167 (327)
T ss_dssp EEEEEEECCTTCBHHHHHHH---------HGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEE
T ss_pred eEEEEEeecCCCCHHHHHHh---------cccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChhhEEECCCCCEE
Confidence 78999999999999999953 1235899999999999999999999 89999999999999999999999
Q ss_pred Eecccccccccccccc-ccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhc
Q 002857 316 VADFGIARFLEATNEQ-TSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSA 394 (873)
Q Consensus 316 LsDFGla~~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~ 394 (873)
|+|||+++........ .......+|..|+|||++.+..++.++||||||+++|||++|+.||.....+.... +....
T Consensus 168 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~--~~~~~ 245 (327)
T 3lxl_A 168 IADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRM--MGCER 245 (327)
T ss_dssp ECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHH--CC---
T ss_pred EcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhh--ccccc
Confidence 9999999876443321 12223457888999999998889999999999999999999999986532211100 00000
Q ss_pred CchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHHHHhh
Q 002857 395 LPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLIKKKL 472 (873)
Q Consensus 395 ~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i~~~l 472 (873)
.......+.+..... ...+... .+...+.+++.+||+.||++|||+.||++.|+.+....
T Consensus 246 ~~~~~~~~~~~~~~~-----------~~~~~~~-------~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 246 DVPALSRLLELLEEG-----------QRLPAPP-------ACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp -CCHHHHHHHHHHTT-----------CCCCCCT-------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred ccccHHHHHHHhhcc-----------cCCCCCC-------cccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 001111111111000 0001100 12345889999999999999999999999999875544
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=347.71 Aligned_cols=264 Identities=25% Similarity=0.407 Sum_probs=213.3
Q ss_pred HhhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCce
Q 002857 157 SATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDF 236 (873)
Q Consensus 157 ~at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~ 236 (873)
...++|++.+.||+|+||.||+|.+..++..||||++... ....+.+.+|++++++++||||+++++++ .....
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~ 83 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVC-----TREPP 83 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSSS
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----ccCCC
Confidence 3467899999999999999999999888999999999743 33457899999999999999999999996 45667
Q ss_pred EEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEE
Q 002857 237 KALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACV 316 (873)
Q Consensus 237 ~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKL 316 (873)
.++||||+++++|.+++.. .....+++..++.|+.||+.||+||| +.+|+||||||+||+++.++.+||
T Consensus 84 ~~~v~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l 152 (288)
T 3kfa_A 84 FYIITEFMTYGNLLDYLRE--------CNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKV 152 (288)
T ss_dssp EEEEEECCTTEEHHHHHHH--------CCTTTSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEEEEcCCCCcHHHHHHh--------cccCCccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcCCCCEEE
Confidence 8999999999999999953 23456899999999999999999999 889999999999999999999999
Q ss_pred eccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHHHhhcC
Q 002857 317 ADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQSAL 395 (873)
Q Consensus 317 sDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~~~~~~ 395 (873)
+|||+++...... ........+|..|+|||++.+..++.++||||||+++|+|++ |..||.......
T Consensus 153 ~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~----------- 220 (288)
T 3kfa_A 153 ADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----------- 220 (288)
T ss_dssp CCCCGGGTSCSSS-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-----------
T ss_pred ccCccceeccCCc-cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-----------
Confidence 9999998764332 222233457889999999998899999999999999999999 999987532111
Q ss_pred chhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHHHHhhh
Q 002857 396 PERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLIKKKLL 473 (873)
Q Consensus 396 ~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i~~~l~ 473 (873)
+.+.+....... .+ ..+...+.+++.+||+.||++|||+.||++.|+.+.....
T Consensus 221 ---~~~~~~~~~~~~------------~~---------~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~~ 274 (288)
T 3kfa_A 221 ---VYELLEKDYRME------------RP---------EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 274 (288)
T ss_dssp ---HHHHHHTTCCCC------------CC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred ---HHHHHhccCCCC------------CC---------CCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 111111100000 00 0112357889999999999999999999999999876543
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=342.53 Aligned_cols=264 Identities=23% Similarity=0.360 Sum_probs=204.2
Q ss_pred CCCcceeecccCceEEEEEEEcCCCc---EEEEEEeeccCC-cchhHHHHHHHHHHhhhhccceeeeeeeecccccCCce
Q 002857 161 GFSSENLIGAGNFASVYKGILFEGAP---AVAIKVFNFLHH-DASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDF 236 (873)
Q Consensus 161 ~f~~~~~LG~G~fG~VYkg~~~~~g~---~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~ 236 (873)
.|...++||+|+||.||+|.+..++. .||+|++..... ...+.+.+|+.++++++||||+++++++. ..+..
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----~~~~~ 97 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIML----PPEGL 97 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEC----CSSSC
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEe----cCCCC
Confidence 35566899999999999999765544 799999874333 33467899999999999999999999963 23344
Q ss_pred EEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEE
Q 002857 237 KALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACV 316 (873)
Q Consensus 237 ~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKL 316 (873)
.++||||+.+|+|.+++.. ....+++..++.|+.||+.||+||| +.+|+||||||+|||++.++.+||
T Consensus 98 ~~~v~e~~~~~~L~~~~~~---------~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nili~~~~~~kl 165 (298)
T 3pls_A 98 PHVLLPYMCHGDLLQFIRS---------PQRNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKV 165 (298)
T ss_dssp CEEEECCCTTCBHHHHHHC---------TTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEE
T ss_pred cEEEEecccCCCHHHHHhc---------cccCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEe
Confidence 5899999999999999952 3456899999999999999999999 889999999999999999999999
Q ss_pred ecccccccccccc--ccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhc
Q 002857 317 ADFGIARFLEATN--EQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSA 394 (873)
Q Consensus 317 sDFGla~~~~~~~--~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~ 394 (873)
+|||+++...... .........+|..|+|||.+.+..++.++||||||+++|||++|..|+...... ..+...+
T Consensus 166 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~-~~~~~~~--- 241 (298)
T 3pls_A 166 ADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP-FDLTHFL--- 241 (298)
T ss_dssp CCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG-GGHHHHH---
T ss_pred CcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH-HHHHHHh---
Confidence 9999998654322 112223345789999999999999999999999999999999966664331111 1111111
Q ss_pred CchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHHHHhhhc
Q 002857 395 LPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLIKKKLLE 474 (873)
Q Consensus 395 ~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i~~~l~~ 474 (873)
.... ..+... .+...+.+++.+||+.||++|||+.+|++.|+.+.+.+..
T Consensus 242 ---------~~~~--------------~~~~~~-------~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~ 291 (298)
T 3pls_A 242 ---------AQGR--------------RLPQPE-------YCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG 291 (298)
T ss_dssp ---------HTTC--------------CCCCCT-------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCS
T ss_pred ---------hcCC--------------CCCCCc-------cchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 0000 000000 0123478899999999999999999999999999887753
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=354.30 Aligned_cols=276 Identities=22% Similarity=0.323 Sum_probs=211.7
Q ss_pred HHhhcCCCcceeecccCceEEEEEEEcCCC-----cEEEEEEeeccCC-cchhHHHHHHHHHHhh-hhccceeeeeeeec
Q 002857 156 YSATKGFSSENLIGAGNFASVYKGILFEGA-----PAVAIKVFNFLHH-DASKSFTVECEVMRNI-IHRKIIKVVTACSR 228 (873)
Q Consensus 156 ~~at~~f~~~~~LG~G~fG~VYkg~~~~~g-----~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L-~HpNIV~llg~c~~ 228 (873)
....++|.+.+.||+|+||.||+|.+..++ ..||+|+++.... ...+.+.+|+++++++ +||||+++++++
T Consensus 42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~-- 119 (333)
T 2i1m_A 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC-- 119 (333)
T ss_dssp BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE--
T ss_pred cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE--
Confidence 344578999999999999999999986654 3799999975432 3446789999999999 899999999996
Q ss_pred ccccCCceEEEEEeecCCCChhhhccccccccc----ccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCC
Q 002857 229 VDYQGNDFKALVYEFMPNGSLEEWIHPITEEDK----RHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPS 304 (873)
Q Consensus 229 ~~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~----~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKps 304 (873)
...+..++||||+++|+|.+++........ .......+++..++.++.||+.||+||| +.+|+||||||+
T Consensus 120 ---~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~ 193 (333)
T 2i1m_A 120 ---THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAAR 193 (333)
T ss_dssp ---CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGG
T ss_pred ---ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCcccc
Confidence 445678999999999999999964111000 0001346899999999999999999999 889999999999
Q ss_pred CeeeCCCCCeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCccccc
Q 002857 305 NILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKD 383 (873)
Q Consensus 305 NILLd~~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~ 383 (873)
|||++.++.+||+|||+++...............+|..|+|||++.+..++.++||||||+++|||+| |..||......
T Consensus 194 NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~ 273 (333)
T 2i1m_A 194 NVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN 273 (333)
T ss_dssp GCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS
T ss_pred eEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchh
Confidence 99999999999999999987654433333334457889999999988899999999999999999999 99998753221
Q ss_pred chhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 384 NLNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 384 ~~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
. .+..++....... .+. .+...+.+++.+||+.||.+|||+.||++
T Consensus 274 ~-------------~~~~~~~~~~~~~------------~~~---------~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 319 (333)
T 2i1m_A 274 S-------------KFYKLVKDGYQMA------------QPA---------FAPKNIYSIMQACWALEPTHRPTFQQICS 319 (333)
T ss_dssp H-------------HHHHHHHHTCCCC------------CCT---------TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred H-------------HHHHHHhcCCCCC------------CCC---------CCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 1 1111111110000 000 01234788999999999999999999999
Q ss_pred HHHHHHHhhh
Q 002857 464 GLRLIKKKLL 473 (873)
Q Consensus 464 ~Le~i~~~l~ 473 (873)
.|+.+.....
T Consensus 320 ~L~~~~~~~~ 329 (333)
T 2i1m_A 320 FLQEQAQEDR 329 (333)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHhhh
Confidence 9998876543
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=342.40 Aligned_cols=251 Identities=25% Similarity=0.370 Sum_probs=189.9
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCC----cchhHHHHHHHHHHhhhhccceeeeeeeecccccCC
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH----DASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGN 234 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~----~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~ 234 (873)
.++|++.+.||+|+||.||+|.+ .++.||||+++.... ...+.+.+|+++++.++||||+++++++ ...
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~ 78 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVC-----LKE 78 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEE-----CCC
T ss_pred hhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE-----ecC
Confidence 35789999999999999999987 478999999864322 2346789999999999999999999996 445
Q ss_pred ceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCC---eeeccCCCCCeeeCC-
Q 002857 235 DFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPP---IAHCDIKPSNILLND- 310 (873)
Q Consensus 235 ~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~g---IvHrDLKpsNILLd~- 310 (873)
+..++||||+++++|.+++. ...+++..++.++.|++.||+||| +.+ |+||||||+|||++.
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~-----------~~~~~~~~~~~i~~~l~~~l~~lH---~~~~~~i~H~dikp~Nil~~~~ 144 (271)
T 3dtc_A 79 PNLCLVMEFARGGPLNRVLS-----------GKRIPPDILVNWAVQIARGMNYLH---DEAIVPIIHRDLKSSNILILQK 144 (271)
T ss_dssp --CEEEEECCTTEEHHHHHT-----------SSCCCHHHHHHHHHHHHHHHHHHH---HSSSSCCCCSCCSGGGEEESSC
T ss_pred CceEEEEEcCCCCCHHHHhh-----------cCCCCHHHHHHHHHHHHHHHHHHH---hCCCCceeecCCchHHEEEecc
Confidence 67899999999999999983 246899999999999999999999 666 999999999999986
Q ss_pred -------CCCeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCccccc
Q 002857 311 -------EMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKD 383 (873)
Q Consensus 311 -------~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~ 383 (873)
++.+||+|||+++...... .....||..|+|||++.+..++.++||||||+++|||++|+.||......
T Consensus 145 ~~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~ 220 (271)
T 3dtc_A 145 VENGDLSNKILKITDFGLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL 220 (271)
T ss_dssp CSSSCCSSCCEEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH
T ss_pred cccccccCcceEEccCCccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 6789999999998654322 12346899999999999889999999999999999999999999753211
Q ss_pred chhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 384 NLNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 384 ~~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
... ..+...... .+... .+...+.+++.+||+.||++|||+.||++
T Consensus 221 ~~~-------------~~~~~~~~~--------------~~~~~-------~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 266 (271)
T 3dtc_A 221 AVA-------------YGVAMNKLA--------------LPIPS-------TCPEPFAKLMEDCWNPDPHSRPSFTNILD 266 (271)
T ss_dssp HHH-------------HHHHTSCCC--------------CCCCT-------TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHH-------------HhhhcCCCC--------------CCCCc-------ccCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 100 000000000 00000 11235788999999999999999999999
Q ss_pred HHHHH
Q 002857 464 GLRLI 468 (873)
Q Consensus 464 ~Le~i 468 (873)
.|+.|
T Consensus 267 ~L~~l 271 (271)
T 3dtc_A 267 QLTTI 271 (271)
T ss_dssp HHHC-
T ss_pred HHhcC
Confidence 99753
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=354.27 Aligned_cols=256 Identities=21% Similarity=0.264 Sum_probs=201.4
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeecc-----CCcchhHHHHHHHHHHhhhhccceeeeeeeecccccC
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFL-----HHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQG 233 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~-----~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~ 233 (873)
.++|++.+.||+|+||.||+|++..+++.||||++... .....+.+.+|+.++++++||||+++++++ ..
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-----~~ 97 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETY-----SS 97 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEE-----EE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEE-----Ee
Confidence 35689999999999999999999999999999998632 122356799999999999999999999986 44
Q ss_pred CceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCC
Q 002857 234 NDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMT 313 (873)
Q Consensus 234 ~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~ 313 (873)
.+..++||||+++|+|.+++.. .......+++..++.|+.||+.||+||| +.+|+||||||+|||++.++.
T Consensus 98 ~~~~~lv~e~~~g~~L~~~l~~------~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~~~ 168 (351)
T 3c0i_A 98 DGMLYMVFEFMDGADLCFEIVK------RADAGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKEN 168 (351)
T ss_dssp TTEEEEEEECCSSCBHHHHHHH------HHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSSST
T ss_pred CCEEEEEEeCCCCCCHHHHHHH------hcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecCCC
Confidence 6679999999999999988843 1123445899999999999999999999 899999999999999986554
Q ss_pred ---eEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHH
Q 002857 314 ---ACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNW 390 (873)
Q Consensus 314 ---vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~ 390 (873)
+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+
T Consensus 169 ~~~vkl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~--- 240 (351)
T 3c0i_A 169 SAPVKLGGFGVAIQLGESG--LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE---RL--- 240 (351)
T ss_dssp TCCEEECCCTTCEECCTTS--CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH---HH---
T ss_pred CCcEEEecCcceeEecCCC--eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH---HH---
Confidence 9999999998764432 122335699999999999999999999999999999999999999975211 00
Q ss_pred HhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 391 VQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 391 ~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
...+......... .........+.+++.+||+.||++|||+.|+++
T Consensus 241 --------~~~i~~~~~~~~~-------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 241 --------FEGIIKGKYKMNP-------------------RQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp --------HHHHHHTCCCCCH-------------------HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --------HHHHHcCCCCCCc-------------------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1111111100000 000011235788999999999999999999985
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=355.62 Aligned_cols=270 Identities=20% Similarity=0.236 Sum_probs=198.5
Q ss_pred hcCCCcceeecccCceEEEEEEEcC---CCcEEEEEEeeccCCc-----------chhHHHHHHHHHHhhhhccceeeee
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFE---GAPAVAIKVFNFLHHD-----------ASKSFTVECEVMRNIIHRKIIKVVT 224 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~---~g~~VAVK~l~~~~~~-----------~~~~f~~Ei~iL~~L~HpNIV~llg 224 (873)
.++|.+.+.||+|+||.||+|.+.. ++..||||++...... ....+.+|+.+++.++|+||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 3578999999999999999999976 7789999998744321 1234667888889999999999999
Q ss_pred eeecccccCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCC
Q 002857 225 ACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPS 304 (873)
Q Consensus 225 ~c~~~~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKps 304 (873)
++... +......++||||+ +++|.+++.. ...+++.+++.|+.||+.||+||| +.+|+||||||+
T Consensus 116 ~~~~~-~~~~~~~~lv~e~~-~~~L~~~l~~----------~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~ 180 (345)
T 2v62_A 116 SGLTE-FKGRSYRFMVMERL-GIDLQKISGQ----------NGTFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAA 180 (345)
T ss_dssp EEEEE-SSSCEEEEEEEECE-EEEHHHHCBG----------GGBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGG
T ss_pred ccccc-cCCCcEEEEEEecc-CCCHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCHH
Confidence 97542 23467899999999 9999999953 237899999999999999999999 889999999999
Q ss_pred CeeeCCCC--CeEEecccccccccccccc-----ccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCC
Q 002857 305 NILLNDEM--TACVADFGIARFLEATNEQ-----TSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPS 377 (873)
Q Consensus 305 NILLd~~~--~vKLsDFGla~~~~~~~~~-----~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf 377 (873)
|||++.++ .+||+|||+++.+...... .......||..|+|||++.+..++.++||||||+++|||+||+.||
T Consensus 181 NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf 260 (345)
T 2v62_A 181 NLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPW 260 (345)
T ss_dssp GEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred HEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence 99999877 9999999999876443211 1113446999999999999999999999999999999999999999
Q ss_pred CcccccchhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCC
Q 002857 378 DDMFKDNLNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMK 457 (873)
Q Consensus 378 ~~~~~~~~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPT 457 (873)
................ ....+.... ... .+. ..+...+.+++..||+.||++|||
T Consensus 261 ~~~~~~~~~~~~~~~~---------~~~~~~~~~------~~~--~~~--------~~~~~~l~~li~~~l~~dp~~Rps 315 (345)
T 2v62_A 261 EQNLKDPVAVQTAKTN---------LLDELPQSV------LKW--APS--------GSSCCEIAQFLVCAHSLAYDEKPN 315 (345)
T ss_dssp GGGTTCHHHHHHHHHH---------HHHTTTHHH------HHH--SCT--------TSCCHHHHHHHHHHHTCCTTCCCC
T ss_pred cccccccHHHHHHHHh---------hcccccHHH------Hhh--ccc--------cccHHHHHHHHHHHhhcCcccCCC
Confidence 6532222111111000 000000000 000 000 011335889999999999999999
Q ss_pred HHHHHHHHHHH
Q 002857 458 INDVELGLRLI 468 (873)
Q Consensus 458 m~EVl~~Le~i 468 (873)
+.+|++.|+.+
T Consensus 316 ~~~l~~~L~~~ 326 (345)
T 2v62_A 316 YQALKKILNPH 326 (345)
T ss_dssp HHHHHHHHCTT
T ss_pred HHHHHHHHhcc
Confidence 99999999864
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=345.88 Aligned_cols=260 Identities=23% Similarity=0.357 Sum_probs=195.6
Q ss_pred hcCCCcceeecccCceEEEEEEEcCC---CcEEEEEEeeccCC-cchhHHHHHHHHHHhhhhccceeeeeeeecccccCC
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEG---APAVAIKVFNFLHH-DASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGN 234 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~---g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~ 234 (873)
.++|++.+.||+|+||.||+|.+..+ +..||||+++.... ...+.+.+|+.++++++||||+++++++. .
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------~ 87 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT------E 87 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC------S
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc------c
Confidence 46789999999999999999998643 45799999875332 23467899999999999999999999852 3
Q ss_pred ceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCe
Q 002857 235 DFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTA 314 (873)
Q Consensus 235 ~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~v 314 (873)
+..++||||+++|+|.+++.. ....+++..++.++.||+.||+||| +.+|+||||||+|||++.++.+
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~ 155 (281)
T 1mp8_A 88 NPVWIIMELCTLGELRSFLQV---------RKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCV 155 (281)
T ss_dssp SSCEEEEECCTTEEHHHHHHH---------TTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEE
T ss_pred CccEEEEecCCCCCHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEECCCCCE
Confidence 457899999999999999953 2346899999999999999999999 8999999999999999999999
Q ss_pred EEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHHHhh
Q 002857 315 CVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQS 393 (873)
Q Consensus 315 KLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~~~~ 393 (873)
||+|||+++....... .......+|..|+|||++.+..++.++||||||+++|||++ |..||....... ...
T Consensus 156 kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~--~~~---- 228 (281)
T 1mp8_A 156 KLGDFGLSRYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--VIG---- 228 (281)
T ss_dssp EECC--------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHH----
T ss_pred EECccccccccCcccc-cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH--HHH----
Confidence 9999999987644321 11223346789999999988899999999999999999997 999997632211 111
Q ss_pred cCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHHHHhh
Q 002857 394 ALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLIKKKL 472 (873)
Q Consensus 394 ~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i~~~l 472 (873)
.+..... .+... .+...+.+++.+||+.||++|||+.||++.|+.+.+..
T Consensus 229 -------~i~~~~~---------------~~~~~-------~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 278 (281)
T 1mp8_A 229 -------RIENGER---------------LPMPP-------NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 278 (281)
T ss_dssp -------HHHTTCC---------------CCCCT-------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -------HHHcCCC---------------CCCCC-------CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 1100000 00000 11235788999999999999999999999999987654
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=354.30 Aligned_cols=275 Identities=22% Similarity=0.328 Sum_probs=208.5
Q ss_pred CCcceeecccCceEEEEEEEc----CCCcEEEEEEeeccCC-cchhHHHHHHHHHHhhhhccceeeeeeeecccccCCce
Q 002857 162 FSSENLIGAGNFASVYKGILF----EGAPAVAIKVFNFLHH-DASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDF 236 (873)
Q Consensus 162 f~~~~~LG~G~fG~VYkg~~~----~~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~ 236 (873)
|++.+.||+|+||.||++.+. .+++.||||+++.... ...+.+.+|++++++++||||+++++++.. .....
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~~~~ 109 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCED---AGAAS 109 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE---TTTTE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEec---CCCce
Confidence 488999999999999888653 4678999999975432 334678999999999999999999999753 23567
Q ss_pred EEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEE
Q 002857 237 KALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACV 316 (873)
Q Consensus 237 ~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKL 316 (873)
.++||||+++|+|.+++.. ..+++..++.|+.||+.||+||| +.+|+||||||+|||++.++.+||
T Consensus 110 ~~lv~e~~~~~~L~~~l~~-----------~~~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~kl 175 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPR-----------HSIGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKI 175 (318)
T ss_dssp EEEEECCCTTCBHHHHGGG-----------SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEE
T ss_pred EEEEEecccCCcHHHHHhh-----------CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEEcCCCCEEE
Confidence 8999999999999999942 23899999999999999999999 889999999999999999999999
Q ss_pred ecccccccccccccc-ccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcC
Q 002857 317 ADFGIARFLEATNEQ-TSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSAL 395 (873)
Q Consensus 317 sDFGla~~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~ 395 (873)
+|||+++........ .......+|..|+|||++.+..++.++||||||+++|||+||+.||............+.....
T Consensus 176 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 255 (318)
T 3lxp_A 176 GDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQM 255 (318)
T ss_dssp CCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHH
T ss_pred CCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccch
Confidence 999999876543321 1222345788899999999889999999999999999999999998653221111111000000
Q ss_pred ch-hHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHHHHhhhc
Q 002857 396 PE-RVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLIKKKLLE 474 (873)
Q Consensus 396 ~~-~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i~~~l~~ 474 (873)
.. .+.+.+... ...+... .+...+.+|+.+||+.||++|||+.||++.|+.+.+.+..
T Consensus 256 ~~~~~~~~~~~~--------------~~~~~~~-------~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~ 314 (318)
T 3lxp_A 256 TVLRLTELLERG--------------ERLPRPD-------KCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQG 314 (318)
T ss_dssp HHHHHHHHHHTT--------------CCCCCCT-------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC
T ss_pred hHHHHHHHHhcc--------------cCCCCCc-------cccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhcc
Confidence 00 111111110 0001110 1233588999999999999999999999999999888764
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=344.95 Aligned_cols=263 Identities=23% Similarity=0.403 Sum_probs=201.7
Q ss_pred cCCCcceeecccCceEEEEEEEcCCC---cEEEEEEeeccCC-cchhHHHHHHHHHHhhhhccceeeeeeeecccccCCc
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGA---PAVAIKVFNFLHH-DASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGND 235 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g---~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~ 235 (873)
.+|++.++||+|+||.||+|++..++ ..||+|.++.... ...+.+.+|+.++++++||||++++++|. ..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----~~~~ 100 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL----RSEG 100 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEC----CSSS
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEE----cCCC
Confidence 45788899999999999999875433 3589999874332 33467899999999999999999999863 3456
Q ss_pred eEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeE
Q 002857 236 FKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTAC 315 (873)
Q Consensus 236 ~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vK 315 (873)
..++||||+++|+|.+++.. ....+++..++.|+.||+.||+||| +.+|+||||||+|||++.++.+|
T Consensus 101 ~~~~v~e~~~~~~L~~~l~~---------~~~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~k 168 (298)
T 3f66_A 101 SPLVVLPYMKHGDLRNFIRN---------ETHNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVK 168 (298)
T ss_dssp CCEEEEECCTTCBHHHHHHC---------TTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEE
T ss_pred ceEEEEeCCCCCCHHHHHHh---------cccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEECCCCCEE
Confidence 78999999999999999952 3456889999999999999999999 89999999999999999999999
Q ss_pred Eeccccccccccccc--cccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHHHh
Q 002857 316 VADFGIARFLEATNE--QTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQ 392 (873)
Q Consensus 316 LsDFGla~~~~~~~~--~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~~~ 392 (873)
|+|||+++....... ........+|..|+|||.+.+..++.++||||||+++|||++ |..||....... ....
T Consensus 169 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~--~~~~-- 244 (298)
T 3f66_A 169 VADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--ITVY-- 244 (298)
T ss_dssp ECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT--HHHH--
T ss_pred ECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH--HHHH--
Confidence 999999986643321 122233457889999999998899999999999999999999 555554422111 1110
Q ss_pred hcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHHHHhh
Q 002857 393 SALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLIKKKL 472 (873)
Q Consensus 393 ~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i~~~l 472 (873)
+....... .+. .+...+.+++.+||+.+|++|||+.||++.|+.+...+
T Consensus 245 ---------~~~~~~~~-------------~~~---------~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 293 (298)
T 3f66_A 245 ---------LLQGRRLL-------------QPE---------YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293 (298)
T ss_dssp ---------HHTTCCCC-------------CCT---------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred ---------HhcCCCCC-------------CCc---------cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 00000000 000 01234788999999999999999999999999987755
Q ss_pred h
Q 002857 473 L 473 (873)
Q Consensus 473 ~ 473 (873)
.
T Consensus 294 ~ 294 (298)
T 3f66_A 294 I 294 (298)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-39 Score=359.01 Aligned_cols=206 Identities=20% Similarity=0.232 Sum_probs=176.4
Q ss_pred hcCCCcceeeccc--CceEEEEEEEcCCCcEEEEEEeeccCC--cchhHHHHHHHHHHhhhhccceeeeeeeecccccCC
Q 002857 159 TKGFSSENLIGAG--NFASVYKGILFEGAPAVAIKVFNFLHH--DASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGN 234 (873)
Q Consensus 159 t~~f~~~~~LG~G--~fG~VYkg~~~~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~ 234 (873)
.++|++.++||+| +||.||+|++..+++.||||+++.... ...+.+.+|+.++++++|||||++++++ ...
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~ 98 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF-----IAD 98 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----EET
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEE-----EEC
Confidence 4679999999999 999999999998999999999975432 2346788899999999999999999996 446
Q ss_pred ceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCe
Q 002857 235 DFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTA 314 (873)
Q Consensus 235 ~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~v 314 (873)
+..++||||+++|+|.+++.. .....+++..++.|+.||+.||+||| +.+|+||||||+|||++.++.+
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~--------~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~ 167 (389)
T 3gni_B 99 NELWVVTSFMAYGSAKDLICT--------HFMDGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKV 167 (389)
T ss_dssp TEEEEEEECCTTCBHHHHHHH--------TCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCE
T ss_pred CEEEEEEEccCCCCHHHHHhh--------hcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCE
Confidence 679999999999999999953 23456899999999999999999999 8999999999999999999999
Q ss_pred EEeccccccccccccc-----cccccccccccccCCCcccCC--CCCCcchhhHhHHHHHHHHHhCCCCCCcc
Q 002857 315 CVADFGIARFLEATNE-----QTSSIGVKGTTGYIAPEYGMG--HETSSYGDVYSFGILLLEMFTGLRPSDDM 380 (873)
Q Consensus 315 KLsDFGla~~~~~~~~-----~~~~~~~~Gt~~Y~APE~l~~--~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~ 380 (873)
||+|||.+........ ........||..|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 168 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 240 (389)
T 3gni_B 168 YLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 240 (389)
T ss_dssp EECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred EEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCC
Confidence 9999999875433211 111222468999999999987 57999999999999999999999999764
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=347.25 Aligned_cols=207 Identities=26% Similarity=0.371 Sum_probs=161.9
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCC-cchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceE
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH-DASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFK 237 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~ 237 (873)
.++|++.+.||+|+||.||+|.+..+++.||||+++.... ...+.+.+|++++++++||||+++++++ ..++..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~ 78 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI-----HTENKL 78 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEE-----CCTTEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEE-----EECCeE
Confidence 4689999999999999999999988999999999975432 3346789999999999999999999995 456789
Q ss_pred EEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEe
Q 002857 238 ALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVA 317 (873)
Q Consensus 238 ~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLs 317 (873)
++||||++ |+|.+++... ........+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+
T Consensus 79 ~lv~e~~~-~~L~~~l~~~----~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~ 150 (317)
T 2pmi_A 79 TLVFEFMD-NDLKKYMDSR----TVGNTPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLG 150 (317)
T ss_dssp EEEEECCC-CBHHHHHHHH----HSSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEEC
T ss_pred EEEEEecC-CCHHHHHHhc----cccccccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEEC
Confidence 99999998 5999998531 11123456899999999999999999999 8999999999999999999999999
Q ss_pred ccccccccccccccccccccccccccCCCcccCCC-CCCcchhhHhHHHHHHHHHhCCCCCCcc
Q 002857 318 DFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGH-ETSSYGDVYSFGILLLEMFTGLRPSDDM 380 (873)
Q Consensus 318 DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELlTGk~Pf~~~ 380 (873)
|||+++....... ......||..|+|||++.+. .++.++|||||||++|||+||+.||...
T Consensus 151 Dfg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 212 (317)
T 2pmi_A 151 DFGLARAFGIPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGT 212 (317)
T ss_dssp CCSSCEETTSCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cCccceecCCCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999986543221 12234689999999998764 6899999999999999999999999763
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-39 Score=351.73 Aligned_cols=269 Identities=21% Similarity=0.253 Sum_probs=201.9
Q ss_pred HHHhhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeecc-----CCcchhHHHHHHHHHHhhhhccceeeeeeeecc
Q 002857 155 LYSATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFL-----HHDASKSFTVECEVMRNIIHRKIIKVVTACSRV 229 (873)
Q Consensus 155 l~~at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~-----~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~ 229 (873)
+....++|.+.+.||+|+||.||+|.+..+++.||||++... .....+.+.+|++++++++||||+++++++
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~--- 97 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVY--- 97 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEE---
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhh---
Confidence 455677899999999999999999999999999999998643 334557899999999999999999999996
Q ss_pred cccCCceEEEEEeecCCCChhhhcccccccc------------------------------cccCCCCCCchhhhHHHHH
Q 002857 230 DYQGNDFKALVYEFMPNGSLEEWIHPITEED------------------------------KRHKAPGNLNSLERLNIAI 279 (873)
Q Consensus 230 ~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~------------------------------~~~~~~~~Ls~~~~l~Ia~ 279 (873)
...+..++||||+++|+|.+++....... ........+++..++.|+.
T Consensus 98 --~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 175 (345)
T 3hko_A 98 --EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMR 175 (345)
T ss_dssp --ECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHH
T ss_pred --ccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHH
Confidence 45678999999999999999995311100 0001122356778889999
Q ss_pred HHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCC--CeEEecccccccccccccc--ccccccccccccCCCcccCC--CC
Q 002857 280 DVASALEYLHLGCKPPIAHCDIKPSNILLNDEM--TACVADFGIARFLEATNEQ--TSSIGVKGTTGYIAPEYGMG--HE 353 (873)
Q Consensus 280 qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~--~vKLsDFGla~~~~~~~~~--~~~~~~~Gt~~Y~APE~l~~--~~ 353 (873)
||+.||+||| +.+|+||||||+|||++.++ .+||+|||+++.+...... .......||+.|+|||++.+ ..
T Consensus 176 qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 252 (345)
T 3hko_A 176 QIFSALHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNES 252 (345)
T ss_dssp HHHHHHHHHH---HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSC
T ss_pred HHHHHHHHHH---HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCC
Confidence 9999999999 88999999999999998766 8999999999866432221 12234569999999999875 67
Q ss_pred CCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHH
Q 002857 354 TSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSII 433 (873)
Q Consensus 354 ~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~ 433 (873)
++.++||||||+++|||++|+.||....... ....+......... ...
T Consensus 253 ~~~~~DiwslG~il~el~~g~~pf~~~~~~~-------------~~~~~~~~~~~~~~---------------~~~---- 300 (345)
T 3hko_A 253 YGPKCDAWSAGVLLHLLLMGAVPFPGVNDAD-------------TISQVLNKKLCFEN---------------PNY---- 300 (345)
T ss_dssp CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------------HHHHHHHCCCCTTS---------------GGG----
T ss_pred CCcHHHHHHHHHHHHHHHHCCCCCCCCChHH-------------HHHHHHhcccccCC---------------ccc----
Confidence 8999999999999999999999997532211 01111111110000 000
Q ss_pred HHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 434 LECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 434 ~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
......+.+++.+||+.||++|||+.|+++
T Consensus 301 ~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 330 (345)
T 3hko_A 301 NVLSPLARDLLSNLLNRNVDERFDAMRALQ 330 (345)
T ss_dssp GGSCHHHHHHHHHHSCSCTTTSCCHHHHHH
T ss_pred ccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 001234778999999999999999999876
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=346.90 Aligned_cols=253 Identities=21% Similarity=0.324 Sum_probs=199.9
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCC-------cEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccc
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGA-------PAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDY 231 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g-------~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~ 231 (873)
.++|.+.+.||+|+||.||+|++..++ ..||+|++........+.+.+|++++++++||||+++++++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~----- 81 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVC----- 81 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEE-----
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEE-----
Confidence 357899999999999999999987666 47999999766666668899999999999999999999996
Q ss_pred cCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCC
Q 002857 232 QGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDE 311 (873)
Q Consensus 232 ~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~ 311 (873)
...+..++||||+++|+|.+++.. ....+++..++.|+.||+.||+||| +.+|+||||||+|||++.+
T Consensus 82 ~~~~~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~ 149 (289)
T 4fvq_A 82 VCGDENILVQEFVKFGSLDTYLKK---------NKNCINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIRE 149 (289)
T ss_dssp CCTTCCEEEEECCTTCBHHHHHHH---------TGGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEEEC
T ss_pred EeCCCCEEEEECCCCCCHHHHHHh---------CCCCCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceEEEecC
Confidence 345667999999999999999953 2334889999999999999999999 8999999999999999988
Q ss_pred CC--------eEEeccccccccccccccccccccccccccCCCcccCC-CCCCcchhhHhHHHHHHHHHhCCCCCCcccc
Q 002857 312 MT--------ACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMG-HETSSYGDVYSFGILLLEMFTGLRPSDDMFK 382 (873)
Q Consensus 312 ~~--------vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~ 382 (873)
+. +||+|||++...... ....+|..|+|||++.+ ..++.++||||||+++|||++|..|+.....
T Consensus 150 ~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~ 223 (289)
T 4fvq_A 150 EDRKTGNPPFIKLSDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD 223 (289)
T ss_dssp CBGGGTBCCEEEECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred CcccccccceeeeccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccc
Confidence 87 999999999754221 22457899999999987 6789999999999999999996555432111
Q ss_pred cchhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHH
Q 002857 383 DNLNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVE 462 (873)
Q Consensus 383 ~~~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl 462 (873)
... . ....... ...+... ...+.+++.+||+.||++|||+.||+
T Consensus 224 ~~~-~------------~~~~~~~--------------~~~~~~~---------~~~l~~li~~~l~~dp~~Rps~~~ll 267 (289)
T 4fvq_A 224 SQR-K------------LQFYEDR--------------HQLPAPK---------AAELANLINNCMDYEPDHRPSFRAII 267 (289)
T ss_dssp HHH-H------------HHHHHTT--------------CCCCCCS---------SCTTHHHHHHHSCSSGGGSCCHHHHH
T ss_pred hHH-H------------HHHhhcc--------------CCCCCCC---------CHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 110 0 0000000 0000000 11367899999999999999999999
Q ss_pred HHHHHHHH
Q 002857 463 LGLRLIKK 470 (873)
Q Consensus 463 ~~Le~i~~ 470 (873)
+.|+.+..
T Consensus 268 ~~l~~l~~ 275 (289)
T 4fvq_A 268 RDLNSLFT 275 (289)
T ss_dssp HHHHTCC-
T ss_pred HHHHHhcC
Confidence 99997643
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=342.58 Aligned_cols=256 Identities=21% Similarity=0.343 Sum_probs=204.6
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccc-------
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDY------- 231 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~------- 231 (873)
.++|++.+.||+|+||.||+|.+..+++.||||+++... +.+.+|++++++++||||+++++++....+
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 85 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK 85 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence 357899999999999999999998889999999987432 467899999999999999999998743221
Q ss_pred ----cCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCee
Q 002857 232 ----QGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNIL 307 (873)
Q Consensus 232 ----~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNIL 307 (873)
......++||||+++|+|.+++.. .....+++..++.|+.||+.||.||| +.+|+||||||+|||
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~--------~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil 154 (284)
T 2a19_B 86 NSSRSKTKCLFIQMEFCDKGTLEQWIEK--------RRGEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIF 154 (284)
T ss_dssp ---CCEEEEEEEEECCCCSCBHHHHHHH--------GGGSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEE
T ss_pred cccccCcceEEEEEeccCCCCHHHHHhh--------ccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHEE
Confidence 124457999999999999999953 12356889999999999999999999 889999999999999
Q ss_pred eCCCCCeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhh
Q 002857 308 LNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNL 387 (873)
Q Consensus 308 Ld~~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l 387 (873)
++.++.+||+|||+++....... .....||..|+|||++.+..++.++||||||+++|||++|..|+....
T Consensus 155 ~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~------ 225 (284)
T 2a19_B 155 LVDTKQVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS------ 225 (284)
T ss_dssp EEETTEEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH------
T ss_pred EcCCCCEEECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH------
Confidence 99999999999999987644322 223458999999999999999999999999999999999998863210
Q ss_pred HHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHH
Q 002857 388 QNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRL 467 (873)
Q Consensus 388 ~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~ 467 (873)
. ....+.+..+... ....+.+++.+||+.||++|||+.||++.|+.
T Consensus 226 -~--------~~~~~~~~~~~~~-------------------------~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~ 271 (284)
T 2a19_B 226 -K--------FFTDLRDGIISDI-------------------------FDKKEKTLLQKLLSKKPEDRPNTSEILRTLTV 271 (284)
T ss_dssp -H--------HHHHHHTTCCCTT-------------------------SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -H--------HHHHhhccccccc-------------------------CCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 0 0011111111000 01236789999999999999999999999998
Q ss_pred HHHhh
Q 002857 468 IKKKL 472 (873)
Q Consensus 468 i~~~l 472 (873)
++...
T Consensus 272 ~~~~~ 276 (284)
T 2a19_B 272 WKKSP 276 (284)
T ss_dssp HTC--
T ss_pred HhhCC
Confidence 75433
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=372.08 Aligned_cols=260 Identities=24% Similarity=0.386 Sum_probs=205.8
Q ss_pred HHHhhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCC
Q 002857 155 LYSATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGN 234 (873)
Q Consensus 155 l~~at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~ 234 (873)
.....++|.+.+.||+|+||.||+|.+. ++..||||+++... ...+.|.+|+.+|++++||||+++++++. .
T Consensus 183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~------~ 254 (454)
T 1qcf_A 183 WEIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT------K 254 (454)
T ss_dssp SBCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC------S
T ss_pred eeechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe------C
Confidence 3445678899999999999999999884 56789999997543 34578999999999999999999999863 3
Q ss_pred ceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCe
Q 002857 235 DFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTA 314 (873)
Q Consensus 235 ~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~v 314 (873)
+..+|||||+++|+|.++|+. .....+++..++.|+.||+.||+||| +.+|+||||||+|||++.++.+
T Consensus 255 ~~~~lv~e~~~~g~L~~~l~~--------~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~ 323 (454)
T 1qcf_A 255 EPIYIITEFMAKGSLLDFLKS--------DEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVC 323 (454)
T ss_dssp SSCEEEECCCTTCBHHHHHHS--------HHHHTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCCE
T ss_pred CccEEEEeecCCCcHHHHHHh--------ccCCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEECCCCcE
Confidence 457999999999999999953 11235788899999999999999999 8899999999999999999999
Q ss_pred EEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHHHhh
Q 002857 315 CVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQS 393 (873)
Q Consensus 315 KLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~~~~ 393 (873)
||+|||+++...... ........++..|+|||++....++.++||||||+++|||+| |+.||....... .
T Consensus 324 kl~DFG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~--~------ 394 (454)
T 1qcf_A 324 KIADFGLARVIEDNE-YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE--V------ 394 (454)
T ss_dssp EECSTTGGGGBCCHH-HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--H------
T ss_pred EEeeCCCceEcCCCc-eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH--H------
Confidence 999999998764321 111223346788999999998899999999999999999999 999997532111 0
Q ss_pred cCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHHH
Q 002857 394 ALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLIK 469 (873)
Q Consensus 394 ~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i~ 469 (873)
...+.... ..+.. ..+...+.+|+.+||+.||++||||.+|++.|+.+.
T Consensus 395 ------~~~i~~~~--------------~~~~~-------~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~ 443 (454)
T 1qcf_A 395 ------IRALERGY--------------RMPRP-------ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFY 443 (454)
T ss_dssp ------HHHHHHTC--------------CCCCC-------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred ------HHHHHcCC--------------CCCCC-------CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 00000000 00000 012345889999999999999999999999998753
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=353.01 Aligned_cols=264 Identities=22% Similarity=0.313 Sum_probs=195.9
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCc---chhHHHHHHHHHHhhhhccceeeeeeeecccccCCc
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHD---ASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGND 235 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~---~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~ 235 (873)
.++|++.+.||+|+||.||+|++..+++.||||+++..... ....+.+|++++++++||||+++++++.... ....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~~ 89 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAGP 89 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEE-TTEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccC-CCCc
Confidence 46899999999999999999999999999999999754322 2356889999999999999999999875422 2223
Q ss_pred eEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeE
Q 002857 236 FKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTAC 315 (873)
Q Consensus 236 ~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vK 315 (873)
..++||||+++|+|.++++. ...+++.+++.|+.||+.||+||| +.+|+||||||+|||++.++.+|
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~----------~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~k 156 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHT----------EGPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVK 156 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHH----------HCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSCEE
T ss_pred ccEEEEecCCCCCHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCCEE
Confidence 46999999999999999953 346899999999999999999999 88999999999999999999999
Q ss_pred Eecccccccccccccc-ccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhc
Q 002857 316 VADFGIARFLEATNEQ-TSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSA 394 (873)
Q Consensus 316 LsDFGla~~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~ 394 (873)
|+|||+++.+...... .......||..|+|||++.+..++.++||||||+++|||+||+.||..........
T Consensus 157 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~------- 229 (311)
T 3ork_A 157 VMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY------- 229 (311)
T ss_dssp ECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH-------
T ss_pred EeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHH-------
Confidence 9999999866443221 22233568999999999999999999999999999999999999997632211100
Q ss_pred CchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHH-HHHHHH
Q 002857 395 LPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVE-LGLRLI 468 (873)
Q Consensus 395 ~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl-~~Le~i 468 (873)
..+...... . ..........+.+++.+||+.||++||++.+++ ..|..+
T Consensus 230 ------~~~~~~~~~-----------------~--~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 230 ------QHVREDPIP-----------------P--SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp ------HHHHCCCCC-----------------H--HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred ------HHhcCCCCC-----------------c--ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 000000000 0 000001123578899999999999999666544 455443
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=352.64 Aligned_cols=260 Identities=17% Similarity=0.150 Sum_probs=205.1
Q ss_pred HhhcCCCcceeecccCceEEEEEE-----EcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhh---hccceeeeeeeec
Q 002857 157 SATKGFSSENLIGAGNFASVYKGI-----LFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNII---HRKIIKVVTACSR 228 (873)
Q Consensus 157 ~at~~f~~~~~LG~G~fG~VYkg~-----~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~---HpNIV~llg~c~~ 228 (873)
...++|.+.++||+|+||.||+|. ...+++.||||+++.. ...++..|++++.+++ |+||+++++++
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~-- 136 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAH-- 136 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEE--
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheee--
Confidence 345789999999999999999994 5567889999998643 3467888888888886 99999999996
Q ss_pred ccccCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeee
Q 002857 229 VDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILL 308 (873)
Q Consensus 229 ~~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILL 308 (873)
...+..+|||||+++|+|.+++... .......+++..++.|+.||+.||+||| +.+|+||||||+|||+
T Consensus 137 ---~~~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NIll 205 (365)
T 3e7e_A 137 ---LFQNGSVLVGELYSYGTLLNAINLY-----KNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFIL 205 (365)
T ss_dssp ---ECSSCEEEEECCCCSCBHHHHHHHH-----HTSTTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEE
T ss_pred ---ecCCCcEEEEeccCCCcHHHHHHHh-----hcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEe
Confidence 4456789999999999999999531 1123567999999999999999999999 8999999999999999
Q ss_pred CC-----------CCCeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCC
Q 002857 309 ND-----------EMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPS 377 (873)
Q Consensus 309 d~-----------~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf 377 (873)
+. ++.+||+|||+++.+.............||..|+|||++.+..++.++|||||||++|||+||+.||
T Consensus 206 ~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 285 (365)
T 3e7e_A 206 GNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMK 285 (365)
T ss_dssp CGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCC
T ss_pred cccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCcc
Confidence 98 8999999999998654333333444567999999999999999999999999999999999999998
Q ss_pred CcccccchhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCC-C
Q 002857 378 DDMFKDNLNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGER-M 456 (873)
Q Consensus 378 ~~~~~~~~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eR-P 456 (873)
.......... ...+... +. .+.+.+++..|++.+|.+| |
T Consensus 286 ~~~~~~~~~~----------------~~~~~~~--------------~~----------~~~~~~~~~~~l~~~p~~r~~ 325 (365)
T 3e7e_A 286 VKNEGGECKP----------------EGLFRRL--------------PH----------LDMWNEFFHVMLNIPDCHHLP 325 (365)
T ss_dssp EEEETTEEEE----------------CSCCTTC--------------SS----------HHHHHHHHHHHHCCCCTTCCC
T ss_pred ccCCCCceee----------------chhcccc--------------Cc----------HHHHHHHHHHHcCCCCCCcch
Confidence 6532211000 0000000 00 1235678899999999998 6
Q ss_pred CHHHHHHHHHHHHHhh
Q 002857 457 KINDVELGLRLIKKKL 472 (873)
Q Consensus 457 Tm~EVl~~Le~i~~~l 472 (873)
++.++.+.|+.+....
T Consensus 326 ~~~~l~~~l~~~l~~~ 341 (365)
T 3e7e_A 326 SLDLLRQKLKKVFQQH 341 (365)
T ss_dssp CHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHh
Confidence 8899999998876654
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=346.58 Aligned_cols=276 Identities=21% Similarity=0.271 Sum_probs=198.6
Q ss_pred hhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCC--cchhHHHHHHHHHHhhhhccceeeeeeeecccccCCc
Q 002857 158 ATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH--DASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGND 235 (873)
Q Consensus 158 at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~ 235 (873)
..++|++.+.||+|+||.||+|++. +++.||||+++.... .....+.+|++++++++||||+++++++ ....
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~ 92 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI-----HSER 92 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEE-----CCSS
T ss_pred hHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEE-----ccCC
Confidence 4578999999999999999999984 588999999874322 2346789999999999999999999995 4566
Q ss_pred eEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeE
Q 002857 236 FKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTAC 315 (873)
Q Consensus 236 ~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vK 315 (873)
..++||||+++ +|.+++.. ....+++..++.++.||+.||+||| +.+|+||||||+|||++.++.+|
T Consensus 93 ~~~lv~e~~~~-~l~~~~~~---------~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~k 159 (311)
T 3niz_A 93 CLTLVFEFMEK-DLKKVLDE---------NKTGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALK 159 (311)
T ss_dssp CEEEEEECCSE-EHHHHHHT---------CTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEE
T ss_pred EEEEEEcCCCC-CHHHHHHh---------ccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCCCEE
Confidence 78999999975 88888742 3456899999999999999999999 89999999999999999999999
Q ss_pred EeccccccccccccccccccccccccccCCCcccCC-CCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHh--
Q 002857 316 VADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMG-HETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQ-- 392 (873)
Q Consensus 316 LsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~-- 392 (873)
|+|||+++...... .......+|..|+|||++.+ ..++.++||||||+++|||++|+.||........ +.....
T Consensus 160 l~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~i~~~~ 236 (311)
T 3niz_A 160 LADFGLARAFGIPV--RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ-LPKIFSIL 236 (311)
T ss_dssp ECCCTTCEETTSCC--C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH-HHHHHHHH
T ss_pred EccCcCceecCCCc--ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHH
Confidence 99999998654322 12223468999999999876 5689999999999999999999999976433221 111111
Q ss_pred -hcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 393 -SALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 393 -~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
...+..+....+..... .....................++.+++.+||+.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 237 GTPNPREWPQVQELPLWK--------QRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp CCCCTTTSGGGTTSHHHH--------SCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred CCCChHHhhhhhccchhh--------hcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 00000000000000000 0000000000001111112235789999999999999999999864
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=349.47 Aligned_cols=245 Identities=20% Similarity=0.219 Sum_probs=190.8
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCc--chhHHHHHHHHHHhh-hhccceeeeeeeecccccCCce
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHD--ASKSFTVECEVMRNI-IHRKIIKVVTACSRVDYQGNDF 236 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L-~HpNIV~llg~c~~~~~~~~~~ 236 (873)
++|++.++||+|+||+||+|++..+++.||||++...... ....+..|+..+.++ +|+||++++++| ..++.
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~-----~~~~~ 131 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAW-----EEGGI 131 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----EETTE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEE-----EeCCE
Confidence 5799999999999999999999989999999998643322 233556666666666 899999999996 44677
Q ss_pred EEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEE
Q 002857 237 KALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACV 316 (873)
Q Consensus 237 ~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKL 316 (873)
.+|||||+ +++|.+++.. ....+++..++.|+.||+.||+||| +.+|+||||||+|||++.++.+||
T Consensus 132 ~~lv~e~~-~~~L~~~~~~---------~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl 198 (311)
T 3p1a_A 132 LYLQTELC-GPSLQQHCEA---------WGASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKL 198 (311)
T ss_dssp EEEEEECC-CCBHHHHHHH---------HCSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECGGGCEEE
T ss_pred EEEEEecc-CCCHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEE
Confidence 99999999 7799998853 2346999999999999999999999 789999999999999999999999
Q ss_pred eccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCc
Q 002857 317 ADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALP 396 (873)
Q Consensus 317 sDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~ 396 (873)
+|||+++...... ......||..|+|||++.+ .++.++||||||+++|||++|..|+.... ..
T Consensus 199 ~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~----~~--------- 261 (311)
T 3p1a_A 199 GDFGLLVELGTAG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE----GW--------- 261 (311)
T ss_dssp CCCTTCEECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH----HH---------
T ss_pred ccceeeeecccCC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc----HH---------
Confidence 9999998654322 2223458999999999876 78999999999999999999977764311 01
Q ss_pred hhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 397 ERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 397 ~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
..+....+... ........+.+++.+||+.||++|||+.||++
T Consensus 262 ---~~~~~~~~~~~---------------------~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 262 ---QQLRQGYLPPE---------------------FTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp ---HHHTTTCCCHH---------------------HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ---HHHhccCCCcc---------------------cccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 11111111000 00011235788999999999999999999875
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=344.84 Aligned_cols=270 Identities=21% Similarity=0.294 Sum_probs=199.7
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC---CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCc
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH---HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGND 235 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~ 235 (873)
.++|.+.+.||+|+||.||+|.+..+++.||||+++... ......+.+|+.++++++|+||+++++++. ..+
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~ 105 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI-----EDN 105 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----ETT
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----cCC
Confidence 357899999999999999999998899999999987432 223467899999999999999999999963 456
Q ss_pred eEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeE
Q 002857 236 FKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTAC 315 (873)
Q Consensus 236 ~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vK 315 (873)
..++||||+++|+|.+++... ......+++..++.++.||+.||.||| +.+|+||||||+|||++.++.+|
T Consensus 106 ~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~~~k 176 (310)
T 2wqm_A 106 ELNIVLELADAGDLSRMIKHF------KKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVK 176 (310)
T ss_dssp EEEEEEECCCSCBHHHHHHHH------HHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEE
T ss_pred cEEEEEecCCCCCHHHHHHHh------cccccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCCCEE
Confidence 789999999999999998531 123456899999999999999999999 89999999999999999999999
Q ss_pred EeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcC
Q 002857 316 VADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSAL 395 (873)
Q Consensus 316 LsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~ 395 (873)
|+|||+++....... ......|+..|+|||++.+..++.++||||||+++|||++|+.||.........+...+
T Consensus 177 l~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---- 250 (310)
T 2wqm_A 177 LGDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI---- 250 (310)
T ss_dssp ECCC--------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHH----
T ss_pred EEeccceeeecCCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHh----
Confidence 999999986543221 12234689999999999999999999999999999999999999865321111111100
Q ss_pred chhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHHHHhhhcC
Q 002857 396 PERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLIKKKLLET 475 (873)
Q Consensus 396 ~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i~~~l~~~ 475 (873)
....+ .+... ......+.+++.+||+.||++|||+.+|++.|+.++......
T Consensus 251 -------~~~~~---------------~~~~~------~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~ 302 (310)
T 2wqm_A 251 -------EQCDY---------------PPLPS------DHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASS 302 (310)
T ss_dssp -------HTTCS---------------CCCCT------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC--
T ss_pred -------hcccC---------------CCCcc------cccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhh
Confidence 00000 00000 001234788999999999999999999999999998877544
Q ss_pred C
Q 002857 476 P 476 (873)
Q Consensus 476 ~ 476 (873)
+
T Consensus 303 ~ 303 (310)
T 2wqm_A 303 L 303 (310)
T ss_dssp -
T ss_pred h
Confidence 3
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=346.16 Aligned_cols=266 Identities=23% Similarity=0.280 Sum_probs=193.6
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhh-hccceeeeeeeeccc---ccCC
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNII-HRKIIKVVTACSRVD---YQGN 234 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~-HpNIV~llg~c~~~~---~~~~ 234 (873)
..+|++.++||+|+||.||+|++..+++.||||++........+.+.+|+.++.++. ||||+++++++.... ....
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 457899999999999999999998899999999987665555678999999999996 999999999874221 1345
Q ss_pred ceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCC--eeeccCCCCCeeeCCCC
Q 002857 235 DFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPP--IAHCDIKPSNILLNDEM 312 (873)
Q Consensus 235 ~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~g--IvHrDLKpsNILLd~~~ 312 (873)
...++||||+. |+|.+++... .....+++.+++.|+.||+.||+||| +.+ |+||||||+|||++.++
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~-------~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Dikp~NIl~~~~~ 175 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKM-------ESRGPLSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDLKVENLLLSNQG 175 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHH-------HTTCSCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCCCGGGCEECTTS
T ss_pred ceEEEEEEecC-CCHHHHHHHh-------hccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccCCcccEEECCCC
Confidence 56899999995 7999988531 23456999999999999999999999 778 99999999999999999
Q ss_pred CeEEeccccccccccccccc----------cccccccccccCCCccc---CCCCCCcchhhHhHHHHHHHHHhCCCCCCc
Q 002857 313 TACVADFGIARFLEATNEQT----------SSIGVKGTTGYIAPEYG---MGHETSSYGDVYSFGILLLEMFTGLRPSDD 379 (873)
Q Consensus 313 ~vKLsDFGla~~~~~~~~~~----------~~~~~~Gt~~Y~APE~l---~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~ 379 (873)
.+||+|||+++......... ......||..|+|||++ .+..++.++||||||+++|||+||+.||..
T Consensus 176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~ 255 (337)
T 3ll6_A 176 TIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED 255 (337)
T ss_dssp CEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--
T ss_pred CEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcc
Confidence 99999999998764432211 11134589999999998 566789999999999999999999999965
Q ss_pred ccccchhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHH
Q 002857 380 MFKDNLNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKIN 459 (873)
Q Consensus 380 ~~~~~~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~ 459 (873)
.... .++...... +.... ....+.+|+.+||+.||++|||+.
T Consensus 256 ~~~~-----------------~~~~~~~~~--------------~~~~~-------~~~~~~~li~~~l~~~p~~Rps~~ 297 (337)
T 3ll6_A 256 GAKL-----------------RIVNGKYSI--------------PPHDT-------QYTVFHSLIRAMLQVNPEERLSIA 297 (337)
T ss_dssp ---------------------------CCC--------------CTTCC-------SSGGGHHHHHHHSCSSGGGSCCHH
T ss_pred hhHH-----------------HhhcCcccC--------------Ccccc-------cchHHHHHHHHHccCChhhCcCHH
Confidence 2111 001000000 00000 011266899999999999999999
Q ss_pred HHHHHHHHHHHhhh
Q 002857 460 DVELGLRLIKKKLL 473 (873)
Q Consensus 460 EVl~~Le~i~~~l~ 473 (873)
||++.|+.+.....
T Consensus 298 e~l~~l~~~~~~~~ 311 (337)
T 3ll6_A 298 EVVHQLQEIAAARN 311 (337)
T ss_dssp HHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHhccC
Confidence 99999999876543
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=352.93 Aligned_cols=260 Identities=23% Similarity=0.402 Sum_probs=199.0
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcE----EEEEEeecc-CCcchhHHHHHHHHHHhhhhccceeeeeeeecccccC
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPA----VAIKVFNFL-HHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQG 233 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~----VAVK~l~~~-~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~ 233 (873)
.++|++.++||+|+||.||+|.+..+++. ||+|.+... .....+.+.+|+.++++++||||+++++++..
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----- 88 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT----- 88 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEES-----
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEec-----
Confidence 36799999999999999999998877765 467766533 33455789999999999999999999999742
Q ss_pred CceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCC
Q 002857 234 NDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMT 313 (873)
Q Consensus 234 ~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~ 313 (873)
...++|+||+.+|+|.+++.. ....+++..++.|+.||+.||+||| +.+|+||||||+|||++.++.
T Consensus 89 -~~~~~v~~~~~~g~L~~~l~~---------~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~ 155 (327)
T 3lzb_A 89 -STVQLITQLMPFGCLLDYVRE---------HKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQH 155 (327)
T ss_dssp -SSEEEEECCCSSCBHHHHHHH---------TTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTE
T ss_pred -CCceEEEEecCCCcHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEEcCCCC
Confidence 237899999999999999853 3456899999999999999999999 899999999999999999999
Q ss_pred eEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHHHh
Q 002857 314 ACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQ 392 (873)
Q Consensus 314 vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~~~ 392 (873)
+||+|||+++...............+|..|+|||++.+..++.++||||||+++|||++ |+.||.......
T Consensus 156 ~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-------- 227 (327)
T 3lzb_A 156 VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-------- 227 (327)
T ss_dssp EEECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--------
T ss_pred EEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--------
Confidence 99999999987654433333334457889999999999999999999999999999999 999997632221
Q ss_pred hcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHHHHh
Q 002857 393 SALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLIKKK 471 (873)
Q Consensus 393 ~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i~~~ 471 (873)
+...+.... ..+.... +...+.+++.+||+.||++|||+.||++.|+.+...
T Consensus 228 ------~~~~~~~~~--------------~~~~~~~-------~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 228 ------ISSILEKGE--------------RLPQPPI-------CTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp ------HHHHHHTTC--------------CCCCCTT-------BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred ------HHHHHHcCC--------------CCCCCcc-------CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 111111100 0000000 122477899999999999999999999999998653
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=354.45 Aligned_cols=252 Identities=24% Similarity=0.313 Sum_probs=187.0
Q ss_pred hhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceE
Q 002857 158 ATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFK 237 (873)
Q Consensus 158 at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~ 237 (873)
..++|.+.+.||+|+||.||+|++..+++.||||+++... ..+.+.+|++++++++||||+++++++ ......
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~ 123 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIF-----ETPTEI 123 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEE-----ECSSEE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeE-----ecCCeE
Confidence 4578999999999999999999998889999999997443 346788999999999999999999996 446679
Q ss_pred EEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCC---CCCe
Q 002857 238 ALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLND---EMTA 314 (873)
Q Consensus 238 ~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~---~~~v 314 (873)
++||||+++|+|.+++. ....+++.+++.++.||+.||.||| +.+|+||||||+|||++. ++.+
T Consensus 124 ~lv~e~~~~~~L~~~l~----------~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~ 190 (349)
T 2w4o_A 124 SLVLELVTGGELFDRIV----------EKGYYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPL 190 (349)
T ss_dssp EEEECCCCSCBHHHHHT----------TCSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCE
T ss_pred EEEEEeCCCCCHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCE
Confidence 99999999999999984 2456899999999999999999999 889999999999999975 8899
Q ss_pred EEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhc
Q 002857 315 CVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSA 394 (873)
Q Consensus 315 KLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~ 394 (873)
||+|||+++...... ......||..|+|||++.+..++.++|||||||++|||++|+.||.........+
T Consensus 191 kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~------- 260 (349)
T 2w4o_A 191 KIADFGLSKIVEHQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMF------- 260 (349)
T ss_dssp EECCCC-------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHH-------
T ss_pred EEccCccccccCccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHH-------
Confidence 999999998654321 1223568999999999999999999999999999999999999996532221111
Q ss_pred CchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 395 LPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 395 ~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
..+....... ..++.. +....+.+++.+||+.||++|||+.|+++
T Consensus 261 -----~~i~~~~~~~------------~~~~~~-------~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 261 -----RRILNCEYYF------------ISPWWD-------EVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp -----HHHHTTCCCC------------CTTTTT-------TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -----HHHHhCCCcc------------CCchhh-------hCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1111110000 000000 11234778999999999999999998864
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=355.74 Aligned_cols=268 Identities=15% Similarity=0.169 Sum_probs=204.0
Q ss_pred cCCCcceeecccCceEEEEEEEcC--------CCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhcccee----------
Q 002857 160 KGFSSENLIGAGNFASVYKGILFE--------GAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIK---------- 221 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~--------~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~---------- 221 (873)
++|.+.+.||+|+||.||+|++.. .++.||||++... +.+.+|++++++++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 579999999999999999999876 4789999998733 57899999999999999998
Q ss_pred -----eeeeeecccccCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCe
Q 002857 222 -----VVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPI 296 (873)
Q Consensus 222 -----llg~c~~~~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gI 296 (873)
+++++. ..+...++||||+ +++|.+++.. .....+++.+++.|+.||+.||+||| +.+|
T Consensus 117 ~~i~~~~~~~~----~~~~~~~lv~e~~-~~~L~~~l~~--------~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~i 180 (352)
T 2jii_A 117 LAIPTCMGFGV----HQDKYRFLVLPSL-GRSLQSALDV--------SPKHVLSERSVLQVACRLLDALEFLH---ENEY 180 (352)
T ss_dssp CSCCCCCEEEE----ETTTEEEEEEECC-CEEHHHHHHH--------SGGGCCCHHHHHHHHHHHHHHHHHHH---HTTC
T ss_pred cCccchhhccc----cCCcEEEEEecCC-CcCHHHHHHh--------CCcCCCCHHHHHHHHHHHHHHHHHHH---hCCc
Confidence 444432 2357789999999 9999999953 12356899999999999999999999 8899
Q ss_pred eeccCCCCCeeeCCCC--CeEEeccccccccccccccc-----cccccccccccCCCcccCCCCCCcchhhHhHHHHHHH
Q 002857 297 AHCDIKPSNILLNDEM--TACVADFGIARFLEATNEQT-----SSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLE 369 (873)
Q Consensus 297 vHrDLKpsNILLd~~~--~vKLsDFGla~~~~~~~~~~-----~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~E 369 (873)
+||||||+|||++.++ .+||+|||+++.+....... ......||..|+|||++.+..++.++||||||+++||
T Consensus 181 vH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~e 260 (352)
T 2jii_A 181 VHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLK 260 (352)
T ss_dssp BCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHH
T ss_pred cCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHH
Confidence 9999999999999998 99999999998765432211 1123469999999999999999999999999999999
Q ss_pred HHhCCCCCCcccccchhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhc
Q 002857 370 MFTGLRPSDDMFKDNLNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSA 449 (873)
Q Consensus 370 LlTGk~Pf~~~~~~~~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~ 449 (873)
|++|+.||.........+..... .+... ... +....... ......+.+++.+||+
T Consensus 261 l~~g~~pf~~~~~~~~~~~~~~~--------~~~~~-~~~----------~~~~~~~~------~~~~~~l~~li~~~l~ 315 (352)
T 2jii_A 261 WLYGFLPWTNCLPNTEDIMKQKQ--------KFVDK-PGP----------FVGPCGHW------IRPSETLQKYLKVVMA 315 (352)
T ss_dssp HHHSCCTTGGGTTCHHHHHHHHH--------HHHHS-CCC----------EECTTSCE------ECCCHHHHHHHHHHHT
T ss_pred HHhCCCCcccCCcCHHHHHHHHH--------hccCC-hhh----------hhhhcccc------CCCcHHHHHHHHHHHh
Confidence 99999999764322111111100 00000 000 00000000 0012347889999999
Q ss_pred cCcCCCCCHHHHHHHHHHHHHhhh
Q 002857 450 ELPGERMKINDVELGLRLIKKKLL 473 (873)
Q Consensus 450 ~dP~eRPTm~EVl~~Le~i~~~l~ 473 (873)
.||++|||+.+|++.|+.+.....
T Consensus 316 ~dp~~Rps~~~l~~~L~~~~~~~~ 339 (352)
T 2jii_A 316 LTYEEKPPYAMLRNNLEALLQDLR 339 (352)
T ss_dssp CCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred CChhhCCCHHHHHHHHHHHHHhcC
Confidence 999999999999999999877664
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=337.38 Aligned_cols=257 Identities=28% Similarity=0.410 Sum_probs=205.2
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEE
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKA 238 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~ 238 (873)
.++|++.+.||+|+||.||+|.+. +++.||+|++..... ..+.+.+|++++++++||||+++++++ ...+..+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 79 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVC-----LEQAPIC 79 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEE-----CSSSSCE
T ss_pred hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEE-----ccCCCeE
Confidence 357889999999999999999885 667899999975443 346899999999999999999999996 3456789
Q ss_pred EEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEec
Q 002857 239 LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVAD 318 (873)
Q Consensus 239 LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsD 318 (873)
+||||+++++|.+++.. ....+++..++.++.||+.||+||| +.+|+||||||+||+++.++.+||+|
T Consensus 80 lv~e~~~~~~L~~~~~~---------~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~d 147 (267)
T 3t9t_A 80 LVTEFMEHGCLSDYLRT---------QRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSD 147 (267)
T ss_dssp EEECCCTTCBHHHHHHH---------TTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECC
T ss_pred EEEeCCCCCcHHHHHhh---------CcccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEECCCCCEEEcc
Confidence 99999999999999953 2356889999999999999999999 89999999999999999999999999
Q ss_pred cccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHHHhhcCch
Q 002857 319 FGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQSALPE 397 (873)
Q Consensus 319 FGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~~~~~~~~ 397 (873)
||+++...... ........++..|+|||++.+..++.++||||||+++|||++ |+.||....... ..
T Consensus 148 fg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~--------- 215 (267)
T 3t9t_A 148 FGMTRFVLDDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VV--------- 215 (267)
T ss_dssp TTGGGGBCCHH-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HH---------
T ss_pred ccccccccccc-ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH--HH---------
Confidence 99998654321 111223457788999999988889999999999999999999 899987532111 00
Q ss_pred hHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHHHH
Q 002857 398 RVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLIKK 470 (873)
Q Consensus 398 ~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i~~ 470 (873)
..+... ... ..+. .....+.+++.+||+.||++|||+.|+++.|+.+.+
T Consensus 216 --~~i~~~-~~~------------~~~~---------~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 216 --EDISTG-FRL------------YKPR---------LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp --HHHHTT-CCC------------CCCT---------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --HHHhcC-CcC------------CCCc---------cCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 011000 000 0000 012247789999999999999999999999999865
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=354.77 Aligned_cols=253 Identities=21% Similarity=0.306 Sum_probs=201.4
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCC--cchhHHHHHHHHHHhhhhccceeeeeeeecccccCCce
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH--DASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDF 236 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~ 236 (873)
.++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+.++++++||||+++++++ ...+.
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~~ 102 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEESF 102 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSSE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeCCE
Confidence 4679999999999999999999998999999999975432 2346788999999999999999999995 45678
Q ss_pred EEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCC---CC
Q 002857 237 KALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDE---MT 313 (873)
Q Consensus 237 ~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~---~~ 313 (873)
.++||||+++|+|.+++. ....+++..++.++.||+.||+||| +.+|+||||||+|||++.+ +.
T Consensus 103 ~~lv~e~~~gg~L~~~l~----------~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~ 169 (362)
T 2bdw_A 103 HYLVFDLVTGGELFEDIV----------AREFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAA 169 (362)
T ss_dssp EEEEECCCCSCBHHHHHT----------TCSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEESCSSTTCC
T ss_pred EEEEEecCCCCCHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCC
Confidence 899999999999999984 2456899999999999999999999 8899999999999999865 45
Q ss_pred eEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhh
Q 002857 314 ACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQS 393 (873)
Q Consensus 314 vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~ 393 (873)
+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+..
T Consensus 170 ~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~--~~~~---- 240 (362)
T 2bdw_A 170 VKLADFGLAIEVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH--RLYA---- 240 (362)
T ss_dssp EEECCCTTCBCCTTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHH----
T ss_pred EEEeecCcceEecCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH--HHHH----
Confidence 9999999998664322 223356999999999999999999999999999999999999999653211 0110
Q ss_pred cCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHH
Q 002857 394 ALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELG 464 (873)
Q Consensus 394 ~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~ 464 (873)
.+....+. .+.. .. ......+.+++.+||+.||++|||+.|+++.
T Consensus 241 -------~i~~~~~~--------------~~~~-~~----~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 241 -------QIKAGAYD--------------YPSP-EW----DTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp -------HHHHTCCC--------------CCTT-GG----GGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred -------HHHhCCCC--------------CCcc-cc----cCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11100000 0000 00 0112347789999999999999999998753
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=337.18 Aligned_cols=252 Identities=22% Similarity=0.260 Sum_probs=202.9
Q ss_pred hhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceE
Q 002857 158 ATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFK 237 (873)
Q Consensus 158 at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~ 237 (873)
..++|.+.+.||+|+||.||+|.+..++..||+|++........+.+.+|++++++++||||+++++++ ......
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~ 81 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF-----EDNTDI 81 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSSEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEE-----ecCCeE
Confidence 346799999999999999999999989999999999876666678899999999999999999999996 456778
Q ss_pred EEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeee---CCCCCe
Q 002857 238 ALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILL---NDEMTA 314 (873)
Q Consensus 238 ~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILL---d~~~~v 314 (873)
++||||+++++|.+++.. ...+++..++.|+.||+.||+||| +.+|+||||||+|||+ +.++.+
T Consensus 82 ~lv~e~~~~~~L~~~~~~----------~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~ 148 (277)
T 3f3z_A 82 YLVMELCTGGELFERVVH----------KRVFRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPL 148 (277)
T ss_dssp EEEEECCCSCBHHHHHHH----------HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCE
T ss_pred EEEEeccCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEecCCCCCcE
Confidence 999999999999998842 345899999999999999999999 8999999999999999 788999
Q ss_pred EEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhc
Q 002857 315 CVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSA 394 (873)
Q Consensus 315 KLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~ 394 (873)
||+|||++....... ......||..|+|||++.+. ++.++||||||+++|||++|+.||....... ..
T Consensus 149 ~l~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~------ 216 (277)
T 3f3z_A 149 KLIDFGLAARFKPGK---MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSE--VM------ 216 (277)
T ss_dssp EECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HH------
T ss_pred EEEecccceeccCcc---chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHH--HH------
Confidence 999999998664332 22234589999999998765 8999999999999999999999997632111 00
Q ss_pred CchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 395 LPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 395 ~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
..+........ ..........+.+++.+||+.||++|||+.|+++
T Consensus 217 -----~~~~~~~~~~~-------------------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 217 -----LKIREGTFTFP-------------------EKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp -----HHHHHCCCCCC-------------------HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred -----HHHHhCCCCCC-------------------chhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 01111000000 0000011235788999999999999999999875
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-39 Score=350.21 Aligned_cols=278 Identities=23% Similarity=0.378 Sum_probs=210.5
Q ss_pred hcCCCcceeecccCceEEEEEEE----cCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCC
Q 002857 159 TKGFSSENLIGAGNFASVYKGIL----FEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGN 234 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~----~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~ 234 (873)
.++|++.+.||+|+||.||+|++ ..+++.||||++........+.+.+|++++++++|+||+++++++.. ...
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~~ 116 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYS---AGR 116 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC------
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe---cCC
Confidence 35688999999999999999984 45788999999986655566789999999999999999999998642 223
Q ss_pred ceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCe
Q 002857 235 DFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTA 314 (873)
Q Consensus 235 ~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~v 314 (873)
...++||||+++++|.+++.. ....+++.+++.++.||+.||+||| +.+|+||||||+|||++.++.+
T Consensus 117 ~~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~ 184 (326)
T 2w1i_A 117 RNLKLIMEYLPYGSLRDYLQK---------HKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRV 184 (326)
T ss_dssp -CCEEEECCCTTCBHHHHHHH---------STTSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEE
T ss_pred CceEEEEECCCCCCHHHHHHh---------cccCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEEcCCCcE
Confidence 467999999999999999953 2346899999999999999999999 8999999999999999999999
Q ss_pred EEeccccccccccccccc-cccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhh
Q 002857 315 CVADFGIARFLEATNEQT-SSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQS 393 (873)
Q Consensus 315 KLsDFGla~~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~ 393 (873)
||+|||+++......... ......++..|+|||++.+..++.++||||||+++|||+||..||...... +......
T Consensus 185 kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~---~~~~~~~ 261 (326)
T 2w1i_A 185 KIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE---FMRMIGN 261 (326)
T ss_dssp EECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHH---HHHHHCT
T ss_pred EEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHH---HHHhhcc
Confidence 999999998765433211 122234778899999998888999999999999999999999987642111 1111100
Q ss_pred cCch-h-HHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHHHHh
Q 002857 394 ALPE-R-VEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLIKKK 471 (873)
Q Consensus 394 ~~~~-~-l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i~~~ 471 (873)
.... . ...+.+ .+.. ....+... .+...+.+++.+||+.||++|||+.||++.|+.+++.
T Consensus 262 ~~~~~~~~~~~~~-~~~~----------~~~~~~~~-------~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 262 DKQGQMIVFHLIE-LLKN----------NGRLPRPD-------GCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp TCCTHHHHHHHHH-HHHT----------TCCCCCCT-------TCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ccchhhhHHHHHH-Hhhc----------CCCCCCCC-------cccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 0000 0 001100 0000 00011110 1234588999999999999999999999999999876
Q ss_pred h
Q 002857 472 L 472 (873)
Q Consensus 472 l 472 (873)
+
T Consensus 324 l 324 (326)
T 2w1i_A 324 M 324 (326)
T ss_dssp H
T ss_pred h
Confidence 5
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=349.84 Aligned_cols=272 Identities=21% Similarity=0.335 Sum_probs=207.5
Q ss_pred hcCCCcceeecccCceEEEEEEEc-------CCCcEEEEEEeeccCC-cchhHHHHHHHHHHhh-hhccceeeeeeeecc
Q 002857 159 TKGFSSENLIGAGNFASVYKGILF-------EGAPAVAIKVFNFLHH-DASKSFTVECEVMRNI-IHRKIIKVVTACSRV 229 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~-------~~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L-~HpNIV~llg~c~~~ 229 (873)
.++|.+.+.||+|+||.||+|.+. .++..||||+++.... ...+.+.+|+++++++ +||||+++++++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~--- 110 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC--- 110 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE---
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE---
Confidence 468899999999999999999875 3567899999975432 2346789999999999 899999999996
Q ss_pred cccCCceEEEEEeecCCCChhhhcccccccc------cccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCC
Q 002857 230 DYQGNDFKALVYEFMPNGSLEEWIHPITEED------KRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKP 303 (873)
Q Consensus 230 ~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~------~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKp 303 (873)
...+..++||||+++|+|.+++....... ........+++..++.++.||+.||+||| +.+|+||||||
T Consensus 111 --~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp 185 (334)
T 2pvf_A 111 --TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAA 185 (334)
T ss_dssp --CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSG
T ss_pred --ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCcc
Confidence 44567899999999999999996411100 00011235899999999999999999999 88999999999
Q ss_pred CCeeeCCCCCeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccc
Q 002857 304 SNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFK 382 (873)
Q Consensus 304 sNILLd~~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~ 382 (873)
+|||++.++.+||+|||+++...............+|..|+|||++.+..++.++||||||+++|||+| |+.||.....
T Consensus 186 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 265 (334)
T 2pvf_A 186 RNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 265 (334)
T ss_dssp GGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred ceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH
Confidence 999999999999999999987654332223333457889999999988889999999999999999999 9999865321
Q ss_pred cchhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHH
Q 002857 383 DNLNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVE 462 (873)
Q Consensus 383 ~~~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl 462 (873)
.. +.. .+..... .+... .+...+.+++.+||+.+|++|||+.||+
T Consensus 266 ~~--~~~------------~~~~~~~--------------~~~~~-------~~~~~l~~li~~~l~~dp~~Rps~~ell 310 (334)
T 2pvf_A 266 EE--LFK------------LLKEGHR--------------MDKPA-------NCTNELYMMMRDCWHAVPSQRPTFKQLV 310 (334)
T ss_dssp HH--HHH------------HHHHTCC--------------CCCCT-------TCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HH--HHH------------HHhcCCC--------------CCCCc-------cCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 11 000 0000000 00000 1123478899999999999999999999
Q ss_pred HHHHHHHHhhh
Q 002857 463 LGLRLIKKKLL 473 (873)
Q Consensus 463 ~~Le~i~~~l~ 473 (873)
+.|+.+.....
T Consensus 311 ~~L~~l~~~~~ 321 (334)
T 2pvf_A 311 EDLDRILTLTT 321 (334)
T ss_dssp HHHHHHHHHHC
T ss_pred HHHHHHHhccc
Confidence 99999877553
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=346.96 Aligned_cols=280 Identities=23% Similarity=0.349 Sum_probs=207.8
Q ss_pred HHHHHHhhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHh--hhhccceeeeeeeecc
Q 002857 152 YEALYSATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRN--IIHRKIIKVVTACSRV 229 (873)
Q Consensus 152 ~~el~~at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~--L~HpNIV~llg~c~~~ 229 (873)
+..-....++|.+.+.||+|+||.||+|++ +++.||||+++. .....+.+|++++.. ++||||+++++++...
T Consensus 34 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~ 108 (342)
T 1b6c_B 34 LLVQRTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAADNKD 108 (342)
T ss_dssp HHHHHHHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECG---GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECC
T ss_pred eeecccccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCc---hhHHHHHHHHHHHHHhhcCCCcEEEEEeeeccc
Confidence 333344567899999999999999999987 588999999863 234678889999988 7899999999997432
Q ss_pred cccCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCC-----CCCeeeccCCCC
Q 002857 230 DYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGC-----KPPIAHCDIKPS 304 (873)
Q Consensus 230 ~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~-----s~gIvHrDLKps 304 (873)
. ......++||||+++|+|.+++.. ..+++.+++.++.||+.||+|||... +.+|+||||||+
T Consensus 109 ~-~~~~~~~lv~e~~~~g~L~~~l~~-----------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~ 176 (342)
T 1b6c_B 109 N-GTWTQLWLVSDYHEHGSLFDYLNR-----------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSK 176 (342)
T ss_dssp C-SSCCCEEEEECCCTTCBHHHHHHH-----------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGG
T ss_pred C-CccceeEEEEeecCCCcHHHHHhc-----------cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHH
Confidence 1 111378999999999999999942 35889999999999999999999321 478999999999
Q ss_pred CeeeCCCCCeEEeccccccccccccccc--cccccccccccCCCcccCCC------CCCcchhhHhHHHHHHHHHhC---
Q 002857 305 NILLNDEMTACVADFGIARFLEATNEQT--SSIGVKGTTGYIAPEYGMGH------ETSSYGDVYSFGILLLEMFTG--- 373 (873)
Q Consensus 305 NILLd~~~~vKLsDFGla~~~~~~~~~~--~~~~~~Gt~~Y~APE~l~~~------~~s~ksDVwSfGvvL~ELlTG--- 373 (873)
|||++.++.+||+|||+++......... ......||..|+|||++.+. .++.++||||||+++|||+||
T Consensus 177 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~ 256 (342)
T 1b6c_B 177 NILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI 256 (342)
T ss_dssp GEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCB
T ss_pred HEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCc
Confidence 9999999999999999998765433211 12334689999999998776 334789999999999999999
Q ss_pred -------CCCCCcccccchhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHH
Q 002857 374 -------LRPSDDMFKDNLNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVA 446 (873)
Q Consensus 374 -------k~Pf~~~~~~~~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~ 446 (873)
+.||............+.. .+....+... ... .....++...+.+++.+
T Consensus 257 ~~~~~~~~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~---------------~~~-~~~~~~~~~~l~~li~~ 312 (342)
T 1b6c_B 257 GGIHEDYQLPYYDLVPSDPSVEEMRK--------VVCEQKLRPN---------------IPN-RWQSCEALRVMAKIMRE 312 (342)
T ss_dssp TTBCCCCCCTTTTTSCSSCCHHHHHH--------HHTTSCCCCC---------------CCG-GGGTSHHHHHHHHHHHH
T ss_pred CCcccccccCccccCcCcccHHHHHH--------HHHHHHhCCC---------------Ccc-cccchhHHHHHHHHHHH
Confidence 6676543221111111110 0111111100 000 00012345578899999
Q ss_pred hhccCcCCCCCHHHHHHHHHHHHHhh
Q 002857 447 CSAELPGERMKINDVELGLRLIKKKL 472 (873)
Q Consensus 447 CL~~dP~eRPTm~EVl~~Le~i~~~l 472 (873)
||+.||++|||+.||++.|+.+.++.
T Consensus 313 cl~~dp~~Rps~~~i~~~L~~i~~~~ 338 (342)
T 1b6c_B 313 CWYANGAARLTALRIKKTLSQLSQQE 338 (342)
T ss_dssp HCCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred HhccChhhCCCHHHHHHHHHHHHHHh
Confidence 99999999999999999999987643
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=364.89 Aligned_cols=201 Identities=24% Similarity=0.345 Sum_probs=158.9
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCC--cchhHHHHHHHHHHhhhhccceeeeeeeecccccCCce
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH--DASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDF 236 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~ 236 (873)
.++|.+.++||+|+||.||+|++..+++.||||++..... ...+.+.+|+++|++++|+|||++++++..........
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 4689999999999999999999999999999999864322 23467899999999999999999999986544445567
Q ss_pred EEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEE
Q 002857 237 KALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACV 316 (873)
Q Consensus 237 ~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKL 316 (873)
.++||||+ +|+|.+++. ....+++..+..|+.||+.||+||| +.+|+||||||+||||+.++.+||
T Consensus 132 ~~lv~e~~-~~~L~~~~~----------~~~~l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~~~~kl 197 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFR----------TPVYLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKV 197 (458)
T ss_dssp EEEEECCC-SEEHHHHHH----------SSCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEE
T ss_pred EEEEEecc-ccchhhhcc----------cCCCCCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEECCCCCEee
Confidence 99999998 579999884 3456999999999999999999999 889999999999999999999999
Q ss_pred ecccccccccccccc-------------------------ccccccccccccCCCccc-CCCCCCcchhhHhHHHHHHHH
Q 002857 317 ADFGIARFLEATNEQ-------------------------TSSIGVKGTTGYIAPEYG-MGHETSSYGDVYSFGILLLEM 370 (873)
Q Consensus 317 sDFGla~~~~~~~~~-------------------------~~~~~~~Gt~~Y~APE~l-~~~~~s~ksDVwSfGvvL~EL 370 (873)
+|||+++........ .......||..|+|||++ .+..++.++|||||||++|||
T Consensus 198 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~el 277 (458)
T 3rp9_A 198 CDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAEL 277 (458)
T ss_dssp CCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHH
T ss_pred cccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHH
Confidence 999999876432111 122345689999999975 556799999999999999999
Q ss_pred HhC
Q 002857 371 FTG 373 (873)
Q Consensus 371 lTG 373 (873)
+||
T Consensus 278 ltg 280 (458)
T 3rp9_A 278 LNM 280 (458)
T ss_dssp HTT
T ss_pred HHh
Confidence 994
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=343.76 Aligned_cols=277 Identities=20% Similarity=0.260 Sum_probs=197.8
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCc--chhHHHHHHHHHHhhhhccceeeeeeeecccccCCceE
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHD--ASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFK 237 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~ 237 (873)
++|++.+.||+|+||.||+|++..+++.||||++...... ..+.+.+|++++++++||||+++++++ ...+..
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~ 77 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVF-----RRKRRL 77 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----EETTEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhhee-----ecCCeE
Confidence 6799999999999999999999888999999998644332 245688999999999999999999996 345678
Q ss_pred EEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEe
Q 002857 238 ALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVA 317 (873)
Q Consensus 238 ~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLs 317 (873)
++||||+++++|.+++. ....+++..+..|+.|++.||+||| +.+|+||||||+|||++.++.+||+
T Consensus 78 ~lv~e~~~~~~l~~~~~----------~~~~~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~ 144 (311)
T 4agu_A 78 HLVFEYCDHTVLHELDR----------YQRGVPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLC 144 (311)
T ss_dssp EEEEECCSEEHHHHHHH----------TSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEEC
T ss_pred EEEEEeCCCchHHHHHh----------hhcCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCEEEe
Confidence 99999999999999874 2456899999999999999999999 8999999999999999999999999
Q ss_pred ccccccccccccccccccccccccccCCCcccCC-CCCCcchhhHhHHHHHHHHHhCCCCCCcccccch-hhHHHHhhcC
Q 002857 318 DFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMG-HETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNL-NLQNWVQSAL 395 (873)
Q Consensus 318 DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~-~l~~~~~~~~ 395 (873)
|||+++....... ......||..|+|||++.+ ..++.++||||||+++|||+||+.||........ ..........
T Consensus 145 Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 222 (311)
T 4agu_A 145 DFGFARLLTGPSD--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDL 222 (311)
T ss_dssp CCTTCEECC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSC
T ss_pred eCCCchhccCccc--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccc
Confidence 9999987643222 1223468999999999876 5689999999999999999999999976432211 0000000111
Q ss_pred chhHHHHhh-hhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 396 PERVEEIVD-TLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 396 ~~~l~elid-~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
.+....... ....... .+...................+.+++.+||+.||++|||+.||++
T Consensus 223 ~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 223 IPRHQQVFSTNQYFSGV-------KIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp CHHHHHHHHTCGGGTTC-------CCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred ccccccccccccccccC-------cCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 111111110 0000000 000000000000001122345789999999999999999999875
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=360.41 Aligned_cols=244 Identities=24% Similarity=0.296 Sum_probs=193.9
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeecc---CCcchhHHHHHHHHHHhh-hhccceeeeeeeecccccCC
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFL---HHDASKSFTVECEVMRNI-IHRKIIKVVTACSRVDYQGN 234 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~L-~HpNIV~llg~c~~~~~~~~ 234 (873)
.++|++.+.||+|+||.||+|++..+++.||||+++.. .....+.+.+|+.+++.+ +||||+++++++ ...
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~-----~~~ 96 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCF-----QTP 96 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECS
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEE-----EeC
Confidence 46899999999999999999999999999999999743 223446688999999998 799999999995 556
Q ss_pred ceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCe
Q 002857 235 DFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTA 314 (873)
Q Consensus 235 ~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~v 314 (873)
+..+|||||+++|+|.+++.. ...+++..++.++.||+.||+||| +.+|+||||||+|||++.++++
T Consensus 97 ~~~~lv~E~~~gg~L~~~l~~----------~~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~i 163 (353)
T 3txo_A 97 DRLFFVMEFVNGGDLMFHIQK----------SRRFDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHC 163 (353)
T ss_dssp SEEEEEEECCCSCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCE
T ss_pred CEEEEEEeCCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCCE
Confidence 789999999999999999843 346899999999999999999999 8999999999999999999999
Q ss_pred EEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhc
Q 002857 315 CVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSA 394 (873)
Q Consensus 315 KLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~ 394 (873)
||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 164 kL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~---------- 231 (353)
T 3txo_A 164 KLADFGMCKEGICNG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD---------- 231 (353)
T ss_dssp EECCCTTCBCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----------
T ss_pred EEccccceeecccCC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH----------
Confidence 999999998543221 22334569999999999998889999999999999999999999997532111
Q ss_pred CchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCH
Q 002857 395 LPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKI 458 (873)
Q Consensus 395 ~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm 458 (873)
+....+.... ..|.. ....+.+++.+||+.||++||++
T Consensus 232 -------~~~~i~~~~~----------~~p~~---------~~~~~~~li~~lL~~dP~~R~~~ 269 (353)
T 3txo_A 232 -------LFEAILNDEV----------VYPTW---------LHEDATGILKSFMTKNPTMRLGS 269 (353)
T ss_dssp -------HHHHHHHCCC----------CCCTT---------SCHHHHHHHHHHTCSSGGGSTTS
T ss_pred -------HHHHHHcCCC----------CCCCC---------CCHHHHHHHHHHhhhCHHHccCC
Confidence 1111111100 00100 12247789999999999999998
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=345.17 Aligned_cols=252 Identities=20% Similarity=0.287 Sum_probs=202.0
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCc------chhHHHHHHHHHHhhhhccceeeeeeeeccccc
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHD------ASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQ 232 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~------~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~ 232 (873)
.++|.+.+.||+|+||.||+|++..+++.||||+++..... ..+.+.+|+.++++++||||+++++++ .
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~ 85 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVY-----E 85 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----E
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEE-----e
Confidence 45789999999999999999999989999999999754322 246799999999999999999999996 4
Q ss_pred CCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCC
Q 002857 233 GNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEM 312 (873)
Q Consensus 233 ~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~ 312 (873)
.....++||||+++++|.+++. ....+++..++.++.||+.||+||| +.+|+||||||+|||++.++
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~----------~~~~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~~ 152 (321)
T 2a2a_A 86 NRTDVVLILELVSGGELFDFLA----------QKESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKN 152 (321)
T ss_dssp CSSEEEEEECCCCSCBHHHHHH----------TCSCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTT
T ss_pred cCCEEEEEEEcCCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecCC
Confidence 5667999999999999999994 2456899999999999999999999 88999999999999999887
Q ss_pred ----CeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhH
Q 002857 313 ----TACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQ 388 (873)
Q Consensus 313 ----~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~ 388 (873)
.+||+|||+++....... .....||..|+|||++.+..++.++||||||+++|||++|+.||....... ..
T Consensus 153 ~~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~ 227 (321)
T 2a2a_A 153 IPIPHIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE--TL 227 (321)
T ss_dssp SSSCCEEECCCTTCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH--HH
T ss_pred CCcCCEEEccCccceecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHH--HH
Confidence 799999999986644321 223468999999999999999999999999999999999999996532111 00
Q ss_pred HHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 389 NWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 389 ~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
..+...... .. ..........+.+++.+||+.||++|||+.|+++
T Consensus 228 -----------~~i~~~~~~--~~-----------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 228 -----------ANITSVSYD--FD-----------------EEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp -----------HHHHTTCCC--CC-----------------HHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred -----------HHHHhcccc--cC-----------------hhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 011100000 00 0000111234778999999999999999999875
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=359.65 Aligned_cols=253 Identities=19% Similarity=0.241 Sum_probs=202.8
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEE
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKA 238 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~ 238 (873)
.++|++.+.||+|+||.||+|.+..+++.||+|++..........+.+|+++|++++||||+++++++ ......+
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~~~~ 124 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF-----EDKYEMV 124 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEE-----ECSSEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEE-----EeCCEEE
Confidence 46799999999999999999999999999999999765544556799999999999999999999996 4567899
Q ss_pred EEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCC--CCCeEE
Q 002857 239 LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLND--EMTACV 316 (873)
Q Consensus 239 LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~--~~~vKL 316 (873)
+||||+++|+|.+++.. ....+++..++.++.||+.||+||| +.+|+||||||+|||++. ++.+||
T Consensus 125 lv~E~~~gg~L~~~l~~---------~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~vkL 192 (387)
T 1kob_A 125 LILEFLSGGELFDRIAA---------EDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKI 192 (387)
T ss_dssp EEEECCCCCBHHHHTTC---------TTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEE
T ss_pred EEEEcCCCCcHHHHHHh---------hcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEEecCCCCceEE
Confidence 99999999999999842 3346899999999999999999999 899999999999999974 578999
Q ss_pred eccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCc
Q 002857 317 ADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALP 396 (873)
Q Consensus 317 sDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~ 396 (873)
+|||+++....... .....||..|+|||++.+..++.++|||||||++|||++|+.||....... ..
T Consensus 193 ~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~--~~-------- 259 (387)
T 1kob_A 193 IDFGLATKLNPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE--TL-------- 259 (387)
T ss_dssp CCCTTCEECCTTSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH--HH--------
T ss_pred EecccceecCCCcc---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHH--HH--------
Confidence 99999987643321 223468999999999999999999999999999999999999997532110 00
Q ss_pred hhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 397 ERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 397 ~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
..+....+... ...+ ......+.+++.+||+.||++|||+.|+++
T Consensus 260 ---~~i~~~~~~~~-----------~~~~--------~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 260 ---QNVKRCDWEFD-----------EDAF--------SSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp ---HHHHHCCCCCC-----------SSTT--------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ---HHHHhCCCCCC-----------cccc--------ccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 01100000000 0000 011234778999999999999999999865
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=337.74 Aligned_cols=251 Identities=24% Similarity=0.332 Sum_probs=196.8
Q ss_pred CCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC--CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEE
Q 002857 161 GFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH--HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKA 238 (873)
Q Consensus 161 ~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~ 238 (873)
.|.+.+.||+|+||.||+|.+..++..||+|++.... ....+.+.+|+.++++++||||+++++++... .......+
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~~~~~ 105 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST-VKGKKCIV 105 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE-SSSCEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccc-cCCCceEE
Confidence 4677889999999999999999999999999987433 23446789999999999999999999987532 23456789
Q ss_pred EEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCC--eeeccCCCCCeeeC-CCCCeE
Q 002857 239 LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPP--IAHCDIKPSNILLN-DEMTAC 315 (873)
Q Consensus 239 LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~g--IvHrDLKpsNILLd-~~~~vK 315 (873)
+||||+++|+|.+++.. ...+++..++.|+.||+.||.||| +.+ |+||||||+|||++ .++.+|
T Consensus 106 lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~~~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~k 172 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKR----------FKVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVK 172 (290)
T ss_dssp EEEECCCSCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEE
T ss_pred EEEEecCCCCHHHHHHH----------ccCCCHHHHHHHHHHHHHHHHHHH---cCCCCEEECCCCHHHEEEECCCCCEE
Confidence 99999999999999942 245889999999999999999999 777 99999999999998 789999
Q ss_pred EeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcC
Q 002857 316 VADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSAL 395 (873)
Q Consensus 316 LsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~ 395 (873)
|+|||++...... ......||..|+|||++.+ .++.++||||||+++|+|++|+.||.......... .
T Consensus 173 l~Dfg~~~~~~~~----~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~-~------ 240 (290)
T 1t4h_A 173 IGDLGLATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY-R------ 240 (290)
T ss_dssp ECCTTGGGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHH-H------
T ss_pred EeeCCCccccccc----ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHH-H------
Confidence 9999999754332 2223468999999998764 58999999999999999999999996532211110 0
Q ss_pred chhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 396 PERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 396 ~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
.+.......... ......+.+++.+||+.||++|||+.||++
T Consensus 241 -----~~~~~~~~~~~~---------------------~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 241 -----RVTSGVKPASFD---------------------KVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp -----HHTTTCCCGGGG---------------------GCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -----HHhccCCccccC---------------------CCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 000000000000 001124788999999999999999999875
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=349.05 Aligned_cols=246 Identities=24% Similarity=0.307 Sum_probs=200.1
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeecc---CCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCc
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFL---HHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGND 235 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~ 235 (873)
.++|++.+.||+|+||.||+|+...+++.||+|+++.. .....+.+.+|+.+++.++||||+++++++ ....
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~~ 79 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF-----QDAQ 79 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEE-----ECSS
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEE-----EeCC
Confidence 35789999999999999999999989999999999743 223446788999999999999999999985 4567
Q ss_pred eEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeE
Q 002857 236 FKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTAC 315 (873)
Q Consensus 236 ~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vK 315 (873)
..++||||+++|+|.+++.. ...+++..++.++.||+.||+||| +.+|+||||||+|||++.++.+|
T Consensus 80 ~~~lv~e~~~gg~L~~~l~~----------~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~k 146 (318)
T 1fot_A 80 QIFMIMDYIEGGELFSLLRK----------SQRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIK 146 (318)
T ss_dssp EEEEEECCCCSCBHHHHHHH----------TSSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEE
T ss_pred EEEEEEeCCCCCCHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEE
Confidence 89999999999999999942 346889999999999999999999 89999999999999999999999
Q ss_pred EeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcC
Q 002857 316 VADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSAL 395 (873)
Q Consensus 316 LsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~ 395 (873)
|+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||.......
T Consensus 147 L~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~----------- 210 (318)
T 1fot_A 147 ITDFGFAKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK----------- 210 (318)
T ss_dssp ECCCSSCEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-----------
T ss_pred EeecCcceecCCc-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH-----------
Confidence 9999999865321 223569999999999999999999999999999999999999996521110
Q ss_pred chhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCC-----CHHHHHH
Q 002857 396 PERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERM-----KINDVEL 463 (873)
Q Consensus 396 ~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRP-----Tm~EVl~ 463 (873)
....++...+ ..|. . ....+.+++.+||+.||++|| ++.||++
T Consensus 211 --~~~~i~~~~~--------------~~p~--~-------~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 211 --TYEKILNAEL--------------RFPP--F-------FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp --HHHHHHHCCC--------------CCCT--T-------SCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred --HHHHHHhCCC--------------CCCC--C-------CCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 0111111100 0010 0 012477899999999999999 7887753
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-38 Score=341.93 Aligned_cols=280 Identities=16% Similarity=0.196 Sum_probs=202.9
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhh-hccceeeeeeeecccccCCceE
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNII-HRKIIKVVTACSRVDYQGNDFK 237 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~-HpNIV~llg~c~~~~~~~~~~~ 237 (873)
.++|++.+.||+|+||.||+|++..+++.||||+++. ...+.+.+|++++++++ |+||+++++++.. ......
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~---~~~~~~ 108 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKD---PVSRTP 108 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CCHHHHHHHHHHHHHHTTSTTBCCEEEEEEC---TTTCCE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc---cchHHHHHHHHHHHHcCCCCCEEEeeeeecc---CCCCce
Confidence 3678999999999999999999999999999999863 33577999999999997 9999999999742 235678
Q ss_pred EEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCC-CeEE
Q 002857 238 ALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEM-TACV 316 (873)
Q Consensus 238 ~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~-~vKL 316 (873)
++||||+++++|.+++. .+++..++.|+.||+.||+||| +.+|+||||||+|||++.++ .+||
T Consensus 109 ~lv~e~~~~~~l~~~~~-------------~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~~kl 172 (330)
T 3nsz_A 109 ALVFEHVNNTDFKQLYQ-------------TLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRL 172 (330)
T ss_dssp EEEEECCCCCCHHHHGG-------------GCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEE
T ss_pred EEEEeccCchhHHHHHH-------------hCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCEEEE
Confidence 99999999999999883 2788899999999999999999 89999999999999999776 8999
Q ss_pred eccccccccccccccccccccccccccCCCcccCC-CCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcC
Q 002857 317 ADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMG-HETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSAL 395 (873)
Q Consensus 317 sDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~ 395 (873)
+|||+++....... .....++..|+|||++.+ ..++.++||||||+++|||++|+.||.........+.......-
T Consensus 173 ~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~ 249 (330)
T 3nsz_A 173 IDWGLAEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG 249 (330)
T ss_dssp CCCTTCEECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHC
T ss_pred EeCCCceEcCCCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcC
Confidence 99999986644322 223458999999999877 67899999999999999999999999653332222222222211
Q ss_pred chhHHHHhhhhhhh-hhhHHHHHhhhccCCCCchh-HHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 396 PERVEEIVDTLFFK-EIEEEETVYKYKKAPSSSTQ-RSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 396 ~~~l~elid~~L~~-~~~~r~~~~~i~~~p~~~~~-~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
.+.+.+.++..-.. ...............+.... ..........+.+++.+||+.||++|||+.|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 250 TEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 12222222111100 00000000000000000000 0000011345889999999999999999999875
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=355.27 Aligned_cols=254 Identities=22% Similarity=0.277 Sum_probs=192.1
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEE
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKA 238 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~ 238 (873)
.++|.+.+.||+|+||.||++++..+++.||||++..... ..+.+.+|+.++++++||||+++++++ ......+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~~~~~ 92 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVI-----LTPTHLA 92 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSSEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEE-----eeCCEEE
Confidence 4689999999999999999999998999999999975432 346789999999999999999999996 4566799
Q ss_pred EEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCC--eEE
Q 002857 239 LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMT--ACV 316 (873)
Q Consensus 239 LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~--vKL 316 (873)
+||||+++|+|.+++.. ...+++..++.|+.||+.||+||| +.+|+||||||+|||++.++. +||
T Consensus 93 lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~kl 159 (361)
T 3uc3_A 93 IIMEYASGGELYERICN----------AGRFSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKI 159 (361)
T ss_dssp EEEECCCSCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCEEE
T ss_pred EEEEeCCCCCHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceEEE
Confidence 99999999999999842 345899999999999999999999 899999999999999987765 999
Q ss_pred eccccccccccccccccccccccccccCCCcccCCCCCCcc-hhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcC
Q 002857 317 ADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSY-GDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSAL 395 (873)
Q Consensus 317 sDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~k-sDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~ 395 (873)
+|||+++...... ......||+.|+|||++.+..++.+ +||||||+++|||++|+.||....... .+
T Consensus 160 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-~~-------- 227 (361)
T 3uc3_A 160 CDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR-DY-------- 227 (361)
T ss_dssp CCCCCC------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CC-CH--------
T ss_pred eecCccccccccC---CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH-HH--------
Confidence 9999997432221 2233469999999999988887666 899999999999999999997632211 11
Q ss_pred chhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHH
Q 002857 396 PERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELG 464 (873)
Q Consensus 396 ~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~ 464 (873)
..++...+.... ..|... .....+.+|+.+||+.||++|||+.|+++.
T Consensus 228 ----~~~~~~~~~~~~----------~~~~~~-------~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 228 ----RKTIQRILSVKY----------SIPDDI-------RISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp ----HHHHHHHHTTCC----------CCCTTS-------CCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred ----HHHHHHHhcCCC----------CCCCcC-------CCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 111111111100 000000 012247789999999999999999999764
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=338.37 Aligned_cols=261 Identities=24% Similarity=0.400 Sum_probs=205.6
Q ss_pred hhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceE
Q 002857 158 ATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFK 237 (873)
Q Consensus 158 at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~ 237 (873)
..++|++.+.||+|+||.||+|.+. ++..||||+++... ...+.+.+|++++++++||||+++++++. .+..
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~~~ 82 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT------QEPI 82 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC------SSSC
T ss_pred CHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc------CCCc
Confidence 3467899999999999999999874 56789999987543 34578999999999999999999999853 3457
Q ss_pred EEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEe
Q 002857 238 ALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVA 317 (873)
Q Consensus 238 ~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLs 317 (873)
++||||+++++|.+++.. .....+++..++.++.||+.||+||| +.+|+||||||+|||++.++.+||+
T Consensus 83 ~~v~e~~~~~~L~~~l~~--------~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~ 151 (279)
T 1qpc_A 83 YIITEYMENGSLVDFLKT--------PSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIA 151 (279)
T ss_dssp EEEEECCTTCBHHHHTTS--------HHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEEC
T ss_pred EEEEecCCCCCHHHHHhc--------CCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEEC
Confidence 899999999999999953 11235889999999999999999999 8999999999999999999999999
Q ss_pred ccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHHHhhcCc
Q 002857 318 DFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQSALP 396 (873)
Q Consensus 318 DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~~~~~~~ 396 (873)
|||+++....... .......++..|+|||++.+..++.++||||||+++|||++ |+.||....... ...
T Consensus 152 Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~~------- 221 (279)
T 1qpc_A 152 DFGLARLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE--VIQ------- 221 (279)
T ss_dssp CCTTCEECSSSCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHH-------
T ss_pred CCcccccccCccc-ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH--HHH-------
Confidence 9999987643321 12223446789999999988889999999999999999999 999986532111 000
Q ss_pred hhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHHHHhhh
Q 002857 397 ERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLIKKKLL 473 (873)
Q Consensus 397 ~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i~~~l~ 473 (873)
.+... ... ..+. .+...+.+++.+||+.+|++|||+.+|++.|+.+.....
T Consensus 222 ----~~~~~-~~~------------~~~~---------~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 272 (279)
T 1qpc_A 222 ----NLERG-YRM------------VRPD---------NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE 272 (279)
T ss_dssp ----HHHTT-CCC------------CCCT---------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred ----HHhcc-cCC------------CCcc---------cccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhcc
Confidence 00000 000 0000 112357889999999999999999999999999876543
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=358.12 Aligned_cols=262 Identities=23% Similarity=0.401 Sum_probs=195.5
Q ss_pred CCCcceeecccCceEEEEEEEcCCC---cEEEEEEeeccC-CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCce
Q 002857 161 GFSSENLIGAGNFASVYKGILFEGA---PAVAIKVFNFLH-HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDF 236 (873)
Q Consensus 161 ~f~~~~~LG~G~fG~VYkg~~~~~g---~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~ 236 (873)
.|.+.+.||+|+||.||+|++..++ ..||||.++... ....+.|.+|+.++++++||||++++++|. ..++.
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~----~~~~~ 165 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL----RSEGS 165 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEEC----CCSSC
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEE----cCCCC
Confidence 3566789999999999999875432 468999986433 334578999999999999999999999863 34456
Q ss_pred EEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEE
Q 002857 237 KALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACV 316 (873)
Q Consensus 237 ~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKL 316 (873)
.++||||+++|+|.+++.. ....+++..++.++.||+.||+||| +.+|+||||||+|||++.++.+||
T Consensus 166 ~~lv~e~~~~g~L~~~l~~---------~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL 233 (373)
T 3c1x_A 166 PLVVLPYMKHGDLRNFIRN---------ETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKV 233 (373)
T ss_dssp CEEEEECCTTCBHHHHHHC---------TTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEE
T ss_pred eEEEEECCCCCCHHHHHhh---------cccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCccchheEEECCCCCEEE
Confidence 7899999999999999953 3456889999999999999999999 899999999999999999999999
Q ss_pred ecccccccccccccc--ccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHHHhh
Q 002857 317 ADFGIARFLEATNEQ--TSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQS 393 (873)
Q Consensus 317 sDFGla~~~~~~~~~--~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~~~~ 393 (873)
+|||+++........ .......+|..|+|||++.+..++.++||||||+++|||+| |..||....... ....+
T Consensus 234 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~--~~~~~-- 309 (373)
T 3c1x_A 234 ADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--ITVYL-- 309 (373)
T ss_dssp CCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC--HHHHH--
T ss_pred eeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH--HHHHH--
Confidence 999999865433211 11223457889999999999999999999999999999999 677776532211 11110
Q ss_pred cCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHHHHhhh
Q 002857 394 ALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLIKKKLL 473 (873)
Q Consensus 394 ~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i~~~l~ 473 (873)
...... ..|. .+...+.+++.+||+.||++|||+.||++.|+.+...+.
T Consensus 310 ---------~~~~~~-------------~~p~---------~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 310 ---------LQGRRL-------------LQPE---------YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358 (373)
T ss_dssp ---------HTTCCC-------------CCCT---------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred ---------HcCCCC-------------CCCC---------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 000000 0000 112357889999999999999999999999999877664
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=356.10 Aligned_cols=205 Identities=24% Similarity=0.354 Sum_probs=164.7
Q ss_pred hhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeecc--CCcchhHHHHHHHHHHhhh-hccceeeeeeeecccccCC
Q 002857 158 ATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFL--HHDASKSFTVECEVMRNII-HRKIIKVVTACSRVDYQGN 234 (873)
Q Consensus 158 at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~L~-HpNIV~llg~c~~~~~~~~ 234 (873)
..++|++.+.||+|+||.||+|.+..+++.||||++... .......+.+|+.++.++. |+||+++++++.. .+.
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~---~~~ 83 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRA---DND 83 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC---TTS
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEec---CCC
Confidence 457899999999999999999999999999999998643 2233467889999999997 9999999999742 234
Q ss_pred ceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCe
Q 002857 235 DFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTA 314 (873)
Q Consensus 235 ~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~v 314 (873)
...++||||++ |+|.+++.. ..+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+
T Consensus 84 ~~~~lv~e~~~-~~L~~~~~~-----------~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~ 148 (388)
T 3oz6_A 84 RDVYLVFDYME-TDLHAVIRA-----------NILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHV 148 (388)
T ss_dssp SCEEEEEECCS-EEHHHHHHH-----------TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCE
T ss_pred CEEEEEecccC-cCHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcCCCCE
Confidence 57899999997 599998842 35888999999999999999999 8999999999999999999999
Q ss_pred EEecccccccccccc-------------------ccccccccccccccCCCcccCC-CCCCcchhhHhHHHHHHHHHhCC
Q 002857 315 CVADFGIARFLEATN-------------------EQTSSIGVKGTTGYIAPEYGMG-HETSSYGDVYSFGILLLEMFTGL 374 (873)
Q Consensus 315 KLsDFGla~~~~~~~-------------------~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELlTGk 374 (873)
||+|||+++.+.... .........||..|+|||++.+ ..++.++|||||||++|||++|+
T Consensus 149 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~ 228 (388)
T 3oz6_A 149 KVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228 (388)
T ss_dssp EECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred EecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCC
Confidence 999999998653211 0111233569999999999887 67899999999999999999999
Q ss_pred CCCCcc
Q 002857 375 RPSDDM 380 (873)
Q Consensus 375 ~Pf~~~ 380 (873)
.||...
T Consensus 229 ~pf~~~ 234 (388)
T 3oz6_A 229 PIFPGS 234 (388)
T ss_dssp CSCCCS
T ss_pred CCCCCC
Confidence 999763
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=357.87 Aligned_cols=247 Identities=21% Similarity=0.262 Sum_probs=193.9
Q ss_pred ceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEEEEeec
Q 002857 165 ENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKALVYEFM 244 (873)
Q Consensus 165 ~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~LV~Ey~ 244 (873)
.+.||+|+||.||+|.+..+++.||||+++.......+.+.+|+++|++++||||+++++++ ...+..+|||||+
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-----~~~~~~~lv~E~~ 168 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAF-----ESKNDIVLVMEYV 168 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSEEEEEEECC
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEE-----EECCEEEEEEeCC
Confidence 57899999999999999999999999999865555667899999999999999999999996 4466799999999
Q ss_pred CCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeee--CCCCCeEEeccccc
Q 002857 245 PNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILL--NDEMTACVADFGIA 322 (873)
Q Consensus 245 ~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILL--d~~~~vKLsDFGla 322 (873)
++|+|.+++.. ....+++..++.|+.||+.||+||| +.+|+||||||+|||+ +.++.+||+|||++
T Consensus 169 ~~~~L~~~l~~---------~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a 236 (373)
T 2x4f_A 169 DGGELFDRIID---------ESYNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLA 236 (373)
T ss_dssp TTCEEHHHHHH---------TGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECCCSSC
T ss_pred CCCcHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEeCCCc
Confidence 99999998842 2345889999999999999999999 8999999999999999 57789999999999
Q ss_pred cccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCchhHHHH
Q 002857 323 RFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPERVEEI 402 (873)
Q Consensus 323 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~~l~el 402 (873)
+.+..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....... .+..+
T Consensus 237 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-------------~~~~i 300 (373)
T 2x4f_A 237 RRYKPREK---LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE-------------TLNNI 300 (373)
T ss_dssp EECCTTCB---CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-------------HHHHH
T ss_pred eecCCccc---cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH-------------HHHHH
Confidence 87644322 223458999999999999999999999999999999999999997532111 11111
Q ss_pred hhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 403 VDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 403 id~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
+....... ... .......+.+|+.+||+.||++|||+.|+++
T Consensus 301 ~~~~~~~~---------------~~~----~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 301 LACRWDLE---------------DEE----FQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp HHTCCCSC---------------SGG----GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HhccCCCC---------------hhh----hccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 11110000 000 0011235788999999999999999999986
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=339.55 Aligned_cols=261 Identities=20% Similarity=0.332 Sum_probs=202.4
Q ss_pred hhcCCCcceeecccCceEEEEEEEcCC---CcEEEEEEeeccC-CcchhHHHHHHHHHHhhhhccceeeeeeeecccccC
Q 002857 158 ATKGFSSENLIGAGNFASVYKGILFEG---APAVAIKVFNFLH-HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQG 233 (873)
Q Consensus 158 at~~f~~~~~LG~G~fG~VYkg~~~~~---g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~ 233 (873)
..++|.+.+.||+|+||.||+|++..+ +..||||++.... ....+.+.+|+.++++++||||+++++++.
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------ 83 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIE------ 83 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEEC------
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEc------
Confidence 356889999999999999999987543 3469999987542 234567999999999999999999999853
Q ss_pred CceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCC
Q 002857 234 NDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMT 313 (873)
Q Consensus 234 ~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~ 313 (873)
.+..++||||+++++|.+++.. ....+++..++.++.||+.||+||| +.+|+||||||+|||++.++.
T Consensus 84 ~~~~~~v~e~~~~~~L~~~l~~---------~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~ 151 (281)
T 3cc6_A 84 EEPTWIIMELYPYGELGHYLER---------NKNSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPEC 151 (281)
T ss_dssp SSSCEEEEECCTTCBHHHHHHH---------HTTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEEETTE
T ss_pred CCCCEEEEecCCCCCHHHHHHh---------ccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEECCCCc
Confidence 2346899999999999999953 2345889999999999999999999 899999999999999999999
Q ss_pred eEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHHHh
Q 002857 314 ACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQ 392 (873)
Q Consensus 314 vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~~~ 392 (873)
+||+|||+++....... .......++..|+|||++.+..++.++||||||+++|||+| |+.||....... ....+
T Consensus 152 ~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~--~~~~~- 227 (281)
T 3cc6_A 152 VKLGDFGLSRYIEDEDY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD--VIGVL- 227 (281)
T ss_dssp EEECCCCGGGCC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG--HHHHH-
T ss_pred EEeCccCCCcccccccc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH--HHHHH-
Confidence 99999999986644321 11223457889999999988899999999999999999998 999996532211 11100
Q ss_pred hcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHHHHhh
Q 002857 393 SALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLIKKKL 472 (873)
Q Consensus 393 ~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i~~~l 472 (873)
.... ..+... .+...+.+++.+||+.||++|||+.||++.|+.+....
T Consensus 228 ----------~~~~---------------~~~~~~-------~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 275 (281)
T 3cc6_A 228 ----------EKGD---------------RLPKPD-------LCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQME 275 (281)
T ss_dssp ----------HHTC---------------CCCCCT-------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ----------hcCC---------------CCCCCC-------CCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhh
Confidence 0000 000000 01234788999999999999999999999999986543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-38 Score=356.39 Aligned_cols=253 Identities=21% Similarity=0.292 Sum_probs=191.5
Q ss_pred hhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC--------CcchhHHHHHHHHHHhhhhccceeeeeeeecc
Q 002857 158 ATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH--------HDASKSFTVECEVMRNIIHRKIIKVVTACSRV 229 (873)
Q Consensus 158 at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~--------~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~ 229 (873)
..++|.+.+.||+|+||.||+|.+..+++.||||++.... ......+.+|+++|++++||||+++++++.
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-- 210 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-- 210 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE--
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe--
Confidence 4678999999999999999999999999999999987432 112245889999999999999999999852
Q ss_pred cccCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeC
Q 002857 230 DYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLN 309 (873)
Q Consensus 230 ~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd 309 (873)
.+..++||||+++|+|.+++. ....+++..++.|+.||+.||+||| +.+|+||||||+|||++
T Consensus 211 ----~~~~~lv~e~~~~g~L~~~l~----------~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIll~ 273 (419)
T 3i6u_A 211 ----AEDYYIVLELMEGGELFDKVV----------GNKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLS 273 (419)
T ss_dssp ----SSEEEEEEECCTTCBGGGGTS----------SSCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEES
T ss_pred ----cCceEEEEEcCCCCcHHHHHh----------ccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEe
Confidence 345799999999999999884 3456899999999999999999999 88999999999999997
Q ss_pred CC---CCeEEeccccccccccccccccccccccccccCCCcccCC---CCCCcchhhHhHHHHHHHHHhCCCCCCccccc
Q 002857 310 DE---MTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMG---HETSSYGDVYSFGILLLEMFTGLRPSDDMFKD 383 (873)
Q Consensus 310 ~~---~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~---~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~ 383 (873)
.+ +.+||+|||+++...... ......||+.|+|||++.+ ..++.++||||||+++|||+||+.||......
T Consensus 274 ~~~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~ 350 (419)
T 3i6u_A 274 SQEEDCLIKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ 350 (419)
T ss_dssp SSSSSCCEEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSS
T ss_pred cCCCcceEEEeecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcch
Confidence 54 469999999998764322 2234569999999999864 57888999999999999999999999753221
Q ss_pred chhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 384 NLNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 384 ~~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
. .+...+... .... . ..........+.+++.+||+.||++|||+.|+++
T Consensus 351 ~-~~~~~i~~~-----------~~~~-~------------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 351 V-SLKDQITSG-----------KYNF-I------------------PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp C-CHHHHHHTT-----------CCCC-C------------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred H-HHHHHHhcC-----------CCCC-C------------------chhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 1 111111100 0000 0 0000112335788999999999999999999875
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=351.99 Aligned_cols=253 Identities=23% Similarity=0.333 Sum_probs=192.0
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCC--cchhHHHHHHHHHHhhhh--ccceeeeeeeecccccCC
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH--DASKSFTVECEVMRNIIH--RKIIKVVTACSRVDYQGN 234 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~H--pNIV~llg~c~~~~~~~~ 234 (873)
.++|++.+.||+|+||.||++.+ .+++.||||++..... ...+.+.+|+++|.+++| +||+++++++ ...
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~-----~~~ 81 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE-----ITD 81 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECS
T ss_pred cCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeE-----eeC
Confidence 45799999999999999999987 5688999999874432 234678999999999976 9999999996 456
Q ss_pred ceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCe
Q 002857 235 DFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTA 314 (873)
Q Consensus 235 ~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~v 314 (873)
...+|||| +.+|+|.+++.. ...+++.+++.|+.||+.||+||| +.+|+||||||+|||++ ++.+
T Consensus 82 ~~~~lv~e-~~~~~L~~~l~~----------~~~~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NIll~-~~~~ 146 (343)
T 3dbq_A 82 QYIYMVME-CGNIDLNSWLKK----------KKSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGML 146 (343)
T ss_dssp SEEEEEEC-CCSEEHHHHHHH----------SCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEE
T ss_pred CEEEEEEe-CCCCCHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEE-CCcE
Confidence 68999999 568899999942 356889999999999999999999 88999999999999997 5789
Q ss_pred EEeccccccccccccccccccccccccccCCCcccCC-----------CCCCcchhhHhHHHHHHHHHhCCCCCCccccc
Q 002857 315 CVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMG-----------HETSSYGDVYSFGILLLEMFTGLRPSDDMFKD 383 (873)
Q Consensus 315 KLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-----------~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~ 383 (873)
||+|||+++...............||+.|+|||++.+ ..++.++|||||||++|||++|+.||......
T Consensus 147 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~ 226 (343)
T 3dbq_A 147 KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 226 (343)
T ss_dssp EECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH
T ss_pred EEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH
Confidence 9999999987654433333344579999999999854 67899999999999999999999999753221
Q ss_pred chhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 384 NLNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 384 ~~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
.. .+..+++...... .|.. ....+.+++.+||+.||++|||+.||++
T Consensus 227 ~~------------~~~~~~~~~~~~~------------~~~~---------~~~~l~~li~~~L~~dp~~Rpt~~e~l~ 273 (343)
T 3dbq_A 227 IS------------KLHAIIDPNHEIE------------FPDI---------PEKDLQDVLKCCLKRDPKQRISIPELLA 273 (343)
T ss_dssp HH------------HHHHHHCTTSCCC------------CCCC---------SCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HH------------HHHHHhcCCcccC------------Cccc---------CCHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence 11 1111221111100 0000 0124778999999999999999999986
Q ss_pred HH
Q 002857 464 GL 465 (873)
Q Consensus 464 ~L 465 (873)
.-
T Consensus 274 hp 275 (343)
T 3dbq_A 274 HP 275 (343)
T ss_dssp SH
T ss_pred Cc
Confidence 53
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=347.66 Aligned_cols=267 Identities=23% Similarity=0.349 Sum_probs=201.0
Q ss_pred hcCCCcceeecccCceEEEEEE-----EcCCCcEEEEEEeeccC-CcchhHHHHHHHHHHhhhhccceeeeeeeeccccc
Q 002857 159 TKGFSSENLIGAGNFASVYKGI-----LFEGAPAVAIKVFNFLH-HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQ 232 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~-----~~~~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~ 232 (873)
.++|.+.+.||+|+||.||+|+ ...+++.||||++.... ......+.+|+.++++++||||+++++++ .
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~ 103 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVS-----L 103 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----C
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEE-----c
Confidence 4678999999999999999998 44567899999996432 23446789999999999999999999996 3
Q ss_pred CCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCC--
Q 002857 233 GNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLND-- 310 (873)
Q Consensus 233 ~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~-- 310 (873)
.....++||||+++|+|.+++.... ........+++..++.++.||+.||.||| +.+|+||||||+|||++.
T Consensus 104 ~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~NIli~~~~ 177 (327)
T 2yfx_A 104 QSLPRFILMELMAGGDLKSFLRETR---PRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPG 177 (327)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTS---CCSSSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSS
T ss_pred CCCCcEEEEecCCCCcHHHHHHhhc---ccccccccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCHhHEEEecCC
Confidence 4556799999999999999996411 11122356899999999999999999999 889999999999999984
Q ss_pred -CCCeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhH
Q 002857 311 -EMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQ 388 (873)
Q Consensus 311 -~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~ 388 (873)
+..+||+|||+++...............+|..|+|||++.+..++.++||||||+++|||+| |+.||...... ...
T Consensus 178 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~ 255 (327)
T 2yfx_A 178 PGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--EVL 255 (327)
T ss_dssp TTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HHH
T ss_pred CcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH--HHH
Confidence 45699999999986544333233334567899999999988899999999999999999998 99998653211 111
Q ss_pred HHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHH
Q 002857 389 NWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLI 468 (873)
Q Consensus 389 ~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i 468 (873)
..+ ..... .. .+. .+...+.+++.+||+.||++|||+.||++.|+.+
T Consensus 256 ~~~-----------~~~~~-~~------------~~~---------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 256 EFV-----------TSGGR-MD------------PPK---------NCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp HHH-----------HTTCC-CC------------CCT---------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHH-----------hcCCC-CC------------CCC---------CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 110 00000 00 000 0123478899999999999999999999999987
Q ss_pred HHh
Q 002857 469 KKK 471 (873)
Q Consensus 469 ~~~ 471 (873)
...
T Consensus 303 ~~~ 305 (327)
T 2yfx_A 303 TQD 305 (327)
T ss_dssp HHC
T ss_pred hcC
Confidence 653
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=345.68 Aligned_cols=268 Identities=21% Similarity=0.262 Sum_probs=196.4
Q ss_pred cCCCcc-eeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhh-hhccceeeeeeeecccccCCceE
Q 002857 160 KGFSSE-NLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNI-IHRKIIKVVTACSRVDYQGNDFK 237 (873)
Q Consensus 160 ~~f~~~-~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~llg~c~~~~~~~~~~~ 237 (873)
+.|.+. ++||+|+||.||+|++..+++.||||++..........+.+|++++.++ +||||+++++++ ...+..
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~-----~~~~~~ 86 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF-----EEEDRF 86 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEE-----EETTEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEE-----eeCCEE
Confidence 567774 7899999999999999889999999999866555667899999999995 799999999996 346689
Q ss_pred EEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCC---e
Q 002857 238 ALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMT---A 314 (873)
Q Consensus 238 ~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~---v 314 (873)
++||||+++|+|.+++.. ...+++..++.|+.||+.||+||| +.+|+||||||+|||++.++. +
T Consensus 87 ~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~~ 153 (316)
T 2ac3_A 87 YLVFEKMRGGSILSHIHK----------RRHFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPV 153 (316)
T ss_dssp EEEEECCTTCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESCSSSSCSE
T ss_pred EEEEEcCCCCcHHHHHhc----------cCCCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEccCCCcCce
Confidence 999999999999999953 246889999999999999999999 889999999999999998765 9
Q ss_pred EEeccccccccccccc-----cccccccccccccCCCcccCC-----CCCCcchhhHhHHHHHHHHHhCCCCCCcccccc
Q 002857 315 CVADFGIARFLEATNE-----QTSSIGVKGTTGYIAPEYGMG-----HETSSYGDVYSFGILLLEMFTGLRPSDDMFKDN 384 (873)
Q Consensus 315 KLsDFGla~~~~~~~~-----~~~~~~~~Gt~~Y~APE~l~~-----~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~ 384 (873)
||+|||+++....... ........||..|+|||++.+ ..++.++||||||+++|||++|+.||.......
T Consensus 154 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~ 233 (316)
T 2ac3_A 154 KICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSD 233 (316)
T ss_dssp EECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSC
T ss_pred EEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccc
Confidence 9999999986543211 111223458999999999875 457899999999999999999999997643222
Q ss_pred hhhHHHHhhcCch-hHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 385 LNLQNWVQSALPE-RVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 385 ~~l~~~~~~~~~~-~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
..+ ....... ....+......... .... .........+.+++.+||+.||++|||+.|+++
T Consensus 234 ~~~---~~~~~~~~~~~~~~~~i~~~~~------------~~~~---~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 234 CGW---DRGEACPACQNMLFESIQEGKY------------EFPD---KDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp SCC-------CCHHHHHHHHHHHHHCCC------------CCCH---HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ccc---cccccchhHHHHHHHHHhccCc------------ccCc---hhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 110 0000000 01111111100000 0000 000112335789999999999999999999865
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=357.39 Aligned_cols=201 Identities=24% Similarity=0.309 Sum_probs=175.2
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC---CcchhHHHHHHHHHHhh-hhccceeeeeeeecccccCC
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH---HDASKSFTVECEVMRNI-IHRKIIKVVTACSRVDYQGN 234 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L-~HpNIV~llg~c~~~~~~~~ 234 (873)
.++|++.++||+|+||.||+|++..+++.||||+++... ....+.+..|..+|.++ +||||+++++++ ...
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~-----~~~ 125 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----QTE 125 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEE-----ECS
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEE-----EEC
Confidence 467999999999999999999999999999999997542 23345688999999988 899999999985 556
Q ss_pred ceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCe
Q 002857 235 DFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTA 314 (873)
Q Consensus 235 ~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~v 314 (873)
...+|||||+++|+|.+++.. ...+++..+..++.||+.||+||| +.+|+||||||+|||++.++++
T Consensus 126 ~~~~lV~E~~~gg~L~~~l~~----------~~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~i 192 (396)
T 4dc2_A 126 SRLFFVIEYVNGGDLMFHMQR----------QRKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHI 192 (396)
T ss_dssp SEEEEEEECCTTCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCE
T ss_pred CEEEEEEEcCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCCE
Confidence 789999999999999999842 346899999999999999999999 8999999999999999999999
Q ss_pred EEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCc
Q 002857 315 CVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDD 379 (873)
Q Consensus 315 KLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~ 379 (873)
||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 193 kL~DFGla~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~ 255 (396)
T 4dc2_A 193 KLTDYGMCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 255 (396)
T ss_dssp EECCCTTCBCCCCTT--CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTT
T ss_pred EEeecceeeecccCC--CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcc
Confidence 999999998532221 223345799999999999999999999999999999999999999964
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=355.50 Aligned_cols=249 Identities=23% Similarity=0.304 Sum_probs=198.7
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeecc---CCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCce
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFL---HHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDF 236 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~ 236 (873)
++|.+.+.||+|+||.||+|.+..+++.||||++... .....+.+.+|+++|+.++||||+++++++ .....
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~~~~ 89 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSF-----QDEED 89 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSSE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EeCCE
Confidence 5789999999999999999999999999999998642 233456789999999999999999999985 45678
Q ss_pred EEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEE
Q 002857 237 KALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACV 316 (873)
Q Consensus 237 ~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKL 316 (873)
.++||||+.+|+|.+++. ....+++..++.++.||+.||.||| +.+|+||||||+|||++.++.+||
T Consensus 90 ~~lv~e~~~gg~L~~~l~----------~~~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL 156 (384)
T 4fr4_A 90 MFMVVDLLLGGDLRYHLQ----------QNVHFKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHI 156 (384)
T ss_dssp EEEEECCCTTEEHHHHHH----------TTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEE
T ss_pred EEEEEecCCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCCEEE
Confidence 999999999999999984 3456899999999999999999999 899999999999999999999999
Q ss_pred eccccccccccccccccccccccccccCCCcccCC---CCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhh
Q 002857 317 ADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMG---HETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQS 393 (873)
Q Consensus 317 sDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~---~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~ 393 (873)
+|||+++.+.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........
T Consensus 157 ~DFG~a~~~~~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~-------- 225 (384)
T 4fr4_A 157 TDFNIAAMLPRET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSS-------- 225 (384)
T ss_dssp CCCTTCEECCTTC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCH--------
T ss_pred eccceeeeccCCC---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccH--------
Confidence 9999998764322 2234569999999999874 4589999999999999999999999975322110
Q ss_pred cCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCC-HHHHH
Q 002857 394 ALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMK-INDVE 462 (873)
Q Consensus 394 ~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPT-m~EVl 462 (873)
.+++....... ...|. .....+.+|+.+||+.||++||+ +.+|.
T Consensus 226 ------~~~~~~~~~~~----------~~~p~---------~~s~~~~~li~~lL~~dP~~R~s~~~~l~ 270 (384)
T 4fr4_A 226 ------KEIVHTFETTV----------VTYPS---------AWSQEMVSLLKKLLEPNPDQRFSQLSDVQ 270 (384)
T ss_dssp ------HHHHHHHHHCC----------CCCCT---------TSCHHHHHHHHHHSCSSGGGSCCSHHHHH
T ss_pred ------HHHHHHHhhcc----------cCCCC---------cCCHHHHHHHHHHhcCCHhHhcccHHHHH
Confidence 11111000000 00010 01234788999999999999998 55553
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=363.64 Aligned_cols=254 Identities=19% Similarity=0.257 Sum_probs=201.0
Q ss_pred hhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCC--cchhHHHHHHHHHHhhhhccceeeeeeeecccccCCc
Q 002857 158 ATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH--DASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGND 235 (873)
Q Consensus 158 at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~ 235 (873)
..++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|++++++++||||+++++++ ...+
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-----~~~~ 83 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSI-----SEEG 83 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEE-----ECSS
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEE-----EECC
Confidence 35679999999999999999999999999999999875432 2345789999999999999999999995 4567
Q ss_pred eEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeC---CCC
Q 002857 236 FKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLN---DEM 312 (873)
Q Consensus 236 ~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd---~~~ 312 (873)
..++||||+++|+|.+++.. ...+++..+..++.||+.||+||| +.+|+||||||+|||++ .++
T Consensus 84 ~~~lv~E~~~gg~L~~~i~~----------~~~~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~~~~~~~ 150 (444)
T 3soa_A 84 HHYLIFDLVTGGELFEDIVA----------REYYSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGA 150 (444)
T ss_dssp EEEEEECCCBCCBHHHHHHH----------CSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEESBSSTTC
T ss_pred EEEEEEEeCCCCCHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEeccCCCC
Confidence 89999999999999999842 356899999999999999999999 89999999999999998 567
Q ss_pred CeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHh
Q 002857 313 TACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQ 392 (873)
Q Consensus 313 ~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~ 392 (873)
.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||....... +.
T Consensus 151 ~vkL~DFG~a~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~--~~---- 222 (444)
T 3soa_A 151 AVKLADFGLAIEVEGEQ--QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR--LY---- 222 (444)
T ss_dssp CEEECCCSSCBCCCTTC--CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HH----
T ss_pred cEEEccCceeEEecCCC--ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHH--HH----
Confidence 89999999998664432 22234569999999999999999999999999999999999999996532111 00
Q ss_pred hcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 393 SALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 393 ~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
..+........ ...+. .....+.+++.+||+.||++|||+.|+++
T Consensus 223 -------~~i~~~~~~~~-----------~~~~~--------~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 223 -------QQIKAGAYDFP-----------SPEWD--------TVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp -------HHHHHTCCCCC-----------TTTTT--------TSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -------HHHHhCCCCCC-----------ccccc--------cCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 11111000000 00000 11234778999999999999999999986
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=368.12 Aligned_cols=258 Identities=28% Similarity=0.439 Sum_probs=199.7
Q ss_pred HhhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCce
Q 002857 157 SATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDF 236 (873)
Q Consensus 157 ~at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~ 236 (873)
...++|.+.+.||+|+||.||+|.+. ++..||||+++.... ..+.|.+|+++|++++||||+++++++. .+.
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~------~~~ 252 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS------EEP 252 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEEC------SSS
T ss_pred cChhHceeeeeecCCCCeEEEEEEEC-CCceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEc------CCc
Confidence 34567889999999999999999985 456799999975432 3478999999999999999999999963 245
Q ss_pred EEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEE
Q 002857 237 KALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACV 316 (873)
Q Consensus 237 ~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKL 316 (873)
.+|||||+++|+|.++|.. .....+++.+++.|+.||+.||+||| +.+|+||||||+|||++.++.+||
T Consensus 253 ~~iv~e~~~~gsL~~~l~~--------~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl 321 (452)
T 1fmk_A 253 IYIVTEYMSKGSLLDFLKG--------ETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKV 321 (452)
T ss_dssp CEEEECCCTTCBHHHHHSH--------HHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEE
T ss_pred eEEEehhhcCCCHHHHHHh--------cCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEE
Confidence 7999999999999999953 12245889999999999999999999 899999999999999999999999
Q ss_pred eccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHHHhhcC
Q 002857 317 ADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQSAL 395 (873)
Q Consensus 317 sDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~~~~~~ 395 (873)
+|||+++...... ........++..|+|||++.+..++.++||||||+++|||+| |+.||....... ..
T Consensus 322 ~DfG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~--~~------- 391 (452)
T 1fmk_A 322 ADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VL------- 391 (452)
T ss_dssp CCCCTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HH-------
T ss_pred CCCccceecCCCc-eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH--HH-------
Confidence 9999998764322 112223447889999999998899999999999999999999 999997532111 00
Q ss_pred chhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHHH
Q 002857 396 PERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLIK 469 (873)
Q Consensus 396 ~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i~ 469 (873)
+.+.... ..+.. ..+...+.+++.+||+.||++|||+.+|++.|+.+.
T Consensus 392 -----~~i~~~~--------------~~~~~-------~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~ 439 (452)
T 1fmk_A 392 -----DQVERGY--------------RMPCP-------PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 439 (452)
T ss_dssp -----HHHHTTC--------------CCCCC-------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred -----HHHHcCC--------------CCCCC-------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 0000000 00000 012345788999999999999999999999998763
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=347.67 Aligned_cols=262 Identities=27% Similarity=0.442 Sum_probs=198.9
Q ss_pred cCCCcceeecccCceEEEEEEEcCCC----cEEEEEEeeccCC-cchhHHHHHHHHHHhhhhccceeeeeeeecccccCC
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGA----PAVAIKVFNFLHH-DASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGN 234 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g----~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~ 234 (873)
++|...+.||+|+||.||+|.+..++ ..||||+++.... .....+.+|++++++++||||+++++++ ...
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~ 118 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVI-----SKY 118 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----CSS
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----ecC
Confidence 46777899999999999999886543 3599999975432 2345789999999999999999999996 445
Q ss_pred ceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCe
Q 002857 235 DFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTA 314 (873)
Q Consensus 235 ~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~v 314 (873)
+..+|||||+++|+|.+++.. ....+++.+++.|+.||+.||+||| +.+|+||||||+|||++.++.+
T Consensus 119 ~~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~ 186 (333)
T 1mqb_A 119 KPMMIITEYMENGALDKFLRE---------KDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVC 186 (333)
T ss_dssp SSEEEEEECCTTEEHHHHHHH---------TTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCE
T ss_pred CCcEEEEeCCCCCcHHHHHHh---------CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChheEEECCCCcE
Confidence 678999999999999999953 3456899999999999999999999 8899999999999999999999
Q ss_pred EEeccccccccccccccc-cccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHHHh
Q 002857 315 CVADFGIARFLEATNEQT-SSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQ 392 (873)
Q Consensus 315 KLsDFGla~~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~~~ 392 (873)
||+|||+++......... ......+|..|+|||++.+..++.++||||||+++|||++ |+.||....... +.
T Consensus 187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~--~~---- 260 (333)
T 1mqb_A 187 KVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE--VM---- 260 (333)
T ss_dssp EECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HH----
T ss_pred EECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH--HH----
Confidence 999999998764432211 1222346788999999998999999999999999999999 999996532111 00
Q ss_pred hcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHHHHhh
Q 002857 393 SALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLIKKKL 472 (873)
Q Consensus 393 ~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i~~~l 472 (873)
..+.+.. ..+... .+...+.+++.+||+.+|++||++.||++.|+.+....
T Consensus 261 -------~~~~~~~---------------~~~~~~-------~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 311 (333)
T 1mqb_A 261 -------KAINDGF---------------RLPTPM-------DCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 311 (333)
T ss_dssp -------HHHHTTC---------------CCCCCT-------TCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred -------HHHHCCC---------------cCCCcc-------cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 0010000 000000 11235788999999999999999999999999987644
Q ss_pred h
Q 002857 473 L 473 (873)
Q Consensus 473 ~ 473 (873)
.
T Consensus 312 ~ 312 (333)
T 1mqb_A 312 D 312 (333)
T ss_dssp G
T ss_pred h
Confidence 3
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=341.54 Aligned_cols=200 Identities=24% Similarity=0.378 Sum_probs=168.0
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCC--cchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceE
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH--DASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFK 237 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~ 237 (873)
++|++.+.||+|+||.||+|++ .+++.||||++..... ...+.+.+|++++++++||||+++++++ ...+..
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~ 75 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI-----HTKKRL 75 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEE-----ECSSCE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEE-----ccCCeE
Confidence 5789999999999999999988 6788999999864432 2346788999999999999999999996 445678
Q ss_pred EEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEe
Q 002857 238 ALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVA 317 (873)
Q Consensus 238 ~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLs 317 (873)
++||||+++ +|.+++.. ....+++..++.++.||+.||+||| +.+|+||||||+|||++.++.+||+
T Consensus 76 ~lv~e~~~~-~l~~~~~~---------~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~ 142 (288)
T 1ob3_A 76 VLVFEHLDQ-DLKKLLDV---------CEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIA 142 (288)
T ss_dssp EEEEECCSE-EHHHHHHT---------STTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEEC
T ss_pred EEEEEecCC-CHHHHHHh---------cccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEe
Confidence 999999975 99998842 3356889999999999999999999 8999999999999999999999999
Q ss_pred ccccccccccccccccccccccccccCCCcccCCC-CCCcchhhHhHHHHHHHHHhCCCCCCcc
Q 002857 318 DFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGH-ETSSYGDVYSFGILLLEMFTGLRPSDDM 380 (873)
Q Consensus 318 DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELlTGk~Pf~~~ 380 (873)
|||+++...... .......+|..|+|||++.+. .++.++||||||+++|||+||+.||...
T Consensus 143 Dfg~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 204 (288)
T 1ob3_A 143 DFGLARAFGIPV--RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV 204 (288)
T ss_dssp CTTHHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ECccccccCccc--cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999998654321 112234589999999998764 5899999999999999999999999763
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=339.27 Aligned_cols=249 Identities=22% Similarity=0.314 Sum_probs=198.7
Q ss_pred hhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC---CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCC
Q 002857 158 ATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH---HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGN 234 (873)
Q Consensus 158 at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~ 234 (873)
+.++|++.+.||+|+||.||+|.+..++..||||++.... ......+.+|+.++++++||||+++++++ ...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~ 81 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF-----HDA 81 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECS
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheE-----ecC
Confidence 3568999999999999999999999999999999986322 22346789999999999999999999996 456
Q ss_pred ceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCe
Q 002857 235 DFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTA 314 (873)
Q Consensus 235 ~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~v 314 (873)
...++||||+++|+|.+++.. ...+++..++.|+.||+.||+||| +.+|+||||||+|||++.++.+
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~----------~~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~ 148 (279)
T 3fdn_A 82 TRVYLILEYAPLGTVYRELQK----------LSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGEL 148 (279)
T ss_dssp SEEEEEECCCTTEEHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCE
T ss_pred CEEEEEEecCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCE
Confidence 678999999999999999843 245889999999999999999999 8999999999999999999999
Q ss_pred EEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhc
Q 002857 315 CVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSA 394 (873)
Q Consensus 315 KLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~ 394 (873)
||+|||++....... .....||..|+|||++.+..++.++||||||+++|||++|+.||....... .
T Consensus 149 ~l~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~------- 215 (279)
T 3fdn_A 149 KIADFGWSVHAPSSR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE--T------- 215 (279)
T ss_dssp EECSCCEESCC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH--H-------
T ss_pred EEEeccccccCCccc----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHH--H-------
Confidence 999999986543321 223468999999999999999999999999999999999999997532110 0
Q ss_pred CchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHH
Q 002857 395 LPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELG 464 (873)
Q Consensus 395 ~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~ 464 (873)
...+..... ..|. .....+.+++.+||+.||++|||+.||++.
T Consensus 216 ----~~~~~~~~~--------------~~~~---------~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 216 ----YKRISRVEF--------------TFPD---------FVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp ----HHHHHHTCC--------------CCCT---------TSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred ----HHHHHhCCC--------------CCCC---------cCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000000 0000 012247789999999999999999999874
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=335.97 Aligned_cols=252 Identities=21% Similarity=0.308 Sum_probs=200.6
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCC--cchhHHHHHHHHHHhhhhccceeeeeeeecccccCCce
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH--DASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDF 236 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~ 236 (873)
.++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|++++++++||||+++++++ .....
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~ 79 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEESF 79 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSSE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEE-----EcCCE
Confidence 5789999999999999999999999999999999974432 2346788999999999999999999996 45667
Q ss_pred EEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCC---
Q 002857 237 KALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMT--- 313 (873)
Q Consensus 237 ~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~--- 313 (873)
.++||||+++++|.+++.. ...+++..++.++.||+.||+||| +.+|+||||||+|||++.++.
T Consensus 80 ~~~v~e~~~~~~l~~~~~~----------~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~~ 146 (284)
T 3kk8_A 80 HYLVFDLVTGGELFEDIVA----------REFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAA 146 (284)
T ss_dssp EEEEECCCCSCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSTTCC
T ss_pred EEEEEecCCCCCHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCCCCc
Confidence 8999999999999998842 345899999999999999999999 899999999999999986655
Q ss_pred eEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhh
Q 002857 314 ACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQS 393 (873)
Q Consensus 314 vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~ 393 (873)
+||+|||++........ .....||..|+|||++.+..++.++||||||+++|+|++|+.||....... ..
T Consensus 147 ~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~----- 216 (284)
T 3kk8_A 147 VKLADFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR--LY----- 216 (284)
T ss_dssp EEECCCTTCEECCSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HH-----
T ss_pred EEEeeceeeEEcccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH--HH-----
Confidence 99999999976543222 223568999999999999999999999999999999999999996532111 00
Q ss_pred cCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 394 ALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 394 ~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
..+...... .+.. . .......+.+++.+||+.||++|||+.|+++
T Consensus 217 ------~~~~~~~~~--------------~~~~-~----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 217 ------AQIKAGAYD--------------YPSP-E----WDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp ------HHHHHTCCC--------------CCTT-T----TTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ------HHHHhcccc--------------CCch-h----hcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 000000000 0000 0 0011234778999999999999999999976
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-38 Score=346.94 Aligned_cols=292 Identities=19% Similarity=0.194 Sum_probs=202.3
Q ss_pred CHHHHHHhhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcc-----------hhHHHHHHHHHHhhhhccc
Q 002857 151 SYEALYSATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDA-----------SKSFTVECEVMRNIIHRKI 219 (873)
Q Consensus 151 s~~el~~at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~-----------~~~f~~Ei~iL~~L~HpNI 219 (873)
...++....++|.+.+.||+|+||.||+|.+. +++.||||++....... .+.+.+|++++++++||||
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 91 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECT-TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECC-CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence 35678888999999999999999999999875 48899999986432211 2678999999999999999
Q ss_pred eeeeeeeecccccCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeec
Q 002857 220 IKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHC 299 (873)
Q Consensus 220 V~llg~c~~~~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHr 299 (873)
+++++++...........++||||+. |+|.+++.. ....+++..++.|+.||+.||.||| +.+|+||
T Consensus 92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---------~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~ 158 (362)
T 3pg1_A 92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD---------QRIVISPQHIQYFMYHILLGLHVLH---EAGVVHR 158 (362)
T ss_dssp CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC---------TTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCC
T ss_pred cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh---------cccCCCHHHHHHHHHHHHHHHHHHH---HCcCEec
Confidence 99999975543344557899999997 688888742 3456899999999999999999999 8899999
Q ss_pred cCCCCCeeeCCCCCeEEeccccccccccccccccccccccccccCCCcccCC-CCCCcchhhHhHHHHHHHHHhCCCCCC
Q 002857 300 DIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMG-HETSSYGDVYSFGILLLEMFTGLRPSD 378 (873)
Q Consensus 300 DLKpsNILLd~~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELlTGk~Pf~ 378 (873)
||||+|||++.++.+||+|||+++...... ......+|..|+|||++.+ ..++.++||||||+++|||++|+.||.
T Consensus 159 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~ 235 (362)
T 3pg1_A 159 DLHPGNILLADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFR 235 (362)
T ss_dssp CCCGGGEEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CCChHHEEEcCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCC
Confidence 999999999999999999999998543322 2233468999999999877 678999999999999999999999997
Q ss_pred cccccchhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCH
Q 002857 379 DMFKDNLNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKI 458 (873)
Q Consensus 379 ~~~~~~~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm 458 (873)
...... .+.............+.... ...............................+.+++.+||+.||++|||+
T Consensus 236 ~~~~~~-~~~~i~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~ 311 (362)
T 3pg1_A 236 GSTFYN-QLNKIVEVVGTPKIEDVVMF---SSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRIST 311 (362)
T ss_dssp CSSHHH-HHHHHHHHHCCCCHHHHHHT---SCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred CCCHHH-HHHHHHHHcCCCChHHhhhc---cchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCH
Confidence 632211 11111111111111111000 00000000000000000000111111223457899999999999999999
Q ss_pred HHHHH
Q 002857 459 NDVEL 463 (873)
Q Consensus 459 ~EVl~ 463 (873)
.|+++
T Consensus 312 ~ell~ 316 (362)
T 3pg1_A 312 EQALR 316 (362)
T ss_dssp HHHHT
T ss_pred HHHHc
Confidence 99864
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=355.48 Aligned_cols=249 Identities=23% Similarity=0.307 Sum_probs=199.6
Q ss_pred HhhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC---CcchhHHHHHHHHHHhh-hhccceeeeeeeeccccc
Q 002857 157 SATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH---HDASKSFTVECEVMRNI-IHRKIIKVVTACSRVDYQ 232 (873)
Q Consensus 157 ~at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L-~HpNIV~llg~c~~~~~~ 232 (873)
...++|.+.+.||+|+||.||+|++..+++.||||+++... ......+..|..++..+ +||||+++++++ .
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~-----~ 88 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF-----Q 88 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE-----E
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEE-----E
Confidence 45678999999999999999999999999999999997432 33456788899999987 999999999985 4
Q ss_pred CCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCC
Q 002857 233 GNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEM 312 (873)
Q Consensus 233 ~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~ 312 (873)
..+..++||||+++|+|.+++.. ...+++..+..++.||+.||+||| +.+|+||||||+|||++.++
T Consensus 89 ~~~~~~lv~E~~~gg~L~~~l~~----------~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g 155 (345)
T 1xjd_A 89 TKENLFFVMEYLNGGDLMYHIQS----------CHKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDG 155 (345)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTS
T ss_pred eCCEEEEEEeCCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEECCCC
Confidence 56789999999999999999842 345889999999999999999999 89999999999999999999
Q ss_pred CeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHh
Q 002857 313 TACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQ 392 (873)
Q Consensus 313 ~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~ 392 (873)
++||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 156 ~vkL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-------- 225 (345)
T 1xjd_A 156 HIKIADFGMCKENMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE-------- 225 (345)
T ss_dssp CEEECCCTTCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------
T ss_pred CEEEeEChhhhhcccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH--------
Confidence 99999999998543222 12334569999999999999999999999999999999999999997532111
Q ss_pred hcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHH-HH
Q 002857 393 SALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKIN-DV 461 (873)
Q Consensus 393 ~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~-EV 461 (873)
+........+ ..|. .....+.+++.+||+.||++||++. ||
T Consensus 226 ---------~~~~i~~~~~----------~~p~---------~~s~~~~~li~~lL~~dp~~R~~~~~~i 267 (345)
T 1xjd_A 226 ---------LFHSIRMDNP----------FYPR---------WLEKEAKDLLVKLFVREPEKRLGVRGDI 267 (345)
T ss_dssp ---------HHHHHHHCCC----------CCCT---------TSCHHHHHHHHHHSCSSGGGSBTTBSCG
T ss_pred ---------HHHHHHhCCC----------CCCc---------ccCHHHHHHHHHHhcCCHhHcCCChHHH
Confidence 1111110000 0000 0122477899999999999999997 54
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=359.23 Aligned_cols=204 Identities=24% Similarity=0.237 Sum_probs=169.4
Q ss_pred hhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeecc--CCcchhHHHHHHHHHHhhhhccceeeeeeeecccc-cCC
Q 002857 158 ATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFL--HHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDY-QGN 234 (873)
Q Consensus 158 at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~-~~~ 234 (873)
..++|++.+.||+|+||.||+|.+..+++.||||++... .....+.+.+|+.+|+.++||||+++++++..... ...
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 357899999999999999999999999999999999743 23345678899999999999999999999754321 234
Q ss_pred ceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCe
Q 002857 235 DFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTA 314 (873)
Q Consensus 235 ~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~v 314 (873)
...+|||||+++ +|.+.+. ..+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+
T Consensus 140 ~~~~lv~E~~~~-~l~~~~~------------~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIll~~~~~~ 203 (464)
T 3ttj_A 140 QDVYLVMELMDA-NLCQVIQ------------MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTL 203 (464)
T ss_dssp CEEEEEEECCSE-EHHHHHT------------SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCE
T ss_pred CeEEEEEeCCCC-CHHHHHh------------hcCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEEEeCCCCE
Confidence 568999999976 5666652 23888999999999999999999 8899999999999999999999
Q ss_pred EEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcc
Q 002857 315 CVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDM 380 (873)
Q Consensus 315 KLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~ 380 (873)
||+|||+++...... ......||..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 204 kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~ 266 (464)
T 3ttj_A 204 KILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 266 (464)
T ss_dssp EECCCCCC-----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EEEEEEeeeecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999999998664321 223456999999999999999999999999999999999999999763
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=352.67 Aligned_cols=248 Identities=25% Similarity=0.330 Sum_probs=198.8
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeecc---CCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCc
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFL---HHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGND 235 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~ 235 (873)
.++|.+.+.||+|+||.||+|.+..+++.||||++... .......+.+|+.+++.++||||+++++++ ....
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~-----~~~~ 82 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVI-----TTPT 82 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSS
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeCC
Confidence 36899999999999999999999999999999998632 223346789999999999999999999996 4566
Q ss_pred eEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeE
Q 002857 236 FKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTAC 315 (873)
Q Consensus 236 ~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vK 315 (873)
..++||||+ +|+|.+++.. ...+++.+++.++.||+.||.||| +.+|+||||||+|||++.++.+|
T Consensus 83 ~~~lv~E~~-~g~l~~~l~~----------~~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~k 148 (336)
T 3h4j_B 83 DIVMVIEYA-GGELFDYIVE----------KKRMTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVK 148 (336)
T ss_dssp EEEEEECCC-CEEHHHHHHH----------HCSCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTCCEE
T ss_pred EEEEEEECC-CCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCCCEE
Confidence 799999999 7899998842 346899999999999999999999 88999999999999999999999
Q ss_pred EeccccccccccccccccccccccccccCCCcccCCCCC-CcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhc
Q 002857 316 VADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHET-SSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSA 394 (873)
Q Consensus 316 LsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~-s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~ 394 (873)
|+|||+++....... .....||+.|+|||++.+..+ +.++||||||+++|+|++|+.||........
T Consensus 149 l~DFG~s~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~--------- 216 (336)
T 3h4j_B 149 IADFGLSNIMTDGNF---LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL--------- 216 (336)
T ss_dssp ECCSSCTBTTTTSBT---TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC---------
T ss_pred EEEeccceeccCCcc---cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH---------
Confidence 999999986644322 223469999999999988876 7899999999999999999999975321110
Q ss_pred CchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHH
Q 002857 395 LPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELG 464 (873)
Q Consensus 395 ~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~ 464 (873)
........+ ..|.. ....+.+++.+||+.||.+|||+.||++.
T Consensus 217 --------~~~i~~~~~----------~~p~~---------~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 217 --------FKKVNSCVY----------VMPDF---------LSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp --------BCCCCSSCC----------CCCTT---------SCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred --------HHHHHcCCC----------CCccc---------CCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 000000000 00000 11246789999999999999999998753
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=348.62 Aligned_cols=250 Identities=22% Similarity=0.271 Sum_probs=177.3
Q ss_pred ceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhh-hccceeeeeeeecccccCCceEEEEEee
Q 002857 165 ENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNII-HRKIIKVVTACSRVDYQGNDFKALVYEF 243 (873)
Q Consensus 165 ~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~-HpNIV~llg~c~~~~~~~~~~~~LV~Ey 243 (873)
.+.||+|+||.||+|.+..+++.||||++... ....+.+|+.+++++. ||||+++++++ ......++||||
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~-----~~~~~~~lv~e~ 87 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVF-----HDQLHTFLVMEL 87 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECSSEEEEEECC
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEE-----EcCCEEEEEEEc
Confidence 37899999999999999999999999998632 3467889999999997 99999999996 456788999999
Q ss_pred cCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCC---CeEEeccc
Q 002857 244 MPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEM---TACVADFG 320 (873)
Q Consensus 244 ~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~---~vKLsDFG 320 (873)
+++|+|.+++.. ...+++.+++.|+.||+.||+||| +.+|+||||||+|||++.++ .+||+|||
T Consensus 88 ~~~~~L~~~l~~----------~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg 154 (325)
T 3kn6_A 88 LNGGELFERIKK----------KKHFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFG 154 (325)
T ss_dssp CCSCBHHHHHHH----------CSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEECCCT
T ss_pred cCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEEeccc
Confidence 999999999942 356899999999999999999999 89999999999999997665 89999999
Q ss_pred cccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCchhHH
Q 002857 321 IARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPERVE 400 (873)
Q Consensus 321 la~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~~l~ 400 (873)
+++....... ......||..|+|||++.+..++.++||||||+++|||++|+.||........ .....
T Consensus 155 ~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~----------~~~~~ 222 (325)
T 3kn6_A 155 FARLKPPDNQ--PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLT----------CTSAV 222 (325)
T ss_dssp TCEECCC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-----------------CCCHH
T ss_pred cceecCCCCC--cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccc----------cccHH
Confidence 9986543322 22234589999999999999999999999999999999999999976322100 00111
Q ss_pred HHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHH
Q 002857 401 EIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVE 462 (873)
Q Consensus 401 elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl 462 (873)
+++.......+. .. ..........+.+++.+||+.||++|||+.||+
T Consensus 223 ~~~~~i~~~~~~------------~~---~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell 269 (325)
T 3kn6_A 223 EIMKKIKKGDFS------------FE---GEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLR 269 (325)
T ss_dssp HHHHHHTTTCCC------------CC---SHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTST
T ss_pred HHHHHHHcCCCC------------CC---cccccCCCHHHHHHHHHHCCCChhHCCCHHHHh
Confidence 111111111100 00 000111234578999999999999999999874
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=359.08 Aligned_cols=287 Identities=21% Similarity=0.250 Sum_probs=209.9
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC-CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceE
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH-HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFK 237 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~ 237 (873)
.++|.+.++||+|+||.||+|++..+++.||||+++... ....+.+.+|++++++++||||+++++++.. ......
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~---~~~~~~ 84 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEE---TTTRHK 84 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC---TTTCCE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeecc---CCCCee
Confidence 357899999999999999999999889999999997433 2345678899999999999999999998642 234478
Q ss_pred EEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeee----CCCCC
Q 002857 238 ALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILL----NDEMT 313 (873)
Q Consensus 238 ~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILL----d~~~~ 313 (873)
++||||+++|+|.+++... .....+++..++.|+.||+.||+||| +.+|+||||||+|||+ +.++.
T Consensus 85 ~lv~e~~~~g~L~~~l~~~-------~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~ 154 (396)
T 4eut_A 85 VLIMEFCPCGSLYTVLEEP-------SNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSV 154 (396)
T ss_dssp EEEECCCTTEEHHHHTTSG-------GGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCEE
T ss_pred EEEEecCCCCCHHHHHHhh-------hcccCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCcee
Confidence 9999999999999999531 12334899999999999999999999 8999999999999999 77888
Q ss_pred eEEeccccccccccccccccccccccccccCCCcccCC--------CCCCcchhhHhHHHHHHHHHhCCCCCCcccccch
Q 002857 314 ACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMG--------HETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNL 385 (873)
Q Consensus 314 vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~--------~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~ 385 (873)
+||+|||+++....... .....||..|+|||++.+ ..++.++||||||+++|||+||+.||........
T Consensus 155 ~kL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~ 231 (396)
T 4eut_A 155 YKLTDFGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR 231 (396)
T ss_dssp EEECCGGGCEECCCGGG---SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTT
T ss_pred EEEecCCCceEccCCCc---cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccc
Confidence 99999999987644322 223468999999998764 4678899999999999999999999965322111
Q ss_pred --h-hHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHH
Q 002857 386 --N-LQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVE 462 (873)
Q Consensus 386 --~-l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl 462 (873)
. +...........+..+ .........+ ....+... .........+.+++.+||+.||++||++.|++
T Consensus 232 ~~~~~~~~~~~~p~~~~~~~-~~~~~~~~~~------~~~~~~~~---~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l 301 (396)
T 4eut_A 232 NKEVMYKIITGKPSGAISGV-QKAENGPIDW------SGDMPVSC---SLSRGLQVLLTPVLANILEADQEKCWGFDQFF 301 (396)
T ss_dssp CHHHHHHHHHSCCTTCCEEE-ECSTTCCEEE------ESSCCTTC---SSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHH
T ss_pred hHHHHHHHhcCCCcccchhh-eeccCCCccc------CccCCccc---ccchHHHhhchHHHHHhhccChhhhccHHHHH
Confidence 1 1111110000000000 0000000000 00000000 11123345688999999999999999999999
Q ss_pred HHHHHHHHh
Q 002857 463 LGLRLIKKK 471 (873)
Q Consensus 463 ~~Le~i~~~ 471 (873)
+.|+.+...
T Consensus 302 ~~l~~il~~ 310 (396)
T 4eut_A 302 AETSDILHR 310 (396)
T ss_dssp HHHHHHHTC
T ss_pred HHHHHHhhc
Confidence 999887654
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=335.25 Aligned_cols=257 Identities=23% Similarity=0.293 Sum_probs=201.3
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCc------chhHHHHHHHHHHhhhhccceeeeeeeecccccC
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHD------ASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQG 233 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~------~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~ 233 (873)
++|.+.+.||+|+||.||+|++..+++.||+|+++..... ..+.+.+|++++++++||||+++++++ ..
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~ 79 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIF-----EN 79 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----EC
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhhee-----cC
Confidence 5689999999999999999999888999999998743221 346799999999999999999999996 44
Q ss_pred CceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCC-
Q 002857 234 NDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEM- 312 (873)
Q Consensus 234 ~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~- 312 (873)
....++||||+++++|.+++.. ...+++..++.++.||+.||+||| +.+|+||||||+||+++.++
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~ 146 (283)
T 3bhy_A 80 KTDVVLILELVSGGELFDFLAE----------KESLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNV 146 (283)
T ss_dssp SSEEEEEEECCCSCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSS
T ss_pred CCeEEEEEeecCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCCC
Confidence 6678999999999999999842 346899999999999999999999 88999999999999998877
Q ss_pred ---CeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHH
Q 002857 313 ---TACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQN 389 (873)
Q Consensus 313 ---~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~ 389 (873)
.+||+|||++........ .....++..|+|||++.+..++.++||||||+++|||++|+.||....... ..
T Consensus 147 ~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~- 220 (283)
T 3bhy_A 147 PNPRIKLIDFGIAHKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE--TL- 220 (283)
T ss_dssp SSCCEEECCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH--HH-
T ss_pred CCCceEEEecccceeccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH--HH-
Confidence 899999999986543221 223458999999999999999999999999999999999999997532111 00
Q ss_pred HHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH--HHHH
Q 002857 390 WVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL--GLRL 467 (873)
Q Consensus 390 ~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~--~Le~ 467 (873)
..+........ ..........+.+++.+||+.||++|||+.|+++ .++.
T Consensus 221 ----------~~~~~~~~~~~-------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 271 (283)
T 3bhy_A 221 ----------TNISAVNYDFD-------------------EEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKA 271 (283)
T ss_dssp ----------HHHHTTCCCCC-------------------HHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHH
T ss_pred ----------HHhHhcccCCc-------------------chhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHH
Confidence 00000000000 0000111235788999999999999999999987 4555
Q ss_pred HH
Q 002857 468 IK 469 (873)
Q Consensus 468 i~ 469 (873)
++
T Consensus 272 ~~ 273 (283)
T 3bhy_A 272 IR 273 (283)
T ss_dssp HH
T ss_pred HH
Confidence 43
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=352.85 Aligned_cols=245 Identities=20% Similarity=0.275 Sum_probs=199.6
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeecc---CCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCce
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFL---HHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDF 236 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~ 236 (873)
++|++.+.||+|+||.||+|++..+++.||||+++.. .....+.+.+|+.+|++++||||+++++++ .....
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~ 115 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-----KDNSN 115 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EcCCE
Confidence 5789999999999999999999989999999998643 223456788999999999999999999985 45678
Q ss_pred EEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEE
Q 002857 237 KALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACV 316 (873)
Q Consensus 237 ~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKL 316 (873)
.++||||+++|+|.+++.. ...+++..++.++.||+.||+||| +.+|+||||||+|||++.++.+||
T Consensus 116 ~~lv~e~~~gg~L~~~l~~----------~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL 182 (350)
T 1rdq_E 116 LYMVMEYVAGGEMFSHLRR----------IGRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQV 182 (350)
T ss_dssp EEEEEECCTTCBHHHHHHH----------HCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEE
T ss_pred EEEEEcCCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEECCCCCEEE
Confidence 9999999999999999953 245899999999999999999999 899999999999999999999999
Q ss_pred eccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCc
Q 002857 317 ADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALP 396 (873)
Q Consensus 317 sDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~ 396 (873)
+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....... .
T Consensus 183 ~DFg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~--------- 246 (350)
T 1rdq_E 183 TDFGFAKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ--I--------- 246 (350)
T ss_dssp CCCTTCEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--H---------
T ss_pred cccccceeccCC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH--H---------
Confidence 999999865332 223569999999999999999999999999999999999999996531110 0
Q ss_pred hhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCC-----HHHHHH
Q 002857 397 ERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMK-----INDVEL 463 (873)
Q Consensus 397 ~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPT-----m~EVl~ 463 (873)
...+....+ ..|. .....+.+++.+||+.||++||+ +.||++
T Consensus 247 --~~~i~~~~~--------------~~p~---------~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 247 --YEKIVSGKV--------------RFPS---------HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp --HHHHHHCCC--------------CCCT---------TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred --HHHHHcCCC--------------CCCC---------CCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 011111000 0010 01224778999999999999998 777653
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=363.32 Aligned_cols=211 Identities=24% Similarity=0.275 Sum_probs=182.0
Q ss_pred CHHHHHHhhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeecc---CCcchhHHHHHHHHHHhhhhccceeeeeeee
Q 002857 151 SYEALYSATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFL---HHDASKSFTVECEVMRNIIHRKIIKVVTACS 227 (873)
Q Consensus 151 s~~el~~at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~ 227 (873)
.+.++...+++|++.++||+|+||.||+|++..+++.||||+++.. .......+.+|+.++..++||||++++++|
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~- 143 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF- 143 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE-
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-
Confidence 3455666788999999999999999999999999999999999742 222334589999999999999999999996
Q ss_pred cccccCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCee
Q 002857 228 RVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNIL 307 (873)
Q Consensus 228 ~~~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNIL 307 (873)
...+..+|||||+++|+|.++|.. ....+++..+..++.||+.||+||| +.+|+||||||+|||
T Consensus 144 ----~~~~~~~lV~Ey~~gg~L~~~l~~---------~~~~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NIL 207 (437)
T 4aw2_A 144 ----QDDNNLYLVMDYYVGGDLLTLLSK---------FEDRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNIL 207 (437)
T ss_dssp ----ECSSEEEEEECCCTTCBHHHHHHT---------TTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEE
T ss_pred ----eeCCEEEEEEecCCCCcHHHHHHH---------ccCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHee
Confidence 456789999999999999999952 2456999999999999999999999 899999999999999
Q ss_pred eCCCCCeEEeccccccccccccccccccccccccccCCCcccC-----CCCCCcchhhHhHHHHHHHHHhCCCCCCc
Q 002857 308 LNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGM-----GHETSSYGDVYSFGILLLEMFTGLRPSDD 379 (873)
Q Consensus 308 Ld~~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~-----~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~ 379 (873)
++.++++||+|||+++....... .......||+.|+|||++. ...++.++|||||||++|||++|+.||..
T Consensus 208 l~~~g~vkL~DFGla~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~ 283 (437)
T 4aw2_A 208 MDMNGHIRLADFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYA 283 (437)
T ss_dssp ECTTSCEEECCCTTCEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred EcCCCCEEEcchhhhhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999986543322 2223356999999999987 56789999999999999999999999975
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=361.95 Aligned_cols=260 Identities=20% Similarity=0.237 Sum_probs=204.5
Q ss_pred HHHHHHhhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeecc---CCcchhHHHHHHHHHHhhhhccceeeeeeeec
Q 002857 152 YEALYSATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFL---HHDASKSFTVECEVMRNIIHRKIIKVVTACSR 228 (873)
Q Consensus 152 ~~el~~at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~ 228 (873)
+.++....++|++.++||+|+||.||+|++..+++.||+|+++.. .......+.+|+.+++.++||||+++++++
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-- 138 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF-- 138 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEE--
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE--
Confidence 345556678999999999999999999999999999999998642 223345688999999999999999999995
Q ss_pred ccccCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeee
Q 002857 229 VDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILL 308 (873)
Q Consensus 229 ~~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILL 308 (873)
......+|||||+++|+|.++++. ..+++..+..++.||+.||+||| +.+|+||||||+|||+
T Consensus 139 ---~~~~~~~lV~E~~~gg~L~~~l~~-----------~~~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl 201 (410)
T 3v8s_A 139 ---QDDRYLYMVMEYMPGGDLVNLMSN-----------YDVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLL 201 (410)
T ss_dssp ---ECSSEEEEEECCCTTEEHHHHHHH-----------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEE
T ss_pred ---EECCEEEEEEeCCCCCcHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeeE
Confidence 456789999999999999999842 24888999999999999999999 8999999999999999
Q ss_pred CCCCCeEEeccccccccccccccccccccccccccCCCcccCCCC----CCcchhhHhHHHHHHHHHhCCCCCCcccccc
Q 002857 309 NDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHE----TSSYGDVYSFGILLLEMFTGLRPSDDMFKDN 384 (873)
Q Consensus 309 d~~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~----~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~ 384 (873)
+.++++||+|||+++....... .......||+.|+|||++.+.. ++.++|||||||++|||++|+.||.......
T Consensus 202 ~~~g~ikL~DFG~a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~ 280 (410)
T 3v8s_A 202 DKSGHLKLADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG 280 (410)
T ss_dssp CTTSCEEECCCTTCEECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred CCCCCEEEeccceeEeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhh
Confidence 9999999999999986643321 1223456999999999987665 7899999999999999999999997532110
Q ss_pred hhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCC--CCCHHHHH
Q 002857 385 LNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGE--RMKINDVE 462 (873)
Q Consensus 385 ~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~e--RPTm~EVl 462 (873)
....++..... ...|.... ....+.+|+.+||+.+|++ ||++.||+
T Consensus 281 -------------~~~~i~~~~~~------------~~~p~~~~-------~s~~~~~li~~lL~~~~~rlgR~~~~ei~ 328 (410)
T 3v8s_A 281 -------------TYSKIMNHKNS------------LTFPDDND-------ISKEAKNLICAFLTDREVRLGRNGVEEIK 328 (410)
T ss_dssp -------------HHHHHHTHHHH------------CCCCTTCC-------CCHHHHHHHHHHSSCGGGCTTSSCHHHHH
T ss_pred -------------HHHHHHhcccc------------ccCCCccc-------ccHHHHHHHHHHccChhhhCCCCCHHHHh
Confidence 01111110000 00011000 1224778999999999988 99999886
Q ss_pred H
Q 002857 463 L 463 (873)
Q Consensus 463 ~ 463 (873)
+
T Consensus 329 ~ 329 (410)
T 3v8s_A 329 R 329 (410)
T ss_dssp T
T ss_pred c
Confidence 5
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=337.75 Aligned_cols=254 Identities=22% Similarity=0.271 Sum_probs=195.6
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC-CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceE
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH-HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFK 237 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~ 237 (873)
.++|.+.+.||+|+||.||+|.+..++..||+|++.... ....+.+.+|++++++++||||+++++++ ......
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~ 95 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF-----EDYHNM 95 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSSEE
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHhe-----ecCCeE
Confidence 357889999999999999999999999999999987543 33457899999999999999999999996 456678
Q ss_pred EEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeee---CCCCCe
Q 002857 238 ALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILL---NDEMTA 314 (873)
Q Consensus 238 ~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILL---d~~~~v 314 (873)
++||||+++|+|.+++.... .....+++..++.|+.||+.||+||| +.+|+||||||+|||+ +.++.+
T Consensus 96 ~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~~ 166 (285)
T 3is5_A 96 YIVMETCEGGELLERIVSAQ------ARGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPI 166 (285)
T ss_dssp EEEECCCSCCBHHHHHHHHH------HHTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCCE
T ss_pred EEEEEeCCCCcHHHHHHhhh------hcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHEEEecCCCCCCE
Confidence 99999999999999985311 12456899999999999999999999 8999999999999999 456789
Q ss_pred EEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhc
Q 002857 315 CVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSA 394 (873)
Q Consensus 315 KLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~ 394 (873)
||+|||+++...... ......||..|+|||++. ..++.++||||||+++|||++|+.||........
T Consensus 167 kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~--------- 233 (285)
T 3is5_A 167 KIIDFGLAELFKSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEV--------- 233 (285)
T ss_dssp EECCCCCCCC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---------
T ss_pred EEEeeecceecCCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHH---------
Confidence 999999998654332 123346899999999875 5689999999999999999999999976321110
Q ss_pred CchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 395 LPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 395 ~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
........ ......... ....+.+++.+||+.||++|||+.||++
T Consensus 234 --------~~~~~~~~------------~~~~~~~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 234 --------QQKATYKE------------PNYAVECRP----LTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp --------HHHHHHCC------------CCCCC--CC----CCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred --------HhhhccCC------------cccccccCc----CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000000 000000000 1224778999999999999999999874
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=338.89 Aligned_cols=255 Identities=24% Similarity=0.349 Sum_probs=196.2
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEE
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKA 238 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~ 238 (873)
.++|++.+.||+|+||.||+|.+ .++.||||+++.. ...+.+.+|++++++++||||+++++++. ...+..+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----~~~~~~~ 91 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIV----EEKGGLY 91 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEEC----CC--CCE
T ss_pred hhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEE----cCCCceE
Confidence 46789999999999999999987 4789999998743 24578999999999999999999999863 3344689
Q ss_pred EEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEec
Q 002857 239 LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVAD 318 (873)
Q Consensus 239 LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsD 318 (873)
+||||+++|+|.+++.. .....+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|
T Consensus 92 lv~e~~~~~~L~~~l~~--------~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~D 160 (278)
T 1byg_A 92 IVTEYMAKGSLVDYLRS--------RGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSD 160 (278)
T ss_dssp EEECCCTTEEHHHHHHH--------HHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECC
T ss_pred EEEecCCCCCHHHHHHh--------cccccCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceEEEeCCCcEEEee
Confidence 99999999999999953 11223788899999999999999999 89999999999999999999999999
Q ss_pred cccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHHHhhcCch
Q 002857 319 FGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQSALPE 397 (873)
Q Consensus 319 FGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~~~~~~~~ 397 (873)
||+++...... ....++..|+|||++.+..++.++||||||+++|||+| |+.||....... ...
T Consensus 161 fg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~--~~~-------- 225 (278)
T 1byg_A 161 FGLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVP-------- 225 (278)
T ss_dssp CCC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG--HHH--------
T ss_pred ccccccccccc-----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH--HHH--------
Confidence 99998553321 12347889999999988899999999999999999998 999997532111 000
Q ss_pred hHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHHHHhh
Q 002857 398 RVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLIKKKL 472 (873)
Q Consensus 398 ~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i~~~l 472 (873)
.+... ... +.. ..+...+.+++.+||+.||++|||+.||++.|+.++...
T Consensus 226 ---~~~~~-~~~--------------~~~-------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~ 275 (278)
T 1byg_A 226 ---RVEKG-YKM--------------DAP-------DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 275 (278)
T ss_dssp ---HHTTT-CCC--------------CCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred ---HHhcC-CCC--------------CCc-------ccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence 00000 000 000 011235788999999999999999999999999987643
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=356.42 Aligned_cols=206 Identities=24% Similarity=0.307 Sum_probs=170.6
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCC--cchhHHHHHHHHHHhhhhccceeeeeeeecccccCCce
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH--DASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDF 236 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~ 236 (873)
.++|.+.+.||+|+||.||+|++..+++.||||+++.... ...+.+.+|+++|++++|+||+++++++....+.....
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 5689999999999999999999999999999999974322 23467899999999999999999999975443333467
Q ss_pred EEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEE
Q 002857 237 KALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACV 316 (873)
Q Consensus 237 ~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKL 316 (873)
.++||||+. |+|.+++. ....+++..++.|+.||+.||+||| +.+|+||||||+|||++.++.+||
T Consensus 105 ~~lv~e~~~-~~L~~~~~----------~~~~l~~~~~~~i~~qil~aL~~LH---~~givHrDlkp~NILl~~~~~~kL 170 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFK----------TPIFLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKV 170 (432)
T ss_dssp EEEEEECCS-EEHHHHHH----------SSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEE
T ss_pred EEEEEecCC-cCHHHHHh----------ccCCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHeEECCCCCEEE
Confidence 999999986 59999984 3456899999999999999999999 889999999999999999999999
Q ss_pred ecccccccccccccc--------------------ccccccccccccCCCccc-CCCCCCcchhhHhHHHHHHHHHhCCC
Q 002857 317 ADFGIARFLEATNEQ--------------------TSSIGVKGTTGYIAPEYG-MGHETSSYGDVYSFGILLLEMFTGLR 375 (873)
Q Consensus 317 sDFGla~~~~~~~~~--------------------~~~~~~~Gt~~Y~APE~l-~~~~~s~ksDVwSfGvvL~ELlTGk~ 375 (873)
+|||+++........ .......||..|+|||++ ....++.++|||||||++|||++|..
T Consensus 171 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~ 250 (432)
T 3n9x_A 171 CDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQ 250 (432)
T ss_dssp CCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCT
T ss_pred ccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccc
Confidence 999999876443211 112446789999999985 55679999999999999999999766
Q ss_pred CCC
Q 002857 376 PSD 378 (873)
Q Consensus 376 Pf~ 378 (873)
||.
T Consensus 251 p~~ 253 (432)
T 3n9x_A 251 SHI 253 (432)
T ss_dssp TTC
T ss_pred ccc
Confidence 654
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-38 Score=348.06 Aligned_cols=287 Identities=18% Similarity=0.219 Sum_probs=205.9
Q ss_pred HhhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCC-cchhHHHHHHHHHHhhhhccceeeeeeeecccccCCc
Q 002857 157 SATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH-DASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGND 235 (873)
Q Consensus 157 ~at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~ 235 (873)
...++|++.+.||+|+||.||+|.+..+++.||||++..... ...+.+.+|++++++++||||+++++++.........
T Consensus 24 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 103 (364)
T 3qyz_A 24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 103 (364)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred cccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence 345689999999999999999999998999999999974332 2336789999999999999999999997654434446
Q ss_pred eEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeE
Q 002857 236 FKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTAC 315 (873)
Q Consensus 236 ~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vK 315 (873)
..++||||+. |+|.+++.. ..+++.+++.|+.||+.||+||| +.+|+||||||+|||++.++.+|
T Consensus 104 ~~~iv~e~~~-~~L~~~l~~-----------~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~k 168 (364)
T 3qyz_A 104 DVYIVQDLME-TDLYKLLKT-----------QHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLK 168 (364)
T ss_dssp CEEEEEECCS-EEHHHHHHH-----------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEE
T ss_pred eEEEEEcccC-cCHHHHHHh-----------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEEECCCCCEE
Confidence 7899999997 599998842 35899999999999999999999 89999999999999999999999
Q ss_pred Eeccccccccccccccc-cccccccccccCCCcccCC-CCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhh
Q 002857 316 VADFGIARFLEATNEQT-SSIGVKGTTGYIAPEYGMG-HETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQS 393 (873)
Q Consensus 316 LsDFGla~~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~ 393 (873)
|+|||+++......... ......||..|+|||++.+ ..++.++||||||+++|||++|+.||....... .+.... .
T Consensus 169 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~i~-~ 246 (364)
T 3qyz_A 169 ICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD-QLNHIL-G 246 (364)
T ss_dssp ECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGG-HHHHHH-H
T ss_pred EEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHH-HHHHHH-H
Confidence 99999998765432221 1234569999999998654 458999999999999999999999997633221 111111 1
Q ss_pred cCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 394 ALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 394 ~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
.......+.+....... .+...... ..+...............+.+|+.+||+.||++|||+.|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~--~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 247 ILGSPSQEDLNCIINLK--ARNYLLSL-PHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HHCSCCHHHHHTCCCHH--HHHHHHTS-CCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HhCCCCHHHHHHhhhhh--HHHHHHhc-CCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 11100001010000000 00000000 000000011111112345789999999999999999999864
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=354.53 Aligned_cols=259 Identities=20% Similarity=0.247 Sum_probs=192.6
Q ss_pred hcCCCcc-eeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhh-hhccceeeeeeeecccccCCce
Q 002857 159 TKGFSSE-NLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNI-IHRKIIKVVTACSRVDYQGNDF 236 (873)
Q Consensus 159 t~~f~~~-~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~llg~c~~~~~~~~~~ 236 (873)
.++|.+. ++||+|+||.||+|.+..+++.||||+++. ...+.+|++++.++ +||||+++++++... +.+...
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~-~~~~~~ 133 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENL-YAGRKC 133 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeec-ccCCcE
Confidence 3466665 789999999999999999999999999862 25678899988555 899999999986432 233567
Q ss_pred EEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCC---CCC
Q 002857 237 KALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLND---EMT 313 (873)
Q Consensus 237 ~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~---~~~ 313 (873)
.+|||||+++|+|.+++.. .....+++.+++.|+.||+.||.||| +.+|+||||||+|||++. ++.
T Consensus 134 ~~lv~E~~~gg~L~~~l~~--------~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~~ 202 (400)
T 1nxk_A 134 LLIVMECLDGGELFSRIQD--------RGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAI 202 (400)
T ss_dssp EEEEEECCCSEEHHHHHHC--------C---CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSTTCC
T ss_pred EEEEEEeCCCCcHHHHHHH--------hCCCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCcceEEEecCCCCcc
Confidence 8999999999999999953 22346999999999999999999999 899999999999999997 789
Q ss_pred eEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhh
Q 002857 314 ACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQS 393 (873)
Q Consensus 314 vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~ 393 (873)
+||+|||+++...... ......||..|+|||++.+..++.++|||||||++|||++|+.||.........
T Consensus 203 ~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~------- 272 (400)
T 1nxk_A 203 LKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS------- 272 (400)
T ss_dssp EEECCCTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSC-------
T ss_pred EEEEecccccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcccccc-------
Confidence 9999999998654322 223456899999999999999999999999999999999999999753221100
Q ss_pred cCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHH
Q 002857 394 ALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGL 465 (873)
Q Consensus 394 ~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~L 465 (873)
......+....+.. ....+ ..+...+.+|+.+||+.||++|||+.||++.-
T Consensus 273 --~~~~~~i~~~~~~~-----------~~~~~--------~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp 323 (400)
T 1nxk_A 273 --PGMKTRIRMGQYEF-----------PNPEW--------SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 323 (400)
T ss_dssp --CSHHHHHHHTCCCC-----------CTTTT--------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred --HHHHHHHHcCcccC-----------CCccc--------ccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 00000110000000 00000 01123478899999999999999999998753
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=348.85 Aligned_cols=243 Identities=24% Similarity=0.327 Sum_probs=199.7
Q ss_pred hhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCC--------cchhHHHHHHHHHHhhhhccceeeeeeeecc
Q 002857 158 ATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH--------DASKSFTVECEVMRNIIHRKIIKVVTACSRV 229 (873)
Q Consensus 158 at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~--------~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~ 229 (873)
..++|.+.+.||+|+||.||+|++..+++.||||+++.... .....+.+|++++++++||||+++++++
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~--- 98 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIF--- 98 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEE---
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEE---
Confidence 35689999999999999999999999999999999975432 1334688899999999999999999996
Q ss_pred cccCCceEEEEEeecCCC-ChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeee
Q 002857 230 DYQGNDFKALVYEFMPNG-SLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILL 308 (873)
Q Consensus 230 ~~~~~~~~~LV~Ey~~~G-SL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILL 308 (873)
...+..++||||+.+| +|.+++. ....+++..++.|+.||+.||+||| +.+|+||||||+|||+
T Consensus 99 --~~~~~~~lv~e~~~~g~~l~~~~~----------~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll 163 (335)
T 3dls_A 99 --ENQGFFQLVMEKHGSGLDLFAFID----------RHPRLDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVI 163 (335)
T ss_dssp --ECSSEEEEEEECCTTSCBHHHHHH----------TCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEE
T ss_pred --eeCCEEEEEEEeCCCCccHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEE
Confidence 4567889999999777 9999984 3456999999999999999999999 8899999999999999
Q ss_pred CCCCCeEEeccccccccccccccccccccccccccCCCcccCCCCC-CcchhhHhHHHHHHHHHhCCCCCCcccccchhh
Q 002857 309 NDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHET-SSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNL 387 (873)
Q Consensus 309 d~~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~-s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l 387 (873)
+.++.+||+|||+++....... .....||..|+|||++.+..+ +.++||||||+++|||++|+.||......
T Consensus 164 ~~~~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---- 236 (335)
T 3dls_A 164 AEDFTIKLIDFGSAAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET---- 236 (335)
T ss_dssp CTTSCEEECCCTTCEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG----
T ss_pred cCCCcEEEeecccceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH----
Confidence 9999999999999987644322 223568999999999988876 88999999999999999999999652110
Q ss_pred HHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 388 QNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 388 ~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
....+ ..|.. ....+.+++.+||+.||++|||+.||++
T Consensus 237 ---------------~~~~~--------------~~~~~---------~~~~l~~li~~~L~~dP~~Rps~~ell~ 274 (335)
T 3dls_A 237 ---------------VEAAI--------------HPPYL---------VSKELMSLVSGLLQPVPERRTTLEKLVT 274 (335)
T ss_dssp ---------------TTTCC--------------CCSSC---------CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------Hhhcc--------------CCCcc---------cCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000 00000 1224778999999999999999999865
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=341.05 Aligned_cols=263 Identities=23% Similarity=0.345 Sum_probs=204.0
Q ss_pred HhhcCCCcce-eecccCceEEEEEEE--cCCCcEEEEEEeeccCC--cchhHHHHHHHHHHhhhhccceeeeeeeecccc
Q 002857 157 SATKGFSSEN-LIGAGNFASVYKGIL--FEGAPAVAIKVFNFLHH--DASKSFTVECEVMRNIIHRKIIKVVTACSRVDY 231 (873)
Q Consensus 157 ~at~~f~~~~-~LG~G~fG~VYkg~~--~~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~ 231 (873)
...++|.+.+ .||+|+||.||+|.+ ..+++.||||+++.... ...+.+.+|++++++++||||+++++++
T Consensus 13 ~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~----- 87 (291)
T 1xbb_A 13 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC----- 87 (291)
T ss_dssp CCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----
T ss_pred ecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-----
Confidence 3446788887 999999999999965 45578999999975432 2346799999999999999999999986
Q ss_pred cCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCC
Q 002857 232 QGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDE 311 (873)
Q Consensus 232 ~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~ 311 (873)
..+..++||||+++++|.+++.. ...+++..++.++.||+.||+||| +.+|+||||||+|||++.+
T Consensus 88 -~~~~~~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~~~ 153 (291)
T 1xbb_A 88 -EAESWMLVMEMAELGPLNKYLQQ----------NRHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQ 153 (291)
T ss_dssp -ESSSEEEEEECCTTEEHHHHHHH----------CTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEET
T ss_pred -CCCCcEEEEEeCCCCCHHHHHHh----------CcCCCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEeCC
Confidence 23457999999999999999943 345889999999999999999999 8899999999999999999
Q ss_pred CCeEEeccccccccccccccc-cccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHH
Q 002857 312 MTACVADFGIARFLEATNEQT-SSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQN 389 (873)
Q Consensus 312 ~~vKLsDFGla~~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~ 389 (873)
+.+||+|||+++......... ......++..|+|||++.+..++.++||||||+++|||+| |+.||....... ..
T Consensus 154 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~- 230 (291)
T 1xbb_A 154 HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--VT- 230 (291)
T ss_dssp TEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HH-
T ss_pred CcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH--HH-
Confidence 999999999998764432211 1222346788999999988889999999999999999999 999997632111 11
Q ss_pred HHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHHH
Q 002857 390 WVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLIK 469 (873)
Q Consensus 390 ~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i~ 469 (873)
..+..... .+.. ..+...+.+++.+||+.||++|||+.||++.|+.+.
T Consensus 231 -----------~~~~~~~~--------------~~~~-------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 278 (291)
T 1xbb_A 231 -----------AMLEKGER--------------MGCP-------AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 278 (291)
T ss_dssp -----------HHHHTTCC--------------CCCC-------TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred -----------HHHHcCCC--------------CCCC-------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11100000 0000 011235788999999999999999999999999987
Q ss_pred Hhhh
Q 002857 470 KKLL 473 (873)
Q Consensus 470 ~~l~ 473 (873)
....
T Consensus 279 ~~~~ 282 (291)
T 1xbb_A 279 YDVV 282 (291)
T ss_dssp HHHH
T ss_pred HHHh
Confidence 6554
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=354.81 Aligned_cols=251 Identities=22% Similarity=0.334 Sum_probs=191.6
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCC--cchhHHHHHHHHHHhhh--hccceeeeeeeecccccCCc
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH--DASKSFTVECEVMRNII--HRKIIKVVTACSRVDYQGND 235 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~--HpNIV~llg~c~~~~~~~~~ 235 (873)
++|.+.+.||+|+||.||+|.+.. ++.||||++..... ...+.+.+|+++|++++ |+||+++++++ ...+
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~-----~~~~ 129 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE-----ITDQ 129 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECSS
T ss_pred CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEE-----ecCC
Confidence 459999999999999999998754 88999999875432 33467999999999996 59999999986 3456
Q ss_pred eEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeE
Q 002857 236 FKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTAC 315 (873)
Q Consensus 236 ~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vK 315 (873)
..+|||| +.+++|.+++.. ...+++.+++.|+.||+.||.||| +.+|+||||||+|||++ ++.+|
T Consensus 130 ~~~lv~E-~~~~~L~~~l~~----------~~~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~k 194 (390)
T 2zmd_A 130 YIYMVME-CGNIDLNSWLKK----------KKSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLK 194 (390)
T ss_dssp EEEEEEE-CCSEEHHHHHHH----------CSSCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEE
T ss_pred EEEEEEe-cCCCCHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEE
Confidence 7999999 568899999953 346888899999999999999999 89999999999999996 57999
Q ss_pred EeccccccccccccccccccccccccccCCCcccCC-----------CCCCcchhhHhHHHHHHHHHhCCCCCCcccccc
Q 002857 316 VADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMG-----------HETSSYGDVYSFGILLLEMFTGLRPSDDMFKDN 384 (873)
Q Consensus 316 LsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-----------~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~ 384 (873)
|+|||+++.+.............||+.|+|||++.+ ..++.++|||||||++|||++|+.||.......
T Consensus 195 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~ 274 (390)
T 2zmd_A 195 LIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI 274 (390)
T ss_dssp ECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH
T ss_pred EEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH
Confidence 999999987654333222334569999999999865 368999999999999999999999996532111
Q ss_pred hhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHH
Q 002857 385 LNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELG 464 (873)
Q Consensus 385 ~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~ 464 (873)
. .+..+++...... .|... ...+.+|+.+||+.||++|||+.||++.
T Consensus 275 ~------------~~~~~~~~~~~~~------------~~~~~---------~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 275 S------------KLHAIIDPNHEIE------------FPDIP---------EKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp H------------HHHHHHCTTSCCC------------CCCCS---------CHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred H------------HHHHHhCccccCC------------CCccc---------hHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 1 1112222111100 01000 1247789999999999999999999864
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=348.96 Aligned_cols=200 Identities=25% Similarity=0.309 Sum_probs=174.9
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCC---cchhHHHHHHHHHHhh-hhccceeeeeeeecccccCCc
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH---DASKSFTVECEVMRNI-IHRKIIKVVTACSRVDYQGND 235 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~L-~HpNIV~llg~c~~~~~~~~~ 235 (873)
++|++.+.||+|+||.||+|++..+++.||||+++.... ...+.+.+|+.++.++ +||||+++++++ ....
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~-----~~~~ 83 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----QTES 83 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECSS
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEE-----EeCC
Confidence 578999999999999999999999999999999975432 2345688899999988 899999999995 4567
Q ss_pred eEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeE
Q 002857 236 FKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTAC 315 (873)
Q Consensus 236 ~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vK 315 (873)
..++||||+++|+|.+++.. ...+++..++.++.||+.||+||| +.+|+||||||+|||++.++++|
T Consensus 84 ~~~lv~e~~~gg~L~~~l~~----------~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~k 150 (345)
T 3a8x_A 84 RLFFVIEYVNGGDLMFHMQR----------QRKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIK 150 (345)
T ss_dssp EEEEEECCCCSCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEE
T ss_pred EEEEEEeCCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEE
Confidence 89999999999999999842 245899999999999999999999 89999999999999999999999
Q ss_pred EeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCc
Q 002857 316 VADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDD 379 (873)
Q Consensus 316 LsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~ 379 (873)
|+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 151 L~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 212 (345)
T 3a8x_A 151 LTDYGMCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 212 (345)
T ss_dssp ECCGGGCBCSCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred EEeccccccccCCC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCC
Confidence 99999998543221 123345699999999999999999999999999999999999999965
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-39 Score=366.48 Aligned_cols=249 Identities=20% Similarity=0.260 Sum_probs=191.4
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeecc---CCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCc
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFL---HHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGND 235 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~ 235 (873)
.++|++.++||+|+||.||+|.+..+++.||||+++.. .......+.+|+.++++++||||+++++++ ...+
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~-----~~~~ 221 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF-----QTHD 221 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEE-----EETT
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEE-----eeCC
Confidence 46799999999999999999999999999999999743 333446788899999999999999999996 4456
Q ss_pred eEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCC-CCeeeccCCCCCeeeCCCCCe
Q 002857 236 FKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCK-PPIAHCDIKPSNILLNDEMTA 314 (873)
Q Consensus 236 ~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s-~gIvHrDLKpsNILLd~~~~v 314 (873)
..+|||||+++|+|.+++.. ...+++..+..|+.||+.||+||| + .+|+||||||+|||++.++.+
T Consensus 222 ~~~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~~~~qi~~aL~~LH---~~~giiHrDlkp~NIll~~~~~~ 288 (446)
T 4ejn_A 222 RLCFVMEYANGGELFFHLSR----------ERVFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHI 288 (446)
T ss_dssp EEEEEECCCSSCBHHHHHHH----------HSCCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCCCGGGEEECSSSCE
T ss_pred EEEEEEeeCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHh---hcCCEEECCCCHHHEEECCCCCE
Confidence 78999999999999999842 346899999999999999999999 6 899999999999999999999
Q ss_pred EEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhc
Q 002857 315 CVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSA 394 (873)
Q Consensus 315 KLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~ 394 (873)
||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 289 kl~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---------- 356 (446)
T 4ejn_A 289 KITDFGLCKEGIKDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---------- 356 (446)
T ss_dssp EECCCCCCCTTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----------
T ss_pred EEccCCCceeccCCC--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH----------
Confidence 999999998543222 22234569999999999999999999999999999999999999996532111
Q ss_pred CchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCC-----CHHHHHH
Q 002857 395 LPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERM-----KINDVEL 463 (873)
Q Consensus 395 ~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRP-----Tm~EVl~ 463 (873)
+......... ..|.. ....+.+++.+||+.||++|| ++.|+++
T Consensus 357 -------~~~~i~~~~~----------~~p~~---------~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 357 -------LFELILMEEI----------RFPRT---------LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp -------HHHHHHHCCC----------CCCTT---------SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -------HHHHHHhCCC----------CCCcc---------CCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 1111110000 00100 122477899999999999999 9998865
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=346.71 Aligned_cols=201 Identities=24% Similarity=0.332 Sum_probs=165.0
Q ss_pred hcCCCcceeecccCceEEEEEEEc---CCCcEEEEEEeeccC----CcchhHHHHHHHHHHhhhhccceeeeeeeecccc
Q 002857 159 TKGFSSENLIGAGNFASVYKGILF---EGAPAVAIKVFNFLH----HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDY 231 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~---~~g~~VAVK~l~~~~----~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~ 231 (873)
.++|++.+.||+|+||.||+|+.. .+++.||||+++... ......+.+|+.+|++++||||+++++++
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~----- 90 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAF----- 90 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEE-----
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEE-----
Confidence 467999999999999999999885 578999999997432 22345688899999999999999999996
Q ss_pred cCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCC
Q 002857 232 QGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDE 311 (873)
Q Consensus 232 ~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~ 311 (873)
...+..++||||+++|+|.+++.. ...+++..++.++.||+.||.||| +.+|+||||||+|||++.+
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~ 157 (327)
T 3a62_A 91 QTGGKLYLILEYLSGGELFMQLER----------EGIFMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQ 157 (327)
T ss_dssp ECSSCEEEEEECCTTEEHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTT
T ss_pred EcCCEEEEEEeCCCCCcHHHHHHh----------CCCCCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEECCC
Confidence 456679999999999999999842 345888999999999999999999 8899999999999999999
Q ss_pred CCeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCc
Q 002857 312 MTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDD 379 (873)
Q Consensus 312 ~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~ 379 (873)
+.+||+|||+++...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 158 ~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 223 (327)
T 3a62_A 158 GHVKLTDFGLCKESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTG 223 (327)
T ss_dssp SCEEECCCSCC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CcEEEEeCCcccccccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCC
Confidence 999999999997543222 122335689999999999999999999999999999999999999975
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=334.45 Aligned_cols=250 Identities=24% Similarity=0.371 Sum_probs=180.6
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC---CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCc
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH---HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGND 235 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~ 235 (873)
.++|.+.+.||+|+||.||+|++..+++.||||++.... ....+.+.+|++++++++||||+++++++ ...+
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~ 84 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYF-----EDSN 84 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEE-----ECSS
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEE-----ccCC
Confidence 467999999999999999999998899999999986432 22346789999999999999999999996 4566
Q ss_pred eEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeE
Q 002857 236 FKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTAC 315 (873)
Q Consensus 236 ~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vK 315 (873)
..++||||+++++|.+++.. ....+++..++.++.||+.||+||| +.+|+||||||+|||++.++.+|
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~k 152 (278)
T 3cok_A 85 YVYLVLEMCHNGEMNRYLKN---------RVKPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIK 152 (278)
T ss_dssp EEEEEEECCTTEEHHHHHHT---------CSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEECTTCCEE
T ss_pred eEEEEEecCCCCcHHHHHhh---------ccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEE
Confidence 78999999999999999852 3356899999999999999999999 88999999999999999999999
Q ss_pred EeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcC
Q 002857 316 VADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSAL 395 (873)
Q Consensus 316 LsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~ 395 (873)
|+|||++........ ......||..|+|||++.+..++.++||||||+++|||++|+.||........
T Consensus 153 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---------- 220 (278)
T 3cok_A 153 IADFGLATQLKMPHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT---------- 220 (278)
T ss_dssp ECCCTTCEECC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------------
T ss_pred EEeecceeeccCCCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH----------
Confidence 999999986543221 12234689999999999998999999999999999999999999975321110
Q ss_pred chhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 396 PERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 396 ~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
+..+ ..... ..|. .....+.+++.+||+.||++|||+.||++
T Consensus 221 ---~~~~----~~~~~----------~~~~---------~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 221 ---LNKV----VLADY----------EMPS---------FLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp ------C----CSSCC----------CCCT---------TSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ---HHHH----hhccc----------CCcc---------ccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 0000 00000 0000 01224778999999999999999998864
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=340.65 Aligned_cols=259 Identities=19% Similarity=0.212 Sum_probs=195.8
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCc---chhHHHHHHHHHHhhhhccceeeeeeeecccccCCc
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHD---ASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGND 235 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~---~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~ 235 (873)
.++|.+.+.||+|+||.||+|++..+++.||||++...... ..+.+.+|+.++++++||||+++++++ ...+
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~-----~~~~ 107 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFG-----EIDG 107 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----EETT
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEE-----eeCC
Confidence 46899999999999999999999889999999998744322 236789999999999999999999996 3456
Q ss_pred eEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeE
Q 002857 236 FKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTAC 315 (873)
Q Consensus 236 ~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vK 315 (873)
..++||||+++++|.+++.. ...+++..++.|+.||+.||+||| +.+|+||||||+|||++.++.+|
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~~~~k 174 (309)
T 2h34_A 108 QLYVDMRLINGVDLAAMLRR----------QGPLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAY 174 (309)
T ss_dssp EEEEEEECCCCEEHHHHHHH----------HCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEE
T ss_pred eEEEEEEecCCCCHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCCCCEE
Confidence 78999999999999999953 245899999999999999999999 88999999999999999999999
Q ss_pred EeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcC
Q 002857 316 VADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSAL 395 (873)
Q Consensus 316 LsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~ 395 (873)
|+|||++........ .......|+..|+|||++.+..++.++||||||+++|||++|+.||...... .+..
T Consensus 175 l~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~------ 245 (309)
T 2h34_A 175 LVDFGIASATTDEKL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS--VMGA------ 245 (309)
T ss_dssp ECSCCC-----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH--HHHH------
T ss_pred EecCccCcccccccc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH--HHHH------
Confidence 999999986543321 1222346899999999999999999999999999999999999999753211 0000
Q ss_pred chhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCC-CHHHHHHHHHHHH
Q 002857 396 PERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERM-KINDVELGLRLIK 469 (873)
Q Consensus 396 ~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRP-Tm~EVl~~Le~i~ 469 (873)
.+....... . .........+.+++.+||+.||++|| ++.++++.|+.+.
T Consensus 246 ------~~~~~~~~~-~------------------~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l 295 (309)
T 2h34_A 246 ------HINQAIPRP-S------------------TVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAAL 295 (309)
T ss_dssp ------HHHSCCCCG-G------------------GTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTC
T ss_pred ------HhccCCCCc-c------------------ccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHH
Confidence 010000000 0 00001122477899999999999999 9999999998753
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=336.31 Aligned_cols=262 Identities=22% Similarity=0.326 Sum_probs=206.0
Q ss_pred cCCCcce-eecccCceEEEEEEEc--CCCcEEEEEEeeccCC-cchhHHHHHHHHHHhhhhccceeeeeeeecccccCCc
Q 002857 160 KGFSSEN-LIGAGNFASVYKGILF--EGAPAVAIKVFNFLHH-DASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGND 235 (873)
Q Consensus 160 ~~f~~~~-~LG~G~fG~VYkg~~~--~~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~ 235 (873)
++|.+.+ .||+|+||.||+|.+. .++..||||+++.... ...+.+.+|++++++++||||+++++++. .+
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~ 82 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ------AE 82 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE------SS
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec------CC
Confidence 4566666 9999999999999864 4677899999975432 34567999999999999999999999962 34
Q ss_pred eEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeE
Q 002857 236 FKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTAC 315 (873)
Q Consensus 236 ~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vK 315 (873)
..++||||+++++|.+++.. ....+++..++.++.||+.||.||| +.+|+||||||+|||++.++.+|
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~k 150 (287)
T 1u59_A 83 ALMLVMEMAGGGPLHKFLVG---------KREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAK 150 (287)
T ss_dssp SEEEEEECCTTEEHHHHHTT---------CTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEE
T ss_pred CcEEEEEeCCCCCHHHHHHh---------CCccCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEcCCCCEE
Confidence 58999999999999999842 3456899999999999999999999 88999999999999999999999
Q ss_pred Eecccccccccccccc-ccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHHHhh
Q 002857 316 VADFGIARFLEATNEQ-TSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQS 393 (873)
Q Consensus 316 LsDFGla~~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~~~~ 393 (873)
|+|||+++........ .......+|..|+|||++.+..++.++||||||+++|||+| |+.||....... ....+
T Consensus 151 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~i-- 226 (287)
T 1u59_A 151 ISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--VMAFI-- 226 (287)
T ss_dssp ECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH--HHHHH--
T ss_pred ECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH--HHHHH--
Confidence 9999999876433221 11222346889999999988889999999999999999999 999997532111 11111
Q ss_pred cCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHHHHhhh
Q 002857 394 ALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLIKKKLL 473 (873)
Q Consensus 394 ~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i~~~l~ 473 (873)
..... .+... .+...+.+++..||+.+|++||++.||++.|+.+.....
T Consensus 227 ----------~~~~~--------------~~~~~-------~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 275 (287)
T 1u59_A 227 ----------EQGKR--------------MECPP-------ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 275 (287)
T ss_dssp ----------HTTCC--------------CCCCT-------TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred ----------hcCCc--------------CCCCC-------CcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 00000 00000 112357889999999999999999999999999877665
Q ss_pred c
Q 002857 474 E 474 (873)
Q Consensus 474 ~ 474 (873)
.
T Consensus 276 ~ 276 (287)
T 1u59_A 276 S 276 (287)
T ss_dssp T
T ss_pred C
Confidence 3
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=337.22 Aligned_cols=259 Identities=20% Similarity=0.278 Sum_probs=201.9
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCC--cchhHHHHHHHHHHhhhhccceeeeeeeecccccCCce
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH--DASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDF 236 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~ 236 (873)
.++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|++++++++||||+++++++.. .....
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~~ 81 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID---RTNTT 81 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE---GGGTE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEec---CCCce
Confidence 4689999999999999999999998999999999975432 334678999999999999999999998642 33567
Q ss_pred EEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCC-----eeeccCCCCCeeeCCC
Q 002857 237 KALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPP-----IAHCDIKPSNILLNDE 311 (873)
Q Consensus 237 ~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~g-----IvHrDLKpsNILLd~~ 311 (873)
.++||||+++|+|.+++... ......+++..++.|+.||+.||+||| +.+ |+||||||+|||++.+
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~ivH~dl~p~NIl~~~~ 152 (279)
T 2w5a_A 82 LYIVMEYCEGGDLASVITKG------TKERQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGK 152 (279)
T ss_dssp EEEEEECCTTEEHHHHHHHH------HHTTCCCCHHHHHHHHHHHHHHHHHHH---HHC------CCCCCSGGGEEECSS
T ss_pred EEEEEeCCCCCCHHHHHHhh------cccCCCCCHHHHHHHHHHHHHHHHHHh---cccCCCCeeEEeccchhhEEEcCC
Confidence 89999999999999999531 123455899999999999999999999 667 9999999999999999
Q ss_pred CCeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHH
Q 002857 312 MTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWV 391 (873)
Q Consensus 312 ~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~ 391 (873)
+.+||+|||+++....... ......|+..|+|||++.+..++.++||||||+++|||+||+.||....... +..
T Consensus 153 ~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~-- 226 (279)
T 2w5a_A 153 QNVKLGDFGLARILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE--LAG-- 226 (279)
T ss_dssp SCEEECCCCHHHHC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHH--
T ss_pred CCEEEecCchheeeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHH--HHH--
Confidence 9999999999986543221 1223468999999999999899999999999999999999999997632110 000
Q ss_pred hhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHH
Q 002857 392 QSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLR 466 (873)
Q Consensus 392 ~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le 466 (873)
.+...... ..+. .....+.+++.+||+.||++|||+.||++.+.
T Consensus 227 ---------~i~~~~~~-------------~~~~---------~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 227 ---------KIREGKFR-------------RIPY---------RYSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp ---------HHHHTCCC-------------CCCT---------TSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred ---------HHhhcccc-------------cCCc---------ccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 01000000 0000 01234788999999999999999999987553
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=351.92 Aligned_cols=201 Identities=24% Similarity=0.293 Sum_probs=175.8
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeecc---CCcchhHHHHHHHHHHhh-hhccceeeeeeeecccccCC
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFL---HHDASKSFTVECEVMRNI-IHRKIIKVVTACSRVDYQGN 234 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~L-~HpNIV~llg~c~~~~~~~~ 234 (873)
.++|++.+.||+|+||.||+|++..+++.||||+++.. .....+.+..|..++..+ +||||+++++++ ...
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~-----~~~ 93 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QTM 93 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEE-----ECS
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEE-----EcC
Confidence 46899999999999999999999888999999999743 233456788999999988 899999999985 556
Q ss_pred ceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCe
Q 002857 235 DFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTA 314 (873)
Q Consensus 235 ~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~v 314 (873)
+..++||||+++|+|.+++.. ...+++..++.++.||+.||+||| +.+|+||||||+|||++.++++
T Consensus 94 ~~~~lv~E~~~gg~L~~~l~~----------~~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~v 160 (353)
T 2i0e_A 94 DRLYFVMEYVNGGDLMYHIQQ----------VGRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHI 160 (353)
T ss_dssp SEEEEEEECCCSCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCE
T ss_pred CEEEEEEeCCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEEcCCCcE
Confidence 789999999999999999842 245899999999999999999999 8999999999999999999999
Q ss_pred EEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCc
Q 002857 315 CVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDD 379 (873)
Q Consensus 315 KLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~ 379 (873)
||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 161 kL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~ 223 (353)
T 2i0e_A 161 KIADFGMCKENIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG 223 (353)
T ss_dssp EECCCTTCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred EEEeCCcccccccCC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCC
Confidence 999999998543221 123345699999999999999999999999999999999999999975
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=336.71 Aligned_cols=251 Identities=23% Similarity=0.305 Sum_probs=198.5
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEE
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKA 238 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~ 238 (873)
.++|.+.+.||+|+||.||+|++..+++.||||+++.........+.+|++++++++||||+++++++ ......+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 82 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY-----ESTTHYY 82 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEE-----ECSSEEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhc-----ccCCEEE
Confidence 46789999999999999999999889999999999865544556789999999999999999999985 4566789
Q ss_pred EEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeee---CCCCCeE
Q 002857 239 LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILL---NDEMTAC 315 (873)
Q Consensus 239 LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILL---d~~~~vK 315 (873)
+||||+++++|.+++.. ...+++..++.++.||+.||+||| +.+|+||||||+|||+ +.++.+|
T Consensus 83 lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~~~k 149 (304)
T 2jam_A 83 LVMQLVSGGELFDRILE----------RGVYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIM 149 (304)
T ss_dssp EEECCCCSCBHHHHHHH----------HSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSSSTTCCEE
T ss_pred EEEEcCCCccHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecCCCCCCEE
Confidence 99999999999999842 245889999999999999999999 8899999999999999 7889999
Q ss_pred EeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcC
Q 002857 316 VADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSAL 395 (873)
Q Consensus 316 LsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~ 395 (873)
|+|||+++..... ......||..|+|||++.+..++.++||||||+++|||++|+.||....... +.
T Consensus 150 l~Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~------- 216 (304)
T 2jam_A 150 ITDFGLSKMEQNG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK--LF------- 216 (304)
T ss_dssp BCSCSTTCCCCCB----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HH-------
T ss_pred EccCCcceecCCC----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH--HH-------
Confidence 9999999754322 1223458999999999999999999999999999999999999996532110 00
Q ss_pred chhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 396 PERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 396 ~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
..+........ .+.. ......+.+++.+||+.||++|||+.|+++
T Consensus 217 ----~~i~~~~~~~~------------~~~~-------~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 217 ----EKIKEGYYEFE------------SPFW-------DDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp ----HHHHHCCCCCC------------TTTT-------TTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred ----HHHHcCCCCCC------------cccc-------ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11111000000 0000 011234788999999999999999999875
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=334.64 Aligned_cols=253 Identities=23% Similarity=0.332 Sum_probs=194.8
Q ss_pred CCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEEE
Q 002857 161 GFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKALV 240 (873)
Q Consensus 161 ~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~LV 240 (873)
+|....+||+|+||.||+|.+..+++.||||++........+.+.+|+.++++++||||+++++++ ...+..++|
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv 97 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF-----SENGFIKIF 97 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEE-----EETTEEEEE
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEE-----EeCCcEEEE
Confidence 445566999999999999999999999999999866655667899999999999999999999996 345678999
Q ss_pred EeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCC-CCCeEEecc
Q 002857 241 YEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLND-EMTACVADF 319 (873)
Q Consensus 241 ~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~-~~~vKLsDF 319 (873)
|||+++++|.+++.. ......+++..+..++.||+.||+||| +.+|+|+||||+|||++. ++.+||+||
T Consensus 98 ~e~~~~~~L~~~l~~-------~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~kl~Df 167 (295)
T 2clq_A 98 MEQVPGGSLSALLRS-------KWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDF 167 (295)
T ss_dssp EECCSEEEHHHHHHH-------TTCCCTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCCEEECCT
T ss_pred EEeCCCCCHHHHHHh-------hccCCCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCCEEEeec
Confidence 999999999999853 112345678889999999999999999 889999999999999987 899999999
Q ss_pred ccccccccccccccccccccccccCCCcccCCCC--CCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCch
Q 002857 320 GIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHE--TSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPE 397 (873)
Q Consensus 320 Gla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~--~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~ 397 (873)
|+++....... ......||..|+|||++.+.. ++.++||||||+++|||++|+.||............
T Consensus 168 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-------- 237 (295)
T 2clq_A 168 GTSKRLAGINP--CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFK-------- 237 (295)
T ss_dssp TTCEESCC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHH--------
T ss_pred ccccccCCCCC--cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHh--------
Confidence 99986543221 122346899999999987643 789999999999999999999999642211100000
Q ss_pred hHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 398 RVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 398 ~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
. .. ....+.... .....+.+++.+||+.||++|||+.|+++
T Consensus 238 ----~---~~------------~~~~~~~~~------~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 238 ----V---GM------------FKVHPEIPE------SMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp ----H---HH------------HCCCCCCCT------TSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred ----h---cc------------ccccccccc------cCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0 00 000000000 01234778999999999999999999864
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=343.08 Aligned_cols=267 Identities=25% Similarity=0.393 Sum_probs=203.3
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEE--EEEEeecc-CCcchhHHHHHHHHHHhh-hhccceeeeeeeecccccCCc
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAV--AIKVFNFL-HHDASKSFTVECEVMRNI-IHRKIIKVVTACSRVDYQGND 235 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~V--AVK~l~~~-~~~~~~~f~~Ei~iL~~L-~HpNIV~llg~c~~~~~~~~~ 235 (873)
++|.+.+.||+|+||.||+|++..++..+ |||+++.. .....+.+.+|+++++++ +||||+++++++ ...+
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~-----~~~~ 99 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-----EHRG 99 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEE-----EETT
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceee-----eeCC
Confidence 57889999999999999999998888755 99988743 233456799999999999 999999999996 4456
Q ss_pred eEEEEEeecCCCChhhhcccccccc------cccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeC
Q 002857 236 FKALVYEFMPNGSLEEWIHPITEED------KRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLN 309 (873)
Q Consensus 236 ~~~LV~Ey~~~GSL~~~L~~~~~~~------~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd 309 (873)
..++||||+++|+|.+++....... ........+++.+++.|+.||+.||+||| +.+|+||||||+|||++
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~ 176 (327)
T 1fvr_A 100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVG 176 (327)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC
T ss_pred ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCccceEEEc
Confidence 7999999999999999995411000 00012357899999999999999999999 89999999999999999
Q ss_pred CCCCeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhH
Q 002857 310 DEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQ 388 (873)
Q Consensus 310 ~~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~ 388 (873)
.++.+||+|||+++...... ......++..|+|||++.+..++.++||||||+++|||+| |+.||....... +.
T Consensus 177 ~~~~~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~--~~ 251 (327)
T 1fvr_A 177 ENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--LY 251 (327)
T ss_dssp GGGCEEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HH
T ss_pred CCCeEEEcccCcCccccccc---cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH--HH
Confidence 99999999999997432211 1222346889999999988889999999999999999998 999996532111 00
Q ss_pred HHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHH
Q 002857 389 NWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLI 468 (873)
Q Consensus 389 ~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i 468 (873)
. .+... ... ..+. .+...+.+++.+||+.+|++|||+.|+++.|+.+
T Consensus 252 ~-----------~~~~~-~~~------------~~~~---------~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 298 (327)
T 1fvr_A 252 E-----------KLPQG-YRL------------EKPL---------NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 298 (327)
T ss_dssp H-----------HGGGT-CCC------------CCCT---------TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred H-----------HhhcC-CCC------------CCCC---------CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0 00000 000 0000 0123478899999999999999999999999998
Q ss_pred HHhh
Q 002857 469 KKKL 472 (873)
Q Consensus 469 ~~~l 472 (873)
....
T Consensus 299 ~~~~ 302 (327)
T 1fvr_A 299 LEER 302 (327)
T ss_dssp HHSS
T ss_pred HHhh
Confidence 6643
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-38 Score=344.41 Aligned_cols=203 Identities=21% Similarity=0.323 Sum_probs=164.4
Q ss_pred HhhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCc--chhHHHHHHHHHHhhhhccceeeeeeeecccccCC
Q 002857 157 SATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHD--ASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGN 234 (873)
Q Consensus 157 ~at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~ 234 (873)
...++|.+.+.||+|+||.||+|++..+++.||||+++..... ..+.+.+|++++++++||||+++++++ ..+
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~ 105 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVI-----HHN 105 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEE-----EET
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEE-----ecC
Confidence 3456899999999999999999999999999999999744322 245678999999999999999999996 446
Q ss_pred ceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeee-----C
Q 002857 235 DFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILL-----N 309 (873)
Q Consensus 235 ~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILL-----d 309 (873)
...+|||||++ |+|.+++.. ...+++..++.|+.||+.||+||| +.+|+||||||+|||+ +
T Consensus 106 ~~~~lv~e~~~-~~L~~~~~~----------~~~~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~ 171 (329)
T 3gbz_A 106 HRLHLIFEYAE-NDLKKYMDK----------NPDVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDAS 171 (329)
T ss_dssp TEEEEEEECCS-EEHHHHHHH----------CTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEC----
T ss_pred CEEEEEEecCC-CCHHHHHhh----------cCCCCHHHHHHHHHHHHHHHHHHH---hCCEECCCCCHHHEEEecCCCC
Confidence 67999999997 599999842 345899999999999999999999 8899999999999999 4
Q ss_pred CCCCeEEeccccccccccccccccccccccccccCCCcccCCC-CCCcchhhHhHHHHHHHHHhCCCCCCcc
Q 002857 310 DEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGH-ETSSYGDVYSFGILLLEMFTGLRPSDDM 380 (873)
Q Consensus 310 ~~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELlTGk~Pf~~~ 380 (873)
.++.+||+|||+++...... .......+|..|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 172 ~~~~~kl~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 241 (329)
T 3gbz_A 172 ETPVLKIGDFGLARAFGIPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGD 241 (329)
T ss_dssp -CCEEEECCTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccceEEECcCCCccccCCcc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCC
Confidence 55569999999998764322 122334589999999998875 4899999999999999999999999763
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=346.76 Aligned_cols=273 Identities=20% Similarity=0.261 Sum_probs=193.9
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCc-chhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEE
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHD-ASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKA 238 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~ 238 (873)
++|.+.+.||+|+||.||+|++..+++.||||+++..... ....+.+|++++++++||||+++++++ ......+
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~ 76 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII-----HTEKSLT 76 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEE-----ECSSCEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEE-----eeCCEEE
Confidence 5789999999999999999999889999999998743322 223566799999999999999999996 4466789
Q ss_pred EEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEec
Q 002857 239 LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVAD 318 (873)
Q Consensus 239 LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsD 318 (873)
+||||++ |+|.+++.. ....+++..++.++.||+.||+||| +.+|+||||||+|||++.++.+||+|
T Consensus 77 lv~e~~~-~~l~~~~~~---------~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~D 143 (324)
T 3mtl_A 77 LVFEYLD-KDLKQYLDD---------CGNIINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLAD 143 (324)
T ss_dssp EEEECCS-EEHHHHHHH---------TTTCCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCEEECS
T ss_pred EEecccc-cCHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCEEEcc
Confidence 9999997 599998853 3456899999999999999999999 89999999999999999999999999
Q ss_pred cccccccccccccccccccccccccCCCcccCC-CCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcC--
Q 002857 319 FGIARFLEATNEQTSSIGVKGTTGYIAPEYGMG-HETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSAL-- 395 (873)
Q Consensus 319 FGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~-- 395 (873)
||+++...... .......||..|+|||++.+ ..++.++||||||+++|||++|+.||....... ....+....
T Consensus 144 fg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~i~~~~~~ 219 (324)
T 3mtl_A 144 FGLARAKSIPT--KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE--QLHFIFRILGT 219 (324)
T ss_dssp SSEEECC--------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCC
T ss_pred CcccccccCCc--cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCC
Confidence 99998654322 12223468999999999876 568999999999999999999999997643221 111111100
Q ss_pred --chhHHHHhhhhhhhhhhHHHHHhhhccCCC-CchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 396 --PERVEEIVDTLFFKEIEEEETVYKYKKAPS-SSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 396 --~~~l~elid~~L~~~~~~r~~~~~i~~~p~-~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
...+..+.... .......... ..............+.+|+.+||+.||++|||+.|+++
T Consensus 220 ~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 220 PTEETWPGILSNE---------EFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp CCTTTSTTGGGCH---------HHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CChHhchhhhcch---------hhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 00111110000 0000000000 00000001112335789999999999999999999875
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=357.54 Aligned_cols=268 Identities=21% Similarity=0.289 Sum_probs=208.3
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEE
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKA 238 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~ 238 (873)
.++|.+.++||+|+||.||+|++..+++.||||++..... ...+..|+++++.++|.+++..+.++. ......+
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~----~~~~~~~ 79 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFG----VEGDYNV 79 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEE----EETTEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEE----eeCCEEE
Confidence 4689999999999999999999988999999999874432 356899999999998866555554442 3466789
Q ss_pred EEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeee---CCCCCeE
Q 002857 239 LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILL---NDEMTAC 315 (873)
Q Consensus 239 LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILL---d~~~~vK 315 (873)
|||||+ +++|.+++.. ....+++.+++.|+.||+.||+||| +.+|+||||||+|||| +.++.+|
T Consensus 80 lvme~~-g~sL~~ll~~---------~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vk 146 (483)
T 3sv0_A 80 LVMDLL-GPSLEDLFNF---------CSRKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVY 146 (483)
T ss_dssp EEEECC-CCBHHHHHHH---------TTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEE
T ss_pred EEEECC-CCCHHHHHHh---------hcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEE
Confidence 999999 9999999952 2456999999999999999999999 8999999999999999 6889999
Q ss_pred Eecccccccccccccc-----ccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHH
Q 002857 316 VADFGIARFLEATNEQ-----TSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNW 390 (873)
Q Consensus 316 LsDFGla~~~~~~~~~-----~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~ 390 (873)
|+|||+++.+...... .......||..|+|||++.+..++.++|||||||+||||++|+.||........ ..
T Consensus 147 L~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~--~~- 223 (483)
T 3sv0_A 147 IIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK--KQ- 223 (483)
T ss_dssp ECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSH--HH-
T ss_pred EEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhH--HH-
Confidence 9999999876543321 112245699999999999999999999999999999999999999976432211 00
Q ss_pred HhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHHHH
Q 002857 391 VQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLIKK 470 (873)
Q Consensus 391 ~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i~~ 470 (873)
.+..+....+..... .....+..++.+|+..||+.+|++||++.+|+++|+.+..
T Consensus 224 -------~~~~i~~~~~~~~~~------------------~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~ 278 (483)
T 3sv0_A 224 -------KYEKISEKKVATSIE------------------ALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFI 278 (483)
T ss_dssp -------HHHHHHHHHHHSCHH------------------HHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred -------HHHHHhhccccccHH------------------HHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 011111111100000 0001123458899999999999999999999999999877
Q ss_pred hhh
Q 002857 471 KLL 473 (873)
Q Consensus 471 ~l~ 473 (873)
...
T Consensus 279 ~~~ 281 (483)
T 3sv0_A 279 REG 281 (483)
T ss_dssp HTT
T ss_pred HcC
Confidence 554
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=336.76 Aligned_cols=255 Identities=21% Similarity=0.339 Sum_probs=198.5
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC----CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCC
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH----HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGN 234 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~----~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~ 234 (873)
.++|.+.+.||+|+||.||+|.+..+++.||||+++... ....+.+.+|++++++++|+||+++++++.. ...
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~ 80 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYN---EEK 80 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC---C--
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEc---CCC
Confidence 468999999999999999999998899999999987432 2345779999999999999999999998632 345
Q ss_pred ceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCe
Q 002857 235 DFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTA 314 (873)
Q Consensus 235 ~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~v 314 (873)
...++||||++++ |.+++.. .....+++..++.|+.||+.||.||| +.+|+||||||+|||++.++.+
T Consensus 81 ~~~~lv~e~~~~~-l~~~~~~--------~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~~~~ 148 (305)
T 2wtk_C 81 QKMYMVMEYCVCG-MQEMLDS--------VPEKRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTL 148 (305)
T ss_dssp -CEEEEEECCSEE-HHHHHHH--------STTCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCE
T ss_pred CeEEEEehhccCC-HHHHHHh--------CcccccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCCCcE
Confidence 5789999999876 7777643 23456899999999999999999999 8899999999999999999999
Q ss_pred EEeccccccccccccccccccccccccccCCCcccCCCC--CCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHh
Q 002857 315 CVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHE--TSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQ 392 (873)
Q Consensus 315 KLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~--~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~ 392 (873)
||+|||++................||..|+|||++.+.. ++.++||||||+++|||++|+.||....... .
T Consensus 149 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~----- 221 (305)
T 2wtk_C 149 KISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYK--L----- 221 (305)
T ss_dssp EECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHH--H-----
T ss_pred EeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH--H-----
Confidence 999999998765433333333456899999999987654 4789999999999999999999997521110 0
Q ss_pred hcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHH
Q 002857 393 SALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELG 464 (873)
Q Consensus 393 ~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~ 464 (873)
...+..... ..+. .+...+.+++.+||+.||++|||+.|+++.
T Consensus 222 ------~~~i~~~~~--------------~~~~---------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 222 ------FENIGKGSY--------------AIPG---------DCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp ------HHHHHHCCC--------------CCCS---------SSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ------HHHHhcCCC--------------CCCC---------ccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000000000 0000 012347789999999999999999999864
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-38 Score=372.65 Aligned_cols=259 Identities=22% Similarity=0.326 Sum_probs=200.5
Q ss_pred CCcce-eecccCceEEEEEEEcC--CCcEEEEEEeeccC-CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceE
Q 002857 162 FSSEN-LIGAGNFASVYKGILFE--GAPAVAIKVFNFLH-HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFK 237 (873)
Q Consensus 162 f~~~~-~LG~G~fG~VYkg~~~~--~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~ 237 (873)
+.+.+ .||+|+||.||+|.+.. ++..||||+++... ....+.|.+|+++|++++|||||+++++|.. +..
T Consensus 337 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~------~~~ 410 (613)
T 2ozo_A 337 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA------EAL 410 (613)
T ss_dssp EEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES------SSE
T ss_pred eeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc------CCe
Confidence 33344 79999999999998753 45679999997543 3345789999999999999999999999732 358
Q ss_pred EEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEe
Q 002857 238 ALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVA 317 (873)
Q Consensus 238 ~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLs 317 (873)
+|||||+++|+|.++|.. ....+++..++.|+.||+.||+||| +.+|+||||||+|||++.++.+||+
T Consensus 411 ~lv~E~~~~g~L~~~l~~---------~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkL~ 478 (613)
T 2ozo_A 411 MLVMEMAGGGPLHKFLVG---------KREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKIS 478 (613)
T ss_dssp EEEEECCTTCBHHHHHTT---------CTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEEC
T ss_pred EEEEEeCCCCcHHHHHhh---------ccCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEEEe
Confidence 999999999999999953 3456899999999999999999999 8999999999999999999999999
Q ss_pred cccccccccccccc-ccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHHHhhcC
Q 002857 318 DFGIARFLEATNEQ-TSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQSAL 395 (873)
Q Consensus 318 DFGla~~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~~~~~~ 395 (873)
|||+++.+...... .......+++.|+|||++.+..++.++|||||||++|||+| |+.||....... ...
T Consensus 479 DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~--~~~------ 550 (613)
T 2ozo_A 479 DFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--VMA------ 550 (613)
T ss_dssp CCSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH--HHH------
T ss_pred eccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--HHH------
Confidence 99999876433221 11122335689999999998999999999999999999998 999997632211 111
Q ss_pred chhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHHHHhhh
Q 002857 396 PERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLIKKKLL 473 (873)
Q Consensus 396 ~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i~~~l~ 473 (873)
.+...... ..| ..+...+.+|+..||+.+|++||++.+|++.|+.+...+.
T Consensus 551 ------~i~~~~~~------------~~p---------~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~ 601 (613)
T 2ozo_A 551 ------FIEQGKRM------------ECP---------PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 601 (613)
T ss_dssp ------HHHTTCCC------------CCC---------TTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHS
T ss_pred ------HHHcCCCC------------CCC---------CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhc
Confidence 11100000 000 0123458899999999999999999999999999876654
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=350.32 Aligned_cols=200 Identities=27% Similarity=0.349 Sum_probs=173.9
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC-CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceE
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH-HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFK 237 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~ 237 (873)
.++|.+.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.++++++||||+++++++ ..++..
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~ 106 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF-----YSDGEI 106 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEE-----EETTEE
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEE-----EECCEE
Confidence 357899999999999999999999899999999997543 23346789999999999999999999986 345679
Q ss_pred EEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCC-CeeeccCCCCCeeeCCCCCeEE
Q 002857 238 ALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKP-PIAHCDIKPSNILLNDEMTACV 316 (873)
Q Consensus 238 ~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~-gIvHrDLKpsNILLd~~~~vKL 316 (873)
++||||+++|+|.+++.. ...+++..+..|+.||+.||+||| +. +|+||||||+|||++.++.+||
T Consensus 107 ~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl 173 (360)
T 3eqc_A 107 SICMEHMDGGSLDQVLKK----------AGRIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKL 173 (360)
T ss_dssp EEEECCCTTCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEE
T ss_pred EEEEECCCCCCHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHH---HhCCEEcCCccHHHEEECCCCCEEE
Confidence 999999999999999953 245889999999999999999999 64 8999999999999999999999
Q ss_pred eccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcc
Q 002857 317 ADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDM 380 (873)
Q Consensus 317 sDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~ 380 (873)
+|||+++...... .....||..|+|||++.+..++.++||||||+++|||+||+.||...
T Consensus 174 ~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 233 (360)
T 3eqc_A 174 CDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 233 (360)
T ss_dssp CCCCCCHHHHHHC--------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCC
T ss_pred EECCCCccccccc----ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999997653321 22346899999999999999999999999999999999999999763
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=359.28 Aligned_cols=248 Identities=25% Similarity=0.358 Sum_probs=201.2
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC---CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCc
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH---HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGND 235 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~ 235 (873)
.++|.+.+.||+|+||.||+|++..+++.||||+++... ......+.+|+.+++.++||||+++++++ ....
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~-----~~~~ 89 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVI-----STPS 89 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSS
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECC
Confidence 357899999999999999999998899999999996432 23346789999999999999999999996 4466
Q ss_pred eEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeE
Q 002857 236 FKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTAC 315 (873)
Q Consensus 236 ~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vK 315 (873)
..++||||+++|+|.+++. ....+++..++.++.||+.||+||| +.+|+||||||+|||++.++.+|
T Consensus 90 ~~~lv~E~~~gg~L~~~l~----------~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vk 156 (476)
T 2y94_A 90 DIFMVMEYVSGGELFDYIC----------KNGRLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAK 156 (476)
T ss_dssp EEEEEEECCSSEEHHHHTT----------SSSSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEE
T ss_pred EEEEEEeCCCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeE
Confidence 7999999999999999994 2456899999999999999999999 89999999999999999999999
Q ss_pred EeccccccccccccccccccccccccccCCCcccCCCCC-CcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhc
Q 002857 316 VADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHET-SSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSA 394 (873)
Q Consensus 316 LsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~-s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~ 394 (873)
|+|||+++...... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||.......
T Consensus 157 L~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~---------- 223 (476)
T 2y94_A 157 IADFGLSNMMSDGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT---------- 223 (476)
T ss_dssp ECCCSSCEECCTTC---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH----------
T ss_pred EEeccchhhccccc---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH----------
Confidence 99999998764322 1223469999999999988765 689999999999999999999997532110
Q ss_pred CchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 395 LPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 395 ~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
....+.+... ..|.. ....+.+++.+||+.||++|||+.||++
T Consensus 224 ---~~~~i~~~~~--------------~~p~~---------~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 224 ---LFKKICDGIF--------------YTPQY---------LNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp ---HHHHHHTTCC--------------CCCTT---------CCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ---HHHHHhcCCc--------------CCCcc---------CCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 0111111110 00100 0124778999999999999999999876
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=359.07 Aligned_cols=211 Identities=25% Similarity=0.308 Sum_probs=181.2
Q ss_pred CHHHHHHhhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeecc---CCcchhHHHHHHHHHHhhhhccceeeeeeee
Q 002857 151 SYEALYSATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFL---HHDASKSFTVECEVMRNIIHRKIIKVVTACS 227 (873)
Q Consensus 151 s~~el~~at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~ 227 (873)
.++++....++|++.++||+|+||.||+|++..+++.||||+++.. .......+.+|+.++..++|+||+++++++
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~- 130 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF- 130 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE-
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE-
Confidence 4455666778999999999999999999999999999999999742 223345689999999999999999999985
Q ss_pred cccccCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCee
Q 002857 228 RVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNIL 307 (873)
Q Consensus 228 ~~~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNIL 307 (873)
...+..+|||||+++|+|.++|.. ....+++..++.++.||+.||+||| +.+|+||||||+|||
T Consensus 131 ----~~~~~~~lVmE~~~gg~L~~~l~~---------~~~~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NIL 194 (412)
T 2vd5_A 131 ----QDENYLYLVMEYYVGGDLLTLLSK---------FGERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNIL 194 (412)
T ss_dssp ----ECSSEEEEEECCCCSCBHHHHHHH---------HSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEE
T ss_pred ----eeCCEEEEEEcCCCCCcHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHee
Confidence 556789999999999999999953 1246899999999999999999999 899999999999999
Q ss_pred eCCCCCeEEeccccccccccccccccccccccccccCCCcccC-------CCCCCcchhhHhHHHHHHHHHhCCCCCCc
Q 002857 308 LNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGM-------GHETSSYGDVYSFGILLLEMFTGLRPSDD 379 (873)
Q Consensus 308 Ld~~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~-------~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~ 379 (873)
++.++++||+|||+++....... .......||+.|+|||++. ...++.++|||||||++|||++|+.||..
T Consensus 195 ld~~g~vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~ 272 (412)
T 2vd5_A 195 LDRCGHIRLADFGSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYA 272 (412)
T ss_dssp ECTTSCEEECCCTTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred ecCCCCEEEeechhheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCC
Confidence 99999999999999987644322 1222356999999999987 45789999999999999999999999975
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-38 Score=342.82 Aligned_cols=262 Identities=18% Similarity=0.222 Sum_probs=201.2
Q ss_pred CHHHHHHhhcCCCcc-eeecccCceEEEEEEEcCCCcEEEEEEeeccC--CcchhHHHHHHHHHHhh-hhccceeeeeee
Q 002857 151 SYEALYSATKGFSSE-NLIGAGNFASVYKGILFEGAPAVAIKVFNFLH--HDASKSFTVECEVMRNI-IHRKIIKVVTAC 226 (873)
Q Consensus 151 s~~el~~at~~f~~~-~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L-~HpNIV~llg~c 226 (873)
.++......+.|.+. +.||+|+||.||+|++..+++.||||+++... ......+.+|+.++.++ +||||+++++++
T Consensus 19 ~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~ 98 (327)
T 3lm5_A 19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY 98 (327)
T ss_dssp CSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred HHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 334444455677777 89999999999999999899999999987433 23356789999999999 569999999995
Q ss_pred ecccccCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCe
Q 002857 227 SRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNI 306 (873)
Q Consensus 227 ~~~~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNI 306 (873)
......++||||+++|+|.+++.. .....+++.+++.|+.||+.||+||| +.+|+||||||+||
T Consensus 99 -----~~~~~~~lv~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp~NI 162 (327)
T 3lm5_A 99 -----ENTSEIILILEYAAGGEIFSLCLP--------ELAEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNI 162 (327)
T ss_dssp -----ECSSEEEEEEECCTTEEGGGGGSS--------CC-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGE
T ss_pred -----EeCCeEEEEEEecCCCcHHHHHHH--------hcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCChHHE
Confidence 456779999999999999999843 23466899999999999999999999 88999999999999
Q ss_pred eeCC---CCCeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCccccc
Q 002857 307 LLND---EMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKD 383 (873)
Q Consensus 307 LLd~---~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~ 383 (873)
|++. ++.+||+|||+++....... .....||+.|+|||++.+..++.++||||||+++|||++|+.||......
T Consensus 163 l~~~~~~~~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 239 (327)
T 3lm5_A 163 LLSSIYPLGDIKIVDFGMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQ 239 (327)
T ss_dssp EESCBTTBCCEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred EEecCCCCCcEEEeeCccccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch
Confidence 9997 78999999999987643221 22356899999999999999999999999999999999999999653211
Q ss_pred chhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 384 NLNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 384 ~~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
.. + ..+....... +. .. ...+...+.+++.+||+.||++|||+.|+++
T Consensus 240 ~~-~------------~~i~~~~~~~--------------~~-~~----~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 240 ET-Y------------LNISQVNVDY--------------SE-ET----FSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp HH-H------------HHHHHTCCCC--------------CT-TT----TTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HH-H------------HHHHhccccc--------------Cc-hh----hcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 10 0 0000000000 00 00 0011234778999999999999999998854
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=331.86 Aligned_cols=247 Identities=19% Similarity=0.217 Sum_probs=195.2
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC--CcchhHHHHHHHHHHhh-hhccceeeeeeeecccccCCc
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH--HDASKSFTVECEVMRNI-IHRKIIKVVTACSRVDYQGND 235 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L-~HpNIV~llg~c~~~~~~~~~ 235 (873)
+++|++.+.||+|+||.||+|++..+++.||||+++... ......+.+|+.++.++ +||||+++++++ ...+
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~-----~~~~ 84 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAW-----AEDD 84 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEE-----EETT
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeee-----ecCC
Confidence 467999999999999999999998899999999987532 33446788999999999 999999999996 4456
Q ss_pred eEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCC-----
Q 002857 236 FKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLND----- 310 (873)
Q Consensus 236 ~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~----- 310 (873)
..++||||+++|+|.+++... ......+++..++.|+.||+.||+||| +.+|+||||||+|||++.
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~~ 155 (289)
T 1x8b_A 85 HMLIQNEYCNGGSLADAISEN------YRIMSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPN 155 (289)
T ss_dssp EEEEEEECCTTCBHHHHHHHH------HHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC------
T ss_pred eEEEEEEecCCCcHHHHHHhh------cccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCCCCc
Confidence 889999999999999999531 112356899999999999999999999 899999999999999984
Q ss_pred --------------CCCeEEeccccccccccccccccccccccccccCCCcccCCC-CCCcchhhHhHHHHHHHHHhCCC
Q 002857 311 --------------EMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGH-ETSSYGDVYSFGILLLEMFTGLR 375 (873)
Q Consensus 311 --------------~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELlTGk~ 375 (873)
...+||+|||++....... ...||..|+|||++.+. .++.++||||||+++|||++|..
T Consensus 156 ~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~ 229 (289)
T 1x8b_A 156 AASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEP 229 (289)
T ss_dssp --------------CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCC
T ss_pred ccccccccccccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCC
Confidence 4489999999998654321 23489999999998876 56789999999999999999988
Q ss_pred CCCcccccchhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCC
Q 002857 376 PSDDMFKDNLNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGER 455 (873)
Q Consensus 376 Pf~~~~~~~~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eR 455 (873)
++.... . ...+....+.. .+. .....+.+++.+||+.||++|
T Consensus 230 ~~~~~~----~------------~~~~~~~~~~~-------------~~~---------~~~~~~~~li~~~l~~dp~~R 271 (289)
T 1x8b_A 230 LPRNGD----Q------------WHEIRQGRLPR-------------IPQ---------VLSQEFTELLKVMIHPDPERR 271 (289)
T ss_dssp CCSSSH----H------------HHHHHTTCCCC-------------CSS---------CCCHHHHHHHHHHTCSSGGGS
T ss_pred CCcchh----H------------HHHHHcCCCCC-------------CCc---------ccCHHHHHHHHHHhCCCcccC
Confidence 764310 0 11111110000 000 012347789999999999999
Q ss_pred CCHHHHHH
Q 002857 456 MKINDVEL 463 (873)
Q Consensus 456 PTm~EVl~ 463 (873)
||+.|+++
T Consensus 272 ps~~~ll~ 279 (289)
T 1x8b_A 272 PSAMALVK 279 (289)
T ss_dssp CCHHHHHT
T ss_pred CCHHHHhh
Confidence 99999864
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=342.34 Aligned_cols=267 Identities=24% Similarity=0.300 Sum_probs=199.5
Q ss_pred ccCHHHHHHhhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhh-hhccceeeeeeee
Q 002857 149 YVSYEALYSATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNI-IHRKIIKVVTACS 227 (873)
Q Consensus 149 ~~s~~el~~at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~llg~c~ 227 (873)
.+++.++....++|++.+.||+|+||.||+|++..+++.||||++.... ...+.+.+|+.+++++ +||||+++++++.
T Consensus 13 ~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 91 (326)
T 2x7f_A 13 EIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFI 91 (326)
T ss_dssp ---CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred hccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEe
Confidence 3444555667889999999999999999999998899999999997543 3447899999999999 8999999999975
Q ss_pred cccc-cCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCe
Q 002857 228 RVDY-QGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNI 306 (873)
Q Consensus 228 ~~~~-~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNI 306 (873)
.... ......++||||+++|+|.+++.. .....+++..++.|+.||+.||+||| +.+|+||||||+||
T Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--------~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NI 160 (326)
T 2x7f_A 92 KKNPPGMDDQLWLVMEFCGAGSVTDLIKN--------TKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNV 160 (326)
T ss_dssp ECC--CCCCEEEEEEECCTTEEHHHHHHH--------SGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGE
T ss_pred eccCccccceEEEEEEcCCCCcHHHHHHh--------cccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCcHHHE
Confidence 4211 114678999999999999999953 12346888999999999999999999 88999999999999
Q ss_pred eeCCCCCeEEeccccccccccccccccccccccccccCCCcccC-----CCCCCcchhhHhHHHHHHHHHhCCCCCCccc
Q 002857 307 LLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGM-----GHETSSYGDVYSFGILLLEMFTGLRPSDDMF 381 (873)
Q Consensus 307 LLd~~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~-----~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~ 381 (873)
|++.++.+||+|||++........ ......||..|+|||++. +..++.++||||||+++|||++|+.||....
T Consensus 161 l~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 238 (326)
T 2x7f_A 161 LLTENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH 238 (326)
T ss_dssp EECTTCCEEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred EEcCCCCEEEeeCcCceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCc
Confidence 999999999999999986543221 122346899999999987 5678999999999999999999999996532
Q ss_pred ccchhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHH
Q 002857 382 KDNLNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDV 461 (873)
Q Consensus 382 ~~~~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EV 461 (873)
.... + ..+..... +.... . .....+.+++.+||+.||++|||+.||
T Consensus 239 ~~~~-~------------~~~~~~~~----------------~~~~~-~----~~~~~l~~li~~~l~~dp~~Rps~~~l 284 (326)
T 2x7f_A 239 PMRA-L------------FLIPRNPA----------------PRLKS-K----KWSKKFQSFIESCLVKNHSQRPATEQL 284 (326)
T ss_dssp HHHH-H------------HHHHHSCC----------------CCCSC-S----CSCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred HHHH-H------------HHhhcCcc----------------ccCCc-c----ccCHHHHHHHHHHhccChhhCCCHHHH
Confidence 1110 0 00000000 00000 0 012347789999999999999999998
Q ss_pred HH
Q 002857 462 EL 463 (873)
Q Consensus 462 l~ 463 (873)
++
T Consensus 285 l~ 286 (326)
T 2x7f_A 285 MK 286 (326)
T ss_dssp HT
T ss_pred hh
Confidence 76
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=344.80 Aligned_cols=203 Identities=22% Similarity=0.296 Sum_probs=171.5
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhh--------hccceeeeeeeeccc
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNII--------HRKIIKVVTACSRVD 230 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~--------HpNIV~llg~c~~~~ 230 (873)
.++|.+.++||+|+||.||+|++..+++.||||+++.. ....+.+.+|++++++++ |+||+++++++....
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 46899999999999999999999999999999999733 233467899999999996 788999999864321
Q ss_pred ccCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCC-CeeeccCCCCCeeeC
Q 002857 231 YQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKP-PIAHCDIKPSNILLN 309 (873)
Q Consensus 231 ~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~-gIvHrDLKpsNILLd 309 (873)
......+|||||+ +++|.+++.. .....+++..++.|+.||+.||+||| +. +|+||||||+|||++
T Consensus 115 -~~~~~~~lv~e~~-~~~l~~~~~~--------~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~givHrDikp~NIll~ 181 (397)
T 1wak_A 115 -VNGTHICMVFEVL-GHHLLKWIIK--------SNYQGLPLPCVKKIIQQVLQGLDYLH---TKCRIIHTDIKPENILLS 181 (397)
T ss_dssp -TTEEEEEEEECCC-CCBHHHHHHH--------TTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECCCCSGGGEEEC
T ss_pred -CCCceEEEEEecc-CccHHHHHHh--------cccCCCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHeeEe
Confidence 2456789999999 6677766632 23356899999999999999999999 77 999999999999999
Q ss_pred CCC-------------------------------------------------CeEEeccccccccccccccccccccccc
Q 002857 310 DEM-------------------------------------------------TACVADFGIARFLEATNEQTSSIGVKGT 340 (873)
Q Consensus 310 ~~~-------------------------------------------------~vKLsDFGla~~~~~~~~~~~~~~~~Gt 340 (873)
.++ .+||+|||+++..... .....||
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt 256 (397)
T 1wak_A 182 VNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQT 256 (397)
T ss_dssp CCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSC
T ss_pred ccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCC
Confidence 775 8999999999865432 2234689
Q ss_pred cccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcc
Q 002857 341 TGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDM 380 (873)
Q Consensus 341 ~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~ 380 (873)
..|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 257 ~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 296 (397)
T 1wak_A 257 RQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPH 296 (397)
T ss_dssp GGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCC
T ss_pred CcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCC
Confidence 9999999999999999999999999999999999999764
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=332.54 Aligned_cols=247 Identities=23% Similarity=0.327 Sum_probs=200.3
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeecc---CCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCc
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFL---HHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGND 235 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~ 235 (873)
.++|.+.+.||+|+||.||+|++..+++.||||++... .......+.+|++++++++||||+++++++ ...+
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~ 87 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYF-----HDRK 87 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSS
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEE-----EcCC
Confidence 35789999999999999999999888999999998643 122346789999999999999999999996 4466
Q ss_pred eEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeE
Q 002857 236 FKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTAC 315 (873)
Q Consensus 236 ~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vK 315 (873)
..++||||+++|+|.+++.. ...+++..++.++.||+.||.||| +.+|+||||||+||+++.++.+|
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~k 154 (284)
T 2vgo_A 88 RIYLMLEFAPRGELYKELQK----------HGRFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELK 154 (284)
T ss_dssp EEEEEECCCTTEEHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEE
T ss_pred EEEEEEEeCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEE
Confidence 78999999999999999843 235889999999999999999999 89999999999999999999999
Q ss_pred EeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcC
Q 002857 316 VADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSAL 395 (873)
Q Consensus 316 LsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~ 395 (873)
|+|||++....... .....|+..|+|||++.+..++.++||||||+++|||++|+.||....... .
T Consensus 155 l~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~-------- 220 (284)
T 2vgo_A 155 IADFGWSVHAPSLR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE--T-------- 220 (284)
T ss_dssp ECCCTTCEECSSSC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH--H--------
T ss_pred EecccccccCcccc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH--H--------
Confidence 99999997553321 223468999999999999999999999999999999999999997532111 0
Q ss_pred chhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 396 PERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 396 ~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
...+....+ ..|. .....+.+++.+||+.||++|||+.||++
T Consensus 221 ---~~~~~~~~~--------------~~~~---------~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 221 ---HRRIVNVDL--------------KFPP---------FLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp ---HHHHHTTCC--------------CCCT---------TSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---HHHHhcccc--------------CCCC---------cCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 001111000 0000 01224778999999999999999999976
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=334.42 Aligned_cols=252 Identities=24% Similarity=0.337 Sum_probs=203.3
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC-CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceE
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH-HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFK 237 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~ 237 (873)
.+.|.+.+.||+|+||.||+|++..+++.||||++.... ....+.+.+|+.++++++|+||+++++++. .....
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 95 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL-----KDTKL 95 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEe-----cCCeE
Confidence 356889999999999999999998899999999997543 334578999999999999999999999863 45678
Q ss_pred EEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEe
Q 002857 238 ALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVA 317 (873)
Q Consensus 238 ~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLs 317 (873)
++||||+++++|.+++. ...+++..++.++.||+.||.||| +.+|+||||||+|||++.++.+||+
T Consensus 96 ~lv~e~~~~~~L~~~~~-----------~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~ 161 (303)
T 3a7i_A 96 WIIMEYLGGGSALDLLE-----------PGPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLA 161 (303)
T ss_dssp EEEEECCTTEEHHHHHT-----------TSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEEC
T ss_pred EEEEEeCCCCcHHHHHh-----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEECCCCCEEEe
Confidence 99999999999999984 245899999999999999999999 8899999999999999999999999
Q ss_pred ccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCch
Q 002857 318 DFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPE 397 (873)
Q Consensus 318 DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~ 397 (873)
|||++........ ......||..|+|||++.+..++.++||||||+++|||++|+.||....... ....+
T Consensus 162 Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~------ 231 (303)
T 3a7i_A 162 DFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK--VLFLI------ 231 (303)
T ss_dssp CCTTCEECBTTBC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHHH------
T ss_pred ecccceecCcccc--ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH--HHHHh------
Confidence 9999986643321 2233468999999999999999999999999999999999999996532111 00000
Q ss_pred hHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHH
Q 002857 398 RVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLR 466 (873)
Q Consensus 398 ~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le 466 (873)
... . .+.... .....+.+++.+||+.||++|||+.||++..-
T Consensus 232 -----~~~----~------------~~~~~~------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~ 273 (303)
T 3a7i_A 232 -----PKN----N------------PPTLEG------NYSKPLKEFVEACLNKEPSFRPTAKELLKHKF 273 (303)
T ss_dssp -----HHS----C------------CCCCCS------SCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHH
T ss_pred -----hcC----C------------CCCCcc------ccCHHHHHHHHHHcCCChhhCcCHHHHhhChh
Confidence 000 0 000000 01234778999999999999999999987543
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-38 Score=343.00 Aligned_cols=275 Identities=23% Similarity=0.293 Sum_probs=199.3
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCc--chhHHHHHHHHHHhhhhccceeeeeeeecccccCCce
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHD--ASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDF 236 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~ 236 (873)
.++|++.+.||+|+||.||+|++..+++.||||++...... ..+.+.+|++++++++||||+++++++ .....
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~ 98 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVC-----KKKKR 98 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----EETTE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEe-----ecCCE
Confidence 35789999999999999999999988999999998644332 235678999999999999999999996 34667
Q ss_pred EEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEE
Q 002857 237 KALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACV 316 (873)
Q Consensus 237 ~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKL 316 (873)
.++||||+++++|.+++. ....+++..++.|+.||+.||+||| +.+|+||||||+|||++.++.+||
T Consensus 99 ~~lv~e~~~~~~l~~~~~----------~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl 165 (331)
T 4aaa_A 99 WYLVFEFVDHTILDDLEL----------FPNGLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKL 165 (331)
T ss_dssp EEEEEECCSEEHHHHHHH----------STTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEE
T ss_pred EEEEEecCCcchHHHHHh----------hccCCCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcEEE
Confidence 899999999999998863 2456899999999999999999999 889999999999999999999999
Q ss_pred eccccccccccccccccccccccccccCCCcccCCC-CCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHh--h
Q 002857 317 ADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGH-ETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQ--S 393 (873)
Q Consensus 317 sDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~--~ 393 (873)
+|||+++....... ......||..|+|||++.+. .++.++||||||+++|||++|+.||........ +..... .
T Consensus 166 ~Dfg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~ 242 (331)
T 4aaa_A 166 CDFGFARTLAAPGE--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQ-LYHIMMCLG 242 (331)
T ss_dssp CCCTTC--------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHC
T ss_pred EeCCCceeecCCcc--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHhC
Confidence 99999986543221 22234589999999998875 789999999999999999999999976432211 111111 1
Q ss_pred cCchhHHHHhhhhhhhhhhHHHHHhhhccCCC---CchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 394 ALPERVEEIVDTLFFKEIEEEETVYKYKKAPS---SSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 394 ~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~---~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
...+.........-. .... ..+. ..............+.+++.+||+.||++|||+.||++
T Consensus 243 ~~~~~~~~~~~~~~~--------~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 243 NLIPRHQELFNKNPV--------FAGV-RLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp SCCHHHHHHHHHCGG--------GTTC-CCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred CCChhhhhHhhhccc--------cccc-cCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 111111111110000 0000 0000 00000111122346889999999999999999999875
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=336.57 Aligned_cols=254 Identities=22% Similarity=0.278 Sum_probs=196.6
Q ss_pred hhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceE
Q 002857 158 ATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFK 237 (873)
Q Consensus 158 at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~ 237 (873)
..++|++.+.||+|+||.||+|++..+++.||+|++........+.+.+|++++++++||||+++++++ ...+..
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 91 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY-----YHDGKL 91 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECC-CE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeee-----eeCCeE
Confidence 356899999999999999999999888999999999866666678899999999999999999999996 345678
Q ss_pred EEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEe
Q 002857 238 ALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVA 317 (873)
Q Consensus 238 ~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLs 317 (873)
++||||+++++|.+++.. ....+++..++.++.||+.||.||| +.+|+||||||+|||++.++.+||+
T Consensus 92 ~lv~e~~~~~~l~~~~~~---------~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~ 159 (302)
T 2j7t_A 92 WIMIEFCPGGAVDAIMLE---------LDRGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLA 159 (302)
T ss_dssp EEEEECCTTEEHHHHHHH---------HTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTSCEEEC
T ss_pred EEEEEeCCCCcHHHHHHh---------hccCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCCCCEEEE
Confidence 999999999999998842 2345899999999999999999999 8899999999999999999999999
Q ss_pred ccccccccccccccccccccccccccCCCccc-----CCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHh
Q 002857 318 DFGIARFLEATNEQTSSIGVKGTTGYIAPEYG-----MGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQ 392 (873)
Q Consensus 318 DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l-----~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~ 392 (873)
|||++....... .......||..|+|||++ .+..++.++||||||+++|||++|+.||........ .
T Consensus 160 Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~----- 231 (302)
T 2j7t_A 160 DFGVSAKNLKTL--QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV-L----- 231 (302)
T ss_dssp CCHHHHHHHHHH--HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-H-----
T ss_pred ECCCCccccccc--cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHH-H-----
Confidence 999986432211 112234589999999987 466789999999999999999999999975321110 0
Q ss_pred hcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 393 SALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 393 ~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
..+... . .+...... .....+.+++.+||+.||++|||+.||++
T Consensus 232 -------~~~~~~----~------------~~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 232 -------LKIAKS----D------------PPTLLTPS----KWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp -------HHHHHS----C------------CCCCSSGG----GSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred -------HHHhcc----C------------CcccCCcc----ccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 000000 0 00000000 01234778999999999999999998864
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=371.18 Aligned_cols=257 Identities=28% Similarity=0.445 Sum_probs=203.6
Q ss_pred HhhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCce
Q 002857 157 SATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDF 236 (873)
Q Consensus 157 ~at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~ 236 (873)
...++|++.++||+|+||.||+|.+. ++..||||+++.... ..+.|.+|+++|++++|+||+++++++. .+.
T Consensus 264 i~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~------~~~ 335 (535)
T 2h8h_A 264 IPRESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS------EEP 335 (535)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET-TTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEEC------SSS
T ss_pred cchhhhhhheecccCCCeEEEEEEEC-CCceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEe------ecc
Confidence 34567888999999999999999985 456799999975443 3478999999999999999999999863 245
Q ss_pred EEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEE
Q 002857 237 KALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACV 316 (873)
Q Consensus 237 ~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKL 316 (873)
.+|||||+++|+|.++|+. .....+++.+++.|+.||+.||+||| +.+|+||||||+|||++.++.+||
T Consensus 336 ~~lv~e~~~~gsL~~~l~~--------~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl 404 (535)
T 2h8h_A 336 IYIVTEYMSKGSLLDFLKG--------ETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKV 404 (535)
T ss_dssp CEEEECCCTTEEHHHHHSH--------HHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEE
T ss_pred ceEeeehhcCCcHHHHHhh--------cCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcEEE
Confidence 7999999999999999953 12245889999999999999999999 899999999999999999999999
Q ss_pred eccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHHHhhcC
Q 002857 317 ADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQSAL 395 (873)
Q Consensus 317 sDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~~~~~~ 395 (873)
+|||+++...... ........++..|+|||++.+..++.++|||||||+||||+| |+.||....... ..
T Consensus 405 ~DFG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~--~~------- 474 (535)
T 2h8h_A 405 ADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VL------- 474 (535)
T ss_dssp CCTTSTTTCCCHH-HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH--HH-------
T ss_pred cccccceecCCCc-eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HH-------
Confidence 9999998664321 111223346789999999998899999999999999999999 999997532111 00
Q ss_pred chhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHH
Q 002857 396 PERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLI 468 (873)
Q Consensus 396 ~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i 468 (873)
+.+.... ..+.. ..+...+.+|+.+||+.||++|||+.+|++.|+.+
T Consensus 475 -----~~i~~~~--------------~~~~~-------~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~ 521 (535)
T 2h8h_A 475 -----DQVERGY--------------RMPCP-------PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 521 (535)
T ss_dssp -----HHHHTTC--------------CCCCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred -----HHHHcCC--------------CCCCC-------CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 0000000 00000 01233578899999999999999999999999875
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-38 Score=348.39 Aligned_cols=248 Identities=23% Similarity=0.290 Sum_probs=196.2
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCc---chhHHHHHHHHHHhhhhccceeeeeeeecccccCCce
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHD---ASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDF 236 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~---~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~ 236 (873)
+.|...+.||+|+||.||+|++..+++.||||++...... ..+.+.+|++++++++||||+++++++. ..+.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~~ 128 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL-----REHT 128 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----ECCe
Confidence 4588899999999999999999889999999999754322 2356889999999999999999999963 4567
Q ss_pred EEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEE
Q 002857 237 KALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACV 316 (873)
Q Consensus 237 ~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKL 316 (873)
.+|||||+. |+|.+++.. ....+++..++.|+.||+.||+||| +.+|+||||||+|||++.++.+||
T Consensus 129 ~~lv~e~~~-g~l~~~l~~---------~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL 195 (348)
T 1u5q_A 129 AWLVMEYCL-GSASDLLEV---------HKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKL 195 (348)
T ss_dssp EEEEEECCS-EEHHHHHHH---------HTSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEE
T ss_pred EEEEEecCC-CCHHHHHHH---------hcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEE
Confidence 899999997 688888742 2356899999999999999999999 889999999999999999999999
Q ss_pred eccccccccccccccccccccccccccCCCcccC---CCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhh
Q 002857 317 ADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGM---GHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQS 393 (873)
Q Consensus 317 sDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~---~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~ 393 (873)
+|||+++..... ....||..|+|||++. ...++.++||||||+++|||++|+.||....... .
T Consensus 196 ~DfG~a~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~-~------- 261 (348)
T 1u5q_A 196 GDFGSASIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-A------- 261 (348)
T ss_dssp CCCTTCBSSSSB------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-H-------
T ss_pred eeccCceecCCC------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-H-------
Confidence 999999865322 2346899999999874 5678999999999999999999999986532110 0
Q ss_pred cCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHH
Q 002857 394 ALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGL 465 (873)
Q Consensus 394 ~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~L 465 (873)
+..+.... .+.... . .....+.+++.+||+.||++|||+.+|++..
T Consensus 262 -----~~~~~~~~----------------~~~~~~-~----~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~ 307 (348)
T 1u5q_A 262 -----LYHIAQNE----------------SPALQS-G----HWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 307 (348)
T ss_dssp -----HHHHHHSC----------------CCCCCC-T----TSCHHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred -----HHHHHhcC----------------CCCCCC-C----CCCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 00010000 000000 0 0122477899999999999999999997643
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=356.52 Aligned_cols=261 Identities=15% Similarity=0.145 Sum_probs=192.4
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeecc---CCcchhHHHHHHH---HHHhhhhccceeeeeeeeccc--
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFL---HHDASKSFTVECE---VMRNIIHRKIIKVVTACSRVD-- 230 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~---~~~~~~~f~~Ei~---iL~~L~HpNIV~llg~c~~~~-- 230 (873)
.++|.+.+.||+|+||.||+|++..+++.||||++... .....+.+.+|++ +|++++|||||++++.+....
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46788999999999999999998888999999999733 3344578899994 555568999999984432100
Q ss_pred ccCC------------c-----eEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCC
Q 002857 231 YQGN------------D-----FKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCK 293 (873)
Q Consensus 231 ~~~~------------~-----~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s 293 (873)
+... + ..+|||||+ +|+|.+++.... ........+++..++.|+.||+.||+||| +
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~---~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~ 224 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLL---SHSSTHKSLVHHARLQLTLQVIRLLASLH---H 224 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHH---HTTTTTHHHHHHHHHHHHHHHHHHHHHHH---H
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhcc---ccccccccccHHHHHHHHHHHHHHHHHHH---h
Confidence 1111 1 378999999 689999996411 01111234667889999999999999999 8
Q ss_pred CCeeeccCCCCCeeeCCCCCeEEeccccccccccccccccccccccccccCCCcccCCC-----------CCCcchhhHh
Q 002857 294 PPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGH-----------ETSSYGDVYS 362 (873)
Q Consensus 294 ~gIvHrDLKpsNILLd~~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-----------~~s~ksDVwS 362 (873)
.+|+||||||+|||++.++.+||+|||+++.... ......| ..|+|||++.+. .++.++||||
T Consensus 225 ~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwS 298 (377)
T 3byv_A 225 YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWA 298 (377)
T ss_dssp TTEECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHH
T ss_pred CCeecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHH
Confidence 8999999999999999999999999999985322 2223457 999999999887 8999999999
Q ss_pred HHHHHHHHHhCCCCCCcccccchhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHH
Q 002857 363 FGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICE 442 (873)
Q Consensus 363 fGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~ 442 (873)
|||++|||+||+.||........ .. .+ ... .+ .+...+.+
T Consensus 299 lG~il~elltg~~Pf~~~~~~~~--~~-----------~~----~~~-------------~~----------~~~~~~~~ 338 (377)
T 3byv_A 299 LGLVIYWIWCADLPITKDAALGG--SE-----------WI----FRS-------------CK----------NIPQPVRA 338 (377)
T ss_dssp HHHHHHHHHHSSCCC------CC--SG-----------GG----GSS-------------CC----------CCCHHHHH
T ss_pred HHHHHHHHHHCCCCCcccccccc--hh-----------hh----hhh-------------cc----------CCCHHHHH
Confidence 99999999999999965321110 00 00 000 00 01224778
Q ss_pred HHHHhhccCcCCCCCHHHHHH--HHHHHHHhh
Q 002857 443 IGVACSAELPGERMKINDVEL--GLRLIKKKL 472 (873)
Q Consensus 443 L~~~CL~~dP~eRPTm~EVl~--~Le~i~~~l 472 (873)
++.+||+.||++|||+.|+++ .++.++...
T Consensus 339 li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~~ 370 (377)
T 3byv_A 339 LLEGFLRYPKEDRLLPLQAMETPEYEQLRTEL 370 (377)
T ss_dssp HHHHHTCSSGGGCCCHHHHHTSHHHHHHHHHH
T ss_pred HHHHHcCCCchhCCCHHHHhhChHHHHHHHHH
Confidence 999999999999999999986 555554443
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=335.69 Aligned_cols=281 Identities=18% Similarity=0.248 Sum_probs=197.5
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeeccc--------
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVD-------- 230 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~-------- 230 (873)
.++|.+.+.||+|+||.||+|.+..+++.||||++........+.+.+|++++++++||||+++++++....
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 468999999999999999999998889999999998665556678999999999999999999999864221
Q ss_pred -ccCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeC
Q 002857 231 -YQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLN 309 (873)
Q Consensus 231 -~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd 309 (873)
.......++||||++ |+|.+++. ...+++..++.++.||+.||+||| +.+|+||||||+|||++
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~-----------~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~ 154 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLE-----------QGPLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFIN 154 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHT-----------TCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhh-----------cCCccHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEc
Confidence 134567899999997 69999983 245889999999999999999999 89999999999999997
Q ss_pred -CCCCeEEeccccccccccccc-cccccccccccccCCCcccCC-CCCCcchhhHhHHHHHHHHHhCCCCCCcccccchh
Q 002857 310 -DEMTACVADFGIARFLEATNE-QTSSIGVKGTTGYIAPEYGMG-HETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLN 386 (873)
Q Consensus 310 -~~~~vKLsDFGla~~~~~~~~-~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~ 386 (873)
+++.+||+|||+++....... ........+|..|+|||++.+ ..++.++||||||+++|||+||+.||....... .
T Consensus 155 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-~ 233 (320)
T 2i6l_A 155 TEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE-Q 233 (320)
T ss_dssp TTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-H
T ss_pred CCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHH-H
Confidence 567999999999987643221 112223457899999998765 678999999999999999999999997643211 1
Q ss_pred hHHHHhhc--Cch-hHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 387 LQNWVQSA--LPE-RVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 387 l~~~~~~~--~~~-~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
+....... ... ...++.... ... .......+... ...........+.+++.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~-~~~------~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 234 MQLILESIPVVHEEDRQELLSVI-PVY------IRNDMTEPHKP-LTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HHHHHHHSCCCCHHHHHHHHTTS-CHH------HHHHTTSCCCC-HHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHHHHhcCCCchhhhhhhhhcC-ccc------ccccccCCCCC-hhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 11111110 000 111111100 000 00000001000 00111122346889999999999999999999875
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-38 Score=374.72 Aligned_cols=253 Identities=24% Similarity=0.358 Sum_probs=197.5
Q ss_pred eeecccCceEEEEEEEc--CCCcEEEEEEeeccCC--cchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEEEE
Q 002857 166 NLIGAGNFASVYKGILF--EGAPAVAIKVFNFLHH--DASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKALVY 241 (873)
Q Consensus 166 ~~LG~G~fG~VYkg~~~--~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~LV~ 241 (873)
+.||+|+||.||+|.+. ..++.||||+++.... ...+.+.+|+++|++++|||||+++++|. .+..+|||
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~------~~~~~lv~ 448 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE------AESWMLVM 448 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE------SSSEEEEE
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe------cCCEEEEE
Confidence 47999999999999664 4567899999975432 23478999999999999999999999963 23478999
Q ss_pred eecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEecccc
Q 002857 242 EFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGI 321 (873)
Q Consensus 242 Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDFGl 321 (873)
||+++|+|.++|.. ...+++..++.|+.||+.||+||| +.+|+||||||+||||+.++.+||+|||+
T Consensus 449 E~~~~g~L~~~l~~----------~~~l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFGl 515 (635)
T 4fl3_A 449 EMAELGPLNKYLQQ----------NRHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGL 515 (635)
T ss_dssp ECCTTEEHHHHHHH----------CTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTTH
T ss_pred EccCCCCHHHHHhh----------CCCCCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcCC
Confidence 99999999999942 356899999999999999999999 89999999999999999999999999999
Q ss_pred cccccccccc-ccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHHHhhcCchhH
Q 002857 322 ARFLEATNEQ-TSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQSALPERV 399 (873)
Q Consensus 322 a~~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~~~~~~~~~l 399 (873)
++.+...... .......+|..|+|||++.+..++.++|||||||++|||+| |+.||....... +
T Consensus 516 a~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~--------------~ 581 (635)
T 4fl3_A 516 SKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--------------V 581 (635)
T ss_dssp HHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--------------H
T ss_pred ccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--------------H
Confidence 9876543321 12223346789999999999999999999999999999999 999997632211 1
Q ss_pred HHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHHHHhh
Q 002857 400 EEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLIKKKL 472 (873)
Q Consensus 400 ~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i~~~l 472 (873)
.+.+...... +.. ..+...+.+|+..||+.||++|||+.+|+++|+.+...+
T Consensus 582 ~~~i~~~~~~--------------~~p-------~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l 633 (635)
T 4fl3_A 582 TAMLEKGERM--------------GCP-------AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 633 (635)
T ss_dssp HHHHHTTCCC--------------CCC-------TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHcCCCC--------------CCC-------CCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 1111110000 000 012345889999999999999999999999999886654
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=347.28 Aligned_cols=291 Identities=19% Similarity=0.213 Sum_probs=202.1
Q ss_pred HHhhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccc----
Q 002857 156 YSATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDY---- 231 (873)
Q Consensus 156 ~~at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~---- 231 (873)
....++|.+.+.||+|+||.||+|++..+++.||||++.... ....+|+++|+.++|+||+++++++.....
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP----RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 445678999999999999999999999999999999986432 233479999999999999999999753221
Q ss_pred -----------------------------cCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHH
Q 002857 232 -----------------------------QGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVA 282 (873)
Q Consensus 232 -----------------------------~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa 282 (873)
......++||||++ |+|.+.+... ......+++..+..|+.||+
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~------~~~~~~l~~~~~~~i~~qi~ 151 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSF------IRSGRSIPMNLISIYIYQLF 151 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHH------HHTTCCCCHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHH------HhcCCCCCHHHHHHHHHHHH
Confidence 23445889999998 5888887531 12356789999999999999
Q ss_pred HHHHHHhhCCCCCeeeccCCCCCeeeC-CCCCeEEeccccccccccccccccccccccccccCCCcccCCC-CCCcchhh
Q 002857 283 SALEYLHLGCKPPIAHCDIKPSNILLN-DEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGH-ETSSYGDV 360 (873)
Q Consensus 283 ~gL~yLH~~~s~gIvHrDLKpsNILLd-~~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDV 360 (873)
+||+||| +.+|+||||||+|||++ .++.+||+|||+++.+..... .....+|..|+|||++.+. .++.++||
T Consensus 152 ~aL~~LH---~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Di 225 (383)
T 3eb0_A 152 RAVGFIH---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDL 225 (383)
T ss_dssp HHHHHHH---TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHH
T ss_pred HHHHHHH---HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhh
Confidence 9999999 89999999999999998 688999999999986644322 2234689999999998775 48999999
Q ss_pred HhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHH
Q 002857 361 YSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSI 440 (873)
Q Consensus 361 wSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L 440 (873)
||||+++|||++|+.||....... .+...+...-......+... ...+.. ..........+ ...........+
T Consensus 226 wslG~il~ell~g~~pf~~~~~~~-~~~~i~~~~g~p~~~~~~~~--~~~~~~-~~~~~~~~~~~---~~~~~~~~~~~~ 298 (383)
T 3eb0_A 226 WSIGCVFGELILGKPLFSGETSID-QLVRIIQIMGTPTKEQMIRM--NPHYTE-VRFPTLKAKDW---RKILPEGTPSLA 298 (383)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCHHHHHHH--CTTC---CCCCCCCCCCH---HHHSCTTCCHHH
T ss_pred hhHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCHHHHHHh--Cccccc-ccCCccCcccH---HhhCCCCCCHHH
Confidence 999999999999999997632211 11121111111111111000 000000 00000000000 000001123357
Q ss_pred HHHHHHhhccCcCCCCCHHHHHH--HHHHHHH
Q 002857 441 CEIGVACSAELPGERMKINDVEL--GLRLIKK 470 (873)
Q Consensus 441 ~~L~~~CL~~dP~eRPTm~EVl~--~Le~i~~ 470 (873)
.+|+.+||+.||++|||+.|+++ .++.++.
T Consensus 299 ~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (383)
T 3eb0_A 299 IDLLEQILRYEPDLRINPYEAMAHPFFDHLRN 330 (383)
T ss_dssp HHHHHHHCCSSGGGSCCHHHHHTSGGGHHHHH
T ss_pred HHHHHHHccCChhhCCCHHHHhcCHHHHHHHh
Confidence 89999999999999999999984 3455444
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-38 Score=335.15 Aligned_cols=254 Identities=20% Similarity=0.219 Sum_probs=184.5
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCc-c-hhHHHHHHHHHHhhhhccceeeeeeeecccccCCce
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHD-A-SKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDF 236 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~-~-~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~ 236 (873)
.++|++.+.||+|+||.||+|.+..+++.||||+++..... . .+.+.++...++.++||||+++++++ ...+.
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~-----~~~~~ 80 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGAL-----FREGD 80 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSS
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeee-----eccCC
Confidence 46899999999999999999999999999999998744222 2 23344455557788999999999996 34567
Q ss_pred EEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCC-CeeeccCCCCCeeeCCCCCeE
Q 002857 237 KALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKP-PIAHCDIKPSNILLNDEMTAC 315 (873)
Q Consensus 237 ~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~-gIvHrDLKpsNILLd~~~~vK 315 (873)
.++||||++ |+|.+++... ......+++..++.|+.||+.||+||| +. +|+||||||+|||++.++.+|
T Consensus 81 ~~lv~e~~~-~~l~~~l~~~------~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~k 150 (290)
T 3fme_A 81 VWICMELMD-TSLDKFYKQV------IDKGQTIPEDILGKIAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVK 150 (290)
T ss_dssp EEEEEECCS-EEHHHHHHHH------HHTTCCCCHHHHHHHHHHHHHHHHHHH---HHSCCCCCCCSGGGCEECTTCCEE
T ss_pred EEEEEehhc-cchHHHHHHH------HhcCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEE
Confidence 899999997 5988887431 123567999999999999999999999 76 999999999999999999999
Q ss_pred EeccccccccccccccccccccccccccCCCccc----CCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHH
Q 002857 316 VADFGIARFLEATNEQTSSIGVKGTTGYIAPEYG----MGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWV 391 (873)
Q Consensus 316 LsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l----~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~ 391 (873)
|+|||+++....... .....||..|+|||++ .+..++.++||||||+++|||+||+.||.........+.
T Consensus 151 l~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~--- 224 (290)
T 3fme_A 151 MCDFGISGYLVDDVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLK--- 224 (290)
T ss_dssp BCCC------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHH---
T ss_pred EeecCCccccccccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHH---
Confidence 999999986644322 2223589999999995 556789999999999999999999999975222111111
Q ss_pred hhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 392 QSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 392 ~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
..+...... .+.. .....+.+++.+||+.||++|||+.||++
T Consensus 225 ---------~~~~~~~~~-------------~~~~--------~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 225 ---------QVVEEPSPQ-------------LPAD--------KFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp ---------HHHHSCCCC-------------CCTT--------TSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ---------HHhccCCCC-------------cccc--------cCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 111110000 0000 01234788999999999999999999986
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=335.59 Aligned_cols=250 Identities=22% Similarity=0.291 Sum_probs=201.6
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC---CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCc
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH---HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGND 235 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~ 235 (873)
.++|.+.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.++++++|+||+++++++ ...+
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~ 88 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF-----EDND 88 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSS
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeee-----ccCC
Confidence 457899999999999999999999899999999986432 22346788999999999999999999996 4466
Q ss_pred eEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeE
Q 002857 236 FKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTAC 315 (873)
Q Consensus 236 ~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vK 315 (873)
..++||||+++++|.+++.. ...+++.+++.|+.||+.||+||| +.+|+||||||+|||++.++.+|
T Consensus 89 ~~~lv~e~~~~~~L~~~~~~----------~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~k 155 (294)
T 2rku_A 89 FVFVVLELCRRRSLLELHKR----------RKALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVK 155 (294)
T ss_dssp EEEEEEECCTTCBHHHHHHH----------HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEE
T ss_pred EEEEEEecCCCCCHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEcCCCCEE
Confidence 78999999999999998842 346899999999999999999999 88999999999999999999999
Q ss_pred EeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcC
Q 002857 316 VADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSAL 395 (873)
Q Consensus 316 LsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~ 395 (873)
|+|||+++....... ......||..|+|||++.+..++.++||||||+++|||++|+.||.......
T Consensus 156 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----------- 222 (294)
T 2rku_A 156 IGDFGLATKVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE----------- 222 (294)
T ss_dssp ECCCTTCEECCSTTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-----------
T ss_pred EEeccCceecccCcc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----------
Confidence 999999986543221 1223468999999999999899999999999999999999999997532111
Q ss_pred chhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHH
Q 002857 396 PERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELG 464 (873)
Q Consensus 396 ~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~ 464 (873)
....+..... ..|. .....+.+++.+||+.||++|||+.|+++.
T Consensus 223 --~~~~~~~~~~--------------~~~~---------~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 223 --TYLRIKKNEY--------------SIPK---------HINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp --HHHHHHTTCC--------------CCCT---------TSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred --HHHHHhhccC--------------CCcc---------ccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0000100000 0000 011247789999999999999999998764
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=331.32 Aligned_cols=249 Identities=25% Similarity=0.358 Sum_probs=192.5
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeecc---CCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCc
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFL---HHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGND 235 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~ 235 (873)
.++|.+.+.||+|+||.||+|++..+++.||||++... .....+.+.+|+.++++++||||+++++++ ...+
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~ 84 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVI-----STPT 84 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSS
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEE-----ecCC
Confidence 46899999999999999999999888999999998643 223446789999999999999999999996 4466
Q ss_pred eEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeE
Q 002857 236 FKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTAC 315 (873)
Q Consensus 236 ~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vK 315 (873)
..++||||+++++|.+++.. ...+++..++.++.||+.||+||| +.+|+|+||||+|||++.++.+|
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~ 151 (276)
T 2h6d_A 85 DFFMVMEYVSGGELFDYICK----------HGRVEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAK 151 (276)
T ss_dssp EEEEEEECCCSCBHHHHHHH----------HCSCCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCCGGGEEECTTSCEE
T ss_pred eEEEEEeccCCCcHHHHHhc----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChhhEEECCCCCEE
Confidence 79999999999999999943 245889999999999999999999 88999999999999999999999
Q ss_pred EeccccccccccccccccccccccccccCCCcccCCCCC-CcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhc
Q 002857 316 VADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHET-SSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSA 394 (873)
Q Consensus 316 LsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~-s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~ 394 (873)
|+|||++....... ......++..|+|||++.+..+ +.++||||||+++|||++|+.||....... ..
T Consensus 152 l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~------ 220 (276)
T 2h6d_A 152 IADFGLSNMMSDGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT--LF------ 220 (276)
T ss_dssp ECCCCGGGCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HH------
T ss_pred EeecccccccCCCc---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH--HH------
Confidence 99999998654322 1223458999999999988765 689999999999999999999996521110 00
Q ss_pred CchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHH
Q 002857 395 LPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELG 464 (873)
Q Consensus 395 ~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~ 464 (873)
..+..... ..|. .....+.+++.+||+.||++|||+.||++.
T Consensus 221 -----~~~~~~~~--------------~~~~---------~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 221 -----KKIRGGVF--------------YIPE---------YLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp -----HHHHHCCC--------------CCCT---------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred -----HHhhcCcc--------------cCch---------hcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 00000000 0000 012247789999999999999999999863
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=337.32 Aligned_cols=252 Identities=22% Similarity=0.292 Sum_probs=194.2
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC--------CcchhHHHHHHHHHHhhhhccceeeeeeeeccc
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH--------HDASKSFTVECEVMRNIIHRKIIKVVTACSRVD 230 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~--------~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~ 230 (873)
.++|.+.+.||+|+||.||+|++..+++.||||++.... ......+.+|++++++++||||+++++++.
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--- 85 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD--- 85 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEE---
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEc---
Confidence 467999999999999999999999999999999986432 122346889999999999999999999853
Q ss_pred ccCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCC
Q 002857 231 YQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLND 310 (873)
Q Consensus 231 ~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~ 310 (873)
. +..++||||+++|+|.+++. ....+++..++.++.||+.||+||| +.+|+||||||+|||++.
T Consensus 86 --~-~~~~lv~e~~~~~~L~~~~~----------~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~ 149 (322)
T 2ycf_A 86 --A-EDYYIVLELMEGGELFDKVV----------GNKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSS 149 (322)
T ss_dssp --S-SSEEEEEECCTTEETHHHHS----------TTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESS
T ss_pred --C-CceEEEEecCCCCcHHHHHh----------ccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEec
Confidence 2 23799999999999999884 3456899999999999999999999 899999999999999987
Q ss_pred CCC---eEEeccccccccccccccccccccccccccCCCcccC---CCCCCcchhhHhHHHHHHHHHhCCCCCCcccccc
Q 002857 311 EMT---ACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGM---GHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDN 384 (873)
Q Consensus 311 ~~~---vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~---~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~ 384 (873)
++. +||+|||+++...... ......||..|+|||++. ...++.++||||||+++|||++|+.||.......
T Consensus 150 ~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 226 (322)
T 2ycf_A 150 QEEDCLIKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV 226 (322)
T ss_dssp SSSSCCEEECCCTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS
T ss_pred CCCCCeEEEccCccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH
Confidence 654 9999999998654321 122346899999999863 5678999999999999999999999997532211
Q ss_pred hhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 385 LNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 385 ~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
.+...+.. ..... . ..........+.+++.+||+.||++|||+.|+++
T Consensus 227 -~~~~~~~~-----------~~~~~-~------------------~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 227 -SLKDQITS-----------GKYNF-I------------------PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp -CHHHHHHH-----------TCCCC-C------------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -HHHHHHHh-----------Ccccc-C------------------chhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 11111100 00000 0 0000111335789999999999999999999984
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=339.21 Aligned_cols=270 Identities=25% Similarity=0.316 Sum_probs=183.4
Q ss_pred hhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC-CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCce
Q 002857 158 ATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH-HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDF 236 (873)
Q Consensus 158 at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~ 236 (873)
..++|.+.+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|+.++++++||||+++++++ ...+.
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~ 87 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF-----VVKDE 87 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEE-----ESSSC
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEE-----eecCC
Confidence 3578999999999999999999988889999999986433 23456788999999999999999999996 34557
Q ss_pred EEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEE
Q 002857 237 KALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACV 316 (873)
Q Consensus 237 ~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKL 316 (873)
.++||||+++++|.+++...... .......+++..++.++.||+.||.||| +.+|+||||||+|||++.++.+||
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl 162 (303)
T 2vwi_A 88 LWLVMKLLSGGSVLDIIKHIVAK--GEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQI 162 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHT--TTTTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEE
T ss_pred cEEEehhccCCchHHHHHHHhhc--cccccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCCChhhEEEcCCCCEEE
Confidence 89999999999999998532111 1123456899999999999999999999 889999999999999999999999
Q ss_pred ecccccccccccccc---ccccccccccccCCCcccCC-CCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHh
Q 002857 317 ADFGIARFLEATNEQ---TSSIGVKGTTGYIAPEYGMG-HETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQ 392 (873)
Q Consensus 317 sDFGla~~~~~~~~~---~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~ 392 (873)
+|||++......... .......||..|+|||++.+ ..++.++||||||+++|||++|+.||........ ......
T Consensus 163 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~ 241 (303)
T 2vwi_A 163 ADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV-LMLTLQ 241 (303)
T ss_dssp CCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH-HHHHHT
T ss_pred EeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH-HHHHhc
Confidence 999999866433211 11223468999999999876 4689999999999999999999999976322211 000000
Q ss_pred hcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 393 SALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 393 ~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
...........+..+. ......+.+++.+||+.||++|||+.||++
T Consensus 242 ~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 242 NDPPSLETGVQDKEML-------------------------KKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp SSCCCTTC-----CCC-------------------------CCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred cCCCccccccccchhh-------------------------hhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 0000000000000000 001234778999999999999999999875
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=342.54 Aligned_cols=277 Identities=22% Similarity=0.280 Sum_probs=195.9
Q ss_pred HhhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCc-----chhHHHHHHHHHHhhhhccceeeeeeeecccc
Q 002857 157 SATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHD-----ASKSFTVECEVMRNIIHRKIIKVVTACSRVDY 231 (873)
Q Consensus 157 ~at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~-----~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~ 231 (873)
...++|.+.+.||+|+||.||+|++..+++.||||+++..... ..+.+.+|++++++++||||+++++++
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~----- 81 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAF----- 81 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEE-----
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEE-----
Confidence 3457899999999999999999999888999999998643221 235788999999999999999999996
Q ss_pred cCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCC
Q 002857 232 QGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDE 311 (873)
Q Consensus 232 ~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~ 311 (873)
......++||||+++ +|.+++.. ....+++..++.++.||+.||+||| +.+|+||||||+|||++.+
T Consensus 82 ~~~~~~~lv~e~~~~-~l~~~~~~---------~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~ 148 (346)
T 1ua2_A 82 GHKSNISLVFDFMET-DLEVIIKD---------NSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDEN 148 (346)
T ss_dssp CCTTCCEEEEECCSE-EHHHHHTT---------CCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTT
T ss_pred eeCCceEEEEEcCCC-CHHHHHHh---------cCcCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcCC
Confidence 445678999999976 89888842 3456889999999999999999999 8999999999999999999
Q ss_pred CCeEEeccccccccccccccccccccccccccCCCcccCCC-CCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHH
Q 002857 312 MTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGH-ETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNW 390 (873)
Q Consensus 312 ~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~ 390 (873)
+.+||+|||+++.+..... ......+|..|+|||++.+. .++.++||||||+++|||++|..||....... .+...
T Consensus 149 ~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~-~~~~i 225 (346)
T 1ua2_A 149 GVLKLADFGLAKSFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD-QLTRI 225 (346)
T ss_dssp CCEEECCCGGGSTTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHH
T ss_pred CCEEEEecccceeccCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH-HHHHH
Confidence 9999999999987643221 22334689999999998764 58999999999999999999999987632211 11111
Q ss_pred HhhcCch---hHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHH
Q 002857 391 VQSALPE---RVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELG 464 (873)
Q Consensus 391 ~~~~~~~---~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~ 464 (873)
....... .+.++.. + .+ .......+... ...........+.+++.+||+.||++|||+.|+++.
T Consensus 226 ~~~~~~~~~~~~~~~~~--~-~~------~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 226 FETLGTPTEEQWPDMCS--L-PD------YVTFKSFPGIP-LHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp HHHHCCCCTTTSSSTTS--S-TT------CCCCCCCCCCC-HHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred HHHcCCCChhhhhhhcc--C-cc------cccccccCCCC-hHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 1100000 0000000 0 00 00000000000 000111123458899999999999999999998653
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=339.76 Aligned_cols=209 Identities=20% Similarity=0.294 Sum_probs=172.9
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCC--cchhHHHHHHHHHHhhhhccceeeeeeeecccc---cC
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH--DASKSFTVECEVMRNIIHRKIIKVVTACSRVDY---QG 233 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~---~~ 233 (873)
.++|++.+.||+|+||.||+|++..+++.||||++..... .....+.+|++++++++||||+++++++..... ..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 3679999999999999999999999999999999864332 234578899999999999999999999754221 11
Q ss_pred CceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCC
Q 002857 234 NDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMT 313 (873)
Q Consensus 234 ~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~ 313 (873)
.+..++||||+++ +|.+.+.. ....+++.+++.|+.||+.||+||| +.+|+||||||+|||++.++.
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~---------~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~ 162 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSN---------VLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGV 162 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHC---------TTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSC
T ss_pred CceEEEEEeccCC-CHHHHHhh---------ccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCC
Confidence 4568999999975 77777742 3456899999999999999999999 899999999999999999999
Q ss_pred eEEeccccccccccccc--cccccccccccccCCCcccCC-CCCCcchhhHhHHHHHHHHHhCCCCCCcc
Q 002857 314 ACVADFGIARFLEATNE--QTSSIGVKGTTGYIAPEYGMG-HETSSYGDVYSFGILLLEMFTGLRPSDDM 380 (873)
Q Consensus 314 vKLsDFGla~~~~~~~~--~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~ 380 (873)
+||+|||+++.+..... ........||..|+|||++.+ ..++.++||||||+++|||+||+.||...
T Consensus 163 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 232 (351)
T 3mi9_A 163 LKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN 232 (351)
T ss_dssp EEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred EEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999987643221 122234568999999998876 45899999999999999999999999763
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=346.47 Aligned_cols=280 Identities=19% Similarity=0.213 Sum_probs=195.3
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCC--cchhHHHHHHHHHHhhhhccceeeeeeeecccc-cCCc
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH--DASKSFTVECEVMRNIIHRKIIKVVTACSRVDY-QGND 235 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~-~~~~ 235 (873)
.++|.+.+.||+|+||.||+|.+..+++.||||++..... ...+.+.+|+++|++++||||+++++++..... ....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 5689999999999999999999999999999999864322 234678899999999999999999999753211 1224
Q ss_pred eEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeE
Q 002857 236 FKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTAC 315 (873)
Q Consensus 236 ~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vK 315 (873)
..++||||+ +++|.+++.. ..+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+|
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~-----------~~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~k 168 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH-----------EKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELK 168 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH-----------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEE
T ss_pred eEEEEEecC-CCCHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEcCCCCEE
Confidence 569999999 8899999842 35889999999999999999999 89999999999999999999999
Q ss_pred EeccccccccccccccccccccccccccCCCcccCC-CCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhc
Q 002857 316 VADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMG-HETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSA 394 (873)
Q Consensus 316 LsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~ 394 (873)
|+|||+++..... .....+|..|+|||++.+ ..++.++|||||||++|||++|+.||....... .+.... ..
T Consensus 169 l~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~l~~i~-~~ 241 (367)
T 1cm8_A 169 ILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD-QLKEIM-KV 241 (367)
T ss_dssp ECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHH-HH
T ss_pred EEeeecccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHH-Hh
Confidence 9999999865332 223468999999999877 679999999999999999999999997632211 111111 11
Q ss_pred CchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 395 LPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 395 ~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
......+++...-... .+.........+.. ............+.+++.+||+.||++|||+.|+++
T Consensus 242 ~g~~~~~~~~~~~~~~--~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 242 TGTPPAEFVQRLQSDE--AKNYMKGLPELEKK-DFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp HCCCCHHHHHTCSCHH--HHHHHHHSCCCCCC-CGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred cCCCCHHHHHHhhhHH--HHHHHHhCCCCCCC-CHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 0000011111000000 00000000000000 000001112335789999999999999999998865
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=334.93 Aligned_cols=209 Identities=23% Similarity=0.346 Sum_probs=175.8
Q ss_pred HhhcCCCcceeecccCceEEEEEEEc-CCCcEEEEEEeeccC--CcchhHHHHHHHHHHhh---hhccceeeeeeeeccc
Q 002857 157 SATKGFSSENLIGAGNFASVYKGILF-EGAPAVAIKVFNFLH--HDASKSFTVECEVMRNI---IHRKIIKVVTACSRVD 230 (873)
Q Consensus 157 ~at~~f~~~~~LG~G~fG~VYkg~~~-~~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L---~HpNIV~llg~c~~~~ 230 (873)
.+.++|++.+.||+|+||.||+|++. .+++.||||+++... ......+.+|+.+++.+ +||||+++++++....
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 45688999999999999999999985 678899999987432 22335678898888877 7999999999975332
Q ss_pred ccCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCC
Q 002857 231 YQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLND 310 (873)
Q Consensus 231 ~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~ 310 (873)
.......++||||+. |+|.+++.. .....+++..++.++.||+.||.||| +.+|+||||||+|||++.
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~--------~~~~~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp~Nili~~ 155 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDK--------VPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTS 155 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHH--------SCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECT
T ss_pred cCCCceEEEEEecCC-CCHHHHHHh--------cccCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHHHeEEcC
Confidence 235567899999997 699999853 23345899999999999999999999 889999999999999999
Q ss_pred CCCeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcc
Q 002857 311 EMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDM 380 (873)
Q Consensus 311 ~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~ 380 (873)
++.+||+|||+++...... ......||..|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 156 ~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 222 (326)
T 1blx_A 156 SGQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS 222 (326)
T ss_dssp TCCEEECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CCCEEEecCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCC
Confidence 9999999999998654322 223356899999999999999999999999999999999999999763
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=345.01 Aligned_cols=254 Identities=24% Similarity=0.311 Sum_probs=197.2
Q ss_pred hhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhh-hhccceeeeeeeecccccCCce
Q 002857 158 ATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNI-IHRKIIKVVTACSRVDYQGNDF 236 (873)
Q Consensus 158 at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~llg~c~~~~~~~~~~ 236 (873)
..++|++.+.||+|+||.||+|.+..+++.||||+++.... .+.+|++++.++ +||||+++++++ .+...
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~-----~~~~~ 90 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVY-----DDGKY 90 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEE-----ECSSE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEE-----EcCCE
Confidence 35679999999999999999999999999999999975432 346789999888 799999999995 45678
Q ss_pred EEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCC----C
Q 002857 237 KALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDE----M 312 (873)
Q Consensus 237 ~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~----~ 312 (873)
.++||||+++|+|.+++. ....+++..+..++.||+.||+||| +.+|+||||||+|||+.++ +
T Consensus 91 ~~lv~E~~~gg~L~~~i~----------~~~~~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~~~~~~~ 157 (342)
T 2qr7_A 91 VYVVTELMKGGELLDKIL----------RQKFFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPE 157 (342)
T ss_dssp EEEEECCCCSCBHHHHHH----------TCTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSCSGG
T ss_pred EEEEEeCCCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEecCCCCcC
Confidence 999999999999999984 2456899999999999999999999 8999999999999998533 3
Q ss_pred CeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHh
Q 002857 313 TACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQ 392 (873)
Q Consensus 313 ~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~ 392 (873)
.+||+|||+++....... ......||..|+|||++.+..++.++|||||||++|||++|+.||.....+.
T Consensus 158 ~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-------- 227 (342)
T 2qr7_A 158 SIRICDFGFAKQLRAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDT-------- 227 (342)
T ss_dssp GEEECCCTTCEECBCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSC--------
T ss_pred eEEEEECCCcccCcCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCC--------
Confidence 599999999987644322 2223468999999999988888999999999999999999999997532111
Q ss_pred hcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHH
Q 002857 393 SALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELG 464 (873)
Q Consensus 393 ~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~ 464 (873)
..+++.......+. .....+. .....+.+++.+||+.||++|||+.||++.
T Consensus 228 ------~~~~~~~i~~~~~~-------~~~~~~~--------~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 228 ------PEEILARIGSGKFS-------LSGGYWN--------SVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp ------HHHHHHHHHHCCCC-------CCSTTTT--------TSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred ------HHHHHHHHccCCcc-------cCccccc--------cCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 01111111111000 0000000 012347789999999999999999998753
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-37 Score=341.59 Aligned_cols=258 Identities=21% Similarity=0.319 Sum_probs=202.0
Q ss_pred HHHHHhhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCc--------chhHHHHHHHHHHhh-hhccceeee
Q 002857 153 EALYSATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHD--------ASKSFTVECEVMRNI-IHRKIIKVV 223 (873)
Q Consensus 153 ~el~~at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~--------~~~~f~~Ei~iL~~L-~HpNIV~ll 223 (873)
.......++|.+.+.||+|+||.||+|++..+|+.||||+++..... ..+.+.+|+.+++++ +||||++++
T Consensus 87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 166 (365)
T 2y7j_A 87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI 166 (365)
T ss_dssp HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 33445567899999999999999999999888999999998754321 135678899999999 799999999
Q ss_pred eeeecccccCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCC
Q 002857 224 TACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKP 303 (873)
Q Consensus 224 g~c~~~~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKp 303 (873)
+++ ......++||||+++++|.+++.. ...+++..++.|+.||+.||.||| +.+|+||||||
T Consensus 167 ~~~-----~~~~~~~lv~e~~~g~~L~~~l~~----------~~~l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp 228 (365)
T 2y7j_A 167 DSY-----ESSSFMFLVFDLMRKGELFDYLTE----------KVALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKP 228 (365)
T ss_dssp EEE-----EBSSEEEEEECCCTTCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSG
T ss_pred EEE-----eeCCEEEEEEEeCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCH
Confidence 985 446789999999999999999842 346899999999999999999999 88999999999
Q ss_pred CCeeeCCCCCeEEeccccccccccccccccccccccccccCCCcccCC------CCCCcchhhHhHHHHHHHHHhCCCCC
Q 002857 304 SNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMG------HETSSYGDVYSFGILLLEMFTGLRPS 377 (873)
Q Consensus 304 sNILLd~~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~------~~~s~ksDVwSfGvvL~ELlTGk~Pf 377 (873)
+|||++.++.+||+|||++..+..... .....||+.|+|||++.+ ..++.++||||||+++|||+||+.||
T Consensus 229 ~NIl~~~~~~ikl~DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf 305 (365)
T 2y7j_A 229 ENILLDDNMQIRLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPF 305 (365)
T ss_dssp GGEEECTTCCEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred HHEEECCCCCEEEEecCcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCC
Confidence 999999999999999999987654322 233568999999998753 35889999999999999999999999
Q ss_pred CcccccchhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCC
Q 002857 378 DDMFKDNLNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMK 457 (873)
Q Consensus 378 ~~~~~~~~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPT 457 (873)
...... ... ..+......... .........+.+++.+||+.||++|||
T Consensus 306 ~~~~~~--~~~-----------~~i~~~~~~~~~-------------------~~~~~~~~~~~~li~~~L~~dP~~Rps 353 (365)
T 2y7j_A 306 WHRRQI--LML-----------RMIMEGQYQFSS-------------------PEWDDRSSTVKDLISRLLQVDPEARLT 353 (365)
T ss_dssp CCSSHH--HHH-----------HHHHHTCCCCCH-------------------HHHSSSCHHHHHHHHHHSCSSTTTSCC
T ss_pred CCCCHH--HHH-----------HHHHhCCCCCCC-------------------cccccCCHHHHHHHHHHcCCChhHCcC
Confidence 652111 000 011110000000 000011234788999999999999999
Q ss_pred HHHHHH
Q 002857 458 INDVEL 463 (873)
Q Consensus 458 m~EVl~ 463 (873)
+.|+++
T Consensus 354 ~~ell~ 359 (365)
T 2y7j_A 354 AEQALQ 359 (365)
T ss_dssp HHHHHH
T ss_pred HHHHhc
Confidence 999875
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-38 Score=344.53 Aligned_cols=250 Identities=22% Similarity=0.290 Sum_probs=201.6
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC---CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCc
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH---HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGND 235 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~ 235 (873)
.++|.+.+.||+|+||.||++.+..+++.||+|++.... ....+.+.+|+.++++++|+||+++++++ ...+
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~ 114 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF-----EDND 114 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSS
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----ecCC
Confidence 457899999999999999999999999999999987432 23346789999999999999999999996 4466
Q ss_pred eEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeE
Q 002857 236 FKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTAC 315 (873)
Q Consensus 236 ~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vK 315 (873)
..++||||+++++|.+++.. ...+++.+++.|+.||+.||+||| +.+|+||||||+|||++.++.+|
T Consensus 115 ~~~lv~e~~~~~~L~~~~~~----------~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~k 181 (335)
T 2owb_A 115 FVFVVLELCRRRSLLELHKR----------RKALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVK 181 (335)
T ss_dssp EEEEEECCCTTCBHHHHHHH----------HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEE
T ss_pred eEEEEEecCCCCCHHHHHhc----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCCCEE
Confidence 79999999999999998842 346899999999999999999999 88999999999999999999999
Q ss_pred EeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcC
Q 002857 316 VADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSAL 395 (873)
Q Consensus 316 LsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~ 395 (873)
|+|||+++....... ......||..|+|||++.+..++.++||||||+++|||++|+.||........
T Consensus 182 l~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---------- 249 (335)
T 2owb_A 182 IGDFGLATKVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET---------- 249 (335)
T ss_dssp ECCCTTCEECCSTTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH----------
T ss_pred EeeccCceecccCcc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHH----------
Confidence 999999986643221 22234689999999999998999999999999999999999999975321110
Q ss_pred chhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHH
Q 002857 396 PERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELG 464 (873)
Q Consensus 396 ~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~ 464 (873)
...+..... ..+. .....+.+++.+||+.||++|||+.||++.
T Consensus 250 ---~~~~~~~~~--------------~~~~---------~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 250 ---YLRIKKNEY--------------SIPK---------HINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp ---HHHHHHTCC--------------CCCT---------TSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ---HHHHhcCCC--------------CCCc---------cCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000000 0000 011247789999999999999999998763
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=333.58 Aligned_cols=252 Identities=27% Similarity=0.292 Sum_probs=196.7
Q ss_pred hhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceE
Q 002857 158 ATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFK 237 (873)
Q Consensus 158 at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~ 237 (873)
..++|++.+.||+|+||.||+|.+..+++.||||++.... ..+.+.+|+.++++++||||+++++++. .....
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 99 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYF-----KNTDL 99 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEE-----ETTEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEE-----eCCEE
Confidence 3567999999999999999999998889999999997532 3477999999999999999999999963 45678
Q ss_pred EEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEe
Q 002857 238 ALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVA 317 (873)
Q Consensus 238 ~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLs 317 (873)
++||||+++++|.+++.. ....+++..++.++.||+.||.||| +.+|+|+||||+||+++.++.+||+
T Consensus 100 ~lv~e~~~~~~L~~~~~~---------~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~ 167 (314)
T 3com_A 100 WIVMEYCGAGSVSDIIRL---------RNKTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLA 167 (314)
T ss_dssp EEEEECCTTEEHHHHHHH---------HTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEEC
T ss_pred EEEeecCCCCCHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEEe
Confidence 999999999999999842 2456899999999999999999999 8999999999999999999999999
Q ss_pred ccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCch
Q 002857 318 DFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPE 397 (873)
Q Consensus 318 DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~ 397 (873)
|||++........ ......||..|+|||++.+..++.++||||||+++|||++|+.||........ ..
T Consensus 168 dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~-------- 235 (314)
T 3com_A 168 DFGVAGQLTDTMA--KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRA--IF-------- 235 (314)
T ss_dssp CCTTCEECBTTBS--CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HH--------
T ss_pred ecccchhhhhhcc--ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH--HH--------
Confidence 9999986543221 22234689999999999999999999999999999999999999975321100 00
Q ss_pred hHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 398 RVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 398 ~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
.+.. .. .+...... .....+.+++.+||+.||++|||+.++++
T Consensus 236 ---~~~~-~~---------------~~~~~~~~----~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 236 ---MIPT-NP---------------PPTFRKPE----LWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp ---HHHH-SC---------------CCCCSSGG----GSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ---HHhc-CC---------------CcccCCcc----cCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 0000 00 00000000 01234788999999999999999999976
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=341.52 Aligned_cols=287 Identities=18% Similarity=0.206 Sum_probs=202.9
Q ss_pred hhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCC-cchhHHHHHHHHHHhhhhccceeeeeeeecccccCCce
Q 002857 158 ATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH-DASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDF 236 (873)
Q Consensus 158 at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~ 236 (873)
..++|.+.+.||+|+||.||+|++..+++.||||+++.... .....+.+|++++++++||||+++++++....+.....
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 35789999999999999999999988999999999964332 23457889999999999999999999976544445577
Q ss_pred EEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEE
Q 002857 237 KALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACV 316 (873)
Q Consensus 237 ~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKL 316 (873)
.++||||+. |+|.+++.. ..+++..++.++.||+.||+||| +.+|+||||||+|||++.++.+||
T Consensus 89 ~~lv~e~~~-~~L~~~~~~-----------~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl 153 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVIST-----------QMLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKV 153 (353)
T ss_dssp EEEEECCCS-EEHHHHHHH-----------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEE
T ss_pred EEEEEeccC-ccHHHHHhh-----------cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcCCCcEEE
Confidence 999999997 699998842 35889999999999999999999 889999999999999999999999
Q ss_pred eccccccccccccccc--------cccccccccccCCCcccCC-CCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhh
Q 002857 317 ADFGIARFLEATNEQT--------SSIGVKGTTGYIAPEYGMG-HETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNL 387 (873)
Q Consensus 317 sDFGla~~~~~~~~~~--------~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l 387 (873)
+|||+++......... ......||..|+|||++.+ ..++.++||||||+++|||++|+.||........ +
T Consensus 154 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~ 232 (353)
T 2b9h_A 154 CDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQ-L 232 (353)
T ss_dssp CCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-H
T ss_pred EecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHH-H
Confidence 9999998764322111 1223468999999998654 6789999999999999999999999976422111 1
Q ss_pred HHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 388 QNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 388 ~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
.......-.......... ......+.........+... ...........+.+++.+||+.||++|||+.||++
T Consensus 233 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 233 LLIFGIIGTPHSDNDLRC--IESPRAREYIKSLPMYPAAP-LEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp HHHHHHHCCCCSTTTTTT--CCCHHHHHHHHTSCCCCCCC-HHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHhCCCchhccccc--cccchhhHHhhcccCCCCcc-hhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 110000000000000000 00000000001110111100 01111122345789999999999999999999865
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-38 Score=351.45 Aligned_cols=248 Identities=23% Similarity=0.268 Sum_probs=189.8
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC---CcchhHHHHHHHH-HHhhhhccceeeeeeeecccccCC
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH---HDASKSFTVECEV-MRNIIHRKIIKVVTACSRVDYQGN 234 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~---~~~~~~f~~Ei~i-L~~L~HpNIV~llg~c~~~~~~~~ 234 (873)
.++|++.+.||+|+||.||+|++..+++.||||+++... ......+..|..+ ++.++||||+++++++ ...
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~-----~~~ 111 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF-----QTA 111 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEE-----ECS
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEE-----EeC
Confidence 357899999999999999999999999999999997543 2233456677776 5678999999999985 456
Q ss_pred ceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCe
Q 002857 235 DFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTA 314 (873)
Q Consensus 235 ~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~v 314 (873)
+..++||||+++|+|.+++.. ...+++..++.++.||+.||+||| +.+|+||||||+|||++.++++
T Consensus 112 ~~~~lv~E~~~gg~L~~~l~~----------~~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~i 178 (373)
T 2r5t_A 112 DKLYFVLDYINGGELFYHLQR----------ERCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHI 178 (373)
T ss_dssp SEEEEEEECCCSCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCE
T ss_pred CEEEEEEeCCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCE
Confidence 789999999999999999842 345888899999999999999999 8999999999999999999999
Q ss_pred EEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhc
Q 002857 315 CVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSA 394 (873)
Q Consensus 315 KLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~ 394 (873)
||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 179 kL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~---------- 246 (373)
T 2r5t_A 179 VLTDFGLCKENIEHN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE---------- 246 (373)
T ss_dssp EECCCCBCGGGBCCC--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHH----------
T ss_pred EEeeCccccccccCC--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH----------
Confidence 999999998643222 22334569999999999999999999999999999999999999996532111
Q ss_pred CchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHH
Q 002857 395 LPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVE 462 (873)
Q Consensus 395 ~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl 462 (873)
....++...+. .+. .....+.+++.+||+.||++||++.+.+
T Consensus 247 ---~~~~i~~~~~~--------------~~~---------~~~~~~~~li~~lL~~dp~~R~~~~~~~ 288 (373)
T 2r5t_A 247 ---MYDNILNKPLQ--------------LKP---------NITNSARHLLEGLLQKDRTKRLGAKDDF 288 (373)
T ss_dssp ---HHHHHHHSCCC--------------CCS---------SSCHHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred ---HHHHHHhcccC--------------CCC---------CCCHHHHHHHHHHcccCHHhCCCCCCCH
Confidence 01111111000 000 0122477899999999999999986443
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=339.32 Aligned_cols=293 Identities=21% Similarity=0.224 Sum_probs=194.7
Q ss_pred HHHHHhhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccc-
Q 002857 153 EALYSATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDY- 231 (873)
Q Consensus 153 ~el~~at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~- 231 (873)
.......++|++.+.||+|+||.||+|++..+++.||||++.... .....+.++++.++.++||||+++++++.....
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 455667789999999999999999999998899999999986433 333567888999999999999999999754321
Q ss_pred -cCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCC
Q 002857 232 -QGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLND 310 (873)
Q Consensus 232 -~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~ 310 (873)
......++||||+++ +|.+.+.. .......+++..+..++.||+.||.|||.. +.+|+||||||+|||++.
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~~~ivH~Dlkp~NIll~~ 166 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRN------YYRRQVAPPPILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNE 166 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHH------HHTTTCCCCHHHHHHHHHHHHHHHHHHTST-TTCCBCSCCCGGGEEEET
T ss_pred cccceeEEEEeecccc-cHHHHHHH------HhhcccCCCHHHHHHHHHHHHHHHHHHhCC-CCCeecCcCCHHHEEEeC
Confidence 123347899999976 55554421 113456788999999999999999999943 689999999999999996
Q ss_pred -CCCeEEeccccccccccccccccccccccccccCCCcccCCCC-CCcchhhHhHHHHHHHHHhCCCCCCcccccchhhH
Q 002857 311 -EMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHE-TSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQ 388 (873)
Q Consensus 311 -~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~-~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~ 388 (873)
++.+||+|||+++....... .....||..|+|||++.+.. ++.++||||||+++|||+||+.||....... .+.
T Consensus 167 ~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~-~~~ 242 (360)
T 3e3p_A 167 ADGTLKLCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAG-QLH 242 (360)
T ss_dssp TTTEEEECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHH
T ss_pred CCCcEEEeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHH-HHH
Confidence 89999999999987654322 22345899999999987654 8999999999999999999999997632221 111
Q ss_pred HHHhhcCc--hhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 389 NWVQSALP--ERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 389 ~~~~~~~~--~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
........ ......+++..... ........++..............+.+|+.+||+.||++|||+.||++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 243 EIVRVLGCPSREVLRKLNPSHTDV-----DLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp HHHHHHCCCCHHHHHHHCTTCCCG-----GGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHcCCCCHHHHHhcccchhhc-----cccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 11111110 01111111100000 000000000000000000012346889999999999999999998864
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=339.98 Aligned_cols=203 Identities=24% Similarity=0.248 Sum_probs=164.7
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC--CcchhHHHHHHHHHHhhhhccceeeeeeeeccc-ccCCc
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH--HDASKSFTVECEVMRNIIHRKIIKVVTACSRVD-YQGND 235 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~-~~~~~ 235 (873)
.++|.+.+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|+.+++.++||||+++++++.... .....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 468999999999999999999998899999999997432 223467889999999999999999999975322 12234
Q ss_pred eEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeE
Q 002857 236 FKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTAC 315 (873)
Q Consensus 236 ~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vK 315 (873)
..++||||+++ +|.+++. ..+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+|
T Consensus 104 ~~~lv~e~~~~-~l~~~~~------------~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl~~~~~~~k 167 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ------------MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLK 167 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH------------SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEE
T ss_pred ceEEEEEcCCC-CHHHHHh------------hccCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEE
Confidence 78999999974 7888773 23788899999999999999999 88999999999999999999999
Q ss_pred EeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcc
Q 002857 316 VADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDM 380 (873)
Q Consensus 316 LsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~ 380 (873)
|+|||+++...... ......||..|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 168 l~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 229 (371)
T 2xrw_A 168 ILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 229 (371)
T ss_dssp ECCCCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EEEeeccccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 99999998654321 122356899999999999999999999999999999999999999763
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=346.53 Aligned_cols=281 Identities=17% Similarity=0.229 Sum_probs=187.4
Q ss_pred hhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCC--cchhHHHHHHHHHHhhhhccceeeeeeeecc-cccCC
Q 002857 158 ATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH--DASKSFTVECEVMRNIIHRKIIKVVTACSRV-DYQGN 234 (873)
Q Consensus 158 at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~-~~~~~ 234 (873)
..++|++.+.||+|+||.||+|.+..+++.||||++..... ...+.+.+|+++|+.++||||+++++++... .....
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 35789999999999999999999999999999999864322 2346788999999999999999999987532 11233
Q ss_pred ceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCe
Q 002857 235 DFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTA 314 (873)
Q Consensus 235 ~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~v 314 (873)
...++|+||+ +++|.+++. ...+++..++.++.||+.||+||| +.+|+||||||+|||++.++.+
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~-----------~~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~ 171 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVK-----------CQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCEL 171 (367)
T ss_dssp CCCEEEEECC-CEECC----------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCE
T ss_pred CeEEEEeccc-CCCHHHHHh-----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECCCCCE
Confidence 5679999999 789999883 245899999999999999999999 8999999999999999999999
Q ss_pred EEeccccccccccccccccccccccccccCCCcccCC-CCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhh
Q 002857 315 CVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMG-HETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQS 393 (873)
Q Consensus 315 KLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~ 393 (873)
||+|||+++..... .....||..|+|||++.+ ..++.++|||||||++|||++|+.||...... .....+..
T Consensus 172 kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~l~~i~~ 244 (367)
T 2fst_X 172 KILDFGLARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI--DQLKLILR 244 (367)
T ss_dssp EECC--------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHH
T ss_pred EEeecccccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHH
Confidence 99999999865322 233568999999999887 67899999999999999999999999763221 11111111
Q ss_pred cCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 394 ALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 394 ~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
.+.....+.+....... .+.....+...+.... ..........+.+|+.+||+.||++|||+.|+++
T Consensus 245 ~~g~p~~~~~~~~~~~~--~~~~~~~~~~~~~~~~-~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 245 LVGTPGAELLKKISSES--ARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp HHCSCCHHHHTTCCCHH--HHHHHHTSCCCCCCCH-HHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HhCCCCHHHHHHhhhHH--HHHHHhccCCCCCCCH-HHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 11110111111110000 0000111111111100 1111112335789999999999999999998865
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=336.54 Aligned_cols=259 Identities=24% Similarity=0.335 Sum_probs=193.2
Q ss_pred hcCCCcceeecccCceEEEEEEEcC-CCc--EEEEEEeecc---CCcchhHHHHHHHHHHhhhhccceeeeeeeeccccc
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFE-GAP--AVAIKVFNFL---HHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQ 232 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~-~g~--~VAVK~l~~~---~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~ 232 (873)
.++|++.+.||+|+||.||+|++.. +++ .||||+++.. .....+.+.+|++++++++||||+++++++.
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~----- 91 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL----- 91 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEc-----
Confidence 3578999999999999999998643 333 6899998643 2234567899999999999999999999963
Q ss_pred CCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCC
Q 002857 233 GNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEM 312 (873)
Q Consensus 233 ~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~ 312 (873)
. ...++||||+++|+|.+++.. ....+++..++.++.||+.||.||| +.+|+||||||+|||++.++
T Consensus 92 ~-~~~~~v~e~~~~~~L~~~l~~---------~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nili~~~~ 158 (291)
T 1u46_A 92 T-PPMKMVTELAPLGSLLDRLRK---------HQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRD 158 (291)
T ss_dssp S-SSCEEEEECCTTCBHHHHHHH---------HGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETT
T ss_pred c-CCceeeEecccCCCHHHHHHh---------ccCCcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEcCCC
Confidence 2 237899999999999999853 1245889999999999999999999 88999999999999999999
Q ss_pred CeEEeccccccccccccccc-cccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHH
Q 002857 313 TACVADFGIARFLEATNEQT-SSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNW 390 (873)
Q Consensus 313 ~vKLsDFGla~~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~ 390 (873)
.+||+|||+++......... ......+|..|+|||++.+..++.++||||||+++|||++ |+.||....... ..
T Consensus 159 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~-- 234 (291)
T 1u46_A 159 LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ--IL-- 234 (291)
T ss_dssp EEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HH--
T ss_pred CEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHH--HH--
Confidence 99999999998764433211 1223457888999999988889999999999999999999 999997532111 00
Q ss_pred HhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHHH
Q 002857 391 VQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLIK 469 (873)
Q Consensus 391 ~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i~ 469 (873)
..+.. .. ...+... .+...+.+++.+||+.||++|||+.+|++.|+++.
T Consensus 235 ---------~~~~~----~~----------~~~~~~~-------~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 235 ---------HKIDK----EG----------ERLPRPE-------DCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp ---------HHHHT----SC----------CCCCCCT-------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred ---------HHHHc----cC----------CCCCCCc-------CcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 00000 00 0000000 11235788999999999999999999999998764
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=331.50 Aligned_cols=253 Identities=22% Similarity=0.311 Sum_probs=199.6
Q ss_pred hhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCC---------cchhHHHHHHHHHHhhh-hccceeeeeeee
Q 002857 158 ATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH---------DASKSFTVECEVMRNII-HRKIIKVVTACS 227 (873)
Q Consensus 158 at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~---------~~~~~f~~Ei~iL~~L~-HpNIV~llg~c~ 227 (873)
..++|.+.+.||+|+||.||+|.+..+++.||||+++.... ...+.+.+|+++++++. ||||+++++++
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~- 93 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY- 93 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE-
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee-
Confidence 45789999999999999999999998999999999975431 12356889999999995 99999999996
Q ss_pred cccccCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCee
Q 002857 228 RVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNIL 307 (873)
Q Consensus 228 ~~~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNIL 307 (873)
......++||||+++++|.+++.. ...+++..++.++.||+.||.||| +.+|+||||||+|||
T Consensus 94 ----~~~~~~~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil 156 (298)
T 1phk_A 94 ----ETNTFFFLVFDLMKKGELFDYLTE----------KVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENIL 156 (298)
T ss_dssp ----ECSSEEEEEEECCTTCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEE
T ss_pred ----ccCCeEEEEEeccCCCcHHHHHhc----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEE
Confidence 456789999999999999999942 346899999999999999999999 899999999999999
Q ss_pred eCCCCCeEEeccccccccccccccccccccccccccCCCcccC------CCCCCcchhhHhHHHHHHHHHhCCCCCCccc
Q 002857 308 LNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGM------GHETSSYGDVYSFGILLLEMFTGLRPSDDMF 381 (873)
Q Consensus 308 Ld~~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~------~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~ 381 (873)
++.++.+||+|||++........ .....++..|+|||++. ...++.++||||||+++|||++|+.||....
T Consensus 157 ~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 233 (298)
T 1phk_A 157 LDDDMNIKLTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK 233 (298)
T ss_dssp ECTTCCEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EcCCCcEEEecccchhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCcc
Confidence 99999999999999986643321 22345899999999874 4568899999999999999999999996532
Q ss_pred ccchhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHH
Q 002857 382 KDNLNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDV 461 (873)
Q Consensus 382 ~~~~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EV 461 (873)
... .. ..+....... +. ... ......+.+++.+||+.||++|||+.|+
T Consensus 234 ~~~--~~-----------~~~~~~~~~~--------------~~-~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~l 281 (298)
T 1phk_A 234 QML--ML-----------RMIMSGNYQF--------------GS-PEW----DDYSDTVKDLVSRFLVVQPQKRYTAEEA 281 (298)
T ss_dssp HHH--HH-----------HHHHHTCCCC--------------CT-TTG----GGSCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred HHH--HH-----------HHHhcCCccc--------------Cc-ccc----cccCHHHHHHHHHHccCCcccCCCHHHH
Confidence 110 00 0111100000 00 000 0112357899999999999999999988
Q ss_pred HH
Q 002857 462 EL 463 (873)
Q Consensus 462 l~ 463 (873)
++
T Consensus 282 l~ 283 (298)
T 1phk_A 282 LA 283 (298)
T ss_dssp TT
T ss_pred Hh
Confidence 64
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=346.24 Aligned_cols=256 Identities=22% Similarity=0.293 Sum_probs=197.6
Q ss_pred hcCCCcceeecccCceEEEEEEEc---CCCcEEEEEEeeccC----CcchhHHHHHHHHHHhh-hhccceeeeeeeeccc
Q 002857 159 TKGFSSENLIGAGNFASVYKGILF---EGAPAVAIKVFNFLH----HDASKSFTVECEVMRNI-IHRKIIKVVTACSRVD 230 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~---~~g~~VAVK~l~~~~----~~~~~~f~~Ei~iL~~L-~HpNIV~llg~c~~~~ 230 (873)
.++|.+.+.||+|+||.||+|+.. .+++.||||+++... ....+.+.+|+++|+++ +|+||+++++++
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~---- 128 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF---- 128 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE----
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEE----
Confidence 357999999999999999999884 478999999986432 23346678899999999 599999999986
Q ss_pred ccCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCC
Q 002857 231 YQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLND 310 (873)
Q Consensus 231 ~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~ 310 (873)
......+|||||+++|+|.+++.. ...+++..++.++.||+.||.||| +.+|+||||||+|||++.
T Consensus 129 -~~~~~~~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~ 194 (355)
T 1vzo_A 129 -QTETKLHLILDYINGGELFTHLSQ----------RERFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDS 194 (355)
T ss_dssp -EETTEEEEEECCCCSCBHHHHHHH----------HSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECT
T ss_pred -eeCceEEEEeecCCCCCHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECC
Confidence 445678999999999999999953 245889999999999999999999 889999999999999999
Q ss_pred CCCeEEeccccccccccccccccccccccccccCCCcccCCC--CCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhH
Q 002857 311 EMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGH--ETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQ 388 (873)
Q Consensus 311 ~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~--~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~ 388 (873)
++.+||+|||+++.+..... .......||..|+|||++.+. .++.++||||||+++|||+||+.||........
T Consensus 195 ~~~~kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~--- 270 (355)
T 1vzo_A 195 NGHVVLTDFGLSKEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS--- 270 (355)
T ss_dssp TSCEEESCSSEEEECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC---
T ss_pred CCcEEEeeCCCCeecccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch---
Confidence 99999999999986543222 222345699999999998863 578999999999999999999999975321110
Q ss_pred HHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCC-----CHHHHHH
Q 002857 389 NWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERM-----KINDVEL 463 (873)
Q Consensus 389 ~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRP-----Tm~EVl~ 463 (873)
..++....+... .+... +....+.+|+.+||+.||++|| |+.|+++
T Consensus 271 ----------~~~~~~~~~~~~------------~~~~~-------~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~ 321 (355)
T 1vzo_A 271 ----------QAEISRRILKSE------------PPYPQ-------EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 321 (355)
T ss_dssp ----------HHHHHHHHHHCC------------CCCCT-------TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred ----------HHHHHHHHhccC------------CCCCc-------ccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHc
Confidence 011111111100 00000 0123477899999999999999 8998876
Q ss_pred HH
Q 002857 464 GL 465 (873)
Q Consensus 464 ~L 465 (873)
..
T Consensus 322 h~ 323 (355)
T 1vzo_A 322 HL 323 (355)
T ss_dssp SG
T ss_pred Cc
Confidence 43
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=364.92 Aligned_cols=204 Identities=25% Similarity=0.347 Sum_probs=178.2
Q ss_pred hhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeecc---CCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCC
Q 002857 158 ATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFL---HHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGN 234 (873)
Q Consensus 158 at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~ 234 (873)
..++|.+.+.||+|+||.||+|++..+++.||||++... .......+.+|+++|++++||||+++++++ ...
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~-----~~~ 256 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY-----ETK 256 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECS
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEE-----eeC
Confidence 346799999999999999999999999999999999643 223446788999999999999999999985 456
Q ss_pred ceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCe
Q 002857 235 DFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTA 314 (873)
Q Consensus 235 ~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~v 314 (873)
+..+|||||+++|+|.+++.. .....+++..++.++.||+.||+||| +.+|+||||||+|||++.++++
T Consensus 257 ~~l~lVmEy~~gg~L~~~l~~--------~~~~~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKPeNILld~~g~v 325 (576)
T 2acx_A 257 DALCLVLTLMNGGDLKFHIYH--------MGQAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHI 325 (576)
T ss_dssp SEEEEEECCCCSCBHHHHHHS--------SSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCE
T ss_pred CEEEEEEEcCCCCcHHHHHHh--------cCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCchheEEEeCCCCe
Confidence 789999999999999999853 22345899999999999999999999 8899999999999999999999
Q ss_pred EEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcc
Q 002857 315 CVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDM 380 (873)
Q Consensus 315 KLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~ 380 (873)
||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 326 KL~DFGla~~~~~~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~ 388 (576)
T 2acx_A 326 RISDLGLAVHVPEGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQR 388 (576)
T ss_dssp EECCCTTCEECCTTC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCS
T ss_pred EEEecccceecccCc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCccc
Confidence 999999998764332 122346999999999999999999999999999999999999999763
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-38 Score=348.74 Aligned_cols=267 Identities=8% Similarity=0.005 Sum_probs=184.0
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCC---cchhHHHHHHHHHHhh--hhccceeeeeee-------
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH---DASKSFTVECEVMRNI--IHRKIIKVVTAC------- 226 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~L--~HpNIV~llg~c------- 226 (873)
..+|.+.+.||+|+||.||+|++..+++.||||++..... ...+.+.+|+.+++.+ +||||++++..+
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 3458899999999999999999998999999999986443 2345678887666666 599988855322
Q ss_pred ecccc------------cCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhh------HHHHHHHHHHHHHH
Q 002857 227 SRVDY------------QGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLER------LNIAIDVASALEYL 288 (873)
Q Consensus 227 ~~~~~------------~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~------l~Ia~qIa~gL~yL 288 (873)
..... ......+|||||++ |+|.+++... ...+.+..+ +.|+.||+.||+||
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~---------~~~~~~~~~~~~~vk~~i~~qi~~aL~~L 210 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL---------DFVYVFRGDEGILALHILTAQLIRLAANL 210 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH---------HHSCCCCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh---------ccccchhhhhhhhhHHHHHHHHHHHHHHH
Confidence 11000 00144899999998 8999999631 223455566 78889999999999
Q ss_pred hhCCCCCeeeccCCCCCeeeCCCCCeEEeccccccccccccccccccccccccccCCCcccCC--CCCCcchhhHhHHHH
Q 002857 289 HLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMG--HETSSYGDVYSFGIL 366 (873)
Q Consensus 289 H~~~s~gIvHrDLKpsNILLd~~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~--~~~s~ksDVwSfGvv 366 (873)
| +.+|+||||||+|||++.++.+||+|||+++..... .....+|..|+|||++.+ ..++.++|||||||+
T Consensus 211 H---~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~i 282 (371)
T 3q60_A 211 Q---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLS 282 (371)
T ss_dssp H---HTTEEETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHH
T ss_pred H---HCCCccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHH
Confidence 9 899999999999999999999999999999865321 113457799999999987 679999999999999
Q ss_pred HHHHHhCCCCCCcccccchhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHH
Q 002857 367 LLEMFTGLRPSDDMFKDNLNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVA 446 (873)
Q Consensus 367 L~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~ 446 (873)
+|||+||+.||.......... +.... ...... ... ..+... .+...+.+|+.+
T Consensus 283 l~elltg~~Pf~~~~~~~~~~--~~~~~----~~~~~~----~~~----------~~~~~~-------~~~~~~~~li~~ 335 (371)
T 3q60_A 283 IYRVWCLFLPFGLVTPGIKGS--WKRPS----LRVPGT----DSL----------AFGSCT-------PLPDFVKTLIGR 335 (371)
T ss_dssp HHHHHHSSCSTTBCCTTCTTC--CCBCC----TTSCCC----CSC----------CCTTSS-------CCCHHHHHHHHH
T ss_pred HHHHHhCCCCCCCcCcccccc--hhhhh----hhhccc----ccc----------chhhcc-------CCCHHHHHHHHH
Confidence 999999999997642221100 00000 000000 000 000000 112347889999
Q ss_pred hhccCcCCCCCHHHHHH--HHHHHHH
Q 002857 447 CSAELPGERMKINDVEL--GLRLIKK 470 (873)
Q Consensus 447 CL~~dP~eRPTm~EVl~--~Le~i~~ 470 (873)
||+.||++|||+.|+++ .++.+..
T Consensus 336 ~L~~dP~~Rpt~~e~l~hp~f~~~~~ 361 (371)
T 3q60_A 336 FLNFDRRRRLLPLEAMETPEFLQLQN 361 (371)
T ss_dssp HTCSSTTTCCCHHHHTTSHHHHHHHH
T ss_pred HcCCChhhCCCHHHHhcCHHHHHHHH
Confidence 99999999999999974 3444433
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=355.91 Aligned_cols=252 Identities=23% Similarity=0.332 Sum_probs=201.0
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC---CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCc
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH---HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGND 235 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~ 235 (873)
.++|.+.++||+|+||.||+|++..+++.||||++.... ....+.+.+|+.++++++||||+++++++ ....
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~~ 99 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFF-----EDKG 99 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSS
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EeCC
Confidence 457899999999999999999999899999999986432 33457799999999999999999999996 4567
Q ss_pred eEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeee---CCCC
Q 002857 236 FKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILL---NDEM 312 (873)
Q Consensus 236 ~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILL---d~~~ 312 (873)
..++||||+.+|+|.+++. ....+++..++.|+.||+.||+||| +.+|+||||||+|||+ +.++
T Consensus 100 ~~~lv~e~~~~~~L~~~~~----------~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~ 166 (484)
T 3nyv_A 100 YFYLVGEVYTGGELFDEII----------SRKRFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDA 166 (484)
T ss_dssp EEEEEECCCCSCBHHHHHH----------TCSCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTC
T ss_pred EEEEEEecCCCCCHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCCCCC
Confidence 8999999999999999884 2456899999999999999999999 8899999999999999 5678
Q ss_pred CeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHh
Q 002857 313 TACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQ 392 (873)
Q Consensus 313 ~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~ 392 (873)
.+||+|||+++.+.... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||....... ..
T Consensus 167 ~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~---- 236 (484)
T 3nyv_A 167 NIRIIDFGLSTHFEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD--IL---- 236 (484)
T ss_dssp CEEECCTTHHHHBCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HH----
T ss_pred cEEEEeeeeeEEccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH--HH----
Confidence 99999999998764432 2233569999999999876 68999999999999999999999997632111 11
Q ss_pred hcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHH
Q 002857 393 SALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELG 464 (873)
Q Consensus 393 ~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~ 464 (873)
..+....+... ..... .....+.+++.+||+.+|++|||+.|+++.
T Consensus 237 -------~~i~~~~~~~~---------------~~~~~----~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 237 -------KKVEKGKYTFE---------------LPQWK----KVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp -------HHHHHCCCCCC---------------SGGGG----GSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -------HHHHcCCCCCC---------------Ccccc----cCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 11111000000 00000 112347789999999999999999999863
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=331.21 Aligned_cols=199 Identities=22% Similarity=0.332 Sum_probs=171.0
Q ss_pred hcCCCcceeecccCceEEEEEEE-cCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhcc------ceeeeeeeecccc
Q 002857 159 TKGFSSENLIGAGNFASVYKGIL-FEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRK------IIKVVTACSRVDY 231 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~-~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpN------IV~llg~c~~~~~ 231 (873)
.++|++.+.||+|+||.||+|.+ ..+++.||||+++.. ....+.+.+|+++++.++|+| ++++++++
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~----- 86 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWF----- 86 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEE-----
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccc-----
Confidence 46899999999999999999998 457889999998643 233467899999999998876 89999985
Q ss_pred cCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCC-
Q 002857 232 QGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLND- 310 (873)
Q Consensus 232 ~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~- 310 (873)
...+..++||||+ +++|.+++.. .....+++..++.|+.||+.||+||| +.+|+||||||+|||++.
T Consensus 87 ~~~~~~~lv~e~~-~~~l~~~l~~--------~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~ 154 (339)
T 1z57_A 87 EHHGHICIVFELL-GLSTYDFIKE--------NGFLPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQS 154 (339)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHH--------TTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCC
T ss_pred ccCCcEEEEEcCC-CCCHHHHHHh--------cCCCCCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEecc
Confidence 4456899999999 8899999853 23346889999999999999999999 889999999999999987
Q ss_pred ------------------CCCeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh
Q 002857 311 ------------------EMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT 372 (873)
Q Consensus 311 ------------------~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT 372 (873)
++.+||+|||+++..... .....||..|+|||++.+..++.++||||||+++|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~ 229 (339)
T 1z57_A 155 DYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYL 229 (339)
T ss_dssp CEEEEEC----CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHH
T ss_pred ccccccCCccccccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHh
Confidence 678999999999864322 223468999999999999999999999999999999999
Q ss_pred CCCCCCcc
Q 002857 373 GLRPSDDM 380 (873)
Q Consensus 373 Gk~Pf~~~ 380 (873)
|+.||...
T Consensus 230 g~~pf~~~ 237 (339)
T 1z57_A 230 GFTVFPTH 237 (339)
T ss_dssp SSCSCCCS
T ss_pred CCCCCCCC
Confidence 99999763
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-37 Score=355.44 Aligned_cols=252 Identities=22% Similarity=0.289 Sum_probs=198.7
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeecc--CCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCce
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFL--HHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDF 236 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~ 236 (873)
.++|.+.++||+|+||.||+|++..+++.||||++... .......+.+|+++|++++||||+++++++ .....
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~~~ 95 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL-----EDSSS 95 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSSE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEE-----EcCCE
Confidence 45799999999999999999999889999999998632 233457799999999999999999999996 45678
Q ss_pred EEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeC---CCCC
Q 002857 237 KALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLN---DEMT 313 (873)
Q Consensus 237 ~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd---~~~~ 313 (873)
.++||||+.+|+|.+++.. ...+++..++.|+.||+.||.||| +.+|+||||||+|||++ .++.
T Consensus 96 ~~lv~e~~~~~~L~~~~~~----------~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~ 162 (486)
T 3mwu_A 96 FYIVGELYTGGELFDEIIK----------RKRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCD 162 (486)
T ss_dssp EEEEECCCCSCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEESSSSTTCC
T ss_pred EEEEEEcCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCC
Confidence 9999999999999998842 346899999999999999999999 89999999999999995 5568
Q ss_pred eEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhh
Q 002857 314 ACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQS 393 (873)
Q Consensus 314 vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~ 393 (873)
+||+|||+++...... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||....... +.
T Consensus 163 ~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~----- 231 (486)
T 3mwu_A 163 IKIIDFGLSTCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD--IL----- 231 (486)
T ss_dssp EEECSCSCTTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HH-----
T ss_pred EEEEECCcCeECCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HH-----
Confidence 9999999998664332 2223469999999999876 58999999999999999999999996532111 00
Q ss_pred cCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHH
Q 002857 394 ALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELG 464 (873)
Q Consensus 394 ~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~ 464 (873)
..+........ ..... .....+.+++.+||+.||++|||+.|+++.
T Consensus 232 ------~~i~~~~~~~~---------------~~~~~----~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 232 ------KRVETGKYAFD---------------LPQWR----TISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp ------HHHHHTCCCSC---------------SGGGG----GSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred ------HHHHhCCCCCC---------------CcccC----CCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11111000000 00000 112347789999999999999999999863
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-37 Score=355.94 Aligned_cols=252 Identities=23% Similarity=0.307 Sum_probs=197.7
Q ss_pred hhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCC-------------cchhHHHHHHHHHHhhhhccceeeee
Q 002857 158 ATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH-------------DASKSFTVECEVMRNIIHRKIIKVVT 224 (873)
Q Consensus 158 at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~-------------~~~~~f~~Ei~iL~~L~HpNIV~llg 224 (873)
..++|.+.++||+|+||.||+|++..+++.||||++..... ...+.+.+|+.+|++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 35789999999999999999999999999999999874321 23467899999999999999999999
Q ss_pred eeecccccCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCC
Q 002857 225 ACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPS 304 (873)
Q Consensus 225 ~c~~~~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKps 304 (873)
++ ......+|||||+++|+|.+++.. ...+++..++.|+.||+.||+||| +.+|+||||||+
T Consensus 114 ~~-----~~~~~~~lv~e~~~gg~L~~~l~~----------~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~ 175 (504)
T 3q5i_A 114 VF-----EDKKYFYLVTEFYEGGELFEQIIN----------RHKFDECDAANIMKQILSGICYLH---KHNIVHRDIKPE 175 (504)
T ss_dssp EE-----ECSSEEEEEEECCTTCBHHHHHHH----------HSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGG
T ss_pred EE-----EcCCEEEEEEecCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHH
Confidence 96 456789999999999999998842 345899999999999999999999 899999999999
Q ss_pred CeeeCCCC---CeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCccc
Q 002857 305 NILLNDEM---TACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMF 381 (873)
Q Consensus 305 NILLd~~~---~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~ 381 (873)
|||++.++ .+||+|||+++...... ......||+.|+|||++. ..++.++|||||||++|+|++|..||....
T Consensus 176 Nil~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 251 (504)
T 3q5i_A 176 NILLENKNSLLNIKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQN 251 (504)
T ss_dssp GEEESSTTCCSSEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HEEEecCCCCccEEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99998765 69999999998764432 222346999999999987 468999999999999999999999997632
Q ss_pred ccchhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHH
Q 002857 382 KDNLNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDV 461 (873)
Q Consensus 382 ~~~~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EV 461 (873)
... +. ..+....+.... .........+.+++.+||+.||++|||+.|+
T Consensus 252 ~~~--~~-----------~~i~~~~~~~~~-------------------~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~ 299 (504)
T 3q5i_A 252 DQD--II-----------KKVEKGKYYFDF-------------------NDWKNISDEAKELIKLMLTYDYNKRCTAEEA 299 (504)
T ss_dssp HHH--HH-----------HHHHHCCCCCCH-------------------HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred HHH--HH-----------HHHHcCCCCCCc-------------------cccCCCCHHHHHHHHHHcCCChhHCCCHHHH
Confidence 111 11 111110000000 0000112357889999999999999999998
Q ss_pred HH
Q 002857 462 EL 463 (873)
Q Consensus 462 l~ 463 (873)
++
T Consensus 300 l~ 301 (504)
T 3q5i_A 300 LN 301 (504)
T ss_dssp HT
T ss_pred hc
Confidence 75
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=338.12 Aligned_cols=270 Identities=19% Similarity=0.220 Sum_probs=200.0
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcc---h--------------hHHHHHHHHHHhhhhcccee
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDA---S--------------KSFTVECEVMRNIIHRKIIK 221 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~---~--------------~~f~~Ei~iL~~L~HpNIV~ 221 (873)
.++|.+.+.||+|+||.||+|.+ +++.||||++....... . +.+.+|++++++++||||++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 46899999999999999999988 88999999987432111 1 78999999999999999999
Q ss_pred eeeeeecccccCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCC-CCeeecc
Q 002857 222 VVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCK-PPIAHCD 300 (873)
Q Consensus 222 llg~c~~~~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s-~gIvHrD 300 (873)
+++++ ...+..++||||+++|+|.+++..... ........+++..++.|+.||+.||.||| + .+|+|||
T Consensus 108 ~~~~~-----~~~~~~~lv~e~~~~~~L~~~~~~~~~--l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~d 177 (348)
T 2pml_X 108 CEGII-----TNYDEVYIIYEYMENDSILKFDEYFFV--LDKNYTCFIPIQVIKCIIKSVLNSFSYIH---NEKNICHRD 177 (348)
T ss_dssp CSEEE-----ESSSEEEEEEECCTTCBSSEESSSEES--SCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTSCEECCC
T ss_pred EEEEE-----eeCCeEEEEEeccCCCcHHHHHHHhhh--hhhccccCCCHHHHHHHHHHHHHHHHHHh---ccCCEeecC
Confidence 99996 445689999999999999999421000 00122567999999999999999999999 6 8999999
Q ss_pred CCCCCeeeCCCCCeEEeccccccccccccccccccccccccccCCCcccCCC-CCCc-chhhHhHHHHHHHHHhCCCCCC
Q 002857 301 IKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGH-ETSS-YGDVYSFGILLLEMFTGLRPSD 378 (873)
Q Consensus 301 LKpsNILLd~~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~-ksDVwSfGvvL~ELlTGk~Pf~ 378 (873)
|||+|||++.++.+||+|||++...... ......||..|+|||++.+. .++. ++||||||+++|||++|+.||.
T Consensus 178 l~p~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 253 (348)
T 2pml_X 178 VKPSNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFS 253 (348)
T ss_dssp CCGGGEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CChHhEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999865432 22335689999999999887 6666 9999999999999999999997
Q ss_pred cccccchhhHHHHhhcCch---hHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCC
Q 002857 379 DMFKDNLNLQNWVQSALPE---RVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGER 455 (873)
Q Consensus 379 ~~~~~~~~l~~~~~~~~~~---~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eR 455 (873)
...... .+...+...... ............ ............+.+++.+||+.||++|
T Consensus 254 ~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~l~~li~~~L~~dP~~R 314 (348)
T 2pml_X 254 LKISLV-ELFNNIRTKNIEYPLDRNHFLYPLTNK------------------KSTCSNNFLSNEDIDFLKLFLRKNPAER 314 (348)
T ss_dssp CSSCSH-HHHHHHTSCCCCCCCSSSSSTTTTCC--------------------------CCCHHHHHHHHHHCCSSGGGS
T ss_pred CCCcHH-HHHHHHhccCcCCccchhhhhcccccc------------------ccccchhhcCHHHHHHHHHHccCChhhC
Confidence 633211 111111110000 000000000000 0000001123357899999999999999
Q ss_pred CCHHHHHH
Q 002857 456 MKINDVEL 463 (873)
Q Consensus 456 PTm~EVl~ 463 (873)
||+.|+++
T Consensus 315 ps~~e~l~ 322 (348)
T 2pml_X 315 ITSEDALK 322 (348)
T ss_dssp CCHHHHHT
T ss_pred CCHHHHhc
Confidence 99999875
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-37 Score=356.53 Aligned_cols=252 Identities=21% Similarity=0.263 Sum_probs=195.4
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC--CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCce
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH--HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDF 236 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~ 236 (873)
.++|.+.+.||+|+||.||+|++..++..||||++.... ......+.+|+.++++++||||+++++++ .....
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~~~ 110 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFF-----EDKRN 110 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeCCE
Confidence 456899999999999999999999899999999987443 33457799999999999999999999996 45677
Q ss_pred EEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCC---CCC
Q 002857 237 KALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLND---EMT 313 (873)
Q Consensus 237 ~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~---~~~ 313 (873)
.++||||+++|+|.+++.. ...+++..++.|+.||+.||+||| +.+|+||||||+|||++. ++.
T Consensus 111 ~~lv~e~~~~g~L~~~~~~----------~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~ 177 (494)
T 3lij_A 111 YYLVMECYKGGELFDEIIH----------RMKFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDAL 177 (494)
T ss_dssp EEEEEECCCSCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCC
T ss_pred EEEEEecCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCCCCCCc
Confidence 9999999999999998842 345889999999999999999999 899999999999999975 456
Q ss_pred eEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhh
Q 002857 314 ACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQS 393 (873)
Q Consensus 314 vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~ 393 (873)
+||+|||+++...... ......||+.|+|||++. ..++.++|||||||++|+|++|..||....... +.
T Consensus 178 ~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~----- 246 (494)
T 3lij_A 178 IKIVDFGLSAVFENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE--IL----- 246 (494)
T ss_dssp EEECCCTTCEECBTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HH-----
T ss_pred EEEEECCCCeECCCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH--HH-----
Confidence 9999999998764432 223356999999999886 469999999999999999999999997632211 00
Q ss_pred cCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHH
Q 002857 394 ALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELG 464 (873)
Q Consensus 394 ~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~ 464 (873)
..+....... ...... .....+.+++.+||+.||++|||+.|+++.
T Consensus 247 ------~~i~~~~~~~---------------~~~~~~----~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 247 ------RKVEKGKYTF---------------DSPEWK----NVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp ------HHHHHTCCCC---------------CSGGGT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred ------HHHHhCCCCC---------------Cchhcc----cCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 1111100000 000000 112347789999999999999999999853
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=347.23 Aligned_cols=199 Identities=23% Similarity=0.308 Sum_probs=171.1
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhh------hccceeeeeeeeccccc
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNII------HRKIIKVVTACSRVDYQ 232 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~------HpNIV~llg~c~~~~~~ 232 (873)
..+|++.++||+|+||.||+|.+..+++.||||+++.. ......+.+|+++++.++ |+||+++++++ .
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~-----~ 169 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENF-----T 169 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEE-----E
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeec-----c
Confidence 46799999999999999999999999999999999743 223467888999999884 66999999986 3
Q ss_pred CCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCC
Q 002857 233 GNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEM 312 (873)
Q Consensus 233 ~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~ 312 (873)
.....++||||+. ++|.+++.. .....+++..++.|+.||+.||+||| +.+|+||||||+|||++.++
T Consensus 170 ~~~~~~lv~e~~~-~~L~~~l~~--------~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NILl~~~~ 237 (429)
T 3kvw_A 170 FRNHICMTFELLS-MNLYELIKK--------NKFQGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQG 237 (429)
T ss_dssp ETTEEEEEECCCC-CBHHHHHHH--------TTTCCCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGGEEESSTT
T ss_pred cCCeEEEEEeccC-CCHHHHHHh--------ccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEccCC
Confidence 4567999999996 699999853 23345899999999999999999999 88999999999999999988
Q ss_pred C--eEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcc
Q 002857 313 T--ACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDM 380 (873)
Q Consensus 313 ~--vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~ 380 (873)
. +||+|||+++..... .....||..|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 238 ~~~vkL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 238 RSGIKVIDFGSSCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp SCCEEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CcceEEeecccceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 7 999999999754321 22346899999999999999999999999999999999999999764
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=335.70 Aligned_cols=261 Identities=22% Similarity=0.328 Sum_probs=194.0
Q ss_pred cCHHHHHHhhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCC--cchhHHHHHHHHHHhhhh--ccceeeeee
Q 002857 150 VSYEALYSATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH--DASKSFTVECEVMRNIIH--RKIIKVVTA 225 (873)
Q Consensus 150 ~s~~el~~at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~H--pNIV~llg~ 225 (873)
+.++.+....++|++.+.||+|+||.||++.+. +++.||||++..... ...+.+.+|++++.+++| +||++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~ 96 (313)
T 3cek_A 18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY 96 (313)
T ss_dssp --CCEEEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEE
T ss_pred CCeeeeeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEE
Confidence 344444455678999999999999999999874 588999999974432 344678999999999974 999999998
Q ss_pred eecccccCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCC
Q 002857 226 CSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSN 305 (873)
Q Consensus 226 c~~~~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsN 305 (873)
+ ......++||| +.+++|.+++.. ...+++..++.|+.||+.||.||| +.+|+||||||+|
T Consensus 97 ~-----~~~~~~~lv~e-~~~~~L~~~l~~----------~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~N 157 (313)
T 3cek_A 97 E-----ITDQYIYMVME-CGNIDLNSWLKK----------KKSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPAN 157 (313)
T ss_dssp E-----ECSSEEEEEEC-CCSEEHHHHHHH----------CSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGG
T ss_pred e-----ecCCEEEEEEe-cCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCccc
Confidence 6 44567999999 568899999942 346889999999999999999999 8899999999999
Q ss_pred eeeCCCCCeEEeccccccccccccccccccccccccccCCCcccCC-----------CCCCcchhhHhHHHHHHHHHhCC
Q 002857 306 ILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMG-----------HETSSYGDVYSFGILLLEMFTGL 374 (873)
Q Consensus 306 ILLd~~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-----------~~~s~ksDVwSfGvvL~ELlTGk 374 (873)
||+++ +.+||+|||+++...............||..|+|||++.+ ..++.++||||||+++|||++|+
T Consensus 158 Il~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~ 236 (313)
T 3cek_A 158 FLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236 (313)
T ss_dssp EEEET-TEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSS
T ss_pred EEEEC-CeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCC
Confidence 99965 8999999999987654333222334568999999999875 46888999999999999999999
Q ss_pred CCCCcccccchhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCC
Q 002857 375 RPSDDMFKDNLNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGE 454 (873)
Q Consensus 375 ~Pf~~~~~~~~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~e 454 (873)
.||........ .+..+++...... .+.. ....+.+++.+||+.||++
T Consensus 237 ~pf~~~~~~~~------------~~~~~~~~~~~~~------------~~~~---------~~~~l~~li~~~l~~dp~~ 283 (313)
T 3cek_A 237 TPFQQIINQIS------------KLHAIIDPNHEIE------------FPDI---------PEKDLQDVLKCCLKRDPKQ 283 (313)
T ss_dssp CTTTTCCSHHH------------HHHHHHCTTSCCC------------CCCC---------SCHHHHHHHHHHTCSSTTT
T ss_pred CchhhHHHHHH------------HHHHHHhcccccC------------Cccc---------chHHHHHHHHHHccCCccc
Confidence 99965322111 1111111111000 0000 0124778999999999999
Q ss_pred CCCHHHHHHH
Q 002857 455 RMKINDVELG 464 (873)
Q Consensus 455 RPTm~EVl~~ 464 (873)
|||+.||++.
T Consensus 284 Rps~~ell~h 293 (313)
T 3cek_A 284 RISIPELLAH 293 (313)
T ss_dssp SCCHHHHHTS
T ss_pred CcCHHHHhcC
Confidence 9999998764
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-37 Score=328.23 Aligned_cols=258 Identities=21% Similarity=0.275 Sum_probs=190.9
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeeccc--------
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVD-------- 230 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~-------- 230 (873)
.++|++.+.||+|+||.||+|++..+++.||||++... ....+.+.+|+.++++++||||+++++++....
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 46789999999999999999999889999999998643 233467899999999999999999999875321
Q ss_pred ccCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCC
Q 002857 231 YQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLND 310 (873)
Q Consensus 231 ~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~ 310 (873)
.......++||||+++|+|.+++.. ....+++..++.++.||+.||+||| +.+|+||||||+|||++.
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dlkp~Nil~~~ 151 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHS---------ENLNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDE 151 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHH---------SCGGGCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECT
T ss_pred cccCCceEEEEecCCCCCHHHhhhc---------cccccchHHHHHHHHHHHHHHHHHH---hCCeecccCCHHhEEEcC
Confidence 1234678999999999999999953 2345778899999999999999999 889999999999999999
Q ss_pred CCCeEEeccccccccccccc------------cccccccccccccCCCcccCCC-CCCcchhhHhHHHHHHHHHhCCCCC
Q 002857 311 EMTACVADFGIARFLEATNE------------QTSSIGVKGTTGYIAPEYGMGH-ETSSYGDVYSFGILLLEMFTGLRPS 377 (873)
Q Consensus 311 ~~~vKLsDFGla~~~~~~~~------------~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELlTGk~Pf 377 (873)
++.+||+|||+++....... ........||..|+|||++.+. .++.++||||||+++|||++ ||
T Consensus 152 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~ 228 (303)
T 1zy4_A 152 SRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PF 228 (303)
T ss_dssp TSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CC
T ss_pred CCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---cc
Confidence 99999999999986543210 1112234589999999998765 68999999999999999998 55
Q ss_pred CcccccchhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCC
Q 002857 378 DDMFKDNLNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMK 457 (873)
Q Consensus 378 ~~~~~~~~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPT 457 (873)
....... ... ..+..... ..|... .......+.+++.+||+.||++|||
T Consensus 229 ~~~~~~~-~~~-----------~~~~~~~~--------------~~~~~~-----~~~~~~~~~~li~~~l~~dp~~Rps 277 (303)
T 1zy4_A 229 STGMERV-NIL-----------KKLRSVSI--------------EFPPDF-----DDNKMKVEKKIIRLLIDHDPNKRPG 277 (303)
T ss_dssp SSHHHHH-HHH-----------HHHHSTTC--------------CCCTTC-----CTTTSHHHHHHHHHHTCSSGGGSCC
T ss_pred CCchhHH-HHH-----------Hhcccccc--------------ccCccc-----cccchHHHHHHHHHHHhcCcccCcC
Confidence 4311110 000 00000000 000000 0011234778999999999999999
Q ss_pred HHHHHH
Q 002857 458 INDVEL 463 (873)
Q Consensus 458 m~EVl~ 463 (873)
+.|+++
T Consensus 278 ~~~ll~ 283 (303)
T 1zy4_A 278 ARTLLN 283 (303)
T ss_dssp HHHHHH
T ss_pred HHHHhC
Confidence 999875
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=339.14 Aligned_cols=280 Identities=20% Similarity=0.233 Sum_probs=197.3
Q ss_pred hhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCc--chhHHHHHHHHHHhhhhccceeeeeeeeccccc-CC
Q 002857 158 ATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHD--ASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQ-GN 234 (873)
Q Consensus 158 at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~-~~ 234 (873)
..++|.+.+.||+|+||.||+|.+..+++.||||++...... ..+.+.+|+.++++++||||+++++++...... ..
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 357899999999999999999999999999999999754322 246788999999999999999999997432211 11
Q ss_pred ceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCe
Q 002857 235 DFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTA 314 (873)
Q Consensus 235 ~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~v 314 (873)
...++||||+. ++|.+++. ..+++..++.|+.||+.||+||| +.+|+||||||+|||++.++.+
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~------------~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~ 183 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMG------------MEFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCEL 183 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTT------------SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCE
T ss_pred eeEEEEEcccc-ccHHHHhh------------cCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeEECCCCCE
Confidence 13499999997 68888772 23899999999999999999999 8899999999999999999999
Q ss_pred EEeccccccccccccccccccccccccccCCCcccCC-CCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhh
Q 002857 315 CVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMG-HETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQS 393 (873)
Q Consensus 315 KLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~ 393 (873)
||+|||+++..... .....||..|+|||++.+ ..++.++||||||+++|||++|+.||....... .+.....
T Consensus 184 kL~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~- 256 (371)
T 4exu_A 184 KILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILK- 256 (371)
T ss_dssp EECSTTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHH-
T ss_pred EEEecCcccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHH-
Confidence 99999999865332 223468999999999887 678999999999999999999999997632211 1111111
Q ss_pred cCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 394 ALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 394 ~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
.......+.....-... .......+...+... ...........+.+|+.+||+.||++|||+.|+++
T Consensus 257 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 257 VTGVPGTEFVQKLNDKA--AKSYIQSLPQTPRKD-FTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp HHCCCCHHHHTTCSCHH--HHHHHHHSCCCCCCC-HHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HhCCCcHHHHHHhhhhh--hhhhhhccCCCcchh-HHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 00000001111000000 000011111111110 01111122346889999999999999999998864
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-37 Score=359.60 Aligned_cols=206 Identities=25% Similarity=0.361 Sum_probs=178.4
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC---CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCc
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH---HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGND 235 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~ 235 (873)
.++|.+.++||+|+||.||+|++..+++.||||+++... ......+.+|+++|++++||||+++++++ ....
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~-----~~~~ 258 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAF-----ETKT 258 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSS
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEE-----eeCC
Confidence 367889999999999999999998899999999996432 23346788999999999999999999985 4567
Q ss_pred eEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeE
Q 002857 236 FKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTAC 315 (873)
Q Consensus 236 ~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vK 315 (873)
..+|||||+++|+|.+++... ......+++..++.++.||+.||.||| +.+|+||||||+|||++.++++|
T Consensus 259 ~l~lVmE~~~gg~L~~~l~~~------~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~vk 329 (543)
T 3c4z_A 259 DLCLVMTIMNGGDIRYHIYNV------DEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVR 329 (543)
T ss_dssp EEEEEECCCTTCBHHHHHHTS------STTSCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEE
T ss_pred EEEEEEEeccCCCHHHHHHHh------hcccccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCCEE
Confidence 899999999999999998531 122456899999999999999999999 89999999999999999999999
Q ss_pred EeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcc
Q 002857 316 VADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDM 380 (873)
Q Consensus 316 LsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~ 380 (873)
|+|||+++.+..... ......||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 330 L~DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~ 392 (543)
T 3c4z_A 330 ISDLGLAVELKAGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRAR 392 (543)
T ss_dssp ECCCTTCEECCTTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCT
T ss_pred EeecceeeeccCCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCC
Confidence 999999987643322 223347999999999999999999999999999999999999999763
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=370.17 Aligned_cols=245 Identities=23% Similarity=0.287 Sum_probs=198.4
Q ss_pred hhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeecc---CCcchhHHHHHHHHHHhh-hhccceeeeeeeecccccC
Q 002857 158 ATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFL---HHDASKSFTVECEVMRNI-IHRKIIKVVTACSRVDYQG 233 (873)
Q Consensus 158 at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~L-~HpNIV~llg~c~~~~~~~ 233 (873)
..++|++.++||+|+||.||+|++..+++.||||+++.. .....+.+..|..+|..+ +|+||+++++++ ..
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~-----~~ 413 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QT 413 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEEC-----BC
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEE-----Ee
Confidence 346899999999999999999999999999999999742 233456788999999988 799999999984 56
Q ss_pred CceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCC
Q 002857 234 NDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMT 313 (873)
Q Consensus 234 ~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~ 313 (873)
.+..+|||||+++|+|.++|+. ...+++..++.|+.||+.||+||| +.+||||||||+||||+.+++
T Consensus 414 ~~~~~lV~E~~~gg~L~~~l~~----------~~~~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~ 480 (674)
T 3pfq_A 414 MDRLYFVMEYVNGGDLMYHIQQ----------VGRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGH 480 (674)
T ss_dssp SSEEEEEEECCCSCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSC
T ss_pred CCEEEEEEeCcCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCc
Confidence 7789999999999999999953 246899999999999999999999 899999999999999999999
Q ss_pred eEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhh
Q 002857 314 ACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQS 393 (873)
Q Consensus 314 vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~ 393 (873)
+||+|||+++...... .......||+.|+|||++.+..++.++|||||||+||||++|+.||......
T Consensus 481 ikL~DFGla~~~~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~---------- 548 (674)
T 3pfq_A 481 IKIADFGMCKENIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---------- 548 (674)
T ss_dssp EEECCCTTCEECCCTT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH----------
T ss_pred EEEeecceeeccccCC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH----------
Confidence 9999999998543222 2233457999999999999999999999999999999999999999763211
Q ss_pred cCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCH
Q 002857 394 ALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKI 458 (873)
Q Consensus 394 ~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm 458 (873)
++....+.... ..|. .....+.+|+..||+.||++||++
T Consensus 549 -------~~~~~i~~~~~----------~~p~---------~~s~~~~~li~~lL~~dP~~R~~~ 587 (674)
T 3pfq_A 549 -------ELFQSIMEHNV----------AYPK---------SMSKEAVAICKGLMTKHPGKRLGC 587 (674)
T ss_dssp -------HHHHHHHSSCC----------CCCT---------TSCHHHHHHHHHHSCSSSTTCTTC
T ss_pred -------HHHHHHHhCCC----------CCCc---------cCCHHHHHHHHHHccCCHHHCCCC
Confidence 11111111110 0010 012347789999999999999997
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=345.15 Aligned_cols=277 Identities=21% Similarity=0.248 Sum_probs=196.5
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccc-cCCceEE
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDY-QGNDFKA 238 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~-~~~~~~~ 238 (873)
.+|++.+.||+|+||.||+|++..+++.||||++.... ..+.+|+++|++++|+|||++++++..... .+....+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 46888999999999999999998899999999986432 234579999999999999999998754321 1233467
Q ss_pred EEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCC-CCeEEe
Q 002857 239 LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDE-MTACVA 317 (873)
Q Consensus 239 LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~-~~vKLs 317 (873)
+||||+++ +|.+++... ......+++..++.++.||++||+||| +.+|+||||||+|||++.+ +.+||+
T Consensus 130 lv~e~~~~-~l~~~~~~~------~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~ 199 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHY------SRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLC 199 (420)
T ss_dssp EEEECCCE-EHHHHHHHH------HHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEEC
T ss_pred eehhcccc-cHHHHHHHH------hhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEec
Confidence 99999975 676666321 123467899999999999999999999 8999999999999999955 678999
Q ss_pred ccccccccccccccccccccccccccCCCcccCCC-CCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCc
Q 002857 318 DFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGH-ETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALP 396 (873)
Q Consensus 318 DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~ 396 (873)
|||+++.+..... .....||..|+|||++.+. .++.++|||||||++|||++|+.||...... ..+...+...-.
T Consensus 200 DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~-~~l~~i~~~lg~ 275 (420)
T 1j1b_A 200 DFGSAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-DQLVEIIKVLGT 275 (420)
T ss_dssp CCTTCEECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCS
T ss_pred cchhhhhcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCC
Confidence 9999987643322 2234689999999998765 7899999999999999999999999763221 112222211111
Q ss_pred h---hHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 397 E---RVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 397 ~---~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
. .+..+ ++.... + ....+..++|.... .......+.+|+.+||+.||++|||+.|+++
T Consensus 276 p~~~~~~~~-~~~~~~-~----~~p~~~~~~~~~~~---~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 276 PTREQIREM-NPNYTE-F----KFPQIKAHPWTKVF---RPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp CCHHHHHHH-CSCCCC-C----CCCCCCCCCHHHHS---CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCHHHHHhh-Chhhhh-h----ccCccCCCCHHHhc---CCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 1 11111 000000 0 00001111110000 0011235789999999999999999998864
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=335.93 Aligned_cols=260 Identities=21% Similarity=0.263 Sum_probs=194.8
Q ss_pred hhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC--CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCc
Q 002857 158 ATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH--HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGND 235 (873)
Q Consensus 158 at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~ 235 (873)
..++|++.+.||+|+||.||+|.+.. .||+|+++... ....+.+.+|+.++++++|+||+++++++. ...
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~ 102 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACM-----SPP 102 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEE-----CSS
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEe-----cCC
Confidence 35688999999999999999998743 49999987432 233467889999999999999999999963 456
Q ss_pred eEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeE
Q 002857 236 FKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTAC 315 (873)
Q Consensus 236 ~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vK 315 (873)
..++||||+++++|.+++.. ....+++..++.|+.||+.||+||| +.+|+||||||+|||++ ++.+|
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~NIl~~-~~~~~ 169 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRD---------AKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVV 169 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTS---------SCCCCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCCSTTEEEC---CCE
T ss_pred ceEEEeecccCCcHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChhhEEEe-CCCEE
Confidence 78999999999999999953 3346899999999999999999999 88999999999999998 67999
Q ss_pred Eecccccccccccc---ccccccccccccccCCCcccCC---------CCCCcchhhHhHHHHHHHHHhCCCCCCccccc
Q 002857 316 VADFGIARFLEATN---EQTSSIGVKGTTGYIAPEYGMG---------HETSSYGDVYSFGILLLEMFTGLRPSDDMFKD 383 (873)
Q Consensus 316 LsDFGla~~~~~~~---~~~~~~~~~Gt~~Y~APE~l~~---------~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~ 383 (873)
|+|||+++...... .........||..|+|||++.+ ..++.++||||||+++|||++|+.||.....+
T Consensus 170 l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~ 249 (319)
T 2y4i_B 170 ITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE 249 (319)
T ss_dssp ECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH
T ss_pred EeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 99999987653221 1112223458999999999874 35789999999999999999999999753221
Q ss_pred chhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 384 NLNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 384 ~~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
.. . ..+..... .. .+.. .+...+.+++.+||+.||++|||+.+|++
T Consensus 250 ~~--~-----------~~~~~~~~-~~------------~~~~--------~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 250 AI--I-----------WQMGTGMK-PN------------LSQI--------GMGKEISDILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp HH--H-----------HHHHTTCC-CC------------CCCS--------SCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred HH--H-----------HHhccCCC-CC------------CCcC--------CCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 10 0 00000000 00 0000 01123778999999999999999999999
Q ss_pred HHHHHHHhh
Q 002857 464 GLRLIKKKL 472 (873)
Q Consensus 464 ~Le~i~~~l 472 (873)
+|+.+....
T Consensus 296 ~l~~l~~~~ 304 (319)
T 2y4i_B 296 MLEKLPKRN 304 (319)
T ss_dssp HHTTC----
T ss_pred HHHHHHHhh
Confidence 999886654
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=336.43 Aligned_cols=203 Identities=20% Similarity=0.288 Sum_probs=169.9
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhh-----------hccceeeeeeee
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNII-----------HRKIIKVVTACS 227 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~-----------HpNIV~llg~c~ 227 (873)
.++|.+.+.||+|+||.||+|++..+++.||||++... ....+.+.+|++++++++ |+||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 35799999999999999999999899999999998632 223467889999999886 899999999975
Q ss_pred cccccCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCC-CeeeccCCCCCe
Q 002857 228 RVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKP-PIAHCDIKPSNI 306 (873)
Q Consensus 228 ~~~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~-gIvHrDLKpsNI 306 (873)
... ......++||||+ +++|.+++.. .....+++..++.|+.||+.||+||| +. +|+||||||+||
T Consensus 97 ~~~-~~~~~~~lv~e~~-~~~L~~~~~~--------~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH~Dikp~NI 163 (373)
T 1q8y_A 97 HKG-PNGVHVVMVFEVL-GENLLALIKK--------YEHRGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENV 163 (373)
T ss_dssp EEE-TTEEEEEEEECCC-CEEHHHHHHH--------TTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGE
T ss_pred ccC-CCCceEEEEEecC-CCCHHHHHHH--------hhccCCcHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChHHe
Confidence 421 2334789999999 8899999853 23445899999999999999999999 77 999999999999
Q ss_pred eeC------CCCCeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcc
Q 002857 307 LLN------DEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDM 380 (873)
Q Consensus 307 LLd------~~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~ 380 (873)
|++ ..+.+||+|||+++..... .....||..|+|||++.+..++.++||||||+++|||+||+.||...
T Consensus 164 ll~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 238 (373)
T 1q8y_A 164 LMEIVDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD 238 (373)
T ss_dssp EEEEEETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred EEeccCCCcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 994 4458999999999865432 22346899999999999999999999999999999999999999753
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=337.92 Aligned_cols=207 Identities=23% Similarity=0.270 Sum_probs=172.8
Q ss_pred HHHHHhhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhh-hc-----cceeeeeee
Q 002857 153 EALYSATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNII-HR-----KIIKVVTAC 226 (873)
Q Consensus 153 ~el~~at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~-Hp-----NIV~llg~c 226 (873)
.......++|.+.+.||+|+||.||+|++..+++.||||+++.. ......+..|+.+++.++ |+ +|+++++++
T Consensus 47 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~ 125 (382)
T 2vx3_A 47 KNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHF 125 (382)
T ss_dssp CTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEE
T ss_pred ecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeee
Confidence 33444578999999999999999999999989999999999732 223467788999999885 44 499999985
Q ss_pred ecccccCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCe
Q 002857 227 SRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNI 306 (873)
Q Consensus 227 ~~~~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNI 306 (873)
...+..+|||||+. |+|.+++.. .....+++..++.|+.||+.||.|||.. ..+|+||||||+||
T Consensus 126 -----~~~~~~~lv~e~~~-~~L~~~l~~--------~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NI 190 (382)
T 2vx3_A 126 -----MFRNHLCLVFEMLS-YNLYDLLRN--------TNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENI 190 (382)
T ss_dssp -----EETTEEEEEEECCC-CBHHHHHHH--------TTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGE
T ss_pred -----ccCCceEEEEecCC-CCHHHHHhh--------cCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccE
Confidence 34568999999996 599999853 2334589999999999999999999932 47899999999999
Q ss_pred eeC--CCCCeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcc
Q 002857 307 LLN--DEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDM 380 (873)
Q Consensus 307 LLd--~~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~ 380 (873)
|++ .++.+||+|||+++..... .....||..|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 191 ll~~~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 191 LLCNPKRSAIKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp EESSTTSCCEEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EEecCCCCcEEEEeccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 995 5788999999999866332 22346899999999999999999999999999999999999999763
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-36 Score=328.74 Aligned_cols=199 Identities=21% Similarity=0.329 Sum_probs=169.1
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCC-cEEEEEEeeccCCcchhHHHHHHHHHHhhhhcc------ceeeeeeeecccc
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGA-PAVAIKVFNFLHHDASKSFTVECEVMRNIIHRK------IIKVVTACSRVDY 231 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g-~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpN------IV~llg~c~~~~~ 231 (873)
.++|++.+.||+|+||.||+|.+..++ +.||||+++.. ....+.+.+|+.++++++|++ ++.+++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~----- 91 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWF----- 91 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEE-----
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeee-----
Confidence 468999999999999999999987666 78999999743 233467889999999999887 88888875
Q ss_pred cCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeee---
Q 002857 232 QGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILL--- 308 (873)
Q Consensus 232 ~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILL--- 308 (873)
...+..+|||||+ +++|.+++.. .....+++.+++.|+.||+.||+||| +.+|+||||||+|||+
T Consensus 92 ~~~~~~~lv~e~~-~~~l~~~l~~--------~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~ 159 (355)
T 2eu9_A 92 NFHGHMCIAFELL-GKNTFEFLKE--------NNFQPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNS 159 (355)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHH--------TTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCC
T ss_pred eeCCeEEEEEecc-CCChHHHHHh--------ccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecc
Confidence 4456899999999 6677777743 23356899999999999999999999 8999999999999999
Q ss_pred ----------------CCCCCeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh
Q 002857 309 ----------------NDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT 372 (873)
Q Consensus 309 ----------------d~~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT 372 (873)
+.++.+||+|||+++..... .....||..|+|||++.+..++.++||||||+++|||++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~ 234 (355)
T 2eu9_A 160 EFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYR 234 (355)
T ss_dssp CEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHh
Confidence 56789999999999864322 223468999999999999999999999999999999999
Q ss_pred CCCCCCcc
Q 002857 373 GLRPSDDM 380 (873)
Q Consensus 373 Gk~Pf~~~ 380 (873)
|+.||...
T Consensus 235 g~~pf~~~ 242 (355)
T 2eu9_A 235 GFTLFQTH 242 (355)
T ss_dssp SSCSCCCS
T ss_pred CCCCCCCC
Confidence 99999763
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=324.78 Aligned_cols=251 Identities=22% Similarity=0.280 Sum_probs=197.8
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC--CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCce
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH--HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDF 236 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~ 236 (873)
.++|++.+.||+|+||.||+|++..+++.||||++.... ......+.+|++++++++||||+++++++ .....
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~ 95 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL-----EDSSS 95 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSSE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEE-----eCCCe
Confidence 468999999999999999999998889999999986432 33457899999999999999999999996 44667
Q ss_pred EEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCC---CC
Q 002857 237 KALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDE---MT 313 (873)
Q Consensus 237 ~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~---~~ 313 (873)
.++||||+++++|.+++.. ...+++..++.++.||+.||.||| +.+|+||||||+|||++.+ +.
T Consensus 96 ~~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~~~~~~~ 162 (287)
T 2wei_A 96 FYIVGELYTGGELFDEIIK----------RKRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCD 162 (287)
T ss_dssp EEEEECCCCSCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCC
T ss_pred EEEEEEccCCCCHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEecCCCccc
Confidence 8999999999999998842 235889999999999999999999 8899999999999999754 47
Q ss_pred eEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhh
Q 002857 314 ACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQS 393 (873)
Q Consensus 314 vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~ 393 (873)
+||+|||++........ .....+|..|+|||++.+. ++.++||||||+++|+|++|+.||....... ...
T Consensus 163 ~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~~---- 232 (287)
T 2wei_A 163 IKIIDFGLSTCFQQNTK---MKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYD--ILK---- 232 (287)
T ss_dssp EEECSTTGGGTBCCCSS---CSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHH----
T ss_pred EEEeccCcceeecCCCc---cccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHH--HHH----
Confidence 99999999986643321 1233589999999988764 8999999999999999999999997532111 000
Q ss_pred cCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 394 ALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 394 ~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
.+........ .... ......+.+++.+||+.||++|||+.|+++
T Consensus 233 -------~~~~~~~~~~---------------~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 233 -------RVETGKYAFD---------------LPQW----RTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp -------HHHHCCCCCC---------------SGGG----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------HHHcCCCCCC---------------chhh----hhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 1100000000 0000 011234788999999999999999999986
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-36 Score=331.61 Aligned_cols=258 Identities=19% Similarity=0.238 Sum_probs=173.8
Q ss_pred hhcCCCcce-eecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHH-HHHHhhhhccceeeeeeeecccccCCc
Q 002857 158 ATKGFSSEN-LIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVEC-EVMRNIIHRKIIKVVTACSRVDYQGND 235 (873)
Q Consensus 158 at~~f~~~~-~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei-~iL~~L~HpNIV~llg~c~~~~~~~~~ 235 (873)
..++|.+.+ +||+|+||.||+|.+..+++.||||++... ....+|+ ..++.+.|+||+++++++.... ....
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~~~ 99 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDVYENMH-HGKR 99 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-----HHHHHHHHHHHHhcCCCChHHHHHHHhhcc-CCCc
Confidence 356888854 699999999999999989999999998632 2233333 3456679999999999975321 2345
Q ss_pred eEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCC---CC
Q 002857 236 FKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLND---EM 312 (873)
Q Consensus 236 ~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~---~~ 312 (873)
..++||||+++|+|.+++.. .....+++.+++.|+.||+.||+||| +.+|+||||||+|||++. ++
T Consensus 100 ~~~lv~e~~~gg~L~~~l~~--------~~~~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIll~~~~~~~ 168 (336)
T 3fhr_A 100 CLLIIMECMEGGELFSRIQE--------RGDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDA 168 (336)
T ss_dssp EEEEEEECCTTEEHHHHHHT--------C-CCCCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTC
T ss_pred eEEEEEeccCCCCHHHHHHh--------cCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEecCCCc
Confidence 68999999999999999953 23356999999999999999999999 889999999999999976 45
Q ss_pred CeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHh
Q 002857 313 TACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQ 392 (873)
Q Consensus 313 ~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~ 392 (873)
.+||+|||+++...... .....+|..|+|||++.+..++.++||||||+++|||++|+.||......... ...
T Consensus 169 ~~kl~Dfg~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~- 241 (336)
T 3fhr_A 169 VLKLTDFGFAKETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAIS--PGM- 241 (336)
T ss_dssp CEEECCCTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------
T ss_pred eEEEeccccceeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhh--hhH-
Confidence 69999999998654321 22345899999999998889999999999999999999999999653221110 000
Q ss_pred hcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHH
Q 002857 393 SALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELG 464 (873)
Q Consensus 393 ~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~ 464 (873)
...+...... . ..+.. ..+...+.+++.+||+.||++|||+.|+++.
T Consensus 242 ------~~~~~~~~~~-----------~-~~~~~-------~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 242 ------KRRIRLGQYG-----------F-PNPEW-------SEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp ---------------C-----------C-CTTTS-------TTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ------HHhhhccccc-----------c-Cchhh-------ccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0000000000 0 00000 0112357889999999999999999999863
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-36 Score=332.55 Aligned_cols=279 Identities=20% Similarity=0.239 Sum_probs=195.8
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCc--chhHHHHHHHHHHhhhhccceeeeeeeecccc-cCCc
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHD--ASKSFTVECEVMRNIIHRKIIKVVTACSRVDY-QGND 235 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~-~~~~ 235 (873)
.++|.+.+.||+|+||.||+|++..+++.||||++...... ..+.+.+|+.++++++||||+++++++..... ....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 46899999999999999999999999999999998653322 24678899999999999999999999743211 1112
Q ss_pred eEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeE
Q 002857 236 FKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTAC 315 (873)
Q Consensus 236 ~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vK 315 (873)
..++||||+. ++|.+++. ..+++..++.++.||+.||+||| +.+|+||||||+|||++.++.+|
T Consensus 103 ~~~lv~e~~~-~~l~~~~~------------~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~~~~~~~k 166 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG------------LKFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELK 166 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT------------SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTCCEE
T ss_pred eEEEEecccc-CCHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeECCCCcEE
Confidence 4599999997 68888772 23889999999999999999999 88999999999999999999999
Q ss_pred EeccccccccccccccccccccccccccCCCcccCC-CCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhc
Q 002857 316 VADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMG-HETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSA 394 (873)
Q Consensus 316 LsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~ 394 (873)
|+|||+++..... .....+|..|+|||++.+ ..++.++||||||+++|||++|+.||....... .+..... .
T Consensus 167 l~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-~~~~i~~-~ 239 (353)
T 3coi_A 167 ILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILK-V 239 (353)
T ss_dssp ECSTTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH-HHHHHHH-H
T ss_pred EeecccccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHH-H
Confidence 9999999865322 223468999999999877 678999999999999999999999997632211 1111110 0
Q ss_pred CchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 395 LPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 395 ~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
......+......... .......+...+.... ..........+.+++.+||+.||++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 240 TGVPGTEFVQKLNDKA--AKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp HCBCCHHHHTTCSCHH--HHHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hCCCCHHHHHHHhhHH--HHHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000000000000000 0000011100000000 0000112345889999999999999999998864
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-36 Score=339.39 Aligned_cols=210 Identities=22% Similarity=0.271 Sum_probs=156.2
Q ss_pred CCCc-ceeecccCceEEEEEEEc--CCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceE
Q 002857 161 GFSS-ENLIGAGNFASVYKGILF--EGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFK 237 (873)
Q Consensus 161 ~f~~-~~~LG~G~fG~VYkg~~~--~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~ 237 (873)
.|.+ .++||+|+||.||+|++. .+++.||||++... .....+.+|+++|++++||||+++++++.. ......
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~---~~~~~~ 95 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLS---HADRKV 95 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS--SCCHHHHHHHHHHHHCCCTTBCCCCEEEEE---TTTTEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC--CCCHHHHHHHHHHHhcCCCCeeeEeeEEec---CCCCeE
Confidence 3555 458999999999999976 45789999998643 233578899999999999999999999742 346679
Q ss_pred EEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeee----CCCCC
Q 002857 238 ALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILL----NDEMT 313 (873)
Q Consensus 238 ~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILL----d~~~~ 313 (873)
+|||||+. |+|.+++...... ........+++..++.|+.||+.||+||| +.+|+||||||+|||+ +.++.
T Consensus 96 ~lv~e~~~-~~l~~~~~~~~~~-~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~ 170 (405)
T 3rgf_A 96 WLLFDYAE-HDLWHIIKFHRAS-KANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGR 170 (405)
T ss_dssp EEEEECCS-EEHHHHHHHHHHH-C-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTTTTC
T ss_pred EEEEeCCC-CCHHHHHHHhccc-cccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCCCCc
Confidence 99999996 5888887531111 01122345899999999999999999999 8999999999999999 67889
Q ss_pred eEEeccccccccccccc-cccccccccccccCCCcccCCC-CCCcchhhHhHHHHHHHHHhCCCCCCcc
Q 002857 314 ACVADFGIARFLEATNE-QTSSIGVKGTTGYIAPEYGMGH-ETSSYGDVYSFGILLLEMFTGLRPSDDM 380 (873)
Q Consensus 314 vKLsDFGla~~~~~~~~-~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELlTGk~Pf~~~ 380 (873)
+||+|||+++.+..... ........||..|+|||++.+. .++.++|||||||++|||+||+.||...
T Consensus 171 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 239 (405)
T 3rgf_A 171 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 239 (405)
T ss_dssp EEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred EEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence 99999999987643221 1222345689999999998874 5899999999999999999999999753
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=339.70 Aligned_cols=276 Identities=20% Similarity=0.252 Sum_probs=192.3
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccc-cCCceEE
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDY-QGNDFKA 238 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~-~~~~~~~ 238 (873)
.+|.+.++||+|+||.||+|++..+++ ||+|++.... ....+|+++|+.++||||+++++++..... ......+
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~----~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDK----RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCc----chHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 468999999999999999999876665 8888775322 223479999999999999999999754322 2334578
Q ss_pred EEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeC-CCCCeEEe
Q 002857 239 LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLN-DEMTACVA 317 (873)
Q Consensus 239 LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd-~~~~vKLs 317 (873)
+||||++++ +.+.+.. .......+++..++.++.||++||+||| +.+|+||||||+|||++ .++.+||+
T Consensus 115 lv~e~~~~~-l~~~~~~------~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~kL~ 184 (394)
T 4e7w_A 115 LVLEYVPET-VYRASRH------YAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLI 184 (394)
T ss_dssp EEEECCSEE-HHHHHHH------HHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEEC
T ss_pred EEeeccCcc-HHHHHHH------HHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCCCcEEEe
Confidence 999999874 4333321 0123456899999999999999999999 89999999999999999 79999999
Q ss_pred ccccccccccccccccccccccccccCCCcccCCC-CCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCc
Q 002857 318 DFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGH-ETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALP 396 (873)
Q Consensus 318 DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~ 396 (873)
|||+++....... .....+|..|+|||++.+. .++.++|||||||++|||++|+.||....... .+...+...-.
T Consensus 185 DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~l~~i~~~~g~ 260 (394)
T 4e7w_A 185 DFGSAKILIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGID-QLVEIIKVLGT 260 (394)
T ss_dssp CCTTCEECCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCC
T ss_pred eCCCcccccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCC
Confidence 9999987643322 2234689999999998765 58999999999999999999999997632211 11111111111
Q ss_pred h---hHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 397 E---RVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 397 ~---~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
. .+..+ ++..... ....+...++. ..........+.+|+.+||+.||++|||+.|+++
T Consensus 261 p~~~~~~~~-~~~~~~~-----~~~~~~~~~~~---~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 261 PSREQIKTM-NPNYMEH-----KFPQIRPHPFS---KVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp CCHHHHHHH-CGGGSSS-----CCCCCCCCCHH---HHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCHHHHHhh-Chhhhhh-----ccccccCCcHH---HhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 1 11111 1000000 00000000000 0000012335889999999999999999998865
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=331.87 Aligned_cols=259 Identities=22% Similarity=0.222 Sum_probs=176.7
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCC-cchhHHHHHHH-HHHhhhhccceeeeeeeecccccCCce
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH-DASKSFTVECE-VMRNIIHRKIIKVVTACSRVDYQGNDF 236 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~-~~~~~f~~Ei~-iL~~L~HpNIV~llg~c~~~~~~~~~~ 236 (873)
.++|.+.+.||+|+||.||+|.+..+++.||||+++.... .....+..|+. +++.++||||+++++++ ...+.
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~-----~~~~~ 95 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGAL-----FREGD 95 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEE-----ECSSE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEE-----EeCCc
Confidence 3678899999999999999999988999999999975432 23345666666 67778999999999996 34567
Q ss_pred EEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCC-CeeeccCCCCCeeeCCCCCeE
Q 002857 237 KALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKP-PIAHCDIKPSNILLNDEMTAC 315 (873)
Q Consensus 237 ~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~-gIvHrDLKpsNILLd~~~~vK 315 (873)
.++||||+++ +|.+++... .......+++..+..++.|++.||.||| +. +|+||||||+|||++.++.+|
T Consensus 96 ~~lv~e~~~~-~l~~~~~~~-----~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~NIll~~~~~~k 166 (327)
T 3aln_A 96 CWICMELMST-SFDKFYKYV-----YSVLDDVIPEEILGKITLATVKALNHLK---ENLKIIHRDIKPSNILLDRSGNIK 166 (327)
T ss_dssp EEEEECCCSE-EHHHHHHHH-----HHTTCCCCCHHHHHHHHHHHHHHHHHHH---HHHSCCCSCCCGGGEEEETTTEEE
T ss_pred eEEEEeecCC-ChHHHHHHH-----HhhhcccCcHHHHHHHHHHHHHHHHHHh---ccCCEeECCCCHHHEEEcCCCCEE
Confidence 8999999975 888877421 1123567899999999999999999999 67 999999999999999999999
Q ss_pred EeccccccccccccccccccccccccccCCCccc----CCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHH
Q 002857 316 VADFGIARFLEATNEQTSSIGVKGTTGYIAPEYG----MGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWV 391 (873)
Q Consensus 316 LsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l----~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~ 391 (873)
|+|||+++....... .....||..|+|||++ .+..++.++||||||+++|||++|+.||.........
T Consensus 167 l~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~----- 238 (327)
T 3aln_A 167 LCDFGISGQLVDSIA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ----- 238 (327)
T ss_dssp ECCCSSSCC---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-----------
T ss_pred EccCCCceecccccc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHH-----
Confidence 999999986643221 2233589999999998 4567899999999999999999999999753211000
Q ss_pred hhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHH
Q 002857 392 QSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELG 464 (873)
Q Consensus 392 ~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~ 464 (873)
+......... .+..... ......+.+++.+||+.||++|||+.||++.
T Consensus 239 -----------~~~~~~~~~~------~~~~~~~--------~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 239 -----------LTQVVKGDPP------QLSNSEE--------REFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp ------------CCCCCSCCC------CCCCCSS--------CCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred -----------HHHHhcCCCC------CCCCccc--------ccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 0000000000 0000000 0012347889999999999999999999863
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=362.20 Aligned_cols=260 Identities=23% Similarity=0.364 Sum_probs=201.8
Q ss_pred hhcCCCcceeecccCceEEEEEEEcCC---CcEEEEEEeeccCC-cchhHHHHHHHHHHhhhhccceeeeeeeecccccC
Q 002857 158 ATKGFSSENLIGAGNFASVYKGILFEG---APAVAIKVFNFLHH-DASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQG 233 (873)
Q Consensus 158 at~~f~~~~~LG~G~fG~VYkg~~~~~---g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~ 233 (873)
..++|.+.+.||+|+||.||+|.+..+ +..||||+++.... ...+.+.+|+.++++++||||+++++++.
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~------ 461 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT------ 461 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC------
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe------
Confidence 346688889999999999999998643 45799999875332 23467999999999999999999999862
Q ss_pred CceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCC
Q 002857 234 NDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMT 313 (873)
Q Consensus 234 ~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~ 313 (873)
++..++||||+++|+|.+++.. ....+++..++.++.||+.||+||| +.+|+||||||+|||++.++.
T Consensus 462 ~~~~~lv~E~~~~g~L~~~l~~---------~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDikp~NILl~~~~~ 529 (656)
T 2j0j_A 462 ENPVWIIMELCTLGELRSFLQV---------RKFSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDC 529 (656)
T ss_dssp SSSCEEEEECCTTCBHHHHHHH---------TTTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTE
T ss_pred cCceEEEEEcCCCCcHHHHHHh---------ccCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchHhEEEeCCCC
Confidence 2457999999999999999953 2346899999999999999999999 889999999999999999999
Q ss_pred eEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHHHh
Q 002857 314 ACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQ 392 (873)
Q Consensus 314 vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~~~ 392 (873)
+||+|||+++....... .......+|+.|+|||++.+..++.++||||||+++|||++ |..||....... ..
T Consensus 530 vkL~DFG~a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--~~---- 602 (656)
T 2j0j_A 530 VKLGDFGLSRYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--VI---- 602 (656)
T ss_dssp EEECCCCCCCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HH----
T ss_pred EEEEecCCCeecCCCcc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH--HH----
Confidence 99999999987643321 12223447789999999988899999999999999999997 999997532111 00
Q ss_pred hcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHHHHh
Q 002857 393 SALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLIKKK 471 (873)
Q Consensus 393 ~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i~~~ 471 (873)
..+.... ..+... .+...+.+++.+||+.||++|||+.||++.|+.+.+.
T Consensus 603 -------~~i~~~~---------------~~~~~~-------~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 603 -------GRIENGE---------------RLPMPP-------NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp -------HHHHHTC---------------CCCCCT-------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------HHHHcCC---------------CCCCCc-------cccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 0010000 000000 1123578899999999999999999999999998654
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=328.04 Aligned_cols=245 Identities=25% Similarity=0.351 Sum_probs=189.5
Q ss_pred HHHhhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCC------cchhHHHHHHHHHHhh----hhccceeeee
Q 002857 155 LYSATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH------DASKSFTVECEVMRNI----IHRKIIKVVT 224 (873)
Q Consensus 155 l~~at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~------~~~~~f~~Ei~iL~~L----~HpNIV~llg 224 (873)
.....++|.+.+.||+|+||.||+|++..+++.||||++..... .....+.+|+.++.++ +|+||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 34456789999999999999999999988999999999964432 1234567899999999 8999999999
Q ss_pred eeecccccCCceEEEEEee-cCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCC
Q 002857 225 ACSRVDYQGNDFKALVYEF-MPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKP 303 (873)
Q Consensus 225 ~c~~~~~~~~~~~~LV~Ey-~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKp 303 (873)
++ ...+..++|||| +.+++|.+++.. ...+++..++.++.||+.||+||| +.+|+||||||
T Consensus 106 ~~-----~~~~~~~~v~e~~~~~~~L~~~l~~----------~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp 167 (312)
T 2iwi_A 106 WF-----ETQEGFMLVLERPLPAQDLFDYITE----------KGPLGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKD 167 (312)
T ss_dssp EC----------CEEEEECCSSEEEHHHHHHH----------HCSCCHHHHHHHHHHHHHHHHHHH---HHTEECCCCSG
T ss_pred EE-----ecCCeEEEEEEecCCCCCHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCh
Confidence 85 445668999999 789999999943 345899999999999999999999 88999999999
Q ss_pred CCeeeC-CCCCeEEeccccccccccccccccccccccccccCCCcccCCCCCC-cchhhHhHHHHHHHHHhCCCCCCccc
Q 002857 304 SNILLN-DEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETS-SYGDVYSFGILLLEMFTGLRPSDDMF 381 (873)
Q Consensus 304 sNILLd-~~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s-~ksDVwSfGvvL~ELlTGk~Pf~~~~ 381 (873)
+|||++ .++.+||+|||+++...... .....|+..|+|||++.+..+. .++||||||+++|||++|+.||....
T Consensus 168 ~Nil~~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 243 (312)
T 2iwi_A 168 ENILIDLRRGCAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ 243 (312)
T ss_dssp GGEEEETTTTEEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH
T ss_pred hhEEEeCCCCeEEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH
Confidence 999999 88999999999998764322 2234589999999998776664 58999999999999999999996421
Q ss_pred ccchhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHH
Q 002857 382 KDNLNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDV 461 (873)
Q Consensus 382 ~~~~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EV 461 (873)
++....+. .+. .....+.+++.+||+.||++|||+.||
T Consensus 244 -------------------~~~~~~~~--------------~~~---------~~~~~~~~li~~~l~~~p~~Rps~~e~ 281 (312)
T 2iwi_A 244 -------------------EILEAELH--------------FPA---------HVSPDCCALIRRCLAPKPSSRPSLEEI 281 (312)
T ss_dssp -------------------HHHHTCCC--------------CCT---------TSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred -------------------HHhhhccC--------------Ccc---------cCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 00000000 000 012247789999999999999999999
Q ss_pred HH
Q 002857 462 EL 463 (873)
Q Consensus 462 l~ 463 (873)
++
T Consensus 282 l~ 283 (312)
T 2iwi_A 282 LL 283 (312)
T ss_dssp HH
T ss_pred hc
Confidence 75
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=330.77 Aligned_cols=246 Identities=24% Similarity=0.303 Sum_probs=196.6
Q ss_pred HHHHhhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCc------chhHHHHHHHHHHhhh--hccceeeeee
Q 002857 154 ALYSATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHD------ASKSFTVECEVMRNII--HRKIIKVVTA 225 (873)
Q Consensus 154 el~~at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~------~~~~f~~Ei~iL~~L~--HpNIV~llg~ 225 (873)
+.....++|++.+.||+|+||.||+|++..+++.||||+++..... ....+.+|+.++++++ |+||++++++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~ 116 (320)
T 3a99_A 37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 116 (320)
T ss_dssp ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence 3344567899999999999999999999999999999999754322 2356788999999996 5999999999
Q ss_pred eecccccCCceEEEEEeecCC-CChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCC
Q 002857 226 CSRVDYQGNDFKALVYEFMPN-GSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPS 304 (873)
Q Consensus 226 c~~~~~~~~~~~~LV~Ey~~~-GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKps 304 (873)
+ ...+..++|||++.+ ++|.+++.. ...+++..++.|+.||+.||+||| +.+|+||||||+
T Consensus 117 ~-----~~~~~~~lv~e~~~~~~~L~~~l~~----------~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~ 178 (320)
T 3a99_A 117 F-----ERPDSFVLILERPEPVQDLFDFITE----------RGALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDE 178 (320)
T ss_dssp E-----ECSSEEEEEEECCSSEEEHHHHHHH----------HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGG
T ss_pred E-----ecCCcEEEEEEcCCCCccHHHHHhc----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHH
Confidence 6 456678999999986 899999842 346889999999999999999999 899999999999
Q ss_pred CeeeC-CCCCeEEeccccccccccccccccccccccccccCCCcccCCCCC-CcchhhHhHHHHHHHHHhCCCCCCcccc
Q 002857 305 NILLN-DEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHET-SSYGDVYSFGILLLEMFTGLRPSDDMFK 382 (873)
Q Consensus 305 NILLd-~~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~-s~ksDVwSfGvvL~ELlTGk~Pf~~~~~ 382 (873)
|||++ +++.+||+|||+++...... .....||..|+|||++.+..+ +.++||||||+++|||++|+.||....
T Consensus 179 NIll~~~~~~~kL~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~- 253 (320)
T 3a99_A 179 NILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE- 253 (320)
T ss_dssp GEEEETTTTEEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-
T ss_pred HEEEeCCCCCEEEeeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-
Confidence 99999 78999999999998764321 223458999999999877665 678999999999999999999996521
Q ss_pred cchhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHH
Q 002857 383 DNLNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVE 462 (873)
Q Consensus 383 ~~~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl 462 (873)
++....... +. .....+.+++.+||+.||++|||+.||+
T Consensus 254 ------------------~~~~~~~~~--------------~~---------~~~~~~~~li~~~l~~dp~~Rps~~~ll 292 (320)
T 3a99_A 254 ------------------EIIRGQVFF--------------RQ---------RVSSECQHLIRWCLALRPSDRPTFEEIQ 292 (320)
T ss_dssp ------------------HHHHCCCCC--------------SS---------CCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred ------------------hhhcccccc--------------cc---------cCCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 000000000 00 0122477899999999999999999986
Q ss_pred H
Q 002857 463 L 463 (873)
Q Consensus 463 ~ 463 (873)
+
T Consensus 293 ~ 293 (320)
T 3a99_A 293 N 293 (320)
T ss_dssp T
T ss_pred c
Confidence 5
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=322.09 Aligned_cols=252 Identities=21% Similarity=0.252 Sum_probs=176.1
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCc-c-hhHHHHHHHHHHhhhhccceeeeeeeecccccCCce
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHD-A-SKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDF 236 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~-~-~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~ 236 (873)
.++|++.+.||+|+||.||+|.+..+++.||||++...... . .+.+.++..+++.++||||+++++++ ...+.
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~-----~~~~~ 98 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTF-----ITNTD 98 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECSSE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEE-----ecCCc
Confidence 45788899999999999999999889999999999754322 2 23344455577888999999999996 44567
Q ss_pred EEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCC-CeeeccCCCCCeeeCCCCCeE
Q 002857 237 KALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKP-PIAHCDIKPSNILLNDEMTAC 315 (873)
Q Consensus 237 ~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~-gIvHrDLKpsNILLd~~~~vK 315 (873)
.++||||+ ++.+..++. .....+++..++.++.||+.||.||| +. +|+||||||+|||++.++.+|
T Consensus 99 ~~lv~e~~-~~~~~~l~~---------~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~k 165 (318)
T 2dyl_A 99 VFIAMELM-GTCAEKLKK---------RMQGPIPERILGKMTVAIVKALYYLK---EKHGVIHRDVKPSNILLDERGQIK 165 (318)
T ss_dssp EEEEECCC-SEEHHHHHH---------HHTSCCCHHHHHHHHHHHHHHHHHHH---HHHCCCCCCCCGGGEEECTTSCEE
T ss_pred EEEEEecc-CCcHHHHHH---------HhccCCCHHHHHHHHHHHHHHHHHHH---hhCCEEeCCCCHHHEEECCCCCEE
Confidence 99999999 445555442 12356889999999999999999999 64 999999999999999999999
Q ss_pred EeccccccccccccccccccccccccccCCCcccC-----CCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHH
Q 002857 316 VADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGM-----GHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNW 390 (873)
Q Consensus 316 LsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~-----~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~ 390 (873)
|+|||++........ .....+|..|+|||++. ...++.++||||||+++|||++|+.||.........+
T Consensus 166 l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~--- 239 (318)
T 2dyl_A 166 LCDFGISGRLVDDKA---KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVL--- 239 (318)
T ss_dssp ECCCTTC-----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHH---
T ss_pred EEECCCchhccCCcc---ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHH---
Confidence 999999976543221 22345899999999984 4578899999999999999999999997532111111
Q ss_pred HhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 391 VQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 391 ~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
..+.. .... ..+... .....+.+++.+||+.||.+|||+.||++
T Consensus 240 ---------~~~~~----~~~~---------~~~~~~-------~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 240 ---------TKVLQ----EEPP---------LLPGHM-------GFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp ---------HHHHH----SCCC---------CCCSSS-------CCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ---------HHHhc----cCCC---------CCCccC-------CCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 11110 0000 000000 01224778999999999999999999986
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-35 Score=336.21 Aligned_cols=256 Identities=18% Similarity=0.237 Sum_probs=181.0
Q ss_pred CCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhh-hhccceeeeeeeecccccCCceEEE
Q 002857 161 GFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNI-IHRKIIKVVTACSRVDYQGNDFKAL 239 (873)
Q Consensus 161 ~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~llg~c~~~~~~~~~~~~L 239 (873)
.|...++||+|+||+||.+. ..+++.||||++... ..+.+.+|+++|+++ +||||+++++++ ......+|
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~-----~~~~~~~l 86 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSE-----TTDRFLYI 86 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEE-----ECSSEEEE
T ss_pred eeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEE-----ecCCeEEE
Confidence 44557889999999998754 357899999998642 335678999999987 899999999985 45678999
Q ss_pred EEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCC--------
Q 002857 240 VYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDE-------- 311 (873)
Q Consensus 240 V~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~-------- 311 (873)
||||+. |+|.+++...... .......++..++.|+.||+.||+||| +.+|+||||||+|||++.+
T Consensus 87 v~E~~~-gsL~~~l~~~~~~---~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~ 159 (434)
T 2rio_A 87 ALELCN-LNLQDLVESKNVS---DENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQ 159 (434)
T ss_dssp EECCCS-EEHHHHHHTC---------------CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHHSCCT
T ss_pred EEecCC-CCHHHHHhccCCC---chhhhhccchhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCcccccccc
Confidence 999995 6999999541100 001112345567889999999999999 8999999999999999654
Q ss_pred -----CCeEEeccccccccccccccc--cccccccccccCCCcccCC-------CCCCcchhhHhHHHHHHHHHh-CCCC
Q 002857 312 -----MTACVADFGIARFLEATNEQT--SSIGVKGTTGYIAPEYGMG-------HETSSYGDVYSFGILLLEMFT-GLRP 376 (873)
Q Consensus 312 -----~~vKLsDFGla~~~~~~~~~~--~~~~~~Gt~~Y~APE~l~~-------~~~s~ksDVwSfGvvL~ELlT-Gk~P 376 (873)
+.+||+|||+++......... ......||..|+|||++.+ ..++.++|||||||++|||+| |+.|
T Consensus 160 ~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~P 239 (434)
T 2rio_A 160 TGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP 239 (434)
T ss_dssp TCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCT
T ss_pred cCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCC
Confidence 589999999998765432211 1223569999999999876 578999999999999999999 9999
Q ss_pred CCcccccchhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCC
Q 002857 377 SDDMFKDNLNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERM 456 (873)
Q Consensus 377 f~~~~~~~~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRP 456 (873)
|........ .++....... ..+.. . .......+.+++.+||+.||++||
T Consensus 240 f~~~~~~~~---------------~i~~~~~~~~-----------~~~~~-~----~~~~~~~~~~li~~~L~~dP~~Rp 288 (434)
T 2rio_A 240 FGDKYSRES---------------NIIRGIFSLD-----------EMKCL-H----DRSLIAEATDLISQMIDHDPLKRP 288 (434)
T ss_dssp TCSTTTHHH---------------HHHHTCCCCC-----------CCTTC-C----CHHHHHHHHHHHHHHTCSSGGGSC
T ss_pred CCCchhhHH---------------HHhcCCCCcc-----------ccccc-c----cccchHHHHHHHHHHhhCChhhCC
Confidence 965322111 0111000000 00000 0 011234578999999999999999
Q ss_pred CHHHHHH
Q 002857 457 KINDVEL 463 (873)
Q Consensus 457 Tm~EVl~ 463 (873)
|+.||++
T Consensus 289 s~~eil~ 295 (434)
T 2rio_A 289 TAMKVLR 295 (434)
T ss_dssp CHHHHHT
T ss_pred CHHHHHh
Confidence 9999985
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=312.05 Aligned_cols=234 Identities=12% Similarity=0.043 Sum_probs=180.8
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCc---chhHHHHHHHHHHhhhhccceeeeeeeecccccCCce
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHD---ASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDF 236 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~---~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~ 236 (873)
++|++.+.||+|+||.||+|++..+++.||||++...... ..+.+.+|+.++.+++|+||+++++++ ...+.
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~-----~~~~~ 105 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVV-----HTRAG 105 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----EETTE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEE-----EECCc
Confidence 5799999999999999999999888999999999754332 236789999999999999999999996 34567
Q ss_pred EEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEE
Q 002857 237 KALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACV 316 (873)
Q Consensus 237 ~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKL 316 (873)
.++||||+++++|.+++.. . ....+++.|+.||+.||+||| +.+|+||||||+|||++.++.+||
T Consensus 106 ~~lv~e~~~g~~L~~~l~~-----------~-~~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~kl 170 (286)
T 3uqc_A 106 GLVVAEWIRGGSLQEVADT-----------S-PSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVL 170 (286)
T ss_dssp EEEEEECCCEEEHHHHHTT-----------C-CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCEEE
T ss_pred EEEEEEecCCCCHHHHHhc-----------C-CChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCEEE
Confidence 9999999999999999842 1 244568899999999999999 899999999999999999999999
Q ss_pred eccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCc
Q 002857 317 ADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALP 396 (873)
Q Consensus 317 sDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~ 396 (873)
++++ |++| ++.++||||||+++|||+||+.||........ +. .......
T Consensus 171 ~~~~----------------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~-~~-~~~~~~~ 219 (286)
T 3uqc_A 171 AYPA----------------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSG-LA-PAERDTA 219 (286)
T ss_dssp CSCC----------------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCC-SE-ECCBCTT
T ss_pred Eecc----------------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchh-hH-HHHHHhc
Confidence 8543 3333 68899999999999999999999976332110 00 0000000
Q ss_pred hhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHHHHhh
Q 002857 397 ERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLIKKKL 472 (873)
Q Consensus 397 ~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i~~~l 472 (873)
. ... ........+...+.+++.+||+.||++| |+.|+++.|+.+....
T Consensus 220 ~------------~~~---------------~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 220 G------------QPI---------------EPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA 267 (286)
T ss_dssp S------------CBC---------------CHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred c------------CCC---------------ChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence 0 000 0000000112357889999999999999 9999999999876543
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=349.73 Aligned_cols=249 Identities=20% Similarity=0.322 Sum_probs=195.5
Q ss_pred hcCCCcceeecccCceEEEEEEEcC-CCcEEEEEEeeccC-CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCce
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFE-GAPAVAIKVFNFLH-HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDF 236 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~-~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~ 236 (873)
.++|.+.+.||+|+||.||+|.+.. +++.||||++.... ......+.+|++++++++||||+++++++..........
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 4689999999999999999999876 68999999986432 233457889999999999999999999986533222233
Q ss_pred EEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEE
Q 002857 237 KALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACV 316 (873)
Q Consensus 237 ~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKL 316 (873)
.+|||||+++++|.+++. ..+++.+++.|+.||+.||.||| +.+|+||||||+|||++.+ .+||
T Consensus 159 ~~lv~E~~~g~~L~~~~~------------~~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~~~-~~kl 222 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKG------------QKLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKL 222 (681)
T ss_dssp EEEEEECCCCEECC----------------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSS-CEEE
T ss_pred eEEEEEeCCCCcHHHHHh------------CCCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEEeCC-cEEE
Confidence 699999999999998772 15899999999999999999999 8999999999999999986 8999
Q ss_pred eccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCc
Q 002857 317 ADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALP 396 (873)
Q Consensus 317 sDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~ 396 (873)
+|||+++..... ....||+.|+|||++.+.. +.++|||||||++|||++|..||........ .
T Consensus 223 ~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~----------~ 285 (681)
T 2pzi_A 223 IDLGAVSRINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL----------P 285 (681)
T ss_dssp CCCTTCEETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC----------C
T ss_pred EecccchhcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc----------c
Confidence 999999865432 2346899999999987654 8999999999999999999888765221110 0
Q ss_pred hhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCC-CHHHHHHHHHHHHHhh
Q 002857 397 ERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERM-KINDVELGLRLIKKKL 472 (873)
Q Consensus 397 ~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRP-Tm~EVl~~Le~i~~~l 472 (873)
. ... .......+.+|+.+||+.||++|| ++.++...|..+....
T Consensus 286 ~-----------~~~---------------------~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~ 330 (681)
T 2pzi_A 286 E-----------DDP---------------------VLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLREV 330 (681)
T ss_dssp T-----------TCH---------------------HHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHHHH
T ss_pred c-----------ccc---------------------ccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHHHh
Confidence 0 000 001123477899999999999999 5777778887765443
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-35 Score=332.62 Aligned_cols=250 Identities=21% Similarity=0.281 Sum_probs=181.3
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhh-hhccceeeeeeeecccccCCceE
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNI-IHRKIIKVVTACSRVDYQGNDFK 237 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~llg~c~~~~~~~~~~~ 237 (873)
..+|...++||+|+||+||... ..+++.||||++.... ...+.+|+++|+++ +|||||++++++ ......
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~-~~~~~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~l~~~~-----~~~~~~ 93 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRG-MFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTE-----KDRQFQ 93 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEE-ESSSSEEEEEEECTTT---EEECHHHHHHHHHSCCCTTBCCEEEEE-----EETTEE
T ss_pred cEEEecCCeeecCcCEEEEEEE-EeCCeEEEEEEECHHH---HHHHHHHHHHHHhccCCCCcCeEEEEE-----ecCCEE
Confidence 4568889999999999965432 3578899999986432 24567899999999 799999999985 456678
Q ss_pred EEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCC-----CC
Q 002857 238 ALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLND-----EM 312 (873)
Q Consensus 238 ~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~-----~~ 312 (873)
+|||||+. |+|.+++.. ....+.+..++.|+.||+.||+||| +.+|+||||||+|||++. ..
T Consensus 94 ~lv~E~~~-g~L~~~l~~---------~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~~~ 160 (432)
T 3p23_A 94 YIAIELCA-ATLQEYVEQ---------KDFAHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKI 160 (432)
T ss_dssp EEEEECCS-EEHHHHHHS---------SSCCCCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTTBC
T ss_pred EEEEECCC-CCHHHHHHh---------cCCCccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCCce
Confidence 99999996 699999853 2334556677899999999999999 899999999999999943 34
Q ss_pred CeEEeccccccccccccc-cccccccccccccCCCcccC---CCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhh
Q 002857 313 TACVADFGIARFLEATNE-QTSSIGVKGTTGYIAPEYGM---GHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNL 387 (873)
Q Consensus 313 ~vKLsDFGla~~~~~~~~-~~~~~~~~Gt~~Y~APE~l~---~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l 387 (873)
.+||+|||+++....... ........||..|+|||++. ...++.++|||||||++|||+| |..||........
T Consensus 161 ~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~-- 238 (432)
T 3p23_A 161 KAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA-- 238 (432)
T ss_dssp CEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH--
T ss_pred eEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH--
Confidence 688999999987653321 12233456999999999987 4567889999999999999999 9999854221110
Q ss_pred HHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 388 QNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 388 ~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
..+........ ..+. . .....+.+|+.+||+.||++|||+.||++
T Consensus 239 ------------~~~~~~~~~~~-----------~~~~----~----~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 239 ------------NILLGACSLDC-----------LHPE----K----HEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp ------------HHHTTCCCCTT-----------SCTT----C----HHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ------------HHHhccCCccc-----------cCcc----c----cccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 00000000000 0000 0 01223678999999999999999999983
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-35 Score=333.88 Aligned_cols=261 Identities=13% Similarity=0.129 Sum_probs=187.7
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCC---cchhHHHHHHHHHHhhhh-ccceeee---------ee
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH---DASKSFTVECEVMRNIIH-RKIIKVV---------TA 225 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~L~H-pNIV~ll---------g~ 225 (873)
+.+|...++||+|+||.||+|++..+++.||||+++.... ...+.+.+|+.+++.++| +|...+. ..
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 4567788999999999999999999999999999873322 235789999999999976 3221111 11
Q ss_pred ee------------cccccCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCC
Q 002857 226 CS------------RVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCK 293 (873)
Q Consensus 226 c~------------~~~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s 293 (873)
+. ..........+++|+++ +++|.+++...... ......+++..++.|+.||+.||+||| +
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~---~~~~~~l~~~~~~~i~~qi~~aL~~LH---~ 229 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSH---SSTHKSLVHHARLQLTLQVIRLLASLH---H 229 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHH---TTTSHHHHHHHHHHHHHHHHHHHHHHH---H
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcc---cccCCCCCHHHHHHHHHHHHHHHHHHH---h
Confidence 00 00000022356777765 68999998431111 123456889999999999999999999 8
Q ss_pred CCeeeccCCCCCeeeCCCCCeEEeccccccccccccccccccccccccccCCCccc----------CCCCCCcchhhHhH
Q 002857 294 PPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYG----------MGHETSSYGDVYSF 363 (873)
Q Consensus 294 ~gIvHrDLKpsNILLd~~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l----------~~~~~s~ksDVwSf 363 (873)
.+|+||||||+|||++.++.+||+|||+++..... .....| ..|+|||++ .+..++.++|||||
T Consensus 230 ~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSl 303 (413)
T 3dzo_A 230 YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTL 303 (413)
T ss_dssp TTEECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHH
T ss_pred CCcccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHH
Confidence 99999999999999999999999999999865332 233457 999999998 66678999999999
Q ss_pred HHHHHHHHhCCCCCCcccccchhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHH
Q 002857 364 GILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEI 443 (873)
Q Consensus 364 GvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L 443 (873)
||++|||+||+.||........ .+..+... +. ....+.+|
T Consensus 304 Gvil~elltg~~Pf~~~~~~~~-----------------~~~~~~~~-------------~~----------~~~~~~~l 343 (413)
T 3dzo_A 304 GLAIYWIWCADLPNTDDAALGG-----------------SEWIFRSC-------------KN----------IPQPVRAL 343 (413)
T ss_dssp HHHHHHHHHSSCCCCTTGGGSC-----------------SGGGGSSC-------------CC----------CCHHHHHH
T ss_pred HHHHHHHHHCCCCCCCcchhhh-----------------HHHHHhhc-------------cc----------CCHHHHHH
Confidence 9999999999999975321110 00001000 00 01347789
Q ss_pred HHHhhccCcCCCCCHHHHHHH--HHHHHHhh
Q 002857 444 GVACSAELPGERMKINDVELG--LRLIKKKL 472 (873)
Q Consensus 444 ~~~CL~~dP~eRPTm~EVl~~--Le~i~~~l 472 (873)
+.+||+.||++|||+.|+++. ++.+.+.+
T Consensus 344 i~~~l~~dP~~Rpt~~~~l~~~~~~~~~~~~ 374 (413)
T 3dzo_A 344 LEGFLRYPKEDRLLPLQAMETPEYEQLRTEL 374 (413)
T ss_dssp HHHHTCSSGGGSCCHHHHTTSHHHHHHHHHH
T ss_pred HHHHccCChhhCcCHHHHHhCHHHHHHHHHH
Confidence 999999999999999988753 44444433
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-35 Score=348.07 Aligned_cols=283 Identities=22% Similarity=0.272 Sum_probs=201.1
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeecc-CCcchhHHHHHHHHHHhhhhccceeeeeeeeccc-ccCCceE
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFL-HHDASKSFTVECEVMRNIIHRKIIKVVTACSRVD-YQGNDFK 237 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~-~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~-~~~~~~~ 237 (873)
++|.+.+.||+|+||.||+|.+..+++.||||+++.. .....+.+.+|++++++++||||+++++++.... +..++..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 6899999999999999999999888999999998753 2233467899999999999999999999864321 1236678
Q ss_pred EEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCC---e
Q 002857 238 ALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMT---A 314 (873)
Q Consensus 238 ~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~---v 314 (873)
++||||+++|+|.+++.. ......+++..++.|+.||+.||+||| +.+|+||||||+|||++.++. +
T Consensus 94 ~LVmEy~~ggsL~~~L~~-------~~~~~~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl~~~g~~~~v 163 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQ-------FENCCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIH 163 (676)
T ss_dssp CCEEECCSSCBHHHHHHS-------SSCTTCCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEEECCSSSCEE
T ss_pred EEEEEeCCCCCHHHHHHh-------cccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEeecCCCceeE
Confidence 999999999999999953 122346899999999999999999999 899999999999999996664 9
Q ss_pred EEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhc
Q 002857 315 CVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSA 394 (873)
Q Consensus 315 KLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~ 394 (873)
||+|||+++...... ......||..|+|||++.+..++.++||||||+++|||++|+.||..... ...|....
T Consensus 164 KL~DFG~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~----~~~~~~~i 236 (676)
T 3qa8_A 164 KIIDLGYAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ----PVQWHGKV 236 (676)
T ss_dssp EECSCCCCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH----HHHSSTTC
T ss_pred EEccccccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc----hhhhhhhh
Confidence 999999998764432 22335689999999999999999999999999999999999999965211 11111111
Q ss_pred CchhHHH-HhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHH-----HHHHHHH
Q 002857 395 LPERVEE-IVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDV-----ELGLRLI 468 (873)
Q Consensus 395 ~~~~l~e-lid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EV-----l~~Le~i 468 (873)
....... .....+..... .. ...+...... ......+.+++..||+.||++|||+.|+ .+.++.+
T Consensus 237 ~~~~~~~~~~~~~l~g~~~----~~--~~lp~p~~l~---~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~i 307 (676)
T 3qa8_A 237 REKSNEHIVVYDDLTGAVK----FS--SVLPTPNHLS---GILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSI 307 (676)
T ss_dssp C------CCSCCCCSSSCC----CC--SSSCCSCCCC---GGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHH
T ss_pred hcccchhhhhhhhhccccc----cc--cccCCchhhc---hhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHH
Confidence 1110000 00000100000 00 0001111000 1123468899999999999999999884 4555544
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-34 Score=307.75 Aligned_cols=237 Identities=19% Similarity=0.277 Sum_probs=179.3
Q ss_pred hcCCCcc-eeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHH-HhhhhccceeeeeeeecccccCCce
Q 002857 159 TKGFSSE-NLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVM-RNIIHRKIIKVVTACSRVDYQGNDF 236 (873)
Q Consensus 159 t~~f~~~-~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL-~~L~HpNIV~llg~c~~~~~~~~~~ 236 (873)
.++|.+. +.||+|+||.||+|.+..+++.||||+++. ...+.+|+.++ +.++||||+++++++... ......
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~-~~~~~~ 89 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENL-YAGRKC 89 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhh-cCCCce
Confidence 3567776 789999999999999999999999999863 35678899988 455899999999987432 133567
Q ss_pred EEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCC---CCC
Q 002857 237 KALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLND---EMT 313 (873)
Q Consensus 237 ~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~---~~~ 313 (873)
.++||||+++|+|.+++.. .....+++..++.|+.||+.||+||| +.+|+||||||+|||++. ++.
T Consensus 90 ~~lv~e~~~~~~L~~~l~~--------~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~ 158 (299)
T 3m2w_A 90 LLIVMECLDGGELFSRIQD--------RGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAI 158 (299)
T ss_dssp EEEEECCCCSCBHHHHHHH--------CTTCCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCC
T ss_pred EEEEEeecCCCcHHHHHHh--------ccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCc
Confidence 8999999999999999953 23456999999999999999999999 899999999999999997 789
Q ss_pred eEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhh
Q 002857 314 ACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQS 393 (873)
Q Consensus 314 vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~ 393 (873)
+||+|||++.... +..++.++||||||+++|||+||+.||........ ......
T Consensus 159 ~kl~Dfg~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~--~~~~~~ 212 (299)
T 3m2w_A 159 LKLTDFGFAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI--SPGMKT 212 (299)
T ss_dssp EEECCCTTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC---------CCSCC
T ss_pred EEEeccccccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh--hHHHHH
Confidence 9999999986432 23467899999999999999999999965321110 000000
Q ss_pred cCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHH
Q 002857 394 ALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELG 464 (873)
Q Consensus 394 ~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~ 464 (873)
.+ ..... +.. ..........+.+++.+||+.||++|||+.|+++.
T Consensus 213 ~~-----------~~~~~------------~~~---~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 213 RI-----------RMGQY------------EFP---NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp SS-----------CTTCC------------SSC---HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HH-----------hhccc------------cCC---chhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 00 00000 000 00001123357889999999999999999999763
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.98 E-value=3.3e-33 Score=307.44 Aligned_cols=198 Identities=17% Similarity=0.175 Sum_probs=160.0
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC--------CcchhHHHHHHHHHHhhh---------hcccee
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH--------HDASKSFTVECEVMRNII---------HRKIIK 221 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~--------~~~~~~f~~Ei~iL~~L~---------HpNIV~ 221 (873)
.++|++.+.||+|+||.||+|++ +++.||||+++... ....+.+.+|+.+++.++ |+|||+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 45788999999999999999987 67999999997543 222377999999999997 666666
Q ss_pred eeeeeecc-------------------------cccCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHH
Q 002857 222 VVTACSRV-------------------------DYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLN 276 (873)
Q Consensus 222 llg~c~~~-------------------------~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~ 276 (873)
+.+.+... ++......+|||||+++|++.+.+. ...+++..++.
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~-----------~~~~~~~~~~~ 165 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR-----------TKLSSLATAKS 165 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT-----------TTCCCHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH-----------hcCCCHHHHHH
Confidence 66543210 0112678999999999998776662 14578999999
Q ss_pred HHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCC--------------------CeEEeccccccccccccccccccc
Q 002857 277 IAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEM--------------------TACVADFGIARFLEATNEQTSSIG 336 (873)
Q Consensus 277 Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~--------------------~vKLsDFGla~~~~~~~~~~~~~~ 336 (873)
|+.||+.||+|||+ +.+|+||||||+|||++.++ .+||+|||+++..... .
T Consensus 166 i~~qi~~aL~~lH~--~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~ 236 (336)
T 2vuw_A 166 ILHQLTASLAVAEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------I 236 (336)
T ss_dssp HHHHHHHHHHHHHH--HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------E
T ss_pred HHHHHHHHHHHHHH--hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------c
Confidence 99999999999993 37899999999999999886 8999999999866431 2
Q ss_pred cccccccCCCcccCCCCCCcchhhHhHHHH-HHHHHhCCCCCCc
Q 002857 337 VKGTTGYIAPEYGMGHETSSYGDVYSFGIL-LLEMFTGLRPSDD 379 (873)
Q Consensus 337 ~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvv-L~ELlTGk~Pf~~ 379 (873)
..||..|+|||++.+.. +.++||||||++ .+++++|..||..
T Consensus 237 ~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~ 279 (336)
T 2vuw_A 237 VVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN 279 (336)
T ss_dssp EECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH
T ss_pred EEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcc
Confidence 36999999999998776 899999998777 7778889998743
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.5e-27 Score=282.33 Aligned_cols=186 Identities=15% Similarity=0.061 Sum_probs=129.0
Q ss_pred eecccCceEEEEEEEcCCCcEEEEEEeeccC----------CcchhHHHHHHHHHHhh-hhccceeeeeeeecccccCCc
Q 002857 167 LIGAGNFASVYKGILFEGAPAVAIKVFNFLH----------HDASKSFTVECEVMRNI-IHRKIIKVVTACSRVDYQGND 235 (873)
Q Consensus 167 ~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~----------~~~~~~f~~Ei~iL~~L-~HpNIV~llg~c~~~~~~~~~ 235 (873)
.++.|++|.+..++..-.|+.+|+|++.... ....++|.+|+++|+++ .|+||+++++++ +++.
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-----ed~~ 315 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHG-----ENAQ 315 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEE-----ECSS
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEE-----EECC
Confidence 4566777777766665668889999996432 11235699999999999 799999999994 6778
Q ss_pred eEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeE
Q 002857 236 FKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTAC 315 (873)
Q Consensus 236 ~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vK 315 (873)
..||||||++|++|.++|.. ...++. .+|+.||+.||+||| +++||||||||+||||+.++++|
T Consensus 316 ~~yLVMEyv~G~~L~d~i~~----------~~~l~~---~~I~~QIl~AL~ylH---~~GIIHRDIKPeNILL~~dg~vK 379 (569)
T 4azs_A 316 SGWLVMEKLPGRLLSDMLAA----------GEEIDR---EKILGSLLRSLAALE---KQGFWHDDVRPWNVMVDARQHAR 379 (569)
T ss_dssp EEEEEEECCCSEEHHHHHHT----------TCCCCH---HHHHHHHHHHHHHHH---HTTCEESCCCGGGEEECTTSCEE
T ss_pred EEEEEEecCCCCcHHHHHHh----------CCCCCH---HHHHHHHHHHHHHHH---HCCceeccCchHhEEECCCCCEE
Confidence 89999999999999999953 334544 358999999999999 89999999999999999999999
Q ss_pred EeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCC
Q 002857 316 VADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRP 376 (873)
Q Consensus 316 LsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~P 376 (873)
|+|||+|+...... .......||+.|+|||++.+. +..++|+||+|++++++.++..+
T Consensus 380 L~DFGlAr~~~~~~--~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 380 LIDFGSIVTTPQDC--SWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp ECCCTTEESCC-----CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred EeecccCeeCCCCC--ccccCceechhhccHHHhCCC-CCCcccccccccchhhhccccch
Confidence 99999998764432 223346799999999998764 67789999999998888766444
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.6e-24 Score=254.76 Aligned_cols=185 Identities=18% Similarity=0.140 Sum_probs=141.7
Q ss_pred CcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCc--------chhHHHHHHHHHHhhhhccceeeeeeeecccccCC
Q 002857 163 SSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHD--------ASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGN 234 (873)
Q Consensus 163 ~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~--------~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~ 234 (873)
...++||+|+||.||+|.. .++.+|+|+....... ..+.+.+|+++|++++||||+++..++. ..
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~-----~~ 411 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDV-----DL 411 (540)
T ss_dssp ---------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEE-----ET
T ss_pred CCCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEE-----eC
Confidence 4467999999999999954 5678999986532211 1245899999999999999995555432 23
Q ss_pred ceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCe
Q 002857 235 DFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTA 314 (873)
Q Consensus 235 ~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~v 314 (873)
+..+|||||+++++|.+++.. ++.|+.||++||+||| +.+|+||||||+|||++. ++
T Consensus 412 ~~~~lVmE~~~ggsL~~~l~~------------------~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~--~~ 468 (540)
T 3en9_A 412 DNKRIMMSYINGKLAKDVIED------------------NLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--DL 468 (540)
T ss_dssp TTTEEEEECCCSEEHHHHSTT------------------CTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESS--SE
T ss_pred CccEEEEECCCCCCHHHHHHH------------------HHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECC--eE
Confidence 345999999999999999831 5689999999999999 899999999999999998 99
Q ss_pred EEeccccccccccccccc-----cccccccccccCCCcccCC--CCCCcchhhHhHHHHHHHHHhCCCCC
Q 002857 315 CVADFGIARFLEATNEQT-----SSIGVKGTTGYIAPEYGMG--HETSSYGDVYSFGILLLEMFTGLRPS 377 (873)
Q Consensus 315 KLsDFGla~~~~~~~~~~-----~~~~~~Gt~~Y~APE~l~~--~~~s~ksDVwSfGvvL~ELlTGk~Pf 377 (873)
||+|||+++......... ......||+.|+|||++.. ..|+..+|+||..+-.++.+.++.+|
T Consensus 469 kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 469 YIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp EECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred EEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 999999999765432211 1234569999999999887 56788899999999999988877766
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=4.9e-22 Score=214.73 Aligned_cols=153 Identities=16% Similarity=0.114 Sum_probs=121.5
Q ss_pred HHHHHHhhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCC------------------cchhHHHHHHHHHHh
Q 002857 152 YEALYSATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH------------------DASKSFTVECEVMRN 213 (873)
Q Consensus 152 ~~el~~at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~------------------~~~~~f~~Ei~iL~~ 213 (873)
+..+......|.+.+.||+|+||.||+|.+ .+++.||||+++.... .....+.+|+++|++
T Consensus 82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~ 160 (282)
T 1zar_A 82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQK 160 (282)
T ss_dssp HHHHHHTTSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHhCCeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHh
Confidence 445555566778889999999999999999 7899999999863321 123568899999999
Q ss_pred hhhccceeeeeeeecccccCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCC
Q 002857 214 IIHRKIIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCK 293 (873)
Q Consensus 214 L~HpNIV~llg~c~~~~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s 293 (873)
++ | +++.+++. .+..++||||+++|+|.+ +.. .....++.||+.||.||| +
T Consensus 161 l~--~-~~v~~~~~------~~~~~lvmE~~~g~~L~~-l~~----------------~~~~~i~~qi~~~l~~lH---~ 211 (282)
T 1zar_A 161 LQ--G-LAVPKVYA------WEGNAVLMELIDAKELYR-VRV----------------ENPDEVLDMILEEVAKFY---H 211 (282)
T ss_dssp TT--T-SSSCCEEE------EETTEEEEECCCCEEGGG-CCC----------------SCHHHHHHHHHHHHHHHH---H
T ss_pred cc--C-CCcCeEEe------ccceEEEEEecCCCcHHH-cch----------------hhHHHHHHHHHHHHHHHH---H
Confidence 98 4 66666532 134599999999999998 521 234579999999999999 8
Q ss_pred CCeeeccCCCCCeeeCCCCCeEEeccccccccccccccccccccccccccCCCcccC
Q 002857 294 PPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGM 350 (873)
Q Consensus 294 ~gIvHrDLKpsNILLd~~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~ 350 (873)
.+|+||||||+|||++ ++.+||+|||+++. +..|+|||++.
T Consensus 212 ~giiHrDlkp~NILl~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~ 252 (282)
T 1zar_A 212 RGIVHGDLSQYNVLVS-EEGIWIIDFPQSVE---------------VGEEGWREILE 252 (282)
T ss_dssp TTEECSCCSTTSEEEE-TTEEEECCCTTCEE---------------TTSTTHHHHHH
T ss_pred CCCEeCCCCHHHEEEE-CCcEEEEECCCCeE---------------CCCCCHHHHHH
Confidence 9999999999999999 99999999999973 33467888754
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=9.7e-18 Score=178.38 Aligned_cols=138 Identities=20% Similarity=0.196 Sum_probs=106.7
Q ss_pred CCcceeecccCceEEEEEEEcCCCcE--EEEEEeeccCCcc------------------------hhHHHHHHHHHHhhh
Q 002857 162 FSSENLIGAGNFASVYKGILFEGAPA--VAIKVFNFLHHDA------------------------SKSFTVECEVMRNII 215 (873)
Q Consensus 162 f~~~~~LG~G~fG~VYkg~~~~~g~~--VAVK~l~~~~~~~------------------------~~~f~~Ei~iL~~L~ 215 (873)
|.+.+.||+|+||.||+|.+..+|+. ||||+++...... ...+.+|+.+|.+++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56789999999999999998677888 9999975331110 126889999999999
Q ss_pred hccc--eeeeeeeecccccCCceEEEEEeecCC-C----ChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHH
Q 002857 216 HRKI--IKVVTACSRVDYQGNDFKALVYEFMPN-G----SLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYL 288 (873)
Q Consensus 216 HpNI--V~llg~c~~~~~~~~~~~~LV~Ey~~~-G----SL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yL 288 (873)
|+++ ..++.+ ...+|||||+.+ | +|.+++.. .++..+..++.||+.||.||
T Consensus 129 ~~~i~~p~~~~~---------~~~~lVmE~~g~~g~~~~~L~~~~~~-------------~~~~~~~~i~~qi~~~l~~l 186 (258)
T 1zth_A 129 EAGVSVPQPYTY---------MKNVLLMEFIGEDELPAPTLVELGRE-------------LKELDVEGIFNDVVENVKRL 186 (258)
T ss_dssp HTTCCCCCEEEE---------ETTEEEEECCEETTEECCBHHHHGGG-------------GGGSCHHHHHHHHHHHHHHH
T ss_pred hCCCCCCeEEEc---------CCCEEEEEecCCCCCccccHHHHhhc-------------cChHHHHHHHHHHHHHHHHH
Confidence 9864 333332 235899999942 4 55554311 23557889999999999999
Q ss_pred hhCCCCCeeeccCCCCCeeeCCCCCeEEecccccccc
Q 002857 289 HLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFL 325 (873)
Q Consensus 289 H~~~s~gIvHrDLKpsNILLd~~~~vKLsDFGla~~~ 325 (873)
|. ..+|+||||||+|||++. .++|+|||+|...
T Consensus 187 H~--~~givHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 187 YQ--EAELVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp HH--TSCEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred HH--HCCEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 94 479999999999999998 9999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.57 E-value=3.6e-15 Score=167.46 Aligned_cols=145 Identities=14% Similarity=0.100 Sum_probs=98.6
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCC--------------cchhHHHHHHHHHHhhhhccceeeeee
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH--------------DASKSFTVECEVMRNIIHRKIIKVVTA 225 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~--------------~~~~~f~~Ei~iL~~L~HpNIV~llg~ 225 (873)
.=|++.+.||.|+||.||+|.. .+|+.||||+++.... ........++++.....|+|+++++..
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~ 173 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEE 173 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred CEEEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhc
Confidence 3488999999999999999987 5688999999863210 011122333333333344444444322
Q ss_pred eecccc-cCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCC
Q 002857 226 CSRVDY-QGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPS 304 (873)
Q Consensus 226 c~~~~~-~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKps 304 (873)
...... ......+|||||+++++|.++.. ......++.||+.+|.||| ..+||||||||.
T Consensus 174 gv~vp~p~~~~~~~LVME~i~G~~L~~l~~----------------~~~~~~l~~qll~~l~~lH---~~gIVHrDLKp~ 234 (397)
T 4gyi_A 174 GFPVPEPIAQSRHTIVMSLVDALPMRQVSS----------------VPDPASLYADLIALILRLA---KHGLIHGDFNEF 234 (397)
T ss_dssp TCSCCCEEEEETTEEEEECCSCEEGGGCCC----------------CSCHHHHHHHHHHHHHHHH---HTTEECSCCSTT
T ss_pred CCCCCeeeeccCceEEEEecCCccHhhhcc----------------cHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHH
Confidence 110000 00012369999999988876542 1134578899999999999 789999999999
Q ss_pred CeeeCCCC----------CeEEeccccccc
Q 002857 305 NILLNDEM----------TACVADFGIARF 324 (873)
Q Consensus 305 NILLd~~~----------~vKLsDFGla~~ 324 (873)
|||+++++ .+.|+||+.+..
T Consensus 235 NILl~~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 235 NILIREEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp SEEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred HEEEeCCCCcccccccccceEEEEeCCccc
Confidence 99998776 389999998764
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.23 E-value=3.8e-11 Score=126.63 Aligned_cols=148 Identities=16% Similarity=0.082 Sum_probs=113.9
Q ss_pred HHHhhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhh-hccceeeeeeeecccccC
Q 002857 155 LYSATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNII-HRKIIKVVTACSRVDYQG 233 (873)
Q Consensus 155 l~~at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~-HpNIV~llg~c~~~~~~~ 233 (873)
+.....+|.+...++.|+.+.||++.. ++..+++|+...........+.+|+++++.+. |.++.++++++ ..
T Consensus 9 l~~~l~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~-----~~ 81 (263)
T 3tm0_A 9 LKKLIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFE-----RH 81 (263)
T ss_dssp HHHHHTTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEE-----EE
T ss_pred HHHHhccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEE-----ec
Confidence 444556788888999999999999864 46789999986432233457999999999994 67788888875 33
Q ss_pred CceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhC----------------------
Q 002857 234 NDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLG---------------------- 291 (873)
Q Consensus 234 ~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~---------------------- 291 (873)
.+..++||||++|.+|.+.+. +......++.+++++|+.||.-
T Consensus 82 ~~~~~lv~e~i~G~~l~~~~~---------------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~ 146 (263)
T 3tm0_A 82 DGWSNLLMSEADGVLCSEEYE---------------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLL 146 (263)
T ss_dssp TTEEEEEEECCSSEEHHHHCC---------------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHH
T ss_pred CCceEEEEEecCCeehhhccC---------------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHH
Confidence 567899999999999887641 1123457889999999999951
Q ss_pred ----------------------------------CCCCeeeccCCCCCeeeCCCCCeEEeccccccc
Q 002857 292 ----------------------------------CKPPIAHCDIKPSNILLNDEMTACVADFGIARF 324 (873)
Q Consensus 292 ----------------------------------~s~gIvHrDLKpsNILLd~~~~vKLsDFGla~~ 324 (873)
....++|+|+++.|||++++..+.|+||+.+..
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 147 NNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred hccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 014589999999999998766677999998753
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.08 E-value=2.7e-10 Score=118.76 Aligned_cols=139 Identities=17% Similarity=0.089 Sum_probs=98.0
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhcc--ceeeeeeeecccccCCce
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRK--IIKVVTACSRVDYQGNDF 236 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpN--IV~llg~c~~~~~~~~~~ 236 (873)
..++.+..+.+.|..+.||++.. .+++.+++|+.... ....+..|+++++.+.+.+ +.+++++. ..++.
T Consensus 19 ~~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~-----~~~~~ 89 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVV-----TEAGR 89 (264)
T ss_dssp TTTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEE-----ECSSC
T ss_pred cCCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEec-----cCCCC
Confidence 34555544444566799999964 55678999997543 3356889999999997655 44577763 33456
Q ss_pred EEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCC------------------------
Q 002857 237 KALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGC------------------------ 292 (873)
Q Consensus 237 ~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~------------------------ 292 (873)
.++||||++|.+|. ... .....++.++++.|+.||...
T Consensus 90 ~~~v~e~i~G~~l~--~~~----------------~~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (264)
T 1nd4_A 90 DWLLLGEVPGQDLL--SSH----------------LAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAG 151 (264)
T ss_dssp EEEEEECCSSEETT--TSC----------------CCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTT
T ss_pred CEEEEEecCCcccC--cCc----------------CCHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcC
Confidence 89999999998884 211 012356777777777777321
Q ss_pred -------------------------------CCCeeeccCCCCCeeeCCCCCeEEeccccccc
Q 002857 293 -------------------------------KPPIAHCDIKPSNILLNDEMTACVADFGIARF 324 (873)
Q Consensus 293 -------------------------------s~gIvHrDLKpsNILLd~~~~vKLsDFGla~~ 324 (873)
...++|+|++|.|||++++..+.|+||+.+..
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 152 LVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp CCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12299999999999998876677999998763
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.06 E-value=8e-11 Score=143.74 Aligned_cols=84 Identities=31% Similarity=0.448 Sum_probs=72.4
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCG 80 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G 80 (873)
|++|+|+|.||.+|++|++|+.|+|++|+|+|.||..|++|++|+.||||+|+|+|.+|..+..+..+..+++++|.|+|
T Consensus 639 Ls~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g 718 (768)
T 3rgz_A 639 MSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSG 718 (768)
T ss_dssp CCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEE
T ss_pred CcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccc
Confidence 57888888888888888888888888888888888888888888888888888888888888888888888888888888
Q ss_pred CCCc
Q 002857 81 GIPE 84 (873)
Q Consensus 81 ~~p~ 84 (873)
.+|.
T Consensus 719 ~iP~ 722 (768)
T 3rgz_A 719 PIPE 722 (768)
T ss_dssp ECCS
T ss_pred cCCC
Confidence 7765
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=98.98 E-value=1.9e-10 Score=140.36 Aligned_cols=82 Identities=35% Similarity=0.604 Sum_probs=77.4
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCG 80 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G 80 (873)
|++|+|+|.||.+|++|++|+.||||+|+|+|.||..|++|++|++||||+|+|+|.||....+.......+.+|+.|||
T Consensus 663 Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg 742 (768)
T 3rgz_A 663 LGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCG 742 (768)
T ss_dssp CCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEES
T ss_pred CcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCchhhccCCHHHhcCCchhcC
Confidence 68999999999999999999999999999999999999999999999999999999999987777777778889999999
Q ss_pred CC
Q 002857 81 GI 82 (873)
Q Consensus 81 ~~ 82 (873)
.+
T Consensus 743 ~~ 744 (768)
T 3rgz_A 743 YP 744 (768)
T ss_dssp TT
T ss_pred CC
Confidence 75
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.86 E-value=6.3e-09 Score=115.05 Aligned_cols=146 Identities=14% Similarity=0.166 Sum_probs=105.6
Q ss_pred cceeecccCceEEEEEEEcCCCcEEEEEEee--ccC-CcchhHHHHHHHHHHhhh--hccceeeeeeeecccccCCceEE
Q 002857 164 SENLIGAGNFASVYKGILFEGAPAVAIKVFN--FLH-HDASKSFTVECEVMRNII--HRKIIKVVTACSRVDYQGNDFKA 238 (873)
Q Consensus 164 ~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~--~~~-~~~~~~f~~Ei~iL~~L~--HpNIV~llg~c~~~~~~~~~~~~ 238 (873)
..+.|+.|.++.||+... .+..+++|+.. ... ......+.+|+.+++.+. +..+.+++.++.... ..+..+
T Consensus 42 ~~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~--~~g~~~ 117 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVT--PGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDES--VIGRAF 117 (359)
T ss_dssp EEEECCC-CCSCEEEEEC--SSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTT--TTSSCE
T ss_pred eEEEcCCcccceEEEEEE--CCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCC--ccCCeE
Confidence 357899999999999865 34578888765 222 122357889999999997 456788888864321 114578
Q ss_pred EEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCC--------------------------
Q 002857 239 LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGC-------------------------- 292 (873)
Q Consensus 239 LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~-------------------------- 292 (873)
+||||++|..+.+.. ...++..++..++.++++.|+.||...
T Consensus 118 ~vme~v~G~~l~~~~------------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 185 (359)
T 3dxp_A 118 YIMEFVSGRVLWDQS------------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQ 185 (359)
T ss_dssp EEEECCCCBCCCCTT------------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHH
T ss_pred EEEEecCCeecCCCc------------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHH
Confidence 999999997775422 123677788899999999999999520
Q ss_pred -----------------------------CCCeeeccCCCCCeeeCCCCC--eEEecccccccc
Q 002857 293 -----------------------------KPPIAHCDIKPSNILLNDEMT--ACVADFGIARFL 325 (873)
Q Consensus 293 -----------------------------s~gIvHrDLKpsNILLd~~~~--vKLsDFGla~~~ 325 (873)
...++|+|+++.|||++.++. +.|+||+.+..-
T Consensus 186 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 186 YKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred HHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 257999999999999997653 689999998753
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=98.84 E-value=2.6e-09 Score=107.92 Aligned_cols=84 Identities=20% Similarity=0.221 Sum_probs=72.7
Q ss_pred CCCCccccCcCc-CCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccC
Q 002857 1 MHGNLFEGPIGL-SLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLC 79 (873)
Q Consensus 1 Ls~N~L~G~iP~-~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~ 79 (873)
|++|+|++..|. .|+.|++|++|+|++|+|++.+|..|.++++|++|+|++|+|++..|..+..+..+..+++++|.|.
T Consensus 36 l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 115 (192)
T 1w8a_A 36 LNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQIS 115 (192)
T ss_dssp CCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCC
T ss_pred CCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCC
Confidence 578999865554 3889999999999999999888999999999999999999999888887777888899999999998
Q ss_pred CCCCc
Q 002857 80 GGIPE 84 (873)
Q Consensus 80 G~~p~ 84 (873)
+.++.
T Consensus 116 ~~~~~ 120 (192)
T 1w8a_A 116 CVMPG 120 (192)
T ss_dssp EECTT
T ss_pred eeCHH
Confidence 76553
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=98.84 E-value=4.3e-09 Score=104.33 Aligned_cols=79 Identities=15% Similarity=0.133 Sum_probs=45.5
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCG 80 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G 80 (873)
+++|+|+ .+|..+. ++|++|+|++|+|++..|..|.+|++|++|+|++|+|++..|..+..+..+..+++++|.|.+
T Consensus 16 ~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~ 92 (170)
T 3g39_A 16 CSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQLKS 92 (170)
T ss_dssp CTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC
T ss_pred eCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCccCE
Confidence 3455555 3555553 566666666666665555556666666666666666665544444455555566666666655
Q ss_pred CC
Q 002857 81 GI 82 (873)
Q Consensus 81 ~~ 82 (873)
.+
T Consensus 93 ~~ 94 (170)
T 3g39_A 93 IP 94 (170)
T ss_dssp CC
T ss_pred eC
Confidence 43
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=98.80 E-value=6.9e-09 Score=103.44 Aligned_cols=80 Identities=13% Similarity=0.042 Sum_probs=57.5
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCG 80 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G 80 (873)
+++|+|+ .+|..+. ++|+.|+|++|+|++..|..|++|++|+.|+|++|+|++..+..+..+..+..+++++|.|.+
T Consensus 19 ~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l~~ 95 (174)
T 2r9u_A 19 CQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLKS 95 (174)
T ss_dssp CCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC
T ss_pred eCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCccce
Confidence 4566675 6777664 677888888888876667777778888888888888876555555566677777777777776
Q ss_pred CCC
Q 002857 81 GIP 83 (873)
Q Consensus 81 ~~p 83 (873)
.++
T Consensus 96 l~~ 98 (174)
T 2r9u_A 96 IPR 98 (174)
T ss_dssp CCT
T ss_pred eCH
Confidence 544
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.77 E-value=2.7e-10 Score=131.97 Aligned_cols=82 Identities=23% Similarity=0.099 Sum_probs=57.9
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCccccccc-CCCCcceecccCCCccCCCCcccccccCcccccccccccC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLA-GFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLC 79 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~-~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~ 79 (873)
|++|.|++..|..|+.+++|++|+|++|+|++.+|..+. .|++|+.|+|++|.|++..+. .....+..+++++|.|.
T Consensus 127 L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~~~--~~l~~L~~L~Ls~N~l~ 204 (487)
T 3oja_A 127 LANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQ--VVFAKLKTLDLSSNKLA 204 (487)
T ss_dssp CCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEECC--CCCTTCCEEECCSSCCC
T ss_pred CCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCcccccccc--ccCCCCCEEECCCCCCC
Confidence 567777777777777788888888888888877777765 677777777777777765332 24566667777777777
Q ss_pred CCCCc
Q 002857 80 GGIPE 84 (873)
Q Consensus 80 G~~p~ 84 (873)
+.++.
T Consensus 205 ~~~~~ 209 (487)
T 3oja_A 205 FMGPE 209 (487)
T ss_dssp EECGG
T ss_pred CCCHh
Confidence 65543
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=98.75 E-value=7.1e-09 Score=104.67 Aligned_cols=80 Identities=18% Similarity=0.150 Sum_probs=58.0
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccc-cccCCCCcceecccCCCccCCCCcccccccCcccccccccccC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPE-FLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLC 79 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~-~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~ 79 (873)
+++|+|+ .||..+.. +|+.|+|++|+|++..|. .|+.+++|++|+|++|+|++.+|..+..+..+..+++++|.|.
T Consensus 15 ~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 91 (192)
T 1w8a_A 15 CTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK 91 (192)
T ss_dssp CTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCC
T ss_pred cCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCC
Confidence 4567775 67776654 778888888888744443 3777888888888888888777777777777777788888777
Q ss_pred CCCC
Q 002857 80 GGIP 83 (873)
Q Consensus 80 G~~p 83 (873)
+.++
T Consensus 92 ~~~~ 95 (192)
T 1w8a_A 92 EISN 95 (192)
T ss_dssp EECS
T ss_pred ccCH
Confidence 6554
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.72 E-value=1.5e-08 Score=104.54 Aligned_cols=83 Identities=14% Similarity=0.098 Sum_probs=59.9
Q ss_pred CCCCccccCcCc-CCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccC
Q 002857 1 MHGNLFEGPIGL-SLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLC 79 (873)
Q Consensus 1 Ls~N~L~G~iP~-~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~ 79 (873)
|++|+|++..|. .|+.+++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..+..+..+..+.+++|.|.
T Consensus 39 L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 118 (220)
T 2v70_A 39 LNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRIT 118 (220)
T ss_dssp CCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCC
T ss_pred cCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCC
Confidence 567777765443 3677788888888888887655567777788888888888887777766666677777777777777
Q ss_pred CCCC
Q 002857 80 GGIP 83 (873)
Q Consensus 80 G~~p 83 (873)
+.++
T Consensus 119 ~~~~ 122 (220)
T 2v70_A 119 CVGN 122 (220)
T ss_dssp CBCT
T ss_pred eECH
Confidence 6543
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.72 E-value=1.3e-08 Score=103.00 Aligned_cols=81 Identities=22% Similarity=0.193 Sum_probs=57.7
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCG 80 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G 80 (873)
|++|+|+ .+|..|.++++|+.|+|++|+|++..|..|.+|++|+.|+|++|+|++..|..+..+..+..+++++|.|.+
T Consensus 38 L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~~N~l~~ 116 (193)
T 2wfh_A 38 LDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDISV 116 (193)
T ss_dssp CCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCCCB
T ss_pred CCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECCCCCCCe
Confidence 4567776 677777777777777777777776555667777777777777777777666666666677777777777765
Q ss_pred CC
Q 002857 81 GI 82 (873)
Q Consensus 81 ~~ 82 (873)
.+
T Consensus 117 ~~ 118 (193)
T 2wfh_A 117 VP 118 (193)
T ss_dssp CC
T ss_pred eC
Confidence 43
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.71 E-value=3e-09 Score=115.00 Aligned_cols=190 Identities=18% Similarity=0.160 Sum_probs=118.3
Q ss_pred ceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhh-hcc--ceeeeeeeecccccCCceEEEEE
Q 002857 165 ENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNII-HRK--IIKVVTACSRVDYQGNDFKALVY 241 (873)
Q Consensus 165 ~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~-HpN--IV~llg~c~~~~~~~~~~~~LV~ 241 (873)
.+.++.|....||+.. ..+++|+.... .....+.+|+++|+.+. +.. +.+++...... ..-...++||
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~--~~~~~~~~vm 95 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPS--ETYQMSFAGF 95 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCC--SSCSCSCEEE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCC--CCCCcceEEE
Confidence 4568999999999862 45888886422 23467899999999984 332 33444442110 1112347899
Q ss_pred eecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhC------------------------------
Q 002857 242 EFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLG------------------------------ 291 (873)
Q Consensus 242 Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~------------------------------ 291 (873)
++++|.+|.+... ..++..++..++.++++.|+.||..
T Consensus 96 ~~i~G~~l~~~~~------------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (304)
T 3sg8_A 96 TKIKGVPLTPLLL------------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSR 163 (304)
T ss_dssp ECCCCEECCHHHH------------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTT
T ss_pred cccCCeECCcccc------------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcc
Confidence 9999988865321 1245556677777777777777741
Q ss_pred -------------------------CCCCeeeccCCCCCeeeCC--CCCeEEecccccccccccccccccc---------
Q 002857 292 -------------------------CKPPIAHCDIKPSNILLND--EMTACVADFGIARFLEATNEQTSSI--------- 335 (873)
Q Consensus 292 -------------------------~s~gIvHrDLKpsNILLd~--~~~vKLsDFGla~~~~~~~~~~~~~--------- 335 (873)
....++|+|+++.||++++ ...+.|+||+.+.......+.....
T Consensus 164 ~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~ 243 (304)
T 3sg8_A 164 ELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGME 243 (304)
T ss_dssp TSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHH
T ss_pred cCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHH
Confidence 1245899999999999998 5568899999987543211100000
Q ss_pred ---ccccccccCC-CcccCCCCCCcchhhHhHHHHHHHHHhCCCCC
Q 002857 336 ---GVKGTTGYIA-PEYGMGHETSSYGDVYSFGILLLEMFTGLRPS 377 (873)
Q Consensus 336 ---~~~Gt~~Y~A-PE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf 377 (873)
......++.. |+... ......+.|+++.++|.+.+|..+|
T Consensus 244 ~~~~~l~~Y~~~~~~~~~~--r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 244 FVSKILNHYKHKDIPTVLE--KYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHHHTCSCHHHHHH--HHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHHHHcCCCCcHHHHH--HHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 0001111111 22111 1122368999999999999998765
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=98.69 E-value=1.7e-08 Score=110.66 Aligned_cols=81 Identities=16% Similarity=0.109 Sum_probs=71.5
Q ss_pred CCC-ccccCcCcCCCCCCCCCeEeCCC-CcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccC
Q 002857 2 HGN-LFEGPIGLSLSPLRGLKVLDLSQ-NNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLC 79 (873)
Q Consensus 2 s~N-~L~G~iP~~l~~L~~L~~L~Ls~-N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~ 79 (873)
++| +|+ .||. |+.+++|+.|+|++ |+|++..|..|++|++|+.|+|++|+|++.+|..+..+..+..++|++|.|.
T Consensus 16 ~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 93 (347)
T 2ifg_A 16 TRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE 93 (347)
T ss_dssp CSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCS
T ss_pred CCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCCccc
Confidence 455 788 5999 99999999999996 9999777788999999999999999999999988888889999999999999
Q ss_pred CCCCc
Q 002857 80 GGIPE 84 (873)
Q Consensus 80 G~~p~ 84 (873)
+.++.
T Consensus 94 ~~~~~ 98 (347)
T 2ifg_A 94 SLSWK 98 (347)
T ss_dssp CCCST
T ss_pred eeCHH
Confidence 76544
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=98.68 E-value=1.4e-08 Score=111.45 Aligned_cols=79 Identities=22% Similarity=0.105 Sum_probs=69.2
Q ss_pred CCC-CccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccC
Q 002857 1 MHG-NLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLC 79 (873)
Q Consensus 1 Ls~-N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~ 79 (873)
|++ |+|++..|..|++|++|+.|+|++|+|+|..|..|++|++|+.|+|++|+|++..|..+..+. +..+.+.+|.|.
T Consensus 38 l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~~~ 116 (347)
T 2ifg_A 38 IENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLH 116 (347)
T ss_dssp CCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTCSCC-CCEEECCSSCCC
T ss_pred ccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCCccceeCHHHcccCC-ceEEEeeCCCcc
Confidence 575 999987778899999999999999999998888999999999999999999977666655554 888899999876
Q ss_pred C
Q 002857 80 G 80 (873)
Q Consensus 80 G 80 (873)
.
T Consensus 117 c 117 (347)
T 2ifg_A 117 C 117 (347)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.66 E-value=2.1e-08 Score=103.46 Aligned_cols=84 Identities=15% Similarity=0.126 Sum_probs=76.3
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCG 80 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G 80 (873)
|++|+|++..|..|+.+++|++|+|++|+|++..|..|..+++|++|+|++|+|++..|..+..+..+..+++++|.|.+
T Consensus 64 L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 143 (220)
T 2v70_A 64 FSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITT 143 (220)
T ss_dssp CCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCC
T ss_pred CCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCE
Confidence 68899998777799999999999999999998777889999999999999999999989988888889999999999998
Q ss_pred CCCc
Q 002857 81 GIPE 84 (873)
Q Consensus 81 ~~p~ 84 (873)
.++.
T Consensus 144 ~~~~ 147 (220)
T 2v70_A 144 VAPG 147 (220)
T ss_dssp BCTT
T ss_pred ECHH
Confidence 7543
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=98.66 E-value=3.5e-08 Score=98.29 Aligned_cols=82 Identities=16% Similarity=0.067 Sum_probs=71.9
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCG 80 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G 80 (873)
|++|+|++..|..|++|++|++|+|++|+|++..+..|.+|++|++|+|++|+|++..+..+..+..+..+++++|.+..
T Consensus 40 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~~~c 119 (174)
T 2r9u_A 40 LNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIYLYNNPWDC 119 (174)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCBCT
T ss_pred eCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCccceeCHHHhccccCCCEEEeCCCCccc
Confidence 68999998889999999999999999999996444567999999999999999997777667778889999999998875
Q ss_pred CC
Q 002857 81 GI 82 (873)
Q Consensus 81 ~~ 82 (873)
..
T Consensus 120 ~~ 121 (174)
T 2r9u_A 120 EC 121 (174)
T ss_dssp TB
T ss_pred cc
Confidence 43
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=98.65 E-value=3.6e-08 Score=97.62 Aligned_cols=82 Identities=18% Similarity=0.061 Sum_probs=73.5
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCG 80 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G 80 (873)
|++|+|++..|..|+.|++|++|+|++|+|++..|..|..|++|++|+|++|+|++..+..+..+..+..+++++|.+..
T Consensus 37 L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c 116 (170)
T 3g39_A 37 LYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQLKSIPRGAFDNLKSLTHIWLLNNPWDC 116 (170)
T ss_dssp CCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCT
T ss_pred cCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCccCEeCHHHhcCCCCCCEEEeCCCCCCC
Confidence 68999998889999999999999999999996655678999999999999999998877778788889999999999876
Q ss_pred CC
Q 002857 81 GI 82 (873)
Q Consensus 81 ~~ 82 (873)
..
T Consensus 117 ~c 118 (170)
T 3g39_A 117 AC 118 (170)
T ss_dssp TB
T ss_pred Cc
Confidence 54
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=98.65 E-value=3.3e-08 Score=102.05 Aligned_cols=84 Identities=20% Similarity=0.171 Sum_probs=67.3
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCG 80 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G 80 (873)
|++|+|++..|..|..+++|+.|+|++|+|++..|..|.+|++|++|+|++|+|++..+..+..+..+..+++++|.|.+
T Consensus 39 l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~ 118 (220)
T 2v9t_B 39 LEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINC 118 (220)
T ss_dssp CCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC
T ss_pred CCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCE
Confidence 57888886666678888889999999998887778888888889999999888886555556667778888888888887
Q ss_pred CCCc
Q 002857 81 GIPE 84 (873)
Q Consensus 81 ~~p~ 84 (873)
.++.
T Consensus 119 ~~~~ 122 (220)
T 2v9t_B 119 LRVD 122 (220)
T ss_dssp CCTT
T ss_pred eCHH
Confidence 6543
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=98.64 E-value=5.1e-08 Score=96.55 Aligned_cols=83 Identities=18% Similarity=0.073 Sum_probs=59.5
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCG 80 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G 80 (873)
|++|+|++..|..|+.+++|++|+|++|+|++..+..|+.+++|+.|+|++|+|++..+..+.....+..+++++|.|.+
T Consensus 35 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 114 (177)
T 2o6r_A 35 LESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKS 114 (177)
T ss_dssp CCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSC
T ss_pred eCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceE
Confidence 46777775555556778888888888888875444556778888888888888886666655666677777788887775
Q ss_pred CCC
Q 002857 81 GIP 83 (873)
Q Consensus 81 ~~p 83 (873)
.++
T Consensus 115 ~~~ 117 (177)
T 2o6r_A 115 VPD 117 (177)
T ss_dssp CCT
T ss_pred eCH
Confidence 443
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=98.63 E-value=6.3e-09 Score=113.13 Aligned_cols=84 Identities=32% Similarity=0.390 Sum_probs=72.0
Q ss_pred CCCCcccc--CcCcCCCCCCCCCeEeCCC-CcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccc
Q 002857 1 MHGNLFEG--PIGLSLSPLRGLKVLDLSQ-NNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNK 77 (873)
Q Consensus 1 Ls~N~L~G--~iP~~l~~L~~L~~L~Ls~-N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~ 77 (873)
|++|+|+| .+|..|++|++|++|+|++ |+++|.+|..|++|++|++|+|++|+|++.+|..+.....+..+++++|.
T Consensus 57 L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~ 136 (313)
T 1ogq_A 57 LSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNA 136 (313)
T ss_dssp EECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSE
T ss_pred CCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCc
Confidence 46788888 8899999999999999984 88988899889999999999999999988888888888888888899988
Q ss_pred cCCCCCc
Q 002857 78 LCGGIPE 84 (873)
Q Consensus 78 L~G~~p~ 84 (873)
+.+..|.
T Consensus 137 l~~~~p~ 143 (313)
T 1ogq_A 137 LSGTLPP 143 (313)
T ss_dssp EESCCCG
T ss_pred cCCcCCh
Confidence 8876553
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=98.63 E-value=7.5e-09 Score=112.55 Aligned_cols=82 Identities=30% Similarity=0.484 Sum_probs=76.0
Q ss_pred CCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCCCC
Q 002857 3 GNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCGGI 82 (873)
Q Consensus 3 ~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G~~ 82 (873)
.|+++|.+|.+|++|++|++|+|++|+|+|.+|..|+++++|++|+|++|+|++.+|..+..+..+..+.+++|.+.|..
T Consensus 86 ~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 165 (313)
T 1ogq_A 86 INNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAI 165 (313)
T ss_dssp ETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEEC
T ss_pred CCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcC
Confidence 38999999999999999999999999999999999999999999999999999999999888899999999999998765
Q ss_pred Cc
Q 002857 83 PE 84 (873)
Q Consensus 83 p~ 84 (873)
|.
T Consensus 166 p~ 167 (313)
T 1ogq_A 166 PD 167 (313)
T ss_dssp CG
T ss_pred CH
Confidence 53
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.61 E-value=4.4e-08 Score=99.14 Aligned_cols=80 Identities=25% Similarity=0.173 Sum_probs=71.6
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCG 80 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G 80 (873)
|++|+|++..|..|.+|++|++|+|++|+|++..|..|..|++|+.|+|++|+|++..+..+..+..+..+.+++|.+..
T Consensus 61 Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C 140 (193)
T 2wfh_A 61 LSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYC 140 (193)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred CCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeec
Confidence 68999998778889999999999999999997777899999999999999999997777667777888899999998753
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=98.61 E-value=4.6e-08 Score=100.93 Aligned_cols=79 Identities=20% Similarity=0.217 Sum_probs=61.0
Q ss_pred CCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCCC
Q 002857 2 HGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCGG 81 (873)
Q Consensus 2 s~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G~ 81 (873)
++|.|+ .||..+. ++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..|..+..+..+..+++++|.|...
T Consensus 19 ~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l 95 (220)
T 2v9t_B 19 RGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITEL 95 (220)
T ss_dssp TTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCC
T ss_pred CCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCcc
Confidence 567777 6777665 6788888888888855556788888888888888888877787777777888888888888755
Q ss_pred CC
Q 002857 82 IP 83 (873)
Q Consensus 82 ~p 83 (873)
++
T Consensus 96 ~~ 97 (220)
T 2v9t_B 96 PK 97 (220)
T ss_dssp CT
T ss_pred CH
Confidence 43
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=98.59 E-value=4e-08 Score=115.97 Aligned_cols=77 Identities=25% Similarity=0.248 Sum_probs=65.5
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCG 80 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G 80 (873)
|++|+|++ +|. |+.|++|+.|+|++|+|+ .||..|++|++|+.|+|++|+|++ +| .+..+..+..+++++|.|++
T Consensus 448 Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~ 522 (567)
T 1dce_A 448 LAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQ 522 (567)
T ss_dssp CTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCS
T ss_pred ecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCC
Confidence 67888885 786 889999999999999999 889899999999999999999986 67 66677788888899998887
Q ss_pred CC
Q 002857 81 GI 82 (873)
Q Consensus 81 ~~ 82 (873)
.+
T Consensus 523 ~~ 524 (567)
T 1dce_A 523 SA 524 (567)
T ss_dssp SS
T ss_pred CC
Confidence 63
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=98.59 E-value=5.4e-08 Score=96.33 Aligned_cols=83 Identities=17% Similarity=0.091 Sum_probs=71.0
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCG 80 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G 80 (873)
|++|+|++..|..|+.+++|++|+|++|+|++..|..+..+++|+.|+|++|+|++..+..+.....+..+++++|.+.+
T Consensus 59 l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~ 138 (177)
T 2o6r_A 59 LSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 138 (177)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred CCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeec
Confidence 67899996666668999999999999999997666778999999999999999997666656667788899999999887
Q ss_pred CCC
Q 002857 81 GIP 83 (873)
Q Consensus 81 ~~p 83 (873)
..+
T Consensus 139 ~~~ 141 (177)
T 2o6r_A 139 SCP 141 (177)
T ss_dssp CHH
T ss_pred cCc
Confidence 543
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=98.58 E-value=8.3e-08 Score=99.56 Aligned_cols=79 Identities=20% Similarity=0.092 Sum_probs=48.7
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLC 79 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~ 79 (873)
|++|+|++..|..|..+++|++|+|++|+|++..+..|..+++|++|+|++|+|++..+..+..+..+..+.+++|.|.
T Consensus 47 Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~ 125 (229)
T 3e6j_A 47 LHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT 125 (229)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred cCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc
Confidence 4566666655666666666666666666665333344566666666666666666555555555556666666666665
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=98.55 E-value=1e-07 Score=99.83 Aligned_cols=83 Identities=17% Similarity=0.100 Sum_probs=60.1
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCG 80 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G 80 (873)
|++|+|++..|..|+++++|++|+|++|+|++..|..|..+++|++|+|++|+|++..+..+.....+..+++++|.|.+
T Consensus 42 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 121 (251)
T 3m19_A 42 LQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKS 121 (251)
T ss_dssp CTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCC
T ss_pred ccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCC
Confidence 46777776666677777777777777777776666667777777777777777776666666666677777777777775
Q ss_pred CCC
Q 002857 81 GIP 83 (873)
Q Consensus 81 ~~p 83 (873)
.++
T Consensus 122 ~~~ 124 (251)
T 3m19_A 122 LPS 124 (251)
T ss_dssp CCT
T ss_pred cCh
Confidence 443
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=98.54 E-value=6.8e-08 Score=92.70 Aligned_cols=79 Identities=15% Similarity=0.083 Sum_probs=71.4
Q ss_pred CCCCccc-cCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccC
Q 002857 1 MHGNLFE-GPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLC 79 (873)
Q Consensus 1 Ls~N~L~-G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~ 79 (873)
|++|.++ |.+|..++.+++|+.|+|++|+|++. ..++.+++|++|+|++|+|++.+|..+.....+..+++++|.+.
T Consensus 24 l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls~N~i~ 101 (149)
T 2je0_A 24 LDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIK 101 (149)
T ss_dssp CTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEECTTSCCC
T ss_pred ccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEECCCCcCC
Confidence 5789998 89999999999999999999999965 78999999999999999999888887776788999999999988
Q ss_pred CC
Q 002857 80 GG 81 (873)
Q Consensus 80 G~ 81 (873)
+.
T Consensus 102 ~~ 103 (149)
T 2je0_A 102 DL 103 (149)
T ss_dssp SH
T ss_pred Ch
Confidence 63
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=98.53 E-value=6.9e-08 Score=105.78 Aligned_cols=80 Identities=15% Similarity=0.091 Sum_probs=54.3
Q ss_pred CCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCCC
Q 002857 2 HGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCGG 81 (873)
Q Consensus 2 s~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G~ 81 (873)
++|+|+ .+|..|+++++|++|+|++|+|+ .+|..++.+++|+.|+|++|++.+.+|..+.....+..+.+++|.+.+.
T Consensus 191 ~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~-~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~ 268 (328)
T 4fcg_A 191 EWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLT 268 (328)
T ss_dssp EEECCC-CCCGGGGGCTTCCEEEEESSCCC-CCCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCB
T ss_pred cCCCcC-cchHhhcCCCCCCEEEccCCCCC-cCchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhh
Confidence 456666 67777777777777777777777 4666677777777777777777777776666666666666766666655
Q ss_pred CC
Q 002857 82 IP 83 (873)
Q Consensus 82 ~p 83 (873)
+|
T Consensus 269 ~p 270 (328)
T 4fcg_A 269 LP 270 (328)
T ss_dssp CC
T ss_pred cc
Confidence 44
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=98.52 E-value=1.3e-07 Score=99.06 Aligned_cols=83 Identities=17% Similarity=0.064 Sum_probs=72.8
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCG 80 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G 80 (873)
|++|+|++..|..|..+++|++|+|++|+|++..|..|..+++|++|+|++|+|++..+..+.....+..+++++|.|.+
T Consensus 66 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 145 (251)
T 3m19_A 66 LDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQS 145 (251)
T ss_dssp CTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC
T ss_pred CCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCc
Confidence 67899998888889999999999999999997666788999999999999999997777767778888999999999987
Q ss_pred CCC
Q 002857 81 GIP 83 (873)
Q Consensus 81 ~~p 83 (873)
.++
T Consensus 146 ~~~ 148 (251)
T 3m19_A 146 IPA 148 (251)
T ss_dssp CCT
T ss_pred cCH
Confidence 654
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=98.50 E-value=1.8e-07 Score=97.03 Aligned_cols=82 Identities=18% Similarity=0.119 Sum_probs=70.9
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCG 80 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G 80 (873)
|++|+|++..+..|..|++|++|+|++|+|++..+..|..+++|+.|+|++|+|+ .+|..+.....+..+++++|.|.+
T Consensus 71 L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~ 149 (229)
T 3e6j_A 71 LGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKS 149 (229)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCC
T ss_pred CCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCc
Confidence 6889998544456799999999999999999666667899999999999999999 788888888889999999999986
Q ss_pred CCC
Q 002857 81 GIP 83 (873)
Q Consensus 81 ~~p 83 (873)
.++
T Consensus 150 ~~~ 152 (229)
T 3e6j_A 150 IPH 152 (229)
T ss_dssp CCT
T ss_pred cCH
Confidence 554
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=98.50 E-value=1.8e-07 Score=94.86 Aligned_cols=83 Identities=19% Similarity=0.082 Sum_probs=67.7
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCG 80 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G 80 (873)
|++|+|++..+..|+.+++|++|+|++|+|++..+..|..+++|++|+|++|+|++..+..+.....+..+++++|.+.+
T Consensus 35 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 114 (208)
T 2o6s_A 35 LETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQS 114 (208)
T ss_dssp CCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC
T ss_pred cCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcc
Confidence 57888986666668899999999999999995555567889999999999999997766666677788888999998886
Q ss_pred CCC
Q 002857 81 GIP 83 (873)
Q Consensus 81 ~~p 83 (873)
.++
T Consensus 115 ~~~ 117 (208)
T 2o6s_A 115 LPD 117 (208)
T ss_dssp CCT
T ss_pred cCH
Confidence 554
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=98.50 E-value=2e-07 Score=94.61 Aligned_cols=83 Identities=19% Similarity=0.114 Sum_probs=70.3
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCG 80 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G 80 (873)
|++|+|++..+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|+|++..+..+.....+..+.+++|.+.+
T Consensus 59 l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 138 (208)
T 2o6s_A 59 LGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKS 138 (208)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSC
T ss_pred CCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccce
Confidence 57899996555667899999999999999996555668999999999999999998777767777888999999999987
Q ss_pred CCC
Q 002857 81 GIP 83 (873)
Q Consensus 81 ~~p 83 (873)
.++
T Consensus 139 ~~~ 141 (208)
T 2o6s_A 139 VPD 141 (208)
T ss_dssp CCT
T ss_pred eCH
Confidence 554
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=98.49 E-value=7.6e-08 Score=92.40 Aligned_cols=80 Identities=21% Similarity=0.117 Sum_probs=70.7
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCC-CCcccccccCcccccccccccC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESM-IPTEGIFKNASATSVFGNNKLC 79 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~-iP~~~~~~~~l~~~~l~nN~L~ 79 (873)
|++|+|++. ..++.+++|++|+|++|+|++.+|..+..+++|++|+|++|+|++. .|..+.....+..+.+++|.++
T Consensus 49 l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~ 126 (149)
T 2je0_A 49 TINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVT 126 (149)
T ss_dssp CTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGG
T ss_pred CcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEECCCCcCCChHHHHHHhhCCCCCEEeCcCCccc
Confidence 578999965 8899999999999999999988999999999999999999999973 4467777888999999999998
Q ss_pred CCC
Q 002857 80 GGI 82 (873)
Q Consensus 80 G~~ 82 (873)
+.+
T Consensus 127 ~~~ 129 (149)
T 2je0_A 127 NLN 129 (149)
T ss_dssp GST
T ss_pred chH
Confidence 654
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=98.47 E-value=5.5e-08 Score=116.19 Aligned_cols=83 Identities=14% Similarity=0.140 Sum_probs=72.2
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCC----------------------------------------------------
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQN---------------------------------------------------- 28 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N---------------------------------------------------- 28 (873)
|++|.|+|.+|++|++|++|++|+|++|
T Consensus 88 L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~ 167 (636)
T 4eco_A 88 LEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCIN 167 (636)
T ss_dssp CTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHH
T ss_pred ecCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhh
Confidence 6789999999999999999999999888
Q ss_pred --------------------------cCCCcccccccCCCCcceecccCCCccCC-----------------CCcccc--
Q 002857 29 --------------------------NLSGEIPEFLAGFKFLQNLNLSHNNFESM-----------------IPTEGI-- 63 (873)
Q Consensus 29 --------------------------~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~-----------------iP~~~~-- 63 (873)
+|+| ||.+|++|++|++|+|++|+|+|. +|..+.
T Consensus 168 ~~l~~~~~~~~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~ 246 (636)
T 4eco_A 168 SDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWD 246 (636)
T ss_dssp HCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGG
T ss_pred cCccccccccccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhc
Confidence 4556 899999999999999999999986 888887
Q ss_pred cccCcccccccccccCCCCCc
Q 002857 64 FKNASATSVFGNNKLCGGIPE 84 (873)
Q Consensus 64 ~~~~l~~~~l~nN~L~G~~p~ 84 (873)
.+..+..+.+++|.+.|.+|.
T Consensus 247 ~l~~L~~L~L~~n~l~~~~p~ 267 (636)
T 4eco_A 247 NLKDLTDVEVYNCPNLTKLPT 267 (636)
T ss_dssp GCTTCCEEEEECCTTCSSCCT
T ss_pred ccCCCCEEEecCCcCCccChH
Confidence 788888999999998887653
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=98.46 E-value=7.1e-08 Score=117.17 Aligned_cols=79 Identities=23% Similarity=0.155 Sum_probs=71.8
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCG 80 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G 80 (873)
|++|.|. .||..+++|++|++|+|++|.|+ .||..|++|++|++|+|++|+|+ .+|..+..+..+..+.+++|.|..
T Consensus 231 Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~ 307 (727)
T 4b8c_D 231 LSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVTT 307 (727)
T ss_dssp CTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCCC
T ss_pred CCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCCc
Confidence 6789998 89999999999999999999999 99999999999999999999999 789888888889999999999874
Q ss_pred CC
Q 002857 81 GI 82 (873)
Q Consensus 81 ~~ 82 (873)
.+
T Consensus 308 lp 309 (727)
T 4b8c_D 308 LP 309 (727)
T ss_dssp CC
T ss_pred cC
Confidence 43
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=98.46 E-value=2.5e-07 Score=98.15 Aligned_cols=84 Identities=18% Similarity=0.079 Sum_probs=72.7
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCG 80 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G 80 (873)
|++|+|++..|..|+.+++|++|+|++|+|++..|..|+.+++|+.|+|++|+|++..|..+.....+..+.+++|.+.+
T Consensus 116 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 195 (272)
T 3rfs_A 116 LVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKS 195 (272)
T ss_dssp CTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSC
T ss_pred CCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCc
Confidence 57899997777778999999999999999997666778999999999999999998877777777888999999999998
Q ss_pred CCCc
Q 002857 81 GIPE 84 (873)
Q Consensus 81 ~~p~ 84 (873)
.++.
T Consensus 196 ~~~~ 199 (272)
T 3rfs_A 196 VPDG 199 (272)
T ss_dssp CCTT
T ss_pred cCHH
Confidence 6653
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=98.45 E-value=1.6e-07 Score=110.19 Aligned_cols=84 Identities=32% Similarity=0.322 Sum_probs=72.5
Q ss_pred CCCCcc-ccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccC
Q 002857 1 MHGNLF-EGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLC 79 (873)
Q Consensus 1 Ls~N~L-~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~ 79 (873)
|++|++ .+.+|..|..|++|++|+|++|+|++.+|..|.+|++|++|+|++|+|++..|..+..+..+..+++++|.|.
T Consensus 476 Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~ 555 (635)
T 4g8a_A 476 MAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM 555 (635)
T ss_dssp CTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCC
T ss_pred hhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCC
Confidence 466764 4457888999999999999999999888899999999999999999999888888877888899999999998
Q ss_pred CCCCc
Q 002857 80 GGIPE 84 (873)
Q Consensus 80 G~~p~ 84 (873)
+.++.
T Consensus 556 ~~~~~ 560 (635)
T 4g8a_A 556 TSKKQ 560 (635)
T ss_dssp BCCSS
T ss_pred CCCHH
Confidence 87654
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=98.45 E-value=2.7e-07 Score=97.89 Aligned_cols=84 Identities=21% Similarity=0.130 Sum_probs=74.6
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCG 80 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G 80 (873)
|++|.|++..|..|+++++|++|+|++|+|++..|..|+.+++|++|+|++|+|++..|..+.....+..+.+++|.+.+
T Consensus 92 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 171 (272)
T 3rfs_A 92 LTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQS 171 (272)
T ss_dssp CTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC
T ss_pred CCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCc
Confidence 67899998777778999999999999999997777779999999999999999998888777778889999999999997
Q ss_pred CCCc
Q 002857 81 GIPE 84 (873)
Q Consensus 81 ~~p~ 84 (873)
.++.
T Consensus 172 ~~~~ 175 (272)
T 3rfs_A 172 LPEG 175 (272)
T ss_dssp CCTT
T ss_pred cCHH
Confidence 6553
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=98.44 E-value=1e-07 Score=93.36 Aligned_cols=79 Identities=19% Similarity=0.072 Sum_probs=71.1
Q ss_pred CCCCccc-cCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccC
Q 002857 1 MHGNLFE-GPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLC 79 (873)
Q Consensus 1 Ls~N~L~-G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~ 79 (873)
|++|+++ |.+|..+..+++|+.|+|++|.|++. ..+..+++|++|+|++|+|++.+|..+.....+..+++++|.+.
T Consensus 31 l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 108 (168)
T 2ell_A 31 LDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLK 108 (168)
T ss_dssp CCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEECBSSSCC
T ss_pred CCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEeccCCccC
Confidence 5789998 88999999999999999999999954 78999999999999999999888887776788899999999998
Q ss_pred CC
Q 002857 80 GG 81 (873)
Q Consensus 80 G~ 81 (873)
+.
T Consensus 109 ~~ 110 (168)
T 2ell_A 109 DI 110 (168)
T ss_dssp SS
T ss_pred cc
Confidence 64
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=98.43 E-value=1.5e-07 Score=110.45 Aligned_cols=83 Identities=18% Similarity=0.049 Sum_probs=72.4
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCG 80 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G 80 (873)
|++|+|++..|.+|++|++|++|||++|+|++..|..|.+|++|++|+|++|+|++..|..+..+..++.+.+++|.|.+
T Consensus 59 Ls~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~ 138 (635)
T 4g8a_A 59 LSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLAS 138 (635)
T ss_dssp CTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCC
T ss_pred eeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCC
Confidence 68999997666789999999999999999996556789999999999999999998777777788889999999999987
Q ss_pred CCC
Q 002857 81 GIP 83 (873)
Q Consensus 81 ~~p 83 (873)
.++
T Consensus 139 l~~ 141 (635)
T 4g8a_A 139 LEN 141 (635)
T ss_dssp STT
T ss_pred CCh
Confidence 554
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=98.43 E-value=1.7e-07 Score=110.54 Aligned_cols=81 Identities=23% Similarity=0.223 Sum_probs=74.6
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCC-CcccccccCcccccccccccC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMI-PTEGIFKNASATSVFGNNKLC 79 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~i-P~~~~~~~~l~~~~l~nN~L~ 79 (873)
|++|+|+ .||..|++|++|+.|+|++|+|++ || .|++|++|+.|+|++|+|++.+ |..+..+..+..+.+++|.|+
T Consensus 470 Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~ 546 (567)
T 1dce_A 470 LSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC 546 (567)
T ss_dssp CCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred cCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCC
Confidence 6899999 899999999999999999999995 88 8999999999999999999887 998888899999999999999
Q ss_pred CCCCc
Q 002857 80 GGIPE 84 (873)
Q Consensus 80 G~~p~ 84 (873)
+.++.
T Consensus 547 ~~~~~ 551 (567)
T 1dce_A 547 QEEGI 551 (567)
T ss_dssp GSSSC
T ss_pred CCccH
Confidence 86553
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=98.43 E-value=2.5e-07 Score=101.29 Aligned_cols=83 Identities=16% Similarity=0.139 Sum_probs=77.0
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCG 80 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G 80 (873)
|++|+|++ +|..|+.+++|++|+|++|++.+.+|..++.+++|+.|+|++|++.+.+|..+.....+..+++++|.+.+
T Consensus 213 L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~ 291 (328)
T 4fcg_A 213 IRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLS 291 (328)
T ss_dssp EESSCCCC-CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCC
T ss_pred ccCCCCCc-CchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchh
Confidence 47899994 88899999999999999999999999999999999999999999999999998888999999999999988
Q ss_pred CCCc
Q 002857 81 GIPE 84 (873)
Q Consensus 81 ~~p~ 84 (873)
.+|.
T Consensus 292 ~iP~ 295 (328)
T 4fcg_A 292 RLPS 295 (328)
T ss_dssp CCCG
T ss_pred hccH
Confidence 7765
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.40 E-value=2.3e-07 Score=102.85 Aligned_cols=82 Identities=21% Similarity=0.041 Sum_probs=61.6
Q ss_pred CCCCccccCcCcCCC-CCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccC
Q 002857 1 MHGNLFEGPIGLSLS-PLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLC 79 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~-~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~ 79 (873)
|++|+|++..+..|. +|++|+.|+|++|+|++..|..|.+|++|+.|+|++|+|++..+..+..+..+..+.+++|.|.
T Consensus 46 Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~ 125 (361)
T 2xot_A 46 LSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIV 125 (361)
T ss_dssp CCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC
T ss_pred CCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCccc
Confidence 577888865555566 7888888888888888655567888888888888888888766666666777777888888777
Q ss_pred CCC
Q 002857 80 GGI 82 (873)
Q Consensus 80 G~~ 82 (873)
+..
T Consensus 126 ~~~ 128 (361)
T 2xot_A 126 VVD 128 (361)
T ss_dssp EEC
T ss_pred EEC
Confidence 543
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=98.40 E-value=4.2e-07 Score=97.78 Aligned_cols=80 Identities=21% Similarity=0.168 Sum_probs=51.1
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCG 80 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G 80 (873)
|++|+|++ +|.. +.+++|++|+|++|+|+ .+|..+..+++|+.|+|++|+|++..|..+..+..+..+.+++|.|.+
T Consensus 62 L~~n~l~~-~~~~-~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~ 138 (290)
T 1p9a_G 62 LDRAELTK-LQVD-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKT 138 (290)
T ss_dssp CTTSCCCE-EECC-SCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCC
T ss_pred CCCCccCc-ccCC-CCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCc
Confidence 45666663 4433 66667777777777776 666666667777777777777766555555556666666666666665
Q ss_pred CCC
Q 002857 81 GIP 83 (873)
Q Consensus 81 ~~p 83 (873)
.++
T Consensus 139 ~~~ 141 (290)
T 1p9a_G 139 LPP 141 (290)
T ss_dssp CCT
T ss_pred cCh
Confidence 433
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=98.38 E-value=9.6e-08 Score=118.04 Aligned_cols=84 Identities=17% Similarity=0.154 Sum_probs=71.3
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeC-CCCcCCCc----------------------------------------------
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDL-SQNNLSGE---------------------------------------------- 33 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~L-s~N~LsG~---------------------------------------------- 33 (873)
|++|+|+|.+|++|++|++|++|+| ++|.|+|.
T Consensus 330 Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~ 409 (876)
T 4ecn_A 330 LAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAIN 409 (876)
T ss_dssp CTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHH
T ss_pred CccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhh
Confidence 6789999999999999999999999 77766655
Q ss_pred ------------------------------ccccccCCCCcceecccCCCccC-----------------CCCcccc--c
Q 002857 34 ------------------------------IPEFLAGFKFLQNLNLSHNNFES-----------------MIPTEGI--F 64 (873)
Q Consensus 34 ------------------------------iP~~l~~L~~L~~L~LS~N~Lsg-----------------~iP~~~~--~ 64 (873)
||..|++|++|+.|+|++|+|+| .+|..+. .
T Consensus 410 ~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~ 489 (876)
T 4ecn_A 410 RNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSN 489 (876)
T ss_dssp TCTTSCCCCCCCCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGG
T ss_pred hCccccccccccccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhcc
Confidence 88889999999999999999998 3888876 7
Q ss_pred ccCcccccccccccCCCCCc
Q 002857 65 KNASATSVFGNNKLCGGIPE 84 (873)
Q Consensus 65 ~~~l~~~~l~nN~L~G~~p~ 84 (873)
+..+..+.+++|.+.|.+|.
T Consensus 490 L~~L~~L~Ls~N~l~~~iP~ 509 (876)
T 4ecn_A 490 LKDLTDVELYNCPNMTQLPD 509 (876)
T ss_dssp CTTCCEEEEESCTTCCSCCG
T ss_pred CCCCCEEECcCCCCCccChH
Confidence 77888889999988887653
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=98.38 E-value=1.1e-07 Score=113.45 Aligned_cols=77 Identities=16% Similarity=0.103 Sum_probs=72.8
Q ss_pred CCccccCcCcCCCCCCCCCeEeCCCCcCCCc-----------------cccccc--CCCCcceecccCCCccCCCCcccc
Q 002857 3 GNLFEGPIGLSLSPLRGLKVLDLSQNNLSGE-----------------IPEFLA--GFKFLQNLNLSHNNFESMIPTEGI 63 (873)
Q Consensus 3 ~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~-----------------iP~~l~--~L~~L~~L~LS~N~Lsg~iP~~~~ 63 (873)
+|+|+| ||.+|++|++|++|+|++|+|+|. ||..++ +|++|++|+|++|+++|.+|..+.
T Consensus 192 ~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~ 270 (636)
T 4eco_A 192 SNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLK 270 (636)
T ss_dssp SCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTT
T ss_pred cCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHh
Confidence 689998 999999999999999999999986 999999 999999999999999999999988
Q ss_pred cccCcccccccccc-cCC
Q 002857 64 FKNASATSVFGNNK-LCG 80 (873)
Q Consensus 64 ~~~~l~~~~l~nN~-L~G 80 (873)
.+..+..+++++|. ++|
T Consensus 271 ~l~~L~~L~Ls~n~~l~~ 288 (636)
T 4eco_A 271 ALPEMQLINVACNRGISG 288 (636)
T ss_dssp TCSSCCEEECTTCTTSCH
T ss_pred cCCCCCEEECcCCCCCcc
Confidence 88999999999998 887
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=98.36 E-value=2.6e-07 Score=90.48 Aligned_cols=81 Identities=20% Similarity=0.110 Sum_probs=69.7
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCC-CcccccccCcccccccccccC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMI-PTEGIFKNASATSVFGNNKLC 79 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~i-P~~~~~~~~l~~~~l~nN~L~ 79 (873)
|++|.|++. ..|+.+++|++|+|++|+|++.+|..+.++++|++|+|++|+|++.. +..+.....+..+.+++|.++
T Consensus 56 l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~ 133 (168)
T 2ell_A 56 LINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVT 133 (168)
T ss_dssp EESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGG
T ss_pred CcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEeccCCccCcchhHHHHhcCCCCCEEEeeCCcCc
Confidence 468899865 88999999999999999999889999989999999999999999743 256667788899999999998
Q ss_pred CCCC
Q 002857 80 GGIP 83 (873)
Q Consensus 80 G~~p 83 (873)
+.++
T Consensus 134 ~~~~ 137 (168)
T 2ell_A 134 NLND 137 (168)
T ss_dssp TSTT
T ss_pred chHH
Confidence 6543
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=98.36 E-value=6e-07 Score=96.57 Aligned_cols=82 Identities=26% Similarity=0.213 Sum_probs=69.5
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCG 80 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G 80 (873)
|++|+|+ .+|..+..+++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..+..+.....+..+++++|.|.+
T Consensus 84 Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 162 (290)
T 1p9a_G 84 LSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTE 162 (290)
T ss_dssp CCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSC
T ss_pred CCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCc
Confidence 5788888 789989999999999999999996666789999999999999999997777666677788888999998886
Q ss_pred CCC
Q 002857 81 GIP 83 (873)
Q Consensus 81 ~~p 83 (873)
.++
T Consensus 163 l~~ 165 (290)
T 1p9a_G 163 LPA 165 (290)
T ss_dssp CCT
T ss_pred cCH
Confidence 554
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=98.36 E-value=3.6e-07 Score=103.52 Aligned_cols=83 Identities=18% Similarity=0.076 Sum_probs=60.8
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCG 80 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G 80 (873)
|++|++++.+|..|+.+++|+.|+|++|+|++..|..|+.+++|+.|+|++|+|++..|..+.....+..+++++|.+.+
T Consensus 282 l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 361 (455)
T 3v47_A 282 LSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRA 361 (455)
T ss_dssp CCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCE
T ss_pred ecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccc
Confidence 46777777777777777777777777777776667777777777777777777777667666666677777777777765
Q ss_pred CCC
Q 002857 81 GIP 83 (873)
Q Consensus 81 ~~p 83 (873)
..+
T Consensus 362 ~~~ 364 (455)
T 3v47_A 362 LGD 364 (455)
T ss_dssp ECT
T ss_pred cCh
Confidence 533
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=98.34 E-value=4.2e-07 Score=97.66 Aligned_cols=82 Identities=17% Similarity=0.185 Sum_probs=61.2
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCC-cccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSG-EIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLC 79 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG-~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~ 79 (873)
|++|.+++.+|..|+.+++|++|+|++|.+++ .+|..+..+++|+.|+|++|+|++..|..+.....+..+.+++|.+.
T Consensus 133 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~ 212 (306)
T 2z66_A 133 ISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFF 212 (306)
T ss_dssp CTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCS
T ss_pred CCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccC
Confidence 46777777777777778888888888888776 56777777888888888888887776776666667777777777776
Q ss_pred CCC
Q 002857 80 GGI 82 (873)
Q Consensus 80 G~~ 82 (873)
+.+
T Consensus 213 ~~~ 215 (306)
T 2z66_A 213 SLD 215 (306)
T ss_dssp BCC
T ss_pred ccC
Confidence 543
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=98.34 E-value=3.9e-07 Score=103.18 Aligned_cols=83 Identities=19% Similarity=0.078 Sum_probs=75.4
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCG 80 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G 80 (873)
|++|++++..|..|+.+++|++|+|++|+|++..|..|+++++|++|+|++|+|++..|..+.....+..+++++|.+.+
T Consensus 306 Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 385 (455)
T 3v47_A 306 LAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKS 385 (455)
T ss_dssp CTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSC
T ss_pred CCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCcccc
Confidence 67899998888899999999999999999998888999999999999999999999889888888889999999999987
Q ss_pred CCC
Q 002857 81 GIP 83 (873)
Q Consensus 81 ~~p 83 (873)
.++
T Consensus 386 ~~~ 388 (455)
T 3v47_A 386 VPD 388 (455)
T ss_dssp CCT
T ss_pred CCH
Confidence 554
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=98.33 E-value=4e-07 Score=91.83 Aligned_cols=66 Identities=20% Similarity=0.187 Sum_probs=39.0
Q ss_pred cCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccc
Q 002857 12 LSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNK 77 (873)
Q Consensus 12 ~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~ 77 (873)
+.++.+++|++|+|++|+|++..|..|+.|++|++|+|++|++++..|..+.....+..+.+++|.
T Consensus 82 ~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~ 147 (197)
T 4ezg_A 82 NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNG 147 (197)
T ss_dssp GGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCT
T ss_pred hhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCC
Confidence 355566666666666666665555566666666666666666665555555555555555565555
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.32 E-value=3.8e-07 Score=101.04 Aligned_cols=76 Identities=25% Similarity=0.203 Sum_probs=36.9
Q ss_pred CCCccccCcCcCCCCCCCCCeEeCCCCcCCCccccccc-CCCCcceecccCCCccCCCCcccccccCcccccccccccCC
Q 002857 2 HGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLA-GFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCG 80 (873)
Q Consensus 2 s~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~-~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G 80 (873)
++|+|+ .||..+.. .|+.|+|++|+|++..+..+. ++++|+.|+|++|+|++..|..+..+..+..+++++|.|.+
T Consensus 26 ~~~~l~-~iP~~~~~--~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~ 102 (361)
T 2xot_A 26 SKQQLP-NVPQSLPS--YTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHT 102 (361)
T ss_dssp CSSCCS-SCCSSCCT--TCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCE
T ss_pred CCCCcC-ccCccCCC--CCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCc
Confidence 344444 34544432 345555555555533333444 55555555555555554444444444455555555555543
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=98.29 E-value=4.9e-07 Score=109.84 Aligned_cols=70 Identities=21% Similarity=0.158 Sum_probs=49.5
Q ss_pred CcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCC
Q 002857 9 PIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCG 80 (873)
Q Consensus 9 ~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G 80 (873)
..|..|..+++|+.|+|++|.|+ .||..+.+|++|+.|+|++|.|+ .+|..+..+..+..+++++|.|..
T Consensus 215 ~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~ 284 (727)
T 4b8c_D 215 MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLTS 284 (727)
T ss_dssp -------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCSS
T ss_pred cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCCc
Confidence 34666777888888888888887 77777778888888888888887 677777777777778888887773
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=98.29 E-value=1.1e-06 Score=93.11 Aligned_cols=83 Identities=19% Similarity=0.081 Sum_probs=67.8
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCG 80 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G 80 (873)
|++|+|++..+..|..+++|++|+|++|+|++..|..|+.+++|+.|+|++|+|++..+..+.....+..+.+++|.+.+
T Consensus 92 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~ 171 (270)
T 2o6q_A 92 VTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKR 171 (270)
T ss_dssp CCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSC
T ss_pred CCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcE
Confidence 57888886556667889999999999999997777778899999999999999987666666677788888888888887
Q ss_pred CCC
Q 002857 81 GIP 83 (873)
Q Consensus 81 ~~p 83 (873)
.++
T Consensus 172 ~~~ 174 (270)
T 2o6q_A 172 VPE 174 (270)
T ss_dssp CCT
T ss_pred eCh
Confidence 554
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.28 E-value=2.1e-07 Score=100.76 Aligned_cols=81 Identities=16% Similarity=0.049 Sum_probs=45.6
Q ss_pred CCCCcc-ccCcCcCCC-------CCCCCCeEeCCCCcCCCcccccc--cCCCCcceecccCCCccCCCCcccccc-----
Q 002857 1 MHGNLF-EGPIGLSLS-------PLRGLKVLDLSQNNLSGEIPEFL--AGFKFLQNLNLSHNNFESMIPTEGIFK----- 65 (873)
Q Consensus 1 Ls~N~L-~G~iP~~l~-------~L~~L~~L~Ls~N~LsG~iP~~l--~~L~~L~~L~LS~N~Lsg~iP~~~~~~----- 65 (873)
|++|++ .+.+|..++ ++++|++|+|++|+|+|.+|..+ +.+++|++|+|++|+|++. |..+...
T Consensus 70 L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~ 148 (312)
T 1wwl_A 70 LKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLK 148 (312)
T ss_dssp CCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCC
T ss_pred cccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhc
Confidence 345555 344555554 56666666666666666666554 5666666666666666655 4443333
Q ss_pred cCcccccccccccCCCC
Q 002857 66 NASATSVFGNNKLCGGI 82 (873)
Q Consensus 66 ~~l~~~~l~nN~L~G~~ 82 (873)
..+..+.+++|.+.+.+
T Consensus 149 ~~L~~L~L~~N~l~~~~ 165 (312)
T 1wwl_A 149 PGLKVLSIAQAHSLNFS 165 (312)
T ss_dssp TTCCEEEEESCSCCCCC
T ss_pred CCCcEEEeeCCCCccch
Confidence 45555666666665543
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=98.27 E-value=8.5e-07 Score=95.25 Aligned_cols=84 Identities=31% Similarity=0.309 Sum_probs=74.7
Q ss_pred CCCCcccc-CcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccC
Q 002857 1 MHGNLFEG-PIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLC 79 (873)
Q Consensus 1 Ls~N~L~G-~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~ 79 (873)
|++|.+++ .+|..++.+++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..+..+.....+..+++++|.+.
T Consensus 157 l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 236 (306)
T 2z66_A 157 MAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM 236 (306)
T ss_dssp CTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCC
T ss_pred CCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCc
Confidence 57899987 68999999999999999999999888899999999999999999999877777777788899999999998
Q ss_pred CCCCc
Q 002857 80 GGIPE 84 (873)
Q Consensus 80 G~~p~ 84 (873)
+..+.
T Consensus 237 ~~~~~ 241 (306)
T 2z66_A 237 TSKKQ 241 (306)
T ss_dssp BCSSS
T ss_pred ccCHH
Confidence 86553
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=98.27 E-value=2.8e-07 Score=113.89 Aligned_cols=77 Identities=14% Similarity=0.085 Sum_probs=71.4
Q ss_pred CCccccCcCcCCCCCCCCCeEeCCCCcCCC-----------------ccccccc--CCCCcceecccCCCccCCCCcccc
Q 002857 3 GNLFEGPIGLSLSPLRGLKVLDLSQNNLSG-----------------EIPEFLA--GFKFLQNLNLSHNNFESMIPTEGI 63 (873)
Q Consensus 3 ~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG-----------------~iP~~l~--~L~~L~~L~LS~N~Lsg~iP~~~~ 63 (873)
+|+|+| ||.+|++|++|++|+|++|+|+| .||+.++ +|++|+.|+|++|++.|.+|..+.
T Consensus 434 ~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~ 512 (876)
T 4ecn_A 434 TNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLY 512 (876)
T ss_dssp SCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGG
T ss_pred cCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHh
Confidence 588998 99999999999999999999998 4999988 999999999999999999999888
Q ss_pred cccCcccccccccc-cCC
Q 002857 64 FKNASATSVFGNNK-LCG 80 (873)
Q Consensus 64 ~~~~l~~~~l~nN~-L~G 80 (873)
.+..+..+.+++|. |+|
T Consensus 513 ~L~~L~~L~Ls~N~~lsg 530 (876)
T 4ecn_A 513 DLPELQSLNIACNRGISA 530 (876)
T ss_dssp GCSSCCEEECTTCTTSCH
T ss_pred CCCCCCEEECcCCCCccc
Confidence 88899999999997 887
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=98.26 E-value=6.6e-07 Score=101.94 Aligned_cols=80 Identities=18% Similarity=0.123 Sum_probs=58.5
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCG 80 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G 80 (873)
|++|+|++..|..|++|++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..+..+..+..+..+.+++|.+..
T Consensus 82 L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 161 (452)
T 3zyi_A 82 LMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIES 161 (452)
T ss_dssp CCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEECCSCCCCE
T ss_pred CcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEECCCCCcce
Confidence 56777777667777777777777777777776666777777777777777777776666656666677777777777664
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=98.25 E-value=9.1e-07 Score=94.10 Aligned_cols=83 Identities=17% Similarity=0.146 Sum_probs=71.6
Q ss_pred CCCCc-cccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccC
Q 002857 1 MHGNL-FEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLC 79 (873)
Q Consensus 1 Ls~N~-L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~ 79 (873)
|++|. +++..|..|..+++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..+.....+..+.+++|.+.
T Consensus 87 l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 166 (285)
T 1ozn_A 87 LSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRIS 166 (285)
T ss_dssp CCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred CCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCccc
Confidence 56786 77555888999999999999999999877889999999999999999999877777777888899999999888
Q ss_pred CCCC
Q 002857 80 GGIP 83 (873)
Q Consensus 80 G~~p 83 (873)
+.++
T Consensus 167 ~~~~ 170 (285)
T 1ozn_A 167 SVPE 170 (285)
T ss_dssp EECT
T ss_pred ccCH
Confidence 6544
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=98.25 E-value=1.5e-06 Score=91.99 Aligned_cols=83 Identities=18% Similarity=0.119 Sum_probs=71.5
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCG 80 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G 80 (873)
|++|+|+...+..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|+|++..|..+.....+..+.+++|.+.+
T Consensus 68 l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~ 147 (270)
T 2o6q_A 68 LNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQS 147 (270)
T ss_dssp CCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC
T ss_pred CCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCc
Confidence 57899995444456899999999999999996666778999999999999999998888877788899999999999987
Q ss_pred CCC
Q 002857 81 GIP 83 (873)
Q Consensus 81 ~~p 83 (873)
.++
T Consensus 148 ~~~ 150 (270)
T 2o6q_A 148 LPK 150 (270)
T ss_dssp CCT
T ss_pred cCH
Confidence 654
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=98.24 E-value=1.4e-06 Score=92.64 Aligned_cols=83 Identities=25% Similarity=0.212 Sum_probs=70.0
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCC-ccCCCCcccccccCcccccccccccC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNN-FESMIPTEGIFKNASATSVFGNNKLC 79 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~-Lsg~iP~~~~~~~~l~~~~l~nN~L~ 79 (873)
|++|++++..|..|+++++|++|+|++|+|++..|..|..+++|++|+|++|. ++...|..+.....+..+.+++|.+.
T Consensus 39 l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~ 118 (285)
T 1ozn_A 39 LHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ 118 (285)
T ss_dssp CTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCC
T ss_pred eeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCC
Confidence 57888887666779999999999999999997778899999999999999997 77666777777788888999999888
Q ss_pred CCCC
Q 002857 80 GGIP 83 (873)
Q Consensus 80 G~~p 83 (873)
+.++
T Consensus 119 ~~~~ 122 (285)
T 1ozn_A 119 ELGP 122 (285)
T ss_dssp CCCT
T ss_pred EECH
Confidence 7644
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.23 E-value=9.6e-07 Score=102.76 Aligned_cols=84 Identities=18% Similarity=0.191 Sum_probs=71.4
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCC-CcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLS-GEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLC 79 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~Ls-G~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~ 79 (873)
|++|.+++.+|..|..+++|+.|+|++|+++ +.+|..+..+++|+.|+|++|++++..|..+.....+..+.+++|.+.
T Consensus 428 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 507 (570)
T 2z63_A 428 ISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLK 507 (570)
T ss_dssp CTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCS
T ss_pred CcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCC
Confidence 5788888888888889999999999999987 678888899999999999999999888888777788888888888888
Q ss_pred CCCCc
Q 002857 80 GGIPE 84 (873)
Q Consensus 80 G~~p~ 84 (873)
+.++.
T Consensus 508 ~~~~~ 512 (570)
T 2z63_A 508 SVPDG 512 (570)
T ss_dssp CCCTT
T ss_pred CCCHH
Confidence 76543
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=98.22 E-value=1e-06 Score=93.19 Aligned_cols=82 Identities=18% Similarity=0.053 Sum_probs=59.9
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCG 80 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G 80 (873)
|++|+|++..+..|+++++|++|+|++|+|++..+..|.++++|++|+|++|+|++..|..+.....+..+.+++|.+.+
T Consensus 35 ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 114 (276)
T 2z62_A 35 LSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLAS 114 (276)
T ss_dssp CTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCC
T ss_pred CCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCCCCccc
Confidence 46777776555577778888888888888875555677778888888888888877766666666777777777777765
Q ss_pred CC
Q 002857 81 GI 82 (873)
Q Consensus 81 ~~ 82 (873)
..
T Consensus 115 ~~ 116 (276)
T 2z62_A 115 LE 116 (276)
T ss_dssp ST
T ss_pred cC
Confidence 43
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.22 E-value=1.3e-06 Score=103.48 Aligned_cols=83 Identities=16% Similarity=0.047 Sum_probs=61.9
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCG 80 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G 80 (873)
|++|.|++..|..|+.+++|++|+|++|.|++..|..|++|++|++|+|++|.|++..+..+..+..+..+.+++|.+.+
T Consensus 82 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~ 161 (597)
T 3oja_B 82 LNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLER 161 (597)
T ss_dssp CTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCB
T ss_pred CCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCC
Confidence 56777777666678888888888888888887666777888888888888888886555555666777777888887776
Q ss_pred CCC
Q 002857 81 GIP 83 (873)
Q Consensus 81 ~~p 83 (873)
.++
T Consensus 162 ~~~ 164 (597)
T 3oja_B 162 IED 164 (597)
T ss_dssp CCT
T ss_pred CCh
Confidence 554
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=98.22 E-value=1.2e-06 Score=103.20 Aligned_cols=82 Identities=23% Similarity=0.133 Sum_probs=72.0
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCG 80 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G 80 (873)
|++|++++..|.+|+++++|++|+|++|+|++..|..|+++++|++|+|++|+|++..|..+.....++.+.+++|.+.+
T Consensus 39 Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~ 118 (606)
T 3vq2_A 39 LSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLAS 118 (606)
T ss_dssp CTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCC
T ss_pred CCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEccCCcccc
Confidence 67889988777789999999999999999997778889999999999999999998888888888888999999998876
Q ss_pred CC
Q 002857 81 GI 82 (873)
Q Consensus 81 ~~ 82 (873)
.+
T Consensus 119 ~~ 120 (606)
T 3vq2_A 119 LE 120 (606)
T ss_dssp SS
T ss_pred cc
Confidence 54
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=98.21 E-value=8.1e-07 Score=103.14 Aligned_cols=80 Identities=16% Similarity=-0.002 Sum_probs=62.7
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCG 80 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G 80 (873)
|++|++++..|.+|+++++|++|+|++|+|++..|..|+++++|++|+|++|+|++..|..+.....++.+++++|.+.+
T Consensus 33 Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~ 112 (549)
T 2z81_A 33 LSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQT 112 (549)
T ss_dssp CCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSS
T ss_pred CcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccc
Confidence 56778887777778888888888888888887667778888888888888888887777666677777788888887774
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=98.21 E-value=1.2e-06 Score=95.18 Aligned_cols=81 Identities=25% Similarity=0.193 Sum_probs=51.3
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCG 80 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G 80 (873)
|++|++++..|..|+.+++|+.|+|++|+|++..|..|..+++|+.|+|++|+|+ .+|..+.....+..+++++|.+++
T Consensus 199 l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~ 277 (330)
T 1xku_A 199 LDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISA 277 (330)
T ss_dssp CTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCC
T ss_pred CCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCc
Confidence 4556666555666666666666666666666555556666666666666666666 555555555566666666666665
Q ss_pred CC
Q 002857 81 GI 82 (873)
Q Consensus 81 ~~ 82 (873)
.+
T Consensus 278 ~~ 279 (330)
T 1xku_A 278 IG 279 (330)
T ss_dssp CC
T ss_pred cC
Confidence 43
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=98.21 E-value=8.7e-07 Score=104.28 Aligned_cols=81 Identities=19% Similarity=0.068 Sum_probs=72.9
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCG 80 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G 80 (873)
|++|+|++..|.+|+++++|++|+|++|++++..|..|+++++|++|+|++|++++..|..+.....++.+.+++|.+.+
T Consensus 40 Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~ 119 (606)
T 3t6q_A 40 FSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISS 119 (606)
T ss_dssp CTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEECTTSCCSC
T ss_pred ccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeeccccCccc
Confidence 67899998778899999999999999999998888999999999999999999998888888888888999999998886
Q ss_pred C
Q 002857 81 G 81 (873)
Q Consensus 81 ~ 81 (873)
.
T Consensus 120 l 120 (606)
T 3t6q_A 120 I 120 (606)
T ss_dssp G
T ss_pred C
Confidence 4
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=98.21 E-value=1.5e-06 Score=94.69 Aligned_cols=80 Identities=16% Similarity=0.064 Sum_probs=50.9
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCG 80 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G 80 (873)
|++|.+++..|..|..+++|+.|+|++|+|++..|..+..+++|+.|+|++|+|+ .+|..+.....+..+++++|.+.+
T Consensus 200 l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~ 278 (332)
T 2ft3_A 200 LDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITK 278 (332)
T ss_dssp CCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCB
T ss_pred CCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCc
Confidence 4556666555566666666666666666666555556666666666666666666 556555555566666666666664
Q ss_pred C
Q 002857 81 G 81 (873)
Q Consensus 81 ~ 81 (873)
.
T Consensus 279 ~ 279 (332)
T 2ft3_A 279 V 279 (332)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=98.21 E-value=1e-06 Score=87.25 Aligned_cols=76 Identities=16% Similarity=0.164 Sum_probs=61.1
Q ss_pred CCCCccccCcCcCCCCCC-CCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccC
Q 002857 1 MHGNLFEGPIGLSLSPLR-GLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLC 79 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~-~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~ 79 (873)
|++|+|+ .+|. +..+. +|++|+|++|+|++ + ..|+.+++|++|+|++|+|++..|..+.....+..+++++|.+.
T Consensus 26 l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~-~-~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~ 101 (176)
T 1a9n_A 26 LRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRK-L-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV 101 (176)
T ss_dssp CTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCE-E-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC
T ss_pred eeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCc-c-cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECCCCcCC
Confidence 5788888 5654 65555 99999999999995 4 68899999999999999999665555467778888999999885
Q ss_pred C
Q 002857 80 G 80 (873)
Q Consensus 80 G 80 (873)
.
T Consensus 102 ~ 102 (176)
T 1a9n_A 102 E 102 (176)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=98.20 E-value=1.5e-06 Score=91.97 Aligned_cols=80 Identities=15% Similarity=0.037 Sum_probs=71.0
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCG 80 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G 80 (873)
|++|++++..|..|.++++|++|+|++|+|++..|..|.++++|+.|+|++|++++..+..+.....+..+.+++|.+.+
T Consensus 59 l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 138 (276)
T 2z62_A 59 LSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS 138 (276)
T ss_dssp CTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCC
T ss_pred CCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccce
Confidence 57899997677789999999999999999997777889999999999999999998777677777888999999999886
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.19 E-value=9.7e-06 Score=85.26 Aligned_cols=141 Identities=16% Similarity=0.105 Sum_probs=95.8
Q ss_pred CCCcceeecccCce-EEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhh-hccceeeeeeeecccccCCceEE
Q 002857 161 GFSSENLIGAGNFA-SVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNII-HRKIIKVVTACSRVDYQGNDFKA 238 (873)
Q Consensus 161 ~f~~~~~LG~G~fG-~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~-HpNIV~llg~c~~~~~~~~~~~~ 238 (873)
+|+. ..+..|..+ .||+.....++..+++|+-.. .....+..|+.+|+.+. +-.+.++++++. ..+..+
T Consensus 26 g~~~-~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~-----~~~~~~ 96 (272)
T 4gkh_A 26 GYRW-ARDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIR-----TPDDAW 96 (272)
T ss_dssp TCEE-EEEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEE-----ETTEEE
T ss_pred CCeE-EEccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEE-----ECCeEE
Confidence 4443 344556555 699987766778899998652 23467889999999884 334667777753 346789
Q ss_pred EEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhC---------------------------
Q 002857 239 LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLG--------------------------- 291 (873)
Q Consensus 239 LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~--------------------------- 291 (873)
+|||++++.++.+.... .......++.+++..|+-||.-
T Consensus 97 lvme~l~G~~~~~~~~~--------------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (272)
T 4gkh_A 97 LLTTAIPGKTAFQVLEE--------------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLV 162 (272)
T ss_dssp EEEECCCSEEHHHHHHH--------------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCC
T ss_pred EEEEeeCCccccccccC--------------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhh
Confidence 99999999887765421 1112334555555555555521
Q ss_pred ----------------------------CCCCeeeccCCCCCeeeCCCCCeEEeccccccc
Q 002857 292 ----------------------------CKPPIAHCDIKPSNILLNDEMTACVADFGIARF 324 (873)
Q Consensus 292 ----------------------------~s~gIvHrDLKpsNILLd~~~~vKLsDFGla~~ 324 (873)
....++|+|+.+.|||+++++.+-|+||+.+..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 163 DASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp CGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred hhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 012379999999999999887778999998864
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.18 E-value=1.3e-06 Score=99.91 Aligned_cols=82 Identities=16% Similarity=0.071 Sum_probs=60.6
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCG 80 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G 80 (873)
|++|+|++..|..|.++++|++|+|++|+|++..|..|.+|++|++|+|++|+|++..+..+.....+..+++++|.+.+
T Consensus 39 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~ 118 (477)
T 2id5_A 39 LGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVI 118 (477)
T ss_dssp CCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCE
T ss_pred CCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECCCCcccc
Confidence 56777776667777888888888888888876667778888888888888888876555555666777777777777765
Q ss_pred CC
Q 002857 81 GI 82 (873)
Q Consensus 81 ~~ 82 (873)
.+
T Consensus 119 ~~ 120 (477)
T 2id5_A 119 LL 120 (477)
T ss_dssp EC
T ss_pred CC
Confidence 43
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=98.17 E-value=1.9e-06 Score=101.42 Aligned_cols=80 Identities=16% Similarity=0.042 Sum_probs=73.8
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCG 80 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G 80 (873)
|++|++++..|.+|++|++|++|+|++|+|++..|..|++|++|++|+|++|.+++..|..+.....++.+++++|.+.+
T Consensus 63 Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~ 142 (606)
T 3vq2_A 63 LSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHS 142 (606)
T ss_dssp CTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCC
T ss_pred CCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccc
Confidence 67899998888899999999999999999998889999999999999999999998887888888899999999999886
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.17 E-value=1.2e-06 Score=101.29 Aligned_cols=82 Identities=23% Similarity=0.240 Sum_probs=60.4
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCC--cccccccCCCCcceecccCCCccCCCCcc-cccccCcccccccccc
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSG--EIPEFLAGFKFLQNLNLSHNNFESMIPTE-GIFKNASATSVFGNNK 77 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG--~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~-~~~~~~l~~~~l~nN~ 77 (873)
|++|++++.+|..|+.+++|+.|+|++|+|++ .+|..++.+++|+.|+|++|++++.+|.. +.....+..+.+++|.
T Consensus 331 Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~ 410 (520)
T 2z7x_B 331 FSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNI 410 (520)
T ss_dssp CCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSC
T ss_pred eECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCC
Confidence 56777777777778888888888888888876 56677778888888888888887756654 4455667777777777
Q ss_pred cCCCC
Q 002857 78 LCGGI 82 (873)
Q Consensus 78 L~G~~ 82 (873)
+.+..
T Consensus 411 l~~~~ 415 (520)
T 2z7x_B 411 LTDTI 415 (520)
T ss_dssp CCGGG
T ss_pred CCcch
Confidence 76543
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.17 E-value=1.6e-06 Score=98.45 Aligned_cols=80 Identities=21% Similarity=0.212 Sum_probs=57.8
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCG 80 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G 80 (873)
|++|+|++..|..|++|++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..+..+..+..+..+.+++|.+..
T Consensus 71 L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~ 150 (440)
T 3zyj_A 71 LHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIES 150 (440)
T ss_dssp CCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEECCSCCCCE
T ss_pred ccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeCCCCcccc
Confidence 56777776666777777777777777777776556677777777777777777776555566666677777777777664
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.15 E-value=1.6e-06 Score=95.26 Aligned_cols=80 Identities=15% Similarity=0.045 Sum_probs=49.6
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCG 80 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G 80 (873)
|++|++++..+..|+++++|++|+|++|+|++..|..|+++++|++|+|++|+|++..+..+.....+..+.+++|.+.+
T Consensus 59 l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~ 138 (353)
T 2z80_A 59 LSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKT 138 (353)
T ss_dssp CTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSS
T ss_pred CCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcc
Confidence 45666664334466666667777777666665555666666667777777776665444435555566666666666654
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.15 E-value=2.2e-06 Score=101.41 Aligned_cols=81 Identities=21% Similarity=0.107 Sum_probs=72.3
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCG 80 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G 80 (873)
|++|.|++..|..|++|++|++|+|++|.|++..|..|+++++|++|+|++|+|++..|..+..+..+..+.+++|.|.+
T Consensus 106 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 185 (597)
T 3oja_B 106 MGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH 185 (597)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSB
T ss_pred CCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCC
Confidence 68899998888889999999999999999994444457999999999999999999999888888899999999999987
Q ss_pred C
Q 002857 81 G 81 (873)
Q Consensus 81 ~ 81 (873)
.
T Consensus 186 ~ 186 (597)
T 3oja_B 186 V 186 (597)
T ss_dssp C
T ss_pred c
Confidence 5
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.14 E-value=1.7e-06 Score=98.20 Aligned_cols=82 Identities=23% Similarity=0.184 Sum_probs=71.9
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCG 80 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G 80 (873)
|++|+|+ .+| .+..+++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..|..+.....+..+++++|.|.+
T Consensus 192 L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 269 (440)
T 3zyj_A 192 LAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTL 269 (440)
T ss_dssp CTTSCCS-SCC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCC
T ss_pred CCCCcCc-ccc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCc
Confidence 5788888 677 48999999999999999998888999999999999999999998888888888889999999999987
Q ss_pred CCCc
Q 002857 81 GIPE 84 (873)
Q Consensus 81 ~~p~ 84 (873)
.++.
T Consensus 270 ~~~~ 273 (440)
T 3zyj_A 270 LPHD 273 (440)
T ss_dssp CCTT
T ss_pred cChh
Confidence 6543
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.14 E-value=8.5e-06 Score=88.27 Aligned_cols=137 Identities=16% Similarity=0.155 Sum_probs=88.9
Q ss_pred ceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhc---cceeeeeeeecccccCCceEEEEE
Q 002857 165 ENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHR---KIIKVVTACSRVDYQGNDFKALVY 241 (873)
Q Consensus 165 ~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~Hp---NIV~llg~c~~~~~~~~~~~~LV~ 241 (873)
.+.++.|....||+. +..+++|+.. .......+..|+++|+.+.+. .+.+++.++. ...+..++||
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~----~~~g~~~~v~ 92 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGK----RSDGNPFVGY 92 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEE----CTTSCEEEEE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecc----cCCCceEEEE
Confidence 467888999999987 3567888853 122346789999999999753 2455665542 2345578999
Q ss_pred eecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhC------------------------------
Q 002857 242 EFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLG------------------------------ 291 (873)
Q Consensus 242 Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~------------------------------ 291 (873)
||++|.+|.+... ..++..++..++.++++.|+.||.-
T Consensus 93 e~i~G~~l~~~~~------------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~ 160 (306)
T 3tdw_A 93 RKVQGQILGEDGM------------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQV 160 (306)
T ss_dssp ECCCSEECHHHHH------------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHT
T ss_pred eccCCeECchhhh------------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhc
Confidence 9999988865310 0112223333333333333333321
Q ss_pred ---------------------------CCCCeeeccCCCCCeeeCC---CCC-eEEeccccccc
Q 002857 292 ---------------------------CKPPIAHCDIKPSNILLND---EMT-ACVADFGIARF 324 (873)
Q Consensus 292 ---------------------------~s~gIvHrDLKpsNILLd~---~~~-vKLsDFGla~~ 324 (873)
....++|+|+++.|||++. ++. +.|+||+.+..
T Consensus 161 ~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 161 FPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp GGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred ccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2456799999999999987 455 48999998864
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.14 E-value=1.5e-06 Score=101.04 Aligned_cols=83 Identities=17% Similarity=0.168 Sum_probs=71.5
Q ss_pred CCCCccccCcC-cCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCcc-CCCCcccccccCccccccccccc
Q 002857 1 MHGNLFEGPIG-LSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFE-SMIPTEGIFKNASATSVFGNNKL 78 (873)
Q Consensus 1 Ls~N~L~G~iP-~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Ls-g~iP~~~~~~~~l~~~~l~nN~L 78 (873)
|++|.+++..| ..+.++++|++|+|++|.+++.+|..+..+++|+.|+|++|.++ +.+|..+.....+..+++++|.+
T Consensus 403 l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l 482 (570)
T 2z63_A 403 FQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL 482 (570)
T ss_dssp CTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCC
T ss_pred ccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCcc
Confidence 57888887766 46889999999999999999888999999999999999999998 67888888888889999999988
Q ss_pred CCCCC
Q 002857 79 CGGIP 83 (873)
Q Consensus 79 ~G~~p 83 (873)
.+..+
T Consensus 483 ~~~~~ 487 (570)
T 2z63_A 483 EQLSP 487 (570)
T ss_dssp CEECT
T ss_pred ccCCh
Confidence 87644
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=98.13 E-value=1.6e-06 Score=98.66 Aligned_cols=82 Identities=17% Similarity=0.159 Sum_probs=72.1
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCG 80 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G 80 (873)
|++|+|++ +| .+..+++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..|..+.....+..+++++|.|.+
T Consensus 203 L~~n~l~~-~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 280 (452)
T 3zyi_A 203 LGMCNIKD-MP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSS 280 (452)
T ss_dssp CTTSCCSS-CC-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSC
T ss_pred CCCCcccc-cc-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCc
Confidence 57899984 55 58999999999999999998889999999999999999999999888888888889999999999987
Q ss_pred CCCc
Q 002857 81 GIPE 84 (873)
Q Consensus 81 ~~p~ 84 (873)
.++.
T Consensus 281 ~~~~ 284 (452)
T 3zyi_A 281 LPHD 284 (452)
T ss_dssp CCTT
T ss_pred cChH
Confidence 6543
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=98.11 E-value=2.4e-06 Score=100.50 Aligned_cols=81 Identities=16% Similarity=0.035 Sum_probs=75.2
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCG 80 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G 80 (873)
|++|++++..|.+|+++++|++|+|++|+|++..|..|+++++|++|+|++|+|++..|..+.....+..+.+++|.+.+
T Consensus 64 Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~ 143 (606)
T 3t6q_A 64 LTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISS 143 (606)
T ss_dssp CTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCC
T ss_pred CCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccc
Confidence 68899998889999999999999999999998889999999999999999999998777778888889999999999987
Q ss_pred C
Q 002857 81 G 81 (873)
Q Consensus 81 ~ 81 (873)
.
T Consensus 144 ~ 144 (606)
T 3t6q_A 144 I 144 (606)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.11 E-value=3.3e-06 Score=94.00 Aligned_cols=81 Identities=16% Similarity=0.062 Sum_probs=45.2
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCG 80 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G 80 (873)
|++|.+++..|..|+.+++|++|+|++|++++..|..|+++++|++|+|++|+|+...+..+.....+..+.+++|.+.+
T Consensus 76 L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~ 155 (390)
T 3o6n_A 76 LNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLER 155 (390)
T ss_dssp CTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCB
T ss_pred CCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEECCCCccCc
Confidence 34555554444456666666666666666665555556666666666666666663333333445555556666665554
Q ss_pred C
Q 002857 81 G 81 (873)
Q Consensus 81 ~ 81 (873)
.
T Consensus 156 ~ 156 (390)
T 3o6n_A 156 I 156 (390)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.11 E-value=2.1e-06 Score=98.18 Aligned_cols=82 Identities=18% Similarity=0.119 Sum_probs=73.3
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCG 80 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G 80 (873)
|++|++++..|.+|++|++|++|+|++|+|++..+..|.++++|+.|+|++|++++..|..+.....+..+.+++|.+.+
T Consensus 63 L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~ 142 (477)
T 2id5_A 63 LNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVY 142 (477)
T ss_dssp CTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCE
T ss_pred CCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccce
Confidence 67899998889999999999999999999995444578999999999999999999989888888899999999998876
Q ss_pred CC
Q 002857 81 GI 82 (873)
Q Consensus 81 ~~ 82 (873)
..
T Consensus 143 ~~ 144 (477)
T 2id5_A 143 IS 144 (477)
T ss_dssp EC
T ss_pred eC
Confidence 44
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.10 E-value=2.4e-06 Score=92.42 Aligned_cols=78 Identities=21% Similarity=0.141 Sum_probs=61.7
Q ss_pred CCCCcccc--CcCcC-CCCCCCCCeEeCCCCcCCCccc-ccccCCCCcceecccCCCccCCCCcccccccCccccccccc
Q 002857 1 MHGNLFEG--PIGLS-LSPLRGLKVLDLSQNNLSGEIP-EFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNN 76 (873)
Q Consensus 1 Ls~N~L~G--~iP~~-l~~L~~L~~L~Ls~N~LsG~iP-~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN 76 (873)
|++|+|++ .+|.. +.++++|++|+|++|+|++.+| ..+..+++|++|+|++|+|+ .+|..+. ..+..+++++|
T Consensus 208 L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N 284 (312)
T 1wwl_A 208 LRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYN 284 (312)
T ss_dssp CTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCC--SEEEEEECCSS
T ss_pred CCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhcc--CCceEEECCCC
Confidence 57888883 34433 4578999999999999998776 56777899999999999998 7777654 67788889999
Q ss_pred ccCCC
Q 002857 77 KLCGG 81 (873)
Q Consensus 77 ~L~G~ 81 (873)
.|.+.
T Consensus 285 ~l~~~ 289 (312)
T 1wwl_A 285 RLDRN 289 (312)
T ss_dssp CCCSC
T ss_pred CCCCC
Confidence 98876
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=98.10 E-value=3.3e-06 Score=91.92 Aligned_cols=79 Identities=19% Similarity=0.144 Sum_probs=51.6
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCG 80 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G 80 (873)
|++|++++..|.+|+++++|++|+|++|+|++..|..|+++++|++|+|++|+|+ .+|..+. ..+..+.+++|.+.+
T Consensus 61 l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~--~~L~~L~l~~n~i~~ 137 (332)
T 2ft3_A 61 LQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLP--SSLVELRIHDNRIRK 137 (332)
T ss_dssp CCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCCC-SCCSSCC--TTCCEEECCSSCCCC
T ss_pred CCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCcCC-ccCcccc--ccCCEEECCCCccCc
Confidence 4566666555566777777777777777777666667777777777777777776 4454432 556666677776664
Q ss_pred CC
Q 002857 81 GI 82 (873)
Q Consensus 81 ~~ 82 (873)
.+
T Consensus 138 ~~ 139 (332)
T 2ft3_A 138 VP 139 (332)
T ss_dssp CC
T ss_pred cC
Confidence 43
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=98.09 E-value=2.1e-06 Score=99.56 Aligned_cols=82 Identities=23% Similarity=0.221 Sum_probs=72.3
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccC-CCCcccccccCcccccccccccC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFES-MIPTEGIFKNASATSVFGNNKLC 79 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg-~iP~~~~~~~~l~~~~l~nN~L~ 79 (873)
|++|++++..|.+|++|++|++|+|++|+|++..|..|++|++|++|+|++|+|++ .+|..+.....+..+.+++|.+.
T Consensus 57 Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~ 136 (549)
T 2z81_A 57 LKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETF 136 (549)
T ss_dssp CTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSC
T ss_pred CCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccc
Confidence 68899998888999999999999999999998777789999999999999999997 46777777888899999999855
Q ss_pred CCC
Q 002857 80 GGI 82 (873)
Q Consensus 80 G~~ 82 (873)
+..
T Consensus 137 ~~~ 139 (549)
T 2z81_A 137 SEI 139 (549)
T ss_dssp CEE
T ss_pred ccc
Confidence 443
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.09 E-value=1.5e-06 Score=93.93 Aligned_cols=80 Identities=11% Similarity=-0.074 Sum_probs=70.2
Q ss_pred CCCCccccCcCcCC--CCCCCCCeEeCCCCcCCCccc----ccccCCCCcceecccCCCccCCCCcccccccCccccccc
Q 002857 1 MHGNLFEGPIGLSL--SPLRGLKVLDLSQNNLSGEIP----EFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFG 74 (873)
Q Consensus 1 Ls~N~L~G~iP~~l--~~L~~L~~L~Ls~N~LsG~iP----~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~ 74 (873)
|++|++++.+|..+ +.+++|++|+|++|++++.+| ..+..+++|++|+|++|+|++..|..+.....+..++++
T Consensus 98 l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls 177 (310)
T 4glp_A 98 LEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLS 177 (310)
T ss_dssp EESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECC
T ss_pred eeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCCCEEECC
Confidence 46899999999998 899999999999999998766 455689999999999999998888888888889999999
Q ss_pred ccccCC
Q 002857 75 NNKLCG 80 (873)
Q Consensus 75 nN~L~G 80 (873)
+|.+.+
T Consensus 178 ~N~l~~ 183 (310)
T 4glp_A 178 DNPGLG 183 (310)
T ss_dssp SCTTCH
T ss_pred CCCCcc
Confidence 998764
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=98.08 E-value=3.6e-06 Score=91.45 Aligned_cols=77 Identities=21% Similarity=0.215 Sum_probs=44.1
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCG 80 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G 80 (873)
|++|++++..+..|+++++|++|+|++|+|++..|..|+++++|++|+|++|+|+ .+|..+. ..+..+.+++|.+.+
T Consensus 59 L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~--~~L~~L~l~~n~l~~ 135 (330)
T 1xku_A 59 LQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMP--KTLQELRVHENEITK 135 (330)
T ss_dssp CCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS-BCCSSCC--TTCCEEECCSSCCCB
T ss_pred CCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcCC-ccChhhc--ccccEEECCCCcccc
Confidence 4556666544445666666666666666666555666666666666666666666 3444322 445555566665554
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.08 E-value=2.1e-06 Score=99.21 Aligned_cols=78 Identities=18% Similarity=0.078 Sum_probs=68.9
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCG 80 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G 80 (873)
|++|++++..|.+|.++++|++|+|++|+|++..|..|++|++|++|+|++|+|+ .+|.. ....+..+++++|.+.+
T Consensus 28 Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L~~N~l~~ 104 (520)
T 2z7x_B 28 ISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH--PTVNLKHLDLSFNAFDA 104 (520)
T ss_dssp CCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEECC--CCCCCSEEECCSSCCSS
T ss_pred CCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCcc--ccCCccEEeccCCcccc
Confidence 6789999877789999999999999999999888999999999999999999999 56766 56778899999999886
Q ss_pred C
Q 002857 81 G 81 (873)
Q Consensus 81 ~ 81 (873)
.
T Consensus 105 ~ 105 (520)
T 2z7x_B 105 L 105 (520)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.08 E-value=2e-06 Score=106.02 Aligned_cols=81 Identities=16% Similarity=0.032 Sum_probs=58.0
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcc-cccccCCCCcceecccCCCccCCCCcccccccCcccccccccccC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEI-PEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLC 79 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~i-P~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~ 79 (873)
|++|++++..|.+|++|++|++|+|++|.+.+.| |..|++|++|++|+|++|+|++..|..+..+..+..+.+++|.+.
T Consensus 31 Ls~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~ 110 (844)
T 3j0a_A 31 LSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLS 110 (844)
T ss_dssp EESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEECTTCCCS
T ss_pred CCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEeeCcCCCCC
Confidence 4667777666777777777777777777666666 566777777777777777777777777666677777777777776
Q ss_pred CC
Q 002857 80 GG 81 (873)
Q Consensus 80 G~ 81 (873)
+.
T Consensus 111 ~~ 112 (844)
T 3j0a_A 111 DA 112 (844)
T ss_dssp SC
T ss_pred cc
Confidence 53
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.06 E-value=3.4e-06 Score=103.93 Aligned_cols=82 Identities=16% Similarity=0.134 Sum_probs=58.4
Q ss_pred CCCCccccCc-CcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcc--cccccCcccccccccc
Q 002857 1 MHGNLFEGPI-GLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTE--GIFKNASATSVFGNNK 77 (873)
Q Consensus 1 Ls~N~L~G~i-P~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~--~~~~~~l~~~~l~nN~ 77 (873)
|++|.+.+.| |.+|++|++|++|+|++|+|++..|..|++|++|++|+|++|+|++.+|.. +..+..+..+++++|.
T Consensus 55 Ls~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~ 134 (844)
T 3j0a_A 55 LGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQ 134 (844)
T ss_dssp ECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCC
T ss_pred CCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCc
Confidence 3556566666 666777777777777777777777777777777777777777777766654 5556667777777777
Q ss_pred cCCCC
Q 002857 78 LCGGI 82 (873)
Q Consensus 78 L~G~~ 82 (873)
+.+..
T Consensus 135 l~~~~ 139 (844)
T 3j0a_A 135 IRSLY 139 (844)
T ss_dssp CCCCC
T ss_pred ccccc
Confidence 76643
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.04 E-value=5.2e-06 Score=92.34 Aligned_cols=80 Identities=23% Similarity=0.156 Sum_probs=72.0
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCccccc-ccCCCCcceecccCCCccCCCCcccccccCcccccccccccC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEF-LAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLC 79 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~-l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~ 79 (873)
|++|++++..|..|+++++|++|+|++|+|+ .+|.. |+++++|++|+|++|+|++..|..+.....+..+.+++|.+.
T Consensus 100 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 178 (390)
T 3o6n_A 100 MGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT 178 (390)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCS
T ss_pred CCCCCCCcCCHHHhcCCCCCCEEECCCCccC-cCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCC
Confidence 6789999888888999999999999999999 67765 699999999999999999888888888888999999999988
Q ss_pred CC
Q 002857 80 GG 81 (873)
Q Consensus 80 G~ 81 (873)
+.
T Consensus 179 ~~ 180 (390)
T 3o6n_A 179 HV 180 (390)
T ss_dssp BC
T ss_pred cc
Confidence 64
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=98.04 E-value=2.9e-07 Score=92.92 Aligned_cols=77 Identities=26% Similarity=0.290 Sum_probs=68.4
Q ss_pred CCCCccccCcCc------CCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCccccccc
Q 002857 1 MHGNLFEGPIGL------SLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFG 74 (873)
Q Consensus 1 Ls~N~L~G~iP~------~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~ 74 (873)
|+.|.|+|.+|. .|+.+++|++|+|++|+|++ +| .+..+++|+.|+|++|+|+ .+|..+.....+..++++
T Consensus 25 l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~ 101 (198)
T 1ds9_A 25 AEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWIS 101 (198)
T ss_dssp CSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEE
T ss_pred hheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECc
Confidence 567888998888 89999999999999999995 88 8999999999999999999 678776666788899999
Q ss_pred ccccCC
Q 002857 75 NNKLCG 80 (873)
Q Consensus 75 nN~L~G 80 (873)
+|.+.+
T Consensus 102 ~N~l~~ 107 (198)
T 1ds9_A 102 YNQIAS 107 (198)
T ss_dssp EEECCC
T ss_pred CCcCCc
Confidence 998886
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=98.04 E-value=1.7e-06 Score=89.72 Aligned_cols=81 Identities=10% Similarity=-0.054 Sum_probs=64.8
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCc-CCCcccccccCCCCcceecccC-CCccCCCCcccccccCccccccccccc
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNN-LSGEIPEFLAGFKFLQNLNLSH-NNFESMIPTEGIFKNASATSVFGNNKL 78 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~-LsG~iP~~l~~L~~L~~L~LS~-N~Lsg~iP~~~~~~~~l~~~~l~nN~L 78 (873)
|++|+|++..+..|+.+++|++|+|++|+ +++..+..|.++++|+.|+|++ |+|++..+..+.....+..+.+++|.+
T Consensus 38 l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l 117 (239)
T 2xwt_C 38 LIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGL 117 (239)
T ss_dssp EESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECC
T ss_pred EeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCC
Confidence 46788886555688899999999999997 8744445788999999999998 899876667777777888888998888
Q ss_pred CCC
Q 002857 79 CGG 81 (873)
Q Consensus 79 ~G~ 81 (873)
.+.
T Consensus 118 ~~l 120 (239)
T 2xwt_C 118 KMF 120 (239)
T ss_dssp CSC
T ss_pred ccc
Confidence 863
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=98.04 E-value=2.3e-06 Score=86.22 Aligned_cols=77 Identities=8% Similarity=0.002 Sum_probs=59.9
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCG 80 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G 80 (873)
|++|.++ .+| .+..+++|++|+|++|.++ . ++.+..+++|+.|+|++|+|++..|..+..+..+..+.+++|.+.+
T Consensus 51 l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~-~-~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~ 126 (197)
T 4ezg_A 51 LANINVT-DLT-GIEYAHNIKDLTINNIHAT-N-YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDD 126 (197)
T ss_dssp EESSCCS-CCT-TGGGCTTCSEEEEESCCCS-C-CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBG
T ss_pred ccCCCcc-ChH-HHhcCCCCCEEEccCCCCC-c-chhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCc
Confidence 3567777 677 6888888888888888666 3 3478888888888888888887777777777778888888888776
Q ss_pred C
Q 002857 81 G 81 (873)
Q Consensus 81 ~ 81 (873)
.
T Consensus 127 ~ 127 (197)
T 4ezg_A 127 S 127 (197)
T ss_dssp G
T ss_pred H
Confidence 3
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.03 E-value=3.5e-06 Score=98.61 Aligned_cols=82 Identities=21% Similarity=0.292 Sum_probs=55.5
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCC--cccccccCCCCcceecccCCCccCCCCcc-cccccCcccccccccc
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSG--EIPEFLAGFKFLQNLNLSHNNFESMIPTE-GIFKNASATSVFGNNK 77 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG--~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~-~~~~~~l~~~~l~nN~ 77 (873)
|++|++++.+|..++++++|+.|+|++|+|++ .+|..++++++|+.|+|++|++++.+|.. +.....+..+.+++|.
T Consensus 360 l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~ 439 (562)
T 3a79_B 360 FTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNM 439 (562)
T ss_dssp CCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSC
T ss_pred CCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCC
Confidence 45677777777777777777777777777775 34556777777777777777777655543 4445666667777777
Q ss_pred cCCCC
Q 002857 78 LCGGI 82 (873)
Q Consensus 78 L~G~~ 82 (873)
+.+..
T Consensus 440 l~~~~ 444 (562)
T 3a79_B 440 LTGSV 444 (562)
T ss_dssp CCGGG
T ss_pred CCcch
Confidence 66543
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.03 E-value=5.1e-06 Score=89.70 Aligned_cols=77 Identities=21% Similarity=0.165 Sum_probs=63.5
Q ss_pred CCCCccccCcCc---C-CCCCCCCCeEeCCCCcCCCcccccccCC---CCcceecccCCCccCCCCcccccccCcccccc
Q 002857 1 MHGNLFEGPIGL---S-LSPLRGLKVLDLSQNNLSGEIPEFLAGF---KFLQNLNLSHNNFESMIPTEGIFKNASATSVF 73 (873)
Q Consensus 1 Ls~N~L~G~iP~---~-l~~L~~L~~L~Ls~N~LsG~iP~~l~~L---~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l 73 (873)
|++|+|+ .+|. . ++++++|++|+|++|+|++.+|..+..+ ++|+.|+|++|+|+ .+|..+. ..+..+++
T Consensus 204 Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~L 279 (310)
T 4glp_A 204 LRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDL 279 (310)
T ss_dssp CCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEEC
T ss_pred CCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEEC
Confidence 5788887 3444 2 5788999999999999998889888887 69999999999999 6777653 67888999
Q ss_pred cccccCCC
Q 002857 74 GNNKLCGG 81 (873)
Q Consensus 74 ~nN~L~G~ 81 (873)
++|.|.+.
T Consensus 280 s~N~l~~~ 287 (310)
T 4glp_A 280 SSNRLNRA 287 (310)
T ss_dssp CSCCCCSC
T ss_pred CCCcCCCC
Confidence 99999874
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.03 E-value=3.3e-06 Score=98.79 Aligned_cols=75 Identities=24% Similarity=0.164 Sum_probs=40.3
Q ss_pred CCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccC
Q 002857 2 HGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLC 79 (873)
Q Consensus 2 s~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~ 79 (873)
++|+|+ .||..+. ++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..|..+.....++.+++++|.|.
T Consensus 39 s~~~L~-~ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 113 (562)
T 3a79_B 39 SNRNLT-HVPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ 113 (562)
T ss_dssp TTSCCC-SCCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC
T ss_pred CCCCCc-cCCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC
Confidence 455555 2555443 45555555555555444455555555555555555555555555544555555555555554
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=98.00 E-value=3.8e-06 Score=83.00 Aligned_cols=75 Identities=19% Similarity=0.149 Sum_probs=40.1
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccc-cccCCCCcceecccCCCccCCCCc--ccccccCcccccccccc
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPE-FLAGFKFLQNLNLSHNNFESMIPT--EGIFKNASATSVFGNNK 77 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~-~l~~L~~L~~L~LS~N~Lsg~iP~--~~~~~~~l~~~~l~nN~ 77 (873)
|++|+|++ + ..|+.+++|++|+|++|+|+ .+|+ .+..+++|++|+|++|+|+ .+|. .+.....+..+.+++|.
T Consensus 49 Ls~N~l~~-~-~~l~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~ 124 (176)
T 1a9n_A 49 FSDNEIRK-L-DGFPLLRRLKTLLVNNNRIC-RIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNP 124 (176)
T ss_dssp CCSSCCCE-E-CCCCCCSSCCEEECCSSCCC-EECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSG
T ss_pred CCCCCCCc-c-cccccCCCCCEEECCCCccc-ccCcchhhcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCC
Confidence 35555554 2 45566666666666666666 3333 2355666666666666664 3443 33344445555555555
Q ss_pred cC
Q 002857 78 LC 79 (873)
Q Consensus 78 L~ 79 (873)
++
T Consensus 125 i~ 126 (176)
T 1a9n_A 125 VT 126 (176)
T ss_dssp GG
T ss_pred CC
Confidence 54
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=97.99 E-value=3e-06 Score=97.94 Aligned_cols=80 Identities=23% Similarity=0.080 Sum_probs=68.5
Q ss_pred CCCCccccCcCcCCC-CCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccC
Q 002857 1 MHGNLFEGPIGLSLS-PLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLC 79 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~-~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~ 79 (873)
|++|.|++.+|..++ .|++|+.|+|++|.|++. |. +..+++|+.|+|++|+|++.+|. +.....+..+++++|.|+
T Consensus 151 Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~ 227 (487)
T 3oja_A 151 LKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAFMGPE-FQSAAGVTWISLRNNKLV 227 (487)
T ss_dssp CTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCSSCCCEECGG-GGGGTTCSEEECTTSCCC
T ss_pred CCCCCCCCcChHHHhhhCCcccEEecCCCccccc-cc-cccCCCCCEEECCCCCCCCCCHh-HcCCCCccEEEecCCcCc
Confidence 689999999999987 899999999999999965 43 44699999999999999986554 667788899999999999
Q ss_pred CCCC
Q 002857 80 GGIP 83 (873)
Q Consensus 80 G~~p 83 (873)
+.++
T Consensus 228 ~lp~ 231 (487)
T 3oja_A 228 LIEK 231 (487)
T ss_dssp EECT
T ss_pred ccch
Confidence 7443
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=97.99 E-value=4.3e-06 Score=99.83 Aligned_cols=82 Identities=20% Similarity=0.190 Sum_probs=54.1
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCG 80 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G 80 (873)
|++|+|++..|..|+++++|++|+|++|.+++..|..|++|++|++|+|++|+|++..+..+.....+..+.+++|.+.+
T Consensus 32 Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~ 111 (680)
T 1ziw_A 32 LTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQK 111 (680)
T ss_dssp CCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCC
T ss_pred CCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEECCCCccCc
Confidence 45666665555567777777777777777776666667777777777777777775444455566666667777766655
Q ss_pred CC
Q 002857 81 GI 82 (873)
Q Consensus 81 ~~ 82 (873)
.+
T Consensus 112 ~~ 113 (680)
T 1ziw_A 112 IK 113 (680)
T ss_dssp CC
T ss_pred cC
Confidence 43
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=97.99 E-value=6.8e-06 Score=98.15 Aligned_cols=83 Identities=22% Similarity=0.134 Sum_probs=72.1
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccc-cccCCCCcceecccCCCccCCCCcccccccCcccccccccccC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPE-FLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLC 79 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~-~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~ 79 (873)
|++|.+++..|..|++|++|++|+|++|+|+ .+|. .|+++++|++|+|++|++++..|..+.....+..+.+++|.+.
T Consensus 56 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~ 134 (680)
T 1ziw_A 56 VGFNTISKLEPELCQKLPMLKVLNLQHNELS-QLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLS 134 (680)
T ss_dssp CCSSCCCCCCTTHHHHCTTCCEEECCSSCCC-CCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCS
T ss_pred CCCCccCccCHHHHhcccCcCEEECCCCccC-ccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCccc
Confidence 5789999888999999999999999999999 5554 7999999999999999999887788888888999999999988
Q ss_pred CCCCc
Q 002857 80 GGIPE 84 (873)
Q Consensus 80 G~~p~ 84 (873)
+.++.
T Consensus 135 ~~~~~ 139 (680)
T 1ziw_A 135 STKLG 139 (680)
T ss_dssp CCCCC
T ss_pred ccCch
Confidence 76543
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.95 E-value=6e-06 Score=90.63 Aligned_cols=80 Identities=24% Similarity=0.156 Sum_probs=66.5
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCC-cccccccCcccccccccc-c
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIP-TEGIFKNASATSVFGNNK-L 78 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP-~~~~~~~~l~~~~l~nN~-L 78 (873)
|++|++++..|..|+++++|++|+|++|+|++..+..|+++++|++|+|++|+|++..+ ..+.....+..+.+++|. +
T Consensus 83 L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~ 162 (353)
T 2z80_A 83 LTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTF 162 (353)
T ss_dssp CTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSC
T ss_pred CCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccc
Confidence 67899998788899999999999999999995444459999999999999999995444 356677888899998884 4
Q ss_pred CC
Q 002857 79 CG 80 (873)
Q Consensus 79 ~G 80 (873)
.+
T Consensus 163 ~~ 164 (353)
T 2z80_A 163 TK 164 (353)
T ss_dssp CE
T ss_pred cc
Confidence 43
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.95 E-value=4e-05 Score=84.18 Aligned_cols=85 Identities=9% Similarity=-0.029 Sum_probs=57.0
Q ss_pred ceee-cccCceEEEEEEEc---C---CCcEEEEEEeeccC---CcchhHHHHHHHHHHhhhh---ccceeeeeeeecccc
Q 002857 165 ENLI-GAGNFASVYKGILF---E---GAPAVAIKVFNFLH---HDASKSFTVECEVMRNIIH---RKIIKVVTACSRVDY 231 (873)
Q Consensus 165 ~~~L-G~G~fG~VYkg~~~---~---~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~H---pNIV~llg~c~~~~~ 231 (873)
.+.| +.|....+|+.... . ++..+++|+..... ......+..|+.+|+.+.. -.+.+++.++....
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~- 103 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGD- 103 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSST-
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCC-
Confidence 4677 88999999998653 1 15678899865322 1123568899999999953 24677887753211
Q ss_pred cCCceEEEEEeecCCCChhh
Q 002857 232 QGNDFKALVYEFMPNGSLEE 251 (873)
Q Consensus 232 ~~~~~~~LV~Ey~~~GSL~~ 251 (873)
..+..++||||++|..+.+
T Consensus 104 -~~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 104 -VLGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp -TTSSCEEEEECCCCBCCCB
T ss_pred -ccCCceEEEEecCCCChhh
Confidence 1134689999999877764
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.85 E-value=3.9e-05 Score=85.73 Aligned_cols=76 Identities=17% Similarity=0.075 Sum_probs=49.8
Q ss_pred ceeecccCceEEEEEEEcCCCcEEEEEEeeccCC-------cchhHHHHHHHHHHhhhh--cc-ceeeeeeeecccccCC
Q 002857 165 ENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH-------DASKSFTVECEVMRNIIH--RK-IIKVVTACSRVDYQGN 234 (873)
Q Consensus 165 ~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~-------~~~~~f~~Ei~iL~~L~H--pN-IV~llg~c~~~~~~~~ 234 (873)
.+.||.|.++.||++....+++.++||....... .....+..|+++|+.+.. +. +.+++.+. .
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d-------~ 107 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD-------T 107 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE-------T
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc-------C
Confidence 4689999999999997655677899998642211 123567889999998853 33 44555441 2
Q ss_pred ceEEEEEeecCCC
Q 002857 235 DFKALVYEFMPNG 247 (873)
Q Consensus 235 ~~~~LV~Ey~~~G 247 (873)
+..++||||+++.
T Consensus 108 ~~~~lvmE~l~g~ 120 (397)
T 2olc_A 108 EMAVTVMEDLSHL 120 (397)
T ss_dssp TTTEEEECCCTTS
T ss_pred CccEEEEEeCCCc
Confidence 2347999999764
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=97.82 E-value=1.9e-05 Score=83.46 Aligned_cols=73 Identities=19% Similarity=0.288 Sum_probs=45.5
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCG 80 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G 80 (873)
|++|.++ .+| .++.+++|+.|+|++|+|++ +|. +..+++|+.|+|++|+|++ +|.... ..+..+++++|.+.+
T Consensus 48 l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~-~~~-l~~l~~L~~L~L~~N~l~~-l~~~~~--~~L~~L~L~~N~l~~ 120 (263)
T 1xeu_A 48 GDNSNIQ-SLA-GMQFFTNLKELHLSHNQISD-LSP-LKDLTKLEELSVNRNRLKN-LNGIPS--ACLSRLFLDNNELRD 120 (263)
T ss_dssp CTTSCCC-CCT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCSSCCEEECCSSCCSC-CTTCCC--SSCCEEECCSSCCSB
T ss_pred CcCCCcc-cch-HHhhCCCCCEEECCCCccCC-Chh-hccCCCCCEEECCCCccCC-cCcccc--CcccEEEccCCccCC
Confidence 4566666 455 56667777777777777773 443 6677777777777777765 333222 556666666666664
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=97.82 E-value=7.3e-06 Score=88.84 Aligned_cols=78 Identities=14% Similarity=-0.040 Sum_probs=52.0
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccc-cccCcccccccccccC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGI-FKNASATSVFGNNKLC 79 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~-~~~~l~~~~l~nN~L~ 79 (873)
|++|++++..+.. +++|+.|+|++|+|++..|..++.+++|+.|+|++|+|++..|..+. ....+..+.+++|.+.
T Consensus 106 l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~ 182 (317)
T 3o53_A 106 AANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY 182 (317)
T ss_dssp CCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCC
T ss_pred CCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCc
Confidence 4566666543332 56677777777777766666777777777777777777766665543 4466677777777766
Q ss_pred CC
Q 002857 80 GG 81 (873)
Q Consensus 80 G~ 81 (873)
+.
T Consensus 183 ~~ 184 (317)
T 3o53_A 183 DV 184 (317)
T ss_dssp EE
T ss_pred cc
Confidence 54
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=97.79 E-value=1.4e-05 Score=87.10 Aligned_cols=79 Identities=22% Similarity=0.201 Sum_probs=67.2
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCG 80 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G 80 (873)
|++|.+++ + +.+..+++|++|+|++|++++ +| .+..+++|+.|+|++|++++..|..+.....+..+.+++|.+.+
T Consensus 250 l~~n~l~~-~-~~~~~l~~L~~L~l~~n~l~~-~~-~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~ 325 (347)
T 4fmz_A 250 IGTNQISD-I-NAVKDLTKLKMLNVGSNQISD-IS-VLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITD 325 (347)
T ss_dssp CCSSCCCC-C-GGGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCC
T ss_pred CCCCccCC-C-hhHhcCCCcCEEEccCCccCC-Ch-hhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCcccc
Confidence 57888885 4 468899999999999999995 54 58899999999999999998888888778888999999999987
Q ss_pred CCC
Q 002857 81 GIP 83 (873)
Q Consensus 81 ~~p 83 (873)
.++
T Consensus 326 ~~~ 328 (347)
T 4fmz_A 326 IRP 328 (347)
T ss_dssp CGG
T ss_pred ccC
Confidence 654
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=97.77 E-value=2.1e-05 Score=83.28 Aligned_cols=74 Identities=20% Similarity=0.154 Sum_probs=52.4
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCG 80 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G 80 (873)
|++|+|++ +|.... ++|+.|+|++|+|++ +| .+..+++|+.|+|++|+|++. | .+.....+..+.+++|.+.+
T Consensus 92 L~~N~l~~-l~~~~~--~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~ 164 (263)
T 1xeu_A 92 VNRNRLKN-LNGIPS--ACLSRLFLDNNELRD-TD-SLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEITN 164 (263)
T ss_dssp CCSSCCSC-CTTCCC--SSCCEEECCSSCCSB-SG-GGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCCB
T ss_pred CCCCccCC-cCcccc--CcccEEEccCCccCC-Ch-hhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCcc
Confidence 56777774 555333 788888888888884 44 577888888888888888764 3 34556677777788887775
Q ss_pred C
Q 002857 81 G 81 (873)
Q Consensus 81 ~ 81 (873)
.
T Consensus 165 ~ 165 (263)
T 1xeu_A 165 T 165 (263)
T ss_dssp C
T ss_pred h
Confidence 4
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=97.76 E-value=4.8e-06 Score=88.91 Aligned_cols=67 Identities=25% Similarity=0.244 Sum_probs=55.1
Q ss_pred CCCCCCCeEeCCCCcCCC--cccccccCCCCcceecccCCCccCCCCccccccc--CcccccccccccCCCCC
Q 002857 15 SPLRGLKVLDLSQNNLSG--EIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKN--ASATSVFGNNKLCGGIP 83 (873)
Q Consensus 15 ~~L~~L~~L~Ls~N~LsG--~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~--~l~~~~l~nN~L~G~~p 83 (873)
.+|++|+.|+||+|+|++ .||..+..+++|+.|+||+|+|++. ..+..+. .+..+.+.+|.+++..+
T Consensus 167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~ 237 (267)
T 3rw6_A 167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFR 237 (267)
T ss_dssp HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCS
T ss_pred hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccC
Confidence 568999999999999998 6778889999999999999999975 2223333 67888999999987544
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=97.76 E-value=2.8e-05 Score=91.77 Aligned_cols=69 Identities=25% Similarity=0.311 Sum_probs=54.0
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCG 80 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G 80 (873)
|++|+|+ .|| +.+++|++|+|++|+|++ ||. |.+ +|+.|+|++|+|++ +|. ....+..+++++|.|.+
T Consensus 87 Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~ 154 (571)
T 3cvr_A 87 ITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM 154 (571)
T ss_dssp CCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC
T ss_pred CcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc
Confidence 5788888 688 457888888888888885 887 665 88888888888887 665 45667778888888876
Q ss_pred C
Q 002857 81 G 81 (873)
Q Consensus 81 ~ 81 (873)
.
T Consensus 155 l 155 (571)
T 3cvr_A 155 L 155 (571)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=97.76 E-value=6.6e-07 Score=90.30 Aligned_cols=75 Identities=27% Similarity=0.258 Sum_probs=66.5
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCG 80 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G 80 (873)
|++|+|++ +| .++.+++|++|+|++|+|+ .+|..+..+++|+.|+|++|+|++ +| .+.....+..+++++|.+.+
T Consensus 55 ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~ 129 (198)
T 1ds9_A 55 LSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITN 129 (198)
T ss_dssp CSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCC
T ss_pred CCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCc
Confidence 57899986 88 8999999999999999999 899999999999999999999997 56 45566778889999998875
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=97.74 E-value=2.7e-05 Score=84.23 Aligned_cols=76 Identities=24% Similarity=0.286 Sum_probs=56.4
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCG 80 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G 80 (873)
|++|++++ +|. ++.+++|++|+|++|+|++ +|. ++.+++|+.|+|++|+|++..+ +.....+..+.+++|.+.+
T Consensus 114 l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~ 187 (308)
T 1h6u_A 114 LTSTQITD-VTP-LAGLSNLQVLYLDLNQITN-ISP-LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKISD 187 (308)
T ss_dssp CTTSCCCC-CGG-GTTCTTCCEEECCSSCCCC-CGG-GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC
T ss_pred CCCCCCCC-chh-hcCCCCCCEEECCCCccCc-Ccc-ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCccCc
Confidence 56788875 554 8888888888888888884 443 7888888888888888886444 5556677777888887776
Q ss_pred CC
Q 002857 81 GI 82 (873)
Q Consensus 81 ~~ 82 (873)
.+
T Consensus 188 ~~ 189 (308)
T 1h6u_A 188 IS 189 (308)
T ss_dssp CG
T ss_pred Ch
Confidence 44
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=97.74 E-value=3.5e-05 Score=82.67 Aligned_cols=74 Identities=19% Similarity=0.180 Sum_probs=48.7
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCG 80 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G 80 (873)
|++|.++ .+| .+..+++|+.|+|++|+|++ +|. +.++++|+.|+|++|+|++ +|. +.....+..+.+++|.+.+
T Consensus 53 l~~~~i~-~~~-~~~~l~~L~~L~L~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~L~~n~i~~ 126 (291)
T 1h6t_A 53 ANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTD-IKP-LANLKNLGWLFLDENKVKD-LSS-LKDLKKLKSLSLEHNGISD 126 (291)
T ss_dssp CTTSCCC-CCT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCC-GGG-GTTCTTCCEEECTTSCCCC
T ss_pred ccCCCcc-cCh-hHhcCCCCCEEEccCCccCC-Ccc-cccCCCCCEEECCCCcCCC-Chh-hccCCCCCEEECCCCcCCC
Confidence 4566666 344 37777777777777777774 443 7777777777777777775 333 4455666677777777665
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=97.73 E-value=2e-05 Score=85.39 Aligned_cols=79 Identities=24% Similarity=0.131 Sum_probs=64.8
Q ss_pred CCCCccccCcCcCCC-CCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccC
Q 002857 1 MHGNLFEGPIGLSLS-PLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLC 79 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~-~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~ 79 (873)
|++|.+++..|..+. .+++|++|+|++|+|+ .+|. +..+++|+.|+|++|+|++..+ .+.....+..+++++|.+.
T Consensus 151 Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~-~~~l~~L~~L~Ls~N~l~~l~~-~~~~l~~L~~L~L~~N~l~ 227 (317)
T 3o53_A 151 LKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKG-QVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLV 227 (317)
T ss_dssp CTTSCCCEEEGGGGGGGTTTCCEEECTTSCCC-EEEC-CCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCC
T ss_pred CCCCCCCcccHHHHhhccCcCCEEECCCCcCc-cccc-ccccccCCEEECCCCcCCcchh-hhcccCcccEEECcCCccc
Confidence 678999987788775 7999999999999999 4554 4459999999999999996544 4667788899999999998
Q ss_pred CCC
Q 002857 80 GGI 82 (873)
Q Consensus 80 G~~ 82 (873)
+.+
T Consensus 228 ~l~ 230 (317)
T 3o53_A 228 LIE 230 (317)
T ss_dssp EEC
T ss_pred chh
Confidence 543
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=97.73 E-value=1.6e-05 Score=82.24 Aligned_cols=78 Identities=14% Similarity=0.133 Sum_probs=55.1
Q ss_pred CCCCccccCcCcCCCCCCCCC---eEeCCCC-cCCCcccccccCCCCcc-eecccCCCccCCCCcccccccCcccccccc
Q 002857 1 MHGNLFEGPIGLSLSPLRGLK---VLDLSQN-NLSGEIPEFLAGFKFLQ-NLNLSHNNFESMIPTEGIFKNASATSVFGN 75 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~---~L~Ls~N-~LsG~iP~~l~~L~~L~-~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~n 75 (873)
|++|+|++ +|. |+.+++|+ +|+|++| +|++..+..|..+++|+ .|+|++|+|+ .+|........+..+.+++
T Consensus 112 l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~~~~~~~L~~L~L~~ 188 (239)
T 2xwt_C 112 IFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNK 188 (239)
T ss_dssp EEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTTTTTTCEEEEEECTT
T ss_pred CCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHhhcCCCCCCEEEcCC
Confidence 35677775 776 77888887 8888888 88844445688888888 8888888888 5555433335667777887
Q ss_pred cc-cCCC
Q 002857 76 NK-LCGG 81 (873)
Q Consensus 76 N~-L~G~ 81 (873)
|. +.+.
T Consensus 189 n~~l~~i 195 (239)
T 2xwt_C 189 NKYLTVI 195 (239)
T ss_dssp CTTCCEE
T ss_pred CCCcccC
Confidence 74 7644
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.71 E-value=0.00017 Score=77.98 Aligned_cols=152 Identities=15% Similarity=0.128 Sum_probs=82.8
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhcc--ceeeeeeeeccc-ccCCceEEEEEe
Q 002857 166 NLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRK--IIKVVTACSRVD-YQGNDFKALVYE 242 (873)
Q Consensus 166 ~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpN--IV~llg~c~~~~-~~~~~~~~LV~E 242 (873)
+.|+.|..+.||+... .+ ..+++|+... ....+..|+.++..|.... +.+++....... ....+..++||+
T Consensus 38 ~~l~gG~~n~~~~v~~-~~-~~~vlk~~~~----~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 38 DVIQGNQMALVWKVHT-DS-GAVCLKRIHR----PEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EECC----CEEEEEEE-TT-EEEEEEEECS----CHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eeccccccCcEEEEEe-CC-CCEEEEecCC----CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 4566677899999875 33 3589998864 2245566777777775323 344443210000 012456789999
Q ss_pred ecCCCChh--------------hhccccccccc-ccCC---CCCCchhhh------------------------------
Q 002857 243 FMPNGSLE--------------EWIHPITEEDK-RHKA---PGNLNSLER------------------------------ 274 (873)
Q Consensus 243 y~~~GSL~--------------~~L~~~~~~~~-~~~~---~~~Ls~~~~------------------------------ 274 (873)
|++|.++. ..||....... .... ...-.|...
T Consensus 112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 191 (346)
T 2q83_A 112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE 191 (346)
T ss_dssp CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence 99986553 11111100000 0000 001122110
Q ss_pred -HHHHHHHHHHHHHHhh----------CCCCCeeeccCCCCCeeeCCCCCeEEecccccc
Q 002857 275 -LNIAIDVASALEYLHL----------GCKPPIAHCDIKPSNILLNDEMTACVADFGIAR 323 (873)
Q Consensus 275 -l~Ia~qIa~gL~yLH~----------~~s~gIvHrDLKpsNILLd~~~~vKLsDFGla~ 323 (873)
..+...+..++.+|+. .....++|+|+++.|||++.++.+.|+||+.+.
T Consensus 192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 0111224445666652 025789999999999999888899999999775
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=97.70 E-value=3.3e-05 Score=82.89 Aligned_cols=77 Identities=25% Similarity=0.303 Sum_probs=61.8
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCG 80 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G 80 (873)
|++|+|++ +|. ++.+++|++|+|++|+|++ + +.+..+++|+.|+|++|+|++. ..+.....+..+.+++|.+.+
T Consensus 97 l~~n~l~~-~~~-l~~l~~L~~L~L~~n~i~~-~-~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~ 170 (291)
T 1h6t_A 97 LDENKVKD-LSS-LKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISD 170 (291)
T ss_dssp CCSSCCCC-GGG-GTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCC
T ss_pred CCCCcCCC-Chh-hccCCCCCEEECCCCcCCC-C-hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCcccc
Confidence 57888885 554 8999999999999999985 4 4688899999999999999865 445667778888899998887
Q ss_pred CCC
Q 002857 81 GIP 83 (873)
Q Consensus 81 ~~p 83 (873)
.++
T Consensus 171 ~~~ 173 (291)
T 1h6t_A 171 IVP 173 (291)
T ss_dssp CGG
T ss_pred chh
Confidence 543
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=97.70 E-value=3.8e-05 Score=83.03 Aligned_cols=77 Identities=25% Similarity=0.390 Sum_probs=65.3
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCG 80 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G 80 (873)
|++|+|++ +| .++.+++|+.|+|++|+|++ +|. +..+++|+.|+|++|+|++..+ +.....+..+.+++|.+.+
T Consensus 92 L~~n~l~~-~~-~~~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~ 165 (308)
T 1h6u_A 92 LSGNPLKN-VS-AIAGLQSIKTLDLTSTQITD-VTP-LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSD 165 (308)
T ss_dssp CCSCCCSC-CG-GGTTCTTCCEEECTTSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC
T ss_pred ccCCcCCC-ch-hhcCCCCCCEEECCCCCCCC-chh-hcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCC
Confidence 67899985 55 69999999999999999995 664 9999999999999999997655 5567788899999999987
Q ss_pred CCC
Q 002857 81 GIP 83 (873)
Q Consensus 81 ~~p 83 (873)
.++
T Consensus 166 ~~~ 168 (308)
T 1h6u_A 166 LTP 168 (308)
T ss_dssp CGG
T ss_pred Chh
Confidence 543
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=97.69 E-value=1.8e-05 Score=93.30 Aligned_cols=70 Identities=23% Similarity=0.235 Sum_probs=51.7
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCc-------ccccc
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNAS-------ATSVF 73 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l-------~~~~l 73 (873)
|++|+|++ ||. .+++|+.|+|++|+|++ ||. |. ++|+.|+|++|+|+ .+|. +.. .+ ..+++
T Consensus 147 Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~L 214 (571)
T 3cvr_A 147 ADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRC 214 (571)
T ss_dssp CCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SCCC-CC----------CCEEEEC
T ss_pred CCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEec
Confidence 56788875 776 57888889999998885 887 66 78888888888888 6666 322 55 77788
Q ss_pred cccccCCCC
Q 002857 74 GNNKLCGGI 82 (873)
Q Consensus 74 ~nN~L~G~~ 82 (873)
++|.|+..+
T Consensus 215 s~N~l~~lp 223 (571)
T 3cvr_A 215 RENRITHIP 223 (571)
T ss_dssp CSSCCCCCC
T ss_pred CCCcceecC
Confidence 888887543
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=97.66 E-value=1.9e-05 Score=86.77 Aligned_cols=78 Identities=19% Similarity=0.157 Sum_probs=56.4
Q ss_pred CCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccc-cccCCCCcceecccCCCccCCCCcc-cccccC-ccccccccccc
Q 002857 2 HGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPE-FLAGFKFLQNLNLSHNNFESMIPTE-GIFKNA-SATSVFGNNKL 78 (873)
Q Consensus 2 s~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~-~l~~L~~L~~L~LS~N~Lsg~iP~~-~~~~~~-l~~~~l~nN~L 78 (873)
++|+|+ .||..| .++|+.|+|++|+|+ .||+ .|.+|++|++|+|++|++.+.+|.. +..+.. ...+.+++|.|
T Consensus 17 ~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~-~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l 92 (350)
T 4ay9_X 17 QESKVT-EIPSDL--PRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNL 92 (350)
T ss_dssp ESTTCC-SCCTTC--CTTCSEEEEESCCCS-EECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTC
T ss_pred cCCCCC-ccCcCc--CCCCCEEEccCCcCC-CcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcc
Confidence 467787 788877 368899999999998 6764 6888999999999999987777754 333333 34456667777
Q ss_pred CCCCC
Q 002857 79 CGGIP 83 (873)
Q Consensus 79 ~G~~p 83 (873)
...++
T Consensus 93 ~~l~~ 97 (350)
T 4ay9_X 93 LYINP 97 (350)
T ss_dssp CEECT
T ss_pred cccCc
Confidence 75543
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=97.65 E-value=3.9e-05 Score=91.15 Aligned_cols=75 Identities=21% Similarity=0.257 Sum_probs=61.1
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCG 80 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G 80 (873)
|++|+|++ + +.|+.|++|+.|+|++|+|++ + ..|..|++|+.|+|++|+|++..| +..+..+..+.+++|.|.+
T Consensus 116 Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~ 189 (605)
T 1m9s_A 116 LEHNGISD-I-NGLVHLPQLESLYLGNNKITD-I-TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD 189 (605)
T ss_dssp CTTSCCCC-C-GGGGGCTTCSEEECCSSCCCC-C-GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCB
T ss_pred ecCCCCCC-C-ccccCCCccCEEECCCCccCC-c-hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCCC
Confidence 57888885 4 458889999999999999985 4 678889999999999999988777 5667778888888888876
Q ss_pred C
Q 002857 81 G 81 (873)
Q Consensus 81 ~ 81 (873)
.
T Consensus 190 l 190 (605)
T 1m9s_A 190 L 190 (605)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=97.60 E-value=5e-05 Score=90.28 Aligned_cols=77 Identities=26% Similarity=0.317 Sum_probs=65.8
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCG 80 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G 80 (873)
|++|.|++ +| .|+.|++|+.|+|++|+|++ +| .|..|++|+.|+|++|+|++. ..+..+..+..+.+++|.|.+
T Consensus 94 Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~ 167 (605)
T 1m9s_A 94 LDENKIKD-LS-SLKDLKKLKSLSLEHNGISD-IN-GLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISD 167 (605)
T ss_dssp CCSSCCCC-CT-TSTTCTTCCEEECTTSCCCC-CG-GGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCC
T ss_pred CcCCCCCC-Ch-hhccCCCCCEEEecCCCCCC-Cc-cccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCC
Confidence 67899985 55 79999999999999999995 54 699999999999999999975 456677888999999999988
Q ss_pred CCC
Q 002857 81 GIP 83 (873)
Q Consensus 81 ~~p 83 (873)
.++
T Consensus 168 ~~~ 170 (605)
T 1m9s_A 168 IVP 170 (605)
T ss_dssp CGG
T ss_pred chh
Confidence 655
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=97.60 E-value=7e-05 Score=85.68 Aligned_cols=57 Identities=26% Similarity=0.371 Sum_probs=36.7
Q ss_pred CCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCC
Q 002857 18 RGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCG 80 (873)
Q Consensus 18 ~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G 80 (873)
++|++|+|++|+|++ +| .|+++++|++|+|++|+|++ +|... ..+..+.+++|.+.+
T Consensus 131 ~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~ 187 (454)
T 1jl5_A 131 PLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE 187 (454)
T ss_dssp TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS
T ss_pred CCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc
Confidence 467777777777774 66 47777777777777777765 45432 355566666666665
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=97.59 E-value=5.3e-05 Score=86.47 Aligned_cols=77 Identities=23% Similarity=0.240 Sum_probs=54.4
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCG 80 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G 80 (873)
|++|++++..| ++.+++|+.|+|++|++++..| +..+++|+.|+|++|++++. + .+.....+..+.+++|.+.+
T Consensus 294 L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-~-~l~~l~~L~~L~l~~n~l~~ 367 (466)
T 1o6v_A 294 LNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV-S-SLANLTNINWLSAGHNQISD 367 (466)
T ss_dssp CCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCB
T ss_pred cCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc-h-hhccCCCCCEEeCCCCccCc
Confidence 46777775433 7778888888888888886655 67778888888888887764 2 34455666777777777776
Q ss_pred CCC
Q 002857 81 GIP 83 (873)
Q Consensus 81 ~~p 83 (873)
.+|
T Consensus 368 ~~~ 370 (466)
T 1o6v_A 368 LTP 370 (466)
T ss_dssp CGG
T ss_pred cch
Confidence 554
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=97.59 E-value=1.3e-05 Score=88.47 Aligned_cols=82 Identities=23% Similarity=0.113 Sum_probs=71.0
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCccc----ccccCCC-CcceecccCCCccCCCCcccccc-----cCccc
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIP----EFLAGFK-FLQNLNLSHNNFESMIPTEGIFK-----NASAT 70 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP----~~l~~L~-~L~~L~LS~N~Lsg~iP~~~~~~-----~~l~~ 70 (873)
|+.|+++|.+|..+...++|++|+|++|+|++..+ ..|..++ +|+.|+|++|+|++..+..+... ..+..
T Consensus 5 ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~ 84 (362)
T 3goz_A 5 LTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTS 84 (362)
T ss_dssp CCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCE
T ss_pred cccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccE
Confidence 67899999999988888889999999999997666 7888999 99999999999998877766554 77889
Q ss_pred ccccccccCCCC
Q 002857 71 SVFGNNKLCGGI 82 (873)
Q Consensus 71 ~~l~nN~L~G~~ 82 (873)
+++++|.+.+..
T Consensus 85 L~Ls~n~l~~~~ 96 (362)
T 3goz_A 85 LNLSGNFLSYKS 96 (362)
T ss_dssp EECCSSCGGGSC
T ss_pred EECcCCcCChHH
Confidence 999999888643
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=97.57 E-value=5.3e-05 Score=82.45 Aligned_cols=77 Identities=19% Similarity=0.212 Sum_probs=64.3
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCG 80 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G 80 (873)
|++|.+++ +|. +..+++|+.|+|++|++++ + +.+..+++|+.|+|++|++++. | .+.....+..+.+++|.+.+
T Consensus 228 l~~n~l~~-~~~-~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~l~~n~l~~~-~-~~~~l~~L~~L~L~~n~l~~ 301 (347)
T 4fmz_A 228 IGNNKITD-LSP-LANLSQLTWLEIGTNQISD-I-NAVKDLTKLKMLNVGSNQISDI-S-VLNNLSQLNSLFLNNNQLGN 301 (347)
T ss_dssp CCSSCCCC-CGG-GTTCTTCCEEECCSSCCCC-C-GGGTTCTTCCEEECCSSCCCCC-G-GGGGCTTCSEEECCSSCCCG
T ss_pred ccCCccCC-Ccc-hhcCCCCCEEECCCCccCC-C-hhHhcCCCcCEEEccCCccCCC-h-hhcCCCCCCEEECcCCcCCC
Confidence 57899985 555 9999999999999999995 5 4699999999999999999974 4 35567788899999999886
Q ss_pred CCC
Q 002857 81 GIP 83 (873)
Q Consensus 81 ~~p 83 (873)
..+
T Consensus 302 ~~~ 304 (347)
T 4fmz_A 302 EDM 304 (347)
T ss_dssp GGH
T ss_pred cCh
Confidence 543
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=97.55 E-value=7.1e-05 Score=89.19 Aligned_cols=54 Identities=28% Similarity=0.321 Sum_probs=35.8
Q ss_pred CCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccC
Q 002857 18 RGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLC 79 (873)
Q Consensus 18 ~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~ 79 (873)
++|+.|+|++|+|++ || ..+++|+.|+|++|+|+ .+|. ....+..+.+++|.|.
T Consensus 221 ~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~ 274 (622)
T 3g06_A 221 SGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT 274 (622)
T ss_dssp TTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC
T ss_pred CCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC
Confidence 667777777777773 66 44567777777777777 3454 3455666677777766
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=97.54 E-value=9.9e-05 Score=84.51 Aligned_cols=71 Identities=24% Similarity=0.207 Sum_probs=40.2
Q ss_pred CCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCC
Q 002857 2 HGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCG 80 (873)
Q Consensus 2 s~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G 80 (873)
++|++.+.+ .++.+++|+.|+|++|+|++ +| ++.+++|+.|+|++|+|++. + +.....+..+++++|.+.+
T Consensus 156 ~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~-~--l~~l~~L~~L~Ls~N~l~~ 226 (457)
T 3bz5_A 156 HLNKKITKL--DVTPQTQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL-D--LNQNIQLTFLDCSSNKLTE 226 (457)
T ss_dssp TTCSCCCCC--CCTTCTTCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSC
T ss_pred CCCCccccc--ccccCCcCCEEECCCCccce-ec--cccCCCCCEEECcCCcCCee-c--cccCCCCCEEECcCCcccc
Confidence 455455455 35666666666666666664 44 55666666666666666643 1 3334455555566665555
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=97.53 E-value=1e-05 Score=89.91 Aligned_cols=80 Identities=21% Similarity=0.155 Sum_probs=66.8
Q ss_pred CCCCccc--c---CcCcCCCCCCCCCeEeCCCCcCC----CcccccccCCCCcceecccCCCccCC----CCccccc--c
Q 002857 1 MHGNLFE--G---PIGLSLSPLRGLKVLDLSQNNLS----GEIPEFLAGFKFLQNLNLSHNNFESM----IPTEGIF--K 65 (873)
Q Consensus 1 Ls~N~L~--G---~iP~~l~~L~~L~~L~Ls~N~Ls----G~iP~~l~~L~~L~~L~LS~N~Lsg~----iP~~~~~--~ 65 (873)
|++|+|+ | .+|..+..+++|+.|+|++|.|+ +.+|..|..+++|+.|+|++|+|++. +|..+.. .
T Consensus 194 L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~ 273 (386)
T 2ca6_A 194 MVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLEN 273 (386)
T ss_dssp CCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSS
T ss_pred CcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccC
Confidence 5788887 3 46668999999999999999996 68999999999999999999999876 5555533 6
Q ss_pred cCcccccccccccCC
Q 002857 66 NASATSVFGNNKLCG 80 (873)
Q Consensus 66 ~~l~~~~l~nN~L~G 80 (873)
..+..+.+++|.+.+
T Consensus 274 ~~L~~L~L~~n~i~~ 288 (386)
T 2ca6_A 274 IGLQTLRLQYNEIEL 288 (386)
T ss_dssp CCCCEEECCSSCCBH
T ss_pred CCeEEEECcCCcCCH
Confidence 778889999998886
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=97.53 E-value=6.7e-05 Score=85.84 Aligned_cols=55 Identities=24% Similarity=0.277 Sum_probs=34.3
Q ss_pred CCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCC
Q 002857 18 RGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCG 80 (873)
Q Consensus 18 ~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G 80 (873)
++|+.|+|++|+|++ +|.. +++|+.|+|++|+|+ .+|. ....+..+++++|.+.+
T Consensus 317 ~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~-~lp~---~l~~L~~L~L~~N~l~~ 371 (454)
T 1jl5_A 317 PSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLA-EVPE---LPQNLKQLHVEYNPLRE 371 (454)
T ss_dssp TTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCSS
T ss_pred CcCCEEECCCCcccc-cccc---CCcCCEEECCCCccc-cccc---hhhhccEEECCCCCCCc
Confidence 466777777777764 6654 456667777777666 3554 24555666666666665
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=97.50 E-value=2.6e-05 Score=84.44 Aligned_cols=78 Identities=14% Similarity=0.103 Sum_probs=62.9
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCc-ccccccCCCCcceecccCCCccCCCCcccccccCccccccccc-cc
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGE-IPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNN-KL 78 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~-iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN-~L 78 (873)
|++|.+++.+|. +..+++|++|+|++|.+++. +|..+..+++|+.|+|++|++++.+|..+.....+..+.+++| .+
T Consensus 77 l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l 155 (336)
T 2ast_B 77 CPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGF 155 (336)
T ss_dssp CTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSC
T ss_pred cCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCC
Confidence 467888865554 67889999999999998876 8888889999999999999988877877766777888888887 45
Q ss_pred C
Q 002857 79 C 79 (873)
Q Consensus 79 ~ 79 (873)
.
T Consensus 156 ~ 156 (336)
T 2ast_B 156 S 156 (336)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=97.47 E-value=0.00012 Score=83.57 Aligned_cols=76 Identities=29% Similarity=0.370 Sum_probs=47.4
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCG 80 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G 80 (873)
|++|++++ + +.+..+++|+.|+|++|++++..| +..+++|+.|+|++|++++..| +.....+..+.+++|.+.+
T Consensus 228 l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~ 301 (466)
T 1o6v_A 228 LNGNQLKD-I-GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLED 301 (466)
T ss_dssp CCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSC
T ss_pred CCCCCccc-c-hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccC
Confidence 45666663 3 346667777777777777775443 6667777777777777765444 3445556666666666665
Q ss_pred CC
Q 002857 81 GI 82 (873)
Q Consensus 81 ~~ 82 (873)
.+
T Consensus 302 ~~ 303 (466)
T 1o6v_A 302 IS 303 (466)
T ss_dssp CG
T ss_pred ch
Confidence 43
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=97.47 E-value=0.00011 Score=84.05 Aligned_cols=73 Identities=19% Similarity=0.019 Sum_probs=61.1
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCG 80 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G 80 (873)
|++|+|++ +| ++.+++|+.|+|++|+|++ + .++.+++|+.|+|++|+|++ +| +.....+..+.+++|.|.+
T Consensus 177 ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~-~--~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~ 247 (457)
T 3bz5_A 177 CSFNKITE-LD--VSQNKLLNRLNCDTNNITK-L--DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTE 247 (457)
T ss_dssp CCSSCCCC-CC--CTTCTTCCEEECCSSCCSC-C--CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSC
T ss_pred CCCCccce-ec--cccCCCCCEEECcCCcCCe-e--ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCC
Confidence 57889986 66 8899999999999999996 4 38899999999999999997 66 5566778888999999987
Q ss_pred CC
Q 002857 81 GI 82 (873)
Q Consensus 81 ~~ 82 (873)
.+
T Consensus 248 ~~ 249 (457)
T 3bz5_A 248 LD 249 (457)
T ss_dssp CC
T ss_pred cC
Confidence 64
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=97.47 E-value=1.8e-05 Score=87.88 Aligned_cols=81 Identities=22% Similarity=0.184 Sum_probs=69.3
Q ss_pred CCCCccc-cCcC---cCCCCCCCCCeEeCCCCcCC--C---cccccccCCCCcceecccCCCcc----CCCCcccccccC
Q 002857 1 MHGNLFE-GPIG---LSLSPLRGLKVLDLSQNNLS--G---EIPEFLAGFKFLQNLNLSHNNFE----SMIPTEGIFKNA 67 (873)
Q Consensus 1 Ls~N~L~-G~iP---~~l~~L~~L~~L~Ls~N~Ls--G---~iP~~l~~L~~L~~L~LS~N~Ls----g~iP~~~~~~~~ 67 (873)
|++|+|+ +.+| ..|..+++|+.|+|++|+|+ | .+|..+..+++|+.|+|++|.|+ +.+|..+.....
T Consensus 166 L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~ 245 (386)
T 2ca6_A 166 CGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPN 245 (386)
T ss_dssp CCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTT
T ss_pred CCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCC
Confidence 6789998 5577 57888999999999999998 4 45658999999999999999997 678887777788
Q ss_pred cccccccccccCCC
Q 002857 68 SATSVFGNNKLCGG 81 (873)
Q Consensus 68 l~~~~l~nN~L~G~ 81 (873)
+..+.+++|.+.+.
T Consensus 246 L~~L~L~~n~i~~~ 259 (386)
T 2ca6_A 246 LRELGLNDCLLSAR 259 (386)
T ss_dssp CCEEECTTCCCCHH
T ss_pred cCEEECCCCCCchh
Confidence 99999999988753
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=97.46 E-value=1.4e-05 Score=86.53 Aligned_cols=80 Identities=23% Similarity=0.098 Sum_probs=69.8
Q ss_pred CCCCccccC-cCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCC-CccC-CCCcccccccCccccccccc-
Q 002857 1 MHGNLFEGP-IGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHN-NFES-MIPTEGIFKNASATSVFGNN- 76 (873)
Q Consensus 1 Ls~N~L~G~-iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N-~Lsg-~iP~~~~~~~~l~~~~l~nN- 76 (873)
|++|.+++. +|..+..+++|++|+|++|++++.+|..|+.+++|++|+|++| .+++ .+|..+.....+..+.+++|
T Consensus 100 L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~ 179 (336)
T 2ast_B 100 LSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCF 179 (336)
T ss_dssp CTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCT
T ss_pred ccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCC
Confidence 578888876 8999999999999999999999999999999999999999999 7886 36766666778888999888
Q ss_pred ccCC
Q 002857 77 KLCG 80 (873)
Q Consensus 77 ~L~G 80 (873)
.+++
T Consensus 180 ~l~~ 183 (336)
T 2ast_B 180 DFTE 183 (336)
T ss_dssp TCCH
T ss_pred CcCh
Confidence 7764
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=97.44 E-value=5.4e-05 Score=83.21 Aligned_cols=82 Identities=15% Similarity=0.051 Sum_probs=69.8
Q ss_pred CCCCccccCcCc-CCCCCCCCCeEeCCCCcCCCcccc-cccCCCCcce-ecccCCCccCCCCcccccccCcccccccccc
Q 002857 1 MHGNLFEGPIGL-SLSPLRGLKVLDLSQNNLSGEIPE-FLAGFKFLQN-LNLSHNNFESMIPTEGIFKNASATSVFGNNK 77 (873)
Q Consensus 1 Ls~N~L~G~iP~-~l~~L~~L~~L~Ls~N~LsG~iP~-~l~~L~~L~~-L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~ 77 (873)
|++|+|+ .||. +|.+|++|++|+|++|++.+.||. .|.+|++|.. +++++|+|++..|..+..+..+..+.+++|.
T Consensus 37 Ls~N~i~-~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~ 115 (350)
T 4ay9_X 37 FVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTG 115 (350)
T ss_dssp EESCCCS-EECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEEC
T ss_pred ccCCcCC-CcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhhhccccccccccccc
Confidence 5789999 5665 689999999999999999878885 6789988774 7778899998888888888899999999999
Q ss_pred cCCCCC
Q 002857 78 LCGGIP 83 (873)
Q Consensus 78 L~G~~p 83 (873)
+.+.++
T Consensus 116 l~~~~~ 121 (350)
T 4ay9_X 116 IKHLPD 121 (350)
T ss_dssp CSSCCC
T ss_pred cccCCc
Confidence 986543
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.41 E-value=0.00013 Score=82.31 Aligned_cols=79 Identities=9% Similarity=0.085 Sum_probs=50.1
Q ss_pred CCCeeeccCCCCCeeeCCCCCeEEeccccccccccccccccccccccccccCCCcccCCC---CCCcchhhHhHHHHHHH
Q 002857 293 KPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGH---ETSSYGDVYSFGILLLE 369 (873)
Q Consensus 293 s~gIvHrDLKpsNILLd~~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~---~~s~ksDVwSfGvvL~E 369 (873)
...++|+|+++.|||++.++ ++|+||+.+..-....+...... .-...|.+|+..... ......++.+....+|+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLG-NLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN 308 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHH-HHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHH-HHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence 68899999999999999776 99999999875432211111000 012345666554321 12233556688888888
Q ss_pred HHhC
Q 002857 370 MFTG 373 (873)
Q Consensus 370 LlTG 373 (873)
.+++
T Consensus 309 ~y~~ 312 (420)
T 2pyw_A 309 LFNK 312 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 8765
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=97.38 E-value=6.7e-05 Score=80.06 Aligned_cols=58 Identities=26% Similarity=0.284 Sum_probs=50.1
Q ss_pred CCCCcccc--CcCcCCCCCCCCCeEeCCCCcCCCcccccccCCC--CcceecccCCCccCCCCc
Q 002857 1 MHGNLFEG--PIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFK--FLQNLNLSHNNFESMIPT 60 (873)
Q Consensus 1 Ls~N~L~G--~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~--~L~~L~LS~N~Lsg~iP~ 60 (873)
|++|+|++ .+|..+..|++|+.|+|++|+|++. ..+..|+ +|+.|+|++|.|++.+|.
T Consensus 177 Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~ 238 (267)
T 3rw6_A 177 LSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRD 238 (267)
T ss_dssp CTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSS
T ss_pred CCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCc
Confidence 78999998 6778888999999999999999964 4455555 999999999999998874
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.36 E-value=0.0005 Score=73.25 Aligned_cols=79 Identities=11% Similarity=0.030 Sum_probs=57.3
Q ss_pred CCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhh---ccceeeeeeeecccccCCceE
Q 002857 161 GFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIH---RKIIKVVTACSRVDYQGNDFK 237 (873)
Q Consensus 161 ~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~H---pNIV~llg~c~~~~~~~~~~~ 237 (873)
.......+|.|..+.||+.+. .+|+.|++|+...........|..|+..|+.|.- -.+.+++++. ..
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~---------~~ 85 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD---------DR 85 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE---------TT
T ss_pred CeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc---------Cc
Confidence 345567899999999999986 5678999998764444444578899999999842 2345555541 13
Q ss_pred EEEEeecCCCCh
Q 002857 238 ALVYEFMPNGSL 249 (873)
Q Consensus 238 ~LV~Ey~~~GSL 249 (873)
++||||++.+..
T Consensus 86 ~lv~e~l~~~~~ 97 (288)
T 3f7w_A 86 TLAMEWVDERPP 97 (288)
T ss_dssp EEEEECCCCCCC
T ss_pred eEEEEeecccCC
Confidence 789999987643
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=97.35 E-value=3.5e-05 Score=85.08 Aligned_cols=82 Identities=18% Similarity=0.085 Sum_probs=68.6
Q ss_pred CCCCccccCcC----cCCCCCC-CCCeEeCCCCcCCCcccccccCC-----CCcceecccCCCccCCCCcccccc-----
Q 002857 1 MHGNLFEGPIG----LSLSPLR-GLKVLDLSQNNLSGEIPEFLAGF-----KFLQNLNLSHNNFESMIPTEGIFK----- 65 (873)
Q Consensus 1 Ls~N~L~G~iP----~~l~~L~-~L~~L~Ls~N~LsG~iP~~l~~L-----~~L~~L~LS~N~Lsg~iP~~~~~~----- 65 (873)
|++|.|++..+ ..|..++ +|++|+|++|+|++..+..|..+ ++|+.|+|++|+|++..+..+...
T Consensus 29 Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~ 108 (362)
T 3goz_A 29 LSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIP 108 (362)
T ss_dssp CTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHHTSC
T ss_pred ccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHHHHHHhCC
Confidence 67899987666 7788898 99999999999998888888886 999999999999998777754432
Q ss_pred cCcccccccccccCCCC
Q 002857 66 NASATSVFGNNKLCGGI 82 (873)
Q Consensus 66 ~~l~~~~l~nN~L~G~~ 82 (873)
..+..+++++|.+.+..
T Consensus 109 ~~L~~L~Ls~N~l~~~~ 125 (362)
T 3goz_A 109 FTITVLDLGWNDFSSKS 125 (362)
T ss_dssp TTCCEEECCSSCGGGSC
T ss_pred CCccEEECcCCcCCcHH
Confidence 67888999999887543
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.28 E-value=0.0018 Score=69.65 Aligned_cols=170 Identities=11% Similarity=0.060 Sum_probs=92.1
Q ss_pred ccCHHHHHHhhcCCCc-----ceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccc--ee
Q 002857 149 YVSYEALYSATKGFSS-----ENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKI--IK 221 (873)
Q Consensus 149 ~~s~~el~~at~~f~~-----~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNI--V~ 221 (873)
.++.+++......|.. .+.|+.|....+|+.... ++ .+++|+.... .....+..|+.++..+....+ .+
T Consensus 6 ~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~ 81 (322)
T 2ppq_A 6 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPL 81 (322)
T ss_dssp CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEES-SC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCC
T ss_pred cCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeC-Cc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCc
Confidence 4566667666666654 345677888999998763 34 5889987642 123567789999988864333 33
Q ss_pred eeeeeeccc-ccCCceEEEEEeecCCCChhhh--------------cccccccccccCC---CCCCchhhhHH-------
Q 002857 222 VVTACSRVD-YQGNDFKALVYEFMPNGSLEEW--------------IHPITEEDKRHKA---PGNLNSLERLN------- 276 (873)
Q Consensus 222 llg~c~~~~-~~~~~~~~LV~Ey~~~GSL~~~--------------L~~~~~~~~~~~~---~~~Ls~~~~l~------- 276 (873)
++....... ....+..++||+|++|..+... ||..... -.... .....|...+.
T Consensus 82 ~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~-~~~~~~~~~~~~~w~~~~~~~~~~~~ 160 (322)
T 2ppq_A 82 PLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEG-FEIKRPNALSVDGWKVLWDKSEERAD 160 (322)
T ss_dssp BCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTT-CCCCCBCTTSHHHHHHHHHHHGGGGG
T ss_pred ccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhcc-CCCcccCccChHHHHHHHHHHHHHHH
Confidence 332210000 0112457899999998654321 1110000 00000 00011221100
Q ss_pred -----HHHHHHHHHHHHhhC----CCCCeeeccCCCCCeeeCCCCCeEEecccccc
Q 002857 277 -----IAIDVASALEYLHLG----CKPPIAHCDIKPSNILLNDEMTACVADFGIAR 323 (873)
Q Consensus 277 -----Ia~qIa~gL~yLH~~----~s~gIvHrDLKpsNILLd~~~~vKLsDFGla~ 323 (873)
+...+...+++|+.. ....++|+|+.+.|||++.+..+.|+||+.+.
T Consensus 161 ~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 161 EVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp GTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 111244455555521 24579999999999999987666899998875
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=97.09 E-value=0.00049 Score=81.96 Aligned_cols=70 Identities=20% Similarity=0.198 Sum_probs=48.0
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCG 80 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G 80 (873)
|++|.|+ .||..+. ++|++|+|++|+|+ .||. .+++|++|+|++|+|++ +|. ....+..+.+++|.|.+
T Consensus 47 ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~ 115 (622)
T 3g06_A 47 VGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLTS-LPV---LPPGLLELSIFSNPLTH 115 (622)
T ss_dssp CCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCSC-CCC---CCTTCCEEEECSCCCCC
T ss_pred ecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCCc-CCC---CCCCCCEEECcCCcCCC
Confidence 4677777 7777766 67788888888777 6776 46777777777777773 554 34555666666666665
Q ss_pred C
Q 002857 81 G 81 (873)
Q Consensus 81 ~ 81 (873)
.
T Consensus 116 l 116 (622)
T 3g06_A 116 L 116 (622)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.02 E-value=0.0016 Score=69.84 Aligned_cols=72 Identities=8% Similarity=0.032 Sum_probs=47.1
Q ss_pred ceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccce-eeeeeeecccccCCceEEEEEee
Q 002857 165 ENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKII-KVVTACSRVDYQGNDFKALVYEF 243 (873)
Q Consensus 165 ~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV-~llg~c~~~~~~~~~~~~LV~Ey 243 (873)
.+.|+.|....+|+. ..+++|+...... ......+|+.+++.+....+. ++++++ .+.-++|+||
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~-~~~~r~~E~~~l~~l~~~g~~P~~~~~~-------~~~~~~v~e~ 88 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTE-EYINRANEAVAAREAAKAGVSPEVLHVD-------PATGVMVTRY 88 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC-------TTTCCEEEEC
T ss_pred eeEcCCcccccccee------eeEEEECCCCCcc-ceeCHHHHHHHHHHHHHcCCCCceEEEE-------CCCCEEEEee
Confidence 678999999999998 4588898764321 123456799999888644444 555542 2223689999
Q ss_pred c-CCCChh
Q 002857 244 M-PNGSLE 250 (873)
Q Consensus 244 ~-~~GSL~ 250 (873)
+ ++.+|.
T Consensus 89 i~~g~~l~ 96 (301)
T 3dxq_A 89 IAGAQTMS 96 (301)
T ss_dssp CTTCEECC
T ss_pred cCCCccCC
Confidence 9 655553
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=96.97 E-value=0.0079 Score=65.38 Aligned_cols=76 Identities=11% Similarity=0.080 Sum_probs=58.0
Q ss_pred cceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhh---ccceeeeeeeecccccCCceEEEE
Q 002857 164 SENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIH---RKIIKVVTACSRVDYQGNDFKALV 240 (873)
Q Consensus 164 ~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~H---pNIV~llg~c~~~~~~~~~~~~LV 240 (873)
..+.|+.|....+|+... ++..+++|+.... ....+..|++.|+.|.. ..+.+++.++. ..+..++|
T Consensus 40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~-----~~g~~~lv 109 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGN-----SQGHSFLL 109 (312)
T ss_dssp EEEEECCSSSSEEEEEES--SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEE-----CSSEEEEE
T ss_pred eeEEeCCccceeeeEEEE--CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEee-----cCCceEEE
Confidence 356799999999999864 5668889987532 34678999999999853 45777887742 24568999
Q ss_pred EeecCCCCh
Q 002857 241 YEFMPNGSL 249 (873)
Q Consensus 241 ~Ey~~~GSL 249 (873)
|||+++..+
T Consensus 110 me~l~G~~~ 118 (312)
T 3jr1_A 110 LEALNKSKN 118 (312)
T ss_dssp EECCCCCCC
T ss_pred EEeccCCCC
Confidence 999998865
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.81 E-value=0.0052 Score=69.70 Aligned_cols=74 Identities=16% Similarity=0.220 Sum_probs=51.4
Q ss_pred ceeecccCceEEEEEEEcC-------CCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccc-eeeeeeeecccccCCce
Q 002857 165 ENLIGAGNFASVYKGILFE-------GAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKI-IKVVTACSRVDYQGNDF 236 (873)
Q Consensus 165 ~~~LG~G~fG~VYkg~~~~-------~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNI-V~llg~c~~~~~~~~~~ 236 (873)
.+.|+.|....||+..... ++..+++|+.... .....+..|+.+++.+...++ .++++.+ . +
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~-----~-~-- 147 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIF-----S-G-- 147 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEE-----T-T--
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEe-----C-C--
Confidence 4678889889999997642 2578999998431 122566789999999965555 5566653 1 1
Q ss_pred EEEEEeecCCCCh
Q 002857 237 KALVYEFMPNGSL 249 (873)
Q Consensus 237 ~~LV~Ey~~~GSL 249 (873)
.+|+||++|.+|
T Consensus 148 -g~v~e~l~G~~l 159 (429)
T 1nw1_A 148 -GRLEEYIPSRPL 159 (429)
T ss_dssp -EEEECCCCEEEC
T ss_pred -CEEEEEeCCccc
Confidence 389999986554
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.81 E-value=0.0072 Score=65.09 Aligned_cols=171 Identities=13% Similarity=0.105 Sum_probs=92.0
Q ss_pred CCccCHHHHHHhhcCCCc-----ceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhcc--c
Q 002857 147 FPYVSYEALYSATKGFSS-----ENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRK--I 219 (873)
Q Consensus 147 ~~~~s~~el~~at~~f~~-----~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpN--I 219 (873)
...++.+++..+...|.+ ...|+ |....||+... .+|+.+++|+..... .....+..|+.++..+.... +
T Consensus 8 ~~~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~v 84 (328)
T 1zyl_A 8 FQTLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQD-EDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPV 84 (328)
T ss_dssp CCCCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECC-TTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSB
T ss_pred CCCCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEc-CCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCee
Confidence 344555566555444422 34566 88889998754 345679999986322 23456788999999885433 3
Q ss_pred eeeeeeeeccc-ccCCceEEEEEeecCCCChhh-----------h---cccccccccccCCCCCCchhh-----------
Q 002857 220 IKVVTACSRVD-YQGNDFKALVYEFMPNGSLEE-----------W---IHPITEEDKRHKAPGNLNSLE----------- 273 (873)
Q Consensus 220 V~llg~c~~~~-~~~~~~~~LV~Ey~~~GSL~~-----------~---L~~~~~~~~~~~~~~~Ls~~~----------- 273 (873)
.+++.. .... ....+..++||+|++|..+.. . ||..... ........+++..
T Consensus 85 p~~~~~-~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~ 162 (328)
T 1zyl_A 85 AAPVAF-NGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRK-QLFIHRPTIGLNEYLIEPRKLFED 162 (328)
T ss_dssp CCCCCB-TTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTS-SCCSSSCBCSHHHHTHHHHHHHHT
T ss_pred cceeec-CCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhcc-CCCccCCCCCHHHHHhhHHHHHhh
Confidence 444432 1000 112456789999998865431 0 1110000 0000011111110
Q ss_pred -----------hHHHHHHHHHHHHHHhh-CCCCCeeeccCCCCCeeeCCCCCeEEeccccccc
Q 002857 274 -----------RLNIAIDVASALEYLHL-GCKPPIAHCDIKPSNILLNDEMTACVADFGIARF 324 (873)
Q Consensus 274 -----------~l~Ia~qIa~gL~yLH~-~~s~gIvHrDLKpsNILLd~~~~vKLsDFGla~~ 324 (873)
....+..++..+.-+.. .....++|+|+++.|||++ + .+.|+||+.+..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 163 ATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred cCcCCHHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 01112222222222211 1246789999999999999 4 899999988764
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=96.78 E-value=0.00012 Score=82.74 Aligned_cols=80 Identities=18% Similarity=0.130 Sum_probs=55.3
Q ss_pred CCCCccccCcCcCCCC-----CCCCCeEeCCCCcCCCc----ccccccCCCCcceecccCCCccCCCCccccc-----cc
Q 002857 1 MHGNLFEGPIGLSLSP-----LRGLKVLDLSQNNLSGE----IPEFLAGFKFLQNLNLSHNNFESMIPTEGIF-----KN 66 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~-----L~~L~~L~Ls~N~LsG~----iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~-----~~ 66 (873)
|++|.+++..+..+.. .++|+.|+|++|.|++. +|..+..+++|+.|+|++|++++..+..+.. ..
T Consensus 291 Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~ 370 (461)
T 1z7x_W 291 LAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGS 370 (461)
T ss_dssp CTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTC
T ss_pred CCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCC
Confidence 4677776554444433 36888888888888865 6777778888888888888887654443321 34
Q ss_pred CcccccccccccCC
Q 002857 67 ASATSVFGNNKLCG 80 (873)
Q Consensus 67 ~l~~~~l~nN~L~G 80 (873)
.+..+.+++|.+++
T Consensus 371 ~L~~L~L~~n~i~~ 384 (461)
T 1z7x_W 371 VLRVLWLADCDVSD 384 (461)
T ss_dssp CCCEEECTTSCCCH
T ss_pred ceEEEECCCCCCCh
Confidence 67777888887763
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.57 E-value=0.016 Score=66.32 Aligned_cols=76 Identities=17% Similarity=0.130 Sum_probs=49.6
Q ss_pred ceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccc-eeeeeeeecccccCCceEEEEEee
Q 002857 165 ENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKI-IKVVTACSRVDYQGNDFKALVYEF 243 (873)
Q Consensus 165 ~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNI-V~llg~c~~~~~~~~~~~~LV~Ey 243 (873)
.+.|+.|-...+|+.....++..+++|+..... ...-....|+.++..|...++ .++++.+ . + .+||||
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~~~idR~~E~~vl~~L~~~gl~P~ll~~~-----~-~---G~v~e~ 182 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKT-DEIINREREKKISCILYNKNIAKKIYVFF-----T-N---GRIEEF 182 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-C-CSCSCHHHHHHHHHHHTTSSSBCCEEEEE-----T-T---EEEEEC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCCh-hhhcCHHHHHHHHHHHHhcCCCCCEEEEe-----C-C---eEEEEe
Confidence 467888989999999874334789999875322 112223689999999965555 4566653 1 1 259999
Q ss_pred cCCCChh
Q 002857 244 MPNGSLE 250 (873)
Q Consensus 244 ~~~GSL~ 250 (873)
++|.+|.
T Consensus 183 I~G~~l~ 189 (458)
T 2qg7_A 183 MDGYALS 189 (458)
T ss_dssp CCSEECC
T ss_pred eCCccCC
Confidence 9876553
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.49 E-value=0.0071 Score=67.58 Aligned_cols=149 Identities=13% Similarity=0.188 Sum_probs=83.1
Q ss_pred eeecccCceEEEEEEEcC-------CCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccc-eeeeeeeecccccCCceE
Q 002857 166 NLIGAGNFASVYKGILFE-------GAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKI-IKVVTACSRVDYQGNDFK 237 (873)
Q Consensus 166 ~~LG~G~fG~VYkg~~~~-------~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNI-V~llg~c~~~~~~~~~~~ 237 (873)
+.|..|-...+|+..... +++.+++|+.... ......+.+|..+++.+.-.++ .++++++ . +
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~-----~-~--- 125 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVF-----P-E--- 125 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEE-----T-T---
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEc-----C-C---
Confidence 567778888999987632 3478999986432 2234667799999999854333 4566653 2 1
Q ss_pred EEEEeecCCCChhhh-ccc-------------ccccccccCCCCCCchhhhHHHHHHHHH-------------------H
Q 002857 238 ALVYEFMPNGSLEEW-IHP-------------ITEEDKRHKAPGNLNSLERLNIAIDVAS-------------------A 284 (873)
Q Consensus 238 ~LV~Ey~~~GSL~~~-L~~-------------~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~-------------------g 284 (873)
.+||||++|.+|..- +.. +...+.........-|.++.++..++.. .
T Consensus 126 g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~ 205 (379)
T 3feg_A 126 GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDE 205 (379)
T ss_dssp EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHH
T ss_pred ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHH
Confidence 299999998665421 100 0000000011111123344444433321 2
Q ss_pred HHHH----hh-CCCCCeeeccCCCCCeeeCCC----CCeEEeccccccc
Q 002857 285 LEYL----HL-GCKPPIAHCDIKPSNILLNDE----MTACVADFGIARF 324 (873)
Q Consensus 285 L~yL----H~-~~s~gIvHrDLKpsNILLd~~----~~vKLsDFGla~~ 324 (873)
+..| .. .....++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 206 ~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 206 MGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 2333 21 124578999999999999876 7899999998763
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.40 E-value=0.00036 Score=77.82 Aligned_cols=80 Identities=19% Similarity=0.103 Sum_probs=55.2
Q ss_pred CCCCccccCcCcCC-----CCCCCCCeEeCCCCcCCC----cccccccCCCCcceecccCCCccCC----CCcccccccC
Q 002857 1 MHGNLFEGPIGLSL-----SPLRGLKVLDLSQNNLSG----EIPEFLAGFKFLQNLNLSHNNFESM----IPTEGIFKNA 67 (873)
Q Consensus 1 Ls~N~L~G~iP~~l-----~~L~~L~~L~Ls~N~LsG----~iP~~l~~L~~L~~L~LS~N~Lsg~----iP~~~~~~~~ 67 (873)
|++|+|+..-...| ...++|+.|+|++|.|+. .++..+..+++|++|+|++|+|+.. ++..+.....
T Consensus 133 Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~ 212 (372)
T 3un9_A 133 LQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQ 212 (372)
T ss_dssp CCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSC
T ss_pred cCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCC
Confidence 56787765444444 346788899999998864 3556667888889999999888742 2333344456
Q ss_pred cccccccccccCC
Q 002857 68 SATSVFGNNKLCG 80 (873)
Q Consensus 68 l~~~~l~nN~L~G 80 (873)
+..+++++|.+..
T Consensus 213 L~~L~Ls~N~i~~ 225 (372)
T 3un9_A 213 LQELNVAYNGAGD 225 (372)
T ss_dssp CCEEECCSSCCCH
T ss_pred cCeEECCCCCCCH
Confidence 7788888887753
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.39 E-value=0.014 Score=64.30 Aligned_cols=75 Identities=19% Similarity=0.190 Sum_probs=46.3
Q ss_pred ceeecccCceEEEEEEEcCC--------CcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccc-eeeeeeeecccccCCc
Q 002857 165 ENLIGAGNFASVYKGILFEG--------APAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKI-IKVVTACSRVDYQGND 235 (873)
Q Consensus 165 ~~~LG~G~fG~VYkg~~~~~--------g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNI-V~llg~c~~~~~~~~~ 235 (873)
...|+.|....+|+.....+ +..+++|+..... ........|.++++.+...++ .++++.. .
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~~~~E~~~l~~L~~~g~~P~~~~~~-------~- 108 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-DELYNTISEFEVYKTMSKYKIAPQLLNTF-------N- 108 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-GGTSCHHHHHHHHHHHHHTTSSCCEEEEE-------T-
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-cceecHHHHHHHHHHHHhcCCCCceEEec-------C-
Confidence 35678888889999876431 2688999875322 112235789999998865554 3666542 1
Q ss_pred eEEEEEeecCCCCh
Q 002857 236 FKALVYEFMPNGSL 249 (873)
Q Consensus 236 ~~~LV~Ey~~~GSL 249 (873)
-++||||++|.++
T Consensus 109 -~~~v~e~i~G~~l 121 (369)
T 3c5i_A 109 -GGRIEEWLYGDPL 121 (369)
T ss_dssp -TEEEEECCCSEEC
T ss_pred -CcEEEEEecCCcC
Confidence 2689999987554
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=96.29 E-value=0.00054 Score=77.28 Aligned_cols=80 Identities=18% Similarity=0.073 Sum_probs=58.9
Q ss_pred CCCCccccCcCcCCC-CCC----CCCeEeCCCCcCCC----cccccccCCCCcceecccCCCccCCCCccccc-----cc
Q 002857 1 MHGNLFEGPIGLSLS-PLR----GLKVLDLSQNNLSG----EIPEFLAGFKFLQNLNLSHNNFESMIPTEGIF-----KN 66 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~-~L~----~L~~L~Ls~N~LsG----~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~-----~~ 66 (873)
|++|.+++..+..+. .++ +|++|+|++|+|+. .+|..|..+++|+.|+|++|.+++..+..+.. ..
T Consensus 63 Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~ 142 (461)
T 1z7x_W 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQC 142 (461)
T ss_dssp CTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTC
T ss_pred CCCCcCChHHHHHHHHHHhhCCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCC
Confidence 577888765554443 344 79999999999983 67889999999999999999988654443221 23
Q ss_pred CcccccccccccCC
Q 002857 67 ASATSVFGNNKLCG 80 (873)
Q Consensus 67 ~l~~~~l~nN~L~G 80 (873)
.+..+.+++|.+.+
T Consensus 143 ~L~~L~L~~n~l~~ 156 (461)
T 1z7x_W 143 RLEKLQLEYCSLSA 156 (461)
T ss_dssp CCCEEECTTSCCBG
T ss_pred cceEEECCCCCCCH
Confidence 57788888887775
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.26 E-value=0.017 Score=62.55 Aligned_cols=148 Identities=11% Similarity=0.057 Sum_probs=74.4
Q ss_pred eeecccCceE-EEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhcc--ceeeeeeeecccccCCceEEEEEe
Q 002857 166 NLIGAGNFAS-VYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRK--IIKVVTACSRVDYQGNDFKALVYE 242 (873)
Q Consensus 166 ~~LG~G~fG~-VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpN--IV~llg~c~~~~~~~~~~~~LV~E 242 (873)
+.|+.|.... +|+... .++..+++|...... ...+..|+.++..+.... +.+++.+. ...+ ++|||
T Consensus 24 ~~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~---~~~~~~e~~~l~~L~~~g~~vP~v~~~d-----~~~g--~ll~e 92 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRS-PTGAKAVLMDWSPEE---GGDTQPFVDLAQYLRNLDISAPEIYAEE-----HARG--LLLIE 92 (333)
T ss_dssp CC--------CCEEEEC-TTCCEEEEEECCTTT---TCCSHHHHHHHHHHHHTTCBCCCEEEEE-----TTTT--EEEEC
T ss_pred eECCCCCCCceEEEEEc-CCCCeEEEEECCCCC---CccccHHHHHHHHHHhCCCCCCceeeec-----CCCC--EEEEe
Confidence 4566665544 667643 235677777644221 144567888888885433 45566652 1222 68999
Q ss_pred ecCCCChhhhccccccc----------------ccccCCCCCCchhhhH--------------------HHHHHHHHHHH
Q 002857 243 FMPNGSLEEWIHPITEE----------------DKRHKAPGNLNSLERL--------------------NIAIDVASALE 286 (873)
Q Consensus 243 y~~~GSL~~~L~~~~~~----------------~~~~~~~~~Ls~~~~l--------------------~Ia~qIa~gL~ 286 (873)
++.+..+.+++...... .........++..... .....+...+.
T Consensus 93 ~l~~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~ 172 (333)
T 3csv_A 93 DLGDALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFA 172 (333)
T ss_dssp CCCSCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHH
T ss_pred eCCCcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHH
Confidence 99776776554321100 0000000111110000 00011122222
Q ss_pred HHh---hCCCCCeeeccCCCCCeeeCCC----CCeEEeccccccc
Q 002857 287 YLH---LGCKPPIAHCDIKPSNILLNDE----MTACVADFGIARF 324 (873)
Q Consensus 287 yLH---~~~s~gIvHrDLKpsNILLd~~----~~vKLsDFGla~~ 324 (873)
.|. ......++|||+.+.|||++.+ ..+.|+||+.+..
T Consensus 173 ~l~~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 173 QILSAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp HHHHHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred HHHHhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 331 1125689999999999999874 6789999998864
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.24 E-value=0.0049 Score=58.20 Aligned_cols=51 Identities=20% Similarity=0.294 Sum_probs=38.7
Q ss_pred CCCccc-cCcCcCCCCCCCCCeEeCCCCcCCCccc-ccccCCCCcceecccCCCcc
Q 002857 2 HGNLFE-GPIGLSLSPLRGLKVLDLSQNNLSGEIP-EFLAGFKFLQNLNLSHNNFE 55 (873)
Q Consensus 2 s~N~L~-G~iP~~l~~L~~L~~L~Ls~N~LsG~iP-~~l~~L~~L~~L~LS~N~Ls 55 (873)
+++.|+ ..+|..|. .+|+.|+|++|+|+ .|| ..|..|++|+.|+|++|.+.
T Consensus 16 s~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~-~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 16 GRRGLTWASLPTAFP--VDTTELVLTGNNLT-ALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp CSSCCCTTTSCSCCC--TTCSEEECTTSCCS-SCCTTTGGGCTTCCEEECCSSCCB
T ss_pred CCCCCccccCCCCCC--cCCCEEECCCCcCC-ccChhhhhhccccCEEEecCCCee
Confidence 466665 45776543 37889999999998 565 46788889999999999886
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.88 E-value=0.0012 Score=73.59 Aligned_cols=80 Identities=15% Similarity=0.035 Sum_probs=58.1
Q ss_pred CCCCccccCcCcCCC-CCCCCCeEeCCCCcCCCcccccc-----cCCCCcceecccCCCccC----CCCcccccccCccc
Q 002857 1 MHGNLFEGPIGLSLS-PLRGLKVLDLSQNNLSGEIPEFL-----AGFKFLQNLNLSHNNFES----MIPTEGIFKNASAT 70 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~-~L~~L~~L~Ls~N~LsG~iP~~l-----~~L~~L~~L~LS~N~Lsg----~iP~~~~~~~~l~~ 70 (873)
|++|.|+..-...+. .|++|+.|+|++|+|+..-...| ...++|+.|+|++|.|+. .++..+.....+..
T Consensus 108 Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~ 187 (372)
T 3un9_A 108 LASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTH 187 (372)
T ss_dssp CTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCE
T ss_pred ecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCE
Confidence 578888755444444 46789999999999985544444 356889999999999974 23333344567888
Q ss_pred ccccccccCC
Q 002857 71 SVFGNNKLCG 80 (873)
Q Consensus 71 ~~l~nN~L~G 80 (873)
+++++|.|..
T Consensus 188 L~Ls~N~l~~ 197 (372)
T 3un9_A 188 LSLLHTGLGD 197 (372)
T ss_dssp EECTTSSCHH
T ss_pred EeCCCCCCCc
Confidence 9999998763
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.59 E-value=0.051 Score=59.36 Aligned_cols=32 Identities=25% Similarity=0.453 Sum_probs=28.3
Q ss_pred CCCeeeccCCCCCeeeCCCCCeEEeccccccc
Q 002857 293 KPPIAHCDIKPSNILLNDEMTACVADFGIARF 324 (873)
Q Consensus 293 s~gIvHrDLKpsNILLd~~~~vKLsDFGla~~ 324 (873)
...++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 46799999999999999888899999988764
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=95.17 E-value=0.0018 Score=75.50 Aligned_cols=63 Identities=16% Similarity=0.055 Sum_probs=30.4
Q ss_pred CCCCCeEeCCCCcCCC-cccccccCCCCcceecccCCCccCC-CCcccccccCcccccccccccC
Q 002857 17 LRGLKVLDLSQNNLSG-EIPEFLAGFKFLQNLNLSHNNFESM-IPTEGIFKNASATSVFGNNKLC 79 (873)
Q Consensus 17 L~~L~~L~Ls~N~LsG-~iP~~l~~L~~L~~L~LS~N~Lsg~-iP~~~~~~~~l~~~~l~nN~L~ 79 (873)
+++|+.|+|++|++++ .++..+..+++|+.|+|++|.|++. ++..+.....+..+.+++|.++
T Consensus 462 ~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it 526 (592)
T 3ogk_B 462 SPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRAS 526 (592)
T ss_dssp CTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCC
T ss_pred CccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCC
Confidence 4555555555555554 2344445555555555555555432 2222223344455555555544
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=94.86 E-value=0.0048 Score=61.50 Aligned_cols=66 Identities=11% Similarity=0.075 Sum_probs=40.4
Q ss_pred CCCCCCCCeEeCCCC-cCCCc----ccccccCCCCcceecccCCCccCC----CCcccccccCcccccccccccC
Q 002857 14 LSPLRGLKVLDLSQN-NLSGE----IPEFLAGFKFLQNLNLSHNNFESM----IPTEGIFKNASATSVFGNNKLC 79 (873)
Q Consensus 14 l~~L~~L~~L~Ls~N-~LsG~----iP~~l~~L~~L~~L~LS~N~Lsg~----iP~~~~~~~~l~~~~l~nN~L~ 79 (873)
+...++|+.|+|++| .|+.. |...+...++|++|+|++|+|... +...+.....+..+.+++|.+.
T Consensus 32 l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~ 106 (185)
T 1io0_A 32 QNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS 106 (185)
T ss_dssp HTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred HhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCC
Confidence 455677777777777 77532 445566667777777777777531 2222223345666777777655
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=94.61 E-value=0.2 Score=51.61 Aligned_cols=123 Identities=15% Similarity=0.165 Sum_probs=77.0
Q ss_pred ChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEecccccccccc
Q 002857 248 SLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEA 327 (873)
Q Consensus 248 SL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDFGla~~~~~ 327 (873)
||.++|.. ...++++.++|.++.|.+.+|.-+-. ...-..+=+.|..|+|..+|.+.+.+ ..+.
T Consensus 34 SL~eIL~~---------~~~PlsEEqaWALc~Qc~~~L~~~~~--~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~---- 97 (229)
T 2yle_A 34 SLEEILRL---------YNQPINEEQAWAVCYQCCGSLRAAAR--RRQPRHRVRSAAQIRVWRDGAVTLAP-AADD---- 97 (229)
T ss_dssp EHHHHHHH---------HTSCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCSGGGEEEETTSCEEECC-C-------
T ss_pred cHHHHHHH---------cCCCcCHHHHHHHHHHHHHHHHhhhh--cccCCceecCCcceEEecCCceeccc-cccc----
Confidence 78888853 56789999999999999999877621 11111233456889999999888774 1111
Q ss_pred ccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCchhHHHHhhhhh
Q 002857 328 TNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPERVEEIVDTLF 407 (873)
Q Consensus 328 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~~l~elid~~L 407 (873)
.....+.|||... ...+.+.=|||+|++||.-+--..|-+. ...+.+.+..+++.|.
T Consensus 98 ----------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e~e------------E~eLS~~LE~LL~~Mt 154 (229)
T 2yle_A 98 ----------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKENE------------ERELSPPLEQLIDHMA 154 (229)
T ss_dssp -------------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCTTE------------EECCCHHHHHHHHHHT
T ss_pred ----------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCccc------------chhhCHHHHHHHHHHH
Confidence 1123466888763 3557888999999999998864333221 1234556777776665
Q ss_pred hh
Q 002857 408 FK 409 (873)
Q Consensus 408 ~~ 409 (873)
..
T Consensus 155 ~~ 156 (229)
T 2yle_A 155 NT 156 (229)
T ss_dssp TC
T ss_pred hc
Confidence 44
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=94.43 E-value=0.039 Score=51.90 Aligned_cols=57 Identities=21% Similarity=0.213 Sum_probs=45.7
Q ss_pred CeEeCCCCcCC-CcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccC
Q 002857 21 KVLDLSQNNLS-GEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLC 79 (873)
Q Consensus 21 ~~L~Ls~N~Ls-G~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~ 79 (873)
..++.++++|+ ..||..|. ++|+.|+|++|+|+...+..+..+..+..+.+++|.+.
T Consensus 11 ~~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 11 TLVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp TEEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred CEEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 48999999997 57886543 47999999999999766666777778888888888653
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=94.33 E-value=0.005 Score=61.38 Aligned_cols=79 Identities=13% Similarity=0.066 Sum_probs=57.2
Q ss_pred CCCC-ccccC----cCcCCCCCCCCCeEeCCCCcCCCc----ccccccCCCCcceecccCCCccCC----CCcccccccC
Q 002857 1 MHGN-LFEGP----IGLSLSPLRGLKVLDLSQNNLSGE----IPEFLAGFKFLQNLNLSHNNFESM----IPTEGIFKNA 67 (873)
Q Consensus 1 Ls~N-~L~G~----iP~~l~~L~~L~~L~Ls~N~LsG~----iP~~l~~L~~L~~L~LS~N~Lsg~----iP~~~~~~~~ 67 (873)
|++| .|... +...+...++|++|+|++|+|+.. |...+...++|+.|+|++|.|+.. +...+.....
T Consensus 43 L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~ 122 (185)
T 1io0_A 43 LNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTS 122 (185)
T ss_dssp CTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSS
T ss_pred ecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHHHHHHhCCC
Confidence 4566 66532 455567789999999999999742 556677778999999999999842 3334444556
Q ss_pred cccccc--cccccC
Q 002857 68 SATSVF--GNNKLC 79 (873)
Q Consensus 68 l~~~~l--~nN~L~ 79 (873)
+..+.+ ++|.+.
T Consensus 123 L~~L~L~~~~N~i~ 136 (185)
T 1io0_A 123 LIELRIDNQSQPLG 136 (185)
T ss_dssp CCEEECCCCSSCCC
T ss_pred ceEEEecCCCCCCC
Confidence 788888 667765
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.01 E-value=0.23 Score=56.19 Aligned_cols=75 Identities=15% Similarity=0.217 Sum_probs=50.1
Q ss_pred ceeecccCceEEEEEEEcCC-------CcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccc-eeeeeeeecccccCCce
Q 002857 165 ENLIGAGNFASVYKGILFEG-------APAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKI-IKVVTACSRVDYQGNDF 236 (873)
Q Consensus 165 ~~~LG~G~fG~VYkg~~~~~-------g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNI-V~llg~c~~~~~~~~~~ 236 (873)
.+.|..|-...+|+.....+ +..+++|+..... ...-...+|..+++.+...++ .++++.+ .
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~-----~---- 144 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADF-----P---- 144 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE-----T----
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEc-----C----
Confidence 45677788889999877421 5789999975332 222345789999999864444 4455542 1
Q ss_pred EEEEEeecCCCCh
Q 002857 237 KALVYEFMPNGSL 249 (873)
Q Consensus 237 ~~LV~Ey~~~GSL 249 (873)
-++||||++|.+|
T Consensus 145 ~~~I~efI~G~~l 157 (424)
T 3mes_A 145 EGRIEEFIDGEPL 157 (424)
T ss_dssp TEEEEECCCSEEC
T ss_pred CCEEEEEeCCccC
Confidence 2689999998764
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=93.62 E-value=0.055 Score=58.36 Aligned_cols=57 Identities=26% Similarity=0.300 Sum_probs=27.3
Q ss_pred CCCCCeEeCCCCcCCCcccc-cccCCCCcceecccCCCccCCCCcccccccCcc-cccccc
Q 002857 17 LRGLKVLDLSQNNLSGEIPE-FLAGFKFLQNLNLSHNNFESMIPTEGIFKNASA-TSVFGN 75 (873)
Q Consensus 17 L~~L~~L~Ls~N~LsG~iP~-~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~-~~~l~n 75 (873)
+++|+.|+|++|+++ .||+ .|.++++|+.|+|++| ++..-+.++.....+. .+.+.+
T Consensus 225 ~~~L~~l~L~~n~i~-~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~ 283 (329)
T 3sb4_A 225 MPNLVSLDISKTNAT-TIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA 283 (329)
T ss_dssp CTTCCEEECTTBCCC-EECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT
T ss_pred cCCCeEEECCCCCcc-eecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc
Confidence 455555555555555 4442 4555555555555555 4432233333333343 444433
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=93.45 E-value=0.0097 Score=69.22 Aligned_cols=66 Identities=17% Similarity=0.173 Sum_probs=36.1
Q ss_pred CCCCCCCeEeCCCCcCCCc----ccccccCCCCcceecccCCCccC----CCCcccccccCcccccccccccCC
Q 002857 15 SPLRGLKVLDLSQNNLSGE----IPEFLAGFKFLQNLNLSHNNFES----MIPTEGIFKNASATSVFGNNKLCG 80 (873)
Q Consensus 15 ~~L~~L~~L~Ls~N~LsG~----iP~~l~~L~~L~~L~LS~N~Lsg----~iP~~~~~~~~l~~~~l~nN~L~G 80 (873)
..+++|++|+|++|.+++. ++..+.++++|+.|+|++|.+++ .++..+.....+..+.+++|.+.+
T Consensus 161 ~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~ 234 (592)
T 3ogk_B 161 THCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE 234 (592)
T ss_dssp HHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG
T ss_pred hhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH
Confidence 3556666666666666554 44455556666666666666652 222222233455555555555443
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=92.87 E-value=0.0083 Score=69.77 Aligned_cols=65 Identities=12% Similarity=0.074 Sum_probs=47.4
Q ss_pred CCCCCCCCeEeCCCCcCCCcccccccC-CCCcceecccCCCccCCCCccc-ccccCcccccccccccC
Q 002857 14 LSPLRGLKVLDLSQNNLSGEIPEFLAG-FKFLQNLNLSHNNFESMIPTEG-IFKNASATSVFGNNKLC 79 (873)
Q Consensus 14 l~~L~~L~~L~Ls~N~LsG~iP~~l~~-L~~L~~L~LS~N~Lsg~iP~~~-~~~~~l~~~~l~nN~L~ 79 (873)
+..+++|+.|+|++ ++++..+..++. +++|+.|+|++|.+++..+..+ .....+..+.+++|.++
T Consensus 428 ~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~ 494 (594)
T 2p1m_B 428 VEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFG 494 (594)
T ss_dssp HHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCC
T ss_pred HhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCc
Confidence 56778888888876 777766666766 8888888888888875444333 33566778888888773
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=91.63 E-value=0.75 Score=51.21 Aligned_cols=30 Identities=27% Similarity=0.486 Sum_probs=25.0
Q ss_pred CeeeccCCCCCeee------CCCCCeEEeccccccc
Q 002857 295 PIAHCDIKPSNILL------NDEMTACVADFGIARF 324 (873)
Q Consensus 295 gIvHrDLKpsNILL------d~~~~vKLsDFGla~~ 324 (873)
.++|+|+.+.|||+ +++..+.++||.+|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 35799999999999 4567899999988863
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=91.41 E-value=0.031 Score=61.95 Aligned_cols=65 Identities=14% Similarity=0.095 Sum_probs=40.0
Q ss_pred CCCCCCeEeCCC--CcCCCc-----ccccc--cCCCCcceecccCCCccCCCCcccc---cccCcccccccccccCC
Q 002857 16 PLRGLKVLDLSQ--NNLSGE-----IPEFL--AGFKFLQNLNLSHNNFESMIPTEGI---FKNASATSVFGNNKLCG 80 (873)
Q Consensus 16 ~L~~L~~L~Ls~--N~LsG~-----iP~~l--~~L~~L~~L~LS~N~Lsg~iP~~~~---~~~~l~~~~l~nN~L~G 80 (873)
.|++|+.|+|+. |+..|. |...+ ..+++|++|+|++|.++...+..+. .+..+..+.++.|.|..
T Consensus 217 ~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d 293 (362)
T 2ra8_A 217 DLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTD 293 (362)
T ss_dssp BCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBH
T ss_pred cCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCCh
Confidence 688888888853 332221 11222 2478888888888888754433322 34567777888877664
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=90.89 E-value=0.022 Score=66.17 Aligned_cols=67 Identities=16% Similarity=0.134 Sum_probs=50.3
Q ss_pred CCCCCCCeEeCCCCcCCCccccccc-CCCCcceecccCC-CccCC-CCcccccccCcccccccccccCCC
Q 002857 15 SPLRGLKVLDLSQNNLSGEIPEFLA-GFKFLQNLNLSHN-NFESM-IPTEGIFKNASATSVFGNNKLCGG 81 (873)
Q Consensus 15 ~~L~~L~~L~Ls~N~LsG~iP~~l~-~L~~L~~L~LS~N-~Lsg~-iP~~~~~~~~l~~~~l~nN~L~G~ 81 (873)
..+++|+.|+|++|.+++..+..+. .+++|+.|+|++| .++.. ++........++.+.+++|.+.+.
T Consensus 102 ~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~ 171 (594)
T 2p1m_B 102 SSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDV 171 (594)
T ss_dssp HHCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECC
T ss_pred HhCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCc
Confidence 4578899999999999888887776 6889999999988 55532 444444566788888888877653
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=90.05 E-value=0.024 Score=62.80 Aligned_cols=64 Identities=13% Similarity=0.048 Sum_probs=49.7
Q ss_pred CCCCCCeEeCCCCcCCCccccccc---CCCCcceecccCCCccCC----CCcccccccCcccccccccccC
Q 002857 16 PLRGLKVLDLSQNNLSGEIPEFLA---GFKFLQNLNLSHNNFESM----IPTEGIFKNASATSVFGNNKLC 79 (873)
Q Consensus 16 ~L~~L~~L~Ls~N~LsG~iP~~l~---~L~~L~~L~LS~N~Lsg~----iP~~~~~~~~l~~~~l~nN~L~ 79 (873)
.+++|++|+|++|.++...+..+. .+++|++|+||+|.|++. ++..+.....+..+.+++|.+.
T Consensus 250 ~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~ 320 (362)
T 2ra8_A 250 RFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320 (362)
T ss_dssp TCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCC
T ss_pred CCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCC
Confidence 579999999999999876655554 588999999999999863 3433344567888888888665
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=88.91 E-value=0.28 Score=52.68 Aligned_cols=77 Identities=12% Similarity=0.054 Sum_probs=61.8
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCccc-ccccCCCCcc-eecccCCCccCCCCcccccccCccccccccccc
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIP-EFLAGFKFLQ-NLNLSHNNFESMIPTEGIFKNASATSVFGNNKL 78 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP-~~l~~L~~L~-~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L 78 (873)
|++|+++..-+.+|.++++|+.|+|++| ++ .|+ ..|.++++|+ .|+|++ +++..-+.++.....+..+.+.+|.+
T Consensus 233 L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~-~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i 309 (329)
T 3sb4_A 233 ISKTNATTIPDFTFAQKKYLLKIKLPHN-LK-TIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKI 309 (329)
T ss_dssp CTTBCCCEECTTTTTTCTTCCEEECCTT-CC-EECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCC
T ss_pred CCCCCcceecHhhhhCCCCCCEEECCcc-cc-eehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCcc
Confidence 5678888434456899999999999998 88 566 5799999999 999999 78755566777777888888888877
Q ss_pred CC
Q 002857 79 CG 80 (873)
Q Consensus 79 ~G 80 (873)
..
T Consensus 310 ~~ 311 (329)
T 3sb4_A 310 TT 311 (329)
T ss_dssp CE
T ss_pred Cc
Confidence 64
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 873 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 8e-53 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-46 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 8e-46 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-45 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-44 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-44 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-43 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-42 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-41 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-41 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-41 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-41 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-41 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-41 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-41 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 9e-41 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-40 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-40 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-40 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 6e-40 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-39 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-39 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-39 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-39 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-38 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-38 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-37 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-37 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 5e-37 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-36 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-36 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-36 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-35 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-34 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 7e-34 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-33 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-33 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-32 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-31 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-31 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-31 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-31 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-30 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-30 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-29 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-29 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-29 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-29 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-28 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-28 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-28 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-27 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-27 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-27 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-26 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-25 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 5e-25 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-24 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 9e-24 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-23 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-23 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 5e-23 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-15 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-13 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 4e-08 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-07 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-07 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-05 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 0.002 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 0.004 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-04 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-04 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.003 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.004 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 7e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.001 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.001 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.002 | |
| d1zbdb_ | 124 | g.50.1.1 (B:) Effector domain of rabphilin-3a {Rat | 0.002 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 8e-53
Identities = 64/313 (20%), Positives = 119/313 (38%), Gaps = 56/313 (17%)
Query: 165 ENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDAS--KSFTVECEVMRNIIHRKIIKV 222
IG+G+F +VYKG VA+K+ N ++F E V+R H I+
Sbjct: 13 GQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 69
Query: 223 VTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVA 282
+ + A+V ++ SL +H ++ ++IA A
Sbjct: 70 MGYST------APQLAIVTQWCEGSSLYHHLH---------IIETKFEMIKLIDIARQTA 114
Query: 283 SALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTG 342
++YLH I H D+K +NI L++++T + DFG+A + + G+
Sbjct: 115 QGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 171
Query: 343 YIAPEYGMGHETSSYG---DVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPERV 399
++APE + + Y DVY+FGI+L E+ TG P ++ + + + L +
Sbjct: 172 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDL 231
Query: 400 EEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKIN 459
++ C ++ + C + ER
Sbjct: 232 SKVRS------------------------------NCPKAMKRLMAECLKKKRDERPLFP 261
Query: 460 DVELGLRLIKKKL 472
+ + L+ + L
Sbjct: 262 QILASIELLARSL 274
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 4e-46
Identities = 49/249 (19%), Positives = 86/249 (34%), Gaps = 16/249 (6%)
Query: 162 FSSENLIGAGNFASVYKGILFEGAPAVAIKVFN--FLHHDASKSFTVECEVMRNIIHRKI 219
+ IG G++ K + K + + + E ++R + H I
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65
Query: 220 IKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAI 279
++ + N +V E+ G L I K K L+ L +
Sbjct: 66 VRYYDRII---DRTNTTLYIVMEYCEGGDLASVIT------KGTKERQYLDEEFVLRVMT 116
Query: 280 DVASALEYLHL--GCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGV 337
+ AL+ H + H D+KP+N+ L+ + + DFG+AR L +
Sbjct: 117 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA--F 174
Query: 338 KGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPE 397
GT Y++PE + D++S G LL E+ + P + L +
Sbjct: 175 VGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL-AGKIREGKFRR 233
Query: 398 RVEEIVDTL 406
D L
Sbjct: 234 IPYRYSDEL 242
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 8e-46
Identities = 56/228 (24%), Positives = 88/228 (38%), Gaps = 22/228 (9%)
Query: 162 FSSENLIGAGNFASVYKGILFEGAPAVAIKVFNF-LHHDASKSFTVECEVMRNIIHRKII 220
F + +GAGN V+K +A K+ + + E +V+ I+
Sbjct: 8 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 221 KVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAID 280
A + ++ E M GSL++ + G + ++I
Sbjct: 68 GFYGAF-----YSDGEISICMEHMDGGSLDQVLK----------KAGRIPEQILGKVSIA 112
Query: 281 VASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGT 340
V L YL K I H D+KPSNIL+N + DFG++ L + + GT
Sbjct: 113 VIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS----FVGT 166
Query: 341 TGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQ 388
Y++PE G S D++S G+ L+EM G P L L
Sbjct: 167 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM 214
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (412), Expect = 1e-45
Identities = 57/243 (23%), Positives = 97/243 (39%), Gaps = 20/243 (8%)
Query: 165 ENLIGAGNFASVYKGILFEGAPAVAIKVFN--FLHHDASKSFTVECEVMRNIIHRKIIKV 222
+ IG G+F +VYKG+ E VA L + F E E+++ + H I++
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 223 VTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVA 282
+ +G LV E M +G+L+ ++ + + +
Sbjct: 74 YDSWESTV-KGKKCIVLVTELMTSGTLKTYLK----------RFKVMKIKVLRSWCRQIL 122
Query: 283 SALEYLHLGCKPPIAHCDIKPSNILLNDE-MTACVADFGIARFLEATNEQTSSIGVKGTT 341
L++LH PPI H D+K NI + + + D G+A A+ + V GT
Sbjct: 123 KGLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA----VIGTP 177
Query: 342 GYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPERVEE 401
++APE S DVY+FG+ +LEM T P + + P ++
Sbjct: 178 EFMAPEMYEEKYDES-VDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDK 236
Query: 402 IVD 404
+
Sbjct: 237 VAI 239
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 1e-44
Identities = 56/241 (23%), Positives = 106/241 (43%), Gaps = 20/241 (8%)
Query: 166 NLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTA 225
+GAG F V+ G VA+K + +F E +M+ + H++++++
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTK-VAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 226 CSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASAL 285
+ + ++ E+M NGSL +++ + L + L++A +A +
Sbjct: 77 VT------QEPIYIITEYMENGSLVDFLK--------TPSGIKLTINKLLDMAAQIAEGM 122
Query: 286 EYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIA 345
++ + H D++ +NIL++D ++ +ADFG+AR +E G K + A
Sbjct: 123 AFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE-GAKFPIKWTA 178
Query: 346 PEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPERVEEIVDT 405
PE + DV+SFGILL E+ T R + +QN + R + +
Sbjct: 179 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEE 238
Query: 406 L 406
L
Sbjct: 239 L 239
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 4e-44
Identities = 64/321 (19%), Positives = 117/321 (36%), Gaps = 46/321 (14%)
Query: 165 ENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVT 224
+ IG G F V++G G VA+K+F+ + S E + H I+ +
Sbjct: 8 QESIGKGRFGEVWRGKW-RGEE-VAVKIFS-SREERSWFREAEIYQTVMLRHENILGFIA 64
Query: 225 ACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASA 284
A ++ + LV ++ +GSL ++++ + + +A+ AS
Sbjct: 65 ADNKDNGTWTQL-WLVSDYHEHGSLFDYLNR-----------YTVTVEGMIKLALSTASG 112
Query: 285 LEYLHLGC-----KPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTS--SIGV 337
L +LH+ KP IAH D+K NIL+ T C+AD G+A ++ +
Sbjct: 113 LAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHR 172
Query: 338 KGTTGYIAPEYGMGHETSSYG------DVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWV 391
GT Y+APE + D+Y+ G++ E+ L + V
Sbjct: 173 VGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 232
Query: 392 --QSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSA 449
++ E + + + I R E L + +I C
Sbjct: 233 PSDPSVEEMRKVVCEQKLRPNIPN----------------RWQSCEALRVMAKIMRECWY 276
Query: 450 ELPGERMKINDVELGLRLIKK 470
R+ ++ L + +
Sbjct: 277 ANGAARLTALRIKKTLSQLSQ 297
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 157 bits (399), Expect = 1e-43
Identities = 67/273 (24%), Positives = 113/273 (41%), Gaps = 35/273 (12%)
Query: 151 SYEALYSATKGFSSE---------NLIGAGNFASVYKGIL---FEGAPAVAIKVFNF-LH 197
++E A + F+ E +IGAG F V G L + VAIK
Sbjct: 8 TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67
Query: 198 HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPIT 257
+ F E +M H +I + + ++ EFM NGSL+ +
Sbjct: 68 EKQRRDFLSEASIMGQFDHPNVIHLEGVV-----TKSTPVMIITEFMENGSLDSF----- 117
Query: 258 EEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVA 317
+ G ++ + + +A+ ++YL H D+ NIL+N + V+
Sbjct: 118 ----LRQNDGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVS 170
Query: 318 DFGIARFLE---ATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-G 373
DFG++RFLE + TS++G K + APE + +S DV+S+GI++ E+ + G
Sbjct: 171 DFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYG 230
Query: 374 LRPSDDMFKDNLNLQNWVQSALPERVEEIVDTL 406
RP DM ++ + Q + L
Sbjct: 231 ERPYWDMTNQDV-INAIEQDYRLPPPMDCPSAL 262
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 4e-42
Identities = 53/220 (24%), Positives = 90/220 (40%), Gaps = 24/220 (10%)
Query: 166 NLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTA 225
+G G F VYK E + A KV + + + + VE +++ + H I+K++ A
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 226 CSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASAL 285
+ ++ EF G+++ + + L + + AL
Sbjct: 78 F-----YYENNLWILIEFCAGGAVDAVML---------ELERPLTESQIQVVCKQTLDAL 123
Query: 286 EYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIA 345
YLH I H D+K NIL + +ADFG++ T ++ S GT ++A
Sbjct: 124 NYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMA 178
Query: 346 PEYGMGHETSSYG-----DVYSFGILLLEMFTGLRPSDDM 380
PE M + DV+S GI L+EM P ++
Sbjct: 179 PEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL 218
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 152 bits (386), Expect = 1e-41
Identities = 55/255 (21%), Positives = 88/255 (34%), Gaps = 31/255 (12%)
Query: 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFN---FLHHDASKSFTVECEVMRNII 215
K FS IG G+F +VY + VAIK + ++ + E ++ +
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 216 HRKIIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERL 275
H I+ LV E+ + + L +E
Sbjct: 74 HPNTIQYRGCY-----LREHTAWLVMEYCLGSASDLLEV----------HKKPLQEVEIA 118
Query: 276 NIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSI 335
+ L YLH + H D+K NILL++ + DFG A + N
Sbjct: 119 AVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS----- 170
Query: 336 GVKGTTGYIAPEYGMGHETSSYG---DVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQ 392
GT ++APE + + Y DV+S GI +E+ P +M + L + Q
Sbjct: 171 -FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHIAQ 228
Query: 393 SALPERVEEIVDTLF 407
+ P F
Sbjct: 229 NESPALQSGHWSEYF 243
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 1e-41
Identities = 52/244 (21%), Positives = 90/244 (36%), Gaps = 26/244 (10%)
Query: 162 FSSENLIGAGNFASVYKGILFEGAPAVAIKVFN---FLHHDASKSFTVECEVMRNIIHRK 218
F +G G F +VY + +A+KV E E+ ++ H
Sbjct: 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 67
Query: 219 IIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIA 278
I+++ L+ E+ P G++ + +
Sbjct: 68 ILRLYGYF-----HDATRVYLILEYAPLGTVYRELQK----------LSKFDEQRTATYI 112
Query: 279 IDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVK 338
++A+AL Y H + H DIKP N+LL +ADFG + ++ T +
Sbjct: 113 TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT----LC 165
Query: 339 GTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRP-SDDMFKDNLNLQNWVQSALPE 397
GT Y+ PE G D++S G+L E G P + +++ + V+ P+
Sbjct: 166 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD 225
Query: 398 RVEE 401
V E
Sbjct: 226 FVTE 229
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 152 bits (384), Expect = 1e-41
Identities = 62/319 (19%), Positives = 112/319 (35%), Gaps = 44/319 (13%)
Query: 144 DLDFPYVSYEALYSATKGFSSENLIGAGNFASVYKGILFEGAPA-----VAIKVFNF-LH 197
L++P + E + IG G F V++ P VA+K+
Sbjct: 7 SLEYPRNNIEYV----------RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS 56
Query: 198 HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIH--- 254
D F E +M + I+K++ C L++E+M G L E++
Sbjct: 57 ADMQADFQREAALMAEFDNPNIVKLLGVC-----AVGKPMCLLFEYMAYGDLNEFLRSMS 111
Query: 255 -----------PITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKP 303
T P L+ E+L IA VA+ + YL + H D+
Sbjct: 112 PHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLAT 168
Query: 304 SNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSF 363
N L+ + M +ADFG++R + + + + ++ PE + ++ DV+++
Sbjct: 169 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAY 228
Query: 364 GILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKA 423
G++L E+F+ + + E L +
Sbjct: 229 GVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPENCPLEL--YNLMRLCWSKLPADR 286
Query: 424 PSSSTQRSIILECLNSICE 442
PS + I L +CE
Sbjct: 287 PSFCS----IHRILQRMCE 301
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 2e-41
Identities = 55/258 (21%), Positives = 100/258 (38%), Gaps = 25/258 (9%)
Query: 155 LYSATKGFSSENL-IGAGNFASVYKGILFE--GAPAVAIKVFN-FLHHDASKSFTVECEV 210
L+ ++ +G GNF SV +G+ VAIKV ++ E ++
Sbjct: 3 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQI 62
Query: 211 MRNIIHRKIIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLN 270
M + + I++++ C LV E G L +++ +
Sbjct: 63 MHQLDNPYIVRLIGVCQAEAL------MLVMEMAGGGPLHKFLV---------GKREEIP 107
Query: 271 SLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNE 330
+ V+ ++YL + H D+ N+LL + A ++DFG+++ L A +
Sbjct: 108 VSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS 164
Query: 331 Q-TSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQ 388
T+ K + APE + SS DV+S+G+ + E + G +P M + +
Sbjct: 165 YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV-MA 223
Query: 389 NWVQSALPERVEEIVDTL 406
Q E E L
Sbjct: 224 FIEQGKRMECPPECPPEL 241
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 3e-41
Identities = 64/245 (26%), Positives = 109/245 (44%), Gaps = 20/245 (8%)
Query: 162 FSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIK 221
E +G G F V+ G VAIK + ++F E +VM+ + H K+++
Sbjct: 19 LRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQ 76
Query: 222 VVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDV 281
+ S + +V E+M GSL +++ T + R + +++A +
Sbjct: 77 LYAVVS------EEPIYIVTEYMSKGSLLDFLKGETGKYLRLP--------QLVDMAAQI 122
Query: 282 ASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTT 341
AS + Y+ + H D++ +NIL+ + + VADFG+AR +E NE T+ G K
Sbjct: 123 ASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPI 178
Query: 342 GYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPERVEE 401
+ APE + + DV+SFGILL E+ T R + L + E
Sbjct: 179 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPE 238
Query: 402 IVDTL 406
++L
Sbjct: 239 CPESL 243
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 3e-41
Identities = 54/245 (22%), Positives = 98/245 (40%), Gaps = 24/245 (9%)
Query: 162 FSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIK 221
IG G F V G G VA+K + +++F E VM + H +++
Sbjct: 9 LKLLQTIGKGEFGDVMLGDY-RGNK-VAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQ 64
Query: 222 VVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDV 281
++ + +V E+M GSL +++ + L L ++DV
Sbjct: 65 LLGVI----VEEKGGLYIVTEYMAKGSLVDYLR--------SRGRSVLGGDCLLKFSLDV 112
Query: 282 ASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTT 341
A+EYL H D+ N+L++++ A V+DFG+ + +T + K
Sbjct: 113 CEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT-----GKLPV 164
Query: 342 GYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPERVEE 401
+ APE + S+ DV+SFGILL E+++ R + + + +
Sbjct: 165 KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDG 224
Query: 402 IVDTL 406
+
Sbjct: 225 CPPAV 229
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 4e-41
Identities = 53/245 (21%), Positives = 93/245 (37%), Gaps = 20/245 (8%)
Query: 162 FSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH-HDASKSFTVECEVMRNIIHRKII 220
+ +G G + V + AVA+K+ + D ++ E + + + H ++
Sbjct: 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66
Query: 221 KVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAID 280
K + + + L E+ G L + I P + +
Sbjct: 67 KFYGHR-----REGNIQYLFLEYCSGGELFDRIEP----------DIGMPEPDAQRFFHQ 111
Query: 281 VASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGT 340
+ + + YLH I H DIKP N+LL++ ++DFG+A N + + GT
Sbjct: 112 LMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 168
Query: 341 TGYIAPEYGMGHETSSYG-DVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPERV 399
Y+APE E + DV+S GI+L M G P D +W +
Sbjct: 169 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP 228
Query: 400 EEIVD 404
+ +D
Sbjct: 229 WKKID 233
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 9e-41
Identities = 51/287 (17%), Positives = 104/287 (36%), Gaps = 29/287 (10%)
Query: 131 MKKRGNPTPSISIDLDFPYVSYEALYSATKG-FSSENLIGAGNFASVYKGILFEG----- 184
M + + + +DF Y+ + + ++G+G F V +
Sbjct: 7 MVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGV 66
Query: 185 APAVAIKVFN-FLHHDASKSFTVECEVMRNII-HRKIIKVVTACSRVDYQGNDFKALVYE 242
+ VA+K+ ++ E ++M + H I+ ++ AC + L++E
Sbjct: 67 SIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC-----TLSGPIYLIFE 121
Query: 243 FMPNGSLEEWIH-------------PITEEDKRHKAPGNLNSLERLNIAIDVASALEYLH 289
+ G L ++ + + + L + L A VA +E+L
Sbjct: 122 YCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE 181
Query: 290 LGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYG 349
H D+ N+L+ + DFG+AR + + + + ++APE
Sbjct: 182 ---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESL 238
Query: 350 MGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALP 396
+ DV+S+GILL E+F+ + N +Q+
Sbjct: 239 FEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFK 285
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 2e-40
Identities = 68/306 (22%), Positives = 124/306 (40%), Gaps = 34/306 (11%)
Query: 147 FPYVSYEALYSATKGFSSENLIGAGNFASVYKGILFEGAP--AVAIKVFN-FLHHDASKS 203
+P + + +++IG GNF V K + + AIK + D +
Sbjct: 4 YPVLDWN-------DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD 56
Query: 204 FTVECEVMRNII-HRKIIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIH------PI 256
F E EV+ + H II ++ AC + + L E+ P+G+L +++
Sbjct: 57 FAGELEVLCKLGHHPNIINLLGAC-----EHRGYLYLAIEYAPHGNLLDFLRKSRVLETD 111
Query: 257 TEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACV 316
+ L+S + L+ A DVA ++YL + H D+ NIL+ + A +
Sbjct: 112 PAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKI 168
Query: 317 ADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRP 376
ADFG++R E ++T + ++A E ++ DV+S+G+LL E+ +
Sbjct: 169 ADFGLSRGQEVYVKKTM---GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT 225
Query: 377 SDDMFKDNLNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILEC 436
+ Q E+ D + ++ + K + PS + IL
Sbjct: 226 PYCGMTCAELYEKLPQGYRLEKPLNCDDEV--YDLMRQCWREKPYERPSFAQ----ILVS 279
Query: 437 LNSICE 442
LN + E
Sbjct: 280 LNRMLE 285
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 3e-40
Identities = 61/329 (18%), Positives = 113/329 (34%), Gaps = 57/329 (17%)
Query: 165 ENLIGAGNFASVYKGILFEGAP---AVAIKVFN-FLHHDASKSFTVECEVMRNIIHRKII 220
+IG G+F VY G L + A+K N F E +M++ H ++
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 221 KVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAID 280
++ C + +V +M +G L +I N + + +
Sbjct: 92 SLLGIC----LRSEGSPLVVLPYMKHGDLRNFIRN---------ETHNPTVKDLIGFGLQ 138
Query: 281 VASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFL--EATNEQTSSIGVK 338
VA + H D+ N +L+++ T VADFG+AR + + + + G K
Sbjct: 139 VAKGM---KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK 195
Query: 339 GTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPER 398
++A E + ++ DV+SFG+LL E+ T P +Q +
Sbjct: 196 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ 255
Query: 399 VEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKI 458
E D L ++L+C + R
Sbjct: 256 PEYCPDPL-----------------------YEVMLKCWH-----------PKAEMRPSF 281
Query: 459 NDVELGLRLIKKKLL-ETPVYEEKQTINM 486
+++ + I + E V+ +N+
Sbjct: 282 SELVSRISAIFSTFIGEHYVHVNATYVNV 310
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 3e-40
Identities = 68/283 (24%), Positives = 115/283 (40%), Gaps = 26/283 (9%)
Query: 162 FSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIK 221
+ IG+G F V+ G VAIK + + F E EVM + H K+++
Sbjct: 7 LTFVQEIGSGQFGLVHLGYWLNKDK-VAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQ 64
Query: 222 VVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDV 281
+ C LV+EFM +G L ++ G + L + +DV
Sbjct: 65 LYGVC-----LEQAPICLVFEFMEHGCLSDY---------LRTQRGLFAAETLLGMCLDV 110
Query: 282 ASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTT 341
+ YL + + H D+ N L+ + V+DFG+ RF+ ++ TSS G K
Sbjct: 111 CEGMAYL---EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPV 166
Query: 342 GYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPERVEE 401
+ +PE SS DV+SFG+L+ E+F+ + + + N + + +
Sbjct: 167 KWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN-RSNSEVVEDISTGFRLYKPR 225
Query: 402 IVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIG 444
+ T +I + + P+ S +L L I E G
Sbjct: 226 LAST-HVYQIMNHCWKERPEDRPAFSR----LLRQLAEIAESG 263
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 6e-40
Identities = 58/260 (22%), Positives = 107/260 (41%), Gaps = 26/260 (10%)
Query: 162 FSSENLIGAGNFASVYKGILFEGAPAVAIKVFN---FLHHDASKSFTVECEVMRNIIHRK 218
F ++G G+F++V + AIK+ + + T E +VM + H
Sbjct: 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69
Query: 219 IIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIA 278
+K+ Q ++ + NG L ++I G+ +
Sbjct: 70 FVKLYFTF-----QDDEKLYFGLSYAKNGELLKYIRK----------IGSFDETCTRFYT 114
Query: 279 IDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVK 338
++ SALEYLH I H D+KP NILLN++M + DFG A+ L ++Q +
Sbjct: 115 AEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV 171
Query: 339 GTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRP-----SDDMFKDNLNLQNWVQS 393
GT Y++PE D+++ G ++ ++ GL P +F+ + L+
Sbjct: 172 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE 231
Query: 394 ALPERVEEIVDTLFFKEIEE 413
+ ++V+ L + +
Sbjct: 232 KFFPKARDLVEKLLVLDATK 251
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 2e-39
Identities = 47/250 (18%), Positives = 89/250 (35%), Gaps = 23/250 (9%)
Query: 162 FSSENLIGAGNFASVYKGILFEGAPA-----VAIKVFN-FLHHDASKSFTVECEVMRNII 215
S +GAG F V + + + VA+K+ H ++ E +V+ +
Sbjct: 25 LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG 84
Query: 216 -HRKIIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIH--------PITEEDKRHKAP 266
H I+ ++ AC ++ E+ G L ++ T
Sbjct: 85 NHMNIVNLLGAC-----TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139
Query: 267 GNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLE 326
L+ + L+ + VA + +L H D+ NILL + DFG+AR ++
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIK 196
Query: 327 ATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLN 386
+ + ++APE + DV+S+GI L E+F+ +
Sbjct: 197 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256
Query: 387 LQNWVQSALP 396
++
Sbjct: 257 FYKMIKEGFR 266
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 2e-39
Identities = 60/251 (23%), Positives = 105/251 (41%), Gaps = 23/251 (9%)
Query: 162 FSSENLIGAGNFASVYKGILFEG----APAVAIKVFN-FLHHDASKSFTVECEVMRNIIH 216
+ + +IGAG F VYKG+L VAIK F E +M H
Sbjct: 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 68
Query: 217 RKIIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLN 276
II++ S+ ++ E+M NG+L+++ + G + L+ +
Sbjct: 69 HNIIRLEGVISK-----YKPMMIITEYMENGALDKF---------LREKDGEFSVLQLVG 114
Query: 277 IAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQT-SSI 335
+ +A+ ++YL H D+ NIL+N + V+DFG++R LE E T ++
Sbjct: 115 MLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS 171
Query: 336 GVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSAL 395
G K + APE + +S DV+SFGI++ E+ T ++ ++
Sbjct: 172 GGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR 231
Query: 396 PERVEEIVDTL 406
+ +
Sbjct: 232 LPTPMDCPSAI 242
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 2e-39
Identities = 59/245 (24%), Positives = 108/245 (44%), Gaps = 20/245 (8%)
Query: 162 FSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIK 221
+ +G G F V G VAIK+ + F E +VM N+ H K+++
Sbjct: 6 LTFLKELGTGQFGVVKYGKWRGQYD-VAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQ 63
Query: 222 VVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDV 281
+ C++ ++ E+M NG L ++ + + L + DV
Sbjct: 64 LYGVCTK-----QRPIFIITEYMANGCLLNYLRE---------MRHRFQTQQLLEMCKDV 109
Query: 282 ASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTT 341
A+EYL H D+ N L+ND+ V+DFG++R++ +E TSS+G K
Sbjct: 110 CEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPV 165
Query: 342 GYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPERVEE 401
+ PE M + SS D+++FG+L+ E+++ + + F ++ ++ Q R
Sbjct: 166 RWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHL 225
Query: 402 IVDTL 406
+ +
Sbjct: 226 ASEKV 230
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 3e-39
Identities = 53/222 (23%), Positives = 97/222 (43%), Gaps = 25/222 (11%)
Query: 165 ENLIGAGNFASVYKGILFEGAP--AVAIKVFNFLHHDAS--KSFTVECEVMRNIIHRKII 220
+ +G+GNF +V KG VA+K+ +D + E VM+ + + I+
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 221 KVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAID 280
+++ C + LV E G L +++ ++ + +
Sbjct: 72 RMIGICE------AESWMLVMEMAELGPLNKYLQQ----------NRHVKDKNIIELVHQ 115
Query: 281 VASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEAT-NEQTSSIGVKG 339
V+ ++YL + H D+ N+LL + A ++DFG+++ L A N + K
Sbjct: 116 VSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 172
Query: 340 TTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDM 380
+ APE ++ SS DV+SFG+L+ E F+ G +P M
Sbjct: 173 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 214
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 1e-38
Identities = 51/222 (22%), Positives = 87/222 (39%), Gaps = 21/222 (9%)
Query: 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRK 218
K ++ IG G +VY + VAI+ N + E VMR +
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 219 IIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIA 278
I+ + + D +V E++ GSL + + ++ + +
Sbjct: 79 IVNYLDSY-----LVGDELWVVMEYLAGGSLTDVVTETCMDEG-----------QIAAVC 122
Query: 279 IDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVK 338
+ ALE+LH + H DIK NILL + + + DFG + + S++
Sbjct: 123 RECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM--V 177
Query: 339 GTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDM 380
GT ++APE D++S GI+ +EM G P +
Sbjct: 178 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE 219
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 142 bits (358), Expect = 3e-38
Identities = 56/245 (22%), Positives = 107/245 (43%), Gaps = 18/245 (7%)
Query: 162 FSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIK 221
+ ++ +G G + VY+G+ + + VA+K + F E VM+ I H +++
Sbjct: 19 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQ 77
Query: 222 VVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDV 281
++ C ++ EFM G+L +++ ++++ L +A +
Sbjct: 78 LLGVC-----TREPPFYIITEFMTYGNLLDYLR--------ECNRQEVSAVVLLYMATQI 124
Query: 282 ASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTT 341
+SA+EYL K H D+ N L+ + VADFG++R + + T+ G K
Sbjct: 125 SSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPI 180
Query: 342 GYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPERVEE 401
+ APE ++ S DV++FG+LL E+ T + + + ER E
Sbjct: 181 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEG 240
Query: 402 IVDTL 406
+ +
Sbjct: 241 CPEKV 245
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 1e-37
Identities = 50/220 (22%), Positives = 92/220 (41%), Gaps = 23/220 (10%)
Query: 162 FSSENLIGAGNFASVYKGILF----EGAPAVAIKVFNFLHH-DASKSFTVECEVMRNIIH 216
F ++G+G F +VYKG+ + VAIK A+K E VM ++ +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 217 RKIIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLN 276
+ +++ C L+ + MP G L ++ + N+ S LN
Sbjct: 71 PHVCRLLGICL------TSTVQLITQLMPFGCLLDY---------VREHKDNIGSQYLLN 115
Query: 277 IAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIG 336
+ +A + YL + H D+ N+L+ + DFG+A+ L A ++ + G
Sbjct: 116 WCVQIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 172
Query: 337 VKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRP 376
K ++A E + + DV+S+G+ + E+ T
Sbjct: 173 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 212
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 2e-37
Identities = 51/271 (18%), Positives = 103/271 (38%), Gaps = 20/271 (7%)
Query: 149 YVSYEALYSATK------GFSSENLIGAGNFASVYKGILFEGAPA-----VAIKVFN-FL 196
Y S +Y + + +G G+F VY+G+ VAIK N
Sbjct: 3 YFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA 62
Query: 197 HHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPI 256
F E VM+ +++++ ++ E M G L+ ++ +
Sbjct: 63 SMRERIEFLNEASVMKEFNCHHVVRLLGVV-----SQGQPTLVIMELMTRGDLKSYLRSL 117
Query: 257 TEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACV 316
+ + + + +A ++A + YL H D+ N ++ ++ T +
Sbjct: 118 RPAMANNPVLAPPSLSKMIQMAGEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKI 174
Query: 317 ADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRP 376
DFG+ R + T+ +++PE ++Y DV+SFG++L E+ T
Sbjct: 175 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ 234
Query: 377 SDDMFKDNLNLQNWVQSALPERVEEIVDTLF 407
+ L+ ++ L ++ + D LF
Sbjct: 235 PYQGLSNEQVLRFVMEGGLLDKPDNCPDMLF 265
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 140 bits (354), Expect = 5e-37
Identities = 51/258 (19%), Positives = 95/258 (36%), Gaps = 31/258 (12%)
Query: 167 LIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTAC 226
+G G F V++ A K H ++ E + M + H ++ + A
Sbjct: 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92
Query: 227 SRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALE 286
+ ++ ++YEFM G L E + ++ E + V L
Sbjct: 93 -----EDDNEMVMIYEFMSGGELFEKVA---------DEHNKMSEDEAVEYMRQVCKGLC 138
Query: 287 YLHLGCKPPIAHCDIKPSNILLNDEMTACV--ADFGIARFLEATNEQTSSIGVKGTTGYI 344
++H + H D+KP NI+ + + + DFG+ L + + S GT +
Sbjct: 139 HMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL---DPKQSVKVTTGTAEFA 192
Query: 345 APEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDM---------FKDNLNLQNWVQSAL 395
APE G Y D++S G+L + +GL P + N+ + S +
Sbjct: 193 APEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGI 252
Query: 396 PERVEEIVDTLFFKEIEE 413
E ++ + L +
Sbjct: 253 SEDGKDFIRKLLLADPNT 270
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 136 bits (344), Expect = 2e-36
Identities = 56/238 (23%), Positives = 94/238 (39%), Gaps = 18/238 (7%)
Query: 165 ENLIGAGNFASVYKGILFEGAPAVAIKVFN---FLHHDASKSFTVECEVMRNIIHRKIIK 221
++G G + V+ VA+KV F E + + H I+
Sbjct: 12 GEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 71
Query: 222 VVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDV 281
V G +V E++ +L + +H G + + + D
Sbjct: 72 VYDTGEAETPAGPLP-YIVMEYVDGVTLRDIVHT----------EGPMTPKRAIEVIADA 120
Query: 282 ASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFL-EATNEQTSSIGVKGT 340
AL + + I H D+KP+NI+++ V DFGIAR + ++ N T + V GT
Sbjct: 121 CQALNFS---HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 177
Query: 341 TGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPER 398
Y++PE G + DVYS G +L E+ TG P ++ Q+ + +P
Sbjct: 178 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPS 235
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 138 bits (348), Expect = 3e-36
Identities = 52/242 (21%), Positives = 90/242 (37%), Gaps = 24/242 (9%)
Query: 167 LIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTAC 226
+G+G F V++ + K N + + E +M + H K+I + A
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 227 SRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALE 286
+ L+ EF+ G L + I ++ E +N L+
Sbjct: 96 -----EDKYEMVLILEFLSGGELFDRI---------AAEDYKMSEAEVINYMRQACEGLK 141
Query: 287 YLHLGCKPPIAHCDIKPSNILL--NDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYI 344
++H + I H DIKP NI+ + + DFG+A L N T +
Sbjct: 142 HMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL---NPDEIVKVTTATAEFA 195
Query: 345 APEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPERVEEIVD 404
APE Y D+++ G+L + +GL P D+L V+ E E+
Sbjct: 196 APEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE--DDLETLQNVKRCDWEFDEDAFS 253
Query: 405 TL 406
++
Sbjct: 254 SV 255
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 3e-36
Identities = 55/246 (22%), Positives = 92/246 (37%), Gaps = 23/246 (9%)
Query: 165 ENLIGAGNFASVYKGILFEG---APAVAIKVFNFLHHDASKS-FTVECEVMRNIIHRKII 220
IG G F V++GI A AVAIK D+ + F E MR H I+
Sbjct: 12 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 71
Query: 221 KVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAID 280
K++ + + ++ E G L + +L+ + A
Sbjct: 72 KLIGVIT------ENPVWIIMELCTLGELRSF---------LQVRKYSLDLASLILYAYQ 116
Query: 281 VASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGT 340
+++AL YL H DI N+L++ + DFG++R++E + +S G
Sbjct: 117 LSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGK-LP 172
Query: 341 TGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPERVE 400
++APE +S DV+ FG+ + E+ K+N +
Sbjct: 173 IKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPP 232
Query: 401 EIVDTL 406
TL
Sbjct: 233 NCPPTL 238
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 3e-35
Identities = 46/252 (18%), Positives = 89/252 (35%), Gaps = 18/252 (7%)
Query: 165 ENLIGAGNFASVYKGILFEGAPA-----VAIKVFN-FLHHDASKSFTVECEVMRNIIHRK 218
+G G F V + F VA+K+ H ++ E +++ +I H
Sbjct: 18 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 77
Query: 219 IIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIH------PITEEDKRHKAPGNLNSL 272
+ + + ++ EF G+L ++ + L
Sbjct: 78 NVVNLLGAC---TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 134
Query: 273 ERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQT 332
+ + VA +E+L H D+ NILL+++ + DFG+AR + +
Sbjct: 135 HLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 191
Query: 333 SSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQ 392
+ ++APE + DV+SFG+LL E+F+ K + ++
Sbjct: 192 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 251
Query: 393 SALPERVEEIVD 404
R +
Sbjct: 252 EGTRMRAPDYTT 263
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 1e-34
Identities = 56/247 (22%), Positives = 88/247 (35%), Gaps = 26/247 (10%)
Query: 168 IGAGNFASVYKGILFEGAP---AVAIKVFN---FLHHDASKSFTVECEVMRNIIHRKIIK 221
+G G+F V +G + +VA+K +A F E M ++ HR +I+
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 222 VVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDV 281
+ +V E P GSL D+ K G+ A+ V
Sbjct: 76 LYGVVL------TPPMKMVTELAPLGSLL---------DRLRKHQGHFLLGTLSRYAVQV 120
Query: 282 ASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQ-TSSIGVKGT 340
A + YL H D+ N+LL + DFG+ R L ++ K
Sbjct: 121 AEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP 177
Query: 341 TGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQSALPERV 399
+ APE S D + FG+ L EMFT G P + + + + R
Sbjct: 178 FAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRP 237
Query: 400 EEIVDTL 406
E+ +
Sbjct: 238 EDCPQDI 244
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 7e-34
Identities = 50/256 (19%), Positives = 91/256 (35%), Gaps = 21/256 (8%)
Query: 165 ENLIGAGNFASVYKGIL-------FEGAPAVAIKVFN-FLHHDASKSFTVECEVMRNIIH 216
+G G F V VA+K+ E E+M+ I
Sbjct: 18 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 77
Query: 217 RKIIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHP------ITEEDKRHKAPGNLN 270
K I + + ++ E+ G+L E++ + H L+
Sbjct: 78 HKNIINLLGA----CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 133
Query: 271 SLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNE 330
S + ++ A VA +EYL H D+ N+L+ ++ +ADFG+AR + +
Sbjct: 134 SKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 190
Query: 331 QTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNW 390
+ + ++APE + DV+SFG+LL E+FT +
Sbjct: 191 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 250
Query: 391 VQSALPERVEEIVDTL 406
+ ++ + L
Sbjct: 251 KEGHRMDKPSNCTNEL 266
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 2e-33
Identities = 45/212 (21%), Positives = 82/212 (38%), Gaps = 23/212 (10%)
Query: 167 LIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTAC 226
+G G F V++ + K + E ++ HR I+ + +
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVK-VKGTDQVLVKKEISILNIARHRNILHLHESF 70
Query: 227 SRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALE 286
+ + +++EF+ + E I+ + LN E ++ V AL+
Sbjct: 71 -----ESMEELVMIFEFISGLDIFERIN---------TSAFELNEREIVSYVHQVCEALQ 116
Query: 287 YLHLGCKPPIAHCDIKPSNILL--NDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYI 344
+LH I H DI+P NI+ T + +FG AR L+ + + Y
Sbjct: 117 FLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEYY 170
Query: 345 APEYGMGHETSSYGDVYSFGILLLEMFTGLRP 376
APE S+ D++S G L+ + +G+ P
Sbjct: 171 APEVHQHDVVSTATDMWSLGTLVYVLLSGINP 202
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 127 bits (321), Expect = 2e-33
Identities = 50/226 (22%), Positives = 92/226 (40%), Gaps = 27/226 (11%)
Query: 162 FSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIK 221
+ + ++G G + V + I A+K+ + + + V+ + I++
Sbjct: 5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64
Query: 222 VVTACSRV-----DYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLN 276
V+ + Y+ N F LV++ M G L +++ L+ E
Sbjct: 65 KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT----------EKVTLSEKETRK 114
Query: 277 IAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIG 336
I + + LH K I H D+KP NILL+D+M + DFG + L+ +
Sbjct: 115 IMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE--- 168
Query: 337 VKGTTGYIAPEYGMGHETSSYG------DVYSFGILLLEMFTGLRP 376
V GT Y+APE ++ D++S G+++ + G P
Sbjct: 169 VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 214
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 1e-32
Identities = 59/261 (22%), Positives = 104/261 (39%), Gaps = 29/261 (11%)
Query: 162 FSSENLIGAGNFASVYKGILFEGAPAVAIKVFN---FLHHDASKSFTVECEVMRNII-HR 217
F ++G G+F V+ + AIK L D + VE V+ H
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 218 KIIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNI 277
+ + Q + V E++ G L I + +
Sbjct: 64 FLTHMFCTF-----QTKENLFFVMEYLNGGDLMYHIQ----------SCHKFDLSRATFY 108
Query: 278 AIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGV 337
A ++ L++L I + D+K NILL+ + +ADFG+ + + +T++
Sbjct: 109 AAEIILGLQFL---HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTF-- 163
Query: 338 KGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRP-----SDDMFKDNLNLQNWVQ 392
GT YIAPE +G + + D +SFG+LL EM G P +++F +
Sbjct: 164 CGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYP 223
Query: 393 SALPERVEEIVDTLFFKEIEE 413
L + ++++ LF +E E+
Sbjct: 224 RWLEKEAKDLLVKLFVREPEK 244
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 123 bits (311), Expect = 1e-31
Identities = 43/225 (19%), Positives = 78/225 (34%), Gaps = 19/225 (8%)
Query: 162 FSSENLIGAGNFASVYKGILFEGAPAVAIKVFNF-LHHDASKSFTVECEVMRNIIHRKII 220
+ +++G G F+ V VAIK S E V+ I H I+
Sbjct: 11 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 70
Query: 221 KVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAID 280
+ + L+ + + G L + I G + +
Sbjct: 71 ALDDIY-----ESGGHLYLIMQLVSGGELFDRI----------VEKGFYTERDASRLIFQ 115
Query: 281 VASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGT 340
V A++YLH L+++ ++DFG+++ + + +++ G T
Sbjct: 116 VLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACG---T 172
Query: 341 TGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNL 385
GY+APE S D +S G++ + G P D L
Sbjct: 173 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKL 217
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 1e-31
Identities = 54/218 (24%), Positives = 88/218 (40%), Gaps = 20/218 (9%)
Query: 162 FSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIK 221
++ +IG G+F VY+ L + VAIK + E ++MR + H I++
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVR 77
Query: 222 VVTAC-SRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAID 280
+ S + + + LV +++P H +A L +
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-------YSRAKQTLPVIYVKLYMYQ 130
Query: 281 VASALEYLHLGCKPPIAHCDIKPSNILLNDEMTAC-VADFGIARFLEATNEQTSSIGVKG 339
+ +L Y+H I H DIKP N+LL+ + + DFG A+ L S I
Sbjct: 131 LFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI---C 184
Query: 340 TTGYIAPEYGMGHETSSYG-DVYSFGILLLEMFTGLRP 376
+ Y APE G + DV+S G +L E+ G
Sbjct: 185 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI 222
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 124 bits (312), Expect = 2e-31
Identities = 48/267 (17%), Positives = 96/267 (35%), Gaps = 37/267 (13%)
Query: 162 FSSENLIGAGNFASVYKGILFEGAPAVAIKVFN------FLHHDASKSFTVECEVMRNII 215
FS +IG G F VY + A+K + + + + ++
Sbjct: 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65
Query: 216 HRKIIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERL 275
I+ + A D + + + M G L + G + +
Sbjct: 66 CPFIVCMSYAF-----HTPDKLSFILDLMNGGDLHYHLS----------QHGVFSEADMR 110
Query: 276 NIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSI 335
A ++ LE++H + + D+KP+NILL++ ++D G+A +
Sbjct: 111 FYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDF----SKKKPH 163
Query: 336 GVKGTTGYIAPEYGM-GHETSSYGDVYSFGILLLEMFTGLRPSDD--------MFKDNLN 386
GT GY+APE G S D +S G +L ++ G P + + L
Sbjct: 164 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT 223
Query: 387 LQNWVQSALPERVEEIVDTLFFKEIEE 413
+ + + + +++ L +++
Sbjct: 224 MAVELPDSFSPELRSLLEGLLQRDVNR 250
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (308), Expect = 4e-31
Identities = 43/217 (19%), Positives = 71/217 (32%), Gaps = 18/217 (8%)
Query: 165 ENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNII-HRKIIKVV 223
++G G V + A+K+ E E+ I+++V
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQ-----DCPKARREVELHWRASQCPHIVRIV 71
Query: 224 TACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVAS 283
Y G +V E + G L I + E I +
Sbjct: 72 DVY-ENLYAGRKCLLIVMECLDGGELFSRIQ--------DRGDQAFTEREASEIMKSIGE 122
Query: 284 ALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGY 343
A++YLH IAH D+KP N+L + + F + T S T Y
Sbjct: 123 AIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYY 179
Query: 344 IAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDM 380
+APE + D++S G+++ + G P
Sbjct: 180 VAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN 216
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 119 bits (300), Expect = 2e-30
Identities = 49/287 (17%), Positives = 91/287 (31%), Gaps = 31/287 (10%)
Query: 165 ENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVT 224
IG+G+F +Y G VAIK+ +E ++ + + I +
Sbjct: 12 GRKIGSGSFGDIYLGTDIAAGEEVAIKLEC--VKTKHPQLHIESKIYKMMQGGVGIPTIR 69
Query: 225 ACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASA 284
C D+ +V E + + + + L +A + S
Sbjct: 70 WC----GAEGDYNVMVMELLGPSLEDLFNFC----------SRKFSLKTVLLLADQMISR 115
Query: 285 LEYLHLGCKPPIAHCDIKPSNILLNDE---MTACVADFGIARFLEATNEQT-----SSIG 336
+EY+H H D+KP N L+ + DFG+A+ +
Sbjct: 116 IEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKN 172
Query: 337 VKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNL--NLQNWVQSA 394
+ GT Y + +G E S D+ S G +L+ G P + + +
Sbjct: 173 LTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK 232
Query: 395 LPERVEEIVDTL--FFKEIEEEETVYKYKKAPSSSTQRSIILECLNS 439
+ +E + F ++ P S R + +
Sbjct: 233 MSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 2e-30
Identities = 56/282 (19%), Positives = 102/282 (36%), Gaps = 29/282 (10%)
Query: 166 NLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASK-----SFTVECEVMRNIIHRKII 220
+ +G G FA+VYK VAIK H +K + E ++++ + H II
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 221 KVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAID 280
++ A +LV++FM L +
Sbjct: 64 GLLDAF-----GHKSNISLVFDFMETDLEVII----------KDNSLVLTPSHIKAYMLM 108
Query: 281 VASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGT 340
LEYLH + I H D+KP+N+LL++ +ADFG+A+ + N + T
Sbjct: 109 TLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV--VT 163
Query: 341 TGYIAPEYGMGHETSSYG-DVYSFGILLLEMFTGLRP--SDDMFKDNLNLQNWVQSALPE 397
Y APE G G D+++ G +L E+ + D + + + E
Sbjct: 164 RWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEE 223
Query: 398 RVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQ-RSIILECLN 438
+ ++ + + + + ++ +I
Sbjct: 224 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFL 265
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (298), Expect = 1e-29
Identities = 55/310 (17%), Positives = 108/310 (34%), Gaps = 23/310 (7%)
Query: 155 LYSATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDA-SKSFTVECEVMRN 213
++ +++ + IG G + V VAIK + H + E +++
Sbjct: 3 VFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLR 62
Query: 214 IIHRKIIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLE 273
H II + + LV M L + + +L++
Sbjct: 63 FRHENIIGINDIIRAPTIEQMKDVYLVTHLM-GADLYKLLKT-----------QHLSNDH 110
Query: 274 RLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTS 333
+ L+Y+H + H D+KPSN+LLN + DFG+AR + ++ T
Sbjct: 111 ICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTG 167
Query: 334 SIG-VKGTTGYIAPEY-GMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWV 391
+ T Y APE + D++S G +L EM + + L + +
Sbjct: 168 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ-LNHIL 226
Query: 392 QSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAEL 451
E++ + K ++ K P + + + L+ +
Sbjct: 227 GILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLD----KMLTFN 282
Query: 452 PGERMKINDV 461
P +R+++
Sbjct: 283 PHKRIEVEQA 292
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 117 bits (294), Expect = 1e-29
Identities = 42/290 (14%), Positives = 85/290 (29%), Gaps = 33/290 (11%)
Query: 165 ENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVT 224
IG G+F +++G VAIK + E + + I V
Sbjct: 10 GRRIGEGSFGVIFEGTNLLNNQQVAIKFEP--RRSDAPQLRDEYRTYKLLAGCTGIPNVY 67
Query: 225 ACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASA 284
Q LV + + + + A + +
Sbjct: 68 YF----GQEGLHNVLVIDLLGPSLEDLL----------DLCGRKFSVKTVAMAAKQMLAR 113
Query: 285 LEYLHLGCKPPIAHCDIKPSNILLNDEMT-----ACVADFGIARFLEATNEQTSSI---- 335
++ +H + + + DIKP N L+ + V DFG+ +F +
Sbjct: 114 VQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREK 170
Query: 336 -GVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLN--LQNWVQ 392
+ GT Y++ +G E S D+ + G + + G P + + +
Sbjct: 171 KNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE 230
Query: 393 SALPERVEEIVDTL--FFKEIEEEETVYKYKKAPSSSTQRSIILECLNSI 440
+ E+ F + + P + + + L +
Sbjct: 231 KKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (295), Expect = 1e-29
Identities = 55/281 (19%), Positives = 100/281 (35%), Gaps = 23/281 (8%)
Query: 166 NLIGAGNFASVYKGI-LFEGAPAVAIKVFN--FLHHDASKSFTVECEVMRNII---HRKI 219
IG G + V+K L G VA+K S E V+R++ H +
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 220 IKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAI 279
+++ C+ LV+E + + + ++
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYL---------DKVPEPGVPTETIKDMMF 123
Query: 280 DVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKG 339
+ L++LH + H D+KP NIL+ +ADFG+AR TS +
Sbjct: 124 QLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV---V 177
Query: 340 TTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPERV 399
T Y APE + ++ D++S G + EMF + + LP
Sbjct: 178 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 237
Query: 400 EEIVDTLFFKEIEEEETVYKYKKAPS--SSTQRSIILECLN 438
+ D ++ ++ +K + + ++L+CL
Sbjct: 238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLT 278
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 117 bits (294), Expect = 2e-29
Identities = 57/260 (21%), Positives = 98/260 (37%), Gaps = 31/260 (11%)
Query: 162 FSSENLIGAGNFASVYKGILFEGAPAVAIKVFN---FLHHDASKSFTVECEVMRNIIHRK 218
F +G G+F V+ A+KV + + E ++ + H
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65
Query: 219 IIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIA 278
II++ Q ++ +++ G L + A
Sbjct: 66 IIRMWGTF-----QDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAK----------FYA 110
Query: 279 IDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVK 338
+V ALEYLH I + D+KP NILL+ + DFG A+++ +
Sbjct: 111 AEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT-----LC 162
Query: 339 GTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRP-----SDDMFKDNLNLQNWVQS 393
GT YIAPE + D +SFGIL+ EM G P + ++ LN +
Sbjct: 163 GTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPP 222
Query: 394 ALPERVEEIVDTLFFKEIEE 413
E V++++ L +++ +
Sbjct: 223 FFNEDVKDLLSRLITRDLSQ 242
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (285), Expect = 1e-28
Identities = 56/272 (20%), Positives = 92/272 (33%), Gaps = 48/272 (17%)
Query: 167 LIGAGNFASVYKGILFEGAPAVAIKVFN------FLHHDASKSFTVECEVMRNI--IHRK 218
L+G+G F SVY GI VAIK + +E +++ +
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 219 IIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIA 278
+I+++ R D L+ E G L +
Sbjct: 71 VIRLLDWFER-----PDSFVLILERPEPVQDLFDF---------ITERGALQEELARSFF 116
Query: 279 IDVASALEYLHLGCKPPIAHCDIKPSNILLN-DEMTACVADFGIARFLEATNEQTSSIGV 337
V A+ + + H DIK NIL++ + + DFG L+ T
Sbjct: 117 WQVLEAVRHC---HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD----F 169
Query: 338 KGTTGYIAPEYGMGHETSSYG-DVYSFGILLLEMFTGLRP---SDDMFKDNLNLQNWVQS 393
GT Y PE+ H V+S GILL +M G P +++ + + + V S
Sbjct: 170 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSS 229
Query: 394 AL-----------PER---VEEIVDTLFFKEI 411
P EEI + + +++
Sbjct: 230 ECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 1e-28
Identities = 51/288 (17%), Positives = 101/288 (35%), Gaps = 28/288 (9%)
Query: 166 NLIGAGNFASVYKGILFEGAPAVAIKVFN--FLHHDASKSFTVECEVMRNIIHRKIIKVV 223
IG G F V+K + VA+K + E ++++ + H ++ ++
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75
Query: 224 TACSRVDYQGNDFKA---LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAID 280
C N K LV++F + + + E +
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL----------VKFTLSEIKRVMQM 125
Query: 281 VASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEA--TNEQTSSIGVK 338
+ + L Y+ + I H D+K +N+L+ + +ADFG+AR ++
Sbjct: 126 LLNGLYYI---HRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 182
Query: 339 GTTGYIAPEYGMGHETSSYG-DVYSFGILLLEMFTGLRP-SDDMFKDNLNLQNWVQSALP 396
T Y PE +G D++ G ++ EM+T + + L L + + ++
Sbjct: 183 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 242
Query: 397 ERVEEIVDTLFFKE------IEEEETVYKYKKAPSSSTQRSIILECLN 438
V VD E ++ + + K +I + L
Sbjct: 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLV 290
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (282), Expect = 5e-28
Identities = 52/243 (21%), Positives = 88/243 (36%), Gaps = 40/243 (16%)
Query: 162 FSSENL---------IGAGNFASVYKGILFEGAPAVAIKVFNFLHHDAS------KSFTV 206
F EN+ +G+G FA V K A K +S +
Sbjct: 3 FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 62
Query: 207 ECEVMRNIIHRKIIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAP 266
E +++ I H +I + + L+ E + G L +++
Sbjct: 63 EVSILKEIQHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLA----------EK 107
Query: 267 GNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTA----CVADFGIA 322
+L E + + + YLH IAH D+KP NI+L D + DFG+A
Sbjct: 108 ESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164
Query: 323 RFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFK 382
++ NE + + GT ++APE D++S G++ + +G P K
Sbjct: 165 HKIDFGNEFKN---IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK 221
Query: 383 DNL 385
Sbjct: 222 QET 224
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 112 bits (280), Expect = 1e-27
Identities = 54/284 (19%), Positives = 107/284 (37%), Gaps = 34/284 (11%)
Query: 166 NLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNI-IHRKIIKVVT 224
+G G ++ V++ I V +K+ L K E +++ N+ II +
Sbjct: 41 RKLGRGKYSEVFEAINITNNEKVVVKI---LKPVKKKKIKREIKILENLRGGPNIITLAD 97
Query: 225 ACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASA 284
+ ALV+E + N ++ +T+ D R ++ A
Sbjct: 98 IV---KDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRF-------------YMYEILKA 141
Query: 285 LEYLHLGCKPPIAHCDIKPSNILLNDE-MTACVADFGIARFLEATNEQTSSIGVKGTTGY 343
L+Y H I H D+KP N++++ E + D+G+A F E + + +
Sbjct: 142 LDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV---ASRYF 195
Query: 344 IAPEYGMGHETSSYG-DVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPERVEEI 402
PE + ++ Y D++S G +L M P + L + E + +
Sbjct: 196 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY 255
Query: 403 VDTL------FFKEIEEEETVYKYKKAPSSSTQRSIILECLNSI 440
+D F +I + ++++ S Q + E L+ +
Sbjct: 256 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFL 299
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (277), Expect = 2e-27
Identities = 46/218 (21%), Positives = 75/218 (34%), Gaps = 22/218 (10%)
Query: 162 FSSENLIGAGNFASVYKGILFEGAPAVAIKVFN--FLHHDASKSFTVECEVMRNIIHRKI 219
F IG G + VYK VA+K + E +++ + H I
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 220 IKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAI 279
+K++ + LV+EF+ + A + +
Sbjct: 64 VKLLDVI-----HTENKLYLVFEFLHQDLKKFM---------DASALTGIPLPLIKSYLF 109
Query: 280 DVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKG 339
+ L + + H D+KP N+L+N E +ADFG+AR +
Sbjct: 110 QLLQGLAFC---HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV--V 164
Query: 340 TTGYIAPE-YGMGHETSSYGDVYSFGILLLEMFTGLRP 376
T Y APE S+ D++S G + EM T
Sbjct: 165 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRAL 202
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (277), Expect = 4e-27
Identities = 62/297 (20%), Positives = 106/297 (35%), Gaps = 57/297 (19%)
Query: 162 FSSENLIGAGNFASVYKGILFEGAPAVAIKVFN---FLHHDASKSFTVECEVMRNIIHRK 218
F L+G G F V A+K+ + D E V++N H
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 219 IIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWI---HPITEEDKRHKAPGNLNSLERL 275
+ + A Q +D V E+ G L + TEE R
Sbjct: 67 LTALKYAF-----QTHDRLCFVMEYANGGELFFHLSRERVFTEERARF------------ 109
Query: 276 NIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSI 335
++ SALEYLH + + DIK N++L+ + + DFG+ + +
Sbjct: 110 -YGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--K 163
Query: 336 GVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRP-----SDDMFKDNLN---- 386
GT Y+APE ++ D + G+++ EM G P + +F+ L
Sbjct: 164 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR 223
Query: 387 --------LQNWVQSAL---PER--------VEEIVDTLFFKEIEEEETVYKYKKAP 424
++ + L P++ +E+++ FF I ++ V K P
Sbjct: 224 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPP 280
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 107 bits (267), Expect = 3e-26
Identities = 57/281 (20%), Positives = 95/281 (33%), Gaps = 30/281 (10%)
Query: 166 NLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDAS--KSFTVECEVMRNIIHRKIIKVV 223
IG G + VYK G A+K D + E +++ + H I+K+
Sbjct: 8 EKIGEGTYGVVYKAQNNYGET-FALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLY 66
Query: 224 TACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVAS 283
LV+E + + G L S+ + + + +
Sbjct: 67 DVI-----HTKKRLVLVFEHLDQDLKKLLDVC----------EGGLESVTAKSFLLQLLN 111
Query: 284 ALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGY 343
+ Y H + H D+KP N+L+N E +ADFG+AR + + T Y
Sbjct: 112 GIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH--EIVTLWY 166
Query: 344 IAPEYGMGHETSSYG-DVYSFGILLLEMFTGLRP-----SDDMFKDNLNLQNWVQSALPE 397
AP+ MG + S D++S G + EM G D + S
Sbjct: 167 RAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWP 226
Query: 398 RVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLN 438
V E+ + E + K S ++ + L
Sbjct: 227 NVTELPKYDPNFTVYEPLPWESFLKGLDESG-IDLLSKMLK 266
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (259), Expect = 4e-25
Identities = 49/280 (17%), Positives = 95/280 (33%), Gaps = 26/280 (9%)
Query: 166 NLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDAS--KSFTVECEVMRNIIHRKIIKVV 223
IG G + +V+K E VA+K D S E +++ + H+ I+++
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 224 TACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVAS 283
+ LV+EF + + G+L+ + +
Sbjct: 68 DVL-----HSDKKLTLVFEFCDQDLKKYFDSC----------NGDLDPEIVKSFLFQLLK 112
Query: 284 ALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGY 343
L + H + H D+KP N+L+N +A+FG+AR S+ V
Sbjct: 113 GLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAE-VVTLWYR 168
Query: 344 IAPEYGMGHETSSYGDVYSFGILLLEMFTGLRP---SDDMFKDNLNLQNWVQSALPERVE 400
S+ D++S G + E+ RP +D+ + + + E+
Sbjct: 169 PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWP 228
Query: 401 EIVDTLFFKEIEEEETVYKYKKAPS--SSTQRSIILECLN 438
+ +K ++T R ++ L
Sbjct: 229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLK 268
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (262), Expect = 5e-25
Identities = 61/306 (19%), Positives = 109/306 (35%), Gaps = 32/306 (10%)
Query: 167 LIGAGNFASVYKGILFEGAPAVAIKVFN--FLHHDASKSFTVECEVMRNIIHRKIIKVVT 224
IG+G V VAIK + F + +K E +M+ + H+ II ++
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 225 ACSRVD-YQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVAS 283
+ + LV E M + + E + + +
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSY-------------LLYQMLC 130
Query: 284 ALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGY 343
+++LH I H D+KPSNI++ + T + DFG+AR + T + T Y
Sbjct: 131 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV---VTRYY 184
Query: 344 IAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPERVEEIV 403
APE +G D++S G ++ EM +D ++ N V L E +
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILF--PGRDYIDQWNKVIEQLGTPCPEFM 242
Query: 404 DTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAEL--------PGER 455
L E KY + + ++ + + +L P +R
Sbjct: 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKR 302
Query: 456 MKINDV 461
+ ++D
Sbjct: 303 ISVDDA 308
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 102 bits (255), Expect = 4e-24
Identities = 38/214 (17%), Positives = 75/214 (35%), Gaps = 5/214 (2%)
Query: 165 ENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVT 224
+G G+F++V+ VA+K+ +++ E ++++ + K +
Sbjct: 18 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVR-GDKVYTEAAEDEIKLLQRVNDADNTKEDS 76
Query: 225 ACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERL-NIAIDVAS 283
+ + D + + + K L + I+ +
Sbjct: 77 MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLL 136
Query: 284 ALEYLHLGCKPPIAHCDIKPSNILLN-DEMTACVADFGIARFLEATNEQTSSIGVKGTTG 342
L+Y+H + I H DIKP N+L+ + + IA A T
Sbjct: 137 GLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE 194
Query: 343 YIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRP 376
Y +PE +G D++S L+ E+ TG
Sbjct: 195 YRSPEVLLGAPWGCGADIWSTACLIFELITGDFL 228
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 101 bits (252), Expect = 9e-24
Identities = 42/254 (16%), Positives = 95/254 (37%), Gaps = 31/254 (12%)
Query: 168 IGAGNFASVYKGILFEGAPAVAIKVFN---FLHHDASKSFTVECEVMRNIIHRKIIKVVT 224
+G G+F V E A+K+ + + + E +++ + ++K+
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 225 ACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASA 284
+ V E++ G + + G + A +
Sbjct: 109 SFKDNSNLYM-----VMEYVAGGEMFSHLR----------RIGRFSEPHARFYAAQIVLT 153
Query: 285 LEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYI 344
EYLH + + D+KP N+L++ + V DFG A+ ++ + GT +
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEAL 205
Query: 345 APEYGMGHETSSYGDVYSFGILLLEMFTGLRP-----SDDMFKDNLNLQNWVQSALPERV 399
APE + + D ++ G+L+ EM G P +++ ++ + S +
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 400 EEIVDTLFFKEIEE 413
++++ L ++ +
Sbjct: 266 KDLLRNLLQVDLTK 279
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (252), Expect = 1e-23
Identities = 54/282 (19%), Positives = 105/282 (37%), Gaps = 30/282 (10%)
Query: 167 LIGAGNFASVYKGILFEGAPAVAIKVFN--FLHHDASKSFTVECEVMRNIIHRKIIKVVT 224
+G+G + +V + VAIK F +K E +++++ H +I ++
Sbjct: 25 PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84
Query: 225 ACSRVDYQGNDFK-ALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVAS 283
+ + + LV FM + H L + +
Sbjct: 85 VFTPDETLDDFTDFYLVMPFMGTDLGKLMKH------------EKLGEDRIQFLVYQMLK 132
Query: 284 ALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGY 343
L Y+H I H D+KP N+ +N++ + DFG+AR + + G T Y
Sbjct: 133 GLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD-----SEMTGYVVTRWY 184
Query: 344 IAPEYGMGHETSSYG-DVYSFGILLLEMFTGLRP-----SDDMFKDNLNLQNWVQSALPE 397
APE + + D++S G ++ EM TG D K+ + + + +
Sbjct: 185 RAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 244
Query: 398 RVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQ-RSIILECLN 438
R++ + K + E E ++S +++ + L
Sbjct: 245 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLV 286
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (249), Expect = 1e-23
Identities = 49/252 (19%), Positives = 90/252 (35%), Gaps = 29/252 (11%)
Query: 162 FSSENLIGAGNFASVYKGILFEGAPA---VAIKVFN----FLHHDASKSFTVECEVMRNI 214
F ++G G + V+ G A+KV ++ E +V+ +I
Sbjct: 26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 85
Query: 215 IHRKIIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLER 274
+ + +Q L+ +++ G L +
Sbjct: 86 RQSPFLVTLHYA----FQTETKLHLILDYINGGELFTHLS-------------QRERFTE 128
Query: 275 LNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSS 334
+ I V + L K I + DIK NILL+ + DFG+++ A +E +
Sbjct: 129 HEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA-DETERA 187
Query: 335 IGVKGTTGYIAPEYGMGHETSSYG--DVYSFGILLLEMFTGLRP--SDDMFKDNLNLQNW 390
GT Y+AP+ G ++ D +S G+L+ E+ TG P D +
Sbjct: 188 YDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRR 247
Query: 391 VQSALPERVEEI 402
+ + P +E+
Sbjct: 248 ILKSEPPYPQEM 259
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.2 bits (246), Expect = 5e-23
Identities = 48/282 (17%), Positives = 101/282 (35%), Gaps = 28/282 (9%)
Query: 166 NLIGAGNFASVYKGILFEGAPAVAIKVFN--FLHHDASKSFTVECEVMRNIIHRKIIKVV 223
+ +G+G + SV + VA+K + F +K E +++++ H +I ++
Sbjct: 24 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 224 TACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVAS 283
+ + + L + L + +
Sbjct: 84 DVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----------CQKLTDDHVQFLIYQILR 132
Query: 284 ALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGY 343
L+Y+H I H D+KPSN+ +N++ + DFG+AR + G T Y
Sbjct: 133 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----GYVATRWY 184
Query: 344 IAPEYGMGHETSSYG-DVYSFGILLLEMFTGLRP-----SDDMFKDNLNLQNWVQSALPE 397
APE + + D++S G ++ E+ TG D K L L + L +
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 244
Query: 398 RVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQ-RSIILECLN 438
++ + + + + + ++ ++ + L
Sbjct: 245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 286
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 73.7 bits (180), Expect = 2e-15
Identities = 22/177 (12%), Positives = 46/177 (25%), Gaps = 33/177 (18%)
Query: 166 NLIGAGNFASVYKGILFEGAPAVAIKVFN----------FLHHDASKSFTVECEVMRNII 215
L+G G ++V+ + +K F+V
Sbjct: 6 KLMGEGKESAVFNCYSEKFGE-CVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64
Query: 216 HRKIIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERL 275
R + K+ Y A++ E + L +E
Sbjct: 65 FRALQKLQGLAVPKVYAWEGN-AVLMELIDAKELYRVRVENPDE---------------- 107
Query: 276 NIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQT 332
+ + + + I H D+ N+L+ E + DF + + +
Sbjct: 108 -VLDMILEEVAKFY---HRGIVHGDLSQYNVLV-SEEGIWIIDFPQSVEVGEEGWRE 159
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 69.8 bits (169), Expect = 2e-13
Identities = 24/67 (35%), Positives = 32/67 (47%), Gaps = 4/67 (5%)
Query: 24 DLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCGGIP 83
DL N + G +P+ L KFL +LN+S NN IP G + ++ N LCG
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCG--- 306
Query: 84 EFQLPTC 90
LP C
Sbjct: 307 -SPLPAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 53.6 bits (127), Expect = 4e-08
Identities = 16/59 (27%), Positives = 26/59 (44%), Gaps = 1/59 (1%)
Query: 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIP 59
+ N G + L+ L+ L L++S NNL GEIP+ + ++N P
Sbjct: 251 LRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGSP 308
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 51.2 bits (121), Expect = 3e-07
Identities = 12/52 (23%), Positives = 17/52 (32%), Gaps = 4/52 (7%)
Query: 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHN 52
N SL+ L + L N +S P LA + L L+
Sbjct: 336 FANNKVSDVS--SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 50.8 bits (120), Expect = 4e-07
Identities = 13/59 (22%), Positives = 22/59 (37%), Gaps = 4/59 (6%)
Query: 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIP 59
++ N +S L L+ L + N +S LA + L+ HN + P
Sbjct: 314 LYFNNISDIS--PVSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP 368
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 44.6 bits (104), Expect = 3e-05
Identities = 18/73 (24%), Positives = 30/73 (41%), Gaps = 4/73 (5%)
Query: 16 PLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGN 75
L+ L L L NN+S P ++ LQ L ++N + + N + S G+
Sbjct: 305 NLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD-VSSLANLTNINWLSA-GH 360
Query: 76 NKLCGGIPEFQLP 88
N++ P L
Sbjct: 361 NQISDLTPLANLT 373
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 39.2 bits (90), Expect = 0.002
Identities = 19/63 (30%), Positives = 30/63 (47%), Gaps = 4/63 (6%)
Query: 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPT 60
++GN + +L+ L L LDL+ N +S P L+G L L L N ++ P
Sbjct: 226 LNGNQLKDIG--TLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPL 281
Query: 61 EGI 63
G+
Sbjct: 282 AGL 284
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 38.1 bits (87), Expect = 0.004
Identities = 9/48 (18%), Positives = 19/48 (39%), Gaps = 2/48 (4%)
Query: 12 LSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIP 59
+S + L + L + + I + + L +N S+N + P
Sbjct: 38 VSQTDLDQVTTLQADRLGIK-SI-DGVEYLNNLTQINFSNNQLTDITP 83
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 41.6 bits (97), Expect = 4e-05
Identities = 11/46 (23%), Positives = 22/46 (47%), Gaps = 2/46 (4%)
Query: 21 KVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKN 66
+VL L+ +L+ + L + +L+LSHN ++ P +
Sbjct: 1 RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALAALRC 44
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 41.9 bits (97), Expect = 2e-04
Identities = 12/51 (23%), Positives = 18/51 (35%), Gaps = 4/51 (7%)
Query: 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSH 51
N L+ L L + L N +S P LA L + L++
Sbjct: 180 ADDNKISDIS--PLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 41.6 bits (96), Expect = 3e-04
Identities = 15/82 (18%), Positives = 23/82 (28%)
Query: 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPT 60
+ N L+ L L L N +S P A L+ L LS N + +
Sbjct: 38 LQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEK 97
Query: 61 EGIFKNASATSVFGNNKLCGGI 82
K+ +
Sbjct: 98 MPKTLQELRVHENEITKVRKSV 119
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 39.3 bits (90), Expect = 0.001
Identities = 10/40 (25%), Positives = 15/40 (37%)
Query: 20 LKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIP 59
+LDL N ++ K L L L +N + P
Sbjct: 33 TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISP 72
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.1 bits (94), Expect = 5e-04
Identities = 12/45 (26%), Positives = 16/45 (35%), Gaps = 4/45 (8%)
Query: 14 LSPLRGLKVLDLSQNNLSGE----IPEFLAGFKFLQNLNLSHNNF 54
L L+ +V+ L L+ I L L LNL N
Sbjct: 23 LPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNEL 67
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.8 bits (88), Expect = 0.003
Identities = 12/58 (20%), Positives = 21/58 (36%), Gaps = 4/58 (6%)
Query: 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGE----IPEFLAGFKFLQNLNLSHNNF 54
+ P L+VL L+ ++S + L L+ L+LS+N
Sbjct: 352 LEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCL 409
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.0 bits (86), Expect = 0.004
Identities = 8/36 (22%), Positives = 13/36 (36%), Gaps = 1/36 (2%)
Query: 20 LKVLDLSQNNLSGE-IPEFLAGFKFLQNLNLSHNNF 54
++ LD+ LS E L + Q + L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGL 39
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.2 bits (90), Expect = 7e-04
Identities = 7/51 (13%), Positives = 13/51 (25%), Gaps = 1/51 (1%)
Query: 12 LSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEG 62
+ + LDL + I A ++ S N +
Sbjct: 12 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFPL 61
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 39.9 bits (91), Expect = 0.001
Identities = 12/50 (24%), Positives = 16/50 (32%), Gaps = 5/50 (10%)
Query: 12 LSLSPLRGLKVLDLSQNNLSGEIPEFLA-----GFKFLQNLNLSHNNFES 56
S GL+ L L N + + L L L L+ N F
Sbjct: 267 FSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 316
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 39.5 bits (90), Expect = 0.001
Identities = 13/75 (17%), Positives = 23/75 (30%), Gaps = 4/75 (5%)
Query: 9 PIGLSLSPLRGLKVLDLSQNNLSGE----IPEFLAGFKFLQNLNLSHNNFESMIPTEGIF 64
+ L +K + LS N + E + E +A K L+ S +
Sbjct: 22 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEA 81
Query: 65 KNASATSVFGNNKLC 79
++ KL
Sbjct: 82 LRLLLQALLKCPKLH 96
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 39.0 bits (89), Expect = 0.002
Identities = 11/39 (28%), Positives = 17/39 (43%), Gaps = 4/39 (10%)
Query: 18 RGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFES 56
R L+L+ LS +PE L++L S N+
Sbjct: 38 RQAHELELNNLGLS-SLPELPPH---LESLVASCNSLTE 72
|
| >d1zbdb_ g.50.1.1 (B:) Effector domain of rabphilin-3a {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Small proteins fold: FYVE/PHD zinc finger superfamily: FYVE/PHD zinc finger family: FYVE, a phosphatidylinositol-3-phosphate binding domain domain: Effector domain of rabphilin-3a species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 37.0 bits (85), Expect = 0.002
Identities = 19/99 (19%), Positives = 34/99 (34%), Gaps = 4/99 (4%)
Query: 697 EESDYSEFESIHEKPKAVRKGKKGSCYRCLK--GNRFTKKEFCFVCGARYCSSCVLWAMD 754
+E + + K V C C + G + C C C+ C + +
Sbjct: 26 QERIGRLVDRLETMRKNVAGDGVNRCILCGEQLGMLGSASVVCEDCKKNVCTKCGVETSN 85
Query: 755 SMPEG-RICVTCIGFRLDASKRLSLWKCSGMPKGLLTET 792
+ P +C C+ R + + W G PK +L +
Sbjct: 86 NRPHPVWLCKICLEQREVWKRSGA-WFFKGFPKQVLPQP 123
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 873 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.84 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 98.87 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 98.72 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 98.61 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 98.58 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 98.57 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 98.48 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.38 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 98.29 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 98.28 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 98.21 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 98.15 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 98.14 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 98.13 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 97.96 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 97.89 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 97.86 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 97.85 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.74 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 97.73 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 97.55 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 97.42 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 97.32 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.3 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 97.22 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 97.21 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 97.14 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 97.11 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 97.02 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 96.97 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 96.97 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 96.96 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 96.88 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.72 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 96.41 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.3 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 96.23 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.88 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 95.83 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 93.98 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 93.68 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 93.16 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 91.77 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 90.42 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 90.25 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 84.0 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 81.02 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-49 Score=424.71 Aligned_cols=263 Identities=25% Similarity=0.406 Sum_probs=201.9
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeecc--CCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCce
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFL--HHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDF 236 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~ 236 (873)
.++|++.+.||+|+||+||+|++. ..||||+++.. .....+.|.+|+++|++++|||||++++++. .+.
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~------~~~ 77 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST------APQ 77 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC------SSS
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe------ccE
Confidence 467899999999999999999753 35999998743 3344578999999999999999999999863 245
Q ss_pred EEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEE
Q 002857 237 KALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACV 316 (873)
Q Consensus 237 ~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKL 316 (873)
.+|||||+++|+|.++|+. ....+++.+++.|+.|||+||+||| +++||||||||+||||+.++++||
T Consensus 78 ~~lv~Ey~~~g~L~~~l~~---------~~~~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl 145 (276)
T d1uwha_ 78 LAIVTQWCEGSSLYHHLHI---------IETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKI 145 (276)
T ss_dssp CEEEEECCCEEEHHHHHHT---------SCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEE
T ss_pred EEEEEecCCCCCHHHHHhh---------ccCCCCHHHHHHHHHHHHHHHHHHh---cCCEeccccCHHHEEEcCCCCEEE
Confidence 7999999999999999953 3456999999999999999999999 899999999999999999999999
Q ss_pred eccccccccccccccccccccccccccCCCcccCCC---CCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhh
Q 002857 317 ADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGH---ETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQS 393 (873)
Q Consensus 317 sDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~---~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~ 393 (873)
+|||+|+...............||+.|+|||++.+. .++.++|||||||++|||+||+.||........ +.
T Consensus 146 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~-~~----- 219 (276)
T d1uwha_ 146 GDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ-II----- 219 (276)
T ss_dssp CCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH-HH-----
T ss_pred ccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH-HH-----
Confidence 999999876544433344456799999999998653 589999999999999999999999976322111 11
Q ss_pred cCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHHHHhh
Q 002857 394 ALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLIKKKL 472 (873)
Q Consensus 394 ~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i~~~l 472 (873)
..+..... .|.. ......++..+.+|+.+||+.||++||||+||++.|+.+++.+
T Consensus 220 -------~~~~~~~~--------------~p~~---~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~ 274 (276)
T d1uwha_ 220 -------FMVGRGYL--------------SPDL---SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274 (276)
T ss_dssp -------HHHHHTSC--------------CCCG---GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred -------HHHhcCCC--------------CCcc---hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence 11110000 0000 0000112345889999999999999999999999999987643
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-48 Score=415.47 Aligned_cols=252 Identities=23% Similarity=0.340 Sum_probs=202.2
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC-CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEE
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH-HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKA 238 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~ 238 (873)
++|++.+.||+|+||+||+|+++.+++.||||+++... .+..+.+.+|+++|++++|||||++++++ .+++..+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~-----~~~~~~~ 79 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR-----REGNIQY 79 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEE-----EETTEEE
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeee-----ccCceeE
Confidence 57999999999999999999999999999999997543 23346799999999999999999999996 4567899
Q ss_pred EEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEec
Q 002857 239 LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVAD 318 (873)
Q Consensus 239 LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsD 318 (873)
|||||+++|+|.++|. ....+++.+++.|+.||+.||+||| +.+|+||||||+|||+++++.+||+|
T Consensus 80 ivmEy~~gg~L~~~l~----------~~~~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~D 146 (271)
T d1nvra_ 80 LFLEYCSGGELFDRIE----------PDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISD 146 (271)
T ss_dssp EEEECCTTEEGGGGSB----------TTTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECC
T ss_pred EEEeccCCCcHHHHHh----------cCCCCCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCCEEEcc
Confidence 9999999999999994 3457999999999999999999999 89999999999999999999999999
Q ss_pred cccccccccccccccccccccccccCCCcccCCCCC-CcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCch
Q 002857 319 FGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHET-SSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPE 397 (873)
Q Consensus 319 FGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~-s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~ 397 (873)
||+|+.+.............||+.|+|||++.+..+ +.++|||||||++|||+||+.||.........+..+.
T Consensus 147 FG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~------ 220 (271)
T d1nvra_ 147 FGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK------ 220 (271)
T ss_dssp CTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHH------
T ss_pred chhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHh------
Confidence 999998765444444445679999999999988876 5779999999999999999999976332221111111
Q ss_pred hHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHH
Q 002857 398 RVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVE 462 (873)
Q Consensus 398 ~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl 462 (873)
...... .++ . .....+.+|+.+||+.||++|||++||+
T Consensus 221 ------~~~~~~-------------~~~----~----~~s~~~~~li~~~L~~dP~~R~t~~eil 258 (271)
T d1nvra_ 221 ------EKKTYL-------------NPW----K----KIDSAPLALLHKILVENPSARITIPDIK 258 (271)
T ss_dssp ------TTCTTS-------------TTG----G----GSCHHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred ------cCCCCC-------------Ccc----c----cCCHHHHHHHHHHcCCChhHCcCHHHHh
Confidence 000000 000 0 0122467899999999999999999874
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-48 Score=411.34 Aligned_cols=257 Identities=26% Similarity=0.390 Sum_probs=196.2
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEE
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKAL 239 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~L 239 (873)
++|++.+.||+|+||.||+|++. +++.||||+++... ...++|.+|++++++++|||||+++|+|. .++..++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-----~~~~~~l 77 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCL-----EQAPICL 77 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SSSSCEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceec-----cCCceEE
Confidence 57889999999999999999885 56789999997543 34578999999999999999999999973 4566899
Q ss_pred EEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEecc
Q 002857 240 VYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADF 319 (873)
Q Consensus 240 V~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDF 319 (873)
||||+++|+|.+++.. ....+++..++.|+.|||.||+||| +.+|+||||||+|||++.++++||+||
T Consensus 78 v~E~~~~g~L~~~l~~---------~~~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DF 145 (263)
T d1sm2a_ 78 VFEFMEHGCLSDYLRT---------QRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDF 145 (263)
T ss_dssp EEECCTTCBHHHHHHT---------TTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSC
T ss_pred EEEecCCCcHHHHhhc---------cccCCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCCeEeccc
Confidence 9999999999999852 3466899999999999999999999 899999999999999999999999999
Q ss_pred ccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhC-CCCCCcccccchhhHHHHhhcCchh
Q 002857 320 GIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTG-LRPSDDMFKDNLNLQNWVQSALPER 398 (873)
Q Consensus 320 Gla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTG-k~Pf~~~~~~~~~l~~~~~~~~~~~ 398 (873)
|+++....... .......||..|+|||++.+..++.++|||||||++|||+|+ +.||...... .+...
T Consensus 146 Gla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~--~~~~~-------- 214 (263)
T d1sm2a_ 146 GMTRFVLDDQY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS--EVVED-------- 214 (263)
T ss_dssp C-------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHH--HHHHH--------
T ss_pred chheeccCCCc-eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHH--HHHHH--------
Confidence 99987654332 222345689999999999999999999999999999999995 5444431110 11110
Q ss_pred HHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHHHHh
Q 002857 399 VEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLIKKK 471 (873)
Q Consensus 399 l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i~~~ 471 (873)
+.... ..+... .+..++.+|+.+||+.||++||||+||++.|++|++.
T Consensus 215 ----i~~~~--------------~~~~p~-------~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 215 ----ISTGF--------------RLYKPR-------LASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp ----HHHTC--------------CCCCCT-------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----HHhcC--------------CCCCcc-------ccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 10000 000000 1123578999999999999999999999999998753
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.6e-48 Score=420.57 Aligned_cols=269 Identities=26% Similarity=0.439 Sum_probs=199.5
Q ss_pred cCHHHHHHhhc---------CCCcceeecccCceEEEEEEEcCCCc---EEEEEEeeccC-CcchhHHHHHHHHHHhhhh
Q 002857 150 VSYEALYSATK---------GFSSENLIGAGNFASVYKGILFEGAP---AVAIKVFNFLH-HDASKSFTVECEVMRNIIH 216 (873)
Q Consensus 150 ~s~~el~~at~---------~f~~~~~LG~G~fG~VYkg~~~~~g~---~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~H 216 (873)
++|+++..+++ +|++.++||+|+||+||+|++..+++ .||||.+.... ....+.|.+|+++|++++|
T Consensus 7 ~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H 86 (299)
T d1jpaa_ 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 86 (299)
T ss_dssp GGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCC
T ss_pred CCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCC
Confidence 45555655554 45567899999999999999876553 58999886433 3344679999999999999
Q ss_pred ccceeeeeeeecccccCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCe
Q 002857 217 RKIIKVVTACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPI 296 (873)
Q Consensus 217 pNIV~llg~c~~~~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gI 296 (873)
||||+++|+| ..++..++||||+++|+|.+++.. ....++|.+++.|+.|||+||+||| +++|
T Consensus 87 pnIv~l~g~~-----~~~~~~~iv~Ey~~~g~L~~~~~~---------~~~~l~~~~~~~i~~qia~gl~yLH---~~~i 149 (299)
T d1jpaa_ 87 PNVIHLEGVV-----TKSTPVMIITEFMENGSLDSFLRQ---------NDGQFTVIQLVGMLRGIAAGMKYLA---DMNY 149 (299)
T ss_dssp TTBCCEEEEE-----CSSSSCEEEEECCTTEEHHHHHHT---------TTTCSCHHHHHHHHHHHHHHHHHHH---HTTC
T ss_pred CCCccEEEEE-----eeCCEEEEEEEecCCCcceeeecc---------ccCCCCHHHHHHHHHHHHHHHHHHh---hCCC
Confidence 9999999996 345678999999999999998842 3456999999999999999999999 8999
Q ss_pred eeccCCCCCeeeCCCCCeEEeccccccccccccccc---cccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-
Q 002857 297 AHCDIKPSNILLNDEMTACVADFGIARFLEATNEQT---SSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT- 372 (873)
Q Consensus 297 vHrDLKpsNILLd~~~~vKLsDFGla~~~~~~~~~~---~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT- 372 (873)
+||||||+||||+.++++||+|||+++.+....... ......||+.|+|||++.+..++.++|||||||++|||+|
T Consensus 150 iHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~ 229 (299)
T d1jpaa_ 150 VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSY 229 (299)
T ss_dssp CCSCCCGGGEEECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTT
T ss_pred ccCccccceEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhC
Confidence 999999999999999999999999998765433221 1223457999999999999999999999999999999998
Q ss_pred CCCCCCcccccchhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCc
Q 002857 373 GLRPSDDMFKDNLNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELP 452 (873)
Q Consensus 373 Gk~Pf~~~~~~~~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP 452 (873)
|+.||....... +... +.... ..+.. .++...+.+|+.+||+.||
T Consensus 230 g~~Pf~~~~~~~--~~~~------------i~~~~--------------~~~~~-------~~~~~~l~~li~~cl~~~P 274 (299)
T d1jpaa_ 230 GERPYWDMTNQD--VINA------------IEQDY--------------RLPPP-------MDCPSALHQLMLDCWQKDR 274 (299)
T ss_dssp SCCTTTTCCHHH--HHHH------------HHTTC--------------CCCCC-------TTCCHHHHHHHHHHTCSST
T ss_pred CCCCCCCCCHHH--HHHH------------HHcCC--------------CCCCC-------ccchHHHHHHHHHHcCCCH
Confidence 899997632111 1111 10000 00100 0123458899999999999
Q ss_pred CCCCCHHHHHHHHHHHHH
Q 002857 453 GERMKINDVELGLRLIKK 470 (873)
Q Consensus 453 ~eRPTm~EVl~~Le~i~~ 470 (873)
++||||.||++.|+.+.+
T Consensus 275 ~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 275 NHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp TTSCCHHHHHHHHHHHHH
T ss_pred hHCcCHHHHHHHHHHHhc
Confidence 999999999999998754
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4e-48 Score=417.90 Aligned_cols=259 Identities=24% Similarity=0.375 Sum_probs=209.8
Q ss_pred hhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceE
Q 002857 158 ATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFK 237 (873)
Q Consensus 158 at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~ 237 (873)
..++|++.+.||+|+||+||+|++..+++.||||+++... ...++|.+|+++|++++|||||+++++| ..++..
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~~ 88 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVC-----TREPPF 88 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSSSC
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccE-----eeCCee
Confidence 3467888999999999999999999899999999987543 3457899999999999999999999996 445678
Q ss_pred EEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEe
Q 002857 238 ALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVA 317 (873)
Q Consensus 238 ~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLs 317 (873)
+|||||+++|+|.++|.. .....+++..++.|+.|||.||+||| +++|+||||||+||||+.++++||+
T Consensus 89 ~iv~E~~~~g~l~~~l~~--------~~~~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~ 157 (287)
T d1opja_ 89 YIITEFMTYGNLLDYLRE--------CNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVA 157 (287)
T ss_dssp EEEEECCTTCBHHHHHHH--------SCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEEC
T ss_pred EEEeecccCcchHHHhhh--------ccccchHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEECCCCcEEEc
Confidence 999999999999999853 34567999999999999999999999 8899999999999999999999999
Q ss_pred ccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCch
Q 002857 318 DFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPE 397 (873)
Q Consensus 318 DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~ 397 (873)
|||+|+....... .......|++.|+|||++.+..++.++|||||||++|||++|..||.......
T Consensus 158 DFG~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~------------- 223 (287)
T d1opja_ 158 DFGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS------------- 223 (287)
T ss_dssp CCCCTTTCCSSSS-EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-------------
T ss_pred cccceeecCCCCc-eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHH-------------
Confidence 9999997654322 22334568999999999999999999999999999999999777764321111
Q ss_pred hHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHH
Q 002857 398 RVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLI 468 (873)
Q Consensus 398 ~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i 468 (873)
.+.+++...... +... .+...+.+|+.+||+.||++||||.||++.|+.+
T Consensus 224 ~~~~~i~~~~~~--------------~~~~-------~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~ 273 (287)
T d1opja_ 224 QVYELLEKDYRM--------------ERPE-------GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273 (287)
T ss_dssp HHHHHHHTTCCC--------------CCCT-------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred HHHHHHhcCCCC--------------CCCc-------cchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 111111111100 0000 1133588999999999999999999999999875
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=410.75 Aligned_cols=258 Identities=23% Similarity=0.388 Sum_probs=203.9
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEE
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKA 238 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~ 238 (873)
.++|++.+.||+|+||.||+|++. +++.||||+++... ...+.|.+|+++|++++|||||+++|+|. .+..+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~------~~~~~ 83 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT------QEPIY 83 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC------SSSCE
T ss_pred HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeec------cCCeE
Confidence 357888999999999999999974 67789999997543 34578999999999999999999999863 23468
Q ss_pred EEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEec
Q 002857 239 LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVAD 318 (873)
Q Consensus 239 LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsD 318 (873)
|||||+++|+|.+++.. .....+++.+++.|+.||++||+||| +++|+||||||+||||++++.+||+|
T Consensus 84 iv~Ey~~~g~L~~~~~~--------~~~~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~D 152 (272)
T d1qpca_ 84 IITEYMENGSLVDFLKT--------PSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIAD 152 (272)
T ss_dssp EEEECCTTCBHHHHTTS--------HHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECC
T ss_pred EEEEeCCCCcHHHHHhh--------cCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceeecc
Confidence 99999999999998853 12335899999999999999999999 89999999999999999999999999
Q ss_pred cccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCchh
Q 002857 319 FGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPER 398 (873)
Q Consensus 319 FGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~~ 398 (873)
||+|+.+..... .......||+.|+|||++.+..++.++|||||||++|||+||..|+....... .+..
T Consensus 153 FGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~-~~~~--------- 221 (272)
T d1qpca_ 153 FGLARLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-EVIQ--------- 221 (272)
T ss_dssp CTTCEECSSSCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-HHHH---------
T ss_pred ccceEEccCCcc-ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH-HHHH---------
Confidence 999997754322 22334568999999999999999999999999999999999766654321111 0111
Q ss_pred HHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHHHH
Q 002857 399 VEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLIKK 470 (873)
Q Consensus 399 l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i~~ 470 (873)
.+... . ..+... .+...+.+|+.+||+.||++||||+||+++|+.+..
T Consensus 222 --~i~~~-~--------------~~~~p~-------~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 222 --NLERG-Y--------------RMVRPD-------NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp --HHHTT-C--------------CCCCCT-------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --HHHhc-C--------------CCCCcc-------cChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 01000 0 000000 113357889999999999999999999999998643
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-47 Score=408.47 Aligned_cols=250 Identities=22% Similarity=0.284 Sum_probs=204.1
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEE
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKAL 239 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~L 239 (873)
++|++.+.||+|+||+||+|++..+++.||||+++.......+.+.+|+++|++++|||||++++++ ...+..+|
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~~~i 94 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY-----LVGDELWV 94 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEE-----EETTEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEE-----EECCEEEE
Confidence 4799999999999999999999999999999999866656667899999999999999999999996 45667999
Q ss_pred EEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEecc
Q 002857 240 VYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADF 319 (873)
Q Consensus 240 V~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDF 319 (873)
||||+++|+|.+++.. ..+++.++..|+.||+.||+||| +++|+||||||+|||++.++++||+||
T Consensus 95 vmEy~~gg~L~~~~~~-----------~~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DF 160 (293)
T d1yhwa1 95 VMEYLAGGSLTDVVTE-----------TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDF 160 (293)
T ss_dssp EEECCTTCBHHHHHHH-----------SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCC
T ss_pred EEEecCCCcHHHHhhc-----------cCCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeeccc
Confidence 9999999999998742 35899999999999999999999 899999999999999999999999999
Q ss_pred ccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCchhH
Q 002857 320 GIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPERV 399 (873)
Q Consensus 320 Gla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~~l 399 (873)
|+++.+..... ......||+.|+|||++.+..++.++|||||||++|||+||+.||....... .+
T Consensus 161 G~a~~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-~~------------ 225 (293)
T d1yhwa1 161 GFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-AL------------ 225 (293)
T ss_dssp TTCEECCSTTC--CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HH------------
T ss_pred hhheeeccccc--cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH-HH------------
Confidence 99987644322 2234569999999999999999999999999999999999999996532111 00
Q ss_pred HHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 400 EEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 400 ~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
..+... . .+...... .+...+.+++.+||+.||++|||+.|+++
T Consensus 226 ~~~~~~----~------------~~~~~~~~----~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 226 YLIATN----G------------TPELQNPE----KLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp HHHHHH----C------------SCCCSSGG----GSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HHHHhC----C------------CCCCCCcc----cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000 0 00000000 11234778999999999999999999853
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-47 Score=406.91 Aligned_cols=261 Identities=26% Similarity=0.413 Sum_probs=198.2
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCC----cEEEEEEeeccCC-cchhHHHHHHHHHHhhhhccceeeeeeeecccccC
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGA----PAVAIKVFNFLHH-DASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQG 233 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g----~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~ 233 (873)
.+.|+..++||+|+||.||+|.+..++ ..||||+++.... .....|.+|+++|++++|||||+++|+| ..
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~-----~~ 80 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVI-----SK 80 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----CS
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEE-----ec
Confidence 356888999999999999999987554 4799999874433 2345799999999999999999999996 34
Q ss_pred CceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCC
Q 002857 234 NDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMT 313 (873)
Q Consensus 234 ~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~ 313 (873)
.+..++||||+.+|+|.+++.. ....+++.+++.|+.||+.||+||| +.+|+||||||+||||+.+++
T Consensus 81 ~~~~~~v~e~~~~~~l~~~~~~---------~~~~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~ 148 (283)
T d1mqba_ 81 YKPMMIITEYMENGALDKFLRE---------KDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLV 148 (283)
T ss_dssp SSSEEEEEECCTTEEHHHHHHH---------TTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCC
T ss_pred CCceEEEEEecccCcchhhhhc---------ccccccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECCCCe
Confidence 5678999999999999998742 4467999999999999999999999 899999999999999999999
Q ss_pred eEEecccccccccccccc-ccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHh
Q 002857 314 ACVADFGIARFLEATNEQ-TSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQ 392 (873)
Q Consensus 314 vKLsDFGla~~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~ 392 (873)
+||+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|||+||..|+....... .+
T Consensus 149 ~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~-~~----- 222 (283)
T d1mqba_ 149 CKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH-EV----- 222 (283)
T ss_dssp EEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-HH-----
T ss_pred EEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHH-HH-----
Confidence 999999999876543322 22334568999999999999999999999999999999999766654321111 01
Q ss_pred hcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHHHH
Q 002857 393 SALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLIKK 470 (873)
Q Consensus 393 ~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i~~ 470 (873)
...+.... ..+... .++..+.+|+.+||+.||++||||.||+++|+.+.+
T Consensus 223 -------~~~i~~~~--------------~~~~~~-------~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 223 -------MKAINDGF--------------RLPTPM-------DCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp -------HHHHHTTC--------------CCCCCT-------TCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -------HHHHhccC--------------CCCCch-------hhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 11111100 001110 123458899999999999999999999999998765
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-47 Score=406.22 Aligned_cols=246 Identities=21% Similarity=0.305 Sum_probs=202.3
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeecc---CCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCce
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFL---HHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDF 236 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~ 236 (873)
++|++.+.||+|+||+||+|+++.+++.||||++... .....+.+.+|+++|++++|||||++++++ .+++.
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~~ 80 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF-----HDATR 80 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSSE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEE-----EECCE
Confidence 4789999999999999999999999999999998632 233456789999999999999999999995 45678
Q ss_pred EEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEE
Q 002857 237 KALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACV 316 (873)
Q Consensus 237 ~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKL 316 (873)
.+|||||+++|+|.+++.. ...+++..+..|+.||+.||+||| +.+|+||||||+|||++.++.+||
T Consensus 81 ~~ivmEy~~~g~L~~~l~~----------~~~l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl 147 (263)
T d2j4za1 81 VYLILEYAPLGTVYRELQK----------LSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKI 147 (263)
T ss_dssp EEEEEECCTTCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEE
T ss_pred EEEEEeecCCCcHHHHHhh----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCEee
Confidence 9999999999999999942 346899999999999999999999 899999999999999999999999
Q ss_pred eccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCc
Q 002857 317 ADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALP 396 (873)
Q Consensus 317 sDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~ 396 (873)
+|||+|+...... .....||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 148 ~DFG~a~~~~~~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~------------ 211 (263)
T d2j4za1 148 ADFGWSVHAPSSR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE------------ 211 (263)
T ss_dssp CCCCSCSCCCCCC----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------------
T ss_pred cccceeeecCCCc----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH------------
Confidence 9999998654322 234569999999999999999999999999999999999999997532111
Q ss_pred hhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 397 ERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 397 ~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
+........+ ..|. .....+.+++.+||+.||++|||++||++
T Consensus 212 -----~~~~i~~~~~----------~~p~---------~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 212 -----TYKRISRVEF----------TFPD---------FVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp -----HHHHHHTTCC----------CCCT---------TSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----HHHHHHcCCC----------CCCc---------cCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 1111000000 0000 01234778999999999999999999875
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-47 Score=406.15 Aligned_cols=258 Identities=20% Similarity=0.274 Sum_probs=192.0
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCC--cchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceE
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH--DASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFK 237 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~ 237 (873)
++|++.+.||+|+||.||+|+++.+++.||||+++.... ...+.+.+|+++|++++|||||++++++.+ ..+...
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~---~~~~~~ 80 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID---RTNTTL 80 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-------CE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEe---CCCCEE
Confidence 579999999999999999999999999999999875432 234568999999999999999999998642 234568
Q ss_pred EEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCC--CCCeeeccCCCCCeeeCCCCCeE
Q 002857 238 ALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGC--KPPIAHCDIKPSNILLNDEMTAC 315 (873)
Q Consensus 238 ~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~--s~gIvHrDLKpsNILLd~~~~vK 315 (873)
+|||||+++|+|.+++... ......+++..++.|+.||+.||+|||+.. ..+|+||||||+|||++.++.+|
T Consensus 81 ~ivmEy~~~g~L~~~i~~~------~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vk 154 (269)
T d2java1 81 YIVMEYCEGGDLASVITKG------TKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVK 154 (269)
T ss_dssp EEEEECCTTEEHHHHHHHH------HHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEE
T ss_pred EEEEecCCCCcHHHHHHhc------cccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEE
Confidence 9999999999999998531 123467999999999999999999999321 13499999999999999999999
Q ss_pred EeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcC
Q 002857 316 VADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSAL 395 (873)
Q Consensus 316 LsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~ 395 (873)
|+|||+++.+..... ......||+.|+|||++.+..++.++|||||||++|||+||+.||....... +.
T Consensus 155 l~DFG~a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~--~~------- 223 (269)
T d2java1 155 LGDFGLARILNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE--LA------- 223 (269)
T ss_dssp ECCHHHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HH-------
T ss_pred EeeccceeecccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH--HH-------
Confidence 999999997654322 2234579999999999999999999999999999999999999997532111 00
Q ss_pred chhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 396 PERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 396 ~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
..+....+. ..|. ....++.+|+.+||+.||++|||+.||++
T Consensus 224 ----~~i~~~~~~-------------~~~~---------~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 224 ----GKIREGKFR-------------RIPY---------RYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp ----HHHHHTCCC-------------CCCT---------TSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----HHHHcCCCC-------------CCCc---------ccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 111110000 0010 01234778999999999999999999864
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-46 Score=399.31 Aligned_cols=249 Identities=24% Similarity=0.349 Sum_probs=195.2
Q ss_pred CcceeecccCceEEEEEEEcCCCcEEEEEEeeccC--CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEEE
Q 002857 163 SSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH--HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKALV 240 (873)
Q Consensus 163 ~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~LV 240 (873)
...++||+|+||+||+|++..+++.||+|++.... ....+.|.+|+++|++++|||||++++++... .......+||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-~~~~~~~~iv 90 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST-VKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE-SSSCEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeec-cccCCEEEEE
Confidence 56678999999999999999999999999987543 23346789999999999999999999987432 1345668999
Q ss_pred EeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCC--eeeccCCCCCeeeC-CCCCeEEe
Q 002857 241 YEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPP--IAHCDIKPSNILLN-DEMTACVA 317 (873)
Q Consensus 241 ~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~g--IvHrDLKpsNILLd-~~~~vKLs 317 (873)
|||+++|+|.+++.. ...+++..++.|+.||++||+||| +++ |+||||||+|||++ +++.+||+
T Consensus 91 mE~~~~g~L~~~l~~----------~~~~~~~~~~~~~~qi~~gl~yLH---~~~~~IiHrDiKp~NILl~~~~~~~Kl~ 157 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKR----------FKVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIG 157 (270)
T ss_dssp EECCCSCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEEC
T ss_pred EeCCCCCcHHHHHhc----------cccccHHHHHHHHHHHHHHHHHHH---HCCCCEEeCCcChhhceeeCCCCCEEEe
Confidence 999999999999943 346899999999999999999999 666 99999999999996 57899999
Q ss_pred ccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCch
Q 002857 318 DFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPE 397 (873)
Q Consensus 318 DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~ 397 (873)
|||+++..... ......||+.|+|||++.+ .++.++|||||||++|||+||+.||....... .+...+.....
T Consensus 158 DFGla~~~~~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~-~~~~~i~~~~~- 230 (270)
T d1t4ha_ 158 DLGLATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA-QIYRRVTSGVK- 230 (270)
T ss_dssp CTTGGGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-HHHHHHTTTCC-
T ss_pred ecCcceeccCC----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHH-HHHHHHHcCCC-
Confidence 99999864332 2234579999999999875 59999999999999999999999996532111 11111100000
Q ss_pred hHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 398 RVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 398 ~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
...+ . .....++.+|+.+||+.||++|||+.|+++
T Consensus 231 ----------~~~~------------------~---~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 231 ----------PASF------------------D---KVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp ----------CGGG------------------G---GCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ----------Cccc------------------C---ccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 0000 0 001224778999999999999999999864
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-46 Score=405.98 Aligned_cols=262 Identities=22% Similarity=0.343 Sum_probs=206.9
Q ss_pred cCCCccee-ecccCceEEEEEEEcC--CCcEEEEEEeeccCC-cchhHHHHHHHHHHhhhhccceeeeeeeecccccCCc
Q 002857 160 KGFSSENL-IGAGNFASVYKGILFE--GAPAVAIKVFNFLHH-DASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGND 235 (873)
Q Consensus 160 ~~f~~~~~-LG~G~fG~VYkg~~~~--~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~ 235 (873)
++|.+.+. ||+|+||.||+|.++. ++..||||+++.... ...+.|.+|+++|++++|||||+++|+|. .+
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~------~~ 81 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ------AE 81 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE------SS
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeec------cC
Confidence 45667774 9999999999998754 455799999975433 34578999999999999999999999963 23
Q ss_pred eEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeE
Q 002857 236 FKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTAC 315 (873)
Q Consensus 236 ~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vK 315 (873)
..+|||||+++|+|.+++.. ....+++.+++.|+.|||.||+||| +++|+||||||+|||++.++.+|
T Consensus 82 ~~~lvmE~~~~g~L~~~l~~---------~~~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~K 149 (285)
T d1u59a_ 82 ALMLVMEMAGGGPLHKFLVG---------KREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAK 149 (285)
T ss_dssp SEEEEEECCTTEEHHHHHTT---------CTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEE
T ss_pred eEEEEEEeCCCCcHHHHhhc---------cccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCchhheeeccCCcee
Confidence 47999999999999999842 3457999999999999999999999 89999999999999999999999
Q ss_pred Eecccccccccccccc-ccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHHHhh
Q 002857 316 VADFGIARFLEATNEQ-TSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQS 393 (873)
Q Consensus 316 LsDFGla~~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~~~~ 393 (873)
|+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|||+| |+.||....... +...+.
T Consensus 150 l~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~--~~~~i~- 226 (285)
T d1u59a_ 150 ISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--VMAFIE- 226 (285)
T ss_dssp ECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH--HHHHHH-
T ss_pred eccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH--HHHHHH-
Confidence 9999999977543322 22233458999999999999999999999999999999998 999997632111 111110
Q ss_pred cCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHHHHhhh
Q 002857 394 ALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLIKKKLL 473 (873)
Q Consensus 394 ~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i~~~l~ 473 (873)
. .. ..+.. ..++..+.+|+.+||+.||++||||.+|++.|+.+...+.
T Consensus 227 ----------~----~~-----------~~~~p-------~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~ 274 (285)
T d1u59a_ 227 ----------Q----GK-----------RMECP-------PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 274 (285)
T ss_dssp ----------T----TC-----------CCCCC-------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred ----------c----CC-----------CCCCC-------CcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhh
Confidence 0 00 00000 0123457899999999999999999999999998766554
Q ss_pred c
Q 002857 474 E 474 (873)
Q Consensus 474 ~ 474 (873)
.
T Consensus 275 ~ 275 (285)
T d1u59a_ 275 S 275 (285)
T ss_dssp T
T ss_pred h
Confidence 3
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-46 Score=405.38 Aligned_cols=252 Identities=23% Similarity=0.291 Sum_probs=203.4
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEE
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKAL 239 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~L 239 (873)
+.|++.+.||+|+||.||+|++..+++.||||+++.......+.+.+|+++|++++|||||++++++ ..++..+|
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~~~~~l 86 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF-----YYENNLWI 86 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEE-----EETTEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----eeCCeEEE
Confidence 4689999999999999999999999999999999876666778899999999999999999999996 45667999
Q ss_pred EEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEecc
Q 002857 240 VYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADF 319 (873)
Q Consensus 240 V~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDF 319 (873)
||||+++|+|.+++.. ....+++.++..|+.||+.||.||| +++|+||||||+|||++.++++||+||
T Consensus 87 vmEy~~~g~L~~~~~~---------~~~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DF 154 (288)
T d2jfla1 87 LIEFCAGGAVDAVMLE---------LERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADF 154 (288)
T ss_dssp EEECCTTEEHHHHHHH---------HTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCC
T ss_pred EEecCCCCcHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEEec
Confidence 9999999999999742 2456999999999999999999999 899999999999999999999999999
Q ss_pred ccccccccccccccccccccccccCCCcccC-----CCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhc
Q 002857 320 GIARFLEATNEQTSSIGVKGTTGYIAPEYGM-----GHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSA 394 (873)
Q Consensus 320 Gla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~-----~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~ 394 (873)
|+|+...... .......||+.|+|||++. +..++.++|||||||++|||+||+.||........ +
T Consensus 155 G~a~~~~~~~--~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~-~------- 224 (288)
T d2jfla1 155 GVSAKNTRTI--QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV-L------- 224 (288)
T ss_dssp TTCEECHHHH--HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH-H-------
T ss_pred hhhhccCCCc--ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH-H-------
Confidence 9997654321 1222356999999999874 45689999999999999999999999976322110 0
Q ss_pred CchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 395 LPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 395 ~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
..+.. .. .+...... .....+.+|+.+||+.||++|||+.|+++
T Consensus 225 -----~~i~~----~~------------~~~~~~~~----~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 225 -----LKIAK----SE------------PPTLAQPS----RWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp -----HHHHH----SC------------CCCCSSGG----GSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -----HHHHc----CC------------CCCCCccc----cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11110 00 00000000 11235788999999999999999999854
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-46 Score=411.94 Aligned_cols=266 Identities=22% Similarity=0.328 Sum_probs=204.8
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCc-----EEEEEEeecc-CCcchhHHHHHHHHHHhh-hhccceeeeeeeeccccc
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAP-----AVAIKVFNFL-HHDASKSFTVECEVMRNI-IHRKIIKVVTACSRVDYQ 232 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~-----~VAVK~l~~~-~~~~~~~f~~Ei~iL~~L-~HpNIV~llg~c~~~~~~ 232 (873)
++|++.++||+|+||+||+|++...++ .||||++... .......+.+|+.+|.++ +|||||+++++| .
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~-----~ 111 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC-----T 111 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE-----C
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEE-----e
Confidence 578899999999999999999865443 6999998643 334456799999999999 899999999996 4
Q ss_pred CCceEEEEEeecCCCChhhhcccccccc-------------cccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeec
Q 002857 233 GNDFKALVYEFMPNGSLEEWIHPITEED-------------KRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHC 299 (873)
Q Consensus 233 ~~~~~~LV~Ey~~~GSL~~~L~~~~~~~-------------~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHr 299 (873)
..+..+|||||+++|+|.++|+...... ........+++..++.|+.||++||+||| +++||||
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~IiHR 188 (325)
T d1rjba_ 112 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHR 188 (325)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEET
T ss_pred eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeec
Confidence 5567899999999999999996421100 00112346899999999999999999999 8999999
Q ss_pred cCCCCCeeeCCCCCeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCC
Q 002857 300 DIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSD 378 (873)
Q Consensus 300 DLKpsNILLd~~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~ 378 (873)
||||+|||++.++++||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||+| |+.||.
T Consensus 189 DlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~ 268 (325)
T d1rjba_ 189 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 268 (325)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred cCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCC
Confidence 9999999999999999999999987765544444445668999999999999999999999999999999998 899997
Q ss_pred cccccchhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCH
Q 002857 379 DMFKDNLNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKI 458 (873)
Q Consensus 379 ~~~~~~~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm 458 (873)
...... .+ ..++....... .|. .+...+.+|+.+||+.||++||||
T Consensus 269 ~~~~~~-~~------------~~~~~~~~~~~------------~p~---------~~~~~l~~li~~cl~~dP~~RPt~ 314 (325)
T d1rjba_ 269 GIPVDA-NF------------YKLIQNGFKMD------------QPF---------YATEEIYIIMQSCWAFDSRKRPSF 314 (325)
T ss_dssp TCCCSH-HH------------HHHHHTTCCCC------------CCT---------TCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred CCCHHH-HH------------HHHHhcCCCCC------------CCC---------cCCHHHHHHHHHHcCCChhHCcCH
Confidence 632221 11 11111110000 000 113358899999999999999999
Q ss_pred HHHHHHHHH
Q 002857 459 NDVELGLRL 467 (873)
Q Consensus 459 ~EVl~~Le~ 467 (873)
+||++.|..
T Consensus 315 ~ei~~~L~~ 323 (325)
T d1rjba_ 315 PNLTSFLGC 323 (325)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHhC
Confidence 999999863
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-46 Score=397.97 Aligned_cols=253 Identities=26% Similarity=0.397 Sum_probs=206.3
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEE
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKAL 239 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~L 239 (873)
++|+..++||+|+||+||+|++ .+++.||||+++.... ..++|.+|++++++++|||||+++|+| ..++..++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~-----~~~~~~~i 76 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVC-----TKQRPIFI 76 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEE-TTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEE-----CCSSSEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEE-CCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEE-----eeCCceEE
Confidence 6899999999999999999998 4778999999986443 447899999999999999999999997 34567899
Q ss_pred EEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEecc
Q 002857 240 VYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADF 319 (873)
Q Consensus 240 V~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDF 319 (873)
||||+++|+|.+++.. ....+++..++.|+.|||+||+||| +.+|+||||||+|||++.++.+||+||
T Consensus 77 v~Ey~~~g~l~~~~~~---------~~~~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~Df 144 (258)
T d1k2pa_ 77 ITEYMANGCLLNYLRE---------MRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDF 144 (258)
T ss_dssp EEECCTTEEHHHHHHS---------GGGCCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCC
T ss_pred EEEccCCCcHHHhhhc---------cccCCcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEECcc
Confidence 9999999999999743 3456889999999999999999999 899999999999999999999999999
Q ss_pred ccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHHHhhcCchh
Q 002857 320 GIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQSALPER 398 (873)
Q Consensus 320 Gla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~~~~~~~~~ 398 (873)
|+++....... .......+|..|+|||++.+..++.++|||||||++|||+| |+.||....... +...
T Consensus 145 G~a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~--~~~~-------- 213 (258)
T d1k2pa_ 145 GLSRYVLDDEY-TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE--TAEH-------- 213 (258)
T ss_dssp SSCCBCSSSSC-CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH--HHHH--------
T ss_pred hhheeccCCCc-eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH--HHHH--------
Confidence 99987654332 23334568999999999999999999999999999999998 899997643221 1110
Q ss_pred HHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHH
Q 002857 399 VEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRL 467 (873)
Q Consensus 399 l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~ 467 (873)
+.+. ... ..|. .+...+.+++.+||+.||++||||+||++.|..
T Consensus 214 ---i~~~-~~~------------~~p~---------~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 214 ---IAQG-LRL------------YRPH---------LASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp ---HHTT-CCC------------CCCT---------TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred ---HHhC-CCC------------CCcc---------cccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 1000 000 0010 112358899999999999999999999998864
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-46 Score=412.15 Aligned_cols=201 Identities=26% Similarity=0.345 Sum_probs=177.0
Q ss_pred hhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC-CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCce
Q 002857 158 ATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH-HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDF 236 (873)
Q Consensus 158 at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~ 236 (873)
..++|++.++||+|+||+||+|++..+++.||||+++... ......+.+|+.+|++++|||||+++++| ..++.
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-----~~~~~ 78 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF-----YSDGE 78 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEE-----ECSSE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCE
Confidence 3578999999999999999999999999999999997543 33346789999999999999999999996 45678
Q ss_pred EEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCC-CCeeeccCCCCCeeeCCCCCeE
Q 002857 237 KALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCK-PPIAHCDIKPSNILLNDEMTAC 315 (873)
Q Consensus 237 ~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s-~gIvHrDLKpsNILLd~~~~vK 315 (873)
.+|||||+++|+|.+++.. ...+++..+..++.||+.||.||| + .+|+||||||+|||++.++++|
T Consensus 79 ~~iVmEy~~gg~L~~~l~~----------~~~l~~~~~~~~~~qil~aL~yLH---~~~~IiHRDiKP~NILl~~~~~vk 145 (322)
T d1s9ja_ 79 ISICMEHMDGGSLDQVLKK----------AGRIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIK 145 (322)
T ss_dssp EEEEEECCTTEEHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEE
T ss_pred EEEEEEcCCCCcHHHHHhh----------cCCCCHHHHHHHHHHHHHHHHHHH---HhCCEEccccCHHHeeECCCCCEE
Confidence 9999999999999999953 346899999999999999999999 5 4899999999999999999999
Q ss_pred EeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcc
Q 002857 316 VADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDM 380 (873)
Q Consensus 316 LsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~ 380 (873)
|+|||+|+.+.... .....||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 146 l~DFGla~~~~~~~----~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~ 206 (322)
T d1s9ja_ 146 LCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 206 (322)
T ss_dssp ECCCCCCHHHHHHT----C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCC
T ss_pred EeeCCCccccCCCc----cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 99999998764322 23457999999999999999999999999999999999999999763
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-47 Score=407.59 Aligned_cols=252 Identities=23% Similarity=0.345 Sum_probs=202.3
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeecc---CCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCce
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFL---HHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDF 236 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~ 236 (873)
++|++.+.||+|+||+||+|++..+++.||||+++.. .....+.+.+|+++|++++|||||++++++ .+++.
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~~~ 82 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF-----QDDEK 82 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEE-----ECSSE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEE-----EECCE
Confidence 5799999999999999999999999999999998642 233456799999999999999999999995 55678
Q ss_pred EEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEE
Q 002857 237 KALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACV 316 (873)
Q Consensus 237 ~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKL 316 (873)
.+|||||+++|+|.+++.. ...+++..++.++.||+.||+||| +.+|+||||||+|||+++++.+||
T Consensus 83 ~~ivmEy~~gg~L~~~~~~----------~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl 149 (288)
T d1uu3a_ 83 LYFGLSYAKNGELLKYIRK----------IGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQI 149 (288)
T ss_dssp EEEEECCCTTEEHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEE
T ss_pred EEEEEEccCCCCHHHhhhc----------cCCCCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEe
Confidence 9999999999999999842 356899999999999999999999 899999999999999999999999
Q ss_pred eccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCc
Q 002857 317 ADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALP 396 (873)
Q Consensus 317 sDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~ 396 (873)
+|||+|+.+.............||+.|+|||++.+..++.++|||||||++|||+||+.||......
T Consensus 150 ~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~------------- 216 (288)
T d1uu3a_ 150 TDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY------------- 216 (288)
T ss_dssp CCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-------------
T ss_pred cccccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHH-------------
Confidence 9999999775544333444567999999999999999999999999999999999999999753111
Q ss_pred hhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHH
Q 002857 397 ERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGL 465 (873)
Q Consensus 397 ~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~L 465 (873)
++....+...+ ..|. .....+.+|+.+||+.||++|||++|++...
T Consensus 217 ----~~~~~i~~~~~----------~~p~---------~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~ 262 (288)
T d1uu3a_ 217 ----LIFQKIIKLEY----------DFPE---------KFFPKARDLVEKLLVLDATKRLGCEEMEGYG 262 (288)
T ss_dssp ----HHHHHHHTTCC----------CCCT---------TCCHHHHHHHHTTSCSSGGGSTTSGGGTCHH
T ss_pred ----HHHHHHHcCCC----------CCCc---------cCCHHHHHHHHHHccCCHhHCcCHHHHcCCH
Confidence 11111111110 0010 0122477899999999999999999986543
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.2e-46 Score=406.42 Aligned_cols=274 Identities=21% Similarity=0.337 Sum_probs=210.5
Q ss_pred HHHHHhhcCCCcceeecccCceEEEEEEEcC-----CCcEEEEEEeeccCCc-chhHHHHHHHHHHhhhhccceeeeeee
Q 002857 153 EALYSATKGFSSENLIGAGNFASVYKGILFE-----GAPAVAIKVFNFLHHD-ASKSFTVECEVMRNIIHRKIIKVVTAC 226 (873)
Q Consensus 153 ~el~~at~~f~~~~~LG~G~fG~VYkg~~~~-----~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~llg~c 226 (873)
.+++...++|++.+.||+|+||+||+|+++. +++.||||+++..... ..++|.+|+++|++++||||++++++|
T Consensus 6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence 3444556789999999999999999999753 4578999999754333 346799999999999999999999997
Q ss_pred ecccccCCceEEEEEeecCCCChhhhcccccccc--------------cccCCCCCCchhhhHHHHHHHHHHHHHHhhCC
Q 002857 227 SRVDYQGNDFKALVYEFMPNGSLEEWIHPITEED--------------KRHKAPGNLNSLERLNIAIDVASALEYLHLGC 292 (873)
Q Consensus 227 ~~~~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~--------------~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~ 292 (873)
......++||||+++|+|.++|+...... ........+++..++.|+.||+.||+|||
T Consensus 86 -----~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH--- 157 (301)
T d1lufa_ 86 -----AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS--- 157 (301)
T ss_dssp -----CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---
T ss_pred -----ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc---
Confidence 34567899999999999999996421100 01122345899999999999999999999
Q ss_pred CCCeeeccCCCCCeeeCCCCCeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh
Q 002857 293 KPPIAHCDIKPSNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT 372 (873)
Q Consensus 293 s~gIvHrDLKpsNILLd~~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT 372 (873)
+.+||||||||+|||+|.++++||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++
T Consensus 158 ~~~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~ 237 (301)
T d1lufa_ 158 ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 237 (301)
T ss_dssp HTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred cCCeEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHc
Confidence 89999999999999999999999999999987755544444445668999999999999999999999999999999999
Q ss_pred CC-CCCCcccccchhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccC
Q 002857 373 GL-RPSDDMFKDNLNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAEL 451 (873)
Q Consensus 373 Gk-~Pf~~~~~~~~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~d 451 (873)
|. .||....... +.. .+.+... .+.. ..++..+.+|+.+||+.+
T Consensus 238 ~~~~p~~~~~~~e--~~~-----------~v~~~~~---------------~~~p-------~~~~~~~~~li~~cl~~~ 282 (301)
T d1lufa_ 238 YGLQPYYGMAHEE--VIY-----------YVRDGNI---------------LACP-------ENCPLELYNLMRLCWSKL 282 (301)
T ss_dssp TTCCTTTTSCHHH--HHH-----------HHHTTCC---------------CCCC-------TTCCHHHHHHHHHHTCSS
T ss_pred cCCCCCCCCCHHH--HHH-----------HHHcCCC---------------CCCC-------ccchHHHHHHHHHHcCCC
Confidence 85 5665432111 111 1111100 0000 011235789999999999
Q ss_pred cCCCCCHHHHHHHHHHHH
Q 002857 452 PGERMKINDVELGLRLIK 469 (873)
Q Consensus 452 P~eRPTm~EVl~~Le~i~ 469 (873)
|++||||.||+++|++|.
T Consensus 283 P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 283 PADRPSFCSIHRILQRMC 300 (301)
T ss_dssp GGGSCCHHHHHHHHHHTT
T ss_pred hhHCcCHHHHHHHHHHhc
Confidence 999999999999999874
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-46 Score=400.50 Aligned_cols=251 Identities=24% Similarity=0.372 Sum_probs=197.3
Q ss_pred eeecccCceEEEEEEEcC--CCcEEEEEEeeccC--CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEEEE
Q 002857 166 NLIGAGNFASVYKGILFE--GAPAVAIKVFNFLH--HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKALVY 241 (873)
Q Consensus 166 ~~LG~G~fG~VYkg~~~~--~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~LV~ 241 (873)
++||+|+||+||+|.+.. .++.||||+++... ....+.|.+|+++|++++|||||+++|+|. .+..+|||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~------~~~~~lvm 86 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE------AESWMLVM 86 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE------SSSEEEEE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEec------cCCEEEEE
Confidence 579999999999998754 35689999996432 223467999999999999999999999973 23468999
Q ss_pred eecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEecccc
Q 002857 242 EFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFGI 321 (873)
Q Consensus 242 Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDFGl 321 (873)
||+++|+|.++++. ...+++.+++.|+.|||.||+||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 87 E~~~~g~L~~~l~~----------~~~l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGl 153 (277)
T d1xbba_ 87 EMAELGPLNKYLQQ----------NRHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGL 153 (277)
T ss_dssp ECCTTEEHHHHHHH----------CTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred EcCCCCcHHHHHhh----------ccCCCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccchhh
Confidence 99999999999842 456999999999999999999999 88999999999999999999999999999
Q ss_pred cccccccccc-ccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHHHhhcCchhH
Q 002857 322 ARFLEATNEQ-TSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQSALPERV 399 (873)
Q Consensus 322 a~~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~~~~~~~~~l 399 (873)
++.+...... .......||+.|+|||++.+..++.++|||||||++|||+| |+.||....... +.
T Consensus 154 a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~--~~----------- 220 (277)
T d1xbba_ 154 SKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--VT----------- 220 (277)
T ss_dssp CEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HH-----------
T ss_pred hhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH--HH-----------
Confidence 9876543322 22234568999999999999999999999999999999998 899997632111 11
Q ss_pred HHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHHHH
Q 002857 400 EEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLIKK 470 (873)
Q Consensus 400 ~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i~~ 470 (873)
..+.. .. ..+.. ..++..+.+|+.+||+.||++||||+||+++|+....
T Consensus 221 -~~i~~---~~-----------~~~~p-------~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 221 -AMLEK---GE-----------RMGCP-------AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp -HHHHT---TC-----------CCCCC-------TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -HHHHc---CC-----------CCCCC-------cccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 11110 00 00000 0123457889999999999999999999999987644
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-46 Score=405.24 Aligned_cols=259 Identities=24% Similarity=0.408 Sum_probs=202.4
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCc----EEEEEEeecc-CCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCC
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAP----AVAIKVFNFL-HHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGN 234 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~----~VAVK~l~~~-~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~ 234 (873)
++|++.++||+|+||+||+|++..+++ .||||.++.. .....+.|.+|+++|++++|||||+++|+|.+
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~------ 82 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT------ 82 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES------
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------
Confidence 469999999999999999999977765 5888888643 33455789999999999999999999999742
Q ss_pred ceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCe
Q 002857 235 DFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTA 314 (873)
Q Consensus 235 ~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~v 314 (873)
+..++++||+.+|+|.+++.. ....+++..++.|+.|||.||+||| +++||||||||+|||++.++++
T Consensus 83 ~~~~~v~e~~~~~~l~~~~~~---------~~~~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~ 150 (317)
T d1xkka_ 83 STVQLITQLMPFGCLLDYVRE---------HKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHV 150 (317)
T ss_dssp SSEEEEEECCTTCBHHHHHHH---------TSSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEE
T ss_pred CCeeEEEEeccCCcccccccc---------cccCCCHHHHHHHHHHHHHHHHHHH---HcCcccCcchhhcceeCCCCCe
Confidence 346889999999999998852 4567899999999999999999999 8999999999999999999999
Q ss_pred EEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHHHhh
Q 002857 315 CVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQS 393 (873)
Q Consensus 315 KLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~~~~ 393 (873)
||+|||+++...............||+.|+|||++.++.++.++|||||||++|||+| |+.||+......
T Consensus 151 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~--------- 221 (317)
T d1xkka_ 151 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--------- 221 (317)
T ss_dssp EECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG---------
T ss_pred EeeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH---------
Confidence 9999999998765444444445568999999999999999999999999999999999 788887532211
Q ss_pred cCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHHHHh
Q 002857 394 ALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLIKKK 471 (873)
Q Consensus 394 ~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i~~~ 471 (873)
+...+.... ..+... .+...+.+|+.+||+.||++||||.||++.|+.+...
T Consensus 222 -----~~~~i~~~~--------------~~~~p~-------~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 222 -----ISSILEKGE--------------RLPQPP-------ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp -----HHHHHHHTC--------------CCCCCT-------TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred -----HHHHHHcCC--------------CCCCCc-------ccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence 111111100 000000 1233578899999999999999999999999887553
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-46 Score=400.51 Aligned_cols=255 Identities=27% Similarity=0.403 Sum_probs=197.1
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEE
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKAL 239 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~L 239 (873)
++|++.+.||+|+||.||+|++.. ++.||||+++... ...+.|.+|+.+|++++|+|||+++|+|. .+..++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~-~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~------~~~~~l 88 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS------EEPIYI 88 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC------SSSCEE
T ss_pred HHEEEeeEEeeCCCeEEEEEEECC-CCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEe------cCCeEE
Confidence 578999999999999999998854 4679999997543 34578999999999999999999999963 234689
Q ss_pred EEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEecc
Q 002857 240 VYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADF 319 (873)
Q Consensus 240 V~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDF 319 (873)
||||+++|+|.+++.. .....++|.+++.|+.|||.||+||| +.+|+||||||+|||||.++++||+||
T Consensus 89 v~Ey~~~g~l~~~~~~--------~~~~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~Df 157 (285)
T d1fmka3 89 VTEYMSKGSLLDFLKG--------ETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADF 157 (285)
T ss_dssp EECCCTTCBHHHHHSH--------HHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCC
T ss_pred EEEecCCCchhhhhhh--------cccccchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEEEccc
Confidence 9999999999999853 22346999999999999999999999 889999999999999999999999999
Q ss_pred ccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCchhH
Q 002857 320 GIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPERV 399 (873)
Q Consensus 320 Gla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~~l 399 (873)
|+++....... .......||+.|+|||++.+..++.++||||||+++|||+||..|+....... .+...
T Consensus 158 Gla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~-~~~~~--------- 226 (285)
T d1fmka3 158 GLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-EVLDQ--------- 226 (285)
T ss_dssp CTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-HHHHH---------
T ss_pred chhhhccCCCc-eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHH-HHHHH---------
Confidence 99987644322 22233568999999999999999999999999999999999776654422111 11111
Q ss_pred HHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHH
Q 002857 400 EEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLI 468 (873)
Q Consensus 400 ~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i 468 (873)
+..... .+.. ..+.+++.+++.+||+.||++||||.+|+++|+..
T Consensus 227 ---i~~~~~--------------~~~~-------~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~ 271 (285)
T d1fmka3 227 ---VERGYR--------------MPCP-------PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 271 (285)
T ss_dssp ---HHTTCC--------------CCCC-------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTT
T ss_pred ---HHhcCC--------------CCCC-------cccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhh
Confidence 110000 0100 01234578999999999999999999999998864
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-45 Score=397.51 Aligned_cols=271 Identities=20% Similarity=0.292 Sum_probs=199.8
Q ss_pred hcCCCcceeecccCceEEEEEEEcC-----CCcEEEEEEeeccC-CcchhHHHHHHHHHHhh-hhccceeeeeeeecccc
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFE-----GAPAVAIKVFNFLH-HDASKSFTVECEVMRNI-IHRKIIKVVTACSRVDY 231 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~-----~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L-~HpNIV~llg~c~~~~~ 231 (873)
.++|++.++||+|+||.||+|++.. +++.||||+++... ....+.+.+|+.++.++ +|+|||.+++++.
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~---- 87 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT---- 87 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC----
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeec----
Confidence 4679999999999999999999754 34689999987433 23446788899988888 6899999999863
Q ss_pred cCCceEEEEEeecCCCChhhhccccccccc------ccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCC
Q 002857 232 QGNDFKALVYEFMPNGSLEEWIHPITEEDK------RHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSN 305 (873)
Q Consensus 232 ~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~------~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsN 305 (873)
..+...++||||+++|+|.++|+....... .......+++.+++.|+.||++||+||| +++||||||||+|
T Consensus 88 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrDlKp~N 164 (299)
T d1ywna1 88 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARN 164 (299)
T ss_dssp STTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGG
T ss_pred cCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---hCCCcCCcCCccc
Confidence 345568999999999999999964211000 0012346899999999999999999999 8999999999999
Q ss_pred eeeCCCCCeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCC-CCCCcccccc
Q 002857 306 ILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGL-RPSDDMFKDN 384 (873)
Q Consensus 306 ILLd~~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk-~Pf~~~~~~~ 384 (873)
|||+.++++||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||+||. .||.......
T Consensus 165 ILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~ 244 (299)
T d1ywna1 165 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 244 (299)
T ss_dssp EEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred eeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH
Confidence 999999999999999998765554444444567999999999999999999999999999999999974 5675432111
Q ss_pred hhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHH
Q 002857 385 LNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELG 464 (873)
Q Consensus 385 ~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~ 464 (873)
.+.. .+...... ..|. .+...+.+++.+||+.||++||||.||+++
T Consensus 245 -~~~~------------~~~~~~~~------------~~~~---------~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 245 -EFCR------------RLKEGTRM------------RAPD---------YTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp -HHHH------------HHHHTCCC------------CCCT---------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -HHHH------------HHhcCCCC------------CCCc---------cCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 1111 11100000 0000 112347889999999999999999999999
Q ss_pred HHHHHH
Q 002857 465 LRLIKK 470 (873)
Q Consensus 465 Le~i~~ 470 (873)
|+.|.+
T Consensus 291 L~~ilq 296 (299)
T d1ywna1 291 LGNLLQ 296 (299)
T ss_dssp HHHHHH
T ss_pred HHHHHh
Confidence 998854
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.6e-45 Score=401.34 Aligned_cols=253 Identities=21% Similarity=0.304 Sum_probs=187.9
Q ss_pred hhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC-CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCce
Q 002857 158 ATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH-HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDF 236 (873)
Q Consensus 158 at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~ 236 (873)
..+.|++.+.||+|+||+||+|+++.+++.||||++.... ....+.+.+|+++|++++|||||++++++ ..++.
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-----~~~~~ 81 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIY-----ESGGH 81 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEE-----ECSSE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCE
Confidence 3467999999999999999999999999999999987443 22345688999999999999999999995 55678
Q ss_pred EEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeC---CCCC
Q 002857 237 KALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLN---DEMT 313 (873)
Q Consensus 237 ~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd---~~~~ 313 (873)
.+|||||+++|+|.++|. ....+++.++..|+.||+.||+||| +.+|+||||||+|||+. +++.
T Consensus 82 ~~lvmE~~~gg~L~~~l~----------~~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~ 148 (307)
T d1a06a_ 82 LYLIMQLVSGGELFDRIV----------EKGFYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSK 148 (307)
T ss_dssp EEEEECCCCSCBHHHHHH----------TCSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCC
T ss_pred EEEEEeccCCCcHHHhhh----------cccCCCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCce
Confidence 999999999999999994 3457999999999999999999999 89999999999999994 5789
Q ss_pred eEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhh
Q 002857 314 ACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQS 393 (873)
Q Consensus 314 vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~ 393 (873)
+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||+||+.||....... +..
T Consensus 149 vkl~DFG~a~~~~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~--~~~---- 219 (307)
T d1a06a_ 149 IMISDFGLSKMEDPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK--LFE---- 219 (307)
T ss_dssp EEECCC---------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHH----
T ss_pred EEEeccceeEEccCCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH--HHH----
Confidence 9999999998664332 2233569999999999999999999999999999999999999997532111 111
Q ss_pred cCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 394 ALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 394 ~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
.+........ .+.. . .....+.+|+.+||+.||++|||++|+++
T Consensus 220 -------~i~~~~~~~~------------~~~~---~----~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 220 -------QILKAEYEFD------------SPYW---D----DISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp -------HHHTTCCCCC------------TTTT---T----TSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -------HHhccCCCCC------------Cccc---c----CCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 1111000000 0000 0 11234778999999999999999999865
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3.4e-45 Score=405.71 Aligned_cols=253 Identities=21% Similarity=0.298 Sum_probs=204.8
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEE
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKA 238 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~ 238 (873)
-++|++.+.||+|+||.||+|++..+|+.||||++........+.+.+|+++|++++|||||++++++ .+++..+
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~~~ 99 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF-----EDDNEMV 99 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEE-----EETTEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEEE
Confidence 35899999999999999999999999999999999766555567899999999999999999999995 4567899
Q ss_pred EEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeC--CCCCeEE
Q 002857 239 LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLN--DEMTACV 316 (873)
Q Consensus 239 LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd--~~~~vKL 316 (873)
|||||+++|+|.++|.. ....+++..++.|+.||+.||+||| +.+||||||||+|||++ .++.+||
T Consensus 100 ivmE~~~gg~L~~~l~~---------~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL 167 (350)
T d1koaa2 100 MIYEFMSGGELFEKVAD---------EHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKL 167 (350)
T ss_dssp EEECCCCSCBHHHHHTC---------TTSCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEE
T ss_pred EEEEcCCCCCHHHHHHh---------hcCCCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEEE
Confidence 99999999999999842 3456999999999999999999999 89999999999999996 4678999
Q ss_pred eccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCc
Q 002857 317 ADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALP 396 (873)
Q Consensus 317 sDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~ 396 (873)
+|||+++.+.... ......||+.|+|||++.+..++.++|||||||++|||+||+.||....... .
T Consensus 168 ~DFG~a~~~~~~~---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~--~--------- 233 (350)
T d1koaa2 168 IDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE--T--------- 233 (350)
T ss_dssp CCCTTCEECCTTS---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--H---------
T ss_pred eecchheeccccc---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHH--H---------
Confidence 9999998764432 2234569999999999999999999999999999999999999997532111 0
Q ss_pred hhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 397 ERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 397 ~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
+..+....... + ... .....+.+.+|+.+||+.||++|||++|+++
T Consensus 234 --~~~i~~~~~~~--------------~-~~~----~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 234 --LRNVKSCDWNM--------------D-DSA----FSGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp --HHHHHHTCCCS--------------C-CGG----GGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred --HHHHHhCCCCC--------------C-ccc----ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11111100000 0 000 0011234778999999999999999999865
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-45 Score=398.00 Aligned_cols=281 Identities=23% Similarity=0.329 Sum_probs=202.6
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHH--HHHHHhhhhccceeeeeeeecccccCCceE
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVE--CEVMRNIIHRKIIKVVTACSRVDYQGNDFK 237 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~E--i~iL~~L~HpNIV~llg~c~~~~~~~~~~~ 237 (873)
++|...+.||+|+||.||+|++ +|+.||||+++.. ..+.+..| +..+.+++|||||+++++|.... ......
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~-~~~~~~ 76 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQL 76 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCC-CcceEE
Confidence 4677889999999999999987 6789999998643 22344444 44556789999999999986432 223468
Q ss_pred EEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCC-----CCCeeeccCCCCCeeeCCCC
Q 002857 238 ALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGC-----KPPIAHCDIKPSNILLNDEM 312 (873)
Q Consensus 238 ~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~-----s~gIvHrDLKpsNILLd~~~ 312 (873)
++||||+++|+|.++|+. ..++|.+++.++.|+|.||+|||+.. .++|+||||||+||||+.++
T Consensus 77 ~lv~Ey~~~g~L~~~l~~-----------~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~ 145 (303)
T d1vjya_ 77 WLVSDYHEHGSLFDYLNR-----------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG 145 (303)
T ss_dssp EEEEECCTTCBHHHHHHH-----------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTS
T ss_pred EEEEecccCCCHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCC
Confidence 999999999999999953 35899999999999999999999321 36999999999999999999
Q ss_pred CeEEecccccccccccccc--ccccccccccccCCCcccCCC------CCCcchhhHhHHHHHHHHHhCCCCCCcccccc
Q 002857 313 TACVADFGIARFLEATNEQ--TSSIGVKGTTGYIAPEYGMGH------ETSSYGDVYSFGILLLEMFTGLRPSDDMFKDN 384 (873)
Q Consensus 313 ~vKLsDFGla~~~~~~~~~--~~~~~~~Gt~~Y~APE~l~~~------~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~ 384 (873)
++||+|||+++........ .......||+.|+|||++.+. .++.++|||||||+||||+||..||.......
T Consensus 146 ~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~ 225 (303)
T d1vjya_ 146 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 225 (303)
T ss_dssp CEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCC
T ss_pred CeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccc
Confidence 9999999999877554322 123345799999999998764 26778999999999999999998876533222
Q ss_pred hhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHH
Q 002857 385 LNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELG 464 (873)
Q Consensus 385 ~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~ 464 (873)
......... ......+.+...... ..|...... ...+....+.+|+.+||+.||++||||.||++.
T Consensus 226 ~~~~~~~~~--~~~~~~~~~~~~~~~-----------~~p~~~~~~-~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 226 LPYYDLVPS--DPSVEEMRKVVCEQK-----------LRPNIPNRW-QSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp CTTTTTSCS--SCCHHHHHHHHTTSC-----------CCCCCCGGG-GGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred cchhhcccc--cchHHHHHHHHhccc-----------cCCCCCccc-CChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 111111110 011111111111100 011111100 012345568899999999999999999999999
Q ss_pred HHHHHHh
Q 002857 465 LRLIKKK 471 (873)
Q Consensus 465 Le~i~~~ 471 (873)
|+++.+.
T Consensus 292 L~~i~~~ 298 (303)
T d1vjya_ 292 LSQLSQQ 298 (303)
T ss_dssp HHHHHHH
T ss_pred HHHHHHh
Confidence 9998654
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=393.01 Aligned_cols=253 Identities=25% Similarity=0.369 Sum_probs=196.0
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEE
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKAL 239 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~L 239 (873)
++|++.+.||+|+||.||+|++ .++.||||+++.. ...+.|.+|++++++++|||||+++|+|. ...+..++
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~----~~~~~~~l 78 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIV----EEKGGLYI 78 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEEC----CC--CCEE
T ss_pred HHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEE----ecCCcEEE
Confidence 4678889999999999999998 4678999999643 34578999999999999999999999874 33455799
Q ss_pred EEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEecc
Q 002857 240 VYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADF 319 (873)
Q Consensus 240 V~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDF 319 (873)
||||+++|+|.++|+. .....+++..++.|+.||+.||.||| +.+|+||||||+|||++.++++||+||
T Consensus 79 v~ey~~~g~L~~~l~~--------~~~~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~df 147 (262)
T d1byga_ 79 VTEYMAKGSLVDYLRS--------RGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDF 147 (262)
T ss_dssp EECCCTTEEHHHHHHH--------HHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCC
T ss_pred EEeccCCCCHHHHHHh--------cCCCCCCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEeeccc
Confidence 9999999999999953 12235899999999999999999999 899999999999999999999999999
Q ss_pred ccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHHHhhcCchh
Q 002857 320 GIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQSALPER 398 (873)
Q Consensus 320 Gla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~~~~~~~~~ 398 (873)
|+++..... .....+|..|+|||++.+..++.++||||||+++|||+| |+.||...... .+...+....
T Consensus 148 g~s~~~~~~-----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~--~~~~~i~~~~--- 217 (262)
T d1byga_ 148 GLTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPRVEKGY--- 217 (262)
T ss_dssp CC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG--GHHHHHTTTC---
T ss_pred ccceecCCC-----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH--HHHHHHHcCC---
Confidence 999865332 223357899999999999999999999999999999999 67777653221 1111111100
Q ss_pred HHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHHHHh
Q 002857 399 VEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLIKKK 471 (873)
Q Consensus 399 l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i~~~ 471 (873)
..+... .+..++.+|+.+||+.||++||||.||+++|+.|+..
T Consensus 218 -----------------------~~~~~~-------~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 218 -----------------------KMDAPD-------GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp -----------------------CCCCCT-------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----------------------CCCCCc-------cCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence 000000 1123578899999999999999999999999998753
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-45 Score=392.86 Aligned_cols=252 Identities=21% Similarity=0.277 Sum_probs=202.2
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCC------cchhHHHHHHHHHHhhhhccceeeeeeeeccccc
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH------DASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQ 232 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~------~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~ 232 (873)
.++|++.+.||+|+||+||+|+++.+|+.||||+++.... ...+.+.+|+++|++++|||||++++++ .
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~ 83 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY-----E 83 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----E
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----E
Confidence 4679999999999999999999999999999999864321 2246799999999999999999999995 5
Q ss_pred CCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCC
Q 002857 233 GNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEM 312 (873)
Q Consensus 233 ~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~ 312 (873)
+.+..+|||||+++|+|.++|.. ...+++..++.|+.||+.||+||| +.+|+||||||+|||++.++
T Consensus 84 ~~~~~~iv~E~~~gg~L~~~i~~----------~~~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~ 150 (293)
T d1jksa_ 84 NKTDVILILELVAGGELFDFLAE----------KESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRN 150 (293)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSS
T ss_pred ECCEEEEEEEcCCCccccchhcc----------ccccchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecCC
Confidence 56789999999999999999943 346999999999999999999999 89999999999999998776
Q ss_pred ----CeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhH
Q 002857 313 ----TACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQ 388 (873)
Q Consensus 313 ----~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~ 388 (873)
.+||+|||+++....... .....||+.|+|||++.+..++.++|||||||++|||+||+.||....... ..
T Consensus 151 ~~~~~vkl~DfG~a~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~--~~ 225 (293)
T d1jksa_ 151 VPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE--TL 225 (293)
T ss_dssp SSSCCEEECCCTTCEECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HH
T ss_pred CcccceEecchhhhhhcCCCcc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH--HH
Confidence 599999999987644322 233468999999999999999999999999999999999999997532111 00
Q ss_pred HHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 389 NWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 389 ~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
..+........ ..........+.+|+.+||+.||++|||++|+++
T Consensus 226 -----------~~i~~~~~~~~-------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 226 -----------ANVSAVNYEFE-------------------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp -----------HHHHTTCCCCC-------------------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -----------HHHHhcCCCCC-------------------chhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 01100000000 0000111234778999999999999999999864
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.5e-45 Score=398.92 Aligned_cols=245 Identities=22% Similarity=0.272 Sum_probs=197.1
Q ss_pred CCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCc---chhHHHHHHHHHHhhhhccceeeeeeeecccccCCceE
Q 002857 161 GFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHD---ASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFK 237 (873)
Q Consensus 161 ~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~---~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~ 237 (873)
.|+..+.||+|+||.||+|++..+++.||||+++..... ..+.+.+|+++|++++|||||++++++ ..++..
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~~~~ 90 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCY-----LREHTA 90 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----EETTEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEE-----EECCEE
Confidence 488999999999999999999999999999999754332 235689999999999999999999996 446679
Q ss_pred EEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEe
Q 002857 238 ALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVA 317 (873)
Q Consensus 238 ~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLs 317 (873)
+|||||+++|+|..++. ....+++.+++.|+.||+.||.||| +++|+||||||+|||++.++++||+
T Consensus 91 ~iv~E~~~~g~l~~~~~----------~~~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~ 157 (309)
T d1u5ra_ 91 WLVMEYCLGSASDLLEV----------HKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLG 157 (309)
T ss_dssp EEEEECCSEEHHHHHHH----------HTSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEEC
T ss_pred EEEEEecCCCchHHHHH----------hCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEEe
Confidence 99999999999987663 2456899999999999999999999 8999999999999999999999999
Q ss_pred ccccccccccccccccccccccccccCCCcccCC---CCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhc
Q 002857 318 DFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMG---HETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSA 394 (873)
Q Consensus 318 DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~---~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~ 394 (873)
|||+|+..... ....||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... .
T Consensus 158 DFG~a~~~~~~------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~-~-------- 222 (309)
T d1u5ra_ 158 DFGSASIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-A-------- 222 (309)
T ss_dssp CCTTCBSSSSB------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-H--------
T ss_pred ecccccccCCC------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHH-H--------
Confidence 99999865332 23469999999999864 468999999999999999999999996532111 0
Q ss_pred CchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 395 LPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 395 ~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
+..+.. ... ..+... .....+.+|+.+||+.||++|||++|+++
T Consensus 223 ----~~~i~~----~~~----------~~~~~~-------~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 223 ----LYHIAQ----NES----------PALQSG-------HWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp ----HHHHHH----SCC----------CCCSCT-------TSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ----HHHHHh----CCC----------CCCCCC-------CCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 011110 000 000000 01234778999999999999999999875
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-44 Score=394.99 Aligned_cols=259 Identities=22% Similarity=0.377 Sum_probs=203.1
Q ss_pred ceeecccCceEEEEEEEcCCC---cEEEEEEeecc-CCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEEE
Q 002857 165 ENLIGAGNFASVYKGILFEGA---PAVAIKVFNFL-HHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKALV 240 (873)
Q Consensus 165 ~~~LG~G~fG~VYkg~~~~~g---~~VAVK~l~~~-~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~LV 240 (873)
.++||+|+||+||+|++..++ ..||||+++.. .....++|.+|+++|++++|||||+++|+|. ..+...++|
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~----~~~~~~~lv 107 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL----RSEGSPLVV 107 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE----ETTTEEEEE
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEE----ecCCceEEE
Confidence 478999999999999986543 36899998743 3334578999999999999999999999974 334578999
Q ss_pred EeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEeccc
Q 002857 241 YEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVADFG 320 (873)
Q Consensus 241 ~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsDFG 320 (873)
|||+++|+|.++++. ....+++..++.++.|+|.||.||| +.+|+||||||+||||++++.+||+|||
T Consensus 108 ~E~~~~g~l~~~~~~---------~~~~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG 175 (311)
T d1r0pa_ 108 LPYMKHGDLRNFIRN---------ETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFG 175 (311)
T ss_dssp EECCTTCBHHHHHHC---------TTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSG
T ss_pred EEEeecCchhhhhcc---------ccccchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEeccc
Confidence 999999999999853 4556788899999999999999999 8999999999999999999999999999
Q ss_pred ccccccccccc--ccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCchh
Q 002857 321 IARFLEATNEQ--TSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALPER 398 (873)
Q Consensus 321 la~~~~~~~~~--~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~~~ 398 (873)
+++........ .......||..|+|||++.+..++.++||||||+++|||+||..||....... .+..++.
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~-~~~~~i~------ 248 (311)
T d1r0pa_ 176 LARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-DITVYLL------ 248 (311)
T ss_dssp GGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHHHH------
T ss_pred chhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH-HHHHHHH------
Confidence 99876543322 22334568999999999999999999999999999999999888876422111 1111110
Q ss_pred HHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHHHHhhh
Q 002857 399 VEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLIKKKLL 473 (873)
Q Consensus 399 l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i~~~l~ 473 (873)
... .+..+ ..+...+.+|+.+||+.||++||||.||++.|+.+.+.+.
T Consensus 249 -----~g~----------------~~~~p------~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~ 296 (311)
T d1r0pa_ 249 -----QGR----------------RLLQP------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 296 (311)
T ss_dssp -----TTC----------------CCCCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred -----cCC----------------CCCCc------ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhh
Confidence 000 00000 0112357899999999999999999999999999977554
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=7e-45 Score=403.46 Aligned_cols=253 Identities=20% Similarity=0.245 Sum_probs=204.8
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEE
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKA 238 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~ 238 (873)
.++|++.+.||+|+||.||+|++..+++.||||+++.......+.+.+|+++|++++|||||++++++ .+++..+
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~~~~~ 102 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF-----EDKYEMV 102 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEE-----ECSSEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEEE
Confidence 35799999999999999999999999999999999865555556789999999999999999999995 5577899
Q ss_pred EEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeC--CCCCeEE
Q 002857 239 LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLN--DEMTACV 316 (873)
Q Consensus 239 LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd--~~~~vKL 316 (873)
|||||+++|+|.+++.. ....+++.+++.|+.||+.||+||| +.+|+||||||+||||+ .++.+||
T Consensus 103 ivmE~~~gg~L~~~~~~---------~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL 170 (352)
T d1koba_ 103 LILEFLSGGELFDRIAA---------EDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKI 170 (352)
T ss_dssp EEEECCCCCBHHHHTTC---------TTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEE
T ss_pred EEEEcCCCChHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEEE
Confidence 99999999999988742 3456999999999999999999999 89999999999999998 6789999
Q ss_pred eccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCc
Q 002857 317 ADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALP 396 (873)
Q Consensus 317 sDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~ 396 (873)
+|||+|+.+.... ......||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 171 ~DFGla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~------------ 235 (352)
T d1koba_ 171 IDFGLATKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE------------ 235 (352)
T ss_dssp CCCTTCEECCTTS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH------------
T ss_pred eecccceecCCCC---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH------------
Confidence 9999998765432 2233568999999999999999999999999999999999999997532111
Q ss_pred hhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 397 ERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 397 ~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
++.......+. .+. ... ......+.+|+.+||+.||++|||+.|+++
T Consensus 236 -----~~~~i~~~~~~----------~~~-~~~----~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 236 -----TLQNVKRCDWE----------FDE-DAF----SSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp -----HHHHHHHCCCC----------CCS-STT----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred -----HHHHHHhCCCC----------CCc-ccc----cCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11111100000 000 000 001234778999999999999999999865
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-45 Score=390.27 Aligned_cols=259 Identities=24% Similarity=0.377 Sum_probs=196.3
Q ss_pred cCCCcceeecccCceEEEEEEEcCC---CcEEEEEEeeccCCc-chhHHHHHHHHHHhhhhccceeeeeeeecccccCCc
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEG---APAVAIKVFNFLHHD-ASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGND 235 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~---g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~ 235 (873)
++|++.+.||+|+||.||+|++..+ +..||||+++..... ..+.|.+|+++|++++|||||++++++. .+
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~------~~ 80 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT------EN 80 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC------SS
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe------cC
Confidence 5789999999999999999988654 356899988644333 3467999999999999999999999963 34
Q ss_pred eEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeE
Q 002857 236 FKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTAC 315 (873)
Q Consensus 236 ~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vK 315 (873)
..++||||+++|+|.+++.. ....+++..++.++.||++||.||| +.+|+||||||+|||++.++.+|
T Consensus 81 ~~~iv~E~~~~g~l~~~~~~---------~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~K 148 (273)
T d1mp8a_ 81 PVWIIMELCTLGELRSFLQV---------RKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVK 148 (273)
T ss_dssp SCEEEEECCTTEEHHHHHHH---------TTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEE
T ss_pred eEEEEEEeccCCcHHhhhhc---------cCCCCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCCCcEE
Confidence 57999999999999998742 3457899999999999999999999 89999999999999999999999
Q ss_pred EeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHHHhhc
Q 002857 316 VADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWVQSA 394 (873)
Q Consensus 316 LsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~~~~~ 394 (873)
|+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||+| |..||....... +...
T Consensus 149 l~DfG~a~~~~~~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~--~~~~---- 221 (273)
T d1mp8a_ 149 LGDFGLSRYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--VIGR---- 221 (273)
T ss_dssp ECC--------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHH----
T ss_pred EccchhheeccCCcc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH--HHHH----
Confidence 999999987644322 22334568999999999999999999999999999999998 899987632221 1111
Q ss_pred CchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHHHHhh
Q 002857 395 LPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLIKKKL 472 (873)
Q Consensus 395 ~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i~~~l 472 (873)
+.+ .. ..+... .+...+.+|+.+||+.||++||||.||++.|+.+.+..
T Consensus 222 -------i~~----~~-----------~~~~~~-------~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 270 (273)
T d1mp8a_ 222 -------IEN----GE-----------RLPMPP-------NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 270 (273)
T ss_dssp -------HHT----TC-----------CCCCCT-------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -------HHc----CC-----------CCCCCC-------CCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 100 00 000000 12335889999999999999999999999999987653
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=9.2e-45 Score=388.59 Aligned_cols=265 Identities=22% Similarity=0.315 Sum_probs=202.3
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCC---cchhHHHHHHHHHHhhhhccceeeeeeeecccccCCc
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH---DASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGND 235 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~ 235 (873)
.++|++.+.||+|+||.||+|++..+++.||||+++.... ...+.|.+|+++|++++|||||++++++.... ....
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~-~~~~ 84 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAGP 84 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEC-SSSE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeecc-CCCc
Confidence 4679999999999999999999999999999999975432 23357899999999999999999999875422 2334
Q ss_pred eEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeE
Q 002857 236 FKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTAC 315 (873)
Q Consensus 236 ~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vK 315 (873)
..+|||||+++|+|.+++.. ...+++.+++.|+.||+.||+||| +.+|+||||||+|||++.++..+
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~----------~~~l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~ 151 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHT----------EGPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVK 151 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHH----------HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEE
T ss_pred eEEEEEECCCCCEehhhhcc----------cCCCCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccCccccce
Confidence 58999999999999998842 356899999999999999999999 89999999999999999999999
Q ss_pred Eecccccccccccc-ccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhc
Q 002857 316 VADFGIARFLEATN-EQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSA 394 (873)
Q Consensus 316 LsDFGla~~~~~~~-~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~ 394 (873)
|+|||.++...... .........||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 152 l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~---------- 221 (277)
T d1o6ya_ 152 VMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS---------- 221 (277)
T ss_dssp ECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH----------
T ss_pred eehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHH----------
Confidence 99999987654332 2223344579999999999999999999999999999999999999997532111
Q ss_pred CchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCC-CHHHHHHHHHHHH
Q 002857 395 LPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERM-KINDVELGLRLIK 469 (873)
Q Consensus 395 ~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRP-Tm~EVl~~Le~i~ 469 (873)
+....+...+ .... .........+.+++.+||+.||++|| |+++++..|.+++
T Consensus 222 -------~~~~~~~~~~-------------~~~~--~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 222 -------VAYQHVREDP-------------IPPS--ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp -------HHHHHHHCCC-------------CCGG--GTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred -------HHHHHHhcCC-------------CCCc--hhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 0000111100 0000 00001123578899999999999999 8999999998774
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-44 Score=394.79 Aligned_cols=267 Identities=18% Similarity=0.306 Sum_probs=209.2
Q ss_pred hcCCCcceeecccCceEEEEEEEcC-----CCcEEEEEEeeccCC-cchhHHHHHHHHHHhhhhccceeeeeeeeccccc
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFE-----GAPAVAIKVFNFLHH-DASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQ 232 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~-----~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~ 232 (873)
.++|++.+.||+|+||.||+|.+.. .++.||||+++.... .....|.+|++++++++|||||+++|+| .
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~-----~ 93 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV-----S 93 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE-----C
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEE-----e
Confidence 3678889999999999999998752 357899999974332 2335689999999999999999999997 3
Q ss_pred CCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCC
Q 002857 233 GNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEM 312 (873)
Q Consensus 233 ~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~ 312 (873)
.++..++||||+++|+|.++++..............+++..++.|+.|+|+||.||| +.+|+||||||+|||++.++
T Consensus 94 ~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~~~ 170 (308)
T d1p4oa_ 94 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDF 170 (308)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTC
T ss_pred cCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeeceEcCCceeecCCc
Confidence 456789999999999999999643222222233456789999999999999999999 88999999999999999999
Q ss_pred CeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCC-CCCCcccccchhhHHHH
Q 002857 313 TACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGL-RPSDDMFKDNLNLQNWV 391 (873)
Q Consensus 313 ~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk-~Pf~~~~~~~~~l~~~~ 391 (873)
++||+|||+++...............||+.|+|||.+.+..++.++||||||+++|||+||. .||.......
T Consensus 171 ~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~------- 243 (308)
T d1p4oa_ 171 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ------- 243 (308)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH-------
T ss_pred eEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHH-------
Confidence 99999999999776554444444556899999999999999999999999999999999985 6665421111
Q ss_pred hhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHH
Q 002857 392 QSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLI 468 (873)
Q Consensus 392 ~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i 468 (873)
.+..+.+.... +.. ..+...+.+|+.+||+.+|++||||.||+++|++.
T Consensus 244 ------~~~~i~~~~~~---------------~~p-------~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~ 292 (308)
T d1p4oa_ 244 ------VLRFVMEGGLL---------------DKP-------DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292 (308)
T ss_dssp ------HHHHHHTTCCC---------------CCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred ------HHHHHHhCCCC---------------CCc-------ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 01111111100 000 01233588999999999999999999999999765
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-44 Score=391.19 Aligned_cols=266 Identities=25% Similarity=0.363 Sum_probs=203.3
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCc--EEEEEEeecc-CCcchhHHHHHHHHHHhh-hhccceeeeeeeecccccCCc
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAP--AVAIKVFNFL-HHDASKSFTVECEVMRNI-IHRKIIKVVTACSRVDYQGND 235 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~--~VAVK~l~~~-~~~~~~~f~~Ei~iL~~L-~HpNIV~llg~c~~~~~~~~~ 235 (873)
++|++.++||+|+||.||+|+++.++. .||||+++.. .....+.|.+|+++|+++ +|||||+++|+|. .++
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~-----~~~ 84 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE-----HRG 84 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEE-----ETT
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEe-----cCC
Confidence 578889999999999999999987776 4677877533 333456899999999999 7999999999974 456
Q ss_pred eEEEEEeecCCCChhhhccccccc------ccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeC
Q 002857 236 FKALVYEFMPNGSLEEWIHPITEE------DKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLN 309 (873)
Q Consensus 236 ~~~LV~Ey~~~GSL~~~L~~~~~~------~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd 309 (873)
..++||||+++|+|.++|+..... .........+++.+++.++.|||.||.||| +.+|+||||||+|||++
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~ 161 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVG 161 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCccccccccceEEEc
Confidence 799999999999999999642100 001133567999999999999999999999 89999999999999999
Q ss_pred CCCCeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCC-CCCcccccchhhH
Q 002857 310 DEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLR-PSDDMFKDNLNLQ 388 (873)
Q Consensus 310 ~~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~-Pf~~~~~~~~~l~ 388 (873)
.++.+||+|||+++....... .....||..|+|||.+.+..++.++|||||||++|||++|.. ||......
T Consensus 162 ~~~~~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~----- 233 (309)
T d1fvra_ 162 ENYVAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA----- 233 (309)
T ss_dssp GGGCEEECCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----
T ss_pred CCCceEEcccccccccccccc---ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHH-----
Confidence 999999999999986543322 223458999999999999999999999999999999999764 56542111
Q ss_pred HHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHH
Q 002857 389 NWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLI 468 (873)
Q Consensus 389 ~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i 468 (873)
++.+...... ..+... .+...+.+|+.+||+.||++||||.||++.|+.+
T Consensus 234 ------------~~~~~i~~~~-----------~~~~~~-------~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i 283 (309)
T d1fvra_ 234 ------------ELYEKLPQGY-----------RLEKPL-------NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 283 (309)
T ss_dssp ------------HHHHHGGGTC-----------CCCCCT-------TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------------HHHHHHHhcC-----------CCCCCc-------cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1111100000 000000 1123588999999999999999999999999998
Q ss_pred HHh
Q 002857 469 KKK 471 (873)
Q Consensus 469 ~~~ 471 (873)
.+.
T Consensus 284 ~~~ 286 (309)
T d1fvra_ 284 LEE 286 (309)
T ss_dssp HHS
T ss_pred Hhc
Confidence 653
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-44 Score=389.50 Aligned_cols=270 Identities=21% Similarity=0.296 Sum_probs=209.2
Q ss_pred hcCCCcceeecccCceEEEEEEEc-----CCCcEEEEEEeeccCC-cchhHHHHHHHHHHhh-hhccceeeeeeeecccc
Q 002857 159 TKGFSSENLIGAGNFASVYKGILF-----EGAPAVAIKVFNFLHH-DASKSFTVECEVMRNI-IHRKIIKVVTACSRVDY 231 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~-----~~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L-~HpNIV~llg~c~~~~~ 231 (873)
.++|++.++||+|+||.||+|++. ..++.||||+++.... .....|.+|+.+++++ +|||||+++++|
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~----- 96 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC----- 96 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEE-----
Confidence 467888999999999999999874 3567899999975433 3345789999999999 699999999997
Q ss_pred cCCceEEEEEeecCCCChhhhcccccccc--------cccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCC
Q 002857 232 QGNDFKALVYEFMPNGSLEEWIHPITEED--------KRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKP 303 (873)
Q Consensus 232 ~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~--------~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKp 303 (873)
......+|||||+++|+|.++|+...... ........+++..++.|+.||+.||+||| +++||||||||
T Consensus 97 ~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivHrDLKp 173 (311)
T d1t46a_ 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAA 173 (311)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSG
T ss_pred eeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccccc
Confidence 44566899999999999999996422110 01123346899999999999999999999 89999999999
Q ss_pred CCeeeCCCCCeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhC-CCCCCcccc
Q 002857 304 SNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTG-LRPSDDMFK 382 (873)
Q Consensus 304 sNILLd~~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTG-k~Pf~~~~~ 382 (873)
+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||+|+ .+||.....
T Consensus 174 ~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~ 253 (311)
T d1t46a_ 174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (311)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred ccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999999977655444445556799999999999999999999999999999999995 554543211
Q ss_pred cchhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHH
Q 002857 383 DNLNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVE 462 (873)
Q Consensus 383 ~~~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl 462 (873)
. . .+..+++..+... .|. .+...+.+|+.+||+.||++||||.||+
T Consensus 254 ~-~------------~~~~~i~~~~~~~------------~~~---------~~~~~l~~Li~~cl~~dP~~RPs~~~il 299 (311)
T d1t46a_ 254 D-S------------KFYKMIKEGFRML------------SPE---------HAPAEMYDIMKTCWDADPLKRPTFKQIV 299 (311)
T ss_dssp S-H------------HHHHHHHHTCCCC------------CCT---------TSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred H-H------------HHHHHHhcCCCCC------------Ccc---------cccHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 1 1 1122222111100 000 0123588999999999999999999999
Q ss_pred HHHHHHHH
Q 002857 463 LGLRLIKK 470 (873)
Q Consensus 463 ~~Le~i~~ 470 (873)
++|+++..
T Consensus 300 ~~L~~~i~ 307 (311)
T d1t46a_ 300 QLIEKQIS 307 (311)
T ss_dssp HHHHHHHH
T ss_pred HHHHHhhc
Confidence 99997644
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-44 Score=387.15 Aligned_cols=269 Identities=23% Similarity=0.362 Sum_probs=205.2
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCC-------cEEEEEEeeccCC-cchhHHHHHHHHHHhh-hhccceeeeeeeecc
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGA-------PAVAIKVFNFLHH-DASKSFTVECEVMRNI-IHRKIIKVVTACSRV 229 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g-------~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L-~HpNIV~llg~c~~~ 229 (873)
.++|.+.+.||+|+||.||+|+....+ ..||||+++.... ....++.+|+..+.++ +|||||+++++|.
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~-- 89 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT-- 89 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc--
Confidence 357888999999999999999875443 4799999975443 3347789999999999 8999999999973
Q ss_pred cccCCceEEEEEeecCCCChhhhccccccc------ccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCC
Q 002857 230 DYQGNDFKALVYEFMPNGSLEEWIHPITEE------DKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKP 303 (873)
Q Consensus 230 ~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~------~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKp 303 (873)
.++..++||||+++|+|.++|...... .........+++.+++.++.||+.||+||| +.+||||||||
T Consensus 90 ---~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp 163 (299)
T d1fgka_ 90 ---QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAA 163 (299)
T ss_dssp ---SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSG
T ss_pred ---cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---hCCEEeeeecc
Confidence 456789999999999999999642100 001123456899999999999999999999 89999999999
Q ss_pred CCeeeCCCCCeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccc
Q 002857 304 SNILLNDEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFK 382 (873)
Q Consensus 304 sNILLd~~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~ 382 (873)
+|||++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||+| |..||.....
T Consensus 164 ~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~ 243 (299)
T d1fgka_ 164 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 243 (299)
T ss_dssp GGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred cceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH
Confidence 999999999999999999998766554444555679999999999999999999999999999999998 6888865322
Q ss_pred cchhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHH
Q 002857 383 DNLNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVE 462 (873)
Q Consensus 383 ~~~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl 462 (873)
.. + .+.+..... .+... .+...+.+|+.+||+.||++||||.||+
T Consensus 244 ~~--~------------~~~i~~~~~--------------~~~p~-------~~~~~l~~li~~cl~~dP~~Rps~~eil 288 (299)
T d1fgka_ 244 EE--L------------FKLLKEGHR--------------MDKPS-------NCTNELYMMMRDCWHAVPSQRPTFKQLV 288 (299)
T ss_dssp HH--H------------HHHHHTTCC--------------CCCCS-------SCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HH--H------------HHHHHcCCC--------------CCCCc-------cchHHHHHHHHHHccCCHhHCcCHHHHH
Confidence 11 1 111110000 00000 0123578999999999999999999999
Q ss_pred HHHHHHHH
Q 002857 463 LGLRLIKK 470 (873)
Q Consensus 463 ~~Le~i~~ 470 (873)
++|++|..
T Consensus 289 ~~L~~i~a 296 (299)
T d1fgka_ 289 EDLDRIVA 296 (299)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHhh
Confidence 99998854
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-44 Score=393.70 Aligned_cols=248 Identities=21% Similarity=0.277 Sum_probs=202.5
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeecc---CCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCce
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFL---HHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDF 236 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~ 236 (873)
++|++.+.||+|+||.||+|+++.+++.||||+++.. .....+.+.+|+.+|++++|||||++++++ .+.+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~~~~ 79 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHDR 79 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE-----ECSSE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeee-----ccccc
Confidence 5799999999999999999999999999999999743 234457789999999999999999999995 56778
Q ss_pred EEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEE
Q 002857 237 KALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACV 316 (873)
Q Consensus 237 ~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKL 316 (873)
.++||||+++|+|.+++.. ...+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||
T Consensus 80 ~~iv~ey~~gg~L~~~~~~----------~~~~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl 146 (337)
T d1o6la_ 80 LCFVMEYANGGELFFHLSR----------ERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKI 146 (337)
T ss_dssp EEEEEECCTTCBHHHHHHH----------HSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEE
T ss_pred cccceeccCCCchhhhhhc----------ccCCcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCEEE
Confidence 9999999999999999842 456889999999999999999999 899999999999999999999999
Q ss_pred eccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCc
Q 002857 317 ADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALP 396 (873)
Q Consensus 317 sDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~ 396 (873)
+|||+|+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 147 ~DFG~a~~~~~~~--~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~------------- 211 (337)
T d1o6la_ 147 TDFGLCKEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------------- 211 (337)
T ss_dssp CCCTTCBCSCCTT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-------------
T ss_pred eecccccccccCC--cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH-------------
Confidence 9999998654322 2223457999999999999999999999999999999999999999763211
Q ss_pred hhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCC-----HHHHHH
Q 002857 397 ERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMK-----INDVEL 463 (873)
Q Consensus 397 ~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPT-----m~EVl~ 463 (873)
++........+ ..|.. ...++.+|+.+||+.||++||+ ++||++
T Consensus 212 ----~~~~~i~~~~~----------~~p~~---------~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 212 ----RLFELILMEEI----------RFPRT---------LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp ----HHHHHHHHCCC----------CCCTT---------SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ----HHHHHHhcCCC----------CCCcc---------CCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 11111111100 00110 1224678999999999999995 777654
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-45 Score=388.65 Aligned_cols=257 Identities=25% Similarity=0.314 Sum_probs=193.5
Q ss_pred cCCCcceeecccCceEEEEEEEcCC-C--cEEEEEEeecc---CCcchhHHHHHHHHHHhhhhccceeeeeeeecccccC
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEG-A--PAVAIKVFNFL---HHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQG 233 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~-g--~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~ 233 (873)
++|++.+.||+|+||.||+|++... + ..||||+++.. .....+.|.+|+++|++++|||||+++|+|..
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~----- 82 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT----- 82 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-----
Confidence 5689999999999999999987533 2 36899998643 22334689999999999999999999999732
Q ss_pred CceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCC
Q 002857 234 NDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMT 313 (873)
Q Consensus 234 ~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~ 313 (873)
...++||||+++|+|.+++.. ....+++..++.++.|||.||.||| +++|+||||||+|||++.++.
T Consensus 83 -~~~~lv~e~~~~~~l~~~~~~---------~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~ 149 (273)
T d1u46a_ 83 -PPMKMVTELAPLGSLLDRLRK---------HQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDL 149 (273)
T ss_dssp -SSCEEEEECCTTCBHHHHHHH---------HGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTE
T ss_pred -cchheeeeeecCcchhhhhhc---------ccCCCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeecHHHhccccccc
Confidence 346899999999999998743 2346899999999999999999999 899999999999999999999
Q ss_pred eEEeccccccccccccccc-cccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHh-CCCCCCcccccchhhHHHH
Q 002857 314 ACVADFGIARFLEATNEQT-SSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFT-GLRPSDDMFKDNLNLQNWV 391 (873)
Q Consensus 314 vKLsDFGla~~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlT-Gk~Pf~~~~~~~~~l~~~~ 391 (873)
+||+|||+++.+....... ......|+..|+|||++.+..++.++|||||||++|||+| |+.||....... ....
T Consensus 150 vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~--~~~~- 226 (273)
T d1u46a_ 150 VKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ--ILHK- 226 (273)
T ss_dssp EEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHH-
T ss_pred eeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH--HHHH-
Confidence 9999999999765443222 2233457889999999999999999999999999999998 899997532211 1111
Q ss_pred hhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHH
Q 002857 392 QSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLI 468 (873)
Q Consensus 392 ~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i 468 (873)
+..... ..+... .++..+.+|+.+||+.||++||||.||++.|++.
T Consensus 227 ----------i~~~~~--------------~~~~~~-------~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 227 ----------IDKEGE--------------RLPRPE-------DCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp ----------HHTSCC--------------CCCCCT-------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----------HHhCCC--------------CCCCcc-------cccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 110000 000000 1123578999999999999999999999988864
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6.6e-44 Score=389.95 Aligned_cols=245 Identities=24% Similarity=0.306 Sum_probs=201.1
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeecc---CCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCce
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFL---HHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDF 236 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~ 236 (873)
++|++.+.||+|+||+||+|+++.+++.||||+++.. .....+.+.+|+.+|++++|||||++++++ ..++.
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~ 78 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF-----QDAQQ 78 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEE-----ECSSE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeE-----eeCCe
Confidence 5799999999999999999999999999999999632 233457799999999999999999999995 55778
Q ss_pred EEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEE
Q 002857 237 KALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACV 316 (873)
Q Consensus 237 ~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKL 316 (873)
.++||||+++|+|..++. ....+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||
T Consensus 79 ~~ivmE~~~gg~l~~~~~----------~~~~~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL 145 (316)
T d1fota_ 79 IFMIMDYIEGGELFSLLR----------KSQRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKI 145 (316)
T ss_dssp EEEEECCCCSCBHHHHHH----------HTSSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEE
T ss_pred eeeEeeecCCcccccccc----------ccccccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEE
Confidence 999999999999999884 3456788889999999999999999 899999999999999999999999
Q ss_pred eccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCc
Q 002857 317 ADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALP 396 (873)
Q Consensus 317 sDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~ 396 (873)
+|||+|+..... .....||+.|+|||++.+..++.++|||||||++|||+||+.||......
T Consensus 146 ~DFG~a~~~~~~-----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~------------- 207 (316)
T d1fota_ 146 TDFGFAKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM------------- 207 (316)
T ss_dssp CCCSSCEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-------------
T ss_pred ecCccceEeccc-----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH-------------
Confidence 999999876432 22356999999999999999999999999999999999999999753211
Q ss_pred hhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCC-----CHHHHHH
Q 002857 397 ERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERM-----KINDVEL 463 (873)
Q Consensus 397 ~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRP-----Tm~EVl~ 463 (873)
++....+.... ..|.. ....+.+++.+||+.||.+|| |++|+++
T Consensus 208 ----~~~~~i~~~~~----------~~p~~---------~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 208 ----KTYEKILNAEL----------RFPPF---------FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp ----HHHHHHHHCCC----------CCCTT---------SCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred ----HHHHHHHcCCC----------CCCCC---------CCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 11111111110 00100 122477899999999999996 8888864
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-43 Score=386.93 Aligned_cols=257 Identities=20% Similarity=0.265 Sum_probs=199.0
Q ss_pred hcCCCcce-eecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhh-hhccceeeeeeeecccccCCce
Q 002857 159 TKGFSSEN-LIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNI-IHRKIIKVVTACSRVDYQGNDF 236 (873)
Q Consensus 159 t~~f~~~~-~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~llg~c~~~~~~~~~~ 236 (873)
.++|.+.. .||+|+||+||+|++..+++.||||+++. ...+.+|++++.++ +|||||++++++... ......
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~-~~~~~~ 83 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENL-YAGRKC 83 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeec-ccCCCE
Confidence 46788765 69999999999999999999999999863 35688899997766 899999999986432 133567
Q ss_pred EEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCC---CCC
Q 002857 237 KALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLND---EMT 313 (873)
Q Consensus 237 ~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~---~~~ 313 (873)
.+|||||+++|+|.++|.. .....+++.++..|+.||+.||+||| +.+|+||||||+|||++. ++.
T Consensus 84 ~~ivmEy~~gg~L~~~i~~--------~~~~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~ 152 (335)
T d2ozaa1 84 LLIVMECLDGGELFSRIQD--------RGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAI 152 (335)
T ss_dssp EEEEEECCCSEEHHHHHHS--------CSCCCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCC
T ss_pred EEEEEECCCCCcHHHHHHh--------cCCCCcCHHHHHHHHHHHHHHHHHHH---HcCCcccccccccccccccccccc
Confidence 8999999999999999953 23457999999999999999999999 899999999999999985 567
Q ss_pred eEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhh
Q 002857 314 ACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQS 393 (873)
Q Consensus 314 vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~ 393 (873)
+||+|||+|+....... .....||+.|+|||++.+..++.++|||||||++|||+||+.||........ ..
T Consensus 153 ~Kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~--~~---- 223 (335)
T d2ozaa1 153 LKLTDFGFAKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI--SP---- 223 (335)
T ss_dssp EEECCCTTCEECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC----------
T ss_pred ccccccceeeeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH--HH----
Confidence 99999999987654322 2345699999999999999999999999999999999999999965321110 00
Q ss_pred cCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 394 ALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 394 ~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
.+........+. .|. .........+.+|+.+||+.||++|||+.|+++
T Consensus 224 -------~~~~~i~~~~~~----------~~~-----~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 224 -------GMKTRIRMGQYE----------FPN-----PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp -----------CCCSCSSS----------CCT-----THHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -------HHHHHHhcCCCC----------CCC-----cccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 000000000000 000 001122345788999999999999999999876
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-43 Score=385.96 Aligned_cols=252 Identities=20% Similarity=0.275 Sum_probs=202.5
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEE
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKA 238 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~ 238 (873)
.++|++.+.||+|+||+||+|++..+++.||||+++.... ....+.+|+++|++++|||||++++++ .+++..+
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~~~~~ 77 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESF-----ESMEELV 77 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEE-----EETTEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEE-----EECCEEE
Confidence 4689999999999999999999999999999999975432 335688999999999999999999985 5567899
Q ss_pred EEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCC--CCCeEE
Q 002857 239 LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLND--EMTACV 316 (873)
Q Consensus 239 LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~--~~~vKL 316 (873)
|||||+++|+|.++|.. ....+++.+++.|+.||+.||+||| +.+|+||||||+|||++. ...+||
T Consensus 78 lvmE~~~gg~L~~~i~~---------~~~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl 145 (321)
T d1tkia_ 78 MIFEFISGLDIFERINT---------SAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKI 145 (321)
T ss_dssp EEECCCCCCBHHHHHTS---------SSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEE
T ss_pred EEEecCCCCcHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEEE
Confidence 99999999999999952 3346899999999999999999999 899999999999999984 458999
Q ss_pred eccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCc
Q 002857 317 ADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALP 396 (873)
Q Consensus 317 sDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~ 396 (873)
+|||+++...... ......+|+.|+|||.+.+..++.++|||||||++|||++|+.||....... .
T Consensus 146 ~DFG~~~~~~~~~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~--~--------- 211 (321)
T d1tkia_ 146 IEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ--I--------- 211 (321)
T ss_dssp CCCTTCEECCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH--H---------
T ss_pred cccchhhccccCC---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH--H---------
Confidence 9999998764322 2233468999999999999999999999999999999999999997632111 0
Q ss_pred hhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 397 ERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 397 ~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
+..+....+.. . ..........+.+|+.+||+.||++|||+.|+++
T Consensus 212 --~~~i~~~~~~~--~-----------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 212 --IENIMNAEYTF--D-----------------EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp --HHHHHHTCCCC--C-----------------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --HHHHHhCCCCC--C-----------------hhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11111111000 0 0000111234778999999999999999999976
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=4.8e-43 Score=376.21 Aligned_cols=251 Identities=22% Similarity=0.319 Sum_probs=200.0
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCc---------chhHHHHHHHHHHhhh-hccceeeeeeeecc
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHD---------ASKSFTVECEVMRNII-HRKIIKVVTACSRV 229 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~---------~~~~f~~Ei~iL~~L~-HpNIV~llg~c~~~ 229 (873)
++|++.+.||+|+||+||+|++..+++.||||+++..... ..+.+.+|+.+|++++ |||||++++++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~--- 79 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY--- 79 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE---
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeec---
Confidence 6899999999999999999999999999999999754322 1235889999999997 99999999995
Q ss_pred cccCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeC
Q 002857 230 DYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLN 309 (873)
Q Consensus 230 ~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd 309 (873)
.+++..+|||||+++|+|.++|+. ...+++.+++.++.||+.||+||| +.+|+||||||+|||++
T Consensus 80 --~~~~~~~ivmE~~~~g~L~~~l~~----------~~~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~ 144 (277)
T d1phka_ 80 --ETNTFFFLVFDLMKKGELFDYLTE----------KVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLD 144 (277)
T ss_dssp --ECSSEEEEEEECCTTCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC
T ss_pred --ccCcceEEEEEcCCCchHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEc
Confidence 567789999999999999999953 346999999999999999999999 89999999999999999
Q ss_pred CCCCeEEeccccccccccccccccccccccccccCCCcccCC------CCCCcchhhHhHHHHHHHHHhCCCCCCccccc
Q 002857 310 DEMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMG------HETSSYGDVYSFGILLLEMFTGLRPSDDMFKD 383 (873)
Q Consensus 310 ~~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~------~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~ 383 (873)
.++.+||+|||+++.+.... ......||..|+|||++.+ ..++.++||||+||++|||+||+.||......
T Consensus 145 ~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~ 221 (277)
T d1phka_ 145 DDMNIKLTDFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM 221 (277)
T ss_dssp TTCCEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred CCCCeEEccchheeEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHH
Confidence 99999999999998765432 2234569999999998753 35788999999999999999999999763211
Q ss_pred chhhHHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 384 NLNLQNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 384 ~~~l~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
. .. ..+...... .+. .... ....++.+++.+||+.||++|||+.||++
T Consensus 222 ~--~~-----------~~i~~~~~~--------------~~~-~~~~----~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 222 L--ML-----------RMIMSGNYQ--------------FGS-PEWD----DYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp H--HH-----------HHHHHTCCC--------------CCT-TTGG----GSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred H--HH-----------HHHHhCCCC--------------CCC-cccc----cCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 1 00 011110000 000 0000 11235788999999999999999998854
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-43 Score=380.38 Aligned_cols=197 Identities=26% Similarity=0.324 Sum_probs=166.4
Q ss_pred cceeecccCceEEEEEEEcCCCcEEEEEEeeccCCc-----chhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEE
Q 002857 164 SENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHD-----ASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKA 238 (873)
Q Consensus 164 ~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~-----~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~ 238 (873)
.+++||+|+||+||+|++..+++.||||+++..... ..+.+.+|+++|++++|||||++++++ ..++..+
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~-----~~~~~~~ 76 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAF-----GHKSNIS 76 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEE-----CCTTCCE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeee-----ccCCcee
Confidence 357899999999999999999999999998643221 235689999999999999999999996 4566789
Q ss_pred EEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEec
Q 002857 239 LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVAD 318 (873)
Q Consensus 239 LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLsD 318 (873)
|||||+.++++..++ .....+++.++..|+.||+.||+||| +.+|+||||||+|||++.++.+||+|
T Consensus 77 ivmE~~~~~~~~~~~----------~~~~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~D 143 (299)
T d1ua2a_ 77 LVFDFMETDLEVIIK----------DNSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLAD 143 (299)
T ss_dssp EEEECCSEEHHHHHT----------TCCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred ehhhhhcchHHhhhh----------hcccCCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCcccccc
Confidence 999999988777665 24567899999999999999999999 89999999999999999999999999
Q ss_pred cccccccccccccccccccccccccCCCcccCCC-CCCcchhhHhHHHHHHHHHhCCCCCCcc
Q 002857 319 FGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGH-ETSSYGDVYSFGILLLEMFTGLRPSDDM 380 (873)
Q Consensus 319 FGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELlTGk~Pf~~~ 380 (873)
||+++....... ......||+.|+|||++.+. .++.++|||||||++|||+||+.||...
T Consensus 144 FG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~ 204 (299)
T d1ua2a_ 144 FGLAKSFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD 204 (299)
T ss_dssp CGGGSTTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CccccccCCCcc--cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCC
Confidence 999986644322 22235689999999988755 5799999999999999999999999763
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.5e-43 Score=390.64 Aligned_cols=245 Identities=20% Similarity=0.274 Sum_probs=200.6
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeecc---CCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCce
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFL---HHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDF 236 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~ 236 (873)
++|++.+.||+|+||.||+|+++.+++.||||+++.. .....+.+.+|+++|++++|||||++++++ .....
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~~ 115 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-----KDNSN 115 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccc-----ccccc
Confidence 5799999999999999999999999999999998632 233456789999999999999999999985 55677
Q ss_pred EEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEE
Q 002857 237 KALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACV 316 (873)
Q Consensus 237 ~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKL 316 (873)
.++||||+.+|+|.+++.. ...+++.+++.|+.||+.||.||| +.+||||||||+|||++.++++||
T Consensus 116 ~~~v~e~~~~g~l~~~l~~----------~~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL 182 (350)
T d1rdqe_ 116 LYMVMEYVAGGEMFSHLRR----------IGRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQV 182 (350)
T ss_dssp EEEEEECCTTCBHHHHHHH----------HCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEE
T ss_pred cccccccccccchhhhHhh----------cCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEe
Confidence 8999999999999999843 346899999999999999999999 899999999999999999999999
Q ss_pred eccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCc
Q 002857 317 ADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALP 396 (873)
Q Consensus 317 sDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~ 396 (873)
+|||+|+.+... .....||+.|+|||++.+..++.++|||||||++|||+||+.||......
T Consensus 183 ~DFG~a~~~~~~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~------------- 244 (350)
T d1rdqe_ 183 TDFGFAKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI------------- 244 (350)
T ss_dssp CCCTTCEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------------
T ss_pred eeceeeeecccc-----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHH-------------
Confidence 999999876432 22356999999999999999999999999999999999999999752111
Q ss_pred hhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCC-----CHHHHHH
Q 002857 397 ERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERM-----KINDVEL 463 (873)
Q Consensus 397 ~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRP-----Tm~EVl~ 463 (873)
+++.......+ ..|. .....+.+++.+||+.||++|+ |++||++
T Consensus 245 ----~~~~~i~~~~~----------~~p~---------~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 245 ----QIYEKIVSGKV----------RFPS---------HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ----HHHHHHHHCCC----------CCCT---------TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ----HHHHHHhcCCC----------CCCc---------cCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 01111111100 0010 0123477899999999999994 8888864
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-43 Score=377.19 Aligned_cols=207 Identities=22% Similarity=0.306 Sum_probs=174.7
Q ss_pred hcCCCcceeecccCceEEEEEEEcCC-CcEEEEEEeeccC--CcchhHHHHHHHHHHhh---hhccceeeeeeeeccccc
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEG-APAVAIKVFNFLH--HDASKSFTVECEVMRNI---IHRKIIKVVTACSRVDYQ 232 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~-g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L---~HpNIV~llg~c~~~~~~ 232 (873)
.++|++.++||+|+||+||+|++..+ ++.||||+++... ......+.+|+.+|+.+ +||||++++++|......
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 57899999999999999999998654 6789999986432 23345677888888777 699999999998654445
Q ss_pred CCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCC
Q 002857 233 GNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEM 312 (873)
Q Consensus 233 ~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~ 312 (873)
.....+++|||+.++++..... .....+++..+..|+.||+.||+||| +.+|+||||||+|||++.++
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~ 153 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDK---------VPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSG 153 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHH---------SCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTC
T ss_pred cCceEEEEEEeccCCchhhhhh---------ccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCccEEEEcCCC
Confidence 5667899999998877765442 34567899999999999999999999 89999999999999999999
Q ss_pred CeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcc
Q 002857 313 TACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDM 380 (873)
Q Consensus 313 ~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~ 380 (873)
.+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 154 ~~kl~dfg~~~~~~~~~---~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~ 218 (305)
T d1blxa_ 154 QIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS 218 (305)
T ss_dssp CEEECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred Ceeecchhhhhhhcccc---cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCC
Confidence 99999999998654322 233456999999999999999999999999999999999999999764
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=5.2e-43 Score=390.05 Aligned_cols=249 Identities=20% Similarity=0.269 Sum_probs=194.4
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC---CcchhHHHHH---HHHHHhhhhccceeeeeeeecccccC
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH---HDASKSFTVE---CEVMRNIIHRKIIKVVTACSRVDYQG 233 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~---~~~~~~f~~E---i~iL~~L~HpNIV~llg~c~~~~~~~ 233 (873)
++|++.++||+|+||.||+|++..+++.||||++.... ......+.+| +++++.++|||||++++++ ..
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~-----~~ 78 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-----HT 78 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE-----EC
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEE-----EE
Confidence 68999999999999999999999999999999986321 1222334444 5666677899999999995 45
Q ss_pred CceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCC
Q 002857 234 NDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMT 313 (873)
Q Consensus 234 ~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~ 313 (873)
.+..+|||||+++|+|.++|.. ...+++..++.|+.||+.||+||| +.+||||||||+|||++.++.
T Consensus 79 ~~~~~ivmE~~~gg~L~~~l~~----------~~~~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~ 145 (364)
T d1omwa3 79 PDKLSFILDLMNGGDLHYHLSQ----------HGVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGH 145 (364)
T ss_dssp SSEEEEEECCCCSCBHHHHHHH----------HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSC
T ss_pred CCEEEEEEEecCCCcHHHHHHh----------cccccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCc
Confidence 6789999999999999999943 356788999999999999999999 899999999999999999999
Q ss_pred eEEeccccccccccccccccccccccccccCCCcccCC-CCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHh
Q 002857 314 ACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMG-HETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQ 392 (873)
Q Consensus 314 vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~ 392 (873)
+||+|||+|+.+.... .....||+.|+|||++.. ..++.++|||||||++|||+||+.||........
T Consensus 146 iKl~DFGla~~~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~------- 214 (364)
T d1omwa3 146 VRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK------- 214 (364)
T ss_dssp EEECCCTTCEECSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH-------
T ss_pred EEEeeeceeeecCCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH-------
Confidence 9999999998764432 233569999999999875 5689999999999999999999999976322211
Q ss_pred hcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCC-----HHHHHH
Q 002857 393 SALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMK-----INDVEL 463 (873)
Q Consensus 393 ~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPT-----m~EVl~ 463 (873)
..+........+ ..|. .....+.+|+.+||+.||++||| ++||++
T Consensus 215 -------~~~~~~~~~~~~----------~~~~---------~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 215 -------HEIDRMTLTMAV----------ELPD---------SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp -------HHHHHHSSSCCC----------CCCS---------SSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred -------HHHHHhcccCCC----------CCCC---------CCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 111111110000 0000 01224778999999999999999 577764
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-43 Score=385.90 Aligned_cols=247 Identities=23% Similarity=0.318 Sum_probs=198.9
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeecc---CCcchhHHHHHHHHHH-hhhhccceeeeeeeecccccCCc
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFL---HHDASKSFTVECEVMR-NIIHRKIIKVVTACSRVDYQGND 235 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~---~~~~~~~f~~Ei~iL~-~L~HpNIV~llg~c~~~~~~~~~ 235 (873)
++|.+.+.||+|+||+||+|++..+++.||||+++.. .....+.+..|..++. .++|||||++++++ .+++
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~-----~~~~ 76 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF-----QTKE 76 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE-----ECSS
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEE-----ccCC
Confidence 5799999999999999999999999999999999642 2334456777877766 67999999999995 5567
Q ss_pred eEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeE
Q 002857 236 FKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTAC 315 (873)
Q Consensus 236 ~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vK 315 (873)
..+|||||+++|+|.+++.. ...+++.+++.++.||+.||+||| +.+|+||||||+|||++.++++|
T Consensus 77 ~~yivmEy~~~g~L~~~i~~----------~~~~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~k 143 (320)
T d1xjda_ 77 NLFFVMEYLNGGDLMYHIQS----------CHKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIK 143 (320)
T ss_dssp EEEEEEECCTTCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEE
T ss_pred ceeEEEeecCCCcHHHHhhc----------cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcccceeecCCCcee
Confidence 89999999999999999953 345888999999999999999999 89999999999999999999999
Q ss_pred EeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcC
Q 002857 316 VADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSAL 395 (873)
Q Consensus 316 LsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~ 395 (873)
|+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 144 l~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~----------- 210 (320)
T d1xjda_ 144 IADFGMCKENMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE----------- 210 (320)
T ss_dssp ECCCTTCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----------
T ss_pred ccccchhhhccccc--ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH-----------
Confidence 99999998654332 22234569999999999999999999999999999999999999997532111
Q ss_pred chhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHH-HHH
Q 002857 396 PERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKIN-DVE 462 (873)
Q Consensus 396 ~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~-EVl 462 (873)
+........+ ..|. .+...+.+|+.+||+.||++|||+. ||+
T Consensus 211 ------~~~~i~~~~~----------~~p~---------~~s~~~~dli~~~L~~dP~~R~s~~~~l~ 253 (320)
T d1xjda_ 211 ------LFHSIRMDNP----------FYPR---------WLEKEAKDLLVKLFVREPEKRLGVRGDIR 253 (320)
T ss_dssp ------HHHHHHHCCC----------CCCT---------TSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred ------HHHHHHcCCC----------CCCc---------cCCHHHHHHHHHhcccCCCCCcCHHHHHH
Confidence 1111110100 0010 0123477899999999999999995 664
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-42 Score=376.67 Aligned_cols=202 Identities=24% Similarity=0.338 Sum_probs=170.8
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC--CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceE
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH--HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFK 237 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~ 237 (873)
++|++.+.||+|+||+||+|++..+++.||||+++... ....+.+.+|+++|++++|||||++++++ ..+...
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~-----~~~~~~ 76 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKL 76 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEE-----EETTEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccc-----ccccce
Confidence 58999999999999999999999999999999996433 23357899999999999999999999996 456789
Q ss_pred EEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEe
Q 002857 238 ALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVA 317 (873)
Q Consensus 238 ~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLs 317 (873)
++||||+.+ ++.+++.. .....+++..+..++.||+.||+||| +.+||||||||+|||++.++++||+
T Consensus 77 ~iv~e~~~~-~~~~~~~~--------~~~~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~ 144 (298)
T d1gz8a_ 77 YLVFEFLHQ-DLKKFMDA--------SALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLA 144 (298)
T ss_dssp EEEEECCSE-EHHHHHHH--------TTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEEC
T ss_pred eEEEeecCC-chhhhhhh--------hcccCCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcceec
Confidence 999999975 44444422 34567999999999999999999999 8999999999999999999999999
Q ss_pred ccccccccccccccccccccccccccCCCcccCCCC-CCcchhhHhHHHHHHHHHhCCCCCCcc
Q 002857 318 DFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHE-TSSYGDVYSFGILLLEMFTGLRPSDDM 380 (873)
Q Consensus 318 DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~-~s~ksDVwSfGvvL~ELlTGk~Pf~~~ 380 (873)
|||+|+....... ......||+.|+|||++.... ++.++|||||||++|||++|+.||...
T Consensus 145 DFG~a~~~~~~~~--~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~ 206 (298)
T d1gz8a_ 145 DFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 206 (298)
T ss_dssp STTHHHHHCCCSB--CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cCCcceeccCCcc--cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCC
Confidence 9999987644322 223346999999999877765 578999999999999999999999763
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-42 Score=371.02 Aligned_cols=241 Identities=24% Similarity=0.311 Sum_probs=193.2
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCc------chhHHHHHHHHHHhhh--hccceeeeeeeeccc
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHD------ASKSFTVECEVMRNII--HRKIIKVVTACSRVD 230 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~------~~~~f~~Ei~iL~~L~--HpNIV~llg~c~~~~ 230 (873)
.++|++.++||+|+||.||+|++..+++.||||+++..... ....+.+|+.+|++++ |||||++++++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~---- 78 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF---- 78 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE----
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEE----
Confidence 35799999999999999999999999999999998643211 2245778999999996 89999999995
Q ss_pred ccCCceEEEEEeecCC-CChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeC
Q 002857 231 YQGNDFKALVYEFMPN-GSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLN 309 (873)
Q Consensus 231 ~~~~~~~~LV~Ey~~~-GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd 309 (873)
...+..++||||+.+ +++.+++.. ...+++.+++.|+.||+.||+||| +++|+||||||+|||++
T Consensus 79 -~~~~~~~lv~e~~~~~~~l~~~~~~----------~~~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~ 144 (273)
T d1xwsa_ 79 -ERPDSFVLILERPEPVQDLFDFITE----------RGALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILID 144 (273)
T ss_dssp -ECSSEEEEEEECCSSEEEHHHHHHH----------HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEE
T ss_pred -eeCCeEEEEEEeccCcchHHHHHhc----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEe
Confidence 556789999999976 577777732 356899999999999999999999 89999999999999998
Q ss_pred C-CCCeEEeccccccccccccccccccccccccccCCCcccCCCCC-CcchhhHhHHHHHHHHHhCCCCCCcccccchhh
Q 002857 310 D-EMTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHET-SSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNL 387 (873)
Q Consensus 310 ~-~~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~-s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l 387 (873)
. ++.+||+|||+|+..... ......||+.|+|||++.+..+ +.++|||||||++|||+||+.||....
T Consensus 145 ~~~~~vkl~DFG~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------ 214 (273)
T d1xwsa_ 145 LNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------ 214 (273)
T ss_dssp TTTTEEEECCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------
T ss_pred cCCCeEEECccccceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------
Confidence 5 579999999999865332 2234569999999999987765 567899999999999999999996521
Q ss_pred HHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 388 QNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 388 ~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
++....+. .+. ....++.+++.+||+.||++|||++|+++
T Consensus 215 -------------~i~~~~~~--------------~~~---------~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 215 -------------EIIRGQVF--------------FRQ---------RVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp -------------HHHHCCCC--------------CSS---------CCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -------------HHhhcccC--------------CCC---------CCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 01000000 000 01124778999999999999999999864
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=6.6e-42 Score=367.51 Aligned_cols=272 Identities=20% Similarity=0.251 Sum_probs=197.1
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccC--CcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceE
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLH--HDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFK 237 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~ 237 (873)
++|++.++||+|+||+||+|++. +++.||||+++... ....+.+.+|+.+|++++|||||++++++ ...+..
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~~~ 75 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI-----HTKKRL 75 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEE-----ECSSCE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeec-----ccCCce
Confidence 58999999999999999999884 77899999996543 23357899999999999999999999995 556779
Q ss_pred EEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEe
Q 002857 238 ALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVA 317 (873)
Q Consensus 238 ~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLs 317 (873)
+++|||+.++.+..+.. ....+++..+..|+.||+.||+||| +.+||||||||+|||++.++.+||+
T Consensus 76 ~i~~e~~~~~~~~~~~~----------~~~~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~ 142 (286)
T d1ob3a_ 76 VLVFEHLDQDLKKLLDV----------CEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIA 142 (286)
T ss_dssp EEEEECCSEEHHHHHHT----------STTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEEC
T ss_pred eEEEEeehhhhHHHHHh----------hcCCcchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEec
Confidence 99999998877776652 3567999999999999999999999 8899999999999999999999999
Q ss_pred ccccccccccccccccccccccccccCCCcccCCC-CCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCc
Q 002857 318 DFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGH-ETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALP 396 (873)
Q Consensus 318 DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~ 396 (873)
|||.+........ ......+++.|+|||.+.+. .++.++|||||||++|||++|+.||........ +.........
T Consensus 143 DfG~a~~~~~~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~-~~~i~~~~~~ 219 (286)
T d1ob3a_ 143 DFGLARAFGIPVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ-LMRIFRILGT 219 (286)
T ss_dssp CTTHHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCC
T ss_pred ccccceecccCcc--ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHH-HHHHHHhhCC
Confidence 9999987643322 22334589999999998765 568999999999999999999999976432211 1111111000
Q ss_pred h---hHHHHhhhh-hhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 397 E---RVEEIVDTL-FFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 397 ~---~l~elid~~-L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
. ......... .... .......++ ..........+.+++.+||+.||++|||++|+++
T Consensus 220 ~~~~~~~~~~~~~~~~~~------~~~~~~~~~----~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 220 PNSKNWPNVTELPKYDPN------FTVYEPLPW----ESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CCTTTSTTGGGSTTCCTT------CCCCCCCCG----GGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CChhhccchhhhhhcccc------cccccCcch----hhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 000000000 0000 000000000 0001111235779999999999999999999864
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5e-41 Score=362.93 Aligned_cols=264 Identities=20% Similarity=0.292 Sum_probs=202.2
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceEEE
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFKAL 239 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~~L 239 (873)
++|++.+.||+|+||.||+|++..+++.||||++.... ..+++..|++++++++|+|++..+..+. ..++..++
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~----~~~~~~~i 80 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCG----AEGDYNVM 80 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEE----EETTEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEE----ecCCEEEE
Confidence 57999999999999999999999999999999987543 2356889999999999888777776653 45677899
Q ss_pred EEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeC---CCCCeEE
Q 002857 240 VYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLN---DEMTACV 316 (873)
Q Consensus 240 V~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd---~~~~vKL 316 (873)
||||+ +++|.+.+. .....+++..++.++.|++.||+||| +++|+||||||+|||++ .+..+||
T Consensus 81 vme~~-~~~l~~~~~---------~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl 147 (299)
T d1ckia_ 81 VMELL-GPSLEDLFN---------FCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYI 147 (299)
T ss_dssp EEECC-CCBHHHHHH---------HTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEE
T ss_pred EEEEc-CCchhhhhh---------hccCCCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCceeee
Confidence 99999 557766653 23457999999999999999999999 89999999999999875 4567999
Q ss_pred ecccccccccccccc-----ccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHH
Q 002857 317 ADFGIARFLEATNEQ-----TSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWV 391 (873)
Q Consensus 317 sDFGla~~~~~~~~~-----~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~ 391 (873)
+|||+|+.+...... .......||+.|+|||.+.+..++.++|||||||++|||+||+.||...........
T Consensus 148 ~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~--- 224 (299)
T d1ckia_ 148 IDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK--- 224 (299)
T ss_dssp CCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC----------
T ss_pred eccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHH---
Confidence 999999977543321 122345699999999999999999999999999999999999999976432211100
Q ss_pred hhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHHHHH
Q 002857 392 QSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRLIKK 470 (873)
Q Consensus 392 ~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~i~~ 470 (873)
........+.... ......++.++.+++..||+.+|++||+++++.+.|+.+..
T Consensus 225 -------~~~~~~~~~~~~~------------------~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 225 -------YERISEKKMSTPI------------------EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp -------HHHHHHHHHHSCH------------------HHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred -------HHHhhcccCCCCh------------------hHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 0000000000000 00001123458899999999999999999999999988754
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-41 Score=367.54 Aligned_cols=209 Identities=20% Similarity=0.273 Sum_probs=170.6
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeecc--CCcchhHHHHHHHHHHhhhhccceeeeeeeeccc---ccC
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFL--HHDASKSFTVECEVMRNIIHRKIIKVVTACSRVD---YQG 233 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~---~~~ 233 (873)
.++|++.++||+|+||+||+|++..+++.||||++... .....+.+.+|+++|++++|+||+++++++.... ...
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 36899999999999999999999999999999998643 3334567899999999999999999999875422 122
Q ss_pred CceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCC
Q 002857 234 NDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMT 313 (873)
Q Consensus 234 ~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~ 313 (873)
....++||||+.++.+..+. .....+++..+..|+.||+.||.||| +.+|+||||||+|||++.++.
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~----------~~~~~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~ 155 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLS----------NVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGV 155 (318)
T ss_dssp --CEEEEEECCCEEHHHHHT----------CTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSC
T ss_pred CceEEEEEeccCCCccchhh----------hcccccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCc
Confidence 45689999999887776554 23556888899999999999999999 899999999999999999999
Q ss_pred eEEecccccccccccccc--ccccccccccccCCCcccCCC-CCCcchhhHhHHHHHHHHHhCCCCCCcc
Q 002857 314 ACVADFGIARFLEATNEQ--TSSIGVKGTTGYIAPEYGMGH-ETSSYGDVYSFGILLLEMFTGLRPSDDM 380 (873)
Q Consensus 314 vKLsDFGla~~~~~~~~~--~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELlTGk~Pf~~~ 380 (873)
+||+|||+++.+...... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 156 ~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~ 225 (318)
T d3blha1 156 LKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN 225 (318)
T ss_dssp EEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred EEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCC
Confidence 999999999866433211 122234699999999998765 6899999999999999999999999763
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-41 Score=373.53 Aligned_cols=286 Identities=17% Similarity=0.195 Sum_probs=199.9
Q ss_pred hhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCC-cchhHHHHHHHHHHhhhhccceeeeeeeecccccCCce
Q 002857 158 ATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH-DASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDF 236 (873)
Q Consensus 158 at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~ 236 (873)
.+++|++.++||+|+||+||+|++..+++.||||+++.... ...+.+++|+++|++++||||+++++++....+.....
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 45689999999999999999999999999999999975432 33467899999999999999999999986544333344
Q ss_pred EEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEE
Q 002857 237 KALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACV 316 (873)
Q Consensus 237 ~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKL 316 (873)
.+|+ +|+.+|+|.+++.. ..+++..++.++.||+.||+||| +++||||||||+|||++.++.+||
T Consensus 86 ~~l~-~~~~~g~L~~~l~~-----------~~l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl 150 (345)
T d1pmea_ 86 VYLV-THLMGADLYKLLKT-----------QHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKI 150 (345)
T ss_dssp EEEE-EECCCEEHHHHHHH-----------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEE
T ss_pred EEEE-EeecCCchhhhhhc-----------CCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECCCCCEEE
Confidence 5554 56679999999842 35899999999999999999999 899999999999999999999999
Q ss_pred ecccccccccccccc-ccccccccccccCCCcccCC-CCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhc
Q 002857 317 ADFGIARFLEATNEQ-TSSIGVKGTTGYIAPEYGMG-HETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSA 394 (873)
Q Consensus 317 sDFGla~~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~ 394 (873)
+|||+++........ .......||+.|+|||++.. ..++.++||||+||++|||++|+.||......... .......
T Consensus 151 ~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~-~~~~~~~ 229 (345)
T d1pmea_ 151 CDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL-NHILGIL 229 (345)
T ss_dssp CCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-HHHHHHH
T ss_pred cccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHH-HHHhhhc
Confidence 999999876443322 22334569999999999855 46788999999999999999999999764322111 1111101
Q ss_pred CchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 395 LPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 395 ~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
....... ........ ......... ................++.+++.+||+.||++|||+.|+++
T Consensus 230 ~~~~~~~-~~~~~~~~--~~~~~~~~~-~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 230 GSPSQED-LNCIINLK--ARNYLLSLP-HKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294 (345)
T ss_dssp CSCCHHH-HHTCCCHH--HHHHHHTSC-CCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cCCChhh-hhhhhhhh--hhcccccCC-ccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1110000 00000000 000000000 00000000101111234788999999999999999999865
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-41 Score=369.00 Aligned_cols=278 Identities=19% Similarity=0.217 Sum_probs=195.0
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCC--cchhHHHHHHHHHHhhhhccceeeeeeeecccc-cCCc
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH--DASKSFTVECEVMRNIIHRKIIKVVTACSRVDY-QGND 235 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~-~~~~ 235 (873)
.++|++.++||+|+||+||+|++..+++.||||+++.... ...+.+.+|+++|++++|||||+++++|..... ....
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 5789999999999999999999999999999999974332 234678999999999999999999999754321 2334
Q ss_pred eEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeE
Q 002857 236 FKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTAC 315 (873)
Q Consensus 236 ~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vK 315 (873)
..+|||||+ +.+|..+++ ...+++..++.|+.||+.||+||| +.+|+||||||+|||++.++.+|
T Consensus 97 ~~~lv~e~~-~~~l~~~~~-----------~~~l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~k 161 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMK-----------HEKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELK 161 (346)
T ss_dssp CCEEEEECC-SEEHHHHHH-----------HCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEE
T ss_pred eEEEEEecc-cccHHHHHH-----------hccccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhhcccccccc
Confidence 579999999 567777763 245999999999999999999999 89999999999999999999999
Q ss_pred EeccccccccccccccccccccccccccCCCcccCCC-CCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhh-
Q 002857 316 VADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGH-ETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQS- 393 (873)
Q Consensus 316 LsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~- 393 (873)
|+|||+++..... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||....... .+......
T Consensus 162 l~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~-~~~~~~~~~ 235 (346)
T d1cm8a_ 162 ILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD-QLKEIMKVT 235 (346)
T ss_dssp ECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHH
T ss_pred cccccceeccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHH-HHHHHHhcc
Confidence 9999999865432 2345689999999998764 56899999999999999999999997642211 11111111
Q ss_pred -cCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 394 -ALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 394 -~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
..+....+.......... ..........++.. ........+.+|+.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~----~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~ 300 (346)
T d1cm8a_ 236 GTPPAEFVQRLQSDEAKNY--MKGLPELEKKDFAS----ILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300 (346)
T ss_dssp CCCCHHHHHTCSCHHHHHH--HHHSCCCCCCCGGG----TCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCcHHHHhhhcchhhhhh--hccCCcccccchHH----hccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 111111111000000000 00000000011100 00111234678999999999999999999875
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-40 Score=368.65 Aligned_cols=276 Identities=22% Similarity=0.251 Sum_probs=195.4
Q ss_pred CCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccceeeeeeeecccc-cCCceEEE
Q 002857 161 GFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKIIKVVTACSRVDY-QGNDFKAL 239 (873)
Q Consensus 161 ~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~-~~~~~~~L 239 (873)
+|+..++||+|+||+||+|++..+++.||||+++... ..+.+|+++|++++|+||+++++++..... .+..+.+|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc----hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 5788899999999999999999999999999997543 233579999999999999999999754321 23456799
Q ss_pred EEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCC-CeEEec
Q 002857 240 VYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEM-TACVAD 318 (873)
Q Consensus 240 V~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~-~vKLsD 318 (873)
||||++++.+..+.+. ......+++.++..|+.||+.||+||| +++|+||||||+|||++.++ .+||+|
T Consensus 97 v~Ey~~~~~~~~l~~~-------~~~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~D 166 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHY-------SRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCD 166 (350)
T ss_dssp EEECCSEEHHHHHHHH-------HHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECC
T ss_pred EEeccCCccHHHHHhh-------hhccCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEec
Confidence 9999987544443321 124567999999999999999999999 89999999999999999775 899999
Q ss_pred cccccccccccccccccccccccccCCCcccCC-CCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhcCc-
Q 002857 319 FGIARFLEATNEQTSSIGVKGTTGYIAPEYGMG-HETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSALP- 396 (873)
Q Consensus 319 FGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~~~- 396 (873)
||+++....... .....||..|+|||.+.+ ..++.++|||||||++|||++|+.||....... .+...+.....
T Consensus 167 FG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~-~l~~i~~~~g~~ 242 (350)
T d1q5ka_ 167 FGSAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD-QLVEIIKVLGTP 242 (350)
T ss_dssp CTTCEECCTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH-HHHHHHHHHCCC
T ss_pred ccchhhccCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHH-HHHHHHHHhCCC
Confidence 999987644322 223469999999998765 478999999999999999999999997632211 11111111110
Q ss_pred --hhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 397 --ERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 397 --~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
+.+........... .......++..... ......+.+|+.+||+.||++|||+.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~---~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 243 TREQIREMNPNYTEFK------FPQIKAHPWTKVFR---PRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp CHHHHHHHCC---CCC------CCCCCCCCGGGTSC---TTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hHHhhhhhccchhhcc------ccccccCchhhhcc---cCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 01111110000000 00000111100000 011234778999999999999999999875
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.6e-40 Score=361.83 Aligned_cols=196 Identities=21% Similarity=0.326 Sum_probs=169.5
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhh-hccceeeeeeeecccccCCceEE
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNII-HRKIIKVVTACSRVDYQGNDFKA 238 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~-HpNIV~llg~c~~~~~~~~~~~~ 238 (873)
++|++.++||+|+||+||+|++..+++.||||+++.. ..+.+.+|+++|++++ ||||+++++++.. ......+
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~---~~~~~~~ 108 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKD---PVSRTPA 108 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEEC---TTTCSEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEe---cCCCcee
Confidence 5799999999999999999999999999999998643 3467899999999995 9999999998642 3456789
Q ss_pred EEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCC-CeEEe
Q 002857 239 LVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEM-TACVA 317 (873)
Q Consensus 239 LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~-~vKLs 317 (873)
+||||+.+++|.++. ..+++..+..++.||+.||+||| +.+|+||||||+|||++.++ .+||+
T Consensus 109 ~v~e~~~~~~L~~~~-------------~~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~ 172 (328)
T d3bqca1 109 LVFEHVNNTDFKQLY-------------QTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLI 172 (328)
T ss_dssp EEEECCCSCBGGGTT-------------TSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEEC
T ss_pred EEEeecCCCcHHHHh-------------cCCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeec
Confidence 999999999998764 24889999999999999999999 89999999999999998655 69999
Q ss_pred ccccccccccccccccccccccccccCCCcccCCC-CCCcchhhHhHHHHHHHHHhCCCCCCcc
Q 002857 318 DFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGH-ETSSYGDVYSFGILLLEMFTGLRPSDDM 380 (873)
Q Consensus 318 DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELlTGk~Pf~~~ 380 (873)
|||+|+....... .....+|..|+|||.+.+. .++.++||||+||++|||++|+.||...
T Consensus 173 DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~ 233 (328)
T d3bqca1 173 DWGLAEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 233 (328)
T ss_dssp CGGGCEECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred ccccceeccCCCc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCC
Confidence 9999987654322 2334689999999998775 4799999999999999999999999753
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-41 Score=358.83 Aligned_cols=200 Identities=22% Similarity=0.313 Sum_probs=173.7
Q ss_pred cCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCC--cchhHHHHHHHHHHhhhhccceeeeeeeecccccCCceE
Q 002857 160 KGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH--DASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGNDFK 237 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~~~ 237 (873)
++|++.+.||+|+||+||+|++..+++.||||+++.... .....+.+|+.+|+.++||||+++++++ ......
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~-----~~~~~~ 76 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL-----HSDKKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccc-----ccccce
Confidence 579999999999999999999999999999999974432 3457889999999999999999999996 456678
Q ss_pred EEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeEEe
Q 002857 238 ALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTACVA 317 (873)
Q Consensus 238 ~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vKLs 317 (873)
++|++++.+++|..++. ....+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+
T Consensus 77 ~iv~~~~~~~~l~~~~~----------~~~~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~ 143 (292)
T d1unla_ 77 TLVFEFCDQDLKKYFDS----------CNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLA 143 (292)
T ss_dssp EEEEECCSEEHHHHHHH----------TTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEEC
T ss_pred eEEeeeccccccccccc----------cccccchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCceeee
Confidence 99999999999988773 3567889999999999999999999 8999999999999999999999999
Q ss_pred ccccccccccccccccccccccccccCCCcccCCCC-CCcchhhHhHHHHHHHHHhCCCCCCc
Q 002857 318 DFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHE-TSSYGDVYSFGILLLEMFTGLRPSDD 379 (873)
Q Consensus 318 DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~-~s~ksDVwSfGvvL~ELlTGk~Pf~~ 379 (873)
|||.++....... ......++..|+|||++.+.. ++.++|||||||++|||++|+.||..
T Consensus 144 DFG~a~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~ 204 (292)
T d1unla_ 144 NFGLARAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 204 (292)
T ss_dssp CCTTCEECCSCCS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC
T ss_pred ecchhhcccCCCc--cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCC
Confidence 9999987654332 222345788999999987765 68999999999999999999999754
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=8.4e-40 Score=353.13 Aligned_cols=266 Identities=17% Similarity=0.206 Sum_probs=207.0
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhh-ccceeeeeeeecccccCCceE
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIH-RKIIKVVTACSRVDYQGNDFK 237 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~H-pNIV~llg~c~~~~~~~~~~~ 237 (873)
.++|++.++||+|+||+||+|++..+++.||||+++... ....+.+|+++++.++| +|++.+++++ ..+...
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~~~ 76 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFG-----QEGLHN 76 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEE-----EETTEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEe-----ecCCcc
Confidence 368999999999999999999999999999999986432 33568899999999975 8999999885 456778
Q ss_pred EEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCC-----CC
Q 002857 238 ALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLND-----EM 312 (873)
Q Consensus 238 ~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~-----~~ 312 (873)
++||||+ +++|.+++.. ....+++.++..|+.|++.||+||| +.+|+||||||+|||++. ++
T Consensus 77 ~~vme~~-~~~l~~~~~~---------~~~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~ 143 (293)
T d1csna_ 77 VLVIDLL-GPSLEDLLDL---------CGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNAN 143 (293)
T ss_dssp EEEEECC-CCBHHHHHHH---------TTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTT
T ss_pred EEEEEec-CCCHHHHHHh---------hccchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCC
Confidence 9999998 7899998853 3456899999999999999999999 999999999999999974 57
Q ss_pred CeEEecccccccccccccc-----ccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhh
Q 002857 313 TACVADFGIARFLEATNEQ-----TSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNL 387 (873)
Q Consensus 313 ~vKLsDFGla~~~~~~~~~-----~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l 387 (873)
.+||+|||+|+.+...... .......||+.|+|||++.+..++.++|||||||++|||+||+.||..........
T Consensus 144 ~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~ 223 (293)
T d1csna_ 144 MIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ 223 (293)
T ss_dssp CEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHH
T ss_pred ceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHH
Confidence 8999999999876543221 12334569999999999999999999999999999999999999997532221100
Q ss_pred HHHHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHHHHHH
Q 002857 388 QNWVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVELGLRL 467 (873)
Q Consensus 388 ~~~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~~Le~ 467 (873)
. ...+......... .+....++.++.+++..|++.+|++||+++.+.+.|+.
T Consensus 224 --~--------~~~i~~~~~~~~~------------------~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~ 275 (293)
T d1csna_ 224 --K--------YERIGEKKQSTPL------------------RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSK 275 (293)
T ss_dssp --H--------HHHHHHHHHHSCH------------------HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred --H--------HHHHHhccCCCCh------------------HHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence 0 0001000000000 00001123458889999999999999999999999988
Q ss_pred HHHhh
Q 002857 468 IKKKL 472 (873)
Q Consensus 468 i~~~l 472 (873)
+.+..
T Consensus 276 ~~~~~ 280 (293)
T d1csna_ 276 VLERL 280 (293)
T ss_dssp HHHHT
T ss_pred HHHHc
Confidence 76544
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-39 Score=360.45 Aligned_cols=282 Identities=20% Similarity=0.153 Sum_probs=194.5
Q ss_pred hcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCC--cchhHHHHHHHHHHhhhhccceeeeeeeecccc-cCCc
Q 002857 159 TKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHH--DASKSFTVECEVMRNIIHRKIIKVVTACSRVDY-QGND 235 (873)
Q Consensus 159 t~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~-~~~~ 235 (873)
.++|++.++||+|+||+||+|++..+++.||||+++.... .....+.+|+.+|++++|||||++++++..... ....
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 4689999999999999999999999999999999974432 234568899999999999999999999754322 3457
Q ss_pred eEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeE
Q 002857 236 FKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTAC 315 (873)
Q Consensus 236 ~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vK 315 (873)
..++||||+.++.+ +.+. ..+++..++.++.||+.||.||| +.+|+||||||+|||++.++.+|
T Consensus 96 ~~~iv~Ey~~~~l~-~~~~------------~~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~k 159 (355)
T d2b1pa1 96 DVYLVMELMDANLC-QVIQ------------MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLK 159 (355)
T ss_dssp EEEEEEECCSEEHH-HHHT------------SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEE
T ss_pred eeEEEEeccchHHH-Hhhh------------cCCCHHHHHHHHHHHHHHHHHhh---hcccccccCCcccccccccccee
Confidence 89999999976544 4442 24788999999999999999999 89999999999999999999999
Q ss_pred EeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHH----
Q 002857 316 VADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWV---- 391 (873)
Q Consensus 316 LsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~---- 391 (873)
++|||+++...... ......+|+.|+|||++.+..++.++||||+||++|||++|+.||....... ......
T Consensus 160 l~df~~~~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~-~~~~i~~~~~ 235 (355)
T d2b1pa1 160 ILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID-QWNKVIEQLG 235 (355)
T ss_dssp ECCCCC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHC
T ss_pred eechhhhhcccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHH-HHHHHHHhcc
Confidence 99999988654332 2234568999999999999999999999999999999999999997532111 111111
Q ss_pred ------hhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 392 ------QSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 392 ------~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
+........++.+...................+... .........+.+|+.+||+.||++|||++||++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 236 TPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADS---EHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp CCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSS---HHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccc---cccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 111111222222211110000000000000001111 111223456889999999999999999999864
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-40 Score=363.04 Aligned_cols=282 Identities=16% Similarity=0.219 Sum_probs=198.1
Q ss_pred hhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCc--chhHHHHHHHHHHhhhhccceeeeeeeecccccCCc
Q 002857 158 ATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHD--ASKSFTVECEVMRNIIHRKIIKVVTACSRVDYQGND 235 (873)
Q Consensus 158 at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~llg~c~~~~~~~~~ 235 (873)
.+++|++.++||+|+||+||+|++..+++.||||+++..... ..+.+.+|+++|++++|+|||++++++......+..
T Consensus 16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 467899999999999999999999999999999999754332 345788999999999999999999987543322344
Q ss_pred eEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCCCCeE
Q 002857 236 FKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDEMTAC 315 (873)
Q Consensus 236 ~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~~~vK 315 (873)
..++|++|+.+|+|.++++ ...+++.++..|+.||+.||+||| +++|+||||||+|||++.++.+|
T Consensus 96 ~~~~i~~~~~gg~L~~~~~-----------~~~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~k 161 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVK-----------CQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELK 161 (348)
T ss_dssp CCCEEEEECCSEEHHHHHT-----------TCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEE
T ss_pred ceEEEEEeecCCchhhhcc-----------cccccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCcccccccccccc
Confidence 4567778888999999984 235999999999999999999999 89999999999999999999999
Q ss_pred EeccccccccccccccccccccccccccCCCcccCCC-CCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHHHHhhc
Q 002857 316 VADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGH-ETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQNWVQSA 394 (873)
Q Consensus 316 LsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~~~~~~ 394 (873)
++|||++...... .....||..|+|||.+.+. .++.++|||||||++|+|++|+.||....... ....+...
T Consensus 162 l~dfg~a~~~~~~-----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~--~~~~i~~~ 234 (348)
T d2gfsa1 162 ILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID--QLKLILRL 234 (348)
T ss_dssp ECCC----CCTGG-----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHH
T ss_pred ccccchhcccCcc-----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHH--HHHHHHHh
Confidence 9999999755322 2334689999999987665 46889999999999999999999997632211 11111000
Q ss_pred CchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCCHHHHHH
Q 002857 395 LPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMKINDVEL 463 (873)
Q Consensus 395 ~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPTm~EVl~ 463 (873)
......++..... . .............+.... ..........+.+|+.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 235 VGTPGAELLKKIS-S-ESARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp HCCCCHHHHTTCC-C-HHHHHHHTTSCCCCCCCH-HHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cCCCChHHhhhcc-c-hhhhhhhhhcccCCCcch-hhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 0000000000000 0 000000011111111110 0000111235778999999999999999998864
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-40 Score=358.01 Aligned_cols=253 Identities=22% Similarity=0.297 Sum_probs=195.5
Q ss_pred cCCCcceeecccCceEEEEEEEc---CCCcEEEEEEeecc----CCcchhHHHHHHHHHHhhhh-ccceeeeeeeecccc
Q 002857 160 KGFSSENLIGAGNFASVYKGILF---EGAPAVAIKVFNFL----HHDASKSFTVECEVMRNIIH-RKIIKVVTACSRVDY 231 (873)
Q Consensus 160 ~~f~~~~~LG~G~fG~VYkg~~~---~~g~~VAVK~l~~~----~~~~~~~f~~Ei~iL~~L~H-pNIV~llg~c~~~~~ 231 (873)
++|++.+.||+|+||+||+|+.. .+++.||||+++.. .....+.+.+|+++|++++| |||+++++++
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~----- 98 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF----- 98 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE-----
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeee-----
Confidence 57999999999999999999874 35889999998632 22334678899999999977 7999999985
Q ss_pred cCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeCCC
Q 002857 232 QGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLNDE 311 (873)
Q Consensus 232 ~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd~~ 311 (873)
......++||||+.+|+|.+++.. ...+++..+..++.||+.||+||| +.+|+||||||+|||++.+
T Consensus 99 ~~~~~~~~v~e~~~~~~L~~~i~~----------~~~~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~ 165 (322)
T d1vzoa_ 99 QTETKLHLILDYINGGELFTHLSQ----------RERFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSN 165 (322)
T ss_dssp EETTEEEEEECCCCSCBHHHHHHH----------HSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTT
T ss_pred ccCCceeeeeecccccHHHHHHHh----------cccccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCC
Confidence 456789999999999999999853 345678889999999999999999 8999999999999999999
Q ss_pred CCeEEeccccccccccccccccccccccccccCCCcccCCC--CCCcchhhHhHHHHHHHHHhCCCCCCcccccchhhHH
Q 002857 312 MTACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGH--ETSSYGDVYSFGILLLEMFTGLRPSDDMFKDNLNLQN 389 (873)
Q Consensus 312 ~~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~--~~s~ksDVwSfGvvL~ELlTGk~Pf~~~~~~~~~l~~ 389 (873)
+.+||+|||+++.+...... ......|++.|+|||.+.+. .++.++|||||||+||||+||+.||........
T Consensus 166 ~~vkL~DFG~a~~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~---- 240 (322)
T d1vzoa_ 166 GHVVLTDFGLSKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS---- 240 (322)
T ss_dssp SCEEESCSSEEEECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC----
T ss_pred CCEEEeeccchhhhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH----
Confidence 99999999999876443322 23345699999999998765 468899999999999999999999976432211
Q ss_pred HHhhcCchhHHHHhhhhhhhhhhHHHHHhhhccCCCCchhHHHHHHHHHHHHHHHHHhhccCcCCCCC-----HHHHHH
Q 002857 390 WVQSALPERVEEIVDTLFFKEIEEEETVYKYKKAPSSSTQRSIILECLNSICEIGVACSAELPGERMK-----INDVEL 463 (873)
Q Consensus 390 ~~~~~~~~~l~elid~~L~~~~~~r~~~~~i~~~p~~~~~~~~~~e~~~~L~~L~~~CL~~dP~eRPT-----m~EVl~ 463 (873)
...+........ .+... ....++.+++.+||+.||++||| ++|+++
T Consensus 241 ---------~~~i~~~~~~~~------------~~~~~-------~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 241 ---------QAEISRRILKSE------------PPYPQ-------EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp ---------HHHHHHHHHHCC------------CCCCT-------TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred ---------HHHHHHhcccCC------------CCCcc-------cCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 011111100000 00000 11235788999999999999995 777754
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.1e-35 Score=324.56 Aligned_cols=201 Identities=20% Similarity=0.249 Sum_probs=161.5
Q ss_pred CCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhh-----------hccceeeeeeeecc
Q 002857 161 GFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNII-----------HRKIIKVVTACSRV 229 (873)
Q Consensus 161 ~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~-----------HpNIV~llg~c~~~ 229 (873)
+|++.++||+|+||+||+|++..+++.||||+++... ...+.+.+|++++++++ |+||+++++++..
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~- 91 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH- 91 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE-
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee-
Confidence 5999999999999999999999999999999997432 23367888999998886 5789999988643
Q ss_pred cccCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCCCeeeC
Q 002857 230 DYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPSNILLN 309 (873)
Q Consensus 230 ~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKpsNILLd 309 (873)
......+++|++...+....... .......+++..+..++.||+.||+|||+ ..+|+||||||+|||++
T Consensus 92 --~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~ 160 (362)
T d1q8ya_ 92 --KGPNGVHVVMVFEVLGENLLALI-------KKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLME 160 (362)
T ss_dssp --EETTEEEEEEEECCCCEEHHHHH-------HHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEE
T ss_pred --ccccceeeeeeeccccccccccc-------ccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeee
Confidence 33455677777776554333221 12455678889999999999999999993 38999999999999998
Q ss_pred CCC------CeEEeccccccccccccccccccccccccccCCCcccCCCCCCcchhhHhHHHHHHHHHhCCCCCCc
Q 002857 310 DEM------TACVADFGIARFLEATNEQTSSIGVKGTTGYIAPEYGMGHETSSYGDVYSFGILLLEMFTGLRPSDD 379 (873)
Q Consensus 310 ~~~------~vKLsDFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlTGk~Pf~~ 379 (873)
.++ .++|+|||.+...... .....||+.|+|||++.+..++.++||||+||+++||++|+.||..
T Consensus 161 ~~~~~~~~~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~ 231 (362)
T d1q8ya_ 161 IVDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEP 231 (362)
T ss_dssp EEETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC--
T ss_pred ccCcccccceeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCC
Confidence 654 3999999999754322 2235699999999999999999999999999999999999999975
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.84 E-value=1.1e-21 Score=197.03 Aligned_cols=169 Identities=16% Similarity=0.127 Sum_probs=119.1
Q ss_pred CcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCc------------------chhHHHHHHHHHHhhhhccceeeee
Q 002857 163 SSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHD------------------ASKSFTVECEVMRNIIHRKIIKVVT 224 (873)
Q Consensus 163 ~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~------------------~~~~f~~Ei~iL~~L~HpNIV~llg 224 (873)
.+.++||+|+||.||+|++ .+|+.||||+++..... .......|+..+.++.|.+++..++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~-~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp EEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred hhCCEeeeCcceEEEEEEC-CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 4678999999999999987 46889999987532110 0123456888899999999999887
Q ss_pred eeecccccCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhCCCCCeeeccCCCC
Q 002857 225 ACSRVDYQGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLGCKPPIAHCDIKPS 304 (873)
Q Consensus 225 ~c~~~~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~~s~gIvHrDLKps 304 (873)
+. ..++||||+++..+.+ ++......++.|++.+|+||| +.+|+||||||+
T Consensus 82 ~~---------~~~lvme~~~~~~~~~-----------------l~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~ 132 (191)
T d1zara2 82 WE---------GNAVLMELIDAKELYR-----------------VRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQY 132 (191)
T ss_dssp EE---------TTEEEEECCCCEEGGG-----------------CCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTT
T ss_pred ec---------CCEEEEEeeccccccc-----------------hhhHHHHHHHHHHHHHHHHHh---hCCEEEccCChh
Confidence 62 1279999998755443 233456789999999999999 899999999999
Q ss_pred CeeeCCCCCeEEecccccccccccccccccccc-ccccccCCCcccCCCCCCcchhhHhHHHHHH
Q 002857 305 NILLNDEMTACVADFGIARFLEATNEQTSSIGV-KGTTGYIAPEYGMGHETSSYGDVYSFGILLL 368 (873)
Q Consensus 305 NILLd~~~~vKLsDFGla~~~~~~~~~~~~~~~-~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ 368 (873)
|||++++ .++|+|||+|+.............. .... +++ ...|+.++||||..--++
T Consensus 133 NILv~~~-~~~liDFG~a~~~~~~~~~~~l~rd~~~~~-----~~f-~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 133 NVLVSEE-GIWIIDFPQSVEVGEEGWREILERDVRNII-----TYF-SRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp SEEEETT-EEEECCCTTCEETTSTTHHHHHHHHHHHHH-----HHH-HHHHCCCCCHHHHHHHHH
T ss_pred heeeeCC-CEEEEECCCcccCCCCCcHHHHHHHHHHHH-----HHH-cCCCCCcccHHHHHHHHh
Confidence 9999965 4899999999765322211100000 0000 111 245778899999765443
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=98.87 E-value=5.5e-10 Score=118.42 Aligned_cols=80 Identities=33% Similarity=0.466 Sum_probs=64.6
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCccccccccc-ccC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNN-KLC 79 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN-~L~ 79 (873)
+++|++++.+| +++.+++|+.|+|++|+|+|.||+.|++|++|++|||++|+|+|.+|.. ..+..+..+.+.+| .||
T Consensus 228 ~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~-~~L~~L~~l~l~~N~~l~ 305 (313)
T d1ogqa_ 228 LAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNKCLC 305 (313)
T ss_dssp CCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS-TTGGGSCGGGTCSSSEEE
T ss_pred ccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCc-ccCCCCCHHHhCCCcccc
Confidence 46788887655 6889999999999999999999999999999999999999999999964 34455666666555 588
Q ss_pred CCC
Q 002857 80 GGI 82 (873)
Q Consensus 80 G~~ 82 (873)
|.|
T Consensus 306 g~p 308 (313)
T d1ogqa_ 306 GSP 308 (313)
T ss_dssp STT
T ss_pred CCC
Confidence 853
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=98.72 E-value=1.2e-09 Score=115.64 Aligned_cols=83 Identities=33% Similarity=0.397 Sum_probs=74.9
Q ss_pred CCCCcccc--CcCcCCCCCCCCCeEeCCC-CcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccc
Q 002857 1 MHGNLFEG--PIGLSLSPLRGLKVLDLSQ-NNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNK 77 (873)
Q Consensus 1 Ls~N~L~G--~iP~~l~~L~~L~~L~Ls~-N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~ 77 (873)
|++|.++| .||++|++|++|++|+|++ |+|+|.||++|++|++|++|+|++|+|++..|..+.....+..+.+++|.
T Consensus 57 L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~ 136 (313)
T d1ogqa_ 57 LSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNA 136 (313)
T ss_dssp EECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSE
T ss_pred CCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhccccccccc
Confidence 46788988 5899999999999999996 89999999999999999999999999999999888888888888999888
Q ss_pred cCCCCC
Q 002857 78 LCGGIP 83 (873)
Q Consensus 78 L~G~~p 83 (873)
+.+.+|
T Consensus 137 ~~~~~p 142 (313)
T d1ogqa_ 137 LSGTLP 142 (313)
T ss_dssp EESCCC
T ss_pred ccccCc
Confidence 877654
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=98.61 E-value=1.6e-08 Score=99.78 Aligned_cols=83 Identities=20% Similarity=0.224 Sum_probs=55.9
Q ss_pred CCCCccccCc-CcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccC
Q 002857 1 MHGNLFEGPI-GLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLC 79 (873)
Q Consensus 1 Ls~N~L~G~i-P~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~ 79 (873)
|++|+|++.+ +..|+.|++|+.|+|++|++++.++..+..+++|+.|+|++|+|++..|..+..+..+..+.+++|.|.
T Consensus 36 Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~ 115 (192)
T d1w8aa_ 36 LNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQIS 115 (192)
T ss_dssp CCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCC
T ss_pred eCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccccccccCHHHHhCCCcccccccCCcccc
Confidence 5667776544 344566777777777777777666667777777777777777777666666666666777777777776
Q ss_pred CCCC
Q 002857 80 GGIP 83 (873)
Q Consensus 80 G~~p 83 (873)
+.++
T Consensus 116 ~i~~ 119 (192)
T d1w8aa_ 116 CVMP 119 (192)
T ss_dssp EECT
T ss_pred ccCH
Confidence 5443
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=98.58 E-value=2.9e-08 Score=91.40 Aligned_cols=76 Identities=25% Similarity=0.267 Sum_probs=66.9
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCG 80 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G 80 (873)
|++|+|+ .+| .++.|++|++|+|++|+|+ .+|+.|+.+++|++|+|++|+|+. +|. +.....+..+.+++|.+..
T Consensus 5 Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~~-~~~l~~L~~L~l~~N~i~~ 79 (124)
T d1dcea3 5 LAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VDG-VANLPRLQELLLCNNRLQQ 79 (124)
T ss_dssp CTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CGG-GTTCSSCCEEECCSSCCCS
T ss_pred cCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cCc-cccccccCeEECCCCccCC
Confidence 6899999 676 4999999999999999999 899999999999999999999995 554 5667788999999999885
Q ss_pred C
Q 002857 81 G 81 (873)
Q Consensus 81 ~ 81 (873)
.
T Consensus 80 ~ 80 (124)
T d1dcea3 80 S 80 (124)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=98.57 E-value=2.4e-08 Score=98.38 Aligned_cols=80 Identities=18% Similarity=0.232 Sum_probs=72.7
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCG 80 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G 80 (873)
|++|++.+..+..|..+++|++|+|++|+|++..|..|.+|++|++|+|++|+|++..|..+.....+..+.+++|.+..
T Consensus 61 L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~ 140 (192)
T d1w8aa_ 61 LKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNC 140 (192)
T ss_dssp CCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCC
T ss_pred ccccccccccccccccccccceeeeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCccccccccccccccc
Confidence 67999998899999999999999999999996666789999999999999999998888888888889999999987764
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=98.48 E-value=8.9e-08 Score=88.03 Aligned_cols=78 Identities=24% Similarity=0.275 Sum_probs=66.2
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCC-cccccccCcccccccccccC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIP-TEGIFKNASATSVFGNNKLC 79 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP-~~~~~~~~l~~~~l~nN~L~ 79 (873)
|++|+|+ .+|.+|+.+++|+.|+|++|+|+ .+| .++++++|+.|+|++|+|+.... ..+.....+..+.+++|.++
T Consensus 27 ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 27 LSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred CCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCCccCCCCCchhhcCCCCCCEEECCCCcCC
Confidence 6899998 79999999999999999999999 676 59999999999999999995432 34555667888999999887
Q ss_pred CC
Q 002857 80 GG 81 (873)
Q Consensus 80 G~ 81 (873)
..
T Consensus 104 ~~ 105 (124)
T d1dcea3 104 QE 105 (124)
T ss_dssp GS
T ss_pred cC
Confidence 53
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.38 E-value=9.8e-07 Score=89.95 Aligned_cols=150 Identities=15% Similarity=0.082 Sum_probs=100.7
Q ss_pred HHHHHhhcCCCcceeecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhh-hccceeeeeeeecccc
Q 002857 153 EALYSATKGFSSENLIGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNII-HRKIIKVVTACSRVDY 231 (873)
Q Consensus 153 ~el~~at~~f~~~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~-HpNIV~llg~c~~~~~ 231 (873)
.++...-..|+..+..+.++.+.||+.. .+++.++||+...........+.+|..++..+. +--+.+++.+.
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~----- 79 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFE----- 79 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEE-----
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEE-----
Confidence 3566666777776665555567999875 356678889876555555567889999988884 33356666653
Q ss_pred cCCceEEEEEeecCCCChhhhcccccccccccCCCCCCchhhhHHHHHHHHHHHHHHhhC--------------------
Q 002857 232 QGNDFKALVYEFMPNGSLEEWIHPITEEDKRHKAPGNLNSLERLNIAIDVASALEYLHLG-------------------- 291 (873)
Q Consensus 232 ~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~~~~~~~Ls~~~~l~Ia~qIa~gL~yLH~~-------------------- 291 (873)
..++..++||+++++.++.+.... ......++.++++.|+.||..
T Consensus 80 ~~~~~~~lv~~~l~G~~~~~~~~~---------------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~ 144 (263)
T d1j7la_ 80 RHDGWSNLLMSEADGVLCSEEYED---------------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDY 144 (263)
T ss_dssp EETTEEEEEEECCSSEEHHHHTTT---------------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHH
T ss_pred ecCCceEEEEEecccccccccccc---------------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHH
Confidence 345678999999999887654321 111233444445555555421
Q ss_pred ---------------------------------C---CCCeeeccCCCCCeeeCCCCCeEEeccccccc
Q 002857 292 ---------------------------------C---KPPIAHCDIKPSNILLNDEMTACVADFGIARF 324 (873)
Q Consensus 292 ---------------------------------~---s~gIvHrDLKpsNILLd~~~~vKLsDFGla~~ 324 (873)
. ...++|+|+.+.|||++++...-|+||+.+..
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 145 LLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 0 22378999999999999877777999998863
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.29 E-value=3.4e-07 Score=87.36 Aligned_cols=81 Identities=16% Similarity=0.012 Sum_probs=63.7
Q ss_pred CCCccccCcCcCCCCCCCCCeEeCCCCc-CCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCC
Q 002857 2 HGNLFEGPIGLSLSPLRGLKVLDLSQNN-LSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCG 80 (873)
Q Consensus 2 s~N~L~G~iP~~l~~L~~L~~L~Ls~N~-LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G 80 (873)
++|+++ .+|..|..+++|+.|+|++|+ |+..-+..|.+|++|+.|+|++|+|+...|..+.....+..+++++|.|..
T Consensus 16 ~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~ 94 (156)
T d2ifga3 16 TRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALES 94 (156)
T ss_dssp CSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSC
T ss_pred cCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCCCcc
Confidence 456666 678888888999999997664 773334578889999999999999997777777778888888999998885
Q ss_pred CCC
Q 002857 81 GIP 83 (873)
Q Consensus 81 ~~p 83 (873)
.++
T Consensus 95 l~~ 97 (156)
T d2ifga3 95 LSW 97 (156)
T ss_dssp CCS
T ss_pred cCh
Confidence 544
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.28 E-value=2.5e-07 Score=88.94 Aligned_cols=77 Identities=16% Similarity=0.145 Sum_probs=61.9
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCG 80 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G 80 (873)
|++|+|+ .||..+..+++|++||||+|+|+ .++ .|..+++|+.|+|++|+|+...+..+.....+..+++++|.+..
T Consensus 25 L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~~N~i~~ 101 (162)
T d1a9na_ 25 LRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVE 101 (162)
T ss_dssp CTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCCC
T ss_pred CCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCccccccccccccceeccccccc
Confidence 6788888 57776778899999999999998 675 58889999999999999986555555567778888888888764
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.21 E-value=9.5e-07 Score=84.21 Aligned_cols=78 Identities=22% Similarity=0.116 Sum_probs=61.3
Q ss_pred CCCC-ccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccC
Q 002857 1 MHGN-LFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLC 79 (873)
Q Consensus 1 Ls~N-~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~ 79 (873)
|++| .|+..-+.+|.+|++|+.|+|++|+|+..-|..|..+++|++|+|++|+|+...+..+... .+..+.+++|.+.
T Consensus 38 l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~~-~l~~L~L~~Np~~ 116 (156)
T d2ifga3 38 IENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGL-SLQELVLSGNPLH 116 (156)
T ss_dssp CCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTCSC-CCCEEECCSSCCC
T ss_pred cCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCCCcccChhhhccc-cccccccCCCccc
Confidence 3445 5775445679999999999999999996557789999999999999999995444444333 5778888888764
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.15 E-value=6.4e-07 Score=93.01 Aligned_cols=83 Identities=19% Similarity=0.105 Sum_probs=74.0
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCG 80 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G 80 (873)
|++|+|++..+..|..+++|+.|+|++|+|++..|..|.++++|+.|+|++|++++..|..+.....+..+++++|.+.+
T Consensus 136 l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~ 215 (284)
T d1ozna_ 136 LQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSA 215 (284)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSC
T ss_pred hccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhccccccccccccc
Confidence 57899997666778899999999999999997777889999999999999999999999988888889999999999987
Q ss_pred CCC
Q 002857 81 GIP 83 (873)
Q Consensus 81 ~~p 83 (873)
.++
T Consensus 216 ~~~ 218 (284)
T d1ozna_ 216 LPT 218 (284)
T ss_dssp CCH
T ss_pred ccc
Confidence 654
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.14 E-value=9.4e-07 Score=91.70 Aligned_cols=84 Identities=15% Similarity=0.045 Sum_probs=71.0
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCG 80 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G 80 (873)
|++|.+.+..+..++.+++|+.|++++|+|++..+..|..+++|+.|+|++|+|++..|..+.....+..+.+++|.+.+
T Consensus 112 l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~ 191 (284)
T d1ozna_ 112 LDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAH 191 (284)
T ss_dssp CTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCE
T ss_pred cCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccc
Confidence 56788886677778889999999999999996556788899999999999999998878777777888889999999887
Q ss_pred CCCc
Q 002857 81 GIPE 84 (873)
Q Consensus 81 ~~p~ 84 (873)
..+.
T Consensus 192 i~~~ 195 (284)
T d1ozna_ 192 VHPH 195 (284)
T ss_dssp ECTT
T ss_pred cChh
Confidence 6543
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.13 E-value=1.4e-06 Score=89.61 Aligned_cols=78 Identities=23% Similarity=0.111 Sum_probs=40.7
Q ss_pred CCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccC
Q 002857 2 HGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLC 79 (873)
Q Consensus 2 s~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~ 79 (873)
++|.+.+..+..+..+.+|+.|++++|.|++..+..+..+++|+.|+|++|+|++..+..+.....+..+++++|.|.
T Consensus 108 ~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~ 185 (266)
T d1p9ag_ 108 SFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY 185 (266)
T ss_dssp CSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred cccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCc
Confidence 445555444444555555555555555555333344455555555555555555544444444455555555555555
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=97.96 E-value=3.4e-06 Score=87.94 Aligned_cols=80 Identities=25% Similarity=0.214 Sum_probs=67.7
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCG 80 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G 80 (873)
|++|.+++.+|..|..++.++.|++++|.+++..|..+.++++|++|+|++|+|+ .+|..+.....++.+.+++|+|..
T Consensus 178 l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~ 256 (305)
T d1xkua_ 178 LDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISA 256 (305)
T ss_dssp CTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCC
T ss_pred CCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccccccccCCCEEECCCCccCc
Confidence 4678888888888999999999999999999777788889999999999999998 567777777888888899888875
Q ss_pred C
Q 002857 81 G 81 (873)
Q Consensus 81 ~ 81 (873)
.
T Consensus 257 i 257 (305)
T d1xkua_ 257 I 257 (305)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=97.89 E-value=5e-06 Score=86.63 Aligned_cols=77 Identities=22% Similarity=0.149 Sum_probs=46.7
Q ss_pred CCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCCC
Q 002857 2 HGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCGG 81 (873)
Q Consensus 2 s~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G~ 81 (873)
++|.++ .+|..+ +++|+.|+|++|.+++.+|..|..++.+++|++++|.+++..+..+.....+..+.+++|.|...
T Consensus 158 ~~n~l~-~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~~l 234 (305)
T d1xkua_ 158 ADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKV 234 (305)
T ss_dssp CSSCCC-SCCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSSC
T ss_pred ccCCcc-ccCccc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccccc
Confidence 345554 355443 45666666666666666666666666666666666666665555555555666666666666543
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.86 E-value=5.1e-06 Score=79.47 Aligned_cols=76 Identities=18% Similarity=0.178 Sum_probs=61.9
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccc-cccCCCCcceecccCCCccCCCCc--ccccccCcccccccccc
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPE-FLAGFKFLQNLNLSHNNFESMIPT--EGIFKNASATSVFGNNK 77 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~-~l~~L~~L~~L~LS~N~Lsg~iP~--~~~~~~~l~~~~l~nN~ 77 (873)
|++|.|+ .++ .|..|++|++|+|++|+|+ .+|+ .+..+++|+.|+|++|+|+. ++. .+.....+..+.+.+|.
T Consensus 48 Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~-~l~~~~~~~l~~L~~L~L~~N~i~~-~~~l~~l~~l~~L~~L~l~~N~ 123 (162)
T d1a9na_ 48 FSDNEIR-KLD-GFPLLRRLKTLLVNNNRIC-RIGEGLDQALPDLTELILTNNSLVE-LGDLDPLASLKSLTYLCILRNP 123 (162)
T ss_dssp CCSSCCC-EEC-CCCCCSSCCEEECCSSCCC-EECSCHHHHCTTCCEEECCSCCCCC-GGGGGGGGGCTTCCEEECCSSG
T ss_pred CCCCCCC-ccC-CcccCcchhhhhccccccc-CCCccccccccccccceeccccccc-cccccccccccccchhhcCCCc
Confidence 6899999 675 5999999999999999999 5654 56789999999999999984 443 34456778888899987
Q ss_pred cCC
Q 002857 78 LCG 80 (873)
Q Consensus 78 L~G 80 (873)
++.
T Consensus 124 i~~ 126 (162)
T d1a9na_ 124 VTN 126 (162)
T ss_dssp GGG
T ss_pred ccc
Confidence 763
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=97.85 E-value=5.3e-06 Score=88.36 Aligned_cols=75 Identities=23% Similarity=0.208 Sum_probs=54.5
Q ss_pred CCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCCC
Q 002857 2 HGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCGG 81 (873)
Q Consensus 2 s~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G~ 81 (873)
+.|++++ +..+..+++|+.|+|++|+|++ ++ .+..+++|+.|+|++|+|++ +| .+.....++.+++++|.|++.
T Consensus 293 ~~n~l~~--~~~~~~~~~l~~L~ls~n~l~~-l~-~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l 366 (384)
T d2omza2 293 NENQLED--ISPISNLKNLTYLTLYFNNISD-IS-PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDL 366 (384)
T ss_dssp CSSCCSC--CGGGGGCTTCSEEECCSSCCSC-CG-GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBC
T ss_pred ccccccc--ccccchhcccCeEECCCCCCCC-Cc-ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCC
Confidence 4566664 3347778888888888888885 43 27788888888888888884 44 355567778888888888765
Q ss_pred C
Q 002857 82 I 82 (873)
Q Consensus 82 ~ 82 (873)
+
T Consensus 367 ~ 367 (384)
T d2omza2 367 T 367 (384)
T ss_dssp G
T ss_pred h
Confidence 4
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.74 E-value=4.2e-05 Score=77.04 Aligned_cols=76 Identities=16% Similarity=0.081 Sum_probs=51.1
Q ss_pred eecccC-ceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhcc--ceeeeeeeecccccCCceEEEEEee
Q 002857 167 LIGAGN-FASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRK--IIKVVTACSRVDYQGNDFKALVYEF 243 (873)
Q Consensus 167 ~LG~G~-fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpN--IV~llg~c~~~~~~~~~~~~LV~Ey 243 (873)
.+..|. .+.||+... .++..+++|..... ....+..|+..|+.+.... +.+++.+. .+++..++||+|
T Consensus 17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~---~~~~l~~E~~~l~~L~~~gvpvP~v~~~~-----~~~~~~~~v~~~ 87 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVV-----TEAGRDWLLLGE 87 (255)
T ss_dssp ECSCTTSSCEEEEEEC-TTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEE-----ECSSCEEEEEEC
T ss_pred EcCCcccCCeEEEEEe-CCCCEEEEEeCCcc---CHhHHHHHHHHHHHHHhcCCCCCceeeec-----ccccceEEEEEe
Confidence 445554 368999865 55667888986533 3346788999998885433 45566653 334568999999
Q ss_pred cCCCChhh
Q 002857 244 MPNGSLEE 251 (873)
Q Consensus 244 ~~~GSL~~ 251 (873)
++|.++.+
T Consensus 88 i~G~~~~~ 95 (255)
T d1nd4a_ 88 VPGQDLLS 95 (255)
T ss_dssp CSSEETTT
T ss_pred eecccccc
Confidence 98876644
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.73 E-value=2.5e-05 Score=79.98 Aligned_cols=83 Identities=25% Similarity=0.207 Sum_probs=65.7
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCG 80 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G 80 (873)
|++|+|+ .+|..+..+++|+.|+|++|.+.+..+..+..+.+|+.|++++|.++...+..+.....+..+.+++|+|.+
T Consensus 84 Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~ 162 (266)
T d1p9ag_ 84 LSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTE 162 (266)
T ss_dssp CCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSC
T ss_pred ccccccc-ccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccccccc
Confidence 5778887 467788888888888888888886666778888888888888888887666666667777888888888887
Q ss_pred CCCc
Q 002857 81 GIPE 84 (873)
Q Consensus 81 ~~p~ 84 (873)
.++.
T Consensus 163 ~~~~ 166 (266)
T d1p9ag_ 163 LPAG 166 (266)
T ss_dssp CCTT
T ss_pred cCcc
Confidence 6543
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=97.55 E-value=3.1e-05 Score=77.19 Aligned_cols=74 Identities=19% Similarity=0.144 Sum_probs=51.8
Q ss_pred CCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCCC
Q 002857 2 HGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCGG 81 (873)
Q Consensus 2 s~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G~ 81 (873)
+++.+... ..+...++|+.|++++|.+++. + .++++++|+.|+|++|+|++ +|. +..+..+..+++++|+++..
T Consensus 137 ~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~-~-~l~~l~~L~~L~Ls~n~l~~-l~~-l~~l~~L~~L~Ls~N~lt~i 210 (227)
T d1h6ua2 137 DLNQITNI--SPLAGLTNLQYLSIGNAQVSDL-T-PLANLSKLTTLKADDNKISD-ISP-LASLPNLIEVHLKNNQISDV 210 (227)
T ss_dssp CSSCCCCC--GGGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCC-CGG-GGGCTTCCEEECTTSCCCBC
T ss_pred hhhhhchh--hhhccccccccccccccccccc-h-hhcccccceecccCCCccCC-Chh-hcCCCCCCEEECcCCcCCCC
Confidence 34445432 2367778888888888888743 3 37888888888888888885 343 44556778888888887753
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=97.42 E-value=7e-05 Score=79.36 Aligned_cols=75 Identities=17% Similarity=0.194 Sum_probs=52.7
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCG 80 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G 80 (873)
|++|.++ .+ ..|..|++|++|+|++|+|+ .+|+ |++|++|++|+|++|++++..| +.....+..+.+.++.+++
T Consensus 51 l~~~~I~-~l-~gl~~L~nL~~L~Ls~N~l~-~l~~-l~~L~~L~~L~L~~n~i~~i~~--l~~l~~L~~L~~~~~~~~~ 124 (384)
T d2omza2 51 ADRLGIK-SI-DGVEYLNNLTQINFSNNQLT-DITP-LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITD 124 (384)
T ss_dssp CCSSCCC-CC-TTGGGCTTCCEEECCSSCCC-CCGG-GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC
T ss_pred CCCCCCC-Cc-cccccCCCCCEEeCcCCcCC-CCcc-ccCCcccccccccccccccccc--ccccccccccccccccccc
Confidence 3556666 34 35777888888888888888 4553 8888888888888888876443 4455666777777777665
Q ss_pred C
Q 002857 81 G 81 (873)
Q Consensus 81 ~ 81 (873)
.
T Consensus 125 ~ 125 (384)
T d2omza2 125 I 125 (384)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=97.32 E-value=1e-05 Score=79.81 Aligned_cols=68 Identities=26% Similarity=0.345 Sum_probs=57.0
Q ss_pred cCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCC
Q 002857 10 IGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCG 80 (873)
Q Consensus 10 iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G 80 (873)
+|.+|+.|++|++|+|++|+|+ .|+ .|..|++|+.|+|++|+|+ .+|........+..+++++|.++.
T Consensus 40 l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~ 107 (198)
T d1m9la_ 40 MDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS 107 (198)
T ss_dssp CHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC
T ss_pred hhhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-cccccccccccccccccccccccc
Confidence 3457888999999999999999 776 5999999999999999998 567655555677888899998874
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.30 E-value=0.00038 Score=75.44 Aligned_cols=77 Identities=18% Similarity=0.094 Sum_probs=49.4
Q ss_pred ceeecccCceEEEEEEEcCCCcEEEEEEeec----c---CCcchhHHHHHHHHHHhhh-h--ccceeeeeeeecccccCC
Q 002857 165 ENLIGAGNFASVYKGILFEGAPAVAIKVFNF----L---HHDASKSFTVECEVMRNII-H--RKIIKVVTACSRVDYQGN 234 (873)
Q Consensus 165 ~~~LG~G~fG~VYkg~~~~~g~~VAVK~l~~----~---~~~~~~~f~~Ei~iL~~L~-H--pNIV~llg~c~~~~~~~~ 234 (873)
.+.||.|....||+.....+++.|+||.-.. . ......+...|++.|+.+. + ..+.+++.+. .
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d-------~ 103 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD-------T 103 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE-------T
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc-------C
Confidence 4578999999999998777788899997431 1 1122345667888888773 2 4466666652 2
Q ss_pred ceEEEEEeecCCCC
Q 002857 235 DFKALVYEFMPNGS 248 (873)
Q Consensus 235 ~~~~LV~Ey~~~GS 248 (873)
...++|||++.+..
T Consensus 104 ~~~~lvmE~L~~~~ 117 (392)
T d2pula1 104 EMAVTVMEDLSHLK 117 (392)
T ss_dssp TTTEEEECCCTTSE
T ss_pred CCCEEEEeccCCcc
Confidence 23478999997654
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=97.22 E-value=5.9e-06 Score=81.62 Aligned_cols=75 Identities=27% Similarity=0.259 Sum_probs=62.8
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCG 80 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G 80 (873)
|++|+|+ .|+ .|..|++|+.|+|++|+|+ .||..+..+++|+.|+|++|+|+. ++. +.....+..+++++|.+..
T Consensus 55 Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l~~-~~~l~~L~~L~L~~N~i~~ 129 (198)
T d1m9la_ 55 LSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LSG-IEKLVNLRVLYMSNNKITN 129 (198)
T ss_dssp CSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-HHH-HHHHHHSSEEEESEEECCC
T ss_pred CcccCCC-Ccc-cccCCccccChhhcccccc-cccccccccccccccccccccccc-ccc-ccccccccccccccchhcc
Confidence 6788988 676 5999999999999999999 888777777899999999999995 443 4556778889999998874
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=97.21 E-value=0.00019 Score=70.71 Aligned_cols=61 Identities=23% Similarity=0.183 Sum_probs=30.8
Q ss_pred CCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCccccccccccc
Q 002857 14 LSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKL 78 (873)
Q Consensus 14 l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L 78 (873)
|..+++|+.|+|++|+|++ ++ .++.|++|+.|+|++|+|++ +|. +.....+..+.+.+|.+
T Consensus 64 l~~l~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~i~~-l~~-l~~l~~L~~L~l~~~~~ 124 (210)
T d1h6ta2 64 IQYLPNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDENKVKD-LSS-LKDLKKLKSLSLEHNGI 124 (210)
T ss_dssp GGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCC-GGG-GTTCTTCCEEECTTSCC
T ss_pred HhhCCCCCEEeCCCccccC-cc-ccccCccccccccccccccc-ccc-ccccccccccccccccc
Confidence 5555555555555555553 33 24555555555555555553 332 23334444455555443
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=97.14 E-value=0.0003 Score=68.52 Aligned_cols=62 Identities=19% Similarity=0.246 Sum_probs=28.6
Q ss_pred CCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccC
Q 002857 14 LSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLC 79 (873)
Q Consensus 14 l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~ 79 (873)
+..|++|++|+|++|+|++ ++. +++|++|+.|++++|.+.. ++. +.....+..+.++++.+.
T Consensus 58 l~~l~nL~~L~Ls~N~l~~-~~~-l~~l~~L~~L~l~~n~~~~-~~~-l~~l~~L~~L~l~~~~~~ 119 (199)
T d2omxa2 58 VEYLNNLTQINFSNNQLTD-ITP-LKNLTKLVDILMNNNQIAD-ITP-LANLTNLTGLTLFNNQIT 119 (199)
T ss_dssp GGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCC-CGG-GTTCTTCSEEECCSSCCC
T ss_pred cccCCCcCcCccccccccC-ccc-ccCCccccccccccccccc-ccc-cccccccccccccccccc
Confidence 4455555555555555553 222 5555555555555555542 221 223333444444444433
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=97.11 E-value=0.00032 Score=68.31 Aligned_cols=74 Identities=20% Similarity=0.232 Sum_probs=60.9
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCG 80 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G 80 (873)
|++|+|++ +++ |++|++|++|+|++|.+. .+|. +.+++.|+.|++++|.+....+ +..+..+..+.+++|.+..
T Consensus 69 Ls~N~l~~-~~~-l~~l~~L~~L~l~~n~~~-~~~~-l~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~ 142 (199)
T d2omxa2 69 FSNNQLTD-ITP-LKNLTKLVDILMNNNQIA-DITP-LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD 142 (199)
T ss_dssp CCSSCCCC-CGG-GTTCTTCCEEECCSSCCC-CCGG-GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCC
T ss_pred cccccccC-ccc-ccCCcccccccccccccc-cccc-cccccccccccccccccccccc--cchhhhhHHhhhhhhhhcc
Confidence 68899996 444 999999999999999998 6664 8999999999999999986433 3455677888899998764
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.02 E-value=3.6e-05 Score=73.22 Aligned_cols=66 Identities=24% Similarity=0.191 Sum_probs=49.1
Q ss_pred CCCCCCCeEeCCCCcCCCc--ccccccCCCCcceecccCCCccCCCCc-ccccccCcccccccccccCCC
Q 002857 15 SPLRGLKVLDLSQNNLSGE--IPEFLAGFKFLQNLNLSHNNFESMIPT-EGIFKNASATSVFGNNKLCGG 81 (873)
Q Consensus 15 ~~L~~L~~L~Ls~N~LsG~--iP~~l~~L~~L~~L~LS~N~Lsg~iP~-~~~~~~~l~~~~l~nN~L~G~ 81 (873)
..+++|++|+||+|+|+.. ++..+..+++|+.|+||+|.++. ++. .......+..+.+.+|.++..
T Consensus 62 ~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~-l~~l~~l~~~~L~~L~L~~Npl~~~ 130 (162)
T d1koha1 62 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKS-ERELDKIKGLKLEELWLDGNSLSDT 130 (162)
T ss_dssp HHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCC-GGGHHHHTTCCCSSCCCTTSTTSSS
T ss_pred HhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCcccc-chhhhhhhccccceeecCCCCcCcC
Confidence 4688999999999999842 34567789999999999999994 443 222223456778888888754
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=96.97 E-value=0.0006 Score=66.96 Aligned_cols=74 Identities=28% Similarity=0.421 Sum_probs=60.0
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCG 80 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G 80 (873)
|++|+|++ ++ .++.|++|++|+|++|+|+ .+| .+..+++|+.|++++|.++. ++ .+.....+..+.++.|.+.+
T Consensus 75 L~~n~i~~-l~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~~~~~~-~~-~l~~l~~l~~l~~~~n~l~~ 148 (210)
T d1h6ta2 75 LNGNKLTD-IK-PLANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSLEHNGISD-IN-GLVHLPQLESLYLGNNKITD 148 (210)
T ss_dssp CCSSCCCC-CG-GGTTCTTCCEEECCSSCCC-CGG-GGTTCTTCCEEECTTSCCCC-CG-GGGGCTTCCEEECCSSCCCC
T ss_pred CCCccccC-cc-ccccCcccccccccccccc-ccc-cccccccccccccccccccc-cc-cccccccccccccccccccc
Confidence 67899995 55 3789999999999999999 577 58999999999999999974 33 34455666777788887764
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=96.97 E-value=0.0004 Score=68.76 Aligned_cols=69 Identities=20% Similarity=0.243 Sum_probs=48.3
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccc
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGN 75 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~n 75 (873)
+++|.+++. + .|+++++|+.|+|++|+|+ .+|. ++++++|+.|+|++|+|++..| +.....+..+.++|
T Consensus 158 l~~n~~~~~-~-~l~~l~~L~~L~Ls~n~l~-~l~~-l~~l~~L~~L~Ls~N~lt~i~~--l~~l~~L~~L~lsn 226 (227)
T d1h6ua2 158 IGNAQVSDL-T-PLANLSKLTTLKADDNKIS-DISP-LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226 (227)
T ss_dssp CCSSCCCCC-G-GGTTCTTCCEEECCSSCCC-CCGG-GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEE
T ss_pred ccccccccc-h-hhcccccceecccCCCccC-CChh-hcCCCCCCEEECcCCcCCCCcc--cccCCCCCEEEeeC
Confidence 356666632 2 3788888888888888888 4554 7888888888888888885433 44555566655543
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=96.96 E-value=0.00053 Score=71.01 Aligned_cols=69 Identities=22% Similarity=0.175 Sum_probs=53.0
Q ss_pred CCCCccccCcCcCCCCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCC
Q 002857 1 MHGNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCG 80 (873)
Q Consensus 1 Ls~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G 80 (873)
|++|.|+ .+|+. +++|++|+|++|+|+ .||..+ .+|+.|++++|+++ .++.. ...+..+++++|.+..
T Consensus 45 Ls~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L~~n~l~~ 112 (353)
T d1jl5a_ 45 LNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDL---PPLLEYLGVSNNQLEK 112 (353)
T ss_dssp CTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSC---CTTCCEEECCSSCCSS
T ss_pred eCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhh---cccccccccccccccc
Confidence 6788988 68964 578999999999999 899765 46788888888888 44432 2456778888888875
Q ss_pred C
Q 002857 81 G 81 (873)
Q Consensus 81 ~ 81 (873)
.
T Consensus 113 l 113 (353)
T d1jl5a_ 113 L 113 (353)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.88 E-value=0.00026 Score=70.47 Aligned_cols=74 Identities=19% Similarity=0.130 Sum_probs=52.4
Q ss_pred CCccccCcCcCCCCCCCCCeEeCCCCcCCCcccc-cccCCCCcceecccCCCccCCCCcc-cccccCccccc-ccccccC
Q 002857 3 GNLFEGPIGLSLSPLRGLKVLDLSQNNLSGEIPE-FLAGFKFLQNLNLSHNNFESMIPTE-GIFKNASATSV-FGNNKLC 79 (873)
Q Consensus 3 ~N~L~G~iP~~l~~L~~L~~L~Ls~N~LsG~iP~-~l~~L~~L~~L~LS~N~Lsg~iP~~-~~~~~~l~~~~-l~nN~L~ 79 (873)
++.|+ .+|..+. +++++|+|++|+|+ .||. .|.++++|++|+|++|.+...+|.. +.....+..+. ...|.+.
T Consensus 17 ~~~l~-~iP~~l~--~~l~~L~Ls~n~i~-~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~ 92 (242)
T d1xwdc1 17 ESKVT-EIPSDLP--RNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLL 92 (242)
T ss_dssp SCSCS-SCCSCSC--SCCSEEEEESCCCC-EECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCC
T ss_pred CCCCC-CcCCCCC--CCCCEEECcCCcCC-ccChhHhhccchhhhhhhccccccceeecccccccccccccccccccccc
Confidence 45677 7888764 58999999999998 6665 6899999999999999998766543 33334444333 3445554
Q ss_pred C
Q 002857 80 G 80 (873)
Q Consensus 80 G 80 (873)
.
T Consensus 93 ~ 93 (242)
T d1xwdc1 93 Y 93 (242)
T ss_dssp E
T ss_pred c
Confidence 3
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.72 E-value=0.0023 Score=66.98 Aligned_cols=147 Identities=14% Similarity=0.068 Sum_probs=81.0
Q ss_pred ceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccc--eeeeeeeecccccCCceEEEEEeecCCCChh
Q 002857 173 FASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKI--IKVVTACSRVDYQGNDFKALVYEFMPNGSLE 250 (873)
Q Consensus 173 fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNI--V~llg~c~~~~~~~~~~~~LV~Ey~~~GSL~ 250 (873)
--.||+++. .+|+.+++|+.+... ...+++..|+..+..|....+ +..+.......+...+..+.|+++++|..+.
T Consensus 35 EN~vy~v~~-~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~ 112 (325)
T d1zyla1 35 ENRVYQFQD-EDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFE 112 (325)
T ss_dssp SSEEEEECC-TTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECC
T ss_pred cceeEEEEc-CCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCC
Confidence 358999976 567889999987442 244678899999999864432 2222221111223456788999999875332
Q ss_pred hh-----------c---ccccccccccCCCC-------------------CCchhhhHHHHHHHHHHHHHHh----hCCC
Q 002857 251 EW-----------I---HPITEEDKRHKAPG-------------------NLNSLERLNIAIDVASALEYLH----LGCK 293 (873)
Q Consensus 251 ~~-----------L---~~~~~~~~~~~~~~-------------------~Ls~~~~l~Ia~qIa~gL~yLH----~~~s 293 (873)
.. | |.... ........ .++...+..+...+.+.++.+. ....
T Consensus 113 ~~~~~~~~~lG~~LA~lH~~~~-~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p 191 (325)
T d1zyla1 113 ADNIDQMEAVGRYLGRMHQTGR-KQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFT 191 (325)
T ss_dssp SSCHHHHHHHHHHHHHHHHHHT-SSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSC
T ss_pred CCCHHHHHHHHHHHHHHHhhcc-cCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCC
Confidence 10 0 00000 00000011 1111112122222223333332 2235
Q ss_pred CCeeeccCCCCCeeeCCCCCeEEeccccccc
Q 002857 294 PPIAHCDIKPSNILLNDEMTACVADFGIARF 324 (873)
Q Consensus 294 ~gIvHrDLKpsNILLd~~~~vKLsDFGla~~ 324 (873)
.++||+|+.+.|||++++ ..++||+-+..
T Consensus 192 ~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 192 VLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ceeecCCCCcccEEEeCC--ceEEechhccc
Confidence 679999999999999754 45899998863
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=96.41 E-value=0.0016 Score=67.13 Aligned_cols=58 Identities=24% Similarity=0.237 Sum_probs=48.2
Q ss_pred CCCCCCCeEeCCCCcCCCcccccccCCCCcceecccCCCccCCCCcccccccCcccccccccccCC
Q 002857 15 SPLRGLKVLDLSQNNLSGEIPEFLAGFKFLQNLNLSHNNFESMIPTEGIFKNASATSVFGNNKLCG 80 (873)
Q Consensus 15 ~~L~~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~G 80 (873)
..+++|++|+|++|+|+ .||.. +++|+.|+|++|+|+ .+|.. ...+..+++++|.|..
T Consensus 281 ~~~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~~ 338 (353)
T d1jl5a_ 281 DLPPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLRE 338 (353)
T ss_dssp CCCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCSS
T ss_pred ccCCCCCEEECCCCccC-ccccc---cCCCCEEECCCCcCC-ccccc---cCCCCEEECcCCcCCC
Confidence 44689999999999999 89964 578999999999999 67764 3457788999999884
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.30 E-value=0.014 Score=62.40 Aligned_cols=75 Identities=17% Similarity=0.224 Sum_probs=51.8
Q ss_pred ceeecccCceEEEEEEEcC-------CCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccce-eeeeeeecccccCCce
Q 002857 165 ENLIGAGNFASVYKGILFE-------GAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKII-KVVTACSRVDYQGNDF 236 (873)
Q Consensus 165 ~~~LG~G~fG~VYkg~~~~-------~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV-~llg~c~~~~~~~~~~ 236 (873)
.+.|+.|-.-.+|+..... ..+.|++++... ........+|..+++.+.-.++. ++++++. +
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~--~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~------~-- 116 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN--PETESHLVAESVIFTLLSERHLGPKLYGIFS------G-- 116 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS--CCCHHHHHHHHHHHHHHHHTTSSSCEEEEET------T--
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC--cchhhHHHHHHHHHHHHHhCCCCCeEEEEcC------C--
Confidence 3678889899999998643 245688888752 22334567899999988644554 6777642 1
Q ss_pred EEEEEeecCCCChh
Q 002857 237 KALVYEFMPNGSLE 250 (873)
Q Consensus 237 ~~LV~Ey~~~GSL~ 250 (873)
.+|+||+++.+|.
T Consensus 117 -g~I~efi~g~~l~ 129 (395)
T d1nw1a_ 117 -GRLEEYIPSRPLS 129 (395)
T ss_dssp -EEEECCCCEEECC
T ss_pred -ceEEEEeccccCC
Confidence 5899999875443
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.23 E-value=0.0008 Score=63.53 Aligned_cols=60 Identities=22% Similarity=0.166 Sum_probs=47.5
Q ss_pred CCCCccccC--cCcCCCCCCCCCeEeCCCCcCCCcccc-cccCCCCcceecccCCCccCCCCcc
Q 002857 1 MHGNLFEGP--IGLSLSPLRGLKVLDLSQNNLSGEIPE-FLAGFKFLQNLNLSHNNFESMIPTE 61 (873)
Q Consensus 1 Ls~N~L~G~--iP~~l~~L~~L~~L~Ls~N~LsG~iP~-~l~~L~~L~~L~LS~N~Lsg~iP~~ 61 (873)
|++|+|+.. ++..+..+++|+.|+|++|.++ .+++ ......+|+.|+|++|.++......
T Consensus 72 Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~-~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~ 134 (162)
T d1koha1 72 LSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK-SERELDKIKGLKLEELWLDGNSLSDTFRDQ 134 (162)
T ss_dssp CCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCC-CGGGHHHHTTCCCSSCCCTTSTTSSSSSSH
T ss_pred CCCccccCCchhHHHHhhCCcccccccccCccc-cchhhhhhhccccceeecCCCCcCcCcccc
Confidence 689999842 3455778999999999999999 6665 3344557999999999999766543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.88 E-value=0.028 Score=57.73 Aligned_cols=170 Identities=10% Similarity=0.025 Sum_probs=89.1
Q ss_pred cCHHHHHHhhcCCCccee-----ecccCceEEEEEEEcCCCcEEEEEEeeccCCcchhHHHHHHHHHHhhhhccce--ee
Q 002857 150 VSYEALYSATKGFSSENL-----IGAGNFASVYKGILFEGAPAVAIKVFNFLHHDASKSFTVECEVMRNIIHRKII--KV 222 (873)
Q Consensus 150 ~s~~el~~at~~f~~~~~-----LG~G~fG~VYkg~~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV--~l 222 (873)
++.+++.....+|.+.+. |..|---+.|+.+.. ++ .+++|++... ...+++..|++++..|.+.++. ..
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~-~g-~yVLri~~~~--~~~~~l~~~~~~l~~L~~~g~pvp~p 78 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLP 78 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEES-SC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEEC-CC-cEEEEEcCCC--CCHHHHHHHHHHHHhhhhcccccccc
Confidence 567888888888977544 345666788998763 34 5899998632 2335667788888888643322 11
Q ss_pred eeeee-cccccCCceEEEEEeecCCCChhhhcc--------------ccccc-ccccCCCC----------------CCc
Q 002857 223 VTACS-RVDYQGNDFKALVYEFMPNGSLEEWIH--------------PITEE-DKRHKAPG----------------NLN 270 (873)
Q Consensus 223 lg~c~-~~~~~~~~~~~LV~Ey~~~GSL~~~L~--------------~~~~~-~~~~~~~~----------------~Ls 270 (873)
+.... .....-......++.++.+......-. ..... ........ ...
T Consensus 79 i~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (316)
T d2ppqa1 79 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 158 (316)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred ceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhc
Confidence 11100 000111334567777776643321110 00000 00000000 001
Q ss_pred hhhhHHHHHHHHHHHHHHhh-CCCCCeeeccCCCCCeeeCCCCCeEEecccccc
Q 002857 271 SLERLNIAIDVASALEYLHL-GCKPPIAHCDIKPSNILLNDEMTACVADFGIAR 323 (873)
Q Consensus 271 ~~~~l~Ia~qIa~gL~yLH~-~~s~gIvHrDLKpsNILLd~~~~vKLsDFGla~ 323 (873)
.......+..+...+.-.+. ....++||+|+.+.||+++.+...-|.||+.+.
T Consensus 159 ~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 159 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred chhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 11122223333333333331 235789999999999999988877899999885
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.83 E-value=0.0028 Score=62.62 Aligned_cols=60 Identities=17% Similarity=0.078 Sum_probs=24.1
Q ss_pred CCCeEeCCCCcCCCcccccccCCCCccee-cccCCCccCCCCcccccccCcccccccccccC
Q 002857 19 GLKVLDLSQNNLSGEIPEFLAGFKFLQNL-NLSHNNFESMIPTEGIFKNASATSVFGNNKLC 79 (873)
Q Consensus 19 ~L~~L~Ls~N~LsG~iP~~l~~L~~L~~L-~LS~N~Lsg~iP~~~~~~~~l~~~~l~nN~L~ 79 (873)
.++.|++++|+++ .++..+.++.+++.+ ++++|+|+...+..+.....+..+++++|.|.
T Consensus 154 ~l~~L~l~~n~l~-~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~ 214 (242)
T d1xwdc1 154 ESVILWLNKNGIQ-EIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH 214 (242)
T ss_dssp SCEEEECCSSCCC-EECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCC
T ss_pred cceeeeccccccc-ccccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCC
Confidence 4444444444444 333333333333222 33444444222222333344444444444444
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=93.98 E-value=0.0038 Score=66.47 Aligned_cols=41 Identities=27% Similarity=0.305 Sum_probs=21.9
Q ss_pred CCCCCCCeEeCCCCcCCC----cccccccCCCCcceecccCCCcc
Q 002857 15 SPLRGLKVLDLSQNNLSG----EIPEFLAGFKFLQNLNLSHNNFE 55 (873)
Q Consensus 15 ~~L~~L~~L~Ls~N~LsG----~iP~~l~~L~~L~~L~LS~N~Ls 55 (873)
..+++|+.|+|++|.|+- .|+..|..+++|+.|||++|+|+
T Consensus 24 ~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~ 68 (460)
T d1z7xw1 24 PLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELG 68 (460)
T ss_dssp HHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCH
T ss_pred HhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCC
Confidence 334555566666665551 23444555555666666665554
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=93.68 E-value=0.0042 Score=66.11 Aligned_cols=65 Identities=20% Similarity=0.124 Sum_probs=44.3
Q ss_pred CCCCCCCeEeCCCCcCCCc----cccccc-CCCCcceecccCCCccCC----CCcccccccCcccccccccccC
Q 002857 15 SPLRGLKVLDLSQNNLSGE----IPEFLA-GFKFLQNLNLSHNNFESM----IPTEGIFKNASATSVFGNNKLC 79 (873)
Q Consensus 15 ~~L~~L~~L~Ls~N~LsG~----iP~~l~-~L~~L~~L~LS~N~Lsg~----iP~~~~~~~~l~~~~l~nN~L~ 79 (873)
...++|+.|+|++|+|+.. ++..+. ..+.|++|+|++|+|+.. ++..+.....+..+++++|.+.
T Consensus 337 ~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~ 410 (460)
T d1z7xw1 337 AQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG 410 (460)
T ss_dssp HHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCC
T ss_pred ccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCC
Confidence 4456888889988888643 455554 356788889988888742 3333333466778888888775
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=93.16 E-value=0.0087 Score=62.40 Aligned_cols=71 Identities=20% Similarity=0.147 Sum_probs=46.3
Q ss_pred cCcCCCCCCCCCeEeCCCCcCCCc-----ccccccCCCCcceecccCCCccCC----CCcccccccCcccccccccccCC
Q 002857 10 IGLSLSPLRGLKVLDLSQNNLSGE-----IPEFLAGFKFLQNLNLSHNNFESM----IPTEGIFKNASATSVFGNNKLCG 80 (873)
Q Consensus 10 iP~~l~~L~~L~~L~Ls~N~LsG~-----iP~~l~~L~~L~~L~LS~N~Lsg~----iP~~~~~~~~l~~~~l~nN~L~G 80 (873)
+...+...++|+.|+|++|+++.. +...+..+++|+.|+|++|.|+.. +...+.....+..+.+++|.+.+
T Consensus 178 l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~ 257 (344)
T d2ca6a1 178 WAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSA 257 (344)
T ss_dssp HHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCH
T ss_pred ccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCc
Confidence 333455677888888888887632 344567778888888888887632 22233344556677788877653
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=91.77 E-value=0.066 Score=54.22 Aligned_cols=62 Identities=21% Similarity=0.049 Sum_probs=42.1
Q ss_pred CCCCCCCeEeCCCC-cCCCcccccccCCCCcceecccC-CCccCCCCcccccccCccccccccc
Q 002857 15 SPLRGLKVLDLSQN-NLSGEIPEFLAGFKFLQNLNLSH-NNFESMIPTEGIFKNASATSVFGNN 76 (873)
Q Consensus 15 ~~L~~L~~L~Ls~N-~LsG~iP~~l~~L~~L~~L~LS~-N~Lsg~iP~~~~~~~~l~~~~l~nN 76 (873)
.++++|++|+|++| .+++..+..++++++|++|+|++ ++++......+.....+..+.+.++
T Consensus 172 ~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 172 RRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp HHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred cccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence 45778888888774 57777777888888888888888 4566544444444455556655544
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=90.42 E-value=0.11 Score=52.57 Aligned_cols=62 Identities=18% Similarity=0.132 Sum_probs=39.7
Q ss_pred CCCCeEeCCCC--cCCCc-ccccccCCCCcceecccCC-CccCCCCcccccccCcccccccc-cccC
Q 002857 18 RGLKVLDLSQN--NLSGE-IPEFLAGFKFLQNLNLSHN-NFESMIPTEGIFKNASATSVFGN-NKLC 79 (873)
Q Consensus 18 ~~L~~L~Ls~N--~LsG~-iP~~l~~L~~L~~L~LS~N-~Lsg~iP~~~~~~~~l~~~~l~n-N~L~ 79 (873)
++|+.|+|++. .++.. +...+.++++|+.|+|++| .+++.....+...+.++.+.+++ +.++
T Consensus 148 ~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~ 214 (284)
T d2astb2 148 ETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDII 214 (284)
T ss_dssp TTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCC
T ss_pred cccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCC
Confidence 67888888753 45432 4444456788888888875 46665555555566677777776 3443
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=90.25 E-value=0.021 Score=59.36 Aligned_cols=64 Identities=11% Similarity=0.163 Sum_probs=41.5
Q ss_pred CCCCCCeEeCCCCcCCC----cccccccCCCCcceecccCCCccCC-----CCcccccccCcccccccccccC
Q 002857 16 PLRGLKVLDLSQNNLSG----EIPEFLAGFKFLQNLNLSHNNFESM-----IPTEGIFKNASATSVFGNNKLC 79 (873)
Q Consensus 16 ~L~~L~~L~Ls~N~LsG----~iP~~l~~L~~L~~L~LS~N~Lsg~-----iP~~~~~~~~l~~~~l~nN~L~ 79 (873)
....|+.|++++|+++- .+...+..++.|+.|+|++|.++.. +...+.....+..+.+++|.+.
T Consensus 156 ~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~ 228 (344)
T d2ca6a1 156 NAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFT 228 (344)
T ss_dssp TCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCH
T ss_pred cCcccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhccccccccccc
Confidence 45678888888888762 2444566778888888888887631 2222334455666777777653
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=84.00 E-value=0.16 Score=47.24 Aligned_cols=63 Identities=14% Similarity=0.087 Sum_probs=30.9
Q ss_pred CCCCCeEeCCCC-cCCCc----ccccccCCCCcceecccCCCccCC----CCcccccccCcccccccccccC
Q 002857 17 LRGLKVLDLSQN-NLSGE----IPEFLAGFKFLQNLNLSHNNFESM----IPTEGIFKNASATSVFGNNKLC 79 (873)
Q Consensus 17 L~~L~~L~Ls~N-~LsG~----iP~~l~~L~~L~~L~LS~N~Lsg~----iP~~~~~~~~l~~~~l~nN~L~ 79 (873)
.++|+.|+|+++ .++.. +-..|...+.|+.|+|++|.|... +...+.....+..+.+++|.+.
T Consensus 14 ~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~ 85 (167)
T d1pgva_ 14 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLT 85 (167)
T ss_dssp CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCC
T ss_pred CCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcc
Confidence 456666666653 34321 223455556666666666666521 1111222344555566666554
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=81.02 E-value=0.34 Score=44.82 Aligned_cols=67 Identities=12% Similarity=0.155 Sum_probs=47.1
Q ss_pred CCCCCCCCCeEeCCCCcCCC----cccccccCCCCcceecccCCCccCCCCc----ccccccCcccccccccccC
Q 002857 13 SLSPLRGLKVLDLSQNNLSG----EIPEFLAGFKFLQNLNLSHNNFESMIPT----EGIFKNASATSVFGNNKLC 79 (873)
Q Consensus 13 ~l~~L~~L~~L~Ls~N~LsG----~iP~~l~~L~~L~~L~LS~N~Lsg~iP~----~~~~~~~l~~~~l~nN~L~ 79 (873)
.+...++|+.|+|++|.|+. .+...|...+.|+.|+|++|.|+..--. .+.....+..+.+.+|.++
T Consensus 39 ~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~ 113 (167)
T d1pgva_ 39 AACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQS 113 (167)
T ss_dssp HHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSC
T ss_pred HHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCC
Confidence 45677899999999999973 2334566789999999999999842111 1223345667778777654
|